Citrus Sinensis ID: 002738
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 886 | 2.2.26 [Sep-21-2011] | |||||||
| Q54R82 | 942 | Mitogen-activated protein | no | no | 0.252 | 0.237 | 0.277 | 2e-19 | |
| Q39008 | 608 | Mitogen-activated protein | no | no | 0.278 | 0.406 | 0.314 | 8e-18 | |
| Q55A09 | 1331 | Probable serine/threonine | no | no | 0.241 | 0.160 | 0.299 | 8e-18 | |
| Q9NQU5 | 681 | Serine/threonine-protein | yes | no | 0.231 | 0.301 | 0.269 | 1e-17 | |
| Q5R8Z4 | 681 | Serine/threonine-protein | yes | no | 0.231 | 0.301 | 0.269 | 1e-17 | |
| Q8BTW9 | 593 | Serine/threonine-protein | yes | no | 0.197 | 0.295 | 0.300 | 1e-17 | |
| P38692 | 1080 | Serine/threonine-protein | yes | no | 0.231 | 0.189 | 0.307 | 2e-17 | |
| Q54XJ4 | 1495 | Probable serine/threonine | no | no | 0.181 | 0.107 | 0.330 | 2e-17 | |
| Q3ULB5 | 682 | Serine/threonine-protein | no | no | 0.196 | 0.255 | 0.293 | 2e-17 | |
| Q55EC7 | 960 | RasGEF domain-containing | no | no | 0.225 | 0.208 | 0.336 | 2e-17 |
| >sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 98.6 bits (244), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 81/292 (27%), Positives = 128/292 (43%), Gaps = 68/292 (23%)
Query: 581 VRTLKVCGSSAD-EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHH 639
V+ L++ ++D +++N S E+ ++ +LRH IV G + +L
Sbjct: 198 VKQLEIVDINSDPKLKNMILSFSKEIEVMRSLRHDNIVRYLGTSLDQSFL---------- 247
Query: 640 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 699
++F+EY+ GGS+ + + K E + V + + L LH+ I+HRDI
Sbjct: 248 ----SVFLEYIPGGSISSLLGKFGAFSENVIKV-----YTKQILQGLSFLHANSIIHRDI 298
Query: 700 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV-GTPRWMA 758
K NILID K +VKL DF C + GI + + GTP WMA
Sbjct: 299 KGANILIDT-------KGIVKLSDFG-----------CSKSFSGIVSQFKSMQGTPYWMA 340
Query: 759 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL 818
PEV+ K +G DIWS GC+++E+ T Q P+ ++EL
Sbjct: 341 PEVI----KQTGHGRSSDIWSLGCVIVEMATAQPPWSNITEL------------------ 378
Query: 819 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 870
+ + +A S S P + + +F D C + +P ERP A L
Sbjct: 379 ----AAVMYHIASSNSIPNIP-SHMSQEAF--DFLNLCFKRDPKERPDANQL 423
|
Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5 |
| >sp|Q39008|M3K1_ARATH Mitogen-activated protein kinase kinase kinase 1 OS=Arabidopsis thaliana GN=MEKK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 93.2 bits (230), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 101/321 (31%), Positives = 139/321 (43%), Gaps = 74/321 (23%)
Query: 560 GKSVSSSLFRCKFGSADA-AAKVRTLKVCGSSADE-IRNFEYSCLGEVRMLGALRHSCIV 617
G+ S++ G D A K +L GS A E I+ E GE+++L L+H IV
Sbjct: 340 GRGSFGSVYEGISGDGDFFAVKEVSLLDQGSQAQECIQQLE----GEIKLLSQLQHQNIV 395
Query: 618 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALF 677
G + DG+ + IF+E V GS + KL + + SV ++L+
Sbjct: 396 RYRGT--------AKDGSNLY------IFLELVTQGS----LLKLYQRYQLRDSV-VSLY 436
Query: 678 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 737
Q + L LH K +HRDIK NIL+D A+G VKL DF A + F
Sbjct: 437 TRQ-ILDGLKYLHDKGFIHRDIKCANILVD-----ANG--AVKLADFGLA-KVSKFNDIK 487
Query: 738 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL 797
C GTP WMAPEV+ + YG DIWS GC +LE+ T Q+PY L
Sbjct: 488 S-----------CKGTPFWMAPEVINRKDS-DGYGSPADIWSLGCTVLEMCTGQIPYSDL 535
Query: 798 SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 857
++ I G P + D L L+ F++ +C
Sbjct: 536 EPVQALFRIGRGTLPEVPDTL-----------------------SLDARLFIL----KCL 568
Query: 858 EENPTERPTAGDLYEM-FVAR 877
+ NP ERPTA +L FV R
Sbjct: 569 KVNPEERPTAAELLNHPFVRR 589
|
Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates downstream MKK2, MKK4 and MKK5. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 93.2 bits (230), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 79/264 (29%), Positives = 121/264 (45%), Gaps = 50/264 (18%)
Query: 558 EAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV 617
E GK S + + + D A K + + I+ F+ EV +LG+L+H +V
Sbjct: 1078 EIGKGHFSKVLKGNWKGKDVAVKKLNSNKDKAREEMIQEFK----AEVELLGSLQHPNLV 1133
Query: 618 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKL--- 674
YG+ + NP I ME++ G++ I S+ E+ S+KL
Sbjct: 1134 TCYGYSL----------NP------MCIVMEFLPSGNLFELIH--SKPSEQQQSIKLDST 1175
Query: 675 -ALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSF 733
L IA D+A + LH+++I+HRD+KS N+L+D +K+ D A SF
Sbjct: 1176 LILAIAFDIARGMQHLHTRNIIHRDLKSSNLLMDKHFN-------IKIADLGIARE-TSF 1227
Query: 734 LHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 793
T +GT W APE+LR H+ Y + D++SY +L ELLT + P
Sbjct: 1228 TQTMT-----------TIGTVAWTAPEILR--HES--YNQKADVYSYAIVLYELLTGEEP 1272
Query: 794 YMGLSELEIHDLI-QMGKRPRLTD 816
Y G+ + L+ G RP L D
Sbjct: 1273 YQGIPPMNAGILVASKGLRPELPD 1296
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9NQU5|PAK6_HUMAN Serine/threonine-protein kinase PAK 6 OS=Homo sapiens GN=PAK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 92.8 bits (229), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 73/271 (26%), Positives = 121/271 (44%), Gaps = 66/271 (24%)
Query: 602 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 661
EV ++ +H +VEMY + + L + ME+++GG++ + + +
Sbjct: 450 FNEVVIMRDYQHFNVVEMYKSYLVGEEL--------------WVLMEFLQGGALTDIVSQ 495
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
+ E+ +V + V AL LH++ ++HRDIKS++IL+ L DG+ VKL
Sbjct: 496 VRLNEEQIATV------CEAVLQALAYLHAQGVIHRDIKSDSILLTL-----DGR--VKL 542
Query: 722 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781
DF C + +P VGTP WMAPEV+ +LY EVDIWS G
Sbjct: 543 SDFG----------FCAQISKDVPKRKSLVGTPYWMAPEVISR----SLYATEVDIWSLG 588
Query: 782 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 841
+++E++ + PY S ++ ++ P+L + H+V+
Sbjct: 589 IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN---------SHKVS----------- 628
Query: 842 ELETLSFLVDVFRRCTEENPTERPTAGDLYE 872
L D R +P ER TA +L +
Sbjct: 629 -----PVLRDFLERMLVRDPQERATAQELLD 654
|
Serine/threonine protein kinase that plays a role in the regulation of gene transcription. The kinase activity is induced by various effectors including AR or MAP2K6/MAPKK6. Phosphorylates the DNA-binding domain of androgen receptor/AR and thereby inhibits AR-mediated transcription. Inhibits also ESR1-mediated transcription. May play a role in cytoskeleton regulation by interacting with IQGAP1. May protect cells from apoptosis through phosphorylation of BAD. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5R8Z4|PAK6_PONAB Serine/threonine-protein kinase PAK 6 OS=Pongo abelii GN=PAK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 92.8 bits (229), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 73/271 (26%), Positives = 121/271 (44%), Gaps = 66/271 (24%)
Query: 602 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 661
EV ++ +H +VEMY + + L + ME+++GG++ + + +
Sbjct: 450 FNEVVIMRDYQHFNVVEMYKSYLVGEEL--------------WVLMEFLQGGALTDIVSQ 495
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
+ E+ +V + V AL LH++ ++HRDIKS++IL+ L DG+ VKL
Sbjct: 496 VRLNEEQIATV------CEAVLQALAYLHAQGVIHRDIKSDSILLTL-----DGR--VKL 542
Query: 722 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781
DF C + +P VGTP WMAPEV+ +LY EVDIWS G
Sbjct: 543 SDFG----------FCAQISKDVPKRKSLVGTPYWMAPEVISR----SLYATEVDIWSLG 588
Query: 782 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 841
+++E++ + PY S ++ ++ P+L + H+V+
Sbjct: 589 IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN---------SHKVS----------- 628
Query: 842 ELETLSFLVDVFRRCTEENPTERPTAGDLYE 872
L D R +P ER TA +L +
Sbjct: 629 -----PVLRDFLERMLVRDPQERATAQELLD 654
|
Serine/threonine protein kinase that plays a role in the regulation of gene transcription. The kinase activity is induced by various effectors including AR or MAP2K6/MAPKK6. Phosphorylates the DNA-binding domain of androgen receptor/AR and thereby inhibits AR-mediated transcription. Inhibits also ESR1-mediated transcription. May play a role in cytoskeleton regulation by interacting with IQGAP1. May protect cells from apoptosis through phosphorylation of BAD. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8BTW9|PAK4_MOUSE Serine/threonine-protein kinase PAK 4 OS=Mus musculus GN=Pak4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 92.8 bits (229), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 41/216 (18%)
Query: 601 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 660
EV ++ RH +VEMY + L + ME+++GG++ + +
Sbjct: 365 LFNEVVIMRDYRHENVVEMYNSYLVGDEL--------------WVVMEFLEGGALTDIVT 410
Query: 661 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 720
E+ +V LA V AL LH++ ++HRDIKS++IL+ DG+ VK
Sbjct: 411 HTRMNEEQIAAVCLA------VLQALAVLHAQGVIHRDIKSDSILLT-----HDGR--VK 457
Query: 721 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 780
L DF C + +P VGTP WMAPE++ + YG EVDIWS
Sbjct: 458 LSDFG----------FCAQVSKEVPRRKSLVGTPYWMAPELISRLP----YGPEVDIWSL 503
Query: 781 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 816
G +++E++ + PY L+ +I+ PRL +
Sbjct: 504 GVMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKN 539
|
Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell migration, growth, proliferation or cell survival. Activation by various effectors including growth factor receptors or active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues. Phosphorylates and inactivates the protein phosphatase SSH1, leading to increased inhibitory phosphorylation of the actin binding/depolymerizing factor cofilin. Decreased cofilin activity may lead to stabilization of actin filaments. Phosphorylates LIMK1, a kinase that also inhibits the activity of cofilin. Phosphorylates integrin beta5/ITGB5 and thus regulates cell motility. Phosphorylates ARHGEF2 and activates the downstream target RHOA that plays a role in the regulation of assembly of focal adhesions and actin stress fibers. Stimulates cell survival by phosphorylating the BCL2 antagonist of cell death BAD. Alternatively, inhibits apoptosis by preventing caspase-8 binding to death domain receptors in a kinase independent manner. Plays a role in cell-cycle progression by controlling levels of the cell-cycle regulatory protein CDKN1A and by phosphorylating RAN. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P38692|KIC1_YEAST Serine/threonine-protein kinase KIC1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=KIC1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 92.4 bits (228), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 83/270 (30%), Positives = 120/270 (44%), Gaps = 65/270 (24%)
Query: 565 SSLF-------RCKFGSADAAAKVRTLKVCG-------SSADEIRNFEYSCLGEVRMLGA 610
SSLF R KFG V+T +V S +DE+ + + E++ L +
Sbjct: 20 SSLFKRTEVIGRGKFGVVYKGYNVKTGRVYAIKVLNLDSDSDEVEDVQR----EIQFLAS 75
Query: 611 LRH-SCIVEMYGH--KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE 667
L+ S I YG K +S W I ME+ GGS+++ + + + E
Sbjct: 76 LKQISNITRYYGSYLKDTSLW----------------IIMEHCAGGSLRSLL-RPGKIDE 118
Query: 668 KHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA 727
K++ V I +++ AL +H +++HRDIK+ N+LI E VKLCDF A
Sbjct: 119 KYIGV-----IMRELLVALKCIHKDNVIHRDIKAANVLITNEGN-------VKLCDFGVA 166
Query: 728 VPL-RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786
+ ++ L +A GTP WMAPEV+ Y +VDIWS G E
Sbjct: 167 AQVNQTSLRRQTMA-----------GTPYWMAPEVIMEGV---YYDTKVDIWSLGITTYE 212
Query: 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTD 816
+ T PY + L LI K PRL D
Sbjct: 213 IATGNPPYCDVEALRAMQLIIKSKPPRLED 242
|
Protein kinase involved in morphogenesis and cell integrity. Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54XJ4|Y8901_DICDI Probable serine/threonine-protein kinase DDB_G0278901 OS=Dictyostelium discoideum GN=DDB_G0278901 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 92.0 bits (227), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 67/203 (33%), Positives = 97/203 (47%), Gaps = 42/203 (20%)
Query: 598 EYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 657
+ S + E+ +L L H IV Y H +PS+ S I ME+++ GS++
Sbjct: 66 QISLMAEINLLKVLSHHNIVRYYEH------IPSSS--------HSYIVMEFIENGSLEK 111
Query: 658 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 717
I++ E V+V +IAQ V L LH + ++HRDIK+ N+LI DG
Sbjct: 112 IIKRHGLLPESLVTV----YIAQ-VLNGLEYLHRQGVIHRDIKAANLLIS-----TDGS- 160
Query: 718 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV-- 775
+KL DF A + D GTP WMAPEV++ + G+
Sbjct: 161 -IKLADFGVATKVSDL--------SSDNPDDTFAGTPYWMAPEVIQ------MQGISTAC 205
Query: 776 DIWSYGCLLLELLTLQVPYMGLS 798
D+WS GC ++ELLT PY GL+
Sbjct: 206 DVWSLGCTIIELLTGTPPYFGLA 228
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3ULB5|PAK6_MOUSE Serine/threonine-protein kinase PAK 6 OS=Mus musculus GN=Pak6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 92.0 bits (227), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 41/215 (19%)
Query: 602 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 661
EV ++ +H +VEMY + + L + ME+++GG++ + I +
Sbjct: 451 FNEVVIMRDYQHLNVVEMYKSYLVGEEL--------------WVLMEFLQGGALTDIISQ 496
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
+ E+ +V + V AL LH++ ++HRDIKS++IL+ L DG+ VKL
Sbjct: 497 VRLNEEQIATV------CEAVLQALAYLHAQGVIHRDIKSDSILLTL-----DGR--VKL 543
Query: 722 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781
DF C + +P VGTP WMAPEV+ +LY EVDIWS G
Sbjct: 544 SDFG----------FCAQISKDVPKRKSLVGTPYWMAPEVISR----SLYATEVDIWSLG 589
Query: 782 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 816
+++E++ + PY S ++ ++ P+L +
Sbjct: 590 IMVIEMVDGEPPYFSDSPVQAMKRLRDSAPPKLKN 624
|
Serine/threonine protein kinase that plays a role in the regulation of gene transcription. The kinase activity is induced by various effectors including AR or MAP2K6/MAPKK6. Phosphorylates the DNA-binding domain of androgen receptor/AR and thereby inhibits AR-mediated transcription. Inhibits also ESR1-mediated transcription. May play a role in cytoskeleton regulation by interacting with IQGAP1. May protect cells from apoptosis through phosphorylation of BAD. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55EC7|GEFX_DICDI RasGEF domain-containing serine/threonine-protein kinase X OS=Dictyostelium discoideum GN=gefX PE=2 SV=1 | Back alignment and function description |
|---|
Score = 91.7 bits (226), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 84/250 (33%), Positives = 117/250 (46%), Gaps = 50/250 (20%)
Query: 550 FPSLSSCDEAGKSVSSSLFR-CKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRML 608
F SL ++ GK S+FR C G A K+ AD+ +Y EV ML
Sbjct: 18 FESLEFNEKIGKGSFGSVFRGCYLGLDVAIKKIE-------KADDPEYLKY-IDREVSML 69
Query: 609 GALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG-E 667
+LRH IV G + S L I E+V GG V+ ++K G +
Sbjct: 70 QSLRHPFIVNFSGICVHSSGL--------------YIVTEFVSGGDVRQLLKKTPPIGWD 115
Query: 668 KHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA 727
K VS IA D+A A+V LH+K I+HRD+KS+NIL+D ++ ++LCDF A
Sbjct: 116 KRVS------IAVDLAKAMVFLHAKKIIHRDLKSKNILLDEFQR-------IRLCDFGFA 162
Query: 728 VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787
R T H + GT W+APE+L M Y D++SYG +L EL
Sbjct: 163 ---RMSEQTKKSRHMTM------CGTEGWVAPEILLGMS----YDTSCDVFSYGVVLAEL 209
Query: 788 LTLQVPYMGL 797
+T + P + L
Sbjct: 210 ITGRKPGVDL 219
|
Promotes the exchange of Ras-bound GDP by GTP. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 886 | ||||||
| 225432806 | 1117 | PREDICTED: uncharacterized protein LOC10 | 0.980 | 0.777 | 0.692 | 0.0 | |
| 255552033 | 1152 | ATP binding protein, putative [Ricinus c | 0.988 | 0.760 | 0.651 | 0.0 | |
| 449525764 | 970 | PREDICTED: uncharacterized protein LOC10 | 0.972 | 0.888 | 0.595 | 0.0 | |
| 449433293 | 1131 | PREDICTED: uncharacterized protein LOC10 | 0.972 | 0.762 | 0.593 | 0.0 | |
| 224099855 | 1214 | predicted protein [Populus trichocarpa] | 0.878 | 0.640 | 0.656 | 0.0 | |
| 356534187 | 1109 | PREDICTED: uncharacterized protein LOC10 | 0.967 | 0.772 | 0.607 | 0.0 | |
| 15219675 | 1112 | leucine-rich repeat protein kinase-like | 0.970 | 0.773 | 0.555 | 0.0 | |
| 297843232 | 1115 | leucine-rich repeat family protein [Arab | 0.975 | 0.774 | 0.548 | 0.0 | |
| 356574435 | 1021 | PREDICTED: uncharacterized protein LOC10 | 0.848 | 0.736 | 0.610 | 0.0 | |
| 218193736 | 1112 | hypothetical protein OsI_13471 [Oryza sa | 0.950 | 0.757 | 0.457 | 0.0 |
| >gi|225432806|ref|XP_002279386.1| PREDICTED: uncharacterized protein LOC100249467 [Vitis vinifera] gi|297737117|emb|CBI26318.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1217 bits (3150), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 616/890 (69%), Positives = 722/890 (81%), Gaps = 21/890 (2%)
Query: 1 MHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDVYEGPMLENDGN 60
MHNLQNLNLQYNKLLS CQ+PSWICCNLEGNGKD+ ND+FISSS EMDV E E D +
Sbjct: 245 MHNLQNLNLQYNKLLSCCQIPSWICCNLEGNGKDACNDEFISSSVEMDVLETTNQEIDES 304
Query: 61 VSFSESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQQRARQERLNNSRKWRG 119
+ + GS +TSSS T SSNSR AR S K WKR ++LQQRARQERLNNSRKW+
Sbjct: 305 ICCN----GSPNTSSSTLTGPSSNSRCFVARMSQKGWKRRYYLQQRARQERLNNSRKWKS 360
Query: 120 EGHAQT-SMKEGQRYKSGNLDALASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVE 178
E HA+ ++K ++ + G L L E+ +E A DI+ LD+DDKQLLS EAESENLL SVE
Sbjct: 361 EDHAEVLTIKAAEKCEHGKLAVLHPESLAEHAPDIVVLDNDDKQLLSEEAESENLLNSVE 420
Query: 179 DDKIRSGTGLHVENCSCAGLESTG--KEGNDECSKHDSSSLSTANGATEQDEGSSSENSK 236
D + G SCA L+S + EC+ D+S S + GA+E++EGSSSE SK
Sbjct: 421 DAESGPRKG------SCAVLDSIAINQGSKSECNDDDASLSSLSKGASEKNEGSSSEVSK 474
Query: 237 AVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPF 296
+ K+KRHSDRDLDNPKPCK+R+ + E+SN S KYS +S+C+IEDRLPDGFYDAGRDRPF
Sbjct: 475 STPKSKRHSDRDLDNPKPCKARRPVNEHSNLSCKYSKISYCNIEDRLPDGFYDAGRDRPF 534
Query: 297 MQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNL 356
M LT YEQ H DSREVIL+DR+ DEELDAI LSAQALV LKQLNGLTK+ DNL
Sbjct: 535 MPLTVYEQNFHFDSREVILLDRERDEELDAITLSAQALVSQLKQLNGLTKERKQVTDDNL 594
Query: 357 QIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILD 416
QIA LLALFVSDHFGGSD+S ++ERTRK+VSGSNY+KPFVC+CSTGN ++ +TS KQ LD
Sbjct: 595 QIASLLALFVSDHFGGSDKSALIERTRKSVSGSNYQKPFVCSCSTGNRNNISTSNKQNLD 654
Query: 417 AVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELV 476
VEDIV+SDLCEKSLRSIK++RNS++VPIG++QFGVCRHRAVL+KYLCDR+EPPVPCELV
Sbjct: 655 TVEDIVVSDLCEKSLRSIKARRNSIIVPIGTLQFGVCRHRAVLMKYLCDRMEPPVPCELV 714
Query: 477 RGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAPFSTE 536
RGYLDF PHAWN + K+GDSW+RMIVDACRPHDIREE DPEYF RYIPL R P ST+
Sbjct: 715 RGYLDFLPHAWNVVHTKRGDSWVRMIVDACRPHDIREETDPEYFCRYIPLSRINVPLSTQ 774
Query: 537 SDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRN 596
S +P +G GSFPSLS+CDE + SSSL +CKFGS +AAAKVR L+VCG S DE+RN
Sbjct: 775 S--TPVTG---GSFPSLSACDEIANAPSSSLIQCKFGSVEAAAKVRILEVCGDSVDEVRN 829
Query: 597 FEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVK 656
FEY CLGEVR+LGAL+HSCIVE+YGH+ISSKW+P++DGN EH +LQSAI ME+VKGGS+K
Sbjct: 830 FEYCCLGEVRILGALKHSCIVEIYGHQISSKWIPASDGNLEHRVLQSAILMEHVKGGSLK 889
Query: 657 NYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 716
+Y+EKLSE GEKHV V+LAL IA+DVA+AL ELHSKHI+HRDIKSENILIDL++K+ADG
Sbjct: 890 SYLEKLSEAGEKHVPVELALCIARDVASALAELHSKHIIHRDIKSENILIDLDKKRADGT 949
Query: 717 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 776
PVVKLCDFDRAVPLRSFLH+CCIAH GIP PDVCVGTPRWMAPEVLRAMHK +YGLEVD
Sbjct: 950 PVVKLCDFDRAVPLRSFLHSCCIAHIGIPPPDVCVGTPRWMAPEVLRAMHKREIYGLEVD 1009
Query: 777 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 836
IWSYGCLLLELLTLQVPY LSE + HD +QMGKRP+L +ELEALGS E E+AQSG
Sbjct: 1010 IWSYGCLLLELLTLQVPYFELSESQFHDQLQMGKRPQLPEELEALGS-QEPEMAQSGKE- 1067
Query: 837 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSISSRS 886
E PE E+E L FLVD+ R CT+ NPT+RPTA +LY+M + +T + SSRS
Sbjct: 1068 EGPETEVEKLGFLVDLVRWCTKGNPTDRPTAENLYKMLLTQTRTFTSSRS 1117
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255552033|ref|XP_002517061.1| ATP binding protein, putative [Ricinus communis] gi|223543696|gb|EEF45224.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1163 bits (3008), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 582/893 (65%), Positives = 694/893 (77%), Gaps = 17/893 (1%)
Query: 1 MHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDVYEGPMLENDGN 60
MHNLQNL+LQ+NKLLS C +P+WICCNLEGNG D SNDD ISSS EMDVYE + +
Sbjct: 270 MHNLQNLDLQHNKLLSCCHIPAWICCNLEGNGLDLSNDDSISSSVEMDVYETTIQSDHTK 329
Query: 61 VSFSESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQQRARQERLNNSRKWRG 119
S + GS++ +SS+ T SNS+ AR+ +K+WKR H+LQQRARQERLNNSRKW+G
Sbjct: 330 FSCN----GSQNATSSLLTGPPSNSKCFAARRLNKRWKRRHYLQQRARQERLNNSRKWKG 385
Query: 120 EGHAQTSM-KEGQRYKSGNLDALASETPSEEASDIIGL-----DDDDKQLLSPEAESENL 173
EG A S KE + KS NLD L SET + SDIIGL D +DK + S E E+ENL
Sbjct: 386 EGRADLSTPKESKNCKSDNLDLLTSETCEDGTSDIIGLVDNNEDKEDKVVPSSEVEAENL 445
Query: 174 LFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSE 233
L S +DD++ S G ++++CS ES DEC H+ S T NG + +DEGSSSE
Sbjct: 446 LVSGKDDRMNSKKGFYIKSCS-HNPESVSNGEEDECCVHEKSLALTQNGVSGEDEGSSSE 504
Query: 234 NSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRD 293
N+K + K+KRH D LDNPKPCK R+ ++ + S KYS +SFCS ED LPDGFYDAGRD
Sbjct: 505 NTKFILKSKRHFDGALDNPKPCKCRRPTEDSLSLSHKYSDLSFCSTEDHLPDGFYDAGRD 564
Query: 294 RPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPV 353
RPFM L YEQ HLDSREVIL+DR+ DE+LDA LSAQALV LK+LNG ++G + V
Sbjct: 565 RPFMPLRRYEQILHLDSREVILLDREKDEKLDATVLSAQALVCRLKRLNGFFEEGNKDAV 624
Query: 354 DNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQ 413
D LQIA LLALFVSDHFGGSDRS +ERTRK VSGSNY+KPFVCTCSTGN +S NTS KQ
Sbjct: 625 DVLQIASLLALFVSDHFGGSDRSFTIERTRKAVSGSNYKKPFVCTCSTGNDESINTSTKQ 684
Query: 414 ILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPC 473
IL + EDIV SDLCEKSLRS+K+KRNS++VP+G++QFGVCRHRA+L KYLCDR++PP+PC
Sbjct: 685 ILGSAEDIVFSDLCEKSLRSVKAKRNSIIVPLGNLQFGVCRHRALLFKYLCDRMDPPIPC 744
Query: 474 ELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAPF 533
ELVRGYLDF PHAWNTILVK+GDSW+RM+VDACRPHDIREE DPEYF RY+PL T P
Sbjct: 745 ELVRGYLDFIPHAWNTILVKRGDSWVRMLVDACRPHDIREETDPEYFCRYVPLSHTRVPL 804
Query: 534 STESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADE 593
STES HSP S S S+ DE K+V S++ +CKF S +AAAKVRTL++C + DE
Sbjct: 805 STESIHSPGC-----SITSFSTHDELEKTVLSTVIQCKFESVEAAAKVRTLEICETPVDE 859
Query: 594 IRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG 653
IRNFEYSC+GEVR+L ALRH CIVE+YGH+ISSKW+ + DG P H +L+S I ME+VKGG
Sbjct: 860 IRNFEYSCIGEVRILRALRHPCIVELYGHQISSKWIHAEDGKPPHQILRSTILMEHVKGG 919
Query: 654 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 713
S+K+YIEK+S+T +KHV + AL IA+D++ A+ +LHSKHI+HRD+KSENILIDL+ K+A
Sbjct: 920 SLKSYIEKMSKTSKKHVPMDFALCIARDISCAMADLHSKHIIHRDVKSENILIDLDSKRA 979
Query: 714 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 773
DG PVVKLCDFDRAVPLRSFLHTCCIAH GIP PDVCVGTPRWMAPEVLRAMHK N YGL
Sbjct: 980 DGMPVVKLCDFDRAVPLRSFLHTCCIAHNGIPPPDVCVGTPRWMAPEVLRAMHKRNPYGL 1039
Query: 774 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG 833
EVDIWS+GCLLLELLTLQ+PY GLSE I +L+QMG+RP LTDELE L S +E QSG
Sbjct: 1040 EVDIWSFGCLLLELLTLQIPYSGLSEFHIKELLQMGERPPLTDELETLVSMNEPVATQSG 1099
Query: 834 SGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSISSRS 886
S PEAE ETL FLVD+FRRCTE NP RPTA ++YE+ + +S+ SSRS
Sbjct: 1100 SDVAAPEAESETLRFLVDLFRRCTEANPASRPTAAEIYELLLGCSSAFTSSRS 1152
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449525764|ref|XP_004169886.1| PREDICTED: uncharacterized protein LOC101227936, partial [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1031 bits (2666), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 528/887 (59%), Positives = 678/887 (76%), Gaps = 25/887 (2%)
Query: 1 MHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGK-DSSNDDFISSSAEMDVYEGPMLENDG 59
MH+L+NLNLQYNKLL CQ+PSWICCN EGN + D++N+++ISS+ EMDVYE + +N+
Sbjct: 89 MHSLRNLNLQYNKLLKSCQIPSWICCNFEGNLEYDTANEEWISSTVEMDVYEATVQDNEN 148
Query: 60 NVSFSESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQQRARQERLNNSRKWR 118
+ G R+ SS++ S+NSRS +++S K+W+R H+LQQ+ARQERLN+SRKW+
Sbjct: 149 SFPLK----GMRNISSNLLMGPSTNSRSFASKRSGKRWRRRHYLQQKARQERLNSSRKWK 204
Query: 119 GEGHAQTSMKEGQRYKSGNLD-ALASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSV 177
G H T +K + + LD A SET ++S I L D K+ + AE EN + S
Sbjct: 205 GVDH-HTEVKIHENQEPERLDSASISETTVGDSSAIDELFDS-KETCAVGAERENHIESH 262
Query: 178 EDDKIRSGTGLHVENCS--CAGLESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENS 235
E+D VE+CS C T +EC + + T NGA +Q EGSSS+ S
Sbjct: 263 ENDNFDPKKEFPVEDCSSICDAAAETMTRDENECCETSKTLPLTGNGAHDQ-EGSSSQVS 321
Query: 236 KAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRP 295
K K KR S+R+LDNPKPCKSRK + +S+ S KY+S SFC++ED LPDGFYDAGRDRP
Sbjct: 322 KDNAKLKRCSERELDNPKPCKSRKPVEYSSSLSCKYNSTSFCNVEDYLPDGFYDAGRDRP 381
Query: 296 FMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGLT--KDGVIEPV 353
FM L YEQ HLDSREVI+V+R+ DE LD+I ++A++LVL LKQ+N LT +D VI
Sbjct: 382 FMPLRNYEQNFHLDSREVIIVNREHDEVLDSITIAAKSLVLRLKQINQLTQERDQVI--- 438
Query: 354 DNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQ 413
D++ IA LLALFVSDHFGGSDRS +VE+TR+ VSGS Y+KPFVCTCSTG+ D+ +S K
Sbjct: 439 DDVYIAQLLALFVSDHFGGSDRSAMVEKTRRAVSGSKYQKPFVCTCSTGDRDNLTSSTKL 498
Query: 414 ILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPC 473
+D EDI+ +D+CEKSLRSIK+ RNS++VP+G++QFGVCRHRA+LLKYLCDR+EPPVPC
Sbjct: 499 TVDNYEDILFTDICEKSLRSIKASRNSIIVPLGALQFGVCRHRALLLKYLCDRMEPPVPC 558
Query: 474 ELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAPF 533
ELVRGYLDF PHAWN ILV++G++ +RM+VDACRP+DIREEADPEYF RYIPL R P
Sbjct: 559 ELVRGYLDFLPHAWNVILVQRGNTLVRMVVDACRPNDIREEADPEYFCRYIPLSRAKLPI 618
Query: 534 STESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADE 593
S SP G+ SFPSLS+CDE K+ SSS+ +CK S +AAAK+R +VC SS +E
Sbjct: 619 SFGVTSSP--GI---SFPSLSNCDEIEKAPSSSVIKCKLASVEAAAKLRKREVCESSFEE 673
Query: 594 IRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG 653
IRNFE+SCLGEVR+LGAL+HSCIV+MYGH+ISS+W+PS +G P+ LL+SAIF+E+VKGG
Sbjct: 674 IRNFEFSCLGEVRILGALKHSCIVQMYGHQISSEWIPSENGKPKRRLLRSAIFLEHVKGG 733
Query: 654 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 713
S+K+Y++KL + G++HV + LAL +A+DVA+ALVELHSKHI+HRDIKSENIL+D + +K+
Sbjct: 734 SLKSYMDKLYKAGKEHVPMDLALHVARDVASALVELHSKHIIHRDIKSENILMDFD-EKS 792
Query: 714 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 773
DG P+VKLCDFDRAVPLRS LHTCCIAH GIP PDVCVGTPRWMAPEVLRAMH PN+YGL
Sbjct: 793 DGVPIVKLCDFDRAVPLRSLLHTCCIAHTGIPPPDVCVGTPRWMAPEVLRAMHTPNVYGL 852
Query: 774 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL-EALGSCHEHEVAQS 832
EVDIWS+GCLLLELLTLQ+P++GL+EL+I D +QMGKRP L +L E LG+ + ++QS
Sbjct: 853 EVDIWSFGCLLLELLTLQIPFLGLTELQIFDHLQMGKRPELAGDLEEELGTIKQSTMSQS 912
Query: 833 G-SGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 878
E E + ET + L+D+FR+CT+ENP +RPTA +L+ + + T
Sbjct: 913 SVQESEGQEKDQETKALLIDLFRKCTQENPNDRPTAEELHRILLEHT 959
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449433293|ref|XP_004134432.1| PREDICTED: uncharacterized protein LOC101218031 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1025 bits (2650), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 526/887 (59%), Positives = 676/887 (76%), Gaps = 25/887 (2%)
Query: 1 MHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGK-DSSNDDFISSSAEMDVYEGPMLENDG 59
MH+L+NLNLQYNKLL CQ+PSWICCN EGN + D++N+++ISS+ EMDVYE +N+
Sbjct: 250 MHSLRNLNLQYNKLLKSCQIPSWICCNFEGNLEYDTANEEWISSTVEMDVYEATDQDNEN 309
Query: 60 NVSFSESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQQRARQERLNNSRKWR 118
+ G R+ SS++ S+NSRS +++S K+W+R H+LQQ+ARQERLN+SRKW+
Sbjct: 310 SFPLK----GMRNISSNLLMGPSTNSRSFASKRSGKRWRRRHYLQQKARQERLNSSRKWK 365
Query: 119 GEGHAQTSMKEGQRYKSGNLD-ALASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSV 177
G H T +K + + LD A SET ++S I L D K+ AE EN + S
Sbjct: 366 GVDH-HTEVKIHENQEPERLDSASISETTVGDSSAIDELFDS-KETCDVGAERENHIESH 423
Query: 178 EDDKIRSGTGLHVENCS--CAGLESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENS 235
E+D VE+CS C T +EC + + T NGA +Q EGSSS+ S
Sbjct: 424 ENDNFDPKKEFPVEDCSSICDAAAETMTRDENECCETSKTLPLTGNGAHDQ-EGSSSQVS 482
Query: 236 KAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRP 295
K K KR S+++LDNPKPCKSRK + +S+ S KY+S SFC++ED LPDGFYDAGRDRP
Sbjct: 483 KDNAKLKRCSEKELDNPKPCKSRKPVEYSSSLSCKYNSTSFCNVEDYLPDGFYDAGRDRP 542
Query: 296 FMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGLT--KDGVIEPV 353
FM L YEQ HLDSREVI+V+R+ DE LD+I ++A++LVL LKQ+N LT +D VI
Sbjct: 543 FMPLRNYEQNFHLDSREVIIVNREHDEVLDSITIAAKSLVLRLKQINQLTQERDQVI--- 599
Query: 354 DNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQ 413
D++ IA LLALFVSDHFGGSDRS +VE+TR+ VSGS Y+KPFVCTCSTG+ D+ +S K
Sbjct: 600 DDVYIAQLLALFVSDHFGGSDRSAMVEKTRRVVSGSKYQKPFVCTCSTGDRDNLTSSTKL 659
Query: 414 ILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPC 473
+D EDI+ +D+CEKSLRSIK+ RNS++VP+G++QFGVCRHRA+LLKYLCDR+EPPVPC
Sbjct: 660 TVDNYEDILFTDICEKSLRSIKASRNSIIVPLGALQFGVCRHRALLLKYLCDRMEPPVPC 719
Query: 474 ELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAPF 533
ELVRGYLDF PHAWN ILV++G++ +RM+VDACRP+DIREEADPEYF RYIPL R P
Sbjct: 720 ELVRGYLDFLPHAWNVILVQRGNTLVRMVVDACRPNDIREEADPEYFCRYIPLSRAKLPI 779
Query: 534 STESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADE 593
S SP G+ SFPSLS+CDE K+ SSS+ +CK S +AAAK+R +VC SS +E
Sbjct: 780 SFGVTSSP--GI---SFPSLSNCDEIEKAPSSSVIKCKLASVEAAAKLRKREVCESSFEE 834
Query: 594 IRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG 653
IRNFE+SCLGEVR+LGAL+HSCIV+MYGH+ISS+W+PS +G P+ LL+SAIF+E+VKGG
Sbjct: 835 IRNFEFSCLGEVRILGALKHSCIVQMYGHQISSEWIPSENGKPKRRLLRSAIFLEHVKGG 894
Query: 654 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 713
S+K+Y++KL + G++HV + LAL +A+DVA+ALVELHSKHI+HRDIKSENIL+D + +K+
Sbjct: 895 SLKSYMDKLYKAGKEHVPMDLALHVARDVASALVELHSKHIIHRDIKSENILMDFD-EKS 953
Query: 714 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 773
DG P+VKLCDFDRAVPLRS LHTCCIAH GIP PDVCVGTPRWMAPEVLRAMH P++YGL
Sbjct: 954 DGVPIVKLCDFDRAVPLRSLLHTCCIAHTGIPPPDVCVGTPRWMAPEVLRAMHTPHVYGL 1013
Query: 774 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL-EALGSCHEHEVAQS 832
EVDIWS+GCLLLELLTLQ+P++GL+EL+I D +QMGKRP L +L E LG+ + ++QS
Sbjct: 1014 EVDIWSFGCLLLELLTLQIPFLGLTELQIFDHLQMGKRPELAGDLEEELGTIKQSTMSQS 1073
Query: 833 G-SGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 878
E E + ET + L+D+FR+CT+ENP +RPTA +L+ + + T
Sbjct: 1074 SVQESEGQEKDQETKALLIDLFRKCTQENPNDRPTAEELHRILLEHT 1120
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224099855|ref|XP_002311646.1| predicted protein [Populus trichocarpa] gi|222851466|gb|EEE89013.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1020 bits (2637), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 531/809 (65%), Positives = 619/809 (76%), Gaps = 31/809 (3%)
Query: 1 MHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDVYEGPMLENDGN 60
MHNLQ+LNLQYNKLLS CQ+PSWICCNLEGNGKD SND+FISSS EMDVYE E+D
Sbjct: 263 MHNLQHLNLQYNKLLSCCQIPSWICCNLEGNGKDLSNDEFISSSVEMDVYETSFQEDDRK 322
Query: 61 VSFSESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWKRHHLQQRARQERLNNSRKWRGE 120
S + GS H+ SSI T SSN + R S + +RH+LQQ+ARQERLNNSRKW+GE
Sbjct: 323 FSCN----GSNHSMSSIVTGPSSNRSFASRRSSKRWKRRHYLQQKARQERLNNSRKWKGE 378
Query: 121 GHAQT-SMKEGQRYKSGNLDALASETPSEEASDIIGLDDDDKQL-LSPEAESENLLFSVE 178
G A+ ++KE + +KS NLD L E SD++G+DDD++++ LS EAE ENL SVE
Sbjct: 379 GCAEALALKESESFKSNNLDVLTPEVHEGGTSDVVGVDDDNEKVELSVEAEGENLHTSVE 438
Query: 179 DDKIRSGTGLHVENCSCAGLESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAV 238
DDKI S VE+CSC L S K + C D ST + A QDE SSSE SK
Sbjct: 439 DDKISSKKVFSVESCSC-DLGSINKSEEEVCCVQDEPLASTRDEAASQDESSSSEKSKIT 497
Query: 239 CKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQ 298
K+KRH DRD+DNPKPCK R+ ++SN S KYS +SFCSIEDRLPDGFYDAGRDRPFM
Sbjct: 498 YKSKRHHDRDIDNPKPCKCRRPTEDSSNFSCKYSELSFCSIEDRLPDGFYDAGRDRPFMP 557
Query: 299 LTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQI 358
L +EQ LDSREVIL+DR+ DE+LDA+ALSAQALV K+ NG TK+ VDNLQI
Sbjct: 558 LRRFEQILPLDSREVILLDREKDEQLDAVALSAQALVFRFKRSNGSTKERNKVAVDNLQI 617
Query: 359 ALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAV 418
A LLALFVSDHFGGSDRSG VERTRK VSGSNYRKPFVCTC TGN++S + + KQ L+ V
Sbjct: 618 ASLLALFVSDHFGGSDRSGAVERTRKAVSGSNYRKPFVCTCPTGNNESISLAGKQALETV 677
Query: 419 EDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRG 478
EDI+ SDLCE+SLRSIK++R S+V+P+GS+QFGVCRHRA+L+KYLCDR++PPVPCELVRG
Sbjct: 678 EDIIFSDLCERSLRSIKARRGSIVIPLGSLQFGVCRHRALLMKYLCDRMDPPVPCELVRG 737
Query: 479 YLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAPFSTESD 538
YLDF PHAWN IL ++GDS +RM+VDAC PHDIREE DPEYF RYIPL RT P STES
Sbjct: 738 YLDFMPHAWNVILRRRGDSLVRMVVDACHPHDIREETDPEYFCRYIPLSRTKVPLSTESV 797
Query: 539 HSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFE 598
P SFP++S+ D+ K+ SS+L RCKFGS +AAAKVRTL+VC +SADEIRNFE
Sbjct: 798 PGPGC-----SFPTMSTSDKIEKAGSSTLIRCKFGSVEAAAKVRTLEVCEASADEIRNFE 852
Query: 599 YSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 658
Y CLGE +SSKW+PS DGNPE +LQS I MEYV GGS+KNY
Sbjct: 853 YICLGE-------------------LSSKWVPSEDGNPERRILQSVILMEYVDGGSLKNY 893
Query: 659 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 718
+E++S+TGEKHV V++AL IA+DVA AL E+HSK I+HRDIKSENILIDL+ +ADG PV
Sbjct: 894 LEEVSKTGEKHVPVEMALCIARDVACALAEIHSKDIIHRDIKSENILIDLDDTRADGMPV 953
Query: 719 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 778
VKLCDFDRAVP +SFLHTCCIAHRGI PDVCVGTPRWMAPEVLR M K N Y LEVDIW
Sbjct: 954 VKLCDFDRAVPRKSFLHTCCIAHRGIAPPDVCVGTPRWMAPEVLRTMDKRNTYALEVDIW 1013
Query: 779 SYGCLLLELLTLQVPYMGLSELEIHDLIQ 807
SYGCLLLELLTLQVPY GL E IH+L+Q
Sbjct: 1014 SYGCLLLELLTLQVPYAGLPESRIHELLQ 1042
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356534187|ref|XP_003535639.1| PREDICTED: uncharacterized protein LOC100819959 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 999 bits (2583), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 535/881 (60%), Positives = 655/881 (74%), Gaps = 24/881 (2%)
Query: 1 MHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDVYEGPMLENDGN 60
MH LQ LNLQYNKLL Q+PSWICCN++GN K DD SSS EMD+YE END
Sbjct: 245 MHRLQELNLQYNKLLGIFQIPSWICCNMDGNDKARCKDD-CSSSVEMDLYESNFQENDET 303
Query: 61 VSFSESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQQRARQERLNNSRKWRG 119
+S G +TSSS+ T SSS+SR +RKS K+WKR HHLQQ+ARQERLNNSRKW+
Sbjct: 304 LS-----DGPHNTSSSMLTSSSSSSRCFASRKSGKRWKRRHHLQQKARQERLNNSRKWKA 358
Query: 120 EGHA-QTSMKEGQRY-KSGNLDALASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSV 177
H Q K+ R + N D+LASE+ +E S+ LDD++K++ S A ++N + +
Sbjct: 359 VDHDDQLLSKKIHRISEPENHDSLASESCAEIVSENGSLDDNNKRISSERAVNDNAIDND 418
Query: 178 EDDKIRSGTGLHVENCSCAGLESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKA 237
+D++ + E+C E DE + S S +EQDE S E +
Sbjct: 419 NNDEVITEKQFSGEDCCTT-------ESKDE---KEESLCSLDKRPSEQDEASCLELLEC 468
Query: 238 VCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFM 297
V K+KRH DRDLDNPKPCKSRKS+ +S S KYS +SFC IED L DGFYDAGRDR FM
Sbjct: 469 VSKSKRHLDRDLDNPKPCKSRKSISSSSLLSCKYSKISFCGIEDHLSDGFYDAGRDRLFM 528
Query: 298 QLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQ 357
L YEQ L SREVIL+DRK DEELDA+ L+AQALV +LK+LNGL++ G + VDNLQ
Sbjct: 529 PLECYEQNHCLASREVILLDRKIDEELDAVMLAAQALVYNLKKLNGLSRYGNQDGVDNLQ 588
Query: 358 IALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDA 417
+A LLALFVSDHFGGSDRSGIVERTRK+VSGSNY KPFVCTCS G+S S ++ + + +
Sbjct: 589 MASLLALFVSDHFGGSDRSGIVERTRKSVSGSNYNKPFVCTCSAGSSTSISSPTEPVANT 648
Query: 418 VEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVR 477
+EDI LS + EKSL SIK +RNS+++PIGSVQ+GVCRHRA+L KYLCD +EPPVPCELVR
Sbjct: 649 IEDITLSKMSEKSLDSIKKRRNSIIIPIGSVQYGVCRHRALLFKYLCDHMEPPVPCELVR 708
Query: 478 GYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAPFSTES 537
GYLDF PHAWN IL+K+G +W+RM++DACRP DIREE DPEYF RYIPL RT P S+
Sbjct: 709 GYLDFSPHAWNIILIKRGATWVRMLIDACRPLDIREEKDPEYFCRYIPLNRTTIPISSIG 768
Query: 538 DHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNF 597
P SFPSL++CDE S++L +CKFGS +AAAKVRTL+ GSSAD+I+NF
Sbjct: 769 SPGP-----DYSFPSLTTCDELETKASTTLVKCKFGSVEAAAKVRTLEEQGSSADKIKNF 823
Query: 598 EYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 657
EY+CLGE+R+LGAL+H CIVEMYGH+IS +W SADGNPEH +L+SAIFMEYV+GGS+KN
Sbjct: 824 EYNCLGEIRILGALKHPCIVEMYGHQISCQWSVSADGNPEHRVLRSAIFMEYVEGGSLKN 883
Query: 658 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 717
Y+EKLSE GEKHV V+LAL IA+DV+ AL ELHSKHI+HRDIKSENIL +L+RK+ DG P
Sbjct: 884 YLEKLSEAGEKHVPVELALHIAKDVSCALSELHSKHIIHRDIKSENILFNLDRKRDDGTP 943
Query: 718 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 777
VKLCDFD AVPLRS LH CCIAH G P P +CVGTPRWMAPEV+R M+K N YGLE DI
Sbjct: 944 TVKLCDFDSAVPLRSTLHVCCIAHAGTPPPCICVGTPRWMAPEVMRTMYKKNSYGLEADI 1003
Query: 778 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 837
WS+GCLLLE+LTLQ+PY GLS+ D +QMGKRP+LTDEL L S + + SG E
Sbjct: 1004 WSFGCLLLEMLTLQIPYSGLSDSHFLDSLQMGKRPQLTDELRVLSSMNGPTMIPSGEELE 1063
Query: 838 KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 878
K +A ++ L FLVD+F +C EENP++RPTA ++++M +A T
Sbjct: 1064 KSDAGVDMLKFLVDLFHKCVEENPSKRPTAEEIHKMVLAHT 1104
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15219675|ref|NP_171917.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] gi|3142291|gb|AAC16742.1| Contains similarity to adenylate cyclase gb|AF012921 from Magnaporthe grisae. EST gb|Z24512 comes from this gene [Arabidopsis thaliana] gi|20466532|gb|AAM20583.1| unknown protein [Arabidopsis thaliana] gi|34365545|gb|AAQ65084.1| At1g04210 [Arabidopsis thaliana] gi|332189549|gb|AEE27670.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 953 bits (2464), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 489/881 (55%), Positives = 620/881 (70%), Gaps = 21/881 (2%)
Query: 1 MHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDVYEGPMLENDGN 60
M LQ LNL+YNKL SYC +P+WI CN EGN ++ D SS EMDV+E P N
Sbjct: 245 MPRLQILNLRYNKLPSYCWIPTWIQCNFEGNYEEMGVDTCSSSMVEMDVFETPYENNVIT 304
Query: 61 VSFSESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWKR--HHLQQRARQERLNNSRKWR 118
V GS ++ST SS SR +ARKSSK+WKR ++ QQRARQERLNNSRKW+
Sbjct: 305 VPHK----GSHRNPLNMSTGISSISRCFSARKSSKRWKRRQYYFQQRARQERLNNSRKWK 360
Query: 119 GEGHAQTSMKEGQRYKSGNLDALASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVE 178
GE + + + ++G + + D D++DK E + + E
Sbjct: 361 GEVPPEGLSLKMEVEETGKQGMKVPQNTDRGSVDNSCSDENDKLF------EEASVITSE 414
Query: 179 DDKIRSGTGLHVENCSCAGLESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAV 238
+++ + +N C + T + N E + +SS S+ + D SSSE K
Sbjct: 415 EEESSLKADVVSDNSQCVETQLTSERDNYESCEIKTSSPSSGDAPGTVDYNSSSERKKPN 474
Query: 239 CKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQ 298
K+KR S++ LDNPK K K + +N S+KYSS SFCS ED LPDGF+DAGRDRPFM
Sbjct: 475 NKSKRCSEKYLDNPKGSKCHKLSTDITNLSRKYSSNSFCSTEDSLPDGFFDAGRDRPFMT 534
Query: 299 LTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQI 358
L+ YE+ LDSREVIL+DR DE LDAI LSA+ALV LK+LN LT D +DNLQ+
Sbjct: 535 LSKYEKVLPLDSREVILLDRAKDEVLDAITLSARALVARLKKLNCLTPDVDQVSIDNLQV 594
Query: 359 ALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAV 418
A LALFVSDHFGGSDR+ I+ERTRK VSG+NY+KPF+CTC TGN D KQ+
Sbjct: 595 ASFLALFVSDHFGGSDRTAIIERTRKAVSGTNYQKPFICTCLTGNQDDLAALNKQVSTTA 654
Query: 419 EDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRG 478
ED +LSD+CEKSLRSIKSKRNS+VVP+G +QFG+CRHRA+L+KYLCDR+EPPVPCELVRG
Sbjct: 655 EDAILSDVCEKSLRSIKSKRNSIVVPLGKLQFGICRHRALLMKYLCDRMEPPVPCELVRG 714
Query: 479 YLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAPFSTESD 538
YLDF PHAWN + VK+G SW+RM+VDACRPHDIRE+ D EYF RYIPL R +
Sbjct: 715 YLDFMPHAWNIVPVKQGSSWVRMVVDACRPHDIREDTDQEYFCRYIPLNRLNESIRIKEK 774
Query: 539 HSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFE 598
L+PG S S + + +SSL RCK GS +A K+RTL+V G+S D+IR FE
Sbjct: 775 ------LEPGCSVSSLSTGKGVERANSSLIRCKLGSTEAVVKMRTLEVSGASLDDIRTFE 828
Query: 599 YSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 658
Y+CLGEVR+LGAL+H CIVE+YGH+ISSKW+ S +GN EH +LQS+I ME++KGGS+K +
Sbjct: 829 YTCLGEVRILGALKHDCIVELYGHEISSKWITSENGN-EHRVLQSSILMEHIKGGSLKGH 887
Query: 659 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 718
IEKLSE G+ HV + LAL IA+D++ AL+ELHSK I+HRDIKSEN+LIDL+ + A+G+P+
Sbjct: 888 IEKLSEAGKHHVPMDLALSIARDISGALMELHSKDIIHRDIKSENVLIDLDNQSANGEPI 947
Query: 719 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 778
VKLCDFDRAVPLRS LH CCIAH GIP P++CVGTPRWM+PEV RAMH+ N YGLEVDIW
Sbjct: 948 VKLCDFDRAVPLRSHLHGCCIAHVGIPPPNICVGTPRWMSPEVFRAMHEQNFYGLEVDIW 1007
Query: 779 SYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS--GSGF 836
S+GCL+ ELLTLQ PY LSEL+IH+ +Q GKRP+L +LE L S E E + + F
Sbjct: 1008 SFGCLIFELLTLQNPYFDLSELQIHESLQNGKRPKLPKKLETLISETEEEESTNKLSEVF 1067
Query: 837 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 877
+ E++L+T+ FL+DVF +CTEE+P++R AGDL+EM ++R
Sbjct: 1068 DLTESDLDTMRFLIDVFHQCTEESPSDRLNAGDLHEMILSR 1108
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297843232|ref|XP_002889497.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] gi|297335339|gb|EFH65756.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 952 bits (2460), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 484/882 (54%), Positives = 617/882 (69%), Gaps = 18/882 (2%)
Query: 1 MHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDVYEGPMLENDGN 60
M LQ LNL+YNKL SYC +P+WI CNLEGN ++ D SS EMDV+E P N
Sbjct: 245 MPRLQILNLRYNKLPSYCWIPTWIHCNLEGNYEEMGVDTCSSSMVEMDVFETPYENN--- 301
Query: 61 VSFSESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWKR--HHLQQRARQERLNNSRKWR 118
+ + GS ++ST SS SR +ARKSSK+WKR H+ QQRARQERLNNSRKW+
Sbjct: 302 -TITVPHKGSHRNPLNMSTGISSISRCFSARKSSKRWKRRQHYFQQRARQERLNNSRKWK 360
Query: 119 GEGHAQTSMKEGQRYKSGNLDALASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVE 178
GE + + ++G E + D D+DK L E+ + E
Sbjct: 361 GEVPPGGLSLKMEVEETGKQGMKVPENTDRGSVDSTYSGDNDKLL----EEASVITSEEE 416
Query: 179 DDKIRSGTGLHVENCSCAGLESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAV 238
+++ +N + T + N+E + +SS S+ + D SSSE K
Sbjct: 417 EEESSLKAKFASDNSRFVETQLTSERDNNESCEIKASSPSSGDAPGTADYNSSSERKKPN 476
Query: 239 CKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQ 298
K+KR S++ LDNPK K + + +N S KYS SFCS ED LPDGF+DAGRDRPFM
Sbjct: 477 NKSKRCSEKYLDNPKGSKCHRPSTDFANLSHKYSRNSFCSTEDSLPDGFFDAGRDRPFMS 536
Query: 299 LTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQI 358
L+ YE+ LDSREVIL+DR DE LDAI LSA+ LV LK+LN LT D +DNLQ+
Sbjct: 537 LSKYEEILPLDSREVILLDRAKDEVLDAITLSARTLVARLKKLNCLTPDVDQVSIDNLQV 596
Query: 359 ALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAV 418
A LALFVSDHFGGSDR+ I+ERTRK VSG+NY+KPF+CTC TGN D KQ+
Sbjct: 597 ASFLALFVSDHFGGSDRTAIIERTRKAVSGTNYQKPFICTCLTGNQDDLAALNKQVSTTA 656
Query: 419 EDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRG 478
ED++LSD+CEKSLRSIKSKRNS+VVP+G +QFG+CRHRA+L+KYLCDR+EPPVPCELVRG
Sbjct: 657 EDVILSDVCEKSLRSIKSKRNSIVVPLGKLQFGICRHRALLMKYLCDRMEPPVPCELVRG 716
Query: 479 YLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAPFSTESD 538
YLDF PHAWN + VK+G SW+RM+VDACRPHDIRE+ D EYF RYIPL R T+ +
Sbjct: 717 YLDFMPHAWNIVPVKQGSSWVRMVVDACRPHDIREDTDQEYFCRYIPLNRLNESIRTKEN 776
Query: 539 HSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFE 598
L+PG S + + +SSL RCK GS +A K+RTL+V G+S D+IR FE
Sbjct: 777 ------LEPGCSVSSLLTGKGVERANSSLIRCKLGSTEAVVKMRTLEVSGASLDDIRTFE 830
Query: 599 YSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 658
Y+CLGEVR+LGAL+H CIVE+YGH+ISSKW+ S +G+ +LQS+I ME++KGGS+K +
Sbjct: 831 YTCLGEVRILGALKHDCIVELYGHEISSKWITSENGDEHRRVLQSSILMEHIKGGSLKGH 890
Query: 659 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 718
IEKLSE G+ HV + LAL IA+D++ AL+ELHSK I+HRDIKSEN+LIDL+ + A+G+ +
Sbjct: 891 IEKLSEAGKHHVPMDLALSIARDISGALMELHSKDIIHRDIKSENVLIDLDNQSANGEAI 950
Query: 719 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 778
VKLCDFDRAVPLRS LH CCIAH GIP P++CVGTPRWM+PEV RAMH+ N YGLEVDIW
Sbjct: 951 VKLCDFDRAVPLRSHLHGCCIAHVGIPPPNICVGTPRWMSPEVFRAMHEQNFYGLEVDIW 1010
Query: 779 SYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG--SGF 836
S+GCL+ ELLTLQ PY LSEL+IH+ +Q GKRP+L +LE L S E + + + F
Sbjct: 1011 SFGCLIFELLTLQNPYFDLSELQIHESLQKGKRPKLPKKLETLSSETEEDESTNKLCEEF 1070
Query: 837 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 878
+ E++L+T+ FL+DVF +CTEE+P++R AGDL+EM ++RT
Sbjct: 1071 DLTESDLDTMRFLIDVFHQCTEESPSDRLNAGDLHEMILSRT 1112
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574435|ref|XP_003555353.1| PREDICTED: uncharacterized protein LOC100811118 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 882 bits (2278), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 474/776 (61%), Positives = 578/776 (74%), Gaps = 24/776 (3%)
Query: 1 MHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDVYEGPMLENDGN 60
MH LQ LNLQYNKLL Q+PSW+CCN+EGN + DD SSS EMD+YE END
Sbjct: 245 MHRLQELNLQYNKLLRIFQIPSWMCCNMEGNDEARYKDD-CSSSVEMDLYESNFQENDET 303
Query: 61 VSFSESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQQRARQERLNNSRKWRG 119
+S G +TSSS+ T SS+SR +RKS K+WKR ++LQQ+ARQERLNNSRKW+
Sbjct: 304 LS-----DGPHNTSSSMLTSPSSSSRCFASRKSGKRWKRRYYLQQKARQERLNNSRKWKA 358
Query: 120 EGHAQT--SMKEGQRYKSGNLDALASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSV 177
H S K + +SGN D+LASE+ +E S+ LDD++K++ S A ++N + +
Sbjct: 359 VDHDDLLLSKKIHRISESGNHDSLASESCAEIESENGSLDDNNKRIFSERAVNDNAIDND 418
Query: 178 EDDKIRSGTGLHVENCSCAGLESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKA 237
+D++ + E+C E DE D+S S +EQ+E S E ++
Sbjct: 419 NNDEVITEKQFSGEDCCTT-------ESKDE---KDASLCSLEKRQSEQEEASCLELLES 468
Query: 238 VCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFM 297
V K+KRH DRDLDNPKPCKSRKS+ +S S KYS +SFC ED L DGFYDAGRDRPFM
Sbjct: 469 VSKSKRHLDRDLDNPKPCKSRKSISSSSLLSCKYSKISFCGTEDHLSDGFYDAGRDRPFM 528
Query: 298 QLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQ 357
L YEQ L SREVIL+DRK DEELDA+ L+AQALV +LK+LNGL + G VDNLQ
Sbjct: 529 PLESYEQNQCLASREVILLDRKRDEELDAVMLAAQALVYNLKKLNGLNRHGNQVGVDNLQ 588
Query: 358 IALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDA 417
A LLALFVSDHFGGSDRS IVERTRK+VSGSNY KPFVCTCS G+S S ++ + + +
Sbjct: 589 TASLLALFVSDHFGGSDRSAIVERTRKSVSGSNYNKPFVCTCSAGSSTSISSPTEPVANT 648
Query: 418 VEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVR 477
+EDI LS + EKSL S+K ++NS+++PIGSVQ+GVCRHRA+L KYLCD +EPPVPCELVR
Sbjct: 649 IEDITLSKMSEKSLDSMKKRQNSIIIPIGSVQYGVCRHRALLFKYLCDHMEPPVPCELVR 708
Query: 478 GYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAPFSTES 537
GYLDF PHAWN IL+K+G +W+RM++DAC+P DIREE DPEYF RYIPL RT P ST
Sbjct: 709 GYLDFSPHAWNIILIKRGATWVRMLIDACQPLDIREEKDPEYFCRYIPLNRTTIPLSTIG 768
Query: 538 DHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNF 597
C G D SFPSL++CDE S+SL +CKFGS +AAAKVRTL+ GSSAD+I+NF
Sbjct: 769 ----CPGPD-YSFPSLTTCDELETKASTSLVKCKFGSVEAAAKVRTLEEQGSSADKIKNF 823
Query: 598 EYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 657
+Y+CLGE+R+LGAL+H CIVEMYGH+IS +W SADGNPEH +L+SAIFMEYV+GGS+K+
Sbjct: 824 KYNCLGEIRILGALKHPCIVEMYGHQISCQWSVSADGNPEHRVLRSAIFMEYVEGGSLKS 883
Query: 658 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 717
Y+EKLSE GEKHV V+LAL IA+DV+ AL ELHS+HI+HRDIKSENIL DL+RK+ DG P
Sbjct: 884 YLEKLSEAGEKHVPVELALLIAKDVSCALSELHSRHIIHRDIKSENILFDLDRKRDDGTP 943
Query: 718 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 773
VKLCDFD AVPLRS LH CCIAH G P P VCVGTPRWMAPEV+R M+K N YGL
Sbjct: 944 TVKLCDFDSAVPLRSTLHACCIAHAGTPPPCVCVGTPRWMAPEVMRTMYKKNSYGL 999
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|218193736|gb|EEC76163.1| hypothetical protein OsI_13471 [Oryza sativa Indica Group] | Back alignment and taxonomy information |
|---|
Score = 733 bits (1893), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/908 (45%), Positives = 560/908 (61%), Gaps = 66/908 (7%)
Query: 1 MHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDVYEGPMLENDGN 60
M LQ LNLQ+N++ + C +P+W+CC++ GNG+++ + S A +
Sbjct: 231 MLTLQYLNLQFNRISNSCVIPAWVCCDMRGNGENNMKPGKLKSIAVV------------- 277
Query: 61 VSFSESDAGSR---HTSSSISTVS----SSNSRSLTARKSSKQWKRHH-LQQRARQERLN 112
S + A SR HT ++ S S+N + +K+ K WKR LQQ+ARQERL
Sbjct: 278 ---SNTSAESRSMNHTCNASRLCSHPEASANLKVHPTQKTKKGWKRRDCLQQQARQERLE 334
Query: 113 NSRKWRGEGHAQT-------------SMKEGQRYKSGNLDALASETPSEEAS---DIIGL 156
+SR + + M+ K + +A + P E +S D+ +
Sbjct: 335 SSRSKLNDDYVDEMAVNMTEDESPLHDMENKSEMKGIDEEASLQDLPKETSSISEDLSCI 394
Query: 157 DDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVE-NCSCAG----LESTGKEGNDECSK 211
DDD + ++ +++ + G + NCSC + S + + E
Sbjct: 395 VDDDSY---GHIKDSGMMLQDHNEEEKPGLSMKSHGNCSCISGNTDILSRRRIRSVENEL 451
Query: 212 HDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKY 271
DS+S + + A E + SE SK K+KRH D D NPKP K + E S S KY
Sbjct: 452 EDSAS--SVHDAAVVVEENPSETSKHSWKSKRHPDMDC-NPKPSKCPRPFDECSKLSYKY 508
Query: 272 SSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSA 331
S SFCSI+D LPDGFYDAGRD PFM L YE++ L +REVIL+DR+ DEELDAIA SA
Sbjct: 509 SVQSFCSIDDHLPDGFYDAGRDMPFMPLEEYERSIGLYAREVILLDREQDEELDAIASSA 568
Query: 332 QALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNY 391
Q L+ +LK + D + +L A +LALFVSD FGG DRS + RTR+ +
Sbjct: 569 QILLSNLKMPSCFVADE--DAGQDLLRASVLALFVSDCFGGCDRSASLSRTRRAIVSLRK 626
Query: 392 RKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFG 451
+PFVCTCS G+ + + K+I + + LC+KS+ IK +RNS +VPIG++QFG
Sbjct: 627 EQPFVCTCSAGSICDSIEASKRINNLYGHFDFTGLCDKSIHIIKERRNSGIVPIGALQFG 686
Query: 452 VCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDI 511
VCRHRAVL+KYLCDR +PP+PCELVRG+LD+ PHAWN + V+KG++W+RMIVDAC P +I
Sbjct: 687 VCRHRAVLMKYLCDRADPPIPCELVRGHLDYTPHAWNVVPVRKGNTWVRMIVDACYPTNI 746
Query: 512 REEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGS-FPSLSSCDEAGKSVSSSLFRC 570
+EE DPEYF RY+PL R + G P S FPS+S C E + SSS++ C
Sbjct: 747 KEETDPEYFCRYVPLSRLQIILDDQ-------GYTPRSPFPSVSLCKEIETTASSSVYYC 799
Query: 571 KFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWL 629
K G+ DAAAKVR L +S+DE++NFEY L EVRMLGALR H IVE+YGH++ SKW+
Sbjct: 800 KIGAVDAAAKVRYLDTRCASSDEVKNFEYKLLAEVRMLGALRKHQSIVEIYGHQLYSKWV 859
Query: 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVEL 689
AD + E+ +LQS I MEYVKGGS+K Y+ KL + G+KH + LA +I ++VA AL+EL
Sbjct: 860 -QADDDKEYKILQSTIMMEYVKGGSLKGYLTKLLKEGKKHAPIDLAFYIVREVACALLEL 918
Query: 690 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 749
H K ++HRDIKSEN+L+DL+ +++DG PVVKL DFD A+PL S HTCCIAH G P+V
Sbjct: 919 HKKLVIHRDIKSENVLVDLDLERSDGTPVVKLSDFDNAIPLHSLSHTCCIAHLGTYPPNV 978
Query: 750 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG 809
CVGTP WMAPEVLRAM N YGLEVDIWS+GC LLE+LTL++PY GL + EI+DLI
Sbjct: 979 CVGTPCWMAPEVLRAMRDKNQYGLEVDIWSFGCFLLEMLTLRIPYQGLPDSEIYDLIMRK 1038
Query: 810 K-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868
K RPRLT ELEA + + + + G +A E L L+D+F +CT+ +ERP A
Sbjct: 1039 KQRPRLTQELEAFWTL-DKPITRLELGITS-DAHAEKLRLLIDLFYQCTKGIASERPKAE 1096
Query: 869 DLYEMFVA 876
+Y + +
Sbjct: 1097 AVYNLLCS 1104
|
Source: Oryza sativa Indica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 886 | ||||||
| TAIR|locus:2020220 | 1112 | AT1G04210 [Arabidopsis thalian | 0.953 | 0.759 | 0.546 | 4.3e-244 | |
| TAIR|locus:2194055 | 992 | AT1G18160 [Arabidopsis thalian | 0.073 | 0.065 | 0.420 | 1.9e-19 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.073 | 0.063 | 0.420 | 1.8e-18 | |
| TAIR|locus:2143009 | 880 | AT5G11850 [Arabidopsis thalian | 0.099 | 0.1 | 0.320 | 3.8e-15 | |
| TAIR|locus:2076416 | 809 | AT3G58640 [Arabidopsis thalian | 0.225 | 0.247 | 0.243 | 2.5e-14 | |
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.080 | 0.076 | 0.448 | 4.7e-14 | |
| UNIPROTKB|F5H1S7 | 184 | ULK1 "Serine/threonine-protein | 0.176 | 0.847 | 0.305 | 4.1e-13 | |
| TAIR|locus:2133559 | 608 | MEKK1 "MAPK/ERK kinase kinase | 0.076 | 0.111 | 0.434 | 8.1e-13 | |
| UNIPROTKB|F1N1A8 | 324 | MKNK1 "MAP kinase-interacting | 0.155 | 0.425 | 0.348 | 9.4e-13 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.075 | 0.163 | 0.402 | 9.9e-13 |
| TAIR|locus:2020220 AT1G04210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2352 (833.0 bits), Expect = 4.3e-244, P = 4.3e-244
Identities = 473/866 (54%), Positives = 600/866 (69%)
Query: 16 SYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDVYEGPMLENDGNVSFSESDAGXXXXXX 75
SYC +P+WI CN EGN ++ D SS EMDV+E P EN NV + G
Sbjct: 260 SYCWIPTWIQCNFEGNYEEMGVDTCSSSMVEMDVFETPY-EN--NV-ITVPHKGSHRNPL 315
Query: 76 XXXXXXXXXXXXXXXXXXXKQWKR--HHLQQRARQERLNNSRKWRGEGHAQTSMKEGQRY 133
K+WKR ++ QQRARQERLNNSRKW+GE + + +
Sbjct: 316 NMSTGISSISRCFSARKSSKRWKRRQYYFQQRARQERLNNSRKWKGEVPPEGLSLKMEVE 375
Query: 134 KSGNLDALASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENC 193
++G + + D D++DK L EA + + E+++ + +N
Sbjct: 376 ETGKQGMKVPQNTDRGSVDNSCSDENDK--LFEEAS----VITSEEEESSLKADVVSDNS 429
Query: 194 SCAGLESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPK 253
C + T + N E + +SS S+ + D SSSE K K+KR S++ LDNPK
Sbjct: 430 QCVETQLTSERDNYESCEIKTSSPSSGDAPGTVDYNSSSERKKPNNKSKRCSEKYLDNPK 489
Query: 254 PCKSRKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREV 313
K K + +N S+KYSS SFCS ED LPDGF+DAGRDRPFM L+ YE+ LDSREV
Sbjct: 490 GSKCHKLSTDITNLSRKYSSNSFCSTEDSLPDGFFDAGRDRPFMTLSKYEKVLPLDSREV 549
Query: 314 ILVDRKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGS 373
IL+DR DE LDAI LSA+ALV LK+LN LT D +DNLQ+A LALFVSDHFGGS
Sbjct: 550 ILLDRAKDEVLDAITLSARALVARLKKLNCLTPDVDQVSIDNLQVASFLALFVSDHFGGS 609
Query: 374 DRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRS 433
DR+ I+ERTRK VSG+NY+KPF+CTC TGN D KQ+ ED +LSD+CEKSLRS
Sbjct: 610 DRTAIIERTRKAVSGTNYQKPFICTCLTGNQDDLAALNKQVSTTAEDAILSDVCEKSLRS 669
Query: 434 IKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVK 493
IKSKRNS+VVP+G +QFG+CRHRA+L+KYLCDR+EPPVPCELVRGYLDF PHAWN + VK
Sbjct: 670 IKSKRNSIVVPLGKLQFGICRHRALLMKYLCDRMEPPVPCELVRGYLDFMPHAWNIVPVK 729
Query: 494 KGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSL 553
+G SW+RM+VDACRPHDIRE+ D EYF RYIPL R ES L+PG S
Sbjct: 730 QGSSWVRMVVDACRPHDIREDTDQEYFCRYIPLNRL-----NESIRIK-EKLEPGCSVSS 783
Query: 554 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH 613
S + + +SSL RCK GS +A K+RTL+V G+S D+IR FEY+CLGEVR+LGAL+H
Sbjct: 784 LSTGKGVERANSSLIRCKLGSTEAVVKMRTLEVSGASLDDIRTFEYTCLGEVRILGALKH 843
Query: 614 SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVK 673
CIVE+YGH+ISSKW+ S +GN EH +LQS+I ME++KGGS+K +IEKLSE G+ HV +
Sbjct: 844 DCIVELYGHEISSKWITSENGN-EHRVLQSSILMEHIKGGSLKGHIEKLSEAGKHHVPMD 902
Query: 674 LALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSF 733
LAL IA+D++ AL+ELHSK I+HRDIKSEN+LIDL+ + A+G+P+VKLCDFDRAVPLRS
Sbjct: 903 LALSIARDISGALMELHSKDIIHRDIKSENVLIDLDNQSANGEPIVKLCDFDRAVPLRSH 962
Query: 734 LHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 793
LH CCIAH GIP P++CVGTPRWM+PEV RAMH+ N YGLEVDIWS+GCL+ ELLTLQ P
Sbjct: 963 LHGCCIAHVGIPPPNICVGTPRWMSPEVFRAMHEQNFYGLEVDIWSFGCLIFELLTLQNP 1022
Query: 794 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS--GSGFEKPEAELETLSFLVD 851
Y LSEL+IH+ +Q GKRP+L +LE L S E E + + F+ E++L+T+ FL+D
Sbjct: 1023 YFDLSELQIHESLQNGKRPKLPKKLETLISETEEEESTNKLSEVFDLTESDLDTMRFLID 1082
Query: 852 VFRRCTEENPTERPTAGDLYEMFVAR 877
VF +CTEE+P++R AGDL+EM ++R
Sbjct: 1083 VFHQCTEESPSDRLNAGDLHEMILSR 1108
|
|
| TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 127 (49.8 bits), Expect = 1.9e-19, Sum P(5) = 1.9e-19
Identities = 29/69 (42%), Positives = 41/69 (59%)
Query: 433 SIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRG--YLDFQPHAWNTI 490
S+K+ S+V+P+GS+ G+ RHRA+L K LCD V VPC +V+G Y A N+I
Sbjct: 282 SLKATLRSMVLPLGSLTIGLARHRALLFKVLCDSVG--VPCRIVKGQQYTGSDDVAMNSI 339
Query: 491 LVKKGDSWI 499
G +I
Sbjct: 340 KTDDGREYI 348
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 126 (49.4 bits), Expect = 1.8e-18, Sum P(4) = 1.8e-18
Identities = 29/69 (42%), Positives = 41/69 (59%)
Query: 433 SIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRG--YLDFQPHAWNTI 490
S+K+ S+V+P+GS+ G+ RHRA+L K LCD V VPC +V+G Y + A N I
Sbjct: 306 SLKATLGSMVLPLGSLTIGLARHRALLFKVLCDSVG--VPCRIVKGQQYTGSEDVAMNFI 363
Query: 491 LVKKGDSWI 499
G +I
Sbjct: 364 KADDGREYI 372
|
|
| TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 123 (48.4 bits), Expect = 3.8e-15, Sum P(4) = 3.8e-15
Identities = 33/103 (32%), Positives = 56/103 (54%)
Query: 718 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 777
VVK+CDF L H ++ + GTP WMAPEVLR ++P + D+
Sbjct: 745 VVKVCDFG----LSRMKHHTYLSSKST------AGTPEWMAPEVLR--NEPA--NEKCDV 790
Query: 778 WSYGCLLLELLTLQVPYMGLSELEIHDLIQM-GKRPRLTDELE 819
+S+G +L EL T +VP+ GL+ +++ + +R + D+++
Sbjct: 791 YSFGVILWELATSRVPWKGLNPMQVVGAVGFQNRRLEIPDDID 833
|
|
| TAIR|locus:2076416 AT3G58640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 111 (44.1 bits), Expect = 2.5e-14, Sum P(4) = 2.5e-14
Identities = 54/222 (24%), Positives = 94/222 (42%)
Query: 392 RKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFG 451
+K + +G + T K+I V D+ + +S +S N + +G ++ G
Sbjct: 126 QKQLITKLVSGLNSKPATIIKKIAGLVADVYKQSTLQSPAKSTQSFENCGIQLLGQIKHG 185
Query: 452 VCRHRAVLLKYLCD------RVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDA 505
CR RA+L K L D R+ +P + +D H T+L+ + M+VD
Sbjct: 186 SCRPRAILFKVLADTVGLQSRLVVGLPSDGAAESVDSYSHISVTVLLNS----VEMLVDL 241
Query: 506 CR-PHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPC-SGLDPGS----FPSLSSCDEA 559
R P + + F+ +I + A S +++ C S L+P S +P + A
Sbjct: 242 MRFPGQLIPLSTKAIFMSHI----SAAGESDSAENDSCDSPLEPNSPMFGYPEKFDHENA 297
Query: 560 GKSVSSSLFRCKFGSADAAAKV-RTLKVCGSSADEIRNFEYS 600
K + SL R GS + + R + + +SA E R +S
Sbjct: 298 EKDENLSLHRKLDGSPNTSGPPSRNMLLRSASALE-RKLSFS 338
|
|
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 126 (49.4 bits), Expect = 4.7e-14, Sum P(3) = 4.7e-14
Identities = 35/78 (44%), Positives = 45/78 (57%)
Query: 417 AVED--IVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCE 474
+ ED IVL+ EKS K+ N+ V PIG V+ G+ RHRA+L K L D V +PC
Sbjct: 233 SAEDSSIVLARWTEKS-SEFKAALNTCVFPIGFVKIGISRHRALLFKVLADSVR--LPCR 289
Query: 475 LVRG--YLDFQPHAWNTI 490
LV+G Y + A NTI
Sbjct: 290 LVKGSHYTGNEDDAVNTI 307
|
|
| UNIPROTKB|F5H1S7 ULK1 "Serine/threonine-protein kinase ULK1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 184 (69.8 bits), Expect = 4.1e-13, P = 4.1e-13
Identities = 55/180 (30%), Positives = 91/180 (50%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
+ MEY GG + +Y+ + E + LF+ Q +A A+ LHSK I+HRD+K +NI
Sbjct: 7 LVMEYCNGGDLADYLHAMRTLSEDTIR----LFL-QQIAGAMRLLHSKGIIHRDLKPQNI 61
Query: 705 LIDLER-KKADGKPV-VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 762
L+ ++A+ + VK+ DF A L+S + A +C G+P +MAPEV+
Sbjct: 62 LLSNPAGRRANPNSIRVKIADFGFARYLQS----------NMMAATLC-GSPMYMAPEVI 110
Query: 763 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR--PRLTDELEA 820
+ H Y + D+WS G ++ + LT + P+ S ++ + K P + E A
Sbjct: 111 MSQH----YDGKADLWSIGTIVYQCLTGKAPFQASSPQDLRLFYEKNKTLVPTIPRETSA 166
|
|
| TAIR|locus:2133559 MEKK1 "MAPK/ERK kinase kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 144 (55.7 bits), Expect = 8.1e-13, Sum P(4) = 8.1e-13
Identities = 30/69 (43%), Positives = 37/69 (53%)
Query: 750 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG 809
C GTP WMAPEV+ YG DIWS GC +LE+ T Q+PY L ++ I G
Sbjct: 489 CKGTPFWMAPEVINRKDSDG-YGSPADIWSLGCTVLEMCTGQIPYSDLEPVQALFRIGRG 547
Query: 810 KRPRLTDEL 818
P + D L
Sbjct: 548 TLPEVPDTL 556
|
|
| UNIPROTKB|F1N1A8 MKNK1 "MAP kinase-interacting serine/threonine-protein kinase 1" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 197 (74.4 bits), Expect = 9.4e-13, P = 9.4e-13
Identities = 54/155 (34%), Positives = 85/155 (54%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
+ E ++GGS+ +I+K +KH + + A + +DVAAAL LH+K I HRD+K ENI
Sbjct: 110 LVFEKLQGGSILAHIQK-----QKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENI 164
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV--GTPRWMAPEVL 762
L + K + PV K+CDFD ++ L+ C I P++ G+ +MAPEV+
Sbjct: 165 LCESPEKVS---PV-KICDFDLGSGVK--LNNSCTP---ITTPELTTPCGSAEYMAPEVV 215
Query: 763 RAM-HKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 796
+ Y D+WS G +L +L+ P++G
Sbjct: 216 EVFTDEATFYDKRCDLWSLGVVLYIMLSGYPPFVG 250
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 125 (49.1 bits), Expect = 9.9e-13, Sum P(4) = 9.9e-13
Identities = 29/72 (40%), Positives = 45/72 (62%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
I EY KGGSV+ + L+ + V +KLA+ A DVA + +H ++ +HRD+KS+N+
Sbjct: 206 IVTEYAKGGSVRQF---LTRRQNRAVPLKLAVKQALDVARGMAYVHGRNFIHRDLKSDNL 262
Query: 705 LIDLER--KKAD 714
LI ++ K AD
Sbjct: 263 LISADKSIKIAD 274
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 886 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-40 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-40 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-34 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-32 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-31 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-25 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-23 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-21 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-21 | |
| pfam14381 | 203 | pfam14381, EDR1, Ethylene-responsive protein kinas | 6e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-20 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-17 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-17 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-16 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-15 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-15 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-14 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-13 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-13 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-12 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-11 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-10 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-06 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-06 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 9e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.001 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.001 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.001 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.002 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.002 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 83/282 (29%), Positives = 117/282 (41%), Gaps = 71/282 (25%)
Query: 592 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK 651
+I+ L E+++L L+H IV +Y E L + MEY +
Sbjct: 35 KKIKKDRERILREIKILKKLKHPNIVRLYDV-----------FEDEDKLY---LVMEYCE 80
Query: 652 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 711
GG + + ++K +S A F + + +AL LHSK I+HRD+K ENIL+
Sbjct: 81 GGDLFDLLKK-----RGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILL----- 130
Query: 712 KADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 769
D VKL DF R + L T GTP +MAPEVL
Sbjct: 131 --DEDGHVKLADFGLARQLDPGEKLTTFV-------------GTPEYMAPEVLLGKG--- 172
Query: 770 LYGLEVDIWSYGCLLLELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHE 828
YG VDIWS G +L ELLT + P+ G +L E+ I K P E +
Sbjct: 173 -YGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDI-------- 223
Query: 829 VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 870
PEA D+ R+ ++P +R TA +
Sbjct: 224 ---------SPEA--------KDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 7e-40
Identities = 77/281 (27%), Positives = 118/281 (41%), Gaps = 60/281 (21%)
Query: 592 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK 651
E + + E+R+L L H IV + A + +H + MEY +
Sbjct: 36 SEKSKKDQTARREIRILRRLSHPNIVRLID----------AFEDKDH----LYLVMEYCE 81
Query: 652 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 711
GG + +Y+ + +S A IA + L LHS I+HRD+K ENIL+
Sbjct: 82 GGDLFDYLSR-----GGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILL----- 131
Query: 712 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 771
D VVK+ DF A + + VGTP +MAPEVL N Y
Sbjct: 132 --DENGVVKIADFGLA----------KKLLKSSSSLTTFVGTPWYMAPEVLL---GGNGY 176
Query: 772 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ 831
G +VD+WS G +L ELLT + P+ G + L+ LI+ P L
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL----------------- 219
Query: 832 SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 872
+ E + ++C ++P++RPTA ++ +
Sbjct: 220 EFDEPKWSSGSEEAKDLI----KKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 65/230 (28%), Positives = 94/230 (40%), Gaps = 46/230 (20%)
Query: 560 GKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV 617
G+ +++ + A K+ + S +E+ E+ +L L H IV
Sbjct: 2 GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLR-------EIEILKKLNHPNIV 54
Query: 618 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALF 677
++YG L + MEY +GGS+K+ +++ E +S L
Sbjct: 55 KLYGVFEDENHL--------------YLVMEYCEGGSLKDLLKEN----EGKLSEDEILR 96
Query: 678 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 737
I + L LHS I+HRD+K ENIL+D VKL DF + L S
Sbjct: 97 ILLQILEGLEYLHSNGIIHRDLKPENILLD------SDNGKVKLADFGLSKLLTSDKSLL 150
Query: 738 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787
VGTP +MAPEVL Y + DIWS G +L EL
Sbjct: 151 K----------TIVGTPAYMAPEVLLGKGY---YSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 92/297 (30%), Positives = 131/297 (44%), Gaps = 79/297 (26%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+++++ G S +E+ + E+R+L +L+H IV YG + ++ L
Sbjct: 30 VKSVELSGDSEEELE----ALEREIRILSSLQHPNIVRYYGSERD---------EEKNTL 76
Query: 641 LQSAIFMEYVKGGSVKNYIEK---LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 697
IF+EYV GGS+ + ++K L E + + + L LHS I+HR
Sbjct: 77 N---IFLEYVSGGSLSSLLKKFGKLPEPVIRKY--------TRQILEGLAYLHSNGIVHR 125
Query: 698 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 757
DIK NIL+D +DG VVKL DF A L GTP WM
Sbjct: 126 DIKGANILVD-----SDG--VVKLADFGCAKRLGDIETGEGTGSV--------RGTPYWM 170
Query: 758 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP--RLT 815
APEV+R YG DIWS GC ++E+ T GK P L
Sbjct: 171 APEVIRGE----EYGRAADIWSLGCTVIEMAT-------------------GKPPWSELG 207
Query: 816 DELEALGSCHEHEVAQSGSGFEKPEAEL--ETLSFLVDVFRRCTEENPTERPTAGDL 870
+ + AL +++ SG E PE L E FL R+C +P +RPTA +L
Sbjct: 208 NPMAAL-----YKIGSSGEPPEIPE-HLSEEAKDFL----RKCLRRDPKKRPTADEL 254
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 85/306 (27%), Positives = 126/306 (41%), Gaps = 81/306 (26%)
Query: 569 RCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--HKISS 626
R K + A KV L+ I E+++L +H IV+ YG K
Sbjct: 20 RHKRTGKEVAIKVIKLESKEKKEKIIN--------EIQILKKCKHPNIVKYYGSYLKKDE 71
Query: 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-GEKHVSVKLALFIAQDVAAA 685
W I ME+ GGS+K+ ++ ++T E ++ ++ +++
Sbjct: 72 LW----------------IVMEFCSGGSLKDLLKSTNQTLTESQIA-----YVCKELLKG 110
Query: 686 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP 745
L LHS I+HRDIK+ NIL+ +DG+ VKL DF + L
Sbjct: 111 LEYLHSNGIIHRDIKAANILL-----TSDGE--VKLIDFGLSAQLSD-----------TK 152
Query: 746 APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 805
A + VGTP WMAPEV+ Y + DIWS G +EL + PY SEL
Sbjct: 153 ARNTMVGTPYWMAPEVINGKP----YDYKADIWSLGITAIELAEGKPPY---SELPPMKA 205
Query: 806 IQMGKRPRLTDELEALGSCHEHEVAQSGS-GFEKPEAELETLSFLVDVFRRCTEENPTER 864
+ +A +G G P E + F D ++C ++NP +R
Sbjct: 206 LFK--------------------IATNGPPGLRNP--EKWSDEF-KDFLKKCLQKNPEKR 242
Query: 865 PTAGDL 870
PTA L
Sbjct: 243 PTAEQL 248
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 77/297 (25%), Positives = 125/297 (42%), Gaps = 74/297 (24%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+TLK +S +I F L E R++ L H IV++ G + ++ E +
Sbjct: 33 VKTLKE-DASEQQIEEF----LREARIMRKLDHPNIVKLLG--VCTE--------EEPLM 77
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
+ MEY+ GG + +Y L + K +S+ L A +A + L SK+ +HRD+
Sbjct: 78 IV----MEYMPGGDLLDY---LRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLA 130
Query: 701 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 758
+ N L+ VVK+ DF R + + +P RWMA
Sbjct: 131 ARNCLVGENL-------VVKISDFGLSRDLYDDDYYKV---KGGKLPI--------RWMA 172
Query: 759 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 817
PE L+ + + D+WS+G LL E+ TL + PY G+S E+ + ++ G R
Sbjct: 173 PESLKE----GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYR------ 222
Query: 818 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
L +C L + +C E+P +RPT +L E+
Sbjct: 223 LPKPPNCPPE---------------------LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 76/297 (25%), Positives = 125/297 (42%), Gaps = 75/297 (25%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+TLK +S +I F L E R++ L H +V++ G + ++ E
Sbjct: 33 VKTLKE-DASEQQIEEF----LREARIMRKLDHPNVVKLLG--VCTE--------EEPLY 77
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
+ MEY++GG + +Y+ K +S+ L A +A + L SK+ +HRD+
Sbjct: 78 IV----MEYMEGGDLLSYLRKN----RPKLSLSDLLSFALQIARGMEYLESKNFIHRDLA 129
Query: 701 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 758
+ N L+ VVK+ DF R + + +P RWMA
Sbjct: 130 ARNCLV-------GENLVVKISDFGLSRDLYDDDYYRK---RGGKLPI--------RWMA 171
Query: 759 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 817
PE L+ + + D+WS+G LL E+ TL + PY G+S E+ + ++ G R
Sbjct: 172 PESLKEGK----FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYR------ 221
Query: 818 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
L +C L D+ +C E+P +RPT +L E+
Sbjct: 222 LPQPPNCPPE---------------------LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 76/297 (25%), Positives = 125/297 (42%), Gaps = 74/297 (24%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+TLK G+S +E F L E ++ L H IV + G + ++ L
Sbjct: 33 VKTLK-EGASEEEREEF----LEEASIMKKLSHPNIVRLLG--VCTQ---------GEPL 76
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
I EY+ GG + +++ K E +++K L +A +A + L SK+ +HRD+
Sbjct: 77 Y---IVTEYMPGGDLLDFLRKHGE----KLTLKDLLQMALQIAKGMEYLESKNFVHRDLA 129
Query: 701 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 758
+ N L+ VVK+ DF R + + G P +WMA
Sbjct: 130 ARNCLV-------TENLVVKISDFGLSRDIYEDDYYR----KRGGGKLP------IKWMA 172
Query: 759 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 817
PE L+ + + D+WS+G LL E+ TL + PY G+S E+ +L++ G R
Sbjct: 173 PESLKDGK----FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYR------ 222
Query: 818 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
L +C + L ++ +C +P +RPT +L E
Sbjct: 223 LPRPENCPDE---------------------LYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 122 bits (310), Expect = 3e-31
Identities = 78/286 (27%), Positives = 118/286 (41%), Gaps = 67/286 (23%)
Query: 588 GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM 647
S E + L EV++L L H I++ Y L I M
Sbjct: 37 NMSEKERED----ALNEVKILKKLNHPNIIKYYESFEEKG-----------KLC---IVM 78
Query: 648 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707
EY GG + I+K + G K + L + AL LHS+ I+HRDIK +NI +
Sbjct: 79 EYADGGDLSQKIKKQKKEG-KPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT 137
Query: 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 767
++G +VKL DF + + T +A VGTP +++PE+ + +K
Sbjct: 138 -----SNG--LVKLGDFGIS---KVLSSTVDLAK-------TVVGTPYYLSPELCQ--NK 178
Query: 768 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH 827
P Y + DIWS GC+L EL TL+ P+ G + LE+ I G+ P +
Sbjct: 179 P--YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI------------- 223
Query: 828 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 873
P L LV +++P ERP+ + +
Sbjct: 224 -----------PSQYSSELRNLVS---SLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 78/274 (28%), Positives = 115/274 (41%), Gaps = 74/274 (27%)
Query: 603 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 662
E+ +L L+H IV+ G + L IF+E V GGS+ ++K
Sbjct: 51 QEIALLSKLQHPNIVQYLGTEREEDNL--------------YIFLELVPGGSLAKLLKKY 96
Query: 663 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 722
E + L+ Q + L LH ++ +HRDIK NIL+D +G VVKL
Sbjct: 97 GSFPEPVIR----LYTRQ-ILLGLEYLHDRNTVHRDIKGANILVD-----TNG--VVKLA 144
Query: 723 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 782
DF A + F G+P WMAPEV+ + YGL DIWS GC
Sbjct: 145 DFGMAKQVVEFSFA-----------KSFKGSPYWMAPEVIA---QQGGYGLAADIWSLGC 190
Query: 783 LLLELLTLQVPYMGLSELE----IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 838
+LE+ T + P+ S+LE + + + + P + D L
Sbjct: 191 TVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPIPDHLS------------------- 228
Query: 839 PEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 872
EA+ D +C + +P+ RPTA +L E
Sbjct: 229 DEAK--------DFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 77/299 (25%), Positives = 127/299 (42%), Gaps = 70/299 (23%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+TLK +S +E ++F L E R++ L H +V + G + ++ E L
Sbjct: 28 VKTLK-EDASEEERKDF----LKEARVMKKLGHPNVVRLLG--VCTE---------EEPL 71
Query: 641 LQSAIFMEYVKGGSVKNYIEK----LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 696
+ +EY++GG + +Y+ K + +S+K L A +A + L SK +H
Sbjct: 72 Y---LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVH 128
Query: 697 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 756
RD+ + N L+ VVK+ DF + + + +P RW
Sbjct: 129 RDLAARNCLV-------GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI--------RW 173
Query: 757 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 815
MAPE L K ++ + D+WS+G LL E+ TL PY GLS E+ + ++ G R
Sbjct: 174 MAPESL----KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL--- 226
Query: 816 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
KPE + L ++ C + +P +RPT +L E
Sbjct: 227 ---------------------PKPEYCPDELY---ELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 72/281 (25%), Positives = 118/281 (41%), Gaps = 88/281 (31%)
Query: 602 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGS----V 655
+ E+ ++ +H IV+ Y + +L+ ++ MEY+ GGS +
Sbjct: 63 INEILIMKDCKHPNIVDYY----------------DSYLVGDELWVVMEYMDGGSLTDII 106
Query: 656 KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 715
+++E ++ ++ ++V L LHS++++HRDIKS+NIL+ DG
Sbjct: 107 TQNFVRMNEP---QIA-----YVCREVLQGLEYLHSQNVIHRDIKSDNILLSK-----DG 153
Query: 716 KPVVKLCDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 769
VKL DF + R+ + VGTP WMAPEV++
Sbjct: 154 --SVKLADFGFAAQLTKEKSKRNSV----------------VGTPYWMAPEVIKR----K 191
Query: 770 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEV 829
YG +VDIWS G + +E+ + PY+ L LI P L +
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNP------------ 239
Query: 830 AQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 870
EK E FL +C ++P +RP+A +L
Sbjct: 240 -------EKWSPEF--KDFL----NKCLVKDPEKRPSAEEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 69/211 (32%), Positives = 92/211 (43%), Gaps = 52/211 (24%)
Query: 600 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 659
S + E+ +L L+H IV+ G +S L I +EY + GS++ I
Sbjct: 45 SIMQEIDLLKNLKHPNIVKYIGSIETSDSL--------------YIILEYAENGSLRQII 90
Query: 660 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 719
+K E V+V ++ Q V L LH + ++HRDIK+ NIL DG VV
Sbjct: 91 KKFGPFPESLVAV----YVYQ-VLQGLAYLHEQGVIHRDIKAANILT-----TKDG--VV 138
Query: 720 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV--DI 777
KL DF A L VGTP WMAPEV+ + G DI
Sbjct: 139 KLADFGVATKLNDVSKD----------DASVVGTPYWMAPEVI------EMSGASTASDI 182
Query: 778 WSYGCLLLELLTLQVPYMGLSELEIHDLIQM 808
WS GC ++ELLT PY +DL M
Sbjct: 183 WSLGCTVIELLTGNPPY--------YDLNPM 205
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 59/164 (35%), Positives = 81/164 (49%), Gaps = 26/164 (15%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
+EY GG + +++ K E S + A F A ++ AL LHS I++RD+K ENIL+
Sbjct: 72 LEYAPGGELFSHLSK-----EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL 126
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 766
D ADG +KL DF A L S + GTP ++APEVL +
Sbjct: 127 D-----ADGH--IKLTDFGLAKELSSEGSRT----------NTFCGTPEYLAPEVL--LG 167
Query: 767 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
K YG VD WS G LL E+LT + P+ EI++ I
Sbjct: 168 KG--YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP 209
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 81/269 (30%), Positives = 120/269 (44%), Gaps = 59/269 (21%)
Query: 603 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 662
E+++L L+H +V+ YG E H + IFMEY GG+ +E+L
Sbjct: 48 DEMKVLELLKHPNLVKYYG--------------VEVHREKVYIFMEYCSGGT----LEEL 89
Query: 663 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 722
E G + ++ Q + L LHS I+HRDIK NI +D +G V+KL
Sbjct: 90 LEHGRILDEHVIRVYTLQ-LLEGLAYLHSHGIVHRDIKPANIFLD-----HNG--VIKLG 141
Query: 723 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 782
DF AV L++ +T + GTP +MAPEV+ K +G DIWS GC
Sbjct: 142 DFGCAVKLKN--NTTTMGEEV----QSLAGTPAYMAPEVITG-GKGKGHGRAADIWSLGC 194
Query: 783 LLLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 841
++LE+ T + P+ L +E +I + G +P + D L+
Sbjct: 195 VVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGK---------------- 238
Query: 842 ELETLSFLVDVFRRCTEENPTERPTAGDL 870
D RC E +P +RPTA +L
Sbjct: 239 ---------DFLDRCLESDPKKRPTASEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 77/271 (28%), Positives = 115/271 (42%), Gaps = 69/271 (25%)
Query: 603 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK- 661
E+++L L+H IV+ YG + E +IFMEY+ GGSVK+ ++
Sbjct: 53 CEIQLLKNLQHERIVQYYG----------CLRDDET----LSIFMEYMPGGSVKDQLKAY 98
Query: 662 --LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 719
L+ET V+ K I + V LHS I+HRDIK NIL D V
Sbjct: 99 GALTET----VTRKYTRQILEGVEY----LHSNMIVHRDIKGANILRDSAGN-------V 143
Query: 720 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 779
KL DF + L T C + G+ + GTP WM+PEV+ YG + D+WS
Sbjct: 144 KLGDFGAS----KRLQTICSSGTGMKS---VTGTPYWMSPEVISG----EGYGRKADVWS 192
Query: 780 YGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP 839
GC ++E+LT + P+ + + ++ +P P
Sbjct: 193 VGCTVVEMLTEKPPWAEFEAMAA--IFKIATQP------------------------TNP 226
Query: 840 EAELETLSFLVDVFRRCTEENPTERPTAGDL 870
+ + RR EN +RP+A +L
Sbjct: 227 QLPSHVSPDARNFLRRTFVENAKKRPSAEEL 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 78/269 (28%), Positives = 110/269 (40%), Gaps = 71/269 (26%)
Query: 604 EVRMLGALRHSCIVEMYGH--KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 661
E++ L R I + YG K S W I MEY GGS + + K
Sbjct: 49 EIQFLSQCRSPYITKYYGSFLKGSKLW----------------IIMEYCGGGSCLDLL-K 91
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
+ E +++ FI ++V L LH + +HRDIK+ NIL+ +G VKL
Sbjct: 92 PGKLDETYIA-----FILREVLLGLEYLHEEGKIHRDIKAANILLS-----EEGD--VKL 139
Query: 722 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781
DF + L S ++ R + VGTP WMAPEV+ K + Y + DIWS G
Sbjct: 140 ADFGVSGQLTS-----TMSKR-----NTFVGTPFWMAPEVI----KQSGYDEKADIWSLG 185
Query: 782 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 841
+EL + P L + + LI P L G+ F KP
Sbjct: 186 ITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE-----------------GNKFSKP-- 226
Query: 842 ELETLSFLVDVFRRCTEENPTERPTAGDL 870
D C ++P ERP+A +L
Sbjct: 227 -------FKDFVSLCLNKDPKERPSAKEL 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 66/219 (30%), Positives = 93/219 (42%), Gaps = 45/219 (20%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
EV +L L+H IV Y I + + L I MEY +GG + I+K
Sbjct: 49 EVNILRELKHPNIVRYYDRII----------DRSNQTLY--IVMEYCEGGDLAQLIQKCK 96
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELH-----SKHIMHRDIKSENILIDLERKKADGKPV 718
+ + + + I + AL E H ++HRD+K NI +D
Sbjct: 97 KERKY-IEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD-------ANNN 148
Query: 719 VKLCDFDRAVPL---RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 775
VKL DF A L SF T VGTP +M+PE L M Y +
Sbjct: 149 VKLGDFGLAKILGHDSSFAKTY-------------VGTPYYMSPEQLNHMS----YDEKS 191
Query: 776 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 814
DIWS GCL+ EL L P+ ++L++ I+ GK R+
Sbjct: 192 DIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRI 230
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 106 bits (264), Expect = 2e-24
Identities = 76/293 (25%), Positives = 108/293 (36%), Gaps = 43/293 (14%)
Query: 595 RNFEYSCLGEVRMLGALRH-SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG 653
L E+++L +L H IV++Y + MEYV GG
Sbjct: 38 SKEVERFLREIQILASLNHPPNIVKLYDFFQDEG--------------SLYLVMEYVDGG 83
Query: 654 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 713
S+++ ++K+ G +S ALFI + +AL LHSK I+HRDIK ENIL+D + +
Sbjct: 84 SLEDLLKKIGRKGP--LSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRV- 140
Query: 714 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 773
VKL DF L L P VGTP +MAPEVL +
Sbjct: 141 -----VKLIDF----GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAY-ASS 190
Query: 774 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG 833
DIWS G L ELLT P+ G T L
Sbjct: 191 SSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL--------------- 235
Query: 834 SGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSISSRS 886
+ P D+ ++ ++P R ++ + S
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDL 288
|
Length = 384 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 71/229 (31%), Positives = 95/229 (41%), Gaps = 52/229 (22%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
I MEY +GGSV+ + K EK++SV I ++V AL +H ++HRDIK+ NI
Sbjct: 79 IIMEYAEGGSVRT-LMKAGPIAEKYISV-----IIREVLVALKYIHKVGVIHRDIKAANI 132
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 764
L+ VKLCDF A L VGTP WMAPEV+
Sbjct: 133 LVTNTGN-------VKLCDFGVAALLNQ----------NSSKRSTFVGTPYWMAPEVIT- 174
Query: 765 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 824
+ Y + DIWS G + E+ T PY + LI K PRL D
Sbjct: 175 --EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDN------- 225
Query: 825 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 873
G+ K L + C +E P ER +A +L +
Sbjct: 226 ----------GYSK---------LLREFVAACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 4e-22
Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 43/210 (20%)
Query: 601 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 660
L E R+L ++RH +V +YG L +L+ MEYV GG + +++
Sbjct: 48 VLNEKRILQSIRHPFLVNLYGSFQDDSNL---------YLV-----MEYVPGGELFSHLR 93
Query: 661 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 720
K E A F A V AL LHS I++RD+K EN+L+D +DG +K
Sbjct: 94 KSGRFPEPV-----ARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD-----SDGY--IK 141
Query: 721 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 780
+ DF A ++ +T C GTP ++APE++ K YG VD W+
Sbjct: 142 ITDFGFAKRVKGRTYTLC-------------GTPEYLAPEIIL--SKG--YGKAVDWWAL 184
Query: 781 GCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
G L+ E+L P+ + ++I++ I GK
Sbjct: 185 GILIYEMLAGYPPFFDDNPIQIYEKILEGK 214
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 76/272 (27%), Positives = 107/272 (39%), Gaps = 67/272 (24%)
Query: 603 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 662
E+ ML RH IV +G + L I MEY GGS+++ +
Sbjct: 49 QEISMLKECRHPNIVAYFGSYLRRDKL--------------WIVMEYCGGGSLQDIYQVT 94
Query: 663 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 722
+S ++ ++ L LH +HRDIK NIL+ DG VKL
Sbjct: 95 RG----PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL-----TEDGD--VKLA 143
Query: 723 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 782
DF + L T IA R +GTP WMAPEV A+ + Y + DIW+ G
Sbjct: 144 DFGVSAQL-----TATIAKR-----KSFIGTPYWMAPEVA-AVERKGGYDGKCDIWALGI 192
Query: 783 LLLELLTLQVPYMGLSELEIHDLIQMGKR----PRLTDELEALGSCHEHEVAQSGSGFEK 838
+EL LQ P L + L + K P+L D+
Sbjct: 193 TAIELAELQPPMFDLHPMRA--LFLISKSNFPPPKLKDK--------------------- 229
Query: 839 PEAELETLSFLVDVFRRCTEENPTERPTAGDL 870
E + F D ++C ++P +RPTA L
Sbjct: 230 ---EKWSPVF-HDFIKKCLTKDPKKRPTATKL 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 75/302 (24%), Positives = 113/302 (37%), Gaps = 70/302 (23%)
Query: 577 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGN 635
A K+ + + +EI+ E +L H I YG I N
Sbjct: 34 VAIKI--MDIIEDEEEEIKE-------EYNILRKYSNHPNIATFYGAFIKK--------N 76
Query: 636 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETG----EKHVSVKLALFIAQDVAAALVELHS 691
P + Q + ME GGSV + ++ L + G E+ ++ +I ++ L LH
Sbjct: 77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA-----YILRETLRGLAYLHE 131
Query: 692 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV 751
++HRDIK +NIL+ K A+ VKL DF + L S L + +
Sbjct: 132 NKVIHRDIKGQNILLT---KNAE----VKLVDFGVSAQLDSTLG----------RRNTFI 174
Query: 752 GTPRWMAPEVLRAMHKPNL-YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
GTP WMAPEV+ +P+ Y D+WS G +EL + P + + I
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP 234
Query: 811 RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 870
P L E + F D C +N +RP +L
Sbjct: 235 PPTLK------------------------SPENWSKKF-NDFISECLIKNYEQRPFMEEL 269
Query: 871 YE 872
E
Sbjct: 270 LE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 75/269 (27%), Positives = 118/269 (43%), Gaps = 70/269 (26%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 661
EV ++ +H IVEMY +L+ ++ ME+++GG++ + +
Sbjct: 66 EVVIMRDYQHPNIVEMYSS----------------YLVGDELWVVMEFLEGGALTDIVTH 109
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
E+ +V LA V AL LH++ ++HRDIKS++IL+ +DG VKL
Sbjct: 110 TRMNEEQIATVCLA------VLKALSFLHAQGVIHRDIKSDSILL-----TSDG--RVKL 156
Query: 722 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781
DF F C + +P VGTP WMAPEV+ + YG EVDIWS G
Sbjct: 157 SDF-------GF---CAQVSKEVPRRKSLVGTPYWMAPEVISRL----PYGTEVDIWSLG 202
Query: 782 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 841
+++E++ + PY L+ I+ P+L + H+V+ F
Sbjct: 203 IMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLK---------NLHKVSPRLRSF----- 248
Query: 842 ELETLSFLVDVFRRCTEENPTERPTAGDL 870
R +P +R TA +L
Sbjct: 249 -----------LDRMLVRDPAQRATAAEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (234), Expect = 5e-21
Identities = 60/217 (27%), Positives = 91/217 (41%), Gaps = 57/217 (26%)
Query: 600 SCLGEVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSV 655
+ L E+ +L L+H IV++ H +L +F + +
Sbjct: 44 TALREISLLKELKHPNIVKLLDVIHTERKLYL---------------VFEYCDM----DL 84
Query: 656 KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 715
K Y++K +S L I + L HS I+HRD+K +NILI +
Sbjct: 85 KKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI-------NR 133
Query: 716 KPVVKLCDFD--RA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 771
V+KL DF RA +PLR++ H V T + APE+L Y
Sbjct: 134 DGVLKLADFGLARAFGIPLRTYTHE--------------VVTLWYRAPEILLGSKH---Y 176
Query: 772 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 808
VDIWS GC+ E++T + + G S EI L ++
Sbjct: 177 STAVDIWSVGCIFAEMITGKPLFPGDS--EIDQLFKI 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|222722 pfam14381, EDR1, Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 6e-21
Identities = 69/255 (27%), Positives = 93/255 (36%), Gaps = 75/255 (29%)
Query: 265 SNASQKYSSVSFCSIEDRLPDGFYD---------AGRDRPFMQLTGYEQTPHLD-SREVI 314
S +Y S +D++PDGFYD L + P D S EV+
Sbjct: 5 EALSHRYWVYGCLSYDDKIPDGFYDIYGMDPCSDLKEFGRIPSLEDLQAVPPGDSSFEVV 64
Query: 315 LVDRKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSD 374
LVDR++D +L + A+ LV + + LA VSDH GG
Sbjct: 65 LVDRRTDPKLKELEQLARCLVSGC-------------GTNTAALVQKLAGLVSDHMGGP- 110
Query: 375 RSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSI 434
V + S L S
Sbjct: 111 -----------VKDAE---------------------------------SMLARWKECSN 126
Query: 435 KSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRG--YLDFQPHAWNTILV 492
+ K NS VVP+GS++ G+CRHRA+L K L D + +PC LV+G Y A N LV
Sbjct: 127 ELKENSGVVPLGSLKIGLCRHRALLFKVLADSIG--LPCRLVKGCKYCGSDDDASN--LV 182
Query: 493 KKGDSWIRMIVDACR 507
K D +VD
Sbjct: 183 KFDDG-REYLVDLMG 196
|
EDR1 regulates disease resistance and ethylene-induced senescence, and is also involved in stress response signalling and cell death regulation. Length = 203 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 9e-21
Identities = 51/171 (29%), Positives = 76/171 (44%), Gaps = 26/171 (15%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
+EY G + YI K + K F A ++ AL LHSK I+HRD+K ENIL+
Sbjct: 81 LEYAPNGELLQYIRKYGS-----LDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL 135
Query: 707 DLERKKADGKPVVKLCDFDRA-------VPLRSFLHTCCIAHRGIPAPDVC---VGTPRW 756
D D +K+ DF A P + I + VGT +
Sbjct: 136 D-----KDMH--IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEY 188
Query: 757 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ 807
++PE+L KP G D+W+ GC++ ++LT + P+ G +E I
Sbjct: 189 VSPELLN--EKP--AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 82/308 (26%), Positives = 136/308 (44%), Gaps = 74/308 (24%)
Query: 577 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY-GHKISSK-WLPSADG 634
AAAK+ ++ S +E+ +F + E+ +L +H IV +Y + +K W
Sbjct: 33 AAAKIIQIE----SEEELEDF----MVEIDILSECKHPNIVGLYEAYFYENKLW------ 78
Query: 635 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHI 694
I +E+ GG++ + + +L E+ ++ ++ + + AL LHS +
Sbjct: 79 ----------ILIEFCDGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHSHKV 124
Query: 695 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 754
+HRD+K+ NIL+ L+ VKL DF + +S L D +GTP
Sbjct: 125 IHRDLKAGNILLTLDGD-------VKLADFGVSAKNKSTLQK----------RDTFIGTP 167
Query: 755 RWMAPEVLRA-MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPR 813
WMAPEV+ K N Y + DIWS G L+EL ++ P+ L+ + + I + P
Sbjct: 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPT 227
Query: 814 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 873
L Q S + SF D + C ++P +RPTA +L +
Sbjct: 228 L---------------DQP-SKWSS--------SF-NDFLKSCLVKDPDDRPTAAELLKH 262
Query: 874 -FVARTSS 880
FV+ S
Sbjct: 263 PFVSDQSD 270
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 68/268 (25%), Positives = 104/268 (38%), Gaps = 66/268 (24%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E+ +L IV+ YG + L I MEY GSV + ++ +
Sbjct: 48 EISILKQCDSPYIVKYYGSYFKNT-----------DLW---IVMEYCGAGSVSDIMKITN 93
Query: 664 ET-GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 722
+T E+ ++ I L LHS +HRDIK+ NIL++ +G KL
Sbjct: 94 KTLTEEEIAA-----ILYQTLKGLEYLHSNKKIHRDIKAGNILLN-----EEG--QAKLA 141
Query: 723 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 782
DF + L + A R +GTP WMAPEV+ + Y + DIWS G
Sbjct: 142 DFGVSGQLTDTM-----AKRN-----TVIGTPFWMAPEVI----QEIGYNNKADIWSLGI 187
Query: 783 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 842
+E+ + PY +IH + + P + PE
Sbjct: 188 TAIEMAEGKPPYS-----DIHPMRAIFMIPN-----------------KPPPTLSDPE-- 223
Query: 843 LETLSFLVDVFRRCTEENPTERPTAGDL 870
+ D ++C ++P ERP+A L
Sbjct: 224 -KWSPEFNDFVKKCLVKDPEERPSAIQL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 77/285 (27%), Positives = 117/285 (41%), Gaps = 90/285 (31%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E+ L L H IV+ G E +IF+EYV GGS+ + +
Sbjct: 58 EIETLKDLDHLNIVQYLGF--------------ETTEEYLSIFLEYVPGGSIGSCLRTYG 103
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
E+ V F + V L LHSK I+HRD+K++N+L+D ADG + K+ D
Sbjct: 104 RFEEQLVR-----FFTEQVLEGLAYLHSKGILHRDLKADNLLVD-----ADG--ICKISD 151
Query: 724 F------------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 771
F D+ + ++ G+ WMAPEV+ + + Y
Sbjct: 152 FGISKKSDDIYDNDQNMSMQ--------------------GSVFWMAPEVIHSYSQG--Y 189
Query: 772 GLEVDIWSYGCLLLELLTLQVPYMGLSELE-IHDLIQMG---KRPRLTDELEALGSCHEH 827
+VDIWS GC++LE+ + P+ S+ E I + ++G P + ++ S
Sbjct: 190 SAKVDIWSLGCVVLEMFAGRRPW---SDEEAIAAMFKLGNKRSAPPIPPDVSMNLS---- 242
Query: 828 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 872
P A L FL C NP RPTA +L +
Sbjct: 243 -----------PVA----LDFL----NACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 76/321 (23%), Positives = 125/321 (38%), Gaps = 69/321 (21%)
Query: 557 DEAGKSVSSSLFR--CKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS 614
+ G ++ ++ C + A K L+ C +S DE+R EV+ + H
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRK-------EVQAMSQCNHP 59
Query: 615 CIVEMYGHKI--SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE-KLSETGEKHVS 671
+V+ Y + W + M Y+ GGS+ + ++ G
Sbjct: 60 NVVKYYTSFVVGDELW----------------LVMPYLSGGSLLDIMKSSYPRGGLDEAI 103
Query: 672 VKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 731
+ + ++V L LHS +HRDIK+ NIL+ DG VK+ DF +
Sbjct: 104 IA---TVLKEVLKGLEYLHSNGQIHRDIKAGNILLG-----EDGS--VKIADFGVSA--- 150
Query: 732 SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 791
S + VGTP WMAPEV M + + Y + DIWS+G +EL T
Sbjct: 151 SLADGGDRTRK---VRKTFVGTPCWMAPEV---MEQVHGYDFKADIWSFGITAIELATGA 204
Query: 792 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 851
PY +++ L P L + + F K ++
Sbjct: 205 APYSKYPPMKVLMLTLQNDPPSLE---------TGADYKKYSKSFRK----------MIS 245
Query: 852 VFRRCTEENPTERPTAGDLYE 872
C +++P++RPTA +L +
Sbjct: 246 ---LCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 75/278 (26%), Positives = 122/278 (43%), Gaps = 67/278 (24%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
EV ++ +H +VEMY + + L + ME+++GG++ + + +
Sbjct: 68 EVVIMRDYQHQNVVEMYKSYLVGEEL--------------WVLMEFLQGGALTDIVSQTR 113
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
E+ +V + V AL LHS+ ++HRDIKS++IL+ L DG+ VKL D
Sbjct: 114 LNEEQIATV------CESVLQALCYLHSQGVIHRDIKSDSILLTL-----DGR--VKLSD 160
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
F C + +P VGTP WMAPEV+ YG EVDIWS G +
Sbjct: 161 FG----------FCAQISKDVPKRKSLVGTPYWMAPEVI----SRTPYGTEVDIWSLGIM 206
Query: 784 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 843
++E++ + PY S ++ ++ P+L + H+++
Sbjct: 207 VIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN---------AHKIS------------- 244
Query: 844 ETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSS 880
L D R P ER TA +L + F+ +T
Sbjct: 245 ---PVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 74/234 (31%), Positives = 110/234 (47%), Gaps = 46/234 (19%)
Query: 587 CGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF 646
++ E+ E C E+++L LRH IV+ YG +PE L +IF
Sbjct: 41 SQETSKEVNALE--C--EIQLLKNLRHDRIVQYYG----------CLRDPEEKKL--SIF 84
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
+EY+ GGS+K+ ++ E V+ + I Q V+ LHS I+HRDIK NIL
Sbjct: 85 VEYMPGGSIKDQLKAYGALTEN-VTRRYTRQILQGVSY----LHSNMIVHRDIKGANIL- 138
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 766
D VKL DF + + T C++ GI + GTP WM+PEV+
Sbjct: 139 ------RDSAGNVKLGDFGAS----KRIQTICMSGTGIKS---VTGTPYWMSPEVISG-- 183
Query: 767 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE----IHDLIQMGKRPRLTD 816
YG + D+WS C ++E+LT + P+ +E E I + +P L D
Sbjct: 184 --EGYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPMLPD 232
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 73/290 (25%), Positives = 116/290 (40%), Gaps = 58/290 (20%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+ + +++ E + E+R++ L H I+ M G A H
Sbjct: 30 VKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLG----------ATCEDSHF- 78
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
+F+E++ GGSV + + K E V + + + L LH I+HRD+K
Sbjct: 79 ---NLFVEWMAGGSVSHLLSKYGAFKEA-VIINYTEQLLR----GLSYLHENQIIHRDVK 130
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 760
N+LID + G+ +++ DF A L + T +G +GT +MAPE
Sbjct: 131 GANLLID-----STGQ-RLRIADFGAAARLAAKG-TGAGEFQG-----QLLGTIAFMAPE 178
Query: 761 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEA 820
VLR YG D+WS GC+++E+ T K P ++
Sbjct: 179 VLRGEQ----YGRSCDVWSVGCVIIEMAT-------------------AKPPWNAEKH-- 213
Query: 821 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 870
S H + + S P L DV RC E P +RP + +L
Sbjct: 214 --SNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 61/207 (29%), Positives = 88/207 (42%), Gaps = 37/207 (17%)
Query: 601 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 660
CL E+ +L L H +++ I + L I +E G + I+
Sbjct: 49 CLKEIDLLKQLDHPNVIKYLASFIENNEL--------------NIVLELADAGDLSRMIK 94
Query: 661 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 720
+ + + Q + +AL +HSK IMHRDIK N+ I A G VVK
Sbjct: 95 HFKKQKRLIPERTIWKYFVQ-LCSALEHMHSKRIMHRDIKPANVFIT-----ATG--VVK 146
Query: 721 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 780
L D R F AH VGTP +M+PE + N Y + DIWS
Sbjct: 147 LGDLGLG---RFFSSKTTAAHS-------LVGTPYYMSPERIHE----NGYNFKSDIWSL 192
Query: 781 GCLLLELLTLQVPYMGLSELEIHDLIQ 807
GCLL E+ LQ P+ G ++ ++ L +
Sbjct: 193 GCLLYEMAALQSPFYG-DKMNLYSLCK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 71/227 (31%), Positives = 104/227 (45%), Gaps = 38/227 (16%)
Query: 577 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 636
A +V V SS D R+ + E+ +L L+H IV+ G + + L
Sbjct: 29 AVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL------- 81
Query: 637 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 696
IF+EYV GGSV + E V F+ Q + L LH++ I+H
Sbjct: 82 -------NIFLEYVPGGSVAALLNNYGAFEETLVRN----FVRQ-ILKGLNYLHNRGIIH 129
Query: 697 RDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 754
RDIK NIL+D K +K+ DF + + S L T R P + G+
Sbjct: 130 RDIKGANILVD-------NKGGIKISDFGISKKLEANS-LSTKTNGAR----PSL-QGSV 176
Query: 755 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 801
WMAPEV+ K Y + DIWS GCL++E+LT + P+ ++L+
Sbjct: 177 FWMAPEVV----KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 57/168 (33%), Positives = 80/168 (47%), Gaps = 22/168 (13%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
+ MEY+ GG + + +E + E ++IA+ + AL LHS I+HRD+K +NI
Sbjct: 70 LVMEYLPGGDLASLLENVGSLDEDVA----RIYIAE-IVLALEYLHSNGIIHRDLKPDNI 124
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSF-LHTCCIAHRGIPAPDV-CVGTPRWMAPEVL 762
LID ++G +KL DF L L I D VGTP ++APEV+
Sbjct: 125 LID-----SNGH--LKLTDFG----LSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 763 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
+ VD WS GC+L E L P+ G + EI I GK
Sbjct: 174 LGQG----HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK 217
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 74/267 (27%), Positives = 118/267 (44%), Gaps = 66/267 (24%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
EV ++ +H +VEMY + L + ME+++GG++ + +
Sbjct: 67 EVVIMRDYQHENVVEMYNSYLVGDEL--------------WVVMEFLEGGALTDIVTHTR 112
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
E+ +V LA V AL LH++ ++HRDIKS++IL+ DG+ VKL D
Sbjct: 113 MNEEQIAAVCLA------VLKALSVLHAQGVIHRDIKSDSILL-----THDGR--VKLSD 159
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
F C + +P VGTP WMAPE++ + YG EVDIWS G +
Sbjct: 160 FG----------FCAQVSKEVPRRKSLVGTPYWMAPELISRLP----YGPEVDIWSLGIM 205
Query: 784 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 843
++E++ + PY L+ +I+ P+L + H+V+ S GF
Sbjct: 206 VIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKN---------LHKVSPSLKGF------- 249
Query: 844 ETLSFLVDVFRRCTEENPTERPTAGDL 870
R +P +R TA +L
Sbjct: 250 ---------LDRLLVRDPAQRATAAEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 65/191 (34%), Positives = 93/191 (48%), Gaps = 35/191 (18%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E+++L L H IV+ YG E L +IFME++ GGS+K+ ++
Sbjct: 54 EIQLLKNLLHERIVQYYG---------CLRDPMERTL---SIFMEHMPGGSIKDQLKSYG 101
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
E V+ K I + V+ LHS I+HRDIK NIL D VKL D
Sbjct: 102 ALTEN-VTRKYTRQILEGVSY----LHSNMIVHRDIKGANIL-------RDSVGNVKLGD 149
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
F + L T C++ G+ + GTP WM+PEV+ YG + DIWS GC
Sbjct: 150 FGAS----KRLQTICLSGTGMKS---VTGTPYWMSPEVISG----EGYGRKADIWSVGCT 198
Query: 784 LLELLTLQVPY 794
++E+LT + P+
Sbjct: 199 VVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 80/297 (26%), Positives = 126/297 (42%), Gaps = 63/297 (21%)
Query: 590 SADEIRNFEYSCLGEVRMLGALRHSCIVEMY-GHKISSKWLPSADGNPEHHLLQSAIFME 648
++++ + L EV++L LRH IV + + + +L+ E
Sbjct: 39 DDEDVKK---TALREVKVLRQLRHENIVNLKEAFRRKGRL----------YLV-----FE 80
Query: 649 YVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708
YV ++ +E S G +V+ ++ + A+ HS +I+HRDIK ENIL+
Sbjct: 81 YV-ERTLLELLEA-SPGGLPPDAVRSYIW---QLLQAIAYCHSHNIIHRDIKPENILVSE 135
Query: 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHK 767
V+KLCDF A LR+ R V T RW APE+L
Sbjct: 136 SG-------VLKLCDFGFARALRA---------RPASPLTDYVAT-RWYRAPELLV---G 175
Query: 768 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ--MGKRPRLTDELEALGSCH 825
YG VD+W+ GC++ ELL + + G S+++ LIQ +G P EL
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF------ 229
Query: 826 EHEVAQSGSGFEKPEAELETL---------SFLVDVFRRCTEENPTERPTAGDLYEM 873
+G F +P + E+L S +D + C +P ER T +L +
Sbjct: 230 SSNPRFAGVAFPEPS-QPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 65/276 (23%), Positives = 111/276 (40%), Gaps = 67/276 (24%)
Query: 599 YSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 658
L E+ +L L+H I+ Y H + L I MEY GG
Sbjct: 44 RDALNEIVILSLLQHPNIIAYYNHFMDDNTL--------------LIEMEYANGG---TL 86
Query: 659 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 718
+K+ + ++ L+ + +A+ +H I+HRDIK+ NI + KA +
Sbjct: 87 YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT----KAG---L 139
Query: 719 VKLCDFDRAVPLRS-FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 777
+KL DF + L S + + VGTP +M+PE+ + + Y + DI
Sbjct: 140 IKLGDFGISKILGSEYSMA-----------ETVVGTPYYMSPELCQGVK----YNFKSDI 184
Query: 778 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 837
W+ GC+L ELLTL+ + + L + I G + V+ S
Sbjct: 185 WALGCVLYELLTLKRTFDATNPLNLVVKIVQGN--------------YTPVVSVYSSE-- 228
Query: 838 KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 873
L+ + +++P +RPTA ++ +
Sbjct: 229 -----------LISLVHSLLQQDPEKRPTADEVLDQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 65/191 (34%), Positives = 92/191 (48%), Gaps = 35/191 (18%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E+++L L+H IV+ YG E L IFMEY+ GGSVK+ ++
Sbjct: 54 EIQLLKNLQHERIVQYYG---------CLRDRAEKTL---TIFMEYMPGGSVKDQLKAYG 101
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
E V+ K + + + LHS I+HRDIK NIL D VKL D
Sbjct: 102 ALTES-VTRKYT----RQILEGMSYLHSNMIVHRDIKGANIL-------RDSAGNVKLGD 149
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
F + L T C++ GI + GTP WM+PEV+ YG + D+WS GC
Sbjct: 150 FGAS----KRLQTICMSGTGIRS---VTGTPYWMSPEVISG----EGYGRKADVWSLGCT 198
Query: 784 LLELLTLQVPY 794
++E+LT + P+
Sbjct: 199 VVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 55/172 (31%), Positives = 89/172 (51%), Gaps = 27/172 (15%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
+ ME+++GG++ + + E+ +V L+ V AL LH++ ++HRDIKS++I
Sbjct: 96 VVMEFLEGGALTDIVTHTRMNEEQIATVCLS------VLRALSYLHNQGVIHRDIKSDSI 149
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 764
L+ +DG+ +KL DF C + +P VGTP WMAPEV+
Sbjct: 150 LL-----TSDGR--IKLSDFG----------FCAQVSKEVPKRKSLVGTPYWMAPEVISR 192
Query: 765 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 816
+ YG EVDIWS G +++E++ + PY L+ I+ PR+ D
Sbjct: 193 LP----YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKD 240
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 58/217 (26%), Positives = 87/217 (40%), Gaps = 45/217 (20%)
Query: 592 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK 651
+RN L E R+L L H +V ++ + + E+ L ++ +
Sbjct: 42 GSVRNV----LNERRILQELNHPFLVNLW----------YSFQDEENMYL----VVDLLL 83
Query: 652 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 711
GG ++ ++ + + E+ V F ++ AL LHSK I+HRDIK +NIL+D
Sbjct: 84 GGDLRYHLSQKVKFSEEQVK-----FWICEIVLALEYLHSKGIIHRDIKPDNILLD---- 134
Query: 712 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 771
G V + DF+ A GTP +MAPEVL Y
Sbjct: 135 -EQGH--VHITDFNIA----------TKVTPDTLTTSTS-GTPGYMAPEVLCR----QGY 176
Query: 772 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 808
+ VD WS G E L + PY G S +
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK 213
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 59/184 (32%), Positives = 80/184 (43%), Gaps = 38/184 (20%)
Query: 637 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 696
E HL + MEY+ GG + N + + E+ A F ++ AL +H +H
Sbjct: 73 EEHLY---LVMEYMPGGDLMNLLIRKDVFPEET-----ARFYIAELVLALDSVHKLGFIH 124
Query: 697 RDIKSENILIDLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPA 746
RDIK +NILID ADG +KL DF DR L + + +
Sbjct: 125 RDIKPDNILID-----ADGH--IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 747 PD---------VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL 797
D VGTP ++APEVLR YGLE D WS G +L E+L P+
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTP----YGLECDWWSLGVILYEMLYGFPPFYSD 233
Query: 798 SELE 801
+ E
Sbjct: 234 TLQE 237
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 53/162 (32%), Positives = 74/162 (45%), Gaps = 29/162 (17%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
MEY GG + + E A F V A LH++ I++RD+K EN+L+
Sbjct: 72 MEYCLGGELWTILRDRGLFDEYT-----ARFYIACVVLAFEYLHNRGIIYRDLKPENLLL 126
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 766
D ++G VKL DF A L+S T GTP ++APE++
Sbjct: 127 D-----SNG--YVKLVDFGFAKKLKSGQKTWTF-----------CGTPEYVAPEIILNKG 168
Query: 767 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE--LEIHDLI 806
Y VD WS G LL ELLT + P+ E +EI++ I
Sbjct: 169 ----YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI 206
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 43/207 (20%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E R+L + H I+ ++ + + L + MEYV GG + +Y+
Sbjct: 51 EKRVLKEVSHPFIIRLF-----------WTEHDQRFLY---MLMEYVPGGELFSYLR--- 93
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
S LF A ++ AL LHSK I++RD+K ENIL+D +G +KL D
Sbjct: 94 --NSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD-----KEGH--IKLTD 144
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
F A LR T C GTP ++APEV+++ + VD W+ G L
Sbjct: 145 FGFAKKLRDRTWTLC-------------GTPEYLAPEVIQSKG----HNKAVDWWALGIL 187
Query: 784 LLELLTLQVPYMGLSELEIHDLIQMGK 810
+ E+L P+ + I++ I GK
Sbjct: 188 IYEMLVGYPPFFDDNPFGIYEKILAGK 214
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 3e-17
Identities = 67/204 (32%), Positives = 97/204 (47%), Gaps = 42/204 (20%)
Query: 645 IFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703
+ MEY+ GGS+ + + E + G+ + ++ AL LHS ++HRDIKS+N
Sbjct: 93 VVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQALEFLHSNQVIHRDIKSDN 145
Query: 704 ILIDLERKKADGKPVVKLCDFD---RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 760
IL+ + DG VKL DF + P +S T VGTP WMAPE
Sbjct: 146 ILLGM-----DGS--VKLTDFGFCAQITPEQSKRST-------------MVGTPYWMAPE 185
Query: 761 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT--DEL 818
V+ YG +VDIWS G + +E++ + PY+ + L LI P L ++L
Sbjct: 186 VVTRKA----YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241
Query: 819 EA-----LGSCHEHEVAQSGSGFE 837
A L C E +V + GS E
Sbjct: 242 SAIFRDFLNRCLEMDVEKRGSAKE 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 50/165 (30%), Positives = 75/165 (45%), Gaps = 32/165 (19%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
MEYV GG + +I++ E A F A ++ L LH + I++RD+K +N+L+
Sbjct: 75 MEYVNGGDLMFHIQRSGRFDEPR-----ARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL 129
Query: 707 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 763
D ++G +K+ DF + T C GTP ++APE+L
Sbjct: 130 D-----SEGH--IKIADFGMCKEGILGGVTTSTFC-------------GTPDYIAPEILS 169
Query: 764 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 808
YG VD W+ G LL E+L Q P+ G E E+ I
Sbjct: 170 YQ----PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE 210
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 38/215 (17%)
Query: 600 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 659
+ E+R+L ++ H I+ + DGN + I MEY G + I
Sbjct: 45 DAVNEIRILASVNHPNIISYKEAFL--------DGN------KLCIVMEYAPFGDLSKAI 90
Query: 660 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 719
K + K + + I + L LH + I+HRD+KS NIL+ +V
Sbjct: 91 SKRKKKR-KLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL------VAND-LV 142
Query: 720 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 779
K+ D + L+ + I GTP +MAPEV + +P Y + DIWS
Sbjct: 143 KIGDLGISKVLKKNMAKTQI------------GTPHYMAPEVWKG--RP--YSYKSDIWS 186
Query: 780 YGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 814
GCLL E+ T P+ S ++ +Q GK P +
Sbjct: 187 LGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI 221
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 4e-17
Identities = 54/158 (34%), Positives = 85/158 (53%), Gaps = 30/158 (18%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
MEYV GG + +I+++ + E H A+F A ++A L LHSK I++RD+K +N+++
Sbjct: 80 MEYVNGGDLMYHIQQVGKFKEPH-----AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPEVLRA 764
D A+G +K+ DF C + G C GTP ++APE++
Sbjct: 135 D-----AEGH--IKIADFGM-----------CKENIFGGKTTRTFC-GTPDYIAPEII-- 173
Query: 765 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEI 802
++P YG VD W++G LL E+L Q P+ G E E+
Sbjct: 174 AYQP--YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 61/238 (25%), Positives = 98/238 (41%), Gaps = 70/238 (29%)
Query: 644 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSE 702
+I +EY+ GGS+ + ++K+ + E ++ +IA+ + L LH+K HI+HRDIK
Sbjct: 75 SIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYLHTKRHIIHRDIKPS 129
Query: 703 NILIDLERKKADGKPVVKLCDF-------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 755
N+LI+ K VK+ DF + +F VGT
Sbjct: 130 NLLINS-------KGEVKIADFGISKVLENTLDQCNTF-----------------VGTVT 165
Query: 756 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL---IQMGKRP 812
+M+PE ++ Y DIWS G LLE + P++ + +L I G P
Sbjct: 166 YMSPERIQGES----YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP 221
Query: 813 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 870
L E E E F+ C +++P +RP+A +L
Sbjct: 222 SLPAE----------------------EFSPEFRDFI----SACLQKDPKKRPSAAEL 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-17
Identities = 66/227 (29%), Positives = 102/227 (44%), Gaps = 52/227 (22%)
Query: 570 CKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629
C+ + ++ + V + DE + E ++L L H I+E Y + + K L
Sbjct: 19 CRRKADQKLVIIKQIPVEQMTKDE----RLAAQNECQVLKLLSHPNIIEYYENFLEDKAL 74
Query: 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK-----LSETGEKHVSVKLALFIAQDVAA 684
I MEY GG++ YI+K L E H V++ L
Sbjct: 75 --------------MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILL-------- 112
Query: 685 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 744
AL +H+K I+HRD+K++NIL+D + K VVK+ DF + L S
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLD--KHKM----VVKIGDFGISKILSS-----------K 155
Query: 745 PAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 791
VGTP +++PE+ KP Y + DIW+ GC+L EL +L+
Sbjct: 156 SKAYTVVGTPCYISPELCEG--KP--YNQKSDIWALGCVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 70/283 (24%), Positives = 106/283 (37%), Gaps = 77/283 (27%)
Query: 602 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYI 659
L E ++ +L H ++ +YG +L + M E GS+ +
Sbjct: 44 LKEAAIMHSLDHENLIRLYGV-----------------VLTHPLMMVTELAPLGSL---L 83
Query: 660 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 719
++L + H + A +A + L SK +HRD+ + NIL+ + K V
Sbjct: 84 DRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK-------V 136
Query: 720 KLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM---HKPNLYGLE 774
K+ DF RA+P H H +P W APE LR H
Sbjct: 137 KIGDFGLMRALPQNE-DHYVMEEHLKVPFA--------WCAPESLRTRTFSHAS------ 181
Query: 775 VDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG 833
D+W +G L E+ T + P+ GLS +I I E E L
Sbjct: 182 -DVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID--------KEGERL------------ 220
Query: 834 SGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 876
E+PEA + + +V +C NP +RPT L E
Sbjct: 221 ---ERPEACPQD---IYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 72/235 (30%), Positives = 101/235 (42%), Gaps = 52/235 (22%)
Query: 644 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703
I MEY +GGS+ + +K+ + G + + K+ IA+ V L LHS+ I+HRDIK N
Sbjct: 77 GIAMEYCEGGSLDSIYKKVKKRGGR-IGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSN 135
Query: 704 ILIDLERKKADGKPVVKLCDFDRAVPL-RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 762
IL+ K VKLCDF + L S T GT +MAPE
Sbjct: 136 ILLTR-------KGQVKLCDFGVSGELVNSLAGT-------------FTGTSFYMAPE-- 173
Query: 763 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY-----MGLSELEIHDLIQMGKRPRLTDE 817
R KP Y + D+WS G LLE+ + P+ L +E+ I P L DE
Sbjct: 174 RIQGKP--YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE 231
Query: 818 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 872
P ++ D ++C E++PT RPT D+ E
Sbjct: 232 ---------------------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 7e-17
Identities = 84/320 (26%), Positives = 127/320 (39%), Gaps = 67/320 (20%)
Query: 557 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYS--CLGEVRMLGALRHS 614
DE G+ V L + +G AA + T R+ Y E+ + L+H
Sbjct: 8 DENGERVV--LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 615 CIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKL 674
IV+ G + + IFME V GGS+ + S+ G + +
Sbjct: 66 NIVQYLGSDSENGFF--------------KIFMEQVPGGSLSALLR--SKWGPLKDNEQT 109
Query: 675 ALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFL 734
+F + + L LH I+HRDIK +N+L++ VVK+ DF
Sbjct: 110 IIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSG------VVKISDFG--------- 154
Query: 735 HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 794
T P + GT ++MAPEV+ P YG DIWS GC ++E+ T + P+
Sbjct: 155 -TSKRLAGINPCTETFTGTLQYMAPEVID--KGPRGYGAPADIWSLGCTIVEMATGKPPF 211
Query: 795 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL-ETLSFLVDVF 853
I++G E + A G K E+ E+LS F
Sbjct: 212 -----------IELG----------------EPQAAMFKVGMFKIHPEIPESLSAEAKNF 244
Query: 854 -RRCTEENPTERPTAGDLYE 872
RC E +P +R +A DL +
Sbjct: 245 ILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 1e-16
Identities = 55/174 (31%), Positives = 78/174 (44%), Gaps = 33/174 (18%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
MEYV GG + + L E H A F ++ A+ LH +HRD+K EN LI
Sbjct: 80 MEYVPGGDFRTLLNNLGVLSEDH-----ARFYMAEMFEAVDALHELGYIHRDLKPENFLI 134
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 766
D A G +KL DF + + ++ ++ VG+P +MAPEVLR
Sbjct: 135 D-----ASGH--IKLTDFGLSKGIVTYANS-------------VVGSPDYMAPEVLRGKG 174
Query: 767 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI----QMGKRPRLTD 816
Y VD WS GC+L E L P+ G + E + + + +RP D
Sbjct: 175 ----YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDD 224
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 66/235 (28%), Positives = 96/235 (40%), Gaps = 59/235 (25%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSEN 703
I MEY+ GGS ++K+ + + + ++ IA V L LH KH I+HRD+K N
Sbjct: 76 ICMEYMDGGS----LDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSN 131
Query: 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 763
IL++ + G+ +KLCDF + L +A VGT +MAPE ++
Sbjct: 132 ILVN-----SRGQ--IKLCDFGVSGQL-----VNSLA-------KTFVGTSSYMAPERIQ 172
Query: 764 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG-----LSELEIHDLIQMGKRPRLTDEL 818
N Y ++ DIWS G L+EL T + PY E+ I PRL
Sbjct: 173 ----GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP--- 225
Query: 819 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 873
F D C ++P ERP+ +L E
Sbjct: 226 --------------SGKFSPD---------FQDFVNLCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 54/162 (33%), Positives = 83/162 (51%), Gaps = 30/162 (18%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
MEYV GG + I+++ E H A+F A ++A L LHSK I++RD+K +N+++
Sbjct: 80 MEYVNGGDLMYQIQQVGRFKEPH-----AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPEVLRA 764
D E +K+ DF C + G+ C GTP ++APE++
Sbjct: 135 DSEGH-------IKIADFGM-----------CKENMWDGVTTKTFC-GTPDYIAPEIIA- 174
Query: 765 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 806
++P YG VD W++G LL E+L Q P+ G E E+ I
Sbjct: 175 -YQP--YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-16
Identities = 52/162 (32%), Positives = 83/162 (51%), Gaps = 30/162 (18%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
MEYV GG + +I+++ + E A+F A +++ L LH + I++RD+K +N+++
Sbjct: 80 MEYVNGGDLMYHIQQVGKFKEPQ-----AVFYAAEISVGLFFLHRRGIIYRDLKLDNVML 134
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPEVLRA 764
D E +K+ DF C H G+ C GTP ++APE++
Sbjct: 135 DSEGH-------IKIADFGM-----------CKEHMVDGVTTRTFC-GTPDYIAPEII-- 173
Query: 765 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 806
++P YG VD W+YG LL E+L Q P+ G E E+ I
Sbjct: 174 AYQP--YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 76/297 (25%), Positives = 122/297 (41%), Gaps = 63/297 (21%)
Query: 573 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 632
GS V+TL+ G++ E + F L E ++ H IV++ G
Sbjct: 23 GSGPIRVAVKTLRK-GATDQEKKEF----LKEAHLMSNFNHPNIVKLLG--------VCL 69
Query: 633 DGNPEHHLLQSAIFMEYVKGGSVKNYIE--KLSETGEKHVSVKLALFIAQDVAAALVELH 690
P++ I ME ++GG + +Y+ ++ G +++K L I DVA V L
Sbjct: 70 LNEPQY------IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE 123
Query: 691 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC 750
H +HRD+ + N L+ K D VVK+ DF A + + +P
Sbjct: 124 QMHFIHRDLAARNCLV--SEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV---- 177
Query: 751 VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMG 809
RWMAPE L + + D+WS+G L+ E+LTL Q PY L+ E+ + G
Sbjct: 178 ----RWMAPESL----LDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG 229
Query: 810 KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866
R L+ +C + + + C ++P+ERPT
Sbjct: 230 GR------LQKPENCPDK---------------------IYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 40/203 (19%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
+ MEY+ GGS+ + + +ET + + ++ AL LH+ ++HRDIKS+N+
Sbjct: 93 VVMEYLAGGSLTDVV---TETCMDEAQIAA---VCRECLQALEFLHANQVIHRDIKSDNV 146
Query: 705 LIDLERKKADGKPVVKLCDFD---RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 761
L+ ++ VKL DF + P +S T VGTP WMAPEV
Sbjct: 147 LLGMDGS-------VKLTDFGFCAQITPEQSKRST-------------MVGTPYWMAPEV 186
Query: 762 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE---- 817
+ YG +VDIWS G + +E++ + PY+ + L LI P L +
Sbjct: 187 VTR----KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 242
Query: 818 ---LEALGSCHEHEVAQSGSGFE 837
+ L C E +V + GS E
Sbjct: 243 PIFRDFLNRCLEMDVEKRGSAKE 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 602 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 661
L E +L H IV++ G P + I ME V GGS+ ++ K
Sbjct: 40 LQEAEILKQYDHPNIVKLIG--------VCVQKQPIY------IVMELVPGGSLLTFLRK 85
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
+ ++VK L ++ D AA + L SK+ +HRD+ + N L+ V+K+
Sbjct: 86 ----KKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN-------VLKI 134
Query: 722 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781
DF + ++T + IP +W APE L Y E D+WSYG
Sbjct: 135 SDFGMSREEEGGIYTVSDGLKQIPI--------KWTAPEALNY----GRYTSESDVWSYG 182
Query: 782 CLLLELLTL-QVPYMGLSELEIHDLIQMGKR---PRLTDE 817
LL E +L PY G+S + + I+ G R P+L E
Sbjct: 183 ILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPE 222
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 53/162 (32%), Positives = 74/162 (45%), Gaps = 26/162 (16%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
MEY+ GG + +I+ E A F A ++ L LH K I++RD+K +N+L+
Sbjct: 75 MEYLNGGDLMFHIQSSGRFDEAR-----ARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL 129
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 766
D DG +K+ DF C G GTP ++APE+L
Sbjct: 130 D-----KDGH--IKIADFG----------MCKENMNGEGKASTFCGTPDYIAPEIL---- 168
Query: 767 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 808
K Y VD WS+G LL E+L Q P+ G E E+ D I
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 2e-15
Identities = 71/234 (30%), Positives = 107/234 (45%), Gaps = 49/234 (20%)
Query: 645 IFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703
+ MEY+ GGS+ + + E + G+ + ++ AL LHS ++HRDIKS+N
Sbjct: 94 VVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQALEFLHSNQVIHRDIKSDN 146
Query: 704 ILIDLERKKADGKPVVKLCDFD---RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 760
IL+ + DG VKL DF + P +S VGTP WMAPE
Sbjct: 147 ILLGM-----DGS--VKLTDFGFCAQITPEQS-------------KRSTMVGTPYWMAPE 186
Query: 761 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT--DEL 818
V+ YG +VDIWS G + +E++ + PY+ + L LI P L ++L
Sbjct: 187 VVTR----KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242
Query: 819 EA-----LGSCHEHEVAQSGSG-------FEKPEAELETLSFLVDVFRRCTEEN 860
A L C + +V + GS F K L +L+ L+ + T+ N
Sbjct: 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATKNN 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 72/272 (26%), Positives = 104/272 (38%), Gaps = 69/272 (25%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
EV +L +L+H IV+ G + + +IFME+V GGS+ + + +
Sbjct: 52 EVDLLKSLKHVNIVQYLGTCLDDNTI--------------SIFMEFVPGGSISSILNRFG 97
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
E V K I VA LH+ ++HRDIK N+++ +G ++KL D
Sbjct: 98 PLPEP-VFCKYTKQILDGVAY----LHNNCVVHRDIKGNNVML-----MPNG--IIKLID 145
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCV---GTPRWMAPEVLRAMHKPNLYGLEVDIWSY 780
F A L ++ GTP WMAPEV+ YG + DIWS
Sbjct: 146 FGCARRL-------AWVGLHGTHSNMLKSMHGTPYWMAPEVINESG----YGRKSDIWSI 194
Query: 781 GCLLLELLTLQVPYMGLSELEIHDLI--QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 838
GC + E+ T + P + L I G PRL D A
Sbjct: 195 GCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA---------------- 238
Query: 839 PEAELETLSFLVDVFRRCTEENPTERPTAGDL 870
+D C + ERP+A L
Sbjct: 239 -----------IDFVTSCLTRDQHERPSALQL 259
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 3e-15
Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 42/204 (20%)
Query: 645 IFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703
+ MEY+ GGS+ + + E + G+ + ++ AL LHS ++HRDIKS+N
Sbjct: 93 VVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQALDFLHSNQVIHRDIKSDN 145
Query: 704 ILIDLERKKADGKPVVKLCDFD---RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 760
IL+ + DG VKL DF + P +S T VGTP WMAPE
Sbjct: 146 ILLGM-----DGS--VKLTDFGFCAQITPEQSKRST-------------MVGTPYWMAPE 185
Query: 761 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT--DEL 818
V+ YG +VDIWS G + +E++ + PY+ + L LI P L + L
Sbjct: 186 VVTR----KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL 241
Query: 819 EA-----LGSCHEHEVAQSGSGFE 837
A L C E +V + GS E
Sbjct: 242 SAVFRDFLNRCLEMDVDRRGSAKE 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 53/162 (32%), Positives = 78/162 (48%), Gaps = 30/162 (18%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
ME+V GG + +I+K E A F A ++ +AL+ LH K I++RD+K +N+L+
Sbjct: 75 MEFVNGGDLMFHIQKSRRFDEAR-----ARFYAAEITSALMFLHDKGIIYRDLKLDNVLL 129
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA--HRGIPAPDVCVGTPRWMAPEVLRA 764
D E KL DF C G C GTP ++APE+L+
Sbjct: 130 DHEGH-------CKLADFGM-----------CKEGIFNGKTTSTFC-GTPDYIAPEILQE 170
Query: 765 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 806
M LYG VD W+ G LL E+L P+ +E ++ + I
Sbjct: 171 M----LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 73/244 (29%), Positives = 106/244 (43%), Gaps = 44/244 (18%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E+ M+ +H IV +G +S + L I MEY GGS+++
Sbjct: 56 EIFMVKECKHCNIVAYFGSYLSREKL--------------WICMEYCGGGSLQDIYHVTG 101
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
E ++ ++ ++ L LHSK MHRDIK NIL+ D VKL D
Sbjct: 102 PLSELQIA-----YVCRETLQGLAYLHSKGKMHRDIKGANILLT---DNGD----VKLAD 149
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
F A + T IA R +GTP WMAPEV A+ K Y DIW+ G
Sbjct: 150 FGVAAKI-----TATIAKR-----KSFIGTPYWMAPEV-AAVEKNGGYNQLCDIWAVGIT 198
Query: 784 LLELLTLQVPYMGLSELEIHDLIQMGKR----PRLTDELEALGSCHEH-EVAQSGSGFEK 838
+EL LQ P L + L M K P+L D+ + + H +++ + + ++
Sbjct: 199 AIELAELQPPMFDLHPMRA--LFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKR 256
Query: 839 PEAE 842
P AE
Sbjct: 257 PTAE 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 3e-15
Identities = 70/245 (28%), Positives = 101/245 (41%), Gaps = 51/245 (20%)
Query: 575 ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK------- 627
AA K+ L++ D I+ GEV+++ RH ++Y K+ SK
Sbjct: 29 EKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLV---RHKSSKQVYAMKLLSKFEMIKRS 85
Query: 628 -----WLPS---ADGNPE-----HHLLQSA----IFMEYVKGGSVKNYIEKLSETGEKHV 670
W A N E H+ Q + MEY+ GG + N +
Sbjct: 86 DSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNL------MSNYDI 139
Query: 671 SVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 730
K A F +V AL +HS +HRD+K +N+L+D G +KL DF
Sbjct: 140 PEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-----KSGH--LKLADFG----- 187
Query: 731 RSFLHTCCIAHR-GIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789
TC G+ D VGTP +++PEVL++ YG E D WS G L E+L
Sbjct: 188 -----TCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 242
Query: 790 LQVPY 794
P+
Sbjct: 243 GDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 64/277 (23%), Positives = 108/277 (38%), Gaps = 58/277 (20%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E+ +L L H IV+ G + G L+ MEY+ GS+++Y+++
Sbjct: 56 EIEILRTLDHENIVKYKG-------VCEKPGGRSLRLI-----MEYLPSGSLRDYLQRHR 103
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
+ +++K L + + + L S+ +HRD+ + NIL++ E VK+ D
Sbjct: 104 D----QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL-------VKISD 152
Query: 724 F--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781
F + +P + P W APE LR + + D+WS+G
Sbjct: 153 FGLAKVLPEDKDYYY-VKEPGESPI--------FWYAPECLRT----SKFSSASDVWSFG 199
Query: 782 CLLLELLTL----QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 837
L EL T Q P + QM +T LE L + G
Sbjct: 200 VTLYELFTYGDPSQSPPAEFLRMIGIAQGQM----IVTRLLELL---------KEGERLP 246
Query: 838 KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
+P + + D+ + C E P +RP+ DL +
Sbjct: 247 RPPS---CPDEVYDLMKLCWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 9e-15
Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 59/270 (21%)
Query: 550 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLG 609
FP+L K++ + L R K D K+R L++ + ++ GEV+++
Sbjct: 12 FPAL----RKNKNIDNFLNRYK----DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLV- 62
Query: 610 ALRHSCIVEMYGHKISSKW--LPSADGN---PEHHLLQSA-------------------I 645
RH ++Y K+ SK+ + +D E ++ A +
Sbjct: 63 --RHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120
Query: 646 FMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705
MEY+ GG + N + V K A F +V AL +HS +HRD+K +N+L
Sbjct: 121 VMEYMPGGDLVNLMSNYD------VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 174
Query: 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR-GIPAPDVCVGTPRWMAPEVLRA 764
+D +KL DF TC ++ G+ D VGTP +++PEVL++
Sbjct: 175 LDKSGH-------LKLADFG----------TCMKMNKEGMVRCDTAVGTPDYISPEVLKS 217
Query: 765 MHKPNLYGLEVDIWSYGCLLLELLTLQVPY 794
YG E D WS G L E+L P+
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 63/311 (20%), Positives = 115/311 (36%), Gaps = 71/311 (22%)
Query: 569 RCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628
G + ++T+ S E F L E ++ +V + G + S
Sbjct: 29 GVVKGEPETRVAIKTVNENASM-RERIEF----LNEASVMKEFNCHHVVRLLG--VVST- 80
Query: 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKH-----VSVKLALFIAQDVA 683
G P + + ME + G +K+Y+ E + +++ + +A ++A
Sbjct: 81 -----GQP------TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 684 AALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG 743
+ L +K +HRD+ + N ++ + VK+ DF + +
Sbjct: 130 DGMAYLAAKKFVHRDLAARNCMVAEDL-------TVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 744 IPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEI 802
+P RWMAPE L K ++ + D+WS+G +L E+ TL + PY GLS E+
Sbjct: 183 LPV--------RWMAPESL----KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV 230
Query: 803 HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 862
+ G L + L+++ R C + NP
Sbjct: 231 LKFVIDGGHLDLPENCP---------------------------DKLLELMRMCWQYNPK 263
Query: 863 ERPTAGDLYEM 873
RPT ++
Sbjct: 264 MRPTFLEIVSS 274
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 58/215 (26%), Positives = 86/215 (40%), Gaps = 57/215 (26%)
Query: 678 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 737
I + L +H HRD+K EN+L+ G VVK+ DF A +RS
Sbjct: 104 IIYQILQGLAHIHKHGFFHRDLKPENLLV-------SGPEVVKIADFGLAREIRS----- 151
Query: 738 CIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 796
P V T RW APE+L + + Y VDIW+ GC++ EL TL+ + G
Sbjct: 152 ------RPPYTDYVST-RWYRAPEIL--LRSTS-YSSPVDIWALGCIMAELYTLRPLFPG 201
Query: 797 LSELEIHDLIQMGKRPRLTDEL----EALGSCHE------HEVAQSGSGFEKPEAE---L 843
SE D+L LG+ + +++A GF P+ L
Sbjct: 202 SSE---------------IDQLYKICSVLGTPTKQDWPEGYKLASK-LGFRFPQFAPTSL 245
Query: 844 ETL-----SFLVDVFRRCTEENPTERPTAGDLYEM 873
L +D+ + +P +RPTA +
Sbjct: 246 HQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 66/206 (32%), Positives = 92/206 (44%), Gaps = 54/206 (26%)
Query: 685 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 744
L LHS I+HRD+K N+LI +DG V+KL DF A RSF
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIA-----SDG--VLKLADFGLA---RSF----------- 152
Query: 745 PAPDVCVGTP----RWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM-GLS 798
+P+ T RW APE+L YG+ VD+WS GC+ ELL L+VP++ G S
Sbjct: 153 GSPNR-KMTHQVVTRWYRAPELLFG---ARHYGVGVDMWSVGCIFAELL-LRVPFLPGDS 207
Query: 799 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ-----SGSGFEK-PEAELETL-----S 847
+++ Q+GK EALG+ E F+ P L+ +
Sbjct: 208 DID-----QLGKI------FEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASD 256
Query: 848 FLVDVFRRCTEENPTERPTAGDLYEM 873
+D+ +R NP +R TA E
Sbjct: 257 DALDLLQRLLTLNPNKRITARQALEH 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 83/288 (28%), Positives = 126/288 (43%), Gaps = 74/288 (25%)
Query: 604 EVRMLGALRHSCIV---EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 660
E+RML LRH +V E++ K + +L+ E+V +V + +E
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRK--KRL----------YLV-----FEFVDH-TVLDDLE 91
Query: 661 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 720
K G V+ LF + + HS +I+HRDIK ENIL+ VVK
Sbjct: 92 KY-PNGLDESRVRKYLF---QILRGIEFCHSHNIIHRDIKPENILVSQSG-------VVK 140
Query: 721 LCDFDRAVPLRSFLHTCCIAHRGIPAP-DVC---VGTPRWM-APEVLRAMHKPNLYGLEV 775
LCDF A R + AP +V V T RW APE+L K YG V
Sbjct: 141 LCDFGFA--------------RTLAAPGEVYTDYVAT-RWYRAPELLVGDTK---YGRAV 182
Query: 776 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS--G 833
DIW+ GCL+ E+LT + + G S++ D + + L L H+ ++
Sbjct: 183 DIWAVGCLVTEMLTGEPLFPGDSDI---DQLY-----HIIKCLGNLIPRHQEIFQKNPLF 234
Query: 834 SGFEKPEA-ELETL--------SFLVDVFRRCTEENPTERPTAGDLYE 872
+G PE E+E L ++D+ ++C +P +RP++ L
Sbjct: 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 60/213 (28%), Positives = 86/213 (40%), Gaps = 56/213 (26%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE--- 660
E+++L LRH IV + S + +I+M V Y++
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKG--------------KGSIYM-------VFEYMDHDL 86
Query: 661 -KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 719
L ++ E + + + L LHS I+HRDIK NILI+ DG V+
Sbjct: 87 TGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN-----NDG--VL 139
Query: 720 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG-TPR----WM-APEVLRAMHKPNLYGL 773
KL DF A R + T R W PE+L + YG
Sbjct: 140 KLADFGLA---RPY------------TKRNSADYTNRVITLWYRPPELL--LGATR-YGP 181
Query: 774 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 806
EVD+WS GC+L EL + + G +ELE + I
Sbjct: 182 EVDMWSVGCILAELFLGKPIFQGSTELEQLEKI 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 51/162 (31%), Positives = 75/162 (46%), Gaps = 26/162 (16%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
MEY+ GG + +I+ + + A F A ++ L LHSK I++RD+K +NIL+
Sbjct: 75 MEYLNGGDLMFHIQSCHK-----FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL 129
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 766
D + +K+ DF C G GTP ++APE+L
Sbjct: 130 DTDGH-------IKIADFG----------MCKENMLGDAKTCTFCGTPDYIAPEILLGQK 172
Query: 767 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 808
Y VD WS+G LL E+L Q P+ G E E+ I+M
Sbjct: 173 ----YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-14
Identities = 65/240 (27%), Positives = 103/240 (42%), Gaps = 51/240 (21%)
Query: 580 KVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW--LPSADGN-- 635
K+R L++ D ++ GEV+++ RH ++Y K+ SK+ + +D
Sbjct: 34 KIRKLQMKAEDYDVVKVIGRGAFGEVQLV---RHKSSQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 636 -PEHHLLQSA-------------------IFMEYVKGGSVKNYIEKLSETGEKHVSVKLA 675
E ++ A + MEY+ GG + N + V K A
Sbjct: 91 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD------VPEKWA 144
Query: 676 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 735
F +V AL +HS ++HRD+K +N+L+D +KL DF
Sbjct: 145 KFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH-------LKLADFG---------- 187
Query: 736 TCC-IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 794
TC + G+ D VGTP +++PEVL++ YG E D WS G L E+L P+
Sbjct: 188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 60/236 (25%), Positives = 95/236 (40%), Gaps = 57/236 (24%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
I ME V+GG ++ T + VK + + ++ AA + L SKH +HRD+ + N
Sbjct: 70 IVMELVQGGDFLTFLR----TEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNC 125
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 764
L+ K V+K+ DF + ++ + IP +W APE L
Sbjct: 126 LV-------TEKNVLKISDFGMSREEEDGVYASTGGMKQIPV--------KWTAPEALNY 170
Query: 765 MHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 823
Y E D+WS+G LL E +L VPY LS + + I+ G R L
Sbjct: 171 ----GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR------LPCPEL 220
Query: 824 CHEHEVAQSGSGFEKPEAELETLSFLVDVFR---RCTEENPTERPTAGDLYEMFVA 876
C + V+R RC E +P +RP+ +++ +
Sbjct: 221 CPD------------------------AVYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 51/152 (33%), Positives = 79/152 (51%), Gaps = 23/152 (15%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
I MEY GG + I + + G ++ + Q ++ L +H + I+HRDIKS+NI
Sbjct: 76 IVMEYCDGGDLMKRINR--QRGVLFSEDQILSWFVQ-ISLGLKHIHDRKILHRDIKSQNI 132
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 764
+ +G V KL DF A R + +A+ CVGTP +++PE+ +
Sbjct: 133 FL-----SKNGM-VAKLGDFGIA---RQLNDSMELAY-------TCVGTPYYLSPEICQ- 175
Query: 765 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 796
++P Y + DIWS GC+L EL TL+ P+ G
Sbjct: 176 -NRP--YNNKTDIWSLGCVLYELCTLKHPFEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 73/278 (26%), Positives = 119/278 (42%), Gaps = 73/278 (26%)
Query: 602 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 661
L E +++ LRH +V++Y + S + P + I EY+ GS+ ++++
Sbjct: 49 LQEAQIMKKLRHDKLVQLYA--VCS------EEEPIY------IVTEYMSKGSLLDFLK- 93
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
S G+K +L AQ +A + L S++ +HRD+ + NIL+ V K+
Sbjct: 94 -SGEGKKLRLPQLVDMAAQ-IAEGMAYLESRNYIHRDLAARNILV-------GENLVCKI 144
Query: 722 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIW 778
DF A R A G P +W APE YG ++ D+W
Sbjct: 145 ADFGLA---RLIEDDEYTAREGAKFP------IKWTAPEAA-------NYGRFTIKSDVW 188
Query: 779 SYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGF 836
S+G LL E++T +VPY G++ E+ + ++ G R PR + C
Sbjct: 189 SFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPN-------C------------ 229
Query: 837 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
PE L D+ +C +++P ERPT L
Sbjct: 230 --PEE-------LYDLMLQCWDKDPEERPTFEYLQSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 82/311 (26%), Positives = 135/311 (43%), Gaps = 70/311 (22%)
Query: 577 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 636
AAAKV K S +E+ ++ + E+ +L H IV++ G + W DG
Sbjct: 40 AAAKVIETK----SEEELEDY----MVEIEILATCNHPYIVKLLG---AFYW----DG-- 82
Query: 637 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 696
+ I +E+ GG+V + +L + G +++ I + + AL LHS I+H
Sbjct: 83 -----KLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQV---ICRQMLEALQYLHSMKIIH 133
Query: 697 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 756
RD+K+ N+L+ L DG +KL DF V ++ + + D +GTP W
Sbjct: 134 RDLKAGNVLLTL-----DGD--IKLADF--GVSAKNV--------KTLQRRDSFIGTPYW 176
Query: 757 MAPEVLRA-MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT 815
MAPEV+ K Y + DIWS G L+E+ ++ P+ L+ + + I + P L+
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLS 236
Query: 816 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-F 874
K E D + +++P RP+A L E F
Sbjct: 237 QP-------------------SKWSMEFR------DFLKTALDKHPETRPSAAQLLEHPF 271
Query: 875 VARTSSSISSR 885
V+ +S+ R
Sbjct: 272 VSSVTSNRPLR 282
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 62/256 (24%), Positives = 101/256 (39%), Gaps = 35/256 (13%)
Query: 560 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 619
G +++ + A ++ + V G +EI+ E+ ML H +
Sbjct: 15 GNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ-------EINMLKKYSHHRNIAT 67
Query: 620 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 679
Y K P D Q + ME+ GSV + I+ T + + +I
Sbjct: 68 YYGAFIKKNPPGMDD-------QLWLVMEFCGAGSVTDLIKN---TKGNTLKEEWIAYIC 117
Query: 680 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 739
+++ L LH ++HRDIK +N+L+ + VKL DF + L
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLTENAE-------VKLVDFGVSAQL--------- 161
Query: 740 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPN-LYGLEVDIWSYGCLLLELLTLQVPYMGLS 798
R + + +GTP WMAPEV+ P+ Y + D+WS G +E+ P +
Sbjct: 162 -DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220
Query: 799 ELEIHDLIQMGKRPRL 814
+ LI PRL
Sbjct: 221 PMRALFLIPRNPAPRL 236
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 48/174 (27%), Positives = 78/174 (44%), Gaps = 25/174 (14%)
Query: 638 HHLLQSAIF----MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 693
H+ Q M+Y GG + + K E + +A F ++ A+ +H
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 694 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 753
+HRDIK +N+L+D ++L DF + L + G +V VGT
Sbjct: 123 YVHRDIKPDNVLLDKNGH-------IRLADFGSCLRLLA---------DGTVQSNVAVGT 166
Query: 754 PRWMAPEVLRAMHK-PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 806
P +++PE+L+AM YG E D WS G + E+L + P+ S +E + I
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 65/231 (28%), Positives = 100/231 (43%), Gaps = 50/231 (21%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENIL 705
ME++ GS+ +K + V++ IA V L L++ H IMHRDIK NIL
Sbjct: 82 MEFMDCGSLDRIYKKGGP-----IPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNIL 136
Query: 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 765
+ + + +KLCDF + L + IA D VGT +M+PE ++
Sbjct: 137 V-------NSRGQIKLCDFGVSGELIN-----SIA-------DTFVGTSTYMSPERIQG- 176
Query: 766 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 825
K Y ++ D+WS G ++EL + P+ + + MG L+ L
Sbjct: 177 GK---YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI-------LDLL---- 222
Query: 826 EHEVAQSGSGFEKPEAELETLSF---LVDVFRRCTEENPTERPTAGDLYEM 873
++ Q +P L + F L D C ++PTERPT L M
Sbjct: 223 -QQIVQ------EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 71/244 (29%), Positives = 106/244 (43%), Gaps = 44/244 (18%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E+ M+ +HS IV +G + L I ME+ GGS+++
Sbjct: 56 EIIMMKDCKHSNIVAYFGSYLRRDKL--------------WICMEFCGGGSLQDIYHVTG 101
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
E ++ +++++ L LHSK MHRDIK NIL+ VKL D
Sbjct: 102 PLSESQIA-----YVSRETLQGLYYLHSKGKMHRDIKGANILL-------TDNGHVKLAD 149
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
F + + T IA R +GTP WMAPEV A+ + Y DIW+ G
Sbjct: 150 FGVSAQI-----TATIAKR-----KSFIGTPYWMAPEV-AAVERKGGYNQLCDIWAVGIT 198
Query: 784 LLELLTLQVPYMGLSELEIHDLIQMGKR----PRLTDELEALGSCHEH-EVAQSGSGFEK 838
+EL LQ P L + L M K P+L D+++ S H ++A + + ++
Sbjct: 199 AIELAELQPPMFDLHPMRA--LFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKR 256
Query: 839 PEAE 842
P AE
Sbjct: 257 PTAE 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 61/238 (25%), Positives = 96/238 (40%), Gaps = 37/238 (15%)
Query: 579 AKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPE 637
A ++ + V +EI+ E+ ML H I YG I +P
Sbjct: 44 AAIKVMDVTEDEEEEIKL-------EINMLKKYSHHRNIATYYGAFIKK--------SPP 88
Query: 638 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 697
H Q + ME+ GSV + ++ K + +I +++ L LH+ ++HR
Sbjct: 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA---YICREILRGLAHLHAHKVIHR 145
Query: 698 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 757
DIK +N+L+ + VKL DF + L R + + +GTP WM
Sbjct: 146 DIKGQNVLLTENAE-------VKLVDFGVSAQL----------DRTVGRRNTFIGTPYWM 188
Query: 758 APEVLRAMHKPN-LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 814
APEV+ P+ Y DIWS G +E+ P + + LI P+L
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 34/100 (34%), Positives = 45/100 (45%), Gaps = 19/100 (19%)
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 748
+H+ IMHRD+K N+LI ADG V+K+ DF A
Sbjct: 115 MHANGIMHRDLKPANLLIS-----ADG--VLKIADFGLARLFSE---------EEPRLYS 158
Query: 749 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788
V T + APE+L K Y VD+W+ GC+ ELL
Sbjct: 159 HQVATRWYRAPELLYGARK---YDPGVDLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-13
Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 35/203 (17%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
+ M+Y GG + + K E + +A F ++ A+ +H H +HRDIK +NI
Sbjct: 78 LVMDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI 133
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 764
L+D+ ++L DF + L G V VGTP +++PE+L+A
Sbjct: 134 LMDMNGH-------IRLADFGSCLKL---------MEDGTVQSSVAVGTPDYISPEILQA 177
Query: 765 MHK-PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL--------- 814
M YG E D WS G + E+L + P+ S +E + I M + R
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI-MNHKERFQFPAQVTDV 236
Query: 815 ----TDELEALGSCHEHEVAQSG 833
D + L EH + Q+G
Sbjct: 237 SEDAKDLIRRLICSREHRLGQNG 259
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 57/208 (27%), Positives = 85/208 (40%), Gaps = 55/208 (26%)
Query: 602 LGEVRMLGALRHSCIV---EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 658
L E+++L L H I+ +++ HK L + E++
Sbjct: 46 LREIKLLKELNHPNIIKLLDVFRHK--------------GDL---YLVFEFMDTD----- 83
Query: 659 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 718
+ KL + ++ + L + L HS I+HRD+K EN+LI +G V
Sbjct: 84 LYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI-----NTEG--V 136
Query: 719 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP----RWM-APEVLRAMHKPNLYGL 773
+KL DF A RSF V T RW APE+L Y
Sbjct: 137 LKLADFGLA---RSF------------GSPVRPYTHYVVTRWYRAPELLLGD---KGYST 178
Query: 774 EVDIWSYGCLLLELLTLQVPYMGLSELE 801
VDIWS GC+ ELL+ + + G SE++
Sbjct: 179 PVDIWSVGCIFAELLSRRPLFPGKSEID 206
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 56/231 (24%), Positives = 107/231 (46%), Gaps = 51/231 (22%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
I E++ G N ++ L E + V+ + L++A +++A+ L K+ +HRD+ + N
Sbjct: 79 IITEFMTYG---NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 135
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 764
L+ E +VK+ DF + + +T AH G P +W APE L
Sbjct: 136 LVG-ENH------LVKVADFGLSRLMTGDTYT---AHAGAKFP------IKWTAPESLAY 179
Query: 765 MHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGS 823
N + ++ D+W++G LL E+ T + PY G+ ++++L++ G R
Sbjct: 180 ----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR------------ 223
Query: 824 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
E+PE + ++ R C + NP++RP+ ++++ F
Sbjct: 224 ------------MERPEGCPPK---VYELMRACWQWNPSDRPSFAEIHQAF 259
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 61/275 (22%), Positives = 97/275 (35%), Gaps = 75/275 (27%)
Query: 601 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 660
+ E R+L L S I+ Y + L I MEY + G + ++
Sbjct: 46 AIDEARVLAKLDSSYIIRYYESFLDKGKL--------------NIVMEYAENGDLHKLLK 91
Query: 661 K-----LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 715
L E +++ L L LHSK I+HRDIKS N+ +D D
Sbjct: 92 MQRGRPLPEDQVWRFFIQILL--------GLAHLHSKKILHRDIKSLNLFLD----AYDN 139
Query: 716 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 775
VK+ D A L I VGTP +++PE+ KP Y +
Sbjct: 140 ---VKIGDLGVA----KLLSDNTNFANTI------VGTPYYLSPELCE--DKP--YNEKS 182
Query: 776 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG 835
D+W+ G +L E T + P+ ++ + I G P +
Sbjct: 183 DVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV------------------SQM 224
Query: 836 FEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 870
+ + L + +C ++ +RP L
Sbjct: 225 YSQQ---------LAQLIDQCLTKDYRQRPDTFQL 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 59/196 (30%), Positives = 84/196 (42%), Gaps = 36/196 (18%)
Query: 601 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 660
C+ E+ +L L H +++ Y I L I +E G + I+
Sbjct: 49 CIKEIDLLKQLNHPNVIKYYASFIEDNEL--------------NIVLELADAGDLSRMIK 94
Query: 661 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 720
+ + + Q + +AL +HS+ +MHRDIK N+ I A G VVK
Sbjct: 95 HFKKQKRLIPEKTVWKYFVQ-LCSALEHMHSRRVMHRDIKPANVFI-----TATG--VVK 146
Query: 721 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 780
L D R F AH VGTP +M+PE +H+ N Y + DIWS
Sbjct: 147 LGDLGLG---RFFSSKTTAAHS-------LVGTPYYMSPE---RIHE-NGYNFKSDIWSL 192
Query: 781 GCLLLELLTLQVPYMG 796
GCLL E+ LQ P+ G
Sbjct: 193 GCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 67/248 (27%), Positives = 102/248 (41%), Gaps = 52/248 (20%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSEN 703
I ME++ GGS+ ++K E + I+ V L L KH IMHRD+K N
Sbjct: 76 ICMEHMDGGSLDQVLKKAGRIPENILGK-----ISIAVLRGLTYLREKHKIMHRDVKPSN 130
Query: 704 ILIDLERKKADGKPVVKLCDFDRAVPL-----RSFLHTCCIAHRGIPAPDVCVGTPRWMA 758
IL++ + G+ +KLCDF + L SF VGT +M+
Sbjct: 131 ILVN-----SRGE--IKLCDFGVSGQLIDSMANSF-----------------VGTRSYMS 166
Query: 759 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL 818
PE L+ H Y ++ DIWS G L+E+ + P E+ + E
Sbjct: 167 PERLQGTH----YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKES 222
Query: 819 EALGSCHEHEVAQSGSGFE-------KPEAELETLSF---LVDVFRRCTEENPTERPTAG 868
S H + + + FE +P +L + +F D +C ++NP ER
Sbjct: 223 HRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERA--- 279
Query: 869 DLYEMFVA 876
DL E+
Sbjct: 280 DLKELTKH 287
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 57/192 (29%), Positives = 86/192 (44%), Gaps = 30/192 (15%)
Query: 685 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 744
AL +HS +++HRD+K NIL++ + + VKL DF A RS + +
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCR-------VKLADFGLA---RSL--SELEENPEN 166
Query: 745 PAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIH 803
P V T RW APE+L + Y VD+WS GC+L E+L + + G S L
Sbjct: 167 PVLTDYVAT-RWYRAPEILLGSTR---YTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQL 222
Query: 804 DLIQMGKRPRLTDE-LEALGSCHEHEV-AQSGSGFEKPEAEL------ETLSFLVDVFRR 855
+ I + + E +E++ S + S KP EL + L L ++
Sbjct: 223 EKI-IEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLL----KK 277
Query: 856 CTEENPTERPTA 867
NP +R TA
Sbjct: 278 LLVFNPNKRLTA 289
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 50/163 (30%), Positives = 68/163 (41%), Gaps = 33/163 (20%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
MEY GG + +I S A+F A V L LH I++RD+K +N+L+
Sbjct: 81 MEYAAGGDLMMHIH------TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL 134
Query: 707 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 763
D E VK+ DF + T C GTP ++APEVL
Sbjct: 135 DTE-------GFVKIADFGLCKEGMGFGDRTSTFC-------------GTPEFLAPEVLT 174
Query: 764 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 806
Y VD W G L+ E+L + P+ G E E+ D I
Sbjct: 175 ETS----YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI 213
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 68/240 (28%), Positives = 101/240 (42%), Gaps = 55/240 (22%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
I MEY+ GGS + + K E +++ I +++ L LHS+ +HRDIK+ N+
Sbjct: 79 IIMEYLGGGSALDLL-KPGPLEETYIAT-----ILREILKGLDYLHSERKIHRDIKAANV 132
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 764
L+ ++ D VKL DF A L T R + VGTP WMAPEV+
Sbjct: 133 LLS---EQGD----VKLADFGVAGQL-----TDTQIKR-----NTFVGTPFWMAPEVI-- 173
Query: 765 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 824
K + Y + DIWS G +EL + P L + + LI P L +
Sbjct: 174 --KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQ------- 224
Query: 825 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE-MFVARTSSSIS 883
+ KP + C ++P RPTA +L + F+ R + S
Sbjct: 225 -----------YSKP---------FKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTS 264
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 77/287 (26%), Positives = 113/287 (39%), Gaps = 80/287 (27%)
Query: 602 LGEVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 659
+ EVR L LRH +E G + + WL MEY G S + +
Sbjct: 63 IKEVRFLQQLRHPNTIEYKGCYLREHTAWL----------------VMEYCLG-SASDIL 105
Query: 660 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 719
E + ++ V++A I L LHS +HRDIK+ NIL+ G V
Sbjct: 106 EVHKKPLQE---VEIAA-ICHGALQGLAYLHSHERIHRDIKAGNILL-----TEPG--TV 154
Query: 720 KLCDFDRAV---PLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 776
KL DF A P SF VGTP WMAPEV+ AM + Y +VD
Sbjct: 155 KLADFGSASLVSPANSF-----------------VGTPYWMAPEVILAMDEGQ-YDGKVD 196
Query: 777 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS-G 835
+WS G +EL + P + + + AL + +AQ+ S
Sbjct: 197 VWSLGITCIELAERKPPLFNM------------------NAMSAL-----YHIAQNDSPT 233
Query: 836 FEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSSS 881
+ +F+ C ++ P +RP++ +L + FV R
Sbjct: 234 LSSNDWSDYFRNFV----DSCLQKIPQDRPSSEELLKHRFVLRERPP 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 69/251 (27%), Positives = 111/251 (44%), Gaps = 61/251 (24%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+TLK +S D ++FE E +L +H IV+ YG +G+P
Sbjct: 40 VKTLKE-TASNDARKDFER----EAELLTNFQHENIVKFYG--------VCTEGDPPI-- 84
Query: 641 LQSAIFMEYVKGGSVKNYIEK-------LSETGEKHVSVKLA--LFIAQDVAAALVELHS 691
+F EY++ G + ++ L + L+ L IA +A+ +V L S
Sbjct: 85 ---MVF-EYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS 140
Query: 692 KHIMHRDIKSENILI--DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 749
+H +HRD+ + N L+ DL VVK+ DF + + + + H +P
Sbjct: 141 QHFVHRDLATRNCLVGYDL---------VVKIGDFGMSRDVYTTDYYRVGGHTMLPI--- 188
Query: 750 CVGTPRWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDL 805
RWM PE + +Y E D+WS+G +L E+ T + P+ GLS E+ +
Sbjct: 189 -----RWMPPESI-------MYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236
Query: 806 IQMGK---RPR 813
I G+ RPR
Sbjct: 237 ITQGRLLQRPR 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 81/353 (22%), Positives = 145/353 (41%), Gaps = 107/353 (30%)
Query: 558 EAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV 617
E GK V ++ FR K + V+ LK +S+ E+R+ L E +L + H ++
Sbjct: 12 EFGKVVKATAFRLKGRAGYTTVAVKMLKE-NASSSELRDL----LSEFNLLKQVNHPHVI 66
Query: 618 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI------------------ 659
++YG S DG + +EY K GS+++++
Sbjct: 67 KLYG-------ACSQDGPL-------LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112
Query: 660 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 718
L E+ +++ + A ++ + L ++HRD+ + N+L+ A+G+
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV------AEGR-K 165
Query: 719 VKLCDF--------DRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWMAPEVLRAMHKPN 769
+K+ DF + + RS +G IP +WMA E L H
Sbjct: 166 MKISDFGLSRDVYEEDSYVKRS---------KGRIPV--------KWMAIESL-FDH--- 204
Query: 770 LYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE 828
+Y + D+WS+G LL E++TL PY G++ + +L++ G R
Sbjct: 205 IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYR----------------- 247
Query: 829 VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT----AGDLYEMFVAR 877
E+PE E + L+ C ++ P +RPT + +L +M V
Sbjct: 248 -------MERPENCSEEMYNLM---LTCWKQEPDKRPTFADISKELEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 9e-13
Identities = 49/162 (30%), Positives = 79/162 (48%), Gaps = 26/162 (16%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
ME++ GG + +I+ + + A F A ++ L LHSK I++RD+K +N+++
Sbjct: 75 MEFLNGGDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML 129
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 766
D DG +K+ DF C G GTP ++APE+L+ +
Sbjct: 130 D-----RDGH--IKIADFG----------MCKENVFGDNRASTFCGTPDYIAPEILQGLK 172
Query: 767 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 808
Y VD WS+G LL E+L Q P+ G E E+ + I++
Sbjct: 173 ----YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 9e-13
Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 32/153 (20%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
+ +EYV GG + ++++ + E+H A F A ++ AL LH + I++RD+K +N+
Sbjct: 73 LVIEYVNGGDLMFHMQRQRKLPEEH-----ARFYAAEICIALNFLHERGIIYRDLKLDNV 127
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEV 761
L+D ADG +KL D+ + G+ D GTP ++APE+
Sbjct: 128 LLD-----ADGH--IKLTDYG-------------MCKEGLGPGDTTSTFCGTPNYIAPEI 167
Query: 762 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 794
LR YG VD W+ G L+ E++ + P+
Sbjct: 168 LRGEE----YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 21/163 (12%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
+ M+Y GG + + K E + +A F ++ A+ +H H +HRDIK +N+
Sbjct: 78 LVMDYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNV 133
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 764
L+D+ ++L DF + + G V VGTP +++PE+L+A
Sbjct: 134 LLDMNGH-------IRLADFGSCLKMNQ---------DGTVQSSVAVGTPDYISPEILQA 177
Query: 765 MHKP-NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 806
M YG E D WS G + E+L + P+ S +E + I
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 51/168 (30%), Positives = 79/168 (47%), Gaps = 33/168 (19%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
+E+V GG + ++ K +A F ++ A LHSK I++RD+K EN+
Sbjct: 95 FLLEFVVGGELFTHLRKAGRFPND-----VAKFYHAELVLAFEYLHSKDIIYRDLKPENL 149
Query: 705 LIDLERKKADGKPVVKLCDFDRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 762
L+ D K VK+ DF A VP R+F T C GTP ++APEV+
Sbjct: 150 LL-------DNKGHVKVTDFGFAKKVPDRTF--TLC-------------GTPEYLAPEVI 187
Query: 763 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
++ +G VD W+ G LL E + P+ + I++ I G+
Sbjct: 188 QSKG----HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR 231
|
Length = 329 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 44/230 (19%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E +++ L H +V++YG + +K P I EY+ G + NY+ +
Sbjct: 49 EAKVMMKLSHPNLVQLYG--VCTKQRPIF------------IVTEYMANGCLLNYLRERK 94
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
+ L + DV A+ L S +HRD+ + N L+ + VVK+ D
Sbjct: 95 GKLGT----EWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN-------VVKVSD 143
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
F A R L + +G P +W PEV + + + + D+WS+G L
Sbjct: 144 FGLA---RYVLDDQYTSSQGTKFP------VKWAPPEVF--DY--SRFSSKSDVWSFGVL 190
Query: 784 LLELLTL-QVPYMGLSELEIHDLIQMG---KRPRL--TDELEALGSCHEH 827
+ E+ + ++PY S E+ + + G RP+L T+ + SC
Sbjct: 191 MWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHE 240
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 59/184 (32%), Positives = 86/184 (46%), Gaps = 37/184 (20%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
+ +EY+ GG + ++E+ E A F +++ AL LH + I++RD+K ENI
Sbjct: 77 LILEYLSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENI 131
Query: 705 LIDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 761
L+D A G VKL DF ++ + HT C GT +MAPE+
Sbjct: 132 LLD-----AQGH--VKLTDFGLCKESIHEGTVTHTFC-------------GTIEYMAPEI 171
Query: 762 L-RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK---RPRLTDE 817
L R+ H G VD WS G L+ ++LT P+ + + D I GK P LT E
Sbjct: 172 LMRSGH-----GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPE 226
Query: 818 LEAL 821
L
Sbjct: 227 ARDL 230
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 63/287 (21%), Positives = 115/287 (40%), Gaps = 72/287 (25%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+TLK + L E +++ LRH ++++Y P +
Sbjct: 35 VKTLKPGTMDPKDF-------LAEAQIMKKLRHPKLIQLYA--------VCTLEEPIY-- 77
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
I E +K GS+ Y++ + + + + +A VA+ + L +++ +HRD+
Sbjct: 78 ----IVTELMKYGSLLEYLQG---GAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLA 130
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 760
+ N+L+ + + K+ DF A R A G P +W APE
Sbjct: 131 ARNVLV------GENN-ICKVADFGLA---RVIKEDIYEAREGAKFP------IKWTAPE 174
Query: 761 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 819
N + ++ D+WS+G LL E++T ++PY G++ E+ + G R +
Sbjct: 175 AALY----NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR------MP 224
Query: 820 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866
C P+ L D+ C +E+P +RPT
Sbjct: 225 CPPGC--------------PKE-------LYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 48/174 (27%), Positives = 79/174 (45%), Gaps = 27/174 (15%)
Query: 625 SSKWLPSADG--NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDV 682
+S W+P + +L + MEY GG + + + + + ++ +A F ++
Sbjct: 59 NSPWIPQLQYAFQDKDNLY---LVMEYQPGGDLLSLLNRYEDQFDE----DMAQFYLAEL 111
Query: 683 AAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR 742
A+ +H +HRDIK EN+LID +KL DF A L +
Sbjct: 112 VLAIHSVHQMGYVHRDIKPENVLIDRTGH-------IKLADFGSAARLTANKMV------ 158
Query: 743 GIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYGCLLLELLTLQVPY 794
+ VGTP ++APEVL M+ YG+E D WS G + E++ + P+
Sbjct: 159 ---NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 50/164 (30%), Positives = 79/164 (48%), Gaps = 34/164 (20%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
MEYV GG + I++ + E + F A +V AL+ LH +++RD+K +NIL+
Sbjct: 75 MEYVNGGDLMFQIQRSRKFDEPR-----SRFYAAEVTLALMFLHRHGVIYRDLKLDNILL 129
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV----GTPRWMAPEVL 762
D A+G KL DF + GI V GTP ++APE+L
Sbjct: 130 D-----AEGH--CKLADFG-------------MCKEGI-LNGVTTTTFCGTPDYIAPEIL 168
Query: 763 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 806
+ + YG VD W+ G L+ E++ Q P+ +E ++ + I
Sbjct: 169 QELE----YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 56/226 (24%), Positives = 98/226 (43%), Gaps = 55/226 (24%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
+ EY G + N++ + E+ ++++ L + VA + L SK+ +HRD+ + N+
Sbjct: 116 VITEYCCYGDLLNFLRRKRES---FLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNV 172
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG---IPAPDVCVGTPRWMAPEV 761
L+ GK +VK+CDF A R ++ +G +P +WMAPE
Sbjct: 173 LL------THGK-IVKICDFGLA---RDIMNDSNYVVKGNARLPV--------KWMAPES 214
Query: 762 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEA 820
+ +Y E D+WSYG LL E+ +L PY G+ D
Sbjct: 215 IFN----CVYTFESDVWSYGILLWEIFSLGSNPYPGM----------------PVDSK-- 252
Query: 821 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866
+++ + G +PE + D+ + C + +P +RPT
Sbjct: 253 -----FYKLIKEGYRMAQPEHAPAE---IYDIMKTCWDADPLKRPT 290
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 51/171 (29%), Positives = 79/171 (46%), Gaps = 22/171 (12%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
I +E+ GG+V + +L E+ ++ + + AL LH I+HRD+K+ NI
Sbjct: 79 ILIEFCAGGAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNI 134
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 764
L L DG +KL DF + R I D +GTP WMAPEV+
Sbjct: 135 LFTL-----DGD--IKLADFGVSAK----------NTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 765 -MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 814
K Y + D+WS G L+E+ ++ P+ L+ + + I + P L
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL 228
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-12
Identities = 57/174 (32%), Positives = 90/174 (51%), Gaps = 28/174 (16%)
Query: 633 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 692
D ++L A+ ++Y G ++ I+ ++T + L Q V A+ +HSK
Sbjct: 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ-VLLAVHHVHSK 162
Query: 693 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV--- 749
H++HRDIKS NIL+ ++G +VKL DF + + + T + DV
Sbjct: 163 HMIHRDIKSANILL-----CSNG--LVKLGDFGFS---KMYAATV--------SDDVGRT 204
Query: 750 -CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEI 802
C GTP ++APE+ R KP Y + D++S G LL ELLTL+ P+ G + E+
Sbjct: 205 FC-GTPYYVAPEIWR--RKP--YSKKADMFSLGVLLYELLTLKRPFDGENMEEV 253
|
Length = 496 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 71/274 (25%), Positives = 111/274 (40%), Gaps = 62/274 (22%)
Query: 601 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 660
C+ E+ +L L H ++ K+L S + E + I +E G + I+
Sbjct: 49 CVKEIDLLKQLNHPNVI---------KYLDSFIEDNELN-----IVLELADAGDLSQMIK 94
Query: 661 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 720
+ + + Q + +A+ +HS+ +MHRDIK N+ I A G VVK
Sbjct: 95 YFKKQKRLIPERTVWKYFVQ-LCSAVEHMHSRRVMHRDIKPANVFI-----TATG--VVK 146
Query: 721 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 780
L D R F AH VGTP +M+PE +H+ N Y + DIWS
Sbjct: 147 LGDLGLG---RFFSSKTTAAHS-------LVGTPYYMSPE---RIHE-NGYNFKSDIWSL 192
Query: 781 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 840
GCLL E+ LQ P+ G D++ C + E + P
Sbjct: 193 GCLLYEMAALQSPFYG-------------------DKMNLFSLCQKIEQC------DYPP 227
Query: 841 AELETLS-FLVDVFRRCTEENPTERPTAGDLYEM 873
E S L ++ C +P +RP G ++++
Sbjct: 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 67/235 (28%), Positives = 98/235 (41%), Gaps = 62/235 (26%)
Query: 600 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVK---GGS 654
S L E+ +L LRH IVE+ + K L S IF MEY +
Sbjct: 52 SSLREITLLLNLRHPNIVELK-EVVVGKHLDS-------------IFLVMEYCEQDLASL 97
Query: 655 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 714
+ N SE+ VK + + L LH I+HRD+K N+L+
Sbjct: 98 LDNMPTPFSES-----QVKC---LMLQLLRGLQYLHENFIIHRDLKVSNLLL-------T 142
Query: 715 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV--CVGTPRWMAPEVLRAMHKPNLYG 772
K +K+ DF A R++ G+PA + V T + APE+L Y
Sbjct: 143 DKGCLKIADFGLA---RTY---------GLPAKPMTPKVVTLWYRAPELLLGCTT---YT 187
Query: 773 LEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH 827
+D+W+ GC+L ELL + G SE+E DLI ++ LG+ +E
Sbjct: 188 TAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLI-----------IQLLGTPNES 231
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 32/151 (21%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
+E+V GG + ++++ + E+H A F + +++ AL LH + I++RD+K +N+L+
Sbjct: 75 IEFVSGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNFLHERGIIYRDLKLDNVLL 129
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEVLR 763
D A+G +KL D+ + GI D GTP ++APE+LR
Sbjct: 130 D-----AEGH--IKLTDYG-------------MCKEGIRPGDTTSTFCGTPNYIAPEILR 169
Query: 764 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 794
YG VD W+ G L+ E++ + P+
Sbjct: 170 GED----YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 67/267 (25%)
Query: 602 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 661
L E ++ L+H +V +Y + +K P I EY+ GS+ ++++
Sbjct: 49 LEEANLMKTLQHDKLVRLYA--VVTKEEPIY------------IITEYMAKGSLLDFLK- 93
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
S+ G K + KL F AQ +A + + K+ +HRD+++ N+L+ + K+
Sbjct: 94 -SDEGGKVLLPKLIDFSAQ-IAEGMAYIERKNYIHRDLRAANVLVS-------ESLMCKI 144
Query: 722 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781
DF A + +T A G P +W APE + + ++ D+WS+G
Sbjct: 145 ADFGLARVIEDNEYT---AREGAKFP------IKWTAPEAINF----GSFTIKSDVWSFG 191
Query: 782 CLLLELLTL-QVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKP 839
LL E++T ++PY G+S ++ +Q G R PR+ + C +
Sbjct: 192 ILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMEN-------CPDE------------ 232
Query: 840 EAELETLSFLVDVFRRCTEENPTERPT 866
L D+ + C +E ERPT
Sbjct: 233 ---------LYDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 71/319 (22%), Positives = 113/319 (35%), Gaps = 82/319 (25%)
Query: 562 SVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 621
SV ++ K G A V+TLK + I + L E ++ L H CIV + G
Sbjct: 10 SVVKGVYLMKSGKEVEVA-VKTLK-----QEHIAAGKKEFLREASVMAQLDHPCIVRLIG 63
Query: 622 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQD 681
+ + ME G + Y++K + + V +A
Sbjct: 64 VCKGEPLM---------------LVMELAPLGPLLKYLKK-----RREIPVSDLKELAHQ 103
Query: 682 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCI 739
VA + L SKH +HRD+ + N+L L + K+ DF RA+ S +
Sbjct: 104 VAMGMAYLESKHFVHRDLAARNVL--LVNRHQ-----AKISDFGMSRALGAGSDYYR--- 153
Query: 740 AHRGIPAPDVCVGTPRWMAPEVL---RAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYM 795
A P +W APE + + K D+WSYG L E + PY
Sbjct: 154 ATTAGRWP------LKWYAPECINYGKFSSKS-------DVWSYGVTLWEAFSYGAKPYG 200
Query: 796 GLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 855
+ E+ +++ G+R L C + + +
Sbjct: 201 EMKGAEVIAMLESGER------LPRPEECPQE---------------------IYSIMLS 233
Query: 856 CTEENPTERPTAGDLYEMF 874
C + P +RPT +L F
Sbjct: 234 CWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 51/150 (34%), Positives = 72/150 (48%), Gaps = 23/150 (15%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
+ ++YV GG + ++ + E V V +A ++ AL LH I++RDIK ENI
Sbjct: 82 LILDYVNGGELFTHLYQREHFTESEVRVYIA-----EIVLALDHLHQLGIIYRDIKLENI 136
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 764
L+D ++G V L DF + + FL A A C GT +MAPEV+R
Sbjct: 137 LLD-----SEGH--VVLTDFGLS---KEFL-----AEEEERAYSFC-GTIEYMAPEVIRG 180
Query: 765 MHKPNLYGLEVDIWSYGCLLLELLTLQVPY 794
+ VD WS G L ELLT P+
Sbjct: 181 --GSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 52/228 (22%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---- 659
E +L L+H IV+ YG DG+P + EY+K G + ++
Sbjct: 57 EAELLTNLQHEHIVKFYG--------VCGDGDP------LIMVFEYMKHGDLNKFLRAHG 102
Query: 660 ---------EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 710
+ GE + + L IA +A+ +V L S+H +HRD+ + N L+
Sbjct: 103 PDAMILVDGQPRQAKGE--LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---- 156
Query: 711 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 770
+VK+ DF + + S + H +P RWM PE + M++
Sbjct: 157 ---GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI--------RWMPPESI--MYRK-- 201
Query: 771 YGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGK---RPRL 814
+ E D+WS+G +L E+ T + P+ LS E+ + I G+ RPR+
Sbjct: 202 FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRV 249
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 56/191 (29%), Positives = 87/191 (45%), Gaps = 37/191 (19%)
Query: 685 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 744
+L +H I HRDIK ENILI + ++KL DF +C +
Sbjct: 112 SLDHMHRNGIFHRDIKPENILIKDD--------ILKLADFG----------SCRGIYSKP 153
Query: 745 PAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE-- 801
P + + T RW APE L YG ++DIW+ GC+ E+L+L + G +EL+
Sbjct: 154 PYTEY-IST-RWYRAPECLLTD---GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI 208
Query: 802 --IHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEK--PEAELETLSFLVDVFRRC 856
IHD+ +G + + + + ++ G+G K P A E L D+ ++
Sbjct: 209 AKIHDV--LGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGL----DLLKKL 262
Query: 857 TEENPTERPTA 867
+P ER TA
Sbjct: 263 LAYDPDERITA 273
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 62/206 (30%), Positives = 91/206 (44%), Gaps = 34/206 (16%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
I ME + G++ N+ L G VSV L + DVA + L SK ++HRD+ + NI
Sbjct: 75 IVMELMSKGNLVNF---LRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNI 131
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 764
L+ DG V K+ DF +A G D +W APE L
Sbjct: 132 LV-----SEDG--VAKVSDFG-------------LARVGSMGVDNSKLPVKWTAPEAL-- 169
Query: 765 MHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEA--- 820
K + + D+WSYG LL E+ + + PY +S E+ + ++ G R + A
Sbjct: 170 --KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVY 227
Query: 821 --LGSCHEHEVAQSGSGFEKPEAELE 844
+ SC E E + S F K +LE
Sbjct: 228 VLMTSCWETEPKKRPS-FHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 74/311 (23%), Positives = 111/311 (35%), Gaps = 94/311 (30%)
Query: 597 FEYSCLGEVRMLGALRHSCIV---EMY--GHKISSKWLPS---------AD-----GNPE 637
F + L E+++L L+H +V +M S + S D NP
Sbjct: 50 FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPS 109
Query: 638 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 697
L +S I K Y+ +L E G + LH HI+HR
Sbjct: 110 VKLTESQI----------KCYMLQLLE-GINY-------------------LHENHILHR 139
Query: 698 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV-----CVG 752
DIK+ NILI D + ++K+ DF A R + +G V
Sbjct: 140 DIKAANILI-------DNQGILKIADFGLA---RPY-DGPPPNPKGGGGGGTRKYTNLVV 188
Query: 753 TPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR 811
T RW PE+L + + Y VDIW GC+ E+ T + G S+++ LI
Sbjct: 189 T-RWYRPPELL--LGERR-YTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI----- 239
Query: 812 PRLTDELEALGSCHEHE--VAQSGSGFEKPEAELETLSFLVDVFRRCTEE---------- 859
+ G+ E +S G E + L + F + E
Sbjct: 240 ------FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLS 293
Query: 860 -NPTERPTAGD 869
+P +R TA D
Sbjct: 294 LDPYKRLTASD 304
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 44/148 (29%), Positives = 66/148 (44%), Gaps = 30/148 (20%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
MEY+ GG + I+ L E +A +V + +LH + I+HRDIK EN+LI
Sbjct: 76 MEYLNGGDCASLIKTLGGLPEDWAKQYIA-----EVVLGVEDLHQRGIIHRDIKPENLLI 130
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 766
D G +KL DF ++ G+ VGTP ++APE + +
Sbjct: 131 D-----QTGH--LKLTDFG-------------LSRNGLENKKF-VGTPDYLAPETI--LG 167
Query: 767 KPNLYGLEVDIWSYGCLLLELLTLQVPY 794
+ D WS GC++ E L P+
Sbjct: 168 VGDDK--MSDWWSLGCVIFEFLFGYPPF 193
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 51/154 (33%), Positives = 70/154 (45%), Gaps = 24/154 (15%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
I MEY GG + ++K+ K L + + +H K ++HRDIKS+NI
Sbjct: 75 IVMEYCDGGDL---MQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNI 131
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 764
+ +GK VKL DF A L S C VGTP ++ PE+
Sbjct: 132 FL-----TQNGK--VKLGDFGSARLLTSPGAYAC----------TYVGTPYYVPPEIWEN 174
Query: 765 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS 798
M Y + DIWS GC+L EL TL+ P+ S
Sbjct: 175 MP----YNNKSDIWSLGCILYELCTLKHPFQANS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 5e-12
Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 33/161 (20%)
Query: 634 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 693
+ H+L M+Y+K G + + ++K E +S I + + AL +LH +
Sbjct: 79 TTLKGHVL----IMDYIKDGDLFDLLKK-----EGKLSEAEVKKIIRQLVEALNDLHKHN 129
Query: 694 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 753
I+H DIK EN+L D + + + LCD+ C I P GT
Sbjct: 130 IIHNDIKLENVLYDRAKDR------IYLCDYG----------LCKIIG----TPSCYDGT 169
Query: 754 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 794
+ +PE ++ Y + D W+ G L ELLT + P+
Sbjct: 170 LDYFSPEKIK--GHN--YDVSFDWWAVGVLTYELLTGKHPF 206
|
Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 33/152 (21%)
Query: 655 VKNYIEKLSETGEKHVSVKLALF-IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 713
+K +++ +G +K LF + Q +A HS ++HRD+K +N+LI+
Sbjct: 85 LKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC----HSHRVLHRDLKPQNLLIN-----T 135
Query: 714 DGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 769
+G +KL DF A VP+R++ H V T + APE+L
Sbjct: 136 EGA--IKLADFGLARAFGVPVRTYTHE--------------VVTLWYRAPEILLGC---K 176
Query: 770 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 801
Y VDIWS GC+ E++T + + G SE++
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 58/226 (25%), Positives = 100/226 (44%), Gaps = 57/226 (25%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
I E++ GS+ ++++ S+ G K KL F AQ +A + + ++ +HRD+++ NI
Sbjct: 77 IITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQ-IAEGMAFIEQRNYIHRDLRAANI 133
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 764
L+ V K+ DF A + +T A G P +W APE +
Sbjct: 134 LVS-------ASLVCKIADFGLARVIEDNEYT---AREGAKFP------IKWTAPEAIN- 176
Query: 765 MHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEA 820
+G ++ D+WS+G LL+E++T ++PY G+S E+ ++ G R +
Sbjct: 177 ------FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE---- 226
Query: 821 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866
+C E L ++ RC + P ERPT
Sbjct: 227 --NCPEE---------------------LYNIMMRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 6e-12
Identities = 53/164 (32%), Positives = 79/164 (48%), Gaps = 34/164 (20%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
++YV GG + ++++ E+ A F A ++A+AL LHS +I++RD+K ENIL+
Sbjct: 75 LDYVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL 129
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV----CVGTPRWMAPEVL 762
D + G V L DF + GI C GTP ++APEVL
Sbjct: 130 D-----SQGH--VVLTDFG-------------LCKEGIEHSKTTSTFC-GTPEYLAPEVL 168
Query: 763 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 806
R +P Y VD W G +L E+L P+ E++D I
Sbjct: 169 R--KQP--YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 26/163 (15%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
M + GG +K +I GE A+F A + L LH + I++RD+K EN+L+
Sbjct: 72 MTLMNGGDLKYHI---YNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL 128
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 766
D G V++ D AV L +G GTP +MAPEVL
Sbjct: 129 D-----DHGN--VRISDLGLAVEL-----------KGGKKIKGRAGTPGYMAPEVL---- 166
Query: 767 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE-LEIHDLIQM 808
+ +Y VD ++ GC L E++ + P+ E +E +L +
Sbjct: 167 QGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 71/242 (29%), Positives = 103/242 (42%), Gaps = 59/242 (24%)
Query: 645 IFMEYVKGGSVKNYIEK--LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 702
I MEY+ GGS + +E L ET ++A I +++ L LHS+ +HRDIK+
Sbjct: 79 IIMEYLGGGSALDLLEPGPLDET-------QIAT-ILREILKGLDYLHSEKKIHRDIKAA 130
Query: 703 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 762
N+L+ + VKL DF A L T R + VGTP WMAPEV+
Sbjct: 131 NVLLSEHGE-------VKLADFGVAGQL-----TDTQIKR-----NTFVGTPFWMAPEVI 173
Query: 763 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALG 822
K + Y + DIWS G +EL + P+ L +++ LI P L
Sbjct: 174 ----KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLE------- 222
Query: 823 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE-MFVARTSSS 881
+ KP L + C + P+ RPTA +L + F+ R +
Sbjct: 223 -----------GNYSKP---------LKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKK 262
Query: 882 IS 883
S
Sbjct: 263 TS 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-12
Identities = 52/181 (28%), Positives = 90/181 (49%), Gaps = 35/181 (19%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
MEY GG + ++ + E+ + + A F ++ +AL LHS+ +++RDIK EN+++
Sbjct: 74 MEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 128
Query: 707 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 763
D DG +K+ DF + + + T C GTP ++APEVL
Sbjct: 129 D-----KDGH--IKITDFGLCKEGISDGATMKTFC-------------GTPEYLAPEVL- 167
Query: 764 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG--KRPR-LTDELEA 820
+ N YG VD W G ++ E++ ++P+ + +LI M + PR L+ E ++
Sbjct: 168 ---EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS 224
Query: 821 L 821
L
Sbjct: 225 L 225
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 26/148 (17%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
+EYV GG + ++++ + E+H A F + +++ AL LH + I++RD+K +N+L+
Sbjct: 75 IEYVNGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNYLHERGIIYRDLKLDNVLL 129
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 766
D E +KL D+ C R GTP ++APE+LR
Sbjct: 130 DSEGH-------IKLTDYG----------MCKEGLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 767 KPNLYGLEVDIWSYGCLLLELLTLQVPY 794
YG VD W+ G L+ E++ + P+
Sbjct: 173 ----YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 53/178 (29%), Positives = 87/178 (48%), Gaps = 29/178 (16%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
MEY GG + ++ + E+ S A F ++ +AL LHS +++RD+K EN+++
Sbjct: 74 MEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML 128
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 766
D DG +K+ DF S G C GTP ++APEVL
Sbjct: 129 D-----KDGH--IKITDFGLCKEGISD---------GATMKTFC-GTPEYLAPEVL---- 167
Query: 767 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG--KRPR-LTDELEAL 821
+ N YG VD W G ++ E++ ++P+ ++ +LI M + PR L+ E ++L
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSL 225
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 49/149 (32%), Positives = 76/149 (51%), Gaps = 28/149 (18%)
Query: 645 IFMEYVKGGSVKNYI--EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 702
I M+Y +GG + I ++ E + L F+ + AL +H + I+HRDIKS+
Sbjct: 76 IVMDYCEGGDLYKKINAQRGVLFPEDQI---LDWFV--QICLALKHVHDRKILHRDIKSQ 130
Query: 703 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 762
NI + DG +KL DF A L S T +A C+GTP +++PE+
Sbjct: 131 NIFL-----TKDG--TIKLGDFGIARVLNS---TVELAR-------TCIGTPYYLSPEIC 173
Query: 763 RAMHKPNLYGLEVDIWSYGCLLLELLTLQ 791
++P Y + DIW+ GC+L E+ TL+
Sbjct: 174 E--NRP--YNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 75/274 (27%), Positives = 103/274 (37%), Gaps = 77/274 (28%)
Query: 602 LGEVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 659
+ EV+ L L+H +E G K + WL MEY G +
Sbjct: 69 IKEVKFLQQLKHPNTIEYKGCYLKEHTAWL----------------VMEYCLGSA----- 107
Query: 660 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 719
L E +K + I L LHS +++HRDIK+ NIL+ + V
Sbjct: 108 SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ-------V 160
Query: 720 KLCDFDRAV---PLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 776
KL DF A P SF VGTP WMAPEV+ AM + Y +VD
Sbjct: 161 KLADFGSASKSSPANSF-----------------VGTPYWMAPEVILAMDEGQ-YDGKVD 202
Query: 777 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 836
+WS G +EL + P ++ + I P L +E S GF
Sbjct: 203 VWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL----------QSNEWTDSFRGF 252
Query: 837 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 870
VD C ++ P ERP + +L
Sbjct: 253 -------------VDY---CLQKIPQERPASAEL 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 58/298 (19%), Positives = 119/298 (39%), Gaps = 68/298 (22%)
Query: 581 VRTLKVCGSSADEIRNF--EYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEH 638
V+T+K+ + EI F E +C+ + H ++++ G + S+
Sbjct: 32 VKTMKLDIHTYSEIEEFLSEAACMKD------FDHPNVMKLIGVCFEA----SSLQKIPK 81
Query: 639 HLLQSAIFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 697
+ + + ++K G + +++ + + ++ L D+A + L +++ +HR
Sbjct: 82 PM----VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHR 137
Query: 698 DIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 755
D+ + N ++ + V + DF + + + IA +P +
Sbjct: 138 DLAARNCMLREDMT-------VCVADFGLSKKIYSGDYYRQGRIAK--MPV--------K 180
Query: 756 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRL 814
W+A E L +Y + D+W++G + E+ T Q PY G+ EI+D ++ G R
Sbjct: 181 WIAIESL----ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR--- 233
Query: 815 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 872
++PE + L L D+ C +P +RPT L E
Sbjct: 234 ---------------------LKQPE---DCLDELYDLMYSCWRADPKDRPTFTKLRE 267
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 65/229 (28%), Positives = 97/229 (42%), Gaps = 62/229 (27%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
+ +++++GG + + K E+ V LA ++A AL LHS I++RD+K ENI
Sbjct: 75 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-----ELALALDHLHSLGIIYRDLKPENI 129
Query: 705 LIDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 761
L+D +G +KL DF ++ ++ C GT +MAPEV
Sbjct: 130 LLD-----EEGH--IKLTDFGLSKESIDHEKKAYSFC-------------GTVEYMAPEV 169
Query: 762 L-RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEA 820
+ R H D WS+G L+ E+LT +P+ G E +I K
Sbjct: 170 VNRRGHT-----QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK---------- 214
Query: 821 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 869
LG F PEA+ S L +F+R NP R AG
Sbjct: 215 LGMPQ----------FLSPEAQ----SLLRALFKR----NPANRLGAGP 245
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 47/212 (22%)
Query: 581 VRTLKV-CGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHH 639
V+TLK CG E+ +L L H IV+ G ++ +
Sbjct: 38 VKTLKRECGQQNTS------GWKKEINILKTLYHENIVKYKG--------CCSEQGGKGL 83
Query: 640 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 699
L MEYV GS+++Y+ K +++ L AQ + + LHS+H +HRD+
Sbjct: 84 QL----IMEYVPLGSLRDYLPKHK------LNLAQLLLFAQQICEGMAYLHSQHYIHRDL 133
Query: 700 KSENILIDLERKKADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 757
+ N+L+D +R +VK+ DF +AVP +R D V W
Sbjct: 134 AARNVLLDNDR-------LVKIGDFGLAKAVP------EGHEYYRVREDGDSPV---FWY 177
Query: 758 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789
A E L K N + D+WS+G L ELLT
Sbjct: 178 AVECL----KENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 87/298 (29%), Positives = 123/298 (41%), Gaps = 88/298 (29%)
Query: 602 LGEVRMLGALRHSCIV---EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 658
L E+RML L+H +V E++ K + L HL+ EY +V N
Sbjct: 48 LREIRMLKQLKHPNLVNLIEVFRRK---RKL---------HLV-----FEYCDH-TVLNE 89
Query: 659 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 718
+EK +H+ K+ Q V H + +HRD+K ENILI K
Sbjct: 90 LEKNPRGVPEHLIKKIIWQTLQAVNFC----HKHNCIHRDVKPENILI----TKQG---Q 138
Query: 719 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV----CVGTPRWM-APEVLRAMHKPNLYGL 773
+KLCDF A R + P V T RW APE+L + YG
Sbjct: 139 IKLCDFGFA--------------RILTGPGDDYTDYVAT-RWYRAPELLVGDTQ---YGP 180
Query: 774 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ--MGKR-PRLTDELEALGSCHEHEVA 830
VD+W+ GC+ ELLT Q + G S+++ LI+ +G PR H+ +
Sbjct: 181 PVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR-----------HQQIFS 229
Query: 831 QSG--SGFEKPEAE----LE---------TLSFLVDVFRRCTEENPTERPTAGDLYEM 873
+ G PE E LE LSFL + C + +PTER + +L E
Sbjct: 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFL----KGCLQMDPTERLSCEELLEH 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 72/301 (23%), Positives = 117/301 (38%), Gaps = 92/301 (30%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+ LK ++A + L E ++ LRH +V++ G GNP +
Sbjct: 34 VKCLKDDSTAAQ-------AFLAEASVMTTLRHPNLVQLLG--------VVLQGNPLY-- 76
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
I EY+ GS+ +Y L G +++ L A DV + L K+ +HRD+
Sbjct: 77 ----IVTEYMAKGSLVDY---LRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLA 129
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP------ 754
+ N+L+ + V K+ DF G+ A + G
Sbjct: 130 ARNVLVSEDL-------VAKVSDF------------------GL-AKEASQGQDSGKLPV 163
Query: 755 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPY--MGLSELEIHDLIQMGKR 811
+W APE LR + + D+WS+G LL E+ + +VPY + L ++ H ++ G R
Sbjct: 164 KWTAPEALRE----KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH--VEKGYR 217
Query: 812 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 871
+EA C + V + C E +P +RPT L
Sbjct: 218 ------MEAPEGCPPE---------------------VYKVMKDCWELDPAKRPTFKQLR 250
Query: 872 E 872
E
Sbjct: 251 E 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-11
Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 38/209 (18%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E+ L A H IV+ + D + LL + MEY GG + I++
Sbjct: 115 ELHCLAACDHFGIVKHFD-----------DFKSDDKLL---LIMEYGSGGDLNKQIKQRL 160
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP--VVKL 721
+ ++ L Q + AL E+HS+ +MHRD+KS NI + P ++KL
Sbjct: 161 KEHLPFQEYEVGLLFYQ-IVLALDEVHSRKMMHRDLKSANIFL---------MPTGIIKL 210
Query: 722 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781
DF + + + + + A C GTP ++APE+ Y + D+WS G
Sbjct: 211 GDFGFS---KQYSDSVSLD----VASSFC-GTPYYLAPELWERKR----YSKKADMWSLG 258
Query: 782 CLLLELLTLQVPYMGLSELEIHDLIQMGK 810
+L ELLTL P+ G S+ EI + GK
Sbjct: 259 VILYELLTLHRPFKGPSQREIMQQVLYGK 287
|
Length = 478 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 39/209 (18%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
EV+ L LRH ++ + + S G P + I E ++ GS+ + L
Sbjct: 52 EVQALKRLRHKHLISL--FAVCSV------GEPVY------IITELMEKGSLLAF---LR 94
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
+ + V + +A VA + L ++ +HRD+ + NIL+ + V K+ D
Sbjct: 95 SPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL-------VCKVAD 147
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
F A ++ ++ + + IP +W APE + + D+WS+G L
Sbjct: 148 FGLARLIKEDVYLS--SDKKIPY--------KWTAPEAASHGT----FSTKSDVWSFGIL 193
Query: 784 LLELLTL-QVPYMGLSELEIHDLIQMGKR 811
L E+ T QVPY G++ E++D I G R
Sbjct: 194 LYEMFTYGQVPYPGMNNHEVYDQITAGYR 222
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 65/240 (27%), Positives = 104/240 (43%), Gaps = 45/240 (18%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E +++ L H +V++YG + +K P I EY+ G + NY L
Sbjct: 49 EAKVMMKLSHEKLVQLYG--VCTKQRPIY------------IVTEYMSNGCLLNY---LR 91
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
E G++ +L L + +DV + L SK +HRD+ + N L+D G VK+ D
Sbjct: 92 EHGKRFQPSQL-LEMCKDVCEGMAYLESKQFIHRDLAARNCLVD-----DQG--CVKVSD 143
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
F + R L + G P RW PEVL + + D+W++G L
Sbjct: 144 FGLS---RYVLDDEYTSSVGSKFP------VRWSPPEVLLYSK----FSSKSDVWAFGVL 190
Query: 784 LLELLTL-QVPYMGLSELEIHDLIQMGK---RPRLTDE--LEALGSCHEHEVAQSGSGFE 837
+ E+ +L ++PY + E + + G RP L E + SC HE A+ F+
Sbjct: 191 MWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCW-HEKAEERPTFQ 249
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 66/234 (28%), Positives = 102/234 (43%), Gaps = 50/234 (21%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
MEYV+GG ++ + + V +A + AL LH+ I+HRD+K +N+LI
Sbjct: 80 MEYVEGGDCATLLKNIGA-----LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI 134
Query: 707 DLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPE 760
+ G +KL DF + + L + L+ I R VC GTP ++APE
Sbjct: 135 -----TSMGH--IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC-GTPEYIAPE 186
Query: 761 V-LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 819
V LR YG VD W+ G +L E L VP+ G + E+ + ++D++E
Sbjct: 187 VILRQG-----YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV-------ISDDIE 234
Query: 820 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 873
G E A+ + D+ R +NP ER G +E+
Sbjct: 235 WPE------------GDEALPADAQ------DLISRLLRQNPLERLGTGGAFEV 270
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 72/271 (26%), Positives = 108/271 (39%), Gaps = 45/271 (16%)
Query: 549 SFPSLSSCDEA----GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGE 604
SFP S E GK +F+ + A V+ L D I + + E
Sbjct: 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL-------DPIHDIDEEIEAE 64
Query: 605 VRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
+L AL H +V+ YG K + + D Q + +E GGSV + ++
Sbjct: 65 YNILKALSDHPNVVKFYG-MYYKKDVKNGD--------QLWLVLELCNGGSVTDLVKGFL 115
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
+ GE+ + + +I + L LH +HRD+K NIL+ E VKL D
Sbjct: 116 KRGER-MEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG-------VKLVD 167
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLEVDIWSYGC 782
F + L S + VGTP WMAPEV+ + + Y D+WS G
Sbjct: 168 FGVSAQLTSTRLR----------RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGI 217
Query: 783 LLLELLTLQVPYMGLSELEIHDLIQMGKRPR 813
+EL P ++H + + K PR
Sbjct: 218 TAIELGDGDPPLA-----DLHPMRALFKIPR 243
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 4e-11
Identities = 61/232 (26%), Positives = 87/232 (37%), Gaps = 47/232 (20%)
Query: 584 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 643
LKV RN L E +L L H + +Y + +L L+
Sbjct: 31 LKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYL---------CLV-- 79
Query: 644 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703
M+Y GG L K +S ++A F A +V AL LH I++RD+K EN
Sbjct: 80 ---MDYCPGG---ELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPEN 133
Query: 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLH-TCCIAHRGIPAPDV------------- 749
IL+ G + L DFD + +G V
Sbjct: 134 ILL-----HESGH--IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 750 -----CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 796
VGT ++APEV+ + +G VD W+ G LL E+L P+ G
Sbjct: 187 FRSNSFVGTEEYIAPEVISG----DGHGSAVDWWTLGILLYEMLYGTTPFKG 234
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 64/247 (25%), Positives = 93/247 (37%), Gaps = 72/247 (29%)
Query: 645 IFMEYVKGGSVKNYI-------EKLS-----ETGEKHVSVKLALFIAQDVAAALVELHSK 692
+ +EY G++++++ E S E L F Q VA + L SK
Sbjct: 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQ-VARGMEFLASK 151
Query: 693 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 752
+HRD+ + N+L+ + V+K+ DF A R I D
Sbjct: 152 KCIHRDLAARNVLVTEDH-------VMKIADFGLA--------------RDIHHIDYYRK 190
Query: 753 TPR------WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ-VPYMGLSELEIHDL 805
T WMAPE L +Y + D+WS+G LL E+ TL PY G+ E+ L
Sbjct: 191 TTNGRLPVKWMAPEALFD----RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246
Query: 806 IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865
++ G R EKP L + R C E P++RP
Sbjct: 247 LKEGYR------------------------MEKP---QNCTQELYHLMRDCWHEVPSQRP 279
Query: 866 TAGDLYE 872
T L E
Sbjct: 280 TFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 67/245 (27%), Positives = 109/245 (44%), Gaps = 51/245 (20%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+TLK +S + ++F E +L L+H IV+ YG +G+P
Sbjct: 40 VKTLK--DASDNARKDFHR----EAELLTNLQHEHIVKFYG--------VCVEGDP---- 81
Query: 641 LQSAIFMEYVKGGSVKNYIEK------LSETGE--KHVSVKLALFIAQDVAAALVELHSK 692
+ EY+K G + ++ L G ++ L IAQ +AA +V L S+
Sbjct: 82 --LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ 139
Query: 693 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 752
H +HRD+ + N L+ +VK+ DF + + S + H +P
Sbjct: 140 HFVHRDLATRNCLV-------GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI------ 186
Query: 753 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGK- 810
RWM PE + M++ + E D+WS G +L E+ T + P+ LS E+ + I G+
Sbjct: 187 --RWMPPESI--MYRK--FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 240
Query: 811 --RPR 813
RPR
Sbjct: 241 LQRPR 245
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 6e-11
Identities = 53/226 (23%), Positives = 86/226 (38%), Gaps = 58/226 (25%)
Query: 658 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 717
Y+ K + G + + + + + + LHS I+HRD+K +NIL+ + +
Sbjct: 95 YLSKCPKPG---LPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ------ 145
Query: 718 VVKLCDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 771
VK+ DF + L S V T + APEVL + Y
Sbjct: 146 -VKIADFGLARIYSFEMALTS-----------------VVVTLWYRAPEVL--LQSS--Y 183
Query: 772 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE--- 828
VD+WS GC+ EL + + G SE + D I + +G E E
Sbjct: 184 ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI-----------FDVIGLPSEEEWPR 232
Query: 829 -VAQSGSGFE----KPEAEL--ETLSFLVDVFRRCTEENPTERPTA 867
V+ S F + E +D+ ++ NP +R +A
Sbjct: 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 51/172 (29%), Positives = 83/172 (48%), Gaps = 34/172 (19%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
MEYV GG + ++ + E+ S F ++ +AL LHS I++RD+K EN+++
Sbjct: 74 MEYVNGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML 128
Query: 707 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 763
D DG +K+ DF + + + T C GTP ++APEVL
Sbjct: 129 D-----KDGH--IKITDFGLCKEGITDAATMKTFC-------------GTPEYLAPEVL- 167
Query: 764 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG--KRPR 813
+ N YG VD W G ++ E++ ++P+ ++ +LI M K PR
Sbjct: 168 ---EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR 216
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 74/309 (23%), Positives = 114/309 (36%), Gaps = 83/309 (26%)
Query: 578 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 637
V+TL S DE +F L E ++ H IV + G S + P
Sbjct: 38 QVAVKTLPESCSEQDES-DF----LMEALIMSKFNHQNIVRLIG--------VSFERLPR 84
Query: 638 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA--LFIAQDVAAALVELHSKHIM 695
I +E + GG +K+++ + E+ S+ + LF A+DVA L H +
Sbjct: 85 F------ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFI 138
Query: 696 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV-----C 750
HRDI + N L+ K G+ V K+ DF A R I
Sbjct: 139 HRDIAARNCLLT---CKGPGR-VAKIADFGMA--------------RDIYRASYYRKGGR 180
Query: 751 VGTP-RWMAPEVLRAMHKPNLYGL---EVDIWSYGCLLLELLTL-QVPYMGLSELEIHDL 805
P +WM PE L G+ + D+WS+G LL E+ +L +PY G + E+ +
Sbjct: 181 AMLPIKWMPPEAF-------LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF 233
Query: 806 IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865
+ G R L+ C P + + C + P +RP
Sbjct: 234 VTGGGR------LDPPKGC--------------PGP-------VYRIMTDCWQHTPEDRP 266
Query: 866 TAGDLYEMF 874
+ E
Sbjct: 267 NFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 6e-11
Identities = 71/304 (23%), Positives = 120/304 (39%), Gaps = 85/304 (27%)
Query: 592 DEIRNFEYSCLGEVRMLGALRHSCIVEM----YGHKISSKWLPSADGNPEHHLLQSAIF- 646
E F + L E+ +L L+H IV + G + I+
Sbjct: 42 KEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDK------------------IYM 83
Query: 647 -MEYVKGGSVKNYIEKLSE---TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 702
MEYV+ +K+ +E + + E VK + + + + LH I+HRD+K+
Sbjct: 84 VMEYVEH-DLKSLMETMKQPFLQSE----VK---CLMLQLLSGVAHLHDNWILHRDLKTS 135
Query: 703 NILIDLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 758
N+L++ + ++K+CDF A PL+ + V T + A
Sbjct: 136 NLLLN-------NRGILKICDFGLAREYGSPLKPYTQL--------------VVTLWYRA 174
Query: 759 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL---- 814
PE+L + Y +D+WS GC+ ELLT + + G SE++ Q+ K +L
Sbjct: 175 PELLLGAKE---YSTAIDMWSVGCIFAELLTKKPLFPGKSEID-----QLNKIFKLLGTP 226
Query: 815 TDE-------LEALGSCH--EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865
T++ L ++ Q F P L F D+ R +P +R
Sbjct: 227 TEKIWPGFSELPGAKKKTFTKYPYNQLRKKF--PALSLSDNGF--DLLNRLLTYDPAKRI 282
Query: 866 TAGD 869
+A D
Sbjct: 283 SAED 286
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 41/115 (35%), Positives = 52/115 (45%), Gaps = 23/115 (20%)
Query: 685 ALVELHSKH-IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG 743
AL L KH ++HRD+K NIL+D A G VKLCDF I+ R
Sbjct: 126 ALHYLKEKHGVIHRDVKPSNILLD-----ASG--NVKLCDFG-------------ISGRL 165
Query: 744 IP--APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 796
+ A G +MAPE + Y + D+WS G L+EL T Q PY
Sbjct: 166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 38/118 (32%), Positives = 57/118 (48%), Gaps = 29/118 (24%)
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRA--VPLRSFLHTCCIAHRGI 744
H +MHRD+K +N+L+D K ++K+ D RA +P++S+ H
Sbjct: 126 CHKHGVMHRDLKPQNLLVD------KQKGLLKIADLGLGRAFSIPVKSYTHE-------- 171
Query: 745 PAPDVCVGTPRWMAPEVLR-AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 801
+ T + APEVL + H Y VDIWS GC+ E+ Q + G SEL+
Sbjct: 172 ------IVTLWYRAPEVLLGSTH----YSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 47/158 (29%), Positives = 73/158 (46%), Gaps = 31/158 (19%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
+ + + GG +K +I + G + + ALF A ++ L +LH ++ ++RD+K ENI
Sbjct: 77 LVLTIMNGGDLKFHIYNMGNPGFEE---ERALFYAAEILCGLEDLHRENTVYRDLKPENI 133
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEV 761
L+D G +++ D AV IP + VGT +MAPEV
Sbjct: 134 LLD-----DYGH--IRISDLGLAVK--------------IPEGESIRGRVGTVGYMAPEV 172
Query: 762 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE 799
L Y L D W GCL+ E++ Q P+ G E
Sbjct: 173 L----NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 66/256 (25%), Positives = 102/256 (39%), Gaps = 41/256 (16%)
Query: 560 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVE 618
GK +++ + A V+ L D I + + E +L +L H +V+
Sbjct: 31 GKGTYGKVYKVTNKKDGSLAAVKIL-------DPISDVDEEIEAEYNILQSLPNHPNVVK 83
Query: 619 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFI 678
YG + L Q + +E GGSV ++ L G++ ++ +I
Sbjct: 84 FYGMFYKADKLVGG---------QLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS-YI 133
Query: 679 AQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCC 738
L LH+ I+HRD+K NIL+ E VKL DF + L T
Sbjct: 134 LYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG-------VKLVDFGVSAQL-----TST 181
Query: 739 IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL-YGLEVDIWSYGCLLLELLTLQVPYMGL 797
R + VGTP WMAPEV+ + + Y D+WS G +EL P
Sbjct: 182 RLRR-----NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL--- 233
Query: 798 SELEIHDLIQMGKRPR 813
++H + + K PR
Sbjct: 234 --FDMHPVKTLFKIPR 247
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 51/198 (25%), Positives = 78/198 (39%), Gaps = 46/198 (23%)
Query: 678 IAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 736
IA + AL LHSK ++HRD+K N+LI+ + VKLCDF + L +
Sbjct: 108 IAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ-------VKLCDFGISGYLVDSV-- 158
Query: 737 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 796
A + G +MAPE + Y ++ D+WS G ++EL T + PY
Sbjct: 159 ---------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY-- 207
Query: 797 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRR 855
+ L +V + S P+ E S D +
Sbjct: 208 ---------------DSWKTPFQQL-----KQVVEEPS----PQLPAEKFSPEFQDFVNK 243
Query: 856 CTEENPTERPTAGDLYEM 873
C ++N ERP +L +
Sbjct: 244 CLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 43/148 (29%), Positives = 67/148 (45%), Gaps = 25/148 (16%)
Query: 652 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 711
GG +K +I + G + A+F A ++ L +LH + I++RD+K ENIL+D
Sbjct: 84 GGDLKFHIYNMGNPGFDE---ERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD---- 136
Query: 712 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 771
+++ D AV + I R VGT +MAPEV+ K Y
Sbjct: 137 ---DYGHIRISDLGLAVEIPE---GETIRGR--------VGTVGYMAPEVV----KNERY 178
Query: 772 GLEVDIWSYGCLLLELLTLQVPYMGLSE 799
D W GCL+ E++ + P+ E
Sbjct: 179 TFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 60/267 (22%), Positives = 108/267 (40%), Gaps = 64/267 (23%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E ++L L H IV+ + + I EY +G + +E+L
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAF--------------CIITEYCEGRDLDCKLEELK 97
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
TG+ ++ + Q + + +H + I+HRD+K++NI + ++K+ D
Sbjct: 98 HTGKTLSENQVCEWFIQ-LLLGVHYMHQRRILHRDLKAKNIFLK--------NNLLKIGD 148
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
F + R + +C +A GTP +M+PE L+ H+ Y + DIWS GC+
Sbjct: 149 FGVS---RLLMGSCDLA-------TTFTGTPYYMSPEALK--HQG--YDSKSDIWSLGCI 194
Query: 784 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 843
L E+ L + G + L + I G P L PE
Sbjct: 195 LYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL------------------------PETYS 230
Query: 844 ETLSFLVDVFRRCTEENPTERPTAGDL 870
L+ ++ ++P+ RP+A ++
Sbjct: 231 RQLNSIMQ---SMLNKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 58/240 (24%), Positives = 90/240 (37%), Gaps = 56/240 (23%)
Query: 641 LQSAIF--MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHR 697
++ A++ MEY+ GS+ T V L I V L L +H I+HR
Sbjct: 70 IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDV-LR-RITYAVVKGLKFLKEEHNIIHR 127
Query: 698 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 757
D+K N+L+ +G VKLCDF + L + L I G +M
Sbjct: 128 DVKPTNVLV-------NGNGQVKLCDFGVSGNLVASLAKTNI------------GCQSYM 168
Query: 758 APEVLRA--MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM---GKRP 812
APE +++ ++ Y ++ D+WS G +LE+ + PY + I + G P
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP 228
Query: 813 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 872
L +A+ D +C + P RPT L E
Sbjct: 229 TLPSGYS-------------------DDAQ--------DFVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 39/117 (33%), Positives = 61/117 (52%), Gaps = 30/117 (25%)
Query: 690 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA----VPLRSFLH-TCCIAHRGI 744
HS+ ++HRD+K +N+LI D K V+KL DF A +P+R + H + +R
Sbjct: 118 HSRRVLHRDLKPQNLLI-------DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYR-- 168
Query: 745 PAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 801
AP+V +G+PR+ P VDIWS G + E+ T + + G SE++
Sbjct: 169 -APEVLLGSPRYSTP---------------VDIWSIGTIFAEMATKKPLFHGDSEID 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 67/249 (26%), Positives = 106/249 (42%), Gaps = 57/249 (22%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+ LK SA + +F+ E +L L+H IV YG +G P
Sbjct: 40 VKALKEASESARQ--DFQR----EAELLTVLQHQHIVRFYG--------VCTEGRP---- 81
Query: 641 LQSAIFMEYVKGGSVKNYIE------KLSETGEKHVSVKLAL----FIAQDVAAALVELH 690
+ EY++ G + ++ K+ GE +L L IA +A+ +V L
Sbjct: 82 --LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA 139
Query: 691 SKHIMHRDIKSENILI--DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 748
S H +HRD+ + N L+ L VVK+ DF + + S + +P
Sbjct: 140 SLHFVHRDLATRNCLVGQGL---------VVKIGDFGMSRDIYSTDYYRVGGRTMLPI-- 188
Query: 749 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQ 807
RWM PE + +++ + E DIWS+G +L E+ T + P+ LS E + I
Sbjct: 189 ------RWMPPESI--LYRK--FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238
Query: 808 MGK---RPR 813
G+ RPR
Sbjct: 239 QGRELERPR 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 44/150 (29%), Positives = 69/150 (46%), Gaps = 31/150 (20%)
Query: 656 KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 715
K Y++ TG +K ++ Q + + HS ++HRD+K +N+LID E
Sbjct: 85 KKYMDSSPLTGLDPPLIKS--YLYQ-LLQGIAYCHSHRVLHRDLKPQNLLIDREG----- 136
Query: 716 KPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 771
+KL DF A VP+R++ H V T + APE+L Y
Sbjct: 137 --ALKLADFGLARAFGVPVRTYTHE--------------VVTLWYRAPEILLGSR---QY 177
Query: 772 GLEVDIWSYGCLLLELLTLQVPYMGLSELE 801
VDIWS GC+ E++ + + G SE++
Sbjct: 178 STPVDIWSIGCIFAEMVNRRPLFPGDSEID 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-10
Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 35/205 (17%)
Query: 602 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI-- 659
L E ++ L H IV +Y I S DG+P ++ M Y++G ++K+ +
Sbjct: 50 LREAKIAADLIHPGIVPVY--SICS------DGDPVYYT------MPYIEGYTLKSLLKS 95
Query: 660 ----EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 715
E LS+ + SV L I + A + +HSK ++HRD+K +NIL+ L G
Sbjct: 96 VWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLF-----G 150
Query: 716 KPVV------KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 769
+ V+ + L + I + + P VGTP +MAPE L
Sbjct: 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG----V 206
Query: 770 LYGLEVDIWSYGCLLLELLTLQVPY 794
DI++ G +L ++LTL PY
Sbjct: 207 PASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 1e-10
Identities = 57/205 (27%), Positives = 87/205 (42%), Gaps = 62/205 (30%)
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI-PAP 747
LHS +++HRD+K NIL++ +K+CDF A RG+ P
Sbjct: 119 LHSANVIHRDLKPSNILVNSN-------CDLKICDFGLA--------------RGVDPDE 157
Query: 748 DVC------VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL 800
D V T RW APE+L + + Y +DIWS GC+ ELLT + + G +
Sbjct: 158 DEKGFLTEYVVT-RWYRAPELLLSSSR---YTKAIDIWSVGCIFAELLTRKPLFPGRDYI 213
Query: 801 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-----LVDVFRR 855
+ +LI +E LG+ E ++ S EK L++L L +F
Sbjct: 214 DQLNLI-----------VEVLGTPSEEDLKFITS--EKARNYLKSLPKKPKKPLSKLFPG 260
Query: 856 CTEE-----------NPTERPTAGD 869
+ E +P +R TA +
Sbjct: 261 ASPEAIDLLEKMLVFDPKKRITADE 285
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 47/203 (23%), Positives = 80/203 (39%), Gaps = 59/203 (29%)
Query: 676 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 735
L IA+ VAA + L + +HRD+ + N L+ VVK+ DF +
Sbjct: 133 LCIAKQVAAGMAYLSERKFVHRDLATRNCLV-------GENMVVKIADFGLS-------- 177
Query: 736 TCCIAHRGIPAPDVCVGTP------RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789
R I + D + RWM PE + N Y E D+W+YG +L E+ +
Sbjct: 178 ------RNIYSADYYKASENDAIPIRWMPPESIFY----NRYTTESDVWAYGVVLWEIFS 227
Query: 790 LQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 848
+ PY G++ E+ ++ G + SC ++
Sbjct: 228 YGMQPYYGMAHEEVIYYVRDGN----------VLSCPDN-----------------CPLE 260
Query: 849 LVDVFRRCTEENPTERPTAGDLY 871
L ++ R C + P++RP+ +
Sbjct: 261 LYNLMRLCWSKLPSDRPSFASIN 283
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 88/324 (27%), Positives = 127/324 (39%), Gaps = 97/324 (29%)
Query: 572 FGSADAAAKVRTLKVCGSSADEIRNFEYS----------CLGEVRMLGALRHSCIVEMYG 621
FG+ A VRT +V I+ YS + EV+ L ++H +E G
Sbjct: 38 FGAVYFARDVRTNEVVA-----IKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 622 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQD 681
+ EH + + MEY G + L E +K + I
Sbjct: 93 CYLR-----------EH---TAWLVMEYCLGSA-----SDLLEVHKKPLQEVEIAAITHG 133
Query: 682 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV---PLRSFLHTCC 738
L LHS +++HRDIK+ NIL+ + VKL DF A P SF
Sbjct: 134 ALQGLAYLHSHNMIHRDIKAGNILLTEPGQ-------VKLADFGSASIASPANSF----- 181
Query: 739 IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS 798
VGTP WMAPEV+ AM + Y +VD+WS G +EL + P +
Sbjct: 182 ------------VGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPLFNM- 227
Query: 799 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR--- 855
+ + AL + +AQ+ E P + S D FR
Sbjct: 228 -----------------NAMSAL-----YHIAQN----ESPTLQSNEWS---DYFRNFVD 258
Query: 856 -CTEENPTERPTAGDLYE-MFVAR 877
C ++ P +RPT+ +L + MFV R
Sbjct: 259 SCLQKIPQDRPTSEELLKHMFVLR 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 51/189 (26%), Positives = 86/189 (45%), Gaps = 37/189 (19%)
Query: 649 YVKGGSVKNYIEK---LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705
Y+ G++K ++++ + +S + + +A +A + LH + ++H+DI + N +
Sbjct: 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCV 149
Query: 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT----P-RWMAPE 760
ID E + VK+ D A+ F P C+G P +WMA E
Sbjct: 150 IDEELQ-------VKITD--NALSRDLF-----------PMDYHCLGDNENRPVKWMALE 189
Query: 761 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR----PRLT 815
L Y D+WS+G LL EL+TL Q PY+ + E+ ++ G R
Sbjct: 190 SL----VNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINCP 245
Query: 816 DELEALGSC 824
DEL A+ +C
Sbjct: 246 DELFAVMAC 254
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 57/226 (25%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
I EY++ GS+ ++++ + G K KL AQ +A + + K+ +HRD+++ NI
Sbjct: 77 IITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQ-IAEGMAFIERKNYIHRDLRAANI 133
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 764
L+ K+ DF A R A G P +W APE +
Sbjct: 134 LVSETL-------CCKIADFGLA---RLIEDNEYTAREGAKFP------IKWTAPEAIN- 176
Query: 765 MHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEA 820
YG ++ D+WS+G LL E++T ++PY G++ E+ ++ G R D
Sbjct: 177 ------YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPD---- 226
Query: 821 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866
+C PE L ++ R C +E P ERPT
Sbjct: 227 --NC--------------PEE-------LYELMRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 73/276 (26%), Positives = 121/276 (43%), Gaps = 37/276 (13%)
Query: 600 SCLGEVRMLGALRHSCIVEMYGHKI--SSKWLPSADGNPEHHLLQSA-IFMEYVKGGSVK 656
L E++++ L H IV++Y + S L G+ L S I EY++ +
Sbjct: 48 HALREIKIIRRLDHDNIVKVY-EVLGPSGSDLTEDVGSLTE--LNSVYIVQEYMET-DLA 103
Query: 657 NYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 716
N +E+ E+H LF+ Q + L +HS +++HRD+K N+ I+ E
Sbjct: 104 NVLEQ-GPLSEEHAR----LFMYQ-LLRGLKYIHSANVLHRDLKPANVFINTE------D 151
Query: 717 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEV 775
V+K+ DF A + +H+G + + +W +P +L + PN Y +
Sbjct: 152 LVLKIGDFGLARIVDPHY-----SHKGYLSEGL---VTKWYRSPRLLLS---PNNYTKAI 200
Query: 776 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP--RLTDELEALGSCHEHEVAQSG 833
D+W+ GC+ E+LT + + G ELE LI + P R D E L + V G
Sbjct: 201 DMWAAGCIFAEMLTGKPLFAGAHELEQMQLI-LESVPVVREEDRNELL-NVIPSFVRNDG 258
Query: 834 SGFEKPEAEL--ETLSFLVDVFRRCTEENPTERPTA 867
+P +L +D + NP +R TA
Sbjct: 259 GEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 39/115 (33%), Positives = 53/115 (46%), Gaps = 27/115 (23%)
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKP--VVKLCDFDRA----VPLRSFLHTCCIAHR 742
LHS ++HRD+K NIL+ +G VVK+ D A PL+
Sbjct: 124 LHSNWVLHRDLKPANILV-----MGEGPERGVVKIGDLGLARLFNAPLKPLADL------ 172
Query: 743 GIPAPDVCVGTPRWMAPEVLR-AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 796
D V T + APE+L A H Y +DIW+ GC+ ELLTL+ + G
Sbjct: 173 -----DPVVVTIWYRAPELLLGARH----YTKAIDIWAIGCIFAELLTLEPIFKG 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 48/166 (28%), Positives = 72/166 (43%), Gaps = 31/166 (18%)
Query: 648 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707
+Y+ GG + +++K E S A F ++ AL LH I++RD+K ENIL+D
Sbjct: 76 DYMSGGELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD 130
Query: 708 LERKKADGKPVVKLCDFDRAVPLRS---FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 764
A G + LCDF + + +T C GT ++APEVL
Sbjct: 131 -----ATGH--IALCDFGLSKANLTDNKTTNTFC-------------GTTEYLAPEVLL- 169
Query: 765 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
Y VD WS G L+ E+ P+ +++ I GK
Sbjct: 170 --DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK 213
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 56/178 (31%), Positives = 81/178 (45%), Gaps = 42/178 (23%)
Query: 638 HHLLQSA----IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 693
H+ Q+A ++YV GG + ++++ E+ A F A +VA+A+ LHS +
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHSLN 116
Query: 694 IMHRDIKSENILIDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVC 750
I++RD+K ENIL+D + V L DF V T C
Sbjct: 117 IIYRDLKPENILLDSQGH-------VVLTDFGLCKEGVEPEETTSTFC------------ 157
Query: 751 VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 808
GTP ++APEVLR +P Y VD W G +L E+L GL D+ QM
Sbjct: 158 -GTPEYLAPEVLR--KEP--YDRTVDWWCLGAVLYEML------YGLPPFYSRDVSQM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 61/217 (28%), Positives = 87/217 (40%), Gaps = 53/217 (24%)
Query: 604 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 661
EVR L LRH ++ G + + WL MEY G +
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWL----------------VMEYCLGSA-----SD 103
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP-VVK 720
L E +K + + L LHS +++HRD+K+ NIL+ +P +VK
Sbjct: 104 LLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS--------EPGLVK 155
Query: 721 LCDFDRA---VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 777
L DF A P F VGTP WMAPEV+ AM + Y +VD+
Sbjct: 156 LGDFGSASIMAPANXF-----------------VGTPYWMAPEVILAMDEGQ-YDGKVDV 197
Query: 778 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 814
WS G +EL + P ++ + I + P L
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 234
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-10
Identities = 50/146 (34%), Positives = 71/146 (48%), Gaps = 23/146 (15%)
Query: 653 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 712
VKN LS+ G + ++ L VA + L SK+ +HRD+ + N+L+
Sbjct: 220 SEVKNL---LSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL------ 270
Query: 713 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 772
A GK +VK+CDF A R +H +G V +WMAPE + NLY
Sbjct: 271 AQGK-IVKICDFGLA---RDIMHDSNYVSKGSTFLPV-----KWMAPESIF----DNLYT 317
Query: 773 LEVDIWSYGCLLLELLTL-QVPYMGL 797
D+WSYG LL E+ +L PY G+
Sbjct: 318 TLSDVWSYGILLWEIFSLGGTPYPGM 343
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 51/163 (31%), Positives = 79/163 (48%), Gaps = 32/163 (19%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
+++V GG + ++++ E+ A F A ++A+AL LHS +I++RD+K ENIL+
Sbjct: 75 LDFVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL 129
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV---GTPRWMAPEVLR 763
D + G V L DF + GI D GTP ++APEV+R
Sbjct: 130 D-----SQGHVV--LTDFG-------------LCKEGIAQSDTTTTFCGTPEYLAPEVIR 169
Query: 764 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 806
+P Y VD W G +L E+L P+ E++D I
Sbjct: 170 --KQP--YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 70/276 (25%), Positives = 106/276 (38%), Gaps = 78/276 (28%)
Query: 602 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 661
L E R+L H IV++ G + ++ P I ME V GG +++ K
Sbjct: 40 LSEARILKQYDHPNIVKLIG--VCTQRQPIY------------IVMELVPGGDFLSFLRK 85
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
+ + VK AL D AA + L SK+ +HRD+ + N L+ V+K+
Sbjct: 86 KKDELKTKQLVKFAL----DAAAGMAYLESKNCIHRDLAARNCLVGENN-------VLKI 134
Query: 722 CDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 775
DF D + S L + IP +W APE L Y E
Sbjct: 135 SDFGMSRQEDDGIYSSSGL-------KQIPI--------KWTAPEALNY----GRYSSES 175
Query: 776 DIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS 834
D+WSYG LL E +L V PY G++ + + ++ G R + C +
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR------MSCPQKCPDD------- 222
Query: 835 GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 870
+ V +RC + P RP +L
Sbjct: 223 --------------VYKVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 33/166 (19%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENIL 705
MEY GG + ++ + E+ S A F ++ +AL LHS K++++RD+K EN++
Sbjct: 74 MEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 128
Query: 706 IDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 762
+D DG +K+ DF + + + T C GTP ++APEVL
Sbjct: 129 LD-----KDGH--IKITDFGLCKEGIKDGATMKTFC-------------GTPEYLAPEVL 168
Query: 763 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 808
+ N YG VD W G ++ E++ ++P+ ++ +LI M
Sbjct: 169 ----EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 28/128 (21%)
Query: 690 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIP 745
HS ++HRD+K +N+LID +KL DF A +P+R+F H
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTN------ALKLADFGLARAFGIPVRTFTHE--------- 163
Query: 746 APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL-EIHD 804
V T + APE+L Y VDIWS GC+ E++ + + G SE+ E+
Sbjct: 164 -----VVTLWYRAPEILLGSRH---YSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK 215
Query: 805 LIQMGKRP 812
+ ++ P
Sbjct: 216 IFRILGTP 223
|
Length = 294 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 65/247 (26%), Positives = 103/247 (41%), Gaps = 53/247 (21%)
Query: 560 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 619
G+ + +C+ ++ K ++E + + L E++ML L+ IVE+
Sbjct: 10 GEGAYGVVLKCRHKETKEIVAIKKFK----DSEENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 620 YGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYIEKLSETGEKHVSVKLALF 677
E + +++ EYV+ KN +E L E K+ +
Sbjct: 66 ----------------KEAFRRRGKLYLVFEYVE----KNMLELLEEMPNGVPPEKVRSY 105
Query: 678 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFL--- 734
I Q + A+ H I+HRDIK EN+LI V+KLCDF A L
Sbjct: 106 IYQ-LIKAIHWCHKNDIVHRDIKPENLLIS-------HNDVLKLCDFGFARNLSEGSNAN 157
Query: 735 HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 794
+T +A R +P++ +G P YG VD+WS GC+L EL Q +
Sbjct: 158 YTEYVATRWYRSPELLLGAP----------------YGKAVDMWSVGCILGELSDGQPLF 201
Query: 795 MGLSELE 801
G SE++
Sbjct: 202 PGESEID 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 76/290 (26%), Positives = 130/290 (44%), Gaps = 79/290 (27%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+TLK G+ + E S L E +++ LRH +V++Y + S+ P +
Sbjct: 35 VKTLKP-GTMSPE------SFLEEAQIMKKLRHDKLVQLYA--VVSE-------EPIY-- 76
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
I EY+ GS+ ++ L + + + + + +A VAA + + + +HRD++
Sbjct: 77 ----IVTEYMSKGSLLDF---LKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLR 129
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 760
S NIL+ DG V K+ DF A + +T A +G P +W APE
Sbjct: 130 SANILV------GDGL-VCKIADFGLARLIEDNEYT---ARQGAKFP------IKWTAPE 173
Query: 761 VLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTD 816
LYG ++ D+WS+G LL EL+T +VPY G++ E+ + ++ G R
Sbjct: 174 AA-------LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR----- 221
Query: 817 ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866
+ C P + L ++ +C +++P ERPT
Sbjct: 222 -MPCPQDC--------------PIS-------LHELMLQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 54/232 (23%), Positives = 98/232 (42%), Gaps = 43/232 (18%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
++TLK GSS + +F L E ++G H I+ + G S+ +
Sbjct: 37 IKTLKA-GSSDKQRLDF----LTEASIMGQFDHPNIIRLEGVVTKSRPV----------- 80
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
I EY++ GS+ + L E K +L + + + +A+ + L + +HRD+
Sbjct: 81 ---MIITEYMENGSLDKF---LRENDGKFTVGQL-VGMLRGIASGMKYLSEMNYVHRDLA 133
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 760
+ NIL++ V K+ DF + L T IP RW APE
Sbjct: 134 ARNILVNSNL-------VCKVSDFGLSRRLEDSEATYTTKGGKIPI--------RWTAPE 178
Query: 761 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 811
+ + D+WS+G ++ E+++ + PY +S ++ ++ G R
Sbjct: 179 AIAYRK----FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR 226
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 8e-10
Identities = 54/195 (27%), Positives = 75/195 (38%), Gaps = 63/195 (32%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
M+Y+ GG + + + +L E LA F ++ A+ +H +HRDIK +NILI
Sbjct: 80 MDYIPGGDMMSLLIRLGIFEED-----LARFYIAELTCAIESVHKMGFIHRDIKPDNILI 134
Query: 707 DLERKKADGKPVVKLCDF-----------------------------------DRAVP-- 729
D DG +KL DF DR
Sbjct: 135 DR-----DGH--IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKP 187
Query: 730 ---LRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786
R H C+AH VGTP ++APEVL Y D WS G +L E
Sbjct: 188 LERRRKRQHQRCLAHS-------LVGTPNYIAPEVLLRTG----YTQLCDWWSVGVILYE 236
Query: 787 LLTLQVPYMGLSELE 801
+L Q P++ + E
Sbjct: 237 MLVGQPPFLADTPAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 66/269 (24%), Positives = 115/269 (42%), Gaps = 72/269 (26%)
Query: 602 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 661
L E +++ LRH +V +Y P + I E++ GS+ ++
Sbjct: 49 LQEAQIMKKLRHDKLVPLYA---------VVSEEPIY------IVTEFMGKGSLLDF--- 90
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
L E K++ + + +A +A + + + +HRD+++ NIL+ D V K+
Sbjct: 91 LKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV------GDNL-VCKI 143
Query: 722 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIW 778
DF A + +T A +G P +W APE LYG ++ D+W
Sbjct: 144 ADFGLARLIEDNEYT---ARQGAKFP------IKWTAPEAA-------LYGRFTIKSDVW 187
Query: 779 SYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 837
S+G LL EL+T +VPY G+ E+ + ++ G R + C
Sbjct: 188 SFGILLTELVTKGRVPYPGMVNREVLEQVERGYR------MPCPQGC------------- 228
Query: 838 KPEAELETLSFLVDVFRRCTEENPTERPT 866
PE+ L ++ + C +++P ERPT
Sbjct: 229 -PES-------LHELMKLCWKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 67/240 (27%), Positives = 100/240 (41%), Gaps = 55/240 (22%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
I MEY+ GGS + + + E ++ L +++ L LHS+ +HRDIK+ N+
Sbjct: 79 IIMEYLGGGSALDLL-RAGPFDEFQIATML-----KEILKGLDYLHSEKKIHRDIKAANV 132
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 764
L+ + VKL DF A L T R + VGTP WMAPEV++
Sbjct: 133 LLSEQGD-------VKLADFGVAGQL-----TDTQIKR-----NTFVGTPFWMAPEVIQQ 175
Query: 765 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 824
+ Y + DIWS G +EL + P + + + LI P LT E
Sbjct: 176 ----SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGE------- 224
Query: 825 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE-MFVARTSSSIS 883
F KP E C ++P+ RPTA +L + F+ + + S
Sbjct: 225 -----------FSKPFKEF---------IDACLNKDPSFRPTAKELLKHKFIVKNAKKTS 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 59/234 (25%), Positives = 88/234 (37%), Gaps = 65/234 (27%)
Query: 644 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703
+I E++ GGS+ Y K+ E HV + IA V L L S I+HRD+K N
Sbjct: 75 SICTEFMDGGSLDVY-RKIPE----HVLGR----IAVAVVKGLTYLWSLKILHRDVKPSN 125
Query: 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 763
+L++ + VKLCDF + L + + VGT +MAPE +
Sbjct: 126 MLVNTRGQ-------VKLCDFGVSTQLVNSIAK------------TYVGTNAYMAPERIS 166
Query: 764 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM-------GLSELEIHDLIQMGKRPRLTD 816
YG+ D+WS G +EL + PY L L++ I P L
Sbjct: 167 GEQ----YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV 222
Query: 817 ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 870
+ ++ V +C + P ERP +L
Sbjct: 223 ----------GQFSEK----------------FVHFITQCMRKQPKERPAPENL 250
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 70/292 (23%), Positives = 122/292 (41%), Gaps = 69/292 (23%)
Query: 589 SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFME 648
S+A+ +R+FE E+ +L +L+H IV+ G S+ G L+ ME
Sbjct: 44 STAEHLRDFER----EIEILKSLQHDNIVKYKGVCYSA-------GRRNLRLV-----ME 87
Query: 649 YVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708
Y+ GS+++Y++K E+ KL L+ +Q + + L SK +HRD+ + NIL++
Sbjct: 88 YLPYGSLRDYLQK---HRERLDHRKLLLYASQ-ICKGMEYLGSKRYVHRDLATRNILVES 143
Query: 709 ERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR-----WMAPEV 761
E + VK+ DF + +P + V P W APE
Sbjct: 144 ENR-------VKIGDFGLTKVLPQDKEYYK--------------VREPGESPIFWYAPES 182
Query: 762 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL 821
L + + + D+WS+G +L EL T + MG D+ +
Sbjct: 183 L----TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMR---MMGN-----DKQGQM 230
Query: 822 GSCHEHEVAQSGSGFEKPE---AELETLSFLVDVFRRCTEENPTERPTAGDL 870
H E+ ++ P AE+ + + C +P++RP+ +L
Sbjct: 231 IVYHLIELLKNNGRLPAPPGCPAEIYAI------MKECWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 53/160 (33%), Positives = 80/160 (50%), Gaps = 26/160 (16%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
++Y+ GG + ++++ E+ A F A ++A+AL LHS +I++RD+K ENIL+
Sbjct: 75 LDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL 129
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 766
D + G V L DF L I H G + GTP ++APEVL H
Sbjct: 130 D-----SQGHIV--LTDFG--------LCKENIEHNGTTS--TFCGTPEYLAPEVL---H 169
Query: 767 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 806
K Y VD W G +L E+L P+ + E++D I
Sbjct: 170 K-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 53/188 (28%), Positives = 90/188 (47%), Gaps = 37/188 (19%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E ++L L+H IV Y W DG I M + +GG + + +++
Sbjct: 49 EAQLLSQLKHPNIV-AY----RESW-EGEDG-------LLYIVMGFCEGGDLYHKLKE-- 93
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
+ G+ ++ + Q +A AL LH KHI+HRD+K++N+ L R ++K+ D
Sbjct: 94 QKGKLLPENQVVEWFVQ-IAMALQYLHEKHILHRDLKTQNVF--LTRTN-----IIKVGD 145
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
A R + C +A +GTP +M+PE+ +KP Y + D+W+ GC
Sbjct: 146 LGIA---RVLENQCDMA-------STLIGTPYYMSPELFS--NKP--YNYKSDVWALGCC 191
Query: 784 LLELLTLQ 791
+ E+ TL+
Sbjct: 192 VYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 68/255 (26%), Positives = 105/255 (41%), Gaps = 58/255 (22%)
Query: 644 AIFMEYVKGGSVKNYIEKLSETGEKHV-SVKLALFIAQDVAAALVELHSKH-IMHRDIKS 701
+I ME++ GGS+ ++K E+ + V +A V L L KH IMHRD+K
Sbjct: 79 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA------VIKGLTYLREKHKIMHRDVKP 132
Query: 702 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 761
NIL+ + + +KLCDF + L + + VGT +M+PE
Sbjct: 133 SNILV-------NSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPER 173
Query: 762 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL 821
L+ H Y ++ DIWS G L+E+ + P + + +L M P D E+
Sbjct: 174 LQGTH----YSVQSDIWSMGLSLVEMAIGRYP---IPPPDAKELELMFGCPVEGDPAESE 226
Query: 822 GSCHEHEVAQSGSGF----EKPEAELETLSFLV-----------------DVFRRCTEEN 860
S + S + P A E L ++V D +C +N
Sbjct: 227 TSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKN 286
Query: 861 PTERPTAGDLYEMFV 875
P ER DL ++ V
Sbjct: 287 PAER---ADLKQLMV 298
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 50/156 (32%), Positives = 71/156 (45%), Gaps = 28/156 (17%)
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 748
LHS I+HRDIK N+L+ + V+K+CDF A + + +
Sbjct: 119 LHSAGILHRDIKPGNLLV-------NSNCVLKICDFGLA-RVEEPDESKHMTQE------ 164
Query: 749 VCVGTPRWMAPEVLR-AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ 807
V T + APE+L + H Y VDIWS GC+ ELL ++ + S ++ DLI
Sbjct: 165 --VVTQYYRAPEILMGSRH----YTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218
Query: 808 --MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 841
+G T LEA+ S E A G KP +
Sbjct: 219 DLLG-----TPSLEAMRSACEGARAHILRGPHKPPS 249
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-09
Identities = 66/271 (24%), Positives = 99/271 (36%), Gaps = 78/271 (28%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
M+Y+ GG + + + ++ E LA F ++ A+ +H +HRDIK +NILI
Sbjct: 80 MDYIPGGDMMSLLIRMEVFPEV-----LARFYIAELTLAIESVHKMGFIHRDIKPDNILI 134
Query: 707 DLERKKADGKPVVKLCDF-----------------------------------------D 725
DL DG +KL DF D
Sbjct: 135 DL-----DGH--IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGD 187
Query: 726 RAVPLRSFL---HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 782
R L H C+AH VGTP ++APEVL + K Y D WS G
Sbjct: 188 RLKTLEQRATKQHQRCLAHS-------LVGTPNYIAPEVL--LRKG--YTQLCDWWSVGV 236
Query: 783 LLLELLTLQVPYMGLSELE-----------IHDLIQMGKRPRLTDELEALGSCHEHEVAQ 831
+L E+L Q P++ + E +H Q+ P D + L E + +
Sbjct: 237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGR 296
Query: 832 SGSGFEKPEAELETLSFLVDVFRRCTEENPT 862
+G+ K + F D+ + P
Sbjct: 297 NGADDIKAHPFFSEVDFSSDIRTQPAPYVPK 327
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 45/214 (21%)
Query: 602 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 661
L E +++ LRH +V++Y P + I EY+ GS+ ++++
Sbjct: 49 LQEAQVMKKLRHEKLVQLYA---------VVSEEPIY------IVTEYMSKGSLLDFLK- 92
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
E G+ +L AQ +A+ + + + +HRD+++ NIL+ V K+
Sbjct: 93 -GEMGKYLRLPQLVDMAAQ-IASGMAYVERMNYVHRDLRAANILVG-------ENLVCKV 143
Query: 722 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIW 778
DF A + +T A +G P +W APE LYG ++ D+W
Sbjct: 144 ADFGLARLIEDNEYT---ARQGAKFP------IKWTAPEAA-------LYGRFTIKSDVW 187
Query: 779 SYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 811
S+G LL EL T +VPY G+ E+ D ++ G R
Sbjct: 188 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 221
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 51/195 (26%), Positives = 85/195 (43%), Gaps = 50/195 (25%)
Query: 682 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 741
VA + L SK+ +HRD+ + NIL+ R + K+CDF A +R+ + +
Sbjct: 223 VAKGMSFLASKNCIHRDLAARNILLTHGR-------ITKICDFGLARDIRNDSNYVVKGN 275
Query: 742 RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLS-E 799
+P +WMAPE + +Y E D+WSYG LL E+ +L PY G+ +
Sbjct: 276 ARLPV--------KWMAPESIFNC----VYTFESDVWSYGILLWEIFSLGSSPYPGMPVD 323
Query: 800 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE-AELETLSFLVDVFRRCTE 858
+ + +I+ G R PE A E + D+ + C +
Sbjct: 324 SKFYKMIKEGYR------------------------MLSPECAPSE----MYDIMKSCWD 355
Query: 859 ENPTERPTAGDLYEM 873
+P +RPT + ++
Sbjct: 356 ADPLKRPTFKQIVQL 370
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 67/271 (24%), Positives = 102/271 (37%), Gaps = 78/271 (28%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
M+Y+ GG + + + ++ E LA F ++ A+ +H +HRDIK +NILI
Sbjct: 80 MDYIPGGDMMSLLIRMGIFPED-----LARFYIAELTCAVESVHKMGFIHRDIKPDNILI 134
Query: 707 DLERKKADGKPVVKLCDF-----------------------------------------D 725
D DG +KL DF D
Sbjct: 135 D-----RDGH--IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGD 187
Query: 726 RAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 782
R PL + H C+AH VGTP ++APEVL L D WS G
Sbjct: 188 RLKPLERRAARQHQRCLAHS-------LVGTPNYIAPEVLLRTGYTQL----CDWWSVGV 236
Query: 783 LLLELLTLQVPYMGLSELE-----------IHDLIQMGKRPRLTDELEALGSCHEHEVAQ 831
+L E+L Q P++ + LE +H Q P +D + L E + +
Sbjct: 237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGK 296
Query: 832 SGSGFEKPEAELETLSFLVDVFRRCTEENPT 862
+G+ K +T+ F D+ ++ P
Sbjct: 297 NGADEIKAHPFFKTIDFSSDLRQQSAPYIPK 327
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 31/153 (20%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
+ + + GG +K +I + E G + A+F A ++ L +LH + I++RD+K ENI
Sbjct: 77 LVLTLMNGGDLKFHIYHMGEAGFEE---GRAVFYAAEICCGLEDLHQERIVYRDLKPENI 133
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEV 761
L+D G +++ D AV +P VGT +MAPEV
Sbjct: 134 LLD-----DHGH--IRISDLGLAV--------------HVPEGQTIKGRVGTVGYMAPEV 172
Query: 762 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 794
+ K Y D W+ GCLL E++ Q P+
Sbjct: 173 V----KNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 58/240 (24%), Positives = 99/240 (41%), Gaps = 58/240 (24%)
Query: 645 IFMEYVKGGSVKNYIEKLSETG-----------EKHVSVKLALFIAQDVAAALVELHSKH 693
+ +EY G+++ Y+ G E+ ++ K + A VA + L S+
Sbjct: 95 VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK 154
Query: 694 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 753
+HRD+ + N+L+ + V+K+ DF A + + + + +P
Sbjct: 155 CIHRDLAARNVLVTEDN-------VMKIADFGLARDVHNIDYYKKTTNGRLPV------- 200
Query: 754 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 812
+WMAPE L +Y + D+WS+G LL E+ TL PY G+ E+ L++ G R
Sbjct: 201 -KWMAPEALF----DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR- 254
Query: 813 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 872
++ +C HE L + R C P++RPT L E
Sbjct: 255 -----MDKPANC-THE--------------------LYMIMRECWHAVPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 35/154 (22%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALF-IAQDVAAALVELHSKHIMHRDIKSEN 703
+ +E++ GGS++ H++ + L +A+ + + + LH +HI+HRDIK N
Sbjct: 149 VLLEFMDGGSLEG----------THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSN 198
Query: 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 763
+LI+ + VK+ DF + L + C + VGT +M+PE +
Sbjct: 199 LLINSAKN-------VKIADFGVSRILAQTMDPC----------NSSVGTIAYMSPERIN 241
Query: 764 AMHKPNLY-GLEVDIWSYGCLLLELLTLQVPYMG 796
Y G DIWS G +LE Y+G
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEF------YLG 269
|
Length = 353 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 60/246 (24%), Positives = 100/246 (40%), Gaps = 70/246 (28%)
Query: 645 IFMEYVKGGSVKNYIE-----------KLSETGEKHVSVKLALFIAQDVAAALVELHSKH 693
+ +EY G+++ ++ +++ E+ +S K + A VA + L S+
Sbjct: 95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR 154
Query: 694 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 753
+HRD+ + N+L+ + V+K+ DF A RG+ D T
Sbjct: 155 CIHRDLAARNVLVTEDN-------VMKIADFGLA--------------RGVHDIDYYKKT 193
Query: 754 P------RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLI 806
+WMAPE L +Y + D+WS+G L+ E+ TL PY G+ E+ L+
Sbjct: 194 SNGRLPVKWMAPEALF----DRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL 249
Query: 807 QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866
+ G R ++ +C HE L + R C PT+RPT
Sbjct: 250 REGHR------MDKPSNC-THE--------------------LYMLMRECWHAVPTQRPT 282
Query: 867 AGDLYE 872
L E
Sbjct: 283 FKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 69/296 (23%), Positives = 115/296 (38%), Gaps = 78/296 (26%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+T K C +S F L E ++ H IV++ G + ++ NP
Sbjct: 39 VKTCKNC-TSPSVREKF----LQEAYIMRQFDHPHIVKLIG--VITE-------NP---- 80
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
I ME G +++Y++ + + L L+ Q ++ AL L SK +HRDI
Sbjct: 81 --VWIVMELAPLGELRSYLQVNKYSLD---LASLILYSYQ-LSTALAYLESKRFVHRDIA 134
Query: 701 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWM 757
+ N+L+ VKL DF R + S+ A +G +P +WM
Sbjct: 135 ARNVLV-------SSPDCVKLGDFGLSRYLEDESYYK----ASKGKLPI--------KWM 175
Query: 758 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTD 816
APE + + D+W +G + E+L L V P+ G+ ++ I+ G+R
Sbjct: 176 APESINFRR----FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL---- 227
Query: 817 ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 872
P TL L+ +C +P++RP +L
Sbjct: 228 --------------------PMPPNCPPTLYSLM---TKCWAYDPSKRPRFTELKA 260
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 59/272 (21%), Positives = 104/272 (38%), Gaps = 65/272 (23%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---- 659
E+ M L H +V + G + P + +L EY G +K ++
Sbjct: 58 ELDMFRKLSHKNVVRLLGL--------CREAEPHYMIL------EYTDLGDLKQFLRATK 103
Query: 660 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 719
K + +S K + + +A + L + +HRD+ + N L+ +R+
Sbjct: 104 SKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL-- 161
Query: 720 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 779
L + V + R P RW+APE ++ + + + D+WS
Sbjct: 162 SLS---KDVYNSEYYK-----LRNALIP------LRWLAPEAVQE----DDFSTKSDVWS 203
Query: 780 YGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 838
+G L+ E+ T ++P+ GLS+ E+ + +Q GK E
Sbjct: 204 FGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK-------------------------LEL 238
Query: 839 PEAELETLSFLVDVFRRCTEENPTERPTAGDL 870
P E S L + RC NP +RP+ +L
Sbjct: 239 PVPE-GCPSRLYKLMTRCWAVNPKDRPSFSEL 269
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 59/240 (24%), Positives = 96/240 (40%), Gaps = 58/240 (24%)
Query: 645 IFMEYVKGGSVKNYIEKLSETG-----------EKHVSVKLALFIAQDVAAALVELHSKH 693
+ +EY G+++ Y+ G E+ +S K + A VA + L SK
Sbjct: 101 VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK 160
Query: 694 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 753
+HRD+ + N+L+ + V+K+ DF A + + + +P
Sbjct: 161 CIHRDLAARNVLVTEDN-------VMKIADFGLARDIHHIDYYKKTTNGRLPV------- 206
Query: 754 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 812
+WMAPE L +Y + D+WS+G LL E+ TL PY G+ E+ L++ G R
Sbjct: 207 -KWMAPEALF----DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR- 260
Query: 813 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 872
+KP L ++ R C P++RPT L E
Sbjct: 261 -----------------------MDKPSNCTNELYMMM---RDCWHAVPSQRPTFKQLVE 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 7e-09
Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 26/148 (17%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
+ ++ GG + +++++ E + A F ++ AL LH ++++RD+K ENIL+
Sbjct: 72 LAFINGGELFHHLQR-----EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL 126
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 766
D + A LCDF C + + + GTP ++APE+L
Sbjct: 127 DYQGHIA-------LCDFG----------LCKLNMKDDDKTNTFCGTPEYLAPELLLGHG 169
Query: 767 KPNLYGLEVDIWSYGCLLLELLTLQVPY 794
Y VD W+ G LL E+LT P+
Sbjct: 170 ----YTKAVDWWTLGVLLYEMLTGLPPF 193
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 61/273 (22%), Positives = 102/273 (37%), Gaps = 72/273 (26%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E +++ L H +V++YG K L I E+++ G + NY+ +
Sbjct: 49 EAKVMMKLSHPKLVQLYGVCTQQKPL--------------YIVTEFMENGCLLNYLRQ-- 92
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
+ +S + L + QDV + L +HRD+ + N L+ VVK+ D
Sbjct: 93 --RQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG-------VVKVSD 143
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
F R L + G P +W PEV + Y + D+WS+G L
Sbjct: 144 FGMT---RYVLDDEYTSSSGAKFP------VKWSPPEVFNF----SKYSSKSDVWSFGVL 190
Query: 784 LLELLTL-QVPYMGLSELEIHDLIQMGKR---PRLTDELEALGSCHEHEVAQSGSGFEKP 839
+ E+ T ++P+ S E+ ++I G R P+L +
Sbjct: 191 MWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKL--------ASM-------------- 228
Query: 840 EAELETLSFLVDVFRRCTEENPTERPTAGDLYE 872
+ +V C E P RPT +L
Sbjct: 229 --------TVYEVMYSCWHEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 45/175 (25%), Positives = 80/175 (45%), Gaps = 28/175 (16%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
+ M + GG +K +I + GE+ + ++ + + + ++ LHS I++RD+K EN+
Sbjct: 70 LVMSLMNGGDLKYHIYNV---GERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENV 126
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 764
L+D + +L D AV L+ A GT +MAPE+L
Sbjct: 127 LLDDQGN-------CRLSDLGLAVELKDGKTITQRA-----------GTNGYMAPEIL-- 166
Query: 765 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 819
K Y VD ++ GC + E++ + P+ E + + KR L DE++
Sbjct: 167 --KEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL---KRRTLEDEVK 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 50/180 (27%), Positives = 78/180 (43%), Gaps = 26/180 (14%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
+ ++Y+ GG + ++ + E+ V + ++ AL LH I++RDIK ENI
Sbjct: 82 LILDYINGGELFTHLSQRERFKEQEVQIYSG-----EIVLALEHLHKLGIIYRDIKLENI 136
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 764
L+D ++G V L DF + + F A C GT +MAP+++R
Sbjct: 137 LLD-----SNGHVV--LTDFGLS---KEFH-----EDEVERAYSFC-GTIEYMAPDIVRG 180
Query: 765 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ---MGKRPRLTDELEAL 821
+ VD WS G L+ ELLT P+ E I + P E+ AL
Sbjct: 181 GDGG--HDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 238
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 45/158 (28%), Positives = 63/158 (39%), Gaps = 36/158 (22%)
Query: 646 FMEYVKGGSVKN-----YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
M Y GS ++ + E L E FI +DV AL +HSK +HR +K
Sbjct: 80 LMAY---GSCEDLLKTHFPEGLPEL--------AIAFILKDVLNALDYIHSKGFIHRSVK 128
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPL--RSFLHTCCIAHRGIPAPDVCVGTPRWMA 758
+ +IL+ DGK V L +V + P V W++
Sbjct: 129 ASHILLS-----GDGK--VVLSGLRYSVSMIKHGKRQRVVHDF-----PKSSVKNLPWLS 176
Query: 759 PEVLRAMHKPNL--YGLEVDIWSYGCLLLELLTLQVPY 794
PEVL+ NL Y + DI+S G EL VP+
Sbjct: 177 PEVLQQ----NLQGYNEKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 47/152 (30%), Positives = 72/152 (47%), Gaps = 31/152 (20%)
Query: 644 AIFMEYVKGGSVKNYIEKLSETGEKHV-SVKLALFIAQDVAAALVELHSKH-IMHRDIKS 701
+I ME++ GGS+ +++ E+ + V +A V L L KH IMHRD+K
Sbjct: 79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA------VLRGLAYLREKHQIMHRDVKP 132
Query: 702 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 761
NIL+ + + +KLCDF + L + + VGT +M+PE
Sbjct: 133 SNILV-------NSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPER 173
Query: 762 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 793
L+ H Y ++ DIWS G L+EL + P
Sbjct: 174 LQGTH----YSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 38/157 (24%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
+ ++YV GG + ++ + E V F + ++ AL LH I++RDIK ENI
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFSEDEVR-----FYSGEIILALEHLHKLGIVYRDIKLENI 136
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFL-------HTCCIAHRGIPAPDVCVGTPRWM 757
L+D ++G V L DF + + FL ++ C GT +M
Sbjct: 137 LLD-----SEGHVV--LTDFGLS---KEFLSEEKERTYSFC-------------GTIEYM 173
Query: 758 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 794
APE++R +G VD WS G L+ ELLT P+
Sbjct: 174 APEIIRGKGG---HGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 44/137 (32%), Positives = 66/137 (48%), Gaps = 28/137 (20%)
Query: 676 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 735
L IA +AA + L S H +HRD+ + N L+ +G VK+ DF + + S +
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLV------GEGL-TVKISDFGLSRDIYSADY 179
Query: 736 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLT--L 790
+ +P RWM PE + LYG E DIWS+G +L E+ + L
Sbjct: 180 YRVQSKSLLPV--------RWMPPEAI-------LYGKFTTESDIWSFGVVLWEIFSYGL 224
Query: 791 QVPYMGLSELEIHDLIQ 807
Q PY G S E+ ++I+
Sbjct: 225 Q-PYYGFSNQEVIEMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 34/100 (34%), Positives = 48/100 (48%), Gaps = 23/100 (23%)
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 748
+HS ++HRD+K NILI+ + D +K+CDF A P
Sbjct: 124 VHSAGVVHRDLKPSNILIN---ENCD----LKICDFGLARIQD-------------PQMT 163
Query: 749 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788
V T + APE++ K Y +EVDIWS GC+ E+L
Sbjct: 164 GYVSTRYYRAPEIMLTWQK---YDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 42/173 (24%), Positives = 63/173 (36%), Gaps = 50/173 (28%)
Query: 647 MEYVKGGSVKNYIEK---LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703
MEY+ GG + + K +E + F + A+ +H +HRDIK +N
Sbjct: 80 MEYLPGGDMMTLLMKKDTFTE--------EETRFYIAETILAIDSIHKLGYIHRDIKPDN 131
Query: 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSF---LHTCCIAHRGIPAPDV----------- 749
+L+D A G +KL DF L+ ++H
Sbjct: 132 LLLD-----AKGH--IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184
Query: 750 --------------CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788
VGTP ++APEV Y E D WS G ++ E+L
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVF----LQTGYNKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 62/230 (26%), Positives = 93/230 (40%), Gaps = 60/230 (26%)
Query: 651 KGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 710
K S E+ E ++ ++++ + + VA + L S+ +HRD+ + NIL+
Sbjct: 151 KSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS--- 207
Query: 711 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI-PAPD-VCVGTPR----WMAPEVLRA 764
VVK+CDF A R I PD V G R WMAPE +
Sbjct: 208 ----ENNVVKICDFGLA--------------RDIYKDPDYVRKGDARLPLKWMAPESIF- 248
Query: 765 MHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGS 823
+Y + D+WS+G LL E+ +L PY G+ E + + K
Sbjct: 249 ---DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCRRLKE------------ 291
Query: 824 CHEHEVAQSGSGFEKPE-AELETLSFLVDVFRRCTEENPTERPTAGDLYE 872
G+ PE A E S ++D C NP +RPT +L E
Sbjct: 292 ---------GTRMRAPEYATPEIYSIMLD----CWHNNPEDRPTFSELVE 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 61/232 (26%)
Query: 647 MEYVKGGSVKNYIEK-----------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 695
+EY G++ +++ K ++ + +S + L A DVA + L K +
Sbjct: 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFI 146
Query: 696 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 755
HRD+ + NIL+ V K+ DF + ++ +P R
Sbjct: 147 HRDLAARNILVGENY-------VAKIADFGLSRGQEVYVKK---TMGRLPV--------R 188
Query: 756 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRL 814
WMA E L ++Y D+WSYG LL E+++L PY G++ E+++ + G R
Sbjct: 189 WMAIESLNY----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR--- 241
Query: 815 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866
EKP L + D+ R+C E P ERP+
Sbjct: 242 ---------------------LEKP---LNCDDEVYDLMRQCWREKPYERPS 269
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 41/148 (27%), Positives = 66/148 (44%), Gaps = 22/148 (14%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
M + GG ++ +I + E A F + + L LH + I++RD+K EN+L+
Sbjct: 72 MTIMNGGDLRYHIYNVDEENPG-FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL 130
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 766
D DG V++ D AV L+ G GTP +MAPE+L+
Sbjct: 131 D-----NDGN--VRISDLGLAVELKD----------GQSKTKGYAGTPGFMAPELLQGEE 173
Query: 767 KPNLYGLEVDIWSYGCLLLELLTLQVPY 794
Y VD ++ G L E++ + P+
Sbjct: 174 ----YDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 49/207 (23%), Positives = 83/207 (40%), Gaps = 77/207 (37%)
Query: 600 SCLGEVRMLGALRHSCIVEMYG-----HKIS----------SKWLPSADGNPEHHLLQSA 644
S L E+ +L L+H IV +Y K++ K+ S +G+ + +++S
Sbjct: 45 SALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSF 104
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
+F + +KG L HS +++HRD+K +N+
Sbjct: 105 MF-QLLKG---------------------------------LAFCHSHNVLHRDLKPQNL 130
Query: 705 LIDLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 760
LI+ +G+ +KL DF A +P+R + V T + P+
Sbjct: 131 LIN-----KNGE--LKLADFGLARAFGIPVRCYSAE--------------VVTLWYRPPD 169
Query: 761 VLRAMHKPNLYGLEVDIWSYGCLLLEL 787
VL LY +D+WS GC+ EL
Sbjct: 170 VLFG---AKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-08
Identities = 50/158 (31%), Positives = 74/158 (46%), Gaps = 38/158 (24%)
Query: 682 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 741
VA + L SK+ +HRD+ + N+LI +GK +VK+CDF A R +
Sbjct: 248 VANGMEFLASKNCVHRDLAARNVLI------CEGK-LVKICDFGLA---RDIMRDSNYIS 297
Query: 742 RG---IPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGL 797
+G +P +WMAPE + NLY D+WS+G LL E+ TL PY
Sbjct: 298 KGSTFLPL--------KWMAPESIFN----NLYTTLSDVWSFGILLWEIFTLGGTPY--- 342
Query: 798 SELEIHDLI--------QMGKRPRLTDEL-EALGSCHE 826
EL +++ +M K +DE+ E + C E
Sbjct: 343 PELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWE 380
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 60/274 (21%), Positives = 106/274 (38%), Gaps = 72/274 (26%)
Query: 602 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYI 659
L E ++ LRHS +V++ G + K +++ EY+ GS+ +Y
Sbjct: 47 LAEASVMTQLRHSNLVQLLGVIVEEK---------------GGLYIVTEYMAKGSLVDY- 90
Query: 660 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 719
L G + L + DV A+ L + + +HRD+ + N+L+ + V
Sbjct: 91 --LRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN-------VA 141
Query: 720 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 779
K+ DF S T +P +W APE LR + + D+WS
Sbjct: 142 KVSDFGLTKEASSTQDTG-----KLPV--------KWTAPEALRE----KKFSTKSDVWS 184
Query: 780 YGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 838
+G LL E+ + +VPY + ++ ++ G + ++A C
Sbjct: 185 FGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------MDAPDGC-------------- 224
Query: 839 PEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 872
P + DV ++C + RP+ L E
Sbjct: 225 PPV-------VYDVMKQCWHLDAATRPSFLQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 7e-08
Identities = 52/236 (22%), Positives = 90/236 (38%), Gaps = 52/236 (22%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
+E+ G +KNY+ + + +A +VA+ L+ LH +H D+ N +
Sbjct: 74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL 133
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP----APDVCVGTP-RWMAPEV 761
AD VK+ D+ +A P C P RW+APE+
Sbjct: 134 -----TADLS--VKIGDYG-------------LALEQYPEDYYITKDCHAVPLRWLAPEL 173
Query: 762 LRAMH---KPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDE 817
+ P + +IWS G + EL T PY LS+ ++ + + +L
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL--- 230
Query: 818 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 873
KP+ +L+ +V + C + P RPTA +++E+
Sbjct: 231 -------------------PKPQLDLKYSDRWYEVMQFCWLD-PETRPTAEEVHEL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 41/154 (26%), Positives = 73/154 (47%), Gaps = 30/154 (19%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKL-ALFIAQDVAAALVELH-SKHIMHRDIKSE 702
I M+ ++G + + L E ++ ++ +F+ + AL LH K I+HRD+
Sbjct: 86 IVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV--QMVLALRYLHKEKRIVHRDLTPN 143
Query: 703 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV--CVGTPRWMAPE 760
NI++ E K V + DF +A + P + VGT + PE
Sbjct: 144 NIMLG-EDDK------VTITDFG-------------LAKQKQPESKLTSVVGTILYSCPE 183
Query: 761 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 794
+++ P YG + D+W++GC+L ++ TLQ P+
Sbjct: 184 IVKNE--P--YGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 8e-08
Identities = 44/172 (25%), Positives = 79/172 (45%), Gaps = 41/172 (23%)
Query: 645 IFMEYVKGGSVKNYIEKLSETG---EKHVSVKLALFIAQDVAAALVELHS-------KHI 694
I ME+ G + I+K + E+H V I + + AL H+ + +
Sbjct: 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVD----ITRQLLHALAYCHNLKDGPNGERV 146
Query: 695 MHRDIKSENIL----------IDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHR 742
+HRD+K +NI I + +G+P+ K+ DF + + + S H+C
Sbjct: 147 LHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSC----- 201
Query: 743 GIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 794
VGTP + +PE+L +H+ Y + D+W+ GC++ EL + + P+
Sbjct: 202 --------VGTPYYWSPELL--LHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 50/208 (24%), Positives = 84/208 (40%), Gaps = 43/208 (20%)
Query: 602 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 661
E ++L + H V +YG +L + +E+V GG ++ +
Sbjct: 79 FSERKILNYINHPFCVNLYGSFKDESYL--------------YLVLEFVIGGEFFTFLRR 124
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
K + F A + L S +I++RD+K EN+L+D DG +K+
Sbjct: 125 -----NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD-----KDG--FIKM 172
Query: 722 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781
DF A + + +T C GTP ++APE+L + +G D W+ G
Sbjct: 173 TDFGFAKVVDTRTYTLC-------------GTPEYIAPEILLNVG----HGKAADWWTLG 215
Query: 782 CLLLELLTLQVPYMGLSELEIHDLIQMG 809
+ E+L P+ L I+ I G
Sbjct: 216 IFIYEILVGCPPFYANEPLLIYQKILEG 243
|
Length = 340 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 38/132 (28%), Positives = 60/132 (45%), Gaps = 22/132 (16%)
Query: 677 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 736
F A ++ L +H++ +++RD+K NIL+D E + CDF + P S
Sbjct: 101 FYAAEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHAS---- 155
Query: 737 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 796
VGT +MAPEVL+ K Y D +S GC+L +LL P+
Sbjct: 156 --------------VGTHGYMAPEVLQ---KGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 198
Query: 797 LSELEIHDLIQM 808
+ H++ +M
Sbjct: 199 HKTKDKHEIDRM 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 64/314 (20%), Positives = 127/314 (40%), Gaps = 67/314 (21%)
Query: 562 SVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 621
SV + + + GS A V+ LK S+ +I F L E + H ++++ G
Sbjct: 14 SVREAQLKSEDGSFQKVA-VKMLKADIFSSSDIEEF----LREAACMKEFDHPNVIKLIG 68
Query: 622 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFI--A 679
+ S+ + L + + ++K G + ++ +S GE+ ++ L +
Sbjct: 69 VSLRSR--------AKGRLPIPMVILPFMKHGDLHTFL-LMSRIGEEPFTLPLQTLVRFM 119
Query: 680 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS--FLHTC 737
D+A+ + L SK+ +HRD+ + N +++ V + DF + + S +
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMT-------VCVADFGLSKKIYSGDYYRQG 172
Query: 738 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMG 796
C + +P +W+A E L N+Y D+W++G + E++T Q PY G
Sbjct: 173 CASK--LPV--------KWLALESL----ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218
Query: 797 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 856
+ EI++ + G R ++P + L + ++ +C
Sbjct: 219 VENSEIYNYLIKGNR------------------------LKQP---PDCLEDVYELMCQC 251
Query: 857 TEENPTERPTAGDL 870
P RP+ L
Sbjct: 252 WSPEPKCRPSFQHL 265
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 42/162 (25%), Positives = 72/162 (44%), Gaps = 27/162 (16%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
++ + GG + ++ + EK + F A ++ L +H++ +++RD+K NIL+
Sbjct: 76 LDLMNGGDLHYHLSQHGVFSEKEMR-----FYATEIILGLEHMHNRFVVYRDLKPANILL 130
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 766
D E + CDF + P S VGT +MAPEVL+
Sbjct: 131 D-EHGHVRISDLGLACDFSKKKPHAS------------------VGTHGYMAPEVLQ--- 168
Query: 767 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 808
K Y D +S GC+L +LL P+ + H++ +M
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 39/128 (30%), Positives = 59/128 (46%), Gaps = 33/128 (25%)
Query: 677 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 736
FI Q + L +HS +++HRD+K N+L++ AD + +K+CDF A
Sbjct: 110 FIYQ-ILCGLKYIHSANVLHRDLKPGNLLVN-----ADCE--LKICDFGLA--------- 152
Query: 737 CCIAHRGI-PAPDVCVG------TPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788
RG P G RW APE++ + Y +D+WS GC+L ELL
Sbjct: 153 -----RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQS---YTKAIDVWSVGCILAELL 204
Query: 789 TLQVPYMG 796
+ + G
Sbjct: 205 GRKPVFKG 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 41/148 (27%), Positives = 66/148 (44%), Gaps = 31/148 (20%)
Query: 650 VKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709
+ GG +K +I + G + A+F A ++ L +L + I++RD+K ENIL+
Sbjct: 82 MNGGDLKFHIYNMGNPG---FDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL--- 135
Query: 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEVLRAMH 766
D + +++ D AV IP + VGT +MAPEV+
Sbjct: 136 ----DDRGHIRISDLGLAVQ--------------IPEGETVRGRVGTVGYMAPEVI---- 173
Query: 767 KPNLYGLEVDIWSYGCLLLELLTLQVPY 794
Y D W GCL+ E++ Q P+
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 60/275 (21%), Positives = 106/275 (38%), Gaps = 78/275 (28%)
Query: 598 EYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 657
E++C VR+LG + + G P + + ME + G +K+
Sbjct: 65 EFNCHHVVRLLGVV--------------------SQGQP------TLVIMELMTRGDLKS 98
Query: 658 YIEKL-----SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 712
Y+ L + + S+K + +A ++A + L++ +HRD+ + N ++ +
Sbjct: 99 YLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-- 156
Query: 713 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 772
VK+ DF R T G V RWM+PE L K ++
Sbjct: 157 -----TVKIGDFGMT---RDIYETDYYRKGGKGLLPV-----RWMSPESL----KDGVFT 199
Query: 773 LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ 831
D+WS+G +L E+ TL + PY G+S ++ +
Sbjct: 200 TYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV------------------------M 235
Query: 832 SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866
G +KP+ L ++ R C + NP RP+
Sbjct: 236 EGGLLDKPD---NCPDMLFELMRMCWQYNPKMRPS 267
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 54/236 (22%), Positives = 98/236 (41%), Gaps = 52/236 (22%)
Query: 645 IFMEYVKGGSVKNYIEKL-----SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 699
+ ME + G +K+Y+ L + G +++ + +A ++A + L++K +HRD+
Sbjct: 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDL 145
Query: 700 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 759
+ N ++ + VK+ DF R T G V RWMAP
Sbjct: 146 AARNCMVAHDF-------TVKIGDFGMT---RDIYETDYYRKGGKGLLPV-----RWMAP 190
Query: 760 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDEL 818
E L K ++ D+WS+G +L E+ +L + PY GLS ++ +
Sbjct: 191 ESL----KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV------------ 234
Query: 819 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
G ++P+ E ++ D+ R C + NP RPT ++ +
Sbjct: 235 ------------MDGGYLDQPDNCPERVT---DLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 50/206 (24%), Positives = 83/206 (40%), Gaps = 41/206 (19%)
Query: 583 TLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQ 642
LKV GS + F + ++ L H +V++YG + D N
Sbjct: 34 VLKVLGSDHRDSLAFFET----ASLMSQLSHKHLVKLYG-------VCVRDEN------- 75
Query: 643 SAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 702
+ EYVK G + ++ + +VS+ L +A+ +A+AL L K ++H ++ +
Sbjct: 76 -IMVEEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGK 130
Query: 703 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 762
NIL+ P +KL D + + S R P W+APE +
Sbjct: 131 NILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIP--------WIAPECI 176
Query: 763 RAMH-KPNLYGLEVDIWSYGCLLLEL 787
R + D WS+G LLE+
Sbjct: 177 RNGQASLTIAA---DKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 38/133 (28%), Positives = 54/133 (40%), Gaps = 27/133 (20%)
Query: 686 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--------DRAVPLRSFLHTC 737
L LH + MHRD+ NI I+ K + K+ DF S T
Sbjct: 132 LNVLHKWYFMHRDLSPANIFIN-------SKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 738 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL 797
V T + APE+L K Y VD+WS GC+ ELLT + + G
Sbjct: 185 QRREEMTSK----VVTLWYRAPELLMGAEK---YHFAVDMWSVGCIFAELLTGKPLFPGE 237
Query: 798 SELEIHDLIQMGK 810
+E++ Q+G+
Sbjct: 238 NEID-----QLGR 245
|
Length = 335 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-07
Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 30/148 (20%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
+ ME++ +V Y++ + + L+ Q + AL +HSK I HRD+K +N+
Sbjct: 144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQ-LCRALAYIHSKFICHRDLKPQNL 201
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPL----RSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 760
LID +KLCDF A L RS + C +R AP++ +G
Sbjct: 202 LIDPNTH------TLKLCDFGSAKNLLAGQRSVSYICSRFYR---APELMLGATN----- 247
Query: 761 VLRAMHKPNLYGLEVDIWSYGCLLLELL 788
Y +D+WS GC++ E++
Sbjct: 248 ----------YTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 58/241 (24%), Positives = 104/241 (43%), Gaps = 44/241 (18%)
Query: 573 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 632
G + A ++TLK G + + ++F L E ++G H I+ + G + +K+ P+
Sbjct: 30 GRKEVAVAIKTLKP-GYTEKQRQDF----LSEASIMGQFSHHNIIRLEG--VVTKFKPAM 82
Query: 633 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 692
I EY++ G++ Y L + + S +L + + +AA + L
Sbjct: 83 ------------IITEYMENGALDKY---LRDHDGEFSSYQLVGML-RGIAAGMKYLSDM 126
Query: 693 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCV 751
+ +HRD+ + NIL+ + K+ DF + L G IP
Sbjct: 127 NYVHRDLAARNILV-------NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI----- 174
Query: 752 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGK 810
RW APE + A K + D+WS+G ++ E+++ + PY +S E+ I G
Sbjct: 175 ---RWTAPEAI-AYRK---FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF 227
Query: 811 R 811
R
Sbjct: 228 R 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 42/179 (23%), Positives = 80/179 (44%), Gaps = 31/179 (17%)
Query: 645 IFMEYVKGGSVKNYIE-----------KLSETGEKHVSVKLALFIAQDVAAALVELHSKH 693
+ +EY G+++ Y+ ++ ++ ++ K + VA + L S+
Sbjct: 98 VIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK 157
Query: 694 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 753
+HRD+ + N+L+ V+K+ DF A + + + + +P
Sbjct: 158 CIHRDLAARNVLVTENN-------VMKIADFGLARDVNNIDYYKKTTNGRLPV------- 203
Query: 754 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 811
+WMAPE L +Y + D+WS+G L+ E+ TL PY G+ E+ L++ G R
Sbjct: 204 -KWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR 257
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 5e-07
Identities = 39/117 (33%), Positives = 61/117 (52%), Gaps = 20/117 (17%)
Query: 682 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 741
VA + L SK+ +HRD+ + N+L+ DG+ V K+CDF A R ++
Sbjct: 221 VAQGMDFLASKNCIHRDVAARNVLL------TDGR-VAKICDFGLA---RDIMNDSNYVV 270
Query: 742 RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGL 797
+G V +WMAPE + +Y ++ D+WSYG LL E+ +L + PY G+
Sbjct: 271 KGNARLPV-----KWMAPESIFDC----VYTVQSDVWSYGILLWEIFSLGKSPYPGI 318
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 46/156 (29%), Positives = 74/156 (47%), Gaps = 30/156 (19%)
Query: 655 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 714
++ Y++K+ G ++K + + L LH+ I+HRD+K ENIL+ +
Sbjct: 93 LRTYLDKVPPPGLPAETIK---DLMRQFLRGLDFLHANCIVHRDLKPENILV-----TSG 144
Query: 715 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 774
G+ VKL DF A +++C +A V T + APEVL + Y
Sbjct: 145 GQ--VKLADFGLAR-----IYSCQMAL------TPVVVTLWYRAPEVLLQ----STYATP 187
Query: 775 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
VD+WS GC+ E+ + + G SE + Q+GK
Sbjct: 188 VDMWSVGCIFAEMFRRKPLFCGNSEAD-----QLGK 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 9e-07
Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 37/208 (17%)
Query: 597 FEYSCLGEVRMLGALRHSCIVEMYGHKI-SSKWLPSADGNPEHHLLQSAIFMEYVKGGSV 655
F + L E+++L L+H +V + +I +K P +L+ F E+ G +
Sbjct: 54 FPITALREIKILQLLKHENVVNLI--EICRTKATPYNRYKGSFYLVFE--FCEHDLAGLL 109
Query: 656 KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 715
N K + E +K+ L L +H I+HRD+K+ NILI DG
Sbjct: 110 SNKNVKFTL-SEIKKVMKMLL-------NGLYYIHRNKILHRDMKAANILIT-----KDG 156
Query: 716 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEVLRAMHKPNLYG 772
++KL DF A R+F + P+ V T + PE+L YG
Sbjct: 157 --ILKLADFGLA---RAF------SLSKNSKPNRYTNRVVTLWYRPPELLLGERD---YG 202
Query: 773 LEVDIWSYGCLLLELLTLQVPYM-GLSE 799
+D+W GC++ E+ T P M G +E
Sbjct: 203 PPIDMWGAGCIMAEMWTRS-PIMQGNTE 229
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 9e-07
Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 51/204 (25%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM-EYVKGGSVKNYIEKL 662
E +L L+H+ IV + H I H ++ + EY+ +K Y++
Sbjct: 53 EASLLKDLKHANIVTL--HDII-------------HTKKTLTLVFEYLDT-DLKQYMDDC 96
Query: 663 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 722
G +V+L LF + L H + ++HRD+K +N+LI ER + +KL
Sbjct: 97 G-GGLSMHNVRLFLF---QLLRGLAYCHQRRVLHRDLKPQNLLIS-ERGE------LKLA 145
Query: 723 DFDRA----VPLRSFLH-TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 777
DF A VP +++ + + +R PDV +G+ Y +D+
Sbjct: 146 DFGLARAKSVPSKTYSNEVVTLWYR---PPDVLLGSTE---------------YSTSLDM 187
Query: 778 WSYGCLLLELLTLQVPYMGLSELE 801
W GC+ E+ T + + G +++E
Sbjct: 188 WGVGCIFYEMATGRPLFPGSTDVE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 57/241 (23%), Positives = 101/241 (41%), Gaps = 44/241 (18%)
Query: 573 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 632
G + ++TLK G + + R+F L E ++G H I+ + G SK +
Sbjct: 29 GKREIPVAIKTLKA-GYTEKQRRDF----LSEASIMGQFDHPNIIHLEGVVTKSKPV--- 80
Query: 633 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 692
I EY++ GS+ ++ K + +V + + + +A+ + L
Sbjct: 81 -----------MIVTEYMENGSLDAFLRK----HDGQFTVIQLVGMLRGIASGMKYLSDM 125
Query: 693 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCV 751
+HRD+ + NIL++ V K+ DF + L G IP
Sbjct: 126 GYVHRDLAARNILVN-------SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI----- 173
Query: 752 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGK 810
RW APE + A K + D+WSYG ++ E+++ + PY +S ++ I+ G
Sbjct: 174 ---RWTAPEAI-AYRK---FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY 226
Query: 811 R 811
R
Sbjct: 227 R 227
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 40/126 (31%), Positives = 54/126 (42%), Gaps = 36/126 (28%)
Query: 670 VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 729
+ + AL I + + L LH++ I+HRD+K+ENI I+ D D
Sbjct: 154 LPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN---------------DVD---- 194
Query: 730 LRSFLHTCCIAHRG-----IPAPDV--CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 782
CI G + AP GT APEVL A K Y + DIWS G
Sbjct: 195 ------QVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVL-ARDK---YNSKADIWSAGI 244
Query: 783 LLLELL 788
+L E+L
Sbjct: 245 VLFEML 250
|
Length = 357 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 39/132 (29%), Positives = 61/132 (46%), Gaps = 22/132 (16%)
Query: 682 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 741
+A + L K ++HRD+ + N+L+ + VK+ DF A L A
Sbjct: 118 IAKGMSYLEEKRLVHRDLAARNVLVKTPQH-------VKITDFGLA-KLLDVDEKEYHAE 169
Query: 742 RGIPAPDVCVGTP-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSE 799
G P +WMA E + +Y + D+WSYG + EL+T PY G+
Sbjct: 170 GGK--------VPIKWMALESILH----RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA 217
Query: 800 LEIHDLIQMGKR 811
+EI DL++ G+R
Sbjct: 218 VEIPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 45/191 (23%), Positives = 67/191 (35%), Gaps = 61/191 (31%)
Query: 693 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP------- 745
I+HRD+K NIL+ D +KLCDF GI
Sbjct: 128 KIIHRDVKPSNILL-------DRNGNIKLCDF------------------GISGQLVDSI 162
Query: 746 APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 805
A G +MAPE + + Y + D+WS G L E+ T + PY + + D
Sbjct: 163 AKTRDAGCRPYMAPERI-DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQ 219
Query: 806 IQM---GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 862
+ G P L + E E + S V+ C ++ +
Sbjct: 220 LTQVVKGDPPI-------LSNSEEREFSPS----------------FVNFINLCLIKDES 256
Query: 863 ERPTAGDLYEM 873
+RP +L E
Sbjct: 257 KRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 47/169 (27%), Positives = 75/169 (44%), Gaps = 24/169 (14%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKH-VSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703
+ + Y+K G ++N+I E H +VK + VA + L SK +HRD+ + N
Sbjct: 74 VVLPYMKHGDLRNFIRS-----ETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARN 128
Query: 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 763
++D VK+ DF A + + H G P +WMA E L+
Sbjct: 129 CMLD-------ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP------VKWMALESLQ 175
Query: 764 AMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKR 811
K + + D+WS+G LL EL+T PY + +I + G+R
Sbjct: 176 T-QK---FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR 220
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 60/300 (20%), Positives = 118/300 (39%), Gaps = 72/300 (24%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG---HKISSKWLPSADGNPE 637
V+T+K+ + E+ +F L E + H ++ + G + S+ PS
Sbjct: 31 VKTMKIAICTRSEMEDF----LSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP----- 81
Query: 638 HHLLQSAIFMEYVKGGSVKNYI--EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 695
+ + ++K G + +++ +L + + + L F+ D+A+ + L SK +
Sbjct: 82 ------VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT-DIASGMEYLSSKSFI 134
Query: 696 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS--FLHTCCIAHRGIPAPDVCVGT 753
HRD+ + N +++ V + DF + + + + IA +
Sbjct: 135 HRDLAARNCMLNENMN-------VCVADFGLSKKIYNGDYYRQGRIAKMPV--------- 178
Query: 754 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 812
+W+A E L +Y + D+WS+G + E+ T Q PY G+ EI+D ++ G R
Sbjct: 179 -KWIAIESL----ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR- 232
Query: 813 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 872
++P + L L + C NP +RP+ L
Sbjct: 233 -----------------------LKQPP---DCLDGLYSLMSSCWLLNPKDRPSFETLRC 266
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 39/117 (33%), Positives = 51/117 (43%), Gaps = 31/117 (26%)
Query: 677 FIAQDVAAALVELHSKHIMHRDIKSENILI--DLERKKADGKPVVKLCDFDRAVPLRSFL 734
F+ + L +HS I+HRD+K NI + D E +K+ DF A +
Sbjct: 122 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE---------LKILDFGLARHTDDEM 172
Query: 735 HTCCIAHRGIPAPDVCVGTPRW-MAPEV-LRAMHKPNLYGLEVDIWSYGCLLLELLT 789
V T RW APE+ L MH Y VDIWS GC++ ELLT
Sbjct: 173 TG-------------YVAT-RWYRAPEIMLNWMH----YNQTVDIWSVGCIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 54/207 (26%), Positives = 83/207 (40%), Gaps = 43/207 (20%)
Query: 584 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 643
LKV S RN+ S M+ L H +V YG + E ++Q
Sbjct: 32 LKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD---------ESIMVQ- 78
Query: 644 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703
EYVK GS+ Y++K +++ L +A+ +A AL L K + H ++ ++N
Sbjct: 79 ----EYVKFGSLDTYLKKNKNL----INISWKLEVAKQLAWALHFLEDKGLTHGNVCAKN 130
Query: 704 ILIDLERKKADGK-PVVKLCD--FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 760
+L+ E + G P +KL D V + L IP W+ PE
Sbjct: 131 VLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL------LERIP----------WVPPE 174
Query: 761 VLRAMHKPNLYGLEVDIWSYGCLLLEL 787
+ P L D WS+G L E+
Sbjct: 175 CIE---NPQNLSLAADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 33/102 (32%), Positives = 49/102 (48%), Gaps = 24/102 (23%)
Query: 690 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 749
H ++HRD+K +N+LI+ + +KL DF A R+F GIP
Sbjct: 117 HENRVLHRDLKPQNLLIN-------KRGELKLADFGLA---RAF---------GIPVNTF 157
Query: 750 C--VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789
V T + AP+VL Y +DIWS GC++ E++T
Sbjct: 158 SNEVVTLWYRAPDVLLG---SRTYSTSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 36/110 (32%), Positives = 49/110 (44%), Gaps = 27/110 (24%)
Query: 685 ALVELHSKHIMHRDIKSENILI----DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA 740
L +HS +++HRD+K N+L+ DL K+CDF A R
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDL-----------KICDFGLA---RI--ADPEHD 161
Query: 741 HRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789
H G V RW APE+ M Y +DIWS GC+L E+L+
Sbjct: 162 HTGFLTEYVAT---RWYRAPEI---MLNSKGYTKAIDIWSVGCILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 52/223 (23%)
Query: 658 YIEKLSETGEKHVSVK---LALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 714
Y++K+ E G ++K L D LHS ++HRD+K +NIL+ +
Sbjct: 98 YLDKVPEPGVPTETIKDMMFQLLRGLDF------LHSHRVVHRDLKPQNILV-----TSS 146
Query: 715 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 774
G+ +KL DF A + SF A V T + APEVL + Y
Sbjct: 147 GQ--IKLADFGLA-RIYSFQ----------MALTSVVVTLWYRAPEVLLQ----SSYATP 189
Query: 775 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE----HEVA 830
VD+WS GC+ E+ + + G S+++ Q+GK L+ +G E +VA
Sbjct: 190 VDLWSVGCIFAEMFRRKPLFRGSSDVD-----QLGKI------LDVIGLPGEEDWPRDVA 238
Query: 831 QSGSGFE-KPEAELETLSFLVD-----VFRRCTEENPTERPTA 867
F K +E +D + +C NP +R +A
Sbjct: 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 7e-06
Identities = 30/101 (29%), Positives = 47/101 (46%), Gaps = 20/101 (19%)
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 748
+HS +++HRD+K N+L++ D +K+CDF A T +
Sbjct: 124 IHSANVLHRDLKPSNLLLN---ANCD----LKICDFGLA-------RTTSEKGDFMTE-- 167
Query: 749 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789
V T + APE+L + Y +D+WS GC+ ELL
Sbjct: 168 -YVVTRWYRAPELLLNCSE---YTTAIDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 57/200 (28%), Positives = 80/200 (40%), Gaps = 58/200 (29%)
Query: 682 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 741
VA + L S+ +HRD+ + NIL+ VVK+CDF A
Sbjct: 183 VARGMEFLASRKCIHRDLAARNILLSENN-------VVKICDFGLA-------------- 221
Query: 742 RGI-PAPD-VCVGTPR----WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PY 794
R I PD V G+ R WMAPE + +Y + D+WS+G LL E+ +L PY
Sbjct: 222 RDIYKDPDYVRKGSARLPLKWMAPESIF----DKVYTTQSDVWSFGVLLWEIFSLGASPY 277
Query: 795 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 854
G+ E + Q RL D G+ PE + +
Sbjct: 278 PGVQINE--EFCQ-----RLKD----------------GTRMRAPE---NATPEIYRIML 311
Query: 855 RCTEENPTERPTAGDLYEMF 874
C + +P ERPT L E+
Sbjct: 312 ACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 53/233 (22%), Positives = 98/233 (42%), Gaps = 61/233 (26%)
Query: 645 IFMEYVKGGSVKNYIEK--LSET----GEKH-----VSVKLALFIAQDVAAALVELHSKH 693
I +EY G++ +++ K + ET ++H ++ + L A DVA + L K
Sbjct: 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ 139
Query: 694 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 753
+HRD+ + N+L+ K+ DF + ++ +P
Sbjct: 140 FIHRDLAARNVLVG-------ENLASKIADFGLSRGEEVYVKK---TMGRLPV------- 182
Query: 754 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 812
RWMA E L ++Y + D+WS+G LL E+++L PY G++ E+++ + G R
Sbjct: 183 -RWMAIESLNY----SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR- 236
Query: 813 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865
+E +C + + ++ R+C + P ERP
Sbjct: 237 -----MEKPRNCDDE---------------------VYELMRQCWRDRPYERP 263
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 39/122 (31%), Positives = 56/122 (45%), Gaps = 30/122 (24%)
Query: 682 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 741
VA + L S+ +HRD+ + NIL+ VVK+CDF +A
Sbjct: 188 VAKGMEFLASRKCIHRDLAARNILLS-------ENNVVKICDFG-------------LAR 227
Query: 742 RGIPAPD-VCVGTPR----WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYM 795
PD V G R WMAPE + +Y ++ D+WS+G LL E+ +L PY
Sbjct: 228 DIYKDPDYVRKGDARLPLKWMAPETIF----DRVYTIQSDVWSFGVLLWEIFSLGASPYP 283
Query: 796 GL 797
G+
Sbjct: 284 GV 285
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 9e-06
Identities = 61/254 (24%), Positives = 92/254 (36%), Gaps = 57/254 (22%)
Query: 646 FMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705
FM Y GS + ++ G + LF A L LH +HR+IK+ +IL
Sbjct: 80 FMAY---GSANSLLKTYFPEGMSEALIGNILFGA---LRGLNYLHQNGYIHRNIKASHIL 133
Query: 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA------PDVCVGTPRWMAP 759
I DG V L H + G A P W++P
Sbjct: 134 I-----SGDG-----------LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSP 177
Query: 760 EVLRAMHKPNLYGLEV--DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE 817
E+LR +LYG V DI+S G EL T +VP+ + ++ L+Q K P +
Sbjct: 178 ELLRQ----DLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPL 231
Query: 818 LEALGSCHEHEVAQSGSGFEKPEAELETLSF---------------------LVDVFRRC 856
C E + S SG + E + ++ C
Sbjct: 232 DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELC 291
Query: 857 TEENPTERPTAGDL 870
+++P +RP+A L
Sbjct: 292 LQQDPEKRPSASSL 305
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 38/117 (32%), Positives = 55/117 (47%), Gaps = 19/117 (16%)
Query: 690 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 749
H K+ +HRDIK NIL+ + K +KL DF A R + + P +
Sbjct: 133 HKKNFLHRDIKCSNILL-------NNKGQIKLADFGLA---RLY-----NSEESRPYTNK 177
Query: 750 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 806
V T + PE+L + YG +D+WS GC+L EL T + + EL +LI
Sbjct: 178 -VITLWYRPPELLLGEER---YGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI 230
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 41/140 (29%), Positives = 63/140 (45%), Gaps = 26/140 (18%)
Query: 658 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 717
Y+++ + ++ A+ I + + AL LH + I+HRD+K+ENI +D +P
Sbjct: 175 YVDRSGP-----LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD--------EP 221
Query: 718 V-VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 776
L DF A L AH P GT +PE+L A+ + Y + D
Sbjct: 222 ENAVLGDFGAACKLD--------AHPDTPQCYGWSGTLETNSPELL-AL---DPYCAKTD 269
Query: 777 IWSYGCLLLELLTLQVPYMG 796
IWS G +L E+ V G
Sbjct: 270 IWSAGLVLFEMSVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 57/241 (23%), Positives = 98/241 (40%), Gaps = 52/241 (21%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
+ ME++ GS+K Y+ + + +++K L A + + L S+ +HRD+ + N+
Sbjct: 85 LIMEFLPSGSLKEYLPR----NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNV 140
Query: 705 LIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 762
L++ E + VK+ DF +A+ +T D W APE L
Sbjct: 141 LVESEHQ-------VKIGDFGLTKAIETDKEYYT---------VKDDLDSPVFWYAPECL 184
Query: 763 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALG 822
+ + + D+WS+G L ELLT Y + ++M +G
Sbjct: 185 --IQSK--FYIASDVWSFGVTLYELLT----YCDSESSPMTLFLKM------------IG 224
Query: 823 SCHEH-------EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 875
H V + G +P E + L+ R+C E P++R T +L E F
Sbjct: 225 PTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLM---RKCWEFQPSKRTTFQNLIEGFE 281
Query: 876 A 876
A
Sbjct: 282 A 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 60/240 (25%), Positives = 97/240 (40%), Gaps = 75/240 (31%)
Query: 645 IFMEYVKGGSVKNYIEK--LSET----GEKH-----VSVKLALFIAQDVAAALVELHSKH 693
+ +EY G++ +++ K + ET + +S + L A DVA + L K
Sbjct: 73 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 132
Query: 694 IMHRDIKSENILI--DLERKKAD-----GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA 746
+HRD+ + NIL+ + K AD G+ V R +P+R
Sbjct: 133 FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR-LPVR--------------- 176
Query: 747 PDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDL 805
WMA E L ++Y D+WSYG LL E+++L PY G++ E+++
Sbjct: 177 ---------WMAIESLNY----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 223
Query: 806 IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865
+ G R LE +C + + D+ R+C E P ERP
Sbjct: 224 LPQGYR------LEKPLNCDDE---------------------VYDLMRQCWREKPYERP 256
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 47/220 (21%)
Query: 584 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 643
LKV +E ++ + E +L L+H+ IV + H I H ++
Sbjct: 35 LKVISMKTEE--GVPFTAIREASLLKGLKHANIVLL--HDII-------------HTKET 77
Query: 644 AIF-MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 702
F EY+ + I+ G H + LF+ Q + L +H +HI+HRD+K +
Sbjct: 78 LTFVFEYMHTDLAQYMIQ---HPGGLH-PYNVRLFMFQ-LLRGLAYIHGQHILHRDLKPQ 132
Query: 703 NILIDLERKKADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 760
N+LI + +KL DF RA + S ++ + PDV +G
Sbjct: 133 NLLISYLGE-------LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD----- 180
Query: 761 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL 800
Y +DIW GC+ +E+L Q + G+S++
Sbjct: 181 ----------YSSALDIWGAGCIFIEMLQGQPAFPGVSDV 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-05
Identities = 38/109 (34%), Positives = 53/109 (48%), Gaps = 24/109 (22%)
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA-VPLRSFLHTCCIAHRGIPAP 747
LHS I+HRD+K NI++ K+D +K+ DF A SF+ T P
Sbjct: 134 LHSAGIIHRDLKPSNIVV-----KSDC--TLKILDFGLARTAGTSFMMT----------P 176
Query: 748 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 796
V T + APEV+ M Y VDIWS GC++ E++ V + G
Sbjct: 177 YVV--TRYYRAPEVILGMG----YKENVDIWSVGCIMGEMIRGTVLFPG 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 48/212 (22%), Positives = 88/212 (41%), Gaps = 41/212 (19%)
Query: 602 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 661
L E ++ L + IV M G + W+ + ME + G + +++K
Sbjct: 44 LREANVMQQLDNPYIVRMIGICEAESWM---------------LVMELAELGPLNKFLQK 88
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
KHV+ K + V+ + L + +HRD+ + N+L+ + K+
Sbjct: 89 -----NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH-------YAKI 136
Query: 722 CDFDRAVPLRSFL-HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 780
DF + L + + H P +W APE + +K + + D+WS+
Sbjct: 137 SDFGLSKALGADENYYKAKTHGKWPV--------KWYAPECMN-YYK---FSSKSDVWSF 184
Query: 781 GCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 811
G L+ E + Q PY G+ E+ +I+ G+R
Sbjct: 185 GVLMWEAFSYGQKPYKGMKGNEVTQMIESGER 216
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 38/113 (33%), Positives = 53/113 (46%), Gaps = 22/113 (19%)
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 748
LHS I+HRD+K NI++ K+D +K+ DF A T C P
Sbjct: 139 LHSAGIIHRDLKPSNIVV-----KSDC--TLKILDFGLA-------RTACTNFMMTPY-- 182
Query: 749 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 801
V T + APEV+ M Y VDIWS GC++ EL+ V + G ++
Sbjct: 183 --VVTRYYRAPEVILGMG----YKENVDIWSVGCIMGELVKGSVIFQGTDHID 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 47/158 (29%), Positives = 69/158 (43%), Gaps = 36/158 (22%)
Query: 653 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 712
G+ N I K + + HV F+ + L +HS I+HRD+K N+ ++ + +
Sbjct: 105 GADLNNIVKCQKLTDDHVQ-----FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE- 158
Query: 713 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG--TPRWM-APEV-LRAMHKP 768
+K+ DF A HT D G RW APE+ L MH
Sbjct: 159 ------LKILDFGLA------RHT----------DDEMTGYVATRWYRAPEIMLNWMH-- 194
Query: 769 NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 806
Y VDIWS GC++ ELLT + + G ++ LI
Sbjct: 195 --YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 34/109 (31%), Positives = 50/109 (45%), Gaps = 19/109 (17%)
Query: 678 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 737
+A+ + +A+ +H + I+HRDIK+EN+L+ +G + L DF A R
Sbjct: 265 VARQLLSAIDYIHGEGIIHRDIKTENVLV-------NGPEDICLGDFGAACFAR------ 311
Query: 738 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786
P GT APEVL + Y VDIWS G ++ E
Sbjct: 312 --GSWSTPFHYGIAGTVDTNAPEVLAG----DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 49/191 (25%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
EV +L L+H+ IV + H I H + EY+ +K Y++
Sbjct: 53 EVSLLKNLKHANIVTL--HDII------------HTERCLTLVFEYLDS-DLKQYLDNCG 97
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
H +VK+ +F + L H + I+HRD+K +N+LI + K +KL D
Sbjct: 98 NLMSMH-NVKIFMF---QLLRGLSYCHKRKILHRDLKPQNLLI-------NEKGELKLAD 146
Query: 724 FD----RAVPLRSFLH-TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 778
F ++VP +++ + + +R PDV +G+ + P +D+W
Sbjct: 147 FGLARAKSVPTKTYSNEVVTLWYR---PPDVLLGSTEYSTP---------------IDMW 188
Query: 779 SYGCLLLELLT 789
GC+L E+ T
Sbjct: 189 GVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 5e-05
Identities = 37/110 (33%), Positives = 52/110 (47%), Gaps = 26/110 (23%)
Query: 685 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 744
AL +H+ ++ HRD+K +NIL + AD K +K+CDF A +F T
Sbjct: 115 ALKYIHTANVFHRDLKPKNILAN-----ADCK--LKICDFGLARV--AFNDT-------- 157
Query: 745 PAPDVCVGT----PRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789
P T RW APE+ + Y +DIWS GC+ E+LT
Sbjct: 158 --PTAIFWTDYVATRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAEVLT 203
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 5e-05
Identities = 37/122 (30%), Positives = 55/122 (45%), Gaps = 13/122 (10%)
Query: 682 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 741
V AL H++ I+HRD+K +NI++ + +P K+ DF L
Sbjct: 88 VLDALACAHNQGIVHRDLKPQNIMV----SQTGVRPHAKVLDFGIGTLLPGVRD---ADV 140
Query: 742 RGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL 800
+ +GTP + APE LR PN D++++G + LE LT Q G S
Sbjct: 141 ATLTRTTEVLGTPTYCAPEQLRGEPVTPN-----SDLYAWGLIFLECLTGQRVVQGASVA 195
Query: 801 EI 802
EI
Sbjct: 196 EI 197
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 5e-05
Identities = 29/101 (28%), Positives = 49/101 (48%), Gaps = 18/101 (17%)
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 748
+HS +++HRD+K N+L++ +++ DF A L S H+
Sbjct: 123 IHSANVIHRDLKPSNLLVN-------EDCELRIGDFGMARGLSSS----PTEHKYFMTEY 171
Query: 749 VCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788
V RW APE+L ++ + Y +D+WS GC+ E+L
Sbjct: 172 V---ATRWYRAPELLLSLPE---YTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 35/131 (26%), Positives = 61/131 (46%), Gaps = 20/131 (15%)
Query: 682 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 741
+A + L + ++HRD+ + N+L+ VK+ DF A L +
Sbjct: 118 IAKGMNYLEERRLVHRDLAARNVLVK-------TPQHVKITDFGLAKLLGADEKEYHAEG 170
Query: 742 RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSEL 800
+P +WMA E + +H+ +Y + D+WSYG + EL+T PY G+
Sbjct: 171 GKVPI--------KWMALESI--LHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 218
Query: 801 EIHDLIQMGKR 811
EI +++ G+R
Sbjct: 219 EISSILEKGER 229
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 46/217 (21%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYIEK 661
E +++ L H +V++YG +S I + E+++ G + +Y+
Sbjct: 49 EAQVMMKLSHPKLVQLYGVCTE----------------RSPICLVFEFMEHGCLSDYLR- 91
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
++ G+ S + L + DV + L S +++HRD+ + N L+ + VVK+
Sbjct: 92 -AQRGK--FSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ-------VVKV 141
Query: 722 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781
DF R L + G P +W +PEV + Y + D+WS+G
Sbjct: 142 SDFGMT---RFVLDDQYTSSTGTKFP------VKWSSPEVF----SFSKYSSKSDVWSFG 188
Query: 782 CLLLELLTL-QVPYMGLSELEIHDLIQMGKR---PRL 814
L+ E+ + + PY S E+ + I G R PRL
Sbjct: 189 VLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRL 225
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 37/137 (27%), Positives = 67/137 (48%), Gaps = 28/137 (20%)
Query: 676 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 735
+ I +AA + L S H++H+D+ + N+L+ K VK+ D + + +
Sbjct: 127 VHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF-------DKLNVKISDLGLFREVYAADY 179
Query: 736 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLT--L 790
+ + +P RWM+PE + +YG ++ DIWSYG +L E+ + L
Sbjct: 180 YKLMGNSLLPI--------RWMSPEAI-------MYGKFSIDSDIWSYGVVLWEVFSYGL 224
Query: 791 QVPYMGLSELEIHDLIQ 807
Q PY G S ++ ++I+
Sbjct: 225 Q-PYCGYSNQDVIEMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 50/215 (23%), Positives = 97/215 (45%), Gaps = 50/215 (23%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
EV +L L+H+ IV ++ + K L + EY+ +K Y++
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSL--------------TLVFEYLDK-DLKQYMDDCG 98
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
H +VK+ L+ + L H + ++HRD+K +N+LI+ ER + +KL D
Sbjct: 99 NIMSMH-NVKIFLY---QILRGLAYCHRRKVLHRDLKPQNLLIN-ERGE------LKLAD 147
Query: 724 FD----RAVPLRSFLH-TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 778
F ++VP +++ + + +R PDV +G+ Y ++D+W
Sbjct: 148 FGLARAKSVPTKTYSNEVVTLWYR---PPDVLLGSSE---------------YSTQIDMW 189
Query: 779 SYGCLLLELLTLQVPYMGLS-ELEIHDLIQMGKRP 812
GC+ E+ + + + G + E E+H + ++ P
Sbjct: 190 GVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTP 224
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 65/309 (21%), Positives = 118/309 (38%), Gaps = 75/309 (24%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+ L+ +S + +F EV++L L I + G L
Sbjct: 51 VKVLR-PDASDNAREDFL----KEVKILSRLSDPNIARLLGVCTVDPPL----------- 94
Query: 641 LQSAIFMEYVKGGSVKNYIEK------LSETGEKHVSVKLALFIAQDVAAALVELHSKHI 694
+ MEY++ G + +++K K +S L++A +A+ + L S +
Sbjct: 95 ---CMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNF 151
Query: 695 MHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVG 752
+HRD+ + N L+ +K+ DF R + + + R P P
Sbjct: 152 VHRDLATRNCLVGKNYT-------IKIADFGMSRNLYSSDY---YRVQGRA-PLP----- 195
Query: 753 TPRWMAPE-VLRAMHKPNLYGLEVDIWSYGCLLLELLTL--QVPYMGLSELEIHDLIQ-M 808
RWMA E VL + K + + D+W++G L E+LTL + PY L +I+
Sbjct: 196 -IRWMAWESVL--LGK---FTTKSDVWAFGVTLWEILTLCREQPY---EHLTDQQVIENA 246
Query: 809 GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868
G R L +P + + ++ C + +RPT
Sbjct: 247 GHFFRDDGRQIYLP---------------RPPNCPKD---IYELMLECWRRDEEDRPTFR 288
Query: 869 DLYEMFVAR 877
+++ +F+ R
Sbjct: 289 EIH-LFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 8e-05
Identities = 37/146 (25%), Positives = 64/146 (43%), Gaps = 20/146 (13%)
Query: 667 EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDR 726
+ ++ +L L +A ++ L + ++HRD+ + N+L+ VK+ DF
Sbjct: 103 KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH-------VKITDFGL 155
Query: 727 AVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786
A L +P +WMA E + + + D+WSYG + E
Sbjct: 156 ARLLEGDEKEYNADGGKMPI--------KWMALECIHYRK----FTHQSDVWSYGVTIWE 203
Query: 787 LLTL-QVPYMGLSELEIHDLIQMGKR 811
L+T PY G+ EI DL++ G+R
Sbjct: 204 LMTFGGKPYDGIPTREIPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 50/215 (23%), Positives = 98/215 (45%), Gaps = 50/215 (23%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
EV +L L+H+ IV ++ + K L + EY+ +K Y++
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSL--------------TLVFEYLDK-DLKQYLDDCG 98
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
+ H +VKL LF + L H + ++HRD+K +N+LI+ ER + +KL D
Sbjct: 99 NSINMH-NVKLFLF---QLLRGLNYCHRRKVLHRDLKPQNLLIN-ERGE------LKLAD 147
Query: 724 FD----RAVPLRSFLH-TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 778
F +++P +++ + + +R PD+ +G+ Y ++D+W
Sbjct: 148 FGLARAKSIPTKTYSNEVVTLWYR---PPDILLGSTD---------------YSTQIDMW 189
Query: 779 SYGCLLLELLTLQVPYMGLS-ELEIHDLIQMGKRP 812
GC+ E+ T + + G + E ++H + ++ P
Sbjct: 190 GVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTP 224
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 35/133 (26%), Positives = 60/133 (45%), Gaps = 20/133 (15%)
Query: 676 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 735
L IA +AA + L S +H+D+ + NILI + VK+ D + + S +
Sbjct: 127 LHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH-------VKISDLGLSREIYSADY 179
Query: 736 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PY 794
+P RWM PE + + + DIWS+G +L E+ + + PY
Sbjct: 180 YRVQPKSLLPI--------RWMPPEAIMY----GKFSSDSDIWSFGVVLWEIFSFGLQPY 227
Query: 795 MGLSELEIHDLIQ 807
G S E+ ++++
Sbjct: 228 YGFSNQEVIEMVR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 40/133 (30%), Positives = 58/133 (43%), Gaps = 32/133 (24%)
Query: 674 LALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPV-----------VKL 721
LA I Q AL H++ H+MH D+K ENIL++ D PV V++
Sbjct: 233 LAQIIFQ-TGVALDYFHTELHLMHTDLKPENILMETSDTVVD--PVTNRALPPDPCRVRI 289
Query: 722 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781
CD L CC A V T + +PEV+ + + D+WS G
Sbjct: 290 CD----------LGGCCDERHSRTA---IVSTRHYRSPEVVLGLG----WMYSTDMWSMG 332
Query: 782 CLLLELLTLQVPY 794
C++ EL T ++ Y
Sbjct: 333 CIIYELYTGKLLY 345
|
Length = 467 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 32/88 (36%), Positives = 45/88 (51%), Gaps = 16/88 (18%)
Query: 641 LQSA----IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 696
LQSA + MEY+ GG VK+ + E+ +A+ +VA AL LH I+H
Sbjct: 73 LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEE-----MAVKYISEVALALDYLHRHGIIH 127
Query: 697 RDIKSENILIDLERKKADGKPVVKLCDF 724
RD+K +N+LI E +KL DF
Sbjct: 128 RDLKPDNMLISNEGH-------IKLTDF 148
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 60/202 (29%), Positives = 88/202 (43%), Gaps = 39/202 (19%)
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA-VPLRSFLHTCCIAHRGIPAP 747
LHS I+HRD+K NI++ K+D +K+ DF A SF+ T P
Sbjct: 142 LHSAGIIHRDLKPSNIVV-----KSDC--TLKILDFGLARTAGTSFMMT----------P 184
Query: 748 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI- 806
V T + APEV+ M Y VDIWS GC++ E++ V + G ++ + +
Sbjct: 185 YVV--TRYYRAPEVILGMG----YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238
Query: 807 -QMGKR-PRLTDELEALGSCH-EHEVAQSGSGFEKPEAELETLSFLVDV-FRRCTEENPT 862
Q+G P +L+ + E+ +G FEK DV F +E N
Sbjct: 239 EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEK---------LFPDVLFPADSEHNKL 289
Query: 863 ERPTAGDLY-EMFVARTSSSIS 883
+ A DL +M V S IS
Sbjct: 290 KASQARDLLSKMLVIDASKRIS 311
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 55/243 (22%), Positives = 105/243 (43%), Gaps = 46/243 (18%)
Query: 573 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 632
G + ++TLK G + + R+F L E ++G H I+ + G + +K P
Sbjct: 29 GKREIFVAIKTLKS-GYTEKQRRDF----LSEASIMGQFDHPNIIHLEG--VVTKSRPVM 81
Query: 633 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 692
I E+++ G++ +++ + + +V + + + +AA + L
Sbjct: 82 ------------IITEFMENGALDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLSEM 125
Query: 693 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 752
+ +HRD+ + NIL+ + V K+ DF L FL P +G
Sbjct: 126 NYVHRDLAARNILV-------NSNLVCKVSDFG----LSRFLED----DTSDPTYTSSLG 170
Query: 753 TP---RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQM 808
RW APE + A K + D+WSYG ++ E+++ + PY +S ++ + I+
Sbjct: 171 GKIPIRWTAPEAI-AYRK---FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ 226
Query: 809 GKR 811
R
Sbjct: 227 DYR 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 34/109 (31%), Positives = 52/109 (47%), Gaps = 24/109 (22%)
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA-VPLRSFLHTCCIAHRGIPAP 747
LHS I+HRD+K NI++ K+D +K+ DF A SF+ T + R AP
Sbjct: 135 LHSAGIIHRDLKPSNIVV-----KSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 748 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 796
+V +G Y VDIWS GC++ E++ ++ + G
Sbjct: 188 EVILGMG----------------YKENVDIWSVGCIMGEMVRHKILFPG 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 57/256 (22%), Positives = 107/256 (41%), Gaps = 48/256 (18%)
Query: 548 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRM 607
G S ++ G+ +++++ G + K+ LKV +E ++ + E +
Sbjct: 2 GKADSYEKLEKLGEGSYATVYK---GKSKVNGKLVALKVIRLQEEE--GTPFTAIREASL 56
Query: 608 LGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE 667
L L+H+ IV + H I H + EYV + Y++K G
Sbjct: 57 LKGLKHANIVLL--HDII------------HTKETLTLVFEYVHT-DLCQYMDK-HPGGL 100
Query: 668 KHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFD-- 725
+VKL LF + L +H ++I+HRD+K +N+LI + +KL DF
Sbjct: 101 HPENVKLFLF---QLLRGLSYIHQRYILHRDLKPQNLLISDTGE-------LKLADFGLA 150
Query: 726 RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785
RA + S ++ + PDV +G+ Y +D+W GC+ +
Sbjct: 151 RAKSVPSHTYSNEVVTLWYRPPDVLLGSTE---------------YSTCLDMWGVGCIFV 195
Query: 786 ELLTLQVPYMGLSELE 801
E++ + G+ +++
Sbjct: 196 EMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 35/140 (25%), Positives = 65/140 (46%), Gaps = 21/140 (15%)
Query: 648 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707
E+V+ G + ++ + S+ ++ +A+ +A+AL L K ++H ++ ++NIL+
Sbjct: 84 EFVEFGPLDLFMHRKSDV----LTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLA 139
Query: 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 767
E + P +KL D +P+ C+ IP W+APE +
Sbjct: 140 REGIDGECGPFIKLS--DPGIPITVLSRQECVER--IP----------WIAPECVE--DS 183
Query: 768 PNLYGLEVDIWSYGCLLLEL 787
NL + D WS+G L E+
Sbjct: 184 KNL-SIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 36/112 (32%), Positives = 52/112 (46%), Gaps = 20/112 (17%)
Query: 678 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 737
I + + A+ +H K ++HRDIK ENI ++ DGK V L DF A+P
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLN-----CDGKIV--LGDFGTAMPFEK----- 319
Query: 738 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789
VGT +PE+L + Y DIWS G +LL++L+
Sbjct: 320 ----EREAFDYGWVGTVATNSPEILAG----DGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 57/197 (28%), Positives = 86/197 (43%), Gaps = 37/197 (18%)
Query: 648 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707
E+V+ G + + K E G V V + +AQ +A+AL L K+++H ++ ++NIL
Sbjct: 96 EFVEHGPLDVCLRK--EKG--RVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNIL-- 149
Query: 708 LERKK-ADG-KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 765
L R A+G P +KL D P SF + + V W+APE +
Sbjct: 150 LARLGLAEGTSPFIKLSD-----PGVSF---------TALSREERVERIPWIAPECV--- 192
Query: 766 HKPNLYGLE--VDIWSYGCLLLEL-LTLQVPYMGLSELEIHDLIQMGKRPRLTD----EL 818
P L D WS+G LLE+ +VP + E + K+ RL + EL
Sbjct: 193 --PGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE--KKHRLPEPSCKEL 248
Query: 819 EAL-GSCHEHEVAQSGS 834
L C +E Q S
Sbjct: 249 ATLISQCLTYEPTQRPS 265
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 65/265 (24%), Positives = 95/265 (35%), Gaps = 74/265 (27%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
+ ME++ GG + + K E+ +IA+ V A + +H +HRDIK +N+
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLTEEETQ----FYIAETVLA-IDSIHQLGFIHRDIKPDNL 132
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR---------GIPAPDV------ 749
L+ D K VKL DF L+ AHR +P+
Sbjct: 133 LL-------DSKGHVKLSDFGLCTGLKK-------AHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 750 -----------------CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 792
VGTP ++APEV Y D WS G ++ E+L
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ----TGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 793 PYMGLSELEIHDLIQMGKRPRLTDELEA----------LGSCHEHEVAQSGSGFEKPEAE 842
P+ + E + + M + L E L C E E G E E
Sbjct: 235 PFCSETPQETYKKV-MNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVE----E 289
Query: 843 LETLSFLVDVFRRCTEENPTERPTA 867
++T F F E+ ERP A
Sbjct: 290 IKTNPF----FEGVDWEHIRERPAA 310
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 39/132 (29%), Positives = 62/132 (46%), Gaps = 22/132 (16%)
Query: 682 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 741
+A + L ++HRD+ + N+L+ VK+ DF A L T A
Sbjct: 118 IAKGMSYLEEVRLVHRDLAARNVLVKSPNH-------VKITDFGLA-RLLDIDETEYHAD 169
Query: 742 RG-IPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSE 799
G +P +WMA E + +H+ + + D+WSYG + EL+T PY G+
Sbjct: 170 GGKVPI--------KWMALESI--LHRR--FTHQSDVWSYGVTVWELMTFGAKPYDGIPA 217
Query: 800 LEIHDLIQMGKR 811
EI DL++ G+R
Sbjct: 218 REIPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 41/116 (35%), Positives = 49/116 (42%), Gaps = 20/116 (17%)
Query: 676 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 735
L I + V A+ LH I+HRDIK+ENI I+ D V L DF A
Sbjct: 185 LAIERSVLRAIQYLHENRIIHRDIKAENIFIN---HPGD----VCLGDFGAA-------- 229
Query: 736 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 791
C GT APE+L P YG VDIWS G +L E+ T
Sbjct: 230 -CFPVDINANKYYGWAGTIATNAPELL--ARDP--YGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 36/127 (28%), Positives = 57/127 (44%), Gaps = 27/127 (21%)
Query: 677 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 736
F+ + L +H+ I+HRD+K N+ ++ + + +K+ DF A S +
Sbjct: 122 FLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE-------LKILDFGLARQTDSEMTG 174
Query: 737 CCIAHRGIPAPDVCVGTPRWM-APEV-LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 794
+ RW APEV L MH Y VDIWS GC++ E+LT + +
Sbjct: 175 YVVT--------------RWYRAPEVILNWMH----YTQTVDIWSVGCIMAEMLTGKPLF 216
Query: 795 MGLSELE 801
G L+
Sbjct: 217 KGHDHLD 223
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 8e-04
Identities = 35/110 (31%), Positives = 50/110 (45%), Gaps = 27/110 (24%)
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 748
+HS I+HRD+K N+ ++ + + +K+ DF A R A
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCE-------LKILDFGLA--------------RHADAEM 171
Query: 749 VCVGTPRWM-APEV-LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 796
RW APEV L MH Y VDIWS GC++ E+LT + + G
Sbjct: 172 TGYVVTRWYRAPEVILNWMH----YNQTVDIWSVGCIMAEMLTGKTLFKG 217
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 64/255 (25%), Positives = 95/255 (37%), Gaps = 66/255 (25%)
Query: 583 TLKVCGSSA-DEIRNFEYSCLGEVRMLGALRHSCIVE--MYGH-KISSKWLPSADGNPEH 638
+LKV G A E+R + G + + LR + ++E H + L ADG
Sbjct: 5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVV 64
Query: 639 HLLQS-------AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS 691
+ S + ME++ GG + + K E+ +IA+ V A + +H
Sbjct: 65 KMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQ----FYIAETVLA-IDAIHQ 119
Query: 692 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI------- 744
+HRDIK +N+L+ D K VKL DF L+ AHR
Sbjct: 120 LGFIHRDIKPDNLLL-------DAKGHVKLSDFGLCTGLKK-------AHRTEFYRNLTH 165
Query: 745 -PAPDV------------------------CVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 779
P D VGTP ++APEV Y D WS
Sbjct: 166 NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG----YNKLCDWWS 221
Query: 780 YGCLLLELLTLQVPY 794
G ++ E+L P+
Sbjct: 222 LGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 39/144 (27%), Positives = 65/144 (45%), Gaps = 28/144 (19%)
Query: 653 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 712
G+ N I K + ++HV F+ + L +HS I+HRD+K N+ ++ + +
Sbjct: 103 GADLNNIVKCQKLSDEHVQ-----FLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE- 156
Query: 713 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 772
+++ DF A + T +A R AP++ +L MH Y
Sbjct: 157 ------LRILDFGLARQADDEM-TGYVATRWYRAPEI-----------MLNWMH----YN 194
Query: 773 LEVDIWSYGCLLLELLTLQVPYMG 796
VDIWS GC++ ELL + + G
Sbjct: 195 QTVDIWSVGCIMAELLKGKALFPG 218
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 13/101 (12%)
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 748
LH+ ++HRD+K NIL+ E + + VK+ D A S L + + D
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPE---RGRVKIADMGFARLFNSPL-------KPLADLD 173
Query: 749 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789
V T + APE+L Y +DIW+ GC+ ELLT
Sbjct: 174 PVVVTFWYRAPELLLGARH---YTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 13/101 (12%)
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 748
LH+ ++HRD+K NIL+ E + + VK+ D A S L + + D
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPE---RGRVKIADMGFARLFNSPL-------KPLADLD 173
Query: 749 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789
V T + APE+L Y +DIW+ GC+ ELLT
Sbjct: 174 PVVVTFWYRAPELLLGARH---YTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 47/181 (25%), Positives = 67/181 (37%), Gaps = 53/181 (29%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
+ ME++ GG + + K E + F + A+ +H +HRDIK +NI
Sbjct: 78 LIMEFLPGGDLMTMLIKYDTFSED-----VTRFYMAECVLAIEAVHKLGFIHRDIKPDNI 132
Query: 705 LIDLERKKADGKPVVKLCDF----------DRAV---PLRSFLHTCCIAHRGIPAPDV-- 749
LID G +KL DF D A L+ + I +R A D
Sbjct: 133 LID-----RGGH--IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSIN 185
Query: 750 ----------------------CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787
VGTP ++APE+ YG E D WS G ++ E
Sbjct: 186 LTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG----YGQECDWWSLGAIMFEC 241
Query: 788 L 788
L
Sbjct: 242 L 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 48/210 (22%), Positives = 93/210 (44%), Gaps = 49/210 (23%)
Query: 608 LGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE 667
+G+L H+ IV + G P A LQ + + GS+ +++ + ++
Sbjct: 63 MGSLDHAYIVRLLG------ICPGAS-------LQ--LVTQLSPLGSLLDHVRQHRDS-- 105
Query: 668 KHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA 727
+ + L +A + L ++HR++ + NIL+ K+D +V++ DF A
Sbjct: 106 --LDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL-----KSDS--IVQIADFGVA 156
Query: 728 VPL----RSFLHTCCIAHRGIPAPDVCVGTP-RWMAPEVLRAMHKPNLYGLEVDIWSYGC 782
L + + ++ TP +WMA L ++ Y + D+WSYG
Sbjct: 157 DLLYPDDKKYFYSE-------------HKTPIKWMA---LESILFGR-YTHQSDVWSYGV 199
Query: 783 LLLELLTLQV-PYMGLSELEIHDLIQMGKR 811
+ E+++ PY G+ E+ DL++ G+R
Sbjct: 200 TVWEMMSYGAEPYAGMRPHEVPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 41/208 (19%), Positives = 87/208 (41%), Gaps = 40/208 (19%)
Query: 601 CLGEVRMLGALRHSCIVEMYGHKIS-SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 659
E++ L + + I+++YG I LP ++ +EY G ++ +
Sbjct: 65 TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRL-----------SLILEYCTRGYLREVL 113
Query: 660 EKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPV 718
+K EK +S K L +A D L L+ + ++++ S + L+ + K
Sbjct: 114 DK-----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT-----ENYKLK 163
Query: 719 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 778
+ ++ + F + + + + ++L + Y ++ DI+
Sbjct: 164 IICHGLEKILSSPPFKNVNFMVYF---------------SYKMLNDIFSE--YTIKDDIY 206
Query: 779 SYGCLLLELLTLQVPYMGLSELEIHDLI 806
S G +L E+ T ++P+ L+ EI+DLI
Sbjct: 207 SLGVVLWEIFTGKIPFENLTTKEIYDLI 234
|
Length = 283 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.004
Identities = 26/84 (30%), Positives = 35/84 (41%), Gaps = 17/84 (20%)
Query: 678 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 737
I + + AL LHS I+HRD+K +NI+ K+ D A LR
Sbjct: 260 IMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGS------FKIIDLGAAADLRV----- 308
Query: 738 CIAHRGIP-APDVCVGTPRWMAPE 760
GI P + PR+ APE
Sbjct: 309 -----GINYIPKEFLLDPRYAAPE 327
|
Length = 566 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 886 | |||
| PF14381 | 204 | EDR1: Ethylene-responsive protein kinase Le-CTR1 | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.63 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.63 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.53 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.5 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.48 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.24 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.23 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.22 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.21 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.2 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.15 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.14 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.1 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.88 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.85 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.85 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.84 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.78 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.65 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.64 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.48 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.39 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.37 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.34 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.29 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.09 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.93 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.84 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.79 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.77 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.75 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.74 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.71 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.67 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.53 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.44 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.24 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.18 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.03 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.01 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.85 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.84 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.83 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.71 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.65 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.65 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.45 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.3 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.2 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 95.95 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.8 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.59 | |
| smart00460 | 68 | TGc Transglutaminase/protease-like homologues. Tra | 95.07 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.81 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.66 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.55 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.54 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.24 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.08 | |
| PLN02236 | 344 | choline kinase | 93.63 | |
| PF01841 | 113 | Transglut_core: Transglutaminase-like superfamily; | 93.53 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 92.33 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 89.92 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 88.89 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 88.49 | |
| COG5279 | 521 | CYK3 Uncharacterized protein involved in cytokines | 87.89 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 87.85 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 87.45 |
| >PF14381 EDR1: Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=416.05 Aligned_cols=189 Identities=35% Similarity=0.516 Sum_probs=162.8
Q ss_pred CcccccccccccccccCCCCCCCCccccCCCCC----------CCcccccccc-CCCCCcceEEEEcCCCCHHHHHHHHH
Q 002738 262 GENSNASQKYSSVSFCSIEDRLPDGFYDAGRDR----------PFMQLTGYEQ-TPHLDSREVILVDRKSDEELDAIALS 330 (886)
Q Consensus 262 ~~~~~~s~r~~~~~~~~~~d~~~dgfyd~~~~~----------~~~~l~~~~~-~~~~~~~evilvdr~~d~~l~~~~~~ 330 (886)
++++.+|||||++|||+|+|||||||||++++. .+++|++|+. ++...++|||||||.+|++|++|++.
T Consensus 1 ~~~e~lS~r~W~~~~L~y~dki~DGFYdi~g~~~~~~l~~~~~~~Psl~~L~~~~~~~~~~EvIlVDr~~D~~L~~L~~~ 80 (204)
T PF14381_consen 1 SSAESLSHRYWVNGCLSYDDKIPDGFYDIYGMDCTNSLKEEFGRMPSLEDLQAVPPDDSSREVILVDRRRDPSLKELEQR 80 (204)
T ss_pred CcHHHHHHHHHHcCCCCCCCcCCCCCcccccCCCccccccccCCCCCHHHHhcCCCCCCCeeEEEEccccCHHHHHHHHH
Confidence 367999999999999999999999999999872 3557999994 46789999999999999999999999
Q ss_pred HHHHHHHhhhccCcccCCccCccchHHHHHHHHHHHHhhcCCCCcccccccccccccCCCCCCCceeccCCCCCCCcccc
Q 002738 331 AQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTS 410 (886)
Q Consensus 331 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~la~~v~~~mgg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (886)
|+.++..+. .+..+++.+||+|||++|||++..+
T Consensus 81 a~~~~~~~~-------------~~~~~~v~~LA~lVa~~MGG~~~~~--------------------------------- 114 (204)
T PF14381_consen 81 AHELSKGLS-------------TNTKELVQKLAKLVADRMGGPVSDA--------------------------------- 114 (204)
T ss_pred HHHHHhccc-------------cCHHHHHHHHHHHHHHHhCCCCCcc---------------------------------
Confidence 999996541 1345699999999999999998433
Q ss_pred hhhhhcccchhhhhhHHHHHHHHHHhhcCceEEeccccchhhHHHHHHHHHHhhhccCCCccccccccccccCC-CCcce
Q 002738 411 QKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQP-HAWNT 489 (886)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~v~piG~l~~g~crhralLfK~lad~~~~~~pc~lvrG~~~c~~-~a~~s 489 (886)
+ .....|+..++.||+ +++++|||+|++|+|||||||||||||+|+ ||||||||+|||+. +..+.
T Consensus 115 ---------~-~~~~~w~~~s~~lk~--~s~~vplG~l~~G~~rhRALLFKvLAD~ig--lpCrLvrG~~y~g~~~~~a~ 180 (204)
T PF14381_consen 115 ---------E-DMLFRWELRSEKLKE--NSGVVPLGSLRIGLCRHRALLFKVLADRIG--LPCRLVRGCYYCGWDDDDAS 180 (204)
T ss_pred ---------h-hhhHHHHHHHHHHHh--CCCeEEEeeecccchHHHHHHHHHHHHhcC--CCceEEeeccCCccCCCCce
Confidence 1 133489998888888 899999999999999999999999999999 99999999999987 55567
Q ss_pred eEEEeCCceEEEEeccc-CCCCc
Q 002738 490 ILVKKGDSWIRMIVDAC-RPHDI 511 (886)
Q Consensus 490 ~~v~~G~~~~~~lvd~~-~p~~~ 511 (886)
+.|+.++.+ +|+||.+ .||.+
T Consensus 181 ~~V~~~~~~-eyiVDLm~~PG~L 202 (204)
T PF14381_consen 181 NLVKFDDGR-EYIVDLMGAPGQL 202 (204)
T ss_pred EEEEcCCCc-EEEEEcCCCCCCc
Confidence 888888865 8999997 56654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=408.70 Aligned_cols=268 Identities=29% Similarity=0.445 Sum_probs=223.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCee-EEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFGSAD-AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~~~~-VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
+.+..+.+.+.||.|+||+||+|.|.+.. ||||++... ....... ..|.+|+.+|.+|+|||||+|+|++...
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~--~~~~~~~----~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDP--DFDDESR----KAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecch--hcChHHH----HHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 56677778888999999999999999998 999996433 2222223 3459999999999999999999999865
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCCEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENIL 705 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~g-IVHRDLKPsNIL 705 (886)
.. .++|||||+++|+|.+++... ....+++..++.|+.|||+||.|||+++ ||||||||+|||
T Consensus 112 ~~-------------~~~iVtEy~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiL 175 (362)
T KOG0192|consen 112 PG-------------SLCIVTEYMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNIL 175 (362)
T ss_pred CC-------------ceEEEEEeCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEE
Confidence 41 369999999999999999862 3467999999999999999999999999 999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
|+.+. .++||+|||+++....... ..+...||+.|||||++.+. ...|+.|+||||||++||
T Consensus 176 v~~~~------~~~KI~DFGlsr~~~~~~~----------~~~~~~GT~~wMAPEv~~~~--~~~~~~K~DvySFgIvlW 237 (362)
T KOG0192|consen 176 VDLKG------KTLKIADFGLSREKVISKT----------SMTSVAGTYRWMAPEVLRGE--KSPYTEKSDVYSFGIVLW 237 (362)
T ss_pred EcCCC------CEEEECCCccceeeccccc----------cccCCCCCccccChhhhcCC--CCcCCccchhhhHHHHHH
Confidence 99872 2799999999987654221 11225799999999999952 367999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHH-cCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 864 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~-~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kR 864 (886)
||+||+.||.+..+.++...+. ++.+|.++.. +++.+..|+.+||..||.+|
T Consensus 238 El~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~---------------------------~~~~l~~l~~~CW~~dp~~R 290 (362)
T KOG0192|consen 238 ELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKE---------------------------CPPHLSSLMERCWLVDPSRR 290 (362)
T ss_pred HHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCcc---------------------------CCHHHHHHHHHhCCCCCCcC
Confidence 9999999999999888777775 5577766632 34579999999999999999
Q ss_pred CCHHHHHHHHHhhcCCCC
Q 002738 865 PTAGDLYEMFVARTSSSI 882 (886)
Q Consensus 865 PSA~EILehLe~l~sss~ 882 (886)
|++.+|+..|+.+.....
T Consensus 291 P~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 291 PSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CCHHHHHHHHHHHHHhhc
Confidence 999999999998765433
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=402.33 Aligned_cols=270 Identities=23% Similarity=0.276 Sum_probs=220.1
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
..+.|.+.+.||+|+||.|-+|.. .+..||+|++.............. ...+.+|+++|++|+|||||+++++|..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~-~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAK-TRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccc-hhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 345578899999999999999986 678999999765443322111111 11357999999999999999999999987
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
+. .||||||++||.|.+++-. .+.+.+..-+.+++||+.|+.|||++||+||||||+|||+
T Consensus 249 ds--------------~YmVlE~v~GGeLfd~vv~-----nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl 309 (475)
T KOG0615|consen 249 DS--------------SYMVLEYVEGGELFDKVVA-----NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILL 309 (475)
T ss_pred Cc--------------eEEEEEEecCccHHHHHHh-----ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEe
Confidence 75 4999999999999999976 4678888889999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
..+. ....+||+|||+|+....... ..+.+|||.|.|||++.+.. ...+..++||||+||+||-
T Consensus 310 ~~~~----e~~llKItDFGlAK~~g~~sf-----------m~TlCGTpsYvAPEVl~~kg-~~~~~~kVDiWSlGcvLfv 373 (475)
T KOG0615|consen 310 SNDA----EDCLLKITDFGLAKVSGEGSF-----------MKTLCGTPSYVAPEVLASKG-VEYYPSKVDIWSLGCVLFV 373 (475)
T ss_pred ccCC----cceEEEecccchhhcccccee-----------hhhhcCCccccChhheecCC-eecccchheeeeccceEEE
Confidence 8763 347899999999998764322 35668999999999998622 1234469999999999999
Q ss_pred HHhCCCCCCCCCHHH-HHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 787 LLTLQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 787 LLTG~~PF~g~s~~e-l~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
+++|.+||.+..... +.++|.++.....+..| ..++++..+||.+||..||++||
T Consensus 374 cLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w------------------------~~Iseea~dlI~~mL~VdP~~R~ 429 (475)
T KOG0615|consen 374 CLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW------------------------DRISEEALDLINWMLVVDPENRP 429 (475)
T ss_pred EeccCCCcccccCCccHHHHHhcCcccccChhh------------------------hhhhHHHHHHHHHhhEeCcccCc
Confidence 999999997765444 88899988766554333 34577899999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 002738 866 TAGDLYEMFVART 878 (886)
Q Consensus 866 SA~EILehLe~l~ 878 (886)
|++|+|+|-+-..
T Consensus 430 s~~eaL~hpW~~~ 442 (475)
T KOG0615|consen 430 SADEALNHPWFKD 442 (475)
T ss_pred CHHHHhcChhhhc
Confidence 9999999977543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=384.06 Aligned_cols=264 Identities=27% Similarity=0.427 Sum_probs=221.9
Q ss_pred CCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEe
Q 002738 547 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 624 (886)
Q Consensus 547 ~~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~ 624 (886)
..++.+|++.++||+|+||.||++.. .+..+|.|-+... ...... ++.+..|+.+|++|+|||||+++++-.
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~--~md~k~----rq~~v~Ei~lLkQL~HpNIVqYy~~~f 88 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG--MMDAKA----RQDCVKEISLLKQLNHPNIVQYYAHSF 88 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh--hccHHH----HHHHHHHHHHHHhcCCchHHHHHHHhh
Confidence 36788999999999999999999986 6667777764322 223333 344599999999999999999999544
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHh--CC--ccccCCC
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS--KH--IMHRDIK 700 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs--~g--IVHRDLK 700 (886)
.++. ..++||||||.+|+|.+.|+.+.+. ...+++.++|+++.|++.||.++|. .. |+|||||
T Consensus 89 ~~~~------------evlnivmE~c~~GDLsqmIk~~K~q-kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIK 155 (375)
T KOG0591|consen 89 IEDN------------EVLNIVMELCDAGDLSQMIKHFKKQ-KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIK 155 (375)
T ss_pred hccc------------hhhHHHHHhhcccCHHHHHHHHHhc-cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCc
Confidence 3321 1379999999999999999976554 4789999999999999999999999 44 9999999
Q ss_pred CCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHH
Q 002738 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 780 (886)
Q Consensus 701 PsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSL 780 (886)
|.||+|+.+ +.|||+|||+++.+..... .....+|||.||+||.+.+ ..|++||||||+
T Consensus 156 PaNIFl~~~-------gvvKLGDfGL~r~l~s~~t----------fA~S~VGTPyYMSPE~i~~----~~Y~~kSDiWsl 214 (375)
T KOG0591|consen 156 PANIFLTAN-------GVVKLGDFGLGRFLSSKTT----------FAHSLVGTPYYMSPERIHE----SGYNFKSDIWSL 214 (375)
T ss_pred chheEEcCC-------CceeeccchhHhHhcchhH----------HHHhhcCCCcccCHHHHhc----CCCCcchhHHHH
Confidence 999999987 5799999999998865332 2356799999999999997 889999999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 002738 781 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 860 (886)
Q Consensus 781 GVILyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~D 860 (886)
||++|||+.-++||.+.+-.++...|.++..|++|+.. .+..+..||..|+..|
T Consensus 215 GCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~--------------------------YS~~l~~li~~ci~vd 268 (375)
T KOG0591|consen 215 GCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEH--------------------------YSTDLRELINMCIAVD 268 (375)
T ss_pred HHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHH--------------------------hhhHHHHHHHHHccCC
Confidence 99999999999999999999999999999888887543 3668999999999999
Q ss_pred CCCCCCHHHHHHHHHh
Q 002738 861 PTERPTAGDLYEMFVA 876 (886)
Q Consensus 861 P~kRPSA~EILehLe~ 876 (886)
|..||+.-.++..+..
T Consensus 269 ~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 269 PEQRPDTVPYVQDIQS 284 (375)
T ss_pred cccCCCcchHHHHHHH
Confidence 9999997666666554
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=406.15 Aligned_cols=257 Identities=26% Similarity=0.370 Sum_probs=220.7
Q ss_pred CCCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeE
Q 002738 546 DPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 623 (886)
Q Consensus 546 ~~~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~ 623 (886)
|+.. .+|...+.||+|||+.+|.+++ .+..||+|++..+...... . .+++.+||+|.+.|+|||||+++++|
T Consensus 14 D~~~-~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~-~----reKv~~EIeIHr~L~HpnIV~f~~~F 87 (592)
T KOG0575|consen 14 DPRS-KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPK-Q----REKVLNEIEIHRSLKHPNIVQFYHFF 87 (592)
T ss_pred cCCc-ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcc-h----HHHHHHHHHHHHhcCCCcEEeeeeEe
Confidence 3445 6799999999999999999997 7889999998654333222 2 23458999999999999999999999
Q ss_pred ecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 002738 624 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703 (886)
Q Consensus 624 ~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsN 703 (886)
++.++ +|||+|+|+.++|..+++. .+.+++.+++.+++||+.||.|||+++|||||||..|
T Consensus 88 EDs~n--------------VYivLELC~~~sL~el~Kr-----rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGN 148 (592)
T KOG0575|consen 88 EDSNN--------------VYIVLELCHRGSLMELLKR-----RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGN 148 (592)
T ss_pred ecCCc--------------eEEEEEecCCccHHHHHHh-----cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhh
Confidence 98875 6999999999999999986 5789999999999999999999999999999999999
Q ss_pred EEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 002738 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783 (886)
Q Consensus 704 ILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVI 783 (886)
|||+.+ +.|||+|||+|..+..... ...+.+|||.|.|||++.. ...+..+||||+|||
T Consensus 149 lfL~~~-------~~VKIgDFGLAt~le~~~E----------rk~TlCGTPNYIAPEVl~k----~gHsfEvDiWSlGcv 207 (592)
T KOG0575|consen 149 LFLNEN-------MNVKIGDFGLATQLEYDGE----------RKKTLCGTPNYIAPEVLNK----SGHSFEVDIWSLGCV 207 (592)
T ss_pred eeecCc-------CcEEecccceeeeecCccc----------ccceecCCCcccChhHhcc----CCCCCchhhhhhhhH
Confidence 999988 5699999999988764322 1345679999999999985 678999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 784 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 784 LyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
||-|++|++||...+..+.+..|...... +| ...+.+.++||.+||+.||.+
T Consensus 208 mYtLL~G~PPFetk~vkety~~Ik~~~Y~-~P---------------------------~~ls~~A~dLI~~lL~~~P~~ 259 (592)
T KOG0575|consen 208 MYTLLVGRPPFETKTVKETYNKIKLNEYS-MP---------------------------SHLSAEAKDLIRKLLRPNPSE 259 (592)
T ss_pred HHhhhhCCCCcccchHHHHHHHHHhcCcc-cc---------------------------cccCHHHHHHHHHHhcCCccc
Confidence 99999999999999999999888776432 11 123557899999999999999
Q ss_pred CCCHHHHHHHHHh
Q 002738 864 RPTAGDLYEMFVA 876 (886)
Q Consensus 864 RPSA~EILehLe~ 876 (886)
|||+++||.|-.-
T Consensus 260 Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 260 RPSLDEVLDHPFF 272 (592)
T ss_pred CCCHHHHhcCHhh
Confidence 9999999998543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=390.72 Aligned_cols=254 Identities=29% Similarity=0.441 Sum_probs=218.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
+...+++..+.||+|..|+||++++ ++.-+|+|++.+.. ... +.+++.+|+++++..+|||||.+||+|..
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~---~~~----~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI---DPA----LQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC---CHH----HHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 5667889999999999999999998 47778888864332 222 33455999999999999999999999997
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENI 704 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs-~gIVHRDLKPsNI 704 (886)
... ..+|+||||++|||+.++.. .+++++...-.|+.+|++||.|||. ++||||||||+||
T Consensus 149 ~~~-------------~isI~mEYMDgGSLd~~~k~-----~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNl 210 (364)
T KOG0581|consen 149 NGE-------------EISICMEYMDGGSLDDILKR-----VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNL 210 (364)
T ss_pred CCc-------------eEEeehhhcCCCCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHe
Confidence 652 36999999999999999986 3679999999999999999999995 8999999999999
Q ss_pred EEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVIL 784 (886)
||+.. +.|||||||.+..+.... ..+++||..|||||.+.+ ..|+.++||||||+++
T Consensus 211 LvNsk-------GeVKicDFGVS~~lvnS~------------a~tfvGT~~YMsPERi~g----~~Ys~~sDIWSLGLsl 267 (364)
T KOG0581|consen 211 LVNSK-------GEVKICDFGVSGILVNSI------------ANTFVGTSAYMSPERISG----ESYSVKSDIWSLGLSL 267 (364)
T ss_pred eeccC-------CCEEeccccccHHhhhhh------------cccccccccccChhhhcC----CcCCcccceecccHHH
Confidence 99988 459999999998776531 256789999999999997 7899999999999999
Q ss_pred HHHHhCCCCCCCC-----CHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 002738 785 LELLTLQVPYMGL-----SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 859 (886)
Q Consensus 785 yELLTG~~PF~g~-----s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~ 859 (886)
+|+++|+.||... ...+++..|..+..|.+|.. .+++++++|+..||++
T Consensus 268 lE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~--------------------------~fS~ef~~FV~~CL~K 321 (364)
T KOG0581|consen 268 LELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG--------------------------EFSPEFRSFVSCCLRK 321 (364)
T ss_pred HHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc--------------------------cCCHHHHHHHHHHhcC
Confidence 9999999999763 67788888888877776632 2367899999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 002738 860 NPTERPTAGDLYEMFV 875 (886)
Q Consensus 860 DP~kRPSA~EILehLe 875 (886)
||.+||++.|+++|-.
T Consensus 322 dp~~R~s~~qLl~Hpf 337 (364)
T KOG0581|consen 322 DPSERPSAKQLLQHPF 337 (364)
T ss_pred CcccCCCHHHHhcCHH
Confidence 9999999999999954
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=388.68 Aligned_cols=221 Identities=28% Similarity=0.454 Sum_probs=190.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
..+++|.+.+.||+|+||+||+|++ .+..||||.+..+.. .....+. +..|+.+|+.|+|||||++++++..
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~----L~~Ei~iLkel~H~nIV~l~d~~~~ 80 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--NKKLVEL----LLSEIKILKELKHPNIVRLLDCIED 80 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc--CHHHHHH----HHHHHHHHHhcCCcceeeEEEEEec
Confidence 5678999999999999999999997 557888888654422 3333344 4899999999999999999999998
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
++. +|||||||.||+|.+||+. .+.+++.+++.++.||+.||++||+++||||||||+|||
T Consensus 81 ~~~--------------i~lVMEyC~gGDLs~yi~~-----~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiL 141 (429)
T KOG0595|consen 81 DDF--------------IYLVMEYCNGGDLSDYIRR-----RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNIL 141 (429)
T ss_pred CCe--------------EEEEEEeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEE
Confidence 774 6999999999999999997 457999999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
|+..... .....+||+|||+|+.+..... ..+.+|++.|||||+++. ..|+.|+|+||+|+|||
T Consensus 142 Ls~~~~~-~~~~~LKIADFGfAR~L~~~~~-----------a~tlcGSplYMAPEV~~~----~~YdAKADLWSiG~Ily 205 (429)
T KOG0595|consen 142 LSTTARN-DTSPVLKIADFGFARFLQPGSM-----------AETLCGSPLYMAPEVIMS----QQYDAKADLWSIGTILY 205 (429)
T ss_pred eccCCCC-CCCceEEecccchhhhCCchhH-----------HHHhhCCccccCHHHHHh----ccccchhhHHHHHHHHH
Confidence 9876221 1127899999999998875332 244679999999999986 78999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcC
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMG 809 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~ 809 (886)
+|++|+.||...+..++...+.++
T Consensus 206 q~l~g~~Pf~a~t~~eL~~~~~k~ 229 (429)
T KOG0595|consen 206 QCLTGKPPFDAETPKELLLYIKKG 229 (429)
T ss_pred HHHhCCCCccccCHHHHHHHHhcc
Confidence 999999999999999999888776
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=367.59 Aligned_cols=279 Identities=24% Similarity=0.340 Sum_probs=219.4
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
++.|+...++|+|+||+||+|+. .++-||||.+. ....... ++ +-.++||++|++|+|||+|.++++|....
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~--Esedd~~-Vk---KIAlREIrmLKqLkH~NLVnLiEVFrrkr 74 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFV--ESEDDPV-VK---KIALREIRMLKQLKHENLVNLIEVFRRKR 74 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeec--cCCccHH-HH---HHHHHHHHHHHhcccchHHHHHHHHHhcc
Confidence 46789999999999999999997 56677777763 2222222 22 23489999999999999999999998655
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
.++||+|||+. ++.+-|.. . ...++...+..+++|++.|+.|+|++++|||||||+||||+
T Consensus 75 --------------klhLVFE~~dh-TvL~eLe~---~-p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit 135 (396)
T KOG0593|consen 75 --------------KLHLVFEYCDH-TVLHELER---Y-PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT 135 (396)
T ss_pred --------------eeEEEeeecch-HHHHHHHh---c-cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe
Confidence 46999999986 55555554 1 34588999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ +++||||||+|+.+..+... .+.++.|..|+|||.+.+ ...|+..+||||+||++.||
T Consensus 136 ~~-------gvvKLCDFGFAR~L~~pgd~----------YTDYVATRWYRaPELLvG---DtqYG~pVDiWAiGCv~aEl 195 (396)
T KOG0593|consen 136 QN-------GVVKLCDFGFARTLSAPGDN----------YTDYVATRWYRAPELLVG---DTQYGKPVDIWAIGCVFAEL 195 (396)
T ss_pred cC-------CcEEeccchhhHhhcCCcch----------hhhhhhhhhccChhhhcc---cCcCCCcccchhhhHHHHHH
Confidence 88 67999999999988643221 355689999999999987 47899999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccc---cccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH---EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 864 (886)
Q Consensus 788 LTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kR 864 (886)
++|.+.|+|.++.+.+..|.+.....+|.....+.....- .++.....-+.....+..+..+.+|+.+||+.||.+|
T Consensus 196 ~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R 275 (396)
T KOG0593|consen 196 LTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDR 275 (396)
T ss_pred hcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCcccc
Confidence 9999999999999999999887666666655444321110 1111111111122344566789999999999999999
Q ss_pred CCHHHHHHH
Q 002738 865 PTAGDLYEM 873 (886)
Q Consensus 865 PSA~EILeh 873 (886)
++.++++.|
T Consensus 276 ~sc~qll~H 284 (396)
T KOG0593|consen 276 LSCEQLLHH 284 (396)
T ss_pred ccHHHHhcC
Confidence 999999987
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=384.98 Aligned_cols=283 Identities=23% Similarity=0.240 Sum_probs=221.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEe
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 624 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~ 624 (886)
..+++|.++++||.|+||.||+|+. .+..||+|. ++......++.-. +||+..|++|. |||||++.+++.
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~--MK~Kf~s~ee~~n-----LREvksL~kln~hpniikL~Evi~ 79 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKK--MKKKFYSWEECMN-----LREVKSLRKLNPHPNIIKLKEVIR 79 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHH--HHhhhccHHHHHH-----HHHHHHHHhcCCCCcchhhHHHhh
Confidence 4568999999999999999999986 566677776 4444444444433 79999999999 999999999998
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNI 704 (886)
+.+. .+|+|||||+ .+|+++++. .+..|++..++.|++||++||+|+|.+|+.||||||+||
T Consensus 80 d~~~-------------~L~fVfE~Md-~NLYqLmK~----R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENi 141 (538)
T KOG0661|consen 80 DNDR-------------ILYFVFEFMD-CNLYQLMKD----RNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENI 141 (538)
T ss_pred ccCc-------------eEeeeHHhhh-hhHHHHHhh----cCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhhe
Confidence 7652 5899999998 699999987 257899999999999999999999999999999999999
Q ss_pred EEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVIL 784 (886)
|+... ..+||+|||+|+.+.... ..+.++.|..|+|||++.. .+.|+.+.||||+|||+
T Consensus 142 Li~~~-------~~iKiaDFGLARev~Skp-----------PYTeYVSTRWYRAPEvLLr---s~~Ys~pvD~wA~GcI~ 200 (538)
T KOG0661|consen 142 LISGN-------DVIKIADFGLAREVRSKP-----------PYTEYVSTRWYRAPEVLLR---SGYYSSPVDMWAVGCIM 200 (538)
T ss_pred Eeccc-------ceeEecccccccccccCC-----------CcchhhhcccccchHHhhh---ccccCCchHHHHHHHHH
Confidence 99854 579999999999876533 2456789999999999986 47899999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccc---cccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 002738 785 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH---EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 861 (886)
Q Consensus 785 yELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~---~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP 861 (886)
+|+.+-++.|+|.+..+.+..|......+..+.+..-.... .-.+++ ..+.......+..+.++.+||.+|+.+||
T Consensus 201 aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~-~~~~~l~~L~p~~s~~~~~li~~ll~WDP 279 (538)
T KOG0661|consen 201 AELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQ-VKPSPLKDLLPNASSEAASLIERLLAWDP 279 (538)
T ss_pred HHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCc-CCCCChHHhCcccCHHHHHHHHHHhcCCC
Confidence 99999999999999988887776652222222221100000 000000 01111122233467889999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 002738 862 TERPTAGDLYEMFVAR 877 (886)
Q Consensus 862 ~kRPSA~EILehLe~l 877 (886)
.+||||.|+++|..-.
T Consensus 280 ~kRpTA~~al~~pffq 295 (538)
T KOG0661|consen 280 DKRPTASQALQHPFFQ 295 (538)
T ss_pred ccCccHHHHhcCcccc
Confidence 9999999999995533
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=382.60 Aligned_cols=259 Identities=29% Similarity=0.426 Sum_probs=220.1
Q ss_pred CCceeeeeecccCceEEEEEEECCe-eEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKFGSA-DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~~~~-~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
..+.+++.||+|-||.||.|.|++. +||+|..+.. ... .+.| .+|+.+|++|+|+|||+++|++..+..
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~--~m~---~~~f----~~Ea~iMk~L~H~~lV~l~gV~~~~~p- 275 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG--SMS---PEAF----LREAQIMKKLRHEKLVKLYGVCTKQEP- 275 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc--ccC---hhHH----HHHHHHHHhCcccCeEEEEEEEecCCc-
Confidence 3467889999999999999999766 9999996533 222 1233 899999999999999999999997654
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
+||||||++.|+|.+||+. ..+..+...+.+.++.|||.||+||+++++|||||.+.||||+.+
T Consensus 276 -------------iyIVtE~m~~GsLl~yLr~---~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~ 339 (468)
T KOG0197|consen 276 -------------IYIVTEYMPKGSLLDYLRT---REGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDED 339 (468)
T ss_pred -------------eEEEEEecccCcHHHHhhh---cCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccC
Confidence 5999999999999999986 345678999999999999999999999999999999999999988
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
..+||+|||+|+...+...+.. ...--...|.|||.+.. ..++.|||||||||+||||+|
T Consensus 340 -------~~vKIsDFGLAr~~~d~~Y~~~---------~~~kfPIkWtAPEa~~~----~~FS~kSDVWSFGVlL~E~fT 399 (468)
T KOG0197|consen 340 -------LVVKISDFGLARLIGDDEYTAS---------EGGKFPIKWTAPEALNY----GKFSSKSDVWSFGVLLWELFT 399 (468)
T ss_pred -------ceEEEcccccccccCCCceeec---------CCCCCCceecCHHHHhh----CCcccccceeehhhhHHHHhc
Confidence 6799999999995544332211 11124578999999986 789999999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 002738 790 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868 (886)
Q Consensus 790 -G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~ 868 (886)
|+.||.+++..+++..+.++.+.+-|+ .+++.+.+|+..||+.+|++|||++
T Consensus 400 ~G~~py~~msn~ev~~~le~GyRlp~P~---------------------------~CP~~vY~lM~~CW~~~P~~RPtF~ 452 (468)
T KOG0197|consen 400 YGRVPYPGMSNEEVLELLERGYRLPRPE---------------------------GCPDEVYELMKSCWHEDPEDRPTFE 452 (468)
T ss_pred cCCCCCCCCCHHHHHHHHhccCcCCCCC---------------------------CCCHHHHHHHHHHhhCCcccCCCHH
Confidence 999999999999999999998755443 2466899999999999999999999
Q ss_pred HHHHHHHhhcCCCC
Q 002738 869 DLYEMFVARTSSSI 882 (886)
Q Consensus 869 EILehLe~l~sss~ 882 (886)
.+...|+.+.....
T Consensus 453 ~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 453 TLREVLEDFFTSTE 466 (468)
T ss_pred HHHHHHHHhhhccc
Confidence 99999988776543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=368.00 Aligned_cols=254 Identities=28% Similarity=0.345 Sum_probs=215.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
...++|++.+.||+|+||.||.++. .++-+|+|+...+..... .+.+. +..|..||.+++||.||.++-.|.+
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-~e~~~----~~~Er~IL~~v~hPFiv~l~ysFQt 96 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-KEVRH----TKAERNILSKIKHPFIVKLIYSFQT 96 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-hhHHH----HHHHHHHHHhCCCCcEeeeEEeccc
Confidence 5678999999999999999999986 677899998654433222 23333 4899999999999999999999987
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
... +|+|+||+.||.|...|++ ...+++..++.++..|+.||.|||++|||||||||+|||
T Consensus 97 ~~k--------------LylVld~~~GGeLf~hL~~-----eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENIL 157 (357)
T KOG0598|consen 97 EEK--------------LYLVLDYLNGGELFYHLQR-----EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENIL 157 (357)
T ss_pred CCe--------------EEEEEeccCCccHHHHHHh-----cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHee
Confidence 764 6999999999999999986 578999999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
|+.+ +.++|+|||+++..-.... ...+++||+.|||||++.+ ..|+..+|.||||+++|
T Consensus 158 Ld~~-------GHi~LtDFgL~k~~~~~~~----------~t~tfcGT~eYmAPEil~~----~gy~~~vDWWsLGillY 216 (357)
T KOG0598|consen 158 LDEQ-------GHIKLTDFGLCKEDLKDGD----------ATRTFCGTPEYMAPEILLG----KGYDKAVDWWSLGILLY 216 (357)
T ss_pred ecCC-------CcEEEeccccchhcccCCC----------ccccccCCccccChHHHhc----CCCCcccchHhHHHHHH
Confidence 9988 5699999999985543221 1345789999999999997 78999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
||++|.+||.+.+...+.+.|.++..+..+.. .+...++|+.++|..||.+|.
T Consensus 217 eML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~---------------------------ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 217 EMLTGKPPFYAEDVKKMYDKILKGKLPLPPGY---------------------------LSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred HHhhCCCCCcCccHHHHHHHHhcCcCCCCCcc---------------------------CCHHHHHHHHHHhccCHHHhc
Confidence 99999999999999999999988864443321 245789999999999999995
Q ss_pred ----CHHHHHHH
Q 002738 866 ----TAGDLYEM 873 (886)
Q Consensus 866 ----SA~EILeh 873 (886)
++.+|-+|
T Consensus 270 g~~~d~~~ik~H 281 (357)
T KOG0598|consen 270 GGPGDAEEIKRH 281 (357)
T ss_pred CCCCChHHhhcC
Confidence 57776665
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=380.44 Aligned_cols=264 Identities=24% Similarity=0.305 Sum_probs=218.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcceeeeeEe
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 624 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl~g~~~ 624 (886)
....+|.+++.||+|+|++|++|+. .+..+|+||...+.. ......+. +.+|-.+|.+| .||.|+++|-.|.
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~I-ike~KvkY----V~~Ek~~l~~L~~hPgivkLy~TFQ 144 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYI-IKEKKVKY----VTREKEALTQLSGHPGIVKLYFTFQ 144 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHH-Hhhcccch----hhHHHHHHHHhhCCCCeEEEEEEee
Confidence 4678999999999999999999996 677899999642221 11222222 37888999999 6999999999999
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNI 704 (886)
++.. +|+|+||+++|+|.++|++ .+.|++..++.++.+|+.||+|||++|||||||||+||
T Consensus 145 D~~s--------------LYFvLe~A~nGdll~~i~K-----~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENI 205 (604)
T KOG0592|consen 145 DEES--------------LYFVLEYAPNGDLLDLIKK-----YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENI 205 (604)
T ss_pred cccc--------------eEEEEEecCCCcHHHHHHH-----hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhhe
Confidence 8775 5999999999999999998 46799999999999999999999999999999999999
Q ss_pred EEeccccCCCCCCeEEEeecCCccccccccccccc---ccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI---AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~---~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLG 781 (886)
||+.+ +.+||+|||.|+.+......... ..........++||..|.+||+|.. ...++.+|||+||
T Consensus 206 LLd~d-------mhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~----~~~~~~sDiWAlG 274 (604)
T KOG0592|consen 206 LLDKD-------GHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND----SPAGPSSDLWALG 274 (604)
T ss_pred eEcCC-------CcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC----CCCCcccchHHHH
Confidence 99998 56999999999988764433111 1111111256899999999999987 7889999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 002738 782 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 861 (886)
Q Consensus 782 VILyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP 861 (886)
||||+|+.|++||.+.++..+++.|....... + ...++.+.+||.++|..||
T Consensus 275 CilyQmlaG~PPFra~NeyliFqkI~~l~y~f-p---------------------------~~fp~~a~dLv~KLLv~dp 326 (604)
T KOG0592|consen 275 CILYQMLAGQPPFRAANEYLIFQKIQALDYEF-P---------------------------EGFPEDARDLIKKLLVRDP 326 (604)
T ss_pred HHHHHHhcCCCCCccccHHHHHHHHHHhcccC-C---------------------------CCCCHHHHHHHHHHHccCc
Confidence 99999999999999999999999988764321 1 1124578999999999999
Q ss_pred CCCCCHHHHHHHH
Q 002738 862 TERPTAGDLYEMF 874 (886)
Q Consensus 862 ~kRPSA~EILehL 874 (886)
.+|+|+++|.+|.
T Consensus 327 ~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 327 SDRLTSQQIKAHP 339 (604)
T ss_pred cccccHHHHhhCc
Confidence 9999999999984
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=384.28 Aligned_cols=253 Identities=28% Similarity=0.453 Sum_probs=218.5
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
+...|....+||+|+.|.||.|+. .+..||+|.+.+..+... +.+.+|+.+|+.++|+|||.+++.|...
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k--------eLilnEi~Vm~~~~H~NiVnfl~Sylv~ 342 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK--------ELLLNEILVMRDLHHPNIVNFLDSYLVG 342 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch--------hhhHHHHHHHHhccchHHHHHHHHhccc
Confidence 445788899999999999999986 556678887766543321 2348999999999999999999988866
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
+ .+|+||||++||+|.+.+.. ..+++.++..|++++++||+|||.+||+|||||.+|||+
T Consensus 343 d--------------eLWVVMEym~ggsLTDvVt~------~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL 402 (550)
T KOG0578|consen 343 D--------------ELWVVMEYMEGGSLTDVVTK------TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL 402 (550)
T ss_pred c--------------eeEEEEeecCCCchhhhhhc------ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe
Confidence 5 36999999999999999986 569999999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.++ .+||+|||++..+..... ...+.+|||.|||||++.. ..|++|+||||||++++|
T Consensus 403 ~~~g-------~vKltDFGFcaqi~~~~~----------KR~TmVGTPYWMAPEVvtr----k~YG~KVDIWSLGIMaIE 461 (550)
T KOG0578|consen 403 TMDG-------SVKLTDFGFCAQISEEQS----------KRSTMVGTPYWMAPEVVTR----KPYGPKVDIWSLGIMAIE 461 (550)
T ss_pred ccCC-------cEEEeeeeeeeccccccC----------ccccccCCCCccchhhhhh----cccCccccchhhhhHHHH
Confidence 9884 599999999988765332 2466799999999999986 789999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 787 LLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
|+.|++||-..++...++.|.....|.+.. ....+..|++||.+||+.||.+|++
T Consensus 462 MveGEPPYlnE~PlrAlyLIa~ng~P~lk~-------------------------~~klS~~~kdFL~~cL~~dv~~Ras 516 (550)
T KOG0578|consen 462 MVEGEPPYLNENPLRALYLIATNGTPKLKN-------------------------PEKLSPELKDFLDRCLVVDVEQRAS 516 (550)
T ss_pred HhcCCCCccCCChHHHHHHHhhcCCCCcCC-------------------------ccccCHHHHHHHHHHhhcchhcCCC
Confidence 999999999999999999998887766552 1224678999999999999999999
Q ss_pred HHHHHHHHH
Q 002738 867 AGDLYEMFV 875 (886)
Q Consensus 867 A~EILehLe 875 (886)
|.|+|+|-.
T Consensus 517 A~eLL~HpF 525 (550)
T KOG0578|consen 517 AKELLEHPF 525 (550)
T ss_pred HHHHhcChh
Confidence 999999944
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=365.52 Aligned_cols=270 Identities=26% Similarity=0.373 Sum_probs=224.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
.....|++...||.|..++||+|+. .+..||+|++.++.+... .+.+ .+|+..|+.++||||++++..|..
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~---ld~l----~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND---LDAL----RKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh---HHHH----HHHHHHhhhcCCCCcceEEEEEEe
Confidence 4567899999999999999999996 678999999888766443 3444 899999999999999999999998
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
+.. +|+||+||.+||+.++++.....+ +++..+..|++++++||.|||.+|.||||||+.|||
T Consensus 96 ~~~--------------LWvVmpfMa~GS~ldIik~~~~~G---l~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnIL 158 (516)
T KOG0582|consen 96 DSE--------------LWVVMPFMAGGSLLDIIKTYYPDG---LEEASIATILREVLKALDYLHQNGHIHRDVKAGNIL 158 (516)
T ss_pred cce--------------eEEeehhhcCCcHHHHHHHHcccc---ccHHHHHHHHHHHHHHHHHHHhcCceecccccccEE
Confidence 875 599999999999999999866655 999999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
|+.+ +.|||+|||.+..+..... +......+++||+.|||||+++. .-..|+.|+||||||++..
T Consensus 159 i~~d-------G~VkLadFgvsa~l~~~G~------R~~~rf~tfvgtp~wmAPEvl~q--~~~GYdfKaDIwSfGITA~ 223 (516)
T KOG0582|consen 159 IDSD-------GTVKLADFGVSASLFDSGD------RQVTRFNTFVGTPCWMAPEVLMQ--QLHGYDFKADIWSFGITAC 223 (516)
T ss_pred EcCC-------CcEEEcCceeeeeecccCc------eeeEeeccccCcccccChHHhhh--cccCccchhhhhhhhHHHH
Confidence 9998 5699999999876655331 11112266789999999999754 2367999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
||.+|..||....+.+++..-.++..|.+. . .....+........++.++..||+.||.+||
T Consensus 224 ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~--t----------------~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRp 285 (516)
T KOG0582|consen 224 ELAHGHAPFSKYPPMKVLLLTLQNDPPTLL--T----------------SGLDKDEDKKFSKSFREMIALCLVKDPSKRP 285 (516)
T ss_pred HHhcCCCCcccCChHHHHHHHhcCCCCCcc--c----------------ccCChHHhhhhcHHHHHHHHHHhhcCcccCC
Confidence 999999999999999988776666554322 0 0111222233455899999999999999999
Q ss_pred CHHHHHHHH
Q 002738 866 TAGDLYEMF 874 (886)
Q Consensus 866 SA~EILehL 874 (886)
||+++++|-
T Consensus 286 tAskLlkh~ 294 (516)
T KOG0582|consen 286 TASKLLKHA 294 (516)
T ss_pred CHHHHhccH
Confidence 999999983
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=347.72 Aligned_cols=282 Identities=21% Similarity=0.227 Sum_probs=227.4
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
.+|...++||+|.||.||+|++ +++.||+|.+++..... .+....++||..|+.++|+|||.++++|.....
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd------Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~ 75 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD------GINRTALREIKLLQELKHPNIIELIDVFPHKSN 75 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc------CccHHHHHHHHHHHHccCcchhhhhhhccCCCc
Confidence 4788999999999999999997 67788888876653322 222344899999999999999999999987665
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
+.||+||++ .+|+..|+. ....++...+..++.++++||+|||.+.|+||||||.|+||+.
T Consensus 76 --------------l~lVfEfm~-tdLe~vIkd----~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~ 136 (318)
T KOG0659|consen 76 --------------LSLVFEFMP-TDLEVVIKD----KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISS 136 (318)
T ss_pred --------------eEEEEEecc-ccHHHHhcc----cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcC
Confidence 599999998 799999986 4567899999999999999999999999999999999999998
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.+||+|||+|+.+....... ...+-|..|+|||.+.| ...|+..+||||.|||+.||+
T Consensus 137 ~-------g~lKiADFGLAr~f~~p~~~~----------~~~V~TRWYRAPELLfG---sr~Yg~~VDmWavGCI~AELl 196 (318)
T KOG0659|consen 137 D-------GQLKIADFGLARFFGSPNRIQ----------THQVVTRWYRAPELLFG---SRQYGTGVDMWAVGCIFAELL 196 (318)
T ss_pred C-------CcEEeecccchhccCCCCccc----------ccceeeeeccChHHhcc---chhcCCcchhhhHHHHHHHHH
Confidence 8 569999999999887654331 22378999999999997 567999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~ 868 (886)
-|.+-|+|.++.+.+..|......+-++.|+.+...+.....+.............++.++.+|+.+||.+||.+|+++.
T Consensus 197 lr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~ 276 (318)
T KOG0659|consen 197 LRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITAS 276 (318)
T ss_pred ccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHH
Confidence 99999999999988888877655555555655544443322221111111123445567789999999999999999999
Q ss_pred HHHHHHHhh
Q 002738 869 DLYEMFVAR 877 (886)
Q Consensus 869 EILehLe~l 877 (886)
|+++|---.
T Consensus 277 qaL~~~yf~ 285 (318)
T KOG0659|consen 277 QALKHPYFK 285 (318)
T ss_pred HHhcchhhh
Confidence 999985433
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=374.81 Aligned_cols=288 Identities=21% Similarity=0.246 Sum_probs=226.8
Q ss_pred CCCCCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeee
Q 002738 544 GLDPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 621 (886)
Q Consensus 544 ~~~~~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g 621 (886)
.+-+...+.|+.+++||+|.||.||+|++ .+..||+|.+.+.... ..|-....+||.||++|.|||||++.+
T Consensus 110 ~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~------~~~~~t~~REI~ILr~l~HpNIikL~e 183 (560)
T KOG0600|consen 110 GWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK------EGFPITAIREIKILRRLDHPNIIKLEE 183 (560)
T ss_pred cccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC------CcchHHHHHHHHHHHhcCCCcccceee
Confidence 45567788999999999999999999997 5566999887765422 223334589999999999999999999
Q ss_pred eEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 002738 622 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 701 (886)
Q Consensus 622 ~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKP 701 (886)
...... ...+|||+|||++ +|.-++.. +...|++.++..++.||+.||.|+|.+||+|||||.
T Consensus 184 ivt~~~------------~~siYlVFeYMdh-DL~GLl~~----p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~ 246 (560)
T KOG0600|consen 184 IVTSKL------------SGSIYLVFEYMDH-DLSGLLSS----PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKG 246 (560)
T ss_pred EEEecC------------CceEEEEEecccc-hhhhhhcC----CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccc
Confidence 988662 1247999999985 99999875 456899999999999999999999999999999999
Q ss_pred CCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 002738 702 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781 (886)
Q Consensus 702 sNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLG 781 (886)
+||||+.+ +.+||+|||+|+++...... ..+..+-|..|+|||++.| ...|+.++|+||.|
T Consensus 247 SNiLidn~-------G~LKiaDFGLAr~y~~~~~~---------~~T~rVvTLWYRpPELLLG---~t~Yg~aVDlWS~G 307 (560)
T KOG0600|consen 247 SNILIDNN-------GVLKIADFGLARFYTPSGSA---------PYTSRVVTLWYRPPELLLG---ATSYGTAVDLWSVG 307 (560)
T ss_pred cceEEcCC-------CCEEeccccceeeccCCCCc---------ccccceEEeeccChHHhcC---Ccccccceeehhhh
Confidence 99999988 56999999999987654322 1345578999999999998 56799999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCC--CCCchhhhhhHHHHHHHHHHhccc
Q 002738 782 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG--FEKPEAELETLSFLVDVFRRCTEE 859 (886)
Q Consensus 782 VILyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~L~dLL~rCL~~ 859 (886)
|||.||++|++.|+|.+..+.++.|.+....+-.+.|. ...++.....+.... ....+.....+....+|+..||..
T Consensus 308 CIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~l 386 (560)
T KOG0600|consen 308 CILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSL 386 (560)
T ss_pred HHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhcc
Confidence 99999999999999999999888887764444443333 111111101111111 011122344567889999999999
Q ss_pred CCCCCCCHHHHHHHH
Q 002738 860 NPTERPTAGDLYEMF 874 (886)
Q Consensus 860 DP~kRPSA~EILehL 874 (886)
||.+|.||.++|++=
T Consensus 387 dP~kR~tA~~aL~se 401 (560)
T KOG0600|consen 387 DPDKRGTASSALQSE 401 (560)
T ss_pred CccccccHHHHhcCc
Confidence 999999999999873
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=371.08 Aligned_cols=262 Identities=23% Similarity=0.283 Sum_probs=214.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEe
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 624 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~ 624 (886)
...++|.+.+.||+|+||.|++|.. .+..||+|+...+...... ....+.+.+|+.++++++ ||||+++++++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~---~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~ 90 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS---QKLDELIKREISILRRLRSHPNIIRLLEVFA 90 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc---cccchhhHHHHHHHHHhccCCCEeEEEEEEe
Confidence 5678999999999999999999986 6789999976543211111 122233478999999999 999999999999
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNI 704 (886)
.... .|+||||+.||+|.+++.. ..++.+.++..+++||+.|++|||++||+||||||+||
T Consensus 91 t~~~--------------~~ivmEy~~gGdL~~~i~~-----~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENi 151 (370)
T KOG0583|consen 91 TPTK--------------IYIVMEYCSGGDLFDYIVN-----KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENI 151 (370)
T ss_pred cCCe--------------EEEEEEecCCccHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHE
Confidence 7663 6999999999999999986 46789999999999999999999999999999999999
Q ss_pred EEeccccCCCCCCeEEEeecCCccccc-ccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLR-SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKLsDFGlA~~l~-~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVI 783 (886)
|++.+. +.+||+|||++.... .. ....+.+||+.|+|||++.+.. ...+.++||||+||+
T Consensus 152 lld~~~------~~~Kl~DFG~s~~~~~~~-----------~~l~t~cGsp~Y~aPEvl~~~~--~Y~g~~aDvWS~GVi 212 (370)
T KOG0583|consen 152 LLDGNE------GNLKLSDFGLSAISPGED-----------GLLKTFCGSPAYAAPEVLSGKG--TYSGKAADVWSLGVI 212 (370)
T ss_pred EecCCC------CCEEEeccccccccCCCC-----------CcccCCCCCcccCCHHHhCCCC--CcCCchhhhhhhHHH
Confidence 999871 359999999998763 11 1135567999999999998721 134689999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhh-HHHHHHHHHHhcccCCC
Q 002738 784 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET-LSFLVDVFRRCTEENPT 862 (886)
Q Consensus 784 LyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~L~dLL~rCL~~DP~ 862 (886)
||.|++|+.||...+...+...|..+... ++.. . ++.+.+|+.+||..||.
T Consensus 213 Ly~ml~G~~PF~d~~~~~l~~ki~~~~~~-~p~~---------------------------~~S~~~~~Li~~mL~~~P~ 264 (370)
T KOG0583|consen 213 LYVLLCGRLPFDDSNVPNLYRKIRKGEFK-IPSY---------------------------LLSPEARSLIEKMLVPDPS 264 (370)
T ss_pred HHHHHhCCCCCCCccHHHHHHHHhcCCcc-CCCC---------------------------cCCHHHHHHHHHHcCCCcc
Confidence 99999999999998888888887766431 2211 1 45789999999999999
Q ss_pred CCCCHHHHHHHHHhhc
Q 002738 863 ERPTAGDLYEMFVART 878 (886)
Q Consensus 863 kRPSA~EILehLe~l~ 878 (886)
+|+|+.+|++|-+-..
T Consensus 265 ~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 265 TRITLLEILEHPWFQK 280 (370)
T ss_pred cCCCHHHHhhChhhcc
Confidence 9999999998866554
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=366.33 Aligned_cols=262 Identities=33% Similarity=0.446 Sum_probs=206.7
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
..+|...+.||+|+||+||++... +...|||...+... ...+ .+.+|+.+|.+|+|||||+++|......
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~----~~~~----~l~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS----PTSE----SLEREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc----hhHH----HHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence 456889999999999999999985 58899999765511 1123 3489999999999999999999754332
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
. ..++|+|||+++|+|.+++.. .+. .+++..++.+++||+.||.|||++||||+||||+||||+
T Consensus 88 ~------------~~~~i~mEy~~~GsL~~~~~~---~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~ 151 (313)
T KOG0198|consen 88 N------------DEYNIFMEYAPGGSLSDLIKR---YGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD 151 (313)
T ss_pred C------------eeeEeeeeccCCCcHHHHHHH---cCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe
Confidence 1 247999999999999999987 232 699999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.. .+.+||+|||+++........ ........||+.|||||++.. ......++|||||||++.||
T Consensus 152 ~~------~~~~KlaDFG~a~~~~~~~~~-------~~~~~~~~Gtp~~maPEvi~~---g~~~~~~sDiWSlGCtVvEM 215 (313)
T KOG0198|consen 152 PS------NGDVKLADFGLAKKLESKGTK-------SDSELSVQGTPNYMAPEVIRN---GEVARRESDIWSLGCTVVEM 215 (313)
T ss_pred CC------CCeEEeccCcccccccccccc-------ccccccccCCccccCchhhcC---CCcCCccchhhhcCCEEEec
Confidence 83 156999999999876531100 011234679999999999984 12234699999999999999
Q ss_pred HhCCCCCCC-CCHHHHHHHHHcC-CCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 788 LTLQVPYMG-LSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 788 LTG~~PF~g-~s~~el~~~I~~~-~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
+||+.||.. ....+....+... ..|.+++. .++..++||.+|+..||.+||
T Consensus 216 ~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~---------------------------ls~~a~~Fl~~C~~~~p~~Rp 268 (313)
T KOG0198|consen 216 LTGKPPWSEFFEEAEALLLIGREDSLPEIPDS---------------------------LSDEAKDFLRKCFKRDPEKRP 268 (313)
T ss_pred cCCCCcchhhcchHHHHHHHhccCCCCCCCcc---------------------------cCHHHHHHHHHHhhcCcccCc
Confidence 999999987 4444444444433 33444422 356799999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 002738 866 TAGDLYEMFVART 878 (886)
Q Consensus 866 SA~EILehLe~l~ 878 (886)
||.++|+|.....
T Consensus 269 ta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 269 TAEELLEHPFLKQ 281 (313)
T ss_pred CHHHHhhChhhhc
Confidence 9999999987654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=381.06 Aligned_cols=266 Identities=24% Similarity=0.388 Sum_probs=221.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
++.+.+.+...||+|+||+||+|+|.| +||||+..+. ....+..+.| .+|+.+|++-+|.||+-|+|++..+.
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~--~pt~~qlqaF----KnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVD--DPTPEQLQAF----KNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cCHHHhhccceeccccccceeeccccc-ceEEEEEecC--CCCHHHHHHH----HHHHHHHhhcchhhheeeehhhcCCc
Confidence 777888999999999999999999987 5999996544 4455566666 99999999999999999999998654
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
..||+.+|+|.+|+.+|+. .+..|.+...+.|++||++||.|||.++|||||||..|||+.
T Consensus 462 ---------------~AIiTqwCeGsSLY~hlHv----~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~ 522 (678)
T KOG0193|consen 462 ---------------LAIITQWCEGSSLYTHLHV----QETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLH 522 (678)
T ss_pred ---------------eeeeehhccCchhhhhccc----hhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEc
Confidence 3999999999999999986 346789999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
++ .+|||+|||++..-...... .. ....-|...|||||+++ +.+..+|++.+||||||+++|||
T Consensus 523 ~~-------~kVkIgDFGLatvk~~w~g~-----~q---~~qp~gsilwmAPEvIR-mqd~nPfS~qSDVYaFGiV~YEL 586 (678)
T KOG0193|consen 523 ED-------LKVKIGDFGLATVKTRWSGE-----QQ---LEQPHGSLLWMAPEVIR-MQDDNPFSFQSDVYAFGIVWYEL 586 (678)
T ss_pred cC-------CcEEEecccceeeeeeeccc-----cc---cCCCccchhhhcHHHHh-hcccCCCCcccchhhhhHHHHHH
Confidence 87 56999999999754432111 11 12224789999999998 45568999999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 788 LTG~~PF~g~s~~el~~~I~~~~r-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
+||..||......+++..+.++.. +... .....++.++++|+..||.+++++||.
T Consensus 587 ltg~lPysi~~~dqIifmVGrG~l~pd~s------------------------~~~s~~pk~mk~Ll~~C~~~~~~eRP~ 642 (678)
T KOG0193|consen 587 LTGELPYSIQNRDQIIFMVGRGYLMPDLS------------------------KIRSNCPKAMKRLLSDCWKFDREERPL 642 (678)
T ss_pred HhCcCCcCCCChhheEEEecccccCccch------------------------hhhccCHHHHHHHHHHHHhcCcccCcc
Confidence 999999997777788777777732 2211 112334668999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 002738 867 AGDLYEMFVARTS 879 (886)
Q Consensus 867 A~EILehLe~l~s 879 (886)
+.+||..|+.+..
T Consensus 643 F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 643 FPQLLSKLEELLP 655 (678)
T ss_pred HHHHHHHHHHhhh
Confidence 9999998887776
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=373.87 Aligned_cols=250 Identities=28% Similarity=0.411 Sum_probs=215.6
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
+++|.+.+.||+|+||.||+|+. ....||+|. +.+......+++.+ .+|++|+++|+|||||.++++|++..
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~--i~K~gr~~k~l~~l----~~ev~i~r~lkHpniv~m~esfEt~~ 74 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKF--IDKSGRNEKELKNL----RQEVRILRSLKHPNIVEMLESFETSA 74 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEE--ehhcCCchHHHHHH----HHHHHHHHhcCCcchhhHHHhhcccc
Confidence 46899999999999999999996 455677776 55666666777777 99999999999999999999999776
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
++|+|+||+.| +|..+|.. ...++++.+..|+.|++.||.|||+.+|+|||+||.|||+.
T Consensus 75 --------------~~~vVte~a~g-~L~~il~~-----d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~ 134 (808)
T KOG0597|consen 75 --------------HLWVVTEYAVG-DLFTILEQ-----DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE 134 (808)
T ss_pred --------------eEEEEehhhhh-hHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec
Confidence 47999999985 99999987 57899999999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.. +++|+||||+|+........ .+...|||.|||||++.+ .+|+..+|+||+|||+|||
T Consensus 135 ~~-------~~~KlcdFg~Ar~m~~~t~v----------ltsikGtPlYmAPElv~e----~pyd~~sDlWslGcilYE~ 193 (808)
T KOG0597|consen 135 KG-------GTLKLCDFGLARAMSTNTSV----------LTSIKGTPLYMAPELVEE----QPYDHTSDLWSLGCILYEL 193 (808)
T ss_pred CC-------CceeechhhhhhhcccCcee----------eeeccCcccccCHHHHcC----CCccchhhHHHHHHHHHHH
Confidence 77 67999999999876553221 234569999999999986 8899999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 788 LTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
++|++||...+..++...|.....+. + ...+..+.+|++.+|.+||.+|.|.
T Consensus 194 ~~G~PPF~a~si~~Lv~~I~~d~v~~-p---------------------------~~~S~~f~nfl~gLL~kdP~~RltW 245 (808)
T KOG0597|consen 194 YVGQPPFYARSITQLVKSILKDPVKP-P---------------------------STASSSFVNFLQGLLIKDPAQRLTW 245 (808)
T ss_pred hcCCCCchHHHHHHHHHHHhcCCCCC-c---------------------------ccccHHHHHHHHHHhhcChhhcccH
Confidence 99999999888888888887653221 1 1235679999999999999999999
Q ss_pred HHHHHHH
Q 002738 868 GDLYEMF 874 (886)
Q Consensus 868 ~EILehL 874 (886)
.+++.|-
T Consensus 246 ~~Ll~Hp 252 (808)
T KOG0597|consen 246 TDLLGHP 252 (808)
T ss_pred HHHhcCh
Confidence 9999884
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=358.83 Aligned_cols=266 Identities=23% Similarity=0.349 Sum_probs=203.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCccee
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 619 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~-------~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl 619 (886)
++.++|++.+.||+|+||.||+|.+ .+..||+|+.... ......+ .+.+|+.+|..+ +||||+++
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~----~~~~E~~~l~~l~~h~niv~~ 76 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG---ATASEHK----ALMSELKILIHIGNHLNVVNL 76 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc---cchHHHH----HHHHHHHHHHHhccCcceeeE
Confidence 4567899999999999999999974 2346899985421 1222223 348999999999 79999999
Q ss_pred eeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhcc----------------------------------
Q 002738 620 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---------------------------------- 665 (886)
Q Consensus 620 ~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~---------------------------------- 665 (886)
++++..... ..++||||+++|+|.+++......
T Consensus 77 ~~~~~~~~~-------------~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (338)
T cd05102 77 LGACTKPNG-------------PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQAS 143 (338)
T ss_pred EeEecCCCC-------------ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCC
Confidence 998875432 369999999999999999752110
Q ss_pred -----------------------CCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCCCCCeEEEe
Q 002738 666 -----------------------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 722 (886)
Q Consensus 666 -----------------------~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLs 722 (886)
....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~-------~~~kl~ 216 (338)
T cd05102 144 VLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSEN-------NVVKIC 216 (338)
T ss_pred ccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCC-------CcEEEe
Confidence 01347788999999999999999999999999999999999876 469999
Q ss_pred ecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 002738 723 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELE 801 (886)
Q Consensus 723 DFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT-G~~PF~g~s~~e 801 (886)
|||+++........ .......+++.|+|||++.+ ..++.++|||||||+||||++ |..||.+....+
T Consensus 217 DfG~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~ 284 (338)
T cd05102 217 DFGLARDIYKDPDY--------VRKGSARLPLKWMAPESIFD----KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE 284 (338)
T ss_pred ecccccccccCcch--------hcccCCCCCccccCcHHhhc----CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH
Confidence 99999765332111 01122346788999999976 668999999999999999997 999998765332
Q ss_pred -HHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 002738 802 -IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 879 (886)
Q Consensus 802 -l~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EILehLe~l~s 879 (886)
+...+..+..+..+ ...++.+.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus 285 ~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 285 EFCQRLKDGTRMRAP---------------------------ENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHhcCCCCCCC---------------------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 33333333221111 1234578999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=348.30 Aligned_cols=279 Identities=20% Similarity=0.246 Sum_probs=208.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
..+++|++.+.||.|+||.||+|+. .+..||+|+........ .. ..+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~----~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (288)
T cd07871 2 GKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG---AP----CTAIREVSLLKNLKHANIVTLHDIIHT 74 (288)
T ss_pred CccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC---cc----hhHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 3577899999999999999999987 56789999875432111 11 233789999999999999999999876
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
.. ..++||||++ ++|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 75 ~~--------------~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil 135 (288)
T cd07871 75 ER--------------CLTLVFEYLD-SDLKQYLDN----CGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLL 135 (288)
T ss_pred CC--------------eEEEEEeCCC-cCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence 54 3699999998 599999875 2245789999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.+ +.+||+|||++......... .....+|+.|+|||++.+ ...++.++|||||||++|
T Consensus 136 ~~~~-------~~~kl~DfG~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~~l~ 195 (288)
T cd07871 136 INEK-------GELKLADFGLARAKSVPTKT----------YSNEVVTLWYRPPDVLLG---STEYSTPIDMWGVGCILY 195 (288)
T ss_pred ECCC-------CCEEECcCcceeeccCCCcc----------ccCceecccccChHHhcC---CcccCcHHHHHHHHHHHH
Confidence 9877 46999999998754322111 122368999999999864 245789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccC-CCC---CCchhhhhhHHHHHHHHHHhcccCC
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG-SGF---EKPEAELETLSFLVDVFRRCTEENP 861 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~-~~~---~~~~~~~~~s~~L~dLL~rCL~~DP 861 (886)
+|+||+.||.+.+..+....+......+....++...... .+.... ... .........+..+++||.+||++||
T Consensus 196 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp 273 (288)
T cd07871 196 EMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE--EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYET 273 (288)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch--hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCc
Confidence 9999999999888777766665543333333332221110 000000 000 0001112345678999999999999
Q ss_pred CCCCCHHHHHHHH
Q 002738 862 TERPTAGDLYEMF 874 (886)
Q Consensus 862 ~kRPSA~EILehL 874 (886)
.+|||++|+++|-
T Consensus 274 ~~R~t~~~~l~hp 286 (288)
T cd07871 274 KSRISAEAALRHS 286 (288)
T ss_pred ccCCCHHHHhcCC
Confidence 9999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=345.19 Aligned_cols=281 Identities=22% Similarity=0.262 Sum_probs=204.4
Q ss_pred CCceeeeeecccCceEEEEEEE---CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC---CCCCcceeeeeEe
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF---GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKI 624 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~---~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L---~HPNIVrl~g~~~ 624 (886)
.+|++.+.||+|+||.||+|++ ++..+|+|+......... ... .+.+|+.+++.+ .||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~--~~~----~~~~e~~~l~~l~~~~hpniv~~~~~~~ 74 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPL----STIREVAVLRHLETFEHPNVVRLFDVCT 74 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC--chH----HHHHHHHHHHhhcccCCCCcceEEEEEe
Confidence 3799999999999999999986 356789998754432211 111 225677777665 6999999999986
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNI 704 (886)
.... ......++||||+. ++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+||
T Consensus 75 ~~~~---------~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Ni 141 (290)
T cd07862 75 VSRT---------DRETKLTLVFEHVD-QDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 141 (290)
T ss_pred cccC---------CCCCcEEEEEccCC-CCHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHE
Confidence 4321 01235799999997 699999975 2234588999999999999999999999999999999999
Q ss_pred EEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVIL 784 (886)
|++.+ +.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 142 l~~~~-------~~~kl~Dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~il 199 (290)
T cd07862 142 LVTSS-------GQIKLADFGLARIYSFQM-----------ALTSVVVTLWYRAPEVLLQ----SSYATPVDLWSVGCIF 199 (290)
T ss_pred EEcCC-------CCEEEccccceEeccCCc-----------ccccccccccccChHHHhC----CCCCCccchHHHHHHH
Confidence 99877 469999999997653321 1123468999999999975 5688999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 002738 785 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 864 (886)
Q Consensus 785 yELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kR 864 (886)
|||++|++||.+.+..+....+........+..+..........+. ..............+..+.+|+.+||+.||++|
T Consensus 200 ~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 278 (290)
T cd07862 200 AEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFH-SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 278 (290)
T ss_pred HHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhcc-CCCCCCHHHHccCCCHHHHHHHHHHhccCchhc
Confidence 9999999999988887777666654322222222211111111000 000000111122356678999999999999999
Q ss_pred CCHHHHHHH
Q 002738 865 PTAGDLYEM 873 (886)
Q Consensus 865 PSA~EILeh 873 (886)
||+.++++|
T Consensus 279 ~s~~~~l~h 287 (290)
T cd07862 279 ISAYSALSH 287 (290)
T ss_pred CCHHHHhcC
Confidence 999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=374.79 Aligned_cols=248 Identities=25% Similarity=0.395 Sum_probs=209.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
++|+...-++-||.|+.|.||+|++.+..||||.++ +++ ..+|+-|++|+|||||.|.|+|....
T Consensus 121 iPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~---------elk------ETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 121 IPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVR---------ELK------ETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred CCHHHhhhhhhhccCcccceeeeeccCceehhHHHh---------hhh------hhhHHHHHhccCcceeeEeeeecCCc
Confidence 667777778899999999999999999999999742 122 34788899999999999999998654
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
-.|||||||..|-|+..|+. +..+.......|..+||.||+|||.+.|||||||..||||.
T Consensus 186 --------------cyCIiMEfCa~GqL~~VLka-----~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs 246 (904)
T KOG4721|consen 186 --------------CYCIIMEFCAQGQLYEVLKA-----GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS 246 (904)
T ss_pred --------------eeEEeeeccccccHHHHHhc-----cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee
Confidence 46999999999999999986 56788999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ ..|||+|||-++.+..... .-.++||..|||||+++. .+.+.|+|||||||+||||
T Consensus 247 ~~-------d~VKIsDFGTS~e~~~~ST-----------kMSFaGTVaWMAPEvIrn----ePcsEKVDIwSfGVVLWEm 304 (904)
T KOG4721|consen 247 YD-------DVVKISDFGTSKELSDKST-----------KMSFAGTVAWMAPEVIRN----EPCSEKVDIWSFGVVLWEM 304 (904)
T ss_pred cc-------ceEEeccccchHhhhhhhh-----------hhhhhhhHhhhCHHHhhc----CCcccccceehhHHHHHHH
Confidence 88 4699999999988765432 234679999999999997 7889999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 788 LTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
+||..||...+...++.-+..... ....+..+++-|+-||++||+..|..||+|
T Consensus 305 LT~EiPYkdVdssAIIwGVGsNsL--------------------------~LpvPstcP~GfklL~Kqcw~sKpRNRPSF 358 (904)
T KOG4721|consen 305 LTGEIPYKDVDSSAIIWGVGSNSL--------------------------HLPVPSTCPDGFKLLLKQCWNSKPRNRPSF 358 (904)
T ss_pred HhcCCCccccchheeEEeccCCcc--------------------------cccCcccCchHHHHHHHHHHhcCCCCCccH
Confidence 999999988777665544433311 111223456779999999999999999999
Q ss_pred HHHHHHHHhh
Q 002738 868 GDLYEMFVAR 877 (886)
Q Consensus 868 ~EILehLe~l 877 (886)
.+|+.||.-.
T Consensus 359 rqil~HldIa 368 (904)
T KOG4721|consen 359 RQILLHLDIA 368 (904)
T ss_pred HHHHHHHhhc
Confidence 9999999743
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=341.85 Aligned_cols=276 Identities=24% Similarity=0.280 Sum_probs=202.8
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|++.+.||+|+||.||+|++ .+..+|+|++..... ... ....+.+|+.+++.++||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 73 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE--NEE----VKETTLRELKMLRTLKQENIVELKEAFRRRG- 73 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc--ccc----chhhHHHHHHHHHhCCCccccchhhhEecCC-
Confidence 4799999999999999999998 466789998654321 111 1233488999999999999999999987654
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..++||||++++.|..+... ...+++..++.++.||+.||.|||+.||+||||||+|||++.
T Consensus 74 -------------~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~ 135 (287)
T cd07848 74 -------------KLYLVFEYVEKNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISH 135 (287)
T ss_pred -------------EEEEEEecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence 46999999998666554432 346899999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 136 ~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslGvil~el~ 195 (287)
T cd07848 136 N-------DVLKLCDFGFARNLSEGSNA---------NYTEYVATRWYRSPELLLG----APYGKAVDMWSVGCILGELS 195 (287)
T ss_pred C-------CcEEEeeccCcccccccccc---------cccccccccccCCcHHHcC----CCCCCchhHHhHHHHHHHHH
Confidence 7 46999999999865432111 1123468999999999976 56789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccC-CCCC-----CchhhhhhHHHHHHHHHHhcccCCC
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG-SGFE-----KPEAELETLSFLVDVFRRCTEENPT 862 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~s~~L~dLL~rCL~~DP~ 862 (886)
+|++||.+.+..+....+.....+.....+........ ..... .... ........+..+.+||.+||+.||.
T Consensus 196 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~ 273 (287)
T cd07848 196 DGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR--FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPT 273 (287)
T ss_pred hCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch--hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcc
Confidence 99999998776665544444322222222211111000 00000 0000 0011122466899999999999999
Q ss_pred CCCCHHHHHHH
Q 002738 863 ERPTAGDLYEM 873 (886)
Q Consensus 863 kRPSA~EILeh 873 (886)
+|||++++++|
T Consensus 274 ~R~s~~~~l~h 284 (287)
T cd07848 274 DRYLTEQCLNH 284 (287)
T ss_pred cCCCHHHHhcC
Confidence 99999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=350.41 Aligned_cols=281 Identities=25% Similarity=0.292 Sum_probs=221.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
.++++|+.+..|++|+||.||+|++ .++-||+|.++.+. +...|...-++||.+|.+++|||||.+-.+...
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek------ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG 146 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK------EKEGFPITSLREINILLKARHPNIVEVKEVVVG 146 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc------ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec
Confidence 5678999999999999999999998 45567777655443 233455556899999999999999999998875
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
.+ ....|||||||+ -+|..++... .++|...++..++.|+++||+|||.+.|+||||||+|+|
T Consensus 147 ~~------------~d~iy~VMe~~E-hDLksl~d~m----~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLL 209 (419)
T KOG0663|consen 147 SN------------MDKIYIVMEYVE-HDLKSLMETM----KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLL 209 (419)
T ss_pred cc------------cceeeeeHHHHH-hhHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhhee
Confidence 43 235899999998 5999999872 367999999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.. +.+||+|||+|+.+...... .+..+-|..|+|||.+.+ ...|++.+|+||+|||+.
T Consensus 210 m~~~-------G~lKiaDFGLAR~ygsp~k~----------~T~lVVTLWYRaPELLLG---~~tyst~iDMWSvGCI~a 269 (419)
T KOG0663|consen 210 LSHK-------GILKIADFGLAREYGSPLKP----------YTPLVVTLWYRAPELLLG---AKTYSTAVDMWSVGCIFA 269 (419)
T ss_pred eccC-------CcEEecccchhhhhcCCccc----------CcceEEEeeecCHHHhcC---CcccCcchhhhhHHHHHH
Confidence 9988 56999999999998775322 344578999999999998 567999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccc--------cccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH--------EVAQSGSGFEKPEAELETLSFLVDVFRRCT 857 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~--------~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL 857 (886)
||+++++.|+|.+..+.++.|.+....+-...|+.+...+.. +....+..+.. ...++.-.+|+..+|
T Consensus 270 E~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~----~~lse~g~~Lln~ll 345 (419)
T KOG0663|consen 270 ELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGA----LSLSEQGFDLLNKLL 345 (419)
T ss_pred HHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccc----cccchhHHHHHHHHh
Confidence 999999999999998888888765333333333332221111 01111111110 014577889999999
Q ss_pred ccCCCCCCCHHHHHHHHH
Q 002738 858 EENPTERPTAGDLYEMFV 875 (886)
Q Consensus 858 ~~DP~kRPSA~EILehLe 875 (886)
.+||.+|.||.|.|+|=.
T Consensus 346 t~dP~kR~tA~~~L~h~~ 363 (419)
T KOG0663|consen 346 TYDPGKRITAEDGLKHEY 363 (419)
T ss_pred ccCccccccHHHhhcccc
Confidence 999999999999999843
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=349.59 Aligned_cols=249 Identities=28% Similarity=0.371 Sum_probs=203.8
Q ss_pred CCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|++.+.||+|+||.||+|... +..+|+|+....... .... .+.+.+|+.++++++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 74 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-RLKQ----EQHVHNEKRVLKEVSHPFIIRLFWTEHDQR- 74 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hhHH----HHHHHHHHHHHHhCCCCcHhhhHhhhccCC-
Confidence 47899999999999999999974 778999987543211 1111 234588999999999999999998877554
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~ 136 (291)
T cd05612 75 -------------FLYMLMEYVPGGELFSYLRN-----SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDK 136 (291)
T ss_pred -------------eEEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC
Confidence 47999999999999999976 346899999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 137 ~-------~~~kl~Dfg~~~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~~l~ 192 (291)
T cd05612 137 E-------GHIKLTDFGFAKKLRDRT-------------WTLCGTPEYLAPEVIQS----KGHNKAVDWWALGILIYEML 192 (291)
T ss_pred C-------CCEEEEecCcchhccCCc-------------ccccCChhhcCHHHHcC----CCCCchhhHHHHHHHHHHHH
Confidence 6 469999999987653311 22368999999999976 56789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC--
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT-- 866 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS-- 866 (886)
+|+.||.+.+...+...+..+.. .++. ..+..+.+||.+||+.||.+||+
T Consensus 193 ~g~~pf~~~~~~~~~~~i~~~~~-~~~~---------------------------~~~~~~~~li~~~l~~dp~~R~~~~ 244 (291)
T cd05612 193 VGYPPFFDDNPFGIYEKILAGKL-EFPR---------------------------HLDLYAKDLIKKLLVVDRTRRLGNM 244 (291)
T ss_pred hCCCCCCCCCHHHHHHHHHhCCc-CCCc---------------------------cCCHHHHHHHHHHcCCCHHHccCCc
Confidence 99999998888777777655422 1110 12446899999999999999995
Q ss_pred ---HHHHHHHHH
Q 002738 867 ---AGDLYEMFV 875 (886)
Q Consensus 867 ---A~EILehLe 875 (886)
++++++|..
T Consensus 245 ~~~~~~~l~h~~ 256 (291)
T cd05612 245 KNGADDVKNHRW 256 (291)
T ss_pred cCCHHHHhcCcc
Confidence 999999853
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=364.39 Aligned_cols=276 Identities=24% Similarity=0.252 Sum_probs=216.2
Q ss_pred CCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCCh-----HHHH-hhhHhHHHHHHHHhhCCCCCcce
Q 002738 547 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSA-----DEIR-NFEYSCLGEVRMLGALRHSCIVE 618 (886)
Q Consensus 547 ~~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~-----~~~k-~f~~~~lrEI~iLk~L~HPNIVr 618 (886)
-..++.|++++.||+|.||.|-+|+. .+..||+|++..+...... .... .-.+++.+||.||++|.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 36789999999999999999999997 6788999997544321110 0000 00135699999999999999999
Q ss_pred eeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCc-CCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 002738 619 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKH-VSVKLALFIAQDVAAALVELHSKHIMHR 697 (886)
Q Consensus 619 l~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~-Ls~~~i~~Ia~QIa~AL~yLHs~gIVHR 697 (886)
++++..+... ..+|||+|||..|.+...= .... +++.++++++++++.||+|||.+|||||
T Consensus 173 LiEvLDDP~s------------~~~YlVley~s~G~v~w~p------~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHR 234 (576)
T KOG0585|consen 173 LIEVLDDPES------------DKLYLVLEYCSKGEVKWCP------PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHR 234 (576)
T ss_pred EEEeecCccc------------CceEEEEEeccCCccccCC------CCcccccHHHHHHHHHHHHHHHHHHHhcCeecc
Confidence 9999876542 3589999999988765432 2234 8999999999999999999999999999
Q ss_pred CCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhH
Q 002738 698 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 777 (886)
Q Consensus 698 DLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDI 777 (886)
||||+|+||+.+ ++|||+|||.+..+....... ... .-...+|||.|||||...+.......+.+.||
T Consensus 235 DIKPsNLLl~~~-------g~VKIsDFGVs~~~~~~~~~~----~d~-~L~~tvGTPAF~APE~c~~~~~~~~~g~a~Di 302 (576)
T KOG0585|consen 235 DIKPSNLLLSSD-------GTVKISDFGVSNEFPQGSDEG----SDD-QLSRTVGTPAFFAPELCSGGNSFSYSGFALDI 302 (576)
T ss_pred ccchhheEEcCC-------CcEEeeccceeeecccCCccc----cHH-HHhhcCCCccccchHhhcCCCCccccchhhhh
Confidence 999999999988 579999999998664321110 000 01225799999999999864434456889999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 002738 778 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 857 (886)
Q Consensus 778 WSLGVILyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL 857 (886)
||+||+||.|+.|+.||.+....+++..|.+... .++. .++..+.+++||.+||
T Consensus 303 WalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL-~fP~-------------------------~pe~~e~~kDli~~lL 356 (576)
T KOG0585|consen 303 WALGVTLYCLLFGQLPFFDDFELELFDKIVNDPL-EFPE-------------------------NPEINEDLKDLIKRLL 356 (576)
T ss_pred hhhhhhHHHhhhccCCcccchHHHHHHHHhcCcc-cCCC-------------------------cccccHHHHHHHHHHh
Confidence 9999999999999999999999999999977621 1110 0134568999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhc
Q 002738 858 EENPTERPTAGDLYEMFVART 878 (886)
Q Consensus 858 ~~DP~kRPSA~EILehLe~l~ 878 (886)
.+||.+|++..+|..|.+...
T Consensus 357 ~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 357 EKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred hcChhheeehhhheecceecc
Confidence 999999999999999987544
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=348.59 Aligned_cols=287 Identities=20% Similarity=0.245 Sum_probs=204.6
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
+|++.+.||+|+||.||+|+. .+..||+|+..... ....... ++.+|+.++++++||||+++++++.....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~~- 73 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDAT----RILREIKLLRLLRHPDIVEIKHIMLPPSR- 73 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh--ccchhHH----HHHHHHHHHHhCCCCCEeeecceEeccCC-
Confidence 589999999999999999997 56789999864221 1112222 34899999999999999999998875432
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
......|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 74 --------~~~~~~~lv~e~~~-~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~ 139 (338)
T cd07859 74 --------REFKDIYVVFELME-SDLHQVIKA-----NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANAD 139 (338)
T ss_pred --------CCCceEEEEEecCC-CCHHHHHHh-----cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC
Confidence 01235799999996 699999875 3468999999999999999999999999999999999999877
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.+||+|||+++......... .......||+.|+|||++.+. ...++.++|||||||++|||++
T Consensus 140 -------~~~kL~Dfg~~~~~~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~--~~~~~~~~DvwSlGvvl~el~t 203 (338)
T cd07859 140 -------CKLKICDFGLARVAFNDTPTA-------IFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLT 203 (338)
T ss_pred -------CcEEEccCccccccccccCcc-------ccccCCCCCCCcCCHHHHhcc--ccccCchhHHHHHHHHHHHHHc
Confidence 569999999997643321110 011234699999999998642 1457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccccccc---ccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVA---QSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~---~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
|++||.+.+.......+...........+............ ...............++.+.+||.+||..||.+|||
T Consensus 204 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 283 (338)
T cd07859 204 GKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT 283 (338)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCC
Confidence 99999887765554444332221222211111000000000 000000011112234567899999999999999999
Q ss_pred HHHHHHHHH
Q 002738 867 AGDLYEMFV 875 (886)
Q Consensus 867 A~EILehLe 875 (886)
++++++|-.
T Consensus 284 ~~e~l~hp~ 292 (338)
T cd07859 284 AEEALADPY 292 (338)
T ss_pred HHHHhcCch
Confidence 999999843
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=356.21 Aligned_cols=251 Identities=24% Similarity=0.295 Sum_probs=206.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
..+.+|++.+.||+|+||.||+|++ .+..+|+|++...... .... .+.+.+|+.++++++||||+++++++..
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 89 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KMKQ----VQHVAQEKSILMELSHPFIVNMMCSFQD 89 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhh----HHHHHHHHHHHHhCCCCCCCcEEEEEEc
Confidence 4578999999999999999999997 4678999987532111 1111 2345899999999999999999999986
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
.. ..|+||||+.|++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 90 ~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIl 150 (329)
T PTZ00263 90 EN--------------RVYFLLEFVVGGELFTHLRK-----AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLL 150 (329)
T ss_pred CC--------------EEEEEEcCCCCChHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEE
Confidence 55 46999999999999999976 356889999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.+ +.+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 151 l~~~-------~~~kl~Dfg~~~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ 206 (329)
T PTZ00263 151 LDNK-------GHVKVTDFGFAKKVPDRT-------------FTLCGTPEYLAPEVIQS----KGHGKAVDWWTMGVLLY 206 (329)
T ss_pred ECCC-------CCEEEeeccCceEcCCCc-------------ceecCChhhcCHHHHcC----CCCCCcceeechHHHHH
Confidence 9877 469999999997653321 12369999999999986 56789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
||++|..||.+.+.......+..+.. .++. ..+..+.+||.+||+.||.+||
T Consensus 207 elltg~~pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~~~~~~~li~~~L~~dP~~R~ 258 (329)
T PTZ00263 207 EFIAGYPPFFDDTPFRIYEKILAGRL-KFPN---------------------------WFDGRARDLVKGLLQTDHTKRL 258 (329)
T ss_pred HHHcCCCCCCCCCHHHHHHHHhcCCc-CCCC---------------------------CCCHHHHHHHHHHhhcCHHHcC
Confidence 99999999998888777777655421 1111 1234689999999999999998
Q ss_pred C-----HHHHHHHH
Q 002738 866 T-----AGDLYEMF 874 (886)
Q Consensus 866 S-----A~EILehL 874 (886)
+ ++++++|-
T Consensus 259 ~~~~~~~~~ll~hp 272 (329)
T PTZ00263 259 GTLKGGVADVKNHP 272 (329)
T ss_pred CCCCCCHHHHhcCC
Confidence 7 79999884
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=342.44 Aligned_cols=253 Identities=20% Similarity=0.250 Sum_probs=203.6
Q ss_pred eeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 636 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~~~~ 636 (886)
..||+|++|.||+|.+++..||+|....... .. +.+.+.+.+|+.+|++++||||++++|++.....
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~-~~----~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~-------- 92 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHK-GH----KVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD-------- 92 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEecccccc-cc----HHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc--------
Confidence 5789999999999999999999998643211 11 1222344899999999999999999999875210
Q ss_pred CcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEEEeccccCCCC
Q 002738 637 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADG 715 (886)
Q Consensus 637 ~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~-gIVHRDLKPsNILLd~d~~~~~~ 715 (886)
.....++||||+++|+|.+++.. ...+++.....++.|++.||.|||+. +++||||||+|||++.+
T Consensus 93 --~~~~~~lv~Ey~~~g~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~------ 159 (283)
T PHA02988 93 --DLPRLSLILEYCTRGYLREVLDK-----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTEN------ 159 (283)
T ss_pred --CCCceEEEEEeCCCCcHHHHHhh-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCC------
Confidence 12347999999999999999976 34688999999999999999999984 99999999999999877
Q ss_pred CCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 002738 716 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 795 (886)
Q Consensus 716 ~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF~ 795 (886)
+.+||+|||+++...... ....||..|+|||++.+.. ..++.++|||||||++|||++|+.||.
T Consensus 160 -~~~kl~dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~~~--~~~~~k~Di~SlGvil~el~~g~~Pf~ 223 (283)
T PHA02988 160 -YKLKIICHGLEKILSSPP-------------FKNVNFMVYFSYKMLNDIF--SEYTIKDDIYSLGVVLWEIFTGKIPFE 223 (283)
T ss_pred -CcEEEcccchHhhhcccc-------------ccccCcccccCHHHhhhcc--ccccchhhhhHHHHHHHHHHHCCCCCC
Confidence 569999999987653311 1235889999999987521 467899999999999999999999999
Q ss_pred CCCHHHHHHHHHcC-CCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002738 796 GLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874 (886)
Q Consensus 796 g~s~~el~~~I~~~-~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EILehL 874 (886)
+.+..++...+... .++.++ ...++.+.+|+.+||+.||.+|||+.+|++.|
T Consensus 224 ~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l 276 (283)
T PHA02988 224 NLTTKEIYDLIINKNNSLKLP---------------------------LDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276 (283)
T ss_pred CCCHHHHHHHHHhcCCCCCCC---------------------------CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 88887777666543 222211 12355799999999999999999999999999
Q ss_pred Hhhc
Q 002738 875 VART 878 (886)
Q Consensus 875 e~l~ 878 (886)
+.+.
T Consensus 277 ~~~~ 280 (283)
T PHA02988 277 SLYK 280 (283)
T ss_pred HHHH
Confidence 8764
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=339.09 Aligned_cols=263 Identities=22% Similarity=0.352 Sum_probs=208.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceee
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 620 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~~-------~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~ 620 (886)
.++++|++.+.||+|+||.||+|...+ ..+++|..... ..... ...+.+|+.++.+++||||++++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~---~~~~~----~~~~~~ei~~l~~l~h~~i~~~~ 74 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN---AEPKV----QQEFRQEAELMSDLQHPNIVCLL 74 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC---CCHHH----HHHHHHHHHHHHhcCCcccceEE
Confidence 356789999999999999999998633 35777764322 11222 23458999999999999999999
Q ss_pred eeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCC-----------CcCCHHHHHHHHHHHHHHHHHH
Q 002738 621 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE-----------KHVSVKLALFIAQDVAAALVEL 689 (886)
Q Consensus 621 g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~-----------~~Ls~~~i~~Ia~QIa~AL~yL 689 (886)
+++..... .+++|||+++++|.+++........ ..+++..++.++.||+.||.||
T Consensus 75 ~~~~~~~~--------------~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~l 140 (283)
T cd05048 75 GVCTKEQP--------------TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL 140 (283)
T ss_pred EEEcCCCc--------------eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHH
Confidence 99876543 5999999999999999986322111 4578899999999999999999
Q ss_pred HhCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCC
Q 002738 690 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 769 (886)
Q Consensus 690 Hs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~ 769 (886)
|++||+||||||+|||++.+ +.++|+|||++......... .......+++.|+|||++.+ .
T Consensus 141 H~~~i~H~dlkp~Nil~~~~-------~~~~L~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~ 201 (283)
T cd05048 141 SSHHFVHRDLAARNCLVGEG-------LTVKISDFGLSRDIYSADYY--------RVQSKSLLPVRWMPPEAILY----G 201 (283)
T ss_pred HhCCeeccccccceEEEcCC-------CcEEECCCcceeeccccccc--------cccCCCcccccccCHHHhcc----C
Confidence 99999999999999999876 46999999999765332111 01122356889999999875 5
Q ss_pred CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHH
Q 002738 770 LYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 848 (886)
Q Consensus 770 ~~s~KSDIWSLGVILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 848 (886)
.++.++|||||||++|||++ |..||.+....++...+.....+..+ ...+..
T Consensus 202 ~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~ 254 (283)
T cd05048 202 KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCP---------------------------EDCPAR 254 (283)
T ss_pred cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCc---------------------------ccCCHH
Confidence 68899999999999999998 99999988888777777655433222 123567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002738 849 LVDVFRRCTEENPTERPTAGDLYEMFVAR 877 (886)
Q Consensus 849 L~dLL~rCL~~DP~kRPSA~EILehLe~l 877 (886)
+.+|+.+||+.||.+||++.+|+++|+++
T Consensus 255 ~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 255 VYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 99999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=352.16 Aligned_cols=279 Identities=21% Similarity=0.255 Sum_probs=216.4
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
.|.-.+.+|.|+||.||+|.. .+..+|+|..-.+.. .+ .+|+.+|+.+.|||||++.-+|.....
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~k------nrEl~im~~l~HpNIV~L~~~f~~~~~- 91 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YK------NRELQIMRKLDHPNIVRLLYFFSSSTE- 91 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cC------cHHHHHHHhcCCcCeeeEEEEEEecCC-
Confidence 578899999999999999997 556888887643321 11 569999999999999999988875542
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
.......+||||++ .+|.++++..... +..++...++-+++||.+||+|||+.||+||||||.|||+|.+
T Consensus 92 --------~d~~~lnlVleymP-~tL~~~~r~~~~~-~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~ 161 (364)
T KOG0658|consen 92 --------SDEVYLNLVLEYMP-ETLYRVIRHYTRA-NQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPD 161 (364)
T ss_pred --------CchhHHHHHHHhch-HHHHHHHHHHhhc-CCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCC
Confidence 01345789999998 6999999864333 3678888999999999999999999999999999999999987
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
. +.+||||||.|+.+...... .....|..|+|||.+.+ ...|+.+.||||.||++.||+-
T Consensus 162 t------g~LKicDFGSAK~L~~~epn-----------iSYicSRyYRaPELifg---a~~Yt~~IDiWSaGCV~aELl~ 221 (364)
T KOG0658|consen 162 T------GVLKICDFGSAKVLVKGEPN-----------ISYICSRYYRAPELIFG---ATEYTTSIDIWSAGCVMAELLK 221 (364)
T ss_pred C------CeEEeccCCcceeeccCCCc-----------eeEEEeccccCHHHHcC---ccccCceeEEhhhhHHHHHHhc
Confidence 3 78999999999987654322 34568999999999997 5679999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccc-ccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC-HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~ 868 (886)
|++.|+|.+..+.+..|.+....+-.+.+..+... .+..+++.....-........++++.+|+.++|.++|.+|.++.
T Consensus 222 g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~ 301 (364)
T KOG0658|consen 222 GQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSAL 301 (364)
T ss_pred CCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHH
Confidence 99999999988877777766333334444333211 11111111111100113344567899999999999999999999
Q ss_pred HHHHH
Q 002738 869 DLYEM 873 (886)
Q Consensus 869 EILeh 873 (886)
|++.|
T Consensus 302 ~~l~h 306 (364)
T KOG0658|consen 302 EALAH 306 (364)
T ss_pred HHhcc
Confidence 99987
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=368.51 Aligned_cols=258 Identities=21% Similarity=0.313 Sum_probs=219.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
..++-|++++.||.|+.|.|-+|++ +|+.+|||++..... ..... .+.+.+||.||+.|.||||+++|+++..
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~-~s~s~----~~~IerEIviMkLi~HpnVl~LydVwe~ 83 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSE-LSSSQ----PAGIEREIVIMKLIEHPNVLRLYDVWEN 83 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeeccccc-ccccc----ccchhhhhHHHHHhcCCCeeeeeeeecc
Confidence 3567789999999999999999997 788999999865432 12222 2345899999999999999999999987
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
.. ++|+|.||++||-|.+++-. .+.+++.++.++++||+.|+.|+|..+|+||||||+|+|
T Consensus 84 ~~--------------~lylvlEyv~gGELFdylv~-----kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlL 144 (786)
T KOG0588|consen 84 KQ--------------HLYLVLEYVPGGELFDYLVR-----KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLL 144 (786)
T ss_pred Cc--------------eEEEEEEecCCchhHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhh
Confidence 66 46999999999999999986 577999999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
|+..+ .+||+|||+|..-..... -.+.+|.|.|+|||+++| ..+.+.++||||.|||||
T Consensus 145 Ld~~~-------nIKIADFGMAsLe~~gkl-----------LeTSCGSPHYA~PEIV~G---~pYdG~~sDVWSCGVILf 203 (786)
T KOG0588|consen 145 LDVKN-------NIKIADFGMASLEVPGKL-----------LETSCGSPHYAAPEIVSG---RPYDGRPSDVWSCGVILF 203 (786)
T ss_pred hhccc-------CEeeeccceeecccCCcc-----------ccccCCCcccCCchhhcC---CCCCCCccccchhHHHHH
Confidence 99884 399999999975443322 234579999999999998 345589999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
.|+||+.||.+.+...++.++++|.+. +| ..++.++++||.+||..||.+|.
T Consensus 204 ALLtG~LPFdDdNir~LLlKV~~G~f~-MP---------------------------s~Is~eaQdLLr~ml~VDp~~Ri 255 (786)
T KOG0588|consen 204 ALLTGKLPFDDDNIRVLLLKVQRGVFE-MP---------------------------SNISSEAQDLLRRMLDVDPSTRI 255 (786)
T ss_pred HHHhCCCCCCCccHHHHHHHHHcCccc-CC---------------------------CcCCHHHHHHHHHHhccCccccc
Confidence 999999999999999999999988542 22 12356899999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 002738 866 TAGDLYEMFVART 878 (886)
Q Consensus 866 SA~EILehLe~l~ 878 (886)
|++||++|..-..
T Consensus 256 T~~eI~kHP~l~g 268 (786)
T KOG0588|consen 256 TTEEILKHPFLSG 268 (786)
T ss_pred cHHHHhhCchhhc
Confidence 9999999976444
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=352.37 Aligned_cols=244 Identities=25% Similarity=0.358 Sum_probs=197.4
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 634 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~~ 634 (886)
+.||+|+||.||+|+. .+..+|+|+....... ..... ..+.+|+.++++++||||+++++++....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~----~~~~~e~~~l~~l~hp~i~~~~~~~~~~~------- 68 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVII-AKDEV----AHTLTESRVLQNTRHPFLTALKYSFQTHD------- 68 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhHHH----HHHHHHHHHHHhCCCCCCCCEEEEEEcCC-------
Confidence 4699999999999986 5678999987533211 11122 23478999999999999999999988655
Q ss_pred CCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCC
Q 002738 635 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 714 (886)
Q Consensus 635 ~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~ 714 (886)
..||||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 69 -------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~----- 131 (323)
T cd05571 69 -------RLCFVMEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD----- 131 (323)
T ss_pred -------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-----
Confidence 46999999999999999975 3568999999999999999999999999999999999999877
Q ss_pred CCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 002738 715 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 794 (886)
Q Consensus 715 ~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF 794 (886)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 132 --~~~kl~DfG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltg~~Pf 195 (323)
T cd05571 132 --GHIKITDFGLCKEGISDGA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPF 195 (323)
T ss_pred --CCEEEeeCCCCcccccCCC----------cccceecCccccChhhhcC----CCCCccccCcccchhhhhhhcCCCCC
Confidence 4699999999875322111 1123469999999999976 66889999999999999999999999
Q ss_pred CCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHH
Q 002738 795 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGD 869 (886)
Q Consensus 795 ~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP-----SA~E 869 (886)
.+.+...+...+..... .++ ...++.+.+||.+||..||.+|| ++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~-~~p---------------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 247 (323)
T cd05571 196 YNQDHEKLFELILMEEI-RFP---------------------------RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKE 247 (323)
T ss_pred CCCCHHHHHHHHHcCCC-CCC---------------------------CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHH
Confidence 88877766666544321 111 11245789999999999999999 8999
Q ss_pred HHHH
Q 002738 870 LYEM 873 (886)
Q Consensus 870 ILeh 873 (886)
+++|
T Consensus 248 ll~h 251 (323)
T cd05571 248 IMEH 251 (323)
T ss_pred HHcC
Confidence 9987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=333.88 Aligned_cols=257 Identities=19% Similarity=0.301 Sum_probs=204.2
Q ss_pred CCCCceeeeeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeE
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 623 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~~-----~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~ 623 (886)
...+|++.+.||+|+||.||+|.+. +..+|+|+.... ....... .+.+|+.++++++||||+++++++
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~---~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~ 75 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG---CSDKQRR----GFLAEALTLGQFDHSNIVRLEGVI 75 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC---CCHHHHH----HHHHHHHHHhcCCCCCcCeEEEEE
Confidence 4567999999999999999999752 456777775422 1222223 348999999999999999999998
Q ss_pred ecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 002738 624 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703 (886)
Q Consensus 624 ~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsN 703 (886)
.... ..++||||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|
T Consensus 76 ~~~~--------------~~~lv~e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~n 137 (266)
T cd05064 76 TRGN--------------TMMIVTEYMSNGALDSFLRK----HEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHK 137 (266)
T ss_pred ecCC--------------CcEEEEEeCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhh
Confidence 7554 36999999999999999975 12468999999999999999999999999999999999
Q ss_pred EEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 002738 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783 (886)
Q Consensus 704 ILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVI 783 (886)
||++.+ +.++|+|||.+......... ......++..|+|||++.+ ..++.++|||||||+
T Consensus 138 ili~~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~ 197 (266)
T cd05064 138 VLVNSD-------LVCKISGFRRLQEDKSEAIY---------TTMSGKSPVLWAAPEAIQY----HHFSSASDVWSFGIV 197 (266)
T ss_pred EEEcCC-------CcEEECCCcccccccccchh---------cccCCCCceeecCHHHHhh----CCccchhHHHHHHHH
Confidence 999876 56999999987653221110 0112235678999999876 678899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 002738 784 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 862 (886)
Q Consensus 784 LyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~ 862 (886)
+|||++ |..||.+.+..++...+..+..+..+ ...+..+.+++.+||+.+|.
T Consensus 198 l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~c~~~~p~ 250 (266)
T cd05064 198 MWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAP---------------------------RNCPNLLHQLMLDCWQKERG 250 (266)
T ss_pred HHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCC---------------------------CCCCHHHHHHHHHHcCCCch
Confidence 999775 99999988888777776655332222 11245789999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 002738 863 ERPTAGDLYEMFVAR 877 (886)
Q Consensus 863 kRPSA~EILehLe~l 877 (886)
+||++.+|++.|.++
T Consensus 251 ~RP~~~~i~~~l~~~ 265 (266)
T cd05064 251 ERPRFSQIHSILSKM 265 (266)
T ss_pred hCCCHHHHHHHHHhh
Confidence 999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=348.50 Aligned_cols=284 Identities=20% Similarity=0.259 Sum_probs=219.3
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
.|...+.||.|+||.|+.|.+ .+..||+|.+ ......... .++..+|+++|+.++|+|||.+++++..+.
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi--~~~F~~~~~----akRtlRElklLr~~~HeNIi~l~di~~p~~-- 94 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKI--LNPFENQID----AKRTLRELKLLRHLRHENIIGLLDIFRPPS-- 94 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhh--hhhhhchHH----HHHHHHHHHHHHHhcCCCcceEEeeccccc--
Confidence 345579999999999999997 5567777764 322223333 334599999999999999999999988622
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
......+|+|+|+|+ .+|.+.|+. +..++...+..+++||++||.|+|+.+|+||||||.|+|++.+
T Consensus 95 -------~~~f~DvYiV~elMe-tDL~~iik~-----~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~ 161 (359)
T KOG0660|consen 95 -------RDKFNDVYLVFELME-TDLHQIIKS-----QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNAD 161 (359)
T ss_pred -------ccccceeEEehhHHh-hHHHHHHHc-----CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccC
Confidence 123457899999995 799999986 3459999999999999999999999999999999999999988
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.+||+|||+|+....... ....+..+.|..|.|||++.. ...|+.+.||||+||||.||++
T Consensus 162 -------c~lKI~DFGLAR~~~~~~~--------~~~mTeYVaTRWYRAPElll~---~~~Yt~aiDiWSvGCI~AEmL~ 223 (359)
T KOG0660|consen 162 -------CDLKICDFGLARYLDKFFE--------DGFMTEYVATRWYRAPELLLN---SSEYTKAIDIWSVGCILAEMLT 223 (359)
T ss_pred -------CCEEeccccceeeccccCc--------ccchhcceeeeeecCHHHHhc---cccccchhhhhhhhHHHHHHHc
Confidence 5599999999998754311 112255689999999999975 4679999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccC---CCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG---SGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
|++.|.|.+..+.+..|......+-++.+..+.........+.. ...+.....+...+...+|+++||..||.+|+|
T Consensus 224 gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRit 303 (359)
T KOG0660|consen 224 GKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRIT 303 (359)
T ss_pred CCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCC
Confidence 99999999988888888776444444444433211111111111 111222334566788999999999999999999
Q ss_pred HHHHHHHH
Q 002738 867 AGDLYEMF 874 (886)
Q Consensus 867 A~EILehL 874 (886)
++|+|+|.
T Consensus 304 a~eAL~hP 311 (359)
T KOG0660|consen 304 AEEALAHP 311 (359)
T ss_pred HHHHhcCh
Confidence 99999983
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=342.18 Aligned_cols=280 Identities=20% Similarity=0.262 Sum_probs=199.0
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
.-++|++.+.||+|+||.||+|+. .+..+|+|+........ .. ..+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG---TP----FTAIREASLLKGLKHANIVLLHDIIHTK 75 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc---cc----hhHHHHHHHHhhCCCCCcCeEEEEEecC
Confidence 346899999999999999999997 56789999865332111 11 1237899999999999999999998865
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
. ..++||||+. ++|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 76 ~--------------~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill 136 (303)
T cd07869 76 E--------------TLTLVFEYVH-TDLCQYMDK----HPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI 136 (303)
T ss_pred C--------------eEEEEEECCC-cCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 5 3699999996 688888865 23458899999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +.+||+|||++......... .....||+.|+|||++.+ ...++.++|||||||++|+
T Consensus 137 ~~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ 196 (303)
T cd07869 137 SDT-------GELKLADFGLARAKSVPSHT----------YSNEVVTLWYRPPDVLLG---STEYSTCLDMWGVGCIFVE 196 (303)
T ss_pred CCC-------CCEEECCCCcceeccCCCcc----------CCCCcccCCCCChHHHcC---CCCCCcHHHHHHHHHHHHH
Confidence 876 45999999998754321111 123458999999999865 2457889999999999999
Q ss_pred HHhCCCCCCCCCHH-HHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCc-----hhhhhhHHHHHHHHHHhcccC
Q 002738 787 LLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP-----EAELETLSFLVDVFRRCTEEN 860 (886)
Q Consensus 787 LLTG~~PF~g~s~~-el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~-----~~~~~~s~~L~dLL~rCL~~D 860 (886)
|++|..||.+.... .....+...........+......... ........... ......+..+.+|+.+||+.|
T Consensus 197 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 275 (303)
T cd07869 197 MIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF-KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCF 275 (303)
T ss_pred HHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc-ccccccccCCccHHHHhhccCCChHHHHHHHHHhccC
Confidence 99999999876432 233333221111111111100000000 00000000000 000112357889999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 002738 861 PTERPTAGDLYEMFV 875 (886)
Q Consensus 861 P~kRPSA~EILehLe 875 (886)
|.+|||+.|+++|-.
T Consensus 276 p~~R~s~~~~l~h~~ 290 (303)
T cd07869 276 PKNRLSAQAALSHEY 290 (303)
T ss_pred chhccCHHHHhcCcc
Confidence 999999999999843
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=340.60 Aligned_cols=267 Identities=19% Similarity=0.265 Sum_probs=200.7
Q ss_pred CCCCceeeeeecccCceEEEEEEEC------------------CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhh
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKFG------------------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGA 610 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~~------------------~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~ 610 (886)
+.++|.+.++||+|+||.||+|.+. +..+|+|+..... ...... .+.+|+.+|.+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~----~~~~E~~~l~~ 75 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---NKNARN----DFLKEVKILSR 75 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---CHHHHH----HHHHHHHHHhh
Confidence 3468999999999999999999852 2358888864321 222223 34899999999
Q ss_pred CCCCCcceeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhcc--------------CCCcCCHHHHH
Q 002738 611 LRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--------------GEKHVSVKLAL 676 (886)
Q Consensus 611 L~HPNIVrl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~--------------~~~~Ls~~~i~ 676 (886)
++||||+++++++..... .++||||+++++|.+++...... ....+++..++
T Consensus 76 l~h~niv~~~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (304)
T cd05096 76 LKDPNIIRLLGVCVDEDP--------------LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLL 141 (304)
T ss_pred cCCCCeeEEEEEEecCCc--------------eEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHH
Confidence 999999999999986543 69999999999999999752210 11346788899
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcc
Q 002738 677 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 756 (886)
Q Consensus 677 ~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~Y 756 (886)
.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++......... ......++..|
T Consensus 142 ~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~-------~~~kl~DfG~~~~~~~~~~~~--------~~~~~~~~~~y 206 (304)
T cd05096 142 HVALQIASGMKYLSSLNFVHRDLATRNCLVGEN-------LTIKIADFGMSRNLYAGDYYR--------IQGRAVLPIRW 206 (304)
T ss_pred HHHHHHHHHHHHHHHCCccccCcchhheEEcCC-------ccEEECCCccceecccCceeE--------ecCcCCCCccc
Confidence 999999999999999999999999999999877 569999999997653321110 01223467899
Q ss_pred cchhhhhcccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCC
Q 002738 757 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT--LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS 834 (886)
Q Consensus 757 mAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT--G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~ 834 (886)
+|||++.+ ..++.++|||||||++|||++ +..||.+.+..++...+...........
T Consensus 207 ~aPE~~~~----~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~----------------- 265 (304)
T cd05096 207 MAWECILM----GKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQV----------------- 265 (304)
T ss_pred cCHHHHhc----CCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccc-----------------
Confidence 99999875 568999999999999999987 6688888776665544432111000000
Q ss_pred CCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002738 835 GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 875 (886)
Q Consensus 835 ~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EILehLe 875 (886)
........+..+.+|+.+||..||.+|||+.+|.+.|+
T Consensus 266 ---~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 266 ---YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred ---cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 00001123457999999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=342.72 Aligned_cols=255 Identities=23% Similarity=0.300 Sum_probs=197.1
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
.|++.+.||+|+||.||+|.+ .+..+|+|++....... ... ...+.+|+.+++.++|+||+++++++....
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~----~~~~~~E~~il~~l~~~~iv~~~~~~~~~~-- 73 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKG----EAMALNEKRILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh-hhh----HHHHHHHHHHHHhcCCCcEEEEEEEEccCC--
Confidence 478899999999999999986 57789999864332111 111 123478999999999999999999987655
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..++||||+++|+|..++.. .....+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 74 ------------~~~lv~e~~~~g~L~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~ 138 (285)
T cd05631 74 ------------ALCLVLTIMNGGDLKFHIYN---MGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDR 138 (285)
T ss_pred ------------eEEEEEEecCCCcHHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC
Confidence 36999999999999988864 223458999999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 139 -------~~~kl~Dfg~~~~~~~~~~-----------~~~~~g~~~y~aPE~~~~----~~~~~~~DvwslGvil~el~~ 196 (285)
T cd05631 139 -------GHIRISDLGLAVQIPEGET-----------VRGRVGTVGYMAPEVINN----EKYTFSPDWWGLGCLIYEMIQ 196 (285)
T ss_pred -------CCEEEeeCCCcEEcCCCCe-----------ecCCCCCCCccCHhhhcC----CCCCcccCchhHHHHHHHHHh
Confidence 4699999999976532111 123468999999999986 678899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC---
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT--- 866 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS--- 866 (886)
|+.||.+.........+........ .......+..+.+||.+||+.||.+||+
T Consensus 197 g~~pf~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~ 252 (285)
T cd05631 197 GQSPFRKRKERVKREEVDRRVKEDQ------------------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRG 252 (285)
T ss_pred CCCCCCCCCcchhHHHHHHHhhccc------------------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCC
Confidence 9999987654322222221100000 0001123557899999999999999997
Q ss_pred --HHHHHHHH
Q 002738 867 --AGDLYEMF 874 (886)
Q Consensus 867 --A~EILehL 874 (886)
++++++|-
T Consensus 253 ~~~~~~~~h~ 262 (285)
T cd05631 253 NGAAGVKQHP 262 (285)
T ss_pred CCHHHHhcCH
Confidence 89999983
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=349.43 Aligned_cols=255 Identities=24% Similarity=0.335 Sum_probs=205.4
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|++.+.||+|+||.||+|++ .+..||+|++...... ..... ..+.+|+.++..++||||+++++++....
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~----~~~~~e~~~l~~~~h~~iv~~~~~~~~~~- 74 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-KLNEV----RHVLTERDILTTTKSEWLVKLLYAFQDDE- 74 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHH----HHHHHHHHHHHhCCCCCCccEEEEEEcCC-
Confidence 4799999999999999999997 4678999997543211 11122 34488999999999999999999988654
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..||||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~ 136 (333)
T cd05600 75 -------------YLYLAMEYVPGGDFRTLLNN-----LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDA 136 (333)
T ss_pred -------------EEEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC
Confidence 46999999999999999975 346889999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 137 ~-------~~~kL~Dfg~a~~~~~~-------------~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~ell 192 (333)
T cd05600 137 S-------GHIKLTDFGLSKGIVTY-------------ANSVVGSPDYMAPEVLRG----KGYDFTVDYWSLGCMLYEFL 192 (333)
T ss_pred C-------CCEEEEeCcCCcccccc-------------cCCcccCccccChhHhcC----CCCCCccceecchHHHhhhh
Confidence 7 46999999999765431 123469999999999986 57889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCC-CchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRP-RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~~~rp-~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
+|..||.+.+..+....+...... ..+. ........++.+.+||.+||..+|.+||++
T Consensus 193 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---------------------~~~~~~~~s~~~~~li~~~l~~~~~rr~s~ 251 (333)
T cd05600 193 CGFPPFSGSTPNETWENLKYWKETLQRPV---------------------YDDPRFNLSDEAWDLITKLINDPSRRFGSL 251 (333)
T ss_pred hCCCCCCCCCHHHHHHHHHhccccccCCC---------------------CCccccccCHHHHHHHHHHhhChhhhcCCH
Confidence 999999988887776666543110 0000 000002235678999999999999999999
Q ss_pred HHHHHHH
Q 002738 868 GDLYEMF 874 (886)
Q Consensus 868 ~EILehL 874 (886)
.++++|.
T Consensus 252 ~~ll~h~ 258 (333)
T cd05600 252 EDIKNHP 258 (333)
T ss_pred HHHHhCc
Confidence 9999983
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=339.43 Aligned_cols=282 Identities=18% Similarity=0.244 Sum_probs=208.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
..+++|.+.+.||+|+||.||+|++ .+..+|+|.......... . ..+.+|+.++++++||||+++++++..
T Consensus 3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~----~~~~~E~~~l~~l~h~~iv~~~~~~~~ 75 (309)
T cd07872 3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA---P----CTAIREVSLLKDLKHANIVTLHDIVHT 75 (309)
T ss_pred CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc---c----hhHHHHHHHHHhCCCCCcceEEEEEee
Confidence 4678899999999999999999987 566789998654322111 1 123789999999999999999999886
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
.. ..++||||++ ++|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 76 ~~--------------~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nil 136 (309)
T cd07872 76 DK--------------SLTLVFEYLD-KDLKQYMDD----CGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLL 136 (309)
T ss_pred CC--------------eEEEEEeCCC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 55 3699999997 589888865 2345789999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.+ +.+||+|||++......... .....+|+.|+|||++.+ ...++.++|||||||++|
T Consensus 137 l~~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 196 (309)
T cd07872 137 INER-------GELKLADFGLARAKSVPTKT----------YSNEVVTLWYRPPDVLLG---SSEYSTQIDMWGVGCIFF 196 (309)
T ss_pred ECCC-------CCEEECccccceecCCCccc----------cccccccccccCCHHHhC---CCCCCcHHHHHHHHHHHH
Confidence 9877 46999999998754332111 122357899999999875 245788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCC--CchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE--KPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
+|+||+.||.+.+..+....+...........++.................. ........++.+.+||.+||..||.+
T Consensus 197 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 276 (309)
T cd07872 197 EMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKK 276 (309)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhh
Confidence 9999999999888777666665543333333332211110000000000000 00111234667899999999999999
Q ss_pred CCCHHHHHHHHH
Q 002738 864 RPTAGDLYEMFV 875 (886)
Q Consensus 864 RPSA~EILehLe 875 (886)
|||+.|+++|-.
T Consensus 277 R~t~~e~l~h~~ 288 (309)
T cd07872 277 RISAEEAMKHAY 288 (309)
T ss_pred CCCHHHHhcChh
Confidence 999999999854
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=351.33 Aligned_cols=251 Identities=21% Similarity=0.288 Sum_probs=205.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC---eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEe
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 624 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~~---~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~ 624 (886)
..+++|++.+.||+|+||.||+|.+.+ ..+|+|++...... ..... ..+.+|+.+++.++||||+++++++.
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-~~~~~----~~~~~E~~~l~~l~hp~Iv~~~~~~~ 101 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-KQKQV----DHVFSERKILNYINHPFCVNLYGSFK 101 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-hhhhH----HHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 678899999999999999999998632 46899986533211 11122 23488999999999999999999998
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNI 704 (886)
... ..++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 102 ~~~--------------~~~lv~Ey~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NI 162 (340)
T PTZ00426 102 DES--------------YLYLVLEFVIGGEFFTFLRR-----NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENL 162 (340)
T ss_pred eCC--------------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHE
Confidence 655 46999999999999999976 35689999999999999999999999999999999999
Q ss_pred EEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVIL 784 (886)
|++.+ +.+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||++
T Consensus 163 Ll~~~-------~~ikL~DFG~a~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvil 218 (340)
T PTZ00426 163 LLDKD-------GFIKMTDFGFAKVVDTRT-------------YTLCGTPEYIAPEILLN----VGHGKAADWWTLGIFI 218 (340)
T ss_pred EECCC-------CCEEEecCCCCeecCCCc-------------ceecCChhhcCHHHHhC----CCCCccccccchhhHH
Confidence 99876 569999999997653211 23469999999999986 5678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 002738 785 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 864 (886)
Q Consensus 785 yELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kR 864 (886)
|||++|..||.+.+.......+..+.. .++ ...++.+.+||.+||+.||.+|
T Consensus 219 ~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p---------------------------~~~~~~~~~li~~~l~~dp~~R 270 (340)
T PTZ00426 219 YEILVGCPPFYANEPLLIYQKILEGII-YFP---------------------------KFLDNNCKHLMKKLLSHDLTKR 270 (340)
T ss_pred HHHhcCCCCCCCCCHHHHHHHHhcCCC-CCC---------------------------CCCCHHHHHHHHHHcccCHHHc
Confidence 999999999998888777776655421 111 0123468899999999999999
Q ss_pred C-----CHHHHHHHH
Q 002738 865 P-----TAGDLYEMF 874 (886)
Q Consensus 865 P-----SA~EILehL 874 (886)
+ +++++++|.
T Consensus 271 ~~~~~~~~~~~~~hp 285 (340)
T PTZ00426 271 YGNLKKGAQNVKEHP 285 (340)
T ss_pred CCCCCCCHHHHHcCC
Confidence 5 899999983
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=361.86 Aligned_cols=288 Identities=19% Similarity=0.238 Sum_probs=205.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
..-.+|++.+.||+|+||.||+|.. .+..||+|.+.... .. ..+|+.+|+.++|||||++++++..
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~----~~~Ei~il~~l~h~niv~l~~~~~~ 130 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QY----KNRELLIMKNLNHINIIFLKDYYYT 130 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------ch----HHHHHHHHHhcCCCCCcceeeeEee
Confidence 3456899999999999999999987 56789999763211 11 1579999999999999999998764
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
.... .......+++||||++ ++|.+++..... ....+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 131 ~~~~------~~~~~~~l~lvmE~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NIL 202 (440)
T PTZ00036 131 ECFK------KNEKNIFLNVVMEFIP-QTVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLL 202 (440)
T ss_pred cccc------cCCCceEEEEEEecCC-ccHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEE
Confidence 3210 0112234789999997 588888865322 2356899999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
|+.++ ..+||+|||+|+.+..... .....||+.|+|||++.+ ...++.++|||||||+||
T Consensus 203 l~~~~------~~vkL~DFGla~~~~~~~~-----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlGvil~ 262 (440)
T PTZ00036 203 IDPNT------HTLKLCDFGSAKNLLAGQR-----------SVSYICSRFYRAPELMLG---ATNYTTHIDLWSLGCIIA 262 (440)
T ss_pred EcCCC------CceeeeccccchhccCCCC-----------cccCCCCcCccCHHHhcC---CCCCCcHHHHHHHHHHHH
Confidence 98652 4699999999986543211 123468999999999875 246889999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcc-cccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS-CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 864 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kR 864 (886)
||++|.+||.+.+..+.+..+......+..+.+..... .....+............+...++.+.+||.+||.+||.+|
T Consensus 263 elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R 342 (440)
T PTZ00036 263 EMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKR 342 (440)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHC
Confidence 99999999998877666555544322222222211100 00000000000000000111245689999999999999999
Q ss_pred CCHHHHHHHHH
Q 002738 865 PTAGDLYEMFV 875 (886)
Q Consensus 865 PSA~EILehLe 875 (886)
||+.|+++|-.
T Consensus 343 ~ta~e~l~hp~ 353 (440)
T PTZ00036 343 LNPIEALADPF 353 (440)
T ss_pred cCHHHHhCChh
Confidence 99999999844
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=362.11 Aligned_cols=249 Identities=30% Similarity=0.427 Sum_probs=211.5
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
.|+..+.||+|+||.||+|.+ .+..||+|+..+... .++++.+ .+|+.+|..++++||.++||.+.....
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~---~deIedi----qqei~~Ls~~~~~~it~yygsyl~g~~- 85 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA---EDEIEDI----QQEISVLSQCDSPNITEYYGSYLKGTK- 85 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhc---chhhHHH----HHHHHHHHhcCcchHHhhhhheeeccc-
Confidence 467779999999999999997 566789998776643 3344444 889999999999999999999986654
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
+||+||||.||++.+.++. ...+.+..+..|+++++.||.|||.++.+|||||+.|||+..+
T Consensus 86 -------------LwiiMey~~gGsv~~lL~~-----~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~ 147 (467)
T KOG0201|consen 86 -------------LWIIMEYCGGGSVLDLLKS-----GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES 147 (467)
T ss_pred -------------HHHHHHHhcCcchhhhhcc-----CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEecc
Confidence 6999999999999999985 3445888899999999999999999999999999999999988
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.|||+|||.+..+..... ...+++|||.|||||++.+ ..|+.|+||||||++.+||++
T Consensus 148 -------g~vkl~DfgVa~ql~~~~~----------rr~tfvGTPfwMAPEVI~~----~~Y~~KADIWSLGITaiEla~ 206 (467)
T KOG0201|consen 148 -------GDVKLADFGVAGQLTNTVK----------RRKTFVGTPFWMAPEVIKQ----SGYDTKADIWSLGITAIELAK 206 (467)
T ss_pred -------CcEEEEecceeeeeechhh----------ccccccccccccchhhhcc----ccccchhhhhhhhHHHHHHhc
Confidence 4599999999987765332 2366789999999999986 789999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 869 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~E 869 (886)
|.+||....++.++..|-+...|.+.. ..++.+++|+..||..||+.||+|.+
T Consensus 207 GePP~s~~hPmrvlflIpk~~PP~L~~---------------------------~~S~~~kEFV~~CL~k~P~~RpsA~~ 259 (467)
T KOG0201|consen 207 GEPPHSKLHPMRVLFLIPKSAPPRLDG---------------------------DFSPPFKEFVEACLDKNPEFRPSAKE 259 (467)
T ss_pred CCCCCcccCcceEEEeccCCCCCcccc---------------------------ccCHHHHHHHHHHhhcCcccCcCHHH
Confidence 999999988876666665554444332 23567999999999999999999999
Q ss_pred HHHHH
Q 002738 870 LYEMF 874 (886)
Q Consensus 870 ILehL 874 (886)
+|+|=
T Consensus 260 LLKh~ 264 (467)
T KOG0201|consen 260 LLKHK 264 (467)
T ss_pred HhhhH
Confidence 99983
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=357.04 Aligned_cols=265 Identities=23% Similarity=0.325 Sum_probs=213.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
..+++|++++.||+|+||.||+|+- .+..+|+|+.+.... .....++.. +.|-.+|....+|+||++|-.|.+
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M-~~~~Qv~hV----~aERdiL~~~ds~~vVKLyYsFQD 212 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEM-LKKNQVEHV----RAERDILAEVDSPWVVKLYYSFQD 212 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHH-HhhhhHHHH----HHHHHHhhhcCCCcEEEEEEEecC
Confidence 4788999999999999999999985 778899999643322 222334444 889999999999999999999998
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
..+ +||||||++||++..+|.. ...+++..++.++.+++.|+.-||+.|+|||||||+|+|
T Consensus 213 ~~~--------------LYLiMEylPGGD~mTLL~~-----~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlL 273 (550)
T KOG0605|consen 213 KEY--------------LYLIMEYLPGGDMMTLLMR-----KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLL 273 (550)
T ss_pred CCe--------------eEEEEEecCCccHHHHHHh-----cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhhee
Confidence 875 5999999999999999987 567999999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccc---------------cccCC----------------------CCCCC
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCC---------------IAHRG----------------------IPAPD 748 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~---------------~~~~~----------------------~~~~~ 748 (886)
||.. +++||+|||++.-+........ ..... .....
T Consensus 274 iD~~-------GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~ 346 (550)
T KOG0605|consen 274 IDAK-------GHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAY 346 (550)
T ss_pred ecCC-------CCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhh
Confidence 9988 5799999999965432111000 00000 00112
Q ss_pred cccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhcccccc
Q 002738 749 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEH 827 (886)
Q Consensus 749 ~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF~g~s~~el~~~I~~~~-rp~l~~~l~~~~~~~~~ 827 (886)
..+|||.|||||++.+ ..|+..+|.|||||||||||.|.+||.+.++.+....|.+.. ...+|.
T Consensus 347 StVGTPDYiAPEVll~----kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~----------- 411 (550)
T KOG0605|consen 347 STVGTPDYIAPEVLLG----KGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE----------- 411 (550)
T ss_pred cccCCccccchHHHhc----CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-----------
Confidence 3489999999999997 679999999999999999999999999999999999887652 111111
Q ss_pred cccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 002738 828 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP---TAGDLYEM 873 (886)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP---SA~EILeh 873 (886)
....++++++||.+||. ||.+|. .++||.+|
T Consensus 412 --------------~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 412 --------------EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred --------------cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence 11234689999999999 999996 58888877
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=351.55 Aligned_cols=263 Identities=21% Similarity=0.251 Sum_probs=203.9
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|++.+.||+|+||.||+|+. .+..||+|++...... . ......+.+|+.+|..++||||+++++++....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~----~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~- 74 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-E----KEQVAHVRAERDILAEADNPWVVKLYYSFQDEN- 74 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-h----hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-
Confidence 4799999999999999999997 5678999997533211 1 111234488999999999999999999998665
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..||||||++||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~E~~~~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~ 136 (364)
T cd05599 75 -------------YLYLIMEYLPGGDMMTLLMK-----KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDA 136 (364)
T ss_pred -------------eEEEEECCCCCcHHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC
Confidence 36999999999999999976 346899999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCccccccccccccccc----------------------------CCCCCCCcccCCCcccchh
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH----------------------------RGIPAPDVCVGTPRWMAPE 760 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~----------------------------~~~~~~~~~vGT~~YmAPE 760 (886)
+ +.+||+|||++..+........... .........+||+.|+|||
T Consensus 137 ~-------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 209 (364)
T cd05599 137 K-------GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE 209 (364)
T ss_pred C-------CCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHH
Confidence 7 5699999999876532211000000 0000111246999999999
Q ss_pred hhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhcccccccccccCCCCCCc
Q 002738 761 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKP 839 (886)
Q Consensus 761 vL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF~g~s~~el~~~I~~~~r-p~l~~~l~~~~~~~~~~~~~~~~~~~~~ 839 (886)
++.. ..++.++|||||||++|||++|..||.+.+..+....+..... ..++.
T Consensus 210 ~~~~----~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~----------------------- 262 (364)
T cd05599 210 VFLQ----TGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPD----------------------- 262 (364)
T ss_pred HHcC----CCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCC-----------------------
Confidence 9975 6688999999999999999999999998888777666654321 11110
Q ss_pred hhhhhhHHHHHHHHHHhcccCCCCCCC---HHHHHHHH
Q 002738 840 EAELETLSFLVDVFRRCTEENPTERPT---AGDLYEMF 874 (886)
Q Consensus 840 ~~~~~~s~~L~dLL~rCL~~DP~kRPS---A~EILehL 874 (886)
....++.+.+||.+||. +|.+|++ +.++++|-
T Consensus 263 --~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 263 --EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred --CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 01234578999999997 9999997 99999974
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=344.97 Aligned_cols=242 Identities=24% Similarity=0.317 Sum_probs=194.5
Q ss_pred ecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCC
Q 002738 559 AGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 636 (886)
Q Consensus 559 LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~~~~ 636 (886)
||+|+||.||+|++ .+..+|+|+...... ....... .+.+|+.++.+++||||+++++++....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------- 66 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI-VSRSEVT----HTLAERTVLAQVNCPFIVPLKFSFQSPE--------- 66 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHH----HHHHHHHHHHhCCCCcEeceeeEEecCC---------
Confidence 79999999999997 456799998653211 1112222 3488999999999999999999987654
Q ss_pred CcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCCCC
Q 002738 637 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 716 (886)
Q Consensus 637 ~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~~ 716 (886)
..++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 67 -----~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~------- 129 (312)
T cd05585 67 -----KLYLVLAFINGGELFHHLQR-----EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ------- 129 (312)
T ss_pred -----eEEEEEcCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCC-------
Confidence 46999999999999999975 3468999999999999999999999999999999999999877
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 002738 717 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 796 (886)
Q Consensus 717 ~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF~g 796 (886)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+
T Consensus 130 ~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGvil~el~tg~~pf~~ 195 (312)
T cd05585 130 GHIALCDFGLCKLNMKDDD----------KTNTFCGTPEYLAPELLLG----HGYTKAVDWWTLGVLLYEMLTGLPPFYD 195 (312)
T ss_pred CcEEEEECcccccCccCCC----------ccccccCCcccCCHHHHcC----CCCCCccceechhHHHHHHHhCCCCcCC
Confidence 4699999999875322111 1133469999999999986 6688999999999999999999999998
Q ss_pred CCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 002738 797 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP---TAGDLYEM 873 (886)
Q Consensus 797 ~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP---SA~EILeh 873 (886)
.+..++...+..... .++ ...++.+.+||.+||..||.+|| ++.+++.|
T Consensus 196 ~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 196 ENVNEMYRKILQEPL-RFP---------------------------DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCHHHHHHHHHcCCC-CCC---------------------------CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 887777666554321 111 11245789999999999999997 57888887
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=340.39 Aligned_cols=277 Identities=23% Similarity=0.299 Sum_probs=203.7
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
.++|++.+.||+|+||.||++++ .+..+|+|+..... ... +...+.+|+.+|++++||||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPA----IRNQIIRELQVLHECNSPYIVGFYGAFYSDG 76 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc---CHH----HHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 57899999999999999999998 46678888865431 122 2334589999999999999999999988654
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEEE
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILI 706 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~-gIVHRDLKPsNILL 706 (886)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||+
T Consensus 77 --------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~ 137 (331)
T cd06649 77 --------------EISICMEHMDGGSLDQVLKE-----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV 137 (331)
T ss_pred --------------EEEEEeecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE
Confidence 46999999999999999976 34688999999999999999999986 69999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +.+||+|||++....... .....||+.|+|||++.+ ..++.++|||||||++||
T Consensus 138 ~~~-------~~~kl~Dfg~~~~~~~~~------------~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~il~e 194 (331)
T cd06649 138 NSR-------GEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPERLQG----THYSVQSDIWSMGLSLVE 194 (331)
T ss_pred cCC-------CcEEEccCcccccccccc------------cccCCCCcCcCCHhHhcC----CCCCchHhHHHHHHHHHH
Confidence 877 469999999987553311 123468999999999986 568899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCC---chhHHhhhcccccccc----------------cccCC-CCCCchhhhhhH
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKRPR---LTDELEALGSCHEHEV----------------AQSGS-GFEKPEAELETL 846 (886)
Q Consensus 787 LLTG~~PF~g~s~~el~~~I~~~~rp~---l~~~l~~~~~~~~~~~----------------~~~~~-~~~~~~~~~~~s 846 (886)
|++|+.||...+..++...+....... ................ ..... ...........+
T Consensus 195 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (331)
T cd06649 195 LAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFT 274 (331)
T ss_pred HHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCcccc
Confidence 999999998777665544332210000 0000000000000000 00000 000000011245
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002738 847 SFLVDVFRRCTEENPTERPTAGDLYEMFV 875 (886)
Q Consensus 847 ~~L~dLL~rCL~~DP~kRPSA~EILehLe 875 (886)
+.+++||.+||+.||++|||+.+|++|..
T Consensus 275 ~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 275 PDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 68999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=327.72 Aligned_cols=265 Identities=20% Similarity=0.333 Sum_probs=203.6
Q ss_pred ceeeeeecccCceEEEEEEECCe----eEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 553 LSSCDEAGKSVSSSLFRCKFGSA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 553 Y~i~k~LG~G~fG~VY~A~~~~~----~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
|.+.+.||+|+||.||+|.+... .+|+|..... .......+.+ .+|+.+++.++||||+++++++.....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA--ICTRSEMEDF----LSEAVCMKEFDHPNVMRLIGVCLQTVE 74 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccC--cCCHHHHHHH----HHHHHHHHhCCCCCcceEEEEEccCCc
Confidence 45788999999999999997432 5788875432 2223333444 889999999999999999998764321
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHh-ccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS-ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~-~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
.......++||||+++|+|.+++.... ......+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 75 --------~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~ 146 (272)
T cd05075 75 --------SEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN 146 (272)
T ss_pred --------ccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEc
Confidence 011234699999999999999885421 12234588999999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ ..+||+|||++.......... ......+++.|+|||++.+ ..++.++|||||||++|||
T Consensus 147 ~~-------~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~----~~~~~~~Di~slG~il~el 207 (272)
T cd05075 147 EN-------MNVCVADFGLSKKIYNGDYYR--------QGRIAKMPVKWIAIESLAD----RVYTTKSDVWSFGVTMWEI 207 (272)
T ss_pred CC-------CCEEECCCCcccccCccccee--------cCCcccCCcccCCHHHccC----CCcChHHHHHHHHHHHHHH
Confidence 76 569999999998664322110 0122346778999999876 6688999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 788 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 788 LT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
++ |+.||.+....++...+..+..+..+ ...+..+.++|.+||+.||++|||
T Consensus 208 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rps 260 (272)
T cd05075 208 ATRGQTPYPGVENSEIYDYLRQGNRLKQP---------------------------PDCLDGLYSLMSSCWLLNPKDRPS 260 (272)
T ss_pred HcCCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHcCCCcccCcC
Confidence 99 89999888777777666654332211 112456899999999999999999
Q ss_pred HHHHHHHHHhh
Q 002738 867 AGDLYEMFVAR 877 (886)
Q Consensus 867 A~EILehLe~l 877 (886)
+.+|+++|+.+
T Consensus 261 ~~~l~~~l~~~ 271 (272)
T cd05075 261 FETLRCELEKA 271 (272)
T ss_pred HHHHHHHHHhh
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=349.71 Aligned_cols=262 Identities=20% Similarity=0.221 Sum_probs=201.3
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|++.+.||+|+||+||+|+. .+..+|+|+...... ........+.+|+.++..++||||+++++.+.+..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~- 74 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM-----LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL- 74 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH-----HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-
Confidence 4789999999999999999987 567899998753211 01112234588999999999999999999988655
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..||||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~ 136 (363)
T cd05628 75 -------------NLYLIMEFLPGGDMMTLLMK-----KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDS 136 (363)
T ss_pred -------------eEEEEEcCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC
Confidence 36999999999999999976 356899999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccc-------------------------cCCCCCCCcccCCCcccchhhhh
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-------------------------HRGIPAPDVCVGTPRWMAPEVLR 763 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~-------------------------~~~~~~~~~~vGT~~YmAPEvL~ 763 (886)
+ +.+||+|||+++.+.......... ..........+||+.|+|||++.
T Consensus 137 ~-------~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~ 209 (363)
T cd05628 137 K-------GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM 209 (363)
T ss_pred C-------CCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc
Confidence 6 469999999997653221100000 00000112357999999999997
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhcccccccccccCCCCCCchhh
Q 002738 764 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 842 (886)
Q Consensus 764 ~~~~~~~~s~KSDIWSLGVILyELLTG~~PF~g~s~~el~~~I~~~~-rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 842 (886)
+ ..++.++|||||||++|||++|+.||.+.+..+....+.... ...++..
T Consensus 210 ~----~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~------------------------- 260 (363)
T cd05628 210 Q----TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPE------------------------- 260 (363)
T ss_pred C----CCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCc-------------------------
Confidence 6 668899999999999999999999999888887777776532 1111110
Q ss_pred hhhHHHHHHHHHHhcccCCC---CCCCHHHHHHH
Q 002738 843 LETLSFLVDVFRRCTEENPT---ERPTAGDLYEM 873 (886)
Q Consensus 843 ~~~s~~L~dLL~rCL~~DP~---kRPSA~EILeh 873 (886)
...++.+.+||.+|+. +|. .||+++||++|
T Consensus 261 ~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 261 VPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 1124578889988765 444 46899999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=334.91 Aligned_cols=250 Identities=26% Similarity=0.363 Sum_probs=212.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
..+++|++.+.||.|+||.|.+++. ++..+|+|+...... .....+ +...+|..+|+.+.||+|+++++.+.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~v-VklKQv----eH~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKV-VKLKQV----EHTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHH-HHHHHH----HHHhhHHHHHhhccCceeEEEEEeecc
Confidence 6789999999999999999999996 778899999643221 111222 334899999999999999999999987
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
... +|+||||++||-|.+++++ .+++++..++.++.||+.||+|||+++|++|||||+|||
T Consensus 116 ~~~--------------lymvmeyv~GGElFS~Lrk-----~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiL 176 (355)
T KOG0616|consen 116 NSN--------------LYMVMEYVPGGELFSYLRK-----SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLL 176 (355)
T ss_pred CCe--------------EEEEEeccCCccHHHHHHh-----cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHee
Confidence 664 6999999999999999987 468999999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
||.+ +.+||+|||+|+...... -+.+|||.|+|||+++. ..++.++|.|||||++|
T Consensus 177 lD~~-------G~iKitDFGFAK~v~~rT-------------~TlCGTPeYLAPEii~s----k~ynkavDWWalGVLIY 232 (355)
T KOG0616|consen 177 LDQN-------GHIKITDFGFAKRVSGRT-------------WTLCGTPEYLAPEIIQS----KGYNKAVDWWALGVLIY 232 (355)
T ss_pred eccC-------CcEEEEeccceEEecCcE-------------EEecCCccccChHHhhc----CCCCcchhHHHHHHHHH
Confidence 9988 579999999999876542 23479999999999997 78999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC-
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER- 864 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kR- 864 (886)
||+.|.+||...++.++++.|..+... +|. ..+.++++||.++|+.|-.+|
T Consensus 233 EMlaG~pPF~~~~~~~iY~KI~~~~v~-fP~---------------------------~fs~~~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 233 EMLAGYPPFYDDNPIQIYEKILEGKVK-FPS---------------------------YFSSDAKDLLKKLLQVDLTKRF 284 (355)
T ss_pred HHHcCCCCCcCCChHHHHHHHHhCccc-CCc---------------------------ccCHHHHHHHHHHHhhhhHhhh
Confidence 999999999999999999999887431 121 124579999999999999999
Q ss_pred ----CCHHHHHHH
Q 002738 865 ----PTAGDLYEM 873 (886)
Q Consensus 865 ----PSA~EILeh 873 (886)
....+|.+|
T Consensus 285 gnlknG~~dIk~H 297 (355)
T KOG0616|consen 285 GNLKNGVEDIKNH 297 (355)
T ss_pred cCcCCCccccccC
Confidence 244455554
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=326.44 Aligned_cols=257 Identities=23% Similarity=0.368 Sum_probs=206.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~-~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
+..++|++.++||+|+||.||+|.. .+..+++|...... ...+ .+.+|+.+++.++||||+++++.+...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-----~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-----MSVQ----AFLEEANLMKTLQHDKLVRLYAVVTKE 73 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-----hhHH----HHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 5678899999999999999999986 45668888753211 1223 348899999999999999999988755
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
. ..++||||+++++|.+++... ....+++..++.++.||+.||+|||+.+++||||||+||++
T Consensus 74 ~--------------~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili 136 (261)
T cd05072 74 E--------------PIYIITEYMAKGSLLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV 136 (261)
T ss_pred C--------------CcEEEEecCCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe
Confidence 4 359999999999999999752 23468889999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +.++|+|||++......... ......++..|+|||++.+ ..++.++|||||||++|+
T Consensus 137 ~~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~ 196 (261)
T cd05072 137 SES-------LMCKIADFGLARVIEDNEYT---------AREGAKFPIKWTAPEAINF----GSFTIKSDVWSFGILLYE 196 (261)
T ss_pred cCC-------CcEEECCCccceecCCCcee---------ccCCCccceecCCHHHhcc----CCCChhhhhhhhHHHHHH
Confidence 877 56999999999866432211 0112346778999999875 567889999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 787 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 787 LLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
|++ |..||.+.........+......... ...+..+.+|+.+||..+|++||
T Consensus 197 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp 249 (261)
T cd05072 197 IVTYGKIPYPGMSNSDVMSALQRGYRMPRM---------------------------ENCPDELYDIMKTCWKEKAEERP 249 (261)
T ss_pred HHccCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHccCCcccCc
Confidence 998 99999888777777666554321111 11245789999999999999999
Q ss_pred CHHHHHHHHHhh
Q 002738 866 TAGDLYEMFVAR 877 (886)
Q Consensus 866 SA~EILehLe~l 877 (886)
+++++++.|+.+
T Consensus 250 ~~~~i~~~l~~~ 261 (261)
T cd05072 250 TFDYLQSVLDDF 261 (261)
T ss_pred CHHHHHHHHhcC
Confidence 999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.53 Aligned_cols=281 Identities=21% Similarity=0.217 Sum_probs=200.1
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC---CCCCcceeeeeEecC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKISS 626 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L---~HPNIVrl~g~~~~~ 626 (886)
+|++.+.||+|+||.||+|++ .+..+|+|+.......... . ..+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~--~----~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~ 74 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL--P----LSTVREVALLKRLEAFDHPNIVRLMDVCATS 74 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC--c----hHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence 589999999999999999997 5678999986543222111 1 1225677776665 699999999988753
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
.. ......++||||+. ++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 75 ~~---------~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili 141 (288)
T cd07863 75 RT---------DRETKVTLVFEHVD-QDLRTYLDK---VPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV 141 (288)
T ss_pred cC---------CCCceEEEEEcccc-cCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 21 12335799999998 599999875 222458999999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +.+||+|||++........ .....||..|+|||++.+ ..++.++|||||||++|+
T Consensus 142 ~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~~l~~ 199 (288)
T cd07863 142 TSG-------GQVKLADFGLARIYSCQMA-----------LTPVVVTLWYRAPEVLLQ----STYATPVDMWSVGCIFAE 199 (288)
T ss_pred CCC-------CCEEECccCccccccCccc-----------CCCccccccccCchHhhC----CCCCCcchhhhHHHHHHH
Confidence 877 4599999999976543211 123468999999999976 568899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 787 LLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
|++|++||.+.........+...........+..........+.. .............+..+.+||.+||++||.+|||
T Consensus 200 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 278 (288)
T cd07863 200 MFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSP-RGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS 278 (288)
T ss_pred HHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCC-CCCCchHHhCcCcCHHHHHHHHHHhccCcccCCC
Confidence 999999998877665555444321111111111100000000000 0000011122334667899999999999999999
Q ss_pred HHHHHHHH
Q 002738 867 AGDLYEMF 874 (886)
Q Consensus 867 A~EILehL 874 (886)
+.+++.|-
T Consensus 279 ~~~~l~hp 286 (288)
T cd07863 279 AFRALQHP 286 (288)
T ss_pred HHHHhcCC
Confidence 99999873
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=345.45 Aligned_cols=247 Identities=26% Similarity=0.324 Sum_probs=197.2
Q ss_pred eeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCC
Q 002738 556 CDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 630 (886)
Q Consensus 556 ~k~LG~G~fG~VY~A~~-----~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~ 630 (886)
++.||+|+||.||+++. .+..+|+|+............ ...+.+|+.+|+.++||||+++++++....
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~----~~~~~~E~~il~~l~hp~iv~~~~~~~~~~--- 73 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKD----TAHTKAERNILEAVKHPFIVDLIYAFQTGG--- 73 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhh----HHHHHHHHHHHHhCCCCchhceeeEEecCC---
Confidence 36899999999999985 466899998753221111111 223478999999999999999999988655
Q ss_pred CCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccc
Q 002738 631 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 710 (886)
Q Consensus 631 ~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~ 710 (886)
..|+||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 74 -----------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~- 136 (323)
T cd05584 74 -----------KLYLILEYLSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ- 136 (323)
T ss_pred -----------eEEEEEeCCCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-
Confidence 36999999999999999976 3567889999999999999999999999999999999999877
Q ss_pred cCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 002738 711 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 790 (886)
Q Consensus 711 ~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG 790 (886)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||+||||++|
T Consensus 137 ------~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ell~G 196 (323)
T cd05584 137 ------GHVKLTDFGLCKESIHEGT----------VTHTFCGTIEYMAPEILMR----SGHGKAVDWWSLGALMYDMLTG 196 (323)
T ss_pred ------CCEEEeeCcCCeecccCCC----------cccccCCCccccChhhccC----CCCCCcceecccHHHHHHHhcC
Confidence 5699999999875322111 1123469999999999976 5678899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----
Q 002738 791 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP----- 865 (886)
Q Consensus 791 ~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP----- 865 (886)
+.||.+.+.......+..+.. .++ ...++.+.+||.+||+.||.+||
T Consensus 197 ~~pf~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~ 248 (323)
T cd05584 197 APPFTAENRKKTIDKILKGKL-NLP---------------------------PYLTPEARDLLKKLLKRNPSSRLGAGPG 248 (323)
T ss_pred CCCCCCCCHHHHHHHHHcCCC-CCC---------------------------CCCCHHHHHHHHHHcccCHhHcCCCCCC
Confidence 999998887776666654422 111 11245789999999999999999
Q ss_pred CHHHHHHHH
Q 002738 866 TAGDLYEMF 874 (886)
Q Consensus 866 SA~EILehL 874 (886)
++.++++|-
T Consensus 249 ~~~~l~~h~ 257 (323)
T cd05584 249 DAAEVQSHP 257 (323)
T ss_pred CHHHHhcCC
Confidence 899999874
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=345.70 Aligned_cols=283 Identities=17% Similarity=0.211 Sum_probs=207.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
..+++|++.+.||+|+||.||+|.+ .+..+|+|++.... ....... .+.+|+.+++.++||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~----~~~~E~~~l~~l~h~~ii~~~~~~~~ 94 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAK----RAYRELVLMKCVNHKNIIGLLNVFTP 94 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc--cCchhHH----HHHHHHHHHHhcCCCCccccceeecc
Confidence 3468999999999999999999987 56778999864322 1222222 34789999999999999999998875
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
...+ ......|+||||++ ++|.+++.. .+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 95 ~~~~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIl 158 (364)
T cd07875 95 QKSL--------EEFQDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158 (364)
T ss_pred cccc--------cccCeEEEEEeCCC-CCHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEE
Confidence 4321 12235799999997 588887753 3788899999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.+ +.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||+||
T Consensus 159 l~~~-------~~~kL~DfG~a~~~~~~~~-----------~~~~~~t~~y~aPE~~~~----~~~~~~~DiwSlG~il~ 216 (364)
T cd07875 159 VKSD-------CTLKILDFGLARTAGTSFM-----------MTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMG 216 (364)
T ss_pred ECCC-------CcEEEEeCCCccccCCCCc-----------ccCCcccCCcCCHHHHhC----CCCCchhhHHhHHHHHH
Confidence 9877 4699999999976533211 123468999999999986 66889999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccccc------c-----cccCCCC---CCchhhhhhHHHHHH
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE------V-----AQSGSGF---EKPEAELETLSFLVD 851 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~------~-----~~~~~~~---~~~~~~~~~s~~L~d 851 (886)
+|++|+.||.+.+.......+........+..+.......... . ....... ............+++
T Consensus 217 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 296 (364)
T cd07875 217 EMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 296 (364)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHH
Confidence 9999999999888777766665543333332222111000000 0 0000000 001111123457899
Q ss_pred HHHHhcccCCCCCCCHHHHHHHH
Q 002738 852 VFRRCTEENPTERPTAGDLYEMF 874 (886)
Q Consensus 852 LL~rCL~~DP~kRPSA~EILehL 874 (886)
||.+||+.||.+|||+.++++|-
T Consensus 297 ll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 297 LLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred HHHHhcCcCcccCCCHHHHhcCc
Confidence 99999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=347.06 Aligned_cols=244 Identities=25% Similarity=0.361 Sum_probs=196.3
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 634 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~~ 634 (886)
+.||+|+||.||+++. .+..+|+|+...... ...... ..+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~----~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------- 68 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI-IAKDEV----AHTLTESRVLKNTRHPFLTSLKYSFQTKD------- 68 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHH----HHHHHHHHHHHhCCCCCCcceEEEEEcCC-------
Confidence 4699999999999986 567899998753321 111222 23488999999999999999999988655
Q ss_pred CCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCC
Q 002738 635 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 714 (886)
Q Consensus 635 ~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~ 714 (886)
..+|||||+++|+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 69 -------~~~lv~Ey~~~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~----- 131 (328)
T cd05593 69 -------RLCFVMEYVNGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD----- 131 (328)
T ss_pred -------EEEEEEeCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCC-----
Confidence 46999999999999998875 3568999999999999999999999999999999999999877
Q ss_pred CCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 002738 715 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 794 (886)
Q Consensus 715 ~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF 794 (886)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 132 --~~~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~elltG~~Pf 195 (328)
T cd05593 132 --GHIKITDFGLCKEGITDAA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPF 195 (328)
T ss_pred --CcEEEecCcCCccCCCccc----------ccccccCCcCccChhhhcC----CCCCccCCccccchHHHHHhhCCCCC
Confidence 4699999999875322111 1123469999999999976 56789999999999999999999999
Q ss_pred CCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHH
Q 002738 795 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGD 869 (886)
Q Consensus 795 ~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP-----SA~E 869 (886)
.+.+.......+..... .++ ...+..+.+||.+||..||.+|| ++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~-~~p---------------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 247 (328)
T cd05593 196 YNQDHEKLFELILMEDI-KFP---------------------------RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKE 247 (328)
T ss_pred CCCCHHHHHHHhccCCc-cCC---------------------------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHH
Confidence 88777666655543321 111 11245789999999999999997 8999
Q ss_pred HHHH
Q 002738 870 LYEM 873 (886)
Q Consensus 870 ILeh 873 (886)
+++|
T Consensus 248 il~h 251 (328)
T cd05593 248 IMRH 251 (328)
T ss_pred HhcC
Confidence 9988
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=345.09 Aligned_cols=284 Identities=18% Similarity=0.217 Sum_probs=203.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
..+++|++.+.||+|+||.||++.+ .+..+|+|++.... ....... .+.+|+.+++.++||||+++++++..
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF--QNQTHAK----RAYRELVLLKCVNHKNIISLLNVFTP 91 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc--cchhHHH----HHHHHHHHHHhCCCCCEeeeeeeecc
Confidence 3568999999999999999999987 56789999864332 1222222 34889999999999999999999875
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
...+ ......|+||||++ ++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 92 ~~~~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl 155 (359)
T cd07876 92 QKSL--------EEFQDVYLVMELMD-ANLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 155 (359)
T ss_pred CCCc--------cccceeEEEEeCCC-cCHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence 4421 11234799999997 577777643 4788899999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.+ +.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 156 ~~~~-------~~~kl~Dfg~a~~~~~~~~-----------~~~~~~t~~y~aPE~~~~----~~~~~~~DiwSlG~il~ 213 (359)
T cd07876 156 VKSD-------CTLKILDFGLARTACTNFM-----------MTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMG 213 (359)
T ss_pred ECCC-------CCEEEecCCCccccccCcc-----------CCCCcccCCCCCchhccC----CCCCcchhhHHHHHHHH
Confidence 9877 5699999999975432111 122468999999999976 66889999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhh-------cc----cccccccccCCCCC---CchhhhhhHHHHHH
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL-------GS----CHEHEVAQSGSGFE---KPEAELETLSFLVD 851 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~-------~~----~~~~~~~~~~~~~~---~~~~~~~~s~~L~d 851 (886)
+|++|+.||.+.+.......+...........+... .. .....+......+. ........+..+.+
T Consensus 214 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (359)
T cd07876 214 ELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARD 293 (359)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHH
Confidence 999999999887765544444332211111111100 00 00000000000000 00111123467899
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHH
Q 002738 852 VFRRCTEENPTERPTAGDLYEMFV 875 (886)
Q Consensus 852 LL~rCL~~DP~kRPSA~EILehLe 875 (886)
||.+||..||.+|||+.|+++|..
T Consensus 294 li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 294 LLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHhccCcccCCCHHHHhcCch
Confidence 999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=358.66 Aligned_cols=255 Identities=27% Similarity=0.348 Sum_probs=220.2
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
.+++|.+++++|+|+||.+++++. .+..+++|.+.+........ +. ..+|+.++++++|||||.+.+.|..+
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r--~~----A~~E~~lis~~~hP~iv~y~ds~~~~ 75 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER--RS----AIQEMDLLSKLLHPNIVEYKDSFEED 75 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh--HH----HHHHHHHHHhccCCCeeeeccchhcC
Confidence 367899999999999999999886 55678888877665433322 22 38999999999999999999999977
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
+.+ ++|||+||+||+|.+.|... ....++++.++.|+.||+.|++|||+++|+|||||+.|||+
T Consensus 76 ~~~-------------l~Ivm~Y~eGg~l~~~i~~~---k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl 139 (426)
T KOG0589|consen 76 GQL-------------LCIVMEYCEGGDLAQLIKEQ---KGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL 139 (426)
T ss_pred Cce-------------EEEEEeecCCCCHHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc
Confidence 642 79999999999999999873 24679999999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.++ .|||+|||+|+.+...... ..+++||+.||.||++.+ .+|+.|+|||||||++||
T Consensus 140 tk~~-------~VkLgDfGlaK~l~~~~~~----------a~tvvGTp~YmcPEil~d----~pYn~KSDiWsLGC~~yE 198 (426)
T KOG0589|consen 140 TKDK-------KVKLGDFGLAKILNPEDSL----------ASTVVGTPYYMCPEILSD----IPYNEKSDIWSLGCCLYE 198 (426)
T ss_pred cccC-------ceeecchhhhhhcCCchhh----------hheecCCCcccCHHHhCC----CCCCccCcchhhcchHHH
Confidence 9884 4899999999988764311 245789999999999997 789999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 787 LLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
|++-+++|.+.+...+...|.+....+++.. .+.+++.||..||..+|..||+
T Consensus 199 m~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~---------------------------ys~el~~lv~~~l~~~P~~RPs 251 (426)
T KOG0589|consen 199 MCTLKPAFKASNMSELILKINRGLYSPLPSM---------------------------YSSELRSLVKSMLRKNPEHRPS 251 (426)
T ss_pred HHhcccccCccchHHHHHHHhhccCCCCCcc---------------------------ccHHHHHHHHHHhhcCCccCCC
Confidence 9999999999999999999988865555422 3568999999999999999999
Q ss_pred HHHHHHH
Q 002738 867 AGDLYEM 873 (886)
Q Consensus 867 A~EILeh 873 (886)
+.++|.+
T Consensus 252 a~~LL~~ 258 (426)
T KOG0589|consen 252 ALELLRR 258 (426)
T ss_pred HHHHhhC
Confidence 9999987
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=352.15 Aligned_cols=263 Identities=22% Similarity=0.266 Sum_probs=200.5
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|.+.+.||+|+||.||+|.. .+..+|+|+...... ..... ...+.+|+.+++.++||||+++++++....
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~----~~~~~~E~~il~~l~hp~iv~~~~~~~~~~- 74 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM-FKKDQ----LAHVKAERDVLAESDSPWVVSLYYSFQDAQ- 74 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH-HHhHH----HHHHHHHHHHHHhCCCCCcceEEEEEEcCC-
Confidence 4789999999999999999987 667899998643211 11112 234588999999999999999999998655
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..||||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~ 136 (377)
T cd05629 75 -------------YLYLIMEFLPGGDLMTMLIK-----YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDR 136 (377)
T ss_pred -------------eeEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC
Confidence 36999999999999999975 356889999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccc--------cccCC-----------------------------CCCCCccc
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCC--------IAHRG-----------------------------IPAPDVCV 751 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~--------~~~~~-----------------------------~~~~~~~v 751 (886)
+ +.+||+|||+++.+........ ..... .......+
T Consensus 137 ~-------~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (377)
T cd05629 137 G-------GHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTV 209 (377)
T ss_pred C-------CCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccC
Confidence 6 5699999999964322110000 00000 00001246
Q ss_pred CCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhccccccccc
Q 002738 752 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVA 830 (886)
Q Consensus 752 GT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF~g~s~~el~~~I~~~~-rp~l~~~l~~~~~~~~~~~~ 830 (886)
||+.|+|||++.+ ..++.++|||||||+||||++|..||.+.+..+....+.... ...++.
T Consensus 210 gt~~y~aPE~~~~----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------------- 271 (377)
T cd05629 210 GTPDYIAPEIFLQ----QGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPD-------------- 271 (377)
T ss_pred CCccccCHHHHcc----CCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCC--------------
Confidence 9999999999976 668899999999999999999999998887777666655421 111110
Q ss_pred ccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC---CCHHHHHHHH
Q 002738 831 QSGSGFEKPEAELETLSFLVDVFRRCTEENPTER---PTAGDLYEMF 874 (886)
Q Consensus 831 ~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kR---PSA~EILehL 874 (886)
....+..+.+||.+||. +|.+| +++.+++.|.
T Consensus 272 -----------~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp 306 (377)
T cd05629 272 -----------DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHP 306 (377)
T ss_pred -----------CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCC
Confidence 01124578999999998 77765 5999999984
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=344.82 Aligned_cols=253 Identities=25% Similarity=0.274 Sum_probs=195.6
Q ss_pred CceeeeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEec
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 625 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~-----~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~~ 625 (886)
+|++.+.||+|+||.||+++. .+..+|+|+........... ..+.+.+|+.++..++ ||||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAK----TVEHTRTERNVLEHVRQSPFLVTLHYAFQT 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhh----HHHHHHHHHHHHHhccCCCCcccEEEEEec
Confidence 589999999999999999985 46789999875322111111 1234488999999995 9999999999876
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
.. ..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 77 ~~--------------~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil 137 (332)
T cd05614 77 EA--------------KLHLILDYVSGGEMFTHLYQ-----RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENIL 137 (332)
T ss_pred CC--------------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeE
Confidence 54 36999999999999999975 356899999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.+ +.+||+|||++......... ......||+.|+|||++.+ ...++.++|||||||+||
T Consensus 138 i~~~-------~~~kl~DfG~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 198 (332)
T cd05614 138 LDSE-------GHVVLTDFGLSKEFLSEEKE---------RTYSFCGTIEYMAPEIIRG---KGGHGKAVDWWSLGILIF 198 (332)
T ss_pred ECCC-------CCEEEeeCcCCccccccCCC---------ccccccCCccccCHHHhcC---CCCCCCccccccchhhhh
Confidence 9877 46999999998764332111 1123469999999999975 234688999999999999
Q ss_pred HHHhCCCCCCCCC----HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 002738 786 ELLTLQVPYMGLS----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 861 (886)
Q Consensus 786 ELLTG~~PF~g~s----~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP 861 (886)
||++|+.||.... ...+...+.... +.++ ...+..+.+||.+||+.||
T Consensus 199 elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~~~~li~~~l~~dp 250 (332)
T cd05614 199 ELLTGASPFTLEGERNTQSEVSRRILKCD-PPFP---------------------------SFIGPEAQDLLHKLLRKDP 250 (332)
T ss_pred hhhcCCCCCCCCCCCCCHHHHHHHHhcCC-CCCC---------------------------CCCCHHHHHHHHHHcCCCH
Confidence 9999999996432 222222222211 1111 1134578999999999999
Q ss_pred CCCC-----CHHHHHHHH
Q 002738 862 TERP-----TAGDLYEMF 874 (886)
Q Consensus 862 ~kRP-----SA~EILehL 874 (886)
.+|| +++++++|.
T Consensus 251 ~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 251 KKRLGAGPQGASEIKEHP 268 (332)
T ss_pred HHcCCCCCCCHHHHHcCC
Confidence 9999 888999884
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=336.87 Aligned_cols=261 Identities=19% Similarity=0.311 Sum_probs=204.5
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCe----eEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeee
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 622 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~----~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~ 622 (886)
...+|++.+.||+|+||.||+|++ .+. .+|+|+.... ......+ .+.+|+.+++.++||||++++|+
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~----~~~~e~~~l~~l~h~niv~~~g~ 77 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANK----EILDEAYVMASVDNPHVCRLLGI 77 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc---CCHHHHH----HHHHHHHHHHhCCCCCCCeEEEE
Confidence 446799999999999999999986 222 3788875321 1222223 34889999999999999999999
Q ss_pred EecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 002738 623 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 702 (886)
Q Consensus 623 ~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPs 702 (886)
+.... .++|+||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+
T Consensus 78 ~~~~~---------------~~~v~e~~~~g~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~ 138 (316)
T cd05108 78 CLTST---------------VQLITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAAR 138 (316)
T ss_pred EcCCC---------------ceeeeecCCCCCHHHHHHh----ccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchh
Confidence 87543 4899999999999999975 2345888999999999999999999999999999999
Q ss_pred CEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 002738 703 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 782 (886)
Q Consensus 703 NILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGV 782 (886)
|||++.+ +.+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||
T Consensus 139 Nill~~~-------~~~kl~DfG~a~~~~~~~~~~--------~~~~~~~~~~y~apE~~~~----~~~~~~~Di~slGv 199 (316)
T cd05108 139 NVLVKTP-------QHVKITDFGLAKLLGADEKEY--------HAEGGKVPIKWMALESILH----RIYTHQSDVWSYGV 199 (316)
T ss_pred heEecCC-------CcEEEccccccccccCCCcce--------eccCCccceeecChHHhcc----CCCCchhhhHHHHH
Confidence 9999876 469999999998764322110 0111234678999999976 67889999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 002738 783 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 861 (886)
Q Consensus 783 ILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP 861 (886)
++|||++ |..||.+....++...+........+ ...+..+.+++.+||..+|
T Consensus 200 ~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~cl~~~p 252 (316)
T cd05108 200 TVWELMTFGSKPYDGIPASEISSILEKGERLPQP---------------------------PICTIDVYMIMVKCWMIDA 252 (316)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCC---------------------------CCCCHHHHHHHHHHccCCh
Confidence 9999998 99999888776665555444322211 0123468899999999999
Q ss_pred CCCCCHHHHHHHHHhhcCCC
Q 002738 862 TERPTAGDLYEMFVARTSSS 881 (886)
Q Consensus 862 ~kRPSA~EILehLe~l~sss 881 (886)
.+||++.+++.+|..+....
T Consensus 253 ~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 253 DSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred hhCcCHHHHHHHHHHHHcCC
Confidence 99999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=345.65 Aligned_cols=244 Identities=25% Similarity=0.362 Sum_probs=196.4
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 634 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~~ 634 (886)
+.||+|+||.||+++. .+..+|+|+....... ..... ..+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~----~~~~~E~~~l~~l~hp~i~~~~~~~~~~~------- 68 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEV----AHTVTESRVLQNTRHPFLTALKYAFQTHD------- 68 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHH----HHHHHHHHHHHhCCCCCCcceeeEEecCC-------
Confidence 4799999999999986 5678999987543211 11222 23478999999999999999999988655
Q ss_pred CCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCC
Q 002738 635 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 714 (886)
Q Consensus 635 ~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~ 714 (886)
..||||||+++++|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 69 -------~~~lv~E~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~----- 131 (323)
T cd05595 69 -------RLCFVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD----- 131 (323)
T ss_pred -------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCC-----
Confidence 46999999999999998875 3468999999999999999999999999999999999999877
Q ss_pred CCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 002738 715 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 794 (886)
Q Consensus 715 ~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF 794 (886)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 132 --~~~kL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvil~ell~g~~Pf 195 (323)
T cd05595 132 --GHIKITDFGLCKEGISDGA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPF 195 (323)
T ss_pred --CCEEecccHHhccccCCCC----------ccccccCCcCcCCcccccC----CCCCchhchhhhHHHHHHHHhCCCCC
Confidence 4699999999875322111 1123469999999999976 67889999999999999999999999
Q ss_pred CCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHH
Q 002738 795 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGD 869 (886)
Q Consensus 795 ~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP-----SA~E 869 (886)
...+.......+..... .++ ...++.+.+||.+||..||.+|| ++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~-~~p---------------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 247 (323)
T cd05595 196 YNQDHERLFELILMEEI-RFP---------------------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 247 (323)
T ss_pred CCCCHHHHHHHHhcCCC-CCC---------------------------CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHH
Confidence 88877766665543321 111 11345789999999999999998 8999
Q ss_pred HHHH
Q 002738 870 LYEM 873 (886)
Q Consensus 870 ILeh 873 (886)
+++|
T Consensus 248 ~l~h 251 (323)
T cd05595 248 VMEH 251 (323)
T ss_pred HHcC
Confidence 9987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=373.13 Aligned_cols=269 Identities=25% Similarity=0.355 Sum_probs=222.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceee
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 620 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~-------~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~ 620 (886)
++..+..+.+.||+|+||.||+|+. ...-||||. ++... ..... +.|.+|+++|..|+|||||+++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~--LKd~a-~~~~~----~dF~REaeLla~l~H~nIVrLl 555 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKA--LKDKA-ENQAR----QDFRREAELLAELQHPNIVRLL 555 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhh--hcccc-cHHHH----HHHHHHHHHHHhccCCCeEEEE
Confidence 5667788999999999999999985 234566666 44322 12233 3459999999999999999999
Q ss_pred eeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccC---------CCcCCHHHHHHHHHHHHHHHHHHHh
Q 002738 621 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG---------EKHVSVKLALFIAQDVAAALVELHS 691 (886)
Q Consensus 621 g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~---------~~~Ls~~~i~~Ia~QIa~AL~yLHs 691 (886)
|+|...+. +++|+|||..|+|.+||....... +..++..+.+.|+.|||.||.||-+
T Consensus 556 GVC~~~~P--------------~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~ 621 (774)
T KOG1026|consen 556 GVCREGDP--------------LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS 621 (774)
T ss_pred EEEccCCe--------------eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 99998775 599999999999999998754322 2238899999999999999999999
Q ss_pred CCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCC
Q 002738 692 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 771 (886)
Q Consensus 692 ~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~ 771 (886)
+.+|||||-..|+||..+ ..|||+|||+++.+........ + ....-..+|||||.++. +.|
T Consensus 622 ~~FVHRDLATRNCLVge~-------l~VKIsDfGLsRdiYssDYYk~---~-----~~t~lPIRWMppEsIly----~kF 682 (774)
T KOG1026|consen 622 HHFVHRDLATRNCLVGEN-------LVVKISDFGLSRDIYSSDYYKV---R-----GNTLLPIRWMPPESILY----GKF 682 (774)
T ss_pred Ccccccchhhhhceeccc-------eEEEecccccchhhhhhhhhcc---c-----CCceeeeecCCHHHhhc----Ccc
Confidence 999999999999999987 7899999999997765443211 0 11134589999999997 889
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHH
Q 002738 772 GLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 850 (886)
Q Consensus 772 s~KSDIWSLGVILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~ 850 (886)
+++||||||||+|||+++ |+.||.+.+..++++.|.++.-..-| ..++..+.
T Consensus 683 TteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL~~P---------------------------e~CP~~vY 735 (774)
T KOG1026|consen 683 TTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLLSCP---------------------------ENCPTEVY 735 (774)
T ss_pred cchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCcccCC---------------------------CCCCHHHH
Confidence 999999999999999998 99999999999999999988543333 23567899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhcCCCCC
Q 002738 851 DVFRRCTEENPTERPTAGDLYEMFVARTSSSIS 883 (886)
Q Consensus 851 dLL~rCL~~DP~kRPSA~EILehLe~l~sss~S 883 (886)
+||..||+.+|.+||++.||-..|++....++-
T Consensus 736 ~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 736 SLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred HHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 999999999999999999999999998876654
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=341.51 Aligned_cols=290 Identities=21% Similarity=0.269 Sum_probs=222.9
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCC-cceeeeeEecC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC-IVEMYGHKISS 626 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPN-IVrl~g~~~~~ 626 (886)
+..|...++||+|+||+||+|+. .+..||+|...+...... ......+|+.+|+.|+|+| |+++++++.+.
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG------~P~taiREisllk~L~~~~~iv~L~dv~~~~ 83 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG------VPSTAIREISLLKRLSHANHIVRLHDVIHTS 83 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC------CCchhhHHHHHHHHhCCCcceEEEEeeeeec
Confidence 66788899999999999999996 677899999877654211 1223389999999999999 99999999876
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
..+ .....+++||||++ .+|..++....+.. ..++...++.+++||+.||+|||+++|+||||||+||||
T Consensus 84 ~~~--------~~~~~l~lvfe~~d-~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi 153 (323)
T KOG0594|consen 84 NNH--------RGIGKLYLVFEFLD-RDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI 153 (323)
T ss_pred ccc--------cccceEEEEEEeec-ccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE
Confidence 531 12335799999997 69999998743321 357778999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +.+||+|||+|+.+.-+... ....++|..|.|||++.+ ...|+...||||+|||++|
T Consensus 154 ~~~-------G~lKlaDFGlAra~~ip~~~----------yt~evvTlWYRaPEvLlG---s~~Ys~~vDiWs~GcIfaE 213 (323)
T KOG0594|consen 154 SSS-------GVLKLADFGLARAFSIPMRT----------YTPEVVTLWYRAPEVLLG---STSYSTSVDIWSLGCIFAE 213 (323)
T ss_pred CCC-------CcEeeeccchHHHhcCCccc----------ccccEEEeeccCHHHhcC---CCcCCCCcchHhHHHHHHH
Confidence 987 56999999999966543322 234578999999999998 3468999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCC----CchhhhhhHHHHHHHHHHhcccCCC
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE----KPEAELETLSFLVDVFRRCTEENPT 862 (886)
Q Consensus 787 LLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~----~~~~~~~~s~~L~dLL~rCL~~DP~ 862 (886)
|+++++.|++.+..+....|......+-.+.|+.......... ....+. .........+...+|+.+||+++|.
T Consensus 214 m~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~--~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~ 291 (323)
T KOG0594|consen 214 MFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKA--PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPA 291 (323)
T ss_pred HHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccc--cCcCCCCccchHHhccccCccHHHHHHHHhccCcc
Confidence 9999999999999888888877644333344444332222211 111111 1111122235789999999999999
Q ss_pred CCCCHHHHHHH--HHhh
Q 002738 863 ERPTAGDLYEM--FVAR 877 (886)
Q Consensus 863 kRPSA~EILeh--Le~l 877 (886)
+|.|+..++.| +..+
T Consensus 292 ~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 292 KRISAKGALTHPYFSEL 308 (323)
T ss_pred cCcCHHHHhcChhhccc
Confidence 99999999998 5544
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=324.95 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=201.4
Q ss_pred CCCceeeeeecccCceEEEEEEECC-eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~~~-~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
..+|++.+.||+|+||.||++.+.. ..+|+|..... ... .. .+.+|+.+|++++||||+++++++....
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~--~~~---~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 72 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG--AMS---EE----DFIEEAKVMMKLSHPKLVQLYGVCTQQK- 72 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccC--Ccc---HH----HHHHHHHHHHHCCCCCceeEEEEEccCC-
Confidence 4578999999999999999999844 47888875321 111 12 3488999999999999999999987654
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 73 -------------~~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~ 135 (256)
T cd05114 73 -------------PLYIVTEFMENGCLLNYLRQ----RQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSS 135 (256)
T ss_pred -------------CEEEEEEcCCCCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcC
Confidence 36999999999999999875 1235889999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.+||+|||.+......... ......++..|+|||++.+ ..++.++||||||+++|||+
T Consensus 136 ~-------~~~kl~d~g~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~s~G~~l~el~ 195 (256)
T cd05114 136 T-------GVVKVSDFGMTRYVLDDEYT---------SSSGAKFPVKWSPPEVFNF----SKYSSKSDVWSFGVLMWEVF 195 (256)
T ss_pred C-------CeEEECCCCCccccCCCcee---------ccCCCCCchhhCChhhccc----CccchhhhhHHHHHHHHHHH
Confidence 6 56999999998765332111 0112235678999999875 56789999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 789 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 789 T-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
+ |+.||...+..+....+..+.++..+. ..+..+.+|+.+||..+|.+||++
T Consensus 196 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~~~li~~c~~~~p~~Rps~ 248 (256)
T cd05114 196 TEGKMPFEKKSNYEVVEMISRGFRLYRPK---------------------------LASMTVYEVMYSCWHEKPEGRPTF 248 (256)
T ss_pred cCCCCCCCCCCHHHHHHHHHCCCCCCCCC---------------------------CCCHHHHHHHHHHccCCcccCcCH
Confidence 9 999999888877777776654332221 013468999999999999999999
Q ss_pred HHHHHHH
Q 002738 868 GDLYEMF 874 (886)
Q Consensus 868 ~EILehL 874 (886)
.++++.|
T Consensus 249 ~~l~~~l 255 (256)
T cd05114 249 AELLRAI 255 (256)
T ss_pred HHHHHhh
Confidence 9999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=324.85 Aligned_cols=253 Identities=24% Similarity=0.376 Sum_probs=205.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
..+.+|.+.+.||+|+||.||++...+..+++|..... ...+ .+.+|+.++++++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~------~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND------ATAQ----AFLAEASVMTQLRHSNLVQLLGVIVEEK 72 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCC------chHH----HHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence 35678999999999999999999999999999986322 1122 3488999999999999999999876433
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
. ..++||||+++++|.+++.. .....+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 73 ~-------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~ 136 (256)
T cd05082 73 G-------------GLYIVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS 136 (256)
T ss_pred C-------------ceEEEEECCCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEc
Confidence 2 36999999999999999975 2234588999999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ +.+||+|||++....... ....++..|+|||++.+ ..++.++|||||||++|||
T Consensus 137 ~~-------~~~kl~dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~i~~~l 192 (256)
T cd05082 137 ED-------NVAKVSDFGLTKEASSTQ-------------DTGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEI 192 (256)
T ss_pred CC-------CcEEecCCccceeccccC-------------CCCccceeecCHHHHcc----CCCCchhhhHHHHHHHHHH
Confidence 77 469999999987543211 11235678999999875 5678899999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 788 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 788 LT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
++ |+.||......++...+..+..+..+ ...++.+.+|+.+||..+|.+|||
T Consensus 193 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rpt 245 (256)
T cd05082 193 YSFGRVPYPRIPLKDVVPRVEKGYKMDAP---------------------------DGCPPVVYDVMKQCWHLDAATRPS 245 (256)
T ss_pred HhCCCCCCCCCCHHHHHHHHhcCCCCCCC---------------------------CCCCHHHHHHHHHHhcCChhhCcC
Confidence 97 99999887777776666554332221 113457899999999999999999
Q ss_pred HHHHHHHHHhh
Q 002738 867 AGDLYEMFVAR 877 (886)
Q Consensus 867 A~EILehLe~l 877 (886)
+.+++++|+.+
T Consensus 246 ~~~l~~~l~~~ 256 (256)
T cd05082 246 FLQLREQLEHI 256 (256)
T ss_pred HHHHHHHHhcC
Confidence 99999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=325.60 Aligned_cols=257 Identities=22% Similarity=0.379 Sum_probs=206.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
....+|.+.+.||+|+||.||+|.+ .+..+++|+.... ...... +.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEE----FLKEAAVMKEIKHPNLVQLLGVCTR 73 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-----chHHHH----HHHHHHHHHhCCCCChhheEEEEcC
Confidence 3456789999999999999999997 4677888875321 112233 3889999999999999999999876
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
... .++||||+++++|.+++.. .....+++..++.++.|++.||+|||++||+||||||+|||
T Consensus 74 ~~~--------------~~lv~e~~~~~~L~~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil 136 (263)
T cd05052 74 EPP--------------FYIITEFMTYGNLLDYLRE---CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 136 (263)
T ss_pred CCC--------------cEEEEEeCCCCcHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEE
Confidence 553 5999999999999999975 22345889999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.+ +.+||+|||++......... ......++..|+|||++.+ ..++.++|||||||++|
T Consensus 137 ~~~~-------~~~kl~df~~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~ 196 (263)
T cd05052 137 VGEN-------HLVKVADFGLSRLMTGDTYT---------AHAGAKFPIKWTAPESLAY----NKFSIKSDVWAFGVLLW 196 (263)
T ss_pred EcCC-------CcEEeCCCccccccccceee---------ccCCCCCccccCCHHHhcc----CCCCchhHHHHHHHHHH
Confidence 9876 56999999999766432211 0111234678999999876 66788999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 002738 786 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 864 (886)
Q Consensus 786 ELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kR 864 (886)
||++ |..||.+....+....+.....+..+ ...+..+.+|+.+||..||++|
T Consensus 197 el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~cl~~~p~~R 249 (263)
T cd05052 197 EIATYGMSPYPGIDLSQVYELLEKGYRMERP---------------------------EGCPPKVYELMRACWQWNPSDR 249 (263)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---------------------------CCCCHHHHHHHHHHccCCcccC
Confidence 9998 99999888777766666544322211 1134579999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 002738 865 PTAGDLYEMFVAR 877 (886)
Q Consensus 865 PSA~EILehLe~l 877 (886)
|++.++++.|+.+
T Consensus 250 p~~~~l~~~l~~~ 262 (263)
T cd05052 250 PSFAEIHQAFETM 262 (263)
T ss_pred CCHHHHHHHHHhh
Confidence 9999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=361.12 Aligned_cols=266 Identities=25% Similarity=0.329 Sum_probs=211.2
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
.-.+|.+.+.||+|+||+||+|++ .+..+|+|++.... ........ +.+|+.++..++|+||+++++.+...
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~--~~~~~~~~----~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG--MSEADKNR----AQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEeccc--CCHHHHHH----HHHHHHHHhcCCCCcEEEeecceecc
Confidence 346999999999999999999986 67889999975442 22333333 48899999999999999998877643
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
.. .........++||||+++|+|.++|...... ...+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 104 ~~------~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~-~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl 176 (496)
T PTZ00283 104 DP------RNPENVLMIALVLDYANAGDLRQEIKSRAKT-NRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL 176 (496)
T ss_pred cc------cCcccceEEEEEEeCCCCCcHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE
Confidence 31 0111223478999999999999999763322 3568999999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +.+||+|||+++.+...... .......||+.|+|||++.+ ..++.++|||||||+|||
T Consensus 177 ~~~-------~~vkL~DFGls~~~~~~~~~--------~~~~~~~Gt~~Y~aPE~~~~----~~~s~k~DVwSlGvilye 237 (496)
T PTZ00283 177 CSN-------GLVKLGDFGFSKMYAATVSD--------DVGRTFCGTPYYVAPEIWRR----KPYSKKADMFSLGVLLYE 237 (496)
T ss_pred eCC-------CCEEEEecccCeeccccccc--------cccccccCCcceeCHHHhCC----CCCCcHHHHHHHHHHHHH
Confidence 877 46999999999865432111 01233569999999999986 668999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 787 LLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
|++|+.||.+.+...+...+..+....++. ..++.+.+|+.+||..||.+||+
T Consensus 238 LltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~L~~dP~~RPs 290 (496)
T PTZ00283 238 LLTLKRPFDGENMEEVMHKTLAGRYDPLPP---------------------------SISPEMQEIVTALLSSDPKRRPS 290 (496)
T ss_pred HHHCCCCCCCCCHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHHcccChhhCcC
Confidence 999999999888777777666554332221 12457999999999999999999
Q ss_pred HHHHHHH
Q 002738 867 AGDLYEM 873 (886)
Q Consensus 867 A~EILeh 873 (886)
+.++++|
T Consensus 291 ~~ell~~ 297 (496)
T PTZ00283 291 SSKLLNM 297 (496)
T ss_pred HHHHHhC
Confidence 9999987
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=324.80 Aligned_cols=248 Identities=22% Similarity=0.328 Sum_probs=198.4
Q ss_pred eecccCceEEEEEEE----CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCC
Q 002738 558 EAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 633 (886)
Q Consensus 558 ~LG~G~fG~VY~A~~----~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~ 633 (886)
+||+|+||.||+|.+ .+..+|+|+.... ....... +.+.+|+.+++.+.||||+++++++....
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 69 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND--NNDPALK----DELLREANVMQQLDNPYIVRMIGICEAES------ 69 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCC--CCcHHHH----HHHHHHHHHHHhCCCCCcceEEEEEcCCC------
Confidence 689999999999975 4577899985422 2222222 34489999999999999999999875332
Q ss_pred CCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCC
Q 002738 634 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 713 (886)
Q Consensus 634 ~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~ 713 (886)
.++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||.|||++.+
T Consensus 70 ---------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~---- 131 (257)
T cd05116 70 ---------WMLVMELAELGPLNKFLQK-----NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ---- 131 (257)
T ss_pred ---------cEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCC----
Confidence 4899999999999999975 3468999999999999999999999999999999999999876
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCC
Q 002738 714 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQV 792 (886)
Q Consensus 714 ~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT-G~~ 792 (886)
+.+||+|||++........... ......++..|+|||.+.. ..++.++|||||||++|||++ |+.
T Consensus 132 ---~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~t~g~~ 197 (257)
T cd05116 132 ---HYAKISDFGLSKALGADENYYK-------AKTHGKWPVKWYAPECMNY----YKFSSKSDVWSFGVLMWEAFSYGQK 197 (257)
T ss_pred ---CeEEECCCccccccCCCCCeee-------ecCCCCCCccccCHhHhcc----CCcCchhHHHHHHHHHHHHHhCCCC
Confidence 5699999999986643221100 0112235679999999875 567889999999999999998 999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002738 793 PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 872 (886)
Q Consensus 793 PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EILe 872 (886)
||.......+...+..+..+.++. ..++.+.+||.+||+.||.+||++++|.+
T Consensus 198 p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 198 PYKGMKGNEVTQMIESGERMECPQ---------------------------RCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred CCCCCCHHHHHHHHHCCCCCCCCC---------------------------CCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 998888877777776654433321 13457899999999999999999999999
Q ss_pred HHHh
Q 002738 873 MFVA 876 (886)
Q Consensus 873 hLe~ 876 (886)
.|+.
T Consensus 251 ~l~~ 254 (257)
T cd05116 251 RLRN 254 (257)
T ss_pred HHhc
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=347.51 Aligned_cols=263 Identities=24% Similarity=0.312 Sum_probs=205.8
Q ss_pred CCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|.+.+.||+|+||.||+|++. +..+|+|++....... ... ...+.+|+.++..++||||+++++++....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK-RNQ----IAHVRAERDILADADSPWIVKLYYSFQDEE- 74 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh-ccH----HHHHHHHHHHHHhcCCCCccchhhheecCC-
Confidence 47999999999999999999984 7889999975332111 111 234488999999999999999999987655
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..++||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||||+.
T Consensus 75 -------------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~ 136 (350)
T cd05573 75 -------------HLYLVMEYMPGGDLMNLLIR-----KDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDA 136 (350)
T ss_pred -------------eEEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC
Confidence 46999999999999999986 256899999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCccccccccccccc-------------------ccCCCCCCCcccCCCcccchhhhhcccCCC
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCI-------------------AHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 769 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~-------------------~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~ 769 (886)
+ +.+||+|||++............ ............||+.|+|||++.+ .
T Consensus 137 ~-------~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~ 205 (350)
T cd05573 137 D-------GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG----T 205 (350)
T ss_pred C-------CCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcC----C
Confidence 7 46999999999866543200000 0000011234579999999999986 5
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHH
Q 002738 770 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 848 (886)
Q Consensus 770 ~~s~KSDIWSLGVILyELLTG~~PF~g~s~~el~~~I~~~~r-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 848 (886)
.++.++|||||||+||||++|+.||.+.+.......+..... ..++. ....++.
T Consensus 206 ~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------------------------~~~~~~~ 260 (350)
T cd05573 206 PYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPP-------------------------DPPVSPE 260 (350)
T ss_pred CCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCC-------------------------CCCCCHH
Confidence 789999999999999999999999998887766666554211 11110 0013567
Q ss_pred HHHHHHHhcccCCCCCCC-HHHHHHHH
Q 002738 849 LVDVFRRCTEENPTERPT-AGDLYEMF 874 (886)
Q Consensus 849 L~dLL~rCL~~DP~kRPS-A~EILehL 874 (886)
+.+||.+||. ||.+||+ +.++++|.
T Consensus 261 ~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 261 AIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred HHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 9999999997 9999999 99999984
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=348.42 Aligned_cols=263 Identities=24% Similarity=0.368 Sum_probs=201.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCccee
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 619 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~-------~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl 619 (886)
.+.++|++.+.||+|+||.||+|++ .+..||||+.... . .....+ .+.+|+.+|..+ +||||+++
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~--~-~~~~~~----~~~~Ei~il~~l~~HpnIv~l 104 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPS--A-HLTERE----ALMSELKVLSYLGNHINIVNL 104 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCC--c-CcHHHH----HHHHHHHHHHHhcCCcceeee
Confidence 4456899999999999999999974 2447889885422 1 112222 348999999999 79999999
Q ss_pred eeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhc-----------------------------------
Q 002738 620 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE----------------------------------- 664 (886)
Q Consensus 620 ~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~----------------------------------- 664 (886)
++++..... .++||||+++|+|.+++.....
T Consensus 105 ~~~~~~~~~--------------~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 170 (375)
T cd05104 105 LGACTVGGP--------------TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMD 170 (375)
T ss_pred eeeeccCCc--------------ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhh
Confidence 999876553 5999999999999999975211
Q ss_pred -----------------------------------cCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 665 -----------------------------------TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 665 -----------------------------------~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
.....+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~ 250 (375)
T cd05104 171 MKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG 250 (375)
T ss_pred cCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECC
Confidence 011247888999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
..+||+|||++......... .......++..|+|||++.+ ..++.++|||||||++|||++
T Consensus 251 -------~~~kl~DfG~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~sDi~slG~~l~ellt 311 (375)
T cd05104 251 -------RITKICDFGLARDIRNDSNY--------VVKGNARLPVKWMAPESIFN----CVYTFESDVWSYGILLWEIFS 311 (375)
T ss_pred -------CcEEEecCccceeccCcccc--------cccCCCCCCcceeChhHhcC----CCCCCCCCHHHHHHHHHHHHh
Confidence 46999999999765432211 00112235678999999976 678899999999999999998
Q ss_pred -CCCCCCCCCHH-HHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 790 -LQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 790 -G~~PF~g~s~~-el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
|..||...... .....+..+.++..+ ...+..+.+||.+||+.||.+||++
T Consensus 312 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dP~~RPs~ 364 (375)
T cd05104 312 LGSSPYPGMPVDSKFYKMIKEGYRMLSP---------------------------ECAPSEMYDIMKSCWDADPLKRPTF 364 (375)
T ss_pred cCCCCCCCCCchHHHHHHHHhCccCCCC---------------------------CCCCHHHHHHHHHHccCChhHCcCH
Confidence 89999776543 333333333222111 0123478999999999999999999
Q ss_pred HHHHHHHHhh
Q 002738 868 GDLYEMFVAR 877 (886)
Q Consensus 868 ~EILehLe~l 877 (886)
.+|++.|+..
T Consensus 365 ~eil~~l~~~ 374 (375)
T cd05104 365 KQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHHhh
Confidence 9999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=323.96 Aligned_cols=262 Identities=24% Similarity=0.410 Sum_probs=205.9
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
+++|++.+.||+|+||.||+|+. .+..+|+|....... ....... .+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-MDAKARQ----DCVKEIDLLKQLNHPNVIKYLDSFIEDN 75 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-CCHHHHH----HHHHHHHHHHhCCCcceeeeeeeEEECC
Confidence 46899999999999999999986 678899997643221 1222222 3488999999999999999999988654
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
..++||||+++++|.+++..... ....+++..++.++.||+.||.|||++||+|+||||+|||++
T Consensus 76 --------------~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~ 140 (267)
T cd08228 76 --------------ELNIVLELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT 140 (267)
T ss_pred --------------eEEEEEEecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc
Confidence 36999999999999999875322 234578999999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ +.++|+|||++......... .....|++.|+|||++.+ ..++.++||||||+++|||
T Consensus 141 ~~-------~~~~l~d~g~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~----~~~~~~~Di~slG~~l~el 199 (267)
T cd08228 141 AT-------GVVKLGDLGLGRFFSSKTTA----------AHSLVGTPYYMSPERIHE----NGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred CC-------CCEEECccccceeccchhHH----------HhcCCCCccccChhhhcc----CCCCchhhHHHHHHHHHHH
Confidence 77 45999999998766432211 122358899999999876 5678899999999999999
Q ss_pred HhCCCCCCCCC--HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 788 LTLQVPYMGLS--ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 788 LTG~~PF~g~s--~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
++|+.||.... .......+.....+..+ ....+..+.+|+.+||..+|.+||
T Consensus 200 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~cl~~~p~~Rp 253 (267)
T cd08228 200 AALQSPFYGDKMNLFSLCQKIEQCDYPPLP--------------------------TEHYSEKLRELVSMCIYPDPDQRP 253 (267)
T ss_pred hcCCCCCccccccHHHHHHHHhcCCCCCCC--------------------------hhhcCHHHHHHHHHHCCCCcccCc
Confidence 99999996543 23444444433322221 012345789999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 002738 866 TAGDLYEMFVART 878 (886)
Q Consensus 866 SA~EILehLe~l~ 878 (886)
++.+|++.|+.+.
T Consensus 254 ~~~~vl~~~~~~~ 266 (267)
T cd08228 254 DIGYVHQIAKQMH 266 (267)
T ss_pred CHHHHHHHHHHhc
Confidence 9999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=359.01 Aligned_cols=255 Identities=26% Similarity=0.369 Sum_probs=205.0
Q ss_pred CCCceeeeeecccCceEEEEEEEC---CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~~---~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
...|.+.+.||+|+||.||+|... +..+++|..... ...... .+.+|+.+|+.++|||||++++++...
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~----~~~~E~~~l~~l~Hpniv~~~~~~~~~ 137 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAA----YARSELHCLAACDHFGIVKHFDDFKSD 137 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHH----HHHHHHHHHHhCCCCCEeEEEEEEEEC
Confidence 445999999999999999999863 456777764322 122222 347899999999999999999999865
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
. ..||||||++||+|.+++..... ....+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 138 ~--------------~~~lv~E~~~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll 202 (478)
T PTZ00267 138 D--------------KLLLIMEYGSGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL 202 (478)
T ss_pred C--------------EEEEEEECCCCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE
Confidence 5 47999999999999999875322 23468899999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +.+||+|||++..+...... .......||+.|+|||++.+ ..++.++|||||||++||
T Consensus 203 ~~~-------~~~kL~DFgla~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~~l~e 263 (478)
T PTZ00267 203 MPT-------GIIKLGDFGFSKQYSDSVSL--------DVASSFCGTPYYLAPELWER----KRYSKKADMWSLGVILYE 263 (478)
T ss_pred CCC-------CcEEEEeCcCceecCCcccc--------ccccccCCCccccCHhHhCC----CCCCcHHhHHHHHHHHHH
Confidence 877 56999999999866432111 11233469999999999976 678999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 787 LLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
|++|+.||.+.+..++...+..+..+.++. ..+..+.+||.+||..||.+||+
T Consensus 264 l~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~s~~~~~li~~~L~~dP~~Rps 316 (478)
T PTZ00267 264 LLTLHRPFKGPSQREIMQQVLYGKYDPFPC---------------------------PVSSGMKALLDPLLSKNPALRPT 316 (478)
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCCCc---------------------------cCCHHHHHHHHHHhccChhhCcC
Confidence 999999999888877777766554332221 12457899999999999999999
Q ss_pred HHHHHHH
Q 002738 867 AGDLYEM 873 (886)
Q Consensus 867 A~EILeh 873 (886)
+.+++.+
T Consensus 317 ~~~~l~~ 323 (478)
T PTZ00267 317 TQQLLHT 323 (478)
T ss_pred HHHHHhC
Confidence 9999865
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=351.02 Aligned_cols=261 Identities=23% Similarity=0.294 Sum_probs=207.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
..+.+|++.+.||+|+||.||+|+. .+..+|+|+....... ..... ..+.+|+.+++.++||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~----~~~~~e~~il~~~~h~~iv~~~~~~~~ 114 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-KRSDS----AFFWEERDIMAHANSEWIVQLHYAFQD 114 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhhH----HHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 4578999999999999999999997 5678999986432111 11111 234789999999999999999999886
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
.. ..|+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 115 ~~--------------~~~lv~Ey~~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIL 174 (370)
T cd05596 115 DK--------------YLYMVMEYMPGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 174 (370)
T ss_pred CC--------------EEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 55 46999999999999999875 35788999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.+ +.+||+|||++......... ......||+.|+|||++.+......++.++|||||||+||
T Consensus 175 l~~~-------~~~kL~DfG~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvily 238 (370)
T cd05596 175 LDKS-------GHLKLADFGTCMKMDANGMV---------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 238 (370)
T ss_pred EcCC-------CCEEEEeccceeeccCCCcc---------cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHH
Confidence 9877 56999999999765432111 1123469999999999976433345789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC-
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE- 863 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~r-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k- 863 (886)
||++|+.||.+.+.......+..... ..++. ....+..+.+||.+||..+|.+
T Consensus 239 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~~p~r~ 293 (370)
T cd05596 239 EMLVGDTPFYADSLVGTYSKIMDHKNSLTFPD-------------------------DIEISKQAKDLICAFLTDREVRL 293 (370)
T ss_pred HHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCC-------------------------cCCCCHHHHHHHHHHccChhhcc
Confidence 99999999998887777666654321 11110 0123567899999999999998
Q ss_pred -CCCHHHHHHHH
Q 002738 864 -RPTAGDLYEMF 874 (886)
Q Consensus 864 -RPSA~EILehL 874 (886)
||++.++++|.
T Consensus 294 ~R~s~~ell~h~ 305 (370)
T cd05596 294 GRNGVDEIKSHP 305 (370)
T ss_pred CCCCHHHHhcCc
Confidence 99999999984
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=342.48 Aligned_cols=248 Identities=27% Similarity=0.370 Sum_probs=197.4
Q ss_pred ceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHH---hhCCCCCcceeeeeEecCC
Q 002738 553 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRML---GALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 553 Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iL---k~L~HPNIVrl~g~~~~~~ 627 (886)
|++.+.||+|+||.||+|.+ .+..+|+|+....... ..... +.+.+|+.++ ..++||||+++++++....
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~----~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII-ARDEV----ESLMCEKRIFETANSERHPFLVNLFACFQTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHH----HHHHHHHHHHHhccccCCCChhceeeEEEcCC
Confidence 68899999999999999987 5678999997533211 11122 2336666655 5667999999999988654
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
..|+||||+++++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 76 --------------~~~lv~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~ 135 (324)
T cd05589 76 --------------HVCFVMEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD 135 (324)
T ss_pred --------------EEEEEEcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC
Confidence 47999999999999988864 4689999999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ +.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 136 ~~-------~~~kL~Dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~il~el 194 (324)
T cd05589 136 TE-------GFVKIADFGLCKEGMGFGD----------RTSTFCGTPEFLAPEVLTE----TSYTRAVDWWGLGVLIYEM 194 (324)
T ss_pred CC-------CcEEeCcccCCccCCCCCC----------cccccccCccccCHhHhcC----CCCCcccchhhHHHHHHHH
Confidence 87 4699999999864322111 1133569999999999976 6678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC--
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-- 865 (886)
Q Consensus 788 LTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP-- 865 (886)
++|+.||.+.+..++...+..... .++ ...+..+.+||.+||+.||.+||
T Consensus 195 ~~G~~pf~~~~~~~~~~~i~~~~~-~~p---------------------------~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 195 LVGESPFPGDDEEEVFDSIVNDEV-RYP---------------------------RFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCC-CCC---------------------------CCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 999999998888777766655422 111 11245689999999999999999
Q ss_pred ---CHHHHHHHH
Q 002738 866 ---TAGDLYEMF 874 (886)
Q Consensus 866 ---SA~EILehL 874 (886)
++.++++|.
T Consensus 247 ~~~~~~~l~~~~ 258 (324)
T cd05589 247 GEKDAEDVKKQP 258 (324)
T ss_pred CCCCHHHHhhCC
Confidence 688888874
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=330.25 Aligned_cols=266 Identities=23% Similarity=0.340 Sum_probs=209.1
Q ss_pred CCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeee
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 621 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~-------~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g 621 (886)
...+|.+.+.||+|+||.||++.. .+..+++|... .. .....+ .+.+|+.++++++||||+++++
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~--~~--~~~~~~----~~~~e~~~l~~l~h~~i~~~~~ 74 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLK--DA--SDNARK----DFHREAELLTNLQHEHIVKFYG 74 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecC--Cc--CHHHHH----HHHHHHHHHHhCCCCCcceEEE
Confidence 356899999999999999999985 22346666642 21 122223 3489999999999999999999
Q ss_pred eEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhc--------cCCCcCCHHHHHHHHHHHHHHHHHHHhCC
Q 002738 622 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE--------TGEKHVSVKLALFIAQDVAAALVELHSKH 693 (886)
Q Consensus 622 ~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~--------~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~g 693 (886)
++..... .++||||+++++|.+++..... .....+++..++.++.||+.||+|||++|
T Consensus 75 ~~~~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~ 140 (288)
T cd05093 75 VCVEGDP--------------LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH 140 (288)
T ss_pred EEecCCc--------------cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9886543 5999999999999999975321 11235899999999999999999999999
Q ss_pred ccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCc
Q 002738 694 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 773 (886)
Q Consensus 694 IVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~ 773 (886)
|+||||||+|||++.+ +.+||+|||++.......... ......++..|+|||++.+ ..++.
T Consensus 141 i~H~dlkp~Nili~~~-------~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~ 201 (288)
T cd05093 141 FVHRDLATRNCLVGEN-------LLVKIGDFGMSRDVYSTDYYR--------VGGHTMLPIRWMPPESIMY----RKFTT 201 (288)
T ss_pred eeecccCcceEEEccC-------CcEEeccCCccccccCCceee--------cCCCCCccccccCHHHhcc----CCCCc
Confidence 9999999999999877 569999999997653321110 0122346788999999976 56789
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHH
Q 002738 774 EVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 852 (886)
Q Consensus 774 KSDIWSLGVILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dL 852 (886)
++|||||||++|+|++ |..||...........+..+..+..+. ..+..+.+|
T Consensus 202 ~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~l 254 (288)
T cd05093 202 ESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPR---------------------------TCPKEVYDL 254 (288)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCCCCC---------------------------CCCHHHHHH
Confidence 9999999999999998 999998888777777776654322211 123468999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 002738 853 FRRCTEENPTERPTAGDLYEMFVARTSSSI 882 (886)
Q Consensus 853 L~rCL~~DP~kRPSA~EILehLe~l~sss~ 882 (886)
+.+||+.||.+|||+.++++.|+.+...+.
T Consensus 255 i~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~ 284 (288)
T cd05093 255 MLGCWQREPHMRLNIKEIHSLLQNLAKASP 284 (288)
T ss_pred HHHHccCChhhCCCHHHHHHHHHHHHHhcc
Confidence 999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=328.36 Aligned_cols=262 Identities=21% Similarity=0.336 Sum_probs=204.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEE------CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeee
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 621 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~------~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g 621 (886)
.++.+|++.+.||+|+||.||+|.+ .+..+++|.... . ........ +.+|+.+++.++||||+++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~--~-~~~~~~~~----~~~E~~~l~~l~h~niv~~~~ 74 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD--I-NNPQQWGE----FQQEASLMAELHHPNIVCLLG 74 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccC--C-CCHHHHHH----HHHHHHHHhhCCCCCeeeEEE
Confidence 4578899999999999999999985 335677776532 1 12222233 488999999999999999999
Q ss_pred eEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhc------------cCCCcCCHHHHHHHHHHHHHHHHHH
Q 002738 622 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE------------TGEKHVSVKLALFIAQDVAAALVEL 689 (886)
Q Consensus 622 ~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~------------~~~~~Ls~~~i~~Ia~QIa~AL~yL 689 (886)
++..... .|+||||+++++|.+++..... .....+++..++.++.||+.||.||
T Consensus 75 ~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l 140 (283)
T cd05090 75 VVTQEQP--------------VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL 140 (283)
T ss_pred EEecCCc--------------eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 9876543 5999999999999999964211 0123478889999999999999999
Q ss_pred HhCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCC
Q 002738 690 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 769 (886)
Q Consensus 690 Hs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~ 769 (886)
|++||+||||||+|||++.+ ..+||+|||+++......... ......++..|+|||++.+ .
T Consensus 141 H~~~i~H~dlkp~nili~~~-------~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~ 201 (283)
T cd05090 141 SSHFFVHKDLAARNILIGEQ-------LHVKISDLGLSREIYSADYYR--------VQPKSLLPIRWMPPEAIMY----G 201 (283)
T ss_pred HhcCeehhccccceEEEcCC-------CcEEeccccccccccCCccee--------cccCCCccceecChHHhcc----C
Confidence 99999999999999999876 469999999997654322110 1122346778999999875 5
Q ss_pred CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHH
Q 002738 770 LYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 848 (886)
Q Consensus 770 ~~s~KSDIWSLGVILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 848 (886)
.++.++|||||||++|||++ |..||.+.....+...+.....+..+ ...++.
T Consensus 202 ~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~ 254 (283)
T cd05090 202 KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCS---------------------------EDCPPR 254 (283)
T ss_pred CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHH
Confidence 67899999999999999998 99999888777766666554332211 112457
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002738 849 LVDVFRRCTEENPTERPTAGDLYEMFVA 876 (886)
Q Consensus 849 L~dLL~rCL~~DP~kRPSA~EILehLe~ 876 (886)
+.+++.+||+.||.+||++.+|+++|.+
T Consensus 255 ~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 255 MYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 8999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=336.82 Aligned_cols=259 Identities=26% Similarity=0.331 Sum_probs=217.3
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
-+.|++.+.||+|.|+.|+++.. .++.+|+|++..+..... ..+.+ .+|++|-+.|+||||+++++.+....
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~--~~e~l----~rEarIC~~LqHP~IvrL~~ti~~~~ 83 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR--DFQKL----EREARICRKLQHPNIVRLHDSIQEES 83 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc--cHHHH----HHHHHHHHhcCCCcEeehhhhhcccc
Confidence 46799999999999999999976 677899999765543332 34444 89999999999999999999887665
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
. .|||+|++.|++|..-|-. +..+++..+-..++||+.||.|+|.+||||||+||+|+|+.
T Consensus 84 ~--------------~ylvFe~m~G~dl~~eIV~-----R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLA 144 (355)
T KOG0033|consen 84 F--------------HYLVFDLVTGGELFEDIVA-----REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLA 144 (355)
T ss_pred e--------------eEEEEecccchHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeee
Confidence 4 5999999999999877765 25688999999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
...+ ...+||+|||+|..+..... ....+|||.|||||++.. .+|+..+|||+.|||||-|
T Consensus 145 SK~~----~A~vKL~~FGvAi~l~~g~~-----------~~G~~GtP~fmaPEvvrk----dpy~kpvDiW~cGViLfiL 205 (355)
T KOG0033|consen 145 SKAK----GAAVKLADFGLAIEVNDGEA-----------WHGFAGTPGYLSPEVLKK----DPYSKPVDIWACGVILYIL 205 (355)
T ss_pred eccC----CCceeecccceEEEeCCccc-----------cccccCCCcccCHHHhhc----CCCCCcchhhhhhHHHHHH
Confidence 7643 35699999999988763221 245689999999999986 7899999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 788 LTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
+.|.+||.+.+...+++.|.++...--+. .+..+++..++|+++||..||.+|+|+
T Consensus 206 L~G~~PF~~~~~~rlye~I~~g~yd~~~~------------------------~w~~is~~Ak~LvrrML~~dP~kRIta 261 (355)
T KOG0033|consen 206 LVGYPPFWDEDQHRLYEQIKAGAYDYPSP------------------------EWDTVTPEAKSLIRRMLTVNPKKRITA 261 (355)
T ss_pred HhCCCCCCCccHHHHHHHHhccccCCCCc------------------------ccCcCCHHHHHHHHHHhccChhhhccH
Confidence 99999999999999999999885422111 123346789999999999999999999
Q ss_pred HHHHHHHHh
Q 002738 868 GDLYEMFVA 876 (886)
Q Consensus 868 ~EILehLe~ 876 (886)
.|.|+|-+-
T Consensus 262 ~EAL~HpWi 270 (355)
T KOG0033|consen 262 DEALKHPWI 270 (355)
T ss_pred HHHhCCchh
Confidence 999998653
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=323.78 Aligned_cols=265 Identities=22% Similarity=0.357 Sum_probs=206.3
Q ss_pred ceeeeeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 553 LSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 553 Y~i~k~LG~G~fG~VY~A~~~-----~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
|.+.+.||+|+||.||+|... ...+|+|+.... .........+ .+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD--IHTYSEIEEF----LSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccC--cCCHHHHHHH----HHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 568899999999999999863 256899986433 2222333344 89999999999999999999887544
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhc-cCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~-~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
.+ ......++||||+++++|..++..... .....+++..+..++.|++.||.|||+++|+||||||+||++
T Consensus 75 ~~--------~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~ 146 (273)
T cd05035 75 SL--------QKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML 146 (273)
T ss_pred cc--------ccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE
Confidence 21 122346999999999999999865321 123468999999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +.+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++||
T Consensus 147 ~~~-------~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~SlG~il~e 207 (273)
T cd05035 147 RED-------MTVCVADFGLSKKIYSGDYYR--------QGRIAKMPVKWIAIESLAD----RVYTSKSDVWAFGVTMWE 207 (273)
T ss_pred CCC-------CeEEECCccceeecccccccc--------ccccccCCccccCHhhccc----CCCCcccchHHHHHHHHH
Confidence 876 569999999998654322110 0111235678999999865 667899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 787 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 787 LLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
|++ |..||.+....++...+..+..+..+ ...+..+.+++.+||+.||.+||
T Consensus 208 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp 260 (273)
T cd05035 208 IATRGQTPYPGVENHEIYDYLRHGNRLKQP---------------------------EDCLDELYDLMYSCWRADPKDRP 260 (273)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------cCCCHHHHHHHHHHcCCChhhCc
Confidence 999 99999888877777666655433222 11345799999999999999999
Q ss_pred CHHHHHHHHHhh
Q 002738 866 TAGDLYEMFVAR 877 (886)
Q Consensus 866 SA~EILehLe~l 877 (886)
|+.+++++|+.+
T Consensus 261 ~~~e~~~~l~~~ 272 (273)
T cd05035 261 TFTKLREVLENI 272 (273)
T ss_pred CHHHHHHHHHhh
Confidence 999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=348.98 Aligned_cols=263 Identities=23% Similarity=0.283 Sum_probs=199.1
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
.|++++.||+|+||+||+|++ .+..+|+|++...... ..... ..+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~----~~~~~E~~il~~l~h~~iv~l~~~~~~~~-- 74 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-NRNQV----AHVKAERDILAEADNEWVVKLYYSFQDKD-- 74 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHH----HHHHHHHHHHHhcCCCCeeeeEEEEecCC--
Confidence 589999999999999999987 5668999987533211 11122 34589999999999999999999998655
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..++||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||||+.+
T Consensus 75 ------------~~~lv~E~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~ 137 (381)
T cd05626 75 ------------NLYFVMDYIPGGDMMSLLIR-----MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLD 137 (381)
T ss_pred ------------EEEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCC
Confidence 47999999999999999976 3468899999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccc-------------------------------------cCCCCCCCcccC
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-------------------------------------HRGIPAPDVCVG 752 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~-------------------------------------~~~~~~~~~~vG 752 (886)
+.+||+|||++..+.......... ..........+|
T Consensus 138 -------~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 210 (381)
T cd05626 138 -------GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVG 210 (381)
T ss_pred -------CCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccC
Confidence 569999999986442110000000 000001123579
Q ss_pred CCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCchhHHhhhcccccccccc
Q 002738 753 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQ 831 (886)
Q Consensus 753 T~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF~g~s~~el~~~I~~~-~rp~l~~~l~~~~~~~~~~~~~ 831 (886)
|+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+... ....++.
T Consensus 211 t~~Y~aPE~~~~----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------------- 271 (381)
T cd05626 211 TPNYIAPEVLLR----KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPP--------------- 271 (381)
T ss_pred CccccCHHHHcC----CCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCC---------------
Confidence 999999999976 56889999999999999999999999887766655554432 1111110
Q ss_pred cCCCCCCchhhhhhHHHHHHHHHHhc--ccCCCCCCCHHHHHHHH
Q 002738 832 SGSGFEKPEAELETLSFLVDVFRRCT--EENPTERPTAGDLYEMF 874 (886)
Q Consensus 832 ~~~~~~~~~~~~~~s~~L~dLL~rCL--~~DP~kRPSA~EILehL 874 (886)
....++++.+||.+|+ ..+|..||++.+|++|-
T Consensus 272 ----------~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp 306 (381)
T cd05626 272 ----------QVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHP 306 (381)
T ss_pred ----------CCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCc
Confidence 0113457889999855 55666699999999984
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=342.25 Aligned_cols=283 Identities=17% Similarity=0.213 Sum_probs=204.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
..+++|++.+.||+|+||.||+|.+ .+..+|+|+.... ........ .+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~ 87 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP--FQNQTHAK----RAYRELVLMKCVNHKNIISLLNVFTP 87 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCc--ccChHHHH----HHHHHHHHHHHhCCCchhceeeeeec
Confidence 3568999999999999999999986 5677888875422 12222223 34789999999999999999999875
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
...+ ......++||||++ ++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 88 ~~~~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nil 151 (355)
T cd07874 88 QKSL--------EEFQDVYLVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151 (355)
T ss_pred cccc--------cccceeEEEhhhhc-ccHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEE
Confidence 4421 12235799999997 578777753 4788899999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.+ +.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 152 l~~~-------~~~kl~Dfg~~~~~~~~~~-----------~~~~~~t~~y~aPE~~~~----~~~~~~~DiwslG~il~ 209 (355)
T cd07874 152 VKSD-------CTLKILDFGLARTAGTSFM-----------MTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMG 209 (355)
T ss_pred ECCC-------CCEEEeeCcccccCCCccc-----------cCCccccCCccCHHHHcC----CCCCchhhHHHHHHHHH
Confidence 9877 4699999999976533211 123468999999999976 56889999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccc------ccc-----ccccCCC---CCCchhhhhhHHHHHH
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH------EHE-----VAQSGSG---FEKPEAELETLSFLVD 851 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~------~~~-----~~~~~~~---~~~~~~~~~~s~~L~d 851 (886)
+|++|+.||.+.+.......+........+..+....... ... ....... .............+.+
T Consensus 210 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (355)
T cd07874 210 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 289 (355)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHH
Confidence 9999999998887666554443332222222111110000 000 0000000 0001111223457899
Q ss_pred HHHHhcccCCCCCCCHHHHHHHH
Q 002738 852 VFRRCTEENPTERPTAGDLYEMF 874 (886)
Q Consensus 852 LL~rCL~~DP~kRPSA~EILehL 874 (886)
||.+||..||.+|||+.|+++|-
T Consensus 290 li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 290 LLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred HHHHHhcCCchhcCCHHHHhcCc
Confidence 99999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=327.99 Aligned_cols=261 Identities=24% Similarity=0.369 Sum_probs=206.6
Q ss_pred CCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeee
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 621 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~~-------~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g 621 (886)
...+|.+.+.||+|+||.||+|... ...+|+|+..... .....+ .+.+|+.+|+.++||||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~----~~~~e~~~l~~l~~~~i~~~~~ 75 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA---SNDARK----DFEREAELLTNFQHENIVKFYG 75 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC---CHHHHH----HHHHHHHHHHhcCCCCchheee
Confidence 3567899999999999999999862 3578888854221 111223 4489999999999999999999
Q ss_pred eEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhc---------cCCCcCCHHHHHHHHHHHHHHHHHHHhC
Q 002738 622 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE---------TGEKHVSVKLALFIAQDVAAALVELHSK 692 (886)
Q Consensus 622 ~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~---------~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~ 692 (886)
++.... ..++||||+++++|.+++..... .....+++..+..++.||+.||+|||++
T Consensus 76 ~~~~~~--------------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~ 141 (280)
T cd05049 76 VCTEGD--------------PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ 141 (280)
T ss_pred EEecCC--------------CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC
Confidence 988654 36999999999999999976321 1224578899999999999999999999
Q ss_pred CccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCC
Q 002738 693 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 772 (886)
Q Consensus 693 gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s 772 (886)
||+||||||+|||++.+ +.+||+|||++......... .......+++.|+|||++.+ ..++
T Consensus 142 ~i~h~dlkp~nili~~~-------~~~kl~d~g~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~ 202 (280)
T cd05049 142 HFVHRDLATRNCLVGYD-------LVVKIGDFGMSRDVYTTDYY--------RVGGHTMLPIRWMPPESIMY----RKFT 202 (280)
T ss_pred CeeccccccceEEEcCC-------CeEEECCcccceecccCcce--------ecCCCCcccceecChhhhcc----CCcc
Confidence 99999999999999877 56999999998754322110 01122346789999999986 6788
Q ss_pred chhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHH
Q 002738 773 LEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 851 (886)
Q Consensus 773 ~KSDIWSLGVILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~d 851 (886)
.++|||||||++|||++ |..||.+.+.......+..+..+..+. ..+..+.+
T Consensus 203 ~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~ 255 (280)
T cd05049 203 TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPR---------------------------TCPSEVYD 255 (280)
T ss_pred hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCCCCC---------------------------CCCHHHHH
Confidence 99999999999999998 999998888777777766543322211 12457899
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHh
Q 002738 852 VFRRCTEENPTERPTAGDLYEMFVA 876 (886)
Q Consensus 852 LL~rCL~~DP~kRPSA~EILehLe~ 876 (886)
|+.+||..||.+||++.||++.|++
T Consensus 256 li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 256 IMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHcCCCcccCCCHHHHHHHhhC
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=345.20 Aligned_cols=253 Identities=23% Similarity=0.334 Sum_probs=214.5
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
-.+|++.+.||.|.||.|-+|.. .+..||+|.++....... ...- .+.+||+||..|+|||||++|.+|...+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkde-qDlv----hIRREIeIMSsLNHPhII~IyEVFENkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDE-QDLV----HIRREIEIMSSLNHPHIIQIYEVFENKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccH-HHHH----HHHHHHHHHhhcCCCceeehhhhhcCCc
Confidence 35899999999999999999985 678899998654433322 2222 3489999999999999999999999766
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
. ..|||||..+|.|++|+.. .+.+++.+++.+++||+.|+.|+|.++++|||||.+|||+|
T Consensus 127 K--------------IvivMEYaS~GeLYDYiSe-----r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD 187 (668)
T KOG0611|consen 127 K--------------IVIVMEYASGGELYDYISE-----RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLD 187 (668)
T ss_pred e--------------EEEEEEecCCccHHHHHHH-----hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeec
Confidence 4 6999999999999999987 46799999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+++ +||+|||++..+..... -.+++|+|.|.+||++.+ ..+-++.+|-|||||+||-|
T Consensus 188 ~N~N-------iKIADFGLSNly~~~kf-----------LqTFCGSPLYASPEIvNG---~PY~GPEVDsWsLGvLLYtL 246 (668)
T KOG0611|consen 188 QNNN-------IKIADFGLSNLYADKKF-----------LQTFCGSPLYASPEIVNG---TPYKGPEVDSWSLGVLLYTL 246 (668)
T ss_pred CCCC-------eeeeccchhhhhccccH-----------HHHhcCCcccCCccccCC---CCCCCCccchhhHHHHHHHH
Confidence 8854 99999999987765332 245689999999999987 23347899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 788 LTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
+.|..||.|.+...++.+|..+..-.-+ .+....-||..||..||++|.|+
T Consensus 247 VyGtMPFDG~Dhk~lvrQIs~GaYrEP~-----------------------------~PSdA~gLIRwmLmVNP~RRATi 297 (668)
T KOG0611|consen 247 VYGTMPFDGRDHKRLVRQISRGAYREPE-----------------------------TPSDASGLIRWMLMVNPERRATI 297 (668)
T ss_pred hhcccccCCchHHHHHHHhhcccccCCC-----------------------------CCchHHHHHHHHHhcCcccchhH
Confidence 9999999999999999999888432111 12246779999999999999999
Q ss_pred HHHHHHHHh
Q 002738 868 GDLYEMFVA 876 (886)
Q Consensus 868 ~EILehLe~ 876 (886)
.+|..|++-
T Consensus 298 eDiAsHWWv 306 (668)
T KOG0611|consen 298 EDIASHWWV 306 (668)
T ss_pred HHHhhhhee
Confidence 999999863
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=330.26 Aligned_cols=267 Identities=22% Similarity=0.355 Sum_probs=209.5
Q ss_pred CCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeee
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 621 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~~-------~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g 621 (886)
.+.+|.+.+.||+|+||.||+|.+. ...+++|... . ......+ .+.+|+.++++++||||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~--~--~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~ 74 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK--D--PTLAARK----DFQREAELLTNLQHEHIVKFYG 74 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecC--C--ccHHHHH----HHHHHHHHHhcCCCCCcceEEE
Confidence 4668999999999999999999852 2346666542 1 1122222 3489999999999999999999
Q ss_pred eEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhc-----------cCCCcCCHHHHHHHHHHHHHHHHHHH
Q 002738 622 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELH 690 (886)
Q Consensus 622 ~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~-----------~~~~~Ls~~~i~~Ia~QIa~AL~yLH 690 (886)
++.... ..++||||+++++|.+++..... .....+++..++.++.||+.||+|||
T Consensus 75 ~~~~~~--------------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 140 (291)
T cd05094 75 VCGDGD--------------PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA 140 (291)
T ss_pred EEccCC--------------ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 987554 36999999999999999975221 11235889999999999999999999
Q ss_pred hCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCC
Q 002738 691 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 770 (886)
Q Consensus 691 s~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~ 770 (886)
++||+||||||+|||++.+ +.++|+|||++......... .......++..|+|||++.+ ..
T Consensus 141 ~~~i~H~dlkp~Nil~~~~-------~~~~l~dfg~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~ 201 (291)
T cd05094 141 SQHFVHRDLATRNCLVGAN-------LLVKIGDFGMSRDVYSTDYY--------RVGGHTMLPIRWMPPESIMY----RK 201 (291)
T ss_pred hCCeeecccCcceEEEccC-------CcEEECCCCcccccCCCcee--------ecCCCCCcceeecChHHhcc----CC
Confidence 9999999999999999877 56999999999765432211 00122357889999999876 66
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHH
Q 002738 771 YGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 849 (886)
Q Consensus 771 ~s~KSDIWSLGVILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L 849 (886)
++.++|||||||++|||+| |+.||...+..++...+..+..+..+. ..+..+
T Consensus 202 ~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~ 254 (291)
T cd05094 202 FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPR---------------------------VCPKEV 254 (291)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCCCCCc---------------------------cCCHHH
Confidence 8889999999999999999 999998888777766665543322211 124568
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCCC
Q 002738 850 VDVFRRCTEENPTERPTAGDLYEMFVARTSSSIS 883 (886)
Q Consensus 850 ~dLL~rCL~~DP~kRPSA~EILehLe~l~sss~S 883 (886)
.+|+.+||+.+|.+||++.+|++.|+.+..+.++
T Consensus 255 ~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~~ 288 (291)
T cd05094 255 YDIMLGCWQREPQQRLNIKEIYKILHALGKATPI 288 (291)
T ss_pred HHHHHHHcccChhhCcCHHHHHHHHHHHHhhcCc
Confidence 9999999999999999999999999999876553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=333.66 Aligned_cols=265 Identities=25% Similarity=0.415 Sum_probs=203.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcceeeeeEe
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 624 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl~g~~~ 624 (886)
..+++|++.+.||+|+||.||+|.+. +..++++++.++.. ....... .+.+|+.++.++ +||||+++++++.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~----~~~~Ei~~l~~l~~h~~iv~~~~~~~ 78 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHR----DFAGELEVLCKLGHHPNIINLLGACE 78 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHH----HHHHHHHHHHHhcCCCCcceEEEEEC
Confidence 56889999999999999999999863 33444444333321 1222223 348899999999 7999999999987
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhc-----------cCCCcCCHHHHHHHHHHHHHHHHHHHhCC
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELHSKH 693 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~-----------~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~g 693 (886)
.... .|+||||+++++|.+++..... .....+++..++.++.||+.||+|||++|
T Consensus 79 ~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g 144 (303)
T cd05088 79 HRGY--------------LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 144 (303)
T ss_pred CCCC--------------ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 6553 5999999999999999975221 11235789999999999999999999999
Q ss_pred ccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCc
Q 002738 694 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 773 (886)
Q Consensus 694 IVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~ 773 (886)
|+||||||+|||++.+ +.+||+|||++........ .....++..|+|||++.+ ..++.
T Consensus 145 i~H~dlkp~Nili~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~ 202 (303)
T cd05088 145 FIHRDLAARNILVGEN-------YVAKIADFGLSRGQEVYVK-----------KTMGRLPVRWMAIESLNY----SVYTT 202 (303)
T ss_pred ccccccchheEEecCC-------CcEEeCccccCcccchhhh-----------cccCCCcccccCHHHHhc----cCCcc
Confidence 9999999999999876 4699999999863221100 111234678999999875 56789
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHH
Q 002738 774 EVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 852 (886)
Q Consensus 774 KSDIWSLGVILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dL 852 (886)
++|||||||++|||+| |..||.+.+..+....+.....+..+ ...+..+.+|
T Consensus 203 ~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l 255 (303)
T cd05088 203 NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP---------------------------LNCDDEVYDL 255 (303)
T ss_pred cccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCCCC---------------------------CCCCHHHHHH
Confidence 9999999999999998 99999887776665554333221111 1124568999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 002738 853 FRRCTEENPTERPTAGDLYEMFVARTSS 880 (886)
Q Consensus 853 L~rCL~~DP~kRPSA~EILehLe~l~ss 880 (886)
+.+||+.+|++||++++++.+|+.+...
T Consensus 256 i~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 256 MRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=340.96 Aligned_cols=249 Identities=25% Similarity=0.330 Sum_probs=198.2
Q ss_pred CceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCC-CcceeeeeEecCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS-CIVEMYGHKISSKW 628 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HP-NIVrl~g~~~~~~~ 628 (886)
+|++.+.||+|+||.||+|++. +..+|+|++...... .....+ .+..|+.++..+.|+ +|+++++++...+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~----~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII-QDDDVE----CTMVEKRVLALPGKPPFLTQLHSCFQTMD- 74 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHH----HHHHHHHHHHhcCCCCceeeeEEEEEcCC-
Confidence 5899999999999999999974 457999987543211 112222 347899999999765 5888888887554
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..|+||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~ 136 (324)
T cd05587 75 -------------RLYFVMEYVNGGDLMYHIQQ-----VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDA 136 (324)
T ss_pred -------------EEEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcC
Confidence 46999999999999999975 346889999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 137 ~-------~~~kL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~ell 195 (324)
T cd05587 137 E-------GHIKIADFGMCKENIFGGK----------TTRTFCGTPDYIAPEIIAY----QPYGKSVDWWAFGVLLYEML 195 (324)
T ss_pred C-------CCEEEeecCcceecCCCCC----------ceeeecCCccccChhhhcC----CCCCcccchhhhHHHHHHHH
Confidence 7 4699999999864321111 1123469999999999986 66789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA- 867 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA- 867 (886)
||+.||.+.+..++...+..... .++ ...+..+.+|+.+||..||.+|+++
T Consensus 196 tG~~pf~~~~~~~~~~~i~~~~~-~~~---------------------------~~~~~~~~~li~~~l~~~P~~R~~~~ 247 (324)
T cd05587 196 AGQPPFDGEDEDELFQSIMEHNV-SYP---------------------------KSLSKEAVSICKGLLTKHPAKRLGCG 247 (324)
T ss_pred hCCCCCCCCCHHHHHHHHHcCCC-CCC---------------------------CCCCHHHHHHHHHHhhcCHHHcCCCC
Confidence 99999998888777776654321 111 1124578999999999999999976
Q ss_pred ----HHHHHH
Q 002738 868 ----GDLYEM 873 (886)
Q Consensus 868 ----~EILeh 873 (886)
+++++|
T Consensus 248 ~~~~~~~~~h 257 (324)
T cd05587 248 PTGERDIREH 257 (324)
T ss_pred CCCHHHHhcC
Confidence 788876
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=320.47 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=205.7
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
+|++.+.||+|+||.||+|.+ .+..+++|....... ...... .+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 72 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM--NRRERE----EAIDEARVLAKLDSSYIIRYYESFLDKG-- 72 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC--CHHHHH----HHHHHHHHHHhcCCCCeehheeeeccCC--
Confidence 588999999999999999987 567889888654322 223333 3489999999999999999999987654
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..++||||+++++|.+++... ....+++..++.++.||+.||.|||++||+|+||||+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~ 137 (256)
T cd08529 73 ------------KLNIVMEYAENGDLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY 137 (256)
T ss_pred ------------EEEEEEEeCCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC
Confidence 469999999999999999862 23568899999999999999999999999999999999999877
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
..++|+|||++..+...... .....|++.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 138 -------~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l~~ 196 (256)
T cd08529 138 -------DNVKIGDLGVAKLLSDNTNF----------ANTIVGTPYYLSPELCED----KPYNEKSDVWALGVVLYECCT 196 (256)
T ss_pred -------CCEEEcccccceeccCccch----------hhccccCccccCHHHhcC----CCCCCccchHHHHHHHHHHHh
Confidence 45999999998866432211 123358899999999986 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 869 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~E 869 (886)
|+.||...+.......+..+..+.++. ..+..+.+++.+||+.+|++||++.+
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~i~~~l~~~p~~Rp~~~~ 249 (256)
T cd08529 197 GKHPFDANNQGALILKIIRGVFPPVSQ---------------------------MYSQQLAQLIDQCLTKDYRQRPDTFQ 249 (256)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCcc---------------------------ccCHHHHHHHHHHccCCcccCcCHHH
Confidence 999998888777666666554443331 12457899999999999999999999
Q ss_pred HHHH
Q 002738 870 LYEM 873 (886)
Q Consensus 870 ILeh 873 (886)
++++
T Consensus 250 ll~~ 253 (256)
T cd08529 250 LLRN 253 (256)
T ss_pred HhhC
Confidence 9986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=328.81 Aligned_cols=251 Identities=29% Similarity=0.495 Sum_probs=197.9
Q ss_pred eeeeeecccCceEEEEEEEC------CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 554 SSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 554 ~i~k~LG~G~fG~VY~A~~~------~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
.+.+.||.|+||.||+|.+. +..|+||+.. . .......+.+ .+|+.++++++||||++++|++....
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~--~-~~~~~~~~~~----~~e~~~l~~l~h~ni~~~~g~~~~~~ 74 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILK--P-SSSEEEEEEF----LNEIQILRKLRHPNIVKLYGFCIENE 74 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEES--T-TSSHHHHHHH----HHHHHHHHTHSBTTBE-EEEEEESSS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEec--c-ccccccceee----eecccccccccccccccccccccccc
Confidence 57899999999999999987 6788888863 2 2223334444 89999999999999999999999444
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
..++||||+++|+|.++|... ....+++..+..|+.||+.||.|||+++|+|++|+++|||++
T Consensus 75 --------------~~~lv~e~~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~ 137 (259)
T PF07714_consen 75 --------------PLFLVMEYCPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD 137 (259)
T ss_dssp --------------SEEEEEE--TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE
T ss_pred --------------ccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccccc
Confidence 269999999999999999872 235689999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ +.+||+|||++.......... ......+...|+|||.+.. ..++.++||||||+++|||
T Consensus 138 ~~-------~~~Kl~~f~~~~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~----~~~~~ksDVysfG~~l~ei 198 (259)
T PF07714_consen 138 SN-------GQVKLSDFGLSRPISEKSKYK--------NDSSQQLPLRYLAPEVLKD----GEYTKKSDVYSFGMLLYEI 198 (259)
T ss_dssp TT-------TEEEEESTTTGEETTTSSSEE--------ESTTSESGGGGS-HHHHHH----SEESHHHHHHHHHHHHHHH
T ss_pred cc-------ccccccccccccccccccccc--------ccccccccccccccccccc----ccccccccccccccccccc
Confidence 87 579999999998763221110 0122346789999999987 5589999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 788 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 788 LT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
++ |+.||...+..++...+..+.++..+. ..+..+.+||.+||..||.+|||
T Consensus 199 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~C~~~~p~~RPs 251 (259)
T PF07714_consen 199 LTLGKFPFSDYDNEEIIEKLKQGQRLPIPD---------------------------NCPKDIYSLIQQCWSHDPEKRPS 251 (259)
T ss_dssp HTTSSGTTTTSCHHHHHHHHHTTEETTSBT---------------------------TSBHHHHHHHHHHT-SSGGGS--
T ss_pred cccccccccccccccccccccccccceecc---------------------------chhHHHHHHHHHHcCCChhhCcC
Confidence 99 789999998888888886665443331 12446899999999999999999
Q ss_pred HHHHHHHH
Q 002738 867 AGDLYEMF 874 (886)
Q Consensus 867 A~EILehL 874 (886)
+.+|++.|
T Consensus 252 ~~~i~~~L 259 (259)
T PF07714_consen 252 FQEILQEL 259 (259)
T ss_dssp HHHHHHHH
T ss_pred HHHHHhcC
Confidence 99999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=351.27 Aligned_cols=263 Identities=22% Similarity=0.264 Sum_probs=200.0
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
.+|++.+.||+|+||.||+|+. .+..+|+|++..... ........+.+|+.+|..++||||+++++.+....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~- 74 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADV-----LMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD- 74 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHH-----HhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-
Confidence 3699999999999999999997 567899998642211 01111234588999999999999999999998655
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..||||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~E~~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~ 136 (376)
T cd05598 75 -------------NLYFVMDYIPGGDMMSLLIR-----LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR 136 (376)
T ss_pred -------------EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECC
Confidence 46999999999999999976 346889999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCccccccccccccc---------------------------------ccCCCCCCCcccCCCc
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCI---------------------------------AHRGIPAPDVCVGTPR 755 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~---------------------------------~~~~~~~~~~~vGT~~ 755 (886)
+ +.+||+|||+|..+......... ...........+||+.
T Consensus 137 ~-------~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 209 (376)
T cd05598 137 D-------GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN 209 (376)
T ss_pred C-------CCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCcc
Confidence 7 46999999998543210000000 0000001123579999
Q ss_pred ccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhcccccccccccCC
Q 002738 756 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGS 834 (886)
Q Consensus 756 YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF~g~s~~el~~~I~~~~r-p~l~~~l~~~~~~~~~~~~~~~~ 834 (886)
|||||++.+ ..++.++|||||||+||||++|+.||.+.+..+....+..... ..++
T Consensus 210 y~aPE~~~~----~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------- 266 (376)
T cd05598 210 YIAPEVLLR----TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIP------------------- 266 (376)
T ss_pred ccCHHHHcC----CCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCC-------------------
Confidence 999999976 6678999999999999999999999998887766555543211 0000
Q ss_pred CCCCchhhhhhHHHHHHHHHHhcccCCCCCC---CHHHHHHHH
Q 002738 835 GFEKPEAELETLSFLVDVFRRCTEENPTERP---TAGDLYEMF 874 (886)
Q Consensus 835 ~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP---SA~EILehL 874 (886)
.....++.+.+||.+|+ .+|.+|+ ++.++++|-
T Consensus 267 ------~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~ 302 (376)
T cd05598 267 ------SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHP 302 (376)
T ss_pred ------CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCC
Confidence 00123457888999976 5999999 999999983
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=346.32 Aligned_cols=284 Identities=19% Similarity=0.213 Sum_probs=205.9
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
+|++.+.||+|+||.||+|.+ .+..||+|..... .......+ ++.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~- 73 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV--FQNLVSCK----RVFRELKMLCFFKHDNVLSALDILQPPHI- 73 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccc--ccchHHHH----HHHHHHHHHHhCCCCCcCCHhheecCCCc-
Confidence 478899999999999999996 5778999975321 11222223 34899999999999999999999875541
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
......|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 74 --------~~~~~~~lv~e~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~ 139 (372)
T cd07853 74 --------DPFEEIYVVTELMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN 139 (372)
T ss_pred --------cccceEEEEeeccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCC
Confidence 11225799999997 688888864 3568999999999999999999999999999999999999877
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.+||+|||+++........ ......+|+.|+|||++.+ ...++.++|||||||++|||++
T Consensus 140 -------~~~kL~Dfg~a~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~~ 200 (372)
T cd07853 140 -------CVLKICDFGLARVEEPDESK---------HMTQEVVTQYYRAPEILMG---SRHYTSAVDIWSVGCIFAELLG 200 (372)
T ss_pred -------CCEEeccccceeecccCccc---------cCCCCCcCCCcCCHHHHcC---CCCCCcHHHHHhHHHHHHHHHc
Confidence 56999999999765332111 1122358899999999875 2457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCC----chhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK----PEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~----~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
|+.||.+.++.+....+...........+..........+......... .......++.+.+||.+||+.||.+||
T Consensus 201 g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~ 280 (372)
T cd07853 201 RRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRI 280 (372)
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCc
Confidence 9999999888777766655322221222211100000000000000000 001122356789999999999999999
Q ss_pred CHHHHHHHHH
Q 002738 866 TAGDLYEMFV 875 (886)
Q Consensus 866 SA~EILehLe 875 (886)
|+.++++|-.
T Consensus 281 t~~e~l~hp~ 290 (372)
T cd07853 281 SAADALAHPY 290 (372)
T ss_pred CHHHHhcCHh
Confidence 9999999853
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=323.67 Aligned_cols=257 Identities=22% Similarity=0.354 Sum_probs=204.9
Q ss_pred CCCceeeeeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEe
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 624 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~~-----~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~ 624 (886)
.++|++.+.||+|+||.||+|.+. ...+++|+.... ....... .+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~---~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG---SSDKQRL----DFLTEASIMGQFDHPNIIRLEGVVT 75 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC---CChHHHH----HHHHHHHHHHhCCCCCcceEeEEEe
Confidence 457899999999999999999873 346788875322 1222223 3488999999999999999999987
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNI 704 (886)
... ..++||||+++++|.+++.. ....+++..++.++.|++.||+|||+++|+||||||+||
T Consensus 76 ~~~--------------~~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~ni 137 (266)
T cd05033 76 KSR--------------PVMIITEYMENGSLDKFLRE----NDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNI 137 (266)
T ss_pred cCC--------------ceEEEEEcCCCCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceE
Confidence 554 36999999999999999975 124689999999999999999999999999999999999
Q ss_pred EEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVIL 784 (886)
|++.+ +.++|+|||++.......... ......++..|+|||.+.+ ..++.++||||||+++
T Consensus 138 li~~~-------~~~~l~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~~Pe~~~~----~~~~~~~Dv~slG~~l 198 (266)
T cd05033 138 LVNSN-------LVCKVSDFGLSRRLEDSEATY--------TTKGGKIPIRWTAPEAIAY----RKFTSASDVWSFGIVM 198 (266)
T ss_pred EEcCC-------CCEEECccchhhcccccccce--------eccCCCCCccccChhhhcc----CCCccccchHHHHHHH
Confidence 99877 569999999998764211110 0112235678999999876 5678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 785 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 785 yELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
|+|++ |..||......++...+........+ ...+..+.+|+.+||+.+|.+
T Consensus 199 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~~p~~ 251 (266)
T cd05033 199 WEVMSYGERPYWDMSNQDVIKAVEDGYRLPPP---------------------------MDCPSALYQLMLDCWQKDRNE 251 (266)
T ss_pred HHHHccCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHcCCCccc
Confidence 99998 99999888777777666554332211 112457899999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 002738 864 RPTAGDLYEMFVAR 877 (886)
Q Consensus 864 RPSA~EILehLe~l 877 (886)
||++.+|+++|.++
T Consensus 252 Rp~~~ei~~~l~~~ 265 (266)
T cd05033 252 RPTFSQIVSTLDKM 265 (266)
T ss_pred CcCHHHHHHHHHhh
Confidence 99999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=331.21 Aligned_cols=280 Identities=19% Similarity=0.248 Sum_probs=206.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
..+++|++.+.||.|+||.||+|++ .+..||+|.+........ ...+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~nI~~~~~~~~~ 75 (301)
T cd07873 3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA-------PCTAIREVSLLKDLKHANIVTLHDIIHT 75 (301)
T ss_pred ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc-------hhHHHHHHHHHHhcCCCCcceEEEEEec
Confidence 5678999999999999999999987 467789998754432111 1123789999999999999999999986
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
.. ..++||||++ ++|.+++.. ....+++..+..++.||+.||.|||++||+|+||||+|||
T Consensus 76 ~~--------------~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil 136 (301)
T cd07873 76 EK--------------SLTLVFEYLD-KDLKQYLDD----CGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLL 136 (301)
T ss_pred CC--------------eEEEEEeccc-cCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEE
Confidence 54 3699999997 699998875 2345889999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.+ +.++|+|||++......... .....+++.|+|||++.+ ...++.++|||||||++|
T Consensus 137 ~~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~slG~~l~ 196 (301)
T cd07873 137 INER-------GELKLADFGLARAKSIPTKT----------YSNEVVTLWYRPPDILLG---STDYSTQIDMWGVGCIFY 196 (301)
T ss_pred ECCC-------CcEEECcCcchhccCCCCCc----------ccccceeecccCcHHHhC---CCCCccHHHHHHHHHHHH
Confidence 9877 46999999998754322111 122357899999999875 245788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCC---CchhhhhhHHHHHHHHHHhcccCCC
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE---KPEAELETLSFLVDVFRRCTEENPT 862 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~L~dLL~rCL~~DP~ 862 (886)
||++|++||.+.+..+....+...........+.............. .... ........++.+.+||.+||+.||.
T Consensus 197 el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~ 275 (301)
T cd07873 197 EMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNY-PKYRADCLHNHAPRLDSDGAELLSKLLQFEGR 275 (301)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccccc-CccccccHHhhcCCCCHHHHHHHHHHhcCCcc
Confidence 99999999998877666655544322222222221111000000000 0000 0011223466789999999999999
Q ss_pred CCCCHHHHHHHH
Q 002738 863 ERPTAGDLYEMF 874 (886)
Q Consensus 863 kRPSA~EILehL 874 (886)
+|||+.|+++|-
T Consensus 276 ~R~t~~eil~h~ 287 (301)
T cd07873 276 KRISAEEAMKHP 287 (301)
T ss_pred cCcCHHHHhcCc
Confidence 999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=348.90 Aligned_cols=267 Identities=27% Similarity=0.367 Sum_probs=202.2
Q ss_pred CCceeeeeecccCceEEEEEEECC-eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~~~-~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
++|.-...||+|+||.||+|...+ ..||||.. ....... .++| .+|+.+|.+++|||+|+++|||.+...
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~--~~~~~~~--~~eF----~~Ei~~ls~l~H~Nlv~LlGyC~e~~~- 145 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRL--SSNSGQG--EREF----LNEVEILSRLRHPNLVKLLGYCLEGGE- 145 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEEEe--cCCCCcc--hhHH----HHHHHHHhcCCCcCcccEEEEEecCCc-
Confidence 577788999999999999999865 78999953 3322211 2335 999999999999999999999996651
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCCEEE
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---HIMHRDIKSENILI 706 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~---gIVHRDLKPsNILL 706 (886)
+.+||+||+++|+|.++|... ... .++|..+++|+.++|+||+|||.. .||||||||+||||
T Consensus 146 ------------~~~LVYEym~nGsL~d~L~~~--~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL 210 (361)
T KOG1187|consen 146 ------------HRLLVYEYMPNGSLEDHLHGK--KGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL 210 (361)
T ss_pred ------------eEEEEEEccCCCCHHHHhCCC--CCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE
Confidence 369999999999999999861 111 789999999999999999999985 49999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccc-cccccccccCCCCCCCcc-cCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRS-FLHTCCIAHRGIPAPDVC-VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~-~~~~~~~~~~~~~~~~~~-vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVIL 784 (886)
|.+ +.+||+|||+|+.... .... ... .||.+|+|||++.. +..+.|+|||||||+|
T Consensus 211 D~~-------~~aKlsDFGLa~~~~~~~~~~-----------~~~~~gt~gY~~PEy~~~----g~lt~KsDVySFGVvl 268 (361)
T KOG1187|consen 211 DED-------FNAKLSDFGLAKLGPEGDTSV-----------STTVMGTFGYLAPEYAST----GKLTEKSDVYSFGVVL 268 (361)
T ss_pred CCC-------CCEEccCccCcccCCccccce-----------eeecCCCCccCChhhhcc----CCcCcccccccchHHH
Confidence 987 6799999999965543 1111 111 69999999999975 6789999999999999
Q ss_pred HHHHhCCCCCCCCC---HHHHHH----HHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhh-hhHHHHHHHHHHh
Q 002738 785 LELLTLQVPYMGLS---ELEIHD----LIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL-ETLSFLVDVFRRC 856 (886)
Q Consensus 785 yELLTG~~PF~g~s---~~el~~----~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~L~dLL~rC 856 (886)
.||+||+.|..... ...+.. .+..+ .+. .+.+..... ..... .....+..+..+|
T Consensus 269 lElitgr~~~d~~~~~~~~~l~~w~~~~~~~~---~~~------------eiiD~~l~~--~~~~~~~~~~~~~~~a~~C 331 (361)
T KOG1187|consen 269 LELITGRKAVDQSRPRGELSLVEWAKPLLEEG---KLR------------EIVDPRLKE--GEYPDEKEVKKLAELALRC 331 (361)
T ss_pred HHHHhCCcccCCCCCcccccHHHHHHHHHHCc---chh------------heeCCCccC--CCCChHHHHHHHHHHHHHH
Confidence 99999998876432 111222 11111 111 111111110 01111 3456688999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhcCC
Q 002738 857 TEENPTERPTAGDLYEMFVARTSS 880 (886)
Q Consensus 857 L~~DP~kRPSA~EILehLe~l~ss 880 (886)
++.+|.+||++.||++.|+.+...
T Consensus 332 ~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 332 LRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred cCcCCCcCcCHHHHHHHHHhhccc
Confidence 999999999999999999776544
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=326.09 Aligned_cols=260 Identities=21% Similarity=0.351 Sum_probs=202.4
Q ss_pred CCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeee
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 622 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~~-------~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~ 622 (886)
-++|++.+.||+|+||.||+|.+. +..+|+|+... . ....... .+.+|+.+++.++||||++++++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~--~-~~~~~~~----~~~~e~~~l~~l~~~~iv~~~~~ 77 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNE--A-ASMRERI----EFLNEASVMKEFNCHHVVRLLGV 77 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccc--c-CCHHHHH----HHHHHHHHHHhCCCCCeeeEEEE
Confidence 457999999999999999999863 24688887431 1 1112222 34899999999999999999999
Q ss_pred EecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccC-----CCcCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 002738 623 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG-----EKHVSVKLALFIAQDVAAALVELHSKHIMHR 697 (886)
Q Consensus 623 ~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~-----~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHR 697 (886)
+.... ..++||||+++++|.+++....... ...+++..+..++.|++.||.|||+.|++||
T Consensus 78 ~~~~~--------------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~ 143 (277)
T cd05062 78 VSQGQ--------------PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHR 143 (277)
T ss_pred EcCCC--------------CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 87544 3699999999999999997632111 1245788899999999999999999999999
Q ss_pred CCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhH
Q 002738 698 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 777 (886)
Q Consensus 698 DLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDI 777 (886)
||||+|||++.+ +.++|+|||++.......... ......+++.|+|||++.+ ..++.++||
T Consensus 144 dlkp~Nil~~~~-------~~~~l~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di 204 (277)
T cd05062 144 DLAARNCMVAED-------FTVKIGDFGMTRDIYETDYYR--------KGGKGLLPVRWMSPESLKD----GVFTTYSDV 204 (277)
T ss_pred CcchheEEEcCC-------CCEEECCCCCccccCCcceee--------cCCCCccCHhhcChhHhhc----CCcCchhHH
Confidence 999999999876 569999999987654322110 0112246788999999976 668899999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 002738 778 WSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 856 (886)
Q Consensus 778 WSLGVILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rC 856 (886)
|||||++|||++ |..||.+.........+.....+.++. ..+..+.+|+.+|
T Consensus 205 ~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~ 257 (277)
T cd05062 205 WSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPD---------------------------NCPDMLFELMRMC 257 (277)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCC---------------------------CCCHHHHHHHHHH
Confidence 999999999999 789998888777776665543322221 1245789999999
Q ss_pred cccCCCCCCCHHHHHHHHHh
Q 002738 857 TEENPTERPTAGDLYEMFVA 876 (886)
Q Consensus 857 L~~DP~kRPSA~EILehLe~ 876 (886)
|+.+|.+|||+.|++++|++
T Consensus 258 l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 258 WQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred cCCChhhCcCHHHHHHHhhC
Confidence 99999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=324.89 Aligned_cols=264 Identities=22% Similarity=0.360 Sum_probs=203.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceee
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 620 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~~-------~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~ 620 (886)
...++|.+.+.||+|+||.||+|.+.. ..+++|.. .... ....... +.+|+.+++.++|+||++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~--~~~~-~~~~~~~----~~~e~~~l~~l~~~~i~~~~ 75 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL--PESC-SEQDESD----FLMEALIMSKFNHQNIVRLI 75 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEc--CCCC-CHHHHHH----HHHHHHHHHhCCCCCEeeEE
Confidence 445789999999999999999999854 44556553 3221 1222223 48899999999999999999
Q ss_pred eeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhcc--CCCcCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 002738 621 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--GEKHVSVKLALFIAQDVAAALVELHSKHIMHRD 698 (886)
Q Consensus 621 g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~--~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRD 698 (886)
+++..... .++||||++|++|.+++...... ....+++..++.++.||+.||+|||+++++|||
T Consensus 76 ~~~~~~~~--------------~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~d 141 (277)
T cd05036 76 GVSFERLP--------------RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRD 141 (277)
T ss_pred EEEccCCC--------------cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecc
Confidence 98876543 59999999999999999863211 113588999999999999999999999999999
Q ss_pred CCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHH
Q 002738 699 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 778 (886)
Q Consensus 699 LKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIW 778 (886)
|||+|||++..+. ...+||+|||+++......... .......+..|+|||++.+ ..++.++|||
T Consensus 142 lkp~nil~~~~~~----~~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~Diw 205 (277)
T cd05036 142 IAARNCLLTCKGP----GRVAKIADFGMARDIYRASYYR--------KGGRAMLPIKWMPPEAFLD----GIFTSKTDVW 205 (277)
T ss_pred cchheEEEeccCC----CcceEeccCccccccCCcccee--------cCCCCCccHhhCCHHHHhc----CCcCchhHHH
Confidence 9999999986531 2469999999998663221110 0111234568999999976 6689999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 002738 779 SYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 857 (886)
Q Consensus 779 SLGVILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL 857 (886)
||||++|||++ |..||.+.+...+...+.....+..+ ...+..+.+|+.+||
T Consensus 206 slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~cl 258 (277)
T cd05036 206 SFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPP---------------------------KGCPGPVYRIMTDCW 258 (277)
T ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHc
Confidence 99999999997 99999988777766665544322211 112457899999999
Q ss_pred ccCCCCCCCHHHHHHHHH
Q 002738 858 EENPTERPTAGDLYEMFV 875 (886)
Q Consensus 858 ~~DP~kRPSA~EILehLe 875 (886)
+.+|++||++.+|++||+
T Consensus 259 ~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 259 QHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCcccCcCHHHHHHHhh
Confidence 999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=347.24 Aligned_cols=264 Identities=23% Similarity=0.321 Sum_probs=201.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCccee
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 619 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~-------~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl 619 (886)
.+.++|++.+.||+|+||.||+|++. ...||+|+..... ...... .+.+|+.+++.+ +|||||++
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~----~~~~E~~il~~l~~h~nIv~~ 107 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDERE----ALMSELKILSHLGQHKNIVNL 107 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHH----HHHHHHHHHHhhccCCceeeE
Confidence 45668999999999999999999852 2368888864321 122222 348999999999 79999999
Q ss_pred eeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhc-----------------------------------
Q 002738 620 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE----------------------------------- 664 (886)
Q Consensus 620 ~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~----------------------------------- 664 (886)
++++..... .++||||+++|+|.+++.....
T Consensus 108 ~~~~~~~~~--------------~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (374)
T cd05106 108 LGACTHGGP--------------VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGF 173 (374)
T ss_pred eeEecCCCC--------------eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccc
Confidence 999876553 6999999999999999965211
Q ss_pred ------------------------------cCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCC
Q 002738 665 ------------------------------TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 714 (886)
Q Consensus 665 ------------------------------~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~ 714 (886)
.....+++..++.|+.||+.||+|||++||+||||||+|||++.+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~----- 248 (374)
T cd05106 174 SSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDG----- 248 (374)
T ss_pred cccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCC-----
Confidence 011247888999999999999999999999999999999999876
Q ss_pred CCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 002738 715 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVP 793 (886)
Q Consensus 715 ~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT-G~~P 793 (886)
..+||+|||+++........ .......+++.|||||++.. ..++.++|||||||++|||++ |+.|
T Consensus 249 --~~~kL~DfGla~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwSlGvil~ellt~G~~P 314 (374)
T cd05106 249 --RVAKICDFGLARDIMNDSNY--------VVKGNARLPVKWMAPESIFD----CVYTVQSDVWSYGILLWEIFSLGKSP 314 (374)
T ss_pred --CeEEEeeceeeeeccCCcce--------eeccCCCCccceeCHHHhcC----CCCCccccHHHHHHHHHHHHhCCCCC
Confidence 56999999999765432111 01122235678999999875 678999999999999999997 9999
Q ss_pred CCCCCHHHHHHHHH-cCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002738 794 YMGLSELEIHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 872 (886)
Q Consensus 794 F~g~s~~el~~~I~-~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EILe 872 (886)
|...........+. .+..+..+ ...++.+.+|+.+||+.||.+|||+.+|++
T Consensus 315 f~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 315 YPGILVNSKFYKMVKRGYQMSRP---------------------------DFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred CccccccHHHHHHHHcccCccCC---------------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 97765433332222 22111111 012457999999999999999999999999
Q ss_pred HHHhhc
Q 002738 873 MFVART 878 (886)
Q Consensus 873 hLe~l~ 878 (886)
.|+++.
T Consensus 368 ~l~~~~ 373 (374)
T cd05106 368 LIQRQL 373 (374)
T ss_pred HHHHHh
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=343.75 Aligned_cols=245 Identities=26% Similarity=0.358 Sum_probs=196.3
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 634 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~~ 634 (886)
+.||+|+||.||+++. .+..+|+|+....... ..... ..+.+|+.++..++||||+++++++....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~-~~~~~----~~~~~e~~~l~~~~hp~i~~~~~~~~~~~------- 68 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEV----AHTLTENRVLQNSRHPFLTALKYSFQTHD------- 68 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHH----HHHHHHHHHHHhCCCCCCCceEEEEEcCC-------
Confidence 4699999999999986 5678999997533211 11222 23478999999999999999999988655
Q ss_pred CCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEEeccccCC
Q 002738 635 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDLERKKA 713 (886)
Q Consensus 635 ~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs-~gIVHRDLKPsNILLd~d~~~~ 713 (886)
..||||||+++++|..++.. ...+++..+..++.||+.||+|||+ +||+||||||+|||++.+
T Consensus 69 -------~~~lv~E~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~---- 132 (325)
T cd05594 69 -------RLCFVMEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD---- 132 (325)
T ss_pred -------EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCC----
Confidence 46999999999999998875 3468999999999999999999997 799999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 002738 714 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 793 (886)
Q Consensus 714 ~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~P 793 (886)
+.+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||+||||++|+.|
T Consensus 133 ---~~~kL~Dfg~~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~tG~~P 195 (325)
T cd05594 133 ---GHIKITDFGLCKEGIKDGAT----------MKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLP 195 (325)
T ss_pred ---CCEEEecCCCCeecCCCCcc----------cccccCCcccCCHHHHcc----CCCCCccccccccceeeeeccCCCC
Confidence 46999999998753221111 123469999999999976 6688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHH
Q 002738 794 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAG 868 (886)
Q Consensus 794 F~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP-----SA~ 868 (886)
|.+.+.......+..... .++ ...++.+.+||.+||+.||.+|+ ++.
T Consensus 196 f~~~~~~~~~~~i~~~~~-~~p---------------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~ 247 (325)
T cd05594 196 FYNQDHEKLFELILMEEI-RFP---------------------------RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAK 247 (325)
T ss_pred CCCCCHHHHHHHHhcCCC-CCC---------------------------CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHH
Confidence 988877766666544321 111 11245789999999999999996 999
Q ss_pred HHHHHH
Q 002738 869 DLYEMF 874 (886)
Q Consensus 869 EILehL 874 (886)
++++|.
T Consensus 248 ~il~h~ 253 (325)
T cd05594 248 EIMQHK 253 (325)
T ss_pred HHhcCC
Confidence 999883
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=323.12 Aligned_cols=252 Identities=24% Similarity=0.335 Sum_probs=202.0
Q ss_pred CCCceeeeeecccCceEEEEEEECC-eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~~~-~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
..+|.+.+.||+|+||.||+|++.+ ..+|+|..... ... ... +.+|+.++++++||||+++++++.....
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~--~~~---~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMS---EDE----FIEEAKVMMKLSHEKLVQLYGVCTKQRP 73 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC--ccc---HHH----HHHHHHHHhcCCCCCeeeEEEEEccCCC
Confidence 4578999999999999999998754 45888875322 111 122 4889999999999999999999875543
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
.++||||+.+++|.+++.. ....+++..++.++.||+.||.|||++||+|+||||.|||++.
T Consensus 74 --------------~~lv~e~~~~~~l~~~i~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~ 135 (256)
T cd05113 74 --------------IYIVTEYMSNGCLLNYLRE----HGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD 135 (256)
T ss_pred --------------cEEEEEcCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC
Confidence 5999999999999999975 1236899999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.+||+|||.++........ ......++..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 136 ~-------~~~kl~d~g~~~~~~~~~~~---------~~~~~~~~~~y~~pe~~~~----~~~~~~~Di~slG~~l~~l~ 195 (256)
T cd05113 136 Q-------GCVKVSDFGLSRYVLDDEYT---------SSVGSKFPVRWSPPEVLLY----SKFSSKSDVWAFGVLMWEVY 195 (256)
T ss_pred C-------CCEEECCCccceecCCCcee---------ecCCCccChhhCCHHHHhc----CcccchhHHHHHHHHHHHHh
Confidence 6 46999999998765332111 0111235678999999975 56789999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 789 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 789 T-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
+ |..||.......+...+..+.++..+. ..+..+.+++.+||+.+|.+||++
T Consensus 196 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~cl~~~p~~Rp~~ 248 (256)
T cd05113 196 SLGKMPYERFNNSETVEKVSQGLRLYRPH---------------------------LASEKVYAIMYSCWHEKAEERPTF 248 (256)
T ss_pred cCCCCCcCcCCHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCcccCCCH
Confidence 8 999998888777777776654332221 124578999999999999999999
Q ss_pred HHHHHHHH
Q 002738 868 GDLYEMFV 875 (886)
Q Consensus 868 ~EILehLe 875 (886)
.+|++.|+
T Consensus 249 ~~ll~~~~ 256 (256)
T cd05113 249 QQLLSSIE 256 (256)
T ss_pred HHHHHhhC
Confidence 99998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=348.44 Aligned_cols=261 Identities=23% Similarity=0.291 Sum_probs=199.5
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
.|++.+.||+|+||.||+|+. .+..+|+|+...... ........+.+|+.+++.++||||+++++.+....
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~-----~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~-- 74 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV-----LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-- 74 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh-----hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC--
Confidence 589999999999999999997 566789998643211 11122234589999999999999999999998655
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..||||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 75 ------------~~~lv~E~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~ 137 (382)
T cd05625 75 ------------NLYFVMDYIPGGDMMSLLIR-----MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD 137 (382)
T ss_pred ------------EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 36999999999999999975 2468899999999999999999999999999999999999877
Q ss_pred ccCCCCCCeEEEeecCCccccccccccccc-------------------------------------ccCCCCCCCcccC
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCI-------------------------------------AHRGIPAPDVCVG 752 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~-------------------------------------~~~~~~~~~~~vG 752 (886)
+.+||+|||++..+......... ...........+|
T Consensus 138 -------g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 210 (382)
T cd05625 138 -------GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVG 210 (382)
T ss_pred -------CCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccccc
Confidence 56999999998643211000000 0000001123579
Q ss_pred CCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhcccccccccc
Q 002738 753 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQ 831 (886)
Q Consensus 753 T~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF~g~s~~el~~~I~~~~r-p~l~~~l~~~~~~~~~~~~~ 831 (886)
|+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.++.+....+..... ..++.
T Consensus 211 t~~Y~aPE~~~~----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--------------- 271 (382)
T cd05625 211 TPNYIAPEVLLR----TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPP--------------- 271 (382)
T ss_pred CcccCCHHHhcC----CCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCC---------------
Confidence 999999999976 5688999999999999999999999998877766655544211 11110
Q ss_pred cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 002738 832 SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT---AGDLYEM 873 (886)
Q Consensus 832 ~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS---A~EILeh 873 (886)
....++.+.+||.+|+ .+|.+|++ ++++++|
T Consensus 272 ----------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 272 ----------QAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred ----------cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 0123457888998876 59999987 9999988
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=358.56 Aligned_cols=253 Identities=27% Similarity=0.371 Sum_probs=211.8
Q ss_pred CCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeE
Q 002738 547 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHK 623 (886)
Q Consensus 547 ~~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~ 623 (886)
+..+++|.+++.||+|+||.|+++.. ++..+|+|+.+.... ...++++.. +.|.+|+.... ||.+++++..|
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~I-l~~d~Ve~~----~~EkrI~~la~~HPFL~~L~~~f 438 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDI-LQRDEVESL----MCEKRIFELANRHPFLVNLFSCF 438 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccce-eccccHHHH----HHHHHHHHHhccCCeEeeccccc
Confidence 56789999999999999999999997 567899999754433 333445554 78888888776 99999999999
Q ss_pred ecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 002738 624 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703 (886)
Q Consensus 624 ~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsN 703 (886)
.+.. ++|+||||+.||++..+++ ...+++..++.++..|+.||+|||++||||||||.+|
T Consensus 439 QT~~--------------~l~fvmey~~Ggdm~~~~~------~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdN 498 (694)
T KOG0694|consen 439 QTKE--------------HLFFVMEYVAGGDLMHHIH------TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDN 498 (694)
T ss_pred ccCC--------------eEEEEEEecCCCcEEEEEe------cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhh
Confidence 9877 4799999999999555544 2679999999999999999999999999999999999
Q ss_pred EEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 002738 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783 (886)
Q Consensus 704 ILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVI 783 (886)
||||.+ +.+||+|||+++..-.... ...+++|||.|||||++.+ ..|+..+|.|||||+
T Consensus 499 iLLD~e-------Gh~kiADFGlcKe~m~~g~----------~TsTfCGTpey~aPEil~e----~~Yt~aVDWW~lGVL 557 (694)
T KOG0694|consen 499 LLLDTE-------GHVKIADFGLCKEGMGQGD----------RTSTFCGTPEFLAPEVLTE----QSYTRAVDWWGLGVL 557 (694)
T ss_pred eEEccc-------CcEEecccccccccCCCCC----------ccccccCChhhcChhhhcc----CcccchhhHHHHHHH
Confidence 999998 5699999999986432111 2356789999999999997 889999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 784 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 784 LyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
||||+.|+.||.+.+..++.+.|.+... .+|. ..+.+..+||+++|..+|++
T Consensus 558 lyeML~Gq~PF~gddEee~FdsI~~d~~-~yP~---------------------------~ls~ea~~il~~ll~k~p~k 609 (694)
T KOG0694|consen 558 LYEMLVGESPFPGDDEEEVFDSIVNDEV-RYPR---------------------------FLSKEAIAIMRRLLRKNPEK 609 (694)
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCC---------------------------cccHHHHHHHHHHhccCccc
Confidence 9999999999999999999999987632 2221 12557899999999999999
Q ss_pred CCC-----HHHHHHH
Q 002738 864 RPT-----AGDLYEM 873 (886)
Q Consensus 864 RPS-----A~EILeh 873 (886)
|.. +.+|..|
T Consensus 610 RLG~~e~d~~~i~~h 624 (694)
T KOG0694|consen 610 RLGSGERDAEDIKKH 624 (694)
T ss_pred ccCCCCCCchhhhhC
Confidence 975 4666665
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=340.46 Aligned_cols=245 Identities=24% Similarity=0.329 Sum_probs=196.5
Q ss_pred eeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcceeeeeEecCCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 633 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl~g~~~~~~~l~~~~ 633 (886)
+.||+|+||.||+|++. +..+|+|++...... .....+ .+..|+.++..+ +||||+++++++....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~~~~e~~il~~~~~hp~i~~~~~~~~~~~------ 69 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL-QDDDVD----CTMTEKRILALAAKHPFLTALHCCFQTKD------ 69 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHH----HHHHHHHHHHhccCCCCccceeeEEEcCC------
Confidence 46999999999999974 568999987543211 112222 337788888876 6999999999998655
Q ss_pred CCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCC
Q 002738 634 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 713 (886)
Q Consensus 634 ~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~ 713 (886)
..|+||||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~E~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~---- 132 (321)
T cd05591 70 --------RLFFVMEYVNGGDLMFQIQR-----SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE---- 132 (321)
T ss_pred --------eEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC----
Confidence 36999999999999999875 3468899999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 002738 714 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 793 (886)
Q Consensus 714 ~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~P 793 (886)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 133 ---~~~kL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~el~tg~~P 195 (321)
T cd05591 133 ---GHCKLADFGMCKEGILNGV----------TTTTFCGTPDYIAPEILQE----LEYGPSVDWWALGVLMYEMMAGQPP 195 (321)
T ss_pred ---CCEEEeecccceecccCCc----------cccccccCccccCHHHHcC----CCCCCccceechhHHHHHHhcCCCC
Confidence 4699999999875322111 1123468999999999976 6688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-------C
Q 002738 794 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-------T 866 (886)
Q Consensus 794 F~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP-------S 866 (886)
|.+.+.......+...... ++. ..+..+.+||.+||..||.+|| +
T Consensus 196 f~~~~~~~~~~~i~~~~~~-~p~---------------------------~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~ 247 (321)
T cd05591 196 FEADNEDDLFESILHDDVL-YPV---------------------------WLSKEAVSILKAFMTKNPNKRLGCVASQGG 247 (321)
T ss_pred CCCCCHHHHHHHHHcCCCC-CCC---------------------------CCCHHHHHHHHHHhccCHHHcCCCCCCCCC
Confidence 9998888877777654211 110 1245789999999999999999 8
Q ss_pred HHHHHHHH
Q 002738 867 AGDLYEMF 874 (886)
Q Consensus 867 A~EILehL 874 (886)
+.++++|.
T Consensus 248 ~~~~~~hp 255 (321)
T cd05591 248 EDAIKQHP 255 (321)
T ss_pred HHHHhcCC
Confidence 99999884
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=339.44 Aligned_cols=249 Identities=25% Similarity=0.329 Sum_probs=198.6
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEecCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 628 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~~~~~ 628 (886)
+|.+.+.||+|+||.||+|+. .+..+|+|+....... .....+ .+..|..++..+. |++|+++++++...+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVE----CTMVEKRVLALSGKPPFLTQLHSCFQTMD- 74 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHH----HHHHHHHHHHhccCCCeEeeEEEEEecCC-
Confidence 588999999999999999987 4568999987543211 111222 2367888888774 899999999987655
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..++||||+++|+|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~ 136 (323)
T cd05616 75 -------------RLYFVMEYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS 136 (323)
T ss_pred -------------EEEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECC
Confidence 36999999999999999875 346899999999999999999999999999999999999988
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 137 ~-------~~~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvil~ell 195 (323)
T cd05616 137 E-------GHIKIADFGMCKENMWDGV----------TTKTFCGTPDYIAPEIIAY----QPYGKSVDWWAFGVLLYEML 195 (323)
T ss_pred C-------CcEEEccCCCceecCCCCC----------ccccCCCChhhcCHHHhcC----CCCCCccchhchhHHHHHHH
Confidence 7 4699999999875432111 1123469999999999986 67899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA- 867 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA- 867 (886)
||+.||.+.+...+...+..... .++ ...+..+.+|+.+||+.||.+|+++
T Consensus 196 tg~~Pf~~~~~~~~~~~i~~~~~-~~p---------------------------~~~s~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05616 196 AGQAPFEGEDEDELFQSIMEHNV-AYP---------------------------KSMSKEAVAICKGLMTKHPGKRLGCG 247 (323)
T ss_pred hCCCCCCCCCHHHHHHHHHhCCC-CCC---------------------------CcCCHHHHHHHHHHcccCHHhcCCCC
Confidence 99999999888877777665421 111 1124578999999999999999984
Q ss_pred ----HHHHHH
Q 002738 868 ----GDLYEM 873 (886)
Q Consensus 868 ----~EILeh 873 (886)
.++++|
T Consensus 248 ~~~~~~i~~h 257 (323)
T cd05616 248 PEGERDIKEH 257 (323)
T ss_pred CCCHHHHhcC
Confidence 777776
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=326.17 Aligned_cols=262 Identities=20% Similarity=0.278 Sum_probs=204.2
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCe----eEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeee
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 622 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~----~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~ 622 (886)
...+|++.+.||+|+||.||+|.+ .+. .+++|.... ....... ..+..|+.+++++.||||++++++
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~---~~~~~~~----~~~~~~~~~l~~l~h~~iv~~~~~ 77 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD---RSGRQTF----QEITDHMLAMGSLDHAYIVRLLGI 77 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccc---ccchHHH----HHHHHHHHHHhcCCCCCcceEEEE
Confidence 356889999999999999999997 333 355555321 1111222 234788899999999999999998
Q ss_pred EecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 002738 623 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 702 (886)
Q Consensus 623 ~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPs 702 (886)
+... ..+++|||+++|+|.+++.. ....+++..++.|+.||+.||.|||++||+||||||+
T Consensus 78 ~~~~---------------~~~~i~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~ 138 (279)
T cd05111 78 CPGA---------------SLQLVTQLSPLGSLLDHVRQ----HRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAAR 138 (279)
T ss_pred ECCC---------------ccEEEEEeCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcc
Confidence 7532 25899999999999999975 2346899999999999999999999999999999999
Q ss_pred CEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 002738 703 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 782 (886)
Q Consensus 703 NILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGV 782 (886)
|||++.+ +.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||
T Consensus 139 nili~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slG~ 199 (279)
T cd05111 139 NILLKSD-------SIVQIADFGVADLLYPDDKK--------YFYSEHKTPIKWMALESILF----GRYTHQSDVWSYGV 199 (279)
T ss_pred eEEEcCC-------CcEEEcCCccceeccCCCcc--------cccCCCCCcccccCHHHhcc----CCcCchhhHHHHHH
Confidence 9999876 56999999999765432211 01122347788999999975 56889999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 002738 783 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 861 (886)
Q Consensus 783 ILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP 861 (886)
++|||++ |..||.+.....+...+..+..+..+. ..+..+.+++.+||..||
T Consensus 200 il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~c~~~~p 252 (279)
T cd05111 200 TVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQ---------------------------ICTIDVYMVMVKCWMIDE 252 (279)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCC---------------------------CCCHHHHHHHHHHcCCCc
Confidence 9999998 999999887777666665554332221 013367889999999999
Q ss_pred CCCCCHHHHHHHHHhhcCCCC
Q 002738 862 TERPTAGDLYEMFVARTSSSI 882 (886)
Q Consensus 862 ~kRPSA~EILehLe~l~sss~ 882 (886)
.+|||+.|+++.|..+...++
T Consensus 253 ~~Rps~~el~~~l~~~~~~~~ 273 (279)
T cd05111 253 NVRPTFKELANEFTRMARDPP 273 (279)
T ss_pred ccCcCHHHHHHHHHHHHhCCc
Confidence 999999999999998776654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=327.38 Aligned_cols=262 Identities=21% Similarity=0.352 Sum_probs=204.0
Q ss_pred CceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEe
Q 002738 552 SLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 624 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~~~-------~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~ 624 (886)
+|++.+.||+|+||.||+|.... ..+++|+.... ....... .+.+|+.+++.++||||+++++.+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN---ASSSELR----DLLSEFNLLKQVNHPHVIKLYGACS 73 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC---CCHHHHH----HHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 47889999999999999998632 35777764321 1222233 3489999999999999999999987
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhc-------------------cCCCcCCHHHHHHHHHHHHHH
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------------------TGEKHVSVKLALFIAQDVAAA 685 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~-------------------~~~~~Ls~~~i~~Ia~QIa~A 685 (886)
.... .++||||+.+++|.+++..... .....+++..++.++.||+.|
T Consensus 74 ~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~ 139 (290)
T cd05045 74 QDGP--------------LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRG 139 (290)
T ss_pred cCCC--------------cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHH
Confidence 6543 5999999999999999875221 112357889999999999999
Q ss_pred HHHHHhCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcc
Q 002738 686 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 765 (886)
Q Consensus 686 L~yLHs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~ 765 (886)
|.|||+++|+||||||+|||++.+ ..+||+|||++.......... ......++..|+|||++.+
T Consensus 140 l~~LH~~~ivH~dikp~nill~~~-------~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~apE~~~~- 203 (290)
T cd05045 140 MQYLAEMKLVHRDLAARNVLVAEG-------RKMKISDFGLSRDVYEEDSYV--------KRSKGRIPVKWMAIESLFD- 203 (290)
T ss_pred HHHHHHCCeehhhhhhheEEEcCC-------CcEEeccccccccccCccchh--------cccCCCCCccccCHHHHcc-
Confidence 999999999999999999999876 469999999987653321110 0112245678999999875
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhh
Q 002738 766 HKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 844 (886)
Q Consensus 766 ~~~~~~s~KSDIWSLGVILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (886)
..++.++||||||+++|||++ |..||.+..+..+...+........+ ..
T Consensus 204 ---~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~ 253 (290)
T cd05045 204 ---HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERP---------------------------EN 253 (290)
T ss_pred ---CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCC---------------------------CC
Confidence 568899999999999999998 99999888877776665544322211 11
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 002738 845 TLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 880 (886)
Q Consensus 845 ~s~~L~dLL~rCL~~DP~kRPSA~EILehLe~l~ss 880 (886)
.+..+.+|+.+||+.+|.+||++.++++.|+++...
T Consensus 254 ~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 254 CSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred CCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 245789999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=340.45 Aligned_cols=244 Identities=27% Similarity=0.383 Sum_probs=195.4
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcceeeeeEecCCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 633 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl~g~~~~~~~l~~~~ 633 (886)
+.||+|+||.||+|+. .+..+|+|+....... .....+ .+..|+.++..+ +||||+++++++....
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~~~~e~~~l~~~~~h~~iv~~~~~~~~~~------ 69 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-QDDDVE----CTMTEKRILSLARNHPFLTQLYCCFQTPD------ 69 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hccHHH----HHHHHHHHHHhccCCCchhceeeEEEcCC------
Confidence 4799999999999997 4668999987533211 111222 337888888877 5999999999988655
Q ss_pred CCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCC
Q 002738 634 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 713 (886)
Q Consensus 634 ~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~ 713 (886)
..|+||||+++|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 --------~~~iv~Ey~~~g~L~~~i~~-----~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~---- 132 (320)
T cd05590 70 --------RLFFVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE---- 132 (320)
T ss_pred --------EEEEEEcCCCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC----
Confidence 46999999999999999875 3568999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 002738 714 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 793 (886)
Q Consensus 714 ~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~P 793 (886)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 133 ---~~~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~P 195 (320)
T cd05590 133 ---GHCKLADFGMCKEGIFNGK----------TTSTFCGTPDYIAPEILQE----MLYGPSVDWWAMGVLLYEMLCGHAP 195 (320)
T ss_pred ---CcEEEeeCCCCeecCcCCC----------cccccccCccccCHHHHcC----CCCCCccchhhhHHHHHHHhhCCCC
Confidence 4699999999875322111 1123469999999999976 6678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH------
Q 002738 794 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA------ 867 (886)
Q Consensus 794 F~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA------ 867 (886)
|.+.+..++...+..... .++. ..+..+.+||.+||+.||.+||++
T Consensus 196 f~~~~~~~~~~~i~~~~~-~~~~---------------------------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~ 247 (320)
T cd05590 196 FEAENEDDLFEAILNDEV-VYPT---------------------------WLSQDAVDILKAFMTKNPTMRLGSLTLGGE 247 (320)
T ss_pred CCCCCHHHHHHHHhcCCC-CCCC---------------------------CCCHHHHHHHHHHcccCHHHCCCCCCCCCH
Confidence 999888887777765421 1110 124578999999999999999998
Q ss_pred HHHHHH
Q 002738 868 GDLYEM 873 (886)
Q Consensus 868 ~EILeh 873 (886)
++++.|
T Consensus 248 ~~~~~h 253 (320)
T cd05590 248 EAILRH 253 (320)
T ss_pred HHHHcC
Confidence 788887
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=323.99 Aligned_cols=262 Identities=22% Similarity=0.348 Sum_probs=206.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceee
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 620 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~~-------~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~ 620 (886)
...++|++.+.||+|+||.||+|.+.+ ..+++|+.... . ...... .+.+|+.+++.++||||++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~--~-~~~~~~----~~~~e~~~l~~~~~~~i~~~~ 75 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN--A-SMRERI----EFLNEASVMKEFNCHHVVRLL 75 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc--c-CHHHHH----HHHHHHHHHHhCCCCceeEEE
Confidence 456789999999999999999998743 56888885321 1 112222 348899999999999999999
Q ss_pred eeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhcc-----CCCcCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 002738 621 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----GEKHVSVKLALFIAQDVAAALVELHSKHIM 695 (886)
Q Consensus 621 g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~-----~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIV 695 (886)
+++..... .++||||+++++|.+++...... ....+++..++.++.||+.||.|||+++|+
T Consensus 76 ~~~~~~~~--------------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 141 (277)
T cd05032 76 GVVSTGQP--------------TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFV 141 (277)
T ss_pred EEEcCCCC--------------cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 99876543 59999999999999999753221 123478889999999999999999999999
Q ss_pred ccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchh
Q 002738 696 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 775 (886)
Q Consensus 696 HRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KS 775 (886)
||||||+|||++.+ +.+||+|||+++........ .......++..|+|||++.+ ..++.++
T Consensus 142 H~di~p~nill~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~ 202 (277)
T cd05032 142 HRDLAARNCMVAED-------LTVKIGDFGMTRDIYETDYY--------RKGGKGLLPVRWMAPESLKD----GVFTTKS 202 (277)
T ss_pred ccccChheEEEcCC-------CCEEECCcccchhhccCccc--------ccCCCCCccccccCHHHHhc----CCCCccc
Confidence 99999999999877 56999999998765432211 01122346789999999875 5678999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHH
Q 002738 776 DIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 854 (886)
Q Consensus 776 DIWSLGVILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~ 854 (886)
|||||||++|||++ |..||.+.+..+....+..+..+.++. ..+..+.+|+.
T Consensus 203 Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~ 255 (277)
T cd05032 203 DVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPE---------------------------NCPDKLLELMR 255 (277)
T ss_pred chHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHH
Confidence 99999999999998 999998888877776665443332221 12457899999
Q ss_pred HhcccCCCCCCCHHHHHHHHHh
Q 002738 855 RCTEENPTERPTAGDLYEMFVA 876 (886)
Q Consensus 855 rCL~~DP~kRPSA~EILehLe~ 876 (886)
+||+.+|.+|||+.+|++.|++
T Consensus 256 ~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 256 MCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHcCCChhhCCCHHHHHHHhcC
Confidence 9999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=327.00 Aligned_cols=264 Identities=23% Similarity=0.365 Sum_probs=207.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCccee
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 619 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~~-------~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl 619 (886)
...++|++.+.||+|+||.||++.+.+ ..+|+|+.... ........ +.+|+.++.++ +||||+++
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~---~~~~~~~~----~~~E~~~l~~l~~h~~i~~~ 81 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD---ATEKDLSD----LVSEMEMMKMIGKHKNIINL 81 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC---CCHHHHHH----HHHHHHHHHhhcCCCCeeeE
Confidence 456789999999999999999998632 46788875422 12222233 48999999999 79999999
Q ss_pred eeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhc-----------cCCCcCCHHHHHHHHHHHHHHHHH
Q 002738 620 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVE 688 (886)
Q Consensus 620 ~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~-----------~~~~~Ls~~~i~~Ia~QIa~AL~y 688 (886)
++++.... ..++||||+++++|..++..... .....+++..++.++.||+.||+|
T Consensus 82 ~~~~~~~~--------------~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~ 147 (293)
T cd05053 82 LGVCTQEG--------------PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEF 147 (293)
T ss_pred EEEEcCCC--------------CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence 99987654 36999999999999999975211 123568899999999999999999
Q ss_pred HHhCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC
Q 002738 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 768 (886)
Q Consensus 689 LHs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~ 768 (886)
||++||+||||||+|||++.+ +.+||+|||+++.+........ .....++..|+|||++.+
T Consensus 148 LH~~~ivH~dlkp~Nil~~~~-------~~~kL~Dfg~~~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~---- 208 (293)
T cd05053 148 LASKKCIHRDLAARNVLVTED-------HVMKIADFGLARDIHHIDYYRK--------TTNGRLPVKWMAPEALFD---- 208 (293)
T ss_pred HHHCCccccccceeeEEEcCC-------CeEEeCccccccccccccceec--------cCCCCCCccccCHHHhcc----
Confidence 999999999999999999876 5699999999987644221100 111235678999999875
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHH
Q 002738 769 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 847 (886)
Q Consensus 769 ~~~s~KSDIWSLGVILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 847 (886)
..++.++|||||||++|||++ |..||.+....++...+.....+..+ ...+.
T Consensus 209 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~ 261 (293)
T cd05053 209 RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKP---------------------------QNCTQ 261 (293)
T ss_pred CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCH
Confidence 668899999999999999997 99999988877777666554332211 11245
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 002738 848 FLVDVFRRCTEENPTERPTAGDLYEMFVART 878 (886)
Q Consensus 848 ~L~dLL~rCL~~DP~kRPSA~EILehLe~l~ 878 (886)
.+.+|+.+||..||.+|||+.+++++|+++.
T Consensus 262 ~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 262 ELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 7899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=340.59 Aligned_cols=244 Identities=26% Similarity=0.320 Sum_probs=192.3
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHH-HHhhCCCCCcceeeeeEecCCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKISSKWLPSAD 633 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~-iLk~L~HPNIVrl~g~~~~~~~l~~~~ 633 (886)
+.||+|+||.||+|++ .+..+|+|++........ ... ..+..|.. +++.++||||+++++++....
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~----~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~------ 69 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK-KEQ----KHIMAERNVLLKNVKHPFLVGLHYSFQTAD------ 69 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh-hHH----HHHHHHHHHHHhhCCCCCCCCeeEEEEeCC------
Confidence 4799999999999998 577899999753321111 111 22355554 567899999999999987654
Q ss_pred CCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCC
Q 002738 634 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 713 (886)
Q Consensus 634 ~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~ 713 (886)
..++||||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~---- 132 (323)
T cd05575 70 --------KLYFVLDYVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ---- 132 (323)
T ss_pred --------EEEEEEcCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC----
Confidence 46999999999999999875 3568999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 002738 714 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 793 (886)
Q Consensus 714 ~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~P 793 (886)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|..|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~ell~g~~p 195 (323)
T cd05575 133 ---GHVVLTDFGLCKEGIEHSK----------TTSTFCGTPEYLAPEVLRK----QPYDRTVDWWCLGAVLYEMLYGLPP 195 (323)
T ss_pred ---CcEEEeccCCCcccccCCC----------ccccccCChhhcChhhhcC----CCCCccccccccchhhhhhhcCCCC
Confidence 4699999999865322111 1223469999999999976 6688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH----HH
Q 002738 794 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA----GD 869 (886)
Q Consensus 794 F~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA----~E 869 (886)
|.+.+..++...+...... ++ ...+..+.+||.+||+.||.+||++ .+
T Consensus 196 f~~~~~~~~~~~i~~~~~~-~~---------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (323)
T cd05575 196 FYSRDTAEMYDNILNKPLR-LK---------------------------PNISVSARHLLEGLLQKDRTKRLGAKDDFLE 247 (323)
T ss_pred CCCCCHHHHHHHHHcCCCC-CC---------------------------CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHH
Confidence 9988877777666544211 11 1124578999999999999999987 57
Q ss_pred HHHH
Q 002738 870 LYEM 873 (886)
Q Consensus 870 ILeh 873 (886)
+++|
T Consensus 248 il~~ 251 (323)
T cd05575 248 IKNH 251 (323)
T ss_pred HHcC
Confidence 7766
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=348.13 Aligned_cols=262 Identities=22% Similarity=0.304 Sum_probs=205.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
...++|++.+.||+|+||.||++++ .+..+|+|+....... ..... ..+.+|+.+++.++||||+++++++..
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~----~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-KRSDS----AFFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhH----HHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 3457899999999999999999997 4668999986432111 11112 234789999999999999999999986
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
.. ..|+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 115 ~~--------------~~~lv~Ey~~gg~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NIL 174 (370)
T cd05621 115 DK--------------YLYMVMEYMPGGDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNML 174 (370)
T ss_pred CC--------------EEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEE
Confidence 55 46999999999999999975 35889999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.+ +.+||+|||+|......... ......||+.|+|||++.+......++.++|||||||+||
T Consensus 175 l~~~-------~~~kL~DFG~a~~~~~~~~~---------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ily 238 (370)
T cd05621 175 LDKH-------GHLKLADFGTCMKMDETGMV---------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLF 238 (370)
T ss_pred ECCC-------CCEEEEecccceecccCCce---------ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHH
Confidence 9877 46999999999865432111 1134569999999999976333345789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC-
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE- 863 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~r-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k- 863 (886)
||++|+.||.+.+.......+..... ..++. ....+..+.+|+.+||..+|.+
T Consensus 239 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------------------------~~~~s~~~~~li~~~L~~~~~r~ 293 (370)
T cd05621 239 EMLVGDTPFYADSLVGTYSKIMDHKNSLNFPE-------------------------DVEISKHAKNLICAFLTDREVRL 293 (370)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCcccCCCC-------------------------cccCCHHHHHHHHHHccCchhcc
Confidence 99999999998887776666654321 11111 0123557899999999865544
Q ss_pred -CCCHHHHHHHHH
Q 002738 864 -RPTAGDLYEMFV 875 (886)
Q Consensus 864 -RPSA~EILehLe 875 (886)
|+++.++++|-.
T Consensus 294 ~R~~~~e~l~hp~ 306 (370)
T cd05621 294 GRNGVEEIKQHPF 306 (370)
T ss_pred CCCCHHHHhcCcc
Confidence 899999999943
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=342.35 Aligned_cols=254 Identities=22% Similarity=0.314 Sum_probs=194.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
..+.+|++.++||+|+||.||+|++ .+..||+|+..... .. .....+.+|+.+++.++|+||+++++++..
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 143 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---ED----TVRRQICREIEILRDVNHPNVVKCHDMFDH 143 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cH----HHHHHHHHHHHHHHhCCCCCcceeeeEecc
Confidence 4578899999999999999999997 46789999864321 11 222345899999999999999999999875
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
.. ..++||||+++++|... ....+..+..++.||+.||.|||++||+||||||+|||
T Consensus 144 ~~--------------~~~lv~e~~~~~~L~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 200 (353)
T PLN00034 144 NG--------------EIQVLLEFMDGGSLEGT---------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLL 200 (353)
T ss_pred CC--------------eEEEEEecCCCCccccc---------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEE
Confidence 54 36999999999998653 23567788899999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~~s~KSDIWSLGVIL 784 (886)
++.+ +.+||+|||++..+...... ....+||..|+|||++.... .....+.++|||||||++
T Consensus 201 l~~~-------~~~kL~DfG~~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil 263 (353)
T PLN00034 201 INSA-------KNVKIADFGVSRILAQTMDP----------CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSI 263 (353)
T ss_pred EcCC-------CCEEEcccccceeccccccc----------ccccccCccccCccccccccccCcCCCcchhHHHHHHHH
Confidence 9877 46999999999765432111 12346999999999985321 123456799999999999
Q ss_pred HHHHhCCCCCCCCCHHH---HHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 002738 785 LELLTLQVPYMGLSELE---IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 861 (886)
Q Consensus 785 yELLTG~~PF~g~s~~e---l~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP 861 (886)
|||++|+.||....... +...+.....+.. ....+..+.+||.+||..||
T Consensus 264 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~l~~li~~~l~~~P 316 (353)
T PLN00034 264 LEFYLGRFPFGVGRQGDWASLMCAICMSQPPEA---------------------------PATASREFRHFISCCLQREP 316 (353)
T ss_pred HHHHhCCCCCCCCCCccHHHHHHHHhccCCCCC---------------------------CCccCHHHHHHHHHHccCCh
Confidence 99999999997432222 2222211111111 11235579999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 002738 862 TERPTAGDLYEMFV 875 (886)
Q Consensus 862 ~kRPSA~EILehLe 875 (886)
++|||+.||++|-.
T Consensus 317 ~~Rpt~~ell~hp~ 330 (353)
T PLN00034 317 AKRWSAMQLLQHPF 330 (353)
T ss_pred hhCcCHHHHhcCcc
Confidence 99999999999954
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=323.33 Aligned_cols=261 Identities=20% Similarity=0.302 Sum_probs=204.7
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCe----eEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeee
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 622 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~----~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~ 622 (886)
...+|++.+.||+|+||+||+|++ .+. .||+|+.... ...... ..+.+|+.+++.+.||||++++++
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~---~~~~~~----~~~~~e~~~l~~~~~~~i~~~~~~ 77 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN---TSPKAN----KEILDEAYVMAGVGSPYVCRLLGI 77 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC---CCHHHH----HHHHHHHHHHHhcCCCCCceEEEE
Confidence 456789999999999999999986 222 3788875422 122222 234889999999999999999999
Q ss_pred EecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 002738 623 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 702 (886)
Q Consensus 623 ~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPs 702 (886)
+.... .+++|||+++|+|.+++.. ....+++..++.++.||+.||+|||+++|+||||||+
T Consensus 78 ~~~~~---------------~~l~~~~~~~g~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~ 138 (279)
T cd05109 78 CLTST---------------VQLVTQLMPYGCLLDYVRE----NKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAAR 138 (279)
T ss_pred EcCCC---------------cEEEEEcCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 87432 4899999999999999875 2346899999999999999999999999999999999
Q ss_pred CEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 002738 703 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 782 (886)
Q Consensus 703 NILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGV 782 (886)
|||++.+ ..+||+|||+++......... ......+++.|+|||++.+ ..++.++|||||||
T Consensus 139 Nil~~~~-------~~~kL~dfG~~~~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~ 199 (279)
T cd05109 139 NVLVKSP-------NHVKITDFGLARLLDIDETEY--------HADGGKVPIKWMALESILH----RRFTHQSDVWSYGV 199 (279)
T ss_pred eEEEcCC-------CcEEECCCCceeeccccccee--------ecCCCccchhhCCHHHhcc----CCCCchhHHHHHHH
Confidence 9999776 459999999998764322110 0111235678999999875 56889999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 002738 783 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 861 (886)
Q Consensus 783 ILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP 861 (886)
++|||++ |..||.......+...+..+..+..+ ...+..+.+++.+||..||
T Consensus 200 ~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~dp 252 (279)
T cd05109 200 TVWELMTFGAKPYDGIPAREIPDLLEKGERLPQP---------------------------PICTIDVYMIMVKCWMIDS 252 (279)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC---------------------------ccCCHHHHHHHHHHcCCCh
Confidence 9999998 99999887776666655554332211 1124578999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCCC
Q 002738 862 TERPTAGDLYEMFVARTSSS 881 (886)
Q Consensus 862 ~kRPSA~EILehLe~l~sss 881 (886)
.+||++.++++.|+.+...+
T Consensus 253 ~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 253 ECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred hhCcCHHHHHHHHHHhhcCC
Confidence 99999999999998876543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=330.16 Aligned_cols=268 Identities=24% Similarity=0.345 Sum_probs=226.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEe
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 624 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~ 624 (886)
..+..|.-.+.||.|..++|-++.. ++...|+|++.........+...+..+.-.+|+.||+++. |||||.+.++|.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 4577889999999999999999876 6677888887655444444446666677799999999985 999999999999
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNI 704 (886)
++.. +++|+|.|+.|-|.++|.. .-.++++..++|++|+..|+.|||.++||||||||+||
T Consensus 94 s~sF--------------~FlVFdl~prGELFDyLts-----~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENI 154 (411)
T KOG0599|consen 94 SDAF--------------VFLVFDLMPRGELFDYLTS-----KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENI 154 (411)
T ss_pred Ccch--------------hhhhhhhcccchHHHHhhh-----heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhhe
Confidence 8876 4999999999999999987 46799999999999999999999999999999999999
Q ss_pred EEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc--CCCCCCchhhHHHHHH
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYGC 782 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~--~~~~~s~KSDIWSLGV 782 (886)
|++.+ ..+||+|||+|..+...... ...+|||+|.|||.+.... ....|+..+|+||+||
T Consensus 155 Llddn-------~~i~isDFGFa~~l~~GekL-----------relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GV 216 (411)
T KOG0599|consen 155 LLDDN-------MNIKISDFGFACQLEPGEKL-----------RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGV 216 (411)
T ss_pred eeccc-------cceEEeccceeeccCCchhH-----------HHhcCCCcccChhheeeecccCCCCccchhhHHHHHH
Confidence 99988 45999999999887654322 3457999999999998643 2346889999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 002738 783 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 862 (886)
Q Consensus 783 ILyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~ 862 (886)
|||.|+.|.+||......-++..|+.+....-...| .+.+...++||.+||+.||.
T Consensus 217 ImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW------------------------adis~~~KdLIsrlLqVdp~ 272 (411)
T KOG0599|consen 217 IMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW------------------------ADISATVKDLISRLLQVDPT 272 (411)
T ss_pred HHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch------------------------hhccccHHHHHHHHHeeCch
Confidence 999999999999988888888999988664433222 34466899999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 002738 863 ERPTAGDLYEMFVA 876 (886)
Q Consensus 863 kRPSA~EILehLe~ 876 (886)
+|.|+.|+|.|-.-
T Consensus 273 ~Ritake~LaHpff 286 (411)
T KOG0599|consen 273 KRITAKEALAHPFF 286 (411)
T ss_pred hcccHHHHhcChHH
Confidence 99999999998543
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.35 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=206.5
Q ss_pred CCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
..++|++.+.||.|+||.||+|...+..+++|....... ..+ ++.+|+.+++.++|+||+++++++....
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-----~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 73 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-----AAQ----AFLAEASVMTTLRHPNLVQLLGVVLQGN- 73 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-----HHH----HHHHHHHHHHhcCCcceeeeEEEEcCCC-
Confidence 467899999999999999999999999999998753321 223 3489999999999999999999987544
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..++||||+++++|.+++.. .....+++..++.++.|++.||.|||++||+|+||||+|||++.
T Consensus 74 -------------~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~ 137 (256)
T cd05039 74 -------------PLYIVTEYMAKGSLVDYLRS---RGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSE 137 (256)
T ss_pred -------------CeEEEEEecCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeC
Confidence 36999999999999999976 22236899999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.++|+|||.+........ ...++..|+|||++.. ..++.++||||||+++|||+
T Consensus 138 ~-------~~~~l~d~g~~~~~~~~~~-------------~~~~~~~~~ape~~~~----~~~~~~~Di~slG~il~~l~ 193 (256)
T cd05039 138 D-------LVAKVSDFGLAKEASQGQD-------------SGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEIY 193 (256)
T ss_pred C-------CCEEEcccccccccccccc-------------cCCCcccccCchhhcC----CcCCcHHHHHHHHHHHHHHH
Confidence 6 5699999999976532111 1234568999999875 56788999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 789 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 789 T-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
+ |..||...+...+...+.....+..+ ...++.+.+||.+||..+|.+|||+
T Consensus 194 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~ 246 (256)
T cd05039 194 SFGRVPYPRIPLKDVVPHVEKGYRMEAP---------------------------EGCPPEVYKVMKDCWELDPAKRPTF 246 (256)
T ss_pred hcCCCCCCCCCHHHHHHHHhcCCCCCCc---------------------------cCCCHHHHHHHHHHhccChhhCcCH
Confidence 7 99999888777776666544322211 1124578999999999999999999
Q ss_pred HHHHHHHHhh
Q 002738 868 GDLYEMFVAR 877 (886)
Q Consensus 868 ~EILehLe~l 877 (886)
.++++.|+.+
T Consensus 247 ~~l~~~l~~~ 256 (256)
T cd05039 247 KQLREQLALI 256 (256)
T ss_pred HHHHHHHhcC
Confidence 9999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=342.05 Aligned_cols=258 Identities=23% Similarity=0.294 Sum_probs=203.5
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|.+.+.||+|+||.||+|+. .+..+|+|+....... .... ...+.+|+.+++.++||||+++++++....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~----~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~- 74 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-AQET----VSFFEEERDILSISNSPWIPQLQYAFQDKD- 74 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhH----HHHHHHHHHHHHhCCCCCCcceeeEEecCC-
Confidence 4799999999999999999987 5678999987533211 1112 234588999999999999999999887654
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..+|||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~ 137 (330)
T cd05601 75 -------------NLYLVMEYQPGGDLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDR 137 (330)
T ss_pred -------------eEEEEECCCCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECC
Confidence 369999999999999999762 246899999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC--CCCCCchhhHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK--PNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~--~~~~s~KSDIWSLGVILyE 786 (886)
+ +.+||+|||++..+...... ......||+.|+|||++..... ...++.++|||||||++||
T Consensus 138 ~-------~~~kL~Dfg~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~e 201 (330)
T cd05601 138 T-------GHIKLADFGSAARLTANKMV---------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYE 201 (330)
T ss_pred C-------CCEEeccCCCCeECCCCCce---------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeee
Confidence 7 46999999999765432211 1123468999999999874221 2457889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 787 LLTG~~PF~g~s~~el~~~I~~~~r-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
|++|+.||...+.......+..... ..++. ....+..+.+||.+||. +|.+||
T Consensus 202 l~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~~~~~~~li~~ll~-~p~~R~ 255 (330)
T cd05601 202 MIYGRSPFHEGTSAKTYNNIMNFQRFLKFPE-------------------------DPKVSSDFLDLIQSLLC-GQKERL 255 (330)
T ss_pred eccCCCCCCCCCHHHHHHHHHcCCCccCCCC-------------------------CCCCCHHHHHHHHHHcc-ChhhCC
Confidence 9999999988877766666554321 11110 01235578999999998 999999
Q ss_pred CHHHHHHH
Q 002738 866 TAGDLYEM 873 (886)
Q Consensus 866 SA~EILeh 873 (886)
++.++++|
T Consensus 256 t~~~l~~h 263 (330)
T cd05601 256 GYEGLCCH 263 (330)
T ss_pred CHHHHhCC
Confidence 99999987
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=339.78 Aligned_cols=281 Identities=18% Similarity=0.217 Sum_probs=203.7
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
.++|++.+.||.|+||.||+|.+ .+..||+|+..... ...... ..+.+|+.+|++++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF--QSLIHA----RRTYRELRLLKHMKHENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh--hhhHHH----HHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence 36899999999999999999986 55678888864221 111122 23478999999999999999999886433
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
. .......|++|+++ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 88 ~--------~~~~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~ 152 (343)
T cd07878 88 S--------IENFNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN 152 (343)
T ss_pred c--------ccccCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEEC
Confidence 2 11223579999998 6899988764 4689999999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ +.+||+|||++...... .....||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 153 ~~-------~~~kl~Dfg~~~~~~~~-------------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~el 209 (343)
T cd07878 153 ED-------CELRILDFGLARQADDE-------------MTGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAEL 209 (343)
T ss_pred CC-------CCEEEcCCccceecCCC-------------cCCccccccccCchHhcC---CccCCchhhhHhHHHHHHHH
Confidence 77 46999999999765331 123468999999999875 24578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCC---chhhhhhHHHHHHHHHHhcccCCCCC
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK---PEAELETLSFLVDVFRRCTEENPTER 864 (886)
Q Consensus 788 LTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~s~~L~dLL~rCL~~DP~kR 864 (886)
++|+.||.+.+..+....+........+..+.................... ........+.+.+||.+||..||.+|
T Consensus 210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R 289 (343)
T cd07878 210 LKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKR 289 (343)
T ss_pred HHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhC
Confidence 999999988776666555544322222222211110000000000000000 01111234568899999999999999
Q ss_pred CCHHHHHHHH
Q 002738 865 PTAGDLYEMF 874 (886)
Q Consensus 865 PSA~EILehL 874 (886)
||+.|+++|-
T Consensus 290 ~s~~ell~hp 299 (343)
T cd07878 290 ISASEALAHP 299 (343)
T ss_pred CCHHHHhcCc
Confidence 9999999984
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=346.33 Aligned_cols=274 Identities=22% Similarity=0.238 Sum_probs=196.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
....+|++.+.||+|+||.||+|.+ .+..||+|... .. .+.+|+.+|++|+|||||++++++..
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----------~~----~~~~E~~il~~l~HpnIv~~~~~~~~ 154 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----------RG----GTATEAHILRAINHPSIIQLKGTFTY 154 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----------hh----hhHHHHHHHHhCCCCCCCCEeEEEEE
Confidence 3456899999999999999999997 56678888532 11 23789999999999999999999986
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
.. ..++|||++. ++|..++.. ...+++..++.|+.||+.||.|||++|||||||||+|||
T Consensus 155 ~~--------------~~~lv~e~~~-~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIl 214 (391)
T PHA03212 155 NK--------------FTCLILPRYK-TDLYCYLAA-----KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIF 214 (391)
T ss_pred CC--------------eeEEEEecCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEE
Confidence 54 3699999996 799998875 346889999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.+ +.+||+|||+|......... ......||+.|+|||++.+ ..++.++|||||||+||
T Consensus 215 l~~~-------~~vkL~DFG~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvil~ 274 (391)
T PHA03212 215 INHP-------GDVCLGDFGAACFPVDINAN---------KYYGWAGTIATNAPELLAR----DPYGPAVDIWSAGIVLF 274 (391)
T ss_pred EcCC-------CCEEEEeCCccccccccccc---------ccccccCccCCCChhhhcC----CCCCcHHHHHHHHHHHH
Confidence 9877 45999999999653321111 1123469999999999976 67899999999999999
Q ss_pred HHHhCCCCCCCCC-------HHHHHHHHHcC-C-CC-Cch----hHHhhhcccccccccccCCCCCCchhhhhhHHHHHH
Q 002738 786 ELLTLQVPYMGLS-------ELEIHDLIQMG-K-RP-RLT----DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 851 (886)
Q Consensus 786 ELLTG~~PF~g~s-------~~el~~~I~~~-~-rp-~l~----~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~d 851 (886)
||++|..||.+.. ....+..+... . .+ .++ ..+...........................+..+.+
T Consensus 275 elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 354 (391)
T PHA03212 275 EMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEY 354 (391)
T ss_pred HHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHH
Confidence 9999998875421 11222222221 1 11 111 000000000000000000000011112234668999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHH
Q 002738 852 VFRRCTEENPTERPTAGDLYEMFV 875 (886)
Q Consensus 852 LL~rCL~~DP~kRPSA~EILehLe 875 (886)
||.+||+.||.+|||+.|+++|-.
T Consensus 355 Li~~mL~~dP~~Rpta~elL~hp~ 378 (391)
T PHA03212 355 LICKMLAFDAHHRPSAEALLDFAA 378 (391)
T ss_pred HHHHHhcCChhhCCCHHHHhcChh
Confidence 999999999999999999999854
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=328.21 Aligned_cols=260 Identities=23% Similarity=0.387 Sum_probs=201.1
Q ss_pred CCCceeeeeecccCceEEEEEEECC--e--eEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcceeeeeEe
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKFGS--A--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 624 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~~~--~--~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl~g~~~ 624 (886)
|++|++.+.||+|+||.||+|.... . .+++|..+ .. ......+ .+.+|+.++.++ +||||+++++++.
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~--~~-~~~~~~~----~~~~E~~~l~~l~~hp~iv~~~~~~~ 73 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EF-ASENDHR----DFAGELEVLCKLGHHPNIINLLGACE 73 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcc--cc-CCHHHHH----HHHHHHHHHHhhcCCCchhheEEEEc
Confidence 5789999999999999999998733 2 35666532 21 1222223 348899999999 6999999999987
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhcc-----------CCCcCCHHHHHHHHHHHHHHHHHHHhCC
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVELHSKH 693 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~-----------~~~~Ls~~~i~~Ia~QIa~AL~yLHs~g 693 (886)
.... .++||||+++++|.+++...... ....+++..++.++.||+.||+|||++|
T Consensus 74 ~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ 139 (297)
T cd05089 74 NRGY--------------LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ 139 (297)
T ss_pred cCCc--------------ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 6543 59999999999999999752110 1135888999999999999999999999
Q ss_pred ccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCc
Q 002738 694 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 773 (886)
Q Consensus 694 IVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~ 773 (886)
|+||||||+|||++.+ ..+||+|||++........ ......+..|+|||++.+ ..++.
T Consensus 140 ivH~dlkp~Nill~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~ 197 (297)
T cd05089 140 FIHRDLAARNVLVGEN-------LASKIADFGLSRGEEVYVK-----------KTMGRLPVRWMAIESLNY----SVYTT 197 (297)
T ss_pred cccCcCCcceEEECCC-------CeEEECCcCCCccccceec-----------cCCCCcCccccCchhhcc----CCCCc
Confidence 9999999999999876 5699999999864321100 011123567999999875 56789
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHH
Q 002738 774 EVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 852 (886)
Q Consensus 774 KSDIWSLGVILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dL 852 (886)
++|||||||++|||++ |..||.+....++...+..+..+..+ ...+..+.+|
T Consensus 198 ~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l 250 (297)
T cd05089 198 KSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKP---------------------------RNCDDEVYEL 250 (297)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCC---------------------------CCCCHHHHHH
Confidence 9999999999999997 99999888877776666544322221 1124578999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhcC
Q 002738 853 FRRCTEENPTERPTAGDLYEMFVARTS 879 (886)
Q Consensus 853 L~rCL~~DP~kRPSA~EILehLe~l~s 879 (886)
+.+||..+|.+||+++++++.|+.+..
T Consensus 251 i~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 251 MRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=326.94 Aligned_cols=261 Identities=20% Similarity=0.318 Sum_probs=206.0
Q ss_pred CCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeee
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 621 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~~-------~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g 621 (886)
.+.+|.+.+.||.|+||.||+|.+. +..+|+|+...+. ... +...+.+|+.++..++||||+++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~----~~~~~~~e~~~~~~l~h~~iv~~~~ 75 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGP----LREEFKHEAMMRSRLQHPNIVCLLG 75 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---CHH----HHHHHHHHHHHHhcCCCCCcCeEEE
Confidence 4567899999999999999999863 3568888854221 111 2234588999999999999999999
Q ss_pred eEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhc-----------cCCCcCCHHHHHHHHHHHHHHHHHHH
Q 002738 622 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELH 690 (886)
Q Consensus 622 ~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~-----------~~~~~Ls~~~i~~Ia~QIa~AL~yLH 690 (886)
++..... .++++||+.+++|.+++..... .....+++..++.++.|++.||.|||
T Consensus 76 ~~~~~~~--------------~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH 141 (283)
T cd05091 76 VVTKEQP--------------LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS 141 (283)
T ss_pred EEcCCCc--------------eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 9876553 6999999999999999964110 11235788899999999999999999
Q ss_pred hCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCC
Q 002738 691 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 770 (886)
Q Consensus 691 s~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~ 770 (886)
++||+||||||+|||++.+ ..+||+|||+++........ .......+++.|+|||++.+ ..
T Consensus 142 ~~gi~H~dlkp~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~ 202 (283)
T cd05091 142 SHHVVHKDLATRNVLVFDK-------LNVKISDLGLFREVYAADYY--------KLMGNSLLPIRWMSPEAIMY----GK 202 (283)
T ss_pred HcCccccccchhheEecCC-------CceEecccccccccccchhe--------eeccCccCCccccCHHHHhc----CC
Confidence 9999999999999999876 45999999998765432211 00122346789999999875 56
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHH
Q 002738 771 YGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 849 (886)
Q Consensus 771 ~s~KSDIWSLGVILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L 849 (886)
++.++|||||||++|||++ |..||.+....++...+........+. ..+..+
T Consensus 203 ~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~ 255 (283)
T cd05091 203 FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPD---------------------------DCPAWV 255 (283)
T ss_pred CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCC---------------------------CCCHHH
Confidence 7899999999999999998 889999888888777776654332221 234568
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002738 850 VDVFRRCTEENPTERPTAGDLYEMFVA 876 (886)
Q Consensus 850 ~dLL~rCL~~DP~kRPSA~EILehLe~ 876 (886)
.+|+.+||+.+|.+||++.+|+..|+.
T Consensus 256 ~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 256 YTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=337.80 Aligned_cols=244 Identities=27% Similarity=0.388 Sum_probs=191.7
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcceeeeeEecCCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 633 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl~g~~~~~~~l~~~~ 633 (886)
+.||+|+||.||+|++ .+..||+|++....... ....+ .+..|..++..+ +||||+++++++....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~----~~~~e~~~l~~~~~hp~i~~~~~~~~~~~------ 69 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE-DDDVE----CTMVERRVLALAWEHPFLTHLFCTFQTKE------ 69 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhhHH----HHHHHHHHHHhccCCCCccceeeEEEcCC------
Confidence 4799999999999997 45679999875432111 11122 225677777654 7999999999987654
Q ss_pred CCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCC
Q 002738 634 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 713 (886)
Q Consensus 634 ~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~ 713 (886)
..++||||++||+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~gg~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~---- 132 (316)
T cd05592 70 --------HLFFVMEYLNGGDLMFHIQS-----SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD---- 132 (316)
T ss_pred --------EEEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCC----
Confidence 46999999999999999875 3468999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 002738 714 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 793 (886)
Q Consensus 714 ~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~P 793 (886)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 133 ---~~~kL~Dfg~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~ell~G~~P 195 (316)
T cd05592 133 ---GHIKIADFGMCKENMNGEG----------KASTFCGTPDYIAPEILKG----QKYNESVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred ---CCEEEccCcCCeECCCCCC----------ccccccCCccccCHHHHcC----CCCCCcccchhHHHHHHHHHhCCCC
Confidence 4699999999975432111 1233469999999999976 5688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 002738 794 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG-DLYE 872 (886)
Q Consensus 794 F~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~-EILe 872 (886)
|.+.+..++...+... .+.++. ..+..+.+||.+||..||.+||++. ++++
T Consensus 196 f~~~~~~~~~~~i~~~-~~~~~~---------------------------~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 196 FHGEDEDELFDSILND-RPHFPR---------------------------WISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHcC-CCCCCC---------------------------CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 9988887777666543 122211 1245688999999999999999864 6766
Q ss_pred H
Q 002738 873 M 873 (886)
Q Consensus 873 h 873 (886)
|
T Consensus 248 h 248 (316)
T cd05592 248 H 248 (316)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=336.42 Aligned_cols=277 Identities=23% Similarity=0.301 Sum_probs=200.8
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
-++|++.++||+|+||.||++.+ .+..+|+|+..... ..... ..+.+|+++++.++||||+++++++....
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIR----NQIIRELQVLHECNSPYIVGFYGAFYSDG 76 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHH----HHHHHHHHHHHHCCCCcccceeEEEEECC
Confidence 46899999999999999999998 46678888765432 12222 23489999999999999999999998655
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEEE
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILI 706 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~-gIVHRDLKPsNILL 706 (886)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||+
T Consensus 77 --------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili 137 (333)
T cd06650 77 --------------EISICMEHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 137 (333)
T ss_pred --------------EEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE
Confidence 46999999999999999975 34588999999999999999999985 79999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +.+||+|||++..+.... .....||..|+|||++.+ ..++.++|||||||++|+
T Consensus 138 ~~~-------~~~kL~Dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il~~ 194 (333)
T cd06650 138 NSR-------GEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPERLQG----THYSVQSDIWSMGLSLVE 194 (333)
T ss_pred cCC-------CCEEEeeCCcchhhhhhc------------cccCCCCccccCHHHhcC----CCCCcHHHHHHHHHHHHH
Confidence 876 459999999987553211 122368999999999976 567899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHH--hhh-------ccccccc--------ccccC-CCCCCchhhhhhHHH
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL--EAL-------GSCHEHE--------VAQSG-SGFEKPEAELETLSF 848 (886)
Q Consensus 787 LLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l--~~~-------~~~~~~~--------~~~~~-~~~~~~~~~~~~s~~ 848 (886)
|++|+.||......++...+............ ... ....... ..... ............+.+
T Consensus 195 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (333)
T cd06650 195 MAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAE 274 (333)
T ss_pred HHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHH
Confidence 99999999876655544333211000000000 000 0000000 00000 000000000123567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002738 849 LVDVFRRCTEENPTERPTAGDLYEMFV 875 (886)
Q Consensus 849 L~dLL~rCL~~DP~kRPSA~EILehLe 875 (886)
+.+||.+||+.||.+|||+.|++.|-.
T Consensus 275 ~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 275 FQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred HHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 999999999999999999999999844
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.69 Aligned_cols=261 Identities=28% Similarity=0.392 Sum_probs=204.7
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCC-hHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~-~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
+|.+...||.|+||.||+|.. .+..+|+|.+........ ......+.+.+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 478889999999999999986 567899998754433222 22233344566899999999999999999999886553
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||++||+||||+|+|||++.
T Consensus 81 --------------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~ 141 (267)
T cd06628 81 --------------LNIFLEYVPGGSVAALLNN-----YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDN 141 (267)
T ss_pred --------------cEEEEEecCCCCHHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcC
Confidence 5999999999999999976 246888999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.++|+|||.++.......... .........|+..|+|||.+.+ ..++.++|||||||++|+|+
T Consensus 142 ~-------~~~~l~dfg~~~~~~~~~~~~~----~~~~~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~il~~l~ 206 (267)
T cd06628 142 K-------GGIKISDFGISKKLEANSLSTK----TNGARPSLQGSVFWMAPEVVKQ----TSYTRKADIWSLGCLVVEML 206 (267)
T ss_pred C-------CCEEecccCCCcccccccccCC----ccccccccCCCcCccChhHhcc----CCCCchhhhHHHHHHHHHHh
Confidence 6 5699999999987653221100 0011123458899999999876 56788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~ 868 (886)
+|+.||...+.......+.....+.++ ...+..+.++|.+||+.||.+||++.
T Consensus 207 ~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ 259 (267)
T cd06628 207 TGKHPFPDCTQLQAIFKIGENASPEIP---------------------------SNISSEAIDFLEKTFEIDHNKRPTAA 259 (267)
T ss_pred hCCCCCCCccHHHHHHHHhccCCCcCC---------------------------cccCHHHHHHHHHHccCCchhCcCHH
Confidence 999999877665544444443332222 11245789999999999999999999
Q ss_pred HHHHH
Q 002738 869 DLYEM 873 (886)
Q Consensus 869 EILeh 873 (886)
+|++|
T Consensus 260 ~il~~ 264 (267)
T cd06628 260 ELLKH 264 (267)
T ss_pred HHhhC
Confidence 99986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=322.31 Aligned_cols=256 Identities=22% Similarity=0.328 Sum_probs=206.3
Q ss_pred CCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~-~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
+-.+|++.++||.|+||.||+|.+ .+..+++|+..... ..... .+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~----~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 75 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD----LLKQQ----DFQKEVQALKRLRHKHLISLFAVCSVGE 75 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc----hhhHH----HHHHHHHHHhcCCCcchhheeeeEecCC
Confidence 345799999999999999999997 45678888754321 11222 3488999999999999999999987655
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
. .++||||+++++|.+++.. .....+++..+..++.||+.||.|||++||+|+||||+|||++
T Consensus 76 ~--------------~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~ 138 (261)
T cd05148 76 P--------------VYIITELMEKGSLLAFLRS---PEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG 138 (261)
T ss_pred C--------------eEEEEeecccCCHHHHHhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc
Confidence 3 6999999999999999975 2234689999999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ +.+||+|||.+......... .....++..|+|||++.. ..++.++||||||+++|+|
T Consensus 139 ~~-------~~~kl~d~g~~~~~~~~~~~----------~~~~~~~~~~~~PE~~~~----~~~~~~~DiwslG~~l~~l 197 (261)
T cd05148 139 ED-------LVCKVADFGLARLIKEDVYL----------SSDKKIPYKWTAPEAASH----GTFSTKSDVWSFGILLYEM 197 (261)
T ss_pred CC-------ceEEEccccchhhcCCcccc----------ccCCCCceEecCHHHHcc----CCCCchhhHHHHHHHHHHH
Confidence 77 56999999999765432211 112236778999999875 5678899999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 788 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 788 LT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
++ |+.||.+.+..+....+....++..+ ...++.+.+++.+||+.||.+|||
T Consensus 198 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rpt 250 (261)
T cd05148 198 FTYGQVPYPGMNNHEVYDQITAGYRMPCP---------------------------AKCPQEIYKIMLECWAAEPEDRPS 250 (261)
T ss_pred HcCCCCCCCcCCHHHHHHHHHhCCcCCCC---------------------------CCCCHHHHHHHHHHcCCCchhCcC
Confidence 98 89999888877777766654332221 122457899999999999999999
Q ss_pred HHHHHHHHHhh
Q 002738 867 AGDLYEMFVAR 877 (886)
Q Consensus 867 A~EILehLe~l 877 (886)
+.+|++.|+.+
T Consensus 251 ~~~l~~~L~~~ 261 (261)
T cd05148 251 FKALREELDNI 261 (261)
T ss_pred HHHHHHHHhcC
Confidence 99999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=318.46 Aligned_cols=250 Identities=26% Similarity=0.336 Sum_probs=202.5
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
+|++.+.||.|+||.||++.+ .+..+++|.+..... ....+ .+.+|+.+++.++||||+++++.+....
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS---SSAVE----DSRKEAVLLAKMKHPNIVAFKESFEADG-- 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc---hHHHH----HHHHHHHHHHhCCCCCcceEEEEEEECC--
Confidence 588999999999999999987 567889898654321 12223 3378999999999999999999988655
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..++||||+++++|.+++.. .....+++..++.++.||+.||.|||++||+|+||||+|||++.+
T Consensus 72 ------------~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~ 136 (255)
T cd08219 72 ------------HLYIVMEYCDGGDLMQKIKL---QRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN 136 (255)
T ss_pred ------------EEEEEEeeCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC
Confidence 46999999999999999875 223457899999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.++|+|||.+......... .....|++.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 137 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~----~~~~~~~Dv~slG~i~~~l~~ 195 (255)
T cd08219 137 -------GKVKLGDFGSARLLTSPGAY----------ACTYVGTPYYVPPEIWEN----MPYNNKSDIWSLGCILYELCT 195 (255)
T ss_pred -------CcEEEcccCcceeecccccc----------cccccCCccccCHHHHcc----CCcCchhhhhhhchhheehhh
Confidence 46999999998765432111 123468899999999876 567899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 869 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~E 869 (886)
|..||...+.......+..+....++. ..+..+.+||.+||+.||.+||++.+
T Consensus 196 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~P~~Rp~~~~ 248 (255)
T cd08219 196 LKHPFQANSWKNLILKVCQGSYKPLPS---------------------------HYSYELRSLIKQMFKRNPRSRPSATT 248 (255)
T ss_pred ccCCCCCCCHHHHHHHHhcCCCCCCCc---------------------------ccCHHHHHHHHHHHhCCcccCCCHHH
Confidence 999998887776666665554333221 12346899999999999999999999
Q ss_pred HHHH
Q 002738 870 LYEM 873 (886)
Q Consensus 870 ILeh 873 (886)
|+..
T Consensus 249 il~~ 252 (255)
T cd08219 249 ILSR 252 (255)
T ss_pred Hhhc
Confidence 9864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=346.62 Aligned_cols=260 Identities=29% Similarity=0.350 Sum_probs=218.3
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEec
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 625 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~~ 625 (886)
.-..|++.+.||+|.||.||+++. ++..+|+|++..+...... ..+ .+.+|+.+|++|. |||||.++++|.+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~-~~~----~v~~Ev~il~~l~~hpniv~l~~~~e~ 107 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE-DRE----DVRREVAILQQLSGHPNIVQLKDAFED 107 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc-cHH----HHHHHHHHHHhccCCCCEEEEEEEEEc
Confidence 345799999999999999999997 5778999998654432222 222 3489999999999 9999999999998
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
... .++|||++.||.|.+.|... .+++..+..++.||+.|+.|||+.||+||||||+|+|
T Consensus 108 ~~~--------------~~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L 167 (382)
T KOG0032|consen 108 PDS--------------VYLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLL 167 (382)
T ss_pred CCe--------------EEEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHee
Confidence 764 69999999999999999872 3999999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
+..... +...+|++|||+|........ ....+||+.|+|||++.. ..|+..+||||+||++|
T Consensus 168 ~~~~~~---~~~~ik~~DFGla~~~~~~~~-----------~~~~~Gtp~y~APEvl~~----~~y~~~~DiWS~Gvi~y 229 (382)
T KOG0032|consen 168 LASKDE---GSGRIKLIDFGLAKFIKPGER-----------LHTIVGTPEYVAPEVLGG----RPYGDEVDVWSIGVILY 229 (382)
T ss_pred eccccC---CCCcEEEeeCCCceEccCCce-----------EeeecCCccccCchhhcC----CCCCcccchhHHHHHHH
Confidence 987632 235799999999988765211 245689999999999986 78999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
.|++|.+||.+.+.......|..+...... +.+...+..+.+||.+||..||.+|+
T Consensus 230 iLL~G~~PF~~~~~~~~~~~i~~~~~~f~~------------------------~~w~~is~~akd~i~~ll~~dp~~R~ 285 (382)
T KOG0032|consen 230 ILLSGVPPFWGETEFEIFLAILRGDFDFTS------------------------EPWDDISESAKDFIRKLLEFDPRKRL 285 (382)
T ss_pred HHhhCCCCCcCCChhHHHHHHHcCCCCCCC------------------------CCccccCHHHHHHHHHhcccCcccCC
Confidence 999999999999988888888777542111 12233467899999999999999999
Q ss_pred CHHHHHHHHH
Q 002738 866 TAGDLYEMFV 875 (886)
Q Consensus 866 SA~EILehLe 875 (886)
|+.++|+|.+
T Consensus 286 ta~~~L~HpW 295 (382)
T KOG0032|consen 286 TAAQALQHPW 295 (382)
T ss_pred CHHHHhcCcc
Confidence 9999999965
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=316.13 Aligned_cols=252 Identities=22% Similarity=0.345 Sum_probs=201.2
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
+|++.+.||.|++|.||++.. .+..+++|....+. ......+ .+.+|+.++++++||||+++++.+.....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~~- 73 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN--ASRRERK----AAEQEAQLLSQLKHPNIVAYRESWEGEDG- 73 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh--cCHHHHH----HHHHHHHHHHhCCCCCeeeeeeeecCCCC-
Confidence 589999999999999999987 45678988864332 1222222 34889999999999999999987753321
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..++||||+++++|.+++.. .....+++.+++.++.||+.||+|||++||+||||||+||+++.+
T Consensus 74 ------------~~~lv~e~~~~~~l~~~l~~---~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~ 138 (257)
T cd08223 74 ------------LLYIVMGFCEGGDLYHKLKE---QKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT 138 (257)
T ss_pred ------------EEEEEecccCCCcHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecC
Confidence 36999999999999999975 223458999999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.++|+|||++........ ......+++.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 139 -------~~~~l~df~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~~l~~ 197 (257)
T cd08223 139 -------NIIKVGDLGIARVLENQCD----------MASTLIGTPYYMSPELFSN----KPYNYKSDVWALGCCVYEMAT 197 (257)
T ss_pred -------CcEEEecccceEEecccCC----------ccccccCCcCccChhHhcC----CCCCchhhhHHHHHHHHHHHc
Confidence 5699999999876533211 1123458899999999876 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 869 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~E 869 (886)
|+.||...+.......+..+..+.++ ...++.+.+|+.+||+.+|.+||++.+
T Consensus 198 g~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~ 250 (257)
T cd08223 198 LKHAFNAKDMNSLVYRIIEGKLPPMP---------------------------KDYSPELGELIATMLSKRPEKRPSVKS 250 (257)
T ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCc---------------------------cccCHHHHHHHHHHhccCcccCCCHHH
Confidence 99999877766655555444332221 123457999999999999999999999
Q ss_pred HHHH
Q 002738 870 LYEM 873 (886)
Q Consensus 870 ILeh 873 (886)
+++|
T Consensus 251 ~l~~ 254 (257)
T cd08223 251 ILRQ 254 (257)
T ss_pred HhcC
Confidence 9987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.99 Aligned_cols=249 Identities=26% Similarity=0.387 Sum_probs=194.5
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 634 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~~ 634 (886)
+.||+|+||.||+|++ .+..+|+|+.... ...... ..+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~---~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------ 67 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET---LPPDLK----AKFLQEARILKQYSHPNIVRLIGVCTQKQP------ 67 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc---CCHHHH----HHHHHHHHHHHhCCCCCcceEEEEEcCCCC------
Confidence 4799999999999987 5677888875321 122222 344899999999999999999999876543
Q ss_pred CCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCC
Q 002738 635 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 714 (886)
Q Consensus 635 ~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~ 714 (886)
.++||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 68 --------~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~----- 130 (252)
T cd05084 68 --------IYIVMELVQGGDFLTFLRT----EGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK----- 130 (252)
T ss_pred --------eEEEEeeccCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCC-----
Confidence 6999999999999999975 22458899999999999999999999999999999999999876
Q ss_pred CCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 002738 715 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVP 793 (886)
Q Consensus 715 ~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT-G~~P 793 (886)
+.+||+|||++.......... ......++..|+|||.+.+ ..++.++|||||||++|||++ |..|
T Consensus 131 --~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~e~~~~~~~p 196 (252)
T cd05084 131 --NVLKISDFGMSREEEDGVYAS--------TGGMKQIPVKWTAPEALNY----GRYSSESDVWSFGILLWEAFSLGAVP 196 (252)
T ss_pred --CcEEECccccCcccccccccc--------cCCCCCCceeecCchhhcC----CCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 469999999987543211110 0011123467999999876 567899999999999999998 9999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002738 794 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 873 (886)
Q Consensus 794 F~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EILeh 873 (886)
|...........+........+ ...+..+.+|+.+||+.+|.+|||+.+|++.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~ 249 (252)
T cd05084 197 YANLSNQQTREAIEQGVRLPCP---------------------------ELCPDAVYRLMERCWEYDPGQRPSFSTVHQE 249 (252)
T ss_pred ccccCHHHHHHHHHcCCCCCCc---------------------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9877766655555443222211 1124578999999999999999999999998
Q ss_pred HHh
Q 002738 874 FVA 876 (886)
Q Consensus 874 Le~ 876 (886)
|+.
T Consensus 250 l~~ 252 (252)
T cd05084 250 LQS 252 (252)
T ss_pred HhC
Confidence 863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.84 Aligned_cols=255 Identities=26% Similarity=0.387 Sum_probs=202.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~-~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
...++|++.++||+|+||.||+|.+ .+..+|+|...... ... + .+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~--~~~---~----~~~~E~~~l~~l~~~~i~~~~~~~~~~ 73 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT--MSP---E----SFLEEAQIMKKLRHDKLVQLYAVVSEE 73 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC--CCH---H----HHHHHHHHHHhcCCCceEEEEeEECCC
Confidence 3557899999999999999999987 44578888764322 111 2 348899999999999999999887432
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
..++||||+++++|.+++.. .....+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 74 ---------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili 135 (260)
T cd05070 74 ---------------PIYIVTEYMSKGSLLDFLKD---GEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV 135 (260)
T ss_pred ---------------CcEEEEEecCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE
Confidence 24899999999999999975 223458899999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +.++|+|||++......... ......++..|+|||++.+ ..++.++||||||+++|+
T Consensus 136 ~~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~ 195 (260)
T cd05070 136 GDG-------LVCKIADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTE 195 (260)
T ss_pred eCC-------ceEEeCCceeeeeccCcccc---------cccCCCCCccccChHHHhc----CCCcchhhhHHHHHHHHH
Confidence 876 56999999999765432111 0112235678999999875 567899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 787 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 787 LLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
|++ |..||.+.+..+....+.....+..+ ...+..+.+|+.+||..+|.+||
T Consensus 196 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp 248 (260)
T cd05070 196 LVTKGRVPYPGMNNREVLEQVERGYRMPCP---------------------------QDCPISLHELMLQCWKKDPEERP 248 (260)
T ss_pred HHhcCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CcCCHHHHHHHHHHcccCcccCc
Confidence 999 89999888777776666554322211 11245799999999999999999
Q ss_pred CHHHHHHHHHh
Q 002738 866 TAGDLYEMFVA 876 (886)
Q Consensus 866 SA~EILehLe~ 876 (886)
|+.++.+.|+.
T Consensus 249 t~~~l~~~l~~ 259 (260)
T cd05070 249 TFEYLQSFLED 259 (260)
T ss_pred CHHHHHHHHhc
Confidence 99999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=344.53 Aligned_cols=262 Identities=21% Similarity=0.290 Sum_probs=204.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
...++|++.+.||+|+||.||+|++ .+..+|+|+....... .... ...+.+|+.+++.++||||+++++++..
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~----~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSD----SAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-hhHH----HHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4468999999999999999999997 5667899986432111 1111 1234789999999999999999999886
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
.. ..++||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 115 ~~--------------~~~lv~Ey~~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIl 174 (371)
T cd05622 115 DR--------------YLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 174 (371)
T ss_pred CC--------------EEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEE
Confidence 54 46999999999999999975 35888999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.+ +.+||+|||++......... ......||+.|+|||++.+......++.++|||||||+||
T Consensus 175 l~~~-------~~ikL~DfG~a~~~~~~~~~---------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvily 238 (371)
T cd05622 175 LDKS-------GHLKLADFGTCMKMNKEGMV---------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 238 (371)
T ss_pred ECCC-------CCEEEEeCCceeEcCcCCcc---------cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHH
Confidence 9877 46999999999765432111 1134569999999999976333345789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC-
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE- 863 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~r-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k- 863 (886)
||++|+.||.+.+.......+..... ..++. ....+..+.+||.+||..++.+
T Consensus 239 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~~~~r~ 293 (371)
T cd05622 239 EMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD-------------------------DNDISKEAKNLICAFLTDREVRL 293 (371)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCcccCCC-------------------------cCCCCHHHHHHHHHHcCChhhhc
Confidence 99999999998888777766654321 11110 0123567899999999844433
Q ss_pred -CCCHHHHHHHHH
Q 002738 864 -RPTAGDLYEMFV 875 (886)
Q Consensus 864 -RPSA~EILehLe 875 (886)
|+++.+|++|..
T Consensus 294 ~r~~~~ei~~h~~ 306 (371)
T cd05622 294 GRNGVEEIKRHLF 306 (371)
T ss_pred CCCCHHHHhcCcc
Confidence 789999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=329.87 Aligned_cols=254 Identities=22% Similarity=0.299 Sum_probs=197.0
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
+|++.+.||+|+||.||++.. .+..+|+|+........ ......+.+|+.+++.++||||+++++.+....
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 73 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-----RKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhh-----hhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC--
Confidence 488999999999999999997 46789999864322111 111223478999999999999999999987654
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..++||||+++++|..++.. .....+++..+..++.||+.||.|||+.||+||||||+|||++.+
T Consensus 74 ------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~ 138 (285)
T cd05605 74 ------------ALCLVLTLMNGGDLKFHIYN---MGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY 138 (285)
T ss_pred ------------eEEEEEeccCCCcHHHHHHh---cCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCC
Confidence 36999999999999998865 223458999999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.++|+|||++........ .....|++.|+|||++.+ ..++.++|||||||++|||++
T Consensus 139 -------~~~~l~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Diws~G~~l~el~~ 196 (285)
T cd05605 139 -------GHIRISDLGLAVEIPEGET-----------IRGRVGTVGYMAPEVVKN----ERYTFSPDWWGLGCLIYEMIE 196 (285)
T ss_pred -------CCEEEeeCCCceecCCCCc-----------cccccCCCCccCcHHhcC----CCCCccccchhHHHHHHHHHH
Confidence 4699999999876532111 122368999999999975 567899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC----
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP---- 865 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP---- 865 (886)
|+.||.+.........+........ .......+..+.+||.+||..||.+||
T Consensus 197 g~~pf~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 252 (285)
T cd05605 197 GKSPFRQRKEKVKREEVERRVKEDQ------------------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRG 252 (285)
T ss_pred CCCCCCCCchhhHHHHHHHHhhhcc------------------------cccCcccCHHHHHHHHHHccCCHHHhcCCCC
Confidence 9999987655433322221100000 000112355789999999999999999
Q ss_pred -CHHHHHHH
Q 002738 866 -TAGDLYEM 873 (886)
Q Consensus 866 -SA~EILeh 873 (886)
+++++++|
T Consensus 253 ~~~~~l~~~ 261 (285)
T cd05605 253 EGAEEVKAH 261 (285)
T ss_pred CCHHHHhcC
Confidence 89999887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=337.70 Aligned_cols=266 Identities=24% Similarity=0.345 Sum_probs=203.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCccee
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 619 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~-------~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl 619 (886)
.+-++|++.+.||+|+||.||+|... +..||+|++... ......+. +.+|+.++.++ +||||+++
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~----~~~E~~~~~~l~~h~niv~~ 76 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG---ATASEYKA----LMTELKILIHIGHHLNVVNL 76 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCC---CCHHHHHH----HHHHHHHHHhhccCcchhhe
Confidence 34568999999999999999999742 256999986422 12223333 38899999999 79999999
Q ss_pred eeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhcc----------------------------------
Q 002738 620 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---------------------------------- 665 (886)
Q Consensus 620 ~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~---------------------------------- 665 (886)
++++..... ..+++|||+++++|.+++......
T Consensus 77 ~~~~~~~~~-------------~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (337)
T cd05054 77 LGACTKPGG-------------PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSA 143 (337)
T ss_pred eeeEecCCC-------------CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCcccccc
Confidence 998875443 479999999999999999652110
Q ss_pred ----------------------CCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCCCCCeEEEee
Q 002738 666 ----------------------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723 (886)
Q Consensus 666 ----------------------~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsD 723 (886)
....+++..+..++.||+.||+|||++||+||||||+|||++.+ +.++|+|
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~-------~~vkL~D 216 (337)
T cd05054 144 SSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSEN-------NVVKICD 216 (337)
T ss_pred ccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCC-------CcEEEec
Confidence 01257899999999999999999999999999999999999876 4699999
Q ss_pred cCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 002738 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEI 802 (886)
Q Consensus 724 FGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT-G~~PF~g~s~~el 802 (886)
||++..+...... .......++..|+|||++.+ ..++.++|||||||+||||++ |..||.+....+.
T Consensus 217 fG~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~ 284 (337)
T cd05054 217 FGLARDIYKDPDY--------VRKGDARLPLKWMAPESIFD----KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE 284 (337)
T ss_pred cccchhcccCcch--------hhccCCCCCccccCcHHhcC----CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH
Confidence 9999876432211 01123356788999999976 678999999999999999998 9999977543332
Q ss_pred -HHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 002738 803 -HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 879 (886)
Q Consensus 803 -~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EILehLe~l~s 879 (886)
...+..+.++..+ ....+.+.+|+.+||+.+|++||++.+|+++|+.+..
T Consensus 285 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 285 FCRRLKEGTRMRAP---------------------------EYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHhccCCCCCC---------------------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 2333322221111 1124578999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=336.75 Aligned_cols=244 Identities=25% Similarity=0.385 Sum_probs=192.6
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcceeeeeEecCCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 633 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl~g~~~~~~~l~~~~ 633 (886)
+.||+|+||.||+|++ .+..+|+|+......... .... .+..|..++..+ +||||+++++++....
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-~~~~----~~~~e~~~l~~~~~~~~i~~~~~~~~~~~------ 69 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLID-DDVE----CTMVEKRVLALAWENPFLTHLYCTFQTKE------ 69 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhc-chHH----HHHHHHHHHHhccCCCCccCeeEEEEeCC------
Confidence 4799999999999997 566899998754321111 1122 236788888765 7999999999998655
Q ss_pred CCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCC
Q 002738 634 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 713 (886)
Q Consensus 634 ~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~ 713 (886)
..|+||||+.+++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~E~~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~---- 132 (316)
T cd05620 70 --------HLFFVMEFLNGGDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD---- 132 (316)
T ss_pred --------EEEEEECCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC----
Confidence 47999999999999999875 3568899999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 002738 714 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 793 (886)
Q Consensus 714 ~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~P 793 (886)
+.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~el~~g~~P 195 (316)
T cd05620 133 ---GHIKIADFGMCKENVFGD----------NRASTFCGTPDYIAPEILQG----LKYTFSVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred ---CCEEeCccCCCeecccCC----------CceeccCCCcCccCHHHHcC----CCCCcccchhhhHHHHHHHHhCCCC
Confidence 469999999986432111 11233569999999999986 6788999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-HHHHH
Q 002738 794 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA-GDLYE 872 (886)
Q Consensus 794 F~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA-~EILe 872 (886)
|.+.+..++...+.... +.++. ..+..+.+||.+||+.||.+||++ +++++
T Consensus 196 f~~~~~~~~~~~~~~~~-~~~~~---------------------------~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 196 FHGDDEDELFESIRVDT-PHYPR---------------------------WITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred CCCCCHHHHHHHHHhCC-CCCCC---------------------------CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 99888777766654432 11111 124578999999999999999997 57776
Q ss_pred H
Q 002738 873 M 873 (886)
Q Consensus 873 h 873 (886)
|
T Consensus 248 h 248 (316)
T cd05620 248 H 248 (316)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.93 Aligned_cols=256 Identities=23% Similarity=0.373 Sum_probs=204.1
Q ss_pred CCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~-~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
+..+|++.+.||+|+||.||+|.+ .+..+|+|...... . ..+. +.+|+.++++++||||+++++++....
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~---~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--M---DPKD----FLAEAQIMKKLRHPKLIQLYAVCTLEE 74 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--c---cHHH----HHHHHHHHHHCCCCCccceeEEEecCC
Confidence 456799999999999999999987 44578888754221 1 1223 388999999999999999999887654
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
..++||||+++++|.+++... ....+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus 75 --------------~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~ 137 (261)
T cd05068 75 --------------PIYIVTELMKYGSLLEYLQGG---AGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG 137 (261)
T ss_pred --------------CeeeeeecccCCcHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEc
Confidence 369999999999999999752 234689999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ +.+||+|||++......... .......+..|+|||++.+ ..++.++||||||+++|||
T Consensus 138 ~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el 197 (261)
T cd05068 138 EN-------NICKVADFGLARVIKEDIYE---------AREGAKFPIKWTAPEAALY----NRFSIKSDVWSFGILLTEI 197 (261)
T ss_pred CC-------CCEEECCcceEEEccCCccc---------ccCCCcCceeccCcccccc----CCCCchhhHHHHHHHHHHH
Confidence 77 45999999999876532111 0011123468999999875 5678999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 788 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 788 LT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
++ |+.||.+.....+...+........+ ...+..+.+++.+||+.+|.+||+
T Consensus 198 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~P~~Rp~ 250 (261)
T cd05068 198 VTYGRMPYPGMTNAEVLQQVDQGYRMPCP---------------------------PGCPKELYDIMLDCWKEDPDDRPT 250 (261)
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CcCCHHHHHHHHHHhhcCcccCCC
Confidence 99 99999988877777666544322111 112457899999999999999999
Q ss_pred HHHHHHHHHhh
Q 002738 867 AGDLYEMFVAR 877 (886)
Q Consensus 867 A~EILehLe~l 877 (886)
+.+|++.|+.+
T Consensus 251 ~~~l~~~l~~~ 261 (261)
T cd05068 251 FETLQWKLEDF 261 (261)
T ss_pred HHHHHHHHhcC
Confidence 99999999753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=338.41 Aligned_cols=244 Identities=25% Similarity=0.312 Sum_probs=190.0
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHH-HHhhCCCCCcceeeeeEecCCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKISSKWLPSAD 633 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~-iLk~L~HPNIVrl~g~~~~~~~l~~~~ 633 (886)
+.||+|+||.||+|++ .+..+|+|+......... ... ..+..|.. +++.++||||+++++++....
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~----~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~------ 69 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK-KEE----KHIMSERNVLLKNVKHPFLVGLHFSFQTAD------ 69 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh-hHH----HHHHHHHHHHHHhCCCCCCCceeEEEEcCC------
Confidence 4799999999999997 456799998753321111 111 12244444 567889999999999988655
Q ss_pred CCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCC
Q 002738 634 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 713 (886)
Q Consensus 634 ~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~ 713 (886)
..|+||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~---- 132 (325)
T cd05602 70 --------KLYFVLDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ---- 132 (325)
T ss_pred --------eEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC----
Confidence 36999999999999999975 3468888999999999999999999999999999999999876
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 002738 714 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 793 (886)
Q Consensus 714 ~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~P 793 (886)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|..|
T Consensus 133 ---~~~kl~DfG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~p 195 (325)
T cd05602 133 ---GHIVLTDFGLCKENIEHNG----------TTSTFCGTPEYLAPEVLHK----QPYDRTVDWWCLGAVLYEMLYGLPP 195 (325)
T ss_pred ---CCEEEccCCCCcccccCCC----------CcccccCCccccCHHHHcC----CCCCCccccccccHHHHHHhcCCCC
Confidence 4699999999875322111 1233469999999999986 6688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH----H
Q 002738 794 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG----D 869 (886)
Q Consensus 794 F~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~----E 869 (886)
|.+.+..+....+...... ++ ...+..+.+||.+||+.||.+||++. +
T Consensus 196 f~~~~~~~~~~~i~~~~~~-~~---------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 196 FYSRNTAEMYDNILNKPLQ-LK---------------------------PNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CCCCCHHHHHHHHHhCCcC-CC---------------------------CCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 9988877776666443211 00 12345789999999999999999876 5
Q ss_pred HHHH
Q 002738 870 LYEM 873 (886)
Q Consensus 870 ILeh 873 (886)
+++|
T Consensus 248 i~~~ 251 (325)
T cd05602 248 IKNH 251 (325)
T ss_pred HhcC
Confidence 5554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=336.36 Aligned_cols=244 Identities=26% Similarity=0.348 Sum_probs=195.3
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcceeeeeEecCCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 633 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl~g~~~~~~~l~~~~ 633 (886)
+.||+|+||.||+|++ .+..+|+|++...... ...... .+.+|+.++..+ +||||+++++++....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~~~~e~~il~~~~~h~~i~~~~~~~~~~~------ 69 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVIL-QDDDVE----CTMTEKRVLALAGKHPFLTQLHSCFQTKD------ 69 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHHH----HHHHHHHHHHhccCCCCccceeeEEEcCC------
Confidence 4799999999999997 4568999987533211 111222 337888999888 6999999999988654
Q ss_pred CCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCC
Q 002738 634 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 713 (886)
Q Consensus 634 ~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~ 713 (886)
..|+||||++|++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~---- 132 (318)
T cd05570 70 --------RLFFVMEYVNGGDLMFHIQR-----SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE---- 132 (318)
T ss_pred --------EEEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC----
Confidence 47999999999999999876 3468999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 002738 714 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 793 (886)
Q Consensus 714 ~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~P 793 (886)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslGvil~~l~~G~~p 195 (318)
T cd05570 133 ---GHIKIADFGMCKEGILGGV----------TTSTFCGTPDYIAPEILSY----QPYGPAVDWWALGVLLYEMLAGQSP 195 (318)
T ss_pred ---CcEEecccCCCeecCcCCC----------cccceecCccccCHHHhcC----CCCCcchhhhhHHHHHHHHhhCCCC
Confidence 4699999999864322111 1123468999999999986 6788999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-----H
Q 002738 794 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA-----G 868 (886)
Q Consensus 794 F~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA-----~ 868 (886)
|.+.+...+...+..... .++ ...+..+.+||.+||..||.+||++ .
T Consensus 196 f~~~~~~~~~~~i~~~~~-~~~---------------------------~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~ 247 (318)
T cd05570 196 FEGDDEDELFQSILEDEV-RYP---------------------------RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQ 247 (318)
T ss_pred CCCCCHHHHHHHHHcCCC-CCC---------------------------CcCCHHHHHHHHHHccCCHHHcCCCCCCCHH
Confidence 998887777666654321 111 1124578999999999999999999 9
Q ss_pred HHHHH
Q 002738 869 DLYEM 873 (886)
Q Consensus 869 EILeh 873 (886)
++++|
T Consensus 248 ~ll~~ 252 (318)
T cd05570 248 DIKGH 252 (318)
T ss_pred HHhcC
Confidence 99887
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.22 Aligned_cols=252 Identities=24% Similarity=0.364 Sum_probs=200.2
Q ss_pred CCCCceeeeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~~-~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
+..+|++.+.||+|+||.||++.+. +..+|+|+.... ... .. .+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~--~~~---~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG--AMS---ED----DFIEEAKVMMKLSHPNLVQLYGVCTKQR 72 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccC--CCC---HH----HHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 3457899999999999999999874 447888885321 111 12 2378999999999999999999987554
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
. .++||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 73 ~--------------~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~ 134 (256)
T cd05059 73 P--------------IFIVTEYMANGCLLNYLRE----RKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG 134 (256)
T ss_pred c--------------eEEEEecCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEEC
Confidence 3 6999999999999999975 123688999999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ +.+||+|||+++........ ......++..|+|||++.+ ..++.++||||||+++|+|
T Consensus 135 ~~-------~~~kl~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~Pe~~~~----~~~~~~~Di~slG~il~~l 194 (256)
T cd05059 135 ED-------NVVKVSDFGLARYVLDDQYT---------SSQGTKFPVKWAPPEVFDY----SRFSSKSDVWSFGVLMWEV 194 (256)
T ss_pred CC-------CcEEECCcccceeccccccc---------ccCCCCCCccccCHHHhcc----CCCCchhhHHHHHHHHHHH
Confidence 76 56999999998765432111 0111124568999999976 5678899999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 788 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 788 LT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
++ |..||...+..+....+....++..+ ...+..+.+|+.+||..+|++|||
T Consensus 195 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~cl~~~p~~Rpt 247 (256)
T cd05059 195 FSEGKMPYERFSNSEVVESVSAGYRLYRP---------------------------KLAPTEVYTIMYSCWHEKPEDRPA 247 (256)
T ss_pred hccCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHhcCChhhCcC
Confidence 99 89999887777766666544322211 113557999999999999999999
Q ss_pred HHHHHHHH
Q 002738 867 AGDLYEMF 874 (886)
Q Consensus 867 A~EILehL 874 (886)
+.++++.|
T Consensus 248 ~~~~l~~l 255 (256)
T cd05059 248 FKKLLSQL 255 (256)
T ss_pred HHHHHHHh
Confidence 99999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.18 Aligned_cols=243 Identities=24% Similarity=0.308 Sum_probs=195.1
Q ss_pred eeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 631 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~-----~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~ 631 (886)
+.||+|+||.||+++. .+..+|+|++..... .... ...+.+|+.+|++++||||+++++++....
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 71 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRD----RVRTKMERDILAEVNHPFIVKLHYAFQTEG---- 71 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhh----HHHHHHHHHHHHhCCCCCcccEEEEEEcCC----
Confidence 6799999999999875 467899998753321 1111 123478999999999999999999988654
Q ss_pred CCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecccc
Q 002738 632 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 711 (886)
Q Consensus 632 ~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~ 711 (886)
..|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 72 ----------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-- 134 (318)
T cd05582 72 ----------KLYLILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-- 134 (318)
T ss_pred ----------EEEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCC--
Confidence 46999999999999999975 3568999999999999999999999999999999999999877
Q ss_pred CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCC
Q 002738 712 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 791 (886)
Q Consensus 712 ~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~ 791 (886)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 135 -----~~~kL~Dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~il~el~tg~ 195 (318)
T cd05582 135 -----GHIKLTDFGLSKESIDHEK----------KAYSFCGTVEYMAPEVVNR----RGHTQSADWWSFGVLMFEMLTGS 195 (318)
T ss_pred -----CcEEEeeccCCcccCCCCC----------ceecccCChhhcCHHHHcC----CCCCCccceeccceEeeeeccCC
Confidence 4699999999875433211 1123468999999999976 56788999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC-----
Q 002738 792 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT----- 866 (886)
Q Consensus 792 ~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS----- 866 (886)
.||.+.+..+....+..... .++ ...++.+.+||.+||+.||.+||+
T Consensus 196 ~p~~~~~~~~~~~~i~~~~~-~~p---------------------------~~~~~~~~~li~~~l~~~P~~R~~a~~~~ 247 (318)
T cd05582 196 LPFQGKDRKETMTMILKAKL-GMP---------------------------QFLSPEAQSLLRALFKRNPANRLGAGPDG 247 (318)
T ss_pred CCCCCCCHHHHHHHHHcCCC-CCC---------------------------CCCCHHHHHHHHHHhhcCHhHcCCCCCCC
Confidence 99998887777766654321 111 112457899999999999999999
Q ss_pred HHHHHHH
Q 002738 867 AGDLYEM 873 (886)
Q Consensus 867 A~EILeh 873 (886)
+.+++.|
T Consensus 248 ~~~~~~~ 254 (318)
T cd05582 248 VEEIKRH 254 (318)
T ss_pred HHHHhCC
Confidence 5667765
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=328.95 Aligned_cols=267 Identities=24% Similarity=0.361 Sum_probs=207.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC---------eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcc
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIV 617 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~~---------~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIV 617 (886)
...++|.+.+.||+|+||.||+|++.+ ..+|+|+.... ........ +.+|+.+++.+ +||||+
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~----~~~e~~~l~~l~~h~~i~ 87 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD---ATEKDLSD----LISEMEMMKMIGKHKNII 87 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC---CChHHHHH----HHHHHHHHHHhcCCCCEe
Confidence 445789999999999999999998622 35888875422 11222233 48899999999 699999
Q ss_pred eeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhcc-----------CCCcCCHHHHHHHHHHHHHHH
Q 002738 618 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAAL 686 (886)
Q Consensus 618 rl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~-----------~~~~Ls~~~i~~Ia~QIa~AL 686 (886)
++++++.... ..|+||||+++++|.+++...... ....+++.+++.++.||+.||
T Consensus 88 ~~~~~~~~~~--------------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL 153 (307)
T cd05098 88 NLLGACTQDG--------------PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGM 153 (307)
T ss_pred eEEEEEecCC--------------ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHH
Confidence 9999987654 369999999999999999863211 123588899999999999999
Q ss_pred HHHHhCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 002738 687 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 766 (886)
Q Consensus 687 ~yLHs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~ 766 (886)
+|||++||+||||||+|||++.+ +.+||+|||++.......... ......+++.|+|||++.+
T Consensus 154 ~~lH~~gi~H~dlkp~Nill~~~-------~~~kL~dfg~a~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-- 216 (307)
T cd05098 154 EYLASKKCIHRDLAARNVLVTED-------NVMKIADFGLARDIHHIDYYK--------KTTNGRLPVKWMAPEALFD-- 216 (307)
T ss_pred HHHHHCCcccccccHHheEEcCC-------CcEEECCCcccccccccchhh--------ccccCCCccceeChHHhcc--
Confidence 99999999999999999999876 469999999987654321110 0011224578999999876
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhh
Q 002738 767 KPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 845 (886)
Q Consensus 767 ~~~~~s~KSDIWSLGVILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (886)
..++.++|||||||++|||++ |..||.+....++...+........+ ...
T Consensus 217 --~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~ 267 (307)
T cd05098 217 --RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKP---------------------------SNC 267 (307)
T ss_pred --CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCCCCCC---------------------------CcC
Confidence 567899999999999999998 89999887777766666544332221 112
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 002738 846 LSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSS 881 (886)
Q Consensus 846 s~~L~dLL~rCL~~DP~kRPSA~EILehLe~l~sss 881 (886)
+..+.+|+.+||..+|.+|||+.+|+++|+.+....
T Consensus 268 ~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 268 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 457899999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=320.13 Aligned_cols=262 Identities=26% Similarity=0.423 Sum_probs=204.3
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
+.+|++.+.||.|+||.||+|.. .+..+++|....... ...... ..+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~----~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 75 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-MDAKAR----ADCIKEIDLLKQLNHPNVIKYYASFIEDN 75 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-hhHHHH----HHHHHHHHHHHHccCCchhhhhheeEeCC
Confidence 46899999999999999999996 677888887543221 111222 34589999999999999999999988655
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
..++||||+++++|.+++..... ....+++..++.++.||+.||.|||++||+|+||||+||+++
T Consensus 76 --------------~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~ 140 (267)
T cd08229 76 --------------ELNIVLELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT 140 (267)
T ss_pred --------------eEEEEEEecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc
Confidence 36999999999999999975322 235689999999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ +.++|+|||++......... .....|+..|+|||++.+ ..++.++||||||+++|+|
T Consensus 141 ~~-------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~~~ape~~~~----~~~~~~~Dv~slG~il~~l 199 (267)
T cd08229 141 AT-------GVVKLGDLGLGRFFSSKTTA----------AHSLVGTPYYMSPERIHE----NGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred CC-------CCEEECcchhhhccccCCcc----------cccccCCcCccCHHHhcC----CCccchhhHHHHHHHHHHH
Confidence 76 46999999998765432111 123458899999999975 5678899999999999999
Q ss_pred HhCCCCCCCCCH--HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 788 LTLQVPYMGLSE--LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 788 LTG~~PF~g~s~--~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
++|..||.+... ......+.....+..+ ....++.+.+|+.+||..||.+||
T Consensus 200 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~~l~~~p~~Rp 253 (267)
T cd08229 200 AALQSPFYGDKMNLYSLCKKIEQCDYPPLP--------------------------SDHYSEELRQLVNMCINPDPEKRP 253 (267)
T ss_pred HhCCCCcccccchHHHHhhhhhcCCCCCCC--------------------------cccccHHHHHHHHHhcCCCcccCC
Confidence 999999975532 2233333222211111 012356799999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 002738 866 TAGDLYEMFVART 878 (886)
Q Consensus 866 SA~EILehLe~l~ 878 (886)
|+.+|++.++++.
T Consensus 254 t~~~i~~~~~~~~ 266 (267)
T cd08229 254 DITYVYDVAKRMH 266 (267)
T ss_pred CHHHHHHHHhhhc
Confidence 9999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=338.29 Aligned_cols=244 Identities=22% Similarity=0.348 Sum_probs=188.5
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcceeeeeEecCCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 633 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl~g~~~~~~~l~~~~ 633 (886)
+.||+|+||.||+|++ .+..+|+|+....... ..... ..+.+|+.++..+ +||||+++++++....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~-~~~~~----~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~------ 69 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVN-DDEDI----DWVQTEKHVFETASNHPFLVGLHSCFQTES------ 69 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHH----HHHHHHHHHHHhccCCCCCCceEEEEEcCC------
Confidence 4799999999999997 5678999987533211 11122 2347899999998 6999999999998655
Q ss_pred CCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCC
Q 002738 634 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 713 (886)
Q Consensus 634 ~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~ 713 (886)
..||||||++||+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~~g~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~---- 132 (329)
T cd05588 70 --------RLFFVIEFVSGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE---- 132 (329)
T ss_pred --------EEEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC----
Confidence 46999999999999998875 3568999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 002738 714 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 793 (886)
Q Consensus 714 ~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~P 793 (886)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~~l~el~~g~~P 195 (329)
T cd05588 133 ---GHIKLTDYGMCKEGIRPGD----------TTSTFCGTPNYIAPEILRG----EDYGFSVDWWALGVLMFEMMAGRSP 195 (329)
T ss_pred ---CCEEECcCccccccccCCC----------ccccccCCccccCHHHHcC----CCCCCccceechHHHHHHHHHCCCC
Confidence 4699999999864321111 1123469999999999986 6688999999999999999999999
Q ss_pred CCCCCH--------HH-HHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 002738 794 YMGLSE--------LE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 864 (886)
Q Consensus 794 F~g~s~--------~e-l~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kR 864 (886)
|..... .. +...+... ...++ ...+..+.+||.+||+.||.+|
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~p---------------------------~~~~~~~~~li~~~L~~dP~~R 247 (329)
T cd05588 196 FDIVGMSDNPDQNTEDYLFQVILEK-QIRIP---------------------------RSLSVKASSVLKGFLNKDPKER 247 (329)
T ss_pred cccccccccccccchHHHHHHHHcC-CCCCC---------------------------CCCCHHHHHHHHHHhccCHHHc
Confidence 963211 11 11122111 11111 1234578999999999999999
Q ss_pred CC------HHHHHHH
Q 002738 865 PT------AGDLYEM 873 (886)
Q Consensus 865 PS------A~EILeh 873 (886)
|+ +.++++|
T Consensus 248 ~~~~~~~~~~~i~~h 262 (329)
T cd05588 248 LGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCCCHHHHhcC
Confidence 87 7899887
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=318.66 Aligned_cols=249 Identities=21% Similarity=0.322 Sum_probs=196.6
Q ss_pred eecccCceEEEEEEEC----CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCC
Q 002738 558 EAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 633 (886)
Q Consensus 558 ~LG~G~fG~VY~A~~~----~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~ 633 (886)
.||+|+||.||+|.+. +..+|+|+..... ... ..+.+.+|+.++++++||||+++++++...
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~---~~~----~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~------- 67 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN---EKS----VRDEMMREAEIMHQLDNPYIVRMIGVCEAE------- 67 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc---ChH----HHHHHHHHHHHHHhcCCCCeEEEEEEEcCC-------
Confidence 4899999999999763 3457888754221 122 223458999999999999999999987532
Q ss_pred CCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCC
Q 002738 634 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 713 (886)
Q Consensus 634 ~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~ 713 (886)
..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 68 --------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~---- 131 (257)
T cd05115 68 --------ALMLVMEMASGGPLNKFLSG----KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQ---- 131 (257)
T ss_pred --------CeEEEEEeCCCCCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCC----
Confidence 25999999999999999874 23468999999999999999999999999999999999999876
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCC
Q 002738 714 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQV 792 (886)
Q Consensus 714 ~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT-G~~ 792 (886)
..+||+|||++........... ......++..|+|||++.. ..++.++|||||||++|||++ |..
T Consensus 132 ---~~~kl~dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~~~g~~ 197 (257)
T cd05115 132 ---HYAKISDFGLSKALGADDSYYK-------ARSAGKWPLKWYAPECINF----RKFSSRSDVWSYGITMWEAFSYGQK 197 (257)
T ss_pred ---CcEEeccCCccccccCCcccee-------ccCCCCCCcccCCHHHHcc----CCCCchhhHHHHHHHHHHHhcCCCC
Confidence 5699999999975543221100 0111224678999999875 567889999999999999996 999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002738 793 PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 872 (886)
Q Consensus 793 PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EILe 872 (886)
||.......+...+..+..+.++ ...++++.+||.+||..+|.+||++.+|++
T Consensus 198 p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 198 PYKKMKGPEVMSFIEQGKRLDCP---------------------------AECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred CcCcCCHHHHHHHHHCCCCCCCC---------------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99988887777777665443322 113457899999999999999999999999
Q ss_pred HHHhh
Q 002738 873 MFVAR 877 (886)
Q Consensus 873 hLe~l 877 (886)
.|+..
T Consensus 251 ~l~~~ 255 (257)
T cd05115 251 RMRTY 255 (257)
T ss_pred HHhhh
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=334.98 Aligned_cols=244 Identities=27% Similarity=0.374 Sum_probs=192.4
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcceeeeeEecCCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 633 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl~g~~~~~~~l~~~~ 633 (886)
+.||+|+||.||+|++ .+..+|+|+........ ..... .+..|..++..+ +||||+++++++.+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~----~~~~e~~~l~~~~~hp~iv~~~~~~~~~~------ 69 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM-DDDVE----CTMVEKRVLSLAWEHPFLTHLYCTFQTKE------ 69 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-cchHH----HHHHHHHHHHhccCCCcCcceEEEEEeCC------
Confidence 4799999999999997 45679999875432111 11112 236788888764 8999999999998655
Q ss_pred CCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCC
Q 002738 634 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 713 (886)
Q Consensus 634 ~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~ 713 (886)
..+|||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~ey~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~---- 132 (316)
T cd05619 70 --------NLFFVMEYLNGGDLMFHIQS-----CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD---- 132 (316)
T ss_pred --------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC----
Confidence 36999999999999999975 3468899999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 002738 714 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 793 (886)
Q Consensus 714 ~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~P 793 (886)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~G~~p 195 (316)
T cd05619 133 ---GHIKIADFGMCKENMLGDA----------KTCTFCGTPDYIAPEILLG----QKYNTSVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred ---CCEEEccCCcceECCCCCC----------ceeeecCCccccCHHHHcC----CCCCchhhhhhHHHHHHHHHhCCCC
Confidence 4699999999864322111 1123468999999999976 6688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 002738 794 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG-DLYE 872 (886)
Q Consensus 794 F~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~-EILe 872 (886)
|.+.+..++...+.... +.++. ..+..+.+||.+||+.||.+||++. ++++
T Consensus 196 f~~~~~~~~~~~i~~~~-~~~~~---------------------------~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 196 FHGHDEEELFQSIRMDN-PCYPR---------------------------WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHhCC-CCCCc---------------------------cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 99888777766654332 11111 1244689999999999999999996 7776
Q ss_pred H
Q 002738 873 M 873 (886)
Q Consensus 873 h 873 (886)
|
T Consensus 248 h 248 (316)
T cd05619 248 H 248 (316)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=328.24 Aligned_cols=282 Identities=21% Similarity=0.246 Sum_probs=190.4
Q ss_pred eeeecccCceEEEEEEE----CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCC
Q 002738 556 CDEAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 631 (886)
Q Consensus 556 ~k~LG~G~fG~VY~A~~----~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~ 631 (886)
.++||+|+||.||+|+. .+..+|+|..... ... ..+.+|+.+|++++||||+++++++....
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 71 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GIS--------MSACREIALLRELKHPNVISLQKVFLSHA---- 71 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCc--------HHHHHHHHHHHhcCCCCCcceeeeEecCC----
Confidence 46899999999999985 3456888875322 111 12378999999999999999999986433
Q ss_pred CCCCCCcccceEEEEEeccCCCCHHHHHHHHhc----cCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 632 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE----TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 632 ~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~----~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
....++||||+. ++|..++..... .....+++..++.++.||+.||.|||++||+||||||+|||+.
T Consensus 72 --------~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~ 142 (317)
T cd07868 72 --------DRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVM 142 (317)
T ss_pred --------CcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEe
Confidence 125799999996 699998864211 1123588999999999999999999999999999999999996
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.... ..+.+||+|||++......... ........||+.|+|||++.+ ...++.++|||||||++|||
T Consensus 143 ~~~~---~~~~~kl~DfG~a~~~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~el 209 (317)
T cd07868 143 GEGP---ERGRVKIADMGFARLFNSPLKP-------LADLDPVVVTFWYRAPELLLG---ARHYTKAIDIWAIGCIFAEL 209 (317)
T ss_pred cCCC---CcCcEEEeecCceeccCCCCcc-------ccccCCccccccccCCHHHcC---CCCcCchhhHHHHHHHHHHH
Confidence 4321 2357999999999865432211 011233568999999999875 24578999999999999999
Q ss_pred HhCCCCCCCCCH---------HHHHHHHHcCCCCCchhHHhhhcccccc-----cccc-----cCCCCCCchhhhhhHHH
Q 002738 788 LTLQVPYMGLSE---------LEIHDLIQMGKRPRLTDELEALGSCHEH-----EVAQ-----SGSGFEKPEAELETLSF 848 (886)
Q Consensus 788 LTG~~PF~g~s~---------~el~~~I~~~~rp~l~~~l~~~~~~~~~-----~~~~-----~~~~~~~~~~~~~~s~~ 848 (886)
++|++||.+... ......+...........+......... .+.. .................
T Consensus 210 ~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (317)
T cd07868 210 LTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 289 (317)
T ss_pred HhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChH
Confidence 999999965432 1122222221111111111111000000 0000 00000000001112346
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 002738 849 LVDVFRRCTEENPTERPTAGDLYEM 873 (886)
Q Consensus 849 L~dLL~rCL~~DP~kRPSA~EILeh 873 (886)
+.+||.+||++||.+|||++|+++|
T Consensus 290 ~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 290 AFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HHHHHHHHhccCcccCCCHHHHhcC
Confidence 8899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=318.22 Aligned_cols=256 Identities=25% Similarity=0.352 Sum_probs=202.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~~-~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
++.++|++.++||+|+||.||+|++.+ ..+|+|+..... .. .+ .+.+|+.++++++||||+++++.+...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~--~~---~~----~~~~E~~~l~~l~~~~i~~~~~~~~~~ 73 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MS---PE----AFLQEAQVMKKLRHEKLVQLYAVVSEE 73 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc--cC---HH----HHHHHHHHHHhCCCCCcceEEEEECCC
Confidence 345679999999999999999998733 468888754211 11 12 348899999999999999999886432
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
..++||||+++++|.+++.. .....+++..+..++.|++.||+|||+.+|+||||||+||++
T Consensus 74 ---------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill 135 (262)
T cd05071 74 ---------------PIYIVTEYMSKGSLLDFLKG---EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV 135 (262)
T ss_pred ---------------CcEEEEEcCCCCcHHHHHhh---ccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE
Confidence 24999999999999999975 122457899999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +.++|+|||.+..+...... ......++..|+|||++.+ ..++.++|||||||++||
T Consensus 136 ~~~-------~~~~L~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~----~~~~~~~DvwslG~~l~e 195 (262)
T cd05071 136 GEN-------LVCKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTE 195 (262)
T ss_pred cCC-------CcEEeccCCceeeccccccc---------cccCCcccceecCHhHhcc----CCCCchhhHHHHHHHHHH
Confidence 876 46999999999765432211 0112346778999999875 568899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 787 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 787 LLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
|+| |..||.+....++...+........+ ...+..+.+|+.+||+.+|.+||
T Consensus 196 llt~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~~p~~Rp 248 (262)
T cd05071 196 LTTKGRVPYPGMVNREVLDQVERGYRMPCP---------------------------PECPESLHDLMCQCWRKEPEERP 248 (262)
T ss_pred HHcCCCCCCCCCChHHHHHHHhcCCCCCCc---------------------------cccCHHHHHHHHHHccCCcccCC
Confidence 999 89999888776666655443221111 12345789999999999999999
Q ss_pred CHHHHHHHHHhh
Q 002738 866 TAGDLYEMFVAR 877 (886)
Q Consensus 866 SA~EILehLe~l 877 (886)
++.++++.|+..
T Consensus 249 ~~~~~~~~l~~~ 260 (262)
T cd05071 249 TFEYLQAFLEDY 260 (262)
T ss_pred CHHHHHHHHHHh
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=348.93 Aligned_cols=280 Identities=20% Similarity=0.224 Sum_probs=198.0
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC------CCCcceeee
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR------HSCIVEMYG 621 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~------HPNIVrl~g 621 (886)
-++|++.++||+|+||.||+|.+ .+..||||++.... .... .+..|+.++..++ |++|+++++
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-----~~~~----~~~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-----KYTR----DAKIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-----hhHH----HHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence 47899999999999999999987 56789999864211 1111 2255666666665 456888888
Q ss_pred eEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHh-CCccccCCC
Q 002738 622 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIK 700 (886)
Q Consensus 622 ~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs-~gIVHRDLK 700 (886)
++.... .+.+||||++ |++|.+++.. ...+++..+..|+.||+.||.|||+ .||||||||
T Consensus 199 ~~~~~~-------------~~~~iv~~~~-g~~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlK 259 (467)
T PTZ00284 199 YFQNET-------------GHMCIVMPKY-GPCLLDWIMK-----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLK 259 (467)
T ss_pred EEEcCC-------------ceEEEEEecc-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCC
Confidence 887543 2479999998 6799998875 3468999999999999999999998 599999999
Q ss_pred CCCEEEeccccCC---------CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCC
Q 002738 701 SENILIDLERKKA---------DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 771 (886)
Q Consensus 701 PsNILLd~d~~~~---------~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~ 771 (886)
|+|||++.++... .....+||+|||.+...... ....+||+.|+|||++.+ ..+
T Consensus 260 P~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-------------~~~~~gt~~Y~APE~~~~----~~~ 322 (467)
T PTZ00284 260 PENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-------------RTAIVSTRHYRSPEVVLG----LGW 322 (467)
T ss_pred HHHEEEecCCcccccccccccCCCCceEEECCCCccccCccc-------------cccccCCccccCcHHhhc----CCC
Confidence 9999998763210 11236999999987532211 133579999999999986 678
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccc-ccccc----CCCC----------
Q 002738 772 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH-EVAQS----GSGF---------- 836 (886)
Q Consensus 772 s~KSDIWSLGVILyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~-~~~~~----~~~~---------- 836 (886)
+.++|||||||+||||++|++||.+.+..+....+..... .++..+...+..... .+... ....
T Consensus 323 ~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (467)
T PTZ00284 323 MYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLG-RLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIAR 401 (467)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC-CCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhc
Confidence 9999999999999999999999998877766655544322 122222211000000 00000 0000
Q ss_pred CCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002738 837 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 875 (886)
Q Consensus 837 ~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EILehLe 875 (886)
..+.......+.+.+||.+||++||.+|||+.|+|+|-.
T Consensus 402 ~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 440 (467)
T PTZ00284 402 ARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440 (467)
T ss_pred ccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence 000001112456889999999999999999999999854
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=314.09 Aligned_cols=252 Identities=27% Similarity=0.432 Sum_probs=202.3
Q ss_pred eeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 631 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~~-----~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~ 631 (886)
+.||+|+||.||+|.+. +..+++|+..... ... ..+ .+.+|+.++..++|+||+++++++....
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~-~~~----~~~~e~~~l~~~~~~~i~~~~~~~~~~~---- 69 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA--SEE-ERK----DFLKEARVMKKLGHPNVVRLLGVCTEEE---- 69 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeecccc--chh-HHH----HHHHHHHHHhhcCCCChheeeeeecCCC----
Confidence 47999999999999975 6788888864332 111 233 3489999999999999999999988644
Q ss_pred CCCCCCcccceEEEEEeccCCCCHHHHHHHHhcc----CCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 632 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET----GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 632 ~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~----~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
..++||||+++++|.+++...... ....+++..++.++.||+.||+|||++||+||||||+||+++
T Consensus 70 ----------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~ 139 (262)
T cd00192 70 ----------PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG 139 (262)
T ss_pred ----------ceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEEC
Confidence 369999999999999999862111 025689999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ +.+||+|||.+......... .......+++.|+|||.+.. ..++.++||||||+++|+|
T Consensus 140 ~~-------~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l 200 (262)
T cd00192 140 ED-------LVVKISDFGLSRDVYDDDYY--------RKKTGGKLPIRWMAPESLKD----GIFTSKSDVWSFGVLLWEI 200 (262)
T ss_pred CC-------CcEEEccccccccccccccc--------ccccCCCcCccccCHHHhcc----CCcchhhccHHHHHHHHHH
Confidence 87 46999999999876543210 11123457889999999876 4688999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 788 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 788 LT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
++ |..||......++...+..+.....+. ..+..+.+++.+||..+|.+|||
T Consensus 201 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rps 253 (262)
T cd00192 201 FTLGATPYPGLSNEEVLEYLRKGYRLPKPE---------------------------YCPDELYELMLSCWQLDPEDRPT 253 (262)
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cCChHHHHHHHHHccCCcccCcC
Confidence 99 699999888887777776543322221 12457999999999999999999
Q ss_pred HHHHHHHHH
Q 002738 867 AGDLYEMFV 875 (886)
Q Consensus 867 A~EILehLe 875 (886)
+.+++++|+
T Consensus 254 ~~~l~~~l~ 262 (262)
T cd00192 254 FSELVERLE 262 (262)
T ss_pred HHHHHHhhC
Confidence 999999884
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=327.13 Aligned_cols=250 Identities=21% Similarity=0.279 Sum_probs=190.0
Q ss_pred ecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCC
Q 002738 559 AGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 636 (886)
Q Consensus 559 LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~~~~ 636 (886)
||+|+||+||++.+ .+..+|+|+....... ..... +.+..|+.+++.++||||+++++++....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~----~~~~~E~~il~~l~~~~i~~~~~~~~~~~--------- 66 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-KRKGY----EGAMVEKRILAKVHSRFIVSLAYAFQTKT--------- 66 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-hhHHH----HHHHHHHHHHHhCCCCcEeeeeEEEcCCC---------
Confidence 79999999999987 5668899986432211 11111 33478999999999999999999887554
Q ss_pred CcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCCCC
Q 002738 637 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 716 (886)
Q Consensus 637 ~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~~ 716 (886)
..++||||+++|+|..++..... ....+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 67 -----~~~lv~e~~~~g~L~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~------- 133 (280)
T cd05608 67 -----DLCLVMTIMNGGDLRYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDND------- 133 (280)
T ss_pred -----eEEEEEeCCCCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-------
Confidence 36999999999999998864222 23568999999999999999999999999999999999999876
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 002738 717 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 796 (886)
Q Consensus 717 ~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF~g 796 (886)
+.++|+|||++..+..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 134 ~~~~l~dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~g~~pf~~ 199 (280)
T cd05608 134 GNVRISDLGLAVELKDGQS----------KTKGYAGTPGFMAPELLQG----EEYDFSVDYFALGVTLYEMIAARGPFRA 199 (280)
T ss_pred CCEEEeeCccceecCCCCc----------cccccCCCcCccCHHHhcC----CCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 4699999999976543211 1123468999999999986 6778999999999999999999999976
Q ss_pred CCHHHHHHHHHcC-CCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHHH
Q 002738 797 LSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGDL 870 (886)
Q Consensus 797 ~s~~el~~~I~~~-~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP-----SA~EI 870 (886)
.........+... ..... ......+..+.+|+.+||+.||.+|| +++++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~ 254 (280)
T cd05608 200 RGEKVENKELKQRILNDSV-------------------------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGL 254 (280)
T ss_pred CCcchhHHHHHHhhcccCC-------------------------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHH
Confidence 5332111111111 00000 00112356789999999999999999 88999
Q ss_pred HHHH
Q 002738 871 YEMF 874 (886)
Q Consensus 871 LehL 874 (886)
++|-
T Consensus 255 l~h~ 258 (280)
T cd05608 255 RTHP 258 (280)
T ss_pred hcCh
Confidence 9883
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=318.74 Aligned_cols=259 Identities=24% Similarity=0.332 Sum_probs=189.8
Q ss_pred eeecccCceEEEEEEE-C---CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKF-G---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 632 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~-~---~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~ 632 (886)
+.||+|+||.||+|.. . ...+++|... . ........ .+.+|+.+++.++||||+++++.+.....
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~--~-~~~~~~~~----~~~~e~~~~~~l~h~nii~~~~~~~~~~~---- 69 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELR--A-SATPDEQL----LFLQEVQPYRELNHPNVLQCLGQCIESIP---- 69 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecC--c-cCChHHHH----HHHHHHHHHHhCCCCCcceEEEEECCCCc----
Confidence 4699999999999975 2 2345666532 1 11222222 34889999999999999999999876543
Q ss_pred CCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccC
Q 002738 633 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 712 (886)
Q Consensus 633 ~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~ 712 (886)
.++||||+++|+|.+++..........+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 ----------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~--- 136 (269)
T cd05042 70 ----------YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD--- 136 (269)
T ss_pred ----------eEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCC---
Confidence 6999999999999999986332222345678889999999999999999999999999999999887
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc---CCCCCCchhhHHHHHHHHHHHHh
Q 002738 713 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH---KPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 713 ~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~---~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.+||+|||++......... .......+++.|+|||++.... ....++.++|||||||++|||++
T Consensus 137 ----~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~ 204 (269)
T cd05042 137 ----LSVKIGDYGLALEQYPEDYY--------ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204 (269)
T ss_pred ----CcEEEeccccccccccchhe--------eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHh
Confidence 46999999998654321110 0012234677899999986311 12456889999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 002738 790 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868 (886)
Q Consensus 790 -G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~ 868 (886)
|..||......+....+.......++. +......+..+.+++..|| .||++|||++
T Consensus 205 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~ 261 (269)
T cd05042 205 AADQPYPDLSDEQVLKQVVREQDIKLPK----------------------PQLDLKYSDRWYEVMQFCW-LDPETRPTAE 261 (269)
T ss_pred CCCCCCCcCCHHHHHHHHhhccCccCCC----------------------CcccccCCHHHHHHHHHHh-cCcccccCHH
Confidence 889998877666555544433222221 1111223556788999999 5999999999
Q ss_pred HHHHHH
Q 002738 869 DLYEMF 874 (886)
Q Consensus 869 EILehL 874 (886)
+|++.|
T Consensus 262 ~v~~~l 267 (269)
T cd05042 262 EVHELL 267 (269)
T ss_pred HHHHHh
Confidence 999987
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=318.07 Aligned_cols=255 Identities=24% Similarity=0.389 Sum_probs=204.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~-~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
+.-++|++.++||+|+||.||+|.. .+..+|+|...... .. .. .+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~--~~---~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~ 73 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS--MS---PE----AFLAEANLMKQLQHPRLVRLYAVVTQE 73 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC--Cc---HH----HHHHHHHHHHhcCCcCeeeEEEEEccC
Confidence 3456899999999999999999987 55789999864221 11 12 348899999999999999999886432
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
..++||||+.+++|.+++.. .....+++..+..++.|++.||+|||+.||+||||||+||++
T Consensus 74 ---------------~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i 135 (260)
T cd05067 74 ---------------PIYIITEYMENGSLVDFLKT---PEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV 135 (260)
T ss_pred ---------------CcEEEEEcCCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE
Confidence 25999999999999999875 233568899999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +.++|+|||++......... ......++..|+|||++.. ..++.++||||||+++||
T Consensus 136 ~~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~pe~~~~----~~~~~~~Di~slG~~l~e 195 (260)
T cd05067 136 SET-------LCCKIADFGLARLIEDNEYT---------AREGAKFPIKWTAPEAINY----GTFTIKSDVWSFGILLTE 195 (260)
T ss_pred cCC-------CCEEEccCcceeecCCCCcc---------cccCCcccccccCHHHhcc----CCcCcccchHHHHHHHHH
Confidence 877 56999999999765422111 0112346778999999875 567889999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 787 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 787 LLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
|++ |+.||.+.+..+....+........+ ...+..+.+|+.+||..+|++||
T Consensus 196 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp 248 (260)
T cd05067 196 IVTYGRIPYPGMTNPEVIQNLERGYRMPRP---------------------------DNCPEELYELMRLCWKEKPEERP 248 (260)
T ss_pred HHhCCCCCCCCCChHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHccCChhhCC
Confidence 999 99999888877776666544332211 11245799999999999999999
Q ss_pred CHHHHHHHHHh
Q 002738 866 TAGDLYEMFVA 876 (886)
Q Consensus 866 SA~EILehLe~ 876 (886)
+++++++.|+.
T Consensus 249 ~~~~l~~~l~~ 259 (260)
T cd05067 249 TFEYLRSVLED 259 (260)
T ss_pred CHHHHHHHhhc
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=323.31 Aligned_cols=268 Identities=21% Similarity=0.306 Sum_probs=203.2
Q ss_pred CCCCceeeeeecccCceEEEEEEECC------------------eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhh
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKFGS------------------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGA 610 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~~~------------------~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~ 610 (886)
...+|++.+.||+|+||.||+|.... ..+|+|+..... .....+ .+.+|+.++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~----~~~~e~~~l~~ 75 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNARE----DFLKEVKILSR 75 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc---CHHHHH----HHHHHHHHHHh
Confidence 45689999999999999999998632 347788754321 122223 34899999999
Q ss_pred CCCCCcceeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhcc------CCCcCCHHHHHHHHHHHHH
Q 002738 611 LRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------GEKHVSVKLALFIAQDVAA 684 (886)
Q Consensus 611 L~HPNIVrl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~------~~~~Ls~~~i~~Ia~QIa~ 684 (886)
++||||+++++++.... ..++||||+++++|.+++...... ....+++..++.++.||+.
T Consensus 76 l~~~~i~~~~~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 141 (296)
T cd05051 76 LSDPNIARLLGVCTVDP--------------PLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIAS 141 (296)
T ss_pred cCCCCEeEEEEEEecCC--------------CcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHH
Confidence 99999999999988654 359999999999999999863211 1226899999999999999
Q ss_pred HHHHHHhCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhc
Q 002738 685 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 764 (886)
Q Consensus 685 AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~ 764 (886)
||+|||++||+||||||+|||++.+ +.++|+|||++......... .......+++.|+|||++.+
T Consensus 142 al~~LH~~~i~H~dlkp~Nili~~~-------~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~ 206 (296)
T cd05051 142 GMRYLESLNFVHRDLATRNCLVGKN-------YTIKIADFGMSRNLYSSDYY--------RVQGRAPLPIRWMAWESVLL 206 (296)
T ss_pred HHHHHHHcCccccccchhceeecCC-------CceEEccccceeecccCcce--------eecCcCCCCceecCHHHhhc
Confidence 9999999999999999999999877 56999999998765432211 01123346789999999876
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhh
Q 002738 765 MHKPNLYGLEVDIWSYGCLLLELLT--LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 842 (886)
Q Consensus 765 ~~~~~~~s~KSDIWSLGVILyELLT--G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 842 (886)
..++.++|||||||++|||++ +..||...+..++...+.......... . .....
T Consensus 207 ----~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~----------~----------~~~~~ 262 (296)
T cd05051 207 ----GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQ----------I----------YLPRP 262 (296)
T ss_pred ----CCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcccccccc----------c----------cCCCc
Confidence 568899999999999999998 788998777666655544321110000 0 00001
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002738 843 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 876 (886)
Q Consensus 843 ~~~s~~L~dLL~rCL~~DP~kRPSA~EILehLe~ 876 (886)
...+..+.+|+.+||+.||.+|||+.+|++.|+.
T Consensus 263 ~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 263 PNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred cCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1234679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=314.56 Aligned_cols=262 Identities=26% Similarity=0.408 Sum_probs=205.5
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
+++|++.+.||+|+||.||+|.. .+..+++|.+...... .....+ .+.+|+.++++++|+||+++++++....
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~----~~~~ei~~l~~~~~~~i~~~~~~~~~~~ 75 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-DAKARQ----DCLKEIDLLKQLDHPNVIKYLASFIENN 75 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccccc-chhhHH----HHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 36899999999999999999997 5778999986532221 112222 3489999999999999999999988654
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
..++||||+++++|..++..... ....+++..++.++.||+.||.|||+.||+||||||+||+++
T Consensus 76 --------------~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~ 140 (267)
T cd08224 76 --------------ELNIVLELADAGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT 140 (267)
T ss_pred --------------eEEEEEecCCCCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEEC
Confidence 36999999999999999975322 235688999999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ +.++|+|||++......... .....+++.|+|||++.+ ..++.++|||||||++|+|
T Consensus 141 ~~-------~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~y~apE~~~~----~~~~~~~Di~slG~il~~l 199 (267)
T cd08224 141 AT-------GVVKLGDLGLGRFFSSKTTA----------AHSLVGTPYYMSPERIHE----NGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred CC-------CcEEEeccceeeeccCCCcc----------cceecCCccccCHHHhcc----CCCCchhcHHHHHHHHHHH
Confidence 77 45999999998765432111 122358889999999875 5678899999999999999
Q ss_pred HhCCCCCCCCC--HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 788 LTLQVPYMGLS--ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 788 LTG~~PF~g~s--~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
++|+.||.... ...+...+..+..+..+. ...+..+.++|.+||..+|.+||
T Consensus 200 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~i~~cl~~~p~~Rp 253 (267)
T cd08224 200 AALQSPFYGDKMNLYSLCKKIEKCDYPPLPA--------------------------DHYSEELRDLVSRCINPDPEKRP 253 (267)
T ss_pred HHCCCCcccCCccHHHHHhhhhcCCCCCCCh--------------------------hhcCHHHHHHHHHHcCCCcccCC
Confidence 99999996543 223333333332222211 12345789999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 002738 866 TAGDLYEMFVART 878 (886)
Q Consensus 866 SA~EILehLe~l~ 878 (886)
|+.+|++.|+.+.
T Consensus 254 ~~~~il~~~~~~~ 266 (267)
T cd08224 254 DISYVLQVAKEMH 266 (267)
T ss_pred CHHHHHHHHHHhc
Confidence 9999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=352.16 Aligned_cols=275 Identities=23% Similarity=0.264 Sum_probs=214.2
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-C-----CCcceeeeeE
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-H-----SCIVEMYGHK 623 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-H-----PNIVrl~g~~ 623 (886)
+|++.+.||+|+||.|.+|.+ +++.||+||++-+ +.|..+...|+.+|..|+ | -|||+++++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---------k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---------KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---------hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 899999999999999999997 5788999997533 223334478999999997 4 3899999999
Q ss_pred ecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 002738 624 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703 (886)
Q Consensus 624 ~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsN 703 (886)
...+ ++|||+|.+. .+|+++|+. +....++...++.|+.||+.||.+||..||||+||||+|
T Consensus 258 ~fr~--------------HlciVfELL~-~NLYellK~---n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPEN 319 (586)
T KOG0667|consen 258 YFRN--------------HLCIVFELLS-TNLYELLKN---NKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPEN 319 (586)
T ss_pred cccc--------------ceeeeehhhh-hhHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhh
Confidence 8655 5799999996 799999997 444569999999999999999999999999999999999
Q ss_pred EEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 002738 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783 (886)
Q Consensus 704 ILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVI 783 (886)
|||..... ..|||+|||.|........ ..+.+..|+|||++.| .+|+.+.||||||||
T Consensus 320 ILL~~~~r-----~~vKVIDFGSSc~~~q~vy-------------tYiQSRfYRAPEVILG----lpY~~~IDmWSLGCI 377 (586)
T KOG0667|consen 320 ILLKDPKR-----SRIKVIDFGSSCFESQRVY-------------TYIQSRFYRAPEVILG----LPYDTAIDMWSLGCI 377 (586)
T ss_pred eeeccCCc-----CceeEEecccccccCCcce-------------eeeeccccccchhhcc----CCCCCccceeehhhh
Confidence 99987643 6899999999987655332 3467899999999998 789999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccc-----------c-----------------CCC
Q 002738 784 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ-----------S-----------------GSG 835 (886)
Q Consensus 784 LyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~-----------~-----------------~~~ 835 (886)
++||++|.+.|+|.+..+.+..|......+-+..+... ......+.. . ...
T Consensus 378 lAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~-~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~ 456 (586)
T KOG0667|consen 378 LAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA-KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLE 456 (586)
T ss_pred HHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc-cccceehhccCCceeeeeeecccccccchhhhhhhhhhccc
Confidence 99999999999999999888887765332222222211 000000000 0 000
Q ss_pred --CC------CchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002738 836 --FE------KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 876 (886)
Q Consensus 836 --~~------~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EILehLe~ 876 (886)
.+ ...........+.+||.+||.+||.+|+|+.++|+|-.-
T Consensus 457 ~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl 505 (586)
T KOG0667|consen 457 RRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFL 505 (586)
T ss_pred ccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccc
Confidence 00 001111345678999999999999999999999999543
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=315.98 Aligned_cols=254 Identities=23% Similarity=0.353 Sum_probs=201.1
Q ss_pred CCCCceeeeeecccCceEEEEEEECC-eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~~~-~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
..++|.+.+.||+|+||.||+|.+.+ ..+++|+.... .. . .+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~--~~---~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 73 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG--TM---M----PEAFLQEAQIMKKLRHDKLVPLYAVVSEE- 73 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC--Cc---c----HHHHHHHHHHHHhCCCCCeeeEEEEEcCC-
Confidence 34679999999999999999998744 46788874321 11 1 12348899999999999999999887432
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
..++||||+.+++|.+++.. .....+++..+..++.||+.||.|||+.||+|+||||+|||++
T Consensus 74 --------------~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~ 136 (260)
T cd05069 74 --------------PIYIVTEFMGKGSLLDFLKE---GDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG 136 (260)
T ss_pred --------------CcEEEEEcCCCCCHHHHHhh---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc
Confidence 25899999999999999975 2234578999999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ +.++|+|||++......... ......++..|+|||++.+ ..++.++||||||+++|||
T Consensus 137 ~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~Pe~~~~----~~~~~~~Di~slG~~l~el 196 (260)
T cd05069 137 DN-------LVCKIADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTEL 196 (260)
T ss_pred CC-------CeEEECCCccceEccCCccc---------ccCCCccchhhCCHHHhcc----CCcChHHHHHHHHHHHHHH
Confidence 77 56999999999765432211 0112246778999999875 5678999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 788 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 788 LT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
++ |..||.+....+....+.....+..+ ...+..+.+|+.+||..||.+||+
T Consensus 197 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~ 249 (260)
T cd05069 197 VTKGRVPYPGMVNREVLEQVERGYRMPCP---------------------------QGCPESLHELMKLCWKKDPDERPT 249 (260)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------cccCHHHHHHHHHHccCCcccCcC
Confidence 99 99999888777766666554322211 112457999999999999999999
Q ss_pred HHHHHHHHHh
Q 002738 867 AGDLYEMFVA 876 (886)
Q Consensus 867 A~EILehLe~ 876 (886)
+++|++.|+.
T Consensus 250 ~~~i~~~l~~ 259 (260)
T cd05069 250 FEYIQSFLED 259 (260)
T ss_pred HHHHHHHHhc
Confidence 9999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=350.84 Aligned_cols=256 Identities=30% Similarity=0.430 Sum_probs=215.2
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCC-ChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~-~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
..|.-++.||+|+||.||-|++ +...||+|.. ..... ..+. .+.+++||..|.+|+|||+|.+-|+|..+.
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKM--sySGKQs~EK----WqDIlKEVrFL~~l~HPntieYkgCyLre~ 99 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKM--SYSGKQSNEK----WQDILKEVRFLRQLRHPNTIEYKGCYLREH 99 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeec--cccccccHHH----HHHHHHHHHHHHhccCCCcccccceeeccc
Confidence 3467789999999999999997 4555666653 32221 2222 245599999999999999999999998554
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
+.|||||||- |+-.+++.-. .+++.+.++..|..+.+.||+|||+++.||||||..|||++
T Consensus 100 --------------TaWLVMEYCl-GSAsDlleVh----kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs 160 (948)
T KOG0577|consen 100 --------------TAWLVMEYCL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS 160 (948)
T ss_pred --------------hHHHHHHHHh-ccHHHHHHHH----hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec
Confidence 4799999997 6888888752 35688999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.. +.|||+|||.|....+ .+.++|||.|||||++..+. .+.|+-|+||||||++..||
T Consensus 161 e~-------g~VKLaDFGSAsi~~P--------------AnsFvGTPywMAPEVILAMD-EGqYdgkvDvWSLGITCIEL 218 (948)
T KOG0577|consen 161 EP-------GLVKLADFGSASIMAP--------------ANSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIEL 218 (948)
T ss_pred CC-------CeeeeccccchhhcCc--------------hhcccCCccccchhHheecc-ccccCCccceeeccchhhhh
Confidence 87 6799999999876543 35678999999999998754 57899999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 788 LTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
...++|+.+++.+..++.|.++..|.+.. .+.++.+..|+..||+.-|.+|||.
T Consensus 219 AERkPPlFnMNAMSALYHIAQNesPtLqs--------------------------~eWS~~F~~Fvd~CLqKipqeRpts 272 (948)
T KOG0577|consen 219 AERKPPLFNMNAMSALYHIAQNESPTLQS--------------------------NEWSDYFRNFVDSCLQKIPQERPTS 272 (948)
T ss_pred hhcCCCccCchHHHHHHHHHhcCCCCCCC--------------------------chhHHHHHHHHHHHHhhCcccCCcH
Confidence 99999999999999999999988777652 2236789999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 002738 868 GDLYEMFVARTS 879 (886)
Q Consensus 868 ~EILehLe~l~s 879 (886)
++++.|-.-...
T Consensus 273 e~ll~H~fv~R~ 284 (948)
T KOG0577|consen 273 EELLKHRFVLRE 284 (948)
T ss_pred HHHhhcchhccC
Confidence 999999765543
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=321.77 Aligned_cols=277 Identities=21% Similarity=0.257 Sum_probs=200.1
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
+|++.+.||+|+||.||+|+. .+..+|+|+....... ... ...+.+|+.++++++||||+++++++..+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 72 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE--EGV----PSTAIREISLLKELQHPNIVCLQDVLMQES-- 72 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc--CCc----hHHHHHHHHHHHhcCCCCEeeeEEEEeeCC--
Confidence 588999999999999999987 5678999986543211 111 123478999999999999999999988654
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..++||||++ ++|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 73 ------------~~~~v~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~ 137 (285)
T cd07861 73 ------------RLYLIFEFLS-MDLKKYLDSLP--KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNK 137 (285)
T ss_pred ------------eEEEEEecCC-CCHHHHHhcCC--CCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCC
Confidence 3699999997 69999887521 22568999999999999999999999999999999999999877
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.++|+|||++......... .....+++.|+|||++.+ ...++.++|||||||++|+|+|
T Consensus 138 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~~l~t 197 (285)
T cd07861 138 -------GVIKLADFGLARAFGIPVRV----------YTHEVVTLWYRAPEVLLG---SPRYSTPVDIWSIGTIFAEMAT 197 (285)
T ss_pred -------CcEEECcccceeecCCCccc----------ccCCcccccccChHHhcC---CCCcCcHHHHHHHHHHHHHHHH
Confidence 46999999998754322111 122357899999999865 2456889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCC---CCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF---EKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
|+.||.+.........+...........+....... ........+ .........++++.+||.+||..||.+|||
T Consensus 198 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt 275 (285)
T cd07861 198 KKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP--DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS 275 (285)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH--HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCC
Confidence 999998876654443332221111111111100000 000000000 001111234678899999999999999999
Q ss_pred HHHHHHH
Q 002738 867 AGDLYEM 873 (886)
Q Consensus 867 A~EILeh 873 (886)
+.+|++|
T Consensus 276 ~~~ll~~ 282 (285)
T cd07861 276 AKKALNH 282 (285)
T ss_pred HHHHhcC
Confidence 9999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=321.15 Aligned_cols=268 Identities=22% Similarity=0.356 Sum_probs=206.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceee
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 620 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~-------~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~ 620 (886)
...++|++.+.||+|+||.||+|... +..+|+|..... . ...... .+.+|+.+++.++||||++++
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~-~~~~~~----~~~~e~~~l~~l~~~~i~~~~ 75 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--A-SLRERI----EFLNEASVMKGFTCHHVVRLL 75 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc--C-CHHHHH----HHHHHHHHHHhCCCCCeeeEE
Confidence 34568999999999999999999753 336788874321 1 112222 348899999999999999999
Q ss_pred eeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhcc-----CCCcCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 002738 621 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----GEKHVSVKLALFIAQDVAAALVELHSKHIM 695 (886)
Q Consensus 621 g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~-----~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIV 695 (886)
+++.... ..++||||+++|+|.+++...... ....++...+..++.||+.||.|||+++|+
T Consensus 76 ~~~~~~~--------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~ 141 (288)
T cd05061 76 GVVSKGQ--------------PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFV 141 (288)
T ss_pred EEEcCCC--------------CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Confidence 9987554 359999999999999999763221 123456778899999999999999999999
Q ss_pred ccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchh
Q 002738 696 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 775 (886)
Q Consensus 696 HRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KS 775 (886)
||||||+|||++.+ +.++|+|||+++......... ......++..|+|||++.+ ..++.++
T Consensus 142 H~dikp~nili~~~-------~~~~L~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~~pE~~~~----~~~~~~~ 202 (288)
T cd05061 142 HRDLAARNCMVAHD-------FTVKIGDFGMTRDIYETDYYR--------KGGKGLLPVRWMAPESLKD----GVFTTSS 202 (288)
T ss_pred CCCCChheEEEcCC-------CcEEECcCCcccccccccccc--------ccCCCcccccccCHHHhcc----CCCChHh
Confidence 99999999999876 469999999987653322110 0112245678999999876 6678999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHH
Q 002738 776 DIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 854 (886)
Q Consensus 776 DIWSLGVILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~ 854 (886)
|||||||++|||++ |..||.+....++...+..+..+..+. ..++.+.+++.
T Consensus 203 DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~ 255 (288)
T cd05061 203 DMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD---------------------------NCPERVTDLMR 255 (288)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHH
Confidence 99999999999998 789998887777666665443322211 12357999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 002738 855 RCTEENPTERPTAGDLYEMFVARTSSSI 882 (886)
Q Consensus 855 rCL~~DP~kRPSA~EILehLe~l~sss~ 882 (886)
+||+.||.+|||+.++++.|++...++-
T Consensus 256 ~~l~~~p~~Rps~~~ll~~l~~~~~~~~ 283 (288)
T cd05061 256 MCWQFNPKMRPTFLEIVNLLKDDLHPSF 283 (288)
T ss_pred HHcCCChhHCcCHHHHHHHHHhhcCCCC
Confidence 9999999999999999999998765543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=317.34 Aligned_cols=249 Identities=26% Similarity=0.401 Sum_probs=202.9
Q ss_pred CCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
.+.+|++.+.||+|+||.||++...+..+|+|+..... ... .+.+|+.++++++||||+++++++....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~------~~~----~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 72 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV------TAQ----AFLEETAVMTKLHHKNLVRLLGVILHNG- 72 (254)
T ss_pred cHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc------hHH----HHHHHHHHHHhCCCCCcCeEEEEEcCCC-
Confidence 46789999999999999999999988999999864321 112 3488999999999999999999886432
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
.++||||+++++|.+++.. .....+++..++.++.|++.||.|||++|++||||||+|||++.
T Consensus 73 --------------~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~ 135 (254)
T cd05083 73 --------------LYIVMELMSKGNLVNFLRT---RGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSE 135 (254)
T ss_pred --------------cEEEEECCCCCCHHHHHHh---cCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC
Confidence 4899999999999999976 22345889999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.+||+|||++....... .....+..|+|||++.+ ..++.++|||||||++|||+
T Consensus 136 ~-------~~~kl~Dfg~~~~~~~~~-------------~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~~l~el~ 191 (254)
T cd05083 136 D-------GVAKVSDFGLARVGSMGV-------------DNSKLPVKWTAPEALKH----KKFSSKSDVWSYGVLLWEVF 191 (254)
T ss_pred C-------CcEEECCCccceeccccC-------------CCCCCCceecCHHHhcc----CCcCchhhHHHHHHHHHHHH
Confidence 6 469999999987543211 11234568999999875 56889999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 789 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 789 T-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
+ |+.||...+.......+..+.++..+ ...+..+.+|+.+||+.+|.+||++
T Consensus 192 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~ 244 (254)
T cd05083 192 SYGRAPYPKMSLKEVKECVEKGYRMEPP---------------------------EGCPADVYVLMTSCWETEPKKRPSF 244 (254)
T ss_pred hCCCCCCccCCHHHHHHHHhCCCCCCCC---------------------------CcCCHHHHHHHHHHcCCChhhCcCH
Confidence 7 99999888777766666544322111 1124578999999999999999999
Q ss_pred HHHHHHHHh
Q 002738 868 GDLYEMFVA 876 (886)
Q Consensus 868 ~EILehLe~ 876 (886)
.+|++.|+.
T Consensus 245 ~~l~~~l~~ 253 (254)
T cd05083 245 HKLREKLEK 253 (254)
T ss_pred HHHHHHHcc
Confidence 999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=341.83 Aligned_cols=262 Identities=21% Similarity=0.244 Sum_probs=201.9
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|++.+.||+|+||.||+|+. .+..+|+|++...... .......+.+|+.++..++||||+++++.+....
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~- 74 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-----EKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR- 74 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-----hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-
Confidence 4689999999999999999987 5678999987532111 1112234588999999999999999999988655
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..||||||++||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~ 136 (360)
T cd05627 75 -------------NLYLIMEFLPGGDMMTLLMK-----KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDA 136 (360)
T ss_pred -------------EEEEEEeCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC
Confidence 46999999999999999975 356899999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCccccccccccccc-------------------------ccCCCCCCCcccCCCcccchhhhh
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCI-------------------------AHRGIPAPDVCVGTPRWMAPEVLR 763 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~-------------------------~~~~~~~~~~~vGT~~YmAPEvL~ 763 (886)
+ +.+||+|||++..+......... ...........+||+.|+|||++.
T Consensus 137 ~-------~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 209 (360)
T cd05627 137 K-------GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM 209 (360)
T ss_pred C-------CCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc
Confidence 6 56999999998755322110000 000000112347999999999997
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhcccccccccccCCCCCCchhh
Q 002738 764 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 842 (886)
Q Consensus 764 ~~~~~~~~s~KSDIWSLGVILyELLTG~~PF~g~s~~el~~~I~~~~-rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 842 (886)
+ ..++.++|||||||++|||++|+.||.+.++......+.... ...++. .
T Consensus 210 ~----~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------------------------~ 260 (360)
T cd05627 210 Q----TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPP-------------------------E 260 (360)
T ss_pred C----CCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCC-------------------------C
Confidence 6 678899999999999999999999999888877776665431 111110 0
Q ss_pred hhhHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 002738 843 LETLSFLVDVFRRCTEENPTERP---TAGDLYEM 873 (886)
Q Consensus 843 ~~~s~~L~dLL~rCL~~DP~kRP---SA~EILeh 873 (886)
...++.+.+||.+|+. ||.+|+ ++.++++|
T Consensus 261 ~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 261 VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 1134578999999874 999998 48899988
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=316.73 Aligned_cols=257 Identities=28% Similarity=0.436 Sum_probs=201.2
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|.+.+.||+|++|.||+|.. .+..+++|......... .. ......+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~--~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSP--ET-KKEVNALECEIQLLKNLQHERIVQYYGCLRDDE- 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccch--hh-HHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC-
Confidence 4689999999999999999986 56789999865432211 11 111234589999999999999999999998654
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.
T Consensus 78 -------------~~~~v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~ 139 (263)
T cd06625 78 -------------TLSIFMEYMPGGSVKDQLKA-----YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDS 139 (263)
T ss_pred -------------eEEEEEEECCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence 47999999999999999976 245889999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.++|+|||++......... ........|+..|+|||++.+ ..++.++||||||+++|||+
T Consensus 140 ~-------~~~~l~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~el~ 201 (263)
T cd06625 140 A-------GNVKLGDFGASKRLQTICSS-------GTGMKSVTGTPYWMSPEVISG----EGYGRKADVWSVGCTVVEML 201 (263)
T ss_pred C-------CCEEEeecccceeccccccc-------cccccCCCcCccccCcceecc----CCCCchhhhHHHHHHHHHHH
Confidence 6 45999999998765432111 000122357889999999986 55789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcC-CCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 789 TLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~~-~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
+|+.||...+.......+... ..+.++ ...+..+.+||.+||..+|.+|||+
T Consensus 202 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rpt~ 254 (263)
T cd06625 202 TEKPPWAEFEAMAAIFKIATQPTNPQLP---------------------------SHVSPDARNFLRRTFVENAKKRPSA 254 (263)
T ss_pred hCCCCccccchHHHHHHHhccCCCCCCC---------------------------ccCCHHHHHHHHHHhhcCcccCCCH
Confidence 999999876555444333322 111111 1234578999999999999999999
Q ss_pred HHHHHHH
Q 002738 868 GDLYEMF 874 (886)
Q Consensus 868 ~EILehL 874 (886)
.++++|.
T Consensus 255 ~~ll~~~ 261 (263)
T cd06625 255 EELLRHF 261 (263)
T ss_pred HHHhhCC
Confidence 9999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=335.66 Aligned_cols=244 Identities=26% Similarity=0.311 Sum_probs=190.1
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHH-HHhhCCCCCcceeeeeEecCCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKISSKWLPSAD 633 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~-iLk~L~HPNIVrl~g~~~~~~~l~~~~ 633 (886)
+.||+|+||.||+|++ .+..+|+|++....... ... ...+.+|+. +++.++||||+++++++....
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~----~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~------ 69 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK-KKE----QNHIMAERNVLLKNLKHPFLVGLHYSFQTAE------ 69 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hhH----HHHHHHHHHHHHHhCCCCCccceeeEEEcCC------
Confidence 4799999999999997 56789999875332111 111 122355554 578899999999999987654
Q ss_pred CCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCC
Q 002738 634 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 713 (886)
Q Consensus 634 ~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~ 713 (886)
..|+||||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.+
T Consensus 70 --------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~---- 132 (321)
T cd05603 70 --------KLYFVLDYVNGGELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ---- 132 (321)
T ss_pred --------EEEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC----
Confidence 46999999999999988875 3568899999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 002738 714 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 793 (886)
Q Consensus 714 ~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~P 793 (886)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|..|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~p 195 (321)
T cd05603 133 ---GHVVLTDFGLCKEGVEPEE----------TTSTFCGTPEYLAPEVLRK----EPYDRTVDWWCLGAVLYEMLYGLPP 195 (321)
T ss_pred ---CCEEEccCCCCccCCCCCC----------ccccccCCcccCCHHHhcC----CCCCCcCcccccchhhhhhhcCCCC
Confidence 4699999999875322111 1133468999999999975 6688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH----HH
Q 002738 794 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA----GD 869 (886)
Q Consensus 794 F~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA----~E 869 (886)
|.+.+..++...+..... .++ ...+..+.++|.+||+.||.+||++ .+
T Consensus 196 f~~~~~~~~~~~i~~~~~-~~~---------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (321)
T cd05603 196 FYSRDVSQMYDNILHKPL-QLP---------------------------GGKTVAACDLLVGLLHKDQRRRLGAKADFLE 247 (321)
T ss_pred CCCCCHHHHHHHHhcCCC-CCC---------------------------CCCCHHHHHHHHHHccCCHhhcCCCCCCHHH
Confidence 998887776666654321 111 1124568999999999999999875 46
Q ss_pred HHHH
Q 002738 870 LYEM 873 (886)
Q Consensus 870 ILeh 873 (886)
+++|
T Consensus 248 ~~~~ 251 (321)
T cd05603 248 IKNH 251 (321)
T ss_pred HhCC
Confidence 6655
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=318.91 Aligned_cols=266 Identities=23% Similarity=0.315 Sum_probs=207.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC------CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeee
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 621 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~------~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g 621 (886)
+.-++|++.+.||+|+||.||+|.+. +..+++|+.. . .......+. +.+|+.++++++||||+++++
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~--~-~~~~~~~~~----~~~e~~~l~~l~h~ni~~~~~ 75 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVK--D-HASEIQVTL----LLQESCLLYGLSHQNILPILH 75 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEcc--C-CCCHHHHHH----HHHHHHHHHhCCCCCCCeEEE
Confidence 34568999999999999999999974 3677777743 1 122233333 489999999999999999999
Q ss_pred eEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhcc---CCCcCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 002738 622 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---GEKHVSVKLALFIAQDVAAALVELHSKHIMHRD 698 (886)
Q Consensus 622 ~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~---~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRD 698 (886)
++..... ..++++||+++++|.+++...... ....+++..++.++.||+.||+|||+++|+|||
T Consensus 76 ~~~~~~~-------------~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~d 142 (280)
T cd05043 76 VCIEDGE-------------PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKD 142 (280)
T ss_pred EEecCCC-------------CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecc
Confidence 8875432 359999999999999999763211 114688999999999999999999999999999
Q ss_pred CCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHH
Q 002738 699 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 778 (886)
Q Consensus 699 LKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIW 778 (886)
|||+|||++.+ ..+||+|||+++.+........ .....++..|+|||++.+ ..++.++|||
T Consensus 143 i~p~nil~~~~-------~~~kl~d~g~~~~~~~~~~~~~--------~~~~~~~~~y~apE~~~~----~~~~~~~Di~ 203 (280)
T cd05043 143 IAARNCVIDEE-------LQVKITDNALSRDLFPMDYHCL--------GDNENRPVKWMALESLVN----KEYSSASDVW 203 (280)
T ss_pred cCHhhEEEcCC-------CcEEECCCCCcccccCCceEEe--------CCCCCcchhccCHHHHhc----CCCCchhhHH
Confidence 99999999876 5699999999986543221100 112246778999999976 5678999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 002738 779 SYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 857 (886)
Q Consensus 779 SLGVILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL 857 (886)
||||++||+++ |+.||...++.++...+..+.....+ ...++.+.+++.+||
T Consensus 204 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l 256 (280)
T cd05043 204 SFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQP---------------------------INCPDELFAVMACCW 256 (280)
T ss_pred HhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCC---------------------------CcCCHHHHHHHHHHc
Confidence 99999999999 99999888777766655544322111 112457899999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhcC
Q 002738 858 EENPTERPTAGDLYEMFVARTS 879 (886)
Q Consensus 858 ~~DP~kRPSA~EILehLe~l~s 879 (886)
..||++|||+.++++.|+.+..
T Consensus 257 ~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 257 ALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCChhhCCCHHHHHHHHHHHHh
Confidence 9999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=337.26 Aligned_cols=244 Identities=25% Similarity=0.314 Sum_probs=191.4
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHH-HHhhCCCCCcceeeeeEecCCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKISSKWLPSAD 633 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~-iLk~L~HPNIVrl~g~~~~~~~l~~~~ 633 (886)
+.||+|+||.||+|+. .+..+|+|+...+.... ..... .+..|.. +++.++||||+++++++....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~----~~~~e~~~~l~~~~hp~iv~~~~~~~~~~------ 69 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN-RKEQK----HIMAERNVLLKNVKHPFLVGLHYSFQTTE------ 69 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHH----HHHHHHHHHHHhCCCCCCccEEEEEecCC------
Confidence 4699999999999987 56789999975432211 11112 2355554 467799999999999988655
Q ss_pred CCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCC
Q 002738 634 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 713 (886)
Q Consensus 634 ~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~ 713 (886)
..|+||||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~---- 132 (325)
T cd05604 70 --------KLYFVLDFVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ---- 132 (325)
T ss_pred --------EEEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC----
Confidence 36999999999999998875 3568999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 002738 714 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 793 (886)
Q Consensus 714 ~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~P 793 (886)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 133 ---~~~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~G~~p 195 (325)
T cd05604 133 ---GHVVLTDFGLCKEGIAQSD----------TTTTFCGTPEYLAPEVIRK----QPYDNTVDWWCLGAVLYEMLYGLPP 195 (325)
T ss_pred ---CCEEEeecCCcccCCCCCC----------CcccccCChhhCCHHHHcC----CCCCCcCccccccceehhhhcCCCC
Confidence 4699999999864322111 1133469999999999976 6678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH----H
Q 002738 794 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG----D 869 (886)
Q Consensus 794 F~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~----E 869 (886)
|...+..++...+....... . ...+..+.++|.+||..+|.+||++. +
T Consensus 196 f~~~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 196 FYCRDVAEMYDNILHKPLVL-R---------------------------PGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred CCCCCHHHHHHHHHcCCccC-C---------------------------CCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 99888777766665432110 0 11245688999999999999999874 6
Q ss_pred HHHH
Q 002738 870 LYEM 873 (886)
Q Consensus 870 ILeh 873 (886)
+++|
T Consensus 248 i~~h 251 (325)
T cd05604 248 IQEH 251 (325)
T ss_pred HhcC
Confidence 6665
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=325.43 Aligned_cols=266 Identities=22% Similarity=0.349 Sum_probs=208.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC---------CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcc
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIV 617 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~---------~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIV 617 (886)
...++|.+.+.||+|+||.||+|++. ...+|+|+.... ......+. +.+|+.+++.+ +||||+
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~----~~~E~~~l~~l~~h~~i~ 84 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD---ATEKDLSD----LVSEMEMMKMIGKHKNII 84 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc---cchHHHHH----HHHHHHHHHhhccCCCch
Confidence 45678999999999999999999751 235777775321 12222333 48999999999 799999
Q ss_pred eeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhcc-----------CCCcCCHHHHHHHHHHHHHHH
Q 002738 618 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAAL 686 (886)
Q Consensus 618 rl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~-----------~~~~Ls~~~i~~Ia~QIa~AL 686 (886)
++++++.... ..++||||+++++|.+++...... ....+++..+..++.||+.||
T Consensus 85 ~~~~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al 150 (304)
T cd05101 85 NLLGACTQDG--------------PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGM 150 (304)
T ss_pred heeEEEecCC--------------ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHH
Confidence 9999987654 369999999999999999863211 123578889999999999999
Q ss_pred HHHHhCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 002738 687 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 766 (886)
Q Consensus 687 ~yLHs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~ 766 (886)
.|||++||+||||||+|||++.+ +.+||+|||+++......... ......+++.|+|||++.+
T Consensus 151 ~~LH~~givH~dlkp~Nili~~~-------~~~kl~D~g~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-- 213 (304)
T cd05101 151 EYLASQKCIHRDLAARNVLVTEN-------NVMKIADFGLARDVNNIDYYK--------KTTNGRLPVKWMAPEALFD-- 213 (304)
T ss_pred HHHHHCCeeecccccceEEEcCC-------CcEEECCCccceecccccccc--------cccCCCCCceeeCchhhcc--
Confidence 99999999999999999999876 569999999998664322110 0112235678999999976
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhh
Q 002738 767 KPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 845 (886)
Q Consensus 767 ~~~~~s~KSDIWSLGVILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (886)
..++.++||||||+++|+|++ |..||.+.+..++...+....+...+ ...
T Consensus 214 --~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~ 264 (304)
T cd05101 214 --RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP---------------------------ANC 264 (304)
T ss_pred --CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCC---------------------------CCC
Confidence 568899999999999999998 88999888887777776554332211 123
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 002738 846 LSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 880 (886)
Q Consensus 846 s~~L~dLL~rCL~~DP~kRPSA~EILehLe~l~ss 880 (886)
+..+.+|+.+||..+|.+|||+.+|++.|+++...
T Consensus 265 ~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 265 TNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 45789999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.18 Aligned_cols=259 Identities=28% Similarity=0.386 Sum_probs=199.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
....+|++.+.||+|+||.||+|+. .+..+|+|+...+.. ..... +.+|+.++++++||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~----~~~e~~~l~~~~h~~ii~~~~~~~~ 77 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG----DDFSL----IQQEIFMVKECKHCNIVAYFGSYLS 77 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc----chHHH----HHHHHHHHHhcCCCCeeeeeEEEEe
Confidence 3456899999999999999999997 567789998754321 12222 3789999999999999999999876
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
.. ..++||||+++++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 78 ~~--------------~~~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil 138 (267)
T cd06646 78 RE--------------KLWICMEYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANIL 138 (267)
T ss_pred CC--------------EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE
Confidence 54 46999999999999999875 346899999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.+ +.++|+|||++........ ......|++.|+|||.+... ....++.++|||||||++|
T Consensus 139 l~~~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~~-~~~~~~~~~Dvws~G~il~ 200 (267)
T cd06646 139 LTDN-------GDVKLADFGVAAKITATIA----------KRKSFIGTPYWMAPEVAAVE-KNGGYNQLCDIWAVGITAI 200 (267)
T ss_pred ECCC-------CCEEECcCccceeeccccc----------ccCccccCccccCHhHcccc-cCCCCcchhhHHHHHHHHH
Confidence 9876 4599999999976532111 01234588999999998532 1245678999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
||++|+.||....+......+...... .+ ........+..+.+||.+||..+|++||
T Consensus 201 el~~g~~p~~~~~~~~~~~~~~~~~~~-~~----------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rp 257 (267)
T cd06646 201 ELAELQPPMFDLHPMRALFLMSKSNFQ-PP----------------------KLKDKTKWSSTFHNFVKISLTKNPKKRP 257 (267)
T ss_pred HHHhCCCCccccchhhhheeeecCCCC-CC----------------------CCccccccCHHHHHHHHHHhhCChhhCc
Confidence 999999999765443322222111100 00 0000112345789999999999999999
Q ss_pred CHHHHHHHH
Q 002738 866 TAGDLYEMF 874 (886)
Q Consensus 866 SA~EILehL 874 (886)
++++|++||
T Consensus 258 ~~~~il~~l 266 (267)
T cd06646 258 TAERLLTHL 266 (267)
T ss_pred CHHHHhcCC
Confidence 999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=332.78 Aligned_cols=249 Identities=24% Similarity=0.334 Sum_probs=197.1
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEecCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 628 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~~~~~ 628 (886)
+|++.+.||+|+||.||+|+. .+..||+|+....... .....+ .+..|+.++..+. |++|+++++++....
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~----~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVE----CTMVEKRVLALQDKPPFLTQLHSCFQTVD- 74 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHH----HHHHHHHHHHhccCCCchhheeeEEecCC-
Confidence 478899999999999999987 5678999987533211 111222 3377888998886 577888988887654
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..|+||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~Ey~~~g~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~ 136 (323)
T cd05615 75 -------------RLYFVMEYVNGGDLMYHIQQ-----VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS 136 (323)
T ss_pred -------------EEEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC
Confidence 36999999999999999875 356899999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 137 ~-------~~ikL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~ell 195 (323)
T cd05615 137 E-------GHIKIADFGMCKEHMVDGV----------TTRTFCGTPDYIAPEIIAY----QPYGKSVDWWAYGVLLYEML 195 (323)
T ss_pred C-------CCEEEeccccccccCCCCc----------cccCccCCccccCHHHHcC----CCCCCccchhhhHHHHHHHH
Confidence 7 4699999999875422111 1123469999999999976 56889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA- 867 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA- 867 (886)
+|+.||.+.+...+...+..... .++ ...+..+.+|+.+||+.+|.+|+++
T Consensus 196 tG~~pf~~~~~~~~~~~i~~~~~-~~p---------------------------~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 196 AGQPPFDGEDEDELFQSIMEHNV-SYP---------------------------KSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred hCCCCCCCCCHHHHHHHHHhCCC-CCC---------------------------ccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 99999998888777766654321 111 0124468999999999999999974
Q ss_pred ----HHHHHH
Q 002738 868 ----GDLYEM 873 (886)
Q Consensus 868 ----~EILeh 873 (886)
.++++|
T Consensus 248 ~~~~~~i~~h 257 (323)
T cd05615 248 PEGERDIREH 257 (323)
T ss_pred CCCHHHHhcC
Confidence 667766
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=319.95 Aligned_cols=256 Identities=32% Similarity=0.445 Sum_probs=197.6
Q ss_pred ceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCC
Q 002738 553 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 630 (886)
Q Consensus 553 Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~ 630 (886)
|++.+.||+|+||+||+++. .+..+|+|+..... .. ........+|+.++++++||||+++++++....
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~--~~----~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--- 71 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSE--IE----EEEREENIREIKILRRLRHPNIVQILDVFQDDN--- 71 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTT--HH----HHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS---
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccc--cc----ccccchhhhhhhccccccccccccccccccccc---
Confidence 78999999999999999998 44579999975432 11 111122356999999999999999999998755
Q ss_pred CCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccc
Q 002738 631 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 710 (886)
Q Consensus 631 ~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~ 710 (886)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+|||++.+
T Consensus 72 -----------~~~~v~~~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~- 134 (260)
T PF00069_consen 72 -----------YLYIVMEYCPGGSLQDYLQK-----NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDEN- 134 (260)
T ss_dssp -----------EEEEEEEEETTEBHHHHHHH-----HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTT-
T ss_pred -----------cccccccccccccccccccc-----ccccccccccccccccccccccccccccccccccccccccccc-
Confidence 46999999998899999983 2568999999999999999999999999999999999999977
Q ss_pred cCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 002738 711 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 790 (886)
Q Consensus 711 ~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG 790 (886)
+.++|+|||.+........ ......+|..|+|||++.. ...++.++||||||+++|+|++|
T Consensus 135 ------~~~~l~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il~~l~~~ 195 (260)
T PF00069_consen 135 ------GEVKLIDFGSSVKLSENNE----------NFNPFVGTPEYMAPEVLQQ---GKKYTRKSDIWSLGIILYELLTG 195 (260)
T ss_dssp ------SEEEESSGTTTEESTSTTS----------EBSSSSSSGGGSCHHHHTT---TSSBSTHHHHHHHHHHHHHHHHS
T ss_pred ------ccccccccccccccccccc----------ccccccccccccccccccc---ccccccccccccccccccccccc
Confidence 5699999999975411111 1123468999999999871 26788999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 002738 791 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 870 (886)
Q Consensus 791 ~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EI 870 (886)
..||...........+............. ........+.+||.+||+.||.+||++.++
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l 254 (260)
T PF00069_consen 196 KLPFEESNSDDQLEIIEKILKRPLPSSSQ---------------------QSREKSEELRDLIKKMLSKDPEQRPSAEEL 254 (260)
T ss_dssp SSSSTTSSHHHHHHHHHHHHHTHHHHHTT---------------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHH
T ss_pred ccccccccchhhhhhhhhccccccccccc---------------------ccchhHHHHHHHHHHHccCChhHCcCHHHH
Confidence 99998874443333332221111111000 000113689999999999999999999999
Q ss_pred HHHH
Q 002738 871 YEMF 874 (886)
Q Consensus 871 LehL 874 (886)
++|-
T Consensus 255 ~~~~ 258 (260)
T PF00069_consen 255 LKHP 258 (260)
T ss_dssp HTSG
T ss_pred hcCC
Confidence 9873
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=367.87 Aligned_cols=268 Identities=25% Similarity=0.401 Sum_probs=217.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC---Ce--eEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeee
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFG---SA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 622 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~---~~--~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~ 622 (886)
.+....++...||+|+||.||.|... +. ++.|+++.++... +..+...| ++|..+|+.++|||||+++|+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~F----l~Ea~~m~~f~HpNiv~liGv 763 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDF----LKEALLMSKFDHPNIVSLIGV 763 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHH----HHHHHHHhcCCCcceeeEEEe
Confidence 44567789999999999999999962 22 4445555455432 34455555 999999999999999999999
Q ss_pred EecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccC--CCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 002738 623 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG--EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700 (886)
Q Consensus 623 ~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~--~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLK 700 (886)
+.+... .+|++|||+||+|..||++.+... ...++....+.++.|||+|+.||+++++|||||.
T Consensus 764 ~l~~~~--------------~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLA 829 (1025)
T KOG1095|consen 764 CLDSGP--------------PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLA 829 (1025)
T ss_pred ecCCCC--------------cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchh
Confidence 997553 599999999999999999743221 3568899999999999999999999999999999
Q ss_pred CCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHH
Q 002738 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 780 (886)
Q Consensus 701 PsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSL 780 (886)
..|+||+.. .+|||+|||+|+.+....... .. ....-...|||||.+.. +.++.|+|||||
T Consensus 830 aRNCLL~~~-------r~VKIaDFGlArDiy~~~yyr---~~-----~~a~lPvkWm~PEsl~d----~iFtskSDvWsF 890 (1025)
T KOG1095|consen 830 ARNCLLDER-------RVVKIADFGLARDIYDKDYYR---KH-----GEAMLPVKWMPPESLKD----GIFTSKSDVWSF 890 (1025)
T ss_pred hhheeeccc-------CcEEEcccchhHhhhhchhee---cc-----CccccceecCCHHHHhh----cccccccchhhh
Confidence 999999987 679999999999554433221 11 11123478999999996 789999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 002738 781 GCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 859 (886)
Q Consensus 781 GVILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~ 859 (886)
||+|||++| |..||.+.+..+++..+..+.+...|. .+++.+.+||..||+.
T Consensus 891 GVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~---------------------------~CP~~ly~lM~~CW~~ 943 (1025)
T KOG1095|consen 891 GVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPS---------------------------YCPEKLYQLMLQCWKH 943 (1025)
T ss_pred HHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCC---------------------------CCChHHHHHHHHHccC
Confidence 999999999 899999999999998777776544332 2456789999999999
Q ss_pred CCCCCCCHHHHHHHHHhhcCC
Q 002738 860 NPTERPTAGDLYEMFVARTSS 880 (886)
Q Consensus 860 DP~kRPSA~EILehLe~l~ss 880 (886)
+|++||++..|++.+..+...
T Consensus 944 ~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 944 DPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred ChhhCccHHHHHhhhhhhhhh
Confidence 999999999999988877654
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=335.92 Aligned_cols=244 Identities=22% Similarity=0.356 Sum_probs=187.7
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcceeeeeEecCCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 633 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl~g~~~~~~~l~~~~ 633 (886)
+.||+|+||.||+|+. .+..+|+|++...... ...... .+.+|+.++.++ +||||+++++++....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~------ 69 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN-DDEDID----WVQTEKHVFEQASNHPFLVGLHSCFQTES------ 69 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc-chhHHH----HHHHHHHHHHhcCCCCcCCceeeEEEeCC------
Confidence 4799999999999997 5567999987543221 112222 347899888877 7999999999988655
Q ss_pred CCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCC
Q 002738 634 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 713 (886)
Q Consensus 634 ~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~ 713 (886)
..++||||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~E~~~~~~L~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~---- 132 (329)
T cd05618 70 --------RLFFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE---- 132 (329)
T ss_pred --------EEEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC----
Confidence 46999999999999998875 3568999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 002738 714 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 793 (886)
Q Consensus 714 ~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~P 793 (886)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 133 ---~~~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~P 195 (329)
T cd05618 133 ---GHIKLTDYGMCKEGLRPGD----------TTSTFCGTPNYIAPEILRG----EDYGFSVDWWALGVLMFEMMAGRSP 195 (329)
T ss_pred ---CCEEEeeCCccccccCCCC----------ccccccCCccccCHHHHcC----CCCCCccceecccHHHHHHhhCCCC
Confidence 4699999999875322111 1123469999999999986 6778999999999999999999999
Q ss_pred CCCCCH---------HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 002738 794 YMGLSE---------LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 864 (886)
Q Consensus 794 F~g~s~---------~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kR 864 (886)
|..... ..+...+... ...++ ...+..+.+||.+||+.||.+|
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p---------------------------~~~~~~~~~ll~~~L~~dP~~R 247 (329)
T cd05618 196 FDIVGSSDNPDQNTEDYLFQVILEK-QIRIP---------------------------RSLSVKAASVLKSFLNKDPKER 247 (329)
T ss_pred CccCCCcCCcccccHHHHHHHHhcC-CCCCC---------------------------CCCCHHHHHHHHHHhcCCHHHc
Confidence 953211 1111222111 11111 1234578999999999999999
Q ss_pred CC------HHHHHHH
Q 002738 865 PT------AGDLYEM 873 (886)
Q Consensus 865 PS------A~EILeh 873 (886)
|+ +.++++|
T Consensus 248 ~~~~~~~~~~~i~~h 262 (329)
T cd05618 248 LGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCCCHHHHhcC
Confidence 98 5788887
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=326.14 Aligned_cols=265 Identities=23% Similarity=0.361 Sum_probs=206.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC---------CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcc
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIV 617 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~---------~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIV 617 (886)
.+..+|.+.+.||+|+||.||+|+.. ...+|+|+.... ........ +.+|+.+++++ +||||+
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~----~~~E~~~l~~l~~h~~iv 81 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN---ATDKDLAD----LISEMELMKLIGKHKNII 81 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC---CChHHHHH----HHHHHHHHHhccCCCCee
Confidence 45678999999999999999999752 345788875322 12222333 48899999999 599999
Q ss_pred eeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhc-----------cCCCcCCHHHHHHHHHHHHHHH
Q 002738 618 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAAL 686 (886)
Q Consensus 618 rl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~-----------~~~~~Ls~~~i~~Ia~QIa~AL 686 (886)
++++++.... ..++||||+++++|.+++..... .....+++..+..++.||+.||
T Consensus 82 ~~~~~~~~~~--------------~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL 147 (314)
T cd05099 82 NLLGVCTQEG--------------PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGM 147 (314)
T ss_pred eEEEEEccCC--------------ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHH
Confidence 9999987554 36999999999999999976321 1124588999999999999999
Q ss_pred HHHHhCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 002738 687 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 766 (886)
Q Consensus 687 ~yLHs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~ 766 (886)
.|||++||+||||||+|||++.+ +.+||+|||+++......... ......++..|+|||++.+
T Consensus 148 ~~lH~~gi~H~dlkp~Nill~~~-------~~~kL~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-- 210 (314)
T cd05099 148 EYLESRRCIHRDLAARNVLVTED-------NVMKIADFGLARGVHDIDYYK--------KTSNGRLPVKWMAPEALFD-- 210 (314)
T ss_pred HHHHHCCeeeccccceeEEEcCC-------CcEEEcccccccccccccccc--------ccccCCCCccccCHHHHcc--
Confidence 99999999999999999999876 469999999998654321110 0011124568999999875
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhh
Q 002738 767 KPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 845 (886)
Q Consensus 767 ~~~~~s~KSDIWSLGVILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (886)
..++.++|||||||++|||++ |..||.+.+..++...+..+.....+ ...
T Consensus 211 --~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~ 261 (314)
T cd05099 211 --RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKP---------------------------SNC 261 (314)
T ss_pred --CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCC
Confidence 668899999999999999999 89999888877777766554322211 112
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 002738 846 LSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 879 (886)
Q Consensus 846 s~~L~dLL~rCL~~DP~kRPSA~EILehLe~l~s 879 (886)
+..+.+|+.+||..+|.+|||+.++++.|+++..
T Consensus 262 ~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 262 THELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 4478899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=348.81 Aligned_cols=262 Identities=27% Similarity=0.465 Sum_probs=213.7
Q ss_pred CCCceeeeeecccCceEEEEEEEC---C--ee-EEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeE
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKFG---S--AD-AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 623 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~~---~--~~-VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~ 623 (886)
-.+..+.++||+|+||.||+|++. + .. ||+|....+ ........+++ ++|+++|+.++|||||++||+.
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~-~~~~~~~~~e~----m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGS-SELTKEQIKEF----MKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccc-ccccHHHHHHH----HHHHHHHHhCCCCCEEEEEEEE
Confidence 355667799999999999999962 1 12 677765431 22344555555 9999999999999999999999
Q ss_pred ecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 002738 624 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703 (886)
Q Consensus 624 ~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsN 703 (886)
..... ++||||+|.||+|.++|++ ....++..+...++.+.|.||+|||++++|||||-.+|
T Consensus 231 ~~~~P--------------l~ivmEl~~gGsL~~~L~k----~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARN 292 (474)
T KOG0194|consen 231 VLEEP--------------LMLVMELCNGGSLDDYLKK----NKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARN 292 (474)
T ss_pred cCCCc--------------cEEEEEecCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHH
Confidence 98775 4999999999999999997 22369999999999999999999999999999999999
Q ss_pred EEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 002738 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783 (886)
Q Consensus 704 ILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVI 783 (886)
+|++.+ .++||+|||+++.-...... .....-...|+|||.+.. ..|++++|||||||+
T Consensus 293 cL~~~~-------~~vKISDFGLs~~~~~~~~~----------~~~~klPirWLAPEtl~~----~~~s~kTDV~sfGV~ 351 (474)
T KOG0194|consen 293 CLYSKK-------GVVKISDFGLSRAGSQYVMK----------KFLKKLPIRWLAPETLNT----GIFSFKTDVWSFGVL 351 (474)
T ss_pred heecCC-------CeEEeCccccccCCcceeec----------cccccCcceecChhhhcc----Cccccccchhheeee
Confidence 999987 45899999998754311110 011124579999999986 689999999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHH-HcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 002738 784 LLELLT-LQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 861 (886)
Q Consensus 784 LyELLT-G~~PF~g~s~~el~~~I-~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP 861 (886)
+||+++ |..||.+....++...| ..+.+...+. ..+..+..++.+||..+|
T Consensus 352 ~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~---------------------------~~p~~~~~~~~~c~~~~p 404 (474)
T KOG0194|consen 352 LWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS---------------------------KTPKELAKVMKQCWKKDP 404 (474)
T ss_pred EEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC---------------------------CCHHHHHHHHHHhccCCh
Confidence 999999 89999999999999999 5555554442 125578899999999999
Q ss_pred CCCCCHHHHHHHHHhhcCCCC
Q 002738 862 TERPTAGDLYEMFVARTSSSI 882 (886)
Q Consensus 862 ~kRPSA~EILehLe~l~sss~ 882 (886)
+.||++.++.+.|+.+.....
T Consensus 405 ~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 405 EDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred hhccCHHHHHHHHHHHHhccc
Confidence 999999999999998876544
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=312.16 Aligned_cols=255 Identities=29% Similarity=0.422 Sum_probs=204.8
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
+|++.+.||.|+||.||++.. .+..+++|+..... ......+ ++.+|+.++++++||||+++++++.....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~~- 73 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN--MTEKEKQ----QLVSEVNILRELKHPNIVRYYDRIIDRSN- 73 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEeccc--CCHHHHH----HHHHHHHHHHhcCCCccceeeeeeecCCC-
Confidence 588999999999999999987 55678888764332 2233333 34889999999999999999998764331
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHH-----hCCccccCCCCCCE
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH-----SKHIMHRDIKSENI 704 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLH-----s~gIVHRDLKPsNI 704 (886)
...+++|||+++++|.+++..... ....+++..++.++.||+.||.||| +.+|+|+||||+||
T Consensus 74 -----------~~~~~~~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~ni 141 (265)
T cd08217 74 -----------QTLYIVMEYCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANI 141 (265)
T ss_pred -----------CEEEEEehhccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHE
Confidence 257999999999999999976432 2356899999999999999999999 88999999999999
Q ss_pred EEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVIL 784 (886)
+++.+ +.+||+|||++......... .....+++.|+|||++.+ ..++.++||||||+++
T Consensus 142 li~~~-------~~~kl~d~g~~~~~~~~~~~----------~~~~~~~~~~~~pE~~~~----~~~~~~~Dv~slG~il 200 (265)
T cd08217 142 FLDAN-------NNVKLGDFGLAKILGHDSSF----------AKTYVGTPYYMSPEQLNH----MSYDEKSDIWSLGCLI 200 (265)
T ss_pred EEecC-------CCEEEecccccccccCCccc----------ccccccCCCccChhhhcC----CCCCchhHHHHHHHHH
Confidence 99876 56999999999876442211 122358999999999876 5578899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 002738 785 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 864 (886)
Q Consensus 785 yELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kR 864 (886)
|+|++|+.||...+...+...+..+..+.++. ..+..+.+|+.+||..+|.+|
T Consensus 201 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~~~l~~~p~~R 253 (265)
T cd08217 201 YELCALSPPFTARNQLQLASKIKEGKFRRIPY---------------------------RYSSELNEVIKSMLNVDPDKR 253 (265)
T ss_pred HHHHHCCCcccCcCHHHHHHHHhcCCCCCCcc---------------------------ccCHHHHHHHHHHccCCcccC
Confidence 99999999998887766666665554332221 124578999999999999999
Q ss_pred CCHHHHHHH
Q 002738 865 PTAGDLYEM 873 (886)
Q Consensus 865 PSA~EILeh 873 (886)
|++.+|++|
T Consensus 254 p~~~~il~~ 262 (265)
T cd08217 254 PSTEELLQL 262 (265)
T ss_pred CCHHHHhhC
Confidence 999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=316.74 Aligned_cols=257 Identities=21% Similarity=0.310 Sum_probs=202.9
Q ss_pred CCCceeeeeecccCceEEEEEEECC-----eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEe
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 624 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~~~-----~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~ 624 (886)
-.+|.+.+.||+|+||.||+|.+.. ..+++|...... ..... +.+.+|+.+++++.||||+++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~----~~~~~e~~~l~~~~h~~i~~~~~~~~ 77 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVR----EKFLQEAYIMRQFDHPHIVKLIGVIT 77 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC---CHHHH----HHHHHHHHHHHhCCCCchhceeEEEc
Confidence 4568899999999999999998632 357777653221 12222 34489999999999999999999886
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNI 704 (886)
... .++||||+++++|.+++.. ....+++..++.++.||+.||+|||++|++||||||+||
T Consensus 78 ~~~---------------~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~ni 138 (270)
T cd05056 78 ENP---------------VWIVMELAPLGELRSYLQV----NKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNV 138 (270)
T ss_pred CCC---------------cEEEEEcCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheE
Confidence 432 4899999999999999975 223589999999999999999999999999999999999
Q ss_pred EEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVIL 784 (886)
|++.+ +.++|+|||++.......... .....++..|+|||.+.. ..++.++||||||+++
T Consensus 139 li~~~-------~~~~l~d~g~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il 198 (270)
T cd05056 139 LVSSP-------DCVKLGDFGLSRYLEDESYYK---------ASKGKLPIKWMAPESINF----RRFTSASDVWMFGVCM 198 (270)
T ss_pred EEecC-------CCeEEccCceeeeccccccee---------cCCCCccccccChhhhcc----CCCCchhhhHHHHHHH
Confidence 99876 469999999987654321110 111234568999999875 5678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 785 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 785 yELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
|||++ |..||.+....+....+.++.++..+ ...+..+.+|+.+||..+|.+
T Consensus 199 ~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~P~~ 251 (270)
T cd05056 199 WEILMLGVKPFQGVKNNDVIGRIENGERLPMP---------------------------PNCPPTLYSLMTKCWAYDPSK 251 (270)
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHcCCChhh
Confidence 99986 99999888777766666555433221 112457999999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 002738 864 RPTAGDLYEMFVARTS 879 (886)
Q Consensus 864 RPSA~EILehLe~l~s 879 (886)
|||+.++++.|.++..
T Consensus 252 Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 252 RPRFTELKAQLSDILQ 267 (270)
T ss_pred CcCHHHHHHHHHHHHh
Confidence 9999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=316.84 Aligned_cols=258 Identities=21% Similarity=0.337 Sum_probs=202.3
Q ss_pred CCCceeeeeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEe
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 624 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~~-----~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~ 624 (886)
..+|++.+.||+|+||.||+|.+. ...+|+|.. +... .....+. +.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~--~~~~-~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~ 75 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL--KAGY-TEKQRRD----FLSEASIMGQFDHPNIIHLEGVVT 75 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEEC--CCCC-CHHHHHH----HHHHHHHHHhCCCCCcceEEEEEe
Confidence 457899999999999999999862 225677664 3211 2222333 488999999999999999999987
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNI 704 (886)
.... .++||||+++++|.+++.. ....+++.++..++.||+.||+|||++||+||||||+||
T Consensus 76 ~~~~--------------~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~ni 137 (267)
T cd05066 76 KSKP--------------VMIVTEYMENGSLDAFLRK----HDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNI 137 (267)
T ss_pred cCCc--------------cEEEEEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcE
Confidence 5543 6999999999999999975 224589999999999999999999999999999999999
Q ss_pred EEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVIL 784 (886)
|++.+ +.++|+|||++.......... .......++..|+|||++.+ ..++.++|||||||++
T Consensus 138 li~~~-------~~~~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~~l 199 (267)
T cd05066 138 LVNSN-------LVCKVSDFGLSRVLEDDPEAA-------YTTRGGKIPIRWTAPEAIAY----RKFTSASDVWSYGIVM 199 (267)
T ss_pred EECCC-------CeEEeCCCCccccccccccee-------eecCCCccceeecCHhHhcc----CccCchhhhHHHHHHH
Confidence 99876 569999999998664322110 00111224568999999976 5688999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 785 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 785 yELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
||+++ |..||......+....+..+.++..+ ...++.+.+++.+||+.+|.+
T Consensus 200 ~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~ 252 (267)
T cd05066 200 WEVMSYGERPYWEMSNQDVIKAIEEGYRLPAP---------------------------MDCPAALHQLMLDCWQKDRNE 252 (267)
T ss_pred HHHhcCCCCCcccCCHHHHHHHHhCCCcCCCC---------------------------CCCCHHHHHHHHHHcccCchh
Confidence 99886 99999888777766666554322111 112457899999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 002738 864 RPTAGDLYEMFVAR 877 (886)
Q Consensus 864 RPSA~EILehLe~l 877 (886)
||++.++++.|+++
T Consensus 253 Rp~~~~i~~~l~~~ 266 (267)
T cd05066 253 RPKFEQIVSILDKL 266 (267)
T ss_pred CCCHHHHHHHHHhh
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=341.24 Aligned_cols=264 Identities=25% Similarity=0.341 Sum_probs=202.7
Q ss_pred CCCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceee
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMY 620 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~~-------~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~ 620 (886)
+-++|.+.+.||+|+||.||+|++. ...||+|++.... ..... +.+.+|+.+|+++. ||||++++
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~----~~~~~Ei~~l~~l~~HpnIv~l~ 107 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA---RSSEK----QALMSELKIMTHLGPHLNIVNLL 107 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC---ChHHH----HHHHHHHHHHHhcCCCCCeeeEE
Confidence 4568899999999999999999862 2358999864221 12222 24489999999996 99999999
Q ss_pred eeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhcc-----------------------------------
Q 002738 621 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET----------------------------------- 665 (886)
Q Consensus 621 g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~----------------------------------- 665 (886)
+++.... ..||||||+++|+|.++|......
T Consensus 108 ~~~~~~~--------------~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (400)
T cd05105 108 GACTKSG--------------PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFEN 173 (400)
T ss_pred EEEccCC--------------ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcc
Confidence 9997654 369999999999999998753110
Q ss_pred --------------------------------------------------------CCCcCCHHHHHHHHHHHHHHHHHH
Q 002738 666 --------------------------------------------------------GEKHVSVKLALFIAQDVAAALVEL 689 (886)
Q Consensus 666 --------------------------------------------------------~~~~Ls~~~i~~Ia~QIa~AL~yL 689 (886)
....+++..++.++.||+.||+||
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L 253 (400)
T cd05105 174 KGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL 253 (400)
T ss_pred cccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence 112477888999999999999999
Q ss_pred HhCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCC
Q 002738 690 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 769 (886)
Q Consensus 690 Hs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~ 769 (886)
|+++|+||||||+|||++.+ ..+||+|||+++........ .......+++.|+|||++.+ .
T Consensus 254 H~~~ivH~dikp~Nill~~~-------~~~kL~DfGla~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~ 314 (400)
T cd05105 254 ASKNCVHRDLAARNVLLAQG-------KIVKICDFGLARDIMHDSNY--------VSKGSTFLPVKWMAPESIFD----N 314 (400)
T ss_pred HhCCeeCCCCChHhEEEeCC-------CEEEEEeCCcceeccccccc--------cccCCcCCCcceEChhhhcC----C
Confidence 99999999999999999876 56999999999765432111 01122357789999999876 6
Q ss_pred CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHH
Q 002738 770 LYGLEVDIWSYGCLLLELLT-LQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 847 (886)
Q Consensus 770 ~~s~KSDIWSLGVILyELLT-G~~PF~g~s~~e-l~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 847 (886)
.++.++|||||||++|||++ |..||....... +...+..+.++..+ ...+.
T Consensus 315 ~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~ 367 (400)
T cd05105 315 LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKP---------------------------DHATQ 367 (400)
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCC---------------------------ccCCH
Confidence 68899999999999999997 999997764433 33333333222111 12345
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 002738 848 FLVDVFRRCTEENPTERPTAGDLYEMFVARTS 879 (886)
Q Consensus 848 ~L~dLL~rCL~~DP~kRPSA~EILehLe~l~s 879 (886)
.+.+|+.+||+.||++||++.+|.+.|+.+..
T Consensus 368 ~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 368 EVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 78999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=314.68 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=196.9
Q ss_pred eeecccCceEEEEEEECC-----eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 631 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~~~-----~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~ 631 (886)
++||+|+||.||+|.+.. ..+|+|...... .. ... ..+.+|+.+++.+.||||+++++++...
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~--~~-~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 68 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH--IA-AGK----KEFLREASVMAQLDHPCIVRLIGVCKGE----- 68 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEeccccc--ch-HHH----HHHHHHHHHHHhcCCCCeeeEEEEEcCC-----
Confidence 479999999999998622 467888754322 11 222 3448999999999999999999987532
Q ss_pred CCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecccc
Q 002738 632 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 711 (886)
Q Consensus 632 ~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~ 711 (886)
..++||||+++++|.+++.. ...+++..+..++.|++.||+|||.++|+|+||||+|||++.+
T Consensus 69 ----------~~~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~-- 131 (257)
T cd05060 69 ----------PLMLVMELAPLGPLLKYLKK-----RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR-- 131 (257)
T ss_pred ----------ceEEEEEeCCCCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCC--
Confidence 25999999999999999986 2368999999999999999999999999999999999999877
Q ss_pred CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-C
Q 002738 712 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-L 790 (886)
Q Consensus 712 ~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT-G 790 (886)
+.+||+|||++.......... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |
T Consensus 132 -----~~~kl~df~~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~~~~~g 195 (257)
T cd05060 132 -----HQAKISDFGMSRALGAGSDYY-------RATTAGRWPLKWYAPECINY----GKFSSKSDVWSYGVTLWEAFSYG 195 (257)
T ss_pred -----CcEEeccccccceeecCCccc-------ccccCccccccccCHHHhcC----CCCCccchHHHHHHHHHHHHcCC
Confidence 469999999998664322110 00111224568999999875 668899999999999999998 9
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 002738 791 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 870 (886)
Q Consensus 791 ~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EI 870 (886)
..||...+..++...+........+ ...+..+.+||.+||..+|.+||++.+|
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~~p~~Rp~~~~l 248 (257)
T cd05060 196 AKPYGEMKGAEVIAMLESGERLPRP---------------------------EECPQEIYSIMLSCWKYRPEDRPTFSEL 248 (257)
T ss_pred CCCcccCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 9999888877777666554322111 1124578999999999999999999999
Q ss_pred HHHHHhhc
Q 002738 871 YEMFVART 878 (886)
Q Consensus 871 LehLe~l~ 878 (886)
++.|+++.
T Consensus 249 ~~~l~~~~ 256 (257)
T cd05060 249 ESTFRRDP 256 (257)
T ss_pred HHHHHhcc
Confidence 99998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=321.41 Aligned_cols=278 Identities=21% Similarity=0.262 Sum_probs=199.3
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
+|++.+.||+|+||.||+|++ .+..+++|........ .. ....+.+|+.++++++||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~--~~----~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~-- 72 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EG----VPSSALREICLLKELKHKNIVRLYDVLHSDK-- 72 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc--cc----CccchhHHHHHHHhcCCCCeeeHHHHhccCC--
Confidence 588999999999999999997 5678899986543211 11 1123478999999999999999999987554
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..++||||++ ++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 73 ------------~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~ 135 (284)
T cd07839 73 ------------KLTLVFEYCD-QDLKKYFDS----CNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN 135 (284)
T ss_pred ------------ceEEEEecCC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC
Confidence 3699999997 588888764 13468999999999999999999999999999999999999877
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.+||+|||++......... .....+++.|+|||++.+ ...++.++|||||||++|+|+|
T Consensus 136 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~t 195 (284)
T cd07839 136 -------GELKLADFGLARAFGIPVRC----------YSAEVVTLWYRPPDVLFG---AKLYSTSIDMWSAGCIFAELAN 195 (284)
T ss_pred -------CcEEECccchhhccCCCCCC----------cCCCccccCCcChHHHhC---CcccCcHHHHHHHHHHHHHHHh
Confidence 45999999999765332111 122357899999999875 2456889999999999999999
Q ss_pred CCCCC-CCCCHHHHHHHHHcCCCCCchhHHhhhcccccc-cccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 790 LQVPY-MGLSELEIHDLIQMGKRPRLTDELEALGSCHEH-EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 790 G~~PF-~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
|..|| .+.+.......+...........+......... ..................++.+.+||.+||..||.+|||+
T Consensus 196 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~ 275 (284)
T cd07839 196 AGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISA 275 (284)
T ss_pred cCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCH
Confidence 98885 444544444444332211111111111100000 0000000000011122346788999999999999999999
Q ss_pred HHHHHHH
Q 002738 868 GDLYEMF 874 (886)
Q Consensus 868 ~EILehL 874 (886)
+++++|.
T Consensus 276 ~~il~h~ 282 (284)
T cd07839 276 EEALQHP 282 (284)
T ss_pred HHHhcCC
Confidence 9999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=316.27 Aligned_cols=260 Identities=20% Similarity=0.331 Sum_probs=202.3
Q ss_pred CCCceeeeeecccCceEEEEEEECC-----eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEe
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 624 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~~~-----~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~ 624 (886)
+..|++.+.||+|+||.||+|.+.. ..+++|+.... ......+. +..|+.+++.++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~----~~~e~~~l~~l~h~ni~~~~~~~~ 75 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG---YTEKQRRD----FLSEASIMGQFDHPNIIHLEGVVT 75 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC---CCHHHHHH----HHHHHHHHHhCCCcCcceEEEEEC
Confidence 4678999999999999999998732 35888875322 12233333 489999999999999999999987
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNI 704 (886)
... ..++||||+++++|.+++.. ....+++..++.++.|++.||.|||++|++|+||||+||
T Consensus 76 ~~~--------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~ni 137 (269)
T cd05065 76 KSR--------------PVMIITEFMENGALDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNI 137 (269)
T ss_pred CCC--------------ceEEEEecCCCCcHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheE
Confidence 554 36999999999999999975 234688999999999999999999999999999999999
Q ss_pred EEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVIL 784 (886)
|++.+ ..+||+|||++........... .........+..|+|||++.+ ..++.++|||||||++
T Consensus 138 li~~~-------~~~kl~dfg~~~~~~~~~~~~~-----~~~~~~~~~~~~y~~PE~~~~----~~~~~~~DvwslG~~l 201 (269)
T cd05065 138 LVNSN-------LVCKVSDFGLSRFLEDDTSDPT-----YTSSLGGKIPIRWTAPEAIAY----RKFTSASDVWSYGIVM 201 (269)
T ss_pred EEcCC-------CcEEECCCccccccccCccccc-----cccccCCCcceeecCHhHhcc----CcccchhhhhhhHHHH
Confidence 99866 5699999999876543221100 000111112457999999976 6678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 785 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 785 yELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
|||++ |..||...+.......+........+ ...+..+.+++.+||..+|.+
T Consensus 202 ~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~ 254 (269)
T cd05065 202 WEVMSYGERPYWDMSNQDVINAIEQDYRLPPP---------------------------MDCPTALHQLMLDCWQKDRNA 254 (269)
T ss_pred HHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCc---------------------------ccCCHHHHHHHHHHcCCChhh
Confidence 99886 99999888777776666543221111 112456899999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 002738 864 RPTAGDLYEMFVAR 877 (886)
Q Consensus 864 RPSA~EILehLe~l 877 (886)
||++.+|+..|+++
T Consensus 255 Rp~~~~i~~~l~~~ 268 (269)
T cd05065 255 RPKFGQIVSTLDKM 268 (269)
T ss_pred CcCHHHHHHHHHhh
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=321.32 Aligned_cols=259 Identities=29% Similarity=0.472 Sum_probs=205.9
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
+.++|++.+.||.|+||.||++.+ .+..+++|+.... .....+. +.+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELED----FMVEIDILSECKHPNIVGLYEAYFYE 74 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHH----HHHHHHHHHhCCCCceeEEEEEEecC
Confidence 456799999999999999999997 4678888886533 2223333 38899999999999999999998865
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
. ..++||||+++++|.+++.. ....+++..++.++.|++.||.|||++||+|+||||+||++
T Consensus 75 ~--------------~~~lv~e~~~~~~L~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili 136 (280)
T cd06611 75 N--------------KLWILIEFCDGGALDSIMLE----LERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL 136 (280)
T ss_pred C--------------eEEEEeeccCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE
Confidence 4 36999999999999999875 23468999999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~~s~KSDIWSLGVILy 785 (886)
+.+ +.++|+|||++........ ......+++.|+|||++.... ....++.++||||||+++|
T Consensus 137 ~~~-------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~ 199 (280)
T cd06611 137 TLD-------GDVKLADFGVSAKNKSTLQ----------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLI 199 (280)
T ss_pred CCC-------CCEEEccCccchhhccccc----------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHH
Confidence 877 5699999998865433211 112346899999999986321 1245778999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
+|++|+.||...+.......+.....+.+.. ....+..+.+||.+||+.+|.+||
T Consensus 200 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~p~~Rp 254 (280)
T cd06611 200 ELAQMEPPHHELNPMRVLLKILKSEPPTLDQ-------------------------PSKWSSSFNDFLKSCLVKDPDDRP 254 (280)
T ss_pred HHHhCCCCcccCCHHHHHHHHhcCCCCCcCC-------------------------cccCCHHHHHHHHHHhccChhhCc
Confidence 9999999998887766665655443322210 011245789999999999999999
Q ss_pred CHHHHHHHHH
Q 002738 866 TAGDLYEMFV 875 (886)
Q Consensus 866 SA~EILehLe 875 (886)
++.++++|-.
T Consensus 255 s~~~il~~~~ 264 (280)
T cd06611 255 TAAELLKHPF 264 (280)
T ss_pred CHHHHhcChh
Confidence 9999999844
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=333.18 Aligned_cols=261 Identities=23% Similarity=0.284 Sum_probs=200.6
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|++.+.||+|+||.||+++. .+..+|+|+...... ...... ..+.+|+.++..++|+||+++++++....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~----~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM-LKRAET----ACFREERDVLVNGDRRWITNLHYAFQDEN- 74 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhhH----HHHHHHHHHHHhCCCCCCCceEEEEecCC-
Confidence 4799999999999999999997 467899998642111 111122 23488999999999999999999988655
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..|+||||++||+|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 137 (331)
T cd05597 75 -------------NLYLVMDYYVGGDLLTLLSK----FEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDK 137 (331)
T ss_pred -------------eEEEEEecCCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECC
Confidence 36999999999999999975 1346899999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC-CCCCCchhhHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~-~~~~s~KSDIWSLGVILyEL 787 (886)
+ +.+||+|||++..+...... ......||+.|+|||++..... ...++.++|||||||++|||
T Consensus 138 ~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el 201 (331)
T cd05597 138 N-------GHIRLADFGSCLRLLADGTV---------QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEM 201 (331)
T ss_pred C-------CCEEEEECCceeecCCCCCc---------cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHH
Confidence 7 46999999998765432111 1122469999999999974221 24578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--C
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE--R 864 (886)
Q Consensus 788 LTG~~PF~g~s~~el~~~I~~~~-rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k--R 864 (886)
++|+.||.+.+..+....+.... ...++ ......++.+.+||.+||..++.+ |
T Consensus 202 ~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~~li~~ll~~~~~r~~r 257 (331)
T cd05597 202 LYGETPFYAESLVETYGKIMNHKEHFQFP------------------------PDVTDVSEEAKDLIRRLICSPETRLGR 257 (331)
T ss_pred hhCCCCCCCCCHHHHHHHHHcCCCcccCC------------------------CccCCCCHHHHHHHHHHccCcccccCC
Confidence 99999998887776666654331 11111 001123567899999988764444 7
Q ss_pred CCHHHHHHHH
Q 002738 865 PTAGDLYEMF 874 (886)
Q Consensus 865 PSA~EILehL 874 (886)
|++.++++|-
T Consensus 258 ~~~~~~l~hp 267 (331)
T cd05597 258 NGLQDFKDHP 267 (331)
T ss_pred CCHHHHhcCC
Confidence 8999999993
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=320.20 Aligned_cols=246 Identities=21% Similarity=0.342 Sum_probs=186.6
Q ss_pred eecccCceEEEEEEEC--------------------------CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC
Q 002738 558 EAGKSVSSSLFRCKFG--------------------------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL 611 (886)
Q Consensus 558 ~LG~G~fG~VY~A~~~--------------------------~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L 611 (886)
.||+|+||.||+|... ...+++|+.... .......+.+|+.+++.+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--------~~~~~~~~~~~~~~~~~l 73 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--------HRDIALAFFETASLMSQV 73 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--------HHHHHHHHHHHHHHHhcC
Confidence 6999999999999741 123566664211 112223458899999999
Q ss_pred CCCCcceeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHh
Q 002738 612 RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS 691 (886)
Q Consensus 612 ~HPNIVrl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs 691 (886)
+||||+++++++.... ..++||||+++++|..++.. ....+++..+..++.||+.||+|||+
T Consensus 74 ~h~niv~~~~~~~~~~--------------~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~ 135 (274)
T cd05076 74 SHIHLAFVHGVCVRGS--------------ENIMVEEFVEHGPLDVCLRK----EKGRVPVAWKITVAQQLASALSYLED 135 (274)
T ss_pred CCCCeeeEEEEEEeCC--------------ceEEEEecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHc
Confidence 9999999999998654 35999999999999999864 23468899999999999999999999
Q ss_pred CCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCC
Q 002738 692 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 771 (886)
Q Consensus 692 ~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~ 771 (886)
+||+||||||+|||++..+........+||+|||++...... ....++..|+|||.+.+ ...+
T Consensus 136 ~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~--------------~~~~~~~~~~aPe~~~~---~~~~ 198 (274)
T cd05076 136 KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR--------------EERVERIPWIAPECVPG---GNSL 198 (274)
T ss_pred CCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc--------------cccccCCcccCchhhcC---CCCC
Confidence 999999999999999875432223456899999987543221 11247888999999864 2457
Q ss_pred CchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHH
Q 002738 772 GLEVDIWSYGCLLLELL-TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 850 (886)
Q Consensus 772 s~KSDIWSLGVILyELL-TG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~ 850 (886)
+.++|||||||++|||+ +|+.||....+.+....+..... ++ ....+.+.
T Consensus 199 ~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~---------------------------~~~~~~~~ 249 (274)
T cd05076 199 STAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHR--LP---------------------------EPSCKELA 249 (274)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhccC--CC---------------------------CCCChHHH
Confidence 89999999999999995 79999987765544332221110 00 00123689
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHH
Q 002738 851 DVFRRCTEENPTERPTAGDLYEMFV 875 (886)
Q Consensus 851 dLL~rCL~~DP~kRPSA~EILehLe 875 (886)
+||.+||+.+|.+|||+.+|+++|.
T Consensus 250 ~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 250 TLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHHcccChhhCcCHHHHHHhhC
Confidence 9999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=319.31 Aligned_cols=261 Identities=24% Similarity=0.363 Sum_probs=203.8
Q ss_pred CCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeee
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 621 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~-------~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g 621 (886)
..++|++.+.||+|+||.||+|.+ .+..+|+|+.... ....... .+.+|+.+++++.||||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~----~~~~ei~~l~~l~h~~iv~~~~ 75 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQA----DFQREAALMAEFDHPNIVKLLG 75 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC---cCHHHHH----HHHHHHHHHHhcCCCchheEEE
Confidence 457899999999999999999986 3467888875322 1222223 3488999999999999999999
Q ss_pred eEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhc-----------------cCCCcCCHHHHHHHHHHHHH
Q 002738 622 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------------TGEKHVSVKLALFIAQDVAA 684 (886)
Q Consensus 622 ~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~-----------------~~~~~Ls~~~i~~Ia~QIa~ 684 (886)
++..... .++||||+++++|.+++..... .....+++..++.++.||+.
T Consensus 76 ~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~ 141 (288)
T cd05050 76 VCAVGKP--------------MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAA 141 (288)
T ss_pred EEcCCCc--------------cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHH
Confidence 9876543 5999999999999999975321 11134788899999999999
Q ss_pred HHHHHHhCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhc
Q 002738 685 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 764 (886)
Q Consensus 685 AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~ 764 (886)
||.|||+++++||||||+|||++.+ +.++|+|||++......... .......++..|+|||++.+
T Consensus 142 aL~~lH~~~i~H~dl~p~nil~~~~-------~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~ 206 (288)
T cd05050 142 GMAYLSERKFVHRDLATRNCLVGEN-------MVVKIADFGLSRNIYSADYY--------KASENDAIPIRWMPPESIFY 206 (288)
T ss_pred HHHHHHhCCeecccccHhheEecCC-------CceEECccccceecccCccc--------cccCCCccChhhcCHHHHhc
Confidence 9999999999999999999999876 56999999998755332111 00112235678999999876
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhh
Q 002738 765 MHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 843 (886)
Q Consensus 765 ~~~~~~~s~KSDIWSLGVILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (886)
..++.++|||||||++|||++ |..||.+....+....+..+.....+ .
T Consensus 207 ----~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~ 255 (288)
T cd05050 207 ----NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCP---------------------------D 255 (288)
T ss_pred ----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC---------------------------C
Confidence 668899999999999999997 88999888877777666554322111 1
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002738 844 ETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 876 (886)
Q Consensus 844 ~~s~~L~dLL~rCL~~DP~kRPSA~EILehLe~ 876 (886)
..+..+.+||.+||+.+|.+|||+.||++.|+.
T Consensus 256 ~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 256 NCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 124578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=318.57 Aligned_cols=273 Identities=22% Similarity=0.292 Sum_probs=197.4
Q ss_pred CCc-eeeeeecccCceEEEEEEE------CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeE
Q 002738 551 PSL-SSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 623 (886)
Q Consensus 551 ~~Y-~i~k~LG~G~fG~VY~A~~------~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~ 623 (886)
++| ++.+.||+|+||+||++.+ .+..+|+|+..... ...... .+.+|+.+|++++||||+++++++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~----~~~~E~~~l~~l~h~~i~~~~~~~ 75 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTS----GWKKEINILKTLYHENIVKYKGCC 75 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHH----HHHHHHHHHHhCCCCCEeeEEEEE
Confidence 355 8999999999999998763 35578999864331 112222 348899999999999999999988
Q ss_pred ecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 002738 624 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703 (886)
Q Consensus 624 ~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsN 703 (886)
..... ...++||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 76 ~~~~~------------~~~~lv~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~N 137 (283)
T cd05080 76 SEQGG------------KGLQLIMEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARN 137 (283)
T ss_pred ecCCC------------ceEEEEecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChhe
Confidence 65331 246999999999999999975 358999999999999999999999999999999999
Q ss_pred EEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 002738 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783 (886)
Q Consensus 704 ILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVI 783 (886)
||++.+ ..++|+|||++........... ......++..|+|||++.+ ..++.++||||||++
T Consensus 138 ili~~~-------~~~~l~dfg~~~~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~----~~~~~~~Di~slG~~ 199 (283)
T cd05080 138 VLLDND-------RLVKIGDFGLAKAVPEGHEYYR-------VREDGDSPVFWYAVECLKE----NKFSYASDVWSFGVT 199 (283)
T ss_pred EEEcCC-------CcEEEeecccccccCCcchhhc-------cCCCCCCCceeeCHhHhcc----cCCCcccccHHHHHH
Confidence 999876 4699999999986643221100 0111235677999999875 567899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 784 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 784 LyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
+|||+||..||...... ....+...........+... ..... ........+..+.+|+.+||+.+|++
T Consensus 200 l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~--------~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~ 267 (283)
T cd05080 200 LYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIEL--------LERGM---RLPCPKNCPQEVYILMKNCWETEAKF 267 (283)
T ss_pred HHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhh--------hhcCC---CCCCCCCCCHHHHHHHHHHhccChhh
Confidence 99999999998654321 11111110000000000000 00000 00111234568999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 002738 864 RPTAGDLYEMFVART 878 (886)
Q Consensus 864 RPSA~EILehLe~l~ 878 (886)
|||+++|++.|+.+.
T Consensus 268 Rps~~~i~~~l~~~~ 282 (283)
T cd05080 268 RPTFRSLIPILKEMH 282 (283)
T ss_pred CCCHHHHHHHHHHhh
Confidence 999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=313.08 Aligned_cols=256 Identities=25% Similarity=0.391 Sum_probs=204.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~-~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
...++|++.+.||+|+||.||+|.. ++..+++|...... .. .+. +.+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~--~~---~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT--MS---PEA----FLQEAQIMKKLRHDKLVQLYAVCSEE 73 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc--cC---HHH----HHHHHHHHhhCCCCCEeeeeeeeecC
Confidence 5567899999999999999999987 34568888754221 11 222 48899999999999999999998754
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
. ..++||||+++++|.+++.. .....+++..+..++.||+.||.|||++||+|+||||+||++
T Consensus 74 ~--------------~~~~v~e~~~~~~L~~~i~~---~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili 136 (261)
T cd05034 74 E--------------PIYIVTEYMSKGSLLDFLKS---GEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV 136 (261)
T ss_pred C--------------ceEEEEeccCCCCHHHHHhc---cccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE
Confidence 4 36999999999999999975 223468999999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +.++|+|||++......... ......++..|+|||.+.+ ..++.++||||||+++|+
T Consensus 137 ~~~-------~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~il~~ 196 (261)
T cd05034 137 GEN-------LVCKIADFGLARLIEDDEYT---------AREGAKFPIKWTAPEAANY----GRFTIKSDVWSFGILLTE 196 (261)
T ss_pred cCC-------CCEEECccccceeccchhhh---------hhhccCCCccccCHHHhcc----CCcCchhHHHHHHHHHHH
Confidence 877 56999999998766432111 0111235678999999876 567899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 787 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 787 LLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
|++ |+.||.+.+.......+........+. ..+..+.+++.+||..+|.+||
T Consensus 197 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~i~~~l~~~p~~Rp 249 (261)
T cd05034 197 IVTYGRVPYPGMTNREVLEQVERGYRMPRPP---------------------------NCPEELYDLMLQCWDKDPEERP 249 (261)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcccCcccCC
Confidence 998 999998888777776665543222111 1244689999999999999999
Q ss_pred CHHHHHHHHHh
Q 002738 866 TAGDLYEMFVA 876 (886)
Q Consensus 866 SA~EILehLe~ 876 (886)
++.++++.|+.
T Consensus 250 ~~~~l~~~l~~ 260 (261)
T cd05034 250 TFEYLQSFLED 260 (261)
T ss_pred CHHHHHHHHhc
Confidence 99999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=316.61 Aligned_cols=246 Identities=20% Similarity=0.370 Sum_probs=186.5
Q ss_pred eeecccCceEEEEEEEC--------------CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeee
Q 002738 557 DEAGKSVSSSLFRCKFG--------------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 622 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~~--------------~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~ 622 (886)
+.||+|+||.||+|++. ...+++|+.... . ......+.+|+.++..++||||++++++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~----~~~~~~~~~~~~~l~~l~hp~iv~~~~~ 72 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS----H----RDISLAFFETASMMRQVSHKHIVLLYGV 72 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh----h----hhHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 46899999999999852 124666663211 1 1222345889999999999999999999
Q ss_pred EecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 002738 623 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 702 (886)
Q Consensus 623 ~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPs 702 (886)
+..... .++||||+++++|..++.. ....+++..++.++.||+.||+|||++||+||||||+
T Consensus 73 ~~~~~~--------------~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 134 (262)
T cd05077 73 CVRDVE--------------NIMVEEFVEFGPLDLFMHR----KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTK 134 (262)
T ss_pred EecCCC--------------CEEEEecccCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcc
Confidence 886543 5999999999999998864 2245899999999999999999999999999999999
Q ss_pred CEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 002738 703 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 782 (886)
Q Consensus 703 NILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGV 782 (886)
|||++.++........++++|||++...... ....++..|+|||++.. ...++.++|||||||
T Consensus 135 Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~--------------~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~ 197 (262)
T cd05077 135 NILLAREGIDGECGPFIKLSDPGIPITVLSR--------------QECVERIPWIAPECVED---SKNLSIAADKWSFGT 197 (262)
T ss_pred cEEEecCCccCCCCceeEeCCCCCCccccCc--------------ccccccccccChhhhcC---CCCCCchhHHHHHHH
Confidence 9999876432233345999999998654321 22357889999998863 256788999999999
Q ss_pred HHHHHH-hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 002738 783 LLLELL-TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 861 (886)
Q Consensus 783 ILyELL-TG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP 861 (886)
++|||+ +|..||......+...... ..... .....+.+.+||.+||+.||
T Consensus 198 ~l~el~~~~~~p~~~~~~~~~~~~~~-~~~~~----------------------------~~~~~~~~~~li~~cl~~dp 248 (262)
T cd05077 198 TLWEICYNGEIPLKDKTLAEKERFYE-GQCML----------------------------VTPSCKELADLMTHCMNYDP 248 (262)
T ss_pred HHHHHHhCCCCCCCCcchhHHHHHHh-cCccC----------------------------CCCChHHHHHHHHHHcCCCh
Confidence 999998 5888887665443322211 11000 00123578999999999999
Q ss_pred CCCCCHHHHHHHH
Q 002738 862 TERPTAGDLYEMF 874 (886)
Q Consensus 862 ~kRPSA~EILehL 874 (886)
.+||++.+|+++|
T Consensus 249 ~~Rp~~~~il~~~ 261 (262)
T cd05077 249 NQRPFFRAIMRDI 261 (262)
T ss_pred hhCcCHHHHHHhc
Confidence 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=318.87 Aligned_cols=260 Identities=23% Similarity=0.340 Sum_probs=202.1
Q ss_pred CCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeee
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 621 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~-------~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g 621 (886)
.+.+|.+.++||+|+||.||++.. .+..+++|... .. ...... .+.+|+.+++.++||||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~--~~--~~~~~~----~~~~e~~~l~~l~h~~i~~~~~ 74 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK--EA--SESARQ----DFQREAELLTVLQHQHIVRFYG 74 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecC--cC--CHHHHH----HHHHHHHHHhcCCCCCCceEEE
Confidence 356789999999999999999974 23456777642 21 222223 3489999999999999999999
Q ss_pred eEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhcc----------CCCcCCHHHHHHHHHHHHHHHHHHHh
Q 002738 622 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET----------GEKHVSVKLALFIAQDVAAALVELHS 691 (886)
Q Consensus 622 ~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~----------~~~~Ls~~~i~~Ia~QIa~AL~yLHs 691 (886)
++..... .++||||+++++|.+++...... ....+++..++.++.||+.||+|||+
T Consensus 75 ~~~~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 140 (280)
T cd05092 75 VCTEGRP--------------LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS 140 (280)
T ss_pred EEecCCc--------------eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH
Confidence 9876543 59999999999999999763210 11357889999999999999999999
Q ss_pred CCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCC
Q 002738 692 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 771 (886)
Q Consensus 692 ~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~ 771 (886)
+||+||||||+|||++.+ +.+||+|||++.......... ......+++.|+|||++.+ ..+
T Consensus 141 ~~i~H~dlkp~nil~~~~-------~~~kL~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~ 201 (280)
T cd05092 141 LHFVHRDLATRNCLVGQG-------LVVKIGDFGMSRDIYSTDYYR--------VGGRTMLPIRWMPPESILY----RKF 201 (280)
T ss_pred CCeecccccHhhEEEcCC-------CCEEECCCCceeEcCCCceee--------cCCCccccccccCHHHhcc----CCc
Confidence 999999999999999876 569999999987553321110 0122345788999999876 568
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHH
Q 002738 772 GLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 850 (886)
Q Consensus 772 s~KSDIWSLGVILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~ 850 (886)
+.++|||||||++|||++ |.+||...........+..+..+..+ ...++.+.
T Consensus 202 ~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~ 254 (280)
T cd05092 202 TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERP---------------------------RTCPPEVY 254 (280)
T ss_pred CchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccCCCC---------------------------CCCCHHHH
Confidence 899999999999999998 99999887777666666554332211 11245689
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHh
Q 002738 851 DVFRRCTEENPTERPTAGDLYEMFVA 876 (886)
Q Consensus 851 dLL~rCL~~DP~kRPSA~EILehLe~ 876 (886)
+|+.+||+.||.+||++.+|++.|++
T Consensus 255 ~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 255 AIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHHHccCChhhCCCHHHHHHHHhC
Confidence 99999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=311.70 Aligned_cols=257 Identities=28% Similarity=0.422 Sum_probs=202.4
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
-++|++.+.||.|+||.||+|.. .+..+++|+...... ...+ .+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~----~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG----DDFE----IIQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch----hhHH----HHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 36899999999999999999997 456799998764421 1223 3489999999999999999999987654
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
..+++|||+++++|.+++.. ....+++..+..++.|++.||+|||++||+|+||||+||+++
T Consensus 74 --------------~~~l~~e~~~~~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~ 135 (262)
T cd06613 74 --------------KLWIVMEYCGGGSLQDIYQV----TRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT 135 (262)
T ss_pred --------------EEEEEEeCCCCCcHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC
Confidence 47999999999999999876 124688999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ +.+||+|||++......... .....++..|+|||++.+... ..++.++||||||+++|+|
T Consensus 136 ~~-------~~~~l~d~g~~~~~~~~~~~----------~~~~~~~~~y~~Pe~~~~~~~-~~~~~~~Di~slG~~l~~~ 197 (262)
T cd06613 136 ED-------GDVKLADFGVSAQLTATIAK----------RKSFIGTPYWMAPEVAAVERK-GGYDGKCDIWALGITAIEL 197 (262)
T ss_pred CC-------CCEEECccccchhhhhhhhc----------cccccCCccccCchhhccccc-CCcCchhhhHHHHHHHHHH
Confidence 77 45999999998765432111 123468889999999875211 2678899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 788 LTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
++|+.||...+.......+......... .......+..+.+|+.+||..+|..|||+
T Consensus 198 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 254 (262)
T cd06613 198 AELQPPMFDLHPMRALFLISKSNFPPPK-----------------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTA 254 (262)
T ss_pred HhCCCCCCCCCHHHHHHHHHhccCCCcc-----------------------ccchhhhhHHHHHHHHHHcCCChhhCCCH
Confidence 9999999887766555444333111000 00112235679999999999999999999
Q ss_pred HHHHHH
Q 002738 868 GDLYEM 873 (886)
Q Consensus 868 ~EILeh 873 (886)
.+|+.|
T Consensus 255 ~~il~~ 260 (262)
T cd06613 255 TKLLQH 260 (262)
T ss_pred HHHhcC
Confidence 999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=327.62 Aligned_cols=266 Identities=23% Similarity=0.364 Sum_probs=207.0
Q ss_pred CCCceeeeeecccCceEEEEEEEC---------CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCccee
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 619 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~~---------~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl 619 (886)
-.+|++.+.||+|+||.||+|++. ...+|+|+.... ......+. +.+|+.+++++ +||||+++
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~----~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD---ATDKDLSD----LVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc---cCHHHHHH----HHHHHHHHHhhcCCCCeeee
Confidence 357899999999999999999752 125788875322 12222333 48999999999 79999999
Q ss_pred eeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhc-----------cCCCcCCHHHHHHHHHHHHHHHHH
Q 002738 620 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVE 688 (886)
Q Consensus 620 ~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~-----------~~~~~Ls~~~i~~Ia~QIa~AL~y 688 (886)
++++.... ..++||||+++++|.+++..... .....+++..++.++.||+.||+|
T Consensus 84 ~~~~~~~~--------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~ 149 (334)
T cd05100 84 LGACTQDG--------------PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEY 149 (334)
T ss_pred eEEEccCC--------------ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHH
Confidence 99987654 36999999999999999976321 112357888999999999999999
Q ss_pred HHhCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC
Q 002738 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 768 (886)
Q Consensus 689 LHs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~ 768 (886)
||++||+||||||+|||++.+ ..+||+|||+++......... ......++..|+|||++.+
T Consensus 150 LH~~givH~dlkp~Nill~~~-------~~~kL~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~---- 210 (334)
T cd05100 150 LASQKCIHRDLAARNVLVTED-------NVMKIADFGLARDVHNIDYYK--------KTTNGRLPVKWMAPEALFD---- 210 (334)
T ss_pred HHHCCeeccccccceEEEcCC-------CcEEECCcccceecccccccc--------cccCCCcCceEcCHHHhcc----
Confidence 999999999999999999876 469999999997654321110 0111234578999999976
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHH
Q 002738 769 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 847 (886)
Q Consensus 769 ~~~s~KSDIWSLGVILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 847 (886)
..++.++|||||||++|||++ |..||.+.+..+....+.....+..+ ...+.
T Consensus 211 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~ 263 (334)
T cd05100 211 RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP---------------------------ANCTH 263 (334)
T ss_pred CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCH
Confidence 667899999999999999998 89999988877777766554332221 11244
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 002738 848 FLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSI 882 (886)
Q Consensus 848 ~L~dLL~rCL~~DP~kRPSA~EILehLe~l~sss~ 882 (886)
.+.+|+.+||+.+|.+||++.+++++|+.+...+.
T Consensus 264 ~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 264 ELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred HHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 78999999999999999999999999998875443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=317.25 Aligned_cols=278 Identities=24% Similarity=0.299 Sum_probs=202.7
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|++.+.||+|+||.||+|++ .+..+|+|+....... ... .+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~----~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~- 73 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD--PVI----KKIALREIRMLKQLKHPNLVNLIEVFRRKR- 73 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC--ccc----cHHHHHHHHHHHhCCCCCEeeeeeEEeeCC-
Confidence 4799999999999999999997 4678999986433211 111 123478999999999999999999988654
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..++||||+++++|..++.. ...+++..++.++.||+.||+|||++||+||||||+||+++.
T Consensus 74 -------------~~~~v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~ 135 (286)
T cd07847 74 -------------KLHLVFEYCDHTVLNELEKN-----PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITK 135 (286)
T ss_pred -------------EEEEEEeccCccHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcC
Confidence 46999999998888877654 345899999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.++|+|||++......... .....++..|+|||++.+ ...++.++||||||+++|+|+
T Consensus 136 ~-------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~i~~~l~ 195 (286)
T cd07847 136 Q-------GQIKLCDFGFARILTGPGDD----------YTDYVATRWYRAPELLVG---DTQYGPPVDVWAIGCVFAELL 195 (286)
T ss_pred C-------CcEEECccccceecCCCccc----------ccCcccccccCCHHHHhC---CCCcCchhhhHHHHHHHHHHH
Confidence 6 46999999999866432211 122357889999999875 245788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccc----ccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE----HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 864 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~----~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kR 864 (886)
+|..||.+.+..+....+........+... ..+.... ...................+..+.+|+.+||+.+|++|
T Consensus 196 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 274 (286)
T cd07847 196 TGQPLWPGKSDVDQLYLIRKTLGDLIPRHQ-QIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTER 274 (286)
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCChHHh-hhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCcccc
Confidence 999999887766555444432221111110 0000000 00000000000011122346789999999999999999
Q ss_pred CCHHHHHHHH
Q 002738 865 PTAGDLYEMF 874 (886)
Q Consensus 865 PSA~EILehL 874 (886)
|++.+++.|-
T Consensus 275 p~~~eil~~~ 284 (286)
T cd07847 275 LSCEELLEHP 284 (286)
T ss_pred CCHHHHhcCC
Confidence 9999999873
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=363.73 Aligned_cols=268 Identities=21% Similarity=0.322 Sum_probs=204.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
..+++|.+.+.||.|+||.||+|++ .+..+|+|++.... ....... .+..|+.+|+.|+|||||+++++|..
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~--l~e~~~~----~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRG--LKEREKS----QLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccc--cCHHHHH----HHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 5678999999999999999999997 45678888865432 2222333 34899999999999999999999875
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhC-------CccccC
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-------HIMHRD 698 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~-------gIVHRD 698 (886)
... ..+||||||+++++|.++|...... ...+++..++.|+.||+.||.|||+. +|||||
T Consensus 84 e~~------------~~lyIVMEY~~gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRD 150 (1021)
T PTZ00266 84 KAN------------QKLYILMEFCDAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRD 150 (1021)
T ss_pred cCC------------CEEEEEEeCCCCCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceecc
Confidence 431 2479999999999999999763322 24689999999999999999999984 499999
Q ss_pred CCCCCEEEecccc----------CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC
Q 002738 699 IKSENILIDLERK----------KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 768 (886)
Q Consensus 699 LKPsNILLd~d~~----------~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~ 768 (886)
|||+||||+.... ...+...+||+|||++..+..... .....||+.|+|||++.+. .
T Consensus 151 LKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~-----------~~s~vGTp~YmAPEvL~ge--~ 217 (1021)
T PTZ00266 151 LKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM-----------AHSCVGTPYYWSPELLLHE--T 217 (1021)
T ss_pred CcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccccc-----------ccccCCCccccCHHHHhcc--C
Confidence 9999999975321 112345699999999976533211 1234699999999998641 2
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHH
Q 002738 769 NLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 847 (886)
Q Consensus 769 ~~~s~KSDIWSLGVILyELLTG~~PF~g~s~~-el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 847 (886)
..++.++||||||||||||+||+.||...... .+...+.... .++ ....+.
T Consensus 218 ~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p--~lp--------------------------i~~~S~ 269 (1021)
T PTZ00266 218 KSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGP--DLP--------------------------IKGKSK 269 (1021)
T ss_pred CCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCC--CCC--------------------------cCCCCH
Confidence 45789999999999999999999999765443 3333332221 111 001245
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002738 848 FLVDVFRRCTEENPTERPTAGDLYEMFV 875 (886)
Q Consensus 848 ~L~dLL~rCL~~DP~kRPSA~EILehLe 875 (886)
.+.+||..||..+|.+||++.++|.|-.
T Consensus 270 eL~dLI~~~L~~dPeeRPSa~QlL~h~~ 297 (1021)
T PTZ00266 270 ELNILIKNLLNLSAKERPSALQCLGYQI 297 (1021)
T ss_pred HHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence 7899999999999999999999997633
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=312.66 Aligned_cols=258 Identities=21% Similarity=0.326 Sum_probs=201.9
Q ss_pred CCCceeeeeecccCceEEEEEEEC--C---eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEe
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKFG--S---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 624 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~~--~---~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~ 624 (886)
..+|+..+.||+|+||.||+|+.. + ..+++|..... ......+ .+.+|+.++++++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG---YTEKQRQ----DFLSEASIMGQFSHHNIIRLEGVVT 76 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc---CCHHHHH----HHHHHHHHHhcCCCCCeeEEEEEEc
Confidence 357889999999999999999863 2 25777764322 1122223 3489999999999999999999987
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNI 704 (886)
.... .++||||+++++|.+++.. ....+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 77 ~~~~--------------~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Ni 138 (268)
T cd05063 77 KFKP--------------AMIITEYMENGALDKYLRD----HDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNI 138 (268)
T ss_pred cCCC--------------cEEEEEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhE
Confidence 6543 5999999999999999975 224689999999999999999999999999999999999
Q ss_pred EEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVIL 784 (886)
|++.+ ..+||+|||++.......... ........+..|+|||++.+ ..++.++|||||||++
T Consensus 139 li~~~-------~~~kl~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slG~il 200 (268)
T cd05063 139 LVNSN-------LECKVSDFGLSRVLEDDPEGT-------YTTSGGKIPIRWTAPEAIAY----RKFTSASDVWSFGIVM 200 (268)
T ss_pred EEcCC-------CcEEECCCccceecccccccc-------eeccCCCcCceecCHHHhhc----CCcChHhHHHHHHHHH
Confidence 99876 569999999987654322110 00111223567999999875 5678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 785 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 785 yELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
|||++ |..||...+...+...+......+.+ ...+..+.+|+.+||..+|.+
T Consensus 201 ~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~~~~li~~c~~~~p~~ 253 (268)
T cd05063 201 WEVMSFGERPYWDMSNHEVMKAINDGFRLPAP---------------------------MDCPSAVYQLMLQCWQQDRAR 253 (268)
T ss_pred HHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCC---------------------------CCCCHHHHHHHHHHcCCCccc
Confidence 99997 99999887777776666544222111 112457899999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 002738 864 RPTAGDLYEMFVAR 877 (886)
Q Consensus 864 RPSA~EILehLe~l 877 (886)
||++.+|++.|+++
T Consensus 254 Rp~~~~i~~~l~~~ 267 (268)
T cd05063 254 RPRFVDIVNLLDKL 267 (268)
T ss_pred CcCHHHHHHHHHhh
Confidence 99999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=335.75 Aligned_cols=245 Identities=25% Similarity=0.308 Sum_probs=191.6
Q ss_pred ecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC---CCCCcceeeeeEecCCCCCCCC
Q 002738 559 AGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKISSKWLPSAD 633 (886)
Q Consensus 559 LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L---~HPNIVrl~g~~~~~~~l~~~~ 633 (886)
||+|+||.||+|+. .+..+|+|++....... .... ..+..|..++..+ .||||+++++++....
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~----~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~------ 69 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA-KKEV----AHTIGERNILVRTLLDESPFIVGLKFSFQTDS------ 69 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh-hhHH----HHHHHHHHHHHHhccCCCCcCcceEEEEecCC------
Confidence 79999999999987 56789999874322111 1111 1235677777665 6999999999988665
Q ss_pred CCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCC
Q 002738 634 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 713 (886)
Q Consensus 634 ~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~ 713 (886)
..|+||||+++|+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~---- 132 (330)
T cd05586 70 --------DLYLVTDYMSGGELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT---- 132 (330)
T ss_pred --------eEEEEEcCCCCChHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC----
Confidence 36999999999999999875 3568999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 002738 714 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 793 (886)
Q Consensus 714 ~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~P 793 (886)
+.+||+|||++........ ......||+.|+|||++.+ ...++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kl~Dfg~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslGvil~elltG~~P 196 (330)
T cd05586 133 ---GHIALCDFGLSKANLTDNK----------TTNTFCGTTEYLAPEVLLD---EKGYTKHVDFWSLGVLVFEMCCGWSP 196 (330)
T ss_pred ---CCEEEecCCcCcCCCCCCC----------CccCccCCccccCHHHHcC---CCCCCCccceeccccEEEEeccCCCC
Confidence 4699999999875322111 1123469999999999874 23478899999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC----CHHH
Q 002738 794 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP----TAGD 869 (886)
Q Consensus 794 F~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP----SA~E 869 (886)
|.+.+..++...+..+... ++. ...++.+.+||.+||..||.+|| ++.+
T Consensus 197 f~~~~~~~~~~~i~~~~~~-~~~--------------------------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 249 (330)
T cd05586 197 FYAEDTQQMYRNIAFGKVR-FPK--------------------------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVE 249 (330)
T ss_pred CCCCCHHHHHHHHHcCCCC-CCC--------------------------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHH
Confidence 9988877777666544221 110 01245788999999999999998 6888
Q ss_pred HHHHH
Q 002738 870 LYEMF 874 (886)
Q Consensus 870 ILehL 874 (886)
+++|-
T Consensus 250 ll~h~ 254 (330)
T cd05586 250 LKEHP 254 (330)
T ss_pred HhcCc
Confidence 88874
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=318.99 Aligned_cols=288 Identities=18% Similarity=0.230 Sum_probs=202.8
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEecCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 627 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~~~~ 627 (886)
++|++.+.||+|+||.||+|.+ .+..||+|+....... .. ....+.+|+.+++.+. ||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~--~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 74 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE--EG----IPPTALREISLLQMLSESIYIVRLLDVEHVEE 74 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc--cC----CchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence 4789999999999999999997 5678999986543211 11 1123478999999996 699999999987654
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
. ......|+||||+++ +|.+++..........+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 75 ~---------~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~ 144 (295)
T cd07837 75 K---------NGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD 144 (295)
T ss_pred C---------CCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEe
Confidence 2 122347999999985 899998763332235689999999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+. +.+||+|||++..+...... .....+++.|+|||++.+ ...++.++||||||+++|+|
T Consensus 145 ~~~------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~l~~l 205 (295)
T cd07837 145 KQK------GLLKIADLGLGRAFSIPVKS----------YTHEIVTLWYRAPEVLLG---STHYSTPVDIWSVGCIFAEM 205 (295)
T ss_pred cCC------CeEEEeecccceecCCCccc----------cCCcccccCCCChHHhhC---CCCCCchHHHHHHHHHHHHH
Confidence 731 57999999998765332111 112247889999999864 24578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 788 LTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
++|..||.+.+.......+...........+...........................+..+.+||.+||.+||.+||++
T Consensus 206 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~ 285 (295)
T cd07837 206 SRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISA 285 (295)
T ss_pred HcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCH
Confidence 99999998877666554443321111111110000000000000000000001112346779999999999999999999
Q ss_pred HHHHHH
Q 002738 868 GDLYEM 873 (886)
Q Consensus 868 ~EILeh 873 (886)
.+++.|
T Consensus 286 ~eil~~ 291 (295)
T cd07837 286 KAALTH 291 (295)
T ss_pred HHHhcC
Confidence 999987
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.57 Aligned_cols=260 Identities=22% Similarity=0.312 Sum_probs=189.5
Q ss_pred eeecccCceEEEEEEECC----eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKFGS----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 632 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~~~----~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~ 632 (886)
+.||+|+||.||+|.+.+ ..+++|..... .. ..... .+.+|+.++++++||||+++++++.....
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~--~~-~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---- 69 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVS--AS-VQEQM----KFLEEAQPYRSLQHSNLLQCLGQCTEVTP---- 69 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCC--CC-hHHHH----HHHHHHHHHHhCCCCCEeeEEEEEcCCCC----
Confidence 468999999999998632 35677764322 11 12222 34889999999999999999999876543
Q ss_pred CCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccC
Q 002738 633 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 712 (886)
Q Consensus 633 ~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~ 712 (886)
.++||||+++|+|.+++..........+++..+..++.||+.||+|||+++|+||||||+||+++.+
T Consensus 70 ----------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~--- 136 (269)
T cd05087 70 ----------YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD--- 136 (269)
T ss_pred ----------cEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC---
Confidence 5999999999999999976333223456778888999999999999999999999999999999876
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC---CCCCchhhHHHHHHHHHHHHh
Q 002738 713 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP---NLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 713 ~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~---~~~s~KSDIWSLGVILyELLT 789 (886)
.++||+|||++......... .......++..|+|||++.+.... ..++.++||||||+++|||++
T Consensus 137 ----~~~kL~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~ 204 (269)
T cd05087 137 ----LTVKIGDYGLSHNKYKEDYY--------VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFE 204 (269)
T ss_pred ----CcEEECCccccccccCccee--------ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHh
Confidence 56999999998654322110 011223578899999998642111 235789999999999999996
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 002738 790 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868 (886)
Q Consensus 790 -G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~ 868 (886)
|..||......+............++ .+......++.+.+++.+|| .+|.+|||++
T Consensus 205 ~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~ 261 (269)
T cd05087 205 LGSQPYRHLSDEQVLTYTVREQQLKLP----------------------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAE 261 (269)
T ss_pred CCCCCCCCCChHHHHHHHhhcccCCCC----------------------CCccCCCCChHHHHHHHHHh-cCcccCCCHH
Confidence 99999877666554333222111111 01111123456889999999 6899999999
Q ss_pred HHHHHHH
Q 002738 869 DLYEMFV 875 (886)
Q Consensus 869 EILehLe 875 (886)
+|+..|.
T Consensus 262 ~l~~~l~ 268 (269)
T cd05087 262 EVHLLLS 268 (269)
T ss_pred HHHHHhc
Confidence 9998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=321.42 Aligned_cols=242 Identities=23% Similarity=0.297 Sum_probs=183.9
Q ss_pred ecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCC
Q 002738 559 AGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 636 (886)
Q Consensus 559 LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~~~~ 636 (886)
||+|+||.||+++. .+..+|+|....+..... .. ...+..|+.++++++||||+++++++....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-~~----~~~~~~E~~il~~l~hp~i~~~~~~~~~~~--------- 66 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK-SG----EKMALLEKEILEKVNSPFIVNLAYAFESKT--------- 66 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcc-hh----hHHHHHHHHHHHhcCCCcEEEEEEEEecCC---------
Confidence 79999999999986 467888888643221111 11 122367999999999999999999987654
Q ss_pred CcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCCCC
Q 002738 637 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 716 (886)
Q Consensus 637 ~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~~ 716 (886)
..++||||++|++|.+++.. .....+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 67 -----~~~lv~e~~~g~~L~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~------- 131 (277)
T cd05607 67 -----HLCLVMSLMNGGDLKYHIYN---VGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQ------- 131 (277)
T ss_pred -----eEEEEEecCCCCCHHHHHHh---ccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCC-------
Confidence 46999999999999998865 223458899999999999999999999999999999999999877
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 002738 717 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 796 (886)
Q Consensus 717 ~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF~g 796 (886)
..++|+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 132 ~~~~l~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslGv~l~el~~g~~p~~~ 196 (277)
T cd05607 132 GNCRLSDLGLAVELKDGKT-----------ITQRAGTNGYMAPEILKE----EPYSYPVDWFAMGCSIYEMVAGRTPFKD 196 (277)
T ss_pred CCEEEeeceeeeecCCCce-----------eeccCCCCCccCHHHHcc----CCCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 4699999999876543211 122358999999999976 5688999999999999999999999976
Q ss_pred CCHH----HHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 002738 797 LSEL----EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 871 (886)
Q Consensus 797 ~s~~----el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EIL 871 (886)
.... ++...+..... . ......++.+.+||.+||+.||.+||++.|++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~---~------------------------~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 197 HKEKVAKEELKRRTLEDEV---K------------------------FEHQNFTEESKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred CcchhhHHHHHHHhhcccc---c------------------------cccccCCHHHHHHHHHHhccCHhhCCCCccch
Confidence 4322 11111111100 0 00012355789999999999999999995544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.30 Aligned_cols=253 Identities=25% Similarity=0.431 Sum_probs=200.1
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
...+|++.+.||+|+||.||+|.. .+..+++|....... ...+. +.+|+.+++.+.||||+++++.+...
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~----~~~~~----~~~e~~~l~~~~h~~v~~~~~~~~~~ 89 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKEL----IINEILVMRENKNPNIVNYLDSYLVG 89 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc----chHHH----HHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence 456899999999999999999986 567888887654321 11222 38899999999999999999998754
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
. ..++||||+++++|.+++.. ..+++.++..++.|++.||+|||++||+||||||+|||+
T Consensus 90 ~--------------~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill 149 (296)
T cd06654 90 D--------------ELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149 (296)
T ss_pred C--------------EEEEeecccCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 4 47999999999999999865 357899999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +.++|+|||++......... .....|++.|+|||++.+ ..++.++|||||||++|+
T Consensus 150 ~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~s~Gvil~~ 208 (296)
T cd06654 150 GMD-------GSVKLTDFGFCAQITPEQSK----------RSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIE 208 (296)
T ss_pred cCC-------CCEEECccccchhccccccc----------cCcccCCccccCHHHHcC----CCCCccchHHHHHHHHHH
Confidence 876 46999999998764332111 122358899999999875 567899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 787 LLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
|++|+.||....+......+.....+.+. .....+..+.+|+.+||..+|.+||+
T Consensus 209 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt 263 (296)
T cd06654 209 MIEGEPPYLNENPLRALYLIATNGTPELQ-------------------------NPEKLSAIFRDFLNRCLDMDVEKRGS 263 (296)
T ss_pred HHhCCCCCCCCCHHHhHHHHhcCCCCCCC-------------------------CccccCHHHHHHHHHHCcCCcccCcC
Confidence 99999999877654433333222111111 01123456899999999999999999
Q ss_pred HHHHHHHHH
Q 002738 867 AGDLYEMFV 875 (886)
Q Consensus 867 A~EILehLe 875 (886)
+.+|++|-.
T Consensus 264 ~~eil~~~~ 272 (296)
T cd06654 264 AKELLQHQF 272 (296)
T ss_pred HHHHhhChh
Confidence 999999843
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=332.21 Aligned_cols=267 Identities=25% Similarity=0.342 Sum_probs=214.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC--eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~~--~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
..+..|++++.||.|.-|+||+++..+ ..+|+|++..... ...... .++..|-+||+.+.||.++.+|+.|..
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l-~~rkKl----~Ra~tE~eIL~~lDHPFlPTLYa~fet 148 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESL-ASRKKL----KRAQTEREILSLLDHPFLPTLYASFET 148 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHH-hhhhHH----HHHHHHHHHHHhcCCCccchhhheeec
Confidence 456789999999999999999999855 6889999643221 112222 345889999999999999999999998
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
+.+ .|+|||||+||+|..++++ +....+++..++.++..|+.||+|||-.|||+|||||+|||
T Consensus 149 ~~~--------------~cl~meyCpGGdL~~Lrqk---Qp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENIL 211 (459)
T KOG0610|consen 149 DKY--------------SCLVMEYCPGGDLHSLRQK---QPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENIL 211 (459)
T ss_pred cce--------------eEEEEecCCCccHHHHHhh---CCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeE
Confidence 886 5999999999999999886 56678999999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCccccccccccc--------------------c-------c-c-----------------
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTC--------------------C-------I-A----------------- 740 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~--------------------~-------~-~----------------- 740 (886)
|..+ +.+.|+||.++.......... + . .
T Consensus 212 vred-------GHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~ 284 (459)
T KOG0610|consen 212 VRED-------GHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELV 284 (459)
T ss_pred EecC-------CcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhh
Confidence 9988 569999999887542210000 0 0 0
Q ss_pred -cCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHh
Q 002738 741 -HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 819 (886)
Q Consensus 741 -~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~ 819 (886)
.........++||-.|.|||++.| ...+.++|.|+|||+||||+.|..||.|.+..+.+..|..... .++.
T Consensus 285 aep~~~RSnSFVGThEYlAPEvI~G----~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l-~Fp~--- 356 (459)
T KOG0610|consen 285 AEPTGARSNSFVGTHEYLAPEVIRG----EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPL-KFPE--- 356 (459)
T ss_pred cCCCCccccccccccccccceeeec----CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCC-cCCC---
Confidence 001123356799999999999998 6678999999999999999999999999988888777755421 1221
Q ss_pred hhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC----HHHHHHH
Q 002738 820 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT----AGDLYEM 873 (886)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS----A~EILeh 873 (886)
. +..+..+++||+++|.+||.+|.. |.||-+|
T Consensus 357 ---------------------~-~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 357 ---------------------E-PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred ---------------------C-CcchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence 0 134568999999999999999998 9999887
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=311.67 Aligned_cols=251 Identities=26% Similarity=0.407 Sum_probs=202.3
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
+|++.+.||+|+||.||+|.. .+..+++|.+.... ....... .+.+|+.+++.++||||+++++.+....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~----~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 72 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQ--MTKDERL----AAQNECQVLKLLSHPNIIEYYENFLEDK-- 72 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccc--cccHHHH----HHHHHHHHHhhCCCCchhheeeeEecCC--
Confidence 589999999999999999986 66788888865432 2222333 3489999999999999999999887544
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..++||||+++++|.+++... ....+++..+..++.|++.||+|||++||+|+||||+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~ 137 (256)
T cd08220 73 ------------ALMIVMEYAPGGTLAEYIQKR---CNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKH 137 (256)
T ss_pred ------------EEEEEEecCCCCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 469999999999999999762 23458899999999999999999999999999999999999755
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+ ..++|+|||++........ .....|+..|+|||.+.+ ..++.++||||||+++|+|++
T Consensus 138 ~------~~~~l~d~~~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~~l~~l~~ 196 (256)
T cd08220 138 K------MVVKIGDFGISKILSSKSK-----------AYTVVGTPCYISPELCEG----KPYNQKSDIWALGCVLYELAS 196 (256)
T ss_pred C------CEEEEccCCCceecCCCcc-----------ccccccCCcccCchhccC----CCCCcccchHHHHHHHHHHHh
Confidence 2 4689999999986643221 122458899999999875 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 869 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~E 869 (886)
|..||.+.+.......+.......+++ ..+..+.+++.+||..+|.+|||+.+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rpt~~~ 249 (256)
T cd08220 197 LKRAFEAANLPALVLKIMSGTFAPISD---------------------------RYSPDLRQLILSMLNLDPSKRPQLSQ 249 (256)
T ss_pred CCCCcccCchHHHHHHHHhcCCCCCCC---------------------------CcCHHHHHHHHHHccCChhhCCCHHH
Confidence 999998877666655554443322221 12457899999999999999999999
Q ss_pred HHHH
Q 002738 870 LYEM 873 (886)
Q Consensus 870 ILeh 873 (886)
++.|
T Consensus 250 ll~~ 253 (256)
T cd08220 250 IMAQ 253 (256)
T ss_pred HhhC
Confidence 9987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=320.10 Aligned_cols=280 Identities=21% Similarity=0.242 Sum_probs=204.8
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
+|.+.+.||.|+||.||+|.+ .+..+++|.+......... ......+..|+.++++++|+||+++++++....
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-- 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAK---DGINFTALREIKLLQELKHPNIIGLLDVFGHKS-- 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccccc---chhhHHHHHHHHHHhhcCCCCChhhhheeecCC--
Confidence 588999999999999999997 4678999987544322111 112234478999999999999999999998654
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..++||||+ +++|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+|||++.+
T Consensus 76 ------------~~~lv~e~~-~~~L~~~i~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~ 138 (298)
T cd07841 76 ------------NINLVFEFM-ETDLEKVIKD----KSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD 138 (298)
T ss_pred ------------EEEEEEccc-CCCHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC
Confidence 369999999 8899999975 11368999999999999999999999999999999999999877
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.++|+|||++......... .....+++.|+|||.+.+ ...++.++|||||||++|||++
T Consensus 139 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~e~~~ 198 (298)
T cd07841 139 -------GVLKLADFGLARSFGSPNRK----------MTHQVVTRWYRAPELLFG---ARHYGVGVDMWSVGCIFAELLL 198 (298)
T ss_pred -------CCEEEccceeeeeccCCCcc----------ccccccceeeeCHHHHhC---CCCCCcHHHHHHHHHHHHHHHc
Confidence 46999999999766442111 122346889999999864 2457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 869 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~E 869 (886)
|.+||.+.+.......+...........+...........................+..+.+||.+||..||.+|||+.+
T Consensus 199 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e 278 (298)
T cd07841 199 RVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQ 278 (298)
T ss_pred CCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHH
Confidence 99889887766655555433221222222111110000000000111111122334678999999999999999999999
Q ss_pred HHHH
Q 002738 870 LYEM 873 (886)
Q Consensus 870 ILeh 873 (886)
+++|
T Consensus 279 ~l~~ 282 (298)
T cd07841 279 ALEH 282 (298)
T ss_pred HhhC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.23 Aligned_cols=252 Identities=27% Similarity=0.407 Sum_probs=204.3
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
+|++.+.||.|+||.||.++. .+..+++|....... ....... +.+|+.++++++|+||+++++++....
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~----~~~e~~~l~~~~h~~i~~~~~~~~~~~-- 72 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL--SEKERRD----ALNEIVILSLLQHPNIIAYYNHFMDDN-- 72 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc--chhHHHH----HHHHHHHHHhCCCCCeeEEEeEEecCC--
Confidence 589999999999999988886 567788888654332 2233333 389999999999999999999998654
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..++||||+++++|.+++... ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus 73 ------------~~~~~~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~ 137 (256)
T cd08221 73 ------------TLLIEMEYANGGTLYDKIVRQ---KGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA 137 (256)
T ss_pred ------------eEEEEEEecCCCcHHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC
Confidence 369999999999999999762 23468999999999999999999999999999999999999877
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
..+||+|||++........ ......|++.|+|||++.+ ..++.++||||||+++|||++
T Consensus 138 -------~~~kl~d~~~~~~~~~~~~----------~~~~~~~~~~y~ape~~~~----~~~~~~~Dv~slG~i~~~l~~ 196 (256)
T cd08221 138 -------GLIKLGDFGISKILGSEYS----------MAETVVGTPYYMSPELCQG----VKYNFKSDIWALGCVLYELLT 196 (256)
T ss_pred -------CCEEECcCcceEEcccccc----------cccccCCCccccCHhhcCC----CCCCCcchhHHHHHHHHHHHH
Confidence 4599999999876543221 1123468999999999876 457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 869 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~E 869 (886)
|..||......+....+..+..+..+ ...+..+.+++.+||..+|.+||++.+
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~R~s~~~ 249 (256)
T cd08221 197 LKRTFDATNPLNLVVKIVQGNYTPVV---------------------------SVYSSELISLVHSLLQQDPEKRPTADE 249 (256)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCc---------------------------cccCHHHHHHHHHHcccCcccCCCHHH
Confidence 99999888777776666554332211 122457899999999999999999999
Q ss_pred HHHHH
Q 002738 870 LYEMF 874 (886)
Q Consensus 870 ILehL 874 (886)
+++++
T Consensus 250 ll~~~ 254 (256)
T cd08221 250 VLDQP 254 (256)
T ss_pred HhhCc
Confidence 99875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=330.93 Aligned_cols=265 Identities=24% Similarity=0.360 Sum_probs=201.0
Q ss_pred CCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcceee
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMY 620 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~-------~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl~ 620 (886)
+.++|++.+.||+|+||.||+|.+ .+..||||+..... ....... +.+|+.+|.++ +||||++++
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~----~~~E~~~l~~l~~h~niv~~~ 77 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRA----LMSELKILIHIGHHLNVVNLL 77 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHH----HHHHHHHHHhccCCccHhhhc
Confidence 456899999999999999999974 34679999864321 1222333 48899999999 589999999
Q ss_pred eeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhcc-----------------------------------
Q 002738 621 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET----------------------------------- 665 (886)
Q Consensus 621 g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~----------------------------------- 665 (886)
+++..... ..++||||+++|+|.+++......
T Consensus 78 ~~~~~~~~-------------~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (343)
T cd05103 78 GACTKPGG-------------PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSS 144 (343)
T ss_pred ceeecCCC-------------ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccc
Confidence 98875432 368999999999999999752100
Q ss_pred ---------------------------CCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCCCCCe
Q 002738 666 ---------------------------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 718 (886)
Q Consensus 666 ---------------------------~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~~~~ 718 (886)
....+++..+..++.||+.||+|||++||+||||||+|||++.+ ..
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~-------~~ 217 (343)
T cd05103 145 QSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN-------NV 217 (343)
T ss_pred cccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCC-------Cc
Confidence 01246788889999999999999999999999999999999876 46
Q ss_pred EEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 002738 719 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGL 797 (886)
Q Consensus 719 VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT-G~~PF~g~ 797 (886)
+||+|||++......... .......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...
T Consensus 218 ~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 218 VKICDFGLARDIYKDPDY--------VRKGDARLPLKWMAPETIFD----RVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred EEEEecccccccccCcch--------hhcCCCCCCcceECcHHhcC----CCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 999999999765332111 00112245678999999875 568899999999999999997 99999765
Q ss_pred CHH-HHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002738 798 SEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 876 (886)
Q Consensus 798 s~~-el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EILehLe~ 876 (886)
... .....+..+.++..+. ..++.+.+++.+||+.||.+|||+.+|+++|+.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 286 KIDEEFCRRLKEGTRMRAPD---------------------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred cccHHHHHHHhccCCCCCCC---------------------------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 433 2333333332221110 123468999999999999999999999999998
Q ss_pred hcC
Q 002738 877 RTS 879 (886)
Q Consensus 877 l~s 879 (886)
+..
T Consensus 339 ~~~ 341 (343)
T cd05103 339 LLQ 341 (343)
T ss_pred HHh
Confidence 764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=316.08 Aligned_cols=260 Identities=25% Similarity=0.392 Sum_probs=198.6
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcceeeeeEecCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 627 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl~g~~~~~~ 627 (886)
+.|++.+.||+|+||.||+|.. .+..+|+|+..... . ... .+.+|+.++.++ +||||+++++++....
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~---~~~----~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--D---EEE----EIKQEINMLKKYSHHRNIATYYGAFIKKN 76 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--c---cHH----HHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence 4688899999999999999987 56678888865331 1 112 237899999998 6999999999987543
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
. .......|+||||+.+++|.+++.. .....+++..+..++.||+.||+|||+++|+|+||||+||+++
T Consensus 77 ~--------~~~~~~~~iv~e~~~~~~L~~~l~~---~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~ 145 (272)
T cd06637 77 P--------PGMDDQLWLVMEFCGAGSVTDLIKN---TKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT 145 (272)
T ss_pred C--------CCCCcEEEEEEEcCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEEC
Confidence 1 0112357999999999999999975 2234688999999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~~s~KSDIWSLGVILyE 786 (886)
.+ +.++|+|||++........ ......|++.|+|||++.+.. ....++.++|||||||++||
T Consensus 146 ~~-------~~~~l~Dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~e 208 (272)
T cd06637 146 EN-------AEVKLVDFGVSAQLDRTVG----------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 208 (272)
T ss_pred CC-------CCEEEccCCCceecccccc----------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHH
Confidence 77 4699999999876533111 113346899999999986421 12457889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 787 LLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
|++|+.||...........+.....+... ....+..+.+||.+||..+|.+|||
T Consensus 209 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~~l~~~p~~Rpt 262 (272)
T cd06637 209 MAEGAPPLCDMHPMRALFLIPRNPAPRLK--------------------------SKKWSKKFQSFIESCLVKNHSQRPT 262 (272)
T ss_pred HHhCCCCccccCHHHHHHHHhcCCCCCCC--------------------------CCCcCHHHHHHHHHHcCCChhhCCC
Confidence 99999999766554433333221111000 0112457899999999999999999
Q ss_pred HHHHHHH
Q 002738 867 AGDLYEM 873 (886)
Q Consensus 867 A~EILeh 873 (886)
+.++++|
T Consensus 263 ~~~il~~ 269 (272)
T cd06637 263 TEQLMKH 269 (272)
T ss_pred HHHHhhC
Confidence 9999987
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=332.26 Aligned_cols=245 Identities=22% Similarity=0.352 Sum_probs=188.2
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcceeeeeEecCCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 633 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl~g~~~~~~~l~~~~ 633 (886)
+.||+|+||.||+|+. .+..+|+|+....... ..... ..+.+|+.++.++ +||||+++++++....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~----~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~------ 69 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVH-DDEDI----DWVQTEKHVFEQASSNPFLVGLHSCFQTTS------ 69 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHH----HHHHHHHHHHHhhcCCCCEeeEEEEEEeCC------
Confidence 4799999999999987 5667999987533211 11222 2348899999888 5999999999987654
Q ss_pred CCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCC
Q 002738 634 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 713 (886)
Q Consensus 634 ~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~ 713 (886)
..|+||||++|++|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~---- 132 (327)
T cd05617 70 --------RLFLVIEYVNGGDLMFHMQR-----QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD---- 132 (327)
T ss_pred --------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC----
Confidence 46999999999999998875 3468999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 002738 714 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 793 (886)
Q Consensus 714 ~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~P 793 (886)
+.+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||+||||++|..|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~ell~g~~p 195 (327)
T cd05617 133 ---GHIKLTDYGMCKEGLGPGDT----------TSTFCGTPNYIAPEILRG----EEYGFSVDWWALGVLMFEMMAGRSP 195 (327)
T ss_pred ---CCEEEeccccceeccCCCCc----------eecccCCcccCCHHHHCC----CCCCchheeehhHHHHHHHHhCCCC
Confidence 46999999998743221111 123469999999999976 6788999999999999999999999
Q ss_pred CCCCC------HHH-HHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 794 YMGLS------ELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 794 F~g~s------~~e-l~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
|.... ..+ +...+... ...++ ...+..+.++|.+||..||.+|++
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~-~~~~p---------------------------~~~~~~~~~li~~~L~~dP~~R~~ 247 (327)
T cd05617 196 FDIITDNPDMNTEDYLFQVILEK-PIRIP---------------------------RFLSVKASHVLKGFLNKDPKERLG 247 (327)
T ss_pred CCccCCCcccccHHHHHHHHHhC-CCCCC---------------------------CCCCHHHHHHHHHHhccCHHHcCC
Confidence 95421 111 22222111 11111 112456899999999999999998
Q ss_pred ------HHHHHHHH
Q 002738 867 ------AGDLYEMF 874 (886)
Q Consensus 867 ------A~EILehL 874 (886)
+.++++|-
T Consensus 248 ~~~~~~~~~i~~h~ 261 (327)
T cd05617 248 CQPQTGFSDIKSHT 261 (327)
T ss_pred CCCCCCHHHHHcCC
Confidence 56888773
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=309.99 Aligned_cols=252 Identities=22% Similarity=0.355 Sum_probs=200.9
Q ss_pred CCCceeeeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~~-~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
..+|++.+.||.|+||.||++.+. +..+++|+.... ... ... +.+|+.+++++.||||+++++++....
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~--~~~---~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG--AMS---EED----FIEEAQVMMKLSHPKLVQLYGVCTERS- 72 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC--CCC---HHH----HHHHHHHHHhCCCCCeeeEEEEEccCC-
Confidence 457899999999999999999874 677888875322 111 122 388999999999999999999987554
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..++||||+++++|.+++.. ....+++..++.++.|++.||+|||+++|+|+||||+||+++.
T Consensus 73 -------------~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~ 135 (256)
T cd05112 73 -------------PICLVFEFMEHGCLSDYLRA----QRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGE 135 (256)
T ss_pred -------------ceEEEEEcCCCCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcC
Confidence 36999999999999999875 2245789999999999999999999999999999999999986
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ ..++|+|||++......... ......++..|+|||++.+ ..++.++||||||+++|||+
T Consensus 136 ~-------~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~~~aPe~~~~----~~~~~~~Dv~slG~~l~el~ 195 (256)
T cd05112 136 N-------QVVKVSDFGMTRFVLDDQYT---------SSTGTKFPVKWSSPEVFSF----SKYSSKSDVWSFGVLMWEVF 195 (256)
T ss_pred C-------CeEEECCCcceeecccCccc---------ccCCCccchhhcCHhHhcc----CCcChHHHHHHHHHHHHHHH
Confidence 6 46999999998765332111 0112235678999999876 56788999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 789 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 789 T-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
+ |..||.......+...+..+..+..+. ..+..+.+|+.+||+.+|++|||+
T Consensus 196 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~~~l~~~p~~Rp~~ 248 (256)
T cd05112 196 SEGKTPYENRSNSEVVETINAGFRLYKPR---------------------------LASQSVYELMQHCWKERPEDRPSF 248 (256)
T ss_pred cCCCCCCCcCCHHHHHHHHhCCCCCCCCC---------------------------CCCHHHHHHHHHHcccChhhCCCH
Confidence 8 999998877777776665543322110 023579999999999999999999
Q ss_pred HHHHHHHH
Q 002738 868 GDLYEMFV 875 (886)
Q Consensus 868 ~EILehLe 875 (886)
.+++++|.
T Consensus 249 ~~~l~~l~ 256 (256)
T cd05112 249 SLLLHQLA 256 (256)
T ss_pred HHHHHhhC
Confidence 99999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.66 Aligned_cols=252 Identities=27% Similarity=0.441 Sum_probs=192.6
Q ss_pred eeecccCceEEEEEEECC--e--eEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcceeeeeEecCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKFGS--A--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPS 631 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~~~--~--~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl~g~~~~~~~l~~ 631 (886)
+.||+|+||.||+|++.+ . .+++|.. +.. ......+. +.+|+.++.++ +||||+++++++.....
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~--~~~-~~~~~~~~----~~~E~~~l~~l~~h~~iv~~~~~~~~~~~--- 70 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEY-ASKDDHRD----FAGELEVLCKLGHHPNIINLLGACEHRGY--- 70 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEc--ccc-CCHHHHHH----HHHHHHHHHhhccCCCeeeEEEEEecCCC---
Confidence 368999999999999743 2 3455553 221 11222233 48899999999 79999999999886553
Q ss_pred CCCCCCcccceEEEEEeccCCCCHHHHHHHHhc-----------cCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 002738 632 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700 (886)
Q Consensus 632 ~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~-----------~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLK 700 (886)
.++||||+++++|.+++..... .....+++..++.++.||+.||+|||++||+|||||
T Consensus 71 -----------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dik 139 (270)
T cd05047 71 -----------LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLA 139 (270)
T ss_pred -----------ceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccc
Confidence 5999999999999999975221 111357899999999999999999999999999999
Q ss_pred CCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHH
Q 002738 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 780 (886)
Q Consensus 701 PsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSL 780 (886)
|+|||++.+ +.+||+|||++........ ......+..|+|||++.. ..++.++|||||
T Consensus 140 p~nili~~~-------~~~kl~dfgl~~~~~~~~~-----------~~~~~~~~~y~apE~~~~----~~~~~~~Di~sl 197 (270)
T cd05047 140 ARNILVGEN-------YVAKIADFGLSRGQEVYVK-----------KTMGRLPVRWMAIESLNY----SVYTTNSDVWSY 197 (270)
T ss_pred cceEEEcCC-------CeEEECCCCCccccchhhh-----------ccCCCCccccCChHHHcc----CCCCchhhHHHH
Confidence 999999877 5699999999853221100 111224567999999875 668899999999
Q ss_pred HHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 002738 781 GCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 859 (886)
Q Consensus 781 GVILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~ 859 (886)
||++|||++ |..||.+.+.......+........+ ...+..+.+|+.+||..
T Consensus 198 G~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~ 250 (270)
T cd05047 198 GVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP---------------------------LNCDDEVYDLMRQCWRE 250 (270)
T ss_pred HHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCC---------------------------CcCCHHHHHHHHHHccc
Confidence 999999997 99999887776666555443222111 11245689999999999
Q ss_pred CCCCCCCHHHHHHHHHhhc
Q 002738 860 NPTERPTAGDLYEMFVART 878 (886)
Q Consensus 860 DP~kRPSA~EILehLe~l~ 878 (886)
+|.+|||+.+++..|..+.
T Consensus 251 ~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 251 KPYERPSFAQILVSLNRML 269 (270)
T ss_pred ChhhCCCHHHHHHHHHHhh
Confidence 9999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.03 Aligned_cols=266 Identities=26% Similarity=0.369 Sum_probs=205.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcceeeeeEe
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 624 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl~g~~~ 624 (886)
.+.++|++.+.||+|+||.||+|.. .+..+++|+..... ...+ .+.+|+.+++++ .||||+++++++.
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~----~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEE----EIKEEYNILRKYSNHPNIATFYGAFI 73 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHH----HHHHHHHHHHHhcCCCChheEEEEEE
Confidence 4668999999999999999999997 45678888865332 1222 348999999999 6999999999998
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNI 704 (886)
..... ......++||||+++++|.+++...... ...+++..+..++.||+.||.|||++||+|+||+|+||
T Consensus 74 ~~~~~--------~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni 144 (275)
T cd06608 74 KKNPP--------GNDDQLWLVMELCGGGSVTDLVKGLRKK-GKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNI 144 (275)
T ss_pred ecCCC--------CcceEEEEEEEcCCCCcHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHE
Confidence 65420 1234579999999999999998763321 35689999999999999999999999999999999999
Q ss_pred EEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHH
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCL 783 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~~s~KSDIWSLGVI 783 (886)
+++.+ +.++|+|||++......... .....|+..|+|||++.... ....++.++|||||||+
T Consensus 145 ~~~~~-------~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~i 207 (275)
T cd06608 145 LLTKN-------AEVKLVDFGVSAQLDSTLGR----------RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGIT 207 (275)
T ss_pred EEccC-------CeEEECCCccceecccchhh----------hcCccccccccCHhHhcccccccCCccccccHHHhHHH
Confidence 99877 46999999998765432111 12345899999999986421 12456789999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 784 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 784 LyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
||+|++|+.||...........+.....+.+.. ....+..+.+||.+||..||.+
T Consensus 208 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~dp~~ 262 (275)
T cd06608 208 AIELADGKPPLCDMHPMRALFKIPRNPPPTLKS-------------------------PENWSKKFNDFISECLIKNYEQ 262 (275)
T ss_pred HHHHHhCCCCccccchHHHHHHhhccCCCCCCc-------------------------hhhcCHHHHHHHHHHhhcChhh
Confidence 999999999998766555444444332221110 1123457899999999999999
Q ss_pred CCCHHHHHHH
Q 002738 864 RPTAGDLYEM 873 (886)
Q Consensus 864 RPSA~EILeh 873 (886)
|||+.++++|
T Consensus 263 Rpt~~~ll~~ 272 (275)
T cd06608 263 RPFMEELLEH 272 (275)
T ss_pred CcCHHHHhcC
Confidence 9999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=332.38 Aligned_cols=260 Identities=23% Similarity=0.293 Sum_probs=200.8
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|++.+.||+|+||.||+++. .+..+|+|+...... ........+.+|+.++..++|+||+++++++....
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-----LKRAETACFREERDVLVNGDNQWITTLHYAFQDEN- 74 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH-----HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC-
Confidence 4799999999999999999997 456788888642110 01111123478999999999999999999988654
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..++||||+++|+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~ey~~~g~L~~~l~~----~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~ 137 (332)
T cd05623 75 -------------NLYLVMDYYVGGDLLTLLSK----FEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM 137 (332)
T ss_pred -------------EEEEEEeccCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECC
Confidence 46999999999999999975 1246899999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~~s~KSDIWSLGVILyEL 787 (886)
+ +.+||+|||++..+...... ......||+.|+|||++.+.. ....++.++|||||||+||||
T Consensus 138 ~-------~~~kL~DfG~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~el 201 (332)
T cd05623 138 N-------GHIRLADFGSCLKLMEDGTV---------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEM 201 (332)
T ss_pred C-------CCEEEeecchheecccCCcc---------eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHH
Confidence 6 46999999998754322111 112346999999999997422 124578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--C
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE--R 864 (886)
Q Consensus 788 LTG~~PF~g~s~~el~~~I~~~~r-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k--R 864 (886)
++|+.||.+.+..+....+..... ..++ ......++.+.+||.+||..+|.+ |
T Consensus 202 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~p------------------------~~~~~~s~~~~~li~~ll~~~~~r~~r 257 (332)
T cd05623 202 LYGETPFYAESLVETYGKIMNHKERFQFP------------------------AQVTDVSEDAKDLIRRLICSREHRLGQ 257 (332)
T ss_pred hcCCCCCCCCCHHHHHHHHhCCCccccCC------------------------CccccCCHHHHHHHHHHccChhhhcCC
Confidence 999999998888777766654321 1111 111223567899999999765554 6
Q ss_pred CCHHHHHHH
Q 002738 865 PTAGDLYEM 873 (886)
Q Consensus 865 PSA~EILeh 873 (886)
+++.++++|
T Consensus 258 ~~~~~~~~h 266 (332)
T cd05623 258 NGIEDFKQH 266 (332)
T ss_pred CCHHHHhCC
Confidence 899999999
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=316.29 Aligned_cols=255 Identities=24% Similarity=0.268 Sum_probs=215.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
-.+++|++++.||.|-||.||+|+. +..-||+|+.... .-.......++.+|++|-..|+||||+++|++|.+
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKs-----qi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd 93 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKS-----QILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD 93 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHH-----HHHHhcchhhhhheeEeecccCCccHHhhhhheec
Confidence 5688999999999999999999997 4456788875322 12333445677999999999999999999999997
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
... .||++||..+|.|...|.. .....+++..+..++.|+|.||.|+|.++||||||||+|+|
T Consensus 94 ~~r--------------iyLilEya~~gel~k~L~~---~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlL 156 (281)
T KOG0580|consen 94 SKR--------------IYLILEYAPRGELYKDLQE---GRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLL 156 (281)
T ss_pred cce--------------eEEEEEecCCchHHHHHHh---cccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhc
Confidence 764 6999999999999999985 33567999999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++..+ .+||+|||.+...... ...+.+||..|.+||+..+ ...+..+|+|++|++.|
T Consensus 157 lg~~~-------~lkiAdfGwsV~~p~~------------kR~tlcgt~dyl~pEmv~~----~~hd~~Vd~w~lgvl~y 213 (281)
T KOG0580|consen 157 LGSAG-------ELKIADFGWSVHAPSN------------KRKTLCGTLDYLPPEMVEG----RGHDKFVDLWSLGVLCY 213 (281)
T ss_pred cCCCC-------CeeccCCCceeecCCC------------CceeeecccccCCHhhcCC----CCccchhhHHHHHHHHH
Confidence 99884 5999999998755321 1355689999999999987 77899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
|++.|.+||...+..+.+..|.+... .+| ..++..+.+||.+||..+|.+|.
T Consensus 214 eflvg~ppFes~~~~etYkrI~k~~~-~~p---------------------------~~is~~a~dlI~~ll~~~p~~r~ 265 (281)
T KOG0580|consen 214 EFLVGLPPFESQSHSETYKRIRKVDL-KFP---------------------------STISGGAADLISRLLVKNPIERL 265 (281)
T ss_pred HHHhcCCchhhhhhHHHHHHHHHccc-cCC---------------------------cccChhHHHHHHHHhccCccccc
Confidence 99999999998888888888876532 111 12355789999999999999999
Q ss_pred CHHHHHHHHH
Q 002738 866 TAGDLYEMFV 875 (886)
Q Consensus 866 SA~EILehLe 875 (886)
+..|+++|.+
T Consensus 266 ~l~~v~~hpw 275 (281)
T KOG0580|consen 266 ALTEVMDHPW 275 (281)
T ss_pred cHHHHhhhHH
Confidence 9999999975
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=312.22 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=203.6
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
+|++.+.||+|+||.||+++. .+..+++|....... .....+. +.+|+.++++++||||+++++++....
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREE----SRKEVAVLSNMKHPNIVQYQESFEENG-- 72 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHH----HHHHHHHHHhCCCCCeeeeEeeecCCC--
Confidence 589999999999999999986 567889998654322 2222233 488999999999999999999987554
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..++||||+.+++|.+++.. .....+++..++.++.||+.||.|||++|++|+||+|+|||++.+
T Consensus 73 ------------~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~ 137 (256)
T cd08218 73 ------------NLYIVMDYCEGGDLYKKINA---QRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD 137 (256)
T ss_pred ------------eEEEEEecCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC
Confidence 47999999999999999875 222357899999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
..++|+|||++......... .....|++.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 138 -------~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~slG~i~~~l~~ 196 (256)
T cd08218 138 -------GTIKLGDFGIARVLNSTVEL----------ARTCIGTPYYLSPEICEN----RPYNNKSDIWALGCVLYEMCT 196 (256)
T ss_pred -------CCEEEeeccceeecCcchhh----------hhhccCCccccCHHHhCC----CCCCCccchhHHHHHHHHHHc
Confidence 45999999999765432211 122358899999999876 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 869 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~E 869 (886)
|+.||......+....+..+..+..+. ..+..+.++|.+||+.+|.+||++.+
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (256)
T cd08218 197 LKHAFEAGNMKNLVLKIIRGSYPPVSS---------------------------HYSYDLRNLVSQLFKRNPRDRPSVNS 249 (256)
T ss_pred CCCCccCCCHHHHHHHHhcCCCCCCcc---------------------------cCCHHHHHHHHHHhhCChhhCcCHHH
Confidence 999998877777766665554433221 12457899999999999999999999
Q ss_pred HHHH
Q 002738 870 LYEM 873 (886)
Q Consensus 870 ILeh 873 (886)
|++|
T Consensus 250 vl~~ 253 (256)
T cd08218 250 ILEK 253 (256)
T ss_pred HhhC
Confidence 9987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=309.68 Aligned_cols=255 Identities=24% Similarity=0.341 Sum_probs=193.4
Q ss_pred eeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 631 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~~-----~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~ 631 (886)
+.||+|+||.||+|.+. ...+|+|... .. ......+. +.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~--~~-~~~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~~~~~--- 70 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLN--RI-TDLEEVEQ----FLKEGIIMKDFSHPNVLSLLGICLPSEG--- 70 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecC--cc-CCHHHHHH----HHHHHHHHccCCCCCcceEEEEeecCCC---
Confidence 46899999999999862 2457777642 11 12222333 4889999999999999999998764332
Q ss_pred CCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecccc
Q 002738 632 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 711 (886)
Q Consensus 632 ~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~ 711 (886)
..++||||+.+++|.+++.. ....+++..+..++.||+.||+|||+.+|+||||||+|||++.+
T Consensus 71 ----------~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~-- 134 (262)
T cd05058 71 ----------SPLVVLPYMKHGDLRNFIRS----ETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDES-- 134 (262)
T ss_pred ----------CcEEEEecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC--
Confidence 25899999999999999975 12346778889999999999999999999999999999999876
Q ss_pred CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-C
Q 002738 712 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-L 790 (886)
Q Consensus 712 ~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT-G 790 (886)
+.+||+|||++........... .......++..|+|||++.+ ..++.++|||||||++|||++ |
T Consensus 135 -----~~~kl~dfg~~~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~~~~ 199 (262)
T cd05058 135 -----FTVKVADFGLARDIYDKEYYSV------HNHTGAKLPVKWMALESLQT----QKFTTKSDVWSFGVLLWELMTRG 199 (262)
T ss_pred -----CcEEECCccccccccCCcceee------cccccCcCCccccChhHhcc----CccchHHHHHHHHHHHHHHHcCC
Confidence 5699999999975543211100 00122346778999999875 567899999999999999999 5
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 002738 791 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 870 (886)
Q Consensus 791 ~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EI 870 (886)
.+||...+..+....+..+..+..+. ..+..+.+++.+||..+|++||++.+|
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i 252 (262)
T cd05058 200 APPYPDVDSFDITVYLLQGRRLLQPE---------------------------YCPDPLYEVMLSCWHPKPEMRPTFSEL 252 (262)
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCCCC---------------------------cCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 67787777666665554443222110 123468999999999999999999999
Q ss_pred HHHHHhhcC
Q 002738 871 YEMFVARTS 879 (886)
Q Consensus 871 LehLe~l~s 879 (886)
++.|+.+..
T Consensus 253 l~~l~~~~~ 261 (262)
T cd05058 253 VSRIEQIFS 261 (262)
T ss_pred HHHHHHHhc
Confidence 999998653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.72 Aligned_cols=267 Identities=27% Similarity=0.383 Sum_probs=201.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcceeeeeEe
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 624 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl~g~~~ 624 (886)
...++|++.+.||+|+||.||+|.. .+..+++|+.... . .... .+.+|+.+++++ +||||+++++++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~--~---~~~~----~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI--H---DIDE----EIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc--c---chHH----HHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 4678999999999999999999987 5678889875321 1 1112 237899999999 6999999999886
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNI 704 (886)
.... ......++||||+++++|.+++...... ...+++..+..++.|++.||.|||+++|+||||||+||
T Consensus 86 ~~~~---------~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~ni 155 (286)
T cd06638 86 KKDV---------KNGDQLWLVLELCNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNI 155 (286)
T ss_pred eccc---------CCCCeEEEEEeecCCCCHHHHHHHhhcc-CccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhE
Confidence 4321 0123579999999999999998753222 34688999999999999999999999999999999999
Q ss_pred EEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHH
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCL 783 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~~s~KSDIWSLGVI 783 (886)
+++.+ +.++|+|||++........ ......|++.|+|||++.... ....++.++|||||||+
T Consensus 156 li~~~-------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi 218 (286)
T cd06638 156 LLTTE-------GGVKLVDFGVSAQLTSTRL----------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGIT 218 (286)
T ss_pred EECCC-------CCEEEccCCceeecccCCC----------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHH
Confidence 99877 4599999999876543211 112346899999999986311 12457889999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 784 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 784 LyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
+|||++|+.||...........+.....+.+. .+ ...+..+.+||.+||+.||++
T Consensus 219 ~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------------~~---~~~~~~~~~li~~~l~~~p~~ 273 (286)
T cd06638 219 AIELGDGDPPLADLHPMRALFKIPRNPPPTLH----------------------QP---ELWSNEFNDFIRKCLTKDYEK 273 (286)
T ss_pred HHHHhcCCCCCCCCchhHHHhhccccCCCccc----------------------CC---CCcCHHHHHHHHHHccCCccc
Confidence 99999999999876654433332222111110 00 012346899999999999999
Q ss_pred CCCHHHHHHHHH
Q 002738 864 RPTAGDLYEMFV 875 (886)
Q Consensus 864 RPSA~EILehLe 875 (886)
|||+.||++|+.
T Consensus 274 Rps~~ell~~~~ 285 (286)
T cd06638 274 RPTVSDLLQHVF 285 (286)
T ss_pred CCCHHHHhhccc
Confidence 999999999863
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=308.10 Aligned_cols=247 Identities=26% Similarity=0.403 Sum_probs=194.7
Q ss_pred eeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 635 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~-~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~~~ 635 (886)
+.||+|+||.||+|.. .+..+|+|+.... ..... ...+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~---~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------- 66 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKED---LPQEL----KIKFLSEARILKQYDHPNIVKLIGVCTQRQP------- 66 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCc---CCHHH----HHHHHHHHHHHHhCCCCCcCeEEEEEecCCc-------
Confidence 4789999999999986 4567888875322 11222 2245899999999999999999999876543
Q ss_pred CCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCCC
Q 002738 636 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 715 (886)
Q Consensus 636 ~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~ 715 (886)
.++||||+++++|.+++.. ....+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 67 -------~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~------ 129 (250)
T cd05085 67 -------IYIVMELVPGGDFLSFLRK----KKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGEN------ 129 (250)
T ss_pred -------cEEEEECCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCC------
Confidence 5999999999999999865 22457899999999999999999999999999999999999876
Q ss_pred CCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 002738 716 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPY 794 (886)
Q Consensus 716 ~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT-G~~PF 794 (886)
+.+||+|||++......... ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||
T Consensus 130 -~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~ll~~~~~~g~~p~ 195 (250)
T cd05085 130 -NVLKISDFGMSRQEDDGIYS---------SSGLKQIPIKWTAPEALNY----GRYSSESDVWSYGILLWETFSLGVCPY 195 (250)
T ss_pred -CeEEECCCccceeccccccc---------cCCCCCCcccccCHHHhcc----CCCCchhHHHHHHHHHHHHhcCCCCCC
Confidence 56999999998754322111 0111234678999999875 567889999999999999998 99999
Q ss_pred CCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002738 795 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874 (886)
Q Consensus 795 ~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EILehL 874 (886)
.+.........+....+...+ ...+..+.+|+.+||..+|.+||++.++++.|
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 248 (250)
T cd05085 196 PGMTNQQAREQVEKGYRMSCP---------------------------QKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248 (250)
T ss_pred CCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence 888777666666544322211 11245799999999999999999999999987
Q ss_pred H
Q 002738 875 V 875 (886)
Q Consensus 875 e 875 (886)
.
T Consensus 249 ~ 249 (250)
T cd05085 249 A 249 (250)
T ss_pred c
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=311.44 Aligned_cols=255 Identities=22% Similarity=0.368 Sum_probs=202.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~-~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
+..++|++.++||+|+||.||++.+ .+..+++|..... ....+ .+.+|+.++++++|+||+++++.+..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-----~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-----SMSVE----AFLAEANVMKTLQHDKLVKLHAVVTK- 72 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-----hhHHH----HHHHHHHHHHhcCCCCcceEEEEEcC-
Confidence 4567899999999999999999986 4456888875321 11222 34889999999999999999998865
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
. ..++||||+++++|.+++.. .....+++..+..++.||+.||.|||+.|++|+||||+||++
T Consensus 73 ~--------------~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i 135 (260)
T cd05073 73 E--------------PIYIITEFMAKGSLLDFLKS---DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV 135 (260)
T ss_pred C--------------CeEEEEEeCCCCcHHHHHHh---CCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE
Confidence 2 25999999999999999975 223457888999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +.+||+|||.+......... ......++..|+|||++.. ..++.++|||||||++|+
T Consensus 136 ~~~-------~~~~l~d~~~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~~l~~ 195 (260)
T cd05073 136 SAS-------LVCKIADFGLARVIEDNEYT---------AREGAKFPIKWTAPEAINF----GSFTIKSDVWSFGILLME 195 (260)
T ss_pred cCC-------CcEEECCCcceeeccCCCcc---------cccCCcccccccCHhHhcc----CCcCccccchHHHHHHHH
Confidence 876 56999999999765432111 1112245678999999975 567889999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 787 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 787 LLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
|++ |..||.+.+...+...+........+ ...+..+.+++.+||+.+|.+||
T Consensus 196 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rp 248 (260)
T cd05073 196 IVTYGRIPYPGMSNPEVIRALERGYRMPRP---------------------------ENCPEELYNIMMRCWKNRPEERP 248 (260)
T ss_pred HHhcCCCCCCCCCHHHHHHHHhCCCCCCCc---------------------------ccCCHHHHHHHHHHcccCcccCc
Confidence 999 99999988777766666544221111 11245799999999999999999
Q ss_pred CHHHHHHHHHh
Q 002738 866 TAGDLYEMFVA 876 (886)
Q Consensus 866 SA~EILehLe~ 876 (886)
++.++++.|+.
T Consensus 249 ~~~~l~~~L~~ 259 (260)
T cd05073 249 TFEYIQSVLDD 259 (260)
T ss_pred CHHHHHHHHhc
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.28 Aligned_cols=259 Identities=26% Similarity=0.366 Sum_probs=201.1
Q ss_pred CceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 630 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~-~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~ 630 (886)
+|.+.+.||.|+||.||+|.. .+..+|+|+...+.... .........+.+|+.+++.++|+||+++++++....
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNV--LAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN--- 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccch--hhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC---
Confidence 478899999999999999986 66779999865543221 222223345689999999999999999999988654
Q ss_pred CCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccc
Q 002738 631 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 710 (886)
Q Consensus 631 ~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~ 710 (886)
..++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+|+|+||+|+||+++.+
T Consensus 76 -----------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~- 138 (265)
T cd06631 76 -----------TISIFMEFVPGGSISSILNR-----FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPN- 138 (265)
T ss_pred -----------eEEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCC-
Confidence 36999999999999999975 2457899999999999999999999999999999999999876
Q ss_pred cCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 002738 711 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 790 (886)
Q Consensus 711 ~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG 790 (886)
+.++|+|||++........... .........|+..|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 139 ------~~~~l~dfg~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~slG~~~~~l~~g 204 (265)
T cd06631 139 ------GIIKLIDFGCARRLAWVGLHGT----HSNMLKSMHGTPYWMAPEVINE----SGYGRKSDIWSIGCTVFEMATG 204 (265)
T ss_pred ------CeEEeccchhhHhhhhcccccc----ccccccccCCCccccChhhhcC----CCCcchhhHHHHHHHHHHHHhC
Confidence 5699999999876532111100 0011123458999999999976 5678999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcC--CCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 002738 791 QVPYMGLSELEIHDLIQMG--KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868 (886)
Q Consensus 791 ~~PF~g~s~~el~~~I~~~--~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~ 868 (886)
..||...+.......+... ..+.++ ...+..+.++|.+||..+|.+||++.
T Consensus 205 ~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rp~~~ 257 (265)
T cd06631 205 KPPLASMDRLAAMFYIGAHRGLMPRLP---------------------------DSFSAAAIDFVTSCLTRDQHERPSAL 257 (265)
T ss_pred CCccccCChHHHHHHhhhccCCCCCCC---------------------------CCCCHHHHHHHHHHhcCCcccCCCHH
Confidence 9999876554433333222 111111 12355789999999999999999999
Q ss_pred HHHHH
Q 002738 869 DLYEM 873 (886)
Q Consensus 869 EILeh 873 (886)
++++|
T Consensus 258 ~~l~~ 262 (265)
T cd06631 258 QLLRH 262 (265)
T ss_pred HHhcC
Confidence 99986
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=356.35 Aligned_cols=274 Identities=22% Similarity=0.322 Sum_probs=206.3
Q ss_pred CCceeeeeecccCceEEEEEEE-C-CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEecCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF-G-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 627 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~-~-~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~~~~ 627 (886)
.+++|.+.|.+|||+.||+|++ . +..+|+|..... .....+. +.+||.+|++|. |+|||.+++......
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~----v~~EI~~MK~L~gh~nIV~yidss~~~~ 108 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNA----VKREIDIMKLLSGHKNIVSYIDSSAINR 108 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHH----HHHHHHHHHHhcCCCceeeEeccccccc
Confidence 3578999999999999999998 3 378999986543 2334443 499999999998 999999999422211
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCEE
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENIL 705 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~g--IVHRDLKPsNIL 705 (886)
. ......++.|+||||.||+|-+++..+.. ..|++.++++|++|+++|+++||... |||||||-+|||
T Consensus 109 ~-------~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvL 178 (738)
T KOG1989|consen 109 S-------SNNGVWEVLLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVL 178 (738)
T ss_pred c-------CCCceeEEEeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheE
Confidence 0 01123578999999999999999987433 34999999999999999999999986 999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
|..+ +..||||||.|............. .-....-....|+.|+|||++. +..+..+++|+|||||||+||
T Consensus 179 ls~~-------g~~KLCDFGSatt~~~~~~~~~e~-~~ve~eI~k~TTp~YRsPEMID-lysg~pI~eKsDIWALGclLY 249 (738)
T KOG1989|consen 179 LSAD-------GNYKLCDFGSATTKILSPTSAQEV-NYVEEEIEKYTTPQYRSPEMID-LYSGLPIGEKSDIWALGCLLY 249 (738)
T ss_pred EcCC-------CCEEeCcccccccccCCCccHHHH-HHHHHHHHhhCCccccChHHHh-hhcCCCCcchhHHHHHHHHHH
Confidence 9988 459999999986443222110000 0000001125789999999996 344578899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
.|+....||.+.... +|.++.+. +| . .+..+..+.+||..||+.||++||
T Consensus 250 kLCy~t~PFe~sg~l----aIlng~Y~-~P------------------------~-~p~ys~~l~~LI~~mL~~nP~~RP 299 (738)
T KOG1989|consen 250 KLCYFTTPFEESGKL----AILNGNYS-FP------------------------P-FPNYSDRLKDLIRTMLQPNPDERP 299 (738)
T ss_pred HHHHhCCCcCcCcce----eEEecccc-CC------------------------C-CccHHHHHHHHHHHHhccCcccCC
Confidence 999999999766433 23333211 11 1 123467899999999999999999
Q ss_pred CHHHHHHHHHhhcCCC
Q 002738 866 TAGDLYEMFVARTSSS 881 (886)
Q Consensus 866 SA~EILehLe~l~sss 881 (886)
++.+|+.++..+....
T Consensus 300 nI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 300 NIYQVLEEIFELANKP 315 (738)
T ss_pred CHHHHHHHHHHHhcCC
Confidence 9999999999887543
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=314.46 Aligned_cols=262 Identities=23% Similarity=0.343 Sum_probs=205.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--C----eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeee
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFG--S----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 621 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~--~----~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g 621 (886)
....+|++.+.||+|+||.||+|.+. + ..+++|..... . ...... .+.+|+.++++++||||+++++
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~--~-~~~~~~----~~~~e~~~l~~l~h~~i~~~~~ 76 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE--T-SPKANK----EILDEAYVMASVDHPHVVRLLG 76 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCC--C-CHHHHH----HHHHHHHHHHhCCCCCcceEEE
Confidence 34568999999999999999999862 2 24677764322 1 122223 3489999999999999999999
Q ss_pred eEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 002738 622 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 701 (886)
Q Consensus 622 ~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKP 701 (886)
++... ..++||||+++|+|.+++.. ....+++..+..++.||+.||+|||++||+||||||
T Consensus 77 ~~~~~---------------~~~~v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p 137 (279)
T cd05057 77 ICLSS---------------QVQLITQLMPLGCLLDYVRN----HKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAA 137 (279)
T ss_pred EEecC---------------ceEEEEecCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCc
Confidence 98752 36999999999999999975 234589999999999999999999999999999999
Q ss_pred CCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 002738 702 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781 (886)
Q Consensus 702 sNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLG 781 (886)
+|||++.+ ..+||+|||+++......... ......++..|+|||.+.. ..++.++||||||
T Consensus 138 ~nil~~~~-------~~~kL~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG 198 (279)
T cd05057 138 RNVLVKTP-------QHVKITDFGLAKLLDVDEKEY--------HAEGGKVPIKWMALESILH----RIYTHKSDVWSYG 198 (279)
T ss_pred ceEEEcCC-------CeEEECCCcccccccCcccce--------ecCCCcccccccCHHHhhc----CCcCchhhHHHHH
Confidence 99999876 469999999998765322110 0111224678999999875 6678999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 002738 782 CLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 860 (886)
Q Consensus 782 VILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~D 860 (886)
+++|||++ |+.||.+....++...+..+.....+. ..+..+.+++.+||..+
T Consensus 199 ~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~l~~~ 251 (279)
T cd05057 199 VTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPP---------------------------ICTIDVYMVLVKCWMID 251 (279)
T ss_pred HHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCC---------------------------CCCHHHHHHHHHHcCCC
Confidence 99999998 999999888877777666543222111 12346889999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCCC
Q 002738 861 PTERPTAGDLYEMFVARTSSS 881 (886)
Q Consensus 861 P~kRPSA~EILehLe~l~sss 881 (886)
|.+||++.++++.|..+....
T Consensus 252 p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 252 AESRPTFKELINEFSKMARDP 272 (279)
T ss_pred hhhCCCHHHHHHHHHHHHhCC
Confidence 999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=310.88 Aligned_cols=250 Identities=27% Similarity=0.412 Sum_probs=200.3
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
.++|++.+.||.|+||.||+|.+. +..+++|...... ..+ .+.+|+.++++++||||+++++++....
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~----~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQ----EIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------HHH----HHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 468999999999999999999984 5778888864321 123 4489999999999999999999988654
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
..|++|||+++++|.+++.. ....+++..+..++.||+.||.|||+.+|+||||+|.||+++
T Consensus 72 --------------~~~l~~e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~ 133 (256)
T cd06612 72 --------------DLWIVMEYCGAGSVSDIMKI----TNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN 133 (256)
T ss_pred --------------cEEEEEecCCCCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC
Confidence 36999999999999999975 235689999999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ +.++|+|||++......... .....++..|+|||++.+ ..++.++||||||+++|+|
T Consensus 134 ~~-------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~----~~~~~~~Di~s~G~il~~l 192 (256)
T cd06612 134 EE-------GQAKLADFGVSGQLTDTMAK----------RNTVIGTPFWMAPEVIQE----IGYNNKADIWSLGITAIEM 192 (256)
T ss_pred CC-------CcEEEcccccchhcccCccc----------cccccCCccccCHHHHhc----CCCCchhhHHHHHHHHHHH
Confidence 77 46999999999866442211 123458899999999876 5678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 788 LTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
++|+.||...........+.....+.+. .....+..+.++|.+||+.||.+|||+
T Consensus 193 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~i~~~l~~~P~~Rps~ 247 (256)
T cd06612 193 AEGKPPYSDIHPMRAIFMIPNKPPPTLS-------------------------DPEKWSPEFNDFVKKCLVKDPEERPSA 247 (256)
T ss_pred HhCCCCCCCcchhhhhhhhccCCCCCCC-------------------------chhhcCHHHHHHHHHHHhcChhhCcCH
Confidence 9999999876655443333222111111 011234578999999999999999999
Q ss_pred HHHHHH
Q 002738 868 GDLYEM 873 (886)
Q Consensus 868 ~EILeh 873 (886)
.+|++|
T Consensus 248 ~~il~~ 253 (256)
T cd06612 248 IQLLQH 253 (256)
T ss_pred HHHhcC
Confidence 999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=316.92 Aligned_cols=251 Identities=30% Similarity=0.455 Sum_probs=204.3
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|++.+.||.|+||.||+|++ .+..+++|+..... ....... +.+|+.+++.++||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~- 72 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIED----IQQEIQFLSQCRSPYITKYYGSFLKGS- 72 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHH----HHHHHHHHHHcCCCCeeeeeEEEEECC-
Confidence 4688999999999999999997 56789999875432 1222233 388999999999999999999988654
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..++||||+++++|.+++.. ..+++..+..++.||+.||.|||+++|+|+||+|+||+++.
T Consensus 73 -------------~~~~v~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~ 133 (274)
T cd06609 73 -------------KLWIIMEYCGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE 133 (274)
T ss_pred -------------eEEEEEEeeCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC
Confidence 46999999999999999975 26899999999999999999999999999999999999988
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.++|+|||++......... .....+++.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 134 ~-------~~~~l~d~g~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~----~~~~~~sDv~slG~il~~l~ 192 (274)
T cd06609 134 E-------GDVKLADFGVSGQLTSTMSK----------RNTFVGTPFWMAPEVIKQ----SGYDEKADIWSLGITAIELA 192 (274)
T ss_pred C-------CCEEEcccccceeecccccc----------cccccCCccccChhhhcc----CCCCchhhHHHHHHHHHHHH
Confidence 7 45999999999876543211 123468889999999986 55889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~ 868 (886)
+|+.||...++......+.....+.++.. ..+..+.+++.+||..+|++|||++
T Consensus 193 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~~l~~~p~~Rpt~~ 246 (274)
T cd06609 193 KGEPPLSDLHPMRVLFLIPKNNPPSLEGN--------------------------KFSKPFKDFVSLCLNKDPKERPSAK 246 (274)
T ss_pred hCCCCcccCchHHHHHHhhhcCCCCCccc--------------------------ccCHHHHHHHHHHhhCChhhCcCHH
Confidence 99999987776665555554433322210 0245689999999999999999999
Q ss_pred HHHHHHH
Q 002738 869 DLYEMFV 875 (886)
Q Consensus 869 EILehLe 875 (886)
++++|-.
T Consensus 247 ~il~~~~ 253 (274)
T cd06609 247 ELLKHKF 253 (274)
T ss_pred HHhhChh
Confidence 9998744
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=316.82 Aligned_cols=257 Identities=26% Similarity=0.395 Sum_probs=198.5
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
..++|.+.+.||+|+||.||+|+. .+..+|+|+..... ..... .+.+|+.+++.++||||+++++.+...
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~----~~~~e~~~~~~l~h~~ii~~~~~~~~~ 78 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFA----VVQQEIIMMKDCKHSNIVAYFGSYLRR 78 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHH----HHHHHHHHHHhCCCCCeeeEEEEEEeC
Confidence 346899999999999999999987 56788999865432 11222 237899999999999999999998765
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
. ..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+|||+
T Consensus 79 ~--------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili 139 (267)
T cd06645 79 D--------------KLWICMEFCGGGSLQDIYHV-----TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL 139 (267)
T ss_pred C--------------EEEEEEeccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 4 36999999999999999875 3468999999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +.++|+|||++........ ......|+..|+|||++... ....++.++|||||||++|+
T Consensus 140 ~~~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~-~~~~~~~~~DvwSlG~il~~ 201 (267)
T cd06645 140 TDN-------GHVKLADFGVSAQITATIA----------KRKSFIGTPYWMAPEVAAVE-RKGGYNQLCDIWAVGITAIE 201 (267)
T ss_pred CCC-------CCEEECcceeeeEccCccc----------ccccccCcccccChhhhccc-cCCCCCchhhhHHHHHHHHH
Confidence 876 4599999999876532111 11234689999999998521 12457889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 787 LLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
|++|..||....+......+....... + . .......+..+.+||.+||..+|++||+
T Consensus 202 l~~~~~p~~~~~~~~~~~~~~~~~~~~-~-~---------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~ 258 (267)
T cd06645 202 LAELQPPMFDLHPMRALFLMTKSNFQP-P-K---------------------LKDKMKWSNSFHHFVKMALTKNPKKRPT 258 (267)
T ss_pred HhcCCCCcccccchhhHHhhhccCCCC-C-c---------------------ccccCCCCHHHHHHHHHHccCCchhCcC
Confidence 999999997665443333222221100 0 0 0000112456899999999999999999
Q ss_pred HHHHHHH
Q 002738 867 AGDLYEM 873 (886)
Q Consensus 867 A~EILeh 873 (886)
+++|++|
T Consensus 259 ~~~ll~~ 265 (267)
T cd06645 259 AEKLLQH 265 (267)
T ss_pred HHHHhcC
Confidence 9999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=331.68 Aligned_cols=261 Identities=22% Similarity=0.296 Sum_probs=200.8
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|.+.+.||+|+||.||+++. .+..+|+|+...... ..... ...+.+|+.++..+.|+||+++++++...+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~----~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~- 74 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM-LKRAE----TACFREERNVLVNGDCQWITTLHYAFQDEN- 74 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH-HhhHH----HHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-
Confidence 4799999999999999999997 456789998642211 11111 223478999999999999999999998655
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..||||||++||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~Ey~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~ 137 (331)
T cd05624 75 -------------YLYLVMDYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDM 137 (331)
T ss_pred -------------EEEEEEeCCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcC
Confidence 369999999999999999751 246889999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC-CCCCchhhHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-NLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~-~~~s~KSDIWSLGVILyEL 787 (886)
+ +.+||+|||++......... ......||+.|+|||++.+.... ..++.++|||||||+||||
T Consensus 138 ~-------~~~kl~DfG~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~el 201 (331)
T cd05624 138 N-------GHIRLADFGSCLKMNQDGTV---------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEM 201 (331)
T ss_pred C-------CCEEEEeccceeeccCCCce---------eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhh
Confidence 6 45999999999765432111 11234699999999998753211 3468899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--C
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE--R 864 (886)
Q Consensus 788 LTG~~PF~g~s~~el~~~I~~~~-rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k--R 864 (886)
++|+.||...+..+....+.... +..++. .....++.+.+||.+||..++.+ |
T Consensus 202 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~------------------------~~~~~~~~~~~li~~ll~~~~~~~~~ 257 (331)
T cd05624 202 LYGETPFYAESLVETYGKIMNHEERFQFPS------------------------HITDVSEEAKDLIQRLICSRERRLGQ 257 (331)
T ss_pred hhCCCCccCCCHHHHHHHHHcCCCcccCCC------------------------ccccCCHHHHHHHHHHccCchhhcCC
Confidence 99999998887777666665431 111111 11123567999999999876655 4
Q ss_pred CCHHHHHHHH
Q 002738 865 PTAGDLYEMF 874 (886)
Q Consensus 865 PSA~EILehL 874 (886)
++++++++|.
T Consensus 258 ~~~~~~~~h~ 267 (331)
T cd05624 258 NGIEDFKKHA 267 (331)
T ss_pred CCHHHHhcCC
Confidence 7899999883
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=320.92 Aligned_cols=260 Identities=23% Similarity=0.368 Sum_probs=200.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-------CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCccee
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 619 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~-------~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl 619 (886)
...++|.+.+.||+|+||.||++.+ ....+|+|+.... . .....+ .+.+|+.+++++ +||||+++
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~-~~~~~~----~~~~E~~~l~~l~~h~~iv~~ 104 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT--A-HSSERE----ALMSELKIMSHLGNHENIVNL 104 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCcc--C-ChHHHH----HHHHHHHHHHhccCCCCcceE
Confidence 4567899999999999999999975 2236777774322 1 122222 348999999999 79999999
Q ss_pred eeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 002738 620 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 699 (886)
Q Consensus 620 ~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDL 699 (886)
++++..... .++||||+.+++|.+++.. .....+++..+..++.||+.||+|||+++|+|+||
T Consensus 105 ~~~~~~~~~--------------~~lv~e~~~~~~L~~~i~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dl 167 (302)
T cd05055 105 LGACTIGGP--------------ILVITEYCCYGDLLNFLRR---KRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDL 167 (302)
T ss_pred EEEEecCCc--------------eEEEEEcCCCCcHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhh
Confidence 999876543 6999999999999999975 12234899999999999999999999999999999
Q ss_pred CCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHH
Q 002738 700 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 779 (886)
Q Consensus 700 KPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWS 779 (886)
||+|||++.+ ..++|+|||++.......... ......++..|+|||++.+ ..++.++||||
T Consensus 168 kp~Nil~~~~-------~~~~l~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~Diws 228 (302)
T cd05055 168 AARNVLLTHG-------KIVKICDFGLARDIMNDSNYV--------VKGNARLPVKWMAPESIFN----CVYTFESDVWS 228 (302)
T ss_pred ccceEEEcCC-------CeEEECCCcccccccCCCcee--------ecCCCCcccccCCHhhhcc----CCCCcHhHHHH
Confidence 9999999866 569999999997654322110 0122346788999999876 56789999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCHHHHHHH-HHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 002738 780 YGCLLLELLT-LQVPYMGLSELEIHDL-IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 857 (886)
Q Consensus 780 LGVILyELLT-G~~PF~g~s~~el~~~-I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL 857 (886)
|||++|||++ |..||........... +..+..+..+ ...++.+.+|+.+||
T Consensus 229 lGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~cl 281 (302)
T cd05055 229 YGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQP---------------------------EHAPAEIYDIMKTCW 281 (302)
T ss_pred HHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHc
Confidence 9999999998 9999987655443322 2222111110 112457999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhh
Q 002738 858 EENPTERPTAGDLYEMFVAR 877 (886)
Q Consensus 858 ~~DP~kRPSA~EILehLe~l 877 (886)
..+|++|||+.+|++.|+++
T Consensus 282 ~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 282 DADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCchhCcCHHHHHHHHHhh
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=320.86 Aligned_cols=283 Identities=20% Similarity=0.230 Sum_probs=189.4
Q ss_pred eeeecccCceEEEEEEEC----CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCC
Q 002738 556 CDEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 631 (886)
Q Consensus 556 ~k~LG~G~fG~VY~A~~~----~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~ 631 (886)
..+||+|+||.||+|+.. +..+|+|..... ... ..+.+|+.+|+.++||||+++++++....
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 71 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GIS--------MSACREIALLRELKHPNVIALQKVFLSHS---- 71 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCc--------HHHHHHHHHHHhCCCCCeeeEEEEEeccC----
Confidence 468999999999999963 356888875321 111 12378999999999999999999986432
Q ss_pred CCCCCCcccceEEEEEeccCCCCHHHHHHHHhc----cCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 632 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE----TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 632 ~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~----~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
....++||||+. ++|.+++..... .....+++..++.++.||+.||.|||++||+||||||+|||+.
T Consensus 72 --------~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~ 142 (317)
T cd07867 72 --------DRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVM 142 (317)
T ss_pred --------CCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEc
Confidence 125799999997 588888864211 1123588999999999999999999999999999999999996
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.++. ..+.+||+|||+++........ ........||+.|+|||++.+ ...++.++|||||||++|||
T Consensus 143 ~~~~---~~~~~kl~DfG~a~~~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlG~il~el 209 (317)
T cd07867 143 GEGP---ERGRVKIADMGFARLFNSPLKP-------LADLDPVVVTFWYRAPELLLG---ARHYTKAIDIWAIGCIFAEL 209 (317)
T ss_pred cCCC---CCCcEEEeeccceeccCCCccc-------ccccCcceecccccCcHHhcC---CCccCcHHHHHhHHHHHHHH
Confidence 4421 2357999999999866432211 011233468999999999875 24578999999999999999
Q ss_pred HhCCCCCCCCCHH---------HHHHHHHcCCCCCchhHHhhhcccccc-----cccccC-----CCCCCchhhhhhHHH
Q 002738 788 LTLQVPYMGLSEL---------EIHDLIQMGKRPRLTDELEALGSCHEH-----EVAQSG-----SGFEKPEAELETLSF 848 (886)
Q Consensus 788 LTG~~PF~g~s~~---------el~~~I~~~~rp~l~~~l~~~~~~~~~-----~~~~~~-----~~~~~~~~~~~~s~~ 848 (886)
+||++||...... .....+...........+......... .+.... ...............
T Consensus 210 ~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (317)
T cd07867 210 LTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSK 289 (317)
T ss_pred HhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChH
Confidence 9999999653221 111111111111111111111000000 000000 000000011122456
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHH
Q 002738 849 LVDVFRRCTEENPTERPTAGDLYEMF 874 (886)
Q Consensus 849 L~dLL~rCL~~DP~kRPSA~EILehL 874 (886)
+.+||.+||+.||.+|||+.|+++|-
T Consensus 290 ~~~ll~~~l~~dP~~R~t~~e~l~hp 315 (317)
T cd07867 290 VFLLLQKLLTMDPTKRITSEQALQDP 315 (317)
T ss_pred HHHHHHHHhccCcccccCHHHHhcCC
Confidence 88999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=320.03 Aligned_cols=254 Identities=23% Similarity=0.300 Sum_probs=196.9
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
.|+..+.||+|+||.||+|.+ .+..+|+|+........ . .....+.+|+.+|+.++|+||+++++.+...+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~----~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-- 73 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKK-R----KGESMALNEKQILEKVNSQFVVNLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhh-h----hHHHHHHHHHHHHHHcCCcCceeEEEEEecCC--
Confidence 377889999999999999997 46688999864332111 1 11123478999999999999999999887654
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..++||||+++++|..++.. .....+++..+..++.|++.||.|||++||+||||||+||+++.+
T Consensus 74 ------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~ 138 (285)
T cd05632 74 ------------ALCLVLTIMNGGDLKFHIYN---MGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY 138 (285)
T ss_pred ------------EEEEEEEeccCccHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC
Confidence 36999999999999998865 223468999999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
..++|+|||++........ .....|+..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 139 -------~~~kl~Dfg~~~~~~~~~~-----------~~~~~g~~~~~aPE~~~~----~~~~~~~Di~slG~~l~~l~~ 196 (285)
T cd05632 139 -------GHIRISDLGLAVKIPEGES-----------IRGRVGTVGYMAPEVLNN----QRYTLSPDYWGLGCLIYEMIE 196 (285)
T ss_pred -------CCEEEecCCcceecCCCCc-----------ccCCCCCcCccChHHhcC----CCCCcccchHHHHHHHHHHHh
Confidence 4699999999865432111 123468999999999975 668899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC---
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT--- 866 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS--- 866 (886)
|..||.+.........+......... ......+..+.+|+.+||+.||.+||+
T Consensus 197 g~~P~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 252 (285)
T cd05632 197 GQSPFRGRKEKVKREEVDRRVLETEE------------------------VYSAKFSEEAKSICKMLLTKDPKQRLGCQE 252 (285)
T ss_pred CCCCCCCCCHHHHHHHHHHhhhcccc------------------------ccCccCCHHHHHHHHHHccCCHhHcCCCcc
Confidence 99999877655443333221110000 000112456889999999999999999
Q ss_pred --HHHHHHH
Q 002738 867 --AGDLYEM 873 (886)
Q Consensus 867 --A~EILeh 873 (886)
+.++++|
T Consensus 253 ~~~~~l~~~ 261 (285)
T cd05632 253 EGAGEVKRH 261 (285)
T ss_pred cChHHHHcC
Confidence 8899987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.90 Aligned_cols=259 Identities=28% Similarity=0.430 Sum_probs=201.5
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
+-+.|++.++||.|+||.||+|+. .+..+++|+.... .....+. +.+|+.+++.++||||+++++.+...
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~ 81 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELED----YMVEIEILATCNHPYIVKLLGAFYWD 81 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHH----HHHHHHHHHhCCCCcEeeeEEEEEeC
Confidence 346799999999999999999997 4567888876432 2233333 48899999999999999999998765
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
. ..++||||+++++|..++.. ....+++..+..++.||+.||+|||++||+||||||+||++
T Consensus 82 ~--------------~~~lv~e~~~~~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili 143 (292)
T cd06644 82 G--------------KLWIMIEFCPGGAVDAIMLE----LDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL 143 (292)
T ss_pred C--------------eEEEEEecCCCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE
Confidence 4 36999999999999988764 12458999999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~~s~KSDIWSLGVILy 785 (886)
+.+ +.++|+|||++......... .....+++.|+|||++.+.. ....++.++|||||||++|
T Consensus 144 ~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~ 206 (292)
T cd06644 144 TLD-------GDIKLADFGVSAKNVKTLQR----------RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLI 206 (292)
T ss_pred cCC-------CCEEEccCccceeccccccc----------cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHH
Confidence 876 46999999998654321111 12345889999999985321 1245788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
||++|..||...+.......+.....+.+.. ....+..+.+||.+||..+|++||
T Consensus 207 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~p~~Rp 261 (292)
T cd06644 207 EMAQIEPPHHELNPMRVLLKIAKSEPPTLSQ-------------------------PSKWSMEFRDFLKTALDKHPETRP 261 (292)
T ss_pred HHhcCCCCCccccHHHHHHHHhcCCCccCCC-------------------------CcccCHHHHHHHHHHhcCCcccCc
Confidence 9999999998777665554444332221110 012244689999999999999999
Q ss_pred CHHHHHHHHH
Q 002738 866 TAGDLYEMFV 875 (886)
Q Consensus 866 SA~EILehLe 875 (886)
++.++++|-.
T Consensus 262 ~~~~il~~~~ 271 (292)
T cd06644 262 SAAQLLEHPF 271 (292)
T ss_pred CHHHHhcCcc
Confidence 9999998743
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=314.32 Aligned_cols=273 Identities=24% Similarity=0.351 Sum_probs=197.2
Q ss_pred CCceeeeeecccCceEEEEEEE------CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEe
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 624 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~------~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~ 624 (886)
.+|++.+.||+|+||.||++.. .+..+++|..... .....+. +.+|+.++++++||||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~ 75 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRD----FEREIEILKSLQHDNIVKYKGVCY 75 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHH----HHHHHHHHHhCCCCCeeEEEEEEc
Confidence 4789999999999999999974 3567888885422 2223333 489999999999999999999876
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNI 704 (886)
.... ...++||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+||
T Consensus 76 ~~~~------------~~~~lv~e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~ni 139 (284)
T cd05081 76 SAGR------------RNLRLVMEYLPYGSLRDYLQK----HRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNI 139 (284)
T ss_pred cCCC------------CceEEEEEecCCCCHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhE
Confidence 4321 246999999999999999975 124588999999999999999999999999999999999
Q ss_pred EEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVIL 784 (886)
|++.+ +.+||+|||++........... ......++..|+|||++.+ ..++.++|||||||++
T Consensus 140 li~~~-------~~~~l~dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l 201 (284)
T cd05081 140 LVESE-------NRVKIGDFGLTKVLPQDKEYYK-------VREPGESPIFWYAPESLTE----SKFSVASDVWSFGVVL 201 (284)
T ss_pred EECCC-------CeEEECCCcccccccCCCccee-------ecCCCCCceEeeCHHHhcc----CCcChHHHHHHHHHHH
Confidence 99877 4699999999986643221100 0011124456999999875 5678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 785 LELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 785 yELLTG~~PF~g~s~~el~~~I~~~~r-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
|||++|..|+..... .....+..... +.....+.... ..... .......+..+.+|+.+||..+|++
T Consensus 202 ~el~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~ 269 (284)
T cd05081 202 YELFTYSDKSCSPPA-EFMRMMGNDKQGQMIVYHLIELL--------KNNGR---LPAPPGCPAEIYAIMKECWNNDPSQ 269 (284)
T ss_pred HHHhhcCCcCCCcch-hhhhhcccccccccchHHHHHHH--------hcCCc---CCCCCCCCHHHHHHHHHHccCChhh
Confidence 999999887644322 22222222111 11111111000 00000 0111234567999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 002738 864 RPTAGDLYEMFVAR 877 (886)
Q Consensus 864 RPSA~EILehLe~l 877 (886)
|||+.+|++.|+++
T Consensus 270 Rpt~~ei~~~l~~~ 283 (284)
T cd05081 270 RPSFSELALQVEAI 283 (284)
T ss_pred CCCHHHHHHHHHhc
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=320.72 Aligned_cols=253 Identities=23% Similarity=0.298 Sum_probs=194.5
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
.|++.+.||+|+||.||++.+ .+..+|+|........ .... ...+.+|+.++++++|+||+++++.+....
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~-~~~~----~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-- 73 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKG----ESMALNEKQILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc-chHH----HHHHHHHHHHHHhCCCCCeeeeeEEEecCC--
Confidence 478889999999999999997 4668888876433211 1111 123478999999999999999999987654
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..++||||++|++|.+++.. .....+++..+..++.|++.||.|||++||+||||||+||+++.+
T Consensus 74 ------------~~~lv~e~~~g~~L~~~l~~---~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~ 138 (285)
T cd05630 74 ------------ALCLVLTLMNGGDLKFHIYH---MGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH 138 (285)
T ss_pred ------------EEEEEEEecCCCcHHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC
Confidence 36999999999999999865 223458999999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.++|+|||++........ .....||..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 139 -------~~~~l~Dfg~~~~~~~~~~-----------~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~~l~~l~~ 196 (285)
T cd05630 139 -------GHIRISDLGLAVHVPEGQT-----------IKGRVGTVGYMAPEVVKN----ERYTFSPDWWALGCLLYEMIA 196 (285)
T ss_pred -------CCEEEeeccceeecCCCcc-----------ccCCCCCccccChHHHcC----CCCCCccccHHHHHHHHHHHh
Confidence 4599999999865432111 122368999999999976 668899999999999999999
Q ss_pred CCCCCCCCCHHHH---HHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 790 LQVPYMGLSELEI---HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 790 G~~PF~g~s~~el---~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
|+.||........ ...+.......+ ....++.+.+|+.+||+.||.+|||
T Consensus 197 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~li~~~l~~~p~~R~s 249 (285)
T cd05630 197 GQSPFQQRKKKIKREEVERLVKEVQEEY---------------------------SEKFSPDARSLCKMLLCKDPKERLG 249 (285)
T ss_pred CCCCCCCCCccchHHHHHhhhhhhhhhc---------------------------CccCCHHHHHHHHHHhhcCHHHccC
Confidence 9999976532211 111111100000 0113456899999999999999999
Q ss_pred -----HHHHHHHHH
Q 002738 867 -----AGDLYEMFV 875 (886)
Q Consensus 867 -----A~EILehLe 875 (886)
+.|+++|-.
T Consensus 250 ~~~~~~~~~~~h~~ 263 (285)
T cd05630 250 CQGGGAREVKEHPL 263 (285)
T ss_pred CCCCchHHHHcChh
Confidence 899999743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=319.00 Aligned_cols=267 Identities=20% Similarity=0.286 Sum_probs=199.1
Q ss_pred CCCCceeeeeecccCceEEEEEEECC----------------eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKFGS----------------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR 612 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~~~----------------~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~ 612 (886)
+..+|++.+.||+|+||.||+++..+ ..+|+|+.... ....... .+.+|++++++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~----~~~~ei~~l~~l~ 75 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD---VTKTARN----DFLKEIKIMSRLK 75 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC---CCHHHHH----HHHHHHHHHHhCC
Confidence 45689999999999999999987632 24777775322 1222222 3489999999999
Q ss_pred CCCcceeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhc-------cCCCcCCHHHHHHHHHHHHHH
Q 002738 613 HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------TGEKHVSVKLALFIAQDVAAA 685 (886)
Q Consensus 613 HPNIVrl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~-------~~~~~Ls~~~i~~Ia~QIa~A 685 (886)
||||+++++++..... .++||||+++++|.+++..... .....+++..++.++.||+.|
T Consensus 76 h~~i~~~~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~a 141 (295)
T cd05097 76 NPNIIRLLGVCVSDDP--------------LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASG 141 (295)
T ss_pred CCCcCeEEEEEcCCCc--------------cEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHH
Confidence 9999999999876543 5999999999999999965210 011246788999999999999
Q ss_pred HHHHHhCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcc
Q 002738 686 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 765 (886)
Q Consensus 686 L~yLHs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~ 765 (886)
|+|||++||+||||||+|||++.+ +.+||+|||++......... .......++..|+|||++.+
T Consensus 142 l~~lH~~~i~H~dlkp~Nill~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~- 205 (295)
T cd05097 142 MKYLASLNFVHRDLATRNCLVGNH-------YTIKIADFGMSRNLYSGDYY--------RIQGRAVLPIRWMAWESILL- 205 (295)
T ss_pred HHHHHhcCeeccccChhhEEEcCC-------CcEEecccccccccccCcce--------eccCcCcCceeecChhhhcc-
Confidence 999999999999999999999876 46999999999765332111 00122345789999999875
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhh
Q 002738 766 HKPNLYGLEVDIWSYGCLLLELLT--LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 843 (886)
Q Consensus 766 ~~~~~~s~KSDIWSLGVILyELLT--G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (886)
..++.++|||||||++|+|++ +..||...+..+....+........... ......
T Consensus 206 ---~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~ 262 (295)
T cd05097 206 ---GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQI--------------------YLSQTP 262 (295)
T ss_pred ---CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccc--------------------cCCCCC
Confidence 568999999999999999998 6788887776665554432111000000 000011
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002738 844 ETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 875 (886)
Q Consensus 844 ~~s~~L~dLL~rCL~~DP~kRPSA~EILehLe 875 (886)
..++.+.+|+.+||..||.+||++++|++.|+
T Consensus 263 ~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 263 LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 13457999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.05 Aligned_cols=255 Identities=27% Similarity=0.414 Sum_probs=198.7
Q ss_pred ceeeeeecccCceEEEEEEECC--eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCC
Q 002738 553 LSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 630 (886)
Q Consensus 553 Y~i~k~LG~G~fG~VY~A~~~~--~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~ 630 (886)
|++.+.||.|+||.||++.+.. ..+++|..... .....+. +.+|+.+++.++||||+++++++....
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~----~~~e~~~l~~l~h~~ii~~~~~~~~~~--- 75 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK----SEEELED----YMVEIDILASCDHPNIVKLLDAFYYEN--- 75 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC----CHHHHHH----HHHHHHHHHHCCCCCeeeEEEEEeeCC---
Confidence 6788999999999999999844 45566654321 1223333 388999999999999999999987654
Q ss_pred CCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccc
Q 002738 631 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 710 (886)
Q Consensus 631 ~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~ 710 (886)
..++||||+++++|..++.. ....+++..+..++.||+.||.|||+.||+||||||+|||++.+
T Consensus 76 -----------~~~~v~e~~~~~~l~~~~~~----~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~- 139 (282)
T cd06643 76 -----------NLWILIEFCAGGAVDAVMLE----LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD- 139 (282)
T ss_pred -----------EEEEEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC-
Confidence 36999999999999998864 23468999999999999999999999999999999999999876
Q ss_pred cCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcc-cCCCCCCchhhHHHHHHHHHHHHh
Q 002738 711 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM-HKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 711 ~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~-~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.+||+|||++........ ......+++.|+|||++... .....++.++|||||||++|||++
T Consensus 140 ------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~ 203 (282)
T cd06643 140 ------GDIKLADFGVSAKNTRTIQ----------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQ 203 (282)
T ss_pred ------CCEEEcccccccccccccc----------ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHcc
Confidence 4699999999875433211 11234689999999998531 123457789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 869 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~E 869 (886)
|++||...+..+....+.....+.+.. ....+..+.+||.+||+.||.+||++.+
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 258 (282)
T cd06643 204 IEPPHHELNPMRVLLKIAKSEPPTLAQ-------------------------PSRWSSEFKDFLKKCLEKNVDARWTTTQ 258 (282)
T ss_pred CCCCccccCHHHHHHHHhhcCCCCCCC-------------------------ccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 999998877766655554433221110 0112457899999999999999999999
Q ss_pred HHHHHH
Q 002738 870 LYEMFV 875 (886)
Q Consensus 870 ILehLe 875 (886)
+++|..
T Consensus 259 il~~~~ 264 (282)
T cd06643 259 LLQHPF 264 (282)
T ss_pred HhcCCC
Confidence 999855
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=313.21 Aligned_cols=279 Identities=20% Similarity=0.256 Sum_probs=205.3
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
+|++.+.||+|+||.||+|.+ .+..+++|+....... .... ..+.+|+.++++++||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~--~~~~----~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 72 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE--GGIP----NQALREIKALQACQHPYVVKLLDVFPHGS-- 72 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc--chhh----HHHHHHHHHHHhCCCCCCcceeeEEecCC--
Confidence 589999999999999999997 5678999987544321 1122 23489999999999999999999988654
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..++||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+|+||||+||+++.+
T Consensus 73 ------------~~~~v~e~~-~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~ 135 (286)
T cd07832 73 ------------GFVLVMEYM-PSDLSEVLRDE----ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD 135 (286)
T ss_pred ------------eeEEEeccc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCC
Confidence 469999999 89999998752 2568999999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.++|+|||++......... ......|+..|+|||++.+ ...++.++|||||||++|||++
T Consensus 136 -------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~~l~~l~t 196 (286)
T cd07832 136 -------GVLKIADFGLARLFSEEEPR---------LYSHQVATRWYRAPELLYG---ARKYDPGVDLWAVGCIFAELLN 196 (286)
T ss_pred -------CcEEEeeeeecccccCCCCC---------ccccccCcccccCceeeec---cccCCchhHHHHHHHHHHHHHc
Confidence 46999999998766432210 1122368999999999864 2456889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccc-cc-cccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH-EV-AQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~-~~-~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
|.+||.+.........+...........++........ .. ................+..+.+||.+||..+|.+||++
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 276 (286)
T cd07832 197 GSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSA 276 (286)
T ss_pred CCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCH
Confidence 99999887766655555443222222112111000000 00 00000000011122345789999999999999999999
Q ss_pred HHHHHHH
Q 002738 868 GDLYEMF 874 (886)
Q Consensus 868 ~EILehL 874 (886)
+++++|.
T Consensus 277 ~~~l~h~ 283 (286)
T cd07832 277 AEALRHP 283 (286)
T ss_pred HHHhhCc
Confidence 9999884
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=314.32 Aligned_cols=250 Identities=28% Similarity=0.413 Sum_probs=201.7
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
..|+..+.||.|+||.||+|.+ .+..+|+|+..... ...... .+.+|+.+++.+.||||+++++++....
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 75 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIE----DIQQEITVLSQCDSPYVTKYYGSYLKGT- 75 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHH----HHHHHHHHHHhCCCCCEeeEEEEEEECC-
Confidence 4578889999999999999987 56789999865432 122233 3489999999999999999999988654
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..++||||++|++|.+++.. ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.
T Consensus 76 -------------~~~lv~e~~~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~ 136 (277)
T cd06640 76 -------------KLWIIMEYLGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSE 136 (277)
T ss_pred -------------EEEEEEecCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcC
Confidence 46999999999999999864 45888999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ ..++|+|||++......... .....++..|+|||++.+ ..++.++|||||||++|||+
T Consensus 137 ~-------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~apE~~~~----~~~~~~~Dv~slG~il~el~ 195 (277)
T cd06640 137 Q-------GDVKLADFGVAGQLTDTQIK----------RNTFVGTPFWMAPEVIQQ----SAYDSKADIWSLGITAIELA 195 (277)
T ss_pred C-------CCEEEcccccceeccCCccc----------cccccCcccccCHhHhcc----CCCccHHHHHHHHHHHHHHH
Confidence 6 45999999999765432111 122357889999999875 56789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~ 868 (886)
+|..||....+......+.....+.+. ...+..+.+|+.+||+.+|.+||++.
T Consensus 196 tg~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ 248 (277)
T cd06640 196 KGEPPNSDMHPMRVLFLIPKNNPPTLT---------------------------GEFSKPFKEFIDACLNKDPSFRPTAK 248 (277)
T ss_pred HCCCCCCCcChHhHhhhhhcCCCCCCc---------------------------hhhhHHHHHHHHHHcccCcccCcCHH
Confidence 999999877766555444333222221 12356789999999999999999999
Q ss_pred HHHHHHH
Q 002738 869 DLYEMFV 875 (886)
Q Consensus 869 EILehLe 875 (886)
+++.|..
T Consensus 249 ~il~~~~ 255 (277)
T cd06640 249 ELLKHKF 255 (277)
T ss_pred HHHhChH
Confidence 9999844
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=309.83 Aligned_cols=262 Identities=24% Similarity=0.399 Sum_probs=204.4
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|++.+.||.|+||.||+|.. .+..+++|+....... ...+. +.+|+.+++.++|+||+++++.+....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ---TSVDE----LRKEVQAMSQCNHPNVVKYYTSFVVGD- 72 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc---hHHHH----HHHHHHHHHhcCCCCEEEEEEEEeeCC-
Confidence 4789999999999999999986 5667888886433221 13333 489999999999999999999887654
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..++||||+++++|.+++..... ...+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 73 -------------~~~iv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~ 137 (267)
T cd06610 73 -------------ELWLVMPYLSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGE 137 (267)
T ss_pred -------------EEEEEEeccCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcC
Confidence 46999999999999999976211 245889999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ ..++|+|||++..+....... ........|+..|+|||++... ..++.++|||||||++|+|+
T Consensus 138 ~-------~~~~l~df~~~~~~~~~~~~~------~~~~~~~~~~~~y~~Pe~~~~~---~~~~~~~Dv~slG~i~~~l~ 201 (267)
T cd06610 138 D-------GSVKIADFGVSASLADGGDRT------RKVRKTFVGTPCWMAPEVMEQV---HGYDFKADIWSFGITAIELA 201 (267)
T ss_pred C-------CCEEEcccchHHHhccCcccc------ccccccccCChhhcChHHHccc---cCcCcccchHhHhHHHHHHH
Confidence 6 459999999987765432210 0112334689999999998751 36788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~ 868 (886)
+|+.||...+.......+.....+.+.. .......++.+.+|+.+||..||.+||++.
T Consensus 202 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 259 (267)
T cd06610 202 TGAAPYSKYPPMKVLMLTLQNDPPSLET----------------------GADYKKYSKSFRKMISLCLQKDPSKRPTAE 259 (267)
T ss_pred hCCCCccccChhhhHHHHhcCCCCCcCC----------------------ccccccccHHHHHHHHHHcCCChhhCcCHH
Confidence 9999998776665554444432222111 000123356789999999999999999999
Q ss_pred HHHHH
Q 002738 869 DLYEM 873 (886)
Q Consensus 869 EILeh 873 (886)
+|++|
T Consensus 260 ~ll~~ 264 (267)
T cd06610 260 ELLKH 264 (267)
T ss_pred HHhhC
Confidence 99987
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=318.32 Aligned_cols=267 Identities=20% Similarity=0.297 Sum_probs=198.1
Q ss_pred CCCceeeeeecccCceEEEEEEEC------------------CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKFG------------------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL 611 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~~------------------~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L 611 (886)
.++|++.+.||+|+||.||++.+. ...+|+|+..... ..... ..+.+|+.+|+.+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~---~~~~~----~~~~~E~~~l~~l 76 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---NKNAR----NDFLKEIKIMSRL 76 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC---CHHHH----HHHHHHHHHHHhC
Confidence 457999999999999999998642 2357777753221 12222 2348999999999
Q ss_pred CCCCcceeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhcc------CCCcCCHHHHHHHHHHHHHH
Q 002738 612 RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------GEKHVSVKLALFIAQDVAAA 685 (886)
Q Consensus 612 ~HPNIVrl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~------~~~~Ls~~~i~~Ia~QIa~A 685 (886)
+||||+++++++..... .++||||+++++|.+++...... ....+++..+..++.||+.|
T Consensus 77 ~~~~i~~~~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a 142 (296)
T cd05095 77 KDPNIIRLLAVCITSDP--------------LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASG 142 (296)
T ss_pred CCCCcceEEEEEecCCc--------------cEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHH
Confidence 99999999999876553 59999999999999999763211 11347788999999999999
Q ss_pred HHHHHhCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcc
Q 002738 686 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 765 (886)
Q Consensus 686 L~yLHs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~ 765 (886)
|+|||++||+||||||+|||++.+ +.++|+|||++..+...... .......+++.|+|||+..+
T Consensus 143 l~~lH~~~i~H~dlkp~Nili~~~-------~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~- 206 (296)
T cd05095 143 MKYLSSLNFVHRDLATRNCLVGKN-------YTIKIADFGMSRNLYSGDYY--------RIQGRAVLPIRWMSWESILL- 206 (296)
T ss_pred HHHHHHCCeecccCChheEEEcCC-------CCEEeccCcccccccCCcce--------eccCcCcCccccCCHHHHhc-
Confidence 999999999999999999999876 46999999999765332110 00122235678999998875
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhh
Q 002738 766 HKPNLYGLEVDIWSYGCLLLELLT--LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 843 (886)
Q Consensus 766 ~~~~~~s~KSDIWSLGVILyELLT--G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (886)
..++.++|||||||++|||++ |..||...+..+.............. . ... ....
T Consensus 207 ---~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-----------~------~~~---~~~~ 263 (296)
T cd05095 207 ---GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGR-----------Q------VYL---PKPA 263 (296)
T ss_pred ---CCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccc-----------c------ccC---CCCC
Confidence 568899999999999999998 78999877666654433211000000 0 000 0011
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002738 844 ETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 876 (886)
Q Consensus 844 ~~s~~L~dLL~rCL~~DP~kRPSA~EILehLe~ 876 (886)
.++..+.+|+.+||+.||.+||++.+|++.|+.
T Consensus 264 ~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 264 LCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 234679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=309.78 Aligned_cols=257 Identities=27% Similarity=0.396 Sum_probs=197.8
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCC-hHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~-~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
.+|++.+.||+|+||.||++.. .+..+++|.......... ....+ .+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 77 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVN----ALECEIQLLKNLLHERIVQYYGCLRDPM 77 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHH----HHHHHHHHHHhcCCCCeeeEEeEeccCC
Confidence 4789999999999999999987 457789988654332211 12233 3488999999999999999999876542
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
. ..+++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++|+|+||||+|||++
T Consensus 78 ~------------~~~~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~ 140 (265)
T cd06652 78 E------------RTLSIFMEHMPGGSIKDQLKS-----YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD 140 (265)
T ss_pred C------------ceEEEEEEecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec
Confidence 1 246899999999999999975 24578889999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ +.++|+|||++.......... .......|+..|+|||++.+ ..++.++|||||||++|||
T Consensus 141 ~~-------~~~~l~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~el 202 (265)
T cd06652 141 SV-------GNVKLGDFGASKRLQTICLSG-------TGMKSVTGTPYWMSPEVISG----EGYGRKADIWSVGCTVVEM 202 (265)
T ss_pred CC-------CCEEECcCccccccccccccc-------cccccCCCCccccChhhhcC----CCCCcchhHHHHHHHHHHH
Confidence 76 569999999987654321110 01122358899999999875 5678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcC-CCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 788 LTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 788 LTG~~PF~g~s~~el~~~I~~~-~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
++|+.||...........+... ..+.++ ...+..+.++|.+||. +|.+||+
T Consensus 203 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~-~p~~Rp~ 254 (265)
T cd06652 203 LTEKPPWAEFEAMAAIFKIATQPTNPVLP---------------------------PHVSDHCRDFLKRIFV-EAKLRPS 254 (265)
T ss_pred hhCCCCCCccchHHHHHHHhcCCCCCCCc---------------------------hhhCHHHHHHHHHHhc-ChhhCCC
Confidence 9999999876554443333222 111111 1234578899999995 9999999
Q ss_pred HHHHHHHH
Q 002738 867 AGDLYEMF 874 (886)
Q Consensus 867 A~EILehL 874 (886)
+++|++|-
T Consensus 255 ~~~il~~~ 262 (265)
T cd06652 255 ADELLRHT 262 (265)
T ss_pred HHHHhcCc
Confidence 99999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=324.25 Aligned_cols=285 Identities=20% Similarity=0.252 Sum_probs=197.8
Q ss_pred eeeeeccc--CceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCC
Q 002738 555 SCDEAGKS--VSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 630 (886)
Q Consensus 555 i~k~LG~G--~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~ 630 (886)
+.++||+| +|++||++.. .+..||+|....... ..... ..+.+|+.+++.++||||+++++++..+.
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~----~~~~~e~~~l~~l~hpniv~~~~~~~~~~--- 72 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC--TNEMV----TFLQGELHVSKLFNHPNIVPYRATFIADN--- 72 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc--cHHHH----HHHHHHHHHHHhcCCCCeeeEEEEEEECC---
Confidence 56789999 7889999987 567888888643321 22222 23478999999999999999999998665
Q ss_pred CCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccc
Q 002738 631 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 710 (886)
Q Consensus 631 ~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~ 710 (886)
..++||||+++++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 73 -----------~~~lv~e~~~~~~l~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~- 137 (327)
T cd08227 73 -----------ELWVVTSFMAYGSAKDLICTH---FMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD- 137 (327)
T ss_pred -----------EEEEEEeccCCCcHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC-
Confidence 369999999999999999752 12348899999999999999999999999999999999999877
Q ss_pred cCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 002738 711 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 790 (886)
Q Consensus 711 ~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG 790 (886)
+.++++||+.+............ .........++..|+|||++.+. ...++.++|||||||++|||++|
T Consensus 138 ------~~~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~DiwslG~il~el~~g 206 (327)
T cd08227 138 ------GKVYLSGLRSNLSMINHGQRLRV---VHDFPKYSVKVLPWLSPEVLQQN--LQGYDAKSDIYSVGITACELANG 206 (327)
T ss_pred ------CcEEEcccchhhccccccccccc---cccccccccceecccChHHhhcc--cCCCCchhhHHHHHHHHHHHHHC
Confidence 45999999876543321111000 00111223577889999999751 13578999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhH-------Hhhhccc---c-----cccccccCC---CCCCchhhhhhHHHHHHH
Q 002738 791 QVPYMGLSELEIHDLIQMGKRPRLTDE-------LEALGSC---H-----EHEVAQSGS---GFEKPEAELETLSFLVDV 852 (886)
Q Consensus 791 ~~PF~g~s~~el~~~I~~~~rp~l~~~-------l~~~~~~---~-----~~~~~~~~~---~~~~~~~~~~~s~~L~dL 852 (886)
+.||..............+..+.+.+. +...... . ......... ...........++.+.+|
T Consensus 207 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 286 (327)
T cd08227 207 HVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHF 286 (327)
T ss_pred CCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHH
Confidence 999987665554444333322211110 0000000 0 000000000 000011122346689999
Q ss_pred HHHhcccCCCCCCCHHHHHHHH
Q 002738 853 FRRCTEENPTERPTAGDLYEMF 874 (886)
Q Consensus 853 L~rCL~~DP~kRPSA~EILehL 874 (886)
|.+||+.||.+|||++++++|.
T Consensus 287 i~~~l~~dP~~Rpt~~ell~~p 308 (327)
T cd08227 287 VEQCLQRNPDARPSASTLLNHS 308 (327)
T ss_pred HHHHHhhCchhcCCHHHHhcCh
Confidence 9999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=335.91 Aligned_cols=264 Identities=24% Similarity=0.318 Sum_probs=203.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCccee
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEM 619 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~~-------~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl 619 (886)
++..+|.+.++||+|+||.||+|++.+ ..||+|+..... .....+ .+.+|+.+|.++. |||||++
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~----~~~~E~~~l~~l~~H~niv~~ 106 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA---RSSEKQ----ALMSELKIMSHLGPHLNIVNL 106 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC---ChhHHH----HHHHHHHHHHhcCCCCCeEEE
Confidence 566789999999999999999998633 478999864321 122222 3489999999997 9999999
Q ss_pred eeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhc-----------------------------------
Q 002738 620 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE----------------------------------- 664 (886)
Q Consensus 620 ~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~----------------------------------- 664 (886)
++++..... .++||||+++|+|.+++.....
T Consensus 107 ~~~~~~~~~--------------~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (401)
T cd05107 107 LGACTKGGP--------------IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGS 172 (401)
T ss_pred EEEEccCCC--------------cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhh
Confidence 999976543 6999999999999999975211
Q ss_pred ----------------------------------------------------------cCCCcCCHHHHHHHHHHHHHHH
Q 002738 665 ----------------------------------------------------------TGEKHVSVKLALFIAQDVAAAL 686 (886)
Q Consensus 665 ----------------------------------------------------------~~~~~Ls~~~i~~Ia~QIa~AL 686 (886)
.....+++..++.++.||+.||
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL 252 (401)
T cd05107 173 ESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGM 252 (401)
T ss_pred ccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHH
Confidence 0112467778899999999999
Q ss_pred HHHHhCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 002738 687 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 766 (886)
Q Consensus 687 ~yLHs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~ 766 (886)
+|||+++|+||||||+|||++.+ ..+||+|||+++........ .......+++.|+|||++.+
T Consensus 253 ~~LH~~~ivHrdlkp~NiLl~~~-------~~~kL~DfGla~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~-- 315 (401)
T cd05107 253 EFLASKNCVHRDLAARNVLICEG-------KLVKICDFGLARDIMRDSNY--------ISKGSTFLPLKWMAPESIFN-- 315 (401)
T ss_pred HHHhcCCcCcccCCcceEEEeCC-------CEEEEEecCcceeccccccc--------ccCCCcCCCCceeChHHhcC--
Confidence 99999999999999999999876 56999999999765332110 01122357889999999975
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhh
Q 002738 767 KPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 844 (886)
Q Consensus 767 ~~~~~s~KSDIWSLGVILyELLT-G~~PF~g~s~~el~-~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (886)
..++.++|||||||++|||++ |..||......+.. ..+..+.++..+ ..
T Consensus 316 --~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p---------------------------~~ 366 (401)
T cd05107 316 --NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKP---------------------------AH 366 (401)
T ss_pred --CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCC---------------------------CC
Confidence 567899999999999999998 89999776544433 333333322211 11
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 002738 845 TLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 878 (886)
Q Consensus 845 ~s~~L~dLL~rCL~~DP~kRPSA~EILehLe~l~ 878 (886)
.+..+.+|+.+||..+|.+||++.+|++.|+.+.
T Consensus 367 ~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 367 ASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 2457999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=319.52 Aligned_cols=253 Identities=26% Similarity=0.441 Sum_probs=202.8
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
...+|++.+.||.|+||.||+|.. .+..+++|.+..... ...+ .+.+|+.+++.++||||+++++++...
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~----~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~ 88 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ----PKKE----LIINEILVMKELKNPNIVNFLDSFLVG 88 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC----chHH----HHHHHHHHHHhcCCCceeeeeeeEecC
Confidence 456899999999999999999986 667899998754321 1122 348899999999999999999998755
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
. ..++||||+++++|..++.. ..+++..+..++.|++.||+|||++||+||||||+||++
T Consensus 89 ~--------------~~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili 148 (296)
T cd06655 89 D--------------ELFVVMEYLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL 148 (296)
T ss_pred c--------------eEEEEEEecCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 4 47999999999999999875 358999999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +.+||+|||++......... .....++..|+|||.+.+ ..++.++|||||||++|+
T Consensus 149 ~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slGvil~~ 207 (296)
T cd06655 149 GMD-------GSVKLTDFGFCAQITPEQSK----------RSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIE 207 (296)
T ss_pred CCC-------CCEEEccCccchhccccccc----------CCCcCCCccccCcchhcC----CCCCchhhHHHHHHHHHH
Confidence 876 46999999998765432111 122358899999999875 567889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 787 LLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
|++|+.||.+.+.......+.....+.+. .....++.+.+||.+||..||.+||+
T Consensus 208 lltg~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~dp~~Rpt 262 (296)
T cd06655 208 MVEGEPPYLNENPLRALYLIATNGTPELQ-------------------------NPEKLSPIFRDFLNRCLEMDVEKRGS 262 (296)
T ss_pred HHhCCCCCCCCCHHHHHHHHHhcCCcccC-------------------------CcccCCHHHHHHHHHHhhcChhhCCC
Confidence 99999999887765554444332221111 01123457899999999999999999
Q ss_pred HHHHHHHHH
Q 002738 867 AGDLYEMFV 875 (886)
Q Consensus 867 A~EILehLe 875 (886)
+.+|+.|-.
T Consensus 263 ~~~il~~~~ 271 (296)
T cd06655 263 AKELLQHPF 271 (296)
T ss_pred HHHHhhChH
Confidence 999999844
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=334.71 Aligned_cols=255 Identities=22% Similarity=0.260 Sum_probs=214.1
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
.-+-|.+.+.||+|.|+.|-+|++ .+..||||++.. .......... +.+|++.|+.++|||||++|++..+.
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDK--TKlD~~st~h----lfqEVRCMKLVQHpNiVRLYEViDTQ 89 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDK--TKLDTLSTGH----LFQEVRCMKLVQHPNIVRLYEVIDTQ 89 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecc--cccchhhhhH----HHHHHHHHHHhcCcCeeeeeehhccc
Confidence 345688999999999999999985 899999999643 2222222233 48999999999999999999988754
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
. .+|||+|+-++|+|.+||.+. ...+.+..+.+++.||+.|+.|+|+..+|||||||+|+.+
T Consensus 90 T--------------KlyLiLELGD~GDl~DyImKH----e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVF 151 (864)
T KOG4717|consen 90 T--------------KLYLILELGDGGDLFDYIMKH----EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVF 151 (864)
T ss_pred c--------------eEEEEEEecCCchHHHHHHhh----hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEE
Confidence 4 479999999999999999872 4568999999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
.+. .+.|||.|||++..+.+... -++.+|+..|.|||++.| ..+..+++||||||||||-
T Consensus 152 FEK------lGlVKLTDFGFSNkf~PG~k-----------L~TsCGSLAYSAPEILLG---DsYDAPAVDiWSLGVILyM 211 (864)
T KOG4717|consen 152 FEK------LGLVKLTDFGFSNKFQPGKK-----------LTTSCGSLAYSAPEILLG---DSYDAPAVDIWSLGVILYM 211 (864)
T ss_pred eee------cCceEeeeccccccCCCcch-----------hhcccchhhccCchhhhc---CccCCcchhhhHHHHHHHH
Confidence 876 36899999999987655332 245679999999999998 3445689999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 787 LLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
|++|++||+..++.+.+..|....+ .+| ...+.++++||..||..||.+|.+
T Consensus 212 LVCGq~PFqeANDSETLTmImDCKY-tvP---------------------------shvS~eCrdLI~sMLvRdPkkRAs 263 (864)
T KOG4717|consen 212 LVCGQPPFQEANDSETLTMIMDCKY-TVP---------------------------SHVSKECRDLIQSMLVRDPKKRAS 263 (864)
T ss_pred HHhCCCccccccchhhhhhhhcccc-cCc---------------------------hhhhHHHHHHHHHHHhcCchhhcc
Confidence 9999999999999988888877644 222 234678999999999999999999
Q ss_pred HHHHHHHHH
Q 002738 867 AGDLYEMFV 875 (886)
Q Consensus 867 A~EILehLe 875 (886)
.++|..+-+
T Consensus 264 lEeI~s~~W 272 (864)
T KOG4717|consen 264 LEEIVSTSW 272 (864)
T ss_pred HHHHhcccc
Confidence 999998744
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=311.55 Aligned_cols=258 Identities=26% Similarity=0.400 Sum_probs=197.6
Q ss_pred eeecccCceEEEEEEECC--------eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 557 DEAGKSVSSSLFRCKFGS--------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~~~--------~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
+.||+|+||.||+|++.. ..+++|..... ....... .+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~---~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 72 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG---ATDQEKK----EFLKEAHLMSNFNHPNIVKLLGVCLLNE- 72 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc---cchhhHH----HHHHHHHHHHhcCCCCeeeEeeeecCCC-
Confidence 368999999999998743 45788875321 1112223 3488999999999999999999987554
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhcc--CCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~--~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
..++||||+++++|.+++...... ....+++..+..++.||+.||.|||+.+++|+||||+|||+
T Consensus 73 -------------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~ 139 (269)
T cd05044 73 -------------PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLV 139 (269)
T ss_pred -------------CeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEE
Confidence 369999999999999999753221 22347889999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.++. +....++|+|||++.......... ......++..|+|||++.+ ..++.++|||||||++||
T Consensus 140 ~~~~~--~~~~~~~l~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~e 205 (269)
T cd05044 140 SEKGY--DADRVVKIGDFGLARDIYKSDYYR--------KEGEGLLPVRWMAPESLLD----GKFTTQSDVWSFGVLMWE 205 (269)
T ss_pred ecCCC--CCCcceEECCcccccccccccccc--------cCcccCCCccccCHHHHcc----CCcccchhHHHHHHHHHH
Confidence 87631 122469999999997654321110 0112346788999999976 667899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 787 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 787 LLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
|++ |..||...+..+....+..+.....+ ...+..+.+||.+||..+|.+||
T Consensus 206 llt~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp 258 (269)
T cd05044 206 ILTLGQQPYPALNNQEVLQHVTAGGRLQKP---------------------------ENCPDKIYQLMTNCWAQDPSERP 258 (269)
T ss_pred HHHcCCCCCcccCHHHHHHHHhcCCccCCc---------------------------ccchHHHHHHHHHHcCCCcccCC
Confidence 998 99999887777666655443322211 11345789999999999999999
Q ss_pred CHHHHHHHHHh
Q 002738 866 TAGDLYEMFVA 876 (886)
Q Consensus 866 SA~EILehLe~ 876 (886)
++.+|++.|+.
T Consensus 259 ~~~~i~~~l~~ 269 (269)
T cd05044 259 TFDRIQEILQN 269 (269)
T ss_pred CHHHHHHHHhC
Confidence 99999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=345.28 Aligned_cols=259 Identities=29% Similarity=0.444 Sum_probs=216.8
Q ss_pred CCceeeeeecccCceEEEEEEECCe--eEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~~~~--~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
+-|.|+..||.|+||.||+|..... ..|.|++..+ ..++++.| +-||.||..+.||+||++++.|+.++.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk----seEELEDy----lVEIeILa~CdHP~ivkLl~ayy~enk 103 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK----SEEELEDY----LVEIEILAECDHPVIVKLLSAYYFENK 103 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc----chhHHhhh----hhhhhhhhcCCChHHHHHHHHHhccCc
Confidence 4578999999999999999987543 4556664332 44566666 889999999999999999999887664
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
+||+.|||.||.....+-.+ +..+.+.++..+++|++.||.|||+++|||||||..|||++.
T Consensus 104 --------------LwiliEFC~GGAVDaimlEL----~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tl 165 (1187)
T KOG0579|consen 104 --------------LWILIEFCGGGAVDAIMLEL----GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTL 165 (1187)
T ss_pred --------------eEEEEeecCCchHhHHHHHh----ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEe
Confidence 69999999999999988762 467999999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcc-cCCCCCCchhhHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM-HKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~-~~~~~~s~KSDIWSLGVILyEL 787 (886)
+| .++|+|||.+....... .....++|||.|||||+..+. ....+|..++||||||++|.||
T Consensus 166 dG-------dirLADFGVSAKn~~t~----------qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEM 228 (1187)
T KOG0579|consen 166 DG-------DIRLADFGVSAKNKSTR----------QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEM 228 (1187)
T ss_pred cC-------cEeeecccccccchhHH----------hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHH
Confidence 95 49999999986543322 123567899999999998763 2447899999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 788 LTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
..+.+|....+++.++-.|.+...|.+-. +...+..+.+|+.+||..||..||++
T Consensus 229 AqiEPPHhelnpMRVllKiaKSePPTLlq-------------------------PS~Ws~~F~DfLk~cL~Knp~~Rp~a 283 (1187)
T KOG0579|consen 229 AQIEPPHHELNPMRVLLKIAKSEPPTLLQ-------------------------PSHWSRSFSDFLKRCLVKNPRNRPPA 283 (1187)
T ss_pred hccCCCccccchHHHHHHHhhcCCCcccC-------------------------cchhhhHHHHHHHHHHhcCCccCCCH
Confidence 99999999999999999998887665542 11235579999999999999999999
Q ss_pred HHHHHHHHhh
Q 002738 868 GDLYEMFVAR 877 (886)
Q Consensus 868 ~EILehLe~l 877 (886)
+++++|..--
T Consensus 284 aqll~Hpfv~ 293 (1187)
T KOG0579|consen 284 AQLLKHPFVQ 293 (1187)
T ss_pred HHHhhCcccc
Confidence 9999996543
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=316.67 Aligned_cols=249 Identities=28% Similarity=0.419 Sum_probs=198.2
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
.|+..+.||+|+||.||+|.+ .+..+|+|+..... ..... +.+.+|+.++++++||||+++++++....
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 75 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEI----EDIQQEITVLSQCDSPYITRYYGSYLKGT-- 75 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHH----HHHHHHHHHHHcCCCCccHhhhcccccCC--
Confidence 477889999999999999987 46678888864332 11222 34489999999999999999999987554
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..++||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+|+||+|+||+++.+
T Consensus 76 ------------~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~ 137 (277)
T cd06642 76 ------------KLWIIMEYLGGGSALDLLKP------GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ 137 (277)
T ss_pred ------------ceEEEEEccCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCC
Confidence 36999999999999999864 458899999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.++|+|||++..+...... .....|+..|+|||++.+ ..++.++|||||||++|||++
T Consensus 138 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~el~t 196 (277)
T cd06642 138 -------GDVKLADFGVAGQLTDTQIK----------RNTFVGTPFWMAPEVIKQ----SAYDFKADIWSLGITAIELAK 196 (277)
T ss_pred -------CCEEEccccccccccCcchh----------hhcccCcccccCHHHhCc----CCCchhhhHHHHHHHHHHHHh
Confidence 46999999998765432111 122358889999999976 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 869 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~E 869 (886)
|+.||....+......+.....+.+. ...+..+.+||.+||..+|.+||++.+
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (277)
T cd06642 197 GEPPNSDLHPMRVLFLIPKNSPPTLE---------------------------GQYSKPFKEFVEACLNKDPRFRPTAKE 249 (277)
T ss_pred CCCCCcccchhhHHhhhhcCCCCCCC---------------------------cccCHHHHHHHHHHccCCcccCcCHHH
Confidence 99999766655544433332221111 123457899999999999999999999
Q ss_pred HHHHHH
Q 002738 870 LYEMFV 875 (886)
Q Consensus 870 ILehLe 875 (886)
+++|..
T Consensus 250 il~~~~ 255 (277)
T cd06642 250 LLKHKF 255 (277)
T ss_pred HHHhHH
Confidence 999753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=310.15 Aligned_cols=257 Identities=27% Similarity=0.404 Sum_probs=196.3
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
+|++.+.||+|+||.||+|.. .+..+++|+......... .......+.+|+.+++.++||||+++++++.....
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 78 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPE---TSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE- 78 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCch---hHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC-
Confidence 688999999999999999986 567888887654332111 11122345899999999999999999998875321
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
...+++|||+++++|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+||+++.+
T Consensus 79 -----------~~~~l~~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~ 142 (266)
T cd06651 79 -----------KTLTIFMEYMPGGSVKDQLKA-----YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSA 142 (266)
T ss_pred -----------CEEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC
Confidence 247999999999999999975 2458899999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.++|+|||++.......... .......++..|+|||++.+ ..++.++|||||||++|||++
T Consensus 143 -------~~~~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~i~~el~~ 204 (266)
T cd06651 143 -------GNVKLGDFGASKRLQTICMSG-------TGIRSVTGTPYWMSPEVISG----EGYGRKADVWSLGCTVVEMLT 204 (266)
T ss_pred -------CCEEEccCCCccccccccccC-------CccccCCccccccCHHHhCC----CCCCchhhhHHHHHHHHHHHH
Confidence 469999999987653321110 01122358899999999975 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcC-CCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 002738 790 LQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~-~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~ 868 (886)
|+.||...........+... ..+.++ ....+.+.+|+ +||..+|.+||++.
T Consensus 205 g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li-~~~~~~p~~Rp~~~ 256 (266)
T cd06651 205 EKPPWAEYEAMAAIFKIATQPTNPQLP---------------------------SHISEHARDFL-GCIFVEARHRPSAE 256 (266)
T ss_pred CCCCccccchHHHHHHHhcCCCCCCCc---------------------------hhcCHHHHHHH-HHhcCChhhCcCHH
Confidence 99999876554443333221 122211 12244677888 68889999999999
Q ss_pred HHHHHH
Q 002738 869 DLYEMF 874 (886)
Q Consensus 869 EILehL 874 (886)
||++|-
T Consensus 257 eil~hp 262 (266)
T cd06651 257 ELLRHP 262 (266)
T ss_pred HHhcCc
Confidence 999873
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=309.16 Aligned_cols=265 Identities=20% Similarity=0.330 Sum_probs=202.6
Q ss_pred ceeeeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 553 LSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 553 Y~i~k~LG~G~fG~VY~A~~-----~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
|.+.+.||+|+||.||+|.+ .+..+|+|++..+. ......+. +.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~----~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI--FSSSDIEE----FLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc--CChHHHHH----HHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 67788999999999999986 24679999864332 22223333 488999999999999999999887543
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHh-ccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS-ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~-~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
. .......++++||+.+|+|..++.... ......+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 75 ~--------~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili 146 (273)
T cd05074 75 A--------KGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML 146 (273)
T ss_pred C--------CCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE
Confidence 1 011224589999999999999886421 1122357889999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +.+||+|||+++........ .......+++.|++||.+.. ..++.++|||||||++||
T Consensus 147 ~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~----~~~~~~sDi~slG~il~e 207 (273)
T cd05074 147 NEN-------MTVCVADFGLSKKIYSGDYY--------RQGCASKLPVKWLALESLAD----NVYTTHSDVWAFGVTMWE 207 (273)
T ss_pred cCC-------CCEEECcccccccccCCcce--------ecCCCccCchhhcCHhHHhc----CccchhhhhHHHHHHHHH
Confidence 866 56999999999865332110 00112235678999999875 667889999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 787 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 787 LLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
|++ |+.||.+.+.......+........+ ...+..+.+|+.+||..+|++||
T Consensus 208 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~~~l~~~p~~Rp 260 (273)
T cd05074 208 IMTRGQTPYAGVENSEIYNYLIKGNRLKQP---------------------------PDCLEDVYELMCQCWSPEPKCRP 260 (273)
T ss_pred HhhCCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHcCCChhhCc
Confidence 999 89999888777666665544321111 11245799999999999999999
Q ss_pred CHHHHHHHHHhh
Q 002738 866 TAGDLYEMFVAR 877 (886)
Q Consensus 866 SA~EILehLe~l 877 (886)
++.+++..|+.+
T Consensus 261 s~~~~~~~l~~~ 272 (273)
T cd05074 261 SFQHLRDQLELI 272 (273)
T ss_pred CHHHHHHHHHhh
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=306.35 Aligned_cols=249 Identities=27% Similarity=0.413 Sum_probs=196.0
Q ss_pred eeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 635 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~~-~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~~~ 635 (886)
++||+|+||.||+|.+. +..+++|+...... .... ..+.+|+.+++++.||||+++++++....
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~---~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------- 65 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP---PDLK----RKFLQEAEILKQYDHPNIVKLIGVCVQKQ-------- 65 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCC---HHHH----HHHHHHHHHHHhCCCCCeEEEEEEEecCC--------
Confidence 47999999999999974 78889987543321 1222 34489999999999999999999988655
Q ss_pred CCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCCC
Q 002738 636 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 715 (886)
Q Consensus 636 ~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~ 715 (886)
..++||||+++++|.+++.. ....+++..+..++.|++.||.|||+++|+||||||+|||++.+
T Consensus 66 ------~~~~v~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~------ 129 (251)
T cd05041 66 ------PIYIVMELVPGGSLLTFLRK----KKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGEN------ 129 (251)
T ss_pred ------CeEEEEEcCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCC------
Confidence 36999999999999999975 12457899999999999999999999999999999999999877
Q ss_pred CCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 002738 716 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPY 794 (886)
Q Consensus 716 ~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT-G~~PF 794 (886)
..++|+|||++.......... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||
T Consensus 130 -~~~~l~d~g~~~~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~i~~~l~t~~~~p~ 196 (251)
T cd05041 130 -NVLKISDFGMSREEEGGIYTV--------SDGLKQIPIKWTAPEALNY----GRYTSESDVWSYGILLWETFSLGDTPY 196 (251)
T ss_pred -CcEEEeeccccccccCCccee--------ccccCcceeccCChHhhcc----CCCCcchhHHHHHHHHHHHHhccCCCC
Confidence 469999999997654211110 0011234567999999876 568899999999999999999 89999
Q ss_pred CCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002738 795 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874 (886)
Q Consensus 795 ~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EILehL 874 (886)
...........+........+ ...+..+.+|+.+||..+|.+|||+.||++.|
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l 249 (251)
T cd05041 197 PGMSNQQTRERIESGYRMPAP---------------------------QLCPEEIYRLMLQCWAYDPENRPSFSEIYNEL 249 (251)
T ss_pred ccCCHHHHHHHHhcCCCCCCC---------------------------ccCCHHHHHHHHHHhccChhhCcCHHHHHHHh
Confidence 887766665555443222111 11245799999999999999999999999998
Q ss_pred Hh
Q 002738 875 VA 876 (886)
Q Consensus 875 e~ 876 (886)
+.
T Consensus 250 ~~ 251 (251)
T cd05041 250 QI 251 (251)
T ss_pred hC
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=311.40 Aligned_cols=259 Identities=20% Similarity=0.321 Sum_probs=187.1
Q ss_pred eeecccCceEEEEEEE-CCee---EEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKF-GSAD---AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 632 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~-~~~~---VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~ 632 (886)
+.||+|+||.||++.. .+.. +++|.... .......+ .+.+|+.+++.++||||+++++.+....
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~----~~~~e~~~~~~l~h~~iv~~~~~~~~~~----- 68 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKA---NASSKEQN----EFLQQGDPYRILQHPNILQCLGQCVEAI----- 68 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecC---CCChHHHH----HHHHHHHHHhccCCcchhheEEEecCCC-----
Confidence 3699999999999975 3322 34444322 11222223 4489999999999999999999988554
Q ss_pred CCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccC
Q 002738 633 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 712 (886)
Q Consensus 633 ~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~ 712 (886)
..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+++|+||||||+|||++.+
T Consensus 69 ---------~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~--- 135 (268)
T cd05086 69 ---------PYLLVFEYCELGDLKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSD--- 135 (268)
T ss_pred ---------ccEEEEecCCCCcHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCC---
Confidence 35999999999999999976211 12346677888999999999999999999999999999999876
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC---CCCCCchhhHHHHHHHHHHHHh
Q 002738 713 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK---PNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 713 ~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~---~~~~s~KSDIWSLGVILyELLT 789 (886)
+.++|+|||++......... .......++..|+|||++..... ...++.++|||||||++|||++
T Consensus 136 ----~~~~l~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~ 203 (268)
T cd05086 136 ----LTVKVGDYGIGPSRYKEDYI--------ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFE 203 (268)
T ss_pred ----ccEEecccccccccCcchhh--------hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHh
Confidence 56999999998543221100 01123457899999999853111 1345789999999999999997
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 002738 790 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868 (886)
Q Consensus 790 -G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~ 868 (886)
|..||...+..+....+.......+.. +.......+.+.+++..|| .+|.+||+++
T Consensus 204 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~ 260 (268)
T cd05086 204 NAAQPYSHLSDREVLNHVIKDQQVKLFK----------------------PQLELPYSERWYEVLQFCW-LSPEKRATAE 260 (268)
T ss_pred CCCCCCCCCCHHHHHHHHHhhcccccCC----------------------CccCCCCcHHHHHHHHHHh-hCcccCCCHH
Confidence 577898777766665554332211110 0001113457888999999 6899999999
Q ss_pred HHHHHHH
Q 002738 869 DLYEMFV 875 (886)
Q Consensus 869 EILehLe 875 (886)
+|++.|.
T Consensus 261 ~i~~~l~ 267 (268)
T cd05086 261 EVHRLLT 267 (268)
T ss_pred HHHHHhc
Confidence 9998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=308.17 Aligned_cols=246 Identities=23% Similarity=0.375 Sum_probs=186.5
Q ss_pred eeecccCceEEEEEEECCee------------EEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEe
Q 002738 557 DEAGKSVSSSLFRCKFGSAD------------AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 624 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~~~~~------------VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~ 624 (886)
+.||+|+||.||+|.+.... +++|+..... ... ..+.+|+.++++++||||+++++++.
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RDS----LAFFETASLMSQLSHKHLVKLYGVCV 71 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hhH----HHHHHHHHHHHcCCCcchhheeeEEe
Confidence 46899999999999984333 5566533211 112 33488999999999999999999987
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNI 704 (886)
. . ..++||||+++++|.+++... ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 72 ~-~--------------~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Ni 132 (259)
T cd05037 72 R-D--------------ENIMVEEYVKFGPLDVFLHRE----KNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNI 132 (259)
T ss_pred c-C--------------CcEEEEEcCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceE
Confidence 5 3 249999999999999999861 22688999999999999999999999999999999999
Q ss_pred EEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVIL 784 (886)
|++.++........+||+|||++...... ....++..|+|||++.+.. ..++.++|||||||++
T Consensus 133 ll~~~~~~~~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~y~aPE~~~~~~--~~~~~~~Di~slG~~~ 196 (259)
T cd05037 133 LVARYGLNEGYVPFIKLSDPGIPITVLSR--------------EERVERIPWIAPECIRNGQ--ASLTIAADKWSFGTTL 196 (259)
T ss_pred EEecCccccCCceeEEeCCCCcccccccc--------------cccccCCCccChhhhcCCC--CCcchhhHHHHHHHHH
Confidence 99877422223346999999998765331 1234678899999987611 3678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 785 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 785 yELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
|+|++ |..||...+................+ ....+.+|+.+||..+|.+
T Consensus 197 ~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~li~~~l~~~p~~ 247 (259)
T cd05037 197 LEICSNGEEPLSTLSSSEKERFYQDQHRLPMP-----------------------------DCAELANLINQCWTYDPTK 247 (259)
T ss_pred HHHHhCCCCCcccCCchhHHHHHhcCCCCCCC-----------------------------CchHHHHHHHHHhccChhh
Confidence 99999 58888766543333222211100000 0147899999999999999
Q ss_pred CCCHHHHHHHHH
Q 002738 864 RPTAGDLYEMFV 875 (886)
Q Consensus 864 RPSA~EILehLe 875 (886)
|||+.+|++.|.
T Consensus 248 Rpt~~~il~~l~ 259 (259)
T cd05037 248 RPSFRAILRDLN 259 (259)
T ss_pred CCCHHHHHHhcC
Confidence 999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=312.00 Aligned_cols=279 Identities=19% Similarity=0.257 Sum_probs=198.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
..+++|++.+.||+|+||.||+|.. .+..+|+|......... ... .+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~---~~~----~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (291)
T cd07844 2 GKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG---APF----TAIREASLLKDLKHANIVTLHDIIHT 74 (291)
T ss_pred CCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC---Cch----hHHHHHHHHhhCCCcceeeEEEEEec
Confidence 3568899999999999999999987 56789999875432211 111 23789999999999999999999886
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
.. ..++||||+. ++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 75 ~~--------------~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil 135 (291)
T cd07844 75 KK--------------TLTLVFEYLD-TDLKQYMDD----CGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLL 135 (291)
T ss_pred CC--------------eEEEEEecCC-CCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEE
Confidence 54 4699999998 599998875 1236889999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.+ +.+||+|||+++........ .....++..|+|||++.+ ...++.++||||||+++|
T Consensus 136 ~~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Dv~slG~il~ 195 (291)
T cd07844 136 ISER-------GELKLADFGLARAKSVPSKT----------YSNEVVTLWYRPPDVLLG---STEYSTSLDMWGVGCIFY 195 (291)
T ss_pred EcCC-------CCEEECccccccccCCCCcc----------ccccccccccCCcHHhhc---CcccCcHHHHHHHHHHHH
Confidence 9877 46999999998654321111 112246889999999874 245788999999999999
Q ss_pred HHHhCCCCCCCCC-HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCch---h--hhhhHHHHHHHHHHhccc
Q 002738 786 ELLTLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE---A--ELETLSFLVDVFRRCTEE 859 (886)
Q Consensus 786 ELLTG~~PF~g~s-~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~---~--~~~~s~~L~dLL~rCL~~ 859 (886)
+|++|+.||.+.. ..+....+........+..+............ ......... . .......+.+++.+||+.
T Consensus 196 ~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 274 (291)
T cd07844 196 EMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY-SFPFYPPRPLINHAPRLDRIPHGEELALKFLQY 274 (291)
T ss_pred HHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccc-cccccCChhHHHhCcCCCCchhHHHHHHHHhcc
Confidence 9999999997665 33333333322221222222111100000000 000000000 0 001125788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 002738 860 NPTERPTAGDLYEM 873 (886)
Q Consensus 860 DP~kRPSA~EILeh 873 (886)
+|.+|||+.++++|
T Consensus 275 ~p~~Rps~~e~l~~ 288 (291)
T cd07844 275 EPKKRISAAEAMKH 288 (291)
T ss_pred CcccccCHHHHhcC
Confidence 99999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=315.07 Aligned_cols=277 Identities=23% Similarity=0.284 Sum_probs=200.2
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|++.+.||+|+||.||+|.+ .+..+|+|+...... ..... ..+.+|+.+++.++||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 73 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVK----KIAMREIRMLKQLRHENLVNLIEVFRRKK- 73 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC--cchhh----HHHHHHHHHHHhcCCcchhhHHHhcccCC-
Confidence 4789999999999999999998 467889987533221 11122 23478999999999999999999987554
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..++||||+++++|..++.. ...+++..++.++.||+.||+|||++||+|+||+|+||+++.
T Consensus 74 -------------~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~ 135 (286)
T cd07846 74 -------------RLYLVFEFVDHTVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ 135 (286)
T ss_pred -------------eEEEEEecCCccHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC
Confidence 46999999999888887654 235899999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.++|+|||++......... .....++..|+|||++.+ ...++.++||||||+++|||+
T Consensus 136 ~-------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~el~ 195 (286)
T cd07846 136 S-------GVVKLCDFGFARTLAAPGEV----------YTDYVATRWYRAPELLVG---DTKYGRAVDIWAVGCLVTEML 195 (286)
T ss_pred C-------CcEEEEeeeeeeeccCCccc----------cCcccceeeccCcHHhcc---ccccCchHhHHHHHHHHHHHH
Confidence 7 46999999998765432211 123458899999999874 244678999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccc----ccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE----HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 864 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~----~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kR 864 (886)
+|++||......+....+.......... ......... ...................+..+.+|+.+||..+|.+|
T Consensus 196 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 274 (286)
T cd07846 196 TGEPLFPGDSDIDQLYHIIKCLGNLIPR-HQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDR 274 (286)
T ss_pred cCCCCCCCCchHHHHHHHHHHhCCCchh-hHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccc
Confidence 9999998776655444443221111110 000000000 00000000000001122346789999999999999999
Q ss_pred CCHHHHHHH
Q 002738 865 PTAGDLYEM 873 (886)
Q Consensus 865 PSA~EILeh 873 (886)
|++.++++|
T Consensus 275 p~~~~il~~ 283 (286)
T cd07846 275 PSSSQLLHH 283 (286)
T ss_pred hhHHHHhcC
Confidence 999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=317.72 Aligned_cols=286 Identities=21% Similarity=0.224 Sum_probs=209.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
.++++|++.+.||+|+||.||+|.+ .+..||+|++........ ....+.+|+.++++++|+||+++++++..
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG------IPISSLREITLLLNLRHPNIVELKEVVVG 77 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC------CcchhhHHHHHHHhCCCCCCcceEEEEec
Confidence 4678999999999999999999997 567899998765432111 11123679999999999999999999875
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
.. ....++||||+. ++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 78 ~~------------~~~~~lv~e~~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil 140 (309)
T cd07845 78 KH------------LDSIFLVMEYCE-QDLASLLDNM----PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLL 140 (309)
T ss_pred CC------------CCeEEEEEecCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 43 124699999997 5899988752 256899999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.+ +.+||+|||++......... .....+++.|+|||++.+ ...++.++|||||||++|
T Consensus 141 ~~~~-------~~~kL~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslG~il~ 200 (309)
T cd07845 141 LTDK-------GCLKIADFGLARTYGLPAKP----------MTPKVVTLWYRAPELLLG---CTTYTTAIDMWAVGCILA 200 (309)
T ss_pred ECCC-------CCEEECccceeeecCCccCC----------CCcccccccccChhhhcC---CCCcCchHHHHHHHHHHH
Confidence 9877 46999999999866432111 112246788999999865 245788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCC-CC-CCchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS-GF-EKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~-~~-~~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
||++|++||.+.+..+....+......+....+................ .. .........++.+.+||.+||++||.+
T Consensus 201 el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~ 280 (309)
T cd07845 201 ELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKK 280 (309)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhh
Confidence 9999999999888888777766543322222211110000000000000 00 000011123567899999999999999
Q ss_pred CCCHHHHHHHHHh
Q 002738 864 RPTAGDLYEMFVA 876 (886)
Q Consensus 864 RPSA~EILehLe~ 876 (886)
|||+.+++.|-.-
T Consensus 281 R~t~~~il~h~~f 293 (309)
T cd07845 281 RATAEEALESSYF 293 (309)
T ss_pred CcCHHHHhcChhh
Confidence 9999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=319.41 Aligned_cols=253 Identities=26% Similarity=0.426 Sum_probs=200.0
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
...+|++.+.||+|+||.||++.. .+..+|+|....... ...+ .+.+|+.+++.++||||+++++++...
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~----~~~~e~~~l~~~~h~~i~~~~~~~~~~ 88 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ----PKKE----LIINEILVMRENKNPNIVNYLDSYLVG 88 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc----chHH----HHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 347899999999999999999986 577899998754321 1122 248899999999999999999999865
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
. ..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||+
T Consensus 89 ~--------------~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili 148 (297)
T cd06656 89 D--------------ELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL 148 (297)
T ss_pred C--------------EEEEeecccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 4 46999999999999999875 457889999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +.++|+|||++......... .....+++.|+|||.+.+ ..++.++|||||||++|+
T Consensus 149 ~~~-------~~~~l~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slGvil~~ 207 (297)
T cd06656 149 GMD-------GSVKLTDFGFCAQITPEQSK----------RSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIE 207 (297)
T ss_pred CCC-------CCEEECcCccceEccCCccC----------cCcccCCccccCHHHHcC----CCCCcHHHHHHHHHHHHH
Confidence 876 46999999998765332111 123358899999999976 567899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 787 LLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
|++|..||.+.++......+.....+.+. .....+..+.+|+.+||..+|.+||+
T Consensus 208 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~Rps 262 (297)
T cd06656 208 MVEGEPPYLNENPLRALYLIATNGTPELQ-------------------------NPERLSAVFRDFLNRCLEMDVDRRGS 262 (297)
T ss_pred HHhCCCCCCCCCcchheeeeccCCCCCCC-------------------------CccccCHHHHHHHHHHccCChhhCcC
Confidence 99999999776543332222221111110 01123456899999999999999999
Q ss_pred HHHHHHHHH
Q 002738 867 AGDLYEMFV 875 (886)
Q Consensus 867 A~EILehLe 875 (886)
+.+|++|-.
T Consensus 263 ~~~il~~~~ 271 (297)
T cd06656 263 AKELLQHPF 271 (297)
T ss_pred HHHHhcCch
Confidence 999999844
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=307.00 Aligned_cols=250 Identities=25% Similarity=0.351 Sum_probs=195.9
Q ss_pred eeecccCceEEEEEEECC-----eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 631 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~~~-----~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~ 631 (886)
+.||+|++|.||+|.+.. ..+|+|....... . .. .+.+.+|+.++++++||||+++++++.. .
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~--~-~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~---- 68 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--S-DI----MDDFLKEAAIMHSLDHENLIRLYGVVLT-H---- 68 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCccc--H-HH----HHHHHHHHHHHhhcCCCCccceeEEEcC-C----
Confidence 468999999999998732 2578887543221 1 22 3345899999999999999999999875 3
Q ss_pred CCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecccc
Q 002738 632 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 711 (886)
Q Consensus 632 ~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~ 711 (886)
..++||||+++++|.+++... ....+++..++.++.|++.||+|||++||+|+||||+|||++.+
T Consensus 69 ----------~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~-- 133 (257)
T cd05040 69 ----------PLMMVTELAPLGSLLDRLRKD---ALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD-- 133 (257)
T ss_pred ----------eEEEEEEecCCCcHHHHHHhc---ccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecC--
Confidence 369999999999999999862 11468999999999999999999999999999999999999987
Q ss_pred CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-C
Q 002738 712 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-L 790 (886)
Q Consensus 712 ~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT-G 790 (886)
+.+||+|||++..+........ ......++..|+|||++.+ ..++.++|||||||++|||++ |
T Consensus 134 -----~~~kl~dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~~pE~~~~----~~~~~~~Di~slG~~l~el~t~g 197 (257)
T cd05040 134 -----DKVKIGDFGLMRALPQNEDHYV-------MEEHLKVPFAWCAPESLRT----RTFSHASDVWMFGVTLWEMFTYG 197 (257)
T ss_pred -----CEEEecccccccccccccccee-------cccCCCCCceecCHHHhcc----cCcCchhhhHHHHHHHHHHHhCC
Confidence 5699999999987644221100 0112357789999999876 568899999999999999998 9
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 002738 791 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 870 (886)
Q Consensus 791 ~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EI 870 (886)
..||...+..++...+..... .+. . ....+..+.+++.+||..+|.+||++.++
T Consensus 198 ~~p~~~~~~~~~~~~~~~~~~-~~~----------------------~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 251 (257)
T cd05040 198 EEPWAGLSGSQILKKIDKEGE-RLE----------------------R---PEACPQDIYNVMLQCWAHNPADRPTFAAL 251 (257)
T ss_pred CCCCCCCCHHHHHHHHHhcCC-cCC----------------------C---CccCCHHHHHHHHHHCCCCcccCCCHHHH
Confidence 999988877776666543211 000 0 01124579999999999999999999999
Q ss_pred HHHHH
Q 002738 871 YEMFV 875 (886)
Q Consensus 871 LehLe 875 (886)
++.|.
T Consensus 252 ~~~l~ 256 (257)
T cd05040 252 REFLP 256 (257)
T ss_pred HHHhc
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=323.64 Aligned_cols=282 Identities=17% Similarity=0.223 Sum_probs=204.7
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
..++|++.+.||+|+||.||+|.. .+..+|+|+.... ......... +.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRP--FQNVTHAKR----AYRELVLMKLVNHKNIIGLLNVFTPQ 87 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcc--ccChhHHHH----HHHHHHHHHhcCCCCCcceeeeeccC
Confidence 457899999999999999999997 5678899875322 112222223 37899999999999999999998754
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
..+ ......|+||||+. ++|.+++.. .++...+..++.||+.||+|||++||+||||||+|||+
T Consensus 88 ~~~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~ 151 (353)
T cd07850 88 KSL--------EEFQDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 151 (353)
T ss_pred CCc--------cccCcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE
Confidence 421 12235799999997 599998864 28889999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +.+||+|||++........ .....++..|+|||++.+ ..++.++|||||||++|+
T Consensus 152 ~~~-------~~~kL~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~~l~~ 209 (353)
T cd07850 152 KSD-------CTLKILDFGLARTAGTSFM-----------MTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGE 209 (353)
T ss_pred CCC-------CCEEEccCccceeCCCCCC-----------CCCCcccccccCHHHHhC----CCCCCchhhHhHHHHHHH
Confidence 877 4599999999976543211 122358899999999976 668899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccc-----------cccccCCCC----CCchhhhhhHHHHHH
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH-----------EVAQSGSGF----EKPEAELETLSFLVD 851 (886)
Q Consensus 787 LLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~-----------~~~~~~~~~----~~~~~~~~~s~~L~d 851 (886)
|++|+.||...+.......+.........+.+......... .+....... .........++.+.+
T Consensus 210 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
T cd07850 210 MIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARD 289 (353)
T ss_pred HHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHH
Confidence 99999999887766555555433222222111111000000 000000000 000011234667899
Q ss_pred HHHHhcccCCCCCCCHHHHHHHH
Q 002738 852 VFRRCTEENPTERPTAGDLYEMF 874 (886)
Q Consensus 852 LL~rCL~~DP~kRPSA~EILehL 874 (886)
||.+||+.||.+|||+.|+++|-
T Consensus 290 li~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 290 LLSKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred HHHHHcCCChhhCcCHHHHhcCh
Confidence 99999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=313.77 Aligned_cols=262 Identities=25% Similarity=0.391 Sum_probs=199.3
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcceeeeeEec
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 625 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl~g~~~~ 625 (886)
+-+.|++.+.||.|+||.||+|.+ .+..+|+|+..... ..... +..|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-----~~~~~----~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-----DEEEE----IKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-----HHHHH----HHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 346899999999999999999997 56788999864331 12222 37899999998 69999999999864
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
... .......++||||+++++|.+++... ....+++..+..++.||+.||.|||++||+|+||||+||+
T Consensus 85 ~~~--------~~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nil 153 (282)
T cd06636 85 KSP--------PGHDDQLWLVMEFCGAGSVTDLVKNT---KGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVL 153 (282)
T ss_pred ccc--------cCCCCEEEEEEEeCCCCcHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 321 11223579999999999999999752 2345788889999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~~s~KSDIWSLGVIL 784 (886)
++.+ +.++|+|||++........ ......|++.|+|||++.... ....++.++|||||||++
T Consensus 154 i~~~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l 216 (282)
T cd06636 154 LTEN-------AEVKLVDFGVSAQLDRTVG----------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITA 216 (282)
T ss_pred ECCC-------CCEEEeeCcchhhhhcccc----------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHH
Confidence 9877 4599999999875532111 112346899999999986311 124578899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 002738 785 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 864 (886)
Q Consensus 785 yELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kR 864 (886)
|||++|..||....+......+.....+.+. ....+..+.+||.+||..||.+|
T Consensus 217 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~cl~~~p~~R 270 (282)
T cd06636 217 IEMAEGAPPLCDMHPMRALFLIPRNPPPKLK--------------------------SKKWSKKFIDFIEGCLVKNYLSR 270 (282)
T ss_pred HHHHhCCCCccccCHHhhhhhHhhCCCCCCc--------------------------ccccCHHHHHHHHHHhCCChhhC
Confidence 9999999999776554433333222111100 01234579999999999999999
Q ss_pred CCHHHHHHH
Q 002738 865 PTAGDLYEM 873 (886)
Q Consensus 865 PSA~EILeh 873 (886)
|++.||++|
T Consensus 271 p~~~ell~~ 279 (282)
T cd06636 271 PSTEQLLKH 279 (282)
T ss_pred cCHHHHhcC
Confidence 999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=312.81 Aligned_cols=264 Identities=25% Similarity=0.337 Sum_probs=202.4
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcceeeeeEec
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 625 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl~g~~~~ 625 (886)
..++|.+.+.||+|+||.||++.. .+..+|+|+..... ... ..+.+|+.++.++ +||||+++++++..
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-----~~~----~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----DVD----EEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-----cHH----HHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 467899999999999999999997 56778898863211 111 2337899999999 79999999999875
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
.+.. .....++||||+++++|.++++.... ....+++..++.++.|++.||+|||++||+||||||+||+
T Consensus 91 ~~~~---------~~~~~~lv~ey~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nil 160 (291)
T cd06639 91 ADKL---------VGGQLWLVLELCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNIL 160 (291)
T ss_pred cccc---------CCCeeEEEEEECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEE
Confidence 4321 12357999999999999999875322 2356899999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~~s~KSDIWSLGVIL 784 (886)
++.+ +.+||+|||++......... .....|+..|+|||++.... ....++.++|||||||++
T Consensus 161 i~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~ 223 (291)
T cd06639 161 LTTE-------GGVKLVDFGVSAQLTSTRLR----------RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITA 223 (291)
T ss_pred EcCC-------CCEEEeecccchhccccccc----------ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHH
Confidence 9877 45999999998765432211 12235889999999986421 112368899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 002738 785 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 864 (886)
Q Consensus 785 yELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kR 864 (886)
|||++|+.||...........+.....+.+.. .......+.+||.+||+.+|++|
T Consensus 224 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~~p~~R 278 (291)
T cd06639 224 IELGDGDPPLFDMHPVKTLFKIPRNPPPTLLH-------------------------PEKWCRSFNHFISQCLIKDFEAR 278 (291)
T ss_pred HHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCc-------------------------ccccCHHHHHHHHHHhhcChhhC
Confidence 99999999998776655554444332221110 01123468999999999999999
Q ss_pred CCHHHHHHH
Q 002738 865 PTAGDLYEM 873 (886)
Q Consensus 865 PSA~EILeh 873 (886)
|++.+|++|
T Consensus 279 ps~~~il~~ 287 (291)
T cd06639 279 PSVTHLLEH 287 (291)
T ss_pred cCHHHHhcC
Confidence 999999987
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=333.63 Aligned_cols=271 Identities=20% Similarity=0.235 Sum_probs=195.8
Q ss_pred CCCceeeeeecccCceEEEEEEEC----CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~~----~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
-.+|.+.+.||.|+||.||+|... +..+++|..... .. +.+|+.+|++|+||||+++++++..
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------~~----~~~E~~il~~l~h~~iv~~~~~~~~ 157 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------KT----PGREIDILKTISHRAIINLIHAYRW 157 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---------cc----HHHHHHHHHhcCCCCccceeeeEee
Confidence 357999999999999999999753 356777764311 11 2679999999999999999999875
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
.. ..++|||++. ++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||
T Consensus 158 ~~--------------~~~lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nil 217 (392)
T PHA03207 158 KS--------------TVCMVMPKYK-CDLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIF 217 (392)
T ss_pred CC--------------EEEEEehhcC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE
Confidence 54 4699999996 689998854 356899999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.+ +.+||+|||++..+...... .......||+.|+|||++.+ ..++.++|||||||+||
T Consensus 218 l~~~-------~~~~l~DfG~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGvil~ 278 (392)
T PHA03207 218 LDEP-------ENAVLGDFGAACKLDAHPDT--------PQCYGWSGTLETNSPELLAL----DPYCAKTDIWSAGLVLF 278 (392)
T ss_pred EcCC-------CCEEEccCccccccCccccc--------ccccccccccCccCHhHhcC----CCCCchhhHHHHHHHHH
Confidence 9877 46999999999765432211 11123569999999999976 66889999999999999
Q ss_pred HHHhCCCCCCCCCH---HHHHHHHHcC-C--CCCchh-----HHhhhcccccccccccCCCCCCc--hhhhhhHHHHHHH
Q 002738 786 ELLTLQVPYMGLSE---LEIHDLIQMG-K--RPRLTD-----ELEALGSCHEHEVAQSGSGFEKP--EAELETLSFLVDV 852 (886)
Q Consensus 786 ELLTG~~PF~g~s~---~el~~~I~~~-~--rp~l~~-----~l~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~L~dL 852 (886)
||++|+.||.+... ...+..+... . ...++. ....+... .......+..+ ......+..+.+|
T Consensus 279 el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~l 354 (392)
T PHA03207 279 EMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQY----AIVLRPPYTIPPVIRKYGMHMDVEYL 354 (392)
T ss_pred HHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhh----cccccCCccccchhhccCcchhHHHH
Confidence 99999999976532 1222222221 1 101110 00000000 00000001111 1112235578899
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHh
Q 002738 853 FRRCTEENPTERPTAGDLYEMFVA 876 (886)
Q Consensus 853 L~rCL~~DP~kRPSA~EILehLe~ 876 (886)
|.+||..||.+|||+.+++.|-.-
T Consensus 355 i~~ml~~dp~~Rpsa~e~l~~p~f 378 (392)
T PHA03207 355 IAKMLTFDQEFRPSAQDILSLPLF 378 (392)
T ss_pred HHHHhccChhhCCCHHHHhhCchh
Confidence 999999999999999999998543
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=310.17 Aligned_cols=259 Identities=27% Similarity=0.396 Sum_probs=199.0
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
+|+..+.||+|+||.||++.. .+..+|+|+........ .........+.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTS--SEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS-- 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCc--hhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC--
Confidence 478889999999999999986 67789999865433221 122223345689999999999999999999987554
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.+
T Consensus 77 ------------~~~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~ 139 (268)
T cd06630 77 ------------HFNLFVEWMAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDST 139 (268)
T ss_pred ------------eEEEEEeccCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 46999999999999999975 2468899999999999999999999999999999999999765
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+ ..+||+|||.+......... .........|+..|+|||++.+ ..++.++||||||+++|+|++
T Consensus 140 ~------~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~Dv~slG~~l~~l~~ 203 (268)
T cd06630 140 G------QRLRIADFGAAARLAAKGTG------AGEFQGQLLGTIAFMAPEVLRG----EQYGRSCDVWSVGCVIIEMAT 203 (268)
T ss_pred C------CEEEEccccccccccccccc------CCccccccccccceeCHhHhcc----CCCCcccchHHHHHHHHHHHh
Confidence 2 36999999999776543111 0011223468899999999875 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHH---HcC-CCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 790 LQVPYMGLSELEIHDLI---QMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I---~~~-~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
|..||...........+ ... ..+. .....+..+.+++.+||..+|.+||
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~i~~~l~~~p~~R~ 256 (268)
T cd06630 204 AKPPWNAEKHSNHLALIFKIASATTAPS---------------------------IPEHLSPGLRDVTLRCLELQPEDRP 256 (268)
T ss_pred CCCCCCCCCCcchHHHHHHHhccCCCCC---------------------------CchhhCHHHHHHHHHHcCCCcccCc
Confidence 99999654322211111 111 1111 1122356789999999999999999
Q ss_pred CHHHHHHHH
Q 002738 866 TAGDLYEMF 874 (886)
Q Consensus 866 SA~EILehL 874 (886)
++.++++|-
T Consensus 257 ~~~~ll~~~ 265 (268)
T cd06630 257 PSRELLKHP 265 (268)
T ss_pred CHHHHhcCc
Confidence 999999873
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=314.92 Aligned_cols=246 Identities=26% Similarity=0.430 Sum_probs=192.0
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|++.+.||+|+||.||+|.+ .+..+|+|+..... .....+ .+.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 72 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQK----QIMSELEILYKCDSPYIIGFYGAFFVEN- 72 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHH----HHHHHHHHHHhCCCCCeeeEEEEEEECC-
Confidence 3678899999999999999986 66778999865331 222222 3489999999999999999999998655
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..++||||+++++|..+. .+++..+..++.||+.||+|||+.||+|+||||+|||++.
T Consensus 73 -------------~~~lv~e~~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~ 130 (279)
T cd06619 73 -------------RISICTEFMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNT 130 (279)
T ss_pred -------------EEEEEEecCCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECC
Confidence 369999999999996542 3678889999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.++|+|||++....... .....||..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 131 ~-------~~~~l~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~~l~~l~ 187 (279)
T cd06619 131 R-------GQVKLCDFGVSTQLVNSI------------AKTYVGTNAYMAPERISG----EQYGIHSDVWSLGISFMELA 187 (279)
T ss_pred C-------CCEEEeeCCcceeccccc------------ccCCCCChhhcCceeecC----CCCCCcchHHHHHHHHHHHH
Confidence 7 469999999997653321 123468999999999976 56789999999999999999
Q ss_pred hCCCCCCCCCHH-------HHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 002738 789 TLQVPYMGLSEL-------EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 861 (886)
Q Consensus 789 TG~~PF~g~s~~-------el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP 861 (886)
+|+.||...... .....+.....+.++ ....++.+.+|+.+||+.+|
T Consensus 188 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~~l~~~P 241 (279)
T cd06619 188 LGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLP--------------------------VGQFSEKFVHFITQCMRKQP 241 (279)
T ss_pred hCCCCchhhcccccccchHHHHHHHhccCCCCCC--------------------------CCcCCHHHHHHHHHHhhCCh
Confidence 999999653211 111111111111100 01124578999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 002738 862 TERPTAGDLYEMFV 875 (886)
Q Consensus 862 ~kRPSA~EILehLe 875 (886)
.+||+++++++|..
T Consensus 242 ~~Rp~~~eil~~~~ 255 (279)
T cd06619 242 KERPAPENLMDHPF 255 (279)
T ss_pred hhCCCHHHHhcCcc
Confidence 99999999999854
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=313.50 Aligned_cols=271 Identities=23% Similarity=0.328 Sum_probs=195.0
Q ss_pred CceeeeeecccCceEEEEEEE------CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~------~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
-|++.+.||+|+||.||+|++ .+..+|+|..... . .....+ .+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~--~-~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--S-GGNHIA----DLKKEIEILRNLYHENIVKYKGICTE 77 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc--c-cHHHHH----HHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 368899999999999999974 3567888875322 1 122222 34899999999999999999998875
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
... ...++||||++|++|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 78 ~~~------------~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil 141 (284)
T cd05079 78 DGG------------NGIKLIMEFLPSGSLKEYLPR----NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVL 141 (284)
T ss_pred CCC------------CceEEEEEccCCCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEE
Confidence 421 136999999999999999965 1235899999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.+ +.++|+|||++..+....... .......++..|+|||++.+ ..++.++|||||||++|
T Consensus 142 ~~~~-------~~~~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~apE~~~~----~~~~~~~Di~slG~il~ 203 (284)
T cd05079 142 VESE-------HQVKIGDFGLTKAIETDKEYY-------TVKDDLDSPVFWYAPECLIQ----SKFYIASDVWSFGVTLY 203 (284)
T ss_pred EcCC-------CCEEECCCccccccccCccce-------eecCCCCCCccccCHHHhcc----CCCCccccchhhhhhhh
Confidence 9876 469999999998664322110 01123457788999999875 56788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCC--chhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPR--LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~rp~--l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
||++++.|+..... ............ ........ ...... ......+..+.+|+.+||+.+|.+
T Consensus 204 ellt~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~ 269 (284)
T cd05079 204 ELLTYCDSESSPMT--LFLKMIGPTHGQMTVTRLVRVL---------EEGKRL---PRPPNCPEEVYQLMRKCWEFQPSK 269 (284)
T ss_pred hhhcCCCCCccccc--hhhhhcccccccccHHHHHHHH---------HcCccC---CCCCCCCHHHHHHHHHHccCCccc
Confidence 99998876532211 110000000000 00000000 000000 011224568999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 002738 864 RPTAGDLYEMFVAR 877 (886)
Q Consensus 864 RPSA~EILehLe~l 877 (886)
|||+.++++.|+.+
T Consensus 270 Rpt~~~il~~l~~~ 283 (284)
T cd05079 270 RTTFQNLIEGFEAI 283 (284)
T ss_pred CcCHHHHHHHHHhh
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=309.50 Aligned_cols=264 Identities=25% Similarity=0.419 Sum_probs=200.7
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCC--ChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGS--SADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~--~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
+|.+.+.||.|+||.||+|.. .+..+|+|......... .........+.+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 578899999999999999986 56789999865432211 11222233345688999999999999999999987554
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++++||||+|+||+++
T Consensus 82 --------------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~ 142 (272)
T cd06629 82 --------------YLSIFLEYVPGGSIGSCLRT-----YGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD 142 (272)
T ss_pred --------------ceEEEEecCCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc
Confidence 36999999999999999976 24688999999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ +.++|+|||++......... .......|+..|+|||++.... ..++.++||||||+++|+|
T Consensus 143 ~~-------~~~~l~d~~~~~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~--~~~~~~~Dv~slG~~l~~l 205 (272)
T cd06629 143 AD-------GICKISDFGISKKSDDIYDN--------DQNMSMQGSVFWMAPEVIHSYS--QGYSAKVDIWSLGCVVLEM 205 (272)
T ss_pred CC-------CeEEEeeccccccccccccc--------cccccccCCccccCHHHhcccc--CCCCccchhHHHHHHHHHH
Confidence 76 56999999998764322111 0112345889999999987511 2478899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcC-CCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 788 LTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 788 LTG~~PF~g~s~~el~~~I~~~-~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
++|..||...........+... ..+.++. ......+..+.+||.+||.++|.+||+
T Consensus 206 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps 262 (272)
T cd06629 206 FAGRRPWSDEEAIAAMFKLGNKRSAPPIPP-----------------------DVSMNLSPVALDFLNACFTINPDNRPT 262 (272)
T ss_pred HhCCCCCcCcchHHHHHHhhccccCCcCCc-----------------------cccccCCHHHHHHHHHHhcCChhhCCC
Confidence 9999999765554433322221 1111111 011223567999999999999999999
Q ss_pred HHHHHHHH
Q 002738 867 AGDLYEMF 874 (886)
Q Consensus 867 A~EILehL 874 (886)
+.+|++|.
T Consensus 263 ~~~il~~~ 270 (272)
T cd06629 263 ARELLQHP 270 (272)
T ss_pred HHHHhhCC
Confidence 99999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=304.78 Aligned_cols=251 Identities=29% Similarity=0.449 Sum_probs=198.5
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCC-ChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~-~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
+|+..+.||+|+||.||+|.. .+..+++|+........ .....+ .+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~----~~~~e~~~l~~~~h~~i~~~~~~~~~~~- 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVK----QLEQEIALLSKLQHPNIVQYLGTEREED- 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHH----HHHHHHHHHHhcCCCCchheeeeEecCC-
Confidence 477889999999999999987 57789999875433221 122223 4489999999999999999999887554
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.||+|+||+|+||+++.
T Consensus 76 -------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~ 137 (258)
T cd06632 76 -------------NLYIFLELVPGGSLAKLLKK-----YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDT 137 (258)
T ss_pred -------------eEEEEEEecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC
Confidence 36999999999999999976 245889999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.+||+|||++........ .....|+..|+|||.+.. ...++.++|+||||+++|+|+
T Consensus 138 ~-------~~~kl~d~~~~~~~~~~~~-----------~~~~~~~~~y~~pe~~~~---~~~~~~~~D~~slG~~l~~l~ 196 (258)
T cd06632 138 N-------GVVKLADFGMAKQVVEFSF-----------AKSFKGSPYWMAPEVIAQ---QGGYGLAADIWSLGCTVLEMA 196 (258)
T ss_pred C-------CCEEEccCccceecccccc-----------ccccCCCcceeCHHHhcC---CCCCCchhhhHHHHHHHHHHH
Confidence 7 4699999999876543220 123458899999999875 123789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHc-CCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 789 TLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~-~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
+|+.||...........+.. ...+.++ ...++.+.+|+.+||..+|.+||++
T Consensus 197 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~ 249 (258)
T cd06632 197 TGKPPWSQLEGVAAVFKIGRSKELPPIP---------------------------DHLSDEAKDFILKCLQRDPSLRPTA 249 (258)
T ss_pred hCCCCcccCcHHHHHHHHHhcccCCCcC---------------------------CCcCHHHHHHHHHHhhcCcccCcCH
Confidence 99999977665444433332 1111111 1134578999999999999999999
Q ss_pred HHHHHH
Q 002738 868 GDLYEM 873 (886)
Q Consensus 868 ~EILeh 873 (886)
.+++.|
T Consensus 250 ~~~l~~ 255 (258)
T cd06632 250 AELLEH 255 (258)
T ss_pred HHHhcC
Confidence 999976
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=316.08 Aligned_cols=282 Identities=22% Similarity=0.283 Sum_probs=206.1
Q ss_pred CCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
.+++|++.+.||.|+||.||+|.+. +..+++|........ ..+...+.+|+.++.+++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 76 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK------EGFPITSLREINILLKLQHPNIVTVKEVVVGS 76 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc------ccchhhHHHHHHHHHhcCCCCEEEEEEEEEec
Confidence 4578999999999999999999984 567888876543221 12223347899999999999999999998754
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
. ....||||||++ ++|.+++.. ....+++..++.++.||+.||+|||++||+|+||||+|||+
T Consensus 77 ~------------~~~~~lv~e~~~-~~L~~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili 139 (293)
T cd07843 77 N------------LDKIYMVMEYVE-HDLKSLMET----MKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL 139 (293)
T ss_pred C------------CCcEEEEehhcC-cCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE
Confidence 2 124799999997 599999875 12358999999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +.++|+|||++......... .....+++.|+|||++.+ ...++.++||||||+++|+
T Consensus 140 ~~~-------~~~~l~d~g~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~l~~ 199 (293)
T cd07843 140 NNR-------GILKICDFGLAREYGSPLKP----------YTQLVVTLWYRAPELLLG---AKEYSTAIDMWSVGCIFAE 199 (293)
T ss_pred CCC-------CcEEEeecCceeeccCCccc----------cccccccccccCchhhcC---CccccchhhHHHHHHHHHH
Confidence 877 46999999999866542211 122357889999999875 2346889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccc---cccccCCCCCCchhhhh-hHHHHHHHHHHhcccCCC
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH---EVAQSGSGFEKPEAELE-TLSFLVDVFRRCTEENPT 862 (886)
Q Consensus 787 LLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~~-~s~~L~dLL~rCL~~DP~ 862 (886)
|++|..||...+..+....+...........+......... ................. .++.+.+||.+||+.+|+
T Consensus 200 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 279 (293)
T cd07843 200 LLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPA 279 (293)
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCcc
Confidence 99999999988777766666544322223222221111000 00000000000000011 366789999999999999
Q ss_pred CCCCHHHHHHH
Q 002738 863 ERPTAGDLYEM 873 (886)
Q Consensus 863 kRPSA~EILeh 873 (886)
+|||+.|+++|
T Consensus 280 ~R~t~~ell~~ 290 (293)
T cd07843 280 KRISAEDALKH 290 (293)
T ss_pred ccCCHHHHhcC
Confidence 99999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=316.40 Aligned_cols=264 Identities=25% Similarity=0.307 Sum_probs=203.7
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
.+|++.+.||+|+||.||+|.. .+..+|+|........ .... ...+..|+.+++.++||||+++++.+....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 74 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNK----VKRVLTEQEILATLDHPFLPTLYASFQTET- 74 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc-hHHH----HHHHHHHHHHHHhCCCCCchhheeeeecCC-
Confidence 3689999999999999999997 4678999987543211 1112 234589999999999999999999987554
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..++||||+.+++|.+++.. .....+++..+..++.||+.||+|||+.||+|+||||+|||++.
T Consensus 75 -------------~~~lv~e~~~~~~L~~~~~~---~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~ 138 (316)
T cd05574 75 -------------YLCLVMDYCPGGELFRLLQR---QPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHE 138 (316)
T ss_pred -------------EEEEEEEecCCCCHHHHHHh---CCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcC
Confidence 46999999999999999875 22356899999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCccccccccccccc-------------------ccCCCCCCCcccCCCcccchhhhhcccCCC
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCI-------------------AHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 769 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~-------------------~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~ 769 (886)
+ +.++|+|||++............ ...........+||..|+|||++.+ .
T Consensus 139 ~-------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~ 207 (316)
T cd05574 139 S-------GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG----D 207 (316)
T ss_pred C-------CCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC----C
Confidence 7 45999999998765432111000 0000111234578999999999976 5
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHH
Q 002738 770 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 849 (886)
Q Consensus 770 ~~s~KSDIWSLGVILyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L 849 (886)
.++.++||||||+++|+|++|..||.+.+.......+..... .++. ....+..+
T Consensus 208 ~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~-------------------------~~~~~~~~ 261 (316)
T cd05574 208 GHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEV-TFPG-------------------------SPPVSSSA 261 (316)
T ss_pred CCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCc-cCCC-------------------------ccccCHHH
Confidence 678999999999999999999999988776655544432211 1110 00135679
Q ss_pred HHHHHHhcccCCCCCCC----HHHHHHH
Q 002738 850 VDVFRRCTEENPTERPT----AGDLYEM 873 (886)
Q Consensus 850 ~dLL~rCL~~DP~kRPS----A~EILeh 873 (886)
.+||.+||..||.+||+ ++++++|
T Consensus 262 ~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 262 RDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 99999999999999999 9999998
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=314.72 Aligned_cols=248 Identities=27% Similarity=0.380 Sum_probs=201.5
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|++.+.||+|+||.||++.+ .+..+|+|+...... ..... ...+.+|+.++++++||||+++++++....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 74 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI-VKLKQ----VEHVLNEKRILQSIRHPFLVNLYGSFQDDS- 74 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh-hhhhH----HHHHHHHHHHHHhCCCCCccceeeEEEcCC-
Confidence 4799999999999999999997 567899998643211 11111 234589999999999999999999987654
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+|+||+|.|||++.
T Consensus 75 -------------~~~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~ 136 (290)
T cd05580 75 -------------NLYLVMEYVPGGELFSHLRK-----SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDS 136 (290)
T ss_pred -------------eEEEEEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECC
Confidence 36999999999999999976 356899999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.+||+|||++...... .....|++.|+|||.+.+ ...+.++||||||+++|+|+
T Consensus 137 ~-------~~~kl~dfg~~~~~~~~-------------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l~ 192 (290)
T cd05580 137 D-------GYIKITDFGFAKRVKGR-------------TYTLCGTPEYLAPEIILS----KGYGKAVDWWALGILIYEML 192 (290)
T ss_pred C-------CCEEEeeCCCccccCCC-------------CCCCCCCccccChhhhcC----CCCCccccHHHHHHHHHHHH
Confidence 7 46999999998765432 122358899999999875 56788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC---
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP--- 865 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP--- 865 (886)
+|+.||...+.......+..+.. .++. ..+..+.++|.+||..||.+|+
T Consensus 193 ~g~~p~~~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~l~~li~~~l~~~p~~R~~~~ 244 (290)
T cd05580 193 AGYPPFFDDNPIQIYEKILEGKV-RFPS---------------------------FFSPDAKDLIRNLLQVDLTKRLGNL 244 (290)
T ss_pred hCCCCCCCCCHHHHHHHHhcCCc-cCCc---------------------------cCCHHHHHHHHHHccCCHHHccCcc
Confidence 99999988776666655543321 1111 1245789999999999999999
Q ss_pred --CHHHHHHHH
Q 002738 866 --TAGDLYEMF 874 (886)
Q Consensus 866 --SA~EILehL 874 (886)
+++++++|-
T Consensus 245 ~~~~~~l~~~~ 255 (290)
T cd05580 245 KNGVNDIKNHP 255 (290)
T ss_pred cCCHHHHHcCc
Confidence 899999874
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=316.30 Aligned_cols=260 Identities=21% Similarity=0.336 Sum_probs=201.7
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCe----eEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeee
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 622 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~----~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~ 622 (886)
...+|+..+.||+|+||.||+|.+ .+. .+|+|+.... ...... ..+.+|+.+++.++||||++++++
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~----~~~~~e~~~~~~l~h~niv~~~~~ 77 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET---TGPKAN----VEFMDEALIMASMDHPHLVRLLGV 77 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc---CCHHHH----HHHHHHHHHHHhCCCCCcccEEEE
Confidence 456788999999999999999987 333 3566664311 111222 234889999999999999999998
Q ss_pred EecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 002738 623 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 702 (886)
Q Consensus 623 ~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPs 702 (886)
+.... .+++|||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+
T Consensus 78 ~~~~~---------------~~~v~e~~~~g~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~ 138 (303)
T cd05110 78 CLSPT---------------IQLVTQLMPHGCLLDYVHE----HKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAAR 138 (303)
T ss_pred EcCCC---------------ceeeehhcCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccc
Confidence 86432 3799999999999999875 2235889999999999999999999999999999999
Q ss_pred CEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 002738 703 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 782 (886)
Q Consensus 703 NILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGV 782 (886)
|||++.+ ..+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||
T Consensus 139 Nill~~~-------~~~kL~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~----~~~~~~~DiwslG~ 199 (303)
T cd05110 139 NVLVKSP-------NHVKITDFGLARLLEGDEKE--------YNADGGKMPIKWMALECIHY----RKFTHQSDVWSYGV 199 (303)
T ss_pred eeeecCC-------CceEEccccccccccCcccc--------cccCCCccccccCCHHHhcc----CCCChHHHHHHHHH
Confidence 9999876 45999999999865432211 01122346778999999875 66889999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 002738 783 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 861 (886)
Q Consensus 783 ILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP 861 (886)
++|||++ |..||.+.........+..+..+..+ ...+..+.+++.+||..+|
T Consensus 200 ~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~c~~~~p 252 (303)
T cd05110 200 TIWELMTFGGKPYDGIPTREIPDLLEKGERLPQP---------------------------PICTIDVYMVMVKCWMIDA 252 (303)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCC---------------------------CCCCHHHHHHHHHHcCCCh
Confidence 9999997 99999887766665555444322111 0123468899999999999
Q ss_pred CCCCCHHHHHHHHHhhcCC
Q 002738 862 TERPTAGDLYEMFVARTSS 880 (886)
Q Consensus 862 ~kRPSA~EILehLe~l~ss 880 (886)
.+||++.++++.|..+...
T Consensus 253 ~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 253 DSRPKFKELAAEFSRMARD 271 (303)
T ss_pred hhCcCHHHHHHHHHHHHhc
Confidence 9999999999999987644
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=311.47 Aligned_cols=247 Identities=23% Similarity=0.394 Sum_probs=186.1
Q ss_pred eeecccCceEEEEEEECC---------eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 557 DEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~~~---------~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
+.||.|+||.||+|.... ..+++|+.... .....+.+..|+.+++.+.||||+++++++....
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~ 72 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--------HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD 72 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--------hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC
Confidence 469999999999998632 23556653211 1122234588999999999999999999998654
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
. .++||||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 73 ~--------------~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~ 134 (258)
T cd05078 73 E--------------SIMVQEYVKFGSLDTYLKK----NKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLI 134 (258)
T ss_pred C--------------cEEEEecCCCCcHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEe
Confidence 3 5999999999999999975 223588999999999999999999999999999999999998
Q ss_pred ccccC-CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 708 LERKK-ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 708 ~d~~~-~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
.++.. ....+.++++|||++...... ....+++.|+|||++.+ ...++.++|||||||++||
T Consensus 135 ~~~~~~~~~~~~~~l~d~g~~~~~~~~--------------~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~~l~~ 197 (258)
T cd05078 135 REEDRKTGNPPFIKLSDPGISITVLPK--------------EILLERIPWVPPECIEN---PQNLSLAADKWSFGTTLWE 197 (258)
T ss_pred cccccccCCCceEEecccccccccCCc--------------hhccccCCccCchhccC---CCCCCchhhHHHHHHHHHH
Confidence 77431 112345899999998654321 22357889999999875 2356889999999999999
Q ss_pred HHhC-CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 787 LLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 787 LLTG-~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
|++| ..||...+.......... ...++ ......+.+|+.+||+.||++||
T Consensus 198 l~~g~~~~~~~~~~~~~~~~~~~--~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp 248 (258)
T cd05078 198 IFSGGDKPLSALDSQKKLQFYED--RHQLP---------------------------APKWTELANLINQCMDYEPDFRP 248 (258)
T ss_pred HHcCCCCChhhccHHHHHHHHHc--cccCC---------------------------CCCcHHHHHHHHHHhccChhhCC
Confidence 9998 466665554443322211 11111 01134689999999999999999
Q ss_pred CHHHHHHHHH
Q 002738 866 TAGDLYEMFV 875 (886)
Q Consensus 866 SA~EILehLe 875 (886)
|+++|++.|.
T Consensus 249 s~~~il~~l~ 258 (258)
T cd05078 249 SFRAIIRDLN 258 (258)
T ss_pred CHHHHHHhcC
Confidence 9999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=304.26 Aligned_cols=251 Identities=28% Similarity=0.453 Sum_probs=201.0
Q ss_pred ceeeeeecccCceEEEEEEECC------eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 553 LSSCDEAGKSVSSSLFRCKFGS------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 553 Y~i~k~LG~G~fG~VY~A~~~~------~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
+++.+.||.|+||.||++.+.. ..+|+|+..... .....+. +.+|+.++..++|+||+++++++...
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~ 73 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA---DEQQIEE----FLREARIMRKLDHPNIVKLLGVCTEE 73 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC---ChHHHHH----HHHHHHHHHhcCCCchheEEEEEcCC
Confidence 4678899999999999999854 678888863221 1112333 48999999999999999999998865
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
. ..+++|||+++++|.+++... ....+++..+..++.||+.||+|||+.|++|+||||+||++
T Consensus 74 ~--------------~~~~i~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~ 136 (258)
T smart00219 74 E--------------PLMIVMEYMEGGDLLDYLRKN---RPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV 136 (258)
T ss_pred C--------------eeEEEEeccCCCCHHHHHHhh---hhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE
Confidence 4 369999999999999999762 11128999999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +.++|+|||++.......... .....+++.|+|||.+.+ ..++.++||||||+++|+
T Consensus 137 ~~~-------~~~~l~dfg~~~~~~~~~~~~---------~~~~~~~~~y~~Pe~~~~----~~~~~~~Di~slG~i~~~ 196 (258)
T smart00219 137 GEN-------LVVKISDFGLSRDLYDDDYYK---------KKGGKLPIRWMAPESLKD----GKFTSKSDVWSFGVLLWE 196 (258)
T ss_pred ccC-------CeEEEcccCCceecccccccc---------cccCCCcccccChHHhcc----CCCCcchhHHHHHHHHHH
Confidence 877 469999999998765432110 011236789999999865 667899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 787 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 787 LLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
|++ |..||...+...+...+.....+..+. ..+..+.+++.+||..+|.+||
T Consensus 197 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~i~~~l~~~p~~Rp 249 (258)
T smart00219 197 IFTLGESPYPGMSNEEVLEYLKKGYRLPKPE---------------------------NCPPEIYKLMLQCWAEDPEDRP 249 (258)
T ss_pred HHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC---------------------------cCCHHHHHHHHHHCcCChhhCc
Confidence 998 899998888777777776654332221 1345799999999999999999
Q ss_pred CHHHHHHHH
Q 002738 866 TAGDLYEMF 874 (886)
Q Consensus 866 SA~EILehL 874 (886)
|+.++++.|
T Consensus 250 t~~~ll~~l 258 (258)
T smart00219 250 TFSELVEIL 258 (258)
T ss_pred CHHHHHhhC
Confidence 999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=309.56 Aligned_cols=261 Identities=30% Similarity=0.444 Sum_probs=200.6
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|...+.||.|++|.||++.+ .+..+|+|+...... ... ...+.+|++++++++||||+++++++.....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 73 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN---PDL----QKQILRELEINKSCKSPYIVKYYGAFLDESS 73 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc---hHH----HHHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence 4689999999999999999997 567899998653321 122 2344899999999999999999999875431
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..+++||||+++++|.+++..... ....+++..+..++.||+.||.|||+.|++|+||+|.||+++.
T Consensus 74 ------------~~~~lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~ 140 (287)
T cd06621 74 ------------SSIGIAMEYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTR 140 (287)
T ss_pred ------------CeEEEEEEecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEec
Confidence 247999999999999998875333 2356889999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ ..++|+|||++........ ....++..|+|||.+.+ ..++.++|||||||++|+|+
T Consensus 141 ~-------~~~~l~dfg~~~~~~~~~~------------~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slG~il~~l~ 197 (287)
T cd06621 141 K-------GQVKLCDFGVSGELVNSLA------------GTFTGTSFYMAPERIQG----KPYSITSDVWSLGLTLLEVA 197 (287)
T ss_pred C-------CeEEEeecccccccccccc------------ccccCCccccCHHHhcC----CCCCchhhHHHHHHHHHHHH
Confidence 6 4699999999865532111 12347889999999876 56788999999999999999
Q ss_pred hCCCCCCCC-----CHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 789 TLQVPYMGL-----SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 789 TG~~PF~g~-----s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
+|+.||... ...+....+.....+.++.. +......++.+.+||.+||..+|.+
T Consensus 198 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~li~~~l~~~p~~ 256 (287)
T cd06621 198 QNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE---------------------PGNGIKWSEEFKDFIKQCLEKDPTR 256 (287)
T ss_pred hCCCCCCcccCCCCChHHHHHHHhcCCchhhccC---------------------CCCCCchHHHHHHHHHHHcCCCccc
Confidence 999999755 22333333332221111100 0000123567899999999999999
Q ss_pred CCCHHHHHHHHH
Q 002738 864 RPTAGDLYEMFV 875 (886)
Q Consensus 864 RPSA~EILehLe 875 (886)
|||+.||++|-.
T Consensus 257 Rpt~~eil~~~~ 268 (287)
T cd06621 257 RPTPWDMLEHPW 268 (287)
T ss_pred CCCHHHHHhCcc
Confidence 999999999754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=309.09 Aligned_cols=276 Identities=19% Similarity=0.260 Sum_probs=203.9
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
+|++.+.||.|++|.||+|+. .+..+|+|+....... .... .+.+|+.++++++||||+++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~~~- 72 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE---GTPS----TAIREISLMKELKHENIVRLHDVIHTENK- 72 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc---cchH----HHHHHHHHHHhhcCCCEeeeeeeEeeCCc-
Confidence 589999999999999999997 5778999987544221 1112 23789999999999999999999986653
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
.+|||||++ ++|.+++.... ....+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 73 -------------~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~ 136 (284)
T cd07836 73 -------------LMLVFEYMD-KDLKKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR 136 (284)
T ss_pred -------------EEEEEecCC-ccHHHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC
Confidence 699999998 58999887521 12468999999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.++|+|||++......... .....++..|++||++.+ ...++.++|||||||++|+|++
T Consensus 137 -------~~~~l~d~g~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~slG~~l~~l~~ 196 (284)
T cd07836 137 -------GELKLADFGLARAFGIPVNT----------FSNEVVTLWYRAPDVLLG---SRTYSTSIDIWSVGCIMAEMIT 196 (284)
T ss_pred -------CcEEEeecchhhhhcCCccc----------cccccccccccChHHhcC---CCCCCcHHHHHHHHHHHHHHHh
Confidence 45999999999755332111 122357889999999865 2456889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCC---CchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE---KPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
|+.||.+.+..+....+...........+..+..... +........ ........+..+.+++.+||+.||.+||+
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~ 274 (284)
T cd07836 197 GRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE--YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRIS 274 (284)
T ss_pred CCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch--hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCC
Confidence 9999988877666655554432222322222211000 000000000 00111234567899999999999999999
Q ss_pred HHHHHHH
Q 002738 867 AGDLYEM 873 (886)
Q Consensus 867 A~EILeh 873 (886)
+.++++|
T Consensus 275 ~~~~l~~ 281 (284)
T cd07836 275 AHDALQH 281 (284)
T ss_pred HHHHhcC
Confidence 9999976
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=308.56 Aligned_cols=260 Identities=22% Similarity=0.351 Sum_probs=199.9
Q ss_pred CCCceeeeeecccCceEEEEEEEC-------CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeee
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 622 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~~-------~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~ 622 (886)
..+|++.+.||.|+||.||+|+.. ...+++|..... ... .+...+.+|+.++++++||||++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~ 76 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT---KDE----NLQSEFRRELDMFRKLSHKNVVRLLGL 76 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc---cch----HHHHHHHHHHHHHHhcCCcceeeeEEE
Confidence 467899999999999999999962 345777764321 111 122344899999999999999999999
Q ss_pred EecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccC----CCcCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 002738 623 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG----EKHVSVKLALFIAQDVAAALVELHSKHIMHRD 698 (886)
Q Consensus 623 ~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~----~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRD 698 (886)
+..... .++||||+++++|.+++....... ...+++..+..++.||+.||+|||+++|+|||
T Consensus 77 ~~~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~d 142 (275)
T cd05046 77 CREAEP--------------HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRD 142 (275)
T ss_pred ECCCCc--------------ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCc
Confidence 876543 599999999999999997622110 12589999999999999999999999999999
Q ss_pred CCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHH
Q 002738 699 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 778 (886)
Q Consensus 699 LKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIW 778 (886)
|||+|||++.+ +.++|+|||++......... ......++..|+|||.+.+ ..++.++|||
T Consensus 143 lkp~Nili~~~-------~~~~l~~~~~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~ 202 (275)
T cd05046 143 LAARNCLVSSQ-------REVKVSLLSLSKDVYNSEYY---------KLRNALIPLRWLAPEAVQE----DDFSTKSDVW 202 (275)
T ss_pred CccceEEEeCC-------CcEEEcccccccccCccccc---------ccCCceeEEeecChhhhcc----CCCCchhhHH
Confidence 99999999887 45999999998644321110 1122346778999999875 5578899999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 002738 779 SYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 857 (886)
Q Consensus 779 SLGVILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL 857 (886)
|||+++|+|++ |..||...........+..+... ++ . ....+..+.+++.+||
T Consensus 203 slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~-~~----------------------~---~~~~~~~l~~~i~~~l 256 (275)
T cd05046 203 SFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE-LP----------------------V---PEGCPSRLYKLMTRCW 256 (275)
T ss_pred HHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcC-CC----------------------C---CCCCCHHHHHHHHHHc
Confidence 99999999999 88999877766666555433211 00 0 0113457999999999
Q ss_pred ccCCCCCCCHHHHHHHHHh
Q 002738 858 EENPTERPTAGDLYEMFVA 876 (886)
Q Consensus 858 ~~DP~kRPSA~EILehLe~ 876 (886)
+.+|.+||++.+++.+|.+
T Consensus 257 ~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 257 AVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CCCcccCCCHHHHHHHhcC
Confidence 9999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=316.37 Aligned_cols=276 Identities=24% Similarity=0.325 Sum_probs=199.5
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|++.+.||+|+||.||++.+ .+..+++|+...+. ... ...++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 72 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI---KPA----IRNQIIRELKVLHECNSPYIVGFYGAFYSDG- 72 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc---CHH----HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-
Confidence 3689999999999999999997 45567777654321 122 2234589999999999999999999998655
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEEe
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILID 707 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs-~gIVHRDLKPsNILLd 707 (886)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+ .+|+|+||||+|||++
T Consensus 73 -------------~~~lv~ey~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~ 134 (308)
T cd06615 73 -------------EISICMEHMDGGSLDQVLKK-----AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN 134 (308)
T ss_pred -------------EEEEEeeccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe
Confidence 46999999999999999976 2568899999999999999999997 5999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ +.+||+|||++....... .....|++.|+|||++.+ ..++.++|||||||++|+|
T Consensus 135 ~~-------~~~~l~dfg~~~~~~~~~------------~~~~~~~~~~~aPE~~~~----~~~~~~~DiwslG~~l~~l 191 (308)
T cd06615 135 SR-------GEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPERLQG----THYTVQSDIWSLGLSLVEM 191 (308)
T ss_pred cC-------CcEEEccCCCcccccccc------------cccCCCCcCccChhHhcC----CCCCccchHHHHHHHHHHH
Confidence 76 459999999986543211 123468999999999875 5678899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHh-hhcccccc---------cccccCCCCCCch-hhhhhHHHHHHHHHHh
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELE-ALGSCHEH---------EVAQSGSGFEKPE-AELETLSFLVDVFRRC 856 (886)
Q Consensus 788 LTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~-~~~~~~~~---------~~~~~~~~~~~~~-~~~~~s~~L~dLL~rC 856 (886)
++|+.||...+.......+..... ....... ........ ...+.......+. .....+..+.+|+.+|
T Consensus 192 ~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 270 (308)
T cd06615 192 AIGRYPIPPPDAKELEAMFGRPVS-EGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKC 270 (308)
T ss_pred HhCCCCCCCcchhhHHHhhcCccc-cccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHH
Confidence 999999977665544433322110 0000000 00000000 0000000000000 0012456799999999
Q ss_pred cccCCCCCCCHHHHHHHHHh
Q 002738 857 TEENPTERPTAGDLYEMFVA 876 (886)
Q Consensus 857 L~~DP~kRPSA~EILehLe~ 876 (886)
|..+|++|||+.+|++|..-
T Consensus 271 l~~~P~~Rpt~~~ll~~~~~ 290 (308)
T cd06615 271 LKKNPKERADLKELTKHPFI 290 (308)
T ss_pred ccCChhhCcCHHHHhcChhh
Confidence 99999999999999999653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=329.91 Aligned_cols=268 Identities=18% Similarity=0.187 Sum_probs=188.5
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
-.+|++.+.||+|+||.||+|++. +..||+|+.... ....|+.++++++||||+++++++....
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------------~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 130 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------------TTLIEAMLLQNVNHPSVIRMKDTLVSGA 130 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------------ccHHHHHHHHhCCCCCCcChhheEEeCC
Confidence 357999999999999999999984 457788763211 1156999999999999999999988655
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
..++||||+. ++|.+++.. ....+++..++.|+.||+.||.|||++|||||||||+|||++
T Consensus 131 --------------~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~ 191 (357)
T PHA03209 131 --------------ITCMVLPHYS-SDLYTYLTK----RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN 191 (357)
T ss_pred --------------eeEEEEEccC-CcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence 3699999996 699998865 235689999999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ ..+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 192 ~~-------~~~kl~DfG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvvl~el 249 (357)
T PHA03209 192 DV-------DQVCIGDLGAAQFPVVAPA-----------FLGLAGTVETNAPEVLAR----DKYNSKADIWSAGIVLFEM 249 (357)
T ss_pred CC-------CCEEEecCccccccccCcc-----------cccccccccccCCeecCC----CCCCchhhHHHHHHHHHHH
Confidence 77 4599999999874322111 123468999999999976 6689999999999999999
Q ss_pred HhCCCCC-CCCCH----------HHHHHHHHcC--CCCCch-----hHHhhhcccccccccccCCCCCCchhhhhhHHHH
Q 002738 788 LTLQVPY-MGLSE----------LEIHDLIQMG--KRPRLT-----DELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 849 (886)
Q Consensus 788 LTG~~PF-~g~s~----------~el~~~I~~~--~rp~l~-----~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L 849 (886)
+++..|+ ..... ..+...+... ....++ .....+...... ................+..+
T Consensus 250 l~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 327 (357)
T PHA03209 250 LAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASL--ERQPYTRYPCFQRVNLPIDG 327 (357)
T ss_pred HHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhccc--CCCcccccHHHhccCCCchH
Confidence 9865554 32211 1111111111 001111 000000000000 00000000000111234567
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHH
Q 002738 850 VDVFRRCTEENPTERPTAGDLYEMF 874 (886)
Q Consensus 850 ~dLL~rCL~~DP~kRPSA~EILehL 874 (886)
.+||.+||+.||.+|||+.||++|-
T Consensus 328 ~~li~~mL~~dP~~Rpta~e~l~hp 352 (357)
T PHA03209 328 EFLVHKMLTFDAAMRPSAEEILNYP 352 (357)
T ss_pred HHHHHHHHcCCcccCcCHHHHhcCc
Confidence 7899999999999999999999984
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=320.41 Aligned_cols=289 Identities=19% Similarity=0.241 Sum_probs=205.8
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|++.+.||+|+||.||+|.+ .+..||+|+.... .. ... ...+.+|+.++++++||||+++++++.....
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~-~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 77 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EH-QTF----CQRTLREIKILRRFKHENIIGILDIIRPPSF 77 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--cc-chh----HHHHHHHHHHHHhCCCCCcCchhheeecccc
Confidence 5899999999999999999987 5678999985321 11 111 2334789999999999999999998775442
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
. .....++||||+. ++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 78 ~---------~~~~~~lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~ 141 (336)
T cd07849 78 E---------SFNDVYIVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 141 (336)
T ss_pred c---------ccceEEEEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC
Confidence 1 2235799999997 588888764 46899999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.+||+|||++......... ........||+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 142 ~-------~~~kl~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslGvil~el~ 204 (336)
T cd07849 142 N-------CDLKICDFGLARIADPEHDH-------TGFLTEYVATRWYRAPEIMLN---SKGYTKAIDIWSVGCILAEML 204 (336)
T ss_pred C-------CCEEECcccceeeccccccc-------cCCcCCcCcCCCccChHHhhC---CCCCCcHHHHHHHHHHHHHHH
Confidence 7 46999999998765432211 001123468999999998764 245788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccccccccc-C--CCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS-G--SGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~-~--~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
+|+.||.+.+.......+........++.+.............. . ............+..+.+||.+||+.+|.+||
T Consensus 205 ~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 284 (336)
T cd07849 205 SNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI 284 (336)
T ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCc
Confidence 99999987766554444433222222222211110000000000 0 00000111123466799999999999999999
Q ss_pred CHHHHHHH--HHhhcC
Q 002738 866 TAGDLYEM--FVARTS 879 (886)
Q Consensus 866 SA~EILeh--Le~l~s 879 (886)
|+.++++| ++....
T Consensus 285 t~~e~l~hp~~~~~~~ 300 (336)
T cd07849 285 TVEEALAHPYLEQYHD 300 (336)
T ss_pred CHHHHhcCccccccCC
Confidence 99999999 554443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=313.28 Aligned_cols=256 Identities=25% Similarity=0.371 Sum_probs=199.0
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|++.+.||+|+||.||++.+ .+..+|+|.+.... ....... +.+|+.++++++||||+++++.+....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~----~~~e~~~l~~~~~~~i~~~~~~~~~~~- 72 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQ----IIMELDILHKAVSPYIVDFYGAFFIEG- 72 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc---CHHHHHH----HHHHHHHHHhcCCCcHHhhhhheecCC-
Confidence 3689999999999999999998 47788888764321 2222233 489999999999999999999888654
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEEe
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILID 707 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs-~gIVHRDLKPsNILLd 707 (886)
..++||||+++++|..++... .....+++..+..++.||+.||.|||. .||+||||||+|||++
T Consensus 73 -------------~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~ 137 (286)
T cd06622 73 -------------AVYMCMEYMDAGSLDKLYAGG--VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN 137 (286)
T ss_pred -------------eEEEEEeecCCCCHHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC
Confidence 369999999999999998751 112468999999999999999999997 5999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc--CCCCCCchhhHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~--~~~~~s~KSDIWSLGVILy 785 (886)
.+ +.+||+|||++..+.... .....+++.|+|||++.+.. ....++.++|||||||++|
T Consensus 138 ~~-------~~~~l~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~ 198 (286)
T cd06622 138 GN-------GQVKLCDFGVSGNLVASL------------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSIL 198 (286)
T ss_pred CC-------CCEEEeecCCcccccCCc------------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHH
Confidence 76 469999999987653211 12235888999999986522 1134588999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHH---cCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQ---MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 862 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~---~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~ 862 (886)
+|++|+.||...........+. .+..+.++ ...+..+.+||.+||..+|+
T Consensus 199 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~ 251 (286)
T cd06622 199 EMALGRYPYPPETYANIFAQLSAIVDGDPPTLP---------------------------SGYSDDAQDFVAKCLNKIPN 251 (286)
T ss_pred HHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCC---------------------------cccCHHHHHHHHHHcccCcc
Confidence 9999999997655444333322 22222211 12356789999999999999
Q ss_pred CCCCHHHHHHHHH
Q 002738 863 ERPTAGDLYEMFV 875 (886)
Q Consensus 863 kRPSA~EILehLe 875 (886)
+||++.++++|..
T Consensus 252 ~Rp~~~~l~~~~~ 264 (286)
T cd06622 252 RRPTYAQLLEHPW 264 (286)
T ss_pred cCCCHHHHhcChh
Confidence 9999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=305.42 Aligned_cols=253 Identities=26% Similarity=0.391 Sum_probs=200.4
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
+|++.+.||+|+||.||++.. .+..+|+|....... .....+ .+.+|+.+++.++|+||+++++.+....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~----~~~~E~~~l~~~~h~~i~~~~~~~~~~~-- 72 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM--PVKEKE----ASKKEVILLAKMKHPNIVTFFASFQENG-- 72 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc--cchhhH----HHHHHHHHHHhCCCCChhhhhheeccCC--
Confidence 588999999999999999997 456788888654321 112222 3478999999999999999999887554
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..++||||+++++|.+++.. .....+++..+..++.||+.||.|||+.+|+|+||||+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~ 137 (257)
T cd08225 73 ------------RLFIVMEYCDGGDLMKRINR---QRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKN 137 (257)
T ss_pred ------------eEEEEEecCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCC
Confidence 36999999999999999975 222357899999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+ ..+||+|||.+......... .....|++.|+|||++.+ ..++.++||||||+++|||++
T Consensus 138 ~------~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~~~ape~~~~----~~~~~~~Dv~slG~il~~l~~ 197 (257)
T cd08225 138 G------MVAKLGDFGIARQLNDSMEL----------AYTCVGTPYYLSPEICQN----RPYNNKTDIWSLGCVLYELCT 197 (257)
T ss_pred C------CeEEecccccchhccCCccc----------ccccCCCccccCHHHHcC----CCCCchhhHHHHHHHHHHHHh
Confidence 3 35799999998765432111 122458899999999875 567899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 869 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~E 869 (886)
|..||...+..+....+.....+.+. ...+..+.++|.+||..+|++|||+.+
T Consensus 198 g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 250 (257)
T cd08225 198 LKHPFEGNNLHQLVLKICQGYFAPIS---------------------------PNFSRDLRSLISQLFKVSPRDRPSITS 250 (257)
T ss_pred CCCCCCCccHHHHHHHHhcccCCCCC---------------------------CCCCHHHHHHHHHHhccChhhCcCHHH
Confidence 99999877666555544433221111 112457999999999999999999999
Q ss_pred HHHHH
Q 002738 870 LYEMF 874 (886)
Q Consensus 870 ILehL 874 (886)
|++|-
T Consensus 251 ll~~~ 255 (257)
T cd08225 251 ILKRP 255 (257)
T ss_pred HhhCC
Confidence 99873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=313.47 Aligned_cols=291 Identities=21% Similarity=0.251 Sum_probs=200.9
Q ss_pred CceeeeeecccCceEEEEEEE----CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~----~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
+|.+.+.||+|+||.||+|.+ .+..+|+|++..... ....+...+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-----QYTGISQSACREIALLRELKHENVVSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-----cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence 588999999999999999997 457899998754321 01112233478999999999999999999998652
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
....++||||++ ++|.+++..........+++..++.++.||+.||+|||+++|+||||||+|||++
T Consensus 76 ------------~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~ 142 (316)
T cd07842 76 ------------DKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVM 142 (316)
T ss_pred ------------CceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEc
Confidence 125799999997 5888888654333334789999999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.++. ..+.+||+|||++......... ........+|+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 143 ~~~~---~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~~l 209 (316)
T cd07842 143 GEGP---ERGVVKIGDLGLARLFNAPLKP-------LADLDPVVVTIWYRAPELLLG---ARHYTKAIDIWAIGCIFAEL 209 (316)
T ss_pred CCCC---ccceEEECCCccccccCCCccc-------ccccCCccccccccCHHHHhC---CCCCCcHHHHHHHHHHHHHH
Confidence 8321 2367999999999866442211 111233468899999999865 24578899999999999999
Q ss_pred HhCCCCCCCCCHHH---------HHHHHHcCCCCCchhHHhhhcccccccc---cccCCCCCCchh----h--hhhHHHH
Q 002738 788 LTLQVPYMGLSELE---------IHDLIQMGKRPRLTDELEALGSCHEHEV---AQSGSGFEKPEA----E--LETLSFL 849 (886)
Q Consensus 788 LTG~~PF~g~s~~e---------l~~~I~~~~rp~l~~~l~~~~~~~~~~~---~~~~~~~~~~~~----~--~~~s~~L 849 (886)
++|++||.+..... ....+........+..+........... ......+..... . ...+..+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (316)
T cd07842 210 LTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQG 289 (316)
T ss_pred HhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHH
Confidence 99999997654321 1111111111111111110000000000 000000000000 0 1345678
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 002738 850 VDVFRRCTEENPTERPTAGDLYEM 873 (886)
Q Consensus 850 ~dLL~rCL~~DP~kRPSA~EILeh 873 (886)
.++|.+||+.||.+|||+.|+++|
T Consensus 290 ~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 290 FDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHHHhcCCcccCcCHHHHhcC
Confidence 999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=337.00 Aligned_cols=270 Identities=19% Similarity=0.264 Sum_probs=193.7
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
-..|.+.+.||+|+||.||+|.+. +..||+|.... . .+.+|+.+|++|+|||||++++++....
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~----~~~~E~~iL~~L~HpnIv~l~~~~~~~~ 233 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------A----SSVHEARLLRRLSHPAVLALLDVRVVGG 233 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------c----CHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence 347999999999999999999984 45678875211 1 2278999999999999999999987654
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
..++|||++. ++|..++.. ....+++..++.|+.||+.||.|||++|||||||||+||||+
T Consensus 234 --------------~~~lv~e~~~-~~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~ 294 (461)
T PHA03211 234 --------------LTCLVLPKYR-SDLYTYLGA----RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN 294 (461)
T ss_pred --------------EEEEEEEccC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC
Confidence 3699999996 799998865 224689999999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ +.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||+||||
T Consensus 295 ~~-------~~vkL~DFGla~~~~~~~~~--------~~~~~~~GT~~Y~APE~~~~----~~~~~~sDvwSlGviL~El 355 (461)
T PHA03211 295 GP-------EDICLGDFGAACFARGSWST--------PFHYGIAGTVDTNAPEVLAG----DPYTPSVDIWSAGLVIFEA 355 (461)
T ss_pred CC-------CCEEEcccCCceeccccccc--------ccccccCCCcCCcCHHHHcC----CCCCchHHHHHHHHHHHHH
Confidence 76 45999999999765432111 01123469999999999986 6688999999999999999
Q ss_pred HhCCCCCCCC--------CHHHHHHHHHcCCC--CCchh-----HHhhhcccccccccccCCCCCCc--hhhhhhHHHHH
Q 002738 788 LTLQVPYMGL--------SELEIHDLIQMGKR--PRLTD-----ELEALGSCHEHEVAQSGSGFEKP--EAELETLSFLV 850 (886)
Q Consensus 788 LTG~~PF~g~--------s~~el~~~I~~~~r--p~l~~-----~l~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~L~ 850 (886)
++|..|+... ...++...+..... ..++. ....+..... .........+ .........+.
T Consensus 356 ~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 432 (461)
T PHA03211 356 AVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAA---RNRRPAYTRPAWTRYYKLDLDVE 432 (461)
T ss_pred HHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhh---cccCCccCCcchhhhccccchHH
Confidence 9988665322 12334444433211 11110 0000000000 0000000000 01112345788
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHH
Q 002738 851 DVFRRCTEENPTERPTAGDLYEMF 874 (886)
Q Consensus 851 dLL~rCL~~DP~kRPSA~EILehL 874 (886)
+||.+||+.||.+|||+.|||+|-
T Consensus 433 dli~~mL~~DP~~RPsa~elL~hp 456 (461)
T PHA03211 433 YLVCRALTFDGARRPSAAELLRLP 456 (461)
T ss_pred HHHHHHcccChhhCcCHHHHhhCc
Confidence 999999999999999999999984
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=310.03 Aligned_cols=280 Identities=21% Similarity=0.254 Sum_probs=200.7
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
+++|++.+.||.|++|.||+|.+ .+..+++|....... .....+ .+.+|+.++++++||||+++++++....
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPS----TAIREISLLKEMQHGNIVRLQDVVHSEK 74 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc--cccchH----HHHHHHHHHHhccCCCEeeEEEEEecCC
Confidence 46899999999999999999997 466789988643321 111122 3378999999999999999999998654
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
..++||||++ ++|.+++.. .....+++..+..++.||+.||+|||+++|+|+||+|+||+++
T Consensus 75 --------------~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~ 136 (294)
T PLN00009 75 --------------RLYLVFEYLD-LDLKKHMDS---SPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID 136 (294)
T ss_pred --------------eEEEEEeccc-ccHHHHHHh---CCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE
Confidence 4699999996 588888764 2223467888999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
..+ ..+||+|||++......... .....+++.|+|||++.+ ...++.++|||||||++|+|
T Consensus 137 ~~~------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~slG~i~~~l 197 (294)
T PLN00009 137 RRT------NALKLADFGLARAFGIPVRT----------FTHEVVTLWYRAPEILLG---SRHYSTPVDIWSVGCIFAEM 197 (294)
T ss_pred CCC------CEEEEcccccccccCCCccc----------cccCceeecccCHHHHhC---CCCCCcHHHHHHHHHHHHHH
Confidence 642 46999999999755332111 122357899999999865 24578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCC---CchhhhhhHHHHHHHHHHhcccCCCCC
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE---KPEAELETLSFLVDVFRRCTEENPTER 864 (886)
Q Consensus 788 LTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~L~dLL~rCL~~DP~kR 864 (886)
+||+.||...+..+....+...........+......... ......+. ........++.+.+++.+||+.+|.+|
T Consensus 198 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R 275 (294)
T PLN00009 198 VNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY--KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKR 275 (294)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh--hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhC
Confidence 9999999887766555444332111111111110000000 00000000 001112345678999999999999999
Q ss_pred CCHHHHHHHH
Q 002738 865 PTAGDLYEMF 874 (886)
Q Consensus 865 PSA~EILehL 874 (886)
|++.++++|-
T Consensus 276 ps~~~~l~~~ 285 (294)
T PLN00009 276 ITARAALEHE 285 (294)
T ss_pred cCHHHHhcCc
Confidence 9999999873
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=310.99 Aligned_cols=294 Identities=17% Similarity=0.210 Sum_probs=204.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
..+++|++.+.||+|+||.||+|.. .+..+|+|+........ .+...+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE------GFPITALREIKILQLLKHENVVNLIEICRT 82 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC------CchhHHHHHHHHHHhCCCCCccceEEEEec
Confidence 4578899999999999999999997 56789999865432111 111233689999999999999999999876
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
.... ........++||||+. ++|.+++.. ....+++.+++.++.||+.||+|||++||+|+||||+|||
T Consensus 83 ~~~~------~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil 151 (310)
T cd07865 83 KATP------YNRYKGSFYLVFEFCE-HDLAGLLSN----KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANIL 151 (310)
T ss_pred cccc------ccCCCceEEEEEcCCC-cCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 5421 0112335799999997 589888865 2246899999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.+ +.+||+|||++.......... ........++..|+|||++.+ ...++.++||||||+++|
T Consensus 152 ~~~~-------~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~~l~ 215 (310)
T cd07865 152 ITKD-------GILKLADFGLARAFSLSKNSK------PNRYTNRVVTLWYRPPELLLG---ERDYGPPIDMWGAGCIMA 215 (310)
T ss_pred ECCC-------CcEEECcCCCcccccCCcccC------CCCccCcccCccccCcHHhcC---CcccCchhhhHHHHHHHH
Confidence 9877 469999999998664422110 011123457889999999865 234678999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccc---ccccccCC-CCCCchhhhhhHHHHHHHHHHhcccCC
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE---HEVAQSGS-GFEKPEAELETLSFLVDVFRRCTEENP 861 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~---~~~~~~~~-~~~~~~~~~~~s~~L~dLL~rCL~~DP 861 (886)
||++|+.||.+.+.......+........++.++....... ........ ..............+.+||.+||..||
T Consensus 216 el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P 295 (310)
T cd07865 216 EMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDP 295 (310)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCCh
Confidence 99999999988776655544443211111111110000000 00000000 000000000123567899999999999
Q ss_pred CCCCCHHHHHHHH
Q 002738 862 TERPTAGDLYEMF 874 (886)
Q Consensus 862 ~kRPSA~EILehL 874 (886)
.+|||++++++|-
T Consensus 296 ~~R~t~~e~l~h~ 308 (310)
T cd07865 296 AKRIDADTALNHD 308 (310)
T ss_pred hhccCHHHHhcCC
Confidence 9999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=352.57 Aligned_cols=275 Identities=23% Similarity=0.272 Sum_probs=203.1
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
+++|++.++||+|+||.||+|.+ .+..||+|+...... .. .....++.+|+.++++++||||+++++++...+
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~-~~----e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~ 75 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS-EN----PLLKKRFLREAKIAADLIHPGIVPVYSICSDGD 75 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc-cC----HHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC
Confidence 47899999999999999999997 467899998643221 11 122345589999999999999999999987654
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhcc------CCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 701 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~------~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKP 701 (886)
..++||||++|++|.+++...... ....+++..++.++.||+.||+|||++||+||||||
T Consensus 76 --------------~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKP 141 (932)
T PRK13184 76 --------------PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKP 141 (932)
T ss_pred --------------EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCch
Confidence 369999999999999999753211 123456778899999999999999999999999999
Q ss_pred CCEEEeccccCCCCCCeEEEeecCCccccccccccc---c-----cccCCCCCCCcccCCCcccchhhhhcccCCCCCCc
Q 002738 702 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC---C-----IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 773 (886)
Q Consensus 702 sNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~---~-----~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~ 773 (886)
+|||++.+ +.+||+|||+++......... . ............+||+.|||||++.+ ..++.
T Consensus 142 eNILLd~d-------g~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g----~~~S~ 210 (932)
T PRK13184 142 DNILLGLF-------GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG----VPASE 210 (932)
T ss_pred heEEEcCC-------CCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC----CCCCc
Confidence 99999877 459999999998762211000 0 00011112234579999999999976 66799
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHH
Q 002738 774 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVF 853 (886)
Q Consensus 774 KSDIWSLGVILyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL 853 (886)
++|||||||++|||+||+.||.......+........ +..+ ......++.+.+++
T Consensus 211 kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~----P~~~---------------------~p~~~iP~~L~~LI 265 (932)
T PRK13184 211 STDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILS----PIEV---------------------APYREIPPFLSQIA 265 (932)
T ss_pred HhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccC----hhhc---------------------cccccCCHHHHHHH
Confidence 9999999999999999999997754433322110000 0000 00112356789999
Q ss_pred HHhcccCCCCCC-CHHHHHHHHHhhcC
Q 002738 854 RRCTEENPTERP-TAGDLYEMFVARTS 879 (886)
Q Consensus 854 ~rCL~~DP~kRP-SA~EILehLe~l~s 879 (886)
.+||..||.+|| +++++++.|+....
T Consensus 266 ~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 266 MKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 999999999996 57777777777654
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=314.46 Aligned_cols=263 Identities=23% Similarity=0.288 Sum_probs=199.2
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|++.+.||+|+||.||++.. .+..|++|....... ........+.+|+.+++.++||||+++++.+....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-----ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR- 74 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-----hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC-
Confidence 4789999999999999999997 456788887543211 11112234588999999999999999999987654
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..++||||++|++|.+++.. ...+++..+..++.|++.||.|||++||+||||||.|||++.
T Consensus 75 -------------~~~lv~e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~ 136 (305)
T cd05609 75 -------------HLCMVMEYVEGGDCATLLKN-----IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITS 136 (305)
T ss_pred -------------EEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECC
Confidence 46999999999999999976 246899999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCccccccccccccc-----ccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCI-----AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~-----~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVI 783 (886)
+ +.+||+|||+++........... ............++..|+|||++.+ ..++.++|||||||+
T Consensus 137 ~-------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~v 205 (305)
T cd05609 137 M-------GHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR----QGYGKPVDWWAMGII 205 (305)
T ss_pred C-------CCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccC----CCCCchhhHHHHHHH
Confidence 6 56999999998742211110000 0000011123457889999999875 567899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 784 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 784 LyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
+|||++|..||.+....++...+.....+... .....+..+.+||.+||+.||.+
T Consensus 206 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~P~~ 260 (305)
T cd05609 206 LYEFLVGCVPFFGDTPEELFGQVISDDIEWPE-------------------------GDEALPADAQDLISRLLRQNPLE 260 (305)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC-------------------------ccccCCHHHHHHHHHHhccChhh
Confidence 99999999999888777766665543211100 00123457899999999999999
Q ss_pred CCC---HHHHHHH
Q 002738 864 RPT---AGDLYEM 873 (886)
Q Consensus 864 RPS---A~EILeh 873 (886)
||+ +.++++|
T Consensus 261 R~~~~~~~~ll~~ 273 (305)
T cd05609 261 RLGTGGAFEVKQH 273 (305)
T ss_pred ccCccCHHHHHhC
Confidence 998 5666665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=303.31 Aligned_cols=258 Identities=30% Similarity=0.480 Sum_probs=200.0
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
+|.+.+.||+|+||.||+|.. .+..+++|+....... .... ..+.+|+.+++.++|+||+++++++....
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~----~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-- 72 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND--PKTI----KEIADEMKVLELLKHPNLVKYYGVEVHRE-- 72 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc--hHHH----HHHHHHHHHHHhCCCCChhheeeeEecCC--
Confidence 588999999999999999986 5678999987544321 2233 34599999999999999999999877544
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..++|+||+++++|.+++.. ...+++..+..|+.|++.||.|||+.||+|+||+|+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~ 135 (264)
T cd06626 73 ------------KVYIFMEYCSGGTLEELLEH-----GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN 135 (264)
T ss_pred ------------EEEEEEecCCCCcHHHHHhh-----cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC
Confidence 47999999999999999975 3457889999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.+||+|||++........... .......+++.|+|||++.+.. ...++.++||||||+++|+|++
T Consensus 136 -------~~~kl~d~g~~~~~~~~~~~~~------~~~~~~~~~~~~~~PE~~~~~~-~~~~~~~~Dv~s~G~il~~l~~ 201 (264)
T cd06626 136 -------GVIKLGDFGCAVKLKNNTTTMG------EEVQSLAGTPAYMAPEVITGGK-GKGHGRAADIWSLGCVVLEMAT 201 (264)
T ss_pred -------CCEEEcccccccccCCCCCccc------ccccCCcCCcCccChhhccCCC-CCCCCcccchHHHHHHHHHHHh
Confidence 4699999999987654322110 0011245789999999997621 1237889999999999999999
Q ss_pred CCCCCCCCC-HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 002738 790 LQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868 (886)
Q Consensus 790 G~~PF~g~s-~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~ 868 (886)
|+.||.... .......+.....+.++.. ...+..+.+||.+||+.+|.+||++.
T Consensus 202 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~li~~~l~~~p~~R~~~~ 256 (264)
T cd06626 202 GKRPWSELDNEFQIMFHVGAGHKPPIPDS-------------------------LQLSPEGKDFLDRCLESDPKKRPTAS 256 (264)
T ss_pred CCCCccCCcchHHHHHHHhcCCCCCCCcc-------------------------cccCHHHHHHHHHHccCCcccCCCHH
Confidence 999997653 3333333333322222210 11245688999999999999999999
Q ss_pred HHHHH
Q 002738 869 DLYEM 873 (886)
Q Consensus 869 EILeh 873 (886)
+++.|
T Consensus 257 ~i~~~ 261 (264)
T cd06626 257 ELLQH 261 (264)
T ss_pred HHhcC
Confidence 99876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=310.60 Aligned_cols=277 Identities=20% Similarity=0.260 Sum_probs=198.7
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
+|++.+.||.|+||.||+|+. .+..+++|....... .... ...+.+|++++++++||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 72 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGV----PSTAIREISLLKELNHPNIVKLLDVIHTEN-- 72 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc--cccc----chHHHHHHHHHHhcCCCCCcchhhhcccCC--
Confidence 488999999999999999987 567888887644321 1111 123488999999999999999999987554
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..++||||+. ++|..++.. .....+++..++.++.||+.||+|||+++|+||||+|+||+++.+
T Consensus 73 ------------~~~~v~e~~~-~~l~~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~ 136 (284)
T cd07860 73 ------------KLYLVFEFLH-QDLKKFMDA---SPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE 136 (284)
T ss_pred ------------cEEEEeeccc-cCHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC
Confidence 3699999996 689998875 223568999999999999999999999999999999999999877
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.+||+|||++......... .....+++.|+|||++.+ ...++.++|||||||++|||+|
T Consensus 137 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~~l~t 196 (284)
T cd07860 137 -------GAIKLADFGLARAFGVPVRT----------YTHEVVTLWYRAPEILLG---CKYYSTAVDIWSLGCIFAEMVT 196 (284)
T ss_pred -------CCEEEeeccchhhcccCccc----------cccccccccccCCeEEec---CCCCCcHHHHHHHHHHHHHHHH
Confidence 46999999998755332111 122347889999998865 2346889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccc--ccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE--HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
|+.||.+.+.......+...........+........ ..+..... ..........+..+.+||.+||+.||.+|||+
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 275 (284)
T cd07860 197 RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWAR-QDFSKVVPPLDEDGRDLLSQMLHYDPNKRISA 275 (284)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccc-cCHHHHcccCCHHHHHHHHHhcCCCcccCCCH
Confidence 9999988766554444433211111111100000000 00000000 00000112245678999999999999999999
Q ss_pred HHHHHH
Q 002738 868 GDLYEM 873 (886)
Q Consensus 868 ~EILeh 873 (886)
.++++|
T Consensus 276 ~~~l~~ 281 (284)
T cd07860 276 KAALAH 281 (284)
T ss_pred HHHhcC
Confidence 999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=315.62 Aligned_cols=258 Identities=26% Similarity=0.415 Sum_probs=201.2
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
+.|.....||+|+||.||++.. .+..+|+|...... ....+ .+.+|+.+++.++||||+++++.+....
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~----~~~~e~~~l~~l~h~~ii~~~~~~~~~~- 92 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK----QQRRE----LLFNEVVIMRDYHHENVVDMYNSYLVGD- 92 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch----HHHHH----HHHHHHHHHHhCCCCcHHHHHHheecCC-
Confidence 4455577899999999999986 56788998764321 12222 3489999999999999999999987554
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..++||||+++++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||+++.
T Consensus 93 -------------~~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~ 153 (292)
T cd06658 93 -------------ELWVVMEFLEGGALTDIVTH------TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTS 153 (292)
T ss_pred -------------eEEEEEeCCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC
Confidence 36999999999999998864 45889999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.++|+|||++........ ......|+..|+|||++.+ ..++.++||||||+++|||+
T Consensus 154 ~-------~~~kL~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slGvil~el~ 212 (292)
T cd06658 154 D-------GRIKLSDFGFCAQVSKEVP----------KRKSLVGTPYWMAPEVISR----LPYGTEVDIWSLGIMVIEMI 212 (292)
T ss_pred C-------CCEEEccCcchhhcccccc----------cCceeecCccccCHHHHcc----CCCCchhhHHHHHHHHHHHH
Confidence 7 4699999999875432211 1123468999999999875 56788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~ 868 (886)
+|+.||...+.......+.....+.+.. ....+..+.+++.+||..||.+|||+.
T Consensus 213 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~P~~Rpt~~ 267 (292)
T cd06658 213 DGEPPYFNEPPLQAMRRIRDNLPPRVKD-------------------------SHKVSSVLRGFLDLMLVREPSQRATAQ 267 (292)
T ss_pred hCCCCCCCCCHHHHHHHHHhcCCCcccc-------------------------ccccCHHHHHHHHHHccCChhHCcCHH
Confidence 9999998877666554443322211110 011245789999999999999999999
Q ss_pred HHHHHHHhhcCCCC
Q 002738 869 DLYEMFVARTSSSI 882 (886)
Q Consensus 869 EILehLe~l~sss~ 882 (886)
++++|-.-.....+
T Consensus 268 ~il~~~~~~~~~~~ 281 (292)
T cd06658 268 ELLQHPFLKLAGPP 281 (292)
T ss_pred HHhhChhhhccCCc
Confidence 99998554443333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.35 Aligned_cols=261 Identities=22% Similarity=0.339 Sum_probs=202.1
Q ss_pred CceeeeeecccCceEEEEEEEC---CeeEEEEEEecccCCCCh--HHHHhhhHhHHHHHHHHhh-CCCCCcceeeeeEec
Q 002738 552 SLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSA--DEIRNFEYSCLGEVRMLGA-LRHSCIVEMYGHKIS 625 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~~---~~~VAVKI~~lk~~~~~~--~~~k~f~~~~lrEI~iLk~-L~HPNIVrl~g~~~~ 625 (886)
+|++.+.||+|+||.||++.+. +..+|+|........... .........+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4788999999999999999974 477899986543322110 0111112234789988875 789999999999876
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENI 704 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs-~gIVHRDLKPsNI 704 (886)
.. ..++||||++|++|.+++...... ...+++..++.++.|++.||.|||+ .+|+|+||||+||
T Consensus 81 ~~--------------~~~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~ni 145 (269)
T cd08528 81 ND--------------RLYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNI 145 (269)
T ss_pred CC--------------eEEEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHE
Confidence 54 469999999999999998653322 3568999999999999999999996 7899999999999
Q ss_pred EEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVIL 784 (886)
|++.+ +.++|+|||++....... ......|+..|+|||++.+ ..++.++||||||+++
T Consensus 146 l~~~~-------~~~~l~dfg~~~~~~~~~-----------~~~~~~~~~~~~~Pe~~~~----~~~~~~~Dv~slG~ll 203 (269)
T cd08528 146 MLGED-------DKVTITDFGLAKQKQPES-----------KLTSVVGTILYSCPEIVKN----EPYGEKADVWAFGCIL 203 (269)
T ss_pred EECCC-------CcEEEecccceeeccccc-----------ccccccCcccCcChhhhcC----CCCchHHHHHHHHHHH
Confidence 99877 469999999997654321 1123458899999999976 5678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 002738 785 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 864 (886)
Q Consensus 785 yELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kR 864 (886)
|+|++|+.||...........+.......... ...++.+.+||.+||+.||++|
T Consensus 204 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~cl~~~p~~R 257 (269)
T cd08528 204 YQMCTLQPPFYSTNMLSLATKIVEAVYEPLPE--------------------------GMYSEDVTDVITSCLTPDAEAR 257 (269)
T ss_pred HHHHhCCCcccccCHHHHHHHHhhccCCcCCc--------------------------ccCCHHHHHHHHHHCCCCCccC
Confidence 99999999998777666655554433221110 0124578999999999999999
Q ss_pred CCHHHHHHHHH
Q 002738 865 PTAGDLYEMFV 875 (886)
Q Consensus 865 PSA~EILehLe 875 (886)
|++.|+.+++.
T Consensus 258 p~~~e~~~~~~ 268 (269)
T cd08528 258 PDIIQVSAMIS 268 (269)
T ss_pred CCHHHHHHHhc
Confidence 99999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=304.59 Aligned_cols=275 Identities=22% Similarity=0.275 Sum_probs=197.9
Q ss_pred ceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEecCCCC
Q 002738 553 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWL 629 (886)
Q Consensus 553 Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~~~~~l 629 (886)
|++.+.||+|+||.||+|.. .+..+|+|+...... ..... ...+|+.++.++. ||||+++++++.+...
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~-----~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~- 72 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SLEQV-----NNLREIQALRRLSPHPNILRLIEVLFDRKT- 72 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC--Cchhh-----hHHHHHHHHhhcCCCCCccceEEEEecCCC-
Confidence 67899999999999999987 567888988643221 11111 1257899999996 9999999999886521
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
...++||||++ ++|.+++.. ....+++..++.++.||+.||+|||+.||+||||||+||+++.
T Consensus 73 -----------~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~- 135 (282)
T cd07831 73 -----------GRLALVFELMD-MNLYELIKG----RKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD- 135 (282)
T ss_pred -----------CcEEEEEecCC-ccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-
Confidence 14699999997 588888865 1246899999999999999999999999999999999999986
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+ .+||+|||++........ .....++..|+|||++.. ...++.++|||||||++|||++
T Consensus 136 ~-------~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slGv~l~el~~ 194 (282)
T cd07831 136 D-------ILKLADFGSCRGIYSKPP-----------YTEYISTRWYRAPECLLT---DGYYGPKMDIWAVGCVFFEILS 194 (282)
T ss_pred C-------CeEEEecccccccccCCC-----------cCCCCCCcccCChhHhhc---CCCCCcchhHHHHHHHHHHHHc
Confidence 3 599999999976543211 122357899999998754 2456889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccccccccc-CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS-GSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~ 868 (886)
|..||.+.+..+....+.......................... .............+..+.+||.+||.++|.+||++.
T Consensus 195 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 274 (282)
T cd07831 195 LFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAK 274 (282)
T ss_pred CCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHH
Confidence 9999998877766655544322211211111100000000000 000000011123467899999999999999999999
Q ss_pred HHHHH
Q 002738 869 DLYEM 873 (886)
Q Consensus 869 EILeh 873 (886)
++++|
T Consensus 275 ~~l~~ 279 (282)
T cd07831 275 QALRH 279 (282)
T ss_pred HHhhC
Confidence 99987
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=311.89 Aligned_cols=255 Identities=28% Similarity=0.402 Sum_probs=198.8
Q ss_pred CCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
...+|++.+.||+|+||.||++.+. +..+|+|+..... .... ...+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA---KSSV----RKQILRELQIMHECRSPYIVSFYGAFLNE 75 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC---cchH----HHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence 3467999999999999999999974 7788998865331 1112 23458999999999999999999999865
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENIL 705 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs-~gIVHRDLKPsNIL 705 (886)
. ..++||||+++++|.+++.. ...+++..+..++.+++.||.|||+ ++|+||||||+||+
T Consensus 76 ~--------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil 136 (284)
T cd06620 76 N--------------NICMCMEFMDCGSLDRIYKK-----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNIL 136 (284)
T ss_pred C--------------EEEEEEecCCCCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEE
Confidence 4 46999999999999999875 3468999999999999999999997 69999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.+ +.++|+|||++....... .....|+..|+|||++.+ ..++.++|||||||++|
T Consensus 137 ~~~~-------~~~~l~d~gl~~~~~~~~------------~~~~~~~~~~~aPE~~~~----~~~~~~~Di~slG~~l~ 193 (284)
T cd06620 137 VNSR-------GQIKLCDFGVSGELINSI------------ADTFVGTSTYMSPERIQG----GKYTVKSDVWSLGISII 193 (284)
T ss_pred ECCC-------CcEEEccCCcccchhhhc------------cCccccCcccCCHHHHcc----CCCCccchHHHHHHHHH
Confidence 9876 569999999986542211 122468999999999875 56788999999999999
Q ss_pred HHHhCCCCCCCCCHH-----------HHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHH
Q 002738 786 ELLTLQVPYMGLSEL-----------EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 854 (886)
Q Consensus 786 ELLTG~~PF~g~s~~-----------el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~ 854 (886)
+|++|+.||...... .....+.....+.++ ....+..+.+|+.
T Consensus 194 ~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~ 247 (284)
T cd06620 194 ELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP--------------------------SSDFPEDLRDFVD 247 (284)
T ss_pred HHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC--------------------------chhcCHHHHHHHH
Confidence 999999999765432 111111111111110 0113457899999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhhc
Q 002738 855 RCTEENPTERPTAGDLYEMFVART 878 (886)
Q Consensus 855 rCL~~DP~kRPSA~EILehLe~l~ 878 (886)
+||+.||.+|||+.|+++|..-+.
T Consensus 248 ~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 248 ACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred HHhcCCcccCcCHHHHhcCccccc
Confidence 999999999999999999854433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.43 Aligned_cols=248 Identities=29% Similarity=0.422 Sum_probs=199.0
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
-|++.+.||.|+||.||+|.+ .+..+|+|+..... ..... ..+.+|+.++.+++||||+++++++....
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 75 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEI----EDIQQEITVLSQCDSPYVTKYYGSYLKDT-- 75 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc---chHHH----HHHHHHHHHHHhcCCCCEeEEEEEEEeCC--
Confidence 367888999999999999986 56788999864321 11222 23488999999999999999999998654
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..++||||+++++|.+++.. ..+++..+..++.|++.||.|||++||+|+||||+||+++.+
T Consensus 76 ------------~~~lv~e~~~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~ 137 (277)
T cd06641 76 ------------KLWIIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH 137 (277)
T ss_pred ------------eEEEEEEeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCC
Confidence 36999999999999999864 458899999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.++|+|||++..+...... .....++..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 138 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slG~~l~~l~~ 196 (277)
T cd06641 138 -------GEVKLADFGVAGQLTDTQIK----------RNTFVGTPFWMAPEVIKQ----SAYDSKADIWSLGITAIELAK 196 (277)
T ss_pred -------CCEEEeecccceecccchhh----------hccccCCccccChhhhcc----CCCCchhhHHHHHHHHHHHHc
Confidence 45999999998765432111 122357889999999875 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 869 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~E 869 (886)
|..||...........+.....+.+. ...+..+.+++.+||..+|.+||++.+
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 249 (277)
T cd06641 197 GEPPHSELHPMKVLFLIPKNNPPTLE---------------------------GNYSKPLKEFVEACLNKEPSFRPTAKE 249 (277)
T ss_pred CCCCCCccchHHHHHHHhcCCCCCCC---------------------------cccCHHHHHHHHHHccCChhhCcCHHH
Confidence 99999877666555555443322221 112457899999999999999999999
Q ss_pred HHHHH
Q 002738 870 LYEMF 874 (886)
Q Consensus 870 ILehL 874 (886)
+++|-
T Consensus 250 ~l~~~ 254 (277)
T cd06641 250 LLKHK 254 (277)
T ss_pred HHhCH
Confidence 99983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=302.20 Aligned_cols=250 Identities=28% Similarity=0.442 Sum_probs=201.1
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|++.+.||.|++|.||+|+. .+..+++|+....... ... ..+.+|+.++.+++||||+++++++....
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~---~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE---EFR----KQLLRELKTLRSCESPYVVKCYGAFYKEG- 72 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch---HHH----HHHHHHHHHHHhcCCCCeeeEEEEEccCC-
Confidence 3689999999999999999997 4678899886543211 222 34489999999999999999999988654
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEEe
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILID 707 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs-~gIVHRDLKPsNILLd 707 (886)
..++||||+++++|.+++.. ...+++..++.++.||+.||+|||+ .+++||||+|+||+++
T Consensus 73 -------------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~ 134 (264)
T cd06623 73 -------------EISIVLEYMDGGSLADLLKK-----VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN 134 (264)
T ss_pred -------------eEEEEEEecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC
Confidence 47999999999999999976 2568999999999999999999999 9999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ +.++|+|||.+......... .....++..|+|||.+.. ..++.++||||||+++|+|
T Consensus 135 ~~-------~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slG~il~~l 193 (264)
T cd06623 135 SK-------GEVKIADFGISKVLENTLDQ----------CNTFVGTVTYMSPERIQG----ESYSYAADIWSLGLTLLEC 193 (264)
T ss_pred CC-------CCEEEccCccceecccCCCc----------ccceeecccccCHhhhCC----CCCCchhhHHHHHHHHHHH
Confidence 77 46999999998766432211 123458899999999876 5778999999999999999
Q ss_pred HhCCCCCCCC---CHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 002738 788 LTLQVPYMGL---SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 864 (886)
Q Consensus 788 LTG~~PF~g~---s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kR 864 (886)
++|+.||... ...+....+.....+.++. ...+..+.++|.+||..+|.+|
T Consensus 194 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~~p~~R 247 (264)
T cd06623 194 ALGKFPFLPPGQPSFFELMQAICDGPPPSLPA--------------------------EEFSPEFRDFISACLQKDPKKR 247 (264)
T ss_pred HhCCCCCccccccCHHHHHHHHhcCCCCCCCc--------------------------ccCCHHHHHHHHHHccCChhhC
Confidence 9999999776 3444444444332222110 0034579999999999999999
Q ss_pred CCHHHHHHH
Q 002738 865 PTAGDLYEM 873 (886)
Q Consensus 865 PSA~EILeh 873 (886)
|++.++++|
T Consensus 248 ~~~~~ll~~ 256 (264)
T cd06623 248 PSAAELLQH 256 (264)
T ss_pred CCHHHHHhC
Confidence 999999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=307.39 Aligned_cols=279 Identities=20% Similarity=0.250 Sum_probs=195.1
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
...+|.+.+.||+|+||.||+|.. .+..+++|+...+.... . ...+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~----~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 75 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG---V----PFTAIREASLLKGLKHANIVLLHDIIHTK 75 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC---C----cHHHHHHHHHHHhcCCCCEeEEEEEEecC
Confidence 457899999999999999999986 57789999875442211 1 11237899999999999999999998755
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
. ..++||||+. ++|.+++.. ....+++..+..++.||+.||.|||++||+|+||||+|||+
T Consensus 76 ~--------------~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~ 136 (291)
T cd07870 76 E--------------TLTFVFEYMH-TDLAQYMIQ----HPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI 136 (291)
T ss_pred C--------------eEEEEEeccc-CCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE
Confidence 4 3699999996 688887754 12457788899999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +.+||+|||+++........ .....+++.|+|||++.+ ...++.++|||||||++|+
T Consensus 137 ~~~-------~~~~l~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~~ 196 (291)
T cd07870 137 SYL-------GELKLADFGLARAKSIPSQT----------YSSEVVTLWYRPPDVLLG---ATDYSSALDIWGAGCIFIE 196 (291)
T ss_pred cCC-------CcEEEeccccccccCCCCCC----------CCCccccccccCCceeec---CCCCCcHHHHHHHHHHHHH
Confidence 876 46999999998754332111 122357899999999864 2346789999999999999
Q ss_pred HHhCCCCCCCCCHH-HHHHHHHcCCCCCchhHHhhhcccc---ccccccc-CCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 002738 787 LLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCH---EHEVAQS-GSGFEKPEAELETLSFLVDVFRRCTEENP 861 (886)
Q Consensus 787 LLTG~~PF~g~s~~-el~~~I~~~~rp~l~~~l~~~~~~~---~~~~~~~-~~~~~~~~~~~~~s~~L~dLL~rCL~~DP 861 (886)
|++|..||.+.... +....+......+....+......+ ....... ................+.+|+.+||..||
T Consensus 197 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp 276 (291)
T cd07870 197 MLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFP 276 (291)
T ss_pred HHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCc
Confidence 99999999766432 2222221111111111110000000 0000000 00000000001124578899999999999
Q ss_pred CCCCCHHHHHHH
Q 002738 862 TERPTAGDLYEM 873 (886)
Q Consensus 862 ~kRPSA~EILeh 873 (886)
.+|||+.+++.|
T Consensus 277 ~~R~t~~~~l~h 288 (291)
T cd07870 277 KDRISAQDALLH 288 (291)
T ss_pred ccCcCHHHHhcC
Confidence 999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=307.53 Aligned_cols=258 Identities=24% Similarity=0.363 Sum_probs=194.6
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHH-HhhCCCCCcceeeeeEecCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRM-LGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~i-Lk~L~HPNIVrl~g~~~~~~ 627 (886)
++|++.+.||+|+||.||++.+ .+..||+|...... ..... . .+..|+.+ ++.++||||+++++++....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~-~----~~~~e~~~~~~~~~~~~iv~~~~~~~~~~ 73 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV--NSQEQ-K----RLLMDLDISMRSVDCPYTVTFYGALFREG 73 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCC--CcHHH-H----HHHHHHHHHHHHcCCCCeeeeeEEEecCC
Confidence 4789999999999999999997 47789999865332 11121 2 22556665 56678999999999998654
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEEE
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILI 706 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~-gIVHRDLKPsNILL 706 (886)
..++||||++ ++|.+++...... ...+++..++.++.||+.||+|||++ +|+||||||+|||+
T Consensus 74 --------------~~~lv~e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~ 137 (283)
T cd06617 74 --------------DVWICMEVMD-TSLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI 137 (283)
T ss_pred --------------cEEEEhhhhc-ccHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE
Confidence 3699999997 6999998763332 25689999999999999999999998 99999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ ..+||+|||++..+..... .....|+..|+|||++.+......++.++|||||||++|+
T Consensus 138 ~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~ 199 (283)
T cd06617 138 NRN-------GQVKLCDFGISGYLVDSVA-----------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIE 199 (283)
T ss_pred CCC-------CCEEEeecccccccccccc-----------cccccCCccccChhhcCCcccccccCccccchhhHHHHHH
Confidence 877 4699999999876532111 1223588999999998753323457889999999999999
Q ss_pred HHhCCCCCCCC-CHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 787 LLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 787 LLTG~~PF~g~-s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
|++|+.||... ...+....+.....+.++. ...+..+.+||.+||..+|.+||
T Consensus 200 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~~p~~Rp 253 (283)
T cd06617 200 LATGRFPYDSWKTPFQQLKQVVEEPSPQLPA--------------------------EKFSPEFQDFVNKCLKKNYKERP 253 (283)
T ss_pred HHhCCCCCCccccCHHHHHHHHhcCCCCCCc--------------------------cccCHHHHHHHHHHccCChhhCc
Confidence 99999999643 2222222322222222110 01345789999999999999999
Q ss_pred CHHHHHHHHH
Q 002738 866 TAGDLYEMFV 875 (886)
Q Consensus 866 SA~EILehLe 875 (886)
++.+|++|-.
T Consensus 254 ~~~~il~~~~ 263 (283)
T cd06617 254 NYPELLQHPF 263 (283)
T ss_pred CHHHHhcCch
Confidence 9999998743
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=308.18 Aligned_cols=251 Identities=32% Similarity=0.498 Sum_probs=197.6
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC---CCCcceeeeeEecC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---HSCIVEMYGHKISS 626 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~---HPNIVrl~g~~~~~ 626 (886)
.|++.+.||+|+||.||+|.+ .+..+++|+..... .....+. +.+|+.+++.++ ||||+++++++...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~----~~~e~~~l~~l~~~~~~~vi~~~~~~~~~ 74 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT---PDDDVSD----IQREVALLSQLRQSQPPNITKYYGSYLKG 74 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC---CchhHHH----HHHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence 478889999999999999997 56789999865332 1222233 378999999997 99999999998754
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
. ..++||||+++++|.+++.. ..+++..++.++.||+.||.|||+.||+|+||+|+||++
T Consensus 75 ~--------------~~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i 134 (277)
T cd06917 75 P--------------RLWIIMEYAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV 134 (277)
T ss_pred C--------------EEEEEEecCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE
Confidence 4 46999999999999999864 368899999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +.++|+|||++......... .....|+..|+|||++.+ ...++.++|||||||++|+
T Consensus 135 ~~~-------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~~ 194 (277)
T cd06917 135 TNT-------GNVKLCDFGVAALLNQNSSK----------RSTFVGTPYWMAPEVITE---GKYYDTKADIWSLGITIYE 194 (277)
T ss_pred cCC-------CCEEEccCCceeecCCCccc----------cccccCCcceeCHHHhcc---CCccccchhHHHHHHHHHH
Confidence 876 46999999999766442211 123368899999999864 2456889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 787 LLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
|++|..||.+.........+.....+.++. ...+..+.+++.+||..||.+||+
T Consensus 195 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~i~~~l~~~p~~R~~ 248 (277)
T cd06917 195 MATGNPPYSDVDAFRAMMLIPKSKPPRLED--------------------------NGYSKLLREFVAACLDEEPKERLS 248 (277)
T ss_pred HHhCCCCCCCCChhhhhhccccCCCCCCCc--------------------------ccCCHHHHHHHHHHcCCCcccCcC
Confidence 999999998776544433332221111110 013457899999999999999999
Q ss_pred HHHHHHHHH
Q 002738 867 AGDLYEMFV 875 (886)
Q Consensus 867 A~EILehLe 875 (886)
+.+++.|-.
T Consensus 249 ~~~il~~~~ 257 (277)
T cd06917 249 AEELLKSKW 257 (277)
T ss_pred HHHHhhChH
Confidence 999999754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.31 Aligned_cols=274 Identities=23% Similarity=0.351 Sum_probs=197.7
Q ss_pred CCceeeeeecccCceEEEEEEEC------CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEe
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 624 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~~------~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~ 624 (886)
..|++.+.||+|+||.||+|++. +..+|+|+...... . ... ..+.+|+.+++.+.||||+++++++.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~--~-~~~----~~~~~ei~~l~~l~~~~i~~~~~~~~ 76 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE--E-QHR----SDFEREIEILRTLDHENIVKYKGVCE 76 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc--h-HHH----HHHHHHHHHHHhCCCCChheEEeeee
Confidence 46788899999999999999863 56799998643321 1 122 34489999999999999999999887
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNI 704 (886)
... ....++||||+++++|.+++.. ....+++..+..++.||+.||+|||++||+|+||||+||
T Consensus 77 ~~~------------~~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni 140 (284)
T cd05038 77 KPG------------GRSLRLIMEYLPSGSLRDYLQR----HRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNI 140 (284)
T ss_pred cCC------------CCceEEEEecCCCCCHHHHHHh----CccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhE
Confidence 532 1246999999999999999975 123589999999999999999999999999999999999
Q ss_pred EEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVIL 784 (886)
|++.+ +.++|+|||++........... ......++..|+|||.+.+ ..++.++||||||+++
T Consensus 141 l~~~~-------~~~~l~dfg~~~~~~~~~~~~~-------~~~~~~~~~~~~~Pe~~~~----~~~~~~~Di~slG~~l 202 (284)
T cd05038 141 LVESE-------DLVKISDFGLAKVLPEDKDYYY-------VKEPGESPIFWYAPECLRT----SKFSSASDVWSFGVTL 202 (284)
T ss_pred EEcCC-------CCEEEcccccccccccCCccee-------ccCCCCCcccccCcHHHcc----CCCCcccchHHHhhhh
Confidence 99877 5699999999987653221100 0111235567999999876 5678899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 002738 785 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 864 (886)
Q Consensus 785 yELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kR 864 (886)
|||++|..|+......... .............+.... ....... .....+..+.+|+.+||..+|.+|
T Consensus 203 ~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~--------~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~R 270 (284)
T cd05038 203 YELFTYGDPSQSPPAEFLR-MIGIAQGQMIVTRLLELL--------KEGERLP---RPPSCPDEVYDLMKLCWEAEPQDR 270 (284)
T ss_pred heeeccCCCcccccchhcc-ccccccccccHHHHHHHH--------HcCCcCC---CCccCCHHHHHHHHHHhccChhhC
Confidence 9999999998654322110 000000000000000000 0000000 011234679999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 002738 865 PTAGDLYEMFVAR 877 (886)
Q Consensus 865 PSA~EILehLe~l 877 (886)
||+.+|++.|+++
T Consensus 271 pt~~ei~~~l~~i 283 (284)
T cd05038 271 PSFADLILIVDRL 283 (284)
T ss_pred CCHHHHHHHHhhc
Confidence 9999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=311.48 Aligned_cols=257 Identities=27% Similarity=0.403 Sum_probs=202.0
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
...|.+.+.||+|+||.||+|.. .+..+++|+..... .......+ .+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~----~~~~Ei~~l~~l~h~niv~~~~~~~~~~ 88 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG-KQSNEKWQ----DIIKEVRFLQQLRHPNTIEYKGCYLREH 88 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccc-cCcHHHHH----HHHHHHHHHHhCCCCCEEEEEEEEEeCC
Confidence 45689999999999999999986 57789999864322 12222223 3489999999999999999999998654
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
..++||||+. |+|.+++.. ....+++..+..++.||+.||.|||+.||+||||+|.||+++
T Consensus 89 --------------~~~lv~e~~~-g~l~~~~~~----~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~ 149 (307)
T cd06607 89 --------------TAWLVMEYCL-GSASDILEV----HKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT 149 (307)
T ss_pred --------------eEEEEHHhhC-CCHHHHHHH----cccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEC
Confidence 3699999997 688887764 124589999999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ +.++|+|||++...... ....+++.|+|||++.+.. ...++.++||||||+++|||
T Consensus 150 ~~-------~~~kL~dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~~~-~~~~~~~sDv~s~G~il~el 207 (307)
T cd06607 150 EP-------GTVKLADFGSASLVSPA--------------NSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIEL 207 (307)
T ss_pred CC-------CCEEEeecCcceecCCC--------------CCccCCccccCceeeeccC-CCCCCcccchHHHHHHHHHH
Confidence 77 46999999998654321 2235888999999985321 25578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 788 LTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
++|+.||.+.+.......+.....+.+.. ...+..+.+||.+||..+|.+||++
T Consensus 208 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~li~~~l~~~p~~Rp~~ 261 (307)
T cd06607 208 AERKPPLFNMNAMSALYHIAQNDSPTLSS--------------------------NDWSDYFRNFVDSCLQKIPQDRPSS 261 (307)
T ss_pred HcCCCCCCCccHHHHHHHHhcCCCCCCCc--------------------------hhhCHHHHHHHHHHhcCChhhCcCH
Confidence 99999998877666555554332222210 1134578999999999999999999
Q ss_pred HHHHHHHHhhc
Q 002738 868 GDLYEMFVART 878 (886)
Q Consensus 868 ~EILehLe~l~ 878 (886)
.+|+.|..-..
T Consensus 262 ~~il~~~~~~~ 272 (307)
T cd06607 262 EELLKHRFVLR 272 (307)
T ss_pred HHHhcChhhcc
Confidence 99999865443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=338.00 Aligned_cols=251 Identities=27% Similarity=0.443 Sum_probs=201.1
Q ss_pred eeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCC
Q 002738 556 CDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 635 (886)
Q Consensus 556 ~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~~~ 635 (886)
.-.||+|.||+||-|++..+.|-+.|+.+.... .++.+.+..||.+-+.|+|.|||+++|.+...++
T Consensus 580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd------sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf------- 646 (1226)
T KOG4279|consen 580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD------SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGF------- 646 (1226)
T ss_pred eEEeecCceeEEEeeccccceeEEEeeeccccc------chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCe-------
Confidence 346999999999999986666655555444321 1223445889999999999999999999775553
Q ss_pred CCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCCC
Q 002738 636 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 715 (886)
Q Consensus 636 ~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~ 715 (886)
+-|.||-++||+|.++|+. +.+...-.+.++-.+.+||+.||.|||.+.|||||||-+|+||+.-
T Consensus 647 -------~kIFMEqVPGGSLSsLLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTy------ 711 (1226)
T KOG4279|consen 647 -------FKIFMEQVPGGSLSSLLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTY------ 711 (1226)
T ss_pred -------EEEEeecCCCCcHHHHHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeec------
Confidence 5899999999999999987 4444444788999999999999999999999999999999999754
Q ss_pred CCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 002738 716 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 795 (886)
Q Consensus 716 ~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF~ 795 (886)
.+.+||+|||-++.+.... +...++.||..|||||++.. ....|+.++|||||||++.||.||++||.
T Consensus 712 SGvlKISDFGTsKRLAgin----------P~TETFTGTLQYMAPEvIDq--G~RGYG~aADIWS~GCT~vEMATGrPPF~ 779 (1226)
T KOG4279|consen 712 SGVLKISDFGTSKRLAGIN----------PCTETFTGTLQYMAPEVIDQ--GPRGYGKAADIWSFGCTMVEMATGRPPFV 779 (1226)
T ss_pred cceEEecccccchhhccCC----------ccccccccchhhhChHhhcc--CCcCCCchhhhhhccceeEeeccCCCCee
Confidence 3789999999998775422 22356779999999999986 34679999999999999999999999997
Q ss_pred CCCHH-HHHHHHH-cCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002738 796 GLSEL-EIHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 873 (886)
Q Consensus 796 g~s~~-el~~~I~-~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EILeh 873 (886)
..... ....++. ....|++|.. .+.+.+.+|.+|+.+||.+||+|.++|..
T Consensus 780 ElgspqAAMFkVGmyKvHP~iPee---------------------------lsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 780 ELGSPQAAMFKVGMYKVHPPIPEE---------------------------LSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred ecCChhHhhhhhcceecCCCCcHH---------------------------HHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 65433 3333332 2355555544 36689999999999999999999999975
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=302.44 Aligned_cols=257 Identities=26% Similarity=0.391 Sum_probs=199.4
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCC-CChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCG-SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~-~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
.+|.+.+.||+|+||.||+|.+ .+..+++|+....... ...... ..+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~----~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 77 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEV----NALECEIQLLKNLRHDRIVQYYGCLRDPE 77 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHH----HHHHHHHHHHHHcCCCCcceEEEEEEcCC
Confidence 3689999999999999999986 5678999986443211 111222 34589999999999999999999886542
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
....++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++
T Consensus 78 ------------~~~~~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~ 140 (264)
T cd06653 78 ------------EKKLSIFVEYMPGGSIKDQLKA-----YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD 140 (264)
T ss_pred ------------CCEEEEEEEeCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc
Confidence 1247899999999999999975 24578999999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ +.++|+|||++......... ........++..|+|||++.+ ..++.++|||||||++|+|
T Consensus 141 ~~-------~~~~l~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l 202 (264)
T cd06653 141 SA-------GNVKLGDFGASKRIQTICMS-------GTGIKSVTGTPYWMSPEVISG----EGYGRKADVWSVACTVVEM 202 (264)
T ss_pred CC-------CCEEECcccccccccccccc-------CccccccCCcccccCHhhhcC----CCCCccccHHHHHHHHHHH
Confidence 76 45999999999865331110 001123458899999999876 5578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcC-CCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 788 LTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 788 LTG~~PF~g~s~~el~~~I~~~-~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
++|+.||...........+... ..+.++ ...++.+.++|.+||. +|..||+
T Consensus 203 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p---------------------------~~~~~~~~~~i~~~l~-~~~~r~~ 254 (264)
T cd06653 203 LTEKPPWAEYEAMAAIFKIATQPTKPMLP---------------------------DGVSDACRDFLKQIFV-EEKRRPT 254 (264)
T ss_pred HhCCCCCCccCHHHHHHHHHcCCCCCCCC---------------------------cccCHHHHHHHHHHhc-CcccCcc
Confidence 9999999877655544443322 222222 1234679999999999 5799999
Q ss_pred HHHHHHHH
Q 002738 867 AGDLYEMF 874 (886)
Q Consensus 867 A~EILehL 874 (886)
+.+++.|.
T Consensus 255 ~~~~~~~~ 262 (264)
T cd06653 255 AEFLLRHP 262 (264)
T ss_pred HHHHhcCC
Confidence 99999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=298.50 Aligned_cols=253 Identities=30% Similarity=0.441 Sum_probs=204.7
Q ss_pred CceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
+|.+.+.||.|+||.||++.+. +..+++|+..... ......+ .+.+|+++++.++|||++++++.+....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~----~~~~e~~~l~~l~~~~~~~~~~~~~~~~-- 72 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN--MSEKERE----DALNEVKILKKLNHPNIIKYYESFEEKG-- 72 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeeccc--CChHHHH----HHHHHHHHHHhcCCCChhheEEEEecCC--
Confidence 5889999999999999999985 7789999865432 2222223 3488999999999999999999987553
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..++||||+++++|.+++..... ....+++..+..++.||+.||.|||++|++|+||+|+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~ 139 (258)
T cd08215 73 ------------KLCIVMEYADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN 139 (258)
T ss_pred ------------EEEEEEEecCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCC
Confidence 47999999999999999986322 13568999999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.++|+|||.+........ ......|++.|+|||.+.+ ..++.++||||||+++|+|++
T Consensus 140 -------~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~~~~~l~~ 198 (258)
T cd08215 140 -------GLVKLGDFGISKVLSSTVD----------LAKTVVGTPYYLSPELCQN----KPYNYKSDIWSLGCVLYELCT 198 (258)
T ss_pred -------CcEEECCccceeecccCcc----------eecceeeeecccChhHhcc----CCCCccccHHHHHHHHHHHHc
Confidence 4599999999976544221 1123468899999999876 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 869 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~E 869 (886)
|..||...+...+...+.....+.++. ..+..+.+++.+||..+|.+|||+.+
T Consensus 199 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~i~~~l~~~p~~Rp~~~~ 251 (258)
T cd08215 199 LKHPFEGENLLELALKILKGQYPPIPS---------------------------QYSSELRNLVSSLLQKDPEERPSIAQ 251 (258)
T ss_pred CCCCCCCCcHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 999998877766666655443322221 12457899999999999999999999
Q ss_pred HHHH
Q 002738 870 LYEM 873 (886)
Q Consensus 870 ILeh 873 (886)
+++|
T Consensus 252 ll~~ 255 (258)
T cd08215 252 ILQS 255 (258)
T ss_pred HhcC
Confidence 9986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=306.59 Aligned_cols=248 Identities=26% Similarity=0.347 Sum_probs=196.7
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
+|++.+.||.|+||.||+|.+ .+..+++|+....... .....+ .+.+|+.++++++||||+++++.+....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 73 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-EKGSVR----NVLNERRILQELNHPFLVNLWYSFQDEE-- 73 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc-chhHHH----HHHHHHHHHHhCCCCChHHHHHhhcCCC--
Confidence 589999999999999999997 4788999987533211 112223 4489999999999999999999887544
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..++||||+.|++|.+++.. ...+++..+..++.||+.||.|||++||+|+||+|+||+++.+
T Consensus 74 ------------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~ 136 (258)
T cd05578 74 ------------NMYLVVDLLLGGDLRYHLSQ-----KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ 136 (258)
T ss_pred ------------eEEEEEeCCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC
Confidence 47999999999999999976 2468899999999999999999999999999999999999877
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.++|+|||.+........ .....|+..|+|||++.. ..++.++||||||+++|+|++
T Consensus 137 -------~~~~l~d~~~~~~~~~~~~-----------~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~~l~~l~~ 194 (258)
T cd05578 137 -------GHVHITDFNIATKVTPDTL-----------TTSTSGTPGYMAPEVLCR----QGYSVAVDWWSLGVTAYECLR 194 (258)
T ss_pred -------CCEEEeecccccccCCCcc-----------ccccCCChhhcCHHHHcc----cCCCCcccchhhHHHHHHHHh
Confidence 4599999999876543211 123458889999999876 457899999999999999999
Q ss_pred CCCCCCCCCH---HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 790 LQVPYMGLSE---LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 790 G~~PF~g~s~---~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
|..||...+. ..+...... ..+.++ ...+..+.++|.+||..||.+||+
T Consensus 195 g~~p~~~~~~~~~~~~~~~~~~-~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~R~~ 246 (258)
T cd05578 195 GKRPYRGHSRTIRDQIRAKQET-ADVLYP---------------------------ATWSTEAIDAINKLLERDPQKRLG 246 (258)
T ss_pred CCCCCCCCCccHHHHHHHHhcc-ccccCc---------------------------ccCcHHHHHHHHHHccCChhHcCC
Confidence 9999987663 222222111 111111 112467999999999999999999
Q ss_pred H--HHHHHH
Q 002738 867 A--GDLYEM 873 (886)
Q Consensus 867 A--~EILeh 873 (886)
+ .|+++|
T Consensus 247 ~~~~~l~~~ 255 (258)
T cd05578 247 DNLKDLKNH 255 (258)
T ss_pred ccHHHHhcC
Confidence 9 887765
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=310.08 Aligned_cols=298 Identities=20% Similarity=0.215 Sum_probs=207.8
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
.+++|++.+.||.|+||.||+|.+ .+..+++|+......... .. ..+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG--FP----ITALREIKILKKLKHPNVVPLIDMAVER 79 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC--cc----hhHHHHHHHHHhcCCCCccchhhheecc
Confidence 378999999999999999999997 467789998754432111 11 1237899999999999999999987754
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
... ........++||||+. ++|...+.. ....+++..+..++.||+.||.|||++||+|+||||+|||+
T Consensus 80 ~~~------~~~~~~~~~lv~~~~~-~~l~~~~~~----~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~ 148 (311)
T cd07866 80 PDK------SKRKRGSVYMVTPYMD-HDLSGLLEN----PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI 148 (311)
T ss_pred ccc------ccccCceEEEEEecCC-cCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 321 0112335799999997 578777764 23468999999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccc-cCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~-~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
+.+ +.++|+|||++............. ...........+++.|+|||++.+ ...++.++|||||||++|
T Consensus 149 ~~~-------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~ 218 (311)
T cd07866 149 DNQ-------GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG---ERRYTTAVDIWGIGCVFA 218 (311)
T ss_pred CCC-------CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhC---CCccCchhHhHHHHHHHH
Confidence 877 469999999998664432211100 001111233467899999999865 245788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccccc--ccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE--VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
||++|++||.+.+.......+........+..+.......... ..................+.+.+||.+||..||.+
T Consensus 219 el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~ 298 (311)
T cd07866 219 EMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYK 298 (311)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCccc
Confidence 9999999999887776665554432222121111110000000 00000000000111223467899999999999999
Q ss_pred CCCHHHHHHH
Q 002738 864 RPTAGDLYEM 873 (886)
Q Consensus 864 RPSA~EILeh 873 (886)
|||+.+++.|
T Consensus 299 R~t~~ell~~ 308 (311)
T cd07866 299 RLTASDALEH 308 (311)
T ss_pred CcCHHHHhcC
Confidence 9999999986
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=305.33 Aligned_cols=250 Identities=30% Similarity=0.433 Sum_probs=198.5
Q ss_pred CCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|++.+.||.|+||.||++.+. +..+++|....... .... ..+.+|+.++++++||||+++++.+....
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~----~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 72 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN---EAIQ----KQILRELDILHKCNSPYIVGFYGAFYNNG- 72 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC---hHHH----HHHHHHHHHHHHCCCCchhhhheeeecCC-
Confidence 36888999999999999999984 67788887643321 1222 34489999999999999999999987654
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEEe
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILID 707 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs-~gIVHRDLKPsNILLd 707 (886)
..++||||+++++|.+++... ...+++..+..++.||+.||+|||+ .||+|+||||+||+++
T Consensus 73 -------------~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~ 135 (265)
T cd06605 73 -------------DISICMEYMDGGSLDKILKEV----QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN 135 (265)
T ss_pred -------------EEEEEEEecCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC
Confidence 479999999999999999862 1568899999999999999999999 9999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ +.++|+|||.+........ ....++..|+|||++.+ ..++.++||||||+++|+|
T Consensus 136 ~~-------~~~~l~d~g~~~~~~~~~~------------~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slG~~l~~l 192 (265)
T cd06605 136 SR-------GQIKLCDFGVSGQLVNSLA------------KTFVGTSSYMAPERIQG----NDYSVKSDIWSLGLSLIEL 192 (265)
T ss_pred CC-------CCEEEeecccchhhHHHHh------------hcccCChhccCHHHHcC----CCCCchhhHHHHHHHHHHH
Confidence 86 4599999999876543211 11458899999999976 5788999999999999999
Q ss_pred HhCCCCCCCCC-----HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 002738 788 LTLQVPYMGLS-----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 862 (886)
Q Consensus 788 LTG~~PF~g~s-----~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~ 862 (886)
++|..||.... ..+....+.....+.++.. ..+..+.+||.+||..||.
T Consensus 193 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~li~~~l~~~p~ 246 (265)
T cd06605 193 ATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSG--------------------------KFSPDFQDFVNLCLIKDPR 246 (265)
T ss_pred HhCCCCCCccccccccHHHHHHHHhcCCCCCCChh--------------------------hcCHHHHHHHHHHcCCCch
Confidence 99999996542 2233333333322222210 1355799999999999999
Q ss_pred CCCCHHHHHHHH
Q 002738 863 ERPTAGDLYEMF 874 (886)
Q Consensus 863 kRPSA~EILehL 874 (886)
+|||+.+++.|-
T Consensus 247 ~Rpt~~~ll~~~ 258 (265)
T cd06605 247 ERPSYKELLEHP 258 (265)
T ss_pred hCcCHHHHhhCc
Confidence 999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=330.51 Aligned_cols=260 Identities=23% Similarity=0.398 Sum_probs=217.7
Q ss_pred CceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 631 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~ 631 (886)
+....++||-|.||.||.|.|..-...|.++.++.. ..++++| +.|+.+|+.++|||+|+++|+|..+..
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEF----LkEAAvMKeikHpNLVqLLGVCT~EpP--- 337 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTHEPP--- 337 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHH----HHHHHHHHhhcCccHHHHhhhhccCCC---
Confidence 456789999999999999999665444443335542 3455666 999999999999999999999997664
Q ss_pred CCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecccc
Q 002738 632 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 711 (886)
Q Consensus 632 ~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~ 711 (886)
+|||+|||..|+|.+||+.. .+..++.-..+.++.||..||.||..+++|||||...|+|+..+
T Consensus 338 -----------FYIiTEfM~yGNLLdYLRec---nr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEn-- 401 (1157)
T KOG4278|consen 338 -----------FYIITEFMCYGNLLDYLREC---NRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-- 401 (1157)
T ss_pred -----------eEEEEecccCccHHHHHHHh---chhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccccc--
Confidence 59999999999999999873 33557788889999999999999999999999999999999987
Q ss_pred CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-C
Q 002738 712 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-L 790 (886)
Q Consensus 712 ~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT-G 790 (886)
..|||+|||+++.+.....+. + ....-.+.|.|||-+.. ..++.|+|||+|||+|||+.| |
T Consensus 402 -----hiVKvADFGLsRlMtgDTYTA---H------AGAKFPIKWTAPEsLAy----NtFSiKSDVWAFGVLLWEIATYG 463 (1157)
T KOG4278|consen 402 -----HIVKVADFGLSRLMTGDTYTA---H------AGAKFPIKWTAPESLAY----NTFSIKSDVWAFGVLLWEIATYG 463 (1157)
T ss_pred -----ceEEeeccchhhhhcCCceec---c------cCccCcccccCcccccc----cccccchhhHHHHHHHHHHHhcC
Confidence 579999999999987655432 1 12224578999999986 778999999999999999998 8
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 002738 791 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 870 (886)
Q Consensus 791 ~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EI 870 (886)
..||+|.+..+++..+.++.+..-+ ..+++.+.+|+..||+++|.+||++.||
T Consensus 464 MsPYPGidlSqVY~LLEkgyRM~~P---------------------------eGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 464 MSPYPGIDLSQVYGLLEKGYRMDGP---------------------------EGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred CCCCCCccHHHHHHHHhccccccCC---------------------------CCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 9999999999999999888764433 2356689999999999999999999999
Q ss_pred HHHHHhhcCCCC
Q 002738 871 YEMFVARTSSSI 882 (886)
Q Consensus 871 LehLe~l~sss~ 882 (886)
-+.|+.|..+++
T Consensus 517 HqafEtmf~~sS 528 (1157)
T KOG4278|consen 517 HQAFETMFSSSS 528 (1157)
T ss_pred HHHHHHHhcccc
Confidence 999999876643
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=298.79 Aligned_cols=251 Identities=27% Similarity=0.416 Sum_probs=204.0
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
+|++.+.||+|+||.||++.. .+..+++|....... ...... .+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM--SQKERE----DAVNEIRILASVNHPNIISYKEAFLDGN-- 72 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc--cHHHHH----HHHHHHHHHHhCCCCCchhhhhhhccCC--
Confidence 588999999999999999987 556788888643321 222223 3378999999999999999999887543
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..++||||+++++|.+++..... ....+++..++.++.||+.||+|||+.|++|+||+|.||+++.+
T Consensus 73 ------------~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~ 139 (256)
T cd08530 73 ------------KLCIVMEYAPFGDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAN 139 (256)
T ss_pred ------------EEEEEehhcCCCCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecC
Confidence 47999999999999999976332 23568899999999999999999999999999999999999986
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
..+||+|||++....... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++
T Consensus 140 -------~~~kl~d~g~~~~~~~~~------------~~~~~~~~~~~~Pe~~~~----~~~~~~~D~~slG~~~~~l~~ 196 (256)
T cd08530 140 -------DLVKIGDLGISKVLKKNM------------AKTQIGTPHYMAPEVWKG----RPYSYKSDIWSLGCLLYEMAT 196 (256)
T ss_pred -------CcEEEeeccchhhhccCC------------cccccCCccccCHHHHCC----CCCCchhhHHHHHHHHHHHHh
Confidence 459999999997664421 112357889999999976 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 869 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~E 869 (886)
|+.||...+...+...+.....+.++. ..+..+.+++.+||..+|.+||++.+
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (256)
T cd08530 197 FAPPFEARSMQDLRYKVQRGKYPPIPP---------------------------IYSQDLQNFIRSMLQVKPKLRPNCDK 249 (256)
T ss_pred CCCCCCCCCHHHHHHHHhcCCCCCCch---------------------------hhCHHHHHHHHHHcCCCcccCCCHHH
Confidence 999998888776666665544433321 22457999999999999999999999
Q ss_pred HHHH
Q 002738 870 LYEM 873 (886)
Q Consensus 870 ILeh 873 (886)
+++|
T Consensus 250 ~l~~ 253 (256)
T cd08530 250 ILAS 253 (256)
T ss_pred HhcC
Confidence 9987
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=322.30 Aligned_cols=252 Identities=27% Similarity=0.425 Sum_probs=209.3
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
+-|.++.+||+|+||.||+|.+ .+..+|+|.+.+. ..++++ .+|+.||+++..|++|++||.|....
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~------sDLQEI----IKEISIMQQC~S~yVVKYYGSYFK~s- 101 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD------TDLQEI----IKEISIMQQCKSKYVVKYYGSYFKHS- 101 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc------chHHHH----HHHHHHHHHcCCchhhhhhhhhccCC-
Confidence 3478999999999999999987 5666777765443 234444 89999999999999999999887544
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
.+|||||||..|++.+.++. .++.+++.++..+++..++||+|||...-||||||..|||++.
T Consensus 102 -------------DLWIVMEYCGAGSiSDI~R~----R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT 164 (502)
T KOG0574|consen 102 -------------DLWIVMEYCGAGSISDIMRA----RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNT 164 (502)
T ss_pred -------------ceEeehhhcCCCcHHHHHHH----hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcc
Confidence 36999999999999999986 3577999999999999999999999999999999999999998
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.+||+|||.|-.+...... .+++.|||.|||||++.. -.|+.++||||||++..||.
T Consensus 165 ~-------G~AKLADFGVAGQLTDTMAK----------RNTVIGTPFWMAPEVI~E----IGY~~~ADIWSLGITaIEMA 223 (502)
T KOG0574|consen 165 D-------GIAKLADFGVAGQLTDTMAK----------RNTVIGTPFWMAPEVIEE----IGYDTKADIWSLGITAIEMA 223 (502)
T ss_pred c-------chhhhhhccccchhhhhHHh----------hCccccCcccccHHHHHH----hccchhhhHhhhcchhhhhh
Confidence 8 57999999999877653322 356789999999999986 67899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~ 868 (886)
.|++||....++..+..|-....|.+. +|+ ..+..+.+++++||...|++|.||-
T Consensus 224 EG~PPYsDIHPMRAIFMIPT~PPPTF~----------------------KPE---~WS~~F~DFi~~CLiK~PE~R~TA~ 278 (502)
T KOG0574|consen 224 EGRPPYSDIHPMRAIFMIPTKPPPTFK----------------------KPE---EWSSEFNDFIRSCLIKKPEERKTAL 278 (502)
T ss_pred cCCCCcccccccceeEeccCCCCCCCC----------------------ChH---hhhhHHHHHHHHHhcCCHHHHHHHH
Confidence 999999888776655444433333222 222 2466899999999999999999999
Q ss_pred HHHHHHHh
Q 002738 869 DLYEMFVA 876 (886)
Q Consensus 869 EILehLe~ 876 (886)
++++|-.-
T Consensus 279 ~L~~H~Fi 286 (502)
T KOG0574|consen 279 RLCEHTFI 286 (502)
T ss_pred HHhhhhhh
Confidence 99999653
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=306.35 Aligned_cols=278 Identities=26% Similarity=0.320 Sum_probs=200.3
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|++.+.||+|+||.||+|.+ .+..+++|+...... .. .....+.+|+.++++++|+||+++++++....
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~--~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 73 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DE----DVKKTALREVKVLRQLRHENIVNLKEAFRRKG- 73 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc--cc----cchhHHHHHHHHHHhcCCCCeeehhheEEECC-
Confidence 4799999999999999999997 466788887643321 11 12234589999999999999999999998654
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..++||||++++.|..++.. ...+++..+..++.||+.||.|||.++|+|+||+|+||+++.
T Consensus 74 -------------~~~iv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~ 135 (288)
T cd07833 74 -------------RLYLVFEYVERTLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSE 135 (288)
T ss_pred -------------EEEEEEecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC
Confidence 46999999997666655543 345899999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.+||+|||++......... ......++..|+|||++.+ ...++.++||||||+++|+|+
T Consensus 136 ~-------~~~kl~d~g~~~~~~~~~~~---------~~~~~~~~~~~~~PE~~~~---~~~~~~~~Dv~slG~~l~~l~ 196 (288)
T cd07833 136 S-------GVLKLCDFGFARALRARPAS---------PLTDYVATRWYRAPELLVG---DTNYGKPVDVWAIGCIMAELL 196 (288)
T ss_pred C-------CCEEEEeeecccccCCCccc---------cccCcccccCCcCCchhcC---CCCcCchhhHHHHHHHHHHHH
Confidence 6 56999999998776543210 1123467899999999976 126789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCch-----hhhhhHHHHHHHHHHhcccCCCC
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE-----AELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
+|+.||.+.........+........+..... .................+. .....+..+.+||.+||..+|++
T Consensus 197 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 275 (288)
T cd07833 197 DGEPLFPGDSDIDQLYLIQKCLGPLPPSHQEL-FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKE 275 (288)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhh-cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchh
Confidence 99999987766554444333211111111110 0000000000000000000 01123678999999999999999
Q ss_pred CCCHHHHHHH
Q 002738 864 RPTAGDLYEM 873 (886)
Q Consensus 864 RPSA~EILeh 873 (886)
||+++++++|
T Consensus 276 Rps~~~il~~ 285 (288)
T cd07833 276 RLTCDELLQH 285 (288)
T ss_pred cccHHHHhcC
Confidence 9999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=364.77 Aligned_cols=259 Identities=28% Similarity=0.444 Sum_probs=212.7
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
+|.-..+||.|.||.||.|.. +|...|+|-+++... .....+ .+.+|+.+|..|+|||||++||+-...+
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~--~~k~~~----~i~eEm~vlE~lnHpNlV~YyGVEvHRe-- 1307 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDS--DHKTFK----LIAEEMKVLEGLNHPNLVRYYGVEVHRE-- 1307 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCcc--ccccCc----chHHHHHHHHhccCccccccCceeecHH--
Confidence 466788999999999999996 566677776544433 233333 3488999999999999999999977554
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
.++|.||||+||+|.+++.. ....++.....+..|++.|++|||++|||||||||.|||++.+
T Consensus 1308 ------------kv~IFMEyC~~GsLa~ll~~-----gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~ 1370 (1509)
T KOG4645|consen 1308 ------------KVYIFMEYCEGGSLASLLEH-----GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFN 1370 (1509)
T ss_pred ------------HHHHHHHHhccCcHHHHHHh-----cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecC
Confidence 36999999999999999986 3456677778889999999999999999999999999999987
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.+|++|||.|+.+.....+.. ..-...+||+.|||||++.+... ....-+.|||||||++.||+|
T Consensus 1371 -------g~iK~~DFGsa~ki~~~~~~~~------~el~~~~GT~~YMAPEvit~t~~-kG~~~A~DiWslGCVVlEM~t 1436 (1509)
T KOG4645|consen 1371 -------GLIKYGDFGSAVKIKNNAQTMP------GELQSMMGTPMYMAPEVITGTKG-KGHGGAADIWSLGCVVLEMAT 1436 (1509)
T ss_pred -------CcEEeecccceeEecCchhcCC------HHHHhhcCCchhcCchhhccccc-CCCCcchhhhcccceEEEeec
Confidence 5799999999998876532211 11245689999999999998543 334569999999999999999
Q ss_pred CCCCCCCC-CHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 002738 790 LQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868 (886)
Q Consensus 790 G~~PF~g~-s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~ 868 (886)
|+.||... +..++..++..+..|.+|+.+ +.+-.+||.+||+.||.+|.++.
T Consensus 1437 GkrPW~~~dne~aIMy~V~~gh~Pq~P~~l---------------------------s~~g~dFle~Cl~~dP~~Rw~~~ 1489 (1509)
T KOG4645|consen 1437 GKRPWAELDNEWAIMYHVAAGHKPQIPERL---------------------------SSEGRDFLEHCLEQDPKMRWTAS 1489 (1509)
T ss_pred CCCchhhccchhHHHhHHhccCCCCCchhh---------------------------hHhHHHHHHHHHhcCchhhhHHH
Confidence 99999776 466788999999988888543 45688999999999999999999
Q ss_pred HHHHHHHh
Q 002738 869 DLYEMFVA 876 (886)
Q Consensus 869 EILehLe~ 876 (886)
|+++|-..
T Consensus 1490 qlle~~f~ 1497 (1509)
T KOG4645|consen 1490 QLLEHAFG 1497 (1509)
T ss_pred HHHHhhcc
Confidence 99998554
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.59 Aligned_cols=288 Identities=17% Similarity=0.218 Sum_probs=205.9
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
.+|++.+.||+|+||.||+|.. .+..+++|+..... ...... ..+.+|+.+|++++||||+++++++.....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~--~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF--DVPTLA----KRTLRELKILRHFKHDNIIAIRDILRPPGA 78 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc--ccccch----HHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence 5799999999999999999986 57789999864322 111122 234789999999999999999998765431
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
.....++||||+. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 79 ----------~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~ 142 (334)
T cd07855 79 ----------DFKDVYVVMDLME-SDLHHIIHS-----DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNE 142 (334)
T ss_pred ----------CCceEEEEEehhh-hhHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence 2335799999996 689998864 345899999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.+||+|||++......... .........|+..|+|||++.+ ...++.++|||||||++|||+
T Consensus 143 ~-------~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~~Di~slG~~l~el~ 206 (334)
T cd07855 143 D-------CELRIGDFGMARGLSSSPTE------HKYFMTEYVATRWYRAPELLLS---LPEYTTAIDMWSVGCIFAEML 206 (334)
T ss_pred C-------CcEEecccccceeecccCcC------CCcccccccccccccChHHhcC---CcccccccchHHHHHHHHHHH
Confidence 7 56999999999765432211 0111123468999999999864 235789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccc---cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ---SGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
+|+.||.+.+.......+........+..+............+ ..............++.+.++|.+||+.+|.+||
T Consensus 207 ~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 286 (334)
T cd07855 207 GRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERI 286 (334)
T ss_pred cCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCc
Confidence 9999998877665554444321111111111110000000000 0000001111233467899999999999999999
Q ss_pred CHHHHHHHHHh
Q 002738 866 TAGDLYEMFVA 876 (886)
Q Consensus 866 SA~EILehLe~ 876 (886)
++.+++.|..-
T Consensus 287 t~~~~l~~~~~ 297 (334)
T cd07855 287 TVEQALQHPFL 297 (334)
T ss_pred CHHHHHhChhh
Confidence 99999998543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.06 Aligned_cols=253 Identities=28% Similarity=0.462 Sum_probs=199.8
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
..|.....||+|+||.||+|.. .+..+++|+...... ...+ .+.+|+.++..+.||||+++++.+....
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~----~~~~e~~~l~~l~hp~i~~~~~~~~~~~- 91 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ----QRRE----LLFNEVVIMRDYQHQNVVEMYKSYLVGE- 91 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc----chHH----HHHHHHHHHHhCCCCchhhhhhheeeCC-
Confidence 3455566899999999999986 577899998654321 1122 3488999999999999999999987654
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..++||||+++++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 92 -------------~~~iv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~ 152 (297)
T cd06659 92 -------------ELWVLMEFLQGGALTDIVSQ------TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTL 152 (297)
T ss_pred -------------eEEEEEecCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEcc
Confidence 36999999999999998864 45889999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.+||+|||++......... .....|+..|+|||++.+ ..++.++|||||||++|||+
T Consensus 153 ~-------~~~kL~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~el~ 211 (297)
T cd06659 153 D-------GRVKLSDFGFCAQISKDVPK----------RKSLVGTPYWMAPEVISR----TPYGTEVDIWSLGIMVIEMV 211 (297)
T ss_pred C-------CcEEEeechhHhhccccccc----------ccceecCccccCHHHHcc----CCCCchhhHHHHHHHHHHHH
Confidence 7 46999999998754332111 123468999999999976 56789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~ 868 (886)
+|+.||...+.......+.....+.+. .....+..+.++|.+||+.+|.+||++.
T Consensus 212 ~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~~i~~~l~~~P~~Rps~~ 266 (297)
T cd06659 212 DGEPPYFSDSPVQAMKRLRDSPPPKLK-------------------------NAHKISPVLRDFLERMLTREPQERATAQ 266 (297)
T ss_pred hCCCCCCCCCHHHHHHHHhccCCCCcc-------------------------ccCCCCHHHHHHHHHHhcCCcccCcCHH
Confidence 999999877766655554432211110 0011245689999999999999999999
Q ss_pred HHHHHHHhh
Q 002738 869 DLYEMFVAR 877 (886)
Q Consensus 869 EILehLe~l 877 (886)
++++|-.-.
T Consensus 267 ~ll~~~~~~ 275 (297)
T cd06659 267 ELLDHPFLL 275 (297)
T ss_pred HHhhChhhc
Confidence 999975433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=316.19 Aligned_cols=287 Identities=18% Similarity=0.228 Sum_probs=204.8
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
.+|.+.+.||+|+||.||+|+. .+..+|+|...... ....... .+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~----~~~~E~~~l~~l~h~ni~~~~~~~~~~~~ 78 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF--DNRIDAK----RTLREIKLLRHLDHENVIAIKDIMPPPHR 78 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc--cccchhH----HHHHHHHHHHhcCCCCccchHHheecccc
Confidence 5799999999999999999997 56788998754321 1111222 33789999999999999999998875431
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
......++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.
T Consensus 79 ---------~~~~~~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~ 143 (337)
T cd07858 79 ---------EAFNDVYIVYELMD-TDLHQIIRS-----SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA 143 (337)
T ss_pred ---------cccCcEEEEEeCCC-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC
Confidence 01224799999996 699998865 356899999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.+||+|||++........ ......++..|+|||++.. ...++.++|||||||++|+|+
T Consensus 144 ~-------~~~kL~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~ 203 (337)
T cd07858 144 N-------CDLKICDFGLARTTSEKGD----------FMTEYVVTRWYRAPELLLN---CSEYTTAIDVWSVGCIFAELL 203 (337)
T ss_pred C-------CCEEECcCccccccCCCcc----------cccccccccCccChHHHhc---CCCCCCcccHHHHHHHHHHHH
Confidence 7 4599999999976543211 1123357889999999864 134788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCC---CCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG---FEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~---~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
+|+.||.+.+.......+.....+..++.+................. ..........++.+.+||.+||+.+|.+||
T Consensus 204 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 283 (337)
T cd07858 204 GRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRI 283 (337)
T ss_pred cCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhcc
Confidence 99999988766554444433222111111110000000000000000 000111234567899999999999999999
Q ss_pred CHHHHHHH--HHhhc
Q 002738 866 TAGDLYEM--FVART 878 (886)
Q Consensus 866 SA~EILeh--Le~l~ 878 (886)
|+.++++| +..+.
T Consensus 284 s~~ell~h~~~~~~~ 298 (337)
T cd07858 284 TVEEALAHPYLASLH 298 (337)
T ss_pred CHHHHHcCcchhhhc
Confidence 99999999 54443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=302.24 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=189.7
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
.+.+.....||+|+||.||+|++ .+..+++|....+. ....+ .+.+|+.++++++|+||+++++++....
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~----~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD----SRYVQ----PLHEEIALHSYLKHRNIVQYLGSDSENG 78 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC----HHHHH----HHHHHHHHHHhcCCCCeeeeeeeeccCC
Confidence 33444556899999999999986 44567888754321 22223 3489999999999999999999987654
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHV--SVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~L--s~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
..++||||+++++|.+++... ...+ +...+..++.||+.||+|||++||+||||||+||+
T Consensus 79 --------------~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil 140 (268)
T cd06624 79 --------------FFKIFMEQVPGGSLSALLRSK----WGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVL 140 (268)
T ss_pred --------------EEEEEEecCCCCCHHHHHHHh----cccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEE
Confidence 469999999999999999751 1234 78888999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.+. ..++|+|||++......... .....|++.|+|||++... ...++.++||||||+++|
T Consensus 141 ~~~~~------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~~--~~~~~~~~Dv~slGvvl~ 202 (268)
T cd06624 141 VNTYS------GVVKISDFGTSKRLAGINPC----------TETFTGTLQYMAPEVIDKG--PRGYGAPADIWSLGCTIV 202 (268)
T ss_pred EcCCC------CeEEEecchhheecccCCCc----------cccCCCCccccChhhhccc--cccCCchhhhHHHHHHHH
Confidence 97642 46999999998755321110 1223588999999998641 134688999999999999
Q ss_pred HHHhCCCCCCCCCHHHH-HHHHH-cCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 786 ELLTLQVPYMGLSELEI-HDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el-~~~I~-~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
+|++|+.||........ ...+. ....+.++ ....+.+.+|+.+||..+|.+
T Consensus 203 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~ 255 (268)
T cd06624 203 EMATGKPPFIELGEPQAAMFKVGMFKIHPEIP---------------------------ESLSAEAKNFILRCFEPDPDK 255 (268)
T ss_pred HHHhCCCCCccccChhhhHhhhhhhccCCCCC---------------------------cccCHHHHHHHHHHcCCCchh
Confidence 99999999975432211 11110 11111111 123457899999999999999
Q ss_pred CCCHHHHHHH
Q 002738 864 RPTAGDLYEM 873 (886)
Q Consensus 864 RPSA~EILeh 873 (886)
|||+.+++.|
T Consensus 256 Rpt~~~ll~~ 265 (268)
T cd06624 256 RASAHDLLQD 265 (268)
T ss_pred CCCHHHHHhC
Confidence 9999999987
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=302.11 Aligned_cols=244 Identities=27% Similarity=0.324 Sum_probs=194.8
Q ss_pred ecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCC
Q 002738 559 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 636 (886)
Q Consensus 559 LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~~~~ 636 (886)
||.|+||.||+|+.. +..+++|++...... ... ....+.+|+.+++.++||||+++++.+.....
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-------- 67 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV-ETG----QQEHIFSEKEILEECNHPFIVKLYRTFKDKKY-------- 67 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcch-hhh----HHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCc--------
Confidence 799999999999985 788999987533211 111 22345899999999999999999999876553
Q ss_pred CcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCCCC
Q 002738 637 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 716 (886)
Q Consensus 637 ~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~~ 716 (886)
.++||||+++++|.+++.. ...++...+..++.||+.||.|||+++++|+||+|.||+++.+
T Consensus 68 ------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~------- 129 (262)
T cd05572 68 ------IYMLMEYCLGGELWTILRD-----RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN------- 129 (262)
T ss_pred ------cEEEEecCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCC-------
Confidence 6999999999999999976 2458899999999999999999999999999999999999877
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 002738 717 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 796 (886)
Q Consensus 717 ~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF~g 796 (886)
+.++|+|||++........ .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||..
T Consensus 130 ~~~~l~df~~~~~~~~~~~-----------~~~~~~~~~~~~PE~~~~----~~~~~~~Di~slG~il~~l~~g~~p~~~ 194 (262)
T cd05572 130 GYVKLVDFGFAKKLKSGQK-----------TWTFCGTPEYVAPEIILN----KGYDFSVDYWSLGILLYELLTGRPPFGE 194 (262)
T ss_pred CCEEEeeCCcccccCcccc-----------cccccCCcCccChhHhcC----CCCCChhhhhhhHHHHHHHHhCCCCcCC
Confidence 4699999999976644211 122358899999999875 5678899999999999999999999977
Q ss_pred CC--HHHHHHHHHcC-CCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC-----HH
Q 002738 797 LS--ELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT-----AG 868 (886)
Q Consensus 797 ~s--~~el~~~I~~~-~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS-----A~ 868 (886)
.. .......+..+ ..+..+ ...++.+.++|.+||..+|.+||+ +.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 247 (262)
T cd05572 195 DDEDPMEIYNDILKGNGKLEFP---------------------------NYIDKAAKDLIKQLLRRNPEERLGNLKGGIK 247 (262)
T ss_pred CCCCHHHHHHHHhccCCCCCCC---------------------------cccCHHHHHHHHHHccCChhhCcCCcccCHH
Confidence 66 55555554432 111111 111457999999999999999999 99
Q ss_pred HHHHHHH
Q 002738 869 DLYEMFV 875 (886)
Q Consensus 869 EILehLe 875 (886)
|+++|-.
T Consensus 248 ~l~~~~~ 254 (262)
T cd05572 248 DIKKHKW 254 (262)
T ss_pred HHhcChh
Confidence 9998743
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=342.19 Aligned_cols=266 Identities=21% Similarity=0.350 Sum_probs=220.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE---C--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeee
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF---G--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 622 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~---~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~ 622 (886)
++-....|.+.||.|-||.|++|+. + ...||+|. ++.. ........| +.|+.||.++.|||||++.|+
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKT--LK~G-ytekqrrdF----L~EAsIMGQFdHPNIIrLEGV 698 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKT--LKAG-YTEKQRRDF----LSEASIMGQFDHPNIIRLEGV 698 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEee--eccC-ccHHHHhhh----hhhhhhcccCCCCcEEEEEEE
Confidence 3445568999999999999999997 2 33455555 5532 233333444 999999999999999999999
Q ss_pred EecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 002738 623 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 702 (886)
Q Consensus 623 ~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPs 702 (886)
...... ++||+|||++|+|+.||+. ....|...+...+++.|+.||+||-+.|+|||||...
T Consensus 699 VTks~P--------------vMIiTEyMENGsLDsFLR~----~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAAR 760 (996)
T KOG0196|consen 699 VTKSKP--------------VMIITEYMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAAR 760 (996)
T ss_pred EecCce--------------eEEEhhhhhCCcHHHHHhh----cCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhh
Confidence 986654 6999999999999999987 2356999999999999999999999999999999999
Q ss_pred CEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 002738 703 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 782 (886)
Q Consensus 703 NILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGV 782 (886)
||||+.+ ..+|++|||+++.+.+...... ....-.-..+|.|||.+.. ..++.+|||||||+
T Consensus 761 NILVNsn-------LvCKVsDFGLSRvledd~~~~y-------tt~GGKIPiRWTAPEAIa~----RKFTsASDVWSyGI 822 (996)
T KOG0196|consen 761 NILVNSN-------LVCKVSDFGLSRVLEDDPEAAY-------TTLGGKIPIRWTAPEAIAY----RKFTSASDVWSYGI 822 (996)
T ss_pred heeeccc-------eEEEeccccceeecccCCCccc-------cccCCccceeecChhHhhh----cccCchhhccccce
Confidence 9999987 7899999999998765432211 1111123478999999986 78999999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 002738 783 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 861 (886)
Q Consensus 783 ILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP 861 (886)
+|||.++ |..||..++..+++..|.++.+.+-| .+++..|.+|+..||++|-
T Consensus 823 VmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP---------------------------mDCP~aL~qLMldCWqkdR 875 (996)
T KOG0196|consen 823 VMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP---------------------------MDCPAALYQLMLDCWQKDR 875 (996)
T ss_pred EEEEecccCCCcccccchHHHHHHHHhccCCCCC---------------------------CCCcHHHHHHHHHHHHHHh
Confidence 9999876 99999999999999999999764433 3457789999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCCCCC
Q 002738 862 TERPTAGDLYEMFVARTSSSIS 883 (886)
Q Consensus 862 ~kRPSA~EILehLe~l~sss~S 883 (886)
.+||.+.+|+.+|.++...+.|
T Consensus 876 ~~RP~F~qiV~~lDklIrnP~S 897 (996)
T KOG0196|consen 876 NRRPKFAQIVSTLDKLIRNPNS 897 (996)
T ss_pred hcCCCHHHHHHHHHHHhcCchh
Confidence 9999999999999999876654
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=340.53 Aligned_cols=293 Identities=19% Similarity=0.194 Sum_probs=190.9
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCe---eEEEEEEecccCC---------CChHHHHhhhHhHHHHHHHHhhCCCCC
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFGSA---DAAAKVRTLKVCG---------SSADEIRNFEYSCLGEVRMLGALRHSC 615 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~~~---~VAVKI~~lk~~~---------~~~~~~k~f~~~~lrEI~iLk~L~HPN 615 (886)
..+.+|++++.||+|+||.||+|..... .+++|.+...... ............+.+|+.+|++++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 3467899999999999999999875321 1222210000000 000011122345689999999999999
Q ss_pred cceeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 002738 616 IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 695 (886)
Q Consensus 616 IVrl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIV 695 (886)
||++++++..... .|+||+++. ++|..++...............++.|+.||+.||.|||++|||
T Consensus 225 Iv~l~~~~~~~~~--------------~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIi 289 (501)
T PHA03210 225 ILKIEEILRSEAN--------------TYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLI 289 (501)
T ss_pred cCcEeEEEEECCe--------------eEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 9999999986653 599999996 6888887642111122344677889999999999999999999
Q ss_pred ccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchh
Q 002738 696 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 775 (886)
Q Consensus 696 HRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KS 775 (886)
||||||+||||+.+ +.+||+|||++..+...... ......||+.|+|||++.+ ..++.++
T Consensus 290 HrDLKP~NILl~~~-------~~vkL~DFGla~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~----~~~~~~~ 349 (501)
T PHA03210 290 HRDIKLENIFLNCD-------GKIVLGDFGTAMPFEKEREA---------FDYGWVGTVATNSPEILAG----DGYCEIT 349 (501)
T ss_pred cCCCCHHHEEECCC-------CCEEEEeCCCceecCccccc---------ccccccCCcCCCCchhhcC----CCCCcHH
Confidence 99999999999877 46999999999866432211 1123469999999999986 6689999
Q ss_pred hHHHHHHHHHHHHhCCCCC-CCC--CH-HHHHHHHHcCC--CCCchhHHhhhcccc-cccccccCCCCCCchhhhhhHHH
Q 002738 776 DIWSYGCLLLELLTLQVPY-MGL--SE-LEIHDLIQMGK--RPRLTDELEALGSCH-EHEVAQSGSGFEKPEAELETLSF 848 (886)
Q Consensus 776 DIWSLGVILyELLTG~~PF-~g~--s~-~el~~~I~~~~--rp~l~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~ 848 (886)
|||||||+||||++|..++ ... .+ .++...+.... ...+++....++... ...+................+..
T Consensus 350 DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 429 (501)
T PHA03210 350 DIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPAD 429 (501)
T ss_pred HHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChH
Confidence 9999999999999988654 322 22 22222222111 111111100000000 00000000000000111123456
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002738 849 LVDVFRRCTEENPTERPTAGDLYEMFV 875 (886)
Q Consensus 849 L~dLL~rCL~~DP~kRPSA~EILehLe 875 (886)
+.++|.+||++||.+|||+.|++.|-.
T Consensus 430 ~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 430 FEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHHHHHhccCcccCcCHHHHhhChh
Confidence 889999999999999999999999844
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=305.87 Aligned_cols=275 Identities=21% Similarity=0.261 Sum_probs=199.4
Q ss_pred ceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCC
Q 002738 553 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 630 (886)
Q Consensus 553 Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~ 630 (886)
|++.+.||.|++|.||+|.+ .+..+++|+....... ..... .+.+|+.+++.++||||+++++++....
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~----~~~~E~~~l~~l~~~~iv~~~~~~~~~~--- 71 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED--EGVPS----TAIREISLLKELNHPNIVRLLDVVHSEN--- 71 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc--ccchh----HHHHHHHHHHhcCCCCccCHhheeccCC---
Confidence 67889999999999999987 5778999987544221 11112 3378999999999999999999987554
Q ss_pred CCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccc
Q 002738 631 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 710 (886)
Q Consensus 631 ~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~ 710 (886)
..++||||++ ++|.+++... ....+++..++.++.||+.||+|||+++++||||+|+|||++.+
T Consensus 72 -----------~~~iv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~- 135 (283)
T cd07835 72 -----------KLYLVFEFLD-LDLKKYMDSS---PLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE- 135 (283)
T ss_pred -----------eEEEEEeccC-cCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-
Confidence 3699999996 6999998751 22368999999999999999999999999999999999999876
Q ss_pred cCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 002738 711 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 790 (886)
Q Consensus 711 ~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG 790 (886)
+.++|+|||++......... .....+++.|+|||++.+ ...++.++||||||+++|+|++|
T Consensus 136 ------~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~l~~l~~g 196 (283)
T cd07835 136 ------GALKLADFGLARAFGVPVRT----------YTHEVVTLWYRAPEILLG---SRQYSTPVDIWSIGCIFAEMVNR 196 (283)
T ss_pred ------CcEEEeecccccccCCCccc----------cCccccccCCCCCceeec---CcccCcHHHHHHHHHHHHHHHhC
Confidence 46999999998755322111 112246889999998864 23568899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCC---CCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 791 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF---EKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 791 ~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
+.||...+.......+...........+....... .+....... .........+..+.+||.+||+.||.+|||+
T Consensus 197 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 274 (283)
T cd07835 197 RPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP--DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISA 274 (283)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch--hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCH
Confidence 99998877655444443332211111111100000 000000000 0111122345678999999999999999999
Q ss_pred HHHHHH
Q 002738 868 GDLYEM 873 (886)
Q Consensus 868 ~EILeh 873 (886)
.++++|
T Consensus 275 ~~il~~ 280 (283)
T cd07835 275 KAALQH 280 (283)
T ss_pred HHHhcC
Confidence 999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=293.74 Aligned_cols=249 Identities=29% Similarity=0.497 Sum_probs=200.2
Q ss_pred CceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
+|++.+.||+|++|.||++.+. +..+++|+...... ...+ .+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 70 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKE----KIINEIQILKKCKHPNIVKYYGSYLKKD-- 70 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHH----HHHHHHHHHHhCCCCCEeEEEEEEecCC--
Confidence 4788999999999999999984 67788888653321 1223 3489999999999999999999987654
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..+++|||+++++|.+++... ...+++..+..++.|++.||.|||.+|++||||+|.||+++.+
T Consensus 71 ------------~~~l~~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~ 134 (253)
T cd05122 71 ------------ELWIVMEFCSGGSLKDLLKST----NQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD 134 (253)
T ss_pred ------------eEEEEEecCCCCcHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC
Confidence 369999999999999999761 2468999999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.++|+|||.+........ .....++..|+|||++.+ ..++.++||||||+++|+|++
T Consensus 135 -------~~~~l~d~~~~~~~~~~~~-----------~~~~~~~~~~~~PE~~~~----~~~~~~~Dv~slG~il~~l~~ 192 (253)
T cd05122 135 -------GEVKLIDFGLSAQLSDTKA-----------RNTMVGTPYWMAPEVING----KPYDYKADIWSLGITAIELAE 192 (253)
T ss_pred -------CeEEEeecccccccccccc-----------ccceecCCcccCHHHHcC----CCCCccccHHHHHHHHHHHHh
Confidence 4699999999876644221 123458899999999976 457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 869 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~E 869 (886)
|+.||...+.......+.....+.++. ....+..+.++|.+||..||.+|||+.+
T Consensus 193 g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~i~~~l~~~p~~R~t~~~ 247 (253)
T cd05122 193 GKPPYSELPPMKALFKIATNGPPGLRN-------------------------PEKWSDEFKDFLKKCLQKNPEKRPTAEQ 247 (253)
T ss_pred CCCCCCCCchHHHHHHHHhcCCCCcCc-------------------------ccccCHHHHHHHHHHccCChhhCCCHHH
Confidence 999998776555544443332222211 0112457999999999999999999999
Q ss_pred HHHH
Q 002738 870 LYEM 873 (886)
Q Consensus 870 ILeh 873 (886)
+++|
T Consensus 248 ~l~~ 251 (253)
T cd05122 248 LLKH 251 (253)
T ss_pred HhcC
Confidence 9987
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=308.97 Aligned_cols=261 Identities=24% Similarity=0.319 Sum_probs=193.9
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEecC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 626 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~~~ 626 (886)
..+|...+.||+|+||.||++.+ .+..+|+|....... . ... ..+.+|+.++.++. ||||+++++++..+
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~-~~~----~~~~~e~~~l~~~~~~~~iv~~~~~~~~~ 75 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--E-KEQ----KRLLMDLDVVMRSSDCPYIVKFYGALFRE 75 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--h-HHH----HHHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence 45677889999999999999997 567888887643221 1 222 23488999999997 99999999998755
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENIL 705 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~-gIVHRDLKPsNIL 705 (886)
. ..+++|||+. ++|.++...........+++..+..++.|++.||+|||+. +|+||||||+|||
T Consensus 76 ~--------------~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil 140 (288)
T cd06616 76 G--------------DCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNIL 140 (288)
T ss_pred C--------------cEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEE
Confidence 4 3699999996 5776655432222335689999999999999999999975 9999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.+ ..+||+|||++........ .....|++.|+|||++.+.. ...++.++|||||||++|
T Consensus 141 ~~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~ 201 (288)
T cd06616 141 LDRN-------GNIKLCDFGISGQLVDSIA-----------KTRDAGCRPYMAPERIDPSA-RDGYDVRSDVWSLGITLY 201 (288)
T ss_pred EccC-------CcEEEeecchhHHhccCCc-----------cccccCccCccCHHHhcccc-ccCCcchhhhhHHHHHHH
Confidence 9876 4699999999876543211 12235889999999987511 136788999999999999
Q ss_pred HHHhCCCCCCCCCH-HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 002738 786 ELLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 864 (886)
Q Consensus 786 ELLTG~~PF~g~s~-~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kR 864 (886)
+|++|+.||..... .+....+..+..+.+.. ......+..+.+||.+||+.+|.+|
T Consensus 202 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~~p~~R 258 (288)
T cd06616 202 EVATGKFPYPKWNSVFDQLTQVVKGDPPILSN-----------------------SEEREFSPSFVNFINLCLIKDESKR 258 (288)
T ss_pred HHHhCCCCchhcchHHHHHhhhcCCCCCcCCC-----------------------cCCCccCHHHHHHHHHHccCChhhC
Confidence 99999999976542 11222221221111110 0012245679999999999999999
Q ss_pred CCHHHHHHHH
Q 002738 865 PTAGDLYEMF 874 (886)
Q Consensus 865 PSA~EILehL 874 (886)
||+.+|++|-
T Consensus 259 pt~~~i~~~~ 268 (288)
T cd06616 259 PKYKELLEHP 268 (288)
T ss_pred cCHHHHhcCh
Confidence 9999999983
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=331.30 Aligned_cols=255 Identities=22% Similarity=0.381 Sum_probs=211.3
Q ss_pred ceeeeeecccCceEEEEEEE----CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 553 LSSCDEAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 553 Y~i~k~LG~G~fG~VY~A~~----~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
..+.++||.|-||.||.|.+ .+...||.++..+.. ...+..+.| ++|..+|+.++|||||+++|++.+..
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d-~t~d~tekf----lqEa~iMrnfdHphIikLIGv~~e~P- 464 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD-CTPDDTEKF----LQEASIMRNFDHPHIIKLIGVCVEQP- 464 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC-CChhhHHHH----HHHHHHHHhCCCcchhheeeeeeccc-
Confidence 45678899999999999997 344444444434432 223334455 99999999999999999999998664
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
.|||||+++-|-|..||+. ....++......+++||..||+|||+.++|||||...|||+..
T Consensus 465 --------------~WivmEL~~~GELr~yLq~----nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsS 526 (974)
T KOG4257|consen 465 --------------MWIVMELAPLGELREYLQQ----NKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSS 526 (974)
T ss_pred --------------eeEEEecccchhHHHHHHh----ccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecC
Confidence 5999999999999999986 3456889999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
. -.|||+|||+++.+....... .....-...|||||.+.- ..++.++|||-|||.+||++
T Consensus 527 p-------~CVKLaDFGLSR~~ed~~yYk---------aS~~kLPIKWmaPESINf----RrFTtASDVWMFgVCmWEIl 586 (974)
T KOG4257|consen 527 P-------QCVKLADFGLSRYLEDDAYYK---------ASRGKLPIKWMAPESINF----RRFTTASDVWMFGVCMWEIL 586 (974)
T ss_pred c-------ceeeecccchhhhccccchhh---------ccccccceeecCccccch----hcccchhhHHHHHHHHHHHH
Confidence 7 469999999999886644321 112234578999999875 78999999999999999988
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 789 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 789 T-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
. |..||.+....+++..+.++.+++.|+. +++.+..|+.+||.+||.+||.+
T Consensus 587 ~lGvkPfqgvkNsDVI~~iEnGeRlP~P~n---------------------------CPp~LYslmskcWayeP~kRPrf 639 (974)
T KOG4257|consen 587 SLGVKPFQGVKNSDVIGHIENGERLPCPPN---------------------------CPPALYSLMSKCWAYEPSKRPRF 639 (974)
T ss_pred HhcCCccccccccceEEEecCCCCCCCCCC---------------------------CChHHHHHHHHHhccCcccCCcH
Confidence 6 9999999999999989999988776633 46679999999999999999999
Q ss_pred HHHHHHHHhhc
Q 002738 868 GDLYEMFVART 878 (886)
Q Consensus 868 ~EILehLe~l~ 878 (886)
.+|...|..+.
T Consensus 640 tei~~~lsdv~ 650 (974)
T KOG4257|consen 640 TEIKAILSDVL 650 (974)
T ss_pred HHHHHHHHHHH
Confidence 99998887654
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=308.81 Aligned_cols=273 Identities=18% Similarity=0.208 Sum_probs=188.4
Q ss_pred CCceeeeeecccCceEEEEEEECC-----eeEEEEEEecccCCCChHHH--Hh-hhHhHHHHHHHHhhCCCCCcceeeee
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEI--RN-FEYSCLGEVRMLGALRHSCIVEMYGH 622 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~~~-----~~VAVKI~~lk~~~~~~~~~--k~-f~~~~lrEI~iLk~L~HPNIVrl~g~ 622 (886)
.+|.+.+.||+|+||.||+|.+.+ ..+++|+..+.......+.. .. .......++..+..+.|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 589999999999999999999743 35677764433221111100 00 00112344455667789999999997
Q ss_pred EecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 002738 623 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 702 (886)
Q Consensus 623 ~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPs 702 (886)
+..... .....+++||++. .++.+++.. ....++..++.|+.||+.||+|||+++|+||||||+
T Consensus 92 ~~~~~~----------~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~ 155 (294)
T PHA02882 92 GSFKRC----------RMYYRFILLEKLV-ENTKEIFKR-----IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPE 155 (294)
T ss_pred eeEecC----------CceEEEEEEehhc-cCHHHHHHh-----hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 664432 1224588999885 578777765 133578889999999999999999999999999999
Q ss_pred CEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 002738 703 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 782 (886)
Q Consensus 703 NILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGV 782 (886)
|||++.+ ..++|+|||+|+.+......... .........||+.|+|||++.+ ..++.++|||||||
T Consensus 156 Nill~~~-------~~~~l~DFGla~~~~~~~~~~~~---~~~~~~~~~gt~~y~ape~~~~----~~~~~~~DiwSlG~ 221 (294)
T PHA02882 156 NIMVDGN-------NRGYIIDYGIASHFIIHGKHIEY---SKEQKDLHRGTLYYAGLDAHNG----ACVTRRGDLESLGY 221 (294)
T ss_pred HEEEcCC-------CcEEEEEcCCceeeccCCccccc---ccccccccCCCccccCHHHhCC----CCCCcHHHHHHHHH
Confidence 9999866 45999999999876432211100 0111233469999999999886 67899999999999
Q ss_pred HHHHHHhCCCCCCCCCH-HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 002738 783 LLLELLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 861 (886)
Q Consensus 783 ILyELLTG~~PF~g~s~-~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP 861 (886)
+||||++|+.||.+... ..+...........+.. . .. .....++.+.+++..||..+|
T Consensus 222 ~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~----------~-----~~------~~~~~~~~~~~~~~~~~~~~~ 280 (294)
T PHA02882 222 CMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHE----------G-----KI------KIKNANKFIYDFIECVTKLSY 280 (294)
T ss_pred HHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhh----------h-----hh------ccCCCCHHHHHHHHHHHhCCC
Confidence 99999999999987732 22222211110000000 0 00 001124579999999999999
Q ss_pred CCCCCHHHHHHHH
Q 002738 862 TERPTAGDLYEMF 874 (886)
Q Consensus 862 ~kRPSA~EILehL 874 (886)
.+||++++|++.|
T Consensus 281 ~~rp~~~~l~~~~ 293 (294)
T PHA02882 281 EEKPDYDALIKIF 293 (294)
T ss_pred CCCCCHHHHHHhh
Confidence 9999999999876
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.80 Aligned_cols=253 Identities=26% Similarity=0.435 Sum_probs=199.3
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
....+|.+.+.||+|+||.||++.. .+..+++|...... .... +.+.+|+.+++.++||||+++++.+..
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~----~~~~~e~~~l~~l~hp~i~~~~~~~~~ 87 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKK----ELIINEILVMRENKHPNIVNYLDSYLV 87 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc----chHH----HHHHHHHHHHhhcCCCCeeehhheeee
Confidence 3467999999999999999999986 56778998864321 1112 234889999999999999999999876
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
.. ..|+||||+++++|.+++.. ..+++..+..++.||+.||.|||++|++|+||||+||+
T Consensus 88 ~~--------------~~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nil 147 (293)
T cd06647 88 GD--------------ELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNIL 147 (293)
T ss_pred CC--------------cEEEEEecCCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEE
Confidence 54 36999999999999999975 35788999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.+ +.++|+|||++......... .....|++.|+|||.+.. ..++.++|||||||++|
T Consensus 148 i~~~-------~~~kL~dfg~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slG~ll~ 206 (293)
T cd06647 148 LGMD-------GSVKLTDFGFCAQITPEQSK----------RSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAI 206 (293)
T ss_pred EcCC-------CCEEEccCcceecccccccc----------cccccCChhhcCchhhcc----CCCCchhhHHHHHHHHH
Confidence 9876 46999999988755432211 122358899999999875 56788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
+|++|+.||...+.......+.....+.+. .....+..+.+||.+||..+|.+||
T Consensus 207 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~li~~~l~~~p~~Rp 261 (293)
T cd06647 207 EMVEGEPPYLNENPLRALYLIATNGTPELQ-------------------------NPEKLSAIFRDFLNRCLEMDVEKRG 261 (293)
T ss_pred HHHhCCCCCCCCChhhheeehhcCCCCCCC-------------------------CccccCHHHHHHHHHHccCChhhCc
Confidence 999999999876554333222222111111 0111345689999999999999999
Q ss_pred CHHHHHHHH
Q 002738 866 TAGDLYEMF 874 (886)
Q Consensus 866 SA~EILehL 874 (886)
++.+++.|-
T Consensus 262 ~~~~il~h~ 270 (293)
T cd06647 262 SAKELLQHP 270 (293)
T ss_pred CHHHHhcCH
Confidence 999999993
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=303.90 Aligned_cols=279 Identities=23% Similarity=0.291 Sum_probs=201.5
Q ss_pred ceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCC
Q 002738 553 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 630 (886)
Q Consensus 553 Y~i~k~LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~ 630 (886)
|++.+.||.|+||.||+|.+. +..+++|+..... .... +...+.+|+.+++.++||||+++++++....
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 71 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEG----FPITAIREIKLLQKLRHPNIVRLKEIVTSKG--- 71 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--cccc----chHHHHHHHHHHHhccCCCeeeheeeEecCC---
Confidence 678999999999999999974 5789999876442 1111 1223488999999999999999999987651
Q ss_pred CCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccc
Q 002738 631 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 710 (886)
Q Consensus 631 ~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~ 710 (886)
....++||||++ ++|.+++.. ....+++..++.++.||+.||+|||++|++|+||||+|||++.+
T Consensus 72 ---------~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~- 136 (287)
T cd07840 72 ---------KGSIYMVFEYMD-HDLTGLLDS----PEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND- 136 (287)
T ss_pred ---------CCcEEEEecccc-ccHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCC-
Confidence 124799999997 599998865 12468999999999999999999999999999999999999887
Q ss_pred cCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 002738 711 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 790 (886)
Q Consensus 711 ~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG 790 (886)
+.++|+|||++......... ......++..|+|||.+.+ ...++.++||||||+++|||++|
T Consensus 137 ------~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~slG~~l~el~t~ 198 (287)
T cd07840 137 ------GVLKLADFGLARPYTKRNSA---------DYTNRVITLWYRPPELLLG---ATRYGPEVDMWSVGCILAELFLG 198 (287)
T ss_pred ------CCEEEccccceeeccCCCcc---------cccccccccccCCceeeEc---cccCChHHHHHHHHHHHHHHHhC
Confidence 56999999999866443210 0122357889999998764 24578899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCC--CCchhhhh-hHHHHHHHHHHhcccCCCCCCCH
Q 002738 791 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF--EKPEAELE-TLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 791 ~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~--~~~~~~~~-~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
+.||...+.......+...........+.................. ........ .+..+.+++.+||..+|.+||++
T Consensus 199 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~ 278 (287)
T cd07840 199 KPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISA 278 (287)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCH
Confidence 9999888776665555443222111111111000000000000000 00011111 26688999999999999999999
Q ss_pred HHHHHH
Q 002738 868 GDLYEM 873 (886)
Q Consensus 868 ~EILeh 873 (886)
.++++|
T Consensus 279 ~~~l~~ 284 (287)
T cd07840 279 DQALQH 284 (287)
T ss_pred HHHhhC
Confidence 999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=329.18 Aligned_cols=259 Identities=22% Similarity=0.336 Sum_probs=195.8
Q ss_pred CCceeeeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~~-~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~~~~~ 628 (886)
..|++.++||.||.+.||++... .+.+|+|.+.+. ......+..| .+|+..|.+|+ |.+||++|+|-..++.
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~--~~D~qtl~gy----~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLL--EADNQTLDGY----RNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHh--hcCHHHHHHH----HHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 46899999999999999999974 345555543333 2334445555 99999999997 9999999999887765
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
+|+||||-+ .+|..+|++ ....++...++.+..||+.|+.++|.+||||.||||.|+|+-.
T Consensus 435 --------------lYmvmE~Gd-~DL~kiL~k----~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk 495 (677)
T KOG0596|consen 435 --------------LYMVMECGD-IDLNKILKK----KKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK 495 (677)
T ss_pred --------------EEEEeeccc-ccHHHHHHh----ccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe
Confidence 699999986 799999987 2233444488899999999999999999999999999999965
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC-------CCCCchhhHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-------NLYGLEVDIWSYG 781 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~-------~~~s~KSDIWSLG 781 (886)
+.+||+|||+|..+...... +. ....+||+.||+||.+..+... -..+.++||||||
T Consensus 496 --------G~LKLIDFGIA~aI~~DTTs--I~------kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLG 559 (677)
T KOG0596|consen 496 --------GRLKLIDFGIANAIQPDTTS--IV------KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLG 559 (677)
T ss_pred --------eeEEeeeechhcccCccccc--ee------eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhh
Confidence 47999999999887654322 11 2456899999999999865422 2367899999999
Q ss_pred HHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 002738 782 CLLLELLTLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 860 (886)
Q Consensus 782 VILyELLTG~~PF~g~s-~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~D 860 (886)
||||+|+.|+.||.... ....+..|.. |.-. -.++.... ..+++++++.||..|
T Consensus 560 CILYqMvYgktPf~~~~n~~aKl~aI~~---P~~~-----------Iefp~~~~-----------~~~li~~mK~CL~rd 614 (677)
T KOG0596|consen 560 CILYQMVYGKTPFGQIINQIAKLHAITD---PNHE-----------IEFPDIPE-----------NDELIDVMKCCLARD 614 (677)
T ss_pred hHHHHHHhcCCchHHHHHHHHHHHhhcC---CCcc-----------ccccCCCC-----------chHHHHHHHHHHhcC
Confidence 99999999999996543 2222223322 1100 00111111 123899999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 002738 861 PTERPTAGDLYEMFV 875 (886)
Q Consensus 861 P~kRPSA~EILehLe 875 (886)
|.+||++.++|+|-.
T Consensus 615 PkkR~si~eLLqhpF 629 (677)
T KOG0596|consen 615 PKKRWSIPELLQHPF 629 (677)
T ss_pred cccCCCcHHHhcCcc
Confidence 999999999999854
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=295.48 Aligned_cols=249 Identities=31% Similarity=0.446 Sum_probs=200.2
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
+|++.+.||+|++|.||++.. .+..+++|...... ...... ..+.+|+.++.+++||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK--IKEEAL----KSIMQEIDLLKNLKHPNIVKYIGSIETSD-- 72 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccc--cCHHHH----HHHHHHHHHHHhCCCCCccEEEEEEEeCC--
Confidence 588999999999999999987 45678999865332 222233 34589999999999999999999987654
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.+
T Consensus 73 ------------~~~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~ 135 (254)
T cd06627 73 ------------SLYIILEYAENGSLRQIIKK-----FGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD 135 (254)
T ss_pred ------------EEEEEEecCCCCcHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC
Confidence 36999999999999999976 2568999999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.++|+|||.+......... .....++..|+|||.+.+ ..++.++||||||+++|+|++
T Consensus 136 -------~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~~lG~~l~~l~~ 194 (254)
T cd06627 136 -------GVVKLADFGVATKLNDVSKD----------DASVVGTPYWMAPEVIEM----SGASTASDIWSLGCTVIELLT 194 (254)
T ss_pred -------CCEEEeccccceecCCCccc----------ccccccchhhcCHhhhcC----CCCCcchhHHHHHHHHHHHHh
Confidence 46999999999876542211 122358899999999875 447889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 869 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~E 869 (886)
|+.||...........+.....+.++ ...+..+.+++.+||..+|++|||+.+
T Consensus 195 g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~R~~~~~ 247 (254)
T cd06627 195 GNPPYYDLNPMAALFRIVQDDHPPLP---------------------------EGISPELKDFLMQCFQKDPNLRPTAKQ 247 (254)
T ss_pred CCCCCCCccHHHHHHHHhccCCCCCC---------------------------CCCCHHHHHHHHHHHhCChhhCcCHHH
Confidence 99999876655444444333222222 112457899999999999999999999
Q ss_pred HHHH
Q 002738 870 LYEM 873 (886)
Q Consensus 870 ILeh 873 (886)
++.+
T Consensus 248 ~l~~ 251 (254)
T cd06627 248 LLKH 251 (254)
T ss_pred HhcC
Confidence 9875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=336.16 Aligned_cols=250 Identities=24% Similarity=0.397 Sum_probs=205.3
Q ss_pred eeeeeecccCceEEEEEEECCeeEEEEE--EecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCC
Q 002738 554 SSCDEAGKSVSSSLFRCKFGSADAAAKV--RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 631 (886)
Q Consensus 554 ~i~k~LG~G~fG~VY~A~~~~~~VAVKI--~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~ 631 (886)
....+||+|+|-+||+|.+....+.|.- +.+..........+. |..|+.+|+.|+|||||++|.++.+...
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR----~~~Ev~lLKsL~H~NIirfy~SW~d~~n--- 115 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELER----LYSEVHLLKSLKHPNIIRFYDSWVDTDN--- 115 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHH----HHHHHHHHccCCCCceeeeeeheecCCC---
Confidence 4568899999999999998555444432 223333334444444 4999999999999999999999987653
Q ss_pred CCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhC--CccccCCCCCCEEEecc
Q 002738 632 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--HIMHRDIKSENILIDLE 709 (886)
Q Consensus 632 ~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~--gIVHRDLKPsNILLd~d 709 (886)
....+|+|++..|+|..|+++ .+.++.+.++.|++||++||.|||++ .|||||||-+||||+.+
T Consensus 116 ---------~~in~iTEL~TSGtLr~Y~kk-----~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~ 181 (632)
T KOG0584|consen 116 ---------KTINFITELFTSGTLREYRKK-----HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN 181 (632)
T ss_pred ---------ceeeeeeecccCCcHHHHHHH-----hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC
Confidence 246899999999999999998 35688999999999999999999998 59999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
.+.|||+|+|+|....... ...++|||.|||||++. ..|+..+||||||+.|+||+|
T Consensus 182 ------~G~VKIGDLGLAtl~r~s~------------aksvIGTPEFMAPEmYE-----E~YnE~VDVYaFGMCmLEMvT 238 (632)
T KOG0584|consen 182 ------LGEVKIGDLGLATLLRKSH------------AKSVIGTPEFMAPEMYE-----ENYNELVDVYAFGMCMLEMVT 238 (632)
T ss_pred ------cCceeecchhHHHHhhccc------------cceeccCccccChHHHh-----hhcchhhhhhhhhHHHHHHHh
Confidence 3789999999998765432 23468999999999997 478999999999999999999
Q ss_pred CCCCCCC-CCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 002738 790 LQVPYMG-LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868 (886)
Q Consensus 790 G~~PF~g-~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~ 868 (886)
+..||.. .++.+++.++..|..|.- +... ..+++++||.+||.. ..+|||+.
T Consensus 239 ~eYPYsEC~n~AQIYKKV~SGiKP~s---l~kV-----------------------~dPevr~fIekCl~~-~~~R~sa~ 291 (632)
T KOG0584|consen 239 SEYPYSECTNPAQIYKKVTSGIKPAA---LSKV-----------------------KDPEVREFIEKCLAT-KSERLSAK 291 (632)
T ss_pred ccCChhhhCCHHHHHHHHHcCCCHHH---hhcc-----------------------CCHHHHHHHHHHhcC-chhccCHH
Confidence 9999964 578899999998865432 2111 134799999999999 99999999
Q ss_pred HHHHHH
Q 002738 869 DLYEMF 874 (886)
Q Consensus 869 EILehL 874 (886)
|+|++-
T Consensus 292 eLL~d~ 297 (632)
T KOG0584|consen 292 ELLKDP 297 (632)
T ss_pred HHhhCh
Confidence 999873
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=302.68 Aligned_cols=277 Identities=21% Similarity=0.221 Sum_probs=207.7
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
.-.+|++.++||+|||+.||+++. .+..+|+|.+.... .+..+.. ++|++..++++||||++++++...+
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~----~~~~e~~----~rEid~~rkf~s~~vl~l~dh~l~~ 90 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS----QEDIEEA----LREIDNHRKFNSPNVLRLVDHQLRE 90 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc----hHHHHHH----HHHHHHHHhhCCcchHHHHHHHHHh
Confidence 346899999999999999999984 67778888765432 2344444 8999999999999999999987754
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENI 704 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~g--IVHRDLKPsNI 704 (886)
.. + .....||+++|+..|+|.+.|...... +..+++.+++.|+.+|++||++||... ++||||||.||
T Consensus 91 ~~----D-----~~~~~yll~Pyy~~Gsl~d~i~~~k~k-g~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NI 160 (302)
T KOG2345|consen 91 EK----D-----GKHEAYLLLPYYKRGSLLDEIERLKIK-GNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANI 160 (302)
T ss_pred hc----c-----CceeEEEEeehhccccHHHHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCccee
Confidence 32 1 234589999999999999999875443 357999999999999999999999998 99999999999
Q ss_pred EEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVIL 784 (886)
|+..+ +.++|.|||.+....-.........+-. .-.....|..|+|||.+.- ......+.++|||||||+|
T Consensus 161 Lls~~-------~~~vl~D~GS~~~a~i~i~~~~~a~~lQ-e~a~e~Ct~pyRAPELf~v-k~~~ti~ertDIWSLGCtL 231 (302)
T KOG2345|consen 161 LLSDS-------GLPVLMDLGSATQAPIQIEGSRQALRLQ-EWAEERCTIPYRAPELFNV-KSHCTITERTDIWSLGCTL 231 (302)
T ss_pred EecCC-------CceEEEeccCccccceEeechHHHHHHH-HHHHHhCCCcccCchheec-ccCcccccccchhhhhHHH
Confidence 99886 5699999999986543322111000000 0011247899999999864 3346678999999999999
Q ss_pred HHHHhCCCCCCCCCH--HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 002738 785 LELLTLQVPYMGLSE--LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 862 (886)
Q Consensus 785 yELLTG~~PF~g~s~--~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~ 862 (886)
|+|+.|..||...-. ..+..++.++. +..|.. ...++.+.+||+.||+.||.
T Consensus 232 Ya~mf~~sPfe~~~~~GgSlaLAv~n~q-------------------------~s~P~~-~~yse~l~~lik~mlqvdP~ 285 (302)
T KOG2345|consen 232 YAMMFGESPFERIYQQGGSLALAVQNAQ-------------------------ISIPNS-SRYSEALHQLIKSMLQVDPN 285 (302)
T ss_pred HHHHHcCCcchHHhhcCCeEEEeeeccc-------------------------cccCCC-CCccHHHHHHHHHHhcCCcc
Confidence 999999999952210 00111111110 001111 11577899999999999999
Q ss_pred CCCCHHHHHHHHHhhc
Q 002738 863 ERPTAGDLYEMFVART 878 (886)
Q Consensus 863 kRPSA~EILehLe~l~ 878 (886)
+||++.+++.++..+.
T Consensus 286 qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 286 QRPTIPELLSKLDDLI 301 (302)
T ss_pred cCCCHHHHHHHHHhhc
Confidence 9999999999998764
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=305.51 Aligned_cols=250 Identities=27% Similarity=0.427 Sum_probs=198.2
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
.|...+.||+|++|.||++.. .+..+++|...... ....+ .+.+|+.+++.+.||||+++++++....
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~----~~~~e~~~l~~~~h~~vv~~~~~~~~~~-- 89 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK----QQRRE----LLFNEVVIMRDYQHPNIVEMYSSYLVGD-- 89 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc----hhHHH----HHHHHHHHHHHcCCCChheEEEEEEcCC--
Confidence 345567999999999999986 55678888764321 12222 3488999999999999999999987554
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..++||||+++++|.+++.. ..+++..+..++.||+.||+|||++||+||||+|+||+++.+
T Consensus 90 ------------~~~~v~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~ 151 (285)
T cd06648 90 ------------ELWVVMEFLEGGALTDIVTH------TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD 151 (285)
T ss_pred ------------eEEEEEeccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC
Confidence 36999999999999999875 458899999999999999999999999999999999999877
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.++|+|||++........ ......|++.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 152 -------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slGv~l~ell~ 210 (285)
T cd06648 152 -------GRVKLSDFGFCAQVSKEVP----------RRKSLVGTPYWMAPEVISR----LPYGTEVDIWSLGIMVIEMVD 210 (285)
T ss_pred -------CcEEEcccccchhhccCCc----------ccccccCCccccCHHHhcC----CCCCCcccHHHHHHHHHHHHh
Confidence 4699999998865432111 1123458899999999875 567899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 869 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~E 869 (886)
|+.||...++......+.....+.+.. ....+..+.+|+.+||..+|.+||++.+
T Consensus 211 g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 265 (285)
T cd06648 211 GEPPYFNEPPLQAMKRIRDNLPPKLKN-------------------------LHKVSPRLRSFLDRMLVRDPAQRATAAE 265 (285)
T ss_pred CCCCCcCCCHHHHHHHHHhcCCCCCcc-------------------------cccCCHHHHHHHHHHcccChhhCcCHHH
Confidence 999998877666665554432211110 0113457999999999999999999999
Q ss_pred HHHHHH
Q 002738 870 LYEMFV 875 (886)
Q Consensus 870 ILehLe 875 (886)
+++|-.
T Consensus 266 il~~~~ 271 (285)
T cd06648 266 LLNHPF 271 (285)
T ss_pred HccCcc
Confidence 998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.20 Aligned_cols=279 Identities=23% Similarity=0.225 Sum_probs=201.2
Q ss_pred ceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC---CCCCcceeeeeEecCC
Q 002738 553 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKISSK 627 (886)
Q Consensus 553 Y~i~k~LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L---~HPNIVrl~g~~~~~~ 627 (886)
|++.+.||+|+||.||+|++. +..+|+|+........ .... .+.+|+.+++++ .||||+++++++....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~----~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE--GIPL----STLREIALLKQLESFEHPNIVRLLDVCHGPR 74 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc--hhhh----hHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence 678999999999999999983 6789999876443211 1111 236677777666 5999999999998654
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
.. .....+++|||+. ++|.+++.. .....+++..++.++.||+.||.|||+.+|+|+||+|+||+++
T Consensus 75 ~~---------~~~~~~l~~e~~~-~~l~~~l~~---~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~ 141 (287)
T cd07838 75 TD---------RELKLTLVFEHVD-QDLATYLSK---CPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT 141 (287)
T ss_pred CC---------CCceeEEEehhcc-cCHHHHHHH---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc
Confidence 30 1224799999997 589998875 2223589999999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ +.+||+|||++........ .....++..|+|||++.+ ..++.++|||||||++|+|
T Consensus 142 ~~-------~~~~l~dfg~~~~~~~~~~-----------~~~~~~~~~~~~PE~~~~----~~~~~~~Di~s~G~~l~~l 199 (287)
T cd07838 142 SD-------GQVKIADFGLARIYSFEMA-----------LTSVVVTLWYRAPEVLLQ----SSYATPVDMWSVGCIFAEL 199 (287)
T ss_pred cC-------CCEEEeccCcceeccCCcc-----------cccccccccccChHHhcc----CCCCCcchhhhHHHHHHHH
Confidence 87 4699999999876543211 122357889999999976 5678899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 788 LTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
++|.+||.+....+....+...........+......... .................+..+.+||.+||+.||.+||++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~ 278 (287)
T cd07838 200 FRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRS-SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA 278 (287)
T ss_pred HhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchh-hcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCH
Confidence 9999999888777666555432111111110000000000 000000111122223456788999999999999999999
Q ss_pred HHHHHH
Q 002738 868 GDLYEM 873 (886)
Q Consensus 868 ~EILeh 873 (886)
.+++.|
T Consensus 279 ~~il~~ 284 (287)
T cd07838 279 FEALQH 284 (287)
T ss_pred HHHhcC
Confidence 999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=299.96 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=195.9
Q ss_pred CceeeeeecccCceEEEEEEECC--eeEEEEEEeccc-CCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKV-CGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~~~--~~VAVKI~~lk~-~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
+|.+.+.||+|+||.||++++.. ..+++|+.+.-. ......... .+..|+.+++.++||||+++++++....
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV----QANQEAQLLSKLDHPAIVKFHASFLERD- 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHH----HHHHHHHHHHhCCCCcHHHHHHHHhcCC-
Confidence 58999999999999999998743 345555532211 111111112 2367999999999999999999887554
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..++||||+++++|.+++...... ...+++..++.++.|++.||.|||++|++|+||||+||+++.
T Consensus 76 -------------~~~lv~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~ 141 (260)
T cd08222 76 -------------AFCIITEYCEGRDLDCKLEELKHT-GKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN 141 (260)
T ss_pred -------------ceEEEEEeCCCCCHHHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec
Confidence 369999999999999999753222 356899999999999999999999999999999999999964
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ .++|+|||++......... .....|++.|+|||.+.+ ..++.++||||||+++|+|+
T Consensus 142 ~--------~~~l~d~g~~~~~~~~~~~----------~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~slG~~~~~l~ 199 (260)
T cd08222 142 N--------LLKIGDFGVSRLLMGSCDL----------ATTFTGTPYYMSPEALKH----QGYDSKSDIWSLGCILYEMC 199 (260)
T ss_pred C--------CEeecccCceeecCCCccc----------ccCCCCCcCccCHHHHcc----CCCCchhhHHHHHHHHHHHH
Confidence 3 4999999998765432111 122357889999999875 55778999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~ 868 (886)
+|..||...........+..+..+.++ ...+..+.++|.+||..+|++||++.
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ 252 (260)
T cd08222 200 CLAHAFEGQNFLSVVLRIVEGPTPSLP---------------------------ETYSRQLNSIMQSMLNKDPSLRPSAA 252 (260)
T ss_pred hCCCCCCCccHHHHHHHHHcCCCCCCc---------------------------chhcHHHHHHHHHHhcCChhhCcCHH
Confidence 999999876665555555444333222 12345789999999999999999999
Q ss_pred HHHHH
Q 002738 869 DLYEM 873 (886)
Q Consensus 869 EILeh 873 (886)
++++|
T Consensus 253 ~il~~ 257 (260)
T cd08222 253 EILRN 257 (260)
T ss_pred HHhhC
Confidence 99987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=314.70 Aligned_cols=292 Identities=22% Similarity=0.259 Sum_probs=202.9
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
.+|.+.+.||.|+||.||+|.. .+..+++|....+.. ...+ .+.+|+.++++++||||+++++++.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~----~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVK----HALREIKIIRRLDHDNIVKVYEVLGPSGS 76 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHH----HHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence 6899999999999999999987 466788888654432 1222 33789999999999999999988765431
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
....+..........++||||++ ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~ 149 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT 149 (342)
T ss_pred ccccccccccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC
Confidence 00000000111235799999997 599888864 45889999999999999999999999999999999999975
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
++ ..+||+|||++......... ........++..|+|||++.. ...++.++|||||||++|+|+
T Consensus 150 ~~------~~~kl~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwSlGvil~el~ 213 (342)
T cd07854 150 ED------LVLKIGDFGLARIVDPHYSH-------KGYLSEGLVTKWYRSPRLLLS---PNNYTKAIDMWAAGCIFAEML 213 (342)
T ss_pred CC------ceEEECCcccceecCCcccc-------ccccccccccccccCHHHHhC---ccccCchhhHHHHHHHHHHHH
Confidence 42 46899999999765332111 001122357889999998754 245788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccC--CCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG--SGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
+|+.||.+..+......+........................... ...+........+..+.+||.+||..||.+|||
T Consensus 214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 293 (342)
T cd07854 214 TGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293 (342)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccC
Confidence 999999888776665555443221111111111000000000000 000001111234567899999999999999999
Q ss_pred HHHHHHH
Q 002738 867 AGDLYEM 873 (886)
Q Consensus 867 A~EILeh 873 (886)
+.+++.|
T Consensus 294 ~~ell~h 300 (342)
T cd07854 294 AEEALMH 300 (342)
T ss_pred HHHHhCC
Confidence 9999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=303.77 Aligned_cols=254 Identities=28% Similarity=0.460 Sum_probs=203.8
Q ss_pred CCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
....|++...||+|+||.||++.+. +..+++|+...... ..+ .+.+|+.+++.++|+||+++++.+...
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~ 87 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKE----LIINEILIMKDCKHPNIVDYYDSYLVG 87 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHH----HHHHHHHHHHHCCCCCeeEEEEEEEEC
Confidence 4567899999999999999999984 77899998754321 222 348899999999999999999998865
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
. ..++||||+++++|.+++... ...+++..+..++.||+.||+|||+.||+|+||+|+||++
T Consensus 88 ~--------------~~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i 149 (286)
T cd06614 88 D--------------ELWVVMEYMDGGSLTDIITQN----FVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL 149 (286)
T ss_pred C--------------EEEEEEeccCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE
Confidence 4 479999999999999999862 1368999999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +.++|+|||++......... .....++..|+|||++.+ ..++.++|||||||++|+
T Consensus 150 ~~~-------~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slGvil~~ 208 (286)
T cd06614 150 SKD-------GSVKLADFGFAAQLTKEKSK----------RNSVVGTPYWMAPEVIKR----KDYGPKVDIWSLGIMCIE 208 (286)
T ss_pred cCC-------CCEEECccchhhhhccchhh----------hccccCCcccCCHhHhcC----CCCCCccccHHHHHHHHH
Confidence 876 46999999988654332110 122357889999999875 567899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 787 LLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
|++|+.||...++......+.....+.+.. ....+..+.+||.+||+.+|.+||+
T Consensus 209 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~~p~~Rpt 263 (286)
T cd06614 209 MAEGEPPYLREPPLRALFLITTKGIPPLKN-------------------------PEKWSPEFKDFLNKCLVKDPEKRPS 263 (286)
T ss_pred HHhCCCCCCCCCHHHHHHHHHhcCCCCCcc-------------------------hhhCCHHHHHHHHHHhccChhhCcC
Confidence 999999998777665555544332222110 0113457899999999999999999
Q ss_pred HHHHHHHHH
Q 002738 867 AGDLYEMFV 875 (886)
Q Consensus 867 A~EILehLe 875 (886)
+.+|++|..
T Consensus 264 ~~~il~~~~ 272 (286)
T cd06614 264 AEELLQHPF 272 (286)
T ss_pred HHHHhhChH
Confidence 999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=305.99 Aligned_cols=292 Identities=21% Similarity=0.216 Sum_probs=204.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
...++|++.+.||+|+||.||+|.+ .+..+++|+......... ....+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~------~~~~~~~e~~~~~~l~h~~i~~~~~~~~~ 77 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG------FPITAIREIKILRQLNHRNIVNLKEIVTD 77 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccC------chHHHHHHHHHHHhCCCCCeeeeeheecC
Confidence 3467899999999999999999997 467889998754432111 11234789999999999999999999876
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
.... ..........++||||+++ +|..++.. ....+++..++.++.||+.||+|||+.||+||||||+||+
T Consensus 78 ~~~~----~~~~~~~~~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nil 148 (302)
T cd07864 78 KQDA----LDFKKDKGAFYLVFEYMDH-DLMGLLES----GLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNIL 148 (302)
T ss_pred cchh----hhccccCCcEEEEEcccCc-cHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 4310 0000112257999999985 88887764 2346899999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.+ +.+||+|||++......... ......++..|+|||++.+ ...++.++|||||||++|
T Consensus 149 i~~~-------~~~kl~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~---~~~~~~~~Di~slG~~~~ 209 (302)
T cd07864 149 LNNK-------GQIKLADFGLARLYNSEESR---------PYTNKVITLWYRPPELLLG---EERYGPAIDVWSCGCILG 209 (302)
T ss_pred ECCC-------CcEEeCcccccccccCCccc---------ccccceeccCccChHHhcC---CCCCCchhHHHHHHHHHH
Confidence 9877 56999999999766432211 0112246788999998864 234688999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCC--CCCchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG--FEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
||++|++||...+.......+........+..++.+.........+.... ..........+..+.+|+.+||..+|.+
T Consensus 210 el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 289 (302)
T cd07864 210 ELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSK 289 (302)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhh
Confidence 99999999987776665555544322121211111100000000000000 0000011123567999999999999999
Q ss_pred CCCHHHHHHH
Q 002738 864 RPTAGDLYEM 873 (886)
Q Consensus 864 RPSA~EILeh 873 (886)
||++.++++|
T Consensus 290 Rp~~~~il~~ 299 (302)
T cd07864 290 RCTAEEALNS 299 (302)
T ss_pred CCCHHHHhcC
Confidence 9999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=312.20 Aligned_cols=281 Identities=20% Similarity=0.233 Sum_probs=203.4
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
-++|++.+.||+|+||.||+|.. .+..||+|+..... .... ....+.+|+.+|++++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF--QSEL----FAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc--cchH----HHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 46799999999999999999986 56789999864221 1111 2234489999999999999999999987554
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
.+ ......++||||+ +++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 88 ~~--------~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~ 152 (343)
T cd07880 88 SL--------DRFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN 152 (343)
T ss_pred cc--------cccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc
Confidence 21 1123469999999 6799988864 4689999999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ +.++|+|||++....... ....+++.|+|||++.+ ...++.++||||||+++|+|
T Consensus 153 ~~-------~~~kl~dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~ll~~l 209 (343)
T cd07880 153 ED-------CELKILDFGLARQTDSEM-------------TGYVVTRWYRAPEVILN---WMHYTQTVDIWSVGCIMAEM 209 (343)
T ss_pred CC-------CCEEEeecccccccccCc-------------cccccCCcccCHHHHhC---CCCCCcHHHHHHHHHHHHHH
Confidence 76 469999999987543211 22357889999999864 23478899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCC---CchhhhhhHHHHHHHHHHhcccCCCCC
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE---KPEAELETLSFLVDVFRRCTEENPTER 864 (886)
Q Consensus 788 LTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~L~dLL~rCL~~DP~kR 864 (886)
++|..||.+.+.......+..............+................ ........++.+.++|.+||..||.+|
T Consensus 210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 289 (343)
T cd07880 210 LTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESR 289 (343)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhC
Confidence 99999998877655555444432222121111111100000000000000 011122345678999999999999999
Q ss_pred CCHHHHHHHH
Q 002738 865 PTAGDLYEMF 874 (886)
Q Consensus 865 PSA~EILehL 874 (886)
||+.++++|-
T Consensus 290 ~t~~~~l~~~ 299 (343)
T cd07880 290 ITAAEALAHP 299 (343)
T ss_pred CCHHHHhcCc
Confidence 9999999873
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=307.00 Aligned_cols=288 Identities=19% Similarity=0.201 Sum_probs=199.5
Q ss_pred ceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCC
Q 002738 553 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 632 (886)
Q Consensus 553 Y~i~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~ 632 (886)
|.+.+.+|.|+++.||++...+..+|+|+..... ......+. +.+|+.+++.++||||+++++++....
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~----~~~Ei~~l~~l~h~~i~~~~~~~~~~~----- 72 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS--CSKEDLKL----LQQEIITSRQLQHPNILPYVTSFIVDS----- 72 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccc--cchhHHHH----HHHHHHHHHhcCCcchhhhhheeecCC-----
Confidence 3456667777777888887788999999975432 22233333 489999999999999999999988655
Q ss_pred CCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccC
Q 002738 633 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 712 (886)
Q Consensus 633 ~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~ 712 (886)
..+++|||+++++|.+++... ....+++..+..++.||+.||+|||+++|+||||||+|||++.+
T Consensus 73 ---------~~~~~~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~--- 137 (314)
T cd08216 73 ---------ELYVVSPLMAYGSCEDLLKTH---FPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD--- 137 (314)
T ss_pred ---------eEEEEEeccCCCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC---
Confidence 369999999999999999862 22358899999999999999999999999999999999999876
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 002738 713 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 792 (886)
Q Consensus 713 ~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~ 792 (886)
+.+||+|||.+.......... ...........++..|+|||++... ...++.++|||||||++|||++|..
T Consensus 138 ----~~~kl~d~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Diws~G~il~el~~g~~ 208 (314)
T cd08216 138 ----GKVVLSGLRYSVSMIKHGKRQ---RVVHDFPKSSVKNLPWLSPEVLQQN--LQGYNEKSDIYSVGITACELANGHV 208 (314)
T ss_pred ----CceEEecCccceeeccccccc---cccccccccccccccccCHHHhcCC--CCCCCcchhHHHHHHHHHHHHhCCC
Confidence 459999999987654322110 0001112334578899999998751 1347889999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCc-hhH-Hhhhc-ccccc--ccccc-CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 793 PYMGLSELEIHDLIQMGKRPRL-TDE-LEALG-SCHEH--EVAQS-GSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 793 PF~g~s~~el~~~I~~~~rp~l-~~~-l~~~~-~~~~~--~~~~~-~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
||..............+..+.+ ... ..... ..... ..... .............+..+.+|+.+||..||++|||
T Consensus 209 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 288 (314)
T cd08216 209 PFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS 288 (314)
T ss_pred CCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcC
Confidence 9987655443322222211110 000 00000 00000 00000 0000011112234568899999999999999999
Q ss_pred HHHHHHHHH
Q 002738 867 AGDLYEMFV 875 (886)
Q Consensus 867 A~EILehLe 875 (886)
+.++++|..
T Consensus 289 ~~~ll~~p~ 297 (314)
T cd08216 289 ASQLLNHSF 297 (314)
T ss_pred HHHHhcCch
Confidence 999999844
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=309.59 Aligned_cols=285 Identities=20% Similarity=0.245 Sum_probs=202.5
Q ss_pred CceeeeeecccCceEEEEEEEC----CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEecC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 626 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~~----~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~~~ 626 (886)
+|++.+.||+|+||.||++++. +..+|+|...... ..... .+.+.+|+.+++++. ||||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 74 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF--SKKIL----AKRALRELKLLRHFRGHKNITCLYDMDIVF 74 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc--ccchh----HHHHHHHHHHHHHhcCCCChheeeeeeeec
Confidence 5889999999999999999974 4578998854221 11111 223488999999995 99999999876532
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
.. .....+++|||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 75 ~~----------~~~~~~~~~e~~~-~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili 138 (332)
T cd07857 75 PG----------NFNELYLYEELME-ADLHQIIRS-----GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV 138 (332)
T ss_pred cc----------cCCcEEEEEeccc-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE
Confidence 11 1224689999996 699999864 3568999999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +.+||+|||++..+...... .........||+.|+|||++.+ ...++.++|||||||++|+
T Consensus 139 ~~~-------~~~kl~Dfg~a~~~~~~~~~------~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~~Di~slGv~l~~ 202 (332)
T cd07857 139 NAD-------CELKICDFGLARGFSENPGE------NAGFMTEYVATRWYRAPEIMLS---FQSYTKAIDVWSVGCILAE 202 (332)
T ss_pred cCC-------CCEEeCcCCCceeccccccc------ccccccCcccCccccCcHHHhC---CCCCCcHHHHHHHHHHHHH
Confidence 877 46999999999866432211 0011223468999999999864 2457899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccC---CCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG---SGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 787 LLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
|++|.+||.+.+.......+.........+.+............... ............+..+.+|+.+||+.||.+
T Consensus 203 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 282 (332)
T cd07857 203 LLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTK 282 (332)
T ss_pred HHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCccc
Confidence 99999999888776666555544222222222111110000000000 000001111223567999999999999999
Q ss_pred CCCHHHHHHHH
Q 002738 864 RPTAGDLYEMF 874 (886)
Q Consensus 864 RPSA~EILehL 874 (886)
|||+.+++.|-
T Consensus 283 R~t~~~ll~~~ 293 (332)
T cd07857 283 RISVEEALEHP 293 (332)
T ss_pred CCCHHHHhcCh
Confidence 99999999884
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=312.64 Aligned_cols=286 Identities=23% Similarity=0.270 Sum_probs=205.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcceeeeeEe
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 624 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl~g~~~ 624 (886)
...++|++.+.||+|+||.||+|.+ .+..+++|...... ....... .+.+|+.+++++ +||||+++++++.
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~~----~~~~E~~~l~~l~~h~ni~~~~~~~~ 77 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF--RNATDAQ----RTFREIMFLQELGDHPNIVKLLNVIK 77 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc--Ccchhhh----hhhHHHHHHHHhcCCCCccceeeeec
Confidence 4567899999999999999999987 46778888753221 1112222 237899999999 9999999999886
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNI 704 (886)
.... ...++||||++ ++|..++.. ..+++..++.++.||+.||+|||+.||+||||||+||
T Consensus 78 ~~~~------------~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~ni 138 (337)
T cd07852 78 AEND------------KDIYLVFEYME-TDLHAVIRA------NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNI 138 (337)
T ss_pred cCCC------------ceEEEEecccc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 5431 24799999997 599998875 2678889999999999999999999999999999999
Q ss_pred EEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVIL 784 (886)
|++.+ +.+||+|||++.......... .........||..|+|||++.+ ...++.++||||||+++
T Consensus 139 ll~~~-------~~~kl~d~g~~~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~sDi~slG~~l 203 (337)
T cd07852 139 LLNSD-------CRVKLADFGLARSLSELEENP-----ENPVLTDYVATRWYRAPEILLG---STRYTKGVDMWSVGCIL 203 (337)
T ss_pred EEcCC-------CcEEEeeccchhccccccccc-----cCcchhcccccccccCceeeec---cccccccchHHHHHHHH
Confidence 99877 569999999998664432110 1111233468999999998864 24567899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccc---cCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 002738 785 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ---SGSGFEKPEAELETLSFLVDVFRRCTEENP 861 (886)
Q Consensus 785 yELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP 861 (886)
|+|++|+.||.+.........+...........+..+.......... ..............+..+.+||.+||+.||
T Consensus 204 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P 283 (337)
T cd07852 204 GEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNP 283 (337)
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCc
Confidence 99999999998877666555544332211111111110000000000 000000111122246789999999999999
Q ss_pred CCCCCHHHHHHH
Q 002738 862 TERPTAGDLYEM 873 (886)
Q Consensus 862 ~kRPSA~EILeh 873 (886)
.+|||+.++++|
T Consensus 284 ~~Rps~~~il~~ 295 (337)
T cd07852 284 NKRLTAEEALEH 295 (337)
T ss_pred ccccCHHHHhhC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=299.59 Aligned_cols=245 Identities=24% Similarity=0.279 Sum_probs=188.0
Q ss_pred eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHH-hhCCCCCcceeeeeEecCCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRML-GALRHSCIVEMYGHKISSKWLPSAD 633 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iL-k~L~HPNIVrl~g~~~~~~~l~~~~ 633 (886)
+.||.|+||.||+|.. .+..+|+|+....... ...... .+..|..++ ..+.||||+++++++....
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~-~~~~~~----~~~~e~~~~~~~~~~~~i~~~~~~~~~~~------ 70 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI-AKNQVT----NVKAERAIMMIQGESPYVAKLYYSFQSKD------ 70 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh-HHHHHH----HHHHHHHHHhhcCCCCCeeeeeeeEEcCC------
Confidence 5799999999999987 5678999986422110 111111 224555444 4557999999999998654
Q ss_pred CCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCC
Q 002738 634 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 713 (886)
Q Consensus 634 ~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~ 713 (886)
..|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+|+||||+|.|||++.+
T Consensus 71 --------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~---- 133 (260)
T cd05611 71 --------YLYLVMEYLNGGDCASLIKT-----LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT---- 133 (260)
T ss_pred --------eEEEEEeccCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC----
Confidence 36999999999999999975 2468899999999999999999999999999999999999876
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 002738 714 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 793 (886)
Q Consensus 714 ~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~P 793 (886)
..++|+|||++..... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..|
T Consensus 134 ---~~~~l~dfg~~~~~~~--------------~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~il~~l~~g~~p 192 (260)
T cd05611 134 ---GHLKLTDFGLSRNGLE--------------NKKFVGTPDYLAPETILG----VGDDKMSDWWSLGCVIFEFLFGYPP 192 (260)
T ss_pred ---CcEEEeecccceeccc--------------cccCCCCcCccChhhhcC----CCCcchhhhHHHHHHHHHHHHCCCC
Confidence 4699999999865432 122358899999999876 4578999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH---HHH
Q 002738 794 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA---GDL 870 (886)
Q Consensus 794 F~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA---~EI 870 (886)
|...+...+...+...... .+. ......+..+.+++.+||..+|++||++ +|+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~-~~~-----------------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 193 FHAETPDAVFDNILSRRIN-WPE-----------------------EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred CCCCCHHHHHHHHHhcccC-CCC-----------------------cccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 9888777766655443211 000 0001235578999999999999999955 677
Q ss_pred HHHH
Q 002738 871 YEMF 874 (886)
Q Consensus 871 LehL 874 (886)
+.|-
T Consensus 249 l~~~ 252 (260)
T cd05611 249 KSHP 252 (260)
T ss_pred HcCh
Confidence 7664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=291.65 Aligned_cols=254 Identities=32% Similarity=0.491 Sum_probs=199.4
Q ss_pred CceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
+|.+.+.||+|++|.||+|... +..+++|+...... .....+ .+.+|+.++++++||||+++++.+....
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD--SEEELE----ALEREIRILSSLQHPNIVRYYGSERDEE-- 72 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc--chHHHH----HHHHHHHHHHHcCCCCEeeEEEEEecCC--
Confidence 4788999999999999999984 77899998654322 122333 4489999999999999999999988651
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
....++||||+++++|.+++.. ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.+
T Consensus 73 ----------~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~ 137 (260)
T cd06606 73 ----------KNTLNIFLEYVSGGSLSSLLKK-----FGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD 137 (260)
T ss_pred ----------CCeEEEEEEecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC
Confidence 1247999999999999999986 2378999999999999999999999999999999999999886
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.++|+|||.+......... .......++..|+|||.+.. ...+.++||||||+++|+|++
T Consensus 138 -------~~~~l~d~~~~~~~~~~~~~--------~~~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slG~il~~l~~ 198 (260)
T cd06606 138 -------GVVKLADFGCAKRLGDIETG--------EGTGSVRGTPYWMAPEVIRG----EEYGRAADIWSLGCTVIEMAT 198 (260)
T ss_pred -------CCEEEcccccEEeccccccc--------ccccCCCCCccccCHhhhcC----CCCCchhhHHHHHHHHHHHHh
Confidence 46999999998876543211 00123458899999999876 457899999999999999999
Q ss_pred CCCCCCCCC-HHHHHHHHHc-CCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 790 LQVPYMGLS-ELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 790 G~~PF~g~s-~~el~~~I~~-~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
|..||.... .......+.. ...+.++ ...+..+.+||.+||..+|.+||++
T Consensus 199 g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~~i~~~l~~~p~~Rp~~ 251 (260)
T cd06606 199 GKPPWSELGNPMAALYKIGSSGEPPEIP---------------------------EHLSEEAKDFLRKCLRRDPKKRPTA 251 (260)
T ss_pred CCCCCCCCCchHHHHHhccccCCCcCCC---------------------------cccCHHHHHHHHHhCcCChhhCCCH
Confidence 999997765 2222222221 1111111 1124579999999999999999999
Q ss_pred HHHHHHH
Q 002738 868 GDLYEMF 874 (886)
Q Consensus 868 ~EILehL 874 (886)
.+++.|-
T Consensus 252 ~~ll~~~ 258 (260)
T cd06606 252 DELLQHP 258 (260)
T ss_pred HHHhhCC
Confidence 9999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=306.92 Aligned_cols=257 Identities=26% Similarity=0.403 Sum_probs=201.3
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
..|...+.||+|+||.||++++ .+..+|+|+...... ...... ..+.+|+.++++++||||+++++++....
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~-~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 98 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKW----QDIIKEVKFLQRIKHPNSIEYKGCYLREH- 98 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-CchHHH----HHHHHHHHHHHhCCCCCEEEEEEEEeeCC-
Confidence 4588899999999999999997 567788887643211 122222 23488999999999999999999988654
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
..++||||+. |+|.+++.. ....+++..+..++.||+.||.|||++||+||||+|+||+++.
T Consensus 99 -------------~~~lv~e~~~-g~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~ 160 (317)
T cd06635 99 -------------TAWLVMEYCL-GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE 160 (317)
T ss_pred -------------eEEEEEeCCC-CCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECC
Confidence 3699999997 588887764 1345889999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.++|+|||++...... ....|++.|+|||++.... ...++.++|||||||++|||+
T Consensus 161 ~-------~~~kl~dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~~~-~~~~~~~~Dv~slGvil~el~ 218 (317)
T cd06635 161 P-------GQVKLADFGSASIASPA--------------NSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELA 218 (317)
T ss_pred C-------CCEEEecCCCccccCCc--------------ccccCCccccChhhhhcCC-CCCCCccccHHHHHHHHHHHH
Confidence 6 46999999988654321 2235889999999985321 245788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~ 868 (886)
+|+.||...........+.....+.... ...+..+.+|+.+||+.+|.+||++.
T Consensus 219 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~~p~~Rpt~~ 272 (317)
T cd06635 219 ERKPPLFNMNAMSALYHIAQNESPTLQS--------------------------NEWSDYFRNFVDSCLQKIPQDRPTSE 272 (317)
T ss_pred hCCCCCCCccHHHHHHHHHhccCCCCCC--------------------------ccccHHHHHHHHHHccCCcccCcCHH
Confidence 9999998877666665555443222110 11245689999999999999999999
Q ss_pred HHHHHHHhhcC
Q 002738 869 DLYEMFVARTS 879 (886)
Q Consensus 869 EILehLe~l~s 879 (886)
++++|+.....
T Consensus 273 ~il~~~~~~~~ 283 (317)
T cd06635 273 ELLKHMFVLRE 283 (317)
T ss_pred HHHhChhhhcc
Confidence 99999765543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=311.81 Aligned_cols=299 Identities=17% Similarity=0.199 Sum_probs=205.0
Q ss_pred CCCCce-eeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHH------hhhHhHHHHHHHHhhCCCCCccee
Q 002738 549 SFPSLS-SCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIR------NFEYSCLGEVRMLGALRHSCIVEM 619 (886)
Q Consensus 549 ~~~~Y~-i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k------~f~~~~lrEI~iLk~L~HPNIVrl 619 (886)
.-++|. +.+.||.|+||.||+|.+ .+..+|+|+.............. .+...+.+|+.+++.++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 345676 457799999999999986 56789999875432221110000 111235789999999999999999
Q ss_pred eeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 002738 620 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 699 (886)
Q Consensus 620 ~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDL 699 (886)
++++..... .++||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+|+||
T Consensus 86 ~~~~~~~~~--------------~~lv~e~~~-~~l~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl 145 (335)
T PTZ00024 86 VDVYVEGDF--------------INLVMDIMA-SDLKKVVDR-----KIRLTESQVKCILLQILNGLNVLHKWYFMHRDL 145 (335)
T ss_pred eEEEecCCc--------------EEEEEeccc-cCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 999886553 699999997 699999875 356899999999999999999999999999999
Q ss_pred CCCCEEEeccccCCCCCCeEEEeecCCccccccccccccccc----CCCCCCCcccCCCcccchhhhhcccCCCCCCchh
Q 002738 700 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH----RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 775 (886)
Q Consensus 700 KPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~----~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KS 775 (886)
||+|||++.+ +.++|+|||++.............. ..........+++.|+|||++.+ ...++.++
T Consensus 146 ~~~nill~~~-------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~ 215 (335)
T PTZ00024 146 SPANIFINSK-------GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG---AEKYHFAV 215 (335)
T ss_pred cHHHeEECCC-------CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhccc---CCCCCcHH
Confidence 9999999876 4699999999976652111100000 00011122347889999999875 23468899
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHH
Q 002738 776 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 855 (886)
Q Consensus 776 DIWSLGVILyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~r 855 (886)
|||||||++|||++|..||.+.+..+....+...........+...........................+..+.+||.+
T Consensus 216 Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 295 (335)
T PTZ00024 216 DMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQS 295 (335)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHH
Confidence 99999999999999999999887766655554321111111111000000000000000000011112335678999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhh
Q 002738 856 CTEENPTERPTAGDLYEMFVAR 877 (886)
Q Consensus 856 CL~~DP~kRPSA~EILehLe~l 877 (886)
||..+|++||++++++.|..-.
T Consensus 296 ~l~~~P~~R~s~~~~l~~~~~~ 317 (335)
T PTZ00024 296 LLKLNPLERISAKEALKHEYFK 317 (335)
T ss_pred HcCCCchhccCHHHHhcCcccC
Confidence 9999999999999999986543
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=302.54 Aligned_cols=248 Identities=25% Similarity=0.333 Sum_probs=188.6
Q ss_pred ecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCC
Q 002738 559 AGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 636 (886)
Q Consensus 559 LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~~~~ 636 (886)
||+|+||.||+|.. .+..+++|+........ ......+.+|+.+|+.++||||+++++++....
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------- 66 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK-----RKGEQMALNEKKILEKVSSRFIVSLAYAFETKD--------- 66 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh-----hhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC---------
Confidence 69999999999986 46789999865322111 111223478999999999999999999987654
Q ss_pred CcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCCCC
Q 002738 637 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 716 (886)
Q Consensus 637 ~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~~ 716 (886)
..|+||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||+|+|||++.+
T Consensus 67 -----~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~------- 131 (277)
T cd05577 67 -----DLCLVMTLMNGGDLKYHIYNV---GEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDH------- 131 (277)
T ss_pred -----eEEEEEecCCCCcHHHHHHHc---CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-------
Confidence 369999999999999999762 22368999999999999999999999999999999999999877
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 002738 717 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 796 (886)
Q Consensus 717 ~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF~g 796 (886)
+.++|+|||.+........ .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 132 ~~~~l~dfg~~~~~~~~~~-----------~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~il~~l~~g~~p~~~ 196 (277)
T cd05577 132 GNVRISDLGLAVELKGGKK-----------IKGRAGTPGYMAPEVLQG----EVYDFSVDWFALGCTLYEMIAGRSPFRQ 196 (277)
T ss_pred CCEEEccCcchhhhccCCc-----------cccccCCCCcCCHHHhcC----CCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 4699999999876533111 122357889999999876 5578999999999999999999999976
Q ss_pred CCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 002738 797 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGDLY 871 (886)
Q Consensus 797 ~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP-----SA~EIL 871 (886)
.........+....... + .......++.+.++|.+||+.||.+|| ++.+++
T Consensus 197 ~~~~~~~~~~~~~~~~~-~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll 252 (277)
T cd05577 197 RKEKVEKEELKRRTLEM-A-----------------------VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVR 252 (277)
T ss_pred CcccccHHHHHhccccc-c-----------------------ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHH
Confidence 54321111221111000 0 000112355789999999999999999 888898
Q ss_pred HHH
Q 002738 872 EMF 874 (886)
Q Consensus 872 ehL 874 (886)
+|.
T Consensus 253 ~h~ 255 (277)
T cd05577 253 EHP 255 (277)
T ss_pred hCh
Confidence 873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=307.91 Aligned_cols=285 Identities=20% Similarity=0.268 Sum_probs=195.9
Q ss_pred eeeeccc--CceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCC
Q 002738 556 CDEAGKS--VSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 631 (886)
Q Consensus 556 ~k~LG~G--~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~ 631 (886)
...||.| +||+||+|++ .+..||+|+..... ......+ .+.+|+.+++.++||||+++++++.....
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~--~~~~~~~----~~~~e~~~~~~l~h~niv~~~~~~~~~~~--- 73 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLEN--CTEEHLK----ALQNEVVLSHFFRHPNIMTSWTVFTTGSW--- 73 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEecccc--CCHHHHH----HHHHHHHHHHhCCCCCcceEeeeEecCCc---
Confidence 3456666 9999999997 67899999975432 2222333 44889999999999999999999987653
Q ss_pred CCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecccc
Q 002738 632 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 711 (886)
Q Consensus 632 ~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~ 711 (886)
.++||||+.+++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 74 -----------~~~v~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~-- 137 (328)
T cd08226 74 -----------LWVISPFMAYGSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD-- 137 (328)
T ss_pred -----------eEEEEecccCCCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCC--
Confidence 599999999999999998632 2358899999999999999999999999999999999999877
Q ss_pred CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCC
Q 002738 712 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 791 (886)
Q Consensus 712 ~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~ 791 (886)
+.++++||+.+............ .........++..|+|||++.+. ...++.++|||||||++|+|++|+
T Consensus 138 -----~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~DiwslG~~l~el~~g~ 207 (328)
T cd08226 138 -----GLVSLSGLSHLYSLVRNGQKAKV---VYDFPQFSTSVLPWLSPELLRQD--LYGYNVKSDIYSVGITACELATGR 207 (328)
T ss_pred -----CcEEEechHHHhhhhccCccccc---cccccccccCccCccChhhhcCC--CCCCCchhhHHHHHHHHHHHHhCC
Confidence 46999999865433221111000 00011122356789999998751 134688999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCC-CCch-----hHHhhhccc--------cccccc-----ccCCCCCCchhhhhhHHHHHHH
Q 002738 792 VPYMGLSELEIHDLIQMGKR-PRLT-----DELEALGSC--------HEHEVA-----QSGSGFEKPEAELETLSFLVDV 852 (886)
Q Consensus 792 ~PF~g~s~~el~~~I~~~~r-p~l~-----~~l~~~~~~--------~~~~~~-----~~~~~~~~~~~~~~~s~~L~dL 852 (886)
.||................. ..+. ......... ...... ...............++.+.+|
T Consensus 208 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 287 (328)
T cd08226 208 VPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNL 287 (328)
T ss_pred CCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHH
Confidence 99987765544333332211 0000 000000000 000000 0000000111223456789999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHH
Q 002738 853 FRRCTEENPTERPTAGDLYEMFV 875 (886)
Q Consensus 853 L~rCL~~DP~kRPSA~EILehLe 875 (886)
|.+||..||.+|||+.++++|..
T Consensus 288 i~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 288 VELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred HHHHccCCcccCCCHHHHhhCHH
Confidence 99999999999999999998843
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=299.31 Aligned_cols=261 Identities=24% Similarity=0.306 Sum_probs=203.1
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEecCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 627 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~~~~ 627 (886)
++|.+.+.||.|+||.||+|.. .+..+++|+....... ..... ..+.+|+.++.++. ||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-KEKKV----KYVKIEKEVLTRLNGHPGIIKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc-chHHH----HHHHHHHHHHHhcccCCCchhHHHHhcCCc
Confidence 4799999999999999999997 6788999987542211 11122 34488999999999 999999999887554
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
..++||||+++++|.+++.. ...+++..++.|+.||+.||.|||+.|++|+||+|+||+++
T Consensus 76 --------------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~ 136 (280)
T cd05581 76 --------------NLYFVLEYAPNGELLQYIRK-----YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD 136 (280)
T ss_pred --------------eEEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC
Confidence 36999999999999999986 24689999999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCccccccccccccc----------ccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCI----------AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 777 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~----------~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDI 777 (886)
.+ +.++|+|||++............ ............++..|+|||++.. ..++.++||
T Consensus 137 ~~-------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~----~~~~~~~Di 205 (280)
T cd05581 137 KD-------MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE----KPAGKSSDL 205 (280)
T ss_pred CC-------CCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC----CCCChhhhH
Confidence 76 45999999999876543321000 0000112234468899999999875 557889999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 002738 778 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 857 (886)
Q Consensus 778 WSLGVILyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL 857 (886)
||||+++|+|++|+.||...........+..... .++ ...++.+.+||.+||
T Consensus 206 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~li~~~l 257 (280)
T cd05581 206 WALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY-SFP---------------------------PNFPPDAKDLIEKLL 257 (280)
T ss_pred HHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC-CCC---------------------------CccCHHHHHHHHHHh
Confidence 9999999999999999988776555544432211 111 112457899999999
Q ss_pred ccCCCCCCCH----HHHHHHH
Q 002738 858 EENPTERPTA----GDLYEMF 874 (886)
Q Consensus 858 ~~DP~kRPSA----~EILehL 874 (886)
+.+|.+||++ .++++|.
T Consensus 258 ~~~p~~R~~~~~~~~~ll~~~ 278 (280)
T cd05581 258 VLDPQDRLGVNEGYDELKAHP 278 (280)
T ss_pred cCCHhhCCCcccCHHHHhcCC
Confidence 9999999999 8998773
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.43 Aligned_cols=275 Identities=23% Similarity=0.292 Sum_probs=202.4
Q ss_pred ceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCC
Q 002738 553 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 630 (886)
Q Consensus 553 Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~ 630 (886)
|++.+.||.|++|.||+|.. ++..+++|....... .... ...+.+|+.++++++||||+++++++....
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 71 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE--SEGI----PKTALREIKLLKELNHPNIIKLLDVFRHKG--- 71 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc--cchh----HHHHHHHHHHHHHhcCCCcchHHHhhccCC---
Confidence 67789999999999999987 567788887643322 1111 234488999999999999999999987554
Q ss_pred CCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccc
Q 002738 631 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 710 (886)
Q Consensus 631 ~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~ 710 (886)
..++||||++ ++|.+++.. ....+++..+..++.||+.||.|||+++|+|+||||+||+++.+
T Consensus 72 -----------~~~~v~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~- 134 (283)
T cd05118 72 -----------DLYLVFEFMD-TDLYKLIKD----RQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE- 134 (283)
T ss_pred -----------CEEEEEeccC-CCHHHHHHh----hcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCC-
Confidence 3699999997 599888875 12468999999999999999999999999999999999999876
Q ss_pred cCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 002738 711 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 790 (886)
Q Consensus 711 ~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG 790 (886)
+.++|+|||.+......... .....++..|+|||.+.+ ...++.++||||||+++|+|++|
T Consensus 135 ------~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~~~~PE~~~~---~~~~~~~~Di~slG~~l~~l~tg 195 (283)
T cd05118 135 ------GVLKLADFGLARSFGSPVRP----------YTHYVVTRWYRAPELLLG---DKGYSTPVDIWSVGCIFAELLSR 195 (283)
T ss_pred ------CcEEEeeeeeeEecCCCccc----------ccCccCcccccCcHHHhc---CCCCCchhHHHHHHHHHHHHHhC
Confidence 46999999998766443210 122357889999999875 23678999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccc---ccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 791 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC---HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 791 ~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~---~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
+.||...+..+....+........+..+...... ....+.. .............+..+.+||.+||.+||.+||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~ 274 (283)
T cd05118 196 RPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK-KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITA 274 (283)
T ss_pred CCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcc-ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCH
Confidence 9999887776655554433222222221111100 0000000 00001112233457789999999999999999999
Q ss_pred HHHHHH
Q 002738 868 GDLYEM 873 (886)
Q Consensus 868 ~EILeh 873 (886)
.+++.|
T Consensus 275 ~~ll~~ 280 (283)
T cd05118 275 EQALAH 280 (283)
T ss_pred HHHhhC
Confidence 999987
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=311.12 Aligned_cols=282 Identities=20% Similarity=0.220 Sum_probs=202.7
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
.+|.+.+.||+|+||.||+|.+ .+..+|+|+...... .. .+...+.+|+.+++.++||||+++++++.....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 88 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ--SE----IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS 88 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc--cc----cchhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence 5899999999999999999986 567899998643211 11 112234889999999999999999999875432
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
. ......++||||+. .+|..++. ..+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 89 ~--------~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~ 152 (342)
T cd07879 89 G--------DEFQDFYLVMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNE 152 (342)
T ss_pred C--------CCCceEEEEecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC
Confidence 1 11234699999996 57777652 35889999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.+||+|||+++..... .....++..|+|||++.+ ...++.++|||||||++|||+
T Consensus 153 ~-------~~~kL~dfg~~~~~~~~-------------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slGvil~el~ 209 (342)
T cd07879 153 D-------CELKILDFGLARHADAE-------------MTGYVVTRWYRAPEVILN---WMHYNQTVDIWSVGCIMAEML 209 (342)
T ss_pred C-------CCEEEeeCCCCcCCCCC-------------CCCceeeecccChhhhcC---ccccCchHHHHHHHHHHHHHH
Confidence 7 46999999998754221 122357889999999864 235788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCC---CchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE---KPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
+|+.||.+.+.......+........+...................... ........+..+.+||.+||+.||.+||
T Consensus 210 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 289 (342)
T cd07879 210 TGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRL 289 (342)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCc
Confidence 9999999887666655555433222222221111000000000000000 0011123456789999999999999999
Q ss_pred CHHHHHHH--HHhh
Q 002738 866 TAGDLYEM--FVAR 877 (886)
Q Consensus 866 SA~EILeh--Le~l 877 (886)
++.+++.| ++..
T Consensus 290 ~~~e~l~h~~f~~~ 303 (342)
T cd07879 290 TATEALEHPYFDSF 303 (342)
T ss_pred CHHHHhcCcchhhc
Confidence 99999988 5444
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=302.24 Aligned_cols=244 Identities=22% Similarity=0.284 Sum_probs=182.6
Q ss_pred eecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHH---HhhCCCCCcceeeeeEecCCCCCCC
Q 002738 558 EAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRM---LGALRHSCIVEMYGHKISSKWLPSA 632 (886)
Q Consensus 558 ~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~i---Lk~L~HPNIVrl~g~~~~~~~l~~~ 632 (886)
.||+|+||.||++.. .+..+|+|+........... ...+ .+|..+ +....||||+.+++++...+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~i~~~~~~~~~~~----- 70 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLA----LNERIMLSLVSTGDCPFIVCMTYAFHTPD----- 70 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH-HHHH----HHHHHHHHHHhhCCCCcEeEEEEEEecCC-----
Confidence 489999999999997 46789999865433222111 1111 344433 34457999999999988654
Q ss_pred CCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccC
Q 002738 633 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 712 (886)
Q Consensus 633 ~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~ 712 (886)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.+
T Consensus 71 ---------~~~lv~e~~~~~~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~--- 133 (279)
T cd05633 71 ---------KLCFILDLMNGGDLHYHLSQ-----HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEH--- 133 (279)
T ss_pred ---------eEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCC---
Confidence 36999999999999999875 3468999999999999999999999999999999999999876
Q ss_pred CCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 002738 713 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 792 (886)
Q Consensus 713 ~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~ 792 (886)
..++|+|||++....... .....||+.|+|||++.. ...++.++|||||||++|+|++|..
T Consensus 134 ----~~~~l~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~~l~~l~~g~~ 194 (279)
T cd05633 134 ----GHVRISDLGLACDFSKKK------------PHASVGTHGYMAPEVLQK---GTAYDSSADWFSLGCMLFKLLRGHS 194 (279)
T ss_pred ----CCEEEccCCcceeccccC------------ccCcCCCcCccCHHHhcC---CCCCCchhhhHHHHHHHHHHHhCCC
Confidence 469999999986543211 112358999999999863 2457889999999999999999999
Q ss_pred CCCCCCHHHH--HHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----
Q 002738 793 PYMGLSELEI--HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP----- 865 (886)
Q Consensus 793 PF~g~s~~el--~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP----- 865 (886)
||........ ...........+ ....+..+.++|.+||..||.+||
T Consensus 195 pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 247 (279)
T cd05633 195 PFRQHKTKDKHEIDRMTLTVNVEL---------------------------PDSFSPELKSLLEGLLQRDVSKRLGCLGR 247 (279)
T ss_pred CcCCCCCcCHHHHHHHhhcCCcCC---------------------------ccccCHHHHHHHHHHhcCCHHHhcCCCCC
Confidence 9975432211 111111111111 112355789999999999999999
Q ss_pred CHHHHHHHH
Q 002738 866 TAGDLYEMF 874 (886)
Q Consensus 866 SA~EILehL 874 (886)
++.++++|.
T Consensus 248 ~~~~~~~h~ 256 (279)
T cd05633 248 GAQEVKEHV 256 (279)
T ss_pred CHHHHHhCc
Confidence 699999983
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=297.72 Aligned_cols=276 Identities=23% Similarity=0.284 Sum_probs=204.4
Q ss_pred ceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCC
Q 002738 553 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 630 (886)
Q Consensus 553 Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~ 630 (886)
|++.+.||+|+||.||+|+. .+..+++|+...... .. .+...+.+|+.++++++||||+++++++....
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--- 71 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE--EE----GIPSTALREISLLKELKHPNIVKLLDVIHTER--- 71 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc--cc----cccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC---
Confidence 67789999999999999997 468899998754421 11 12223478999999999999999999987654
Q ss_pred CCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccc
Q 002738 631 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 710 (886)
Q Consensus 631 ~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~ 710 (886)
..++||||++ ++|.+++... ...+++..+..++.|++.||+|||++||+||||+|+||+++.+
T Consensus 72 -----------~~~~v~e~~~-~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~- 134 (282)
T cd07829 72 -----------KLYLVFEYCD-MDLKKYLDKR----PGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD- 134 (282)
T ss_pred -----------ceEEEecCcC-cCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCC-
Confidence 3699999998 5999999861 1468999999999999999999999999999999999999886
Q ss_pred cCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 002738 711 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 790 (886)
Q Consensus 711 ~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG 790 (886)
+.++|+|||++......... .....++..|+|||++.+ ...++.++|||||||++|||++|
T Consensus 135 ------~~~~l~d~g~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Dv~slG~~l~~l~~~ 195 (282)
T cd07829 135 ------GVLKLADFGLARAFGIPLRT----------YTHEVVTLWYRAPEILLG---SKHYSTAVDIWSVGCIFAEMITG 195 (282)
T ss_pred ------CCEEEecCCcccccCCCccc----------cCccccCcCcCChHHhcC---CcCCCccccHHHHHHHHHHHHhC
Confidence 56999999998765432211 122346788999999875 23678899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccc--cccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 002738 791 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH--EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868 (886)
Q Consensus 791 ~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~ 868 (886)
..||.+.+.......+........+..+....... ...+.... ...........+..+.++|.+||..||.+||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~ 274 (282)
T cd07829 196 KPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFP-PKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAK 274 (282)
T ss_pred CCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccC-ccchHHhcccccHHHHHHHHHhhccCcccCCCHH
Confidence 99998887766665555443333333332221111 00000000 0000111122356799999999999999999999
Q ss_pred HHHHHH
Q 002738 869 DLYEMF 874 (886)
Q Consensus 869 EILehL 874 (886)
+++.|-
T Consensus 275 ~~l~~p 280 (282)
T cd07829 275 EALKHP 280 (282)
T ss_pred HHhhCc
Confidence 999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=313.93 Aligned_cols=271 Identities=22% Similarity=0.328 Sum_probs=209.6
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHh--hCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLG--ALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk--~L~HPNIVrl~g~~~~ 625 (886)
..+...++.+.||+|.||.||+|...++.||||++.. .+.+.| ..|-.|.+ .++|+||++|+++-..
T Consensus 207 ~~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~-------~~kqs~----~~Ek~Iy~lp~m~h~nIl~Fi~~ekr 275 (534)
T KOG3653|consen 207 LELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE-------QEKQSF----QNEKNIYSLPGMKHENILQFIGAEKR 275 (534)
T ss_pred ccCCchhhHHHhhcCccceeehhhccCceeEEEecCH-------HHHHHH----HhHHHHHhccCccchhHHHhhchhcc
Confidence 3466778899999999999999999999999999753 233344 66666654 5679999999987543
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhC---------Cccc
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---------HIMH 696 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~---------gIVH 696 (886)
... .....+||++|.+.|+|.+||+. ..++|....+|+..|++||+|||.. .|+|
T Consensus 276 ~t~----------~~~eywLVt~fh~kGsL~dyL~~------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaH 339 (534)
T KOG3653|consen 276 GTA----------DRMEYWLVTEFHPKGSLCDYLKA------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAH 339 (534)
T ss_pred CCc----------cccceeEEeeeccCCcHHHHHHh------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcccc
Confidence 221 13468999999999999999987 6799999999999999999999973 6999
Q ss_pred cCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCC--CCCch
Q 002738 697 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN--LYGLE 774 (886)
Q Consensus 697 RDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~--~~s~K 774 (886)
||||+.||||..+ ++..|+|||+|..+...... ......+||.+|||||++.+...-. ..-.+
T Consensus 340 RDlkSkNVLvK~D-------lTccIaDFGLAl~~~p~~~~--------~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr 404 (534)
T KOG3653|consen 340 RDLKSKNVLVKND-------LTCCIADFGLALRLEPGKPQ--------GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKR 404 (534)
T ss_pred ccccccceEEccC-------CcEEeeccceeEEecCCCCC--------cchhhhhhhhhhcCHHHHhhhcccccHHHHHH
Confidence 9999999999988 67999999999988643221 1123468999999999998732211 12257
Q ss_pred hhHHHHHHHHHHHHhCC------------CCCC-----CCCHHHHHHHHH-cCCCCCchhHHhhhcccccccccccCCCC
Q 002738 775 VDIWSYGCLLLELLTLQ------------VPYM-----GLSELEIHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGF 836 (886)
Q Consensus 775 SDIWSLGVILyELLTG~------------~PF~-----g~s~~el~~~I~-~~~rp~l~~~l~~~~~~~~~~~~~~~~~~ 836 (886)
.||||+|.+||||+++. .||. ..+..++...+. +..||.+++.|...
T Consensus 405 ~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h--------------- 469 (534)
T KOG3653|consen 405 IDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH--------------- 469 (534)
T ss_pred HHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC---------------
Confidence 99999999999999853 3342 123344554444 44788888766432
Q ss_pred CCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 002738 837 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSI 882 (886)
Q Consensus 837 ~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EILehLe~l~sss~ 882 (886)
.....+.+.++.||..||+.|.|+.-+.+++..+.....
T Consensus 470 -------~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 470 -------AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred -------ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 124579999999999999999999999999888775553
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=327.53 Aligned_cols=256 Identities=25% Similarity=0.343 Sum_probs=213.3
Q ss_pred CCCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeE
Q 002738 546 DPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 623 (886)
Q Consensus 546 ~~~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~ 623 (886)
+...++.|.+.+.||+|.|+.|.+|++ .+..||+|++ +........... +.+|+.+|+.|.|||||+++.+.
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~i--dkt~ln~~~~~k----~~rev~imk~l~HPnIvkl~~v~ 124 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKII--DKTQLNPSKRQK----LGREVDIMKSLNHPNIVKLFSVI 124 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEe--hhcccChHHHHH----HHHHHHHHHhcCCcceeeeeeee
Confidence 346788999999999999999999996 7889999985 333333333333 38999999999999999999999
Q ss_pred ecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 002738 624 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703 (886)
Q Consensus 624 ~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsN 703 (886)
..+.. +|+||||+.+|.+.+||.+ ...+.+..+..++.|+++|++|||+++|||||||++|
T Consensus 125 ~t~~~--------------lylV~eya~~ge~~~yl~~-----~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eN 185 (596)
T KOG0586|consen 125 ETEAT--------------LYLVMEYASGGELFDYLVK-----HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAEN 185 (596)
T ss_pred eecce--------------eEEEEEeccCchhHHHHHh-----cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhh
Confidence 97764 6999999999999999987 3567779999999999999999999999999999999
Q ss_pred EEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 002738 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783 (886)
Q Consensus 704 ILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVI 783 (886)
|||+.+. .+||+|||++..+..... ..+.+|++.|.|||++.+ ....++.+|+||+|++
T Consensus 186 ilL~~~m-------nikIaDfgfS~~~~~~~~-----------lqt~cgsppyAaPEl~~g---~~y~gpe~D~Wslgvv 244 (596)
T KOG0586|consen 186 ILLDENM-------NIKIADFGFSTFFDYGLM-----------LQTFCGSPPYAAPELFNG---KKYDGPEVDIWSLGVV 244 (596)
T ss_pred ccccccc-------ceeeeccccceeeccccc-----------ccccCCCCCccChHhhcC---cccCCcceehhhhhhh
Confidence 9999884 499999999988764322 245679999999999997 3456899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 784 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 784 LyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
||-|+.|.+||.+.+...+...+..+.. .++- -.+-++.+||.++|..+|.+
T Consensus 245 ly~LV~GsLPFDG~~lk~Lr~rvl~gk~-rIp~---------------------------~ms~dce~lLrk~lvl~Psk 296 (596)
T KOG0586|consen 245 LYALVEGSLPFDGQNLKELRPRVLRGKY-RIPF---------------------------YMSCDCEDLLRKFLVLNPSK 296 (596)
T ss_pred heeeeecccccCCcccccccchheeeee-cccc---------------------------eeechhHHHHHHhhccCccc
Confidence 9999999999998877666655555422 1110 01336889999999999999
Q ss_pred CCCHHHHHHHHH
Q 002738 864 RPTAGDLYEMFV 875 (886)
Q Consensus 864 RPSA~EILehLe 875 (886)
|++.+++++|-+
T Consensus 297 r~~~dqim~~~W 308 (596)
T KOG0586|consen 297 RGPCDQIMKDRW 308 (596)
T ss_pred cCCHHHhhhhcc
Confidence 999999999854
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=328.17 Aligned_cols=258 Identities=24% Similarity=0.356 Sum_probs=212.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC-----CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeee
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 622 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~-----~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~ 622 (886)
++.+...+.++||+|.||.|++|.|+ ...||||+...... .. ....| ++|+.+|.+|+|||+|++||+
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l--~~-~mddf----lrEas~M~~L~H~hliRLyGv 179 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSL--NA-IMDDF----LREASHMLKLQHPHLIRLYGV 179 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCcc--ch-hHHHH----HHHHHHHHhccCcceeEEeee
Confidence 55677788999999999999999992 34688888543322 21 33444 999999999999999999999
Q ss_pred EecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 002738 623 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 702 (886)
Q Consensus 623 ~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPs 702 (886)
..+.. ..+|||+++.|+|.+.|++ .....|.......++.|||.||.||..+++|||||-..
T Consensus 180 Vl~qp---------------~mMV~ELaplGSLldrLrk---a~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAAR 241 (1039)
T KOG0199|consen 180 VLDQP---------------AMMVFELAPLGSLLDRLRK---AKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAAR 241 (1039)
T ss_pred eccch---------------hhHHhhhcccchHHHHHhh---ccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 98643 4899999999999999987 33456888999999999999999999999999999999
Q ss_pred CEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 002738 703 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 782 (886)
Q Consensus 703 NILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGV 782 (886)
||||... -+|||+|||+.+.+........... ...-...|+|||.+.. ..++.++|||+|||
T Consensus 242 Nlllasp-------rtVKI~DFGLmRaLg~ned~Yvm~p-------~rkvPfAWCaPEsLrh----~kFShaSDvWmyGV 303 (1039)
T KOG0199|consen 242 NLLLASP-------RTVKICDFGLMRALGENEDMYVMAP-------QRKVPFAWCAPESLRH----RKFSHASDVWMYGV 303 (1039)
T ss_pred hheeccc-------ceeeeecccceeccCCCCcceEecC-------CCcCcccccCHhHhcc----ccccccchhhhhhh
Confidence 9999876 5799999999998876543322111 0123468999999986 78999999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 002738 783 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 861 (886)
Q Consensus 783 ILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP 861 (886)
+||||+| |..||.|....++++.|..+.+..-+ ..+++.+++++..||..+|
T Consensus 304 TiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRP---------------------------k~csedIY~imk~cWah~p 356 (1039)
T KOG0199|consen 304 TIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRP---------------------------KYCSEDIYQIMKNCWAHNP 356 (1039)
T ss_pred hHHhhhccCCCCCCCCCHHHHHHhccccccCCCC---------------------------CCChHHHHHHHHHhccCCc
Confidence 9999998 89999999999999999866543322 2357789999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 002738 862 TERPTAGDLYEMFV 875 (886)
Q Consensus 862 ~kRPSA~EILehLe 875 (886)
.+||||..|.+.+-
T Consensus 357 aDRptFsair~~~~ 370 (1039)
T KOG0199|consen 357 ADRPTFSAIREDLV 370 (1039)
T ss_pred cccccHHHHHHhHH
Confidence 99999999975443
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=311.82 Aligned_cols=282 Identities=20% Similarity=0.221 Sum_probs=205.6
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
.-++|++.+.||+|+||.||+|+. .+..+|+|+.... ....... ..+.+|+.+++++.||||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~--~~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP--FQSAIHA----KRTYRELRLLKHMDHENVIGLLDVFTPA 86 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccc--cchhhHH----HHHHHHHHHHHhccCCCHHHHHHHhhcc
Confidence 346899999999999999999997 4677899975322 1111222 2347899999999999999999887654
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
... ......++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+||++
T Consensus 87 ~~~--------~~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill 151 (343)
T cd07851 87 SSL--------EDFQDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 151 (343)
T ss_pred ccc--------cccccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE
Confidence 320 1223479999999 5799999874 468999999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +.++|+|||++...... .....++..|+|||.+.+ ...++.++|||||||++|+
T Consensus 152 ~~~-------~~~kL~dfg~~~~~~~~-------------~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslGv~l~e 208 (343)
T cd07851 152 NED-------CELKILDFGLARHTDDE-------------MTGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAE 208 (343)
T ss_pred CCC-------CCEEEcccccccccccc-------------ccCCcccccccCHHHHhC---CCCCCchHhHHHHHHHHHH
Confidence 877 45999999999765332 122357889999999864 2356889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCC---CchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE---KPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 787 LLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
|++|+.||.+.........+........+..+..........+........ ........++.+.+||.+||..+|.+
T Consensus 209 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~ 288 (343)
T cd07851 209 LLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDK 288 (343)
T ss_pred HHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhh
Confidence 999999998887776666655543322222222111000000000000000 01111234678999999999999999
Q ss_pred CCCHHHHHHHH
Q 002738 864 RPTAGDLYEMF 874 (886)
Q Consensus 864 RPSA~EILehL 874 (886)
|||+.+|++|-
T Consensus 289 Rpt~~ell~h~ 299 (343)
T cd07851 289 RITAAEALAHP 299 (343)
T ss_pred CCCHHHHhcCC
Confidence 99999999873
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=322.63 Aligned_cols=267 Identities=21% Similarity=0.299 Sum_probs=209.7
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC-eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~~-~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
.+-..+.+.++||+|-||.|.++...+ ..||||+.+-.. .... ...|.+||++|.+|+|||||+++|+|..+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a---~~~~----r~~F~kEIkiLsqLkhPNIveLvGVC~~D 607 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA---TKNA----RNDFLKEIKILSRLKHPNIVELLGVCVQD 607 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc---chhH----HHHHHHHHHHHhccCCCCeeEEEeeeecC
Confidence 344567889999999999999999855 899999854221 1222 23459999999999999999999999988
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
+.+ ++||||+++|+|.+|+..... ..+.......|+.||+.||+||.+.++|||||.+.|+|+
T Consensus 608 ePi--------------cmI~EYmEnGDLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv 670 (807)
T KOG1094|consen 608 DPL--------------CMITEYMENGDLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV 670 (807)
T ss_pred Cch--------------HHHHHHHhcCcHHHHHHhccC---cccccchhHHHHHHHHHHHHHHHhhchhhccccccceee
Confidence 864 999999999999999987211 124555667899999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +++||+|||+++-+....... .....+-...|||||.+.. +.+++++|||+||++|||
T Consensus 671 ~~e-------~~iKiadfgmsR~lysg~yy~--------vqgr~vlpiRwmawEsill----gkFttaSDvWafgvTlwE 731 (807)
T KOG1094|consen 671 DGE-------FTIKIADFGMSRNLYSGDYYR--------VQGRAVLPIRWMAWESILL----GKFTTASDVWAFGVTLWE 731 (807)
T ss_pred cCc-------ccEEecCcccccccccCCcee--------eecceeeeeeehhHHHHHh----ccccchhhhhhhHHHHHH
Confidence 987 779999999998654433221 1233456789999999986 789999999999999999
Q ss_pred HHh--CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 002738 787 LLT--LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 864 (886)
Q Consensus 787 LLT--G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kR 864 (886)
+++ ...||...+..++.+......+..-... ....+.-++..+.+||.+||..|-.+|
T Consensus 732 ~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~--------------------~l~~P~~cp~~lyelml~Cw~~es~~R 791 (807)
T KOG1094|consen 732 VFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV--------------------VLSRPPACPQGLYELMLRCWRRESEQR 791 (807)
T ss_pred HHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce--------------------eccCCCcCcHHHHHHHHHHhchhhhcC
Confidence 876 7899999888887766543321111100 011122346678899999999999999
Q ss_pred CCHHHHHHHHHhh
Q 002738 865 PTAGDLYEMFVAR 877 (886)
Q Consensus 865 PSA~EILehLe~l 877 (886)
|+++++..+|+..
T Consensus 792 PsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 792 PSFEQLHLFLQED 804 (807)
T ss_pred CCHHHHHHHHHHh
Confidence 9999999999864
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=309.38 Aligned_cols=281 Identities=20% Similarity=0.235 Sum_probs=202.0
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|.+.+.||+|+||.||+|.. .+..+|+|+.... ....... +.+.+|+.++.+++||||+++++++.....
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~----~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP--FQSIIHA----KRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCc--chhhHHH----HHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 7899999999999999999986 5677888875422 1111122 234789999999999999999998875432
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
+ ......+++++++ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.
T Consensus 91 ~--------~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~ 155 (345)
T cd07877 91 L--------EEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 155 (345)
T ss_pred c--------cccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcC
Confidence 1 1122468899987 6899988864 45899999999999999999999999999999999999987
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.+||+|||++...... .....++..|+|||++.+ ...++.++|||||||++|+|+
T Consensus 156 ~-------~~~kl~dfg~~~~~~~~-------------~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslG~il~el~ 212 (345)
T cd07877 156 D-------CELKILDFGLARHTDDE-------------MTGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAELL 212 (345)
T ss_pred C-------CCEEEeccccccccccc-------------ccccccCCCccCHHHHhC---ccCCCchhhHHHHHHHHHHHH
Confidence 7 46999999998754321 122358899999999864 235788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccccccccc---CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS---GSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
+|+.||...+.......+........+..+.............. .............++.+.+||.+||+.||.+||
T Consensus 213 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 292 (345)
T cd07877 213 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 292 (345)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcC
Confidence 99999988776665555544322222222211110000000000 000000111112356789999999999999999
Q ss_pred CHHHHHHHHH
Q 002738 866 TAGDLYEMFV 875 (886)
Q Consensus 866 SA~EILehLe 875 (886)
++.++++|-.
T Consensus 293 t~~e~l~h~~ 302 (345)
T cd07877 293 TAAQALAHAY 302 (345)
T ss_pred CHHHHhcChh
Confidence 9999999853
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=294.62 Aligned_cols=252 Identities=27% Similarity=0.341 Sum_probs=194.9
Q ss_pred ecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCC
Q 002738 559 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 636 (886)
Q Consensus 559 LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~~~~ 636 (886)
||.|+||.||++.+. +..+++|+...... ..+.....+.+|+.++++++||||+++++.+....
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--------- 66 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM-----IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK--------- 66 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh-----hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc---------
Confidence 689999999999984 77899998643221 11222345589999999999999999998887544
Q ss_pred CcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCCCC
Q 002738 637 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 716 (886)
Q Consensus 637 ~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~~ 716 (886)
..|+||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+|+||+|+||+++.+
T Consensus 67 -----~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~------- 129 (265)
T cd05579 67 -----NLYLVMEYLPGGDLASLLEN-----VGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN------- 129 (265)
T ss_pred -----EEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCC-------
Confidence 46999999999999999986 2368999999999999999999999999999999999999887
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 002738 717 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 796 (886)
Q Consensus 717 ~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF~g 796 (886)
..++|+|||++.......... ............++..|+|||++.. ...+.++||||||+++|+|++|..||..
T Consensus 130 ~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~Pe~~~~----~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 203 (265)
T cd05579 130 GHLKLTDFGLSKVGLVRRQIN--LNDDEKEDKRIVGTPDYIAPEVILG----QGHSKTVDWWSLGCILYEFLVGIPPFHG 203 (265)
T ss_pred CCEEEEecccchhcccCcccc--cccccccccCcccCccccCHHHhcC----CCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 469999999987543321100 0000111233468889999999875 4578899999999999999999999988
Q ss_pred CCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH---HHHHHH
Q 002738 797 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA---GDLYEM 873 (886)
Q Consensus 797 ~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA---~EILeh 873 (886)
.........+..+..+ ++.. ...+..+.+|+.+||+.+|.+|||+ .++++|
T Consensus 204 ~~~~~~~~~~~~~~~~-~~~~-------------------------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 204 ETPEEIFQNILNGKIE-WPED-------------------------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CCHHHHHHHHhcCCcC-CCcc-------------------------ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 8777766666543221 1100 0024578999999999999999999 776665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=303.27 Aligned_cols=258 Identities=27% Similarity=0.396 Sum_probs=200.7
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
-..|...+.||+|+||.||+|+. .+..+++|....... ....... .+.+|+.+++.++|+||+++++++....
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 88 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQ----DIIKEVRFLQKLRHPNTIQYRGCYLREH 88 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccc-cChHHHH----HHHHHHHHHHhCCCCCcccEEEEEEcCC
Confidence 34588889999999999999997 566788887643211 1122222 3478999999999999999999988654
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
..++||||+. ++|.+++.. ....+++..+..++.|++.||.|||+++++||||||+|||++
T Consensus 89 --------------~~~lv~e~~~-~~l~~~~~~----~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~ 149 (308)
T cd06634 89 --------------TAWLVMEYCL-GSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS 149 (308)
T ss_pred --------------eeEEEEEccC-CCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEEC
Confidence 3699999997 688887764 134588999999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ +.++|+|||++...... ....+++.|+|||++.+.. ...++.++|||||||++|+|
T Consensus 150 ~~-------~~~kl~dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~el 207 (308)
T cd06634 150 EP-------GLVKLGDFGSASIMAPA--------------NXFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIEL 207 (308)
T ss_pred CC-------CcEEECCcccceeecCc--------------ccccCCccccCHHHHhhcc-cCCCCcccchHHHHHHHHHH
Confidence 76 46999999998654321 2235889999999986422 24567899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 788 LTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
++|..||...........+.....+... ....+..+.+||.+||..+|.+||++
T Consensus 208 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~cl~~~P~~Rp~~ 261 (308)
T cd06634 208 AERKPPLFNMNAMSALYHIAQNESPALQ--------------------------SGHWSEYFRNFVDSCLQKIPQDRPTS 261 (308)
T ss_pred HcCCCCCccccHHHHHHHHhhcCCCCcC--------------------------cccccHHHHHHHHHHhhCCcccCCCH
Confidence 9999999877665555555443322211 01234578999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 002738 868 GDLYEMFVARTS 879 (886)
Q Consensus 868 ~EILehLe~l~s 879 (886)
.++++|..-...
T Consensus 262 ~~ll~~~~~~~~ 273 (308)
T cd06634 262 EVLLKHRFVLRE 273 (308)
T ss_pred HHHhhCcccccc
Confidence 999999765543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=306.82 Aligned_cols=289 Identities=19% Similarity=0.227 Sum_probs=209.7
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
+|++.+.||.|+||.||+|+. .+..+++|...... ...... +.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~- 73 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF--DDLIDA----KRILREIKLLRHLRHENIIGLLDILRPPSP- 73 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc--ccchhh----hhHHHHHHHHHhcCCcchhhhhhhhcccCc-
Confidence 589999999999999999997 46788888764321 112222 334889999999999999999999876541
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
......|+||||++ ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||.|||++.+
T Consensus 74 --------~~~~~~~lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~ 139 (330)
T cd07834 74 --------EDFNDVYIVTELME-TDLHKVIKS-----PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN 139 (330)
T ss_pred --------ccccceEEEecchh-hhHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 12235799999997 589998875 2478999999999999999999999999999999999999877
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.++|+|||++......... ........++..|+|||++.+ ...++.++||||||+++|+|++
T Consensus 140 -------~~~~L~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~sDi~slG~il~~l~~ 202 (330)
T cd07834 140 -------CDLKICDFGLARGVDPDEDE-------KGFLTEYVVTRWYRAPELLLS---SSRYTKAIDIWSVGCIFAELLT 202 (330)
T ss_pred -------CCEEEcccCceEeecccccc-------cccccccccccCcCCceeeec---ccCCCcchhHHHHHHHHHHHHc
Confidence 56999999999876543210 001123458899999999986 1267899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccc---cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ---SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
|++||.+.+..+....+........+..+............. ..............+..+.+||.+||+.+|.+||+
T Consensus 203 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 282 (330)
T cd07834 203 RKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT 282 (330)
T ss_pred CCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCC
Confidence 999999888877766665543222222221100000000000 00000011112234678999999999999999999
Q ss_pred HHHHHHH--HHhhc
Q 002738 867 AGDLYEM--FVART 878 (886)
Q Consensus 867 A~EILeh--Le~l~ 878 (886)
+.+++.| ++...
T Consensus 283 ~~~ll~~~~~~~~~ 296 (330)
T cd07834 283 ADEALAHPYLAQLH 296 (330)
T ss_pred HHHHHhCccHHhhc
Confidence 9999998 44443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=301.27 Aligned_cols=253 Identities=23% Similarity=0.280 Sum_probs=192.8
Q ss_pred CceeeeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcceeeeeEec
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 625 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~-----~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl~g~~~~ 625 (886)
+|++.+.||.|+||.||+|.. .+..+|+|++....... .....+.+.+|+.++.++ +|+||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~----~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQ----KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhh----cchHHHHHHHHHHHHHhcccCCChhceeeEeec
Confidence 488999999999999999986 56789999865322111 111223448899999999 49999999998875
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
.. ..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||
T Consensus 77 ~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil 137 (290)
T cd05613 77 DT--------------KLHLILDYINGGELFTHLSQ-----RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENIL 137 (290)
T ss_pred CC--------------eEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeE
Confidence 54 36999999999999999976 345889999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.+ +.+||+|||++......... ......|+..|+|||++... ...++.++||||||+++|
T Consensus 138 ~~~~-------~~~kl~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Dv~slG~~l~ 199 (290)
T cd05613 138 LDSN-------GHVVLTDFGLSKEFHEDEVE---------RAYSFCGTIEYMAPDIVRGG--DGGHDKAVDWWSMGVLMY 199 (290)
T ss_pred ECCC-------CCEEEeeCccceeccccccc---------ccccccCCcccCChhhccCC--CCCCCccccHHHHHHHHH
Confidence 9876 46999999998765332111 11234588999999998641 134678999999999999
Q ss_pred HHHhCCCCCCCCCH----HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 002738 786 ELLTLQVPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 861 (886)
Q Consensus 786 ELLTG~~PF~g~s~----~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP 861 (886)
+|++|..||..... ..+...+.... +.++ ...+..+.+|+.+||..||
T Consensus 200 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~~~~ll~~~l~~~p 251 (290)
T cd05613 200 ELLTGASPFTVDGEKNSQAEISRRILKSE-PPYP---------------------------QEMSALAKDIIQRLLMKDP 251 (290)
T ss_pred HHhcCCCCCCcCCccccHHHHHHHhhccC-CCCC---------------------------ccCCHHHHHHHHHHhcCCH
Confidence 99999999964322 22222222111 1111 1134578999999999999
Q ss_pred CCCC-----CHHHHHHH
Q 002738 862 TERP-----TAGDLYEM 873 (886)
Q Consensus 862 ~kRP-----SA~EILeh 873 (886)
.+|| ++.+++.|
T Consensus 252 ~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 252 KKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHhcCCCCCCHHHHHcC
Confidence 9997 88999887
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=300.88 Aligned_cols=259 Identities=23% Similarity=0.344 Sum_probs=197.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEe
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 624 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~ 624 (886)
..+++|++.+.||.|+||.||+|.+. +..+|+|+..... . ..... .+.+|+.++.++. ||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~--~-~~~~~----~~~~e~~~~~~~~~~~~i~~~~~~~~ 84 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--N-KEENK----RILMDLDVVLKSHDCPYIVKCYGYFI 84 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC--C-hHHHH----HHHHHHHHHHhccCCCchHhhheeee
Confidence 67889999999999999999999985 7889999865322 1 11222 2366777777775 999999999998
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCC
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSEN 703 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs-~gIVHRDLKPsN 703 (886)
... ..++||||+. ++|.+++... ...+++..+..++.||+.||+|||+ .||+||||+|+|
T Consensus 85 ~~~--------------~~~~v~e~~~-~~l~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~n 145 (296)
T cd06618 85 TDS--------------DVFICMELMS-TCLDKLLKRI----QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSN 145 (296)
T ss_pred cCC--------------eEEEEeeccC-cCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHH
Confidence 655 3699999996 5888887652 2468899999999999999999997 599999999999
Q ss_pred EEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 002738 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783 (886)
Q Consensus 704 ILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVI 783 (886)
|+++.+ +.+||+|||++..+..... .....++..|+|||++.+......++.++||||||++
T Consensus 146 ill~~~-------~~~kL~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~i 207 (296)
T cd06618 146 ILLDAS-------GNVKLCDFGISGRLVDSKA-----------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGIS 207 (296)
T ss_pred EEEcCC-------CCEEECccccchhccCCCc-----------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHH
Confidence 999876 4699999999876533211 1122478899999998753222457889999999999
Q ss_pred HHHHHhCCCCCCCCCH-HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 002738 784 LLELLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 862 (886)
Q Consensus 784 LyELLTG~~PF~g~s~-~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~ 862 (886)
+|+|++|+.||..... .+....+.....+.++. ....+..+.+|+.+||..||.
T Consensus 208 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~~p~ 262 (296)
T cd06618 208 LVELATGQFPYKNCKTEFEVLTKILQEEPPSLPP-------------------------NEGFSPDFCSFVDLCLTKDHR 262 (296)
T ss_pred HHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCC-------------------------CCCCCHHHHHHHHHHccCChh
Confidence 9999999999976432 23333333332221110 001345789999999999999
Q ss_pred CCCCHHHHHHHHH
Q 002738 863 ERPTAGDLYEMFV 875 (886)
Q Consensus 863 kRPSA~EILehLe 875 (886)
+||++.+++.|..
T Consensus 263 ~Rp~~~~il~~~~ 275 (296)
T cd06618 263 KRPKYRELLQHPF 275 (296)
T ss_pred hCCCHHHHhcChh
Confidence 9999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=301.47 Aligned_cols=248 Identities=26% Similarity=0.428 Sum_probs=195.5
Q ss_pred eeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCC
Q 002738 554 SSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 631 (886)
Q Consensus 554 ~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~ 631 (886)
....+||+|+||.||++.. .+..+|+|...... .... ..+.+|+.+++.++||||+++++.+...+
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 90 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK----QQRR----ELLFNEVVIMRDYQHENVVEMYNSYLVGD---- 90 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc----hhHH----HHHHHHHHHHHhcCCcchhheeeEEEeCC----
Confidence 3457899999999999987 56788888754321 1122 23488999999999999999999988654
Q ss_pred CCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecccc
Q 002738 632 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 711 (886)
Q Consensus 632 ~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~ 711 (886)
..++||||+++++|.+++.. ..+++..+..++.|++.||+|||++||+||||+|+||+++.+
T Consensus 91 ----------~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~-- 152 (292)
T cd06657 91 ----------ELWVVMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHD-- 152 (292)
T ss_pred ----------EEEEEEecCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC--
Confidence 46999999999999998754 357899999999999999999999999999999999999877
Q ss_pred CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCC
Q 002738 712 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 791 (886)
Q Consensus 712 ~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~ 791 (886)
+.++|+|||++........ ......|++.|+|||++.+ ..++.++||||||+++|+|++|.
T Consensus 153 -----~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slGvil~el~tg~ 213 (292)
T cd06657 153 -----GRVKLSDFGFCAQVSKEVP----------RRKSLVGTPYWMAPELISR----LPYGPEVDIWSLGIMVIEMVDGE 213 (292)
T ss_pred -----CCEEEcccccceecccccc----------cccccccCccccCHHHhcC----CCCCchhhHHHHHHHHHHHHhCC
Confidence 4699999998865533111 1123458899999999865 56788999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 002738 792 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 871 (886)
Q Consensus 792 ~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EIL 871 (886)
.||.+.........+.....+.+.. ....+..+.+++.+||..+|.+||++.+++
T Consensus 214 ~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~~P~~R~~~~~ll 268 (292)
T cd06657 214 PPYFNEPPLKAMKMIRDNLPPKLKN-------------------------LHKVSPSLKGFLDRLLVRDPAQRATAAELL 268 (292)
T ss_pred CCCCCCCHHHHHHHHHhhCCcccCC-------------------------cccCCHHHHHHHHHHHhCCcccCcCHHHHh
Confidence 9998877666555444332211110 011245688999999999999999999999
Q ss_pred HHHH
Q 002738 872 EMFV 875 (886)
Q Consensus 872 ehLe 875 (886)
+|-.
T Consensus 269 ~~~~ 272 (292)
T cd06657 269 KHPF 272 (292)
T ss_pred cChH
Confidence 9833
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=295.86 Aligned_cols=274 Identities=24% Similarity=0.286 Sum_probs=198.2
Q ss_pred ceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEecCCCC
Q 002738 553 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWL 629 (886)
Q Consensus 553 Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~~~~~l 629 (886)
|.+.+.||+|+||.||+|.. .+..+++|....... .... . ...+|+..+++++ ||||+++++++....
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~~~~-~----~~~~e~~~l~~~~~h~~i~~~~~~~~~~~-- 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--SWEE-C----MNLREVKSLRKLNEHPNIVKLKEVFREND-- 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc--chhH-H----HHHHHHHHHHhccCCCCchhHHHHhhcCC--
Confidence 67889999999999999998 456788887543321 1111 1 2257999999999 999999999987644
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..++||||+ +++|.+++... ....+++..+..++.||+.||.|||++||+|+||+|+||+++.+
T Consensus 72 ------------~~~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~ 135 (283)
T cd07830 72 ------------ELYFVFEYM-EGNLYQLMKDR---KGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP 135 (283)
T ss_pred ------------cEEEEEecC-CCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC
Confidence 469999999 68999998761 12468999999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
+.++|+|||++........ .....++..|+|||++.. ...++.++||||||+++|||++
T Consensus 136 -------~~~~l~d~~~~~~~~~~~~-----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~s~G~~l~el~~ 194 (283)
T cd07830 136 -------EVVKIADFGLAREIRSRPP-----------YTDYVSTRWYRAPEILLR---STSYSSPVDIWALGCIMAELYT 194 (283)
T ss_pred -------CCEEEeecccceeccCCCC-----------cCCCCCcccccCceeeec---CcCcCCccchhhHHHHHHHHHh
Confidence 5699999999876543211 122458899999999864 2457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCC---CCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF---EKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 790 G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
|++||...........+.....+.....+......... ........ .........+..+.+||.+||+.+|.+|||
T Consensus 195 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt 273 (283)
T cd07830 195 LRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK-LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT 273 (283)
T ss_pred CCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc-ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCC
Confidence 99999887766555544433222222111110000000 00000000 001111122467999999999999999999
Q ss_pred HHHHHHH
Q 002738 867 AGDLYEM 873 (886)
Q Consensus 867 A~EILeh 873 (886)
+.|++.|
T Consensus 274 ~~ei~~~ 280 (283)
T cd07830 274 ASQALQH 280 (283)
T ss_pred HHHHhhC
Confidence 9999986
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=301.75 Aligned_cols=250 Identities=27% Similarity=0.406 Sum_probs=195.3
Q ss_pred ceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCC
Q 002738 553 LSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 630 (886)
Q Consensus 553 Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~ 630 (886)
|...+.||+|+||.||+|+. .+..+++|+...... ......+ .+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 94 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTNEKWQ----DIIKEVKFLQQLKHPNTIEYKGCYLKEH--- 94 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc-CchHHHH----HHHHHHHHHHhCCCCCCccEEEEEEeCC---
Confidence 66778899999999999986 567788887643321 1222223 3488999999999999999999998655
Q ss_pred CCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccc
Q 002738 631 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 710 (886)
Q Consensus 631 ~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~ 710 (886)
..|+||||+. ++|.+++.. ....+++..+..++.||+.||.|||++||+|+||||+||+++.+
T Consensus 95 -----------~~~lv~e~~~-~~l~~~l~~----~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~- 157 (313)
T cd06633 95 -----------TAWLVMEYCL-GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP- 157 (313)
T ss_pred -----------EEEEEEecCC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCC-
Confidence 3699999996 688888764 23468899999999999999999999999999999999999876
Q ss_pred cCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 002738 711 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 790 (886)
Q Consensus 711 ~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG 790 (886)
+.+||+|||++..... .....|+..|+|||++.... ...++.++|||||||++|+|++|
T Consensus 158 ------~~~kL~dfg~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~-~~~~~~~sDv~slGvil~el~~g 216 (313)
T cd06633 158 ------GQVKLADFGSASKSSP--------------ANSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAER 216 (313)
T ss_pred ------CCEEEeecCCCcccCC--------------CCCccccccccChhhccccC-CCCCCchhhHHHHHHHHHHHHhC
Confidence 4599999998854221 12346889999999985321 24578899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 002738 791 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 870 (886)
Q Consensus 791 ~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EI 870 (886)
..||...+.......+.....+.... ...+..+.+|+.+||+.+|.+||++.++
T Consensus 217 ~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~~P~~Rp~~~~~ 270 (313)
T cd06633 217 KPPLFNMNAMSALYHIAQNDSPTLQS--------------------------NEWTDSFRGFVDYCLQKIPQERPASAEL 270 (313)
T ss_pred CCCCCCCChHHHHHHHHhcCCCCCCc--------------------------cccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 99998877666555554432222110 1123468999999999999999999999
Q ss_pred HHHH
Q 002738 871 YEMF 874 (886)
Q Consensus 871 LehL 874 (886)
+.|-
T Consensus 271 l~~~ 274 (313)
T cd06633 271 LRHD 274 (313)
T ss_pred hcCc
Confidence 9873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=298.14 Aligned_cols=246 Identities=21% Similarity=0.264 Sum_probs=183.9
Q ss_pred eecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCC
Q 002738 558 EAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 635 (886)
Q Consensus 558 ~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~~~ 635 (886)
.||+|+||.||+|.. .+..+|+|+...+........ ..+ ......+.++....||||+++++++....
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-------- 70 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE-TLA-LNERIMLSLVSTGDCPFIVCMSYAFHTPD-------- 70 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhH-HHH-HHHHHHHHHHHhCCCCcEeeeeeeeecCC--------
Confidence 489999999999986 567899998754322211111 111 00122234455567999999999988654
Q ss_pred CCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCCC
Q 002738 636 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 715 (886)
Q Consensus 636 ~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~ 715 (886)
..++||||+.|++|..++.. ...+++..++.++.|++.||.|||+++|+||||||+||+++.+
T Consensus 71 ------~~~~v~e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~------ 133 (278)
T cd05606 71 ------KLSFILDLMNGGDLHYHLSQ-----HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH------ 133 (278)
T ss_pred ------EEEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCC------
Confidence 36999999999999998875 3468999999999999999999999999999999999999876
Q ss_pred CCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 002738 716 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 795 (886)
Q Consensus 716 ~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF~ 795 (886)
..++|+|||++....... .....|+..|+|||++.+ ...++.++|||||||++|+|++|+.||.
T Consensus 134 -~~~kl~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~s~G~~l~~l~~g~~p~~ 197 (278)
T cd05606 134 -GHVRISDLGLACDFSKKK------------PHASVGTHGYMAPEVLQK---GVAYDSSADWFSLGCMLFKLLRGHSPFR 197 (278)
T ss_pred -CCEEEccCcCccccCccC------------CcCcCCCcCCcCcHHhcC---CCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 469999999987543211 122368999999999874 2357889999999999999999999997
Q ss_pred CCCH---HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CH
Q 002738 796 GLSE---LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TA 867 (886)
Q Consensus 796 g~s~---~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP-----SA 867 (886)
.... ......+ ....+.++ ...+..+.+++.+||..+|.+|| ++
T Consensus 198 ~~~~~~~~~~~~~~-~~~~~~~~---------------------------~~~s~~~~~li~~~l~~~p~~R~~~~~~~~ 249 (278)
T cd05606 198 QHKTKDKHEIDRMT-LTMAVELP---------------------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGA 249 (278)
T ss_pred CCCccchHHHHHHh-hccCCCCC---------------------------CcCCHHHHHHHHHHhhcCHHhccCCCCCCH
Confidence 6532 2221111 11111111 11245799999999999999999 99
Q ss_pred HHHHHHH
Q 002738 868 GDLYEMF 874 (886)
Q Consensus 868 ~EILehL 874 (886)
.++++|-
T Consensus 250 ~~ll~~~ 256 (278)
T cd05606 250 QEVKEHP 256 (278)
T ss_pred HHHHhCc
Confidence 9999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.45 Aligned_cols=297 Identities=19% Similarity=0.236 Sum_probs=215.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC------CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeee
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 621 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~------~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g 621 (886)
..+..|++.+.||+|.||.||+|... ...+|+|.++-... -..+.....+|+.+++.|+|||||.+..
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd------~tGiS~SAcREiaL~REl~h~nvi~Lv~ 94 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD------GTGISMSACREIALLRELKHPNVISLVK 94 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC------CCCcCHHHHHHHHHHHHhcCCcchhHHH
Confidence 45678999999999999999999641 23567776543321 1123334589999999999999999999
Q ss_pred eEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 002738 622 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 701 (886)
Q Consensus 622 ~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKP 701 (886)
+|...+. .+++++||++. +|...|+-.+......++...+..|+.||+.|+.|||++=|+||||||
T Consensus 95 Vfl~~d~-------------~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKP 160 (438)
T KOG0666|consen 95 VFLSHDK-------------KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKP 160 (438)
T ss_pred HHhccCc-------------eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCc
Confidence 9886322 58999999984 999999877666667899999999999999999999999999999999
Q ss_pred CCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 002738 702 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781 (886)
Q Consensus 702 sNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLG 781 (886)
.||||..++. ..+.|||+|||+|+.+..+.... .....++-|..|+|||.+.| ...|+.+.||||+|
T Consensus 161 aNIlvmgdgp---erG~VKIaDlGlaR~~~~plkpl-------~s~d~VVVTiWYRAPELLLG---a~hYT~AiDvWAiG 227 (438)
T KOG0666|consen 161 ANILVMGDGP---ERGRVKIADLGLARLFNNPLKPL-------ASLDPVVVTIWYRAPELLLG---ARHYTKAIDVWAIG 227 (438)
T ss_pred ceEEEeccCC---ccCeeEeecccHHHHhhcccccc-------ccCCceEEEEEecChHHhcc---cccccchhhhHHHH
Confidence 9999998853 46789999999999887755432 12345678999999999998 56799999999999
Q ss_pred HHHHHHHhCCCCCCCCCH---------HHHHHHHHcCCCCCchhHHhhhcccccc--cccccC-CCCCC---ch---hhh
Q 002738 782 CLLLELLTLQVPYMGLSE---------LEIHDLIQMGKRPRLTDELEALGSCHEH--EVAQSG-SGFEK---PE---AEL 843 (886)
Q Consensus 782 VILyELLTG~~PF~g~s~---------~el~~~I~~~~rp~l~~~l~~~~~~~~~--~~~~~~-~~~~~---~~---~~~ 843 (886)
||+.||+|-++.|.+... .+.+..|.+....+-...|+.+...++. .+.+-. ..+.. .. ...
T Consensus 228 CIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k 307 (438)
T KOG0666|consen 228 CIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHK 307 (438)
T ss_pred HHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhc
Confidence 999999999999876421 1223334332111112222222111111 000000 00000 00 001
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 002738 844 ETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 877 (886)
Q Consensus 844 ~~s~~L~dLL~rCL~~DP~kRPSA~EILehLe~l 877 (886)
..++...+|+.+||.+||.+|.|++++++|.--.
T Consensus 308 ~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~ 341 (438)
T KOG0666|consen 308 VKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT 341 (438)
T ss_pred CCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence 1234578999999999999999999999986443
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=297.88 Aligned_cols=243 Identities=21% Similarity=0.275 Sum_probs=184.0
Q ss_pred CCCceeeeee--cccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcceeeeeEe
Q 002738 550 FPSLSSCDEA--GKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 624 (886)
Q Consensus 550 ~~~Y~i~k~L--G~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl~g~~~ 624 (886)
.++|.+.+.+ |+|+||.||++.. .+..+++|+...... . ..|+.....+ +||||+++++.+.
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~-----------~~e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF--N-----------AIEPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc--c-----------hhhHHHHHHhhcCCCEEEEEEEEe
Confidence 3466666666 9999999999986 566788888643211 1 1122222222 6999999999998
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNI 704 (886)
..+ ..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||
T Consensus 80 ~~~--------------~~~iv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ni 140 (267)
T PHA03390 80 TLK--------------GHVLIMDYIKDGDLFDLLKK-----EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENV 140 (267)
T ss_pred cCC--------------eeEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHE
Confidence 655 36999999999999999976 23789999999999999999999999999999999999
Q ss_pred EEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVIL 784 (886)
+++.++ ..++|+|||++...... ....++..|+|||++.+ ..++.++||||||+++
T Consensus 141 l~~~~~------~~~~l~dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il 196 (267)
T PHA03390 141 LYDRAK------DRIYLCDYGLCKIIGTP--------------SCYDGTLDYFSPEKIKG----HNYDVSFDWWAVGVLT 196 (267)
T ss_pred EEeCCC------CeEEEecCccceecCCC--------------ccCCCCCcccChhhhcC----CCCCchhhHHHHHHHH
Confidence 998773 26999999998755321 12358899999999976 5678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHH-HHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 785 LELLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 785 yELLTG~~PF~g~s~~el~-~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
|+|++|..||.......+. ..+........ ......++.+.+||.+||+.+|.+
T Consensus 197 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~~p~~ 251 (267)
T PHA03390 197 YELLTGKHPFKEDEDEELDLESLLKRQQKKL-------------------------PFIKNVSKNANDFVQSMLKYNINY 251 (267)
T ss_pred HHHHHCCCCCCCCCcchhhHHHHHHhhcccC-------------------------CcccccCHHHHHHHHHHhccChhh
Confidence 9999999999755433211 11111100000 001124567999999999999999
Q ss_pred CCC-HHHHHHH
Q 002738 864 RPT-AGDLYEM 873 (886)
Q Consensus 864 RPS-A~EILeh 873 (886)
||+ ++++++|
T Consensus 252 R~~~~~~~l~h 262 (267)
T PHA03390 252 RLTNYNEIIKH 262 (267)
T ss_pred CCchHHHHhcC
Confidence 996 6999987
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.49 Aligned_cols=265 Identities=24% Similarity=0.324 Sum_probs=208.8
Q ss_pred cee-eeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEecCCC
Q 002738 553 LSS-CDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 628 (886)
Q Consensus 553 Y~i-~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~~~~~ 628 (886)
|.+ .+.||+|+|+.|--+.. ++..+||||+. ++.. .. ..++.+|++++...+ |+||++++++|+++..
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiid--Kq~g--Hs----R~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIID--KQPG--HS----RSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhh--cCCc--hH----HHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 444 47899999999998874 88899999953 3211 11 235589999999997 9999999999998774
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
.|||||-+.||+|.+.|.+ ...|++.++.++..+|+.||.|||.+||.||||||+|||-..
T Consensus 151 --------------FYLVfEKm~GGplLshI~~-----~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~ 211 (463)
T KOG0607|consen 151 --------------FYLVFEKMRGGPLLSHIQK-----RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCES 211 (463)
T ss_pred --------------EEEEEecccCchHHHHHHH-----hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecC
Confidence 5999999999999999987 467999999999999999999999999999999999999976
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc-CCCCCCchhhHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ .-.-||||||.++.-+...... +....+.-.+.+|+..|||||+..-.- ....|..+.|.||||||||-|
T Consensus 212 pn----~vsPvKiCDfDLgSg~k~~~~~---spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYIm 284 (463)
T KOG0607|consen 212 PN----KVSPVKICDFDLGSGIKLNNDC---SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIM 284 (463)
T ss_pred CC----CcCceeeeccccccccccCCCC---CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHH
Confidence 53 2345999999988654432221 122233334568999999999975321 235688999999999999999
Q ss_pred HhCCCCCCCCCH---------------HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHH
Q 002738 788 LTLQVPYMGLSE---------------LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 852 (886)
Q Consensus 788 LTG~~PF~g~s~---------------~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dL 852 (886)
+.|.+||.|.-. ..++..|+.+....-.. .+..++.+.++|
T Consensus 285 LsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdk------------------------dWahIS~eakdl 340 (463)
T KOG0607|consen 285 LSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDK------------------------DWAHISSEAKDL 340 (463)
T ss_pred HhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChh------------------------hhHHhhHHHHHH
Confidence 999999976422 34666777775532222 234567889999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHH
Q 002738 853 FRRCTEENPTERPTAGDLYEMFV 875 (886)
Q Consensus 853 L~rCL~~DP~kRPSA~EILehLe 875 (886)
+..+|..||..|.++.++++|.+
T Consensus 341 isnLlvrda~~rlsa~~vlnhPw 363 (463)
T KOG0607|consen 341 ISNLLVRDAKQRLSAAQVLNHPW 363 (463)
T ss_pred HHHHHhccHHhhhhhhhccCCcc
Confidence 99999999999999999999744
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=303.69 Aligned_cols=275 Identities=19% Similarity=0.245 Sum_probs=198.0
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
-++|++.+.||.|+||.||+|.. .+..+|+|....... .....+ .+.+|+.++..++||||+++++++....
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~ 82 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS--TPVLAK----RTYRELKLLKHLRHENIISLSDIFISPL 82 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc--ccchhH----HHHHHHHHHHhcCCCCeeeEeeeEecCC
Confidence 46799999999999999999986 566788887543221 111222 3378999999999999999999987533
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
. ..++||||+. ++|.+++.. ..+++..+..++.||+.||.|||++||+||||+|.|||++
T Consensus 83 ~-------------~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~ 142 (328)
T cd07856 83 E-------------DIYFVTELLG-TDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN 142 (328)
T ss_pred C-------------cEEEEeehhc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeEC
Confidence 2 3699999994 699988864 4578888999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ +.++|+|||++....... ....++..|+|||++.+ ...++.++|||||||++|+|
T Consensus 143 ~~-------~~~~l~dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~el 199 (328)
T cd07856 143 EN-------CDLKICDFGLARIQDPQM-------------TGYVSTRYYRAPEIMLT---WQKYDVEVDIWSAGCIFAEM 199 (328)
T ss_pred CC-------CCEEeCccccccccCCCc-------------CCCcccccccCceeeec---cCCcCcHHHHHHHHHHHHHH
Confidence 76 569999999987542211 22357889999998754 24578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccc-cccCC--CCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEV-AQSGS--GFEKPEAELETLSFLVDVFRRCTEENPTER 864 (886)
Q Consensus 788 LTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~-~~~~~--~~~~~~~~~~~s~~L~dLL~rCL~~DP~kR 864 (886)
++|+.||.+.........+.........+............+ ..... ...........++.+.++|.+||+.+|.+|
T Consensus 200 ~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 279 (328)
T cd07856 200 LEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKR 279 (328)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhC
Confidence 999999988776544433333211111111111000000000 00000 000111112345789999999999999999
Q ss_pred CCHHHHHHH
Q 002738 865 PTAGDLYEM 873 (886)
Q Consensus 865 PSA~EILeh 873 (886)
|++++++.|
T Consensus 280 ~t~~ell~~ 288 (328)
T cd07856 280 ISAAEALAH 288 (328)
T ss_pred CCHHHHhcC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=339.68 Aligned_cols=278 Identities=24% Similarity=0.320 Sum_probs=196.9
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
-+.+|+..+.||+||||.||+++. .+..+|||.+.++. .... ..++.+|+.+|++|+|||||++|..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~----~skI~rEVk~LArLnHpNVVRYysAWVEs 549 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKL----YSKILREVKLLARLNHPNVVRYYSAWVES 549 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHH----HHHHHHHHHHHhhcCCcceeeeehhhhcc
Confidence 457788999999999999999995 88999999977653 2222 23458999999999999999999655432
Q ss_pred CCCCCC------------------------------------------------C----------------------C--
Q 002738 627 KWLPSA------------------------------------------------D----------------------G-- 634 (886)
Q Consensus 627 ~~l~~~------------------------------------------------~----------------------~-- 634 (886)
..-... . +
T Consensus 550 ~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~ 629 (1351)
T KOG1035|consen 550 TAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRN 629 (1351)
T ss_pred CCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccc
Confidence 100000 0 0
Q ss_pred --------------------------CCCc-------ccceEEEEEeccCCCCHHHHHHHHhccCCCcC-CHHHHHHHHH
Q 002738 635 --------------------------NPEH-------HLLQSAIFMEYVKGGSVKNYIEKLSETGEKHV-SVKLALFIAQ 680 (886)
Q Consensus 635 --------------------------~~~~-------~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~L-s~~~i~~Ia~ 680 (886)
.... ....+||-||||+..+|.+++.. +... .....+++++
T Consensus 630 ~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~-----N~~~~~~d~~wrLFr 704 (1351)
T KOG1035|consen 630 LSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR-----NHFNSQRDEAWRLFR 704 (1351)
T ss_pred cccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh-----cccchhhHHHHHHHH
Confidence 0000 11468999999998777777765 2222 4778999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccc------cc--cccccccCCCCCCCcccC
Q 002738 681 DVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS------FL--HTCCIAHRGIPAPDVCVG 752 (886)
Q Consensus 681 QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~------~~--~~~~~~~~~~~~~~~~vG 752 (886)
+|+.||+|+|++|||||||||.|||++.+ ..|||+|||+|..... .. .............+..+|
T Consensus 705 eIlEGLaYIH~~giIHRDLKP~NIFLd~~-------~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VG 777 (1351)
T KOG1035|consen 705 EILEGLAYIHDQGIIHRDLKPRNIFLDSR-------NSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVG 777 (1351)
T ss_pred HHHHHHHHHHhCceeeccCCcceeEEcCC-------CCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccc
Confidence 99999999999999999999999999977 4599999999987320 00 011111122223466799
Q ss_pred CCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCchhHHhhhcccccccccc
Q 002738 753 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG-LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ 831 (886)
Q Consensus 753 T~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF~g-~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~ 831 (886)
|..|+|||++.+... ..|+.|+|+||||+||+||+. ||.. +....++..+..+ .+|.. ..
T Consensus 778 TalYvAPEll~~~~~-~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g---~iP~~-~~----------- 838 (1351)
T KOG1035|consen 778 TALYVAPELLSDTSS-NKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKG---SIPEP-AD----------- 838 (1351)
T ss_pred eeeeecHHHhccccc-ccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccC---CCCCC-cc-----------
Confidence 999999999987433 479999999999999999985 5642 2233333333333 33311 00
Q ss_pred cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002738 832 SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 873 (886)
Q Consensus 832 ~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EILeh 873 (886)
...+..+.-..+|..||+.||.+||||.|+|++
T Consensus 839 ---------f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 839 ---------FFDPEHPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred ---------cccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 111123345789999999999999999999975
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=296.54 Aligned_cols=252 Identities=26% Similarity=0.278 Sum_probs=188.5
Q ss_pred CceeeeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEec
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 625 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~-----~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~~ 625 (886)
+|++.+.||+|+||.||+++. .+..+|+|+....... ........+.+|+.++.++. ||||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~----~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~ 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV----QKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHH----hhhhHHHHHHHHHHHHHhccCCcchhhhheeeec
Confidence 488999999999999999885 4567999986532111 11112234588999999994 9999999998875
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
.. ..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+++||||||.||+
T Consensus 77 ~~--------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil 137 (288)
T cd05583 77 DT--------------KLHLILDYVNGGELFTHLYQ-----REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENIL 137 (288)
T ss_pred CC--------------EEEEEEecCCCCcHHHHHhh-----cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeE
Confidence 44 36999999999999999875 245889999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.+ +.++|+|||++......... ......|+..|+|||.+.+.. ...+.++||||||+++|
T Consensus 138 ~~~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~--~~~~~~~Dv~slG~il~ 199 (288)
T cd05583 138 LDSE-------GHVVLTDFGLSKEFLAEEEE---------RAYSFCGTIEYMAPEVIRGGS--GGHDKAVDWWSLGVLTF 199 (288)
T ss_pred ECCC-------CCEEEEECcccccccccccc---------ccccccCCccccCHHHhcCCC--CCCcchhhhHHHHHHHH
Confidence 9876 46999999998765432111 112235889999999987521 23678999999999999
Q ss_pred HHHhCCCCCCCCCH----HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 002738 786 ELLTLQVPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 861 (886)
Q Consensus 786 ELLTG~~PF~g~s~----~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP 861 (886)
||++|..||..... ..+...+.... +..+ ...+..+.++|.+||+.||
T Consensus 200 el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~l~~li~~~l~~~p 251 (288)
T cd05583 200 ELLTGASPFTVDGEQNSQSEISRRILKSK-PPFP---------------------------KTMSAEARDFIQKLLEKDP 251 (288)
T ss_pred HHHhCCCCcccCcccchHHHHHHHHHccC-CCCC---------------------------cccCHHHHHHHHHHhcCCH
Confidence 99999999964322 12222221111 1111 1124568999999999999
Q ss_pred CCCCCHHHHHH
Q 002738 862 TERPTAGDLYE 872 (886)
Q Consensus 862 ~kRPSA~EILe 872 (886)
++|||+.++.+
T Consensus 252 ~~R~t~~~~~~ 262 (288)
T cd05583 252 KKRLGANGADE 262 (288)
T ss_pred hhccCcchHHH
Confidence 99999655543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=285.60 Aligned_cols=242 Identities=30% Similarity=0.382 Sum_probs=192.5
Q ss_pred ecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCC
Q 002738 559 AGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 636 (886)
Q Consensus 559 LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~~~~ 636 (886)
||.|+||.||++.. .+..+++|+...... ....... .+..|+.++++++||||+++++.+....
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------- 66 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI-IKRKEVE----HTLTERNILSRINHPFIVKLHYAFQTEE--------- 66 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhh-cchHHHH----HHHHHHHHHHHcCCCcHHHHHHHeecCC---------
Confidence 69999999999997 467889998653321 1112223 3488999999999999999999887554
Q ss_pred CcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCCCC
Q 002738 637 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 716 (886)
Q Consensus 637 ~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~~ 716 (886)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+++|+||+|.||+++.+
T Consensus 67 -----~~~~v~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~------- 129 (250)
T cd05123 67 -----KLYLVLEYAPGGELFSHLSK-----EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD------- 129 (250)
T ss_pred -----eeEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCC-------
Confidence 36999999999999999976 2368999999999999999999999999999999999999877
Q ss_pred CeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 002738 717 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 796 (886)
Q Consensus 717 ~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF~g 796 (886)
+.++|+|||++........ ......++..|+|||.+.+ ...+.++|+||||+++|+|++|+.||..
T Consensus 130 ~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~~~~Pe~~~~----~~~~~~~D~~slG~~~~~l~~g~~p~~~ 195 (250)
T cd05123 130 GHIKLTDFGLAKELSSEGS----------RTNTFCGTPEYLAPEVLLG----KGYGKAVDWWSLGVLLYEMLTGKPPFYA 195 (250)
T ss_pred CcEEEeecCcceecccCCC----------cccCCcCCccccChHHhCC----CCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 4699999999876543211 1123458899999999876 5578899999999999999999999987
Q ss_pred CCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH---HHHHHH
Q 002738 797 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA---GDLYEM 873 (886)
Q Consensus 797 ~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA---~EILeh 873 (886)
.+.......+.... ..++. ..+..+.++|.+||..||++||++ .++++|
T Consensus 196 ~~~~~~~~~~~~~~-~~~~~---------------------------~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 196 EDRKEIYEKILKDP-LRFPE---------------------------FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred CCHHHHHHHHhcCC-CCCCC---------------------------CCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 77655555554421 11111 114568999999999999999999 777765
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=328.66 Aligned_cols=150 Identities=25% Similarity=0.284 Sum_probs=127.3
Q ss_pred CCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
.+++|.+.++||.|+||.||+|.+. +..||+|++..... .... +...+.+|+.++..++||||+++++++...
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~-~~~~----~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 76 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM-INKN----MVHQVQAERDALALSKSPFIVHLYYSLQSA 76 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc-cCHH----HHHHHHHHHHHHHhcCCCCcCeEEEEEEEC
Confidence 3679999999999999999999985 78899999753321 1122 223458899999999999999999888755
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
. ..||||||+.|++|.+++.. ...+++..++.|+.||+.||.|||.++||||||||+||||
T Consensus 77 ~--------------~~~lVmEy~~g~~L~~li~~-----~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl 137 (669)
T cd05610 77 N--------------NVYLVMEYLIGGDVKSLLHI-----YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI 137 (669)
T ss_pred C--------------EEEEEEeCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE
Confidence 4 46999999999999999975 2458889999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCccc
Q 002738 707 DLERKKADGKPVVKLCDFDRAVP 729 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~ 729 (886)
+.+ +.+||+|||+++.
T Consensus 138 ~~~-------g~vkL~DFGls~~ 153 (669)
T cd05610 138 SNE-------GHIKLTDFGLSKV 153 (669)
T ss_pred cCC-------CCEEEEeCCCCcc
Confidence 876 5699999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=302.22 Aligned_cols=267 Identities=26% Similarity=0.376 Sum_probs=205.2
Q ss_pred CCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhh--CCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGA--LRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~--L~HPNIVrl~g~~~~~~~ 628 (886)
....+.+.||+|.||.||+|+|.|+.||||++.-.. .+ .+.+|.+|.+. |+|+||+.|++.-..+..
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-------E~----SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-------ER----SWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccc-------hh----hhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 356889999999999999999999999999985321 12 22666666654 689999999987554332
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCC
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--------HIMHRDIK 700 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~--------gIVHRDLK 700 (886)
.-.++|||++|.+.|||++||.. ..++....++++..+|.||+|||.. .|.|||||
T Consensus 280 ----------s~TQLwLvTdYHe~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlK 343 (513)
T KOG2052|consen 280 ----------SWTQLWLVTDYHEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLK 343 (513)
T ss_pred ----------ceEEEEEeeecccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccc
Confidence 34689999999999999999986 6789999999999999999999963 49999999
Q ss_pred CCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCC--CchhhHH
Q 002738 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY--GLEVDIW 778 (886)
Q Consensus 701 PsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~--s~KSDIW 778 (886)
+.||||..+ ++..|+|+|+|.........- ....+..+||.+|||||++........+ -..+|||
T Consensus 344 SKNILVKkn-------~~C~IADLGLAv~h~~~t~~i------di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIY 410 (513)
T KOG2052|consen 344 SKNILVKKN-------GTCCIADLGLAVRHDSDTDTI------DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIY 410 (513)
T ss_pred cccEEEccC-------CcEEEeeceeeEEecccCCcc------cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHH
Confidence 999999988 679999999998776543221 1224556899999999999753322222 2579999
Q ss_pred HHHHHHHHHHhC----------CCCCCCC-----CHHHHHHHHHc-CCCCCchhHHhhhcccccccccccCCCCCCchhh
Q 002738 779 SYGCLLLELLTL----------QVPYMGL-----SELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 842 (886)
Q Consensus 779 SLGVILyELLTG----------~~PF~g~-----s~~el~~~I~~-~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 842 (886)
|||.|+||++.+ ++||.+. +..++...+.- ..+|.++..| ..
T Consensus 411 afgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW----------------------~s 468 (513)
T KOG2052|consen 411 AFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRW----------------------KS 468 (513)
T ss_pred HHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCccc----------------------cc
Confidence 999999999863 6788543 23334433322 2455554322 12
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 002738 843 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 879 (886)
Q Consensus 843 ~~~s~~L~dLL~rCL~~DP~kRPSA~EILehLe~l~s 879 (886)
.+....+..|++.||..+|..|.||--|-+.|.++..
T Consensus 469 ~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 469 DPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 2345678899999999999999999999999998874
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=321.28 Aligned_cols=292 Identities=21% Similarity=0.235 Sum_probs=205.2
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
.-..|...+.||+||||.||+++. .|..||||.+..... .... ++..+|+++|++|+|||||+++++-.+.
T Consensus 11 ~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~---~r~~----e~~~~EieilkKLnh~NIVk~f~iee~~ 83 (732)
T KOG4250|consen 11 ENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS---LRPR----ERWCREIEILKKLNHPNIVKLFDIEETK 83 (732)
T ss_pred CCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcc---cchH----HHHHHHHHHHHHcCchhhhhhcccCCcc
Confidence 335677889999999999999995 788899998653321 1122 2348899999999999999999876544
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
..+ . ......+|||||.||||...+... .....+++.+.+.++.+++.||.|||.+|||||||||.||++
T Consensus 84 ~~~--~------~~~~~vlvmEyC~gGsL~~~L~~P--EN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl 153 (732)
T KOG4250|consen 84 FLG--L------VTRLPVLVMEYCSGGSLRKVLNSP--ENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVL 153 (732)
T ss_pred ccC--c------ccccceEEEeecCCCcHHHHhcCc--ccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEE
Confidence 310 1 122469999999999999999862 333569999999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
.... ++.-..||+|||.|+.+..... -...+||+.|.+||++.. ...|+..+|.|||||++|+
T Consensus 154 ~~Ge---dgq~IyKLtDfG~Arel~d~s~-----------~~S~vGT~~YLhPel~E~---q~~y~~tVDLWS~GvtlY~ 216 (732)
T KOG4250|consen 154 QIGE---DGQSIYKLTDFGAARELDDNSL-----------FTSLVGTEEYLHPELYER---QKKYTATVDLWSFGVTLYE 216 (732)
T ss_pred eecC---CCceEEeeecccccccCCCCCe-----------eeeecCchhhcChHHHhh---ccCcCceeehhhhhhHHHH
Confidence 7663 2567899999999998876542 255789999999999984 3678999999999999999
Q ss_pred HHhCCCCCCCCC----HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 002738 787 LLTLQVPYMGLS----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 862 (886)
Q Consensus 787 LLTG~~PF~g~s----~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~ 862 (886)
.+||..||.... ..++...+........--..... ...+........+ .--........+-..+..+|..+|.
T Consensus 217 caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~--eNgpv~~s~~lP~-p~~Ls~~l~~~~~kwLa~~L~~~~~ 293 (732)
T KOG4250|consen 217 CATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEE--ENGPVEWSSTLPQ-PNHLSRGLATRLTKWLASMLEWNPR 293 (732)
T ss_pred HhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecc--cCCceeeeccCCC-cccccHHHHhhhhHHHHHHHhhhHH
Confidence 999999994332 22244333332211111000000 0000000000000 0011123345567788899999999
Q ss_pred CCC--CHHHHHHHHHhh
Q 002738 863 ERP--TAGDLYEMFVAR 877 (886)
Q Consensus 863 kRP--SA~EILehLe~l 877 (886)
+|- .+.+....+..+
T Consensus 294 ~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 294 KRGHEGFDRFFAEVDDI 310 (732)
T ss_pred HhCCCCcchHHHHHHHH
Confidence 998 666655554443
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=291.32 Aligned_cols=257 Identities=23% Similarity=0.359 Sum_probs=205.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEECC--eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEe
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 624 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~~--~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~ 624 (886)
.++++.+.+..||.|+-|.||++++.. .-.|||.. ... ...++.+.+ ++.+.++..-. .|+||+.+|+|.
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M--~rt-~Nkee~kRI----LmDldvv~~s~dcpyIV~c~GyFi 161 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQM--RRT-GNKEENKRI----LMDLDVVLKSHDCPYIVQCFGYFI 161 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEee--ccc-CCHHHHHHH----HHhhhHHhhccCCCeeeeeeeEEe
Confidence 567788899999999999999999866 55666654 332 233444444 88888877765 999999999999
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCC
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSEN 703 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs-~gIVHRDLKPsN 703 (886)
.... ++|.||.|. .-+..+++. -.+++++..+-++...++.||.||.. +||||||+||+|
T Consensus 162 ~n~d--------------V~IcMelMs-~C~ekLlkr----ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSN 222 (391)
T KOG0983|consen 162 TNTD--------------VFICMELMS-TCAEKLLKR----IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSN 222 (391)
T ss_pred eCch--------------HHHHHHHHH-HHHHHHHHH----hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccc
Confidence 7653 699999995 455666654 23568999999999999999999986 589999999999
Q ss_pred EEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 002738 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783 (886)
Q Consensus 704 ILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVI 783 (886)
||+|..+ .+||||||++-.+..... .....|-+.|||||.+.- .....|..++||||||++
T Consensus 223 ILlDe~G-------niKlCDFGIsGrlvdSkA-----------htrsAGC~~YMaPERidp-~~~~kYDiRaDVWSlGIT 283 (391)
T KOG0983|consen 223 ILLDERG-------NIKLCDFGISGRLVDSKA-----------HTRSAGCAAYMAPERIDP-PDKPKYDIRADVWSLGIT 283 (391)
T ss_pred eEEccCC-------CEEeecccccceeecccc-----------cccccCCccccCccccCC-CCCCccchhhhhhhhccc
Confidence 9999884 599999999987755332 233468999999999975 234678999999999999
Q ss_pred HHHHHhCCCCCCCC-CHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 002738 784 LLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 862 (886)
Q Consensus 784 LyELLTG~~PF~g~-s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~ 862 (886)
|+||.||+.||.+. ...+++..|.+...|.++... ..++.+++|+..||..|+.
T Consensus 284 lveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~-------------------------gFSp~F~~fv~~CL~kd~r 338 (391)
T KOG0983|consen 284 LVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHM-------------------------GFSPDFQSFVKDCLTKDHR 338 (391)
T ss_pred hhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCccc-------------------------CcCHHHHHHHHHHhhcCcc
Confidence 99999999999874 566778888876655555211 1366899999999999999
Q ss_pred CCCCHHHHHHHH
Q 002738 863 ERPTAGDLYEMF 874 (886)
Q Consensus 863 kRPSA~EILehL 874 (886)
+||...++|+|-
T Consensus 339 ~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 339 KRPKYNKLLEHP 350 (391)
T ss_pred cCcchHHHhcCc
Confidence 999999999984
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=295.25 Aligned_cols=299 Identities=18% Similarity=0.252 Sum_probs=218.4
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
....|+-..+||+|.||.||+|+. .+..||+|++.+.. +.+.|-...++|+.+|..|+|+|++.+++.|...
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen------eKeGfpitalreikiL~~lkHenv~nliEic~tk 88 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN------EKEGFPITALREIKILQLLKHENVVNLIEICRTK 88 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc------cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhc
Confidence 456788999999999999999986 55667887764422 1223333448999999999999999999988765
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
.. + .. .....+|+||.+|+ -+|..+|.. ...+++..++.+++.+++.||.|+|...|+|||+||+|+||
T Consensus 89 ~T-p----~~-r~r~t~ylVf~~ce-hDLaGlLsn----~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI 157 (376)
T KOG0669|consen 89 AT-P----TN-RDRATFYLVFDFCE-HDLAGLLSN----RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI 157 (376)
T ss_pred cC-C----cc-cccceeeeeHHHhh-hhHHHHhcC----ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE
Confidence 42 0 01 12345899999998 599999975 34679999999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+.+ +++||+|||+++.+....... .+..+..+-|..|.+||.+.| ...|+++.|||+.|||+.|
T Consensus 158 t~d-------gilklADFGlar~fs~~~n~~------kprytnrvvTLwYrppEllLG---~r~yg~~iDiWgAgCimae 221 (376)
T KOG0669|consen 158 TKD-------GILKLADFGLARAFSTSKNVV------KPRYTNRVVTLWYRPPELLLG---DREYGPPIDIWGAGCIMAE 221 (376)
T ss_pred cCC-------ceEEeeccccccceecccccC------CCCcccceeeeecCCHHHhhc---ccccCCcchhHhHHHHHHH
Confidence 988 679999999998765433221 111334567999999999998 5678999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccc------ccccccc-CCCCCCchhhhhhHHHHHHHHHHhccc
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH------EHEVAQS-GSGFEKPEAELETLSFLVDVFRRCTEE 859 (886)
Q Consensus 787 LLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~------~~~~~~~-~~~~~~~~~~~~~s~~L~dLL~rCL~~ 859 (886)
|+|+.+.+++.+..+.+..|..-....-++.|+.....+ .++..+. ....+..-.+....+...+|+.++|..
T Consensus 222 Mwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~ 301 (376)
T KOG0669|consen 222 MWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKL 301 (376)
T ss_pred HHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhcc
Confidence 999999999999888777776543222222222221111 0101000 000000000111234788999999999
Q ss_pred CCCCCCCHHHHHHHHHhhcCC
Q 002738 860 NPTERPTAGDLYEMFVARTSS 880 (886)
Q Consensus 860 DP~kRPSA~EILehLe~l~ss 880 (886)
||.+|++++++++|-.-...+
T Consensus 302 DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 302 DPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred CcccCcchHhhhchhhhhcCC
Confidence 999999999999996554433
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=294.47 Aligned_cols=260 Identities=24% Similarity=0.258 Sum_probs=206.1
Q ss_pred CCCceee-eeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEec
Q 002738 550 FPSLSSC-DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 625 (886)
Q Consensus 550 ~~~Y~i~-k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~~ 625 (886)
.++|.+. ++||-|-.|.|..+.. .++.+|+|+.. + . .+.++|+++--... |||||.++++|..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-D----s--------~KARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-D----S--------PKARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-c----C--------HHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence 4567654 7899999999999986 67788999852 1 1 12278888866654 9999999999885
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
.-. ....+.||||.++||.|.+.|.. .+...|++.++..|+.||..|+.|||+.+|.||||||+|+|
T Consensus 127 s~~----------~rkcLLiVmE~meGGeLfsriq~---~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLL 193 (400)
T KOG0604|consen 127 SYQ----------GRKCLLIVMECMEGGELFSRIQD---RGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLL 193 (400)
T ss_pred hcc----------CceeeEeeeecccchHHHHHHHH---cccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhhee
Confidence 432 23467899999999999999987 45567999999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
..... .+..+||+|||+|+....... ..+...||.|.|||++.. ..|+...|+||+||++|
T Consensus 194 yt~t~----~na~lKLtDfGFAK~t~~~~~-----------L~TPc~TPyYvaPevlg~----eKydkscdmwSlgVimY 254 (400)
T KOG0604|consen 194 YTTTS----PNAPLKLTDFGFAKETQEPGD-----------LMTPCFTPYYVAPEVLGP----EKYDKSCDMWSLGVIMY 254 (400)
T ss_pred eecCC----CCcceEecccccccccCCCcc-----------ccCCcccccccCHHHhCc----hhcCCCCCccchhHHHH
Confidence 98763 357899999999987653211 133468999999999975 66899999999999999
Q ss_pred HHHhCCCCCCCCCH----HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 002738 786 ELLTLQVPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 861 (886)
Q Consensus 786 ELLTG~~PF~g~s~----~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP 861 (886)
-|+.|.+||..... ..+...|..+....-. +.+...++..+++|+.+|..+|
T Consensus 255 IlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~------------------------pEWs~VSe~aKdlIR~LLkt~P 310 (400)
T KOG0604|consen 255 ILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE------------------------PEWSCVSEAAKDLIRKLLKTEP 310 (400)
T ss_pred HhhcCCCcccccCCccCChhHHhHhhccCccCCC------------------------hhHhHHHHHHHHHHHHHhcCCc
Confidence 99999999965432 2345566655442222 2234567889999999999999
Q ss_pred CCCCCHHHHHHHHHhhc
Q 002738 862 TERPTAGDLYEMFVART 878 (886)
Q Consensus 862 ~kRPSA~EILehLe~l~ 878 (886)
.+|.|+.++++|-+-..
T Consensus 311 teRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 311 TERLTIEEVMDHPWINQ 327 (400)
T ss_pred hhheeHHHhhcCchhcc
Confidence 99999999999976443
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=311.08 Aligned_cols=251 Identities=25% Similarity=0.315 Sum_probs=204.2
Q ss_pred eeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCC
Q 002738 556 CDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 633 (886)
Q Consensus 556 ~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~ 633 (886)
.+.||.|.||+||-|++ .++.||||++. +......... ++++|++||+.+.||.||.+.-.|++.+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvId--KlrFp~kqes----qlR~EVaILq~l~HPGiV~le~M~ET~er----- 637 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVID--KLRFPTKQES----QLRNEVAILQNLHHPGIVNLECMFETPER----- 637 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeee--cccCCCchHH----HHHHHHHHHHhcCCCCeeEEEEeecCCce-----
Confidence 57899999999999986 78899999953 3333333333 34899999999999999999999987764
Q ss_pred CCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCC
Q 002738 634 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 713 (886)
Q Consensus 634 ~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~ 713 (886)
.++|||-+.| +..+.|-. ....++++.....++.||+.||.|||-++|+|.||||+|||+....
T Consensus 638 ---------vFVVMEKl~G-DMLEMILS---sEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~--- 701 (888)
T KOG4236|consen 638 ---------VFVVMEKLHG-DMLEMILS---SEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASAS--- 701 (888)
T ss_pred ---------EEEEehhhcc-hHHHHHHH---hhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCC---
Confidence 6999999975 65555543 2346799999999999999999999999999999999999998763
Q ss_pred CCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 002738 714 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 793 (886)
Q Consensus 714 ~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~P 793 (886)
.-+++||||||+|+.+.+... ....+|||.|+|||+++. ..|+..-|+||.|||+|--++|..|
T Consensus 702 -~FPQvKlCDFGfARiIgEksF-----------RrsVVGTPAYLaPEVLrn----kGyNrSLDMWSVGVIiYVsLSGTFP 765 (888)
T KOG4236|consen 702 -PFPQVKLCDFGFARIIGEKSF-----------RRSVVGTPAYLAPEVLRN----KGYNRSLDMWSVGVIIYVSLSGTFP 765 (888)
T ss_pred -CCCceeeccccceeecchhhh-----------hhhhcCCccccCHHHHhh----ccccccccceeeeEEEEEEeccccc
Confidence 457899999999999876443 256789999999999997 7899999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002738 794 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 873 (886)
Q Consensus 794 F~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EILeh 873 (886)
|... +++.++|++..+.. .+..+.++++..++||..+|+..-.+|.|.+..+.|
T Consensus 766 FNEd--EdIndQIQNAaFMy------------------------Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 766 FNED--EDINDQIQNAAFMY------------------------PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred CCCc--cchhHHhhcccccc------------------------CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 9754 34555666542211 122234557789999999999999999999998887
Q ss_pred HH
Q 002738 874 FV 875 (886)
Q Consensus 874 Le 875 (886)
.+
T Consensus 820 ~W 821 (888)
T KOG4236|consen 820 PW 821 (888)
T ss_pred hh
Confidence 54
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=336.55 Aligned_cols=262 Identities=22% Similarity=0.251 Sum_probs=190.1
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
..|.....||+|+||.||+|++ .+..||+|... ..... . ..|++++++++|||||+++|++.....
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~------~----~~~~~~l~~l~HpnIv~~~~~~~~~~~ 757 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN--DVNSI------P----SSEIADMGKLQHPNIVKLIGLCRSEKG 757 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEcc--CCccc------c----HHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence 3466778999999999999996 56778888753 21110 0 346889999999999999999986653
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCCCCEE
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH---SKHIMHRDIKSENIL 705 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLH---s~gIVHRDLKPsNIL 705 (886)
.++||||+++|+|.++++. +++..+..|+.||+.||+||| +.+|+||||||+|||
T Consensus 758 --------------~~lv~Ey~~~g~L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil 815 (968)
T PLN00113 758 --------------AYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKII 815 (968)
T ss_pred --------------CEEEEeCCCCCcHHHHHhc--------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEE
Confidence 5999999999999999963 788999999999999999999 669999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.+. .+++. ||.+..... .....||+.|||||++.+ ..++.++|||||||++|
T Consensus 816 ~~~~~-------~~~~~-~~~~~~~~~--------------~~~~~~t~~y~aPE~~~~----~~~~~~sDv~S~Gvvl~ 869 (968)
T PLN00113 816 IDGKD-------EPHLR-LSLPGLLCT--------------DTKCFISSAYVAPETRET----KDITEKSDIYGFGLILI 869 (968)
T ss_pred ECCCC-------ceEEE-ecccccccc--------------CCCccccccccCcccccC----CCCCcccchhhHHHHHH
Confidence 98763 35554 555432211 112358899999999876 67899999999999999
Q ss_pred HHHhCCCCCCCCCH--HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 786 ELLTLQVPYMGLSE--LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 786 ELLTG~~PF~g~s~--~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
||+||+.||..... ..+............ . ..+.+..... ...........+.+++.+||+.||++
T Consensus 870 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~--------~~~~~~~~~~-~~~~~~~~~~~~~~l~~~Cl~~~P~~ 937 (968)
T PLN00113 870 ELLTGKSPADAEFGVHGSIVEWARYCYSDCH---L--------DMWIDPSIRG-DVSVNQNEIVEVMNLALHCTATDPTA 937 (968)
T ss_pred HHHhCCCCCCcccCCCCcHHHHHHHhcCccc---h--------hheeCccccC-CCCccHHHHHHHHHHHHhhCcCCchh
Confidence 99999999853211 111111111000000 0 0000000000 11112334557889999999999999
Q ss_pred CCCHHHHHHHHHhhcCCCCCC
Q 002738 864 RPTAGDLYEMFVARTSSSISS 884 (886)
Q Consensus 864 RPSA~EILehLe~l~sss~S~ 884 (886)
|||+.||++.|+++...++++
T Consensus 938 RPt~~evl~~L~~~~~~~~~~ 958 (968)
T PLN00113 938 RPCANDVLKTLESASRSSSSC 958 (968)
T ss_pred CcCHHHHHHHHHHhhcccccc
Confidence 999999999999998866554
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-33 Score=330.85 Aligned_cols=258 Identities=22% Similarity=0.287 Sum_probs=212.6
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|.+++.||+|+||.|.+++. .+..+|.|+...-... ...+.. -|..|-.+|..-..+-|++++-.|.++.+
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMl-Kr~~tA----~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEML-KRAETA----CFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHh-hchhHH----HHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 5799999999999999999997 4567888875321110 111222 24778889988889999999999998875
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
+|+||||++||+|..++.++ ..+++..++.++..|+.||.-||+.|+|||||||+|||||.
T Consensus 150 --------------LYlVMdY~pGGDlltLlSk~-----~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~ 210 (1317)
T KOG0612|consen 150 --------------LYLVMDYMPGGDLLTLLSKF-----DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDK 210 (1317)
T ss_pred --------------eEEEEecccCchHHHHHhhc-----CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecc
Confidence 59999999999999999872 36999999999999999999999999999999999999998
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC-CCCCchhhHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-NLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~-~~~s~KSDIWSLGVILyEL 787 (886)
. +++||+|||.+..+...... .....+|||.|.+||++..+..+ +.|+..+|.||+||++|||
T Consensus 211 ~-------GHikLADFGsClkm~~dG~V---------~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEM 274 (1317)
T KOG0612|consen 211 S-------GHIKLADFGSCLKMDADGTV---------RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEM 274 (1317)
T ss_pred c-------CcEeeccchhHHhcCCCCcE---------EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHH
Confidence 8 57999999999877654433 23556899999999999987766 7899999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 788 LTG~~PF~g~s~~el~~~I~~~~-rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
+.|..||...+..+.+..|.+.. .-.+| ....+++.+++||.+.+. +|+.|..
T Consensus 275 lyG~TPFYadslveTY~KIm~hk~~l~FP-------------------------~~~~VSeeakdLI~~ll~-~~e~RLg 328 (1317)
T KOG0612|consen 275 LYGETPFYADSLVETYGKIMNHKESLSFP-------------------------DETDVSEEAKDLIEALLC-DREVRLG 328 (1317)
T ss_pred HcCCCcchHHHHHHHHHHHhchhhhcCCC-------------------------cccccCHHHHHHHHHHhc-Chhhhcc
Confidence 99999999998888888887652 11122 112357789999999887 7889988
Q ss_pred ---HHHHHHHH
Q 002738 867 ---AGDLYEMF 874 (886)
Q Consensus 867 ---A~EILehL 874 (886)
++++..|.
T Consensus 329 rngiedik~Hp 339 (1317)
T KOG0612|consen 329 RNGIEDIKNHP 339 (1317)
T ss_pred cccHHHHHhCc
Confidence 99999984
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=313.69 Aligned_cols=263 Identities=23% Similarity=0.366 Sum_probs=215.7
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEec
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 625 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~~ 625 (886)
+-+.|++.+.||.|.+|.||+++. .++.+|+||...... .. +++ .-|..||+.+. |||++.+||+|.-
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d--~d---eEi----E~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED--EE---EEI----ELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc--cc---HHH----HHHHHHHHhccCCCCcceEEEEEEE
Confidence 345789999999999999999874 888999999654321 11 222 56888998886 9999999999986
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
... ....++|||||||.|||..++++... ...+.+..+..|++.++.||.|||.+.++|||||-.|||
T Consensus 88 ~~~---------~~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiL 155 (953)
T KOG0587|consen 88 KDP---------GNGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVL 155 (953)
T ss_pred ecC---------CCCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEE
Confidence 552 13457999999999999999999854 567999999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccC-CCCCCchhhHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~-~~~~s~KSDIWSLGVIL 784 (886)
++.++ .|||+|||.+..+..... ...+++|||.|||||++..... ...|+.++|+||||++.
T Consensus 156 LT~e~-------~VKLvDFGvSaQldsT~g----------rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITa 218 (953)
T KOG0587|consen 156 LTENA-------EVKLVDFGVSAQLDSTVG----------RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITA 218 (953)
T ss_pred EeccC-------cEEEeeeeeeeeeecccc----------cccCcCCCcccccceeeecccCCCCCcccccchhhcccee
Confidence 99984 599999999987765332 2466789999999999986432 24578899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 002738 785 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 864 (886)
Q Consensus 785 yELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kR 864 (886)
.||.-|.+|+..+.+...+..|....+|.+.. +...+..+.++|..||..|-.+|
T Consensus 219 IEladG~PPl~DmHPmraLF~IpRNPPPkLkr-------------------------p~kWs~~FndFIs~cL~Kd~e~R 273 (953)
T KOG0587|consen 219 IEMAEGAPPLCDMHPMRALFLIPRNPPPKLKR-------------------------PKKWSKKFNDFISTCLVKDYEQR 273 (953)
T ss_pred ehhcCCCCCccCcchhhhhccCCCCCCccccc-------------------------hhhHHHHHHHHHHHHHhhccccC
Confidence 99999999999888877766665554443331 12236789999999999999999
Q ss_pred CCHHHHHHHH
Q 002738 865 PTAGDLYEMF 874 (886)
Q Consensus 865 PSA~EILehL 874 (886)
|+..++++|-
T Consensus 274 P~~~~ll~hp 283 (953)
T KOG0587|consen 274 PSTEELLKHP 283 (953)
T ss_pred cchhhhccCC
Confidence 9999999873
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=317.00 Aligned_cols=262 Identities=25% Similarity=0.388 Sum_probs=208.9
Q ss_pred CCCCceeeeeecccCceEEEEEEEC---------CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcce
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVE 618 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~~---------~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVr 618 (886)
+-.++.+.+.||+|+||.|++|... ...||||.. +..... .+.+.+ ..|+.+|+.+. ||||+.
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~--k~~~~~-~~~~~~----~~El~~m~~~g~H~niv~ 366 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKML--KENASS-SEKKDL----MSELNVLKELGKHPNIVN 366 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEec--ccccCc-HHHHHH----HHHHHHHHHhcCCcchhh
Confidence 3445567789999999999999841 446777764 433333 444444 99999999996 999999
Q ss_pred eeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHh---------ccCC--CcCCHHHHHHHHHHHHHHHH
Q 002738 619 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS---------ETGE--KHVSVKLALFIAQDVAAALV 687 (886)
Q Consensus 619 l~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~---------~~~~--~~Ls~~~i~~Ia~QIa~AL~ 687 (886)
++|++..... .++|+||+..|+|..|++..+ .... ..++....+.++.|||.||+
T Consensus 367 llG~~t~~~~--------------~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe 432 (609)
T KOG0200|consen 367 LLGACTQDGP--------------LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGME 432 (609)
T ss_pred heeeeccCCc--------------eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHH
Confidence 9999987543 699999999999999999744 1111 13889999999999999999
Q ss_pred HHHhCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccC--CCcccchhhhhcc
Q 002738 688 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG--TPRWMAPEVLRAM 765 (886)
Q Consensus 688 yLHs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vG--T~~YmAPEvL~~~ 765 (886)
||++.++|||||-..|||+..+ .++||+|||+|+.......... ....| ...|||||.+..
T Consensus 433 ~L~~~~~vHRDLAaRNVLi~~~-------~~~kIaDFGlar~~~~~~~y~~---------~~~~~~LP~kWmApEsl~~- 495 (609)
T KOG0200|consen 433 YLASVPCVHRDLAARNVLITKN-------KVIKIADFGLARDHYNKDYYRT---------KSSAGTLPVKWMAPESLFD- 495 (609)
T ss_pred HHhhCCccchhhhhhhEEecCC-------CEEEEccccceeccCCCCceEe---------cCCCCccceeecCHHHhcc-
Confidence 9999999999999999999987 5799999999986544332210 11122 345999999986
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC-HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhh
Q 002738 766 HKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 843 (886)
Q Consensus 766 ~~~~~~s~KSDIWSLGVILyELLT-G~~PF~g~s-~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (886)
..|+.++|||||||+||||+| |..||.+.. ..++...+..+.+...|..
T Consensus 496 ---~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~-------------------------- 546 (609)
T KOG0200|consen 496 ---RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEH-------------------------- 546 (609)
T ss_pred ---CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCC--------------------------
Confidence 789999999999999999998 899999866 6677777888877555432
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 002738 844 ETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 878 (886)
Q Consensus 844 ~~s~~L~dLL~rCL~~DP~kRPSA~EILehLe~l~ 878 (886)
+.+++.+|+..||+.+|++||++.++.+.|..+.
T Consensus 547 -c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 547 -CSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred -CCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 3557899999999999999999999999998753
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=298.52 Aligned_cols=279 Identities=20% Similarity=0.256 Sum_probs=206.1
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC--CCC----cceeee
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSC----IVEMYG 621 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~--HPN----IVrl~g 621 (886)
-++|.+...+|+|.||.|-.+.+ .+..||+||++ .+..+.+..+-|+.+|.+|. -|+ +|++.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik---------~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIK---------NVDKYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHH---------HHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 57899999999999999999987 45688999853 23334444577999999995 233 778888
Q ss_pred eEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 002738 622 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 701 (886)
Q Consensus 622 ~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKP 701 (886)
||...+ +.|||+|.+ |-|+.++|.. +...+++...++.|++|++.+++|||+.+++|-||||
T Consensus 159 wFdyrg--------------hiCivfell-G~S~~dFlk~---N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKP 220 (415)
T KOG0671|consen 159 WFDYRG--------------HICIVFELL-GLSTFDFLKE---NNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKP 220 (415)
T ss_pred hhhccC--------------ceEEEEecc-ChhHHHHhcc---CCccccchHHHHHHHHHHHHHHHHHHhcceeecCCCh
Confidence 877544 579999999 5799999986 5567899999999999999999999999999999999
Q ss_pred CCEEEecccc-------------CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC
Q 002738 702 ENILIDLERK-------------KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 768 (886)
Q Consensus 702 sNILLd~d~~-------------~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~ 768 (886)
+|||+..... .......++|+|||.|+...... ...+.|..|.|||++.+
T Consensus 221 ENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-------------s~iVsTRHYRAPEViLg---- 283 (415)
T KOG0671|consen 221 ENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-------------STIVSTRHYRAPEVILG---- 283 (415)
T ss_pred heEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-------------ceeeeccccCCchheec----
Confidence 9999965421 12235679999999998654422 34578999999999998
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHH-hhhcccccccccccCCCCC----------
Q 002738 769 NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL-EALGSCHEHEVAQSGSGFE---------- 837 (886)
Q Consensus 769 ~~~s~KSDIWSLGVILyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l-~~~~~~~~~~~~~~~~~~~---------- 837 (886)
-.++.++||||+||||+||.||...|++-+..+-+..+..... ++|..+ .... ....+......|.
T Consensus 284 LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlG-p~P~~mi~r~~--~~Kyf~~~rldw~e~~~~~~~k~ 360 (415)
T KOG0671|consen 284 LGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILG-PIPSRMIKKTR--KEKYFRRGRLDWPEVSSKGKSKY 360 (415)
T ss_pred cCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhC-CCcHHHhhhhh--hHhhhhcccccCccccccccchh
Confidence 7799999999999999999999999988765553333333222 233222 1110 0011111111000
Q ss_pred -----Cc-----hhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002738 838 -----KP-----EAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 875 (886)
Q Consensus 838 -----~~-----~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EILehLe 875 (886)
.+ ........+|.+||++||.+||.+|+|+.|+|.|-.
T Consensus 361 v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpF 408 (415)
T KOG0671|consen 361 VFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPF 408 (415)
T ss_pred hhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHH
Confidence 00 011233457999999999999999999999999854
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=269.34 Aligned_cols=276 Identities=20% Similarity=0.252 Sum_probs=212.1
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
.+|...++||+|.||+||+|+. ..+-||+|.++++........ ..++||-+|+.|+|.|||+++++...+..
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvps------salreicllkelkhknivrl~dvlhsdkk 75 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPS------SALREICLLKELKHKNIVRLHDVLHSDKK 75 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcH------HHHHHHHHHHHhhhcceeehhhhhccCce
Confidence 4677889999999999999996 556788888877654433322 33899999999999999999999876663
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
+-+|+|||. .+|..|+.. -++.++.+.++.++.|+++||.|+|++++.||||||.|+||+.
T Consensus 76 --------------ltlvfe~cd-qdlkkyfds----lng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ 136 (292)
T KOG0662|consen 76 --------------LTLVFEFCD-QDLKKYFDS----LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINR 136 (292)
T ss_pred --------------eEEeHHHhh-HHHHHHHHh----cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEecc
Confidence 689999997 689888876 3567899999999999999999999999999999999999998
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.+||+|||+|+.+.-+.... ...+-|..|.+|.++.+ ..-|++..|+||.|||+.|+.
T Consensus 137 n-------gelkladfglarafgipvrcy----------saevvtlwyrppdvlfg---akly~tsidmwsagcifaela 196 (292)
T KOG0662|consen 137 N-------GELKLADFGLARAFGIPVRCY----------SAEVVTLWYRPPDVLFG---AKLYSTSIDMWSAGCIFAELA 196 (292)
T ss_pred C-------CcEEecccchhhhcCCceEee----------eceeeeeeccCcceeee---eehhccchHhhhcchHHHHHh
Confidence 8 569999999999876543221 12357899999999987 467899999999999999998
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCc----hhhhhhHHHHHHHHHHhcccCCCC
Q 002738 789 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP----EAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 789 T-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~----~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
. |++.|++.+..+.+..|......+-.+.|+.+...+.... .+.+... ..-+.....-++|++++|.-+|..
T Consensus 197 nagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~---yp~ypattswsqivp~lns~grdllqkll~cnp~q 273 (292)
T KOG0662|consen 197 NAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP---YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQ 273 (292)
T ss_pred hcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc---cCCccccchHHHHhhhhcchhHHHHHHHhccCccc
Confidence 6 8888999988877777766533333333433322221110 0011111 111222334579999999999999
Q ss_pred CCCHHHHHHHH
Q 002738 864 RPTAGDLYEMF 874 (886)
Q Consensus 864 RPSA~EILehL 874 (886)
|+++++.++|-
T Consensus 274 risaeaalqhp 284 (292)
T KOG0662|consen 274 RISAEAALQHP 284 (292)
T ss_pred ccCHHHHhcCc
Confidence 99999999874
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=292.14 Aligned_cols=253 Identities=25% Similarity=0.379 Sum_probs=210.0
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
..+++|..++.||+|.||.|.+++- .+..+|+||.+.... ...+++..- +.|-++|+..+||.+..+--.|..
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKevi-iakdEVAHT----lTE~RVL~~~~HPFLt~LKYsFQt 239 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVI-IAKDEVAHT----LTENRVLQNCRHPFLTSLKYSFQT 239 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhhe-eehHHhhhh----hhHHHHHHhccCcHHHHhhhhhcc
Confidence 5789999999999999999999985 677899999754433 233344443 789999999999999988777776
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
.+ ++|+||||+.||.|.-.|.. ...+++..++.+...|+.||.|||+++||.||||.+|+|
T Consensus 240 ~d--------------rlCFVMeyanGGeLf~HLsr-----er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLl 300 (516)
T KOG0690|consen 240 QD--------------RLCFVMEYANGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLL 300 (516)
T ss_pred Cc--------------eEEEEEEEccCceEeeehhh-----hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhe
Confidence 55 47999999999999998876 467999999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
++.+ +.+||+|||+++.--....+ ..+++|||.|+|||++.. ..|+.++|.|.+||++|
T Consensus 301 LDkD-------GHIKitDFGLCKE~I~~g~t----------~kTFCGTPEYLAPEVleD----nDYgraVDWWG~GVVMY 359 (516)
T KOG0690|consen 301 LDKD-------GHIKITDFGLCKEEIKYGDT----------TKTFCGTPEYLAPEVLED----NDYGRAVDWWGVGVVMY 359 (516)
T ss_pred eccC-------CceEeeecccchhcccccce----------eccccCChhhcCchhhcc----ccccceeehhhhhHHHH
Confidence 9998 56999999999754332211 356789999999999986 78999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 786 ELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
||++|+.||...+...++..|..... .+| ...+++.+.|+..+|..||.+|.
T Consensus 360 EMmCGRLPFyn~dh~kLFeLIl~ed~-kFP---------------------------r~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 360 EMMCGRLPFYNKDHEKLFELILMEDL-KFP---------------------------RTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred HHHhccCcccccchhHHHHHHHhhhc-cCC---------------------------ccCCHHHHHHHHHHhhcChHhhc
Confidence 99999999999988888888865521 111 12345789999999999999994
Q ss_pred -----CHHHHHHH
Q 002738 866 -----TAGDLYEM 873 (886)
Q Consensus 866 -----SA~EILeh 873 (886)
.+.||.+|
T Consensus 412 GgGpdDakEi~~h 424 (516)
T KOG0690|consen 412 GGGPDDAKEIMRH 424 (516)
T ss_pred CCCchhHHHHHhh
Confidence 47777776
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=311.49 Aligned_cols=257 Identities=23% Similarity=0.318 Sum_probs=212.0
Q ss_pred ceeeeeecccCceEEEEEEE--C----CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 553 LSSCDEAGKSVSSSLFRCKF--G----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 553 Y~i~k~LG~G~fG~VY~A~~--~----~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
....++||.|+||+||+|.| . +.+||+|++.-.. ......+ ++.|+.+|.+|.|||+++++|++..+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t---~~~~s~e----~LdeAl~masldHpnl~RLLgvc~~s 770 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT---SPKASIE----LLDEALRMASLDHPNLLRLLGVCMLS 770 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC---CchhhHH----HHHHHHHHhcCCCchHHHHhhhcccc
Confidence 45678999999999999998 2 3478888863222 2222333 48999999999999999999999865
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
. +.||++|+++|+|.+|++. .+..+.....+.|..|||+||.|||.+++|||||-..||||
T Consensus 771 ~---------------~qlvtq~mP~G~LlDyvr~----hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV 831 (1177)
T KOG1025|consen 771 T---------------LQLVTQLMPLGCLLDYVRE----HRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV 831 (1177)
T ss_pred h---------------HHHHHHhcccchHHHHHHH----hhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee
Confidence 4 4899999999999999986 34568889999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
... ..+||.|||+|+.+........ .....-.+.|||-|.+.. ..|+.++|||||||++||
T Consensus 832 ksP-------~hvkitdfgla~ll~~d~~ey~--------~~~gK~pikwmale~i~~----~~~thqSDVWsfGVtiWE 892 (1177)
T KOG1025|consen 832 KSP-------NHVKITDFGLAKLLAPDEKEYS--------APGGKVPIKWMALESIRI----RKYTHQSDVWSFGVTIWE 892 (1177)
T ss_pred cCC-------CeEEEEecchhhccCccccccc--------ccccccCcHHHHHHHhhc----cCCCchhhhhhhhhhHHH
Confidence 877 4699999999998876543321 112234578999999886 789999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 787 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 787 LLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
|+| |..||.+....++-..+..+.+..-|. .++-++.-++.+||..|+..||
T Consensus 893 lmTFGa~Py~gi~~~eI~dlle~geRLsqPp---------------------------iCtiDVy~~mvkCwmid~~~rp 945 (1177)
T KOG1025|consen 893 LMTFGAKPYDGIPAEEIPDLLEKGERLSQPP---------------------------ICTIDVYMVMVKCWMIDADSRP 945 (1177)
T ss_pred HHhcCCCccCCCCHHHhhHHHhccccCCCCC---------------------------CccHHHHHHHHHHhccCcccCc
Confidence 998 999999999999998888876633331 2345788999999999999999
Q ss_pred CHHHHHHHHHhhcCCC
Q 002738 866 TAGDLYEMFVARTSSS 881 (886)
Q Consensus 866 SA~EILehLe~l~sss 881 (886)
+|+++.+.+.++.+.+
T Consensus 946 ~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 946 TFKELAEEFSRMARDP 961 (1177)
T ss_pred cHHHHHHHHHHHhcCc
Confidence 9999999998887654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=302.26 Aligned_cols=256 Identities=26% Similarity=0.325 Sum_probs=216.6
Q ss_pred CCCCCCceeeeeecccCceEEEEEEECCee--EEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEe
Q 002738 547 PGSFPSLSSCDEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 624 (886)
Q Consensus 547 ~~~~~~Y~i~k~LG~G~fG~VY~A~~~~~~--VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~ 624 (886)
...+.+++++..||-||||.|=++..+... +|+|+.+.+.... ....+. +..|-.||..++.|.||++|-.|.
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd-tkQqeH----v~sEr~Im~~~~s~fIvrLYrTfr 490 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD-TKQQEH----VFSERNIMMECRSDFIVRLYRTFR 490 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccc-hhHHHH----HHhHHHHHHhcCchHHHHHHHHhc
Confidence 356778889999999999999999987666 6888764333222 223333 378999999999999999999999
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNI 704 (886)
++.+ +|++||-|-||.|...|++ ++.|...+++.++..++.|++|||++|||+|||||+|.
T Consensus 491 d~ky--------------vYmLmEaClGGElWTiLrd-----Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENl 551 (732)
T KOG0614|consen 491 DSKY--------------VYMLMEACLGGELWTILRD-----RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENL 551 (732)
T ss_pred cchh--------------hhhhHHhhcCchhhhhhhh-----cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhhe
Confidence 8775 5999999999999999987 57899999999999999999999999999999999999
Q ss_pred EEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVIL 784 (886)
|++.+ +.+||.|||+|+.+.....+ .+++|||.|.|||++.+ .....++|.||||+++
T Consensus 552 lLd~~-------Gy~KLVDFGFAKki~~g~KT-----------wTFcGTpEYVAPEIILn----KGHD~avDyWaLGIli 609 (732)
T KOG0614|consen 552 LLDNR-------GYLKLVDFGFAKKIGSGRKT-----------WTFCGTPEYVAPEIILN----KGHDRAVDYWALGILI 609 (732)
T ss_pred eeccC-------CceEEeehhhHHHhccCCce-----------eeecCCcccccchhhhc----cCcchhhHHHHHHHHH
Confidence 99988 67999999999998775544 45789999999999987 6678899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 785 LELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 785 yELLTG~~PF~g~s~~el~~~I~~~~-rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
|||++|.+||.+.+++..+..|.++. .-.+|. .+.....+||.++...+|.+
T Consensus 610 ~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr---------------------------~I~k~a~~Lik~LCr~~P~E 662 (732)
T KOG0614|consen 610 YELLTGSPPFSGVDPMKTYNLILKGIDKIEFPR---------------------------RITKTATDLIKKLCRDNPTE 662 (732)
T ss_pred HHHHcCCCCCCCCchHHHHHHHHhhhhhhhccc---------------------------ccchhHHHHHHHHHhcCcHh
Confidence 99999999999999999999998873 222221 23446889999999999999
Q ss_pred CCC-----HHHHHHHHH
Q 002738 864 RPT-----AGDLYEMFV 875 (886)
Q Consensus 864 RPS-----A~EILehLe 875 (886)
|.. +.+|-+|-+
T Consensus 663 RLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 663 RLGYQKGGINDIKKHRW 679 (732)
T ss_pred hhccccCChHHHHhhhh
Confidence 975 788888854
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=285.36 Aligned_cols=259 Identities=24% Similarity=0.318 Sum_probs=199.7
Q ss_pred CCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhh-CCCCCcceeeeeEecCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGA-LRHSCIVEMYGHKISSK 627 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~-L~HPNIVrl~g~~~~~~ 627 (886)
.+++-+..||.|+||+|++-.++ +...|||.+... .. ..+.+ +++.|.....+ -+.||||++||+...++
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~--n~-~keq~----rll~e~d~~mks~~cp~IVkfyGa~F~EG 136 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSN--NI-EKEQK----RLLMEHDTVMKSSNCPNIVKFYGALFSEG 136 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeec--cc-hHHHH----HHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence 45566788999999999999874 556666665433 22 22333 44888877554 46999999999988665
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEEE
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILI 706 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~-gIVHRDLKPsNILL 706 (886)
.+||.||+|+ .||..+-+....-....+++..+-.|....+.||.||-.. .||||||||+|||+
T Consensus 137 --------------dcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl 201 (361)
T KOG1006|consen 137 --------------DCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL 201 (361)
T ss_pred --------------ceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE
Confidence 3799999997 7888776654444456799999999999999999999865 89999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+..+ .+||||||++-.+..... .+.-+|-..|||||.+.... ..|..+|||||||++|||
T Consensus 202 dr~G-------~vKLCDFGIcGqLv~SiA-----------kT~daGCrpYmAPERi~p~~--~gyDiRSDvWSLGITL~E 261 (361)
T KOG1006|consen 202 DRHG-------DVKLCDFGICGQLVDSIA-----------KTVDAGCRPYMAPERIDPSD--KGYDIRSDVWSLGITLYE 261 (361)
T ss_pred ecCC-------CEeeecccchHhHHHHHH-----------hhhccCCccccChhccCCcc--CCcchhhhhhhhcceEee
Confidence 9884 599999999976654321 23446889999999998632 368999999999999999
Q ss_pred HHhCCCCCCCCCH-HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 002738 787 LLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 787 LLTG~~PF~g~s~-~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRP 865 (886)
+.||..||.+.+. .+.+..+..+..|.+.. +....+.+..+..+|.-||.+|-..||
T Consensus 262 vAtG~fPyr~w~svfeql~~Vv~gdpp~l~~----------------------~~~~~~~s~~~~~fintCl~Kd~~~Rp 319 (361)
T KOG1006|consen 262 VATGNFPYRKWDSVFEQLCQVVIGDPPILLF----------------------DKECVHYSFSMVRFINTCLIKDRSDRP 319 (361)
T ss_pred eecCCCCcchHHHHHHHHHHHHcCCCCeecC----------------------cccccccCHHHHHHHHHHhhcccccCc
Confidence 9999999987643 34455555665554432 112233466899999999999999999
Q ss_pred CHHHHHHH
Q 002738 866 TAGDLYEM 873 (886)
Q Consensus 866 SA~EILeh 873 (886)
...+++++
T Consensus 320 ky~~Lk~~ 327 (361)
T KOG1006|consen 320 KYDDLKKF 327 (361)
T ss_pred chhhhhcC
Confidence 99999875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=275.03 Aligned_cols=224 Identities=21% Similarity=0.153 Sum_probs=171.6
Q ss_pred cCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCCCcc
Q 002738 562 SVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHH 639 (886)
Q Consensus 562 G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~~~~~~~ 639 (886)
|.||.||++++ .+..+|+|...... .+ .+|...+....||||+++++++....
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~----~~~~~~~~~~~~~~i~~~~~~~~~~~------------ 58 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EY----SRERLTIIPHCVPNMVCLHKYIVSED------------ 58 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---------hh----hhHHHHHHhcCCCceeehhhheecCC------------
Confidence 89999999997 66778999864321 11 34555556667999999999987654
Q ss_pred cceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCCCCCeE
Q 002738 640 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 719 (886)
Q Consensus 640 ~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~~~~V 719 (886)
..++||||++|++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+
T Consensus 59 --~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~-------~~~ 124 (237)
T cd05576 59 --SVFLVLQHAEGGKLWSHISK-----FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR-------GHI 124 (237)
T ss_pred --eEEEEEecCCCCCHHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-------CCE
Confidence 36999999999999999976 2358999999999999999999999999999999999999877 459
Q ss_pred EEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 002738 720 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE 799 (886)
Q Consensus 720 KLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF~g~s~ 799 (886)
+|+|||.+....... ....++..|+|||++.+ ..++.++||||+|+++|||++|..||.....
T Consensus 125 ~l~df~~~~~~~~~~-------------~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~g~~~~~~~~~ 187 (237)
T cd05576 125 QLTYFSRWSEVEDSC-------------DGEAVENMYCAPEVGGI----SEETEACDWWSLGAILFELLTGKTLVECHPS 187 (237)
T ss_pred EEecccchhcccccc-------------ccCCcCccccCCcccCC----CCCCchhhHHHHHHHHHHHHHCcchhhcCch
Confidence 999999876543311 11235678999999865 5678899999999999999999988743211
Q ss_pred HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 002738 800 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA-----GDLYEM 873 (886)
Q Consensus 800 ~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA-----~EILeh 873 (886)
. +.......+ +...++.+.+||.+||+.||.+||++ +++++|
T Consensus 188 ~-----~~~~~~~~~---------------------------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 234 (237)
T cd05576 188 G-----INTHTTLNI---------------------------PEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSH 234 (237)
T ss_pred h-----cccccccCC---------------------------cccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcC
Confidence 0 000000000 01134578999999999999999996 777765
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=302.21 Aligned_cols=242 Identities=25% Similarity=0.256 Sum_probs=195.2
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcceeeeeEec
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 625 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl~g~~~~ 625 (886)
..+.|.+...+|.|+|+.|-.+.. .+...+||++..... . ..+|+.++... +||||+++++.+.+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~--~----------~~~e~~~~~~~~~h~niv~~~~v~~~ 387 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD--D----------NQDEIPISLLVRDHPNIVKSHDVYED 387 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc--c----------cccccchhhhhcCCCcceeecceecC
Confidence 467899999999999999999986 677889999643311 1 14577676666 49999999999886
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
.. +.|+|||++.|+-|.+.+.. ......++..|+.+|+.|+.|||.+|||||||||+|||
T Consensus 388 ~~--------------~~~~v~e~l~g~ell~ri~~------~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL 447 (612)
T KOG0603|consen 388 GK--------------EIYLVMELLDGGELLRRIRS------KPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNIL 447 (612)
T ss_pred Cc--------------eeeeeehhccccHHHHHHHh------cchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhhee
Confidence 55 47999999999888888765 22233778889999999999999999999999999999
Q ss_pred Ee-ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 002738 706 ID-LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 706 Ld-~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVIL 784 (886)
++ .. ++++|+|||.++....... +..-|..|.|||++.. ..|++++||||||++|
T Consensus 448 ~~~~~-------g~lrltyFG~a~~~~~~~~-------------tp~~t~~y~APEvl~~----~~yt~acD~WSLGvlL 503 (612)
T KOG0603|consen 448 LDGSA-------GHLRLTYFGFWSELERSCD-------------TPALTLQYVAPEVLAI----QEYTEACDWWSLGVLL 503 (612)
T ss_pred ecCCC-------CcEEEEEechhhhCchhhc-------------ccchhhcccChhhhcc----CCCCcchhhHHHHHHH
Confidence 96 43 5799999999987765311 1246889999999985 7899999999999999
Q ss_pred HHHHhCCCCCCCCCHH-HHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 785 LELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 785 yELLTG~~PF~g~s~~-el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
|+|++|+.||...... ++...+..+.. . ..+++.+++||.+||+.||.+
T Consensus 504 y~ML~G~tp~~~~P~~~ei~~~i~~~~~---s---------------------------~~vS~~AKdLl~~LL~~dP~~ 553 (612)
T KOG0603|consen 504 YEMLTGRTLFAAHPAGIEIHTRIQMPKF---S---------------------------ECVSDEAKDLLQQLLQVDPAL 553 (612)
T ss_pred HHHHhCCCccccCCchHHHHHhhcCCcc---c---------------------------cccCHHHHHHHHHhccCChhh
Confidence 9999999999765444 55555543321 1 224678999999999999999
Q ss_pred CCCHHHHHHHHHh
Q 002738 864 RPTAGDLYEMFVA 876 (886)
Q Consensus 864 RPSA~EILehLe~ 876 (886)
||++.++..|-+.
T Consensus 554 Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 554 RLGADEIGAHPWF 566 (612)
T ss_pred CcChhhhccCcch
Confidence 9999999999766
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=288.42 Aligned_cols=249 Identities=25% Similarity=0.308 Sum_probs=202.7
Q ss_pred CCCCCCCCceeeeeecccCceEEEEEEECC--eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeee
Q 002738 545 LDPGSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYG 621 (886)
Q Consensus 545 ~~~~~~~~Y~i~k~LG~G~fG~VY~A~~~~--~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g 621 (886)
.+.+...+|.++..||+|+||.|.+|..++ +.+||||.+.+..... +.++-- +.|-++|.... -|.+++++.
T Consensus 343 ~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd-DDvect----m~EKrvLAL~~kppFL~qlHS 417 (683)
T KOG0696|consen 343 RDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD-DDVECT----MVEKRVLALPGKPPFLVQLHS 417 (683)
T ss_pred ccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeec-Ccccce----ehhhhheecCCCCchHHHHHH
Confidence 344667889999999999999999998744 5689998654433222 222222 55777777664 789999999
Q ss_pred eEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 002738 622 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 701 (886)
Q Consensus 622 ~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKP 701 (886)
+|.+.+. +|+||||+.||+|...|++ -+.+.+..+..++..|+-||-|||++|||.||||.
T Consensus 418 cFQTmDR--------------LyFVMEyvnGGDLMyhiQQ-----~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKL 478 (683)
T KOG0696|consen 418 CFQTMDR--------------LYFVMEYVNGGDLMYHIQQ-----VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKL 478 (683)
T ss_pred Hhhhhhh--------------eeeEEEEecCchhhhHHHH-----hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccc
Confidence 9987764 6999999999999999987 35688889999999999999999999999999999
Q ss_pred CCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 002738 702 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781 (886)
Q Consensus 702 sNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLG 781 (886)
+|||++.+ +.+||+|||+++.---... ...++.|||.|+|||++.. .+|+..+|.||||
T Consensus 479 DNvmLd~e-------GHiKi~DFGmcKEni~~~~----------TTkTFCGTPdYiAPEIi~Y----qPYgksvDWWa~G 537 (683)
T KOG0696|consen 479 DNVMLDSE-------GHIKIADFGMCKENIFDGV----------TTKTFCGTPDYIAPEIIAY----QPYGKSVDWWAFG 537 (683)
T ss_pred cceEeccC-------CceEeeecccccccccCCc----------ceeeecCCCcccccceEEe----cccccchhHHHHH
Confidence 99999988 5699999999975432221 2356789999999999987 8899999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 002738 782 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 861 (886)
Q Consensus 782 VILyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP 861 (886)
|+||||+.|++||.+.+..++.+.|....- .+| ...+.+..++....|...|
T Consensus 538 VLLyEmlaGQpPFdGeDE~elF~aI~ehnv-syP---------------------------KslSkEAv~ickg~ltK~P 589 (683)
T KOG0696|consen 538 VLLYEMLAGQPPFDGEDEDELFQAIMEHNV-SYP---------------------------KSLSKEAVAICKGLLTKHP 589 (683)
T ss_pred HHHHHHHcCCCCCCCCCHHHHHHHHHHccC-cCc---------------------------ccccHHHHHHHHHHhhcCC
Confidence 999999999999999999999999876421 111 1235578889999999999
Q ss_pred CCCCC
Q 002738 862 TERPT 866 (886)
Q Consensus 862 ~kRPS 866 (886)
.+|..
T Consensus 590 ~kRLG 594 (683)
T KOG0696|consen 590 GKRLG 594 (683)
T ss_pred ccccC
Confidence 99953
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=260.90 Aligned_cols=238 Identities=33% Similarity=0.436 Sum_probs=187.8
Q ss_pred CceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCCCccc
Q 002738 563 VSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640 (886)
Q Consensus 563 ~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~~~~~~~~ 640 (886)
+||.||+|.+. +..+++|+........ ..+ .+.+|+..+++++|+||+++++.+....
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~~~----~~~~e~~~~~~l~~~~i~~~~~~~~~~~------------- 60 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK---KRE----RILREISILKKLKHPNIVRLYDVFEDED------------- 60 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccccc---HHH----HHHHHHHHHHhCCCCcHHHHHhheeeCC-------------
Confidence 68999999984 5789999865432211 123 3489999999999999999999987644
Q ss_pred ceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCCCCCeEE
Q 002738 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 720 (886)
Q Consensus 641 ~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~~~~VK 720 (886)
..+++|||+++++|.+++.. ...+++..++.++.+++.+|.|||+.+|+|+||+|.||+++.+ +.++
T Consensus 61 -~~~l~~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~-------~~~~ 127 (244)
T smart00220 61 -KLYLVMEYCDGGDLFDLLKK-----RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED-------GHVK 127 (244)
T ss_pred -EEEEEEeCCCCCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC-------CcEE
Confidence 46999999998999999976 2238899999999999999999999999999999999999877 4699
Q ss_pred EeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCH
Q 002738 721 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG-LSE 799 (886)
Q Consensus 721 LsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF~g-~s~ 799 (886)
|+|||.+........ .....++..|++||.+.+ ..++.++||||||+++|+|++|..||.. ...
T Consensus 128 l~d~~~~~~~~~~~~-----------~~~~~~~~~~~~pE~~~~----~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~ 192 (244)
T smart00220 128 LADFGLARQLDPGGL-----------LTTFVGTPEYMAPEVLLG----KGYGKAVDVWSLGVILYELLTGKPPFPGDDQL 192 (244)
T ss_pred Eccccceeeeccccc-----------cccccCCcCCCCHHHHcc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 999999987654321 123458889999999875 5678899999999999999999999977 444
Q ss_pred HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002738 800 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 873 (886)
Q Consensus 800 ~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EILeh 873 (886)
..+...+.......... ....+..+.+++.+||..+|.+||++.++++|
T Consensus 193 ~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 193 LELFKKIGKPKPPFPPP-------------------------EWKISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred HHHHHHHhccCCCCccc-------------------------cccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 44444444332211110 00024578999999999999999999999985
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=291.03 Aligned_cols=256 Identities=24% Similarity=0.291 Sum_probs=201.8
Q ss_pred CCCCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeE
Q 002738 546 DPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 623 (886)
Q Consensus 546 ~~~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~ 623 (886)
.|...+.|..-+.||+||||.||-++. .+.-+|.|....+.. ..+.-+...++|-.||.++..+.||.+--+|
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRi-----Kkr~ge~maLnEk~iL~kV~s~FiVslaYAf 254 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRI-----KKRKGETMALNEKQILEKVSSPFIVSLAYAF 254 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHH-----HHhhhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence 456778899999999999999999875 566677765432211 1122223458899999999999999998888
Q ss_pred ecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 002738 624 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703 (886)
Q Consensus 624 ~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsN 703 (886)
.+.+. +|+||..|.||+|.-+|.+ .+...|++..++.++.+|+.||++||+++||.|||||+|
T Consensus 255 eTkd~--------------LClVLtlMNGGDLkfHiyn---~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeN 317 (591)
T KOG0986|consen 255 ETKDA--------------LCLVLTLMNGGDLKFHIYN---HGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPEN 317 (591)
T ss_pred cCCCc--------------eEEEEEeecCCceeEEeec---cCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhh
Confidence 87764 6999999999999999987 344579999999999999999999999999999999999
Q ss_pred EEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHH
Q 002738 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783 (886)
Q Consensus 704 ILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVI 783 (886)
||+|.. +.+.|+|+|+|..+...... ...+||.+|||||++.+ ..|+...|.|||||+
T Consensus 318 ILLDd~-------GhvRISDLGLAvei~~g~~~-----------~~rvGT~GYMAPEvl~n----e~Y~~s~Dwf~lGCl 375 (591)
T KOG0986|consen 318 ILLDDH-------GHVRISDLGLAVEIPEGKPI-----------RGRVGTVGYMAPEVLQN----EVYDFSPDWFSLGCL 375 (591)
T ss_pred eeeccC-------CCeEeeccceEEecCCCCcc-----------ccccCcccccCHHHHcC----CcccCCccHHHHHhH
Confidence 999988 56999999999987654322 33489999999999987 669999999999999
Q ss_pred HHHHHhCCCCCCCCCHH----HHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 002738 784 LLELLTLQVPYMGLSEL----EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 859 (886)
Q Consensus 784 LyELLTG~~PF~g~s~~----el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~ 859 (886)
||||+.|+.||.....- ++-..+... ... .....++++++|.+.+|..
T Consensus 376 lYemi~G~sPFr~~KeKvk~eEvdrr~~~~-~~e---------------------------y~~kFS~eakslc~~LL~K 427 (591)
T KOG0986|consen 376 LYEMIAGHSPFRQRKEKVKREEVDRRTLED-PEE---------------------------YSDKFSEEAKSLCEGLLTK 427 (591)
T ss_pred HHHHHcccCchhhhhhhhhHHHHHHHHhcc-hhh---------------------------cccccCHHHHHHHHHHHcc
Confidence 99999999999654322 222222221 111 1122467899999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 002738 860 NPTERP-----TAGDLYEM 873 (886)
Q Consensus 860 DP~kRP-----SA~EILeh 873 (886)
||.+|. .+++|.+|
T Consensus 428 dp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 428 DPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred CHHHhccCCCcCcchhhhC
Confidence 999996 45677665
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=301.31 Aligned_cols=285 Identities=15% Similarity=0.109 Sum_probs=173.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEEC------CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeee
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 621 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~------~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g 621 (886)
...++|++.+.||+|+||.||+|++. +..+|+|... .. ... +.. ..| .+....+.+++.++.
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~--~~--~~~--e~~----~~e--~l~~~~~~~~~~~~~ 196 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKAT--EY--GAV--EIW----MNE--RVRRACPNSCADFVY 196 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEec--cc--chh--HHH----HHH--HHHhhchhhHHHHHH
Confidence 46789999999999999999999973 5678888743 11 111 110 111 122223334443333
Q ss_pred eEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhcc---------------CCCcCCHHHHHHHHHHHHHHH
Q 002738 622 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---------------GEKHVSVKLALFIAQDVAAAL 686 (886)
Q Consensus 622 ~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~---------------~~~~Ls~~~i~~Ia~QIa~AL 686 (886)
.+..... .......+|||||+.+++|.+++...... .........+..|+.||+.||
T Consensus 197 ~~~~~~~--------~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL 268 (566)
T PLN03225 197 GFLEPVS--------SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFAL 268 (566)
T ss_pred hhhcccc--------cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHH
Confidence 3221110 01223579999999999999998751100 001112345678999999999
Q ss_pred HHHHhCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 002738 687 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 766 (886)
Q Consensus 687 ~yLHs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~ 766 (886)
.|||+++|+||||||+|||++.+. +.+||+|||+|+.+..... .......+|+.|||||.+....
T Consensus 269 ~yLH~~gIiHRDLKP~NILl~~~~------~~~KL~DFGlA~~l~~~~~---------~~~~~~~~t~~Y~APE~~~~~~ 333 (566)
T PLN03225 269 DGLHSTGIVHRDVKPQNIIFSEGS------GSFKIIDLGAAADLRVGIN---------YIPKEFLLDPRYAAPEQYIMST 333 (566)
T ss_pred HHHHHCCEEeCcCCHHHEEEeCCC------CcEEEEeCCCccccccccc---------cCCcccccCCCccChHHhhccC
Confidence 999999999999999999998642 4699999999976543211 1123457899999999765311
Q ss_pred CC------------------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccccc
Q 002738 767 KP------------------NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE 828 (886)
Q Consensus 767 ~~------------------~~~s~KSDIWSLGVILyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~ 828 (886)
.. ..++.++|||||||+||||+++..|+... ...+...+..... .+........ ...
T Consensus 334 ~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~-~~~~~~~~~~---~~~ 408 (566)
T PLN03225 334 QTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDY-DLVAWRKLVE---PRA 408 (566)
T ss_pred CCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCC-cHHHHHHhhc---ccc
Confidence 10 12345679999999999999977664321 2222222222211 1111100000 000
Q ss_pred ccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002738 829 VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 875 (886)
Q Consensus 829 ~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EILehLe 875 (886)
.......+ ...........+||.+||++||.+|||+.++++|-.
T Consensus 409 ~~~~~~~~---~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpf 452 (566)
T PLN03225 409 SPDLRRGF---EVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPY 452 (566)
T ss_pred chhhhhhh---hhccccchHHHHHHHHHccCCcccCCCHHHHhCCcC
Confidence 00000000 000111235679999999999999999999999944
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=289.19 Aligned_cols=272 Identities=21% Similarity=0.230 Sum_probs=211.6
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|-++.+||+|||+.||+|.+ ....|||||..+..... .+..+++-.-..+|.+|-+.|.||.||++|++|..+..
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~Wr-dEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWR-DEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchh-hHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 5799999999999999999986 77899999987665332 23334444556899999999999999999999986543
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhC--CccccCCCCCCEEE
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--HIMHRDIKSENILI 706 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~--gIVHRDLKPsNILL 706 (886)
.+|-|+|||+|.+|.=||+. ...+++.+++.|+.||+.||.||... .|||-||||.|||+
T Consensus 542 -------------sFCTVLEYceGNDLDFYLKQ-----hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILL 603 (775)
T KOG1151|consen 542 -------------SFCTVLEYCEGNDLDFYLKQ-----HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILL 603 (775)
T ss_pred -------------cceeeeeecCCCchhHHHHh-----hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEE
Confidence 36999999999999999987 46789999999999999999999976 69999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
-... ..+.+||+|||+++.+...... ...+.....-..||..|++||.+.-.......+.|+||||+|||+|.
T Consensus 604 v~Gt----acGeIKITDFGLSKIMdddSy~---~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQ 676 (775)
T KOG1151|consen 604 VNGT----ACGEIKITDFGLSKIMDDDSYN---SVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQ 676 (775)
T ss_pred ecCc----ccceeEeeecchhhhccCCccC---cccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhh
Confidence 7653 3577999999999988765433 12233334446799999999998754444668899999999999999
Q ss_pred HHhCCCCCCCCCHHH-HHH--HHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 787 LLTLQVPYMGLSELE-IHD--LIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 787 LLTG~~PF~g~s~~e-l~~--~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
.+.|+.||......+ ++. .|.+...-.+| ..+..+.+..+||.+||++--++
T Consensus 677 ClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP-------------------------~KPvVsseAkaFIRRCLaYRKeD 731 (775)
T KOG1151|consen 677 CLYGRKPFGHNQSQQDILQENTILKATEVQFP-------------------------PKPVVSSEAKAFIRRCLAYRKED 731 (775)
T ss_pred hhccCCCCCCchhHHHHHhhhchhcceeccCC-------------------------CCCccCHHHHHHHHHHHHhhhhh
Confidence 999999996553322 221 11111110111 00123557899999999999999
Q ss_pred CCCHHHHHHH
Q 002738 864 RPTAGDLYEM 873 (886)
Q Consensus 864 RPSA~EILeh 873 (886)
|....++..+
T Consensus 732 R~DV~qLA~d 741 (775)
T KOG1151|consen 732 RIDVQQLACD 741 (775)
T ss_pred hhhHHHHccC
Confidence 9999998765
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=279.43 Aligned_cols=136 Identities=21% Similarity=0.273 Sum_probs=115.2
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-----C---CCcceee
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-----H---SCIVEMY 620 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-----H---PNIVrl~ 620 (886)
++|.+.++||-|.|++||+|.+ ..+.||+||.+- .+.+.+..+.||++|++++ | .+||+++
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS---------AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll 148 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS---------AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL 148 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh---------hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence 6899999999999999999997 678899999652 2344455689999999984 2 3699999
Q ss_pred eeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhC-CccccCC
Q 002738 621 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDI 699 (886)
Q Consensus 621 g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~-gIVHRDL 699 (886)
+.|..... +..++|+|+|++ |-+|..+|.. ...+.++...++.|++||+.||.|||.+ ||||-||
T Consensus 149 D~FkhsGp----------NG~HVCMVfEvL-GdnLLklI~~---s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDl 214 (590)
T KOG1290|consen 149 DHFKHSGP----------NGQHVCMVFEVL-GDNLLKLIKY---SNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDL 214 (590)
T ss_pred ccceecCC----------CCcEEEEEehhh-hhHHHHHHHH---hCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCC
Confidence 99997653 466899999999 6799999987 3345689999999999999999999986 9999999
Q ss_pred CCCCEEEecc
Q 002738 700 KSENILIDLE 709 (886)
Q Consensus 700 KPsNILLd~d 709 (886)
||+|||+...
T Consensus 215 KPENvLl~~~ 224 (590)
T KOG1290|consen 215 KPENVLLCST 224 (590)
T ss_pred Ccceeeeecc
Confidence 9999999543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=265.00 Aligned_cols=272 Identities=21% Similarity=0.289 Sum_probs=203.9
Q ss_pred CCCCCceeeeeecccCceEEEEEE--ECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEe
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCK--FGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 624 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~--~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~ 624 (886)
...++|++.+++|+|-|+.||.|. .++..+++|+.+ + ...+ .+.+|+.||..|. |||||.++++..
T Consensus 35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK--P-----Vkkk----KIkREikIL~nL~gg~NIi~L~DiV~ 103 (338)
T KOG0668|consen 35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK--P-----VKKK----KIKREIKILQNLRGGPNIIKLLDIVK 103 (338)
T ss_pred cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeec--h-----HHHH----HHHHHHHHHHhccCCCCeeehhhhhc
Confidence 456799999999999999999998 478889999853 2 2223 3489999999998 999999999988
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNI 704 (886)
++.. ..+.||+||+.+.+...+.. .++...++..+.+++.||.|+|++||+|||+||.|+
T Consensus 104 Dp~S------------ktpaLiFE~v~n~Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNv 163 (338)
T KOG0668|consen 104 DPES------------KTPSLIFEYVNNTDFKQLYP--------TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNV 163 (338)
T ss_pred Cccc------------cCchhHhhhhccccHHHHhh--------hhchhhHHHHHHHHHHHHhHHHhcCcccccCCccee
Confidence 6653 24689999999888877764 377788999999999999999999999999999999
Q ss_pred EEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVIL 784 (886)
+|+... -.++|+|+|+|.++...... +..+.+..|.-||.+.. -..|...-|+|||||+|
T Consensus 164 mIdh~~------rkLrlIDWGLAEFYHp~~eY-----------nVRVASRyfKGPELLVd---y~~YDYSLD~WS~Gcml 223 (338)
T KOG0668|consen 164 MIDHEL------RKLRLIDWGLAEFYHPGKEY-----------NVRVASRYFKGPELLVD---YQMYDYSLDMWSLGCML 223 (338)
T ss_pred eechhh------ceeeeeecchHhhcCCCcee-----------eeeeehhhcCCchheee---chhccccHHHHHHHHHH
Confidence 999874 36999999999887664332 34467788999999976 35688899999999999
Q ss_pred HHHHhCCCCCC-CCCHHHHHHHHHcC-C-----------CCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHH
Q 002738 785 LELLTLQVPYM-GLSELEIHDLIQMG-K-----------RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 851 (886)
Q Consensus 785 yELLTG~~PF~-g~s~~el~~~I~~~-~-----------rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~d 851 (886)
..|+..+.||. |.+..+.+-.|.+. . .-.++..+..+..... ......+..++...-.++++.+
T Consensus 224 A~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~---rk~w~~Fi~~~n~hl~~peaiD 300 (338)
T KOG0668|consen 224 ASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHS---RKPWSRFINSENQHLVSPEAID 300 (338)
T ss_pred HHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccc---cccHHHhCCccccccCChHHHH
Confidence 99999999984 44333332233221 1 1112222222111111 1111122223333334578999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 002738 852 VFRRCTEENPTERPTAGDLYEM 873 (886)
Q Consensus 852 LL~rCL~~DP~kRPSA~EILeh 873 (886)
|+.++|.+|-.+|+||.|++.|
T Consensus 301 lldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 301 LLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHHhhccccccchHHHhcC
Confidence 9999999999999999999998
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=300.90 Aligned_cols=255 Identities=26% Similarity=0.324 Sum_probs=190.0
Q ss_pred ceeeeeecccCce-EEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEecCCCCC
Q 002738 553 LSSCDEAGKSVSS-SLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLP 630 (886)
Q Consensus 553 Y~i~k~LG~G~fG-~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~~~~~l~ 630 (886)
|.-.+.+|.|+.| .||+|.+.++.||||.+. .++.....+||..|+.-+ |||||++|+.-.+..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll-----------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q--- 576 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLL-----------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQ--- 576 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHh-----------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCc---
Confidence 3446778999998 589999999999999753 222233489999999886 999999998766554
Q ss_pred CCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccc
Q 002738 631 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 710 (886)
Q Consensus 631 ~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~ 710 (886)
..||..|.|. .+|.+++... ............+.++.|++.||+|||+.+||||||||.||||+...
T Consensus 577 -----------F~YIalELC~-~sL~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~ 643 (903)
T KOG1027|consen 577 -----------FLYIALELCA-CSLQDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPS 643 (903)
T ss_pred -----------eEEEEehHhh-hhHHHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccC
Confidence 3799999997 7999999862 11111111145678899999999999999999999999999998742
Q ss_pred cCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 002738 711 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 790 (886)
Q Consensus 711 ~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG 790 (886)
..+...++|+|||+++.+........ ......||-+|+|||++.. ..-+.++|||||||++|+.++|
T Consensus 644 --~~~~~ra~iSDfglsKkl~~~~sS~~-------r~s~~sGt~GW~APE~L~~----~~~~~avDiFslGCvfyYvltg 710 (903)
T KOG1027|consen 644 --ADGTLRAKISDFGLSKKLAGGKSSFS-------RLSGGSGTSGWQAPEQLRE----DRKTQAVDIFSLGCVFYYVLTG 710 (903)
T ss_pred --CCcceeEEecccccccccCCCcchhh-------cccCCCCcccccCHHHHhc----cccCcccchhhcCceEEEEecC
Confidence 23457899999999998876543321 1244579999999999987 3446699999999999999996
Q ss_pred -CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 002738 791 -QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 869 (886)
Q Consensus 791 -~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~E 869 (886)
.+||...-. ....|..+...... .....+ ....+||.+|+.++|..||+|.+
T Consensus 711 G~HpFGd~~~--R~~NIl~~~~~L~~-----------------------L~~~~d--~eA~dLI~~ml~~dP~~RPsa~~ 763 (903)
T KOG1027|consen 711 GSHPFGDSLE--RQANILTGNYTLVH-----------------------LEPLPD--CEAKDLISRMLNPDPQLRPSATD 763 (903)
T ss_pred CccCCCchHH--hhhhhhcCccceee-----------------------eccCch--HHHHHHHHHhcCCCcccCCCHHH
Confidence 899964422 22234333221100 000001 16899999999999999999999
Q ss_pred HHHHH
Q 002738 870 LYEMF 874 (886)
Q Consensus 870 ILehL 874 (886)
||.|.
T Consensus 764 VL~HP 768 (903)
T KOG1027|consen 764 VLNHP 768 (903)
T ss_pred HhCCC
Confidence 99983
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=288.16 Aligned_cols=276 Identities=21% Similarity=0.275 Sum_probs=211.5
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC------CCCcceeeee
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR------HSCIVEMYGH 622 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~------HPNIVrl~g~ 622 (886)
.+|.+....|+|-|++|.+|.+ .+..|||||+.-... -.+.- ++|++||++|+ --|+++++-.
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-----M~KtG----l~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-----MHKTG----LKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-----Hhhhh----hHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 5799999999999999999997 567999999753321 11222 78999999996 3479999988
Q ss_pred EecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 002738 623 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 702 (886)
Q Consensus 623 ~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPs 702 (886)
|...+ ++|||+|-+. .+|.++|+++..+ ..+....+..++.|+..||..|-..||+|.||||+
T Consensus 503 F~hkn--------------HLClVFE~Ls-lNLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPD 565 (752)
T KOG0670|consen 503 FKHKN--------------HLCLVFEPLS-LNLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPD 565 (752)
T ss_pred hhhcc--------------eeEEEehhhh-chHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHHhcCeeecccCcc
Confidence 87544 6799999996 7999999986443 34778899999999999999999999999999999
Q ss_pred CEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 002738 703 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 782 (886)
Q Consensus 703 NILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGV 782 (886)
|||++... .++||||||.|........+. +.-+..|.|||++.| .+|....|+||.||
T Consensus 566 NiLVNE~k------~iLKLCDfGSA~~~~eneitP------------YLVSRFYRaPEIiLG----~~yd~~iD~WSvgc 623 (752)
T KOG0670|consen 566 NILVNESK------NILKLCDFGSASFASENEITP------------YLVSRFYRAPEIILG----LPYDYPIDTWSVGC 623 (752)
T ss_pred ceEeccCc------ceeeeccCccccccccccccH------------HHHHHhccCcceeec----CcccCCccceeece
Confidence 99998774 589999999998776644332 234678999999998 78999999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccc-------------------cccCCCC-------
Q 002738 783 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEV-------------------AQSGSGF------- 836 (886)
Q Consensus 783 ILyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~-------------------~~~~~~~------- 836 (886)
+||||.||+..|+|.+..+++...+....+.....+.. ..+....+ .......
T Consensus 624 tLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK-gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~ 702 (752)
T KOG0670|consen 624 TLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK-GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLG 702 (752)
T ss_pred eeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh-cchhhhhcccccceEEEeccccccceeEEEecccCcchhHH
Confidence 99999999999999998888776654432221111111 10000000 0000000
Q ss_pred -------CCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002738 837 -------EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 875 (886)
Q Consensus 837 -------~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EILehLe 875 (886)
..+........+|.+||.+||..||++|.|..++|.|..
T Consensus 703 s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpF 748 (752)
T KOG0670|consen 703 SELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPF 748 (752)
T ss_pred HHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCc
Confidence 123334556778999999999999999999999999853
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-31 Score=274.01 Aligned_cols=284 Identities=18% Similarity=0.246 Sum_probs=206.9
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
.+.+-.+.||.|+||.||.+++ .+..|++|.+. .-...... .+++.+|+++|..++|.|++..+++......
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~p--nvfq~L~s----~krvFre~kmLcfFkHdNVLSaLDILQPph~ 126 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMP--NVFQNLAS----CKRVFREIKMLSSFRHDNVLSLLDILQPANP 126 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcc--hHHHHHHH----HHHHHHHHHHHHhhccccHHHHHHhcCCCCc
Confidence 3455678999999999999997 56667777542 21112222 2456899999999999999999887764331
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
.-....|+|+|++. .+|...|-. .+.++...++.+++||++||.|||+.+|.||||||.|+|++.
T Consensus 127 ---------dfFqEiYV~TELmQ-SDLHKIIVS-----PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNS 191 (449)
T KOG0664|consen 127 ---------SFFQELYVLTELMQ-SDLHKIIVS-----PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNS 191 (449)
T ss_pred ---------hHHHHHHHHHHHHH-hhhhheecc-----CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEecc
Confidence 12335789999997 699998875 567899999999999999999999999999999999999988
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ +.+||||||+|+......... .+-.+-|..|.|||+++| ...|+.+.||||.|||+.||+
T Consensus 192 N-------CvLKICDFGLARvee~d~~~h---------MTqEVVTQYYRAPEiLMG---aRhYs~AvDiWSVGCIFaELL 252 (449)
T KOG0664|consen 192 N-------CILKICDFGLARTWDQRDRLN---------MTHEVVTQYYRAPELLMG---ARRYTGAVDIWSVGCIFAELL 252 (449)
T ss_pred C-------ceEEecccccccccchhhhhh---------hHHHHHHHHhccHHHhhc---chhhcCccceehhhHHHHHHH
Confidence 7 889999999998765432210 122356889999999998 567999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcC-CCCCchhHHhhhcccccccccccCCCCCC------chhhhhhHHHHHHHHHHhcccCC
Q 002738 789 TLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEK------PEAELETLSFLVDVFRRCTEENP 861 (886)
Q Consensus 789 TG~~PF~g~s~~el~~~I~~~-~rp~l~~~l~~~~~~~~~~~~~~~~~~~~------~~~~~~~s~~L~dLL~rCL~~DP 861 (886)
-.+..|+..++.+.++.|... ..|... .+..........+.+.....+. .............++..+|.+||
T Consensus 253 gRrILFQAq~PiqQL~lItdLLGTPs~E-aMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~ 331 (449)
T KOG0664|consen 253 QRKILFQAAGPIEQLQMIIDLLGTPSQE-AMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDP 331 (449)
T ss_pred hhhhhhhccChHHHHHHHHHHhCCCcHH-HHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCC
Confidence 999999999988888877665 333332 2221110000111111111000 00011223456788999999999
Q ss_pred CCCCCHHHHHHHHH
Q 002738 862 TERPTAGDLYEMFV 875 (886)
Q Consensus 862 ~kRPSA~EILehLe 875 (886)
++|.+..+.+.|+.
T Consensus 332 dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 332 DKRISVEEALQHRY 345 (449)
T ss_pred cccccHhhhccccc
Confidence 99999999988754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=285.04 Aligned_cols=291 Identities=17% Similarity=0.160 Sum_probs=185.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE------------------CCeeEEEEEEecccCCCChHHH------HhhhHhHHH
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF------------------GSADAAAKVRTLKVCGSSADEI------RNFEYSCLG 603 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~------------------~~~~VAVKI~~lk~~~~~~~~~------k~f~~~~lr 603 (886)
...++|.+.++||+|+||.||+|.+ .+..||||...........+.. ....+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 3567899999999999999999964 2346888886543221111100 011122356
Q ss_pred HHHHHhhCCCCCc-----ceeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhcc-------------
Q 002738 604 EVRMLGALRHSCI-----VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------------- 665 (886)
Q Consensus 604 EI~iLk~L~HPNI-----Vrl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~------------- 665 (886)
|+.++.+++|.++ +++++++..... ++ .......+|||||+++++|.+++......
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~----~g--~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~ 295 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTA----DG--AFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGK 295 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccc----cc--cccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCC
Confidence 7888888876654 677777764321 00 11123579999999999999998742100
Q ss_pred ------CCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCccccccccccccc
Q 002738 666 ------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 739 (886)
Q Consensus 666 ------~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~ 739 (886)
....+++..++.++.||+.||.|||+++|+||||||+|||++.+ ..+||+|||++.........
T Consensus 296 ~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~-------~~~kL~DFGla~~~~~~~~~--- 365 (507)
T PLN03224 296 KIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD-------GQVKIIDFGAAVDMCTGINF--- 365 (507)
T ss_pred chhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCC-------CcEEEEeCcCccccccCCcc---
Confidence 11234677889999999999999999999999999999999877 46999999999654321110
Q ss_pred ccCCCCCCCcccCCCcccchhhhhcccCCC------------------CCCchhhHHHHHHHHHHHHhCCC-CCCCCCHH
Q 002738 740 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPN------------------LYGLEVDIWSYGCLLLELLTLQV-PYMGLSEL 800 (886)
Q Consensus 740 ~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~------------------~~s~KSDIWSLGVILyELLTG~~-PF~g~s~~ 800 (886)
......+|+.|+|||.+....... ....+.||||+||+||+|+++.. ||.+....
T Consensus 366 ------~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f 439 (507)
T PLN03224 366 ------NPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLF 439 (507)
T ss_pred ------CccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhh
Confidence 011223589999999986411000 01235799999999999999886 66543221
Q ss_pred HHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC---CCCCCHHHHHHHHH
Q 002738 801 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP---TERPTAGDLYEMFV 875 (886)
Q Consensus 801 el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP---~kRPSA~EILehLe 875 (886)
... +... . .....+... ......+ + .....++..++|+.+||..+| .+|+|++|+|+|-.
T Consensus 440 ~~~--~~~~-~-~~~~~~r~~--------~~~~~~~--~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 440 NTE--LRQY-D-NDLNRWRMY--------KGQKYDF--S-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF 502 (507)
T ss_pred hhH--Hhhc-c-chHHHHHhh--------cccCCCc--c-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence 110 0000 0 000000000 0000000 0 112245679999999999866 68999999999854
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=251.65 Aligned_cols=227 Identities=25% Similarity=0.362 Sum_probs=182.8
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcceeeeeEec
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 625 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl~g~~~~ 625 (886)
+-+.+..+..||+|+||.|=+-++ ++.-.|+|-++.... ..+. .++++|+.+..+. .+|.+|.|||.+..
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn---~q~q----~r~L~dldi~~r~~~CPf~V~FyGa~~r 116 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN---SQEQ----KRLLMDLDIIMRTVDCPFTVHFYGALFR 116 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC---hHHH----HHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence 345566788999999998877765 777788887654332 2222 3448899886665 59999999998775
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENI 704 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~-gIVHRDLKPsNI 704 (886)
+. ..||.||.+. .||..|-++..+.+ ..+++..+-+|+..|+.||.|||++ .+||||+||+||
T Consensus 117 eg--------------dvwIcME~M~-tSldkfy~~v~~~g-~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNi 180 (282)
T KOG0984|consen 117 EG--------------DVWICMELMD-TSLDKFYRKVLKKG-GTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNI 180 (282)
T ss_pred cc--------------cEEEeHHHhh-hhHHHHHHHHHhcC-CcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceE
Confidence 54 4799999997 79998887766554 6799999999999999999999987 899999999999
Q ss_pred EEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVIL 784 (886)
||+.+ ++||+||||++-.+.+.... +...|-..|||||.+........|+.|+||||||+++
T Consensus 181 LIn~~-------GqVKiCDFGIsG~L~dSiAk-----------t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItm 242 (282)
T KOG0984|consen 181 LINYD-------GQVKICDFGISGYLVDSIAK-----------TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITM 242 (282)
T ss_pred EEccC-------CcEEEcccccceeehhhhHH-----------HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhh
Confidence 99998 56999999999776553221 2245888999999998765556899999999999999
Q ss_pred HHHHhCCCCCCC-CCHHHHHHHHHcCCCCCchh
Q 002738 785 LELLTLQVPYMG-LSELEIHDLIQMGKRPRLTD 816 (886)
Q Consensus 785 yELLTG~~PF~g-~s~~el~~~I~~~~rp~l~~ 816 (886)
+||.+++.||.. .++.+.+.++.....|.++.
T Consensus 243 iElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp~ 275 (282)
T KOG0984|consen 243 IEMAILRFPYESWGTPFQQLKQVVEEPSPQLPA 275 (282)
T ss_pred hhhhhccccccccCCHHHHHHHHhcCCCCCCcc
Confidence 999999999965 47888888888877776663
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=266.56 Aligned_cols=279 Identities=19% Similarity=0.206 Sum_probs=204.0
Q ss_pred CCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
..+|.-.+.+|.|+- .|..|-+ .+..||+|..... .......+ +..+|..++..+.|+|||+++.+|....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p--f~n~~~ak----ra~rel~l~~~v~~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP--FQNQTHAK----RAYRELKLMKCVNHKNIISLLNVFTPQK 88 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc--cccCccch----hhhhhhhhhhhhcccceeeeeeccCccc
Confidence 457888888999998 6777665 5667777765433 22222223 3389999999999999999999998654
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
.+ ......|+||||+. .+|.+.+.. .++-+++..|++|++.|++|||+.||+||||||+||++.
T Consensus 89 ~l--------~~~~e~y~v~e~m~-~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~ 152 (369)
T KOG0665|consen 89 TL--------EEFQEVYLVMELMD-ANLCQVILM-------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVN 152 (369)
T ss_pred cH--------HHHHhHHHHHHhhh-hHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceec
Confidence 32 23446899999997 699999874 467789999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.+ +++||.|||+|+...... ..+-.+.|..|.|||++.+ ..+.+.+||||+||++.||
T Consensus 153 ~~-------~~lKi~dfg~ar~e~~~~-----------~mtpyVvtRyyrapevil~----~~~ke~vdiwSvGci~gEl 210 (369)
T KOG0665|consen 153 SD-------CTLKILDFGLARTEDTDF-----------MMTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGEL 210 (369)
T ss_pred ch-------hheeeccchhhcccCccc-----------ccCchhheeeccCchheec----cCCcccchhhhhhhHHHHH
Confidence 88 679999999998654431 1234578999999999998 4488999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccc---------------cccccccCCCCCCchhhhhhHHHHHHH
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH---------------EHEVAQSGSGFEKPEAELETLSFLVDV 852 (886)
Q Consensus 788 LTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~s~~L~dL 852 (886)
++|+..|.|.+..+...++......+-+..+.++.... ...+++..... ..+...-....+.+|
T Consensus 211 i~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~-~~e~~~~~~~~ardl 289 (369)
T KOG0665|consen 211 ILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPV-VLEGSKLDCSLARDL 289 (369)
T ss_pred hhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccc-cccCCccchHHHHHH
Confidence 99999999887766655554432222222222111000 00011100000 111122345678999
Q ss_pred HHHhcccCCCCCCCHHHHHHHH
Q 002738 853 FRRCTEENPTERPTAGDLYEMF 874 (886)
Q Consensus 853 L~rCL~~DP~kRPSA~EILehL 874 (886)
+.+||..||++|.+++++|.|.
T Consensus 290 l~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 290 LSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred HHHhhccChhhcccHHHHhcCC
Confidence 9999999999999999999983
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=274.85 Aligned_cols=261 Identities=22% Similarity=0.245 Sum_probs=191.9
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
-|..++.||-|+||.|.+++. ....+|.|....+. ...++-..-+..|-.||.....+-||++|-.|.+.+.
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaD-----Vl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn- 703 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKAD-----VLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN- 703 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHH-----HHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc-
Confidence 367899999999999999985 44456666643211 1112222334778899999999999999999998875
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
+|+||+|++||++..+|-+ .+.|++..++.++..+..|+++.|..|+|||||||+|||||.+
T Consensus 704 -------------LYFVMdYIPGGDmMSLLIr-----mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrd 765 (1034)
T KOG0608|consen 704 -------------LYFVMDYIPGGDMMSLLIR-----MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD 765 (1034)
T ss_pred -------------eEEEEeccCCccHHHHHHH-----hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccC
Confidence 5999999999999999876 4679999999999999999999999999999999999999998
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccC--------------------------------CCCCCCcccCCCccc
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR--------------------------------GIPAPDVCVGTPRWM 757 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~--------------------------------~~~~~~~~vGT~~Ym 757 (886)
+.+||+|||++.-+.-.....+.... ........+||+.|+
T Consensus 766 -------GHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyi 838 (1034)
T KOG0608|consen 766 -------GHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYI 838 (1034)
T ss_pred -------CceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCccc
Confidence 56999999998643211111000000 001223458999999
Q ss_pred chhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhcccccccccccCCCC
Q 002738 758 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGF 836 (886)
Q Consensus 758 APEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF~g~s~~el~~~I~~~~-rp~l~~~l~~~~~~~~~~~~~~~~~~ 836 (886)
|||++.. ..++.-+|.||.|||||||+.|++||...++.+....|.+.. ...++
T Consensus 839 apevl~r----~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~--------------------- 893 (1034)
T KOG0608|consen 839 APEVLAR----TGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIP--------------------- 893 (1034)
T ss_pred ChHHhcc----cCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccc---------------------
Confidence 9999986 678999999999999999999999998777766554443321 11111
Q ss_pred CCchhhhhhHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 002738 837 EKPEAELETLSFLVDVFRRCTEENPTERP---TAGDLYEM 873 (886)
Q Consensus 837 ~~~~~~~~~s~~L~dLL~rCL~~DP~kRP---SA~EILeh 873 (886)
.....+.++.+||.++.. +++.|. .+++|..|
T Consensus 894 ----~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaH 928 (1034)
T KOG0608|consen 894 ----YQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAH 928 (1034)
T ss_pred ----cccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcC
Confidence 112235567777776554 677775 35556655
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=262.39 Aligned_cols=261 Identities=22% Similarity=0.306 Sum_probs=210.5
Q ss_pred CCceeeeeecccCceEEEEEEECC-------eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeE
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 623 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~~~-------~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~ 623 (886)
.++++...+-+|.||.||+|.|.. +.|.||.+ +. ..+...+. .+++|..+|..+.|||+.++.++.
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTv--k~-~AS~iQv~----~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTV--KQ-HASQIQVN----LLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHH--Hh-cccHHHHH----HHHHHHHHHhcCcCCCccceeEEE
Confidence 457788889999999999997743 23444442 21 12222233 448999999999999999999998
Q ss_pred ecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHh---ccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 002738 624 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS---ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700 (886)
Q Consensus 624 ~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~---~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLK 700 (886)
..+.. .+++++.+..-|+|..|+...+ ....+.++..+...++.|++.|++|||++||||.||.
T Consensus 357 ie~~~-------------~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiA 423 (563)
T KOG1024|consen 357 IEDYA-------------TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIA 423 (563)
T ss_pred eeccC-------------cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhh
Confidence 86543 3689999998899999998432 2233567778889999999999999999999999999
Q ss_pred CCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHH
Q 002738 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 780 (886)
Q Consensus 701 PsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSL 780 (886)
..|.+|++. ..|||+|=.+++.+-+....+- .. .......||+||.+.. ..|+.++|||||
T Consensus 424 aRNCvIdd~-------LqVkltDsaLSRDLFP~DYhcL-GD-------nEnRPvkWMslEal~n----~~yssasDvWsf 484 (563)
T KOG1024|consen 424 ARNCVIDDQ-------LQVKLTDSALSRDLFPGDYHCL-GD-------NENRPVKWMSLEALQN----SHYSSASDVWSF 484 (563)
T ss_pred hhcceehhh-------eeEEeccchhccccCccccccc-CC-------CCCCcccccCHHHHhh----hhhcchhhhHHH
Confidence 999999877 6799999999997766544322 11 1125678999999987 789999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 002738 781 GCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 859 (886)
Q Consensus 781 GVILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~ 859 (886)
||+||||+| |+.||...++.++...+..+.+..-| .++++++..++.-||..
T Consensus 485 GVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP---------------------------~NCPDeLf~vMacCWal 537 (563)
T KOG1024|consen 485 GVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQP---------------------------FNCPDELFTVMACCWAL 537 (563)
T ss_pred HHHHHHHHhcCCCCccccCHHHHHHHHhccceecCC---------------------------CCCcHHHHHHHHHHHhc
Confidence 999999998 99999999999999999988764332 23577899999999999
Q ss_pred CCCCCCCHHHHHHHHHhh
Q 002738 860 NPTERPTAGDLYEMFVAR 877 (886)
Q Consensus 860 DP~kRPSA~EILehLe~l 877 (886)
.|++||+++|+...|...
T Consensus 538 lpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 538 LPEERPSFSQLVICLSEF 555 (563)
T ss_pred CcccCCCHHHHHHHHHHH
Confidence 999999999999988764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-27 Score=231.39 Aligned_cols=212 Identities=34% Similarity=0.498 Sum_probs=175.8
Q ss_pred ecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCC
Q 002738 559 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 636 (886)
Q Consensus 559 LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~~~~ 636 (886)
||+|++|.||++... +..+++|+........ ....+.+|+.+++.+.|++|+++++++....
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--------- 64 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-------LLEELLREIEILKKLNHPNIVKLYGVFEDEN--------- 64 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-------HHHHHHHHHHHHHhcCCCCeeeEeeeeecCC---------
Confidence 689999999999986 7889999975442211 1234489999999999999999999988643
Q ss_pred CcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec-cccCCCC
Q 002738 637 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL-ERKKADG 715 (886)
Q Consensus 637 ~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~-d~~~~~~ 715 (886)
..+++|||+.|++|.+++... ...+++..++.++.+++.+|++||++|++|+||+|.||+++. +
T Consensus 65 -----~~~~~~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~------ 129 (215)
T cd00180 65 -----HLYLVMEYCEGGSLKDLLKEN----EGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDN------ 129 (215)
T ss_pred -----eEEEEEecCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCC------
Confidence 469999999999999999761 135889999999999999999999999999999999999997 4
Q ss_pred CCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 002738 716 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 795 (886)
Q Consensus 716 ~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF~ 795 (886)
..++|+|||.+........ ......+...|++||.+... ...+.+.|+|++|+++++|
T Consensus 130 -~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~~~~pe~~~~~---~~~~~~~D~~~lg~~~~~l-------- 187 (215)
T cd00180 130 -GKVKLADFGLSKLLTSDKS----------LLKTIVGTPAYMAPEVLLGK---GYYSEKSDIWSLGVILYEL-------- 187 (215)
T ss_pred -CcEEEecCCceEEccCCcc----------hhhcccCCCCccChhHhccc---CCCCchhhhHHHHHHHHHH--------
Confidence 4699999999976644221 01223578899999998751 2678899999999999999
Q ss_pred CCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002738 796 GLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874 (886)
Q Consensus 796 g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EILehL 874 (886)
..+.+++.+|+..+|.+||++.++++++
T Consensus 188 ---------------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---------------------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---------------------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1478899999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-29 Score=285.66 Aligned_cols=255 Identities=28% Similarity=0.422 Sum_probs=211.2
Q ss_pred CCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
+-++|++.+.+|.|.||.||+|++ .+..+|+|++++.... .+..+ .+|+-+++..+|||||.++|.+...
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d----d~~~i----qqei~~~~dc~h~nivay~gsylr~ 84 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD----DFSGI----QQEIGMLRDCRHPNIVAYFGSYLRR 84 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc----ccccc----ccceeeeecCCCcChHHHHhhhhhh
Confidence 446899999999999999999997 6788999998877532 33333 7899999999999999999998866
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
.. +||.||||.||+|.+.-+- ...+++.++..+.+..++||+|||++|-+|||||-.|||+
T Consensus 85 dk--------------lwicMEycgggslQdiy~~-----TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanill 145 (829)
T KOG0576|consen 85 DK--------------LWICMEYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL 145 (829)
T ss_pred cC--------------cEEEEEecCCCcccceeee-----cccchhHHHHHHHhhhhccchhhhcCCcccccccccceee
Confidence 54 5999999999999997654 4679999999999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+..+ .+||.|||.+..+..... ....+.||+.|||||+.. ....+.|+.++|||++|++..|
T Consensus 146 td~g-------DvklaDfgvsaqitati~----------KrksfiGtpywmapEvaa-verkggynqlcdiwa~gitAie 207 (829)
T KOG0576|consen 146 TDEG-------DVKLADFGVSAQITATIA----------KRKSFIGTPYWMAPEVAA-VERKGGYNQLCDIWALGITAIE 207 (829)
T ss_pred cccC-------ceeecccCchhhhhhhhh----------hhhcccCCccccchhHHH-HHhcccccccccccccccchhh
Confidence 9885 499999999877654321 235578999999999975 2344779999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCC--CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKR--PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 864 (886)
Q Consensus 787 LLTG~~PF~g~s~~el~~~I~~~~r--p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kR 864 (886)
|-.-++|.....+++....+.+..+ |.+.+ .....+.+.+|++.+|..+|.+|
T Consensus 208 l~eLqpplfdlhpmr~l~LmTkS~~qpp~lkD-------------------------k~kws~~fh~fvK~altknpKkR 262 (829)
T KOG0576|consen 208 LGELQPPLFDLHPMRALFLMTKSGFQPPTLKD-------------------------KTKWSEFFHNFVKGALTKNPKKR 262 (829)
T ss_pred hhhcCCcccccchHHHHHHhhccCCCCCcccC-------------------------CccchHHHHHHHHHHhcCCCccC
Confidence 9999999888888877766665422 22221 11235679999999999999999
Q ss_pred CCHHHHHHH
Q 002738 865 PTAGDLYEM 873 (886)
Q Consensus 865 PSA~EILeh 873 (886)
|+++.+|.|
T Consensus 263 ptaeklL~h 271 (829)
T KOG0576|consen 263 PTAEKLLQH 271 (829)
T ss_pred CChhhheec
Confidence 999998875
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=259.25 Aligned_cols=203 Identities=23% Similarity=0.385 Sum_probs=169.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcceeeeeEe
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 624 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl~g~~~ 624 (886)
..+++|.+...||+|+|+.|.+++. ..+-+|+|+++..... ..+.+ ..+..|-.++.+. +||.+|-++.+|.
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~n-ddedi----dwvqtek~vfe~asn~pflvglhscfq 321 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVN-DDEDI----DWVQTEKHVFEQASNNPFLVGLHSCFQ 321 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcC-Ccccc----hhHHhhHHHHHhccCCCeEEehhhhhc
Confidence 5678999999999999999999987 5567888886433222 22222 2346677777776 4999999999999
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNI 704 (886)
++.. +++|.||++||+|.=.++. ...++++.++.+...|..||.|||++|||.||||.+|+
T Consensus 322 tesr--------------lffvieyv~ggdlmfhmqr-----qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnv 382 (593)
T KOG0695|consen 322 TESR--------------LFFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNV 382 (593)
T ss_pred ccce--------------EEEEEEEecCcceeeehhh-----hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccce
Confidence 8774 6999999999999887775 35699999999999999999999999999999999999
Q ss_pred EEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVIL 784 (886)
|++.. +.+||+|+|+++.--....+ ..+++|||.|.|||++++ ..|++.+|.|+|||++
T Consensus 383 lldae-------ghikltdygmcke~l~~gd~----------tstfcgtpnyiapeilrg----eeygfsvdwwalgvlm 441 (593)
T KOG0695|consen 383 LLDAE-------GHIKLTDYGMCKEGLGPGDT----------TSTFCGTPNYIAPEILRG----EEYGFSVDWWALGVLM 441 (593)
T ss_pred EEccC-------CceeecccchhhcCCCCCcc----------cccccCCCcccchhhhcc----cccCceehHHHHHHHH
Confidence 99988 56999999999764333222 355789999999999998 7899999999999999
Q ss_pred HHHHhCCCCCC
Q 002738 785 LELLTLQVPYM 795 (886)
Q Consensus 785 yELLTG~~PF~ 795 (886)
+||+.|+.||.
T Consensus 442 femmagrspfd 452 (593)
T KOG0695|consen 442 FEMMAGRSPFD 452 (593)
T ss_pred HHHHcCCCCcc
Confidence 99999999994
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=273.07 Aligned_cols=209 Identities=26% Similarity=0.351 Sum_probs=169.0
Q ss_pred CCCCCCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHh-hhHhHHHHHHHHhhCC---CCCccee
Q 002738 546 DPGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRN-FEYSCLGEVRMLGALR---HSCIVEM 619 (886)
Q Consensus 546 ~~~~~~~Y~i~k~LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~-f~~~~lrEI~iLk~L~---HPNIVrl 619 (886)
.+..+.+|..++.+|.|+||.|++|.++ ...|++|.+....... ...++. -.-.+-.||.||..|+ |+||+++
T Consensus 556 ~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~-DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl 634 (772)
T KOG1152|consen 556 EYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILV-DTWVRDRKLGTVPSEIQILATLNKHSHENILKL 634 (772)
T ss_pred eecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhh-hhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence 3466788999999999999999999984 4456666643221110 011110 0012367999999998 9999999
Q ss_pred eeeEecCCCCCCCCCCCCcccceEEEEEecc-CCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 002738 620 YGHKISSKWLPSADGNPEHHLLQSAIFMEYV-KGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRD 698 (886)
Q Consensus 620 ~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~-~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRD 698 (886)
+++|++++++ ||+||-- +|.+|.++|.. ...+++.++..|+.||+.|+++||++||||||
T Consensus 635 LdfFEddd~y--------------yl~te~hg~gIDLFd~IE~-----kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrd 695 (772)
T KOG1152|consen 635 LDFFEDDDYY--------------YLETEVHGEGIDLFDFIEF-----KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRD 695 (772)
T ss_pred hheeecCCee--------------EEEecCCCCCcchhhhhhc-----cCccchHHHHHHHHHHHhccccccccCceecc
Confidence 9999988864 9999975 46799999986 46799999999999999999999999999999
Q ss_pred CCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHH
Q 002738 699 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 778 (886)
Q Consensus 699 LKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIW 778 (886)
||-+|+.++.+ +.+||+|||.|....... ...++||..|.|||++.| ....+..-|||
T Consensus 696 ikdenvivd~~-------g~~klidfgsaa~~ksgp------------fd~f~gtv~~aapevl~g---~~y~gk~qdiw 753 (772)
T KOG1152|consen 696 IKDENVIVDSN-------GFVKLIDFGSAAYTKSGP------------FDVFVGTVDYAAPEVLGG---EKYLGKPQDIW 753 (772)
T ss_pred cccccEEEecC-------CeEEEeeccchhhhcCCC------------cceeeeeccccchhhhCC---CccCCCcchhh
Confidence 99999999987 679999999987654422 356789999999999987 35568899999
Q ss_pred HHHHHHHHHHhCCCCCCC
Q 002738 779 SYGCLLLELLTLQVPYMG 796 (886)
Q Consensus 779 SLGVILyELLTG~~PF~g 796 (886)
++|++||.++....||.+
T Consensus 754 algillytivykenpyyn 771 (772)
T KOG1152|consen 754 ALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhheeeEEEeccCCCcC
Confidence 999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-26 Score=230.54 Aligned_cols=214 Identities=32% Similarity=0.449 Sum_probs=172.1
Q ss_pred ceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCC
Q 002738 553 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 630 (886)
Q Consensus 553 Y~i~k~LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~ 630 (886)
|.+.+.||.|++|.||++... +..+++|........ ... ..+.+|+..+.+++|+||+++++++....
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~----~~~~~e~~~~~~~~~~~i~~~~~~~~~~~--- 70 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQR----EEFLREIRILKKLKHPNIVKLYGVFEDPE--- 70 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHH----HHHHHHHHHHHhCCCCChhhheeeeecCC---
Confidence 577899999999999999984 578999987543221 122 34488999999999999999999987554
Q ss_pred CCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCc-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 631 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKH-VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 631 ~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~-Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..+++|||+++++|.+++... .. +++..+..++.+++.+|.+||+++++|+||+|.||+++..
T Consensus 71 -----------~~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~ 134 (225)
T smart00221 71 -----------PLYLVMEYCEGGDLFDYLRKK-----GGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD 134 (225)
T ss_pred -----------ceEEEEeccCCCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 369999999999999999861 22 7899999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
..++|+|||.+......... ......++..|++||.+. ....++.++|||+||+++++|++
T Consensus 135 -------~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~~~~pe~~~---~~~~~~~~~Dv~~lG~~~~~l~~ 195 (225)
T smart00221 135 -------GLVKLADFGLARFIHRDLAA---------LLKTVKGTPFYLAPEVLL---GGKGYGEAVDIWSLGVILYELLW 195 (225)
T ss_pred -------CCEEEeeCceeeEecCcccc---------cccceeccCCcCCHhHhc---CCCCCCchhhHHHHHHHHHHHHH
Confidence 46999999998876543200 112345788999999984 23567789999999999999999
Q ss_pred CCCCCCC-CC-HHHHHHHHHcCCC
Q 002738 790 LQVPYMG-LS-ELEIHDLIQMGKR 811 (886)
Q Consensus 790 G~~PF~g-~s-~~el~~~I~~~~r 811 (886)
|+.||.. .+ ...+.+.+.++..
T Consensus 196 g~~pf~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 196 GPEPFSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred CCCCccccchhHHHHHHHHhcCCc
Confidence 9999977 44 4466677766643
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=254.85 Aligned_cols=286 Identities=24% Similarity=0.302 Sum_probs=195.5
Q ss_pred CCCCCceeeeeecccCceEEEEEEE-----CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeee
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYG 621 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~-----~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g 621 (886)
...+.|.++++||+|.|++||++.+ ....||+|-+... ... .++..|+++|..+. +.||+.+.+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p--------~ri~~El~~L~~~gG~~ni~~~~~ 102 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSP--------SRILNELEMLYRLGGSDNIIKLNG 102 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCc--------hHHHHHHHHHHHhccchhhhcchh
Confidence 3456789999999999999999985 4567888875432 111 23489999999997 999999999
Q ss_pred eEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 002738 622 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 701 (886)
Q Consensus 622 ~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKP 701 (886)
++...+ +..+||||++.....++... ++...+..+++.++.||.++|.+|||||||||
T Consensus 103 ~~rnnd--------------~v~ivlp~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKp 160 (418)
T KOG1167|consen 103 CFRNND--------------QVAIVLPYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKP 160 (418)
T ss_pred hhccCC--------------eeEEEecccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccCccccCCCc
Confidence 987554 57999999999999999875 77899999999999999999999999999999
Q ss_pred CCEEEeccccCCCCCCeEEEeecCCccccccccccc-ccc--------------------c-------------CCCCCC
Q 002738 702 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC-CIA--------------------H-------------RGIPAP 747 (886)
Q Consensus 702 sNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~-~~~--------------------~-------------~~~~~~ 747 (886)
.|+|.+... ..-.|+|||+|.......... +.. . ......
T Consensus 161 sNFL~n~~t------~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~ 234 (418)
T KOG1167|consen 161 SNFLYNRRT------QRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSER 234 (418)
T ss_pred ccccccccc------CCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCcccee
Confidence 999998774 357899999998321111000 000 0 000011
Q ss_pred CcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHc--------------CC--
Q 002738 748 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL-SELEIHDLIQM--------------GK-- 810 (886)
Q Consensus 748 ~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF~g~-s~~el~~~I~~--------------~~-- 810 (886)
-..+||++|.|||++... ..-++++||||.|||+.-+++++.||... ++...+..+.. +.
T Consensus 235 anrAGT~GfRaPEvL~k~---~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~ 311 (418)
T KOG1167|consen 235 ANRAGTPGFRAPEVLFRC---PRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRIL 311 (418)
T ss_pred cccCCCCCCCchHHHhhc---cCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCcee
Confidence 224799999999999863 44588999999999999999999998432 11111111100 01
Q ss_pred ------CCCchhHHhhhcccccccccccCCCCCCchhh-hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002738 811 ------RPRLTDELEALGSCHEHEVAQSGSGFEKPEAE-LETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874 (886)
Q Consensus 811 ------rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~L~dLL~rCL~~DP~kRPSA~EILehL 874 (886)
.+.+++....+.+............-...... ...+..+.+|+.+||..||.+|.||+++|+|.
T Consensus 312 l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 312 LWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred eeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 11111111111111100000000000011111 12344789999999999999999999999883
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-26 Score=236.59 Aligned_cols=250 Identities=18% Similarity=0.228 Sum_probs=183.7
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEecC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 626 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~~~ 626 (886)
.+.|.+.+.||+|.||.+.+++++ ++.+++|.+... ....+.| .+|...--.|. |.|||..|++....
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-----~tt~~dF----~rEfhY~~~Ls~H~hIi~tY~vaFqt 93 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-----QTTQADF----VREFHYSFFLSPHQHIIDTYEVAFQT 93 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-----hhhHHHH----HHHhccceeeccchhhhHHHHHHhhc
Confidence 357899999999999999999985 456777765322 2334445 88887766665 99999888764433
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
.. ...++|||++.|+|.+-+.. ..+.+....+++.|+++||.|||++++||||||.+||||
T Consensus 94 ~d-------------~YvF~qE~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLi 154 (378)
T KOG1345|consen 94 SD-------------AYVFVQEFAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILI 154 (378)
T ss_pred Cc-------------eEEEeeccCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEE
Confidence 21 25899999999999998764 457888899999999999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCC-CCCCchhhHHHHHHHHH
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-NLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~-~~~s~KSDIWSLGVILy 785 (886)
...+ -..|||||||..+..+..... .--+..|.+||.......+ -...+.+|||.||+++|
T Consensus 155 f~~d-----f~rvKlcDFG~t~k~g~tV~~-------------~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f 216 (378)
T KOG1345|consen 155 FDAD-----FYRVKLCDFGLTRKVGTTVKY-------------LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFF 216 (378)
T ss_pred ecCC-----ccEEEeeecccccccCceehh-------------hhhhcccCCcHHHhhccccceEecccccchheeeeee
Confidence 7663 258999999998765442211 1245689999988653221 23578899999999999
Q ss_pred HHHhCCCCCCCCC----HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 002738 786 ELLTLQVPYMGLS----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 861 (886)
Q Consensus 786 ELLTG~~PF~g~s----~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP 861 (886)
.++||.+||+... +..-..+..++..+.+|+.+ ...++.+..+.++-|..+|
T Consensus 217 ~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F------------------------~~fs~~a~r~Fkk~lt~~~ 272 (378)
T KOG1345|consen 217 YCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKF------------------------NPFSEKALRLFKKSLTPRF 272 (378)
T ss_pred eeecCCCcchhhhccCchHHHHHHHhcccCccCchhh------------------------cccCHHHHHHHHHhcCCcc
Confidence 9999999997432 11223334444444444332 2235578889999999999
Q ss_pred CCCCCHHH
Q 002738 862 TERPTAGD 869 (886)
Q Consensus 862 ~kRPSA~E 869 (886)
.+|--+.+
T Consensus 273 ~drcki~~ 280 (378)
T KOG1345|consen 273 KDRCKIWT 280 (378)
T ss_pred cccchhHH
Confidence 99943333
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=275.63 Aligned_cols=223 Identities=13% Similarity=0.139 Sum_probs=148.7
Q ss_pred HhhCCC-CCcceeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHH
Q 002738 608 LGALRH-SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAAL 686 (886)
Q Consensus 608 Lk~L~H-PNIVrl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL 686 (886)
.+.+.| +||++++++|..... ++ . +...++++|||+. ++|.++|.. ....+++.+++.++.||+.||
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~----~~-~--~~~~~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al 93 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNL----DG-L--DDDSIVRALECED-VSLRQWLDN----PDRSVDAFECFHVFRQIVEIV 93 (793)
T ss_pred cchhhHHHHHHHhhcccCCccc----cc-c--ccchhhhhhccCC-ccHHHHHhc----ccccccHHHHHHHHHHHHHHH
Confidence 345566 688888988743221 00 0 1123688889885 699999974 235689999999999999999
Q ss_pred HHHHhCCccccCCCCCCEEEeccccC------------CCCCCeEEEeecCCcccccccccc---cccccCC---CCCCC
Q 002738 687 VELHSKHIMHRDIKSENILIDLERKK------------ADGKPVVKLCDFDRAVPLRSFLHT---CCIAHRG---IPAPD 748 (886)
Q Consensus 687 ~yLHs~gIVHRDLKPsNILLd~d~~~------------~~~~~~VKLsDFGlA~~l~~~~~~---~~~~~~~---~~~~~ 748 (886)
.|||++|||||||||+||||+..+.. .+....+||+|||+++........ ....... .....
T Consensus 94 ~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (793)
T PLN00181 94 NAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQI 173 (793)
T ss_pred HHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccccc
Confidence 99999999999999999999653210 012346788888887653211000 0000000 00112
Q ss_pred cccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccccc
Q 002738 749 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE 828 (886)
Q Consensus 749 ~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~ 828 (886)
..+||+.|||||++.+ ..++.++|||||||+||||++|.+|+.... .....+.....+. .
T Consensus 174 ~~~gt~~Y~APE~~~~----~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~---~----------- 233 (793)
T PLN00181 174 LAMEMSWYTSPEEDNG----SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPP---Q----------- 233 (793)
T ss_pred ccCCCcceEChhhhcc----CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcCh---h-----------
Confidence 2468999999999986 668999999999999999999988875321 1122221111110 0
Q ss_pred ccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002738 829 VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 875 (886)
Q Consensus 829 ~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EILehLe 875 (886)
.........+++.+||+++|.+||++.||++|..
T Consensus 234 -------------~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~ 267 (793)
T PLN00181 234 -------------ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEF 267 (793)
T ss_pred -------------hhhcCHHHHHHHHHhCCCChhhCcChHHHhhchh
Confidence 0001224568889999999999999999998854
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=216.67 Aligned_cols=169 Identities=24% Similarity=0.298 Sum_probs=127.5
Q ss_pred CCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccc
Q 002738 653 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 732 (886)
Q Consensus 653 GSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~ 732 (886)
|+|.+++.. ....+++..++.|+.||+.||.|||+++ ||+|||++.+ +.+|+ ||++.....
T Consensus 1 GsL~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~-------~~~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEV----RGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWD-------GLLKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCc-------cceee--ccceEeecc
Confidence 689999975 1346999999999999999999999998 9999999877 45888 999876533
Q ss_pred cccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCC
Q 002738 733 FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL-EIHDLIQMGKR 811 (886)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF~g~s~~-el~~~I~~~~r 811 (886)
. ...||+.|||||++.+ ..++.++|||||||++|||+||+.||...... .....+.....
T Consensus 62 ~---------------~~~g~~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 122 (176)
T smart00750 62 E---------------QSRVDPYFMAPEVIQG----QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP 122 (176)
T ss_pred c---------------cCCCcccccChHHhcC----CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc
Confidence 1 1148899999999986 67889999999999999999999999755332 22333322211
Q ss_pred CCchhHHhhhcccccccccccCCCCCCchhhhhhH--HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 002738 812 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL--SFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 880 (886)
Q Consensus 812 p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s--~~L~dLL~rCL~~DP~kRPSA~EILehLe~l~ss 880 (886)
+..+.. ........ ..+.++|.+||..+|.+||++.++++|+..+...
T Consensus 123 ~~~~~~---------------------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 123 ADDPRD---------------------RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred cCCccc---------------------cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 111100 00011122 2689999999999999999999999999876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-22 Score=219.62 Aligned_cols=272 Identities=21% Similarity=0.214 Sum_probs=195.6
Q ss_pred CceeeeeecccCceEEEEEEECC---eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCC----CCcceeeeeEe
Q 002738 552 SLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH----SCIVEMYGHKI 624 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~~~---~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~H----PNIVrl~g~~~ 624 (886)
+|.+.++||+|+||.||.+.... ..+|+|+.......... .+..|+.++..+.. +++..+++.+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--------~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--------VLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--------cchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 89999999999999999999744 36888887543222111 12668888888873 68899998874
Q ss_pred -cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 002738 625 -SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703 (886)
Q Consensus 625 -~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsN 703 (886)
... ..||||+.+ |.+|.++.... +...++..++..|+.|++.+|.+||+.|++||||||.|
T Consensus 91 ~~~~--------------~~~iVM~l~-G~sL~dl~~~~---~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N 152 (322)
T KOG1164|consen 91 STED--------------FNFIVMSLL-GPSLEDLRKRN---PPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPEN 152 (322)
T ss_pred CCCc--------------eeEEEEecc-CccHHHHHHhC---CCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHH
Confidence 333 259999999 68999988652 24689999999999999999999999999999999999
Q ss_pred EEEeccccCCCCCCeEEEeecCCccccc--ccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHH
Q 002738 704 ILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781 (886)
Q Consensus 704 ILLd~d~~~~~~~~~VKLsDFGlA~~l~--~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLG 781 (886)
+++..... .....+.|.|||+|+.+. ...... ............||..|+++.+..+ ...+.+.|+||++
T Consensus 153 ~~~g~~~~--~~~~~~~llDfGlar~~~~~~~~~~~--~~~~r~~~~~~rGT~ry~S~~~H~~----~e~~r~DDles~~ 224 (322)
T KOG1164|consen 153 FVVGQSSR--SEVRTLYLLDFGLARRFKYVGDSGGN--LRPPRPQKGLFRGTLRYASINVHLG----IEQGRRDDLESLF 224 (322)
T ss_pred eeecCCCC--cccceEEEEecCCCccccccCCCCcc--cccCCCCccCCCCccccccHHHhCC----CccCCchhhhhHH
Confidence 99986621 112469999999998333 222110 0001111234569999999999887 6678999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 002738 782 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 861 (886)
Q Consensus 782 VILyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP 861 (886)
.++.||+.|..||.+.........+........... .....+..+..++..+-..+.
T Consensus 225 Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~ 281 (322)
T KOG1164|consen 225 YMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDR-----------------------FGDLKPEEFAKILEYIDSLDY 281 (322)
T ss_pred HHHHHHhcCCCCCccccccchHHHHHHHhhhhcccc-----------------------ccCCChHHHHHHHHHhhccCC
Confidence 999999999999977654333323222211000000 001123456677777777899
Q ss_pred CCCCCHHHHHHHHHhhcCC
Q 002738 862 TERPTAGDLYEMFVARTSS 880 (886)
Q Consensus 862 ~kRPSA~EILehLe~l~ss 880 (886)
..+|....+...|+.....
T Consensus 282 ~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 282 EDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred cCCCCHHHHHHHHHHHHHh
Confidence 9999999999998766543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-21 Score=203.32 Aligned_cols=269 Identities=32% Similarity=0.413 Sum_probs=197.3
Q ss_pred ceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCC-CcceeeeeEecCCCCCC
Q 002738 553 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS-CIVEMYGHKISSKWLPS 631 (886)
Q Consensus 553 Y~i~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HP-NIVrl~g~~~~~~~l~~ 631 (886)
|.+.+.||.|+||.||++.+. ..+++|+......... .....+.+|+.++..+.|+ +|+++++.+....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~-----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~---- 71 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS-----KEVERFLREIQILASLNHPPNIVKLYDFFQDEG---- 71 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch-----hHHHHHHHHHHHHHHccCCcceeeEEEEEecCC----
Confidence 788999999999999999988 6788888644332221 1233458999999999988 7999999995433
Q ss_pred CCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecccc
Q 002738 632 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 711 (886)
Q Consensus 632 ~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~ 711 (886)
..+++++|+.+++|.+++...... ..+.......++.|++.++.|+|..+++||||||+||+++...
T Consensus 72 ----------~~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~- 138 (384)
T COG0515 72 ----------SLYLVMEYVDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDG- 138 (384)
T ss_pred ----------EEEEEEecCCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCC-
Confidence 269999999999999777651110 2688999999999999999999999999999999999999773
Q ss_pred CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCC
Q 002738 712 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 791 (886)
Q Consensus 712 ~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~ 791 (886)
..++++|||.+............. .......||..|+|||.+.+.. ...+....|+||+|++++++++|.
T Consensus 139 -----~~~~l~dfg~~~~~~~~~~~~~~~----~~~~~~~~t~~~~~pe~~~~~~-~~~~~~~~D~~s~g~~~~~~~~~~ 208 (384)
T COG0515 139 -----RVVKLIDFGLAKLLPDPGSTSSIP----ALPSTSVGTPGYMAPEVLLGLS-LAYASSSSDIWSLGITLYELLTGL 208 (384)
T ss_pred -----CeEEEeccCcceecCCCCcccccc----ccccccccccccCCHHHhcCCC-CCCCCchHhHHHHHHHHHHHHhCC
Confidence 159999999998554332110000 1124567999999999997511 136788999999999999999999
Q ss_pred CCCCCCCH----HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 792 VPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 792 ~PF~g~s~----~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
.||..... ......+.....+...... ...........+.+++.+++..+|..|.+.
T Consensus 209 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~ 269 (384)
T COG0515 209 PPFEGEKNSSATSQTLKIILELPTPSLASPL-------------------SPSNPELISKAASDLLKKLLAKDPKNRLSS 269 (384)
T ss_pred CCCCCCCccccHHHHHHHHHhcCCccccccc-------------------CccccchhhHHHHHHHHHHHhcCchhcCCH
Confidence 99876653 4444444443322000000 000001223568899999999999999999
Q ss_pred HHHHHH
Q 002738 868 GDLYEM 873 (886)
Q Consensus 868 ~EILeh 873 (886)
.+...+
T Consensus 270 ~~~~~~ 275 (384)
T COG0515 270 SSDLSH 275 (384)
T ss_pred HHHhhc
Confidence 887765
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=218.03 Aligned_cols=174 Identities=20% Similarity=0.171 Sum_probs=125.4
Q ss_pred CCCCCceeeeeecccCceEEEEEEE---CCeeEEEEEEecccCC-CChHHHHhhhHhHHHHHHHHhhCCCCCcce-eeee
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF---GSADAAAKVRTLKVCG-SSADEIRNFEYSCLGEVRMLGALRHSCIVE-MYGH 622 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~---~~~~VAVKI~~lk~~~-~~~~~~k~f~~~~lrEI~iLk~L~HPNIVr-l~g~ 622 (886)
...++|.+.+.||+|+||+||+|++ .+..+|+|+....... ..... ...+.+|+.+|++|+|+||+. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~----~~~~~~E~~iL~~L~h~~iv~~l~~~ 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLA----RHLAAREIRALKTVRGIGVVPQLLAT 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHH----HHHHHHHHHHHHhccCCCCCcEEEEc
Confidence 4557899999999999999999986 4566788875322110 11112 234599999999999999985 4432
Q ss_pred EecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CC
Q 002738 623 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI-KS 701 (886)
Q Consensus 623 ~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDL-KP 701 (886)
. ..||||||++|++|.. +.. .. ...++.|++.||.|||++||+|||| ||
T Consensus 91 ----~--------------~~~LVmE~~~G~~L~~-~~~--------~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP 140 (365)
T PRK09188 91 ----G--------------KDGLVRGWTEGVPLHL-ARP--------HG---DPAWFRSAHRALRDLHRAGITHNDLAKP 140 (365)
T ss_pred ----C--------------CcEEEEEccCCCCHHH-hCc--------cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCc
Confidence 1 2499999999999963 211 01 1467899999999999999999999 99
Q ss_pred CCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhc
Q 002738 702 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 764 (886)
Q Consensus 702 sNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~ 764 (886)
+|||++.+ +.+||+|||+|+.+........+. ....-....+++.|+|||++..
T Consensus 141 ~NILv~~~-------~~ikLiDFGlA~~~~~~~~~~~~~--~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 141 QNWLMGPD-------GEAAVIDFQLASVFRRRGALYRIA--AYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ceEEEcCC-------CCEEEEECccceecccCcchhhhh--hhhhhhhhhccCccCCcccCCh
Confidence 99999765 459999999999876533211110 0011134578899999999864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-22 Score=210.16 Aligned_cols=257 Identities=25% Similarity=0.327 Sum_probs=201.2
Q ss_pred CCCCCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecC
Q 002738 547 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 547 ~~~~~~Y~i~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~ 626 (886)
.+++..+.+..+|.+...|..|+|+|.+.++++|+..+. .......+. |..|.-.|+-+.||||+.++|.|..+
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr--~~t~risrd----fneefp~lrifshpnilpvlgacnsp 259 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVR--EVTARISRD----FNEEFPALRIFSHPNILPVLGACNSP 259 (448)
T ss_pred CcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhh--hcchhhcch----hhhhCcceeeecCCchhhhhhhccCC
Confidence 367788889999999999999999999999999995543 333333333 48888899999999999999999865
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENI 704 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~g--IVHRDLKPsNI 704 (886)
. ++.++..|++.|+|+..++. ...-.++..++.+++.+|++|++|||+.. |----|.+..+
T Consensus 260 p--------------nlv~isq~mp~gslynvlhe---~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hv 322 (448)
T KOG0195|consen 260 P--------------NLVIISQYMPFGSLYNVLHE---QTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHV 322 (448)
T ss_pred C--------------CceEeeeeccchHHHHHHhc---CccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceE
Confidence 4 46999999999999999986 33345778899999999999999999973 34446889999
Q ss_pred EEeccccCCCCCCeEEE--eecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 002738 705 LIDLERKKADGKPVVKL--CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 782 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKL--sDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGV 782 (886)
+|+++ .+++| +|--++... ....-.|.||+||.++..+. ..--.++|+|||.+
T Consensus 323 mided-------ltarismad~kfsfqe-----------------~gr~y~pawmspealqrkpe-d~n~raadmwsfai 377 (448)
T KOG0195|consen 323 MIDED-------LTARISMADTKFSFQE-----------------VGRAYSPAWMSPEALQRKPE-DLNIRAADMWSFAI 377 (448)
T ss_pred Eecch-------hhhheecccceeeeec-----------------cccccCcccCCHHHHhcCch-hcchhhhhHHHHHH
Confidence 99988 44554 332222110 11235789999999986322 22346899999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 002738 783 LLLELLTLQVPYMGLSELEIHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 861 (886)
Q Consensus 783 ILyELLTG~~PF~g~s~~el~~~I~-~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP 861 (886)
+||||.|...||...++++.-..|. .+.++.+|. ..+..+..|+.-|+..||
T Consensus 378 llwel~trevpfadlspmecgmkialeglrv~ipp---------------------------gis~hm~klm~icmnedp 430 (448)
T KOG0195|consen 378 LLWELNTREVPFADLSPMECGMKIALEGLRVHIPP---------------------------GISRHMNKLMNICMNEDP 430 (448)
T ss_pred HHHHhhccccccccCCchhhhhhhhhccccccCCC---------------------------CccHHHHHHHHHHhcCCC
Confidence 9999999999999999988765554 445555542 235678999999999999
Q ss_pred CCCCCHHHHHHHHHhhc
Q 002738 862 TERPTAGDLYEMFVART 878 (886)
Q Consensus 862 ~kRPSA~EILehLe~l~ 878 (886)
.+||.++.|+-.|+++.
T Consensus 431 gkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 431 GKRPKFDMIVPILEKMI 447 (448)
T ss_pred CcCCCcceehhhHHHhc
Confidence 99999999999999874
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.4e-21 Score=203.51 Aligned_cols=225 Identities=23% Similarity=0.270 Sum_probs=180.0
Q ss_pred CCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEecCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 627 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~~~~ 627 (886)
..|.+.++||+|+||.++.|+. ++..||+|....+.. . .. +..|.+..+.|. .++|..+|-+.....
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~---A---PQ----LrdEYr~YKlL~g~~GIP~vYYFGqeG~ 97 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE---A---PQ----LRDEYRTYKLLGGTEGIPQVYYFGQEGK 97 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC---c---ch----HHHHHHHHHHHcCCCCCCceeeeccccc
Confidence 5799999999999999999984 899999998765432 1 12 267888888886 799999886654332
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
+-.||||++ |.||.+++.- ....|+.+++..|+.|++.-++|+|++.+|.|||||+|+||.
T Consensus 98 --------------~NiLVidLL-GPSLEDLFD~----CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIG 158 (449)
T KOG1165|consen 98 --------------YNILVIDLL-GPSLEDLFDL----CGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIG 158 (449)
T ss_pred --------------hhhhhhhhh-CcCHHHHHHH----hcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeec
Confidence 348999999 6899999875 567899999999999999999999999999999999999998
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
..+. .....+.|+|||+|+.+..+.....+. -.......||..||+--...+ ..-+.+-|+=|||-+++..
T Consensus 159 rp~~--k~~n~IhiiDFGmAK~YrDp~TkqHIP---YrE~KSLsGTARYMSINTHlG----rEQSRRDDLEaLGHvFmYF 229 (449)
T KOG1165|consen 159 RPGT--KDANVIHIIDFGMAKEYRDPKTKQHIP---YREHKSLSGTARYMSINTHLG----REQSRRDDLEALGHVFMYF 229 (449)
T ss_pred CCCC--CCCceEEEEeccchhhhcCccccccCc---cccccccccceeeeEeecccc----chhhhhhhHHHhhhhhhhh
Confidence 7643 234579999999999988766543332 223455679999999887776 5568899999999999999
Q ss_pred HhCCCCCCCCCH---HHHHHHHHcCCCCC
Q 002738 788 LTLQVPYMGLSE---LEIHDLIQMGKRPR 813 (886)
Q Consensus 788 LTG~~PF~g~s~---~el~~~I~~~~rp~ 813 (886)
+-|.+||+|... .+.++.|....+..
T Consensus 230 LRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 230 LRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred ccCCCccccccCcchHHHHHHhccccccC
Confidence 999999998754 44566666654433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=195.36 Aligned_cols=222 Identities=18% Similarity=0.209 Sum_probs=172.8
Q ss_pred CCCCCceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCC-CCcceeeeeEe
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-SCIVEMYGHKI 624 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~H-PNIVrl~g~~~ 624 (886)
+..++|.++++||.|+||.+|+|.. .+..||+|+...+... . ++..|..+...|++ ..|..+..++.
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h------p----qL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH------P----QLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC------c----chhHHHHHHHHhccCCCCchhhhhcc
Confidence 5668999999999999999999985 7889999986433211 1 22679999999984 56666666655
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCE
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNI 704 (886)
+..+ -.+||+++ |.||.+++.- ....++..+++.++-|++.-++|+|.+++|||||||+|+
T Consensus 82 e~~y--------------nvlVMdLL-GPsLEdLfnf----C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNF 142 (341)
T KOG1163|consen 82 EKDY--------------NVLVMDLL-GPSLEDLFNF----CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNF 142 (341)
T ss_pred cccc--------------ceeeeecc-CccHHHHHHH----HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccce
Confidence 4432 48999999 6899999875 346799999999999999999999999999999999999
Q ss_pred EEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVIL 784 (886)
|..-+. ....+.|+|||+|+.+.+......+ +........||..|.+--...+ ..-+.+-|+=|+|.+|
T Consensus 143 LMGlgr----h~~kl~LIDFGLaKky~d~~t~~HI---pyre~r~ltGTaRYASinAh~g----~eqSRRDDmeSvgYvL 211 (341)
T KOG1163|consen 143 LMGLGR----HCNKLYLIDFGLAKKYRDIRTRQHI---PYREDRNLTGTARYASINAHLG----IEQSRRDDMESVGYVL 211 (341)
T ss_pred eecccc----ccceEEEEeccchhhhccccccccC---ccccCCccceeeeehhhhhhhh----hhhhhhhhhhhhccee
Confidence 997653 2346999999999988765433222 2222345679999999877765 3447789999999999
Q ss_pred HHHHhCCCCCCCCCHHH---HHHHHHcC
Q 002738 785 LELLTLQVPYMGLSELE---IHDLIQMG 809 (886)
Q Consensus 785 yELLTG~~PF~g~s~~e---l~~~I~~~ 809 (886)
..+..|..||++..+.. ..+.|...
T Consensus 212 mYfnrG~LPWQglka~tk~QKyEkI~Ek 239 (341)
T KOG1163|consen 212 MYFNRGSLPWQGLKAATKKQKYEKISEK 239 (341)
T ss_pred eeeecCCCcccccchhhHHHHHHHHHHh
Confidence 99999999999986553 44455444
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5e-22 Score=235.84 Aligned_cols=266 Identities=18% Similarity=0.186 Sum_probs=187.4
Q ss_pred CCc-eeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 551 PSL-SSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 551 ~~Y-~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
..| .....+|.|++|.|+.+.. .....+.|.+.++ .. .......+...+..|+-+-..|.||||+..+..+....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~-~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~ 394 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK-PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID 394 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcc-cC-CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc
Confidence 344 5678899999998887764 2233444433322 11 22233333334688888899999999988777666443
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
. ..-+||||++ +|..++.. ...+...++..++.|++.|++|||..||.||||||+|+++.
T Consensus 395 ~--------------~~~~mE~~~~-Dlf~~~~~-----~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~ 454 (601)
T KOG0590|consen 395 G--------------ILQSMEYCPY-DLFSLVMS-----NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT 454 (601)
T ss_pred c--------------chhhhhcccH-HHHHHHhc-----ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe
Confidence 2 1334999998 99999986 24788999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyEL 787 (886)
.. +++||+|||.+..+.-.... ........+|+..|+|||++.+ ...-....||||.|+++..|
T Consensus 455 ~~-------g~lki~Dfg~~~vf~~~~e~------~~~~~~g~~gS~pY~apE~~~~---~~ydpr~vDiwS~~ii~~~m 518 (601)
T KOG0590|consen 455 EN-------GILKIIDFGAASVFRYPWEK------NIHESSGIVGSDPYLAPEVLTG---KEYDPRAVDVWSCGIIYICM 518 (601)
T ss_pred cC-------CceEEeecCcceeeccCcch------hhhhhcCcccCCcCcCcccccc---cccCcchhhhhhccceEEEE
Confidence 88 57999999999766543321 1122345679999999999986 23345689999999999999
Q ss_pred HhCCCCCCCCCHHHHH-HHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 788 LTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 788 LTG~~PF~g~s~~el~-~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
++|+.||......+.. ........-.. ...........+...+.+|.+||++||.+|.|
T Consensus 519 ~~~~~~Wk~a~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~t 578 (601)
T KOG0590|consen 519 ILGRFPWKVAKKSDNSFKTNNYSDQRNI--------------------FEGPNRLLSLLPRETRIIIYRMLQLDPTKRIT 578 (601)
T ss_pred ecCCCccccccccccchhhhcccccccc--------------------ccChHHHHHhchhhHHHHHHHHccCChhheec
Confidence 9999999644322211 00000000000 00011122344667889999999999999999
Q ss_pred HHHHHHHH
Q 002738 867 AGDLYEMF 874 (886)
Q Consensus 867 A~EILehL 874 (886)
+++|++.=
T Consensus 579 i~~i~~d~ 586 (601)
T KOG0590|consen 579 IEQILNDE 586 (601)
T ss_pred HHHHhhCh
Confidence 99999853
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.8e-21 Score=228.03 Aligned_cols=261 Identities=19% Similarity=0.219 Sum_probs=187.6
Q ss_pred CceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 631 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~ 631 (886)
+|...+.||.+.|=.|.+|++....++||++..+....+-...++. +.|++ ...++|||.+++.-+.....
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qr----L~~ik-~~l~~~pn~lPfqk~~~t~k---- 94 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQR----LEEIK-FALMKAPNCLPFQKVLVTDK---- 94 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHH----HHHHH-HHhhcCCcccchHHHHHhhH----
Confidence 7889999999999999999998888999999665544444443333 55666 67778999999987766544
Q ss_pred CCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecccc
Q 002738 632 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 711 (886)
Q Consensus 632 ~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~ 711 (886)
..|||-+|+. -+|++.|.- +..+...+.+.|+.||+.||.-+|..||+|||||.+||||+.-
T Consensus 95 ----------AAylvRqyvk-hnLyDRlST-----RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSW-- 156 (1431)
T KOG1240|consen 95 ----------AAYLVRQYVK-HNLYDRLST-----RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSW-- 156 (1431)
T ss_pred ----------HHHHHHHHHh-hhhhhhhcc-----chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeee--
Confidence 3589999997 599999975 3557788889999999999999999999999999999999977
Q ss_pred CCCCCCeEEEeecCCcccccccccccccccCCCCCCC----cccCCCcccchhhhhcc-------cCCCCCCchhhHHHH
Q 002738 712 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD----VCVGTPRWMAPEVLRAM-------HKPNLYGLEVDIWSY 780 (886)
Q Consensus 712 ~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~----~~vGT~~YmAPEvL~~~-------~~~~~~s~KSDIWSL 780 (886)
.-+.|+||..-++..- ......... +...-..|.|||.+-.. ......+++.||||+
T Consensus 157 -----NW~~LtDFAsFKPtYL-------PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~ 224 (1431)
T KOG1240|consen 157 -----NWLYLTDFASFKPTYL-------PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSA 224 (1431)
T ss_pred -----chhhhhcccccCCccC-------CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhh
Confidence 3489999976543221 111111111 11233579999998641 111226789999999
Q ss_pred HHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 002738 781 GCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 859 (886)
Q Consensus 781 GVILyELLT-G~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~ 859 (886)
||+++||++ |++||. -.+++. ...+..-.....+..+ ....+++||..|++.
T Consensus 225 GCViaELf~Eg~PlF~---LSQL~a-Yr~~~~~~~e~~Le~I-----------------------ed~~~Rnlil~Mi~r 277 (1431)
T KOG1240|consen 225 GCVIAELFLEGRPLFT---LSQLLA-YRSGNADDPEQLLEKI-----------------------EDVSLRNLILSMIQR 277 (1431)
T ss_pred hHHHHHHHhcCCCccc---HHHHHh-HhccCccCHHHHHHhC-----------------------cCccHHHHHHHHHcc
Confidence 999999988 688883 233332 2222111111122111 122589999999999
Q ss_pred CCCCCCCHHHHHHHHHhhc
Q 002738 860 NPTERPTAGDLYEMFVART 878 (886)
Q Consensus 860 DP~kRPSA~EILehLe~l~ 878 (886)
||.+|.+|++.|+....+.
T Consensus 278 dPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 278 DPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred CchhccCHHHHHHhhhccc
Confidence 9999999999998765543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-19 Score=184.84 Aligned_cols=146 Identities=14% Similarity=0.083 Sum_probs=108.3
Q ss_pred eeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChH------------------HHHhhhHhHHHHHHHHhhCCCCCc
Q 002738 556 CDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSAD------------------EIRNFEYSCLGEVRMLGALRHSCI 616 (886)
Q Consensus 556 ~k~LG~G~fG~VY~A~~-~~~~VAVKI~~lk~~~~~~~------------------~~k~f~~~~lrEI~iLk~L~HPNI 616 (886)
...||+|+||.||+|.. .+..||+|+.+......... ..+.......+|+.+|.++.+++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46899999999999997 57899999976543211110 000112233569999999988877
Q ss_pred ceeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHH-HhCCcc
Q 002738 617 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVEL-HSKHIM 695 (886)
Q Consensus 617 Vrl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yL-Hs~gIV 695 (886)
.....+.. . ..+|||||++|++|...+.. ...++...+..++.||+.+|.|| |+.||+
T Consensus 82 ~~p~~~~~-~---------------~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~~gii 140 (190)
T cd05147 82 PCPEPILL-K---------------SHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQDCRLV 140 (190)
T ss_pred CCCcEEEe-c---------------CCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 54333221 1 12899999998777655432 24688999999999999999999 799999
Q ss_pred ccCCCCCCEEEeccccCCCCCCeEEEeecCCcccc
Q 002738 696 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 730 (886)
Q Consensus 696 HRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l 730 (886)
||||||+|||++. ..++|+|||+|...
T Consensus 141 HrDlkP~NIli~~--------~~v~LiDFG~a~~~ 167 (190)
T cd05147 141 HADLSEYNLLYHD--------GKLYIIDVSQSVEH 167 (190)
T ss_pred cCCCCHHHEEEEC--------CcEEEEEccccccC
Confidence 9999999999983 24999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.9e-19 Score=193.00 Aligned_cols=255 Identities=20% Similarity=0.212 Sum_probs=157.0
Q ss_pred CceeeeeecccCceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCC----------CCccee
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH----------SCIVEM 619 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~H----------PNIVrl 619 (886)
.+...+.||.|+++.||.+++ .++.+|+|++.... .......+.+ .+|.-....+.+ -.++-.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~----~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQL----KEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHH----HHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHH----HHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 457789999999999999999 55899999997766 3333344444 555544444322 123333
Q ss_pred eeeEecCCCCCCCCCCC---CcccceEEEEEeccCCCCHHHHHHHHhccCCC--cCCHHHHHHHHHHHHHHHHHHHhCCc
Q 002738 620 YGHKISSKWLPSADGNP---EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEK--HVSVKLALFIAQDVAAALVELHSKHI 694 (886)
Q Consensus 620 ~g~~~~~~~l~~~~~~~---~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~--~Ls~~~i~~Ia~QIa~AL~yLHs~gI 694 (886)
++.......-+...... .......+++|+-+. ++|.+++......... .+.......+..|+++.+++||.+||
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~Gl 166 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGL 166 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcce
Confidence 33333211000000010 111224588999996 7999987754333322 23344556777999999999999999
Q ss_pred cccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc----CCCC
Q 002738 695 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH----KPNL 770 (886)
Q Consensus 695 VHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~----~~~~ 770 (886)
||+||||+|+|++.+ +.++|+||+.....+..... ...+..|.+||...... ....
T Consensus 167 VHgdi~~~nfll~~~-------G~v~Lg~F~~~~r~g~~~~~-------------~~~~~~~~PPe~~~~~~~~~~~~~~ 226 (288)
T PF14531_consen 167 VHGDIKPENFLLDQD-------GGVFLGDFSSLVRAGTRYRC-------------SEFPVAFTPPELESCAGQFGQNNAP 226 (288)
T ss_dssp EEST-SGGGEEE-TT-------S-EEE--GGGEEETTEEEEG-------------GGS-TTTS-HHHHHHHTSCHHSEEE
T ss_pred EecccceeeEEEcCC-------CCEEEcChHHHeecCceeec-------------cCCCcccCChhhhhhhcccCcccce
Confidence 999999999999988 56999999987765542211 13457899999875421 1235
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHH
Q 002738 771 YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 850 (886)
Q Consensus 771 ~s~KSDIWSLGVILyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~ 850 (886)
++.+.|.|+||+++|.|+++..||....+...... . ...+. +.++.++
T Consensus 227 ~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~--------------~-----------------f~~C~-~~Pe~v~ 274 (288)
T PF14531_consen 227 YTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW--------------D-----------------FSRCR-DMPEPVQ 274 (288)
T ss_dssp E-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG--------------G-----------------GTTSS----HHHH
T ss_pred eeeccCHHHHHHHHHHHHHccCCCCCCCccccccc--------------c-----------------chhcC-CcCHHHH
Confidence 78999999999999999999999975533211100 0 11122 4467899
Q ss_pred HHHHHhcccCCCCC
Q 002738 851 DVFRRCTEENPTER 864 (886)
Q Consensus 851 dLL~rCL~~DP~kR 864 (886)
.||..+|+.||.+|
T Consensus 275 ~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 275 FLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHT-SSGGGS
T ss_pred HHHHHHccCCcccC
Confidence 99999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.7e-19 Score=187.98 Aligned_cols=184 Identities=13% Similarity=0.126 Sum_probs=133.2
Q ss_pred CCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhh--hHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNF--EYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f--~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
++|.+.+.||.|+||.||++...+..+|+|++.-+... .......| -..+.+|+..+.++.||+|..+.+++.....
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~-~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKR-TERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred CceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCc-hHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 68999999999999999998887889999997533221 11111111 0124789999999999999999988775431
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
- .-......+|||||++|.+|.++.. +++ ....+|+.+|..||..|++||||||.||+++.
T Consensus 110 ~------~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 110 K------TLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSK 170 (232)
T ss_pred c------cccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeC
Confidence 0 0001234699999999999988742 222 24569999999999999999999999999986
Q ss_pred cccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+ + ++|+|||.......... ...++.. ..+..++|||+||+++.-+.
T Consensus 171 ~-------g-i~liDfg~~~~~~e~~a----------------------~d~~vle----r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 N-------G-LRIIDLSGKRCTAQRKA----------------------KDRIDLE----RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-------C-EEEEECCCcccccchhh----------------------HHHHHHH----hHhcccccccceeEeehHHH
Confidence 5 4 99999998865432110 0112332 34567999999999987664
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=178.57 Aligned_cols=147 Identities=14% Similarity=0.123 Sum_probs=110.2
Q ss_pred eeeecccCceEEEEEEE-CCeeEEEEEEecccCCCCh------------------HHHHhhhHhHHHHHHHHhhCCCCCc
Q 002738 556 CDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSA------------------DEIRNFEYSCLGEVRMLGALRHSCI 616 (886)
Q Consensus 556 ~k~LG~G~fG~VY~A~~-~~~~VAVKI~~lk~~~~~~------------------~~~k~f~~~~lrEI~iLk~L~HPNI 616 (886)
.+.||+|+||.||+|.. ++..||+|+.......... .........+.+|+..+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 57899999999999997 4889999997654321100 0001112234689999999999988
Q ss_pred ceeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHH-HHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHh-CCc
Q 002738 617 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY-IEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHI 694 (886)
Q Consensus 617 Vrl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~-L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs-~gI 694 (886)
.....+.... .+|||||++|+++... +.. ..++...+..++.|++.+|.+||. +||
T Consensus 82 ~~p~~~~~~~----------------~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~gi 139 (190)
T cd05145 82 PVPEPILLKK----------------NVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEAGL 139 (190)
T ss_pred CCceEEEecC----------------CEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhCCE
Confidence 5544433221 2899999998755443 332 457788999999999999999999 999
Q ss_pred cccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccc
Q 002738 695 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 732 (886)
Q Consensus 695 VHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~ 732 (886)
+||||||+|||++ + +.++|+|||+|.....
T Consensus 140 vHrDlkP~NIll~-~-------~~~~liDFG~a~~~~~ 169 (190)
T cd05145 140 VHGDLSEYNILYH-D-------GKPYIIDVSQAVELDH 169 (190)
T ss_pred ecCCCChhhEEEE-C-------CCEEEEEcccceecCC
Confidence 9999999999998 4 3599999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.4e-19 Score=191.45 Aligned_cols=220 Identities=22% Similarity=0.306 Sum_probs=154.0
Q ss_pred CCCCcceeeeeEecCCCC-CCC-------C-----CCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHH
Q 002738 612 RHSCIVEMYGHKISSKWL-PSA-------D-----GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFI 678 (886)
Q Consensus 612 ~HPNIVrl~g~~~~~~~l-~~~-------~-----~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~I 678 (886)
+|||||+++++|.++-.. |.. . ...-.+...+|+||.-++ .+|.+|+-. ...+.....-|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~------~~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT------RHRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc------CCCchHHHHHH
Confidence 599999999998865321 100 0 001113457999999997 699999975 45778889999
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccc
Q 002738 679 AQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 758 (886)
Q Consensus 679 a~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmA 758 (886)
+.|+++|+.|||++||.|||||++||||..+. +.-+.++|+|||++---......-.... ..-...|+..-||
T Consensus 347 laQlLEav~hL~~hgvAhRDlKSDNiL~Eldd---D~~P~LVvaDFGCcLAd~~hGlqlpy~S----~~Vd~GGNa~lmA 419 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHGVAHRDLKSDNILLELDD---DEIPQLVVADFGCCLADDNHGLQLPYES----DEVDLGGNAKLMA 419 (598)
T ss_pred HHHHHHHHHHHHHccchhhcccccceEEEecC---CCCcEEEEcccceeeecccccccccccc----ccccCCCcceecc
Confidence 99999999999999999999999999998773 3567899999999854333111111111 0112347888999
Q ss_pred hhhhhcccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHcCCCCCchhHHhhhcccccccccccCCC
Q 002738 759 PEVLRAMHKPN--LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSG 835 (886)
Q Consensus 759 PEvL~~~~~~~--~~s~KSDIWSLGVILyELLTG~~PF~g~s~~el~-~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~ 835 (886)
||+....+... .--.|+|.|+.|.+.||+++...||.+...+.+- ...++...|.+++
T Consensus 420 PEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~------------------- 480 (598)
T KOG4158|consen 420 PEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPS------------------- 480 (598)
T ss_pred hhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcc-------------------
Confidence 99987644221 1235999999999999999999999774333221 1122223333332
Q ss_pred CCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002738 836 FEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 872 (886)
Q Consensus 836 ~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EILe 872 (886)
.+++.+++|+..+|+.||++|++..=..+
T Consensus 481 --------~vpp~~rqlV~~lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 481 --------RVPPVARQLVFDLLKRDPSKRVSPNIAAN 509 (598)
T ss_pred --------cCChHHHHHHHHHhcCCccccCCccHHHh
Confidence 24567899999999999999988654433
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.8e-18 Score=176.90 Aligned_cols=201 Identities=12% Similarity=0.031 Sum_probs=140.2
Q ss_pred eeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEecCCCCCCC
Q 002738 554 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSA 632 (886)
Q Consensus 554 ~i~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~~~~~l~~~ 632 (886)
.+...|++|+||+||++...+.+++.+-+....... ..-+...+.+|+++|++|. |++|++++++.
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~----~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~--------- 71 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWL----RGVAWWLARREALALRQLDGLPRTPRLLHWD--------- 71 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhh----hhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------
Confidence 457889999999999988877777766543222110 1111224589999999996 58899998862
Q ss_pred CCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCCEEEecccc
Q 002738 633 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI-KSENILIDLERK 711 (886)
Q Consensus 633 ~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDL-KPsNILLd~d~~ 711 (886)
..+++|||+.|.+|.+.+.. ....++.|++.+|.++|++||+|||| ||.|||++.+
T Consensus 72 ---------~~~lvmeyI~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~-- 128 (218)
T PRK12274 72 ---------GRHLDRSYLAGAAMYQRPPR------------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQED-- 128 (218)
T ss_pred ---------CEEEEEeeecCccHHhhhhh------------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCC--
Confidence 14999999999998754321 11357789999999999999999999 7999999866
Q ss_pred CCCCCCeEEEeecCCccccccccccccccc-CC--CCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHH
Q 002738 712 KADGKPVVKLCDFDRAVPLRSFLHTCCIAH-RG--IPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 712 ~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~-~~--~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELL 788 (886)
+.++|+|||+|.............. +. .........++.|+.|+...-+. ..--...+.++-|+.+|.++
T Consensus 129 -----g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~--~~~~~~~~w~~~g~~~~~~~ 201 (218)
T PRK12274 129 -----GSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLK--RTSWIRELWFATGKPVYRFV 201 (218)
T ss_pred -----CCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhc--cchhHHHHHHHhcchHHHHH
Confidence 4599999999986543221000000 00 00001123678899998765421 12236788899999999999
Q ss_pred hCCCCCCCC
Q 002738 789 TLQVPYMGL 797 (886)
Q Consensus 789 TG~~PF~g~ 797 (886)
|+..|+.+.
T Consensus 202 ~~~~~~~~~ 210 (218)
T PRK12274 202 TRRVLHWED 210 (218)
T ss_pred hccCCcccc
Confidence 999987544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.7e-19 Score=205.86 Aligned_cols=226 Identities=24% Similarity=0.279 Sum_probs=176.7
Q ss_pred eecccCceEEEEEE-----ECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEecCCCCCC
Q 002738 558 EAGKSVSSSLFRCK-----FGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPS 631 (886)
Q Consensus 558 ~LG~G~fG~VY~A~-----~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~~~~~l~~ 631 (886)
.+|+|+||.|++++ +.+.-+|.|+.+.......... . ...|-.++...+ ||.+|+++-.+..+..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~----t~~er~il~~~~~~~f~v~lhyafqt~~k--- 71 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--H----TKQERIILAFVHNTPFLVKLHYAFQTDGK--- 71 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc--c----cccHHHHHhhccCCCceeeeeeeeccccc---
Confidence 37999999999865 3556677777543322222111 1 256788888887 9999999998887664
Q ss_pred CCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecccc
Q 002738 632 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 711 (886)
Q Consensus 632 ~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~ 711 (886)
.+++++|..||.|...+.+ ...+.+.....+...++-|++++|+.+|+|||+|++||+++.+
T Consensus 72 -----------l~l~ld~~rgg~lft~l~~-----~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~-- 133 (612)
T KOG0603|consen 72 -----------LYLILDFLRGGDLFTRLSK-----EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLE-- 133 (612)
T ss_pred -----------hhHhhhhcccchhhhcccc-----CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeeccc--
Confidence 5999999999999988875 4567788888888999999999999999999999999999988
Q ss_pred CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCC
Q 002738 712 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 791 (886)
Q Consensus 712 ~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~ 791 (886)
+.+++.|||+++....... .+||..|||||++.+ ....+|.||||++++||+||.
T Consensus 134 -----Ghi~~tdfglske~v~~~~--------------~cgt~eymApEI~~g------h~~a~D~ws~gvl~felltg~ 188 (612)
T KOG0603|consen 134 -----GHIKLTDFGLSKEAVKEKI--------------ACGTYEYRAPEIING------HLSAADWWSFGVLAFELLTGT 188 (612)
T ss_pred -----CccccCCchhhhHhHhhhh--------------cccchhhhhhHhhhc------cCCcccchhhhhhHHHHhhCC
Confidence 5699999999987654221 168999999999973 467899999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 002738 792 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 792 ~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA 867 (886)
.||.+ ++...|.+... ..| ......+.+++..++..+|..|.-.
T Consensus 189 ~pf~~----~~~~~Il~~~~-~~p---------------------------~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 189 LPFGG----DTMKRILKAEL-EMP---------------------------RELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CCCch----HHHHHHhhhcc-CCc---------------------------hhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 99987 45555544322 122 2235578899999999999999644
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.2e-17 Score=169.79 Aligned_cols=143 Identities=20% Similarity=0.238 Sum_probs=112.8
Q ss_pred eeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 636 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~~~~ 636 (886)
+.||+|++|.||+|.+.+..+++|+...+..............++.+|+.++..+.|++|+....++....
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--------- 72 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE--------- 72 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC---------
Confidence 57999999999999998899999986433222221122222245689999999999999877766655433
Q ss_pred CcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCCCC
Q 002738 637 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 716 (886)
Q Consensus 637 ~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~~ 716 (886)
..++||||++|++|.+++.. ... .+..++.+++.+|.+||+.|++|||++|.|||++ +
T Consensus 73 -----~~~lv~e~~~G~~L~~~~~~--------~~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~------- 130 (211)
T PRK14879 73 -----NFIIVMEYIEGEPLKDLINS--------NGM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-G------- 130 (211)
T ss_pred -----CCEEEEEEeCCcCHHHHHHh--------ccH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-C-------
Confidence 24899999999999999865 112 7889999999999999999999999999999998 3
Q ss_pred CeEEEeecCCcccc
Q 002738 717 PVVKLCDFDRAVPL 730 (886)
Q Consensus 717 ~~VKLsDFGlA~~l 730 (886)
..++|+|||++...
T Consensus 131 ~~~~liDf~~a~~~ 144 (211)
T PRK14879 131 GKIYLIDFGLAEFS 144 (211)
T ss_pred CCEEEEECCcccCC
Confidence 35999999998653
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.7e-17 Score=173.45 Aligned_cols=143 Identities=14% Similarity=0.119 Sum_probs=104.5
Q ss_pred eeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-----CCCCcceeeeeEecCCC
Q 002738 554 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-----RHSCIVEMYGHKISSKW 628 (886)
Q Consensus 554 ~i~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-----~HPNIVrl~g~~~~~~~ 628 (886)
.-.+.||+|+||.||.-... ...++|+...... ...+ .+.+|+.+++.| .||||++++|++.++..
T Consensus 5 ~~~~~LG~G~~~~Vy~hp~~-~~k~IKv~~~~~~----~~~~----~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g 75 (210)
T PRK10345 5 SEQSPLGTGRHRKCYAHPED-AQRCIKIVYHRGD----GGDK----EIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG 75 (210)
T ss_pred CCcceecCCCceEEEECCCC-cCeEEEEEecccc----chHH----HHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC
Confidence 34578999999999962223 3346777654321 1122 349999999999 57999999999987642
Q ss_pred CCCCCCCCCcccce-EEEEEec--cCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHH-HHHHhCCccccCCCCCCE
Q 002738 629 LPSADGNPEHHLLQ-SAIFMEY--VKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAAL-VELHSKHIMHRDIKSENI 704 (886)
Q Consensus 629 l~~~~~~~~~~~~~-~~LVmEy--~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL-~yLHs~gIVHRDLKPsNI 704 (886)
... ..+|||| +.+++|.+++.. ..+++. ..++.|++.++ +|||+++||||||||+||
T Consensus 76 -----------~g~v~~~I~e~~G~~~~tL~~~l~~------~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NI 136 (210)
T PRK10345 76 -----------TGYVYDVIADFDGKPSITLTEFAEQ------CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNI 136 (210)
T ss_pred -----------CeEEEEEEecCCCCcchhHHHHHHc------ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHE
Confidence 122 3488999 557999999975 235554 35678888888 999999999999999999
Q ss_pred EEeccccCCCCCCeEEEeecCCc
Q 002738 705 LIDLERKKADGKPVVKLCDFDRA 727 (886)
Q Consensus 705 LLd~d~~~~~~~~~VKLsDFGlA 727 (886)
|++..+. +...++|+||+.+
T Consensus 137 Ll~~~~~---~~~~~~LiDg~G~ 156 (210)
T PRK10345 137 LCQRISE---SEVIPVVCDNIGE 156 (210)
T ss_pred EEeccCC---CCCcEEEEECCCC
Confidence 9986421 3357999995544
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=192.27 Aligned_cols=220 Identities=25% Similarity=0.345 Sum_probs=167.1
Q ss_pred HhhCCCCCcceeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHH
Q 002738 608 LGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALV 687 (886)
Q Consensus 608 Lk~L~HPNIVrl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~ 687 (886)
|+.+.|.|+.+|+|.+.... ..++|.+||..|+|.+.+.. ....+++.....++++|+.||+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~--------------~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ 62 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGP--------------EMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLA 62 (484)
T ss_pred CcccchhhhhhheeeEecCC--------------ceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHH
Confidence 45788999999999998654 46999999999999999986 3466888899999999999999
Q ss_pred HHHhCCc-cccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhccc
Q 002738 688 ELHSKHI-MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 766 (886)
Q Consensus 688 yLHs~gI-VHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~ 766 (886)
|||...| .|+.|++.|.+++.. +.+||+|||+.......... .......-..-|.|||.+.+..
T Consensus 63 ylh~s~i~~hg~l~s~nClvd~~-------w~lklt~~Gl~~~~~~~~~~--------~~~~~~~~~~lw~aPellr~~~ 127 (484)
T KOG1023|consen 63 YLHNSPIGYHGALKSSNCLVDSR-------WVLKLTDFGLNSLLEETAEP--------EAHHPIRKALLWTAPELLRGAL 127 (484)
T ss_pred HHhcCcceeeeeeccccceeeee-------EEEEechhhhcccccccccc--------cccchhHHHHhccCHHHhcccc
Confidence 9999876 999999999999977 88999999998766431000 0011112346799999998732
Q ss_pred CCCC---CCchhhHHHHHHHHHHHHhCCCCCCC----CCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCc
Q 002738 767 KPNL---YGLEVDIWSYGCLLLELLTLQVPYMG----LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP 839 (886)
Q Consensus 767 ~~~~---~s~KSDIWSLGVILyELLTG~~PF~g----~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~ 839 (886)
.... .+.+.||||||++++|+++.+.||.. .++.++...+.++..+.+...+..
T Consensus 128 ~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~------------------- 188 (484)
T KOG1023|consen 128 SQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIEL------------------- 188 (484)
T ss_pred cccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhh-------------------
Confidence 2222 57889999999999999999999965 234456666666322222211100
Q ss_pred hhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 002738 840 EAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSS 881 (886)
Q Consensus 840 ~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EILehLe~l~sss 881 (886)
. .+..+.+..++.+||..+|..||++++|-..++.+....
T Consensus 189 -~-~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 189 -L-NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred -h-hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 0 023446899999999999999999999999988877643
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.1e-17 Score=199.85 Aligned_cols=201 Identities=17% Similarity=0.225 Sum_probs=154.3
Q ss_pred CCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC---CCCcceeeeeEec
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---HSCIVEMYGHKIS 625 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~-~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~---HPNIVrl~g~~~~ 625 (886)
-..|.|.+.||+|+||+||+|.. ++..+|+|+-+-.. ... -.+ =.+++.+|+ -+.|+.+..++..
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~--~WE---fYI------~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPN--PWE---FYI------CLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCC--cee---eee------hHHHHHhhchhhhcchHHHHHHHcc
Confidence 45789999999999999999986 67889999854222 111 011 123344444 3456666555543
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
.+ ..+||+||.+.|+|.+++.. .+.+++..+..+..|++.-+.+||..+||||||||+|.|
T Consensus 766 ~~--------------~S~lv~ey~~~Gtlld~~N~-----~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfl 826 (974)
T KOG1166|consen 766 QN--------------ASVLVSEYSPYGTLLDLINT-----NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFL 826 (974)
T ss_pred CC--------------cceeeeeccccccHHHhhcc-----CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeE
Confidence 33 35999999999999999973 577999999999999999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILy 785 (886)
|...-....+...++|+|||.+..+...... ..-....+|-.+-.+|+..| .+++..+|.|.|+.+++
T Consensus 827 l~~~~~~~~~~~~l~lIDfG~siDm~lfp~~--------~~F~~~~~td~f~C~EM~~g----rpWtYq~DyfGlAa~~h 894 (974)
T KOG1166|consen 827 LRREICADSDSKGLYLIDFGRSIDMKLFPDG--------TKFKAVWHTDLFDCIEMREG----RPWTYQIDYFGLAATVH 894 (974)
T ss_pred eecccCCCCcccceEEEecccceeeeEcCCC--------cEEeeeeccccchhHHHhcC----CCCchhhhhHHHHHHHH
Confidence 9776443344667999999999765432211 11233468889999999987 89999999999999999
Q ss_pred HHHhCCC
Q 002738 786 ELLTLQV 792 (886)
Q Consensus 786 ELLTG~~ 792 (886)
-|+.|+.
T Consensus 895 ~mLFG~y 901 (974)
T KOG1166|consen 895 VMLFGKY 901 (974)
T ss_pred HHHHHHH
Confidence 9999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=9.4e-17 Score=163.86 Aligned_cols=139 Identities=21% Similarity=0.271 Sum_probs=106.1
Q ss_pred eecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCCC
Q 002738 558 EAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 637 (886)
Q Consensus 558 ~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~~~~~ 637 (886)
.||+|+||.||+|.+.+..+++|++..+...........-..++.+|+.++..+.|++|.....++....
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~---------- 70 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD---------- 70 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC----------
Confidence 4899999999999998899999986543222222112222245689999999999887654444444332
Q ss_pred cccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCCCCC
Q 002738 638 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 717 (886)
Q Consensus 638 ~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~~~ 717 (886)
..++||||++|++|.+++.. .. . .++.+++.+|.+||+.|++|||++|.|||++ + .
T Consensus 71 ----~~~lv~e~~~g~~l~~~~~~-----~~-~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~-------~ 126 (199)
T TIGR03724 71 ----NKTIVMEYIEGKPLKDVIEE-----GN-D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D-------D 126 (199)
T ss_pred ----CCEEEEEEECCccHHHHHhh-----cH-H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C-------C
Confidence 24899999999999998764 11 1 7899999999999999999999999999998 4 3
Q ss_pred eEEEeecCCcccc
Q 002738 718 VVKLCDFDRAVPL 730 (886)
Q Consensus 718 ~VKLsDFGlA~~l 730 (886)
.++|+|||++...
T Consensus 127 ~~~liDfg~a~~~ 139 (199)
T TIGR03724 127 KLYLIDFGLGKYS 139 (199)
T ss_pred cEEEEECCCCcCC
Confidence 5999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-17 Score=200.26 Aligned_cols=216 Identities=23% Similarity=0.309 Sum_probs=152.3
Q ss_pred CCCceeeeeecccCceEEEEEEEC--CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~ 627 (886)
-.+|..++.|..|+||.||..+++ .+.+|.|+-+-+ .|++ ||..+-+.
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~--------------------lilR-----nilt~a~n----- 131 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN--------------------LILR-----NILTFAGN----- 131 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc--------------------hhhh-----ccccccCC-----
Confidence 457899999999999999999875 667777652100 1111 23332211
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEe
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd 707 (886)
.++| |+-...++. .+.++.. ++.+++|||+.||+|||+||+|.+|+
T Consensus 132 ---------------pfvv------gDc~tllk~-----~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT 177 (1205)
T KOG0606|consen 132 ---------------PFVV------GDCATLLKN-----IGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLIT 177 (1205)
T ss_pred ---------------ccee------chhhhhccc-----CCCCcch--------hhHHhHhhccCCeecCCCCCCcceee
Confidence 2334 444454543 1233322 27899999999999999999999999
Q ss_pred ccccCCCCCCeEEEeecCCcccccccccccccc-----cCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHH
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-----HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 782 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~-----~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGV 782 (886)
.- +.+|++|||+++.......++... ..........+||+.|.|||++.. ..|+..+|.|++|+
T Consensus 178 ~m-------GhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr----qgygkpvdwwamGi 246 (1205)
T KOG0606|consen 178 SM-------GHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR----QGYGKPVDWWAMGI 246 (1205)
T ss_pred ec-------ccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh----hccCCCccHHHHHH
Confidence 87 569999999987543322221100 001112344579999999999986 77999999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 002738 783 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 862 (886)
Q Consensus 783 ILyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~ 862 (886)
|+||.+.|..||.+.++++++..+...... ++ +......++++++|.++|+.+|.
T Consensus 247 IlyeFLVgcvpffGdtpeelfg~visd~i~-wp------------------------E~dea~p~Ea~dli~~LL~qnp~ 301 (1205)
T KOG0606|consen 247 ILYEFLVGCVPFFGDTPEELFGQVISDDIE-WP------------------------EEDEALPPEAQDLIEQLLRQNPL 301 (1205)
T ss_pred HHHHHheeeeeccCCCHHHHHhhhhhhhcc-cc------------------------ccCcCCCHHHHHHHHHHHHhChH
Confidence 999999999999999999998887654221 11 11223356799999999999999
Q ss_pred CCC
Q 002738 863 ERP 865 (886)
Q Consensus 863 kRP 865 (886)
.|.
T Consensus 302 ~Rl 304 (1205)
T KOG0606|consen 302 CRL 304 (1205)
T ss_pred hhc
Confidence 994
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.6e-16 Score=187.53 Aligned_cols=146 Identities=20% Similarity=0.218 Sum_probs=113.9
Q ss_pred CCCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCC
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l 629 (886)
...|...+.||+|+||.||++.+.+..+++|++..+..............++.+|+.++..++|++|+..+.++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~- 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE- 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC-
Confidence 3455678999999999999999987777777654332222111112223456899999999999999887766654332
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
.++||||++|++|.+++. ....++.||+.+|.|||+.||+||||||+|||++ +
T Consensus 411 -------------~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~ 463 (535)
T PRK09605 411 -------------KTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-D 463 (535)
T ss_pred -------------CEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-C
Confidence 489999999999999885 2467899999999999999999999999999994 3
Q ss_pred ccCCCCCCeEEEeecCCcccc
Q 002738 710 RKKADGKPVVKLCDFDRAVPL 730 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l 730 (886)
..++|+|||+++..
T Consensus 464 -------~~~~liDFGla~~~ 477 (535)
T PRK09605 464 -------DRLYLIDFGLGKYS 477 (535)
T ss_pred -------CcEEEEeCcccccC
Confidence 35999999998653
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.1e-16 Score=170.13 Aligned_cols=149 Identities=14% Similarity=0.162 Sum_probs=109.7
Q ss_pred CceeeeeecccCceEEEEEE---ECCeeEEEEEEecccCCCCh----------------HHHHhhhHhHHHHHHHHhhCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCK---FGSADAAAKVRTLKVCGSSA----------------DEIRNFEYSCLGEVRMLGALR 612 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~---~~~~~VAVKI~~lk~~~~~~----------------~~~k~f~~~~lrEI~iLk~L~ 612 (886)
-|.+.+.||+|+||.||+|. ..+..||+|+.......... ...+.....+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 36788999999999999998 37889999997654321100 011112234578999999997
Q ss_pred CCC--cceeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHH
Q 002738 613 HSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH 690 (886)
Q Consensus 613 HPN--IVrl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLH 690 (886)
+.+ +.+++++ . ..+|||||++|.+|..++.. ...+....+..++.||+.+|.+||
T Consensus 109 ~~~i~~p~~~~~---~---------------~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH 165 (237)
T smart00090 109 EAGVPVPKPIAW---R---------------RNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLY 165 (237)
T ss_pred hcCCCCCeeeEe---c---------------CceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHH
Confidence 532 3344432 1 13899999998888765422 234556677899999999999999
Q ss_pred hCC-ccccCCCCCCEEEeccccCCCCCCeEEEeecCCccccc
Q 002738 691 SKH-IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 731 (886)
Q Consensus 691 s~g-IVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~ 731 (886)
.+| |+||||||+|||++ + ..++|+|||.+....
T Consensus 166 ~~g~iiH~Dikp~NIli~-~-------~~i~LiDFg~a~~~~ 199 (237)
T smart00090 166 KEGELVHGDLSEYNILVH-D-------GKVVIIDVSQSVELD 199 (237)
T ss_pred hcCCEEeCCCChhhEEEE-C-------CCEEEEEChhhhccC
Confidence 999 99999999999998 4 359999999986543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.4e-16 Score=178.94 Aligned_cols=182 Identities=24% Similarity=0.328 Sum_probs=132.6
Q ss_pred eEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCCCCCeEEE
Q 002738 642 QSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721 (886)
Q Consensus 642 ~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~~~~VKL 721 (886)
.+||.|++|.-.+|.++|.. +......++...+.++.|++.|+.| ++.+|+|+||.||++..+ ..+||
T Consensus 330 ~lyI~Mn~c~~~tledWl~r--r~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d-------~q~kI 397 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRR--RRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDD-------DQLKI 397 (516)
T ss_pred chhhhhhhhhhhhHHHHhhC--CCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccc-------hhhhh
Confidence 58999999999999999974 2233456788899999999999999 999999999999999877 46999
Q ss_pred eecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 002738 722 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSEL 800 (886)
Q Consensus 722 sDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT-G~~PF~g~s~~ 800 (886)
.|||+...........+ .....+..+||..||+||.+.+ ..|+.|+||||||+||+||++ =..+| ...
T Consensus 398 gDFgl~ts~~~~~~~~~----~~a~~t~~~gt~~YmsPEQi~g----~~y~~kvdIyaLGlil~EL~~~f~T~~---er~ 466 (516)
T KOG1033|consen 398 GDFGLVTSQDKDETVAP----AAASHTQQVGTLLYMSPEQIRG----QQYSEKVDIYALGLILAELLIQFSTQF---ERI 466 (516)
T ss_pred hhhhheeecccCCcccc----hhhhhhhcccccccCCHHHHhh----hhhhhhcchhhHHHHHHHHHHHhccHH---HHH
Confidence 99999876654331100 0112344689999999999997 789999999999999999997 12222 111
Q ss_pred HHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002738 801 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 873 (886)
Q Consensus 801 el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EILeh 873 (886)
.....+..+..|+ . ... ..+.-..|+.+||.+.|.+||++.+..-|
T Consensus 467 ~t~~d~r~g~ip~---~-----------------------~~~-d~p~e~~ll~~lls~~p~~RP~~~~~~~~ 512 (516)
T KOG1033|consen 467 ATLTDIRDGIIPP---E-----------------------FLQ-DYPEEYTLLQQLLSPSPEERPSAIEVALH 512 (516)
T ss_pred HhhhhhhcCCCCh---H-----------------------Hhh-cCcHHHHHHHHhcCCCcccCchHHHHhhh
Confidence 2223333333221 0 001 12245689999999999999966665444
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.9e-15 Score=155.20 Aligned_cols=143 Identities=17% Similarity=0.163 Sum_probs=106.2
Q ss_pred ceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChH--------------HHHhhhHhHHHHHHHHhhCCCCC--
Q 002738 553 LSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSAD--------------EIRNFEYSCLGEVRMLGALRHSC-- 615 (886)
Q Consensus 553 Y~i~k~LG~G~fG~VY~A~~-~~~~VAVKI~~lk~~~~~~~--------------~~k~f~~~~lrEI~iLk~L~HPN-- 615 (886)
|.+.+.||.|+||.||++.. .+..+|||++.......... ........+.+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 67789999999999999987 58899999976543111000 00111123578999999998874
Q ss_pred cceeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 002738 616 IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 695 (886)
Q Consensus 616 IVrl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIV 695 (886)
++..++. . ..++||||++|++|..+... .....++.+|+.++.++|..||+
T Consensus 97 v~~~~~~----~--------------~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~gi~ 147 (198)
T cd05144 97 VPKPIDW----N--------------RHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHGII 147 (198)
T ss_pred CCceeec----C--------------CceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCCCC
Confidence 4444331 1 23899999999998765421 23567889999999999999999
Q ss_pred ccCCCCCCEEEeccccCCCCCCeEEEeecCCccccc
Q 002738 696 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 731 (886)
Q Consensus 696 HRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~ 731 (886)
||||||.||+++.+ +.++|+|||++....
T Consensus 148 H~Dl~p~Nill~~~-------~~~~liDfg~~~~~~ 176 (198)
T cd05144 148 HGDLSEFNILVDDD-------EKIYIIDWPQMVSTD 176 (198)
T ss_pred cCCCCcccEEEcCC-------CcEEEEECCccccCC
Confidence 99999999999876 569999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.3e-14 Score=152.66 Aligned_cols=147 Identities=15% Similarity=0.178 Sum_probs=106.3
Q ss_pred eeeec-ccCceEEEEEEECCeeEEEEEEecccC-----CCChHHHHhhhHhHHHHHHHHhhCCCCCc--ceeeeeEecCC
Q 002738 556 CDEAG-KSVSSSLFRCKFGSADAAAKVRTLKVC-----GSSADEIRNFEYSCLGEVRMLGALRHSCI--VEMYGHKISSK 627 (886)
Q Consensus 556 ~k~LG-~G~fG~VY~A~~~~~~VAVKI~~lk~~-----~~~~~~~k~f~~~~lrEI~iLk~L~HPNI--Vrl~g~~~~~~ 627 (886)
...|| .||.|+||.+...+..+++|.+..... ............++.+|+.++.+|.|++| ++.+++.....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 35687 899999999998889999998743211 00000000112356899999999998875 67777654332
Q ss_pred CCCCCCCCCCcccceEEEEEeccCC-CCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEE
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~G-GSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILL 706 (886)
. .....+|||||++| .+|.+++.. ..++.. .+.+|+.+|.+||++||+||||||.|||+
T Consensus 116 ~----------~~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv 175 (239)
T PRK01723 116 G----------LFYRADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILL 175 (239)
T ss_pred C----------cceeeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEE
Confidence 1 11234799999997 699998864 234443 35789999999999999999999999999
Q ss_pred eccccCCCCCCeEEEeecCCccc
Q 002738 707 DLERKKADGKPVVKLCDFDRAVP 729 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGlA~~ 729 (886)
+.+ ..++|+|||.+..
T Consensus 176 ~~~-------~~v~LIDfg~~~~ 191 (239)
T PRK01723 176 DPD-------GKFWLIDFDRGEL 191 (239)
T ss_pred cCC-------CCEEEEECCCccc
Confidence 876 3599999998753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.3e-14 Score=142.04 Aligned_cols=144 Identities=15% Similarity=0.197 Sum_probs=96.4
Q ss_pred eeeecccCceEEEEEEEC-CeeEEEEEEecccCCCChHHHH----------------hhhHhHHHHHHHHhhCCCCC--c
Q 002738 556 CDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIR----------------NFEYSCLGEVRMLGALRHSC--I 616 (886)
Q Consensus 556 ~k~LG~G~fG~VY~A~~~-~~~VAVKI~~lk~~~~~~~~~k----------------~f~~~~lrEI~iLk~L~HPN--I 616 (886)
.+.||+|+||.||+|... +..||+|+.............. ........|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 568999999999999975 8899999875432211110000 00001134666666665432 3
Q ss_pred ceeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHH-HHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHh-CCc
Q 002738 617 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN-YIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHI 694 (886)
Q Consensus 617 Vrl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d-~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs-~gI 694 (886)
.+.++.. ..++||||++|+++.. .+... .. ...+..++.+++.++.++|. +||
T Consensus 82 ~~~~~~~------------------~~~lv~e~~~g~~~~~~~l~~~------~~-~~~~~~~~~~~~~~l~~lh~~~~i 136 (187)
T cd05119 82 PKPIDLN------------------RHVLVMEFIGGDGIPAPRLKDV------RL-LEDPEELYDQILELMRKLYREAGL 136 (187)
T ss_pred CceEecC------------------CCEEEEEEeCCCCccChhhhhh------hh-cccHHHHHHHHHHHHHHHhhccCc
Confidence 4444321 2489999999854332 12210 01 15678999999999999999 999
Q ss_pred cccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccc
Q 002738 695 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 732 (886)
Q Consensus 695 VHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~ 732 (886)
+||||||+||+++ + ..++|+|||.+.....
T Consensus 137 vH~Dl~p~Nili~-~-------~~~~liDfg~a~~~~~ 166 (187)
T cd05119 137 VHGDLSEYNILVD-D-------GKVYIIDVPQAVEIDH 166 (187)
T ss_pred CcCCCChhhEEEE-C-------CcEEEEECcccccccC
Confidence 9999999999998 4 4599999999965543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.5e-13 Score=130.50 Aligned_cols=132 Identities=20% Similarity=0.226 Sum_probs=105.3
Q ss_pred eeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCC--CCcceeeeeEecCCCCCCC
Q 002738 555 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH--SCIVEMYGHKISSKWLPSA 632 (886)
Q Consensus 555 i~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~H--PNIVrl~g~~~~~~~l~~~ 632 (886)
+.+.||.|.++.||++...+..+++|+..... . .. .+.+|+.++..++| .++++++++....+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~--~----~~----~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~----- 66 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSRE--K----GA----DREREVAILQLLARKGLPVPKVLASGESDG----- 66 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCC--c----hh----HHHHHHHHHHHHHHcCCCCCeEEEEcCCCC-----
Confidence 46789999999999999988889999853221 1 12 34889999999986 58889888766432
Q ss_pred CCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCCEEEecc
Q 002738 633 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---HIMHRDIKSENILIDLE 709 (886)
Q Consensus 633 ~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~---gIVHRDLKPsNILLd~d 709 (886)
..+++|||++|+.+..+ +......++.+++.+|++||.. +++|+||+|.|||++..
T Consensus 67 ---------~~~~v~e~~~g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~ 125 (155)
T cd05120 67 ---------WSYLLMEWIEGETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG 125 (155)
T ss_pred ---------ccEEEEEecCCeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC
Confidence 36999999998766543 3456677899999999999985 79999999999999875
Q ss_pred ccCCCCCCeEEEeecCCccc
Q 002738 710 RKKADGKPVVKLCDFDRAVP 729 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~ 729 (886)
..++++|||.+..
T Consensus 126 -------~~~~l~Df~~~~~ 138 (155)
T cd05120 126 -------KILGIIDWEYAGY 138 (155)
T ss_pred -------cEEEEEecccccC
Confidence 4699999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.8e-15 Score=180.09 Aligned_cols=266 Identities=23% Similarity=0.224 Sum_probs=188.4
Q ss_pred CCCCceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEecC
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~Y~i~k~LG~G~fG~VY~A~~-~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~~~ 626 (886)
+...|.+.+.||+|+|+.|-.+.. +....+++...+..........+ .+..|..+-+.+. |+|++.+++.....
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~----~i~~e~~~~~~~s~h~n~~~~~~~~~~~ 93 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSE----HIDTETDIQKKLSKHSNTVHMIEPSSSP 93 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhh----hcCccccccccccccccccccCCccCCC
Confidence 366788899999999999998875 33333333333333322222222 3366888888887 99999999987766
Q ss_pred CCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCCEE
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH-SKHIMHRDIKSENIL 705 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLH-s~gIVHRDLKPsNIL 705 (886)
.. .+++++|..|+++...+.. ......+...+..++.|+..++.|+| ..++.|+||||+|.+
T Consensus 94 ~~--------------~~~~~~~s~g~~~f~~i~~---~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~ 156 (601)
T KOG0590|consen 94 RS--------------YLLSLSYSDGGSLFSKISH---PDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSL 156 (601)
T ss_pred cc--------------cccccCccccccccccccc---CCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccch
Confidence 54 5999999999999998831 12225667788899999999999999 999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccC-CCcccchhhhhcccCCCCCCchhhHHHHHHHH
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG-TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vG-T~~YmAPEvL~~~~~~~~~s~KSDIWSLGVIL 784 (886)
++..+. ..++.|||+|..+....... .......| ++.|+|||...+ .....+..|+||.|+++
T Consensus 157 l~~s~~------~l~~~df~~At~~~~~~g~~-------~~~~~~~g~s~~y~a~E~~~~---~~~~~~~~d~~S~g~~l 220 (601)
T KOG0590|consen 157 LDESGS------ALKIADFGLATAYRNKNGAE-------RSLKDRCGSSPPYGAPEHLSG---KAYRGPSVDVWSLGIVL 220 (601)
T ss_pred hccCCC------cccCCCchhhccccccCCcc-------eeeecccCCCCCCCCcccccc---hhhcCCCcccccccccc
Confidence 998841 59999999998776521110 11122357 999999999876 23567899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHH-HHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 002738 785 LELLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 785 yELLTG~~PF~g~s~~el~-~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~k 863 (886)
.-+++|..||......... ........ ...............+++.+++..+|..
T Consensus 221 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~l~k~l~~~~~~ 276 (601)
T KOG0590|consen 221 SAMLTGELPWDFPSRKDGRYSSWKSNKG------------------------RFTQLPWNSISDQAHDLLHKILKENPSN 276 (601)
T ss_pred cccccCCCCccccccccccceeeccccc------------------------ccccCccccCChhhhhcccccccCCchh
Confidence 9999999999655433211 00000000 0001111223456888999999999999
Q ss_pred CCCHHHHHHHHH
Q 002738 864 RPTAGDLYEMFV 875 (886)
Q Consensus 864 RPSA~EILehLe 875 (886)
|.+.+++..+-.
T Consensus 277 r~s~~~~~~d~~ 288 (601)
T KOG0590|consen 277 RLSIEELKLDNW 288 (601)
T ss_pred cccccccccccc
Confidence 999998866543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.24 E-value=8.7e-11 Score=121.93 Aligned_cols=144 Identities=15% Similarity=0.118 Sum_probs=102.9
Q ss_pred eeeecccCceEEEEEEEC--------CeeEEEEEEecccCCCCh------------------HHHHhhhHhHHHHHHHHh
Q 002738 556 CDEAGKSVSSSLFRCKFG--------SADAAAKVRTLKVCGSSA------------------DEIRNFEYSCLGEVRMLG 609 (886)
Q Consensus 556 ~k~LG~G~fG~VY~A~~~--------~~~VAVKI~~lk~~~~~~------------------~~~k~f~~~~lrEI~iLk 609 (886)
...||.|--+.||.|... +..+|||+++........ ...+.+.....+|++.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 457899999999999853 368999998754322111 112223233458999999
Q ss_pred hCC--CCCcceeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHH-HHHHHhccCCCcCCHHHHHHHHHHHHHHH
Q 002738 610 ALR--HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN-YIEKLSETGEKHVSVKLALFIAQDVAAAL 686 (886)
Q Consensus 610 ~L~--HPNIVrl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d-~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL 686 (886)
+|. .-++.+++++. . .+|||||+.+..+.. .++. ..++......+..+++.+|
T Consensus 82 rl~~~Gv~vP~pi~~~---~---------------~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l 137 (197)
T cd05146 82 RMQKAGIPCPEVVVLK---K---------------HVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMM 137 (197)
T ss_pred HHHHcCCCCCeEEEec---C---------------CEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHH
Confidence 996 35666777541 1 389999997654422 2322 2355566778899999999
Q ss_pred HHH-HhCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCccccc
Q 002738 687 VEL-HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 731 (886)
Q Consensus 687 ~yL-Hs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~ 731 (886)
..| |..|||||||++.|||+..+ .++|+|||.|....
T Consensus 138 ~~l~H~~glVHGDLs~~NIL~~~~--------~v~iIDF~qav~~~ 175 (197)
T cd05146 138 KQLYKECNLVHADLSEYNMLWHDG--------KVWFIDVSQSVEPT 175 (197)
T ss_pred HHHHHhCCeecCCCCHHHEEEECC--------cEEEEECCCceeCC
Confidence 999 89999999999999999743 49999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.7e-11 Score=139.96 Aligned_cols=149 Identities=15% Similarity=0.158 Sum_probs=97.8
Q ss_pred eeecccCceEEEEEEE-CCeeEEEEEEecccCCC--------------------------ChHHHHhhhH------hHHH
Q 002738 557 DEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGS--------------------------SADEIRNFEY------SCLG 603 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~-~~~~VAVKI~~lk~~~~--------------------------~~~~~k~f~~------~~lr 603 (886)
+.||.|++|.||+|+. ++..||||+........ .....+++.. .+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999997 68899999964321100 0111122222 2455
Q ss_pred HHHHHhhCC----CCCcceeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHH
Q 002738 604 EVRMLGALR----HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 679 (886)
Q Consensus 604 EI~iLk~L~----HPNIVrl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia 679 (886)
|+..+.++. |.+-+.+-.++..- ....+|||||++|++|.++.... . ... ....++
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~-------------~~~~vLvmE~i~G~~L~~~~~~~-~---~~~---~~~~ia 262 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDR-------------TSERVLTMEWIDGIPLSDIAALD-E---AGL---DRKALA 262 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhh-------------cCCceEEEEeECCcccccHHHHH-h---cCC---CHHHHH
Confidence 666666653 32223322222211 11248999999999999887541 1 112 234566
Q ss_pred HHHHH-HHHHHHhCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccc
Q 002738 680 QDVAA-ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 732 (886)
Q Consensus 680 ~QIa~-AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~ 732 (886)
.+++. .+..+|..|++|+|+||.||+++.+ +.++|+|||++..+..
T Consensus 263 ~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~-------g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 263 ENLARSFLNQVLRDGFFHADLHPGNIFVLKD-------GKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHHHHHHhCCceeCCCCcccEEECCC-------CcEEEEeCCCeeECCH
Confidence 66666 4788999999999999999999876 4699999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.22 E-value=5.5e-11 Score=117.71 Aligned_cols=127 Identities=15% Similarity=0.172 Sum_probs=93.0
Q ss_pred eeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcc-eeeeeEecCCCCCCCCC
Q 002738 556 CDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV-EMYGHKISSKWLPSADG 634 (886)
Q Consensus 556 ~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIV-rl~g~~~~~~~l~~~~~ 634 (886)
.+.|+.|.++.||+++..+..+++|+...... ... .+.+|+.++..+.+.+++ +++.+...
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-----~~~----~~~~E~~~l~~l~~~~~~P~~~~~~~~--------- 64 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-----LLI----NRENEAENSKLAAEAGIGPKLYYFDPE--------- 64 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc-----ccc----CHHHHHHHHHHHHHhCCCCceEEEeCC---------
Confidence 46789999999999999999999998532211 011 226799999988755544 45543321
Q ss_pred CCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCc-----cccCCCCCCEEEecc
Q 002738 635 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHI-----MHRDIKSENILIDLE 709 (886)
Q Consensus 635 ~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gI-----VHRDLKPsNILLd~d 709 (886)
..++||||++|.++... . .....++.+++.+|+.||..++ +|+|++|.||+++ +
T Consensus 65 -------~~~lv~e~i~G~~l~~~--~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~ 123 (170)
T cd05151 65 -------TGVLITEFIEGSELLTE--D-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D 123 (170)
T ss_pred -------CCeEEEEecCCCccccc--c-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C
Confidence 13899999999877543 0 0113456899999999999885 9999999999998 3
Q ss_pred ccCCCCCCeEEEeecCCcc
Q 002738 710 RKKADGKPVVKLCDFDRAV 728 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~ 728 (886)
..++|+|||.+.
T Consensus 124 -------~~~~liDf~~a~ 135 (170)
T cd05151 124 -------GRLWLIDWEYAG 135 (170)
T ss_pred -------CeEEEEeccccc
Confidence 248999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.7e-11 Score=141.96 Aligned_cols=255 Identities=22% Similarity=0.179 Sum_probs=178.8
Q ss_pred CCceeeeeecc--cCceEEEEEEE----CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeE
Q 002738 551 PSLSSCDEAGK--SVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHK 623 (886)
Q Consensus 551 ~~Y~i~k~LG~--G~fG~VY~A~~----~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~ 623 (886)
..+.+.+.+|. |.+|.||.++. ....+|+|.-.+.... ....... .+|+...+.++ |+|.++.+..+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~-p~~~~~k-----~~~~~s~~~i~~~~~~v~~~~~~ 187 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSP-PLDSKRK-----LREFLSHHKIDSHENPVRDSPAW 187 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCC-ccccccc-----cchhhcccccCccccccccCccc
Confidence 34567889999 99999999875 4556777763222211 1111111 56777777776 99999988777
Q ss_pred ecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHH----HHHHHHhCCccccCC
Q 002738 624 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAA----ALVELHSKHIMHRDI 699 (886)
Q Consensus 624 ~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~----AL~yLHs~gIVHRDL 699 (886)
...+. .++-+|++. .+|.++... ....++...++.++.+... ||.++|..+|+|-|+
T Consensus 188 e~~~~--------------lfiqtE~~~-~sl~~~~~~----~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~ 248 (524)
T KOG0601|consen 188 EGSGI--------------LFIQTELCG-ESLQSYCHT----PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDL 248 (524)
T ss_pred ccCCc--------------ceeeecccc-chhHHhhhc----ccccCCchhhhhHHhhhhhcccccccccCCCccccccc
Confidence 76553 599999995 788888875 2334778888899999999 999999999999999
Q ss_pred CCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHH
Q 002738 700 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 779 (886)
Q Consensus 700 KPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWS 779 (886)
||.||++..+. ...+++|||+...+.......... ......|...|++||.+.+ .++...|||+
T Consensus 249 kp~~i~~~~~~------~s~~~~df~~v~~i~~~~~~~~~~-----~~~r~~~~~~Y~~ke~~~~-----l~~~~~di~s 312 (524)
T KOG0601|consen 249 KPANIFTTSDW------TSCKLTDFGLVSKISDGNFSSVFK-----VSKRPEGDCIYAAKELLNG-----LATFASDIFS 312 (524)
T ss_pred chhheeccccc------ceeecCCcceeEEccCCcccccee-----eeecCCCCceEeChhhhcc-----ccchHhhhcc
Confidence 99999998772 458999999998776644221110 0111247789999999874 6789999999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 002738 780 YGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 859 (886)
Q Consensus 780 LGVILyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~ 859 (886)
+|.++.+..++..++...-.. ....+.+. .++. +....-...+...+..|++.
T Consensus 313 l~ev~l~~~l~~~~~~~g~~~-~W~~~r~~---~ip~-----------------------e~~~~~s~~l~~~~~~~~d~ 365 (524)
T KOG0601|consen 313 LGEVILEAILGSHLPSVGKNS-SWSQLRQG---YIPL-----------------------EFCEGGSSSLRSVTSQMLDE 365 (524)
T ss_pred hhhhhHhhHhhcccccCCCCC-Cccccccc---cCch-----------------------hhhcCcchhhhhHHHHhcCc
Confidence 999999999987766332000 00000000 0111 11112233556689999999
Q ss_pred CCCCCCCHHHHHHH
Q 002738 860 NPTERPTAGDLYEM 873 (886)
Q Consensus 860 DP~kRPSA~EILeh 873 (886)
+|..|++++.+.++
T Consensus 366 ~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 366 DPRLRLTAQILTAL 379 (524)
T ss_pred chhhhhHHHHHhcc
Confidence 99999999988765
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.7e-10 Score=117.19 Aligned_cols=154 Identities=22% Similarity=0.237 Sum_probs=118.2
Q ss_pred eeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCC
Q 002738 555 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 634 (886)
Q Consensus 555 i~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~~ 634 (886)
....|-+|+-+.|+++.+.++..++|-...+.-..+.-+.+-...+..+|+++|.++.--.|.-..=++.+..
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~------- 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY------- 83 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC-------
Confidence 4678889999999999999999999988777666666666666678899999999987545543333333322
Q ss_pred CCCcccceEEEEEeccCC-CCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCC
Q 002738 635 NPEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 713 (886)
Q Consensus 635 ~~~~~~~~~~LVmEy~~G-GSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~ 713 (886)
.-.|+|||++| .++.+++...... .........++.+|-..+.-||..+|||+||..+||++..+++
T Consensus 84 -------~~~i~ME~~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~-- 151 (229)
T KOG3087|consen 84 -------GGQIYMEFIDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGN-- 151 (229)
T ss_pred -------CCeEEEEeccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCC--
Confidence 13899999986 4889998763222 2233333788999999999999999999999999999988753
Q ss_pred CCCCeEEEeecCCccc
Q 002738 714 DGKPVVKLCDFDRAVP 729 (886)
Q Consensus 714 ~~~~~VKLsDFGlA~~ 729 (886)
...+.|+|||++..
T Consensus 152 --~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 152 --QITPILIDFGLSSV 165 (229)
T ss_pred --cCceEEEeecchhc
Confidence 46679999999853
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.6e-10 Score=117.72 Aligned_cols=139 Identities=19% Similarity=0.230 Sum_probs=105.9
Q ss_pred eeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 636 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~~~~ 636 (886)
..+++|+-+.||.+.+-+..+++|....+.-..+.-..+--..+..+|++++.+++--.|.-.+=+..++.
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~--------- 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD--------- 72 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC---------
Confidence 46789999999999998888999988655544444444444467789999999987444433333333333
Q ss_pred CcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCCCC
Q 002738 637 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 716 (886)
Q Consensus 637 ~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~~ 716 (886)
...|+|||++|..|.+++.. . ...++..|-.-+.-||..||||+||.++||++..+
T Consensus 73 -----~~~I~me~I~G~~lkd~l~~------~------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~------- 128 (204)
T COG3642 73 -----NGLIVMEYIEGELLKDALEE------A------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG------- 128 (204)
T ss_pred -----CCEEEEEEeCChhHHHHHHh------c------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-------
Confidence 24899999999889889876 1 24566777777888999999999999999999876
Q ss_pred CeEEEeecCCccc
Q 002738 717 PVVKLCDFDRAVP 729 (886)
Q Consensus 717 ~~VKLsDFGlA~~ 729 (886)
.+.++|||++..
T Consensus 129 -~i~~IDfGLg~~ 140 (204)
T COG3642 129 -RIYFIDFGLGEF 140 (204)
T ss_pred -cEEEEECCcccc
Confidence 399999999863
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.3e-11 Score=143.11 Aligned_cols=169 Identities=14% Similarity=0.153 Sum_probs=98.9
Q ss_pred CCCceeeeeecccCceEEEEEEE-C-CeeEEEEEEecccCC--------------------------CChHHHHhhhHhH
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF-G-SADAAAKVRTLKVCG--------------------------SSADEIRNFEYSC 601 (886)
Q Consensus 550 ~~~Y~i~k~LG~G~fG~VY~A~~-~-~~~VAVKI~~lk~~~--------------------------~~~~~~k~f~~~~ 601 (886)
|..|.. +.||.|++|+||+|+. . ++.||||+....... ......+++.+.+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 455666 7899999999999997 3 789999997533100 1122333455555
Q ss_pred HHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccC--CCcCCHHHHHHHH
Q 002738 602 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG--EKHVSVKLALFIA 679 (886)
Q Consensus 602 lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~--~~~Ls~~~i~~Ia 679 (886)
.+|+..+... .|+.++...|.....+....-.+ ......+|||||++|+.|.++-.- ...+ ...+....+..++
T Consensus 198 ~~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~-d~st~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~~~ 273 (537)
T PRK04750 198 HDELDLMREA--ANASQLRRNFEDSDMLYVPEVYW-DYCSETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEVFF 273 (537)
T ss_pred HHhhCHHHHH--HHHHHHHHHccCCCCeecceeec-ccCCCceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHHHH
Confidence 5555544443 23333333322211100000000 001235899999999999875321 1111 0123333334444
Q ss_pred HHHHHHHHHHHhCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCccccccc
Q 002738 680 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSF 733 (886)
Q Consensus 680 ~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~ 733 (886)
.|| +..|++|+|+||.||+++.++. ..+.++++|||++..+...
T Consensus 274 ~Qi-------f~~GffHaDpHPGNIlv~~~g~---~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 274 TQV-------FRDGFFHADMHPGNIFVSYDPP---ENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHH-------HhCCeeeCCCChHHeEEecCCC---CCCeEEEEecceEEECCHH
Confidence 444 4689999999999999987742 2347999999999877543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.8e-11 Score=147.98 Aligned_cols=261 Identities=22% Similarity=0.254 Sum_probs=175.2
Q ss_pred CCCCCceeeeeecccCceEEEEEEECCe--eEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEec
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~~~~--~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~ 625 (886)
.+++.+.+.+-+-.|+++.++.+.-.+. ..+.|+..+...... ...+. +.++-.++-.-++|-++...--+..
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~-~~~~s----~r~~s~~~i~p~~P~v~~~~~s~~~ 875 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT-NDYES----IRSKSNILITPRSPAVVRSFPSFPC 875 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhcc-ccccc----cCCccCccccCCCCceecccCCCCC
Confidence 5778889999999999999999874222 223333211110000 00111 1222222222334555544332221
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
. ...+|||+|+.|++|...++. ....+.+-+...+..+..+++|||...++|+|++|.|+|
T Consensus 876 r--------------sP~~L~~~~~~~~~~~Skl~~-----~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l 936 (1205)
T KOG0606|consen 876 R--------------SPLPLVGHYLNGGDLPSKLHN-----SGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLL 936 (1205)
T ss_pred C--------------CCcchhhHHhccCCchhhhhc-----CCCcccccccchhHHHHhhhhccccchhhcccccccchh
Confidence 1 236999999999999999986 234566667777888999999999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCccccccccccc---------------------ccccCCCCCCCcccCCCcccchhhhhc
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTC---------------------CIAHRGIPAPDVCVGTPRWMAPEVLRA 764 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~---------------------~~~~~~~~~~~~~vGT~~YmAPEvL~~ 764 (886)
+..+ +..++.|||............ ....+........+||+.|.+||.+.+
T Consensus 937 ~~~~-------gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg 1009 (1205)
T KOG0606|consen 937 IAYD-------GHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG 1009 (1205)
T ss_pred hccc-------CCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc
Confidence 9888 458999998443322111000 000001112345679999999999987
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhh
Q 002738 765 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 844 (886)
Q Consensus 765 ~~~~~~~s~KSDIWSLGVILyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (886)
......+|.|++|++++|.++|.+||....+.+++..|.+...+... ....
T Consensus 1010 ----~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~-------------------------g~~~ 1060 (1205)
T KOG0606|consen 1010 ----RRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPE-------------------------GPEE 1060 (1205)
T ss_pred ----ccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCC-------------------------Cccc
Confidence 55678999999999999999999999999999888777766433211 1122
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHH
Q 002738 845 TLSFLVDVFRRCTEENPTERPTAG 868 (886)
Q Consensus 845 ~s~~L~dLL~rCL~~DP~kRPSA~ 868 (886)
.+...++++.+.+..+|.+|..+.
T Consensus 1061 ~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1061 GSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cChhhhhhhhhhhccCchhccCcc
Confidence 345688999999999999997765
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.8e-11 Score=128.75 Aligned_cols=212 Identities=22% Similarity=0.258 Sum_probs=142.9
Q ss_pred HHHhhCCCCCcceeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHH
Q 002738 606 RMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAA 685 (886)
Q Consensus 606 ~iLk~L~HPNIVrl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~A 685 (886)
.-|-++-|.|||+++.|+.+..+ ...++..+++||+..|+|.++|++..+.. ..+......+|+.||+.|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~---------~e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsa 188 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKY---------EEKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSA 188 (458)
T ss_pred HHHHHHHHHHHHHHHHhhccccc---------ccccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhh
Confidence 34556679999999999886653 24567899999999999999999755543 668888899999999999
Q ss_pred HHHHHhC--CccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhh
Q 002738 686 LVELHSK--HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 763 (886)
Q Consensus 686 L~yLHs~--gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~ 763 (886)
|.|||+. .|+|+++..+-|++..+ +-+|+. -+.-......... .+. .......+-++|.|||.=.
T Consensus 189 l~yLhs~~PpiihgnlTc~tifiq~n-------gLIkig-~~ap~s~h~s~~~----~~~-~Ek~~~~~~~g~~a~~sg~ 255 (458)
T KOG1266|consen 189 LSYLHSCDPPIIHGNLTCDTIFIQHN-------GLIKIG-SVAPDSTHPSVNS----TRE-AEKSVNTSLPGFSAPESGT 255 (458)
T ss_pred hhhhhccCCccccCCcchhheeecCC-------ceEEec-ccCccccchhhhh----hhH-hhhhccccCCccccCCcCc
Confidence 9999987 59999999999999866 345543 1111111100000 000 0011223668899999844
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhh
Q 002738 764 AMHKPNLYGLEVDIWSYGCLLLELLTLQVP-YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 842 (886)
Q Consensus 764 ~~~~~~~~s~KSDIWSLGVILyELLTG~~P-F~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 842 (886)
. ...+.++|||+||....||..+..- -.+.+.......+.+.... +.
T Consensus 256 ~----tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~-le--------------------------- 303 (458)
T KOG1266|consen 256 T----TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIG-LE--------------------------- 303 (458)
T ss_pred c----cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheee-cc---------------------------
Confidence 3 3456799999999999999887643 2222222222222211000 00
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002738 843 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 875 (886)
Q Consensus 843 ~~~s~~L~dLL~rCL~~DP~kRPSA~EILehLe 875 (886)
...-+.++.+|++..|..||+|.+++-|.-
T Consensus 304 ---n~lqr~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 304 ---NGLQRGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred ---CccccCcCcccccCCCCCCcchhhhhcCce
Confidence 001245788999999999999999998753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.10 E-value=8.6e-11 Score=136.11 Aligned_cols=254 Identities=23% Similarity=0.172 Sum_probs=177.1
Q ss_pred CCCCCceeeeeecccCceEEEEEEE---CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeE
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF---GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHK 623 (886)
Q Consensus 548 ~~~~~Y~i~k~LG~G~fG~VY~A~~---~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~ 623 (886)
....+|..+..||.|.|+.|+.... ++..+++|-.. +.......++.. ..|+.+...+. |.+++.++..+
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~s-----l~ev~l~~~l~~~~~~~g~~~~W 335 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFS-----LGEVILEAILGSHLPSVGKNSSW 335 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcc-----hhhhhHhhHhhcccccCCCCCCc
Confidence 4567888999999999999999875 34556666532 222222222222 67888888876 88888876655
Q ss_pred ecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 002738 624 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703 (886)
Q Consensus 624 ~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsN 703 (886)
..-. +.||=.|||+++++...+.- ...+.+...+++..|++.++.++|+..++|+|+||+|
T Consensus 336 ~~~r--------------~~~ip~e~~~~~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psn 396 (524)
T KOG0601|consen 336 SQLR--------------QGYIPLEFCEGGSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSN 396 (524)
T ss_pred cccc--------------cccCchhhhcCcchhhhhHH-----HHhcCcchhhhhHHHHHhccccccchhhhcccccccc
Confidence 4332 34788999999988777643 3567888999999999999999999999999999999
Q ss_pred EEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCccc-chhhhhcccCCCCCCchhhHHHHHH
Q 002738 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGC 782 (886)
Q Consensus 704 ILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~Ym-APEvL~~~~~~~~~s~KSDIWSLGV 782 (886)
|++..++ +..++.|||++..+.-.. ......-.++ .+|.+.. ...+..+.|+||||.
T Consensus 397 i~i~~~~------~~~~~~~~~~~t~~~~~~-------------~~~~~~~r~~p~~~~~~e---~~~~~~~~~~~sl~~ 454 (524)
T KOG0601|consen 397 ILISNDG------FFSKLGDFGCWTRLAFSS-------------GVFHHIDRLYPIAEILLE---DYPHLSKADIFSLGL 454 (524)
T ss_pred eeeccch------hhhhccccccccccceec-------------ccccccccccccchhhcc---ccccccccccccccc
Confidence 9998762 568999999986532211 1112333444 2455443 356788999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 002738 783 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 862 (886)
Q Consensus 783 ILyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~ 862 (886)
.+.+.+++...-..... ...|..+..+..+. ...++..+...++..++.
T Consensus 455 ~~~e~~~~~~ls~~~~~---~~~i~~~~~p~~~~----------------------------~~~~~q~~~kv~~~~~~~ 503 (524)
T KOG0601|consen 455 SVDEAITGSPLSESGVQ---SLTIRSGDTPNLPG----------------------------LKLQLQVLLKVMINPDRK 503 (524)
T ss_pred cccccccCcccCccccc---ceeeecccccCCCc----------------------------hHHhhhhhhhhhcCCccc
Confidence 99999998754322211 12233333332221 124678889999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 002738 863 ERPTAGDLYEMFVARTS 879 (886)
Q Consensus 863 kRPSA~EILehLe~l~s 879 (886)
.||.+.++..|......
T Consensus 504 ~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 504 RRPSAVELSLHSEFYRD 520 (524)
T ss_pred cchhhhhhcccchhhhh
Confidence 99999998887665543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.1e-08 Score=117.79 Aligned_cols=163 Identities=16% Similarity=0.210 Sum_probs=119.1
Q ss_pred CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCCCcccceEEEEEeccCC
Q 002738 573 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKG 652 (886)
Q Consensus 573 ~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~G 652 (886)
.+.+|.|.+...... ... ..+.+-+..|+.|+||||++++..+..+. ..|||+|-+.
T Consensus 36 ~~~~vsVF~~~~~~~----~~~----~~~~~A~k~lKtlRHP~Il~yL~t~e~~~--------------~~ylvTErV~- 92 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG----EVT----ELAKRAVKRLKTLRHPNILSYLDTTEEEG--------------TLYLVTERVR- 92 (690)
T ss_pred cCCceEEEEEeCCCc----hhh----HHHHHHHHHhhhccCchhhhhhhhhcccC--------------ceEEEeeccc-
Confidence 455666666544322 111 22367788999999999999999888665 3699999995
Q ss_pred CCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCEEEeccccCCCCCCeEEEeecCCccccc
Q 002738 653 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 731 (886)
Q Consensus 653 GSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs-~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~ 731 (886)
.|..+++. +....+...+.||+.||.|||. .+++|++|.-+-|+|+..+ ..||++|-++....
T Consensus 93 -Pl~~~lk~--------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-------eWkLggle~v~~~~ 156 (690)
T KOG1243|consen 93 -PLETVLKE--------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-------EWKLGGLELVSKAS 156 (690)
T ss_pred -cHHHHHHH--------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-------cEEEeeeEEEeccc
Confidence 79999986 3366777788999999999984 5899999999999999984 59999998875443
Q ss_pred ccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhC
Q 002738 732 SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 790 (886)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG 790 (886)
.... ......--..|..|+.+.. -....|.|-|||++||++.|
T Consensus 157 ~~~~----------~~~~~~~~~s~~~P~~~~~------s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 157 GFNA----------PAKSLYLIESFDDPEEIDP------SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCCc----------ccccchhhhcccChhhcCc------cccchhhhhHHHHHHHHhCc
Confidence 3211 0011112234666766542 12467999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.5e-08 Score=103.97 Aligned_cols=144 Identities=19% Similarity=0.178 Sum_probs=97.3
Q ss_pred eeecccCceEEEEEEECC-eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCC--CCcceeeeeEecCCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH--SCIVEMYGHKISSKWLPSAD 633 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~~~-~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~H--PNIVrl~g~~~~~~~l~~~~ 633 (886)
+.|+.|.++.||++...+ ..+++|+....... .. ...+.+|+.+++.+.+ .++.+++.+.....
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~---~~----~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~------ 70 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL---PS----AHDVAREYRVLRALAGTGVPVPKVLALCEDPS------ 70 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC---cc----cccHHHHHHHHHHhhCCCCCCCCEEEECCCCC------
Confidence 578999999999999865 78999985332211 01 1234889999999975 34566776654321
Q ss_pred CCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHh----------------------
Q 002738 634 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS---------------------- 691 (886)
Q Consensus 634 ~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs---------------------- 691 (886)
.....++||||++|.+|...+.. ..+++.....++.+++++|.+||+
T Consensus 71 -----~~~~~~~v~e~i~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~ 139 (223)
T cd05154 71 -----VLGTPFYVMERVDGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQV 139 (223)
T ss_pred -----ccCCceEEEEEeCCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHH
Confidence 01235899999999877665421 124555555666666666666653
Q ss_pred ----------------------------------CCccccCCCCCCEEEeccccCCCCCCeEEEeecCCccc
Q 002738 692 ----------------------------------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 729 (886)
Q Consensus 692 ----------------------------------~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~ 729 (886)
..++|+|++|.|||++.+. ...+.|+||+.+..
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~-----~~~~~iID~e~~~~ 206 (223)
T cd05154 140 ARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDE-----PRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCC-----CcEEEEEecccccc
Confidence 2479999999999998731 14589999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=9.9e-08 Score=103.82 Aligned_cols=150 Identities=16% Similarity=0.141 Sum_probs=99.3
Q ss_pred ceEEEEEEECCeeEEEEEEecccCCCChHHHHhhh------HhHHHHHHHHhhCCCCCc--ceeeeeEecCCCCCCCCCC
Q 002738 564 SSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFE------YSCLGEVRMLGALRHSCI--VEMYGHKISSKWLPSADGN 635 (886)
Q Consensus 564 fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~------~~~lrEI~iLk~L~HPNI--Vrl~g~~~~~~~l~~~~~~ 635 (886)
...|++..+.+..+.||...... .....+.+. ..+.+|+..+.+|..-+| ++.++++..... +
T Consensus 35 ~rrvvr~~~~g~~~~vKr~~~~~---~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~-----~- 105 (268)
T PRK15123 35 GRRTLRFELAGKSYFLKWHRGTG---WGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSN-----P- 105 (268)
T ss_pred CceEEEEEECCEEEEEEEecCCc---HHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCC-----C-
Confidence 33477888888889999652211 001111100 024789999888853333 344555542211 0
Q ss_pred CCcccceEEEEEeccCCC-CHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCC
Q 002738 636 PEHHLLQSAIFMEYVKGG-SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 714 (886)
Q Consensus 636 ~~~~~~~~~LVmEy~~GG-SL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~ 714 (886)
.....+||||++++. +|.+++.... ....+......++.+|+..+.-||..||+|+|+++.|||++.+.....
T Consensus 106 ---~~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~ 179 (268)
T PRK15123 106 ---ATRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGRE 179 (268)
T ss_pred ---ccceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCC
Confidence 022469999999975 8999986421 134566778899999999999999999999999999999985200011
Q ss_pred CCCeEEEeecCCcc
Q 002738 715 GKPVVKLCDFDRAV 728 (886)
Q Consensus 715 ~~~~VKLsDFGlA~ 728 (886)
+...+.|+||+.+.
T Consensus 180 ~~~~~~LIDl~r~~ 193 (268)
T PRK15123 180 EDLKLSVIDLHRAQ 193 (268)
T ss_pred CCceEEEEECCccc
Confidence 33679999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.8e-08 Score=104.15 Aligned_cols=132 Identities=20% Similarity=0.242 Sum_probs=85.3
Q ss_pred EEEEEEE-CCeeEEEEEEecccCCCCh------------------HHHHhhhHhHHHHHHHHhhCCCC--CcceeeeeEe
Q 002738 566 SLFRCKF-GSADAAAKVRTLKVCGSSA------------------DEIRNFEYSCLGEVRMLGALRHS--CIVEMYGHKI 624 (886)
Q Consensus 566 ~VY~A~~-~~~~VAVKI~~lk~~~~~~------------------~~~k~f~~~~lrEI~iLk~L~HP--NIVrl~g~~~ 624 (886)
.||.|.. .+..+|+|+.+........ ........+..+|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899987 6789999998764332221 12222334678999999999855 566776553
Q ss_pred cCCCCCCCCCCCCcccceEEEEEeccC--CCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHH-HHhCCccccCCCC
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVK--GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVE-LHSKHIMHRDIKS 701 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~LVmEy~~--GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~y-LHs~gIVHRDLKP 701 (886)
. -+|||||++ |..+..+... .++......++.+++..+.. +|..||||+||.+
T Consensus 80 -~----------------~~ivME~I~~~G~~~~~l~~~-------~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~ 135 (188)
T PF01163_consen 80 -R----------------NVIVMEYIGEDGVPLPRLKDV-------DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSE 135 (188)
T ss_dssp -T----------------TEEEEE--EETTEEGGCHHHC-------GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-ST
T ss_pred -C----------------CEEEEEecCCCccchhhHHhc-------cccchhHHHHHHHHHHHHHHHHHhcCceecCCCh
Confidence 1 289999998 6556554332 12234566778888886666 5799999999999
Q ss_pred CCEEEeccccCCCCCCeEEEeecCCcccc
Q 002738 702 ENILIDLERKKADGKPVVKLCDFDRAVPL 730 (886)
Q Consensus 702 sNILLd~d~~~~~~~~~VKLsDFGlA~~l 730 (886)
.|||++.+ .+.|+|||.+...
T Consensus 136 ~NIlv~~~--------~~~iIDf~qav~~ 156 (188)
T PF01163_consen 136 YNILVDDG--------KVYIIDFGQAVDS 156 (188)
T ss_dssp TSEEEETT--------CEEE--GTTEEET
T ss_pred hhEEeecc--------eEEEEecCcceec
Confidence 99999876 3999999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=2.4e-07 Score=103.99 Aligned_cols=273 Identities=18% Similarity=0.137 Sum_probs=161.7
Q ss_pred eeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhC-CCCCcceeeeeEecCCCCCCCC
Q 002738 555 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 633 (886)
Q Consensus 555 i~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L-~HPNIVrl~g~~~~~~~l~~~~ 633 (886)
....||+|+.+.+|-.---+ +.+.||+..... ... .+-+..|... .||-+-.-+.|-. ..
T Consensus 15 ~gr~LgqGgea~ly~l~e~~-d~VAKIYh~Ppp---a~~--------aqk~a~la~~p~~p~~~~rvaWPq-------a~ 75 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVR-DQVAKIYHAPPP---AAQ--------AQKVAELAATPDAPLLNYRVAWPQ-------AT 75 (637)
T ss_pred CCccccCCccceeeecchhh-chhheeecCCCc---hHH--------HHHHHHhccCCCCcchhhhhcccH-------HH
Confidence 45789999999999754322 345566633221 111 1223344444 3665443222211 11
Q ss_pred CCCCcccceEEEEEeccCCC-CHHHHHHH-HhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecccc
Q 002738 634 GNPEHHLLQSAIFMEYVKGG-SVKNYIEK-LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 711 (886)
Q Consensus 634 ~~~~~~~~~~~LVmEy~~GG-SL~d~L~~-~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~ 711 (886)
-....+.....++|+.+.|. .+..++.. .++..-....|...+++++.|+.+.+-||..|.+-+|+.++|||+..+.
T Consensus 76 L~G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~- 154 (637)
T COG4248 76 LHGGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS- 154 (637)
T ss_pred hhCCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc-
Confidence 11112233478999999875 22222221 1122234567899999999999999999999999999999999999884
Q ss_pred CCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhh-cccCCCCCCchhhHHHHHHHHHHHHhC
Q 002738 712 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR-AMHKPNLYGLEVDIWSYGCLLLELLTL 790 (886)
Q Consensus 712 ~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~-~~~~~~~~s~KSDIWSLGVILyELLTG 790 (886)
.|.|.|=..-........ ..-.+|...|.+||.-. +......-+...|.|.||+++|+|+.|
T Consensus 155 ------~V~LVdsDsfqi~~ng~~-----------~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~g 217 (637)
T COG4248 155 ------KVVLVDSDSFQINANGTL-----------HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFG 217 (637)
T ss_pred ------eEEEEcccceeeccCCce-----------EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhc
Confidence 477776432211111110 11237899999999865 222223446789999999999999987
Q ss_pred -CCCCCCCCH-----HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCC---CchhhhhhHHHHHHHHHHhccc--
Q 002738 791 -QVPYMGLSE-----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE---KPEAELETLSFLVDVFRRCTEE-- 859 (886)
Q Consensus 791 -~~PF~g~s~-----~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~L~dLL~rCL~~-- 859 (886)
++||.|... ...-..|..+.+..-+ +...+.. ......-.++.+..|+.+|+..
T Consensus 218 grHPysGI~~~~~ap~p~E~~Ia~g~f~ya~---------------~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~ 282 (637)
T COG4248 218 GRHPYSGIPLISDAPNPLETDIAHGRFAYAS---------------DQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESG 282 (637)
T ss_pred CCCCCCcccccCCCCCcchhhhhcceeeech---------------hccCCCCCCCCCCChhhcCHHHHHHHHHHhcccC
Confidence 999987521 1111223332211111 0111111 1111223456788899999875
Q ss_pred CCCCCCCHHHHHHHHHhhcC
Q 002738 860 NPTERPTAGDLYEMFVARTS 879 (886)
Q Consensus 860 DP~kRPSA~EILehLe~l~s 879 (886)
+|.-|||++..+..|.++..
T Consensus 283 ~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 283 VATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred CCCCCCCHHHHHHHHHHHHH
Confidence 46789999998888776653
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1e-06 Score=101.22 Aligned_cols=175 Identities=15% Similarity=0.119 Sum_probs=122.5
Q ss_pred CceEEEEEEE--CCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCCCccc
Q 002738 563 VSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640 (886)
Q Consensus 563 ~fG~VY~A~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~~~~~~~~ 640 (886)
-..+.|++.. .|..+++|............. ..=+++++++.|+|||+|.++|.+... +.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~--------t~lve~wkkl~h~NvV~frevf~t~tF----------~D 349 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKD--------TSLVEAWKKLCHTNVVPFREVFLTYTF----------GD 349 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccc--------hHHHHHHHHhccCceeehhhhhhhhcc----------Cc
Confidence 3457888875 555666665422221111111 345788999999999999999985543 33
Q ss_pred ceEEEEEeccCC-CCHHHHHHHHh----------ccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 641 LQSAIFMEYVKG-GSVKNYIEKLS----------ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 641 ~~~~LVmEy~~G-GSL~d~L~~~~----------~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..+++|++|+++ ++|.++--... ...+...++..+|.++.||..||.++|+.|+.-+=|.|.+||++.+
T Consensus 350 ~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~ 429 (655)
T KOG3741|consen 350 LSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGK 429 (655)
T ss_pred ceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCc
Confidence 468999999986 57777543211 1123457789999999999999999999999999999999999876
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
..++|+.-|....+.... + |-+.+ -.+-|.=.||.+++.|.|
T Consensus 430 -------~RIriS~C~i~Dvl~~d~-----------------~-------~~le~-------~Qq~D~~~lG~ll~aLAt 471 (655)
T KOG3741|consen 430 -------MRIRISGCGIMDVLQEDP-----------------T-------EPLES-------QQQNDLRDLGLLLLALAT 471 (655)
T ss_pred -------ceEEEecccceeeecCCC-----------------C-------cchhH-------HhhhhHHHHHHHHHHHhh
Confidence 458888777664443211 0 12222 236799999999999999
Q ss_pred CCCC
Q 002738 790 LQVP 793 (886)
Q Consensus 790 G~~P 793 (886)
|..-
T Consensus 472 ~~~n 475 (655)
T KOG3741|consen 472 GTEN 475 (655)
T ss_pred cccc
Confidence 9643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.8e-07 Score=96.11 Aligned_cols=111 Identities=23% Similarity=0.251 Sum_probs=86.1
Q ss_pred hHHHHHHHHhhCCC--CCcceeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCC-CHHHHHHHHhccCCCcCCHHHHH
Q 002738 600 SCLGEVRMLGALRH--SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG-SVKNYIEKLSETGEKHVSVKLAL 676 (886)
Q Consensus 600 ~~lrEI~iLk~L~H--PNIVrl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GG-SL~d~L~~~~~~~~~~Ls~~~i~ 676 (886)
+..+|...+.+|.. -.+.+.+++...... .....+||||++++. +|.+++... ...+.....
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~----------~~~~s~lite~l~~~~~L~~~~~~~-----~~~~~~~~~ 121 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKG----------GGYRSYLITEALPGAQDLRDLLQQW-----EQLDPSQRR 121 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCC----------CceeEEEEEEeCCCcccHHHHHHhh-----cccchhhHH
Confidence 44788888888863 335566666664332 123569999999974 899999751 226677788
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCccc
Q 002738 677 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 729 (886)
Q Consensus 677 ~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~ 729 (886)
.++.+++..+.-||..||+|+|+++.|||++.++ +...+.|+||+.++.
T Consensus 122 ~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~----~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 122 ELLRALARLIAKLHDAGIYHGDLNPSNILVDPDD----GQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCC----CceeEEEEcchhcee
Confidence 9999999999999999999999999999999874 346799999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.4e-06 Score=89.80 Aligned_cols=148 Identities=14% Similarity=0.083 Sum_probs=101.7
Q ss_pred cccCceEEEEEEECCeeEEEEEEecccCCC--ChHHHHhhhHhHHHHHHHHhhCCCC--CcceeeeeEecCCCCCCCCCC
Q 002738 560 GKSVSSSLFRCKFGSADAAAKVRTLKVCGS--SADEIRNFEYSCLGEVRMLGALRHS--CIVEMYGHKISSKWLPSADGN 635 (886)
Q Consensus 560 G~G~fG~VY~A~~~~~~VAVKI~~lk~~~~--~~~~~k~f~~~~lrEI~iLk~L~HP--NIVrl~g~~~~~~~l~~~~~~ 635 (886)
|+||.+.|++....+..+-+|.-....... .+... ..|.+|+..|.+|..- .+.+..........
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~----ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~------- 95 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGR----PTIVREVAVIKELERAGVIVPKIVFGEAVKIE------- 95 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCc----hHHHHHHHHHHHHHHcCCCCCccceeeeeccC-------
Confidence 568999999988877766666532111000 01112 2348999999998632 24444422111111
Q ss_pred CCcccceEEEEEeccCC-CCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEeccccCCC
Q 002738 636 PEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 714 (886)
Q Consensus 636 ~~~~~~~~~LVmEy~~G-GSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d~~~~~ 714 (886)
...+.+||+|-+.| .+|.+++.. ....+.+......++.+|+..+.-||..|+.|+|+.+.|||++.++
T Consensus 96 ---~~~rA~LVTe~L~g~~~L~~~l~~---~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g---- 165 (216)
T PRK09902 96 ---GEWRALLVTEDMAGFISIADWYAQ---HAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG---- 165 (216)
T ss_pred ---CceEEEEEEEeCCCCccHHHHHhc---CCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC----
Confidence 23468999998864 589998864 2223467778889999999999999999999999999999998653
Q ss_pred CCCeEEEeecCCccc
Q 002738 715 GKPVVKLCDFDRAVP 729 (886)
Q Consensus 715 ~~~~VKLsDFGlA~~ 729 (886)
...++++||--++.
T Consensus 166 -~~~v~lIDlEk~r~ 179 (216)
T PRK09902 166 -KAEAGFLDLEKSRR 179 (216)
T ss_pred -CeeEEEEEhhccch
Confidence 25699999987653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.7e-06 Score=93.31 Aligned_cols=142 Identities=18% Similarity=0.202 Sum_probs=100.5
Q ss_pred eeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCCh--------------HHHHhhhHhHHHHHHHHhhCCCC--Cc
Q 002738 554 SSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSA--------------DEIRNFEYSCLGEVRMLGALRHS--CI 616 (886)
Q Consensus 554 ~i~k~LG~G~fG~VY~A~~-~~~~VAVKI~~lk~~~~~~--------------~~~k~f~~~~lrEI~iLk~L~HP--NI 616 (886)
.+..+||-|--+.||.|.. .+.++|||+-+.-...... ..+..-.....+|.++|.+|... .|
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4678999999999999998 5889999987654322111 00011112347899999999644 56
Q ss_pred ceeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 002738 617 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 696 (886)
Q Consensus 617 Vrl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVH 696 (886)
.+.+++- ...+||||++|--|... ++..+..-.|+..|+.-+..+-..||||
T Consensus 174 P~P~~~n------------------RHaVvMe~ieG~eL~~~----------r~~~en~~~il~~il~~~~~~~~~GiVH 225 (304)
T COG0478 174 PKPIAWN------------------RHAVVMEYIEGVELYRL----------RLDVENPDEILDKILEEVRKAYRRGIVH 225 (304)
T ss_pred CCccccc------------------cceeeeehcccceeecc----------cCcccCHHHHHHHHHHHHHHHHHcCccc
Confidence 6666542 35899999998555432 1234455566677777777777899999
Q ss_pred cCCCCCCEEEeccccCCCCCCeEEEeecCCcccc
Q 002738 697 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 730 (886)
Q Consensus 697 RDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l 730 (886)
+|+.+-|||++.++ .++++||--+...
T Consensus 226 GDlSefNIlV~~dg-------~~~vIDwPQ~v~~ 252 (304)
T COG0478 226 GDLSEFNILVTEDG-------DIVVIDWPQAVPI 252 (304)
T ss_pred cCCchheEEEecCC-------CEEEEeCcccccC
Confidence 99999999999984 4999999766543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.3e-07 Score=111.55 Aligned_cols=156 Identities=19% Similarity=0.173 Sum_probs=103.8
Q ss_pred HHHHHHHHHHhC-CccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccch
Q 002738 681 DVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 759 (886)
Q Consensus 681 QIa~AL~yLHs~-gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAP 759 (886)
+++.||.|+|.. ++||+.|.|++|.++.. +.+||+.|+++..........+ ..-....+-...-...|.||
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~-------~~wkl~Gf~f~v~~~~~~~~p~-~~yd~~lp~~~~~~~~f~ap 178 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNAN-------GDWKLAGFSFCVNANGPTEYPF-SEYDPPLPLLLQPHLNFLAP 178 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccC-------cceeeccchhhhccCCCCcccc-ccCCCCCChhhccCcccccc
Confidence 344999999986 89999999999999988 4599999999876655332111 11111222334566789999
Q ss_pred hhhhcccCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCC
Q 002738 760 EVLRAMHKPNLYGLEVDIWSYGCLLLELL-TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 838 (886)
Q Consensus 760 EvL~~~~~~~~~s~KSDIWSLGVILyELL-TG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~ 838 (886)
|++.+ ...+.++|+||+||++|.+. .|+..+................. .. .
T Consensus 179 E~~~~----~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~--~~----------------------~ 230 (700)
T KOG2137|consen 179 EYLLG----TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLN--AG----------------------A 230 (700)
T ss_pred hhhcc----ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccc--cc----------------------c
Confidence 99986 56689999999999999998 55555543322211111111000 00 0
Q ss_pred chhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002738 839 PEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 872 (886)
Q Consensus 839 ~~~~~~~s~~L~dLL~rCL~~DP~kRPSA~EILe 872 (886)
.......+.++++=|.+++..++..||++.+++.
T Consensus 231 ~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 231 FGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred ccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 0001234567888899999999999997776654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.34 E-value=6.7e-06 Score=85.90 Aligned_cols=147 Identities=18% Similarity=0.201 Sum_probs=101.9
Q ss_pred CCceeeeeecccCc-eEEEEEEECCeeEEEEEEec---ccCCCChHH----------HHhhhHhHHHHHHHHhhCC---C
Q 002738 551 PSLSSCDEAGKSVS-SSLFRCKFGSADAAAKVRTL---KVCGSSADE----------IRNFEYSCLGEVRMLGALR---H 613 (886)
Q Consensus 551 ~~Y~i~k~LG~G~f-G~VY~A~~~~~~VAVKI~~l---k~~~~~~~~----------~k~f~~~~lrEI~iLk~L~---H 613 (886)
.+++.++.||.|.. |.||+++.++..+|+|++.. ......... ...+...|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 68899999999999 99999999999999999332 111111001 1133346788999988876 5
Q ss_pred CCc--ceeeeeEecCC-CCCC---CCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHH
Q 002738 614 SCI--VEMYGHKISSK-WLPS---ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALV 687 (886)
Q Consensus 614 PNI--Vrl~g~~~~~~-~l~~---~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~ 687 (886)
.++ |+.+||..-.. .-.. .++......+...||.||++... .+.. .-+.+|.+-|.
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~~----~~~~~~~~dl~ 178 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQI----RDIPQMLRDLK 178 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccch----hHHHHHHHHHH
Confidence 566 99999986442 0000 01222334567799999987532 1222 23466777888
Q ss_pred HHHhCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCc
Q 002738 688 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA 727 (886)
Q Consensus 688 yLHs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA 727 (886)
.+|..||+-+|+++.|..= -||+|||.+
T Consensus 179 ~~~k~gI~~~Dv~~~ny~~------------G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKLGIVPRDVKPRNYRG------------GKLVDFSSS 206 (207)
T ss_pred HHHHCCeeeccCccccccC------------CEEEecccC
Confidence 9999999999999999872 489999965
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.2e-05 Score=84.90 Aligned_cols=148 Identities=11% Similarity=0.123 Sum_probs=95.2
Q ss_pred CCceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhh--HhHHHHHHHHhhCC---CCCcceeeeeEec
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFE--YSCLGEVRMLGALR---HSCIVEMYGHKIS 625 (886)
Q Consensus 551 ~~Y~i~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~--~~~lrEI~iLk~L~---HPNIVrl~g~~~~ 625 (886)
++|.+.+.+-......|.+....+..+++|...-+.. ........|. ....+++..+.+++ --.+..++.+..-
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~-r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek 109 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENR-RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK 109 (229)
T ss_pred CCceEEEeecCCCccEEEEEEECCcEEEEeccchhhh-hHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence 5788899999999999999999999999998643321 1111111110 01133344344443 2333333333332
Q ss_pred CCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEE
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNIL 705 (886)
... .-....++||||++|..|.++.. +++ .++..|+.+|.-||..|++|+|..|.|++
T Consensus 110 k~~---------~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFl 167 (229)
T PF06176_consen 110 KIF---------RYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFL 167 (229)
T ss_pred eec---------cceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEE
Confidence 211 01223568999999988776542 222 24566788899999999999999999999
Q ss_pred EeccccCCCCCCeEEEeecCCccc
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVP 729 (886)
Q Consensus 706 Ld~d~~~~~~~~~VKLsDFGlA~~ 729 (886)
++.+ .++++||+..+.
T Consensus 168 v~~~--------~i~iID~~~k~~ 183 (229)
T PF06176_consen 168 VSNN--------GIRIIDTQGKRM 183 (229)
T ss_pred EECC--------cEEEEECccccc
Confidence 9865 399999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.4e-05 Score=83.82 Aligned_cols=145 Identities=14% Similarity=0.118 Sum_probs=100.6
Q ss_pred eeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCCh----------------HHHHhhhHhHHHHHHHHhhCC--CCC
Q 002738 555 SCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSA----------------DEIRNFEYSCLGEVRMLGALR--HSC 615 (886)
Q Consensus 555 i~k~LG~G~fG~VY~A~~-~~~~VAVKI~~lk~~~~~~----------------~~~k~f~~~~lrEI~iLk~L~--HPN 615 (886)
+...|..|--+.||+|.. .+..+|||+++........ ...+.......+|+..|+++. +-.
T Consensus 52 ~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 52 LVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred eEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 344777888889999986 5889999998765433222 111222235577888888885 455
Q ss_pred cceeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCC-HHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHh-CC
Q 002738 616 IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS-VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KH 693 (886)
Q Consensus 616 IVrl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGS-L~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs-~g 693 (886)
+.+.+++.. -.|||||+.... -.-.|+ ...+...++..+..++++.+.-|-. .+
T Consensus 132 vP~Pi~~~~------------------nVLvMEfIg~~g~pAP~Lk------Dv~~e~~e~~~~~~~~v~~~~~l~~~a~ 187 (268)
T COG1718 132 VPEPIAFRN------------------NVLVMEFIGDDGLPAPRLK------DVPLELEEAEGLYEDVVEYMRRLYKEAG 187 (268)
T ss_pred CCCceeecC------------------CeEEEEeccCCCCCCCCcc------cCCcCchhHHHHHHHHHHHHHHHHHhcC
Confidence 556665532 389999996421 111111 1233444788899999999999988 89
Q ss_pred ccccCCCCCCEEEeccccCCCCCCeEEEeecCCccccc
Q 002738 694 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 731 (886)
Q Consensus 694 IVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~ 731 (886)
+||+||..=|||+..+ .+.|+|||-|....
T Consensus 188 LVHgDLSEyNiL~~~~--------~p~iID~~QaV~~~ 217 (268)
T COG1718 188 LVHGDLSEYNILVHDG--------EPYIIDVSQAVTID 217 (268)
T ss_pred cccccchhhheEEECC--------eEEEEECccccccC
Confidence 9999999999999833 59999999887554
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.0001 Score=75.80 Aligned_cols=81 Identities=15% Similarity=0.173 Sum_probs=55.8
Q ss_pred eeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCC--CcceeeeeEecCCCCCCCC
Q 002738 556 CDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS--CIVEMYGHKISSKWLPSAD 633 (886)
Q Consensus 556 ~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HP--NIVrl~g~~~~~~~l~~~~ 633 (886)
++.|+.|..+.||+....+..+++|+.... .... .+.+|+.++..|... .+.+++.+.....
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~------~~~~----~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~------ 65 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP------DAAE----RLRREAAVLRQLAEHGIPVPRVLAFDTSDE------ 65 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH------HHHH----HHHHHHHHHHHHHHTTSBS--EEEEEEETE------
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC------CCHH----HHHHHHHHHHHHHhcCCCCceEEeeccccc------
Confidence 468999999999999998889999985311 1222 347899998888633 3566666443322
Q ss_pred CCCCcccceEEEEEeccCCCCHHH
Q 002738 634 GNPEHHLLQSAIFMEYVKGGSVKN 657 (886)
Q Consensus 634 ~~~~~~~~~~~LVmEy~~GGSL~d 657 (886)
.....+++|++++|..+..
T Consensus 66 -----~~~~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 66 -----FNGFPYLLMEYIPGRPLDD 84 (239)
T ss_dssp -----ETSEEEEEEEEESSEEHHH
T ss_pred -----ccccceEEEEEeccccccc
Confidence 1223799999999987777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.84 E-value=5.3e-05 Score=89.47 Aligned_cols=147 Identities=17% Similarity=0.194 Sum_probs=92.9
Q ss_pred eeecccCceEEEEEEEC-CeeEEEEEEecccC--------------------------CCChHHHHhhhHhH------HH
Q 002738 557 DEAGKSVSSSLFRCKFG-SADAAAKVRTLKVC--------------------------GSSADEIRNFEYSC------LG 603 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~~-~~~VAVKI~~lk~~--------------------------~~~~~~~k~f~~~~------lr 603 (886)
..|+.++-|.||+|+.. |+.|||||.+.... .......++|.+.+ .+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67889999999999985 89999999542211 11122334444433 44
Q ss_pred HHHHHhhCC-----CCCc--ceeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHH
Q 002738 604 EVRMLGALR-----HSCI--VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLAL 676 (886)
Q Consensus 604 EI~iLk~L~-----HPNI--Vrl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~ 676 (886)
|+..+.+++ .|+| .++|--+. ....|+|||++|..+.+..... . ..++. .
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t----------------~~~VLtmE~i~Gi~i~d~~~l~-~---~g~d~---k 267 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYT----------------TRRVLTMEWIDGIKISDIAALK-S---AGIDR---K 267 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhcc----------------CCcEEEEEeeCCEecccHHHHH-h---cCCCH---H
Confidence 455555543 2332 22221111 1248999999999998885431 1 22442 2
Q ss_pred HHHHHHHHH-HHHHHhCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCccccccc
Q 002738 677 FIAQDVAAA-LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSF 733 (886)
Q Consensus 677 ~Ia~QIa~A-L~yLHs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~ 733 (886)
.++..++++ +..+-..|++|.|.+|.||+++.+ +.+.+.|||+...+...
T Consensus 268 ~ia~~~~~~f~~q~~~dgffHaDpHpGNi~v~~~-------g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 268 ELAELLVRAFLRQLLRDGFFHADPHPGNILVRSD-------GRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHHHHHHHHHHHHHHhcCccccCCCccceEEecC-------CcEEEEcCcceecCCHH
Confidence 333333333 344445899999999999999988 56999999998877553
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00019 Score=76.35 Aligned_cols=72 Identities=8% Similarity=0.047 Sum_probs=48.0
Q ss_pred eeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCC--cceeeeeEecCCCCCCCCC
Q 002738 557 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSADG 634 (886)
Q Consensus 557 k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPN--IVrl~g~~~~~~~l~~~~~ 634 (886)
..||.|..+.||+.. +..+++|+.... .... .+.+|.+++..+..-. +.+.+++....+
T Consensus 7 ~~i~~G~t~~~y~~~--~~~~VlR~~~~~---~~~~-------~i~~E~~~l~~l~~~glpvP~~~~~~~~~~------- 67 (226)
T TIGR02172 7 TQTGEGGNGESYTHK--TGKWMLKLYNPG---FDKE-------TIKREFDASRKVFSLGIPTPHPFDLVEDGG------- 67 (226)
T ss_pred eeecCCCCcceeEec--CCCEEEEeCCCC---CCHH-------HHHHHHHHHHHHHHcCCCCCceEEEEecCC-------
Confidence 578999999999842 446778875321 1111 2378999998886433 456666665443
Q ss_pred CCCcccceEEEEEeccCCCC
Q 002738 635 NPEHHLLQSAIFMEYVKGGS 654 (886)
Q Consensus 635 ~~~~~~~~~~LVmEy~~GGS 654 (886)
..++|||+++|.+
T Consensus 68 -------~~glv~e~i~G~~ 80 (226)
T TIGR02172 68 -------RLGLIYELIVGKR 80 (226)
T ss_pred -------eeeeeeeecCCcc
Confidence 2478999999853
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00012 Score=74.92 Aligned_cols=130 Identities=25% Similarity=0.243 Sum_probs=91.4
Q ss_pred ceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcc-eeeeeEecCCCCCC
Q 002738 553 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV-EMYGHKISSKWLPS 631 (886)
Q Consensus 553 Y~i~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIV-rl~g~~~~~~~l~~ 631 (886)
..+.+.||+|.+|.||++.|.+..+|+|+..-+. .... +..|+++|..+.-.++. ++|.|..
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds------~r~~----l~kEakiLeil~g~~~~p~vy~yg~------- 86 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS------PRRN----LEKEAKILEILAGEGVTPEVYFYGE------- 86 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCceEEEEEecCCc------chhh----HHHHHHHHHHhhhcCCCceEEEech-------
Confidence 3567899999999999999999999999965332 2223 38899999999876664 4554433
Q ss_pred CCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCC-CC-CEEEecc
Q 002738 632 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK-SE-NILIDLE 709 (886)
Q Consensus 632 ~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLK-Ps-NILLd~d 709 (886)
-++.|||+.|-.|.+.-.. ..... +..++.+---|-..||-|+.|. |. ||++...
T Consensus 87 -----------~~i~me~i~G~~L~~~~~~--------~~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~ 143 (201)
T COG2112 87 -----------DFIRMEYIDGRPLGKLEIG--------GDRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR 143 (201)
T ss_pred -----------hhhhhhhhcCcchhhhhhc--------ccHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCC
Confidence 2567999998888876542 12222 3345555444666799999997 44 5555432
Q ss_pred ccCCCCCCeEEEeecCCcccc
Q 002738 710 RKKADGKPVVKLCDFDRAVPL 730 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l 730 (886)
.+.|+||..|+.-
T Consensus 144 --------~~~iIDFd~At~k 156 (201)
T COG2112 144 --------DVYIIDFDSATFK 156 (201)
T ss_pred --------cEEEEEccchhhc
Confidence 3999999988743
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00028 Score=74.81 Aligned_cols=75 Identities=12% Similarity=0.032 Sum_probs=49.4
Q ss_pred ecccCc-eEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCcceeeeeEecCCCCCCCCCCC
Q 002738 559 AGKSVS-SSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSADGNP 636 (886)
Q Consensus 559 LG~G~f-G~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNIVrl~g~~~~~~~l~~~~~~~ 636 (886)
|-.|.+ ..||+....+..+.+|+..... .. .+.+|+++++.+. +--+.+++++....+
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-------~~----~~~~E~~~l~~l~~~~~vP~v~~~~~~~~--------- 65 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP-------TY----ELEREAERLRWLAGKLPVPEVIDYGSDDG--------- 65 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc-------cc----chHHHHHHHHHHHhcCCCCeEEEEEecCC---------
Confidence 444545 7899998766778888753211 11 2367999988885 444557777665332
Q ss_pred CcccceEEEEEeccCCCCHHHH
Q 002738 637 EHHLLQSAIFMEYVKGGSVKNY 658 (886)
Q Consensus 637 ~~~~~~~~LVmEy~~GGSL~d~ 658 (886)
..++|||+++|.+|...
T Consensus 66 -----~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 66 -----RAWLLTSAVPGVPAAAL 82 (244)
T ss_pred -----ccEEEEEeeCCccHhHh
Confidence 24899999998777644
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00022 Score=89.29 Aligned_cols=81 Identities=19% Similarity=0.199 Sum_probs=53.5
Q ss_pred eeeecccCceEEEEEEECC----eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCC-CCCc--ceeeeeEecCCC
Q 002738 556 CDEAGKSVSSSLFRCKFGS----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCI--VEMYGHKISSKW 628 (886)
Q Consensus 556 ~k~LG~G~fG~VY~A~~~~----~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~-HPNI--Vrl~g~~~~~~~ 628 (886)
.+.|+.|.+..+|+....+ ..+++|+......... . ..+.+|+++|+.|. |++| .+++.++.+...
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~---~----~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v 115 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS---A----HAVEREYQVLRALGEHTDVPVPKVYCLCTDASV 115 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc---H----HHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence 6788999999999988744 3566665432111111 1 12478999999996 6665 777777664321
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCC
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGS 654 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGS 654 (886)
....|+||||++|..
T Consensus 116 -----------~G~~flVME~v~G~~ 130 (822)
T PLN02876 116 -----------IGTAFYIMEYLEGRI 130 (822)
T ss_pred -----------CCCceEEEEecCCcc
Confidence 124689999999754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.71 E-value=5.4e-06 Score=97.40 Aligned_cols=186 Identities=20% Similarity=0.143 Sum_probs=131.0
Q ss_pred ceeeeeecccCceEEEEEEECCeeEE-EEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCC-cceeeeeEecCCCCC
Q 002738 553 LSSCDEAGKSVSSSLFRCKFGSADAA-AKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC-IVEMYGHKISSKWLP 630 (886)
Q Consensus 553 Y~i~k~LG~G~fG~VY~A~~~~~~VA-VKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPN-IVrl~g~~~~~~~l~ 630 (886)
+...+.+++|+++.+++.+...+... .+++... . . ..-++++|.+++||| .+..++-+..+.
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l--~----~rl~~eLLdK~n~P~~~v~~~~d~~~E~--- 307 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------L--S----RRLAIELLDKVNNPNPVVRYLEDYDGED--- 307 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-------h--h----hHHHHHHHHHccCCCCcccccccCCccc---
Confidence 56678899999999999987544333 3332211 1 1 155889999999999 555554443333
Q ss_pred CCCCCCCcccceEEEEEeccCCC-CHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEecc
Q 002738 631 SADGNPEHHLLQSAIFMEYVKGG-SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 631 ~~~~~~~~~~~~~~LVmEy~~GG-SL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~d 709 (886)
..+|+|+++.++ +-...+.. ....+...+...+.+.-+++|++||+..-+|+| ||+....
T Consensus 308 -----------~~~i~~~i~s~~rs~~~~~~~----se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~ 368 (829)
T KOG0576|consen 308 -----------YLWIPMRICSTGRSSALEMTV----SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE 368 (829)
T ss_pred -----------ccchhhhhhcCCccccccCCh----hhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc
Confidence 469999999876 22111110 112334445556677778899999998889999 8888765
Q ss_pred ccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHh
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLT 789 (886)
..++.||+....+.... .++...+|+.|+|||+... ..+..+.|+|++|+-..+|.-
T Consensus 369 --------~~~~~~~~v~~~L~~~~-----------~~~t~~~~~~~~~pev~~~----~~~~~~p~~~~~~~~~~~~ap 425 (829)
T KOG0576|consen 369 --------EVKLLDFAVPPQLTRTM-----------KPRTAIGTPEPLAPEVIQE----NTIDGCPDSGSLAVSAIQMAP 425 (829)
T ss_pred --------ccccccccCCcccCccc-----------ccccCCCCCCCCCchhhcc----cccccCCCccCCCcchhhcCC
Confidence 48999999987665532 2355679999999999876 677889999999998888888
Q ss_pred CCCCCCC
Q 002738 790 LQVPYMG 796 (886)
Q Consensus 790 G~~PF~g 796 (886)
|-+|-..
T Consensus 426 ~~pPr~~ 432 (829)
T KOG0576|consen 426 GLPPRSS 432 (829)
T ss_pred CCCCCCC
Confidence 8777543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00022 Score=84.41 Aligned_cols=151 Identities=15% Similarity=0.190 Sum_probs=91.0
Q ss_pred eeeecccCceEEEEEEE-CCeeEEEEEEecccCCCC-----------------------hHHHHhhhHhH------HHHH
Q 002738 556 CDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSS-----------------------ADEIRNFEYSC------LGEV 605 (886)
Q Consensus 556 ~k~LG~G~fG~VY~A~~-~~~~VAVKI~~lk~~~~~-----------------------~~~~k~f~~~~------lrEI 605 (886)
.+.||.-+.|.||+|+. +++.||||+-........ .--.+++...+ .+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 46788999999999997 677899998432211110 01122222222 3343
Q ss_pred HHHhh----CCCCC------cceeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHH
Q 002738 606 RMLGA----LRHSC------IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA 675 (886)
Q Consensus 606 ~iLk~----L~HPN------IVrl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i 675 (886)
+...+ +.|-+ |.++|-.+.. ...|+|||++|..+.+.-.- .+ ..++...+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----------------~RVLtME~~~G~~i~Dl~~i-~~---~gi~~~~i 305 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLST----------------KRVLTMEYVDGIKINDLDAI-DK---RGISPHDI 305 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCc----------------ceEEEEEecCCccCCCHHHH-HH---cCCCHHHH
Confidence 33322 23444 4444433322 35899999999766655322 11 33555533
Q ss_pred HHHHHHHHHHH-HHHHhCCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccc
Q 002738 676 LFIAQDVAAAL-VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 732 (886)
Q Consensus 676 ~~Ia~QIa~AL-~yLHs~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~ 732 (886)
+..+.++. .-|-..|++|.|=.|.||++..+. .+.+.+.+-|||+...+..
T Consensus 306 ---~~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~---~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 306 ---LNKLVEAYLEQIFKTGFFHADPHPGNILVRPNP---EGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ---HHHHHHHHHHHHHhcCCccCCCCCCcEEEecCC---CCCccEEEEcccccccccH
Confidence 33333332 223356899999999999999653 2457899999999877654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00079 Score=84.27 Aligned_cols=248 Identities=17% Similarity=0.173 Sum_probs=152.4
Q ss_pred eeeeecccCceEEEEEEECC------eeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCcceeeeeEecCCC
Q 002738 555 SCDEAGKSVSSSLFRCKFGS------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 555 i~k~LG~G~fG~VY~A~~~~------~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~ 628 (886)
+...|..-.+|+++..+|.. ..+-.+-..... .....++.. ..-|+..+.++.|+|++.++.|......
T Consensus 182 vy~~ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~-~~~k~~i~~----~E~e~~~l~k~~~~n~~~~~~~~le~~~ 256 (1351)
T KOG1035|consen 182 VYPILSHLTQGTLLLVKWVEQAQSLSEPIEISHDYEST-PCGKKEIQT----TEIELESLSKIAHDNLGGYFVYGLERLF 256 (1351)
T ss_pred eeeeeccccCceEEEEehhhhHHhhcCcccccCcccCc-cchHHHHHH----HHHHHHHHHhhccccccceeEEeehhhc
Confidence 33347777888898888622 112221111111 111112222 2457777888899999999998876543
Q ss_pred CCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCEEEec
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~gIVHRDLKPsNILLd~ 708 (886)
. .....+..+++..-++...+.. -..++..+.+.+..++..||.|+|+....|.-|..+-..
T Consensus 257 ~----------g~~~~v~~~~~s~~~~~~~~q~-----v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~--- 318 (1351)
T KOG1035|consen 257 R----------GIVLDVLQEICSKVELRSLLQS-----VGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSK--- 318 (1351)
T ss_pred c----------hHHHHHHHhhcCccchHHHHhh-----ccccCHHHHHHHHHHHhhhHHHHHHhccceeEEeccccc---
Confidence 1 1133455688888899888876 466889999999999999999999995444433333111
Q ss_pred cccCCCCCCeEEEe--ecCCcccccccccccccccCCCCCCCcccCCCcccchhhhhcccCCCCCCchhhHHHHHHHHHH
Q 002738 709 ERKKADGKPVVKLC--DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 709 d~~~~~~~~~VKLs--DFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyE 786 (886)
+...++.+++.++ ||+....+...... .....+..|-+||.... +........|+|.+|..+..
T Consensus 319 -~~~~~~e~~~~~sl~~~~ss~~l~d~~~~-----------~~~~~~~~~~~~e~~~~--~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 319 -ESTVDGEGVVAISLSDFDSSKPLPDNEKS-----------FSDLLAEIRNADEDLKE--NTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred -ccccCccceeecchhhhcccccCCCcccc-----------hhhcCcccccccccccc--ccchhhhhhHHHHHHHHHhh
Confidence 1112233456666 88888766543322 12234566778887764 11223445799999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 787 LLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dLL~rCL~~DP~kRPS 866 (886)
+..|..+-.... ....+. + ......+.+++.+|+.-++++|++
T Consensus 385 ~~~~~~i~~~~~---~~~~~l-------~---------------------------~~~~~~~~d~~~~~~~~~~~~Rl~ 427 (1351)
T KOG1035|consen 385 LSQGEDISEKSA---VPVSLL-------D---------------------------VLSTSELLDALPKCLDEDSEERLS 427 (1351)
T ss_pred hhhcCccccccc---chhhhh-------c---------------------------cccchhhhhhhhhhcchhhhhccc
Confidence 988775531110 000000 0 000114677889999999999999
Q ss_pred HHHHHHHHHh
Q 002738 867 AGDLYEMFVA 876 (886)
Q Consensus 867 A~EILehLe~ 876 (886)
+.+++.|...
T Consensus 428 ~~~ll~~~f~ 437 (1351)
T KOG1035|consen 428 ALELLTHPFL 437 (1351)
T ss_pred hhhhhhchhc
Confidence 9999998653
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0018 Score=67.88 Aligned_cols=140 Identities=17% Similarity=0.229 Sum_probs=93.3
Q ss_pred eeeecccCceEEEEEEECCeeEEEEEEecccCC------------CChHHHHhhhHhHHHHHHHHhhCC------CCCcc
Q 002738 556 CDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCG------------SSADEIRNFEYSCLGEVRMLGALR------HSCIV 617 (886)
Q Consensus 556 ~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~------------~~~~~~k~f~~~~lrEI~iLk~L~------HPNIV 617 (886)
...||+|+.=.||.--. +....|||....... ......+ ...+|+.....+. +.+|.
T Consensus 6 ~~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~----~~~~E~~~y~~l~~~~~~~~~~i~ 80 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYR----QNRRELRYYKQLSLRRGVDWSHIP 80 (199)
T ss_pred CcccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhH----HHHHHHHHHHHHhhccCCcccccc
Confidence 45789999999997543 345677876543300 0001122 2366666655555 88999
Q ss_pred eeeeeEecCCCCCCCCCCCCcccceEEEEEeccCC------CCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHh
Q 002738 618 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKG------GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS 691 (886)
Q Consensus 618 rl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~G------GSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs 691 (886)
+++|+..++.. ..+|+|.+.. .+|.+++.. ..++. . +...+-.-..||-.
T Consensus 81 r~~G~veT~~G--------------~Glv~e~I~d~dG~~s~TL~~~l~~------~~~~~-~---~~~~L~~f~~~l~~ 136 (199)
T PF10707_consen 81 RFYGFVETNLG--------------LGLVVELIRDADGNISPTLEDYLKE------GGLTE-E---LRQALDEFKRYLLD 136 (199)
T ss_pred cEeEEEecCCc--------------eEEEEEEEECCCCCcCccHHHHHHc------CCccH-H---HHHHHHHHHHHHHH
Confidence 99999997764 4889987643 378888864 34554 3 33344455678889
Q ss_pred CCccccCCCCCCEEEeccccCCCCCCeEEEee-cCCc
Q 002738 692 KHIMHRDIKSENILIDLERKKADGKPVVKLCD-FDRA 727 (886)
Q Consensus 692 ~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsD-FGlA 727 (886)
++|+.+||+|.||++..... +...++|+| ||..
T Consensus 137 ~~Iv~~dl~~~NIv~~~~~~---~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 137 HHIVIRDLNPHNIVVQRRDS---GEFRLVLIDGLGEK 170 (199)
T ss_pred cCCeecCCCcccEEEEecCC---CceEEEEEeCCCCc
Confidence 99999999999999987743 334678887 5543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0014 Score=69.50 Aligned_cols=29 Identities=21% Similarity=0.284 Sum_probs=24.1
Q ss_pred CccccCCCCCCEEEeccccCCCCCCeEEEeecCCcc
Q 002738 693 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 728 (886)
Q Consensus 693 gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~ 728 (886)
+++|+|+.|.|||++.+ ...-|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~-------~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDG-------RLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECC-------CEEEEEeCcccC
Confidence 58999999999999854 346799999773
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.00088 Score=69.41 Aligned_cols=100 Identities=20% Similarity=0.181 Sum_probs=79.7
Q ss_pred HHHHHHHhhCCC-CCcceeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHH---HHHHhccCCCcCCHHHHHH
Q 002738 602 LGEVRMLGALRH-SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY---IEKLSETGEKHVSVKLALF 677 (886)
Q Consensus 602 lrEI~iLk~L~H-PNIVrl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~---L~~~~~~~~~~Ls~~~i~~ 677 (886)
..|.-+|+.+++ +++++++|+|- .++|+||...+++... +.. -...+|..+.+
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG------------------~~~v~E~~~~~~~~~~~~~l~~-----~~~~~w~~R~~ 63 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG------------------RFYVVEYVGAGSLYGIYRPLSQ-----FLQSPWEQRAK 63 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC------------------CEEEEEeecCcccccccccccc-----ccccCHHHHHH
Confidence 458889999985 69999999984 2789999987665421 111 12358999999
Q ss_pred HHHHHHHHHHHHHh---CCccccCCCCCCEEEeccccCCCCCCeEEEeecCCccccc
Q 002738 678 IAQDVAAALVELHS---KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 731 (886)
Q Consensus 678 Ia~QIa~AL~yLHs---~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~ 731 (886)
|+.++++.+.+|+. ..+.-.|++|+|+-++.+ +.+|++|...+....
T Consensus 64 iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~-------~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 64 IALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDD-------GRLKLIDLDDVFVED 113 (188)
T ss_pred HHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCC-------CcEEEEechhcchhH
Confidence 99999999999998 358889999999999977 459999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0056 Score=67.72 Aligned_cols=81 Identities=15% Similarity=0.121 Sum_probs=56.4
Q ss_pred eeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCC---CCcceeeeeEecCCCCC
Q 002738 554 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH---SCIVEMYGHKISSKWLP 630 (886)
Q Consensus 554 ~i~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~H---PNIVrl~g~~~~~~~l~ 630 (886)
.-.+.||.|..+.||+....+..+.+|+.+.. ... . .+..|+..|+.|.- ..+.++++++.....
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~---~~~---~----~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~-- 84 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGNPMPLMARSF---STP---G----VAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS-- 84 (297)
T ss_pred heeeecCCccceeEEEEEcCCCCEEEEEeccc---ccc---h----HHHHHHHHHHHHccCCCCCcCcEEEEeccCCc--
Confidence 45678999999999999876667788874310 011 1 23789999998853 467788887754321
Q ss_pred CCCCCCCcccceEEEEEeccCCCCH
Q 002738 631 SADGNPEHHLLQSAIFMEYVKGGSV 655 (886)
Q Consensus 631 ~~~~~~~~~~~~~~LVmEy~~GGSL 655 (886)
....+||||+++|.++
T Consensus 85 ---------~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 85 ---------PGPDVLLLERLRGVSV 100 (297)
T ss_pred ---------CCCeEEEEeccCCEec
Confidence 1236999999998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0052 Score=64.60 Aligned_cols=73 Identities=14% Similarity=0.178 Sum_probs=46.2
Q ss_pred eeeecccCceEEEEEEEC---CeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCc-ceeeeeEecCCCCCC
Q 002738 556 CDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI-VEMYGHKISSKWLPS 631 (886)
Q Consensus 556 ~k~LG~G~fG~VY~A~~~---~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNI-Vrl~g~~~~~~~l~~ 631 (886)
.+.|..|-...+|+.... +..+++|+...... ... ...+|+.++..+...++ .++++.+. .
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~-----d~~~E~~~~~~l~~~gl~P~v~~~~~--~---- 67 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LII-----DRERELRIHKLLSKHGLAPKLYATFQ--N---- 67 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----cee-----cHHHHHHHHHHHHhCCCCCeEEEEeC--C----
Confidence 467788888899999875 46788887532211 001 11568888888864333 44443321 1
Q ss_pred CCCCCCcccceEEEEEeccCCCCH
Q 002738 632 ADGNPEHHLLQSAIFMEYVKGGSV 655 (886)
Q Consensus 632 ~~~~~~~~~~~~~LVmEy~~GGSL 655 (886)
.+||||++|.++
T Consensus 68 ------------~~l~e~i~G~~l 79 (235)
T cd05157 68 ------------GLIYEFIPGRTL 79 (235)
T ss_pred ------------cEEEEeeCCCcC
Confidence 589999998665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.00063 Score=75.44 Aligned_cols=140 Identities=16% Similarity=0.203 Sum_probs=95.8
Q ss_pred ceeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCCChH----------------HHHhhhHhHHHHHHHHhhCC-CC
Q 002738 553 LSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSAD----------------EIRNFEYSCLGEVRMLGALR-HS 614 (886)
Q Consensus 553 Y~i~k~LG~G~fG~VY~A~~-~~~~VAVKI~~lk~~~~~~~----------------~~k~f~~~~lrEI~iLk~L~-HP 614 (886)
+.++.+||-|--+.||.+-+ .+.+.++|+.++-....... .+.. -...+|+..|+.|. |-
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSR--laa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSR--LAATKEFAFMKALYERG 171 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHH--HHHHHHHHHHHHHHHcC
Confidence 36789999999999999987 48888988866543322111 1111 13467888898885 32
Q ss_pred -CcceeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhCC
Q 002738 615 -CIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 693 (886)
Q Consensus 615 -NIVrl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~g 693 (886)
-+.+.+++ .+.++|||++.|..|.+.-+- .+ +-.+...+..-+--|-.+|
T Consensus 172 fpVPkpiD~------------------~RH~Vvmelv~g~Pl~~v~~v--------~d---~~~ly~~lm~~Iv~la~~G 222 (465)
T KOG2268|consen 172 FPVPKPIDH------------------NRHCVVMELVDGYPLRQVRHV--------ED---PPTLYDDLMGLIVRLANHG 222 (465)
T ss_pred CCCCCcccc------------------cceeeHHHhhcccceeeeeec--------CC---hHHHHHHHHHHHHHHHHcC
Confidence 23343433 245999999998877665321 12 2334455555566788999
Q ss_pred ccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccc
Q 002738 694 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 730 (886)
Q Consensus 694 IVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l 730 (886)
+||+|..-=||+++.+ ..++++||--....
T Consensus 223 lIHgDFNEFNimv~dd-------~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 223 LIHGDFNEFNIMVKDD-------DKIVVIDFPQMVST 252 (465)
T ss_pred ceecccchheeEEecC-------CCEEEeechHhhcc
Confidence 9999999999999977 45999999765443
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.014 Score=62.69 Aligned_cols=137 Identities=13% Similarity=0.146 Sum_probs=75.5
Q ss_pred eecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCc-ceeeeeEecCCCCCCCCCCC
Q 002738 558 EAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI-VEMYGHKISSKWLPSADGNP 636 (886)
Q Consensus 558 ~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNI-Vrl~g~~~~~~~l~~~~~~~ 636 (886)
.+..|-...+|+....+..+++|+......... . ...+|..+++.+....+ .+++... .
T Consensus 3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~---~-----~r~~E~~~l~~l~~~g~~P~~i~~~--~---------- 62 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKALG---V-----DRQREYQILQALSALGLAPKPILVN--E---------- 62 (256)
T ss_pred cCCCcCcCCeEEEEeCCccEEEeeCCccccccc---C-----cHHHHHHHHHHHHhcCCCCceEEEe--C----------
Confidence 355688889999988777888886422111100 0 12678888888864333 3334332 1
Q ss_pred CcccceEEEEEeccCCCCHHH--------------HHHHHhcc--CCCcCCHH-HHHHHHHHH---------HHHHHHHH
Q 002738 637 EHHLLQSAIFMEYVKGGSVKN--------------YIEKLSET--GEKHVSVK-LALFIAQDV---------AAALVELH 690 (886)
Q Consensus 637 ~~~~~~~~LVmEy~~GGSL~d--------------~L~~~~~~--~~~~Ls~~-~i~~Ia~QI---------a~AL~yLH 690 (886)
-++||||++|..+.. .+.+.-.. ....++.. .+..+..++ ...+..+-
T Consensus 63 ------~~~v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 136 (256)
T TIGR02721 63 ------HWLLVEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFR 136 (256)
T ss_pred ------CEEEEEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHH
Confidence 178999999865431 11111111 11122222 111221111 11122221
Q ss_pred h--------CCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcc
Q 002738 691 S--------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 728 (886)
Q Consensus 691 s--------~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~ 728 (886)
. ..++|+|+.|.||+++.+ . +.|+||..|.
T Consensus 137 ~~~~~~~~~~~l~H~Dl~~~Nil~~~~-------~-~~lIDwE~a~ 174 (256)
T TIGR02721 137 SAPEPAPLPLAPLHMDVHAYNLVVTPQ-------G-LKLIDWEYAS 174 (256)
T ss_pred hccCCCCCCCeeecCCCCcCcEEEeCC-------C-CEEEeccccC
Confidence 1 258999999999999865 2 6899999874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.016 Score=66.86 Aligned_cols=78 Identities=14% Similarity=0.038 Sum_probs=50.2
Q ss_pred eeeecccCceEEEEEEECCe--eEEEEEEecccCCCC---hHHHHhhhHhHHHHHHHHhhCC---CCCcceeeeeEecCC
Q 002738 556 CDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSS---ADEIRNFEYSCLGEVRMLGALR---HSCIVEMYGHKISSK 627 (886)
Q Consensus 556 ~k~LG~G~fG~VY~A~~~~~--~VAVKI~~lk~~~~~---~~~~k~f~~~~lrEI~iLk~L~---HPNIVrl~g~~~~~~ 627 (886)
.+.||.|.+..||++...+. .++||.-........ .... .+...|.+.|..+. ..++.+++.+...
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~----eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~-- 104 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTL----DRARIEAEALKIQAKYVPDLVPKVYHYDEE-- 104 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccH----HHHHHHHHHHHHHHhhCCCCCCeEEEECCC--
Confidence 56899999999999998553 789997431111000 1111 23366888887763 3467777776331
Q ss_pred CCCCCCCCCCcccceEEEEEeccCCC
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGG 653 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~LVmEy~~GG 653 (886)
..++||||+++.
T Consensus 105 --------------~~~lVME~L~~~ 116 (401)
T PRK09550 105 --------------LAVTVMEDLSDH 116 (401)
T ss_pred --------------CCEEEEecCCCc
Confidence 248999999864
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.018 Score=63.50 Aligned_cols=152 Identities=15% Similarity=0.143 Sum_probs=81.8
Q ss_pred CceeeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCC--cceeeeeEecCCCC
Q 002738 552 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC--IVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~Y~i~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPN--IVrl~g~~~~~~~l 629 (886)
.....+.++.|-...+|+....+..+++|+.... ..... +..|++++..|.... +.+++.... +.+
T Consensus 23 ~~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~---~~~~~-------i~~e~~~l~~L~~~g~pvp~~i~t~~--g~~ 90 (307)
T TIGR00938 23 ELLSLKGIAEGVENSNYLLTTDVGRYILTLYEKR---VKAEE-------LPFFLALTTHLAARGLPVPKPVKSRD--GRQ 90 (307)
T ss_pred CceeccccCCccccceEEEEeCCCcEEEEEecCC---CCHHH-------HHHHHHHHHHHHHCCCCCCccccCCC--CCe
Confidence 3445677788888899998876667888875321 11111 245677777774222 344433211 100
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHH-----------HHHHHHh---c---cCC-C--cCC-HHHHH------------
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVK-----------NYIEKLS---E---TGE-K--HVS-VKLAL------------ 676 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~-----------d~L~~~~---~---~~~-~--~Ls-~~~i~------------ 676 (886)
. .......++||+|++|..+. ..+...- . ... . ..+ +....
T Consensus 91 ~------~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~ 164 (307)
T TIGR00938 91 L------STLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA 164 (307)
T ss_pred e------hhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH
Confidence 0 00123469999999985421 1111110 0 000 0 001 11000
Q ss_pred HHHHHHHHHHHHHHh-------CCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcc
Q 002738 677 FIAQDVAAALVELHS-------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 728 (886)
Q Consensus 677 ~Ia~QIa~AL~yLHs-------~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~ 728 (886)
.....+...++++.. .+++|+|+.+.||+++.+ ..+.|+||+.+.
T Consensus 165 ~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~-------~~~~vIDfd~~~ 216 (307)
T TIGR00938 165 HMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGD-------SVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECC-------ceEEEeeccccc
Confidence 111223345555543 589999999999999876 346899999873
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.0073 Score=70.58 Aligned_cols=85 Identities=20% Similarity=0.205 Sum_probs=57.4
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHH
Q 002738 773 LEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 852 (886)
Q Consensus 773 ~KSDIWSLGVILyELLTG~~PF~g~s~~el~~~I~~~~rp~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~L~dL 852 (886)
+|+|||++|.++.|+..|...+......+....+.+-............ ........+..+.++
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~----------------e~~~~~~~d~~~~~~ 173 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAM----------------EHLIQLLADKKRLPL 173 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHH----------------HHHHHHhhhHhHHHH
Confidence 4999999999999999999888777666666555544322211111000 002233456678899
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 002738 853 FRRCTEENPTERPTAGDLYEM 873 (886)
Q Consensus 853 L~rCL~~DP~kRPSA~EILeh 873 (886)
+.+|+-..|..||...++.++
T Consensus 174 ~~~c~~~~~~ir~l~~~~~k~ 194 (725)
T KOG1093|consen 174 LKKCLWLEPIIRPLPMELSKR 194 (725)
T ss_pred hccCCccccccccchhHHhcC
Confidence 999999999999977766543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.0007 Score=86.21 Aligned_cols=162 Identities=14% Similarity=-0.045 Sum_probs=114.5
Q ss_pred HhHHHHHHHHhhCCCCCcceeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHH
Q 002738 599 YSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFI 678 (886)
Q Consensus 599 ~~~lrEI~iLk~L~HPNIVrl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~I 678 (886)
+....|...++...|+++...+.-..... ....+++++|+.+|.+.+.|-+-.+.. ..+....+...
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~------------s~ee~~r~~~~~~g~~f~iIikg~ee~-~~ld~~~v~~~ 1340 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSE------------STEEYIRSLYVEFGKLFSIIIKGLEES-PDLDRSPVHLR 1340 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCC------------ChHHHHHHHHHHHhHHHHHHHhccccC-CcchhchHHHH
Confidence 34466666777788999887664433222 224589999999999999997622211 23333444444
Q ss_pred HHHHHHHHHHHHhC-----CccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccccccccccccCCCCCCCcccCC
Q 002738 679 AQDVAAALVELHSK-----HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 753 (886)
Q Consensus 679 a~QIa~AL~yLHs~-----gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~~~~~~~~~~~~~~~~~~~vGT 753 (886)
..+.+.+..-+|++ --+|++||+-|.+|..+ ..+|++++|+.+....... ..+..+++
T Consensus 1341 ~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtn-------y~v~~gk~gLdKIknp~~s----------f~Gl~l~s 1403 (2724)
T KOG1826|consen 1341 HKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTN-------YNVKLGKGGLDKIKNPVLS----------FFGLELCS 1403 (2724)
T ss_pred HHHHHhccchhhhcccCCccchhhhhhhhccceecC-------CcccccccccccccCchHh----------hhhhhhCC
Confidence 44447788888865 27899999999999877 4599999999983322111 12445788
Q ss_pred CcccchhhhhcccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 002738 754 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 794 (886)
Q Consensus 754 ~~YmAPEvL~~~~~~~~~s~KSDIWSLGVILyELLTG~~PF 794 (886)
+.|++|++... -.++.++|+|..|+.+|++.-|..+|
T Consensus 1404 p~~v~qli~N~----ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1404 PIYVLQLIKNE----IKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHHHHHH----HhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 89999998875 45677899999999999998776665
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.02 Score=64.77 Aligned_cols=149 Identities=13% Similarity=0.102 Sum_probs=101.2
Q ss_pred eeeeeecccCceEEEEEEE-CCeeEEEEEEecccCCC------------------ChHHHHhhhHhHHHHHHHHhhCCCC
Q 002738 554 SSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGS------------------SADEIRNFEYSCLGEVRMLGALRHS 614 (886)
Q Consensus 554 ~i~k~LG~G~fG~VY~A~~-~~~~VAVKI~~lk~~~~------------------~~~~~k~f~~~~lrEI~iLk~L~HP 614 (886)
.+...|..|--+-||.|.- .|..+|+||++-..... .....+.+.-....|++-|++|...
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 4567788899999999985 66679999976332211 1112233444557789999998765
Q ss_pred CcceeeeeEecCCCCCCCCCCCCcccceEEEEEeccCCCCH-HHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHh-C
Q 002738 615 CIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSV-KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-K 692 (886)
Q Consensus 615 NIVrl~g~~~~~~~l~~~~~~~~~~~~~~~LVmEy~~GGSL-~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs-~ 692 (886)
.|.-.--+..- ...|||+|+.+... .-.|+ ...++...+..+-.|++.-|.-|.+ .
T Consensus 227 GIP~PePIlLk----------------~hVLVM~FlGrdgw~aPkLK------d~~ls~~ka~~~Y~~~v~~MR~lY~~c 284 (520)
T KOG2270|consen 227 GIPCPEPILLK----------------NHVLVMEFLGRDGWAAPKLK------DASLSTSKARELYQQCVRIMRRLYQKC 284 (520)
T ss_pred CCCCCCceeee----------------cceEeeeeccCCCCcCcccc------cccCChHHHHHHHHHHHHHHHHHHHHh
Confidence 54322111111 23899999953211 11222 2457777888999999999988865 5
Q ss_pred CccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccccc
Q 002738 693 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 732 (886)
Q Consensus 693 gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l~~ 732 (886)
++||.||.-=|+|+... .+.|+|-+-+.....
T Consensus 285 ~LVHADLSEfN~LyhdG--------~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 285 RLVHADLSEFNLLYHDG--------KLYIIDVSQSVEHDH 316 (520)
T ss_pred ceeccchhhhhheEECC--------EEEEEEccccccCCC
Confidence 89999999999999754 699999998876544
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.12 Score=57.21 Aligned_cols=30 Identities=23% Similarity=0.442 Sum_probs=24.9
Q ss_pred CCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcc
Q 002738 692 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 728 (886)
Q Consensus 692 ~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~ 728 (886)
.++||+|+.|.|||++.+ ...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~-------~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGD-------RLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECC-------ceEEEEeccccc
Confidence 389999999999999855 245799999874
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.022 Score=62.40 Aligned_cols=33 Identities=27% Similarity=0.347 Sum_probs=25.0
Q ss_pred CccccCCCCCCEEEeccccCCCCCCeEEEeecCCcc
Q 002738 693 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 728 (886)
Q Consensus 693 gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~ 728 (886)
.++|+|+.|.|||++.+. .....+.|+||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~---~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPS---SETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCC---CCCCcEEEEeeCCCC
Confidence 589999999999998630 001248999999873
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.12 Score=56.28 Aligned_cols=148 Identities=14% Similarity=0.161 Sum_probs=81.9
Q ss_pred eeeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCC--cceeeeeEecCCCCCCC
Q 002738 555 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSA 632 (886)
Q Consensus 555 i~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPN--IVrl~g~~~~~~~l~~~ 632 (886)
-.+.|..|....+|+....+..+++|+... ... . .+..|+.++..|.+.+ +.+++.... ...+.
T Consensus 18 ~i~~i~~G~~n~~y~v~~~~~~~vLr~~~~----~~~---~----~~~~e~~~l~~L~~~g~~vp~~i~~~~-g~~~~-- 83 (296)
T cd05153 18 SFEGISAGIENTNYFVTTDSGRYVLTLFEK----VSA---E----ELPFFLALLDHLAERGLPVPRPIADRD-GEYLS-- 83 (296)
T ss_pred heecccCccccceEEEEeCCCcEEEEEcCC----CCh---H----hccHHHHHHHHHHHCCCCCCccccCCC-CcEee--
Confidence 366778888889999987777889888532 111 1 2266888888875332 444443211 00000
Q ss_pred CCCCCcccceEEEEEeccCCCCHHH-----------HHHHH---hcc-CC-----CcCCHHHH----------HHHHHHH
Q 002738 633 DGNPEHHLLQSAIFMEYVKGGSVKN-----------YIEKL---SET-GE-----KHVSVKLA----------LFIAQDV 682 (886)
Q Consensus 633 ~~~~~~~~~~~~LVmEy~~GGSL~d-----------~L~~~---~~~-~~-----~~Ls~~~i----------~~Ia~QI 682 (886)
......++||+|++|..+.. .+... ... .. ....+... ......+
T Consensus 84 -----~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 158 (296)
T cd05153 84 -----ELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALL 158 (296)
T ss_pred -----eeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHH
Confidence 01124689999999865421 11110 000 00 00011110 0111223
Q ss_pred HHHHHHHHh-------CCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcc
Q 002738 683 AAALVELHS-------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 728 (886)
Q Consensus 683 a~AL~yLHs-------~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~ 728 (886)
..++.++.. .+++|+|+.|.|||++.+ ..+.|+||+.+.
T Consensus 159 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~-------~~~~iIDfe~a~ 204 (296)
T cd05153 159 ADELARQDAFDPSDLPRGVIHADLFRDNVLFDGD-------ELSGVIDFYFAC 204 (296)
T ss_pred HHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCC-------ceEEEeehhhhc
Confidence 344555543 379999999999999876 346899998774
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.085 Score=61.13 Aligned_cols=78 Identities=14% Similarity=0.057 Sum_probs=51.7
Q ss_pred eeeeecccCceEEEEEEECCeeEEEEEEecccCCCCh---HHHHhhhHhHHHHHHHHhhCC---CCCcceeeeeEecCCC
Q 002738 555 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSA---DEIRNFEYSCLGEVRMLGALR---HSCIVEMYGHKISSKW 628 (886)
Q Consensus 555 i~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~---~~~k~f~~~~lrEI~iLk~L~---HPNIVrl~g~~~~~~~ 628 (886)
..+.||.|....||+....+..++||.-.......+. .... +...|+..|+.+. ..++.+++.++.+.
T Consensus 36 ~~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~----R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~-- 109 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKE----RAYFEATALREHGRLCPDHVPEVYHFDRTM-- 109 (418)
T ss_pred eEEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCcc----HHHHHHHHHHHhhhcCCCCCCeEEEECCCC--
Confidence 4778999999999999987777888875422221111 0111 1145677776654 35788888887633
Q ss_pred CCCCCCCCCcccceEEEEEeccCC
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKG 652 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~G 652 (886)
.+++|||+++
T Consensus 110 --------------~vlvME~L~~ 119 (418)
T PLN02756 110 --------------ALIGMRYLEP 119 (418)
T ss_pred --------------CEEEEeecCC
Confidence 3889999976
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.59 E-value=0.056 Score=61.63 Aligned_cols=75 Identities=13% Similarity=-0.001 Sum_probs=45.1
Q ss_pred eecccCceEEEEEEECC--eeEEEEEEecccCCCC---hHHHHhhhHhHHHHHHHHhhCC--CC-CcceeeeeEecCCCC
Q 002738 558 EAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSS---ADEIRNFEYSCLGEVRMLGALR--HS-CIVEMYGHKISSKWL 629 (886)
Q Consensus 558 ~LG~G~fG~VY~A~~~~--~~VAVKI~~lk~~~~~---~~~~k~f~~~~lrEI~iLk~L~--HP-NIVrl~g~~~~~~~l 629 (886)
.||.|-...||++...+ ..++||.-.......+ .-.. .+..-|...|+... -| .+.++|.+-..
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~----~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e---- 73 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTL----DRARIESSALIRQGEHVPHLVPRIFHFDTE---- 73 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCc----cHHHHHHHHHHHhhccCccccCeEEEEccc----
Confidence 57999999999998754 4788887431111111 1111 22356778877764 34 45566654321
Q ss_pred CCCCCCCCcccceEEEEEeccCC
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKG 652 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~G 652 (886)
...+|||+++.
T Consensus 74 ------------~~~~vMEdL~~ 84 (370)
T TIGR01767 74 ------------MAVTVMEDLSH 84 (370)
T ss_pred ------------cceehHhhCcc
Confidence 23799999854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >smart00460 TGc Transglutaminase/protease-like homologues | Back alignment and domain information |
|---|
Probab=95.07 E-value=0.013 Score=49.67 Aligned_cols=30 Identities=33% Similarity=0.706 Sum_probs=27.7
Q ss_pred chhhHHHHHHHHHHhhhccCCCcccccccccc
Q 002738 449 QFGVCRHRAVLLKYLCDRVEPPVPCELVRGYL 480 (886)
Q Consensus 449 ~~g~crhralLfK~lad~~~~~~pc~lvrG~~ 480 (886)
..|.|.+-|.||+.|+-.++ ||||++.|..
T Consensus 5 ~~G~C~~~a~l~~~llr~~G--Ipar~v~g~~ 34 (68)
T smart00460 5 KYGTCGEFAALFVALLRSLG--IPARVVSGYL 34 (68)
T ss_pred cceeeHHHHHHHHHHHHHCC--CCeEEEeeee
Confidence 46999999999999999999 9999999953
|
Transglutaminases are enzymes that establish covalent links between proteins. A subset of transglutaminase homologues appear to catalyse the reverse reaction, the hydrolysis of peptide bonds. Proteins with this domain are both extracellular and intracellular, and it is likely that the eukaryotic intracellular proteins are involved in signalling events. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.81 E-value=0.16 Score=55.70 Aligned_cols=30 Identities=33% Similarity=0.512 Sum_probs=24.3
Q ss_pred CccccCCCCCCEEEeccccCCCCCCeEEEeecCCcc
Q 002738 693 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 728 (886)
Q Consensus 693 gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~ 728 (886)
.++|+|++|.|||++.++ ...-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~------~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDA------RVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCC------CEEEEECcHhcc
Confidence 489999999999998632 246799999874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.66 E-value=0.17 Score=58.58 Aligned_cols=77 Identities=14% Similarity=0.054 Sum_probs=48.0
Q ss_pred eeeecccCceEEEEEEEC--CeeEEEEEEecccC--CCChHHHHhhhHhHHHHHHHHhhCC--CC-CcceeeeeEecCCC
Q 002738 556 CDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVC--GSSADEIRNFEYSCLGEVRMLGALR--HS-CIVEMYGHKISSKW 628 (886)
Q Consensus 556 ~k~LG~G~fG~VY~A~~~--~~~VAVKI~~lk~~--~~~~~~~k~f~~~~lrEI~iLk~L~--HP-NIVrl~g~~~~~~~ 628 (886)
.+.||.|--..||++... +..++||.-..... ....-.. .+..-|..+|+.+. -| .+.++|.+-..
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~----~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e--- 106 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLST----NRIRIESDVLQLEEELAPGLVPKVYLFDSV--- 106 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCCh----HHHHHHHHHHHHHHhhCCCcCCeEEEECcH---
Confidence 678899999999999974 56788886431111 1111111 23366888887764 34 46666654322
Q ss_pred CCCCCCCCCcccceEEEEEeccCC
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKG 652 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~LVmEy~~G 652 (886)
...+|||+++.
T Consensus 107 -------------~~~~vMEdL~~ 117 (409)
T PRK12396 107 -------------MNCCVMEDLSD 117 (409)
T ss_pred -------------HhhHHHHhCcc
Confidence 24789999864
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.55 E-value=0.47 Score=51.93 Aligned_cols=29 Identities=31% Similarity=0.440 Sum_probs=24.2
Q ss_pred CCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcc
Q 002738 692 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 728 (886)
Q Consensus 692 ~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~ 728 (886)
.+++|+|+.+.||+++.+ .+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~--------~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKDN--------EVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeCC--------cEEEEECcccc
Confidence 479999999999999863 37899999653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.54 E-value=0.27 Score=55.32 Aligned_cols=31 Identities=26% Similarity=0.381 Sum_probs=26.3
Q ss_pred CccccCCCCCCEEEeccccCCCCCCeEEEeecCCcccc
Q 002738 693 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 730 (886)
Q Consensus 693 gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~l 730 (886)
.++|+|+.+.||+|+..+ -+=|.||+++..-
T Consensus 199 ~lvHGD~~~gNlii~~~~-------~~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGR-------PTGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEeCCC-------eeEEEeccccccC
Confidence 589999999999999873 2889999998643
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.24 E-value=0.34 Score=55.83 Aligned_cols=29 Identities=31% Similarity=0.200 Sum_probs=23.9
Q ss_pred CCccccCCCCCCEEEeccccCCCCCCeEEEeecCCcc
Q 002738 692 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 728 (886)
Q Consensus 692 ~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~ 728 (886)
...+|.|+-+.|||.+.+ .++++||-.|.
T Consensus 227 ~VfCHNDL~~gNIL~~~~--------~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQ--------GIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecCC--------CEEEEEecccc
Confidence 357999999999998644 39999998774
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.08 E-value=0.46 Score=53.44 Aligned_cols=30 Identities=20% Similarity=0.383 Sum_probs=24.8
Q ss_pred ccccCCCCCCEEEeccccCCCCCCeEEEeecCCccc
Q 002738 694 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 729 (886)
Q Consensus 694 IVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~ 729 (886)
++|.|+.+.|||++.++ ..++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~------~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDE------GKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCC------CcEEEEcccccCC
Confidence 79999999999997542 3599999998753
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=93.63 E-value=0.74 Score=52.17 Aligned_cols=31 Identities=29% Similarity=0.477 Sum_probs=25.7
Q ss_pred CccccCCCCCCEEEeccccCCCCCCeEEEeecCCccc
Q 002738 693 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 729 (886)
Q Consensus 693 gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~ 729 (886)
.++|+|+++.|||++.+. ..+.|+||..|..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~------~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEET------RAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCC------CcEEEEeehhccc
Confidence 589999999999998542 3599999988753
|
|
| >PF01841 Transglut_core: Transglutaminase-like superfamily; InterPro: IPR002931 This domain is found in many proteins known to have transglutaminase activity, i | Back alignment and domain information |
|---|
Probab=93.53 E-value=0.035 Score=51.55 Aligned_cols=46 Identities=30% Similarity=0.676 Sum_probs=34.3
Q ss_pred hhhHHHHHHHHHHhhhccCCCccccccccccc------------cCCCCcceeEEEeCCce
Q 002738 450 FGVCRHRAVLLKYLCDRVEPPVPCELVRGYLD------------FQPHAWNTILVKKGDSW 498 (886)
Q Consensus 450 ~g~crhralLfK~lad~~~~~~pc~lvrG~~~------------c~~~a~~s~~v~~G~~~ 498 (886)
.|.|..-|.||..||-.++ ||||+|.|... ...|+|+++.+ .+..|
T Consensus 51 ~G~C~~~a~l~~allr~~G--ipar~v~g~~~~~~~~~~~~~~~~~~H~w~ev~~-~~~~W 108 (113)
T PF01841_consen 51 RGDCEDYASLFVALLRALG--IPARVVSGYVKGPDPDGDYSVDGNDNHAWVEVYL-PGGGW 108 (113)
T ss_dssp EESHHHHHHHHHHHHHHHT----EEEEEEEEEECSSTTCTSTSSEEEEEEEEEEE-TTTEE
T ss_pred CCccHHHHHHHHHHHhhCC--CceEEEEEEcCCccccccccCCCCCCEEEEEEEE-cCCcE
Confidence 3999999999999999999 99999999654 33477766666 34445
|
e. which cross-link proteins through an acyl-transfer reaction between the gamma-carboxamide group of peptide-bound glutamine and the epsilon-amino group of peptide-bound lysine, resulting in a epsilon-(gamma-glutamyl)lysine isopeptide bond. Tranglutaminases have been found in a diverse range of species, from bacteria through to mammals. The enzymes require calcium binding and their activity leads to post-translational modification of proteins through acyl-transfer reactions, involving peptidyl glutamine residues as acyl donors and a variety of primary amines as acyl acceptors, with the generation of proteinase resistant isopeptide bonds []. Sequence conservation in this superfamily primarily involves three motifs that centre around conserved cysteine, histidine, and aspartate residues that form the catalytic triad in the structurally characterised transglutaminase, the human blood clotting factor XIIIa' []. On the basis of the experimentally demonstrated activity of the Methanobacterium phage psiM2 pseudomurein endoisopeptidase [], it is proposed that many, if not all, microbial homologs of the transglutaminases are proteases and that the eukaryotic transglutaminases have evolved from an ancestral protease []. A subunit of plasma Factor XIII revealed that each Factor XIIIA subunit is composed of four domains (termed N-terminal beta-sandwich, core domain (containing the catalytic and the regulatory sites), and C-terminal beta-barrels 1 and 2) and that two monomers assemble into the native dimer through the surfaces in domains 1 and 2, in opposite orientation. This organisation in four domains is highly conserved during evolution among transglutaminase isoforms [].; PDB: 2F4M_A 2F4O_A 1GGY_B 1FIE_B 1GGU_B 1GGT_B 1F13_A 1QRK_B 1EVU_A 1EX0_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=92.33 E-value=1.3 Score=48.97 Aligned_cols=29 Identities=21% Similarity=0.336 Sum_probs=25.0
Q ss_pred CccccCCCCCCEEEeccccCCCCCCeEEEeecCCcc
Q 002738 693 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 728 (886)
Q Consensus 693 gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~ 728 (886)
+++|+|+.++|||++.++ .+.|+||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~-------~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETR-------GGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCC-------CEEEEEhhhcc
Confidence 799999999999998763 48899998774
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=89.92 E-value=2.9 Score=47.42 Aligned_cols=146 Identities=21% Similarity=0.277 Sum_probs=80.7
Q ss_pred eeeecccCceEEEEEEECCeeEEEEEEecccCCCChHHHHhhhHhHHHHHHHHhhCCCCCc------ceeeeeEecCCCC
Q 002738 556 CDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI------VEMYGHKISSKWL 629 (886)
Q Consensus 556 ~k~LG~G~fG~VY~A~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~lrEI~iLk~L~HPNI------Vrl~g~~~~~~~l 629 (886)
...|.. .-..||+....+..+++|+.... ....+ +..|+..|..|.-..| ...=|-....
T Consensus 31 ~~~l~s-~eN~~f~~~~~~g~~iLki~~~~---~~~~~-------i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~--- 96 (331)
T COG2334 31 LRGLNS-EENSNFRVQTEDGRYILKIYRPG---WTRAE-------IPFELALLQHLAERGIPVPAPLPSLDGELLEA--- 96 (331)
T ss_pred cccccc-ccCceEEEEecCCCeEEEEecCC---CCHHH-------HHHHHHHHHHHHHcCCCCCCCccCCCcchhhh---
Confidence 344444 55679999987777899986533 12221 2557777777742222 1111111110
Q ss_pred CCCCCCCCcccceEEEEEeccCCCCHHH------------HHHH-------Hh--ccC-CCcCCHHH-------------
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKN------------YIEK-------LS--ETG-EKHVSVKL------------- 674 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~LVmEy~~GGSL~d------------~L~~-------~~--~~~-~~~Ls~~~------------- 674 (886)
..+ . +..+-|++|++|..+.. ++-. +. ... .....|..
T Consensus 97 --~~~----~-~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~ 169 (331)
T COG2334 97 --LSG----G-PRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVE 169 (331)
T ss_pred --ccC----C-ceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccC
Confidence 000 1 46789999999877662 1111 00 000 01112210
Q ss_pred HHHHHHHHHHHHHHHHhC--------C--ccccCCCCCCEEEeccccCCCCCCeEEEeecCCcc
Q 002738 675 ALFIAQDVAAALVELHSK--------H--IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 728 (886)
Q Consensus 675 i~~Ia~QIa~AL~yLHs~--------g--IVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~ 728 (886)
......++...+..+... + +||+|+.|.|||++.+. ..+.++|||-+.
T Consensus 170 ~~~l~a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~------~~~g~iDFdDa~ 227 (331)
T COG2334 170 PEDLRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDT------DVSGFIDFDDAG 227 (331)
T ss_pred chhhHHHHHHHHHHHHhhchhhCCcccceeeecCCCccceeEcCCC------CeeeEEEccccc
Confidence 012344455555555542 3 99999999999999872 158899999763
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.89 E-value=0.52 Score=53.15 Aligned_cols=86 Identities=23% Similarity=0.270 Sum_probs=49.4
Q ss_pred EEEEEeccCCCCHHHHHHH-HhccCCCcCCHHHHHHHHHHHHHHHHHHHh----CCccccCCCCCCEEEeccccC-----
Q 002738 643 SAIFMEYVKGGSVKNYIEK-LSETGEKHVSVKLALFIAQDVAAALVELHS----KHIMHRDIKSENILIDLERKK----- 712 (886)
Q Consensus 643 ~~LVmEy~~GGSL~d~L~~-~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs----~gIVHRDLKPsNILLd~d~~~----- 712 (886)
-.||++++.. +-...-.. ..+.+ -..-.+-++.++.||+.-.-.+.. .+++|-||||+||||-...+.
T Consensus 250 nIIIfPLArc-Sadkv~~~~~~e~G-F~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~ 327 (444)
T PHA03111 250 NIIIFPLARC-SADKVTEENAAELG-FKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITL 327 (444)
T ss_pred cEEEEehhhc-ccccCCHHHHHHcC-CccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEE
Confidence 3788888753 22221111 01112 112245667788888765544543 369999999999999776420
Q ss_pred ------CCCCCeEEEeecCCcccc
Q 002738 713 ------ADGKPVVKLCDFDRAVPL 730 (886)
Q Consensus 713 ------~~~~~~VKLsDFGlA~~l 730 (886)
......++|.||.++...
T Consensus 328 ~~~~~vF~Epi~~~LnDFDfSqv~ 351 (444)
T PHA03111 328 KDATYVFNEPIKACLNDFDFSQVA 351 (444)
T ss_pred CCeEEEeccchhhhhcccCHHHHc
Confidence 012334667777777543
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=88.49 E-value=2.9 Score=54.15 Aligned_cols=34 Identities=32% Similarity=0.543 Sum_probs=25.9
Q ss_pred CCccccCCCCCCEEEeccccCCCCCCeEEEeecCCccc
Q 002738 692 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 729 (886)
Q Consensus 692 ~gIVHRDLKPsNILLd~d~~~~~~~~~VKLsDFGlA~~ 729 (886)
+++||+|+.+.|||++.+.. ....=|+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~----~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDG----ERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCC----cceEEEEECccccc
Confidence 47999999999999987631 12334999998753
|
|
| >COG5279 CYK3 Uncharacterized protein involved in cytokinesis, contains TGc (transglutaminase/protease-like) domain [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=87.89 E-value=0.49 Score=55.39 Aligned_cols=67 Identities=31% Similarity=0.725 Sum_probs=48.1
Q ss_pred hhhHHHHHHHHHHhhhccCCCcccccccccc----cc-----CCCCcceeEEEeCCceEEEEeccc-----CCCCccc--
Q 002738 450 FGVCRHRAVLLKYLCDRVEPPVPCELVRGYL----DF-----QPHAWNTILVKKGDSWIRMIVDAC-----RPHDIRE-- 513 (886)
Q Consensus 450 ~g~crhralLfK~lad~~~~~~pc~lvrG~~----~c-----~~~a~~s~~v~~G~~~~~~lvd~~-----~p~~~~~-- 513 (886)
-++|-==|.|||.||-.+| |||.++.|.. ++ -.|||+.|.+.. . -|.+|.. .+.....
T Consensus 209 eavCtgYa~lfK~lcn~lg--Ip~~iIegf~k~~~~~~~~~~iNHaWN~VkiD~--~--yy~VDtTwgdPI~~d~~~~~~ 282 (521)
T COG5279 209 EAVCTGYAELFKELCNALG--IPCEIIEGFLKSPIYYTRDININHAWNIVKIDN--E--YYLVDTTWGDPIHPDQNSKSS 282 (521)
T ss_pred ccccchHHHHHHHHHHhcC--CceEEEeecccccccccCCccccceeeEEEECC--e--EEEEeeecCCCCccccccccc
Confidence 4788889999999999999 9999999981 11 259999887776 3 4788852 3333333
Q ss_pred cCCccceee
Q 002738 514 EADPEYFIR 522 (886)
Q Consensus 514 ~~~~e~f~~ 522 (886)
..++.||+.
T Consensus 283 ~~n~~YF~l 291 (521)
T COG5279 283 KINHSYFLL 291 (521)
T ss_pred ccCchhccC
Confidence 445666653
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=87.85 E-value=0.62 Score=52.81 Aligned_cols=86 Identities=21% Similarity=0.217 Sum_probs=48.5
Q ss_pred EEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHh----CCccccCCCCCCEEEeccccC-------
Q 002738 644 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS----KHIMHRDIKSENILIDLERKK------- 712 (886)
Q Consensus 644 ~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs----~gIVHRDLKPsNILLd~d~~~------- 712 (886)
.||++++.. +-...-......-+-..-.+-++.++.|||.-.--+.. .+.+|-||||+||||-+..+.
T Consensus 247 IIIfPLA~~-Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~ 325 (434)
T PF05445_consen 247 IIIFPLARC-SADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGN 325 (434)
T ss_pred EEEEehhhc-chhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECC
Confidence 789988753 33222111100111112244566777777643322323 369999999999999776421
Q ss_pred ----CCCCCeEEEeecCCcccc
Q 002738 713 ----ADGKPVVKLCDFDRAVPL 730 (886)
Q Consensus 713 ----~~~~~~VKLsDFGlA~~l 730 (886)
......++|.||.++...
T Consensus 326 ~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 326 RNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred eEEEecccceeeecccCHHHhc
Confidence 112345788888887654
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=87.45 E-value=1.3 Score=50.63 Aligned_cols=70 Identities=26% Similarity=0.231 Sum_probs=54.3
Q ss_pred eEEEEEeccCCCCHHHHHHHHhccCCCcCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCEEEeccccCCCCCCeEE
Q 002738 642 QSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPVVK 720 (886)
Q Consensus 642 ~~~LVmEy~~GGSL~d~L~~~~~~~~~~Ls~~~i~~Ia~QIa~AL~yLHs~-gIVHRDLKPsNILLd~d~~~~~~~~~VK 720 (886)
..|++|++- |++|... ....++++..|+.+-+.-+.-+..+ ..=|||+.-.||||+ + +.|.
T Consensus 300 y~yl~~kdh-gt~is~i---------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~-------Gnvt 361 (488)
T COG5072 300 YLYLHFKDH-GTPISII---------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E-------GNVT 361 (488)
T ss_pred EEEEEEecC-Cceeeee---------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c-------CceE
Confidence 468888876 4555432 2245778889999888877777765 789999999999999 5 3599
Q ss_pred EeecCCccc
Q 002738 721 LCDFDRAVP 729 (886)
Q Consensus 721 LsDFGlA~~ 729 (886)
|+||-+++.
T Consensus 362 LIDfklsRl 370 (488)
T COG5072 362 LIDFKLSRL 370 (488)
T ss_pred EEEeeeeec
Confidence 999999984
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 886 | ||||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-18 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-16 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-15 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-15 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-14 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-14 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-13 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-13 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-12 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-09 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-08 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-08 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-08 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-08 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-08 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-08 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-08 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-08 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-08 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-08 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-08 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-08 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-08 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-07 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-07 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 6e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-07 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 7e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-06 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-06 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 5e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 7e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 7e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 8e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 8e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 8e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 8e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 9e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-06 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 9e-06 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 9e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 9e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-06 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 9e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-05 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-05 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-05 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-05 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-05 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-05 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-05 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-04 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-04 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 3e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 4e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 5e-04 |
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 67/311 (21%), Positives = 111/311 (35%), Gaps = 76/311 (24%)
Query: 560 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 619
++ S L++ ++ D KV LKV S + R+F E L H ++ +
Sbjct: 19 NENHSGELWKGRWQGNDIVVKV--LKVRDWSTRKSRDF----NEECPRLRIFSHPNVLPV 72
Query: 620 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 679
G + P H + ++ GS+ N L E V A+ A
Sbjct: 73 LG---------ACQSPPAPHP---TLITHWMPYGSLYNV---LHEGTNFVVDQSQAVKFA 117
Query: 680 QDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 737
D+A + LH+ I + S +++ID + ++ D SF
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM-------TARISMADVK---FSFQSP- 166
Query: 738 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-NLYGLEVDIWSYGCLLLELLTLQVPYMG 796
+ P W+APE L+ KP + D+WS+ LL EL+T +VP+
Sbjct: 167 -----------GRMYAPAWVAPEALQ--KKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
Query: 797 LSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 855
LS +EI + G RP + H + + +
Sbjct: 214 LSNMEIGMKVALEGLRPTIPP------GISPH---------------------VSKLMKI 246
Query: 856 CTEENPTERPT 866
C E+P +RP
Sbjct: 247 CMNEDPAKRPK 257
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-41
Identities = 53/268 (19%), Positives = 103/268 (38%), Gaps = 69/268 (25%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
EV ++ L H IV++YG + + ME+V G + + + +
Sbjct: 73 EVFIMSNLNHPNIVKLYG--LMHNPP--------------RMVMEFVPCGDLYHRLLDKA 116
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVKL 721
+ + L + D+A + + +++ I+HRD++S NI + + A K+
Sbjct: 117 ----HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAP--VCAKV 170
Query: 722 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781
DF + + +H+ +G +WMAPE + A + Y + D +S+
Sbjct: 171 ADFGLS---QQSVHSV----------SGLLGNFQWMAPETIGAEEES--YTEKADTYSFA 215
Query: 782 CLLLELLTLQVPYMGLSELEI---HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 838
+L +LT + P+ S +I + + + G RP + + C
Sbjct: 216 MILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE------DCPPR----------- 258
Query: 839 PEAELETLSFLVDVFRRCTEENPTERPT 866
L +V C +P +RP
Sbjct: 259 ----------LRNVIELCWSGDPKKRPH 276
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-41
Identities = 55/291 (18%), Positives = 98/291 (33%), Gaps = 66/291 (22%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
+R + + + D+++ F EV RH +V G A +P H
Sbjct: 60 IRLIDIERDNEDQLKAF----KREVMAYRQTRHENVVLFMG----------ACMSPPHL- 104
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
AI KG ++ + + + + V IAQ++ + LH+K I+H+D+K
Sbjct: 105 ---AIITSLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLK 157
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 760
S+N+ D V + DF L S R G +APE
Sbjct: 158 SKNVFYD--------NGKVVITDFG----LFSISGVLQAGRREDKLRIQN-GWLCHLAPE 204
Query: 761 VLRAMHKPNL-----YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT 815
++R + + D+++ G + EL + P+ I + G +P
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP--- 261
Query: 816 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866
+++ + D+ C ERPT
Sbjct: 262 -----------------------NLSQIGMGKEISDILLFCWAFEQEERPT 289
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 65/312 (20%), Positives = 108/312 (34%), Gaps = 72/312 (23%)
Query: 560 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 619
G ++R + + A K + I N E ++ L+H I+ +
Sbjct: 16 GIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENV----RQEAKLFAMLKHPNIIAL 71
Query: 620 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 679
G + + ME+ +GG + + K + + + A
Sbjct: 72 RG----------VCLKEPNL----CLVMEFARGGPLNRVLSG------KRIPPDILVNWA 111
Query: 680 QDVAAALVELHSKH---IMHRDIKSENILIDLERKKAD-GKPVVKLCDFDRAVPLRSFLH 735
+A + LH + I+HRD+KS NILI + + D ++K+ DF
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG---------- 161
Query: 736 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 795
HR G WMAPEV+R + D+WSYG LL ELLT +VP+
Sbjct: 162 LAREWHRT--TKMSAAGAYAWMAPEVIR--ASM--FSKGSDVWSYGVLLWELLTGEVPFR 215
Query: 796 GLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 854
G+ L + + + + +C E +
Sbjct: 216 GIDGLAVAYGVAMNKLALPIPS------TCPEP---------------------FAKLME 248
Query: 855 RCTEENPTERPT 866
C +P RP+
Sbjct: 249 DCWNPDPHSRPS 260
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-40
Identities = 75/310 (24%), Positives = 125/310 (40%), Gaps = 73/310 (23%)
Query: 560 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 619
G ++ R ++ +D A K+ L A+ + F L EV ++ LRH IV
Sbjct: 46 GAGSFGTVHRAEWHGSDVAVKI--LMEQDFHAERVNEF----LREVAIMKRLRHPNIVLF 99
Query: 620 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 679
G A P + +I EY+ GS+ + K + + + L +A
Sbjct: 100 MG----------AVTQPPNL----SIVTEYLSRGSLYRLLHK--SGAREQLDERRRLSMA 143
Query: 680 QDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 737
DVA + LH+++ I+HR++KS N+L+D K VK+CDF +
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-------KKYTVKVCDFGLS---------- 186
Query: 738 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL 797
+ + GTP WMAPEVLR +P + D++S+G +L EL TLQ P+ L
Sbjct: 187 RLKASTFLSSKSAAGTPEWMAPEVLR--DEP--SNEKSDVYSFGVILWELATLQQPWGNL 242
Query: 798 SELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 856
+ ++ + KR + + + + + C
Sbjct: 243 NPAQVVAAVGFKCKRLEIPR------NLNPQ---------------------VAAIIEGC 275
Query: 857 TEENPTERPT 866
P +RP+
Sbjct: 276 WTNEPWKRPS 285
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-40
Identities = 66/288 (22%), Positives = 114/288 (39%), Gaps = 65/288 (22%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+ L V + +++ F EV +L RH I+ G S+ L
Sbjct: 51 VKMLNVTAPTPQQLQAF----KNEVGVLRKTRHVNILLFMG--YSTA----------PQL 94
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
AI ++ +G S+ +++ E +K + IA+ A + LH+K I+HRD+K
Sbjct: 95 ---AIVTQWCEGSSLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 760
S NI + VK+ DF A + G+ WMAPE
Sbjct: 148 SNNIFL-------HEDNTVKIGDFGLA---TEKSRWSGSHQFEQLS-----GSILWMAPE 192
Query: 761 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE--IHDLIQMGKRPRLTDEL 818
V+R M N Y + D++++G +L EL+T Q+PY ++ + I + + P L
Sbjct: 193 VIR-MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL---S 248
Query: 819 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866
+ +C + + + C ++ ERP+
Sbjct: 249 KVRSNCPKR---------------------MKRLMAECLKKKRDERPS 275
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 66/312 (21%), Positives = 120/312 (38%), Gaps = 83/312 (26%)
Query: 560 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 619
G+ + + K+ + D A K ++ S E + F E+R L + H IV++
Sbjct: 17 GRGAFGVVCKAKWRAKDVAIKQ--IE----SESERKAFI----VELRQLSRVNHPNIVKL 66
Query: 620 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 679
YG + + MEY +GGS+ N + + + A+
Sbjct: 67 YG--ACLNPV--------------CLVMEYAEGGSLYNVLHGAEPL--PYYTAAHAMSWC 108
Query: 680 QDVAAALVELHS---KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 736
+ + LHS K ++HRD+K N+L+ G V+K+CDF A +++ +
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLV------AGGTVLKICDFGTACDIQTHMTN 162
Query: 737 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 796
G+ WMAPEV Y + D++S+G +L E++T + P+
Sbjct: 163 NK-------------GSAAWMAPEVFE--GSN--YSEKCDVFSWGIILWEVITRRKPFDE 205
Query: 797 LS--ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 854
+ I + G RP L + + + +
Sbjct: 206 IGGPAFRIMWAVHNGTRPPLIK------NLPKP---------------------IESLMT 238
Query: 855 RCTEENPTERPT 866
RC ++P++RP+
Sbjct: 239 RCWSKDPSQRPS 250
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 66/276 (23%), Positives = 102/276 (36%), Gaps = 64/276 (23%)
Query: 600 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 659
C+ E+ +L L H +++ Y I L I +E G + I
Sbjct: 78 DCIKEIDLLKQLNHPNVIKYYASFIEDNEL--------------NIVLELADAGDLSRMI 123
Query: 660 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 719
+ + + + + + +AL +HS+ +MHRDIK N+ I A G VV
Sbjct: 124 KHFKKQK-RLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT-----ATG--VV 175
Query: 720 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 779
KL D R F AH VGTP +M+PE + Y + DIWS
Sbjct: 176 KLGDLGLG---RFFSSKTTAAH-------SLVGTPYYMSPERIH--ENG--YNFKSDIWS 221
Query: 780 YGCLLLELLTLQVPYMG--LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 837
GCLL E+ LQ P+ G ++ + I+ P L + S
Sbjct: 222 LGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD------------HYS----- 264
Query: 838 KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 873
L + C +P +RP +Y++
Sbjct: 265 ---------EELRQLVNMCINPDPEKRPDVTYVYDV 291
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 56/296 (18%), Positives = 101/296 (34%), Gaps = 60/296 (20%)
Query: 593 EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA--IFMEYV 650
++ EV+ L L H IV G + P I ME+
Sbjct: 43 RVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFC 102
Query: 651 KGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 710
G+++ +IEK + + LAL + + + + +HSK +++RD+K NI +
Sbjct: 103 DKGTLEQWIEK---RRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV--- 156
Query: 711 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 770
VK+ DF L++ GT R+M+PE + +
Sbjct: 157 --DTK--QVKIGDFGLVTSLKNDGKRTRS-----------KGTLRYMSPEQIS--SQD-- 197
Query: 771 YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVA 830
YG EVD+++ G +L ELL + E + ++D
Sbjct: 198 YGKEVDLYALGLILAELLHVCDTAF-----ETSKFFTDLRDGIISDIF------------ 240
Query: 831 QSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSSSISSR 885
+ ++ + P +RP ++ V + S + R
Sbjct: 241 -DKK--------------EKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER 281
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-37
Identities = 61/290 (21%), Positives = 107/290 (36%), Gaps = 71/290 (24%)
Query: 584 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 643
L+ + E + F+ E ML L+H IV Y W + G + ++
Sbjct: 59 LQDRKLTKSERQRFK----EEAEMLKGLQHPNIVRFYDS-----WESTVKG--KKCIV-- 105
Query: 644 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKS 701
+ E + G++K Y+++ K + + + L LH++ I+HRD+K
Sbjct: 106 -LVTELMTSGTLKTYLKRFKVMKIKVLRS-----WCRQILKGLQFLHTRTPPIIHRDLKC 159
Query: 702 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 761
+NI I G VK+ D + +GTP +MAPE+
Sbjct: 160 DNIFIT----GPTG--SVKIGDL------------GLATLKRASFAKAVIGTPEFMAPEM 201
Query: 762 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEA 820
Y VD++++G +LE+ T + PY +I+ + G +P D++
Sbjct: 202 YE-----EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256
Query: 821 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 870
PE + + C +N ER + DL
Sbjct: 257 ------------------PEVK----EII----EGCIRQNKDERYSIKDL 280
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 56/286 (19%), Positives = 93/286 (32%), Gaps = 75/286 (26%)
Query: 598 EYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVK 656
E + L EV L +HS +V + W + H+L I EY GGS+
Sbjct: 54 EQNALREVYAHAVLGQHSHVVRYFSA-----WAE------DDHML---IQNEYCNGGSLA 99
Query: 657 NYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID--------- 707
+ I + + + V L +HS ++H DIK NI I
Sbjct: 100 DAISENYRIM-SYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAAS 158
Query: 708 ---LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 764
E A K + K+ D + S P V G R++A EVL+
Sbjct: 159 EEGDEDDWASNKVMFKIGDLGHVTRISS--------------PQVEEGDSRFLANEVLQ- 203
Query: 765 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 824
+ + + DI++ ++ + + I+ G+ PR+ L
Sbjct: 204 ENYT--HLPKADIFALALTVVCAAGAEPLPRNGDQWHE---IRQGRLPRIPQVL------ 252
Query: 825 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 870
S ++ + +P RP+A L
Sbjct: 253 -------SQE--------------FTELLKVMIHPDPERRPSAMAL 277
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-37
Identities = 56/314 (17%), Positives = 108/314 (34%), Gaps = 68/314 (21%)
Query: 567 LFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626
+ ++ L + R F L EV+++ L H +++ G +
Sbjct: 26 AIKVTHRETGEVMVMKELI--RFDEETQRTF----LKEVKVMRCLEHPNVLKFIG--VLY 77
Query: 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAAL 686
K + L EY+KGG+++ I+ + + A+D+A+ +
Sbjct: 78 K---------DKRL---NFITEYIKGGTLRGIIKS----MDSQYPWSQRVSFAKDIASGM 121
Query: 687 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGI 744
LHS +I+HRD+ S N L+ + V + DF R + + +
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENK-------NVVVADFGLARLMVDEKTQPEGLRSLKKP 174
Query: 745 PAPDV--CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY--MGLSEL 800
VG P WMAPE++ + Y +VD++S+G +L E++ +
Sbjct: 175 DRKKRYTVVGNPYWMAPEMIN--GRS--YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM 230
Query: 801 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 860
+ ++ +C + RC + +
Sbjct: 231 DFGLNVRGFLDR------YCPPNCPPS---------------------FFPITVRCCDLD 263
Query: 861 PTERPTAGDLYEMF 874
P +RP+ L
Sbjct: 264 PEKRPSFVKLEHWL 277
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 56/276 (20%), Positives = 99/276 (35%), Gaps = 55/276 (19%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA----IFMEYVKGGSVKNYI 659
EV +L +L H +V Y WL + ++ I MEY + G++ + I
Sbjct: 52 EVMLLASLNHQYVVRYYAA-----WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI 106
Query: 660 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 719
+ + + + AL +HS+ I+HRD+K NI ID V
Sbjct: 107 HS----ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID-----ESRN--V 155
Query: 720 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDV----CVGTPRWMAPEVLRAMHKPNLYGLEV 775
K+ DF A + L + + +P +GT ++A EVL + Y ++
Sbjct: 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG--TGH-YNEKI 212
Query: 776 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG 835
D++S G + E++ G+ + I ++
Sbjct: 213 DMYSLGIIFFEMIYP--FSTGMERVNILKKLRSVS------------------------- 245
Query: 836 FEKPEAELETLS-FLVDVFRRCTEENPTERPTAGDL 870
E P + + R + +P +RP A L
Sbjct: 246 IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 72/279 (25%), Positives = 106/279 (37%), Gaps = 66/279 (23%)
Query: 600 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 659
+ EV +L L+H IV Y I L I MEY +GG + + I
Sbjct: 51 MLVSEVNLLRELKHPNIVRYYDRIIDRT---------NTTLY---IVMEYCEGGDLASVI 98
Query: 660 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-----IMHRDIKSENILIDLERKKAD 714
K ++ +++ + L + + AL E H + ++HRD+K N+ +D
Sbjct: 99 TKGTKER-QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD------- 150
Query: 715 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 774
GK VKL DF A R H A VGTP +M+PE + Y +
Sbjct: 151 GKQNVKLGDFGLA---RILNHDTSFAK-------TFVGTPYYMSPEQMN--RMS--YNEK 196
Query: 775 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS 834
DIWS GCLL EL L P+ S+ E+ I+ GK R+ S
Sbjct: 197 SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY----S----------- 241
Query: 835 GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 873
L ++ R RP+ ++ E
Sbjct: 242 ------------DELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 58/268 (21%), Positives = 92/268 (34%), Gaps = 61/268 (22%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E+ L IV +YG W+ IFME ++GGS+ I+++
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWV--------------NIFMELLEGGSLGQLIKQMG 145
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
E L LH++ I+H D+K++N+L+ +DG LCD
Sbjct: 146 CLPEDRALY-----YLGQALEGLEYLHTRRILHGDVKADNVLLS-----SDGS-RAALCD 194
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
F A+ L+ + D GT MAPEV+ +VDIWS C+
Sbjct: 195 FGHALCLQPDGLGKSLLTG-----DYIPGTETHMAPEVVMG----KPCDAKVDIWSSCCM 245
Query: 784 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 843
+L +L P+ + I P E P
Sbjct: 246 MLHMLNGCHPWTQYFRGPLCLKIASEPPPIR----------------------EIP---- 279
Query: 844 ETLS-FLVDVFRRCTEENPTERPTAGDL 870
+ + + + P R +A +L
Sbjct: 280 PSCAPLTAQAIQEGLRKEPVHRASAMEL 307
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 69/288 (23%), Positives = 107/288 (37%), Gaps = 66/288 (22%)
Query: 600 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 659
EV +L ++H IV+ + L I M+Y +GG + I
Sbjct: 69 ESRREVAVLANMKHPNIVQYRESFEENGSL--------------YIVMDYCEGGDLFKRI 114
Query: 660 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 719
L + AL +H + I+HRDIKS+NI + DG V
Sbjct: 115 NA---QKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT-----KDG--TV 164
Query: 720 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 779
+L DF A R T +A C+GTP +++PE+ +KP Y + DIW+
Sbjct: 165 QLGDFGIA---RVLNSTVELAR-------ACIGTPYYLSPEICE--NKP--YNNKSDIWA 210
Query: 780 YGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP 839
GC+L EL TL+ + S + I G P ++ S
Sbjct: 211 LGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHY----S---------------- 250
Query: 840 EAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSSSISSRS 886
L + + + NP +RP+ + E F+A+ S
Sbjct: 251 -------YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQ 291
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 61/274 (22%), Positives = 96/274 (35%), Gaps = 48/274 (17%)
Query: 600 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 659
+ EV+ L L H IV + + + L I M+ + ++K+++
Sbjct: 49 KVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYL--YIQMQLCRKENLKDWM 106
Query: 660 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 719
+ + L I +A A+ LHSK +MHRD+K NI D VV
Sbjct: 107 NG--RCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT-----MDD--VV 157
Query: 720 KLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 777
K+ DF A+ T VGT +M+PE + Y +VDI
Sbjct: 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS----YSHKVDI 213
Query: 778 WSYGCLLLELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 836
+S G +L ELL P+ E ++ K P L
Sbjct: 214 FSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPL---------------------- 248
Query: 837 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 870
+ +V + +P ERP A ++
Sbjct: 249 --FTQKYPCEYVMV---QDMLSPSPMERPEAINI 277
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 61/285 (21%), Positives = 101/285 (35%), Gaps = 53/285 (18%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E+ LRH I+ +D H Q + Y + GS+ +Y++
Sbjct: 52 ELYNTVMLRHENILGFIA----------SDMTSRHSSTQLWLITHYHEMGSLYDYLQL-- 99
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKH--------IMHRDIKSENILIDLERKKADG 715
+ L I +A+ L LH + I HRD+KS+NIL+ +G
Sbjct: 100 ----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK-----KNG 150
Query: 716 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE- 774
+ D AV + + + VGT R+MAPEVL + +
Sbjct: 151 --QCCIADLGLAVMHSQSTNQLDVGNNPR------VGTKRYMAPEVLD--ETIQVDCFDS 200
Query: 775 ---VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ 831
VDIW++G +L E+ V + + + + P D + V
Sbjct: 201 YKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV--------VCV 252
Query: 832 SGS--GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
TL+ L + + C +NP+ R TA + +
Sbjct: 253 DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 68/286 (23%), Positives = 110/286 (38%), Gaps = 64/286 (22%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E+ + L+H IV+ G + IFME V GGS+ +
Sbjct: 69 EIALHKHLKHKNIVQYLGSFSE-----------NGFIK---IFMEQVPGGSLSALLRSKW 114
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
+ + + + Q + L LH I+HRDIK +N+LI+ G V+K+ D
Sbjct: 115 GPLKDNEQT-IGFYTKQ-ILEGLKYLHDNQIVHRDIKGDNVLINTY----SG--VLKISD 166
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
F + L P + GT ++MAPE++ P YG DIWS GC
Sbjct: 167 FGTSKRLAGI----------NPCTETFTGTLQYMAPEIID--KGPRGYGKAADIWSLGCT 214
Query: 784 LLELLTLQVPYMGLSE-LEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEA 841
++E+ T + P+ L E + M K P + + + A
Sbjct: 215 IIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA------------------- 255
Query: 842 ELETLSFLVDVFRRCTEENPTERPTAGDLYE-MFVARTSSSISSRS 886
+F+ +C E +P +R A DL F+ +S ++
Sbjct: 256 ----KAFI----LKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQP 293
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 64/281 (22%), Positives = 96/281 (34%), Gaps = 75/281 (26%)
Query: 600 SCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 658
L EV + +H C V + W +G L + E G S++ +
Sbjct: 102 RKLAEVGSHEKVGQHPCCVRLEQA-----W---EEGG---ILY---LQTELC-GPSLQQH 146
Query: 659 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 718
E + +D AL LHS+ ++H D+K NI + G
Sbjct: 147 CEAWG----ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG-----PRG--R 195
Query: 719 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 778
KL DF V L + +V G PR+MAPE+L+ YG D++
Sbjct: 196 CKLGDFGLLVELGTAGAG-----------EVQEGDPRYMAPELLQ-----GSYGTAADVF 239
Query: 779 SYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 837
S G +LE+ +++P+ G L Q P T L S
Sbjct: 240 SLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGL----S-------------- 278
Query: 838 KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVAR 877
E L V E +P R TA L + + +
Sbjct: 279 -SE--------LRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 60/299 (20%), Positives = 106/299 (35%), Gaps = 81/299 (27%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
EV L ++H I++ G A+ + + + + GS+ ++++
Sbjct: 68 EVYSLPGMKHENILQFIG----------AEKRGTSVDVDLWLITAFHEKGSLSDFLKA-- 115
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSK----------HIMHRDIKSENILIDLERKKA 713
VS IA+ +A L LH I HRDIKS+N+L+
Sbjct: 116 ----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK-----N 166
Query: 714 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR-AMHKPNLYG 772
+ + DF A+ + + VGT R+MAPEVL A++
Sbjct: 167 NL--TACIADFGLALKFEAGKSAGDTHGQ--------VGTRRYMAPEVLEGAINFQRDAF 216
Query: 773 LEVDIWSYGCLLLELLTLQVPYMGL----------------SELEIHDLI-QMGKRPRLT 815
L +D+++ G +L EL + G S ++ +++ KRP L
Sbjct: 217 LRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLR 276
Query: 816 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
D +H ++ L + C + + R +AG + E
Sbjct: 277 D------YWQKHAG----------------MAMLCETIEECWDHDAEARLSAGCVGERI 313
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 49/288 (17%), Positives = 101/288 (35%), Gaps = 82/288 (28%)
Query: 600 SCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 657
S E+ L L+ I+ +Y ++I+ +++ + ME + +
Sbjct: 72 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI--------------YMVMECG-NIDLNS 116
Query: 658 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 717
+++K +K + +++ A+ +H I+H D+K N LI
Sbjct: 117 WLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--------DG 163
Query: 718 VVKLCDFDRAVPLRS-----FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM------- 765
++KL DF A ++ + GT +M PE ++ M
Sbjct: 164 MLKLIDFGIANQMQPDTTSVVKDSQV-------------GTVNYMPPEAIKDMSSSRENG 210
Query: 766 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 825
+ + D+WS GC+L + + P+ + +++ L
Sbjct: 211 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQ-----------------IINQISKL---- 249
Query: 826 EHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDLYE 872
H + E P + L DV + C + +P +R + +L
Sbjct: 250 -HAIIDPNHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLA 292
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 44/228 (19%), Positives = 82/228 (35%), Gaps = 28/228 (12%)
Query: 601 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 660
E M H I+ + + + + +H + + + K G++ N IE
Sbjct: 73 AQREADMHRLFNHPNILRLVAYCLRER-------GAKHEAW---LLLPFFKRGTLWNEIE 122
Query: 661 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 720
+L + G ++ L++ + L +H+K HRD+K NIL+ +G
Sbjct: 123 RLKDKGN-FLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG-----DEG--QPV 174
Query: 721 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL-YGLEVDIWS 779
L D + A T + APE+ + + D+WS
Sbjct: 175 LMDLGSMNQACIHVEGSRQALTLQDWAAQR-CTISYRAPELFSV--QSHCVIDERTDVWS 231
Query: 780 YGCLLLELLTLQVPYMGLSE-LEIHDLIQMGKR-----PRLTDELEAL 821
GC+L ++ + PY + + + L + PR + L L
Sbjct: 232 LGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQL 279
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-34
Identities = 49/288 (17%), Positives = 101/288 (35%), Gaps = 82/288 (28%)
Query: 600 SCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 657
S E+ L L+ I+ +Y ++I+ +++ + ME + +
Sbjct: 53 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI--------------YMVMECG-NIDLNS 97
Query: 658 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 717
+++K +K + +++ A+ +H I+H D+K N LI
Sbjct: 98 WLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--------DG 144
Query: 718 VVKLCDFDRAVPLRS-----FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM------- 765
++KL DF A ++ + GT +M PE ++ M
Sbjct: 145 MLKLIDFGIANQMQPDTTSVVKDSQV-------------GTVNYMPPEAIKDMSSSRENG 191
Query: 766 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 825
+ + D+WS GC+L + + P+ + +++ L
Sbjct: 192 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQ-----------------IINQISKL---- 230
Query: 826 EHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDLYE 872
H + E P + L DV + C + +P +R + +L
Sbjct: 231 -HAIIDPNHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-34
Identities = 50/277 (18%), Positives = 90/277 (32%), Gaps = 37/277 (13%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E +L L H IV+++ + + H +L ME+ GS+ +E+ S
Sbjct: 57 EFEVLKKLNHKNIVKLFAIE--------EETTTRHKVL----IMEFCPCGSLYTVLEEPS 104
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
+ L + +DV + L I+HR+IK NI+ DG+ V KL D
Sbjct: 105 NAYG--LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRV---IGEDGQSVYKLTD 159
Query: 724 F--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL----YGLEVDI 777
F R + + GT ++ P++ YG VD+
Sbjct: 160 FGAARELEDDEQFVSLY-------------GTEEYLHPDMYERAVLRKDHQKKYGATVDL 206
Query: 778 WSYGCLLLELLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 836
WS G T +P+ + +++ + + + + + SG
Sbjct: 207 WSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMP 266
Query: 837 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 873
L V E + + +
Sbjct: 267 VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 78/316 (24%), Positives = 115/316 (36%), Gaps = 79/316 (25%)
Query: 569 RCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--HKISS 626
C A K L+ C +S DE+ E++ + H IV Y
Sbjct: 35 YCAPKKEKVAIKRINLEKCQTSMDELLK-------EIQAMSQCHHPNIVSYYTSFVVKDE 87
Query: 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG--------EKHVSVKLALFI 678
W + M+ + GGSV + I+ + G E ++ I
Sbjct: 88 LW----------------LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT-----I 126
Query: 679 AQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCC 738
++V L LH +HRD+K+ NIL+ DG V++ DF + L +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLG-----EDGS--VQIADFGVSAFLATGGDITR 179
Query: 739 IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS 798
R VGTP WMAPEV M + Y + DIWS+G +EL T PY
Sbjct: 180 NKVR-----KTFVGTPCWMAPEV---MEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231
Query: 799 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR---- 854
+++ L P L E + E L FR
Sbjct: 232 PMKVLMLTLQNDPPSL----------------------ETGVQDKEMLKKYGKSFRKMIS 269
Query: 855 RCTEENPTERPTAGDL 870
C +++P +RPTA +L
Sbjct: 270 LCLQKDPEKRPTAAEL 285
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 48/288 (16%), Positives = 100/288 (34%), Gaps = 82/288 (28%)
Query: 600 SCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 657
S E+ L L+ I+ +Y ++I+ +++ + ME + +
Sbjct: 100 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI--------------YMVMECG-NIDLNS 144
Query: 658 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 717
+++K +K + +++ A+ +H I+H D+K N LI
Sbjct: 145 WLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--------DG 191
Query: 718 VVKLCDFDRAVPLRS-----FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM------- 765
++KL DF A ++ + G +M PE ++ M
Sbjct: 192 MLKLIDFGIANQMQPDTTSVVKDSQV-------------GAVNYMPPEAIKDMSSSRENG 238
Query: 766 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 825
+ + D+WS GC+L + + P+ + +++ L
Sbjct: 239 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQ-----------------IINQISKL---- 277
Query: 826 EHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDLYE 872
H + E P + L DV + C + +P +R + +L
Sbjct: 278 -HAIIDPNHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLA 320
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 61/283 (21%), Positives = 97/283 (34%), Gaps = 49/283 (17%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E+ +RH I+ AD Q + +Y + GS+ +Y++
Sbjct: 81 EIYQTVLMRHENILGFIA----------ADIKGTGSWTQLYLITDYHENGSLYDYLKS-- 128
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSK--------HIMHRDIKSENILIDLERKKADG 715
+ K L +A + L LH++ I HRD+KS+NIL+
Sbjct: 129 ----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK-------K 177
Query: 716 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL--YGL 773
+ D AV S + I VGT R+M PEVL N +
Sbjct: 178 NGTCCIADLGLAVKFISDTNEVDIPPNTR------VGTKRYMPPEVLDESLNRNHFQSYI 231
Query: 774 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG 833
D++S+G +L E+ V + E ++ + P D E V
Sbjct: 232 MADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREI--------VCIKK 283
Query: 834 S--GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
F + E L + + C NP R TA + +
Sbjct: 284 LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-33
Identities = 50/277 (18%), Positives = 90/277 (32%), Gaps = 37/277 (13%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E +L L H IV+++ + + H +L ME+ GS+ +E+ S
Sbjct: 57 EFEVLKKLNHKNIVKLFAIE--------EETTTRHKVL----IMEFCPCGSLYTVLEEPS 104
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
+ L + +DV + L I+HR+IK NI+ DG+ V KL D
Sbjct: 105 NAYG--LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRV---IGEDGQSVYKLTD 159
Query: 724 F--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL----YGLEVDI 777
F R + + GT ++ P++ YG VD+
Sbjct: 160 FGAARELEDDEQFVSLY-------------GTEEYLHPDMYERAVLRKDHQKKYGATVDL 206
Query: 778 WSYGCLLLELLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 836
WS G T +P+ + +++ + + + + + SG
Sbjct: 207 WSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMP 266
Query: 837 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 873
L V E + + +
Sbjct: 267 VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-32
Identities = 63/323 (19%), Positives = 102/323 (31%), Gaps = 59/323 (18%)
Query: 569 RCKFGSADAAAKVRTLKVC-GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627
R K + L+ C ++ E+ + H IV I+
Sbjct: 47 RYKPTGEYVTVRRINLEACSNEMVTFLQG-------ELHVSKLFNHPNIVPYRATFIADN 99
Query: 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG--EKHVSVKLALFIAQDVAAA 685
L + ++ GS K+ I G E ++ +I Q V A
Sbjct: 100 EL--------------WVVTSFMAYGSAKDLICTHFMDGMNELAIA-----YILQGVLKA 140
Query: 686 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP 745
L +H +HR +K+ +ILI DGK V L S +
Sbjct: 141 LDYIHHMGYVHRSVKASHILIS-----VDGK--VYLSGLRSN---LSMISHGQRQRVVHD 190
Query: 746 APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 805
P V W++PEVL+ + Y + DI+S G EL VP+ + ++
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQG--YDAKSDIYSVGITACELANGHVPFKDMPATQMLLE 248
Query: 806 IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV--------------D 851
G P L D ++S + ++ +
Sbjct: 249 KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSP 308
Query: 852 VFR----RCTEENPTERPTAGDL 870
F +C + NP RP+A L
Sbjct: 309 HFHHFVEQCLQRNPDARPSASTL 331
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 9e-32
Identities = 66/299 (22%), Positives = 103/299 (34%), Gaps = 81/299 (27%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E+ LRH I+ AD Q + +Y + GS+ +Y+ + +
Sbjct: 86 EIYQTVMLRHENILGFIA----------ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT 135
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKH--------IMHRDIKSENILIDLERKKADG 715
V+V+ + +A A+ L LH + I HRD+KS+NIL+
Sbjct: 136 ------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-------K 182
Query: 716 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR----AMHKPNLY 771
+ D AV S T IA VGT R+MAPEVL H
Sbjct: 183 NGTCCIADLGLAVRHDSATDTIDIAPNHR------VGTKRYMAPEVLDDSINMKHFE--S 234
Query: 772 GLEVDIWSYGCLLLELLTL----------QVPYMGL-----SELEIHDLI-QMGKRPRLT 815
DI++ G + E+ Q+PY L S E+ ++ + RP +
Sbjct: 235 FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP 294
Query: 816 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
+ + E L + + R C N R TA + +
Sbjct: 295 NRWQ----------------------SCEALRVMAKIMRECWYANGAARLTALRIKKTL 331
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 70/270 (25%), Positives = 107/270 (39%), Gaps = 72/270 (26%)
Query: 604 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 661
E+ ++ ++ IV W + MEY+ GGS+ + + +
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELW----------------VVMEYLAGGSLTDVVTE 110
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
+ E ++ + ++ AL LHS ++HRDIKS+NIL+ DG VKL
Sbjct: 111 -TCMDEGQIAA-----VCRECLQALEFLHSNQVIHRDIKSDNILLG-----MDGS--VKL 157
Query: 722 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781
DF + T + R VGTP WMAPEV+ YG +VDIWS G
Sbjct: 158 TDFGFCAQI-----TPEQSKR-----STMVGTPYWMAPEVV----TRKAYGPKVDIWSLG 203
Query: 782 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 841
+ +E++ + PY+ + L LI P L +
Sbjct: 204 IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP------------------------ 239
Query: 842 ELETLS-FLVDVFRRCTEENPTERPTAGDL 870
E LS D RC E + +R +A +L
Sbjct: 240 --EKLSAIFRDFLNRCLEMDVEKRGSAKEL 267
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 69/270 (25%), Positives = 115/270 (42%), Gaps = 72/270 (26%)
Query: 604 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 661
EV ++ +H +VEMY W + ME+++GG++ + + +
Sbjct: 92 EVVIMRDYQHFNVVEMYKSYLVGEELW----------------VLMEFLQGGALTDIVSQ 135
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
+ E+ ++ + + V AL LH++ ++HRDIKS++IL+ L DG+ VKL
Sbjct: 136 VRLN-EEQIAT-----VCEAVLQALAYLHAQGVIHRDIKSDSILLTL-----DGR--VKL 182
Query: 722 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781
DF + + + R VGTP WMAPEV+ Y EVDIWS G
Sbjct: 183 SDFGFCAQI-----SKDVPKR-----KSLVGTPYWMAPEVISRSL----YATEVDIWSLG 228
Query: 782 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 841
+++E++ + PY S ++ ++ P+L +
Sbjct: 229 IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNS------------------------ 264
Query: 842 ELETLS-FLVDVFRRCTEENPTERPTAGDL 870
+S L D R +P ER TA +L
Sbjct: 265 --HKVSPVLRDFLERMLVRDPQERATAQEL 292
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 78/311 (25%), Positives = 121/311 (38%), Gaps = 80/311 (25%)
Query: 577 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--HKISSKWLPSADG 634
A K+ L+ ++I+ E+ +L + + YG K + W
Sbjct: 50 VAIKIIDLEEAEDEIEDIQQ-------EITVLSQCDSPYVTKYYGSYLKDTKLW------ 96
Query: 635 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHI 694
I MEY+ GGS + + + E ++ I +++ L LHS+
Sbjct: 97 ----------IIMEYLGGGSALD-LLEPGPLDETQIAT-----ILREILKGLDYLHSEKK 140
Query: 695 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 754
+HRDIK+ N+L+ G+ VKL DF A L T R + VGTP
Sbjct: 141 IHRDIKAANVLLS-----EHGE--VKLADFGVAGQL-----TDTQIKR-----NTFVGTP 183
Query: 755 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 814
WMAPEV+ K + Y + DIWS G +EL + P+ L +++ LI P L
Sbjct: 184 FWMAPEVI----KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL 239
Query: 815 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM- 873
+ KP L + C + P+ RPTA +L +
Sbjct: 240 EGN------------------YSKP---------LKEFVEACLNKEPSFRPTAKELLKHK 272
Query: 874 FVARTSSSISS 884
F+ R + S
Sbjct: 273 FILRNAKKTSY 283
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 65/291 (22%), Positives = 106/291 (36%), Gaps = 64/291 (21%)
Query: 584 LKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQ 642
+KV + DE + E+ ML H I YG ++ + L
Sbjct: 54 IKVMDVTGDEEEEIKQ----EINMLKKYSHHRNIATYYGA-----FIKKNPPGMDDQLW- 103
Query: 643 SAIFMEYVKGGSVKNYIEKLSETG--EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
+ ME+ GSV + I+ E+ ++ +I +++ L LH ++HRDIK
Sbjct: 104 --LVMEFCGAGSVTDLIKNTKGNTLKEEWIA-----YICREILRGLSHLHQHKVIHRDIK 156
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 760
+N+L+ + + VKL DF + L + R + +GTP WMAPE
Sbjct: 157 GQNVLLT-----ENAE--VKLVDFGVSAQL-----DRTVGRR-----NTFIGTPYWMAPE 199
Query: 761 VLRAMHKPNL-YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 819
V+ P+ Y + D+WS G +E+ P + + LI PRL
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL----- 254
Query: 820 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 870
+ K C +N ++RP L
Sbjct: 255 ------------KSKKWSKK---------FQSFIESCLVKNHSQRPATEQL 284
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 5e-30
Identities = 51/301 (16%), Positives = 97/301 (32%), Gaps = 76/301 (25%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
+ + + H I + ++ + MEY GS+ Y+
Sbjct: 57 NIYRVPLMEHDNIARFIV---------GDERVTADGRMEYLLVMEYYPNGSLXKYLSL-- 105
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKH---------IMHRDIKSENILIDLERKKAD 714
+ +A V L LH++ I HRD+ S N+L+ D
Sbjct: 106 ----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK-----ND 156
Query: 715 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR---AMHKPNLY 771
G + DF ++ L +V GT R+MAPEVL +
Sbjct: 157 G--TCVISDFGLSMRLTGNRLVRPGEEDNAAISEV--GTIRYMAPEVLEGAVNLRDXESA 212
Query: 772 GLEVDIWSYGCLLLELLT-------------LQVPYMGL-----SELEIHDLI-QMGKRP 812
+VD+++ G + E+ Q+ + + ++ L+ + +RP
Sbjct: 213 LKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRP 272
Query: 813 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 872
+ + + E+ +A + L + C +++ R TA E
Sbjct: 273 KFPE------AWKENSLA---------------VRSLKETIEDCWDQDAEARLTAQXAEE 311
Query: 873 M 873
Sbjct: 312 R 312
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 73/298 (24%), Positives = 117/298 (39%), Gaps = 75/298 (25%)
Query: 577 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--HKISSKWLPSADG 634
AAAKV K S +E+ ++ E+ +L H IV++ G + W
Sbjct: 47 AAAKVIETK----SEEELEDYI----VEIEILATCDHPYIVKLLGAYYHDGKLW------ 92
Query: 635 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-GEKHVSVKLALFIAQDVAAALVELHSKH 693
I +E+ GG+V + +L E + + + + AL LHSK
Sbjct: 93 ----------IMIEFCPGGAVDAIMLELDRGLTEPQIQ-----VVCRQMLEALNFLHSKR 137
Query: 694 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 753
I+HRD+K+ N+L+ +G ++L DF + L R D +GT
Sbjct: 138 IIHRDLKAGNVLMT-----LEGD--IRLADFGVSAKNLKTL-----QKR-----DSFIGT 180
Query: 754 PRWMAPEV-LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 812
P WMAPEV + K Y + DIWS G L+E+ ++ P+ L+ + + I P
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPP 240
Query: 813 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 870
L + S + D + ++NP RP+A L
Sbjct: 241 TL----------------LTPSKWSVE---------FRDFLKIALDKNPETRPSAAQL 273
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 54/274 (19%), Positives = 107/274 (39%), Gaps = 55/274 (20%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 661
E++++ +++ + G I++ ++ EY++ S+ + E
Sbjct: 93 ELQIITDIKNEYCLTCEGI-ITNY---------------DEVYIIYEYMENDSILKFDEY 136
Query: 662 ---LSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDLERKKADGKP 717
L + + +++ I + V + +H+ K+I HRD+K NIL+D +G+
Sbjct: 137 FFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD-----KNGR- 190
Query: 718 VVKLCDFDRAVPLR-SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 776
VKL DF + + + GT +M PE ++ + G +VD
Sbjct: 191 -VKLSDFGESEYMVDKKIKGSR-------------GTYEFMPPEFF--SNESSYNGAKVD 234
Query: 777 IWSYGCLLLELLTLQVPYMG-LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG 835
IWS G L + VP+ +S +E+ + I+ + ++ + +
Sbjct: 235 IWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKN-IEYPLDRNHFLYPLTNKKSTCSNN 293
Query: 836 FEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 869
F E D + +NP ER T+ D
Sbjct: 294 FLSNEDI--------DFLKLFLRKNPAERITSED 319
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 48/210 (22%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 661
EV + LRH I+ +YG+ + ++ +EY G+V ++K
Sbjct: 59 EVEIQSHLRHPNILRLYGYFHDAT----------------RVYLILEYAPLGTVYRELQK 102
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
+ ++A AL HSK ++HRDIK EN+L+ + G+ +K+
Sbjct: 103 -----LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-----SAGE--LKI 150
Query: 722 CDFDRAVPLRS-FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 780
DF +V S C GT ++ PE++ ++ +VD+WS
Sbjct: 151 ADFGWSVHAPSSRRTDLC-------------GTLDYLPPEMIEG----RMHDEKVDLWSL 193
Query: 781 GCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
G L E L + P+ + E + I +
Sbjct: 194 GVLCYEFLVGKPPFEANTYQETYKRISRVE 223
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 68/271 (25%), Positives = 100/271 (36%), Gaps = 72/271 (26%)
Query: 604 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 661
E+ ++ +V+ YG K + W I MEY GSV + I
Sbjct: 74 EISIMQQCDSPHVVKYYGSYFKNTDLW----------------IVMEYCGAGSVSDIIRL 117
Query: 662 LSET-GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 720
++T E ++ I Q L LH +HRDIK+ NIL++ +G K
Sbjct: 118 RNKTLTEDEIAT-----ILQSTLKGLEYLHFMRKIHRDIKAGNILLN-----TEGH--AK 165
Query: 721 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 780
L DF A L T +A R + +GTP WMAPEV+ + Y DIWS
Sbjct: 166 LADFGVAGQL-----TDTMAKR-----NTVIGTPFWMAPEVI----QEIGYNCVADIWSL 211
Query: 781 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 840
G +E+ + PY + + +I P
Sbjct: 212 GITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKP----------------------- 248
Query: 841 AELETLS-FLVDVFRRCTEENPTERPTAGDL 870
E S D ++C ++P +R TA L
Sbjct: 249 ---ELWSDNFTDFVKQCLVKSPEQRATATQL 276
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 2e-28
Identities = 33/303 (10%), Positives = 69/303 (22%), Gaps = 56/303 (18%)
Query: 584 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH----------KISSKWLPSAD 633
LKV A+ R+ L E + S+ +
Sbjct: 92 LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151
Query: 634 GNPEHHLLQSAIF--MEYVKGGSVKNYIEKLSETGEKH--VSVKLALFIAQDVAAALVEL 689
+ + M ++ L + + + L
Sbjct: 152 SPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL 210
Query: 690 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 749
SK ++H +N+ I DG+ + L D + +
Sbjct: 211 QSKGLVHGHFTPDNLFIM-----PDGR--LMLGDVSALWKVGTRGPASS----------- 252
Query: 750 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG 809
+ E L + ++ W G + + L +P+ ++ +
Sbjct: 253 --VPVTYAPREFLN--ASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPS 308
Query: 810 KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 869
R TD L + + + R + R +
Sbjct: 309 LRVPGTDSLAFGSCTPLPDFVK-------------------TLIGRFLNFDRRRRLLPLE 349
Query: 870 LYE 872
E
Sbjct: 350 AME 352
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 34/202 (16%), Positives = 67/202 (33%), Gaps = 44/202 (21%)
Query: 599 YSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVK 656
Y + L ++ Y HL Q+ E G++
Sbjct: 112 YIGTQLMERLKPSMQHMFMKFY----------------SAHLFQNGSVLVGELYSYGTLL 155
Query: 657 NYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI----DLERKK 712
N I T EK + L + A + + ++H I+H DIK +N ++ + +
Sbjct: 156 NAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215
Query: 713 ADGKPVVKLCDFDRAVPLRSF-----LHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 767
D + L D +++ ++ F C T + E+L +K
Sbjct: 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKC-------------ETSGFQCVEMLS--NK 260
Query: 768 PNLYGLEVDIWSYGCLLLELLT 789
P + ++D + + +L
Sbjct: 261 P--WNYQIDYFGVAATVYCMLF 280
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-28
Identities = 59/276 (21%), Positives = 96/276 (34%), Gaps = 56/276 (20%)
Query: 604 EVRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 662
EV + L H IV+ K + L + E KG V +++K+
Sbjct: 75 EVCFMKKLSGHPNIVQFCSAASIGK---EESDTGQAEFL---LLTELCKGQLV-EFLKKM 127
Query: 663 SETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVK 720
G +S L I A+ +H + I+HRD+K EN+L+ G +K
Sbjct: 128 ESRG--PLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-----NQG--TIK 178
Query: 721 LCDFDRAVPLRSFLHTCCIAHRGIPAPDV--CVGTPRWMAPEVLRAM-HKPNLYGLEVDI 777
LCDF A + + A R + TP + PE++ + P G + DI
Sbjct: 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFP--IGEKQDI 236
Query: 778 WSYGCLLLELLTLQVPYMGLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 836
W+ GC+L L Q P+ ++L I + + +L
Sbjct: 237 WALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDTQYTVFHSL--------------- 281
Query: 837 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 872
R + NP ER + ++
Sbjct: 282 ----------------IRAMLQVNPEERLSIAEVVH 301
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 47/210 (22%), Positives = 79/210 (37%), Gaps = 48/210 (22%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 661
E+ + LRH I+ MY + + I+ +E+ G + ++K
Sbjct: 64 EIEIQSHLRHPNILRMYNY-FHDR---------------KRIYLMLEFAPRGELYKELQK 107
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
+ + +++A AL H + ++HRDIK EN+L+ G +K+
Sbjct: 108 -----HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG-----YKG--ELKI 155
Query: 722 CDFDRAV-PLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 780
DF +V T C GT ++ PE++ K + +VD+W
Sbjct: 156 ADFGWSVHAPSLRRRTMC-------------GTLDYLPPEMIE--GKT--HDEKVDLWCA 198
Query: 781 GCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
G L E L P+ S E H I
Sbjct: 199 GVLCYEFLVGMPPFDSPSHTETHRRIVNVD 228
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 69/303 (22%), Positives = 111/303 (36%), Gaps = 74/303 (24%)
Query: 604 EVRMLGALRHSCIVEMYG-----HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 658
E+++L IV YG +IS I ME++ GGS+
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGEIS-------------------ICMEHMDGGSLDQV 121
Query: 659 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENILIDLERKKADGKP 717
++K E+ + ++ V L L KH IMHRD+K NIL++ +
Sbjct: 122 LKKAGRIPEQILGK-----VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE------ 170
Query: 718 VVKLCDFDRAVPL-RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 776
+KLCDF + L S ++ VGT +M+PE L + Y ++ D
Sbjct: 171 -IKLCDFGVSGQLIDSMANS-------------FVGTRSYMSPERL----QGTHYSVQSD 212
Query: 777 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 836
IWS G L+E+ + P E+ + + + + + G
Sbjct: 213 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT-PGRPLNKFGMDS 271
Query: 837 EKPEAELETLSFLV-----------------DVFRRCTEENPTERPTAGDLYEM-FVART 878
P A E L ++V D +C +NP ER L F+ R+
Sbjct: 272 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331
Query: 879 SSS 881
+
Sbjct: 332 DAE 334
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 9e-28
Identities = 66/295 (22%), Positives = 108/295 (36%), Gaps = 70/295 (23%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V++ + D F L E R+L H IV + G + ++ P +
Sbjct: 144 VKSCR-ETLPPDLKAKF----LQEARILKQYSHPNIVRLIG--VCTQKQP---------I 187
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
I ME V+GG ++ + VK L + D AA + L SK +HRD+
Sbjct: 188 Y---IVMELVQGGDFLTFLRT----EGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLA 240
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 760
+ N L+ + V+K+ DF + ++ R +P +W APE
Sbjct: 241 ARNCLVTEKN-------VLKISDFGMSREEADGVYAASGGLRQVPV--------KWTAPE 285
Query: 761 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 819
L Y E D+WS+G LL E +L PY LS + + ++ G R L
Sbjct: 286 ALNY----GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR------LP 335
Query: 820 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
C + + + +C P +RP+ +Y+
Sbjct: 336 CPELCPDA---------------------VFRLMEQCWAYEPGQRPSFSTIYQEL 369
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 1e-27
Identities = 49/233 (21%), Positives = 82/233 (35%), Gaps = 53/233 (22%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
I +E +++ Y+E+ + + + Q + L LHS +I+HRD+K NI
Sbjct: 95 IAIELC-AATLQEYVEQ----KDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNI 149
Query: 705 LIDLERKKADGKPVVKLCDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 758
LI A GK + DF S GT W+A
Sbjct: 150 LIS--MPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-------------GTEGWIA 194
Query: 759 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 817
PE+L K N VDI+S GC+ +++ P+ + + + L+ L E
Sbjct: 195 PEMLSEDCKEN-PTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE 253
Query: 818 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 870
E A ++ + +P +RP+A +
Sbjct: 254 KH-----------------EDVIAR--------ELIEKMIAMDPQKRPSAKHV 281
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 59/261 (22%), Positives = 93/261 (35%), Gaps = 44/261 (16%)
Query: 612 RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVS 671
+ V++ S P + I M+ + ++K+++ + +
Sbjct: 105 MDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR--RCSLEDRE 162
Query: 672 VKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVP 729
+ L I +A A+ LHSK +MHRD+K NI D VVK+ DF A+
Sbjct: 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT-----MDD--VVKVGDFGLVTAMD 215
Query: 730 LRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789
T VGT +M+PE + + Y +VDI+S G +L ELL
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN----YSHKVDIFSLGLILFELLY 271
Query: 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 849
M + I D+ K P L + +
Sbjct: 272 SFSTQMERVRI-ITDVRN-LKFPLL------------------------FTQKYPQEHMM 305
Query: 850 VDVFRRCTEENPTERPTAGDL 870
V + +PTERP A D+
Sbjct: 306 V---QDMLSPSPTERPEATDI 323
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 66/273 (24%), Positives = 100/273 (36%), Gaps = 79/273 (28%)
Query: 604 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 661
EVR L LRH ++ G + + W + MEY GS + +E
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAW----------------LVMEYC-LGSASDLLEV 146
Query: 662 LSET-GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 720
+ E ++ + L LHS +++HRD+K+ NIL+ G VK
Sbjct: 147 HKKPLQEVEIAA-----VTHGALQGLAYLHSHNMIHRDVKAGNILLS-----EPGL--VK 194
Query: 721 LCDFDRAVPL---RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 777
L DF A + SF VGTP WMAPEV+ AM Y +VD+
Sbjct: 195 LGDFGSASIMAPANSF-----------------VGTPYWMAPEVILAM-DEGQYDGKVDV 236
Query: 778 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 837
WS G +EL + P ++ + I + P L +
Sbjct: 237 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS-----------------GHWS 279
Query: 838 KPEAELETLSFLVDVFRRCTEENPTERPTAGDL 870
+ + C ++ P +RPT+ L
Sbjct: 280 EY---------FRNFVDSCLQKIPQDRPTSEVL 303
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 4e-27
Identities = 45/212 (21%), Positives = 81/212 (38%), Gaps = 33/212 (15%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E++++ L H +V + L D + MEY +GG ++ Y+ +
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPND--------LPLLAMEYCEGGDLRKYLNQFE 113
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
+ + D+++AL LH I+HRD+K ENI++ + + K+ D
Sbjct: 114 NCCG--LKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPG----PQRLIHKIID 167
Query: 724 F--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781
+ + GT +++APE+L K Y + VD WS+G
Sbjct: 168 LGYAKELDQGELCTEFV-------------GTLQYLAPELLE--QKK--YTVTVDYWSFG 210
Query: 782 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPR 813
L E +T P++ + K
Sbjct: 211 TLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 58/234 (24%), Positives = 83/234 (35%), Gaps = 52/234 (22%)
Query: 645 IFMEYVKGGSVKNYIEKLSETG----EKHVSVKLALFIAQDVAAALVELHSKH-IMHRDI 699
I ME + K Y S E+ + I AL L I+HRDI
Sbjct: 98 ICMELMSTSFDKFYKYVYSVLDDVIPEEILGK-----ITLATVKALNHLKENLKIIHRDI 152
Query: 700 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 759
K NIL+D G +KLCDF + L IA G +MAP
Sbjct: 153 KPSNILLD-----RSGN--IKLCDFGISGQL-----VDSIAKT------RDAGCRPYMAP 194
Query: 760 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDEL 818
E + Y + D+WS G L EL T + PY S + + G P+L++
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSE 254
Query: 819 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 872
E S P +F+ C ++ ++RP +L +
Sbjct: 255 EREFS---------------PSFI----NFV----NLCLTKDESKRPKYKELLK 285
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-26
Identities = 51/236 (21%), Positives = 98/236 (41%), Gaps = 41/236 (17%)
Query: 578 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 637
A ++ + + + + + E+ +L L H CI+++ + +
Sbjct: 164 AIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA----------ED 213
Query: 638 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 697
++++ +E ++GG + + + G K + + A+ LH I+HR
Sbjct: 214 YYIV-----LELMEGGELFDKV-----VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHR 263
Query: 698 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPR 755
D+K EN+L+ + + +K+ DF + L S + T C GTP
Sbjct: 264 DLKPENVLLSSQEEDCL----IKITDFGHSKILGETSLMRTLC-------------GTPT 306
Query: 756 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP-YMGLSELEIHDLIQMGK 810
++APEVL ++ Y VD WS G +L L+ P +++ + D I GK
Sbjct: 307 YLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 361
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 44/191 (23%), Positives = 76/191 (39%), Gaps = 49/191 (25%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 661
EV++ L+H I+E+Y + + ++ +E G + Y++
Sbjct: 61 EVKIHCQLKHPSILELYNY-FEDS---------------NYVYLVLEMCHNGEMNRYLKN 104
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
K S A + ++ LHS I+HRD+ N+L+ +K+
Sbjct: 105 RV----KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN-------IKI 153
Query: 722 CDFDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 778
DF A L+ +T C GTP +++PE+ + +GLE D+W
Sbjct: 154 ADFGLATQLKMPHEKHYTLC-------------GTPNYISPEIATR----SAHGLESDVW 196
Query: 779 SYGCLLLELLT 789
S GC+ LL
Sbjct: 197 SLGCMFYTLLI 207
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 57/302 (18%), Positives = 113/302 (37%), Gaps = 72/302 (23%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+ LK ++ +I F L E + H + ++ G +S + L
Sbjct: 56 VKMLKADIIASSDIEEF----LREAACMKEFDHPHVAKLVG--VSL------RSRAKGRL 103
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKH-VSVKLALFIAQDVAAALVELHSKHIMHRDI 699
+ + ++K G + ++ + ++ + D+A + L S++ +HRD+
Sbjct: 104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDL 163
Query: 700 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV-CVGT----P 754
+ N ++ + V + DF + R I + D G P
Sbjct: 164 AARNCMLAEDM-------TVCVADFGLS--------------RKIYSGDYYRQGCASKLP 202
Query: 755 -RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 812
+W+A E L NLY + D+W++G + E++T Q PY G+ EI++ + G R
Sbjct: 203 VKWLALESLAD----NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR- 257
Query: 813 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 872
++P E + + D+ +C +P +RP+ L
Sbjct: 258 -----------------------LKQPP---ECMEEVYDLMYQCWSADPKQRPSFTCLRM 291
Query: 873 MF 874
Sbjct: 292 EL 293
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-26
Identities = 38/256 (14%), Positives = 78/256 (30%), Gaps = 31/256 (12%)
Query: 578 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP- 636
V ++ I+ + + +R+L +++ +++ I L
Sbjct: 107 EVHVPY-FTERPPSNAIKQMK-EEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK 164
Query: 637 --------EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKH--VSVKLALFIAQDVAAAL 686
+ S F+ +++ + E L H + L + V L
Sbjct: 165 MIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLL 224
Query: 687 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA 746
LH ++H ++ +I++D G V L F+ V + +
Sbjct: 225 ASLHHYGLVHTYLRPVDIVLD-----QRGG--VFLTGFEHLVRDGASAVSPI-------- 269
Query: 747 PDVCVGTPRWMAPEVLRAM-HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 805
P A +L H P L D W+ G + + +P + L +
Sbjct: 270 -GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEW 328
Query: 806 IQMGKRPRLTDELEAL 821
I + + AL
Sbjct: 329 I-FRSCKNIPQPVRAL 343
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 62/302 (20%), Positives = 115/302 (38%), Gaps = 73/302 (24%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+T+K+ SS EI F L E + H ++ + G + + P
Sbjct: 67 VKTMKLDNSSQREIEEF----LSEAACMKDFSHPNVIRLLG--VCIEMSSQGIPKP---- 116
Query: 641 LQSAIFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 699
+ + ++K G + Y+ ETG KH+ ++ L D+A + L +++ +HRD+
Sbjct: 117 ---MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDL 173
Query: 700 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV-CVGTP---- 754
+ N ++ + V + DF + + I + D G
Sbjct: 174 AARNCMLRDDM-------TVCVADFGLS--------------KKIYSGDYYRQGRIAKMP 212
Query: 755 -RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 812
+W+A E L +Y + D+W++G + E+ T PY G+ E++D + G R
Sbjct: 213 VKWIAIESLAD----RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR- 267
Query: 813 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 872
++PE + L L ++ C +P +RPT L
Sbjct: 268 -----------------------LKQPE---DCLDELYEIMYSCWRTDPLDRPTFSVLRL 301
Query: 873 MF 874
Sbjct: 302 QL 303
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 40/191 (20%), Positives = 71/191 (37%), Gaps = 50/191 (26%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 661
E+ + +L H +V +G +F +E + S+ ++
Sbjct: 65 EISIHRSLAHQHVVGFHGF-FEDN---------------DFVFVVLELCRRRSLLELHKR 108
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
K ++ A + + + LH ++HRD+K N+ ++ D + VK+
Sbjct: 109 -----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-----EDLE--VKI 156
Query: 722 CDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 778
DF + C GTP ++APEVL + EVD+W
Sbjct: 157 GDFGLATKVEYDGERKKVLC-------------GTPNYIAPEVLSK----KGHSFEVDVW 199
Query: 779 SYGCLLLELLT 789
S GC++ LL
Sbjct: 200 SIGCIMYTLLV 210
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-26
Identities = 52/283 (18%), Positives = 102/283 (36%), Gaps = 69/283 (24%)
Query: 604 EVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK- 661
E+++L H ++ Y + + ++L I +E ++++ +E
Sbjct: 58 EIKLLTESDDHPNVIRYYCSETTDRFL--------------YIALELC-NLNLQDLVESK 102
Query: 662 -LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV-- 718
+S+ K + + + +A+ + LHS I+HRD+K +NIL+ + +
Sbjct: 103 NVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGA 162
Query: 719 ----VKLCDF-------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 767
+ + DF R+ L+ GT W APE+L +
Sbjct: 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPS-------------GTSGWRAPELLEESNN 209
Query: 768 PNL---YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 824
+DI+S GC+ +L+ G + I G L+ +
Sbjct: 210 LQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG-DKYSRESNIIRGIF-----SLDEMKCL 263
Query: 825 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867
H+ + EA D+ + + +P +RPTA
Sbjct: 264 HDRSLI--------AEAT--------DLISQMIDHDPLKRPTA 290
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 33/236 (13%), Positives = 73/236 (30%), Gaps = 40/236 (16%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNP---------EHHLLQSAIFMEYVKGGS 654
+R+L +++ +++ I L + S F+ +
Sbjct: 126 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 185
Query: 655 VKNYIEKLSETGEKH--VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 712
++ + E L H + L + V L LH ++H ++ +I++D
Sbjct: 186 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD----- 240
Query: 713 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL-------RAM 765
G V L F+ V + + + + + PE+
Sbjct: 241 QRGG--VFLTGFEHLVRDGARVVSS--------------VSRGFEPPELEARRATISYHR 284
Query: 766 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL 821
+ L D W+ G ++ + +P + L + I + + AL
Sbjct: 285 DRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI-FRSCKNIPQPVRAL 339
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 59/233 (25%), Positives = 93/233 (39%), Gaps = 54/233 (23%)
Query: 645 IFMEYVKGGSVKNYIEKLSETG---EKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIK 700
I ME + K Y + + + E + IA + AL LHSK ++HRD+K
Sbjct: 83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGK-----IAVSIVKALEHLHSKLSVIHRDVK 137
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 760
N+LI+ A G+ VK+CDF + L + A D+ G +MAPE
Sbjct: 138 PSNVLIN-----ALGQ--VKMCDFGISGYLVDDV-----------AKDIDAGCKPYMAPE 179
Query: 761 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELE 819
+ Y ++ DIWS G ++EL L+ PY + + + P+L +
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD-- 237
Query: 820 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 872
F E + F +C ++N ERPT +L +
Sbjct: 238 ---------------KFSA-----EFVDFT----SQCLKKNSKERPTYPELMQ 266
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 40/191 (20%), Positives = 71/191 (37%), Gaps = 50/191 (26%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 661
E+ + +L H +V +G +F +E + S+ ++
Sbjct: 91 EISIHRSLAHQHVVGFHGF-FEDN---------------DFVFVVLELCRRRSLLELHKR 134
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
K ++ A + + + LH ++HRD+K N+ ++ D + VK+
Sbjct: 135 -----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-----EDLE--VKI 182
Query: 722 CDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 778
DF + C GTP ++APEVL + EVD+W
Sbjct: 183 GDFGLATKVEYDGERKKVLC-------------GTPNYIAPEVLSK----KGHSFEVDVW 225
Query: 779 SYGCLLLELLT 789
S GC++ LL
Sbjct: 226 SIGCIMYTLLV 236
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 54/231 (23%), Positives = 81/231 (35%), Gaps = 51/231 (22%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSEN 703
I ME + + K E+ + + + AL L KH ++HRD+K N
Sbjct: 101 IAMELMGTCAEKLKKRMQGPIPERILGK-----MTVAIVKALYYLKEKHGVIHRDVKPSN 155
Query: 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 763
IL+D G+ +KLCDF + L A D G +MAPE +
Sbjct: 156 ILLD-----ERGQ--IKLCDFGISGRLVDDK-----------AKDRSAGCAAYMAPERID 197
Query: 764 AMHKPNL-YGLEVDIWSYGCLLLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEAL 821
Y + D+WS G L+EL T Q PY ++ E+ + + P L
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH---- 253
Query: 822 GSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 872
GF + C ++ +RP L E
Sbjct: 254 ------------MGFSGD---------FQSFVKDCLTKDHRKRPKYNKLLE 283
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 52/236 (22%), Positives = 98/236 (41%), Gaps = 41/236 (17%)
Query: 578 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 637
A K+ + + + + + E+ +L L H CI+++ + +
Sbjct: 39 AIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA----------ED 88
Query: 638 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 697
++++ +E ++GG + + + G K + + A+ LH I+HR
Sbjct: 89 YYIV-----LELMEGGELFDKV-----VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHR 138
Query: 698 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPR 755
D+K EN+L+ + + +K+ DF + L S + T C GTP
Sbjct: 139 DLKPENVLLSSQEEDCL----IKITDFGHSKILGETSLMRTLC-------------GTPT 181
Query: 756 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP-YMGLSELEIHDLIQMGK 810
++APEVL ++ Y VD WS G +L L+ P +++ + D I GK
Sbjct: 182 YLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-25
Identities = 47/169 (27%), Positives = 74/169 (43%), Gaps = 23/169 (13%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
MEY GG + + K + + ++A F ++ A+ +H +HRDIK +NIL+
Sbjct: 140 MEYYVGGDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL 195
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM- 765
D G ++L DF + LR+ V VGTP +++PE+L+A+
Sbjct: 196 D-----RCGH--IRLADFGSCLKLRADGTVRS---------LVAVGTPDYLSPEILQAVG 239
Query: 766 --HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 812
YG E D W+ G E+ Q P+ S E + I K
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH 288
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-25
Identities = 53/215 (24%), Positives = 83/215 (38%), Gaps = 44/215 (20%)
Query: 602 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF----MEYVKGGSVKN 657
E ++ +V++ + Q + MEY+ GG
Sbjct: 117 WEERDIMAFANSPWVVQL------------------FYAFQDDRYLYMVMEYMPGG---- 154
Query: 658 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 717
+ ++ V K A F +V AL +HS +HRD+K +N+L+D G
Sbjct: 155 --DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-----KSGH- 206
Query: 718 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 777
+KL DF + + C D VGTP +++PEVL++ YG E D
Sbjct: 207 -LKLADFGTCMKMNKEGMVRC---------DTAVGTPDYISPEVLKSQGGDGYYGRECDW 256
Query: 778 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 812
WS G L E+L P+ S + + I K
Sbjct: 257 WSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 291
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 52/235 (22%), Positives = 97/235 (41%), Gaps = 61/235 (25%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
+ MEY++G ++ YIE +SV A+ + + H I+HRDIK +NI
Sbjct: 88 LVMEYIEGPTLSEYIES-----HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNI 142
Query: 705 LIDLERKKADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 762
LID ++ +K+ DF +A+ + + + +GT ++ +PE
Sbjct: 143 LID-----SNKT--LKIFDFGIAKAL-----------SETSLTQTNHVLGTVQYFSPEQA 184
Query: 763 RAMHKPNLYGLEV----DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL 818
+ G DI+S G +L E+L + P+ G + + I I+ + D +
Sbjct: 185 K--------GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIK-----HIQDSV 229
Query: 819 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-TAGDLYE 872
+ + ++ QS L +V R TE++ R T ++ +
Sbjct: 230 PNVTTDVRKDIPQS----------------LSNVILRATEKDKANRYKTIQEMKD 268
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 51/296 (17%), Positives = 97/296 (32%), Gaps = 72/296 (24%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
++ L + +F M+ L H +V YG + +
Sbjct: 45 LKVLDKA--HRNYSESF----FEAASMMSKLSHKHLVLNYG--VCVCGDENI-------- 88
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
+ E+VK GS+ Y++K + +++ L +A+ +AAA+ L ++H ++
Sbjct: 89 ----LVQEFVKFGSLDTYLKK----NKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVC 140
Query: 701 SENILIDLERKKADGKP-VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 759
++NIL+ E + G P +KL D + + D+ W+ P
Sbjct: 141 AKNILLIREEDRKTGNPPFIKLSDPGIS--------------ITVLPKDILQERIPWVPP 186
Query: 760 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDEL 818
E + P L D WS+G L E+ + P L + + L
Sbjct: 187 E---CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ------L 237
Query: 819 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
A + ++ C + P RP+ +
Sbjct: 238 PAPKAAELA-----------------------NLINNCMDYEPDHRPSFRAIIRDL 270
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 56/255 (21%), Positives = 92/255 (36%), Gaps = 39/255 (15%)
Query: 578 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--------------- 621
A K+ K+ + ++ + EVR++ L H I +Y
Sbjct: 55 AIKIMNKNKIRQINPKDVERIK----TEVRLMKKLHHPNIARLYEVYEDEQYICLVMELC 110
Query: 622 ------HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA 675
K++ S + ++ I E+ + KL
Sbjct: 111 HGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLI 170
Query: 676 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 735
I + + +AL LH++ I HRDIK EN L + +KL DF + +
Sbjct: 171 SNIMRQIFSALHYLHNQGICHRDIKPENFLFS-----TNKSFEIKLVDFGLSKEFYKLNN 225
Query: 736 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 795
GTP ++APEVL ++ YG + D WS G LL LL VP+
Sbjct: 226 GEYYGMTTK------AGTPYFVAPEVLNTTNES--YGPKCDAWSAGVLLHLLLMGAVPFP 277
Query: 796 GLSELEIHDLIQMGK 810
G+++ + + K
Sbjct: 278 GVNDADTISQVLNKK 292
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 49/188 (26%), Positives = 75/188 (39%), Gaps = 41/188 (21%)
Query: 645 IFMEYVKGGSVKNYIEK--LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 702
+ E V G V LSE A F QD+ + LH + I+HRDIK
Sbjct: 115 MVFELVNQGPVMEVPTLKPLSE--------DQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166
Query: 703 NILIDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 759
N+L+ DG +K+ DF + + L GTP +MAP
Sbjct: 167 NLLVG-----EDG--HIKIADFGVSNEFKGSDALLSNTV-------------GTPAFMAP 206
Query: 760 EVLRAMHKPNLY-GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-----RPR 813
E L K + G +D+W+ G L + Q P+M + +H I+ +P
Sbjct: 207 ESLSETRKI--FSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPD 264
Query: 814 LTDELEAL 821
+ ++L+ L
Sbjct: 265 IAEDLKDL 272
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 66/297 (22%), Positives = 105/297 (35%), Gaps = 77/297 (25%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+ +K S DE F E + + L H +V+ YG + SK P +
Sbjct: 37 VKMIKEGSMSEDE---F----FQEAQTMMKLSHPKLVKFYG--VCSK------EYPIY-- 79
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
I EY+ G + NY+ K + L + DV + L S +HRD+
Sbjct: 80 ----IVTEYISNGCLLNYLRS----HGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLA 131
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 758
+ N L+D + VK+ DF R L ++ G P +W A
Sbjct: 132 ARNCLVDRDL-------CVKVSDFGMT---RYVLDDQYVSSVGTKFPV--------KWSA 173
Query: 759 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 817
PEV Y + D+W++G L+ E+ +L ++PY + E+ + G R
Sbjct: 174 PEVFHY----FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR------ 223
Query: 818 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
L + + + C E P +RPT L
Sbjct: 224 LYRPHLA--------------SDT-------IYQIMYSCWHELPEKRPTFQQLLSSI 259
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 59/297 (19%), Positives = 106/297 (35%), Gaps = 76/297 (25%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
++T K +S F L E + H IV++ G + ++ NP
Sbjct: 48 IKTCKN-CTSDSVREKF----LQEALTMRQFDHPHIVKLIG--VITE-------NP---- 89
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
I ME G ++++++ + + + + A ++ AL L SK +HRDI
Sbjct: 90 --VWIIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIA 143
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 758
+ N+L+ VKL DF + R + +P +WMA
Sbjct: 144 ARNVLVSSND-------CVKLGDFGLS---RYMEDSTYYKASKGKLPI--------KWMA 185
Query: 759 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 817
PE + + D+W +G + E+L P+ G+ ++ I+ G+R
Sbjct: 186 PESINF----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------ 235
Query: 818 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
L +C P L + +C +P+ RP +L
Sbjct: 236 LPMPPNC--------------PPT-------LYSLMTKCWAYDPSRRPRFTELKAQL 271
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 61/239 (25%), Positives = 95/239 (39%), Gaps = 56/239 (23%)
Query: 578 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 636
AAK+ T K+ ++ E R+ L+H IV ++ S
Sbjct: 35 AAKIINTKKLSARDFQKLER-------EARICRKLQHPNIVRLHD---------SIQEES 78
Query: 637 EHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 693
H+L+ + V GG + I E SE A Q + ++ HS
Sbjct: 79 FHYLV-----FDLVTGGELFEDIVAREFYSE--------ADASHCIQQILESIAYCHSNG 125
Query: 694 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCV 751
I+HR++K EN+L+ KA G VKL DF A+ + H
Sbjct: 126 IVHRNLKPENLLLA---SKAKGAA-VKLADFGLAIEVNDSEAWHGFA------------- 168
Query: 752 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
GTP +++PEVL+ + Y VDIW+ G +L LL P+ + ++ I+ G
Sbjct: 169 GTPGYLSPEVLKK----DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 223
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 66/270 (24%), Positives = 113/270 (41%), Gaps = 39/270 (14%)
Query: 604 EVRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 662
EV ML + H ++E+ + +L+ E ++GGS+ ++I K
Sbjct: 60 EVEMLYQCQGHRNVLELIE---------FFEEEDRFYLV-----FEKMRGGSILSHIHK- 104
Query: 663 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 722
+H + A + QDVA+AL LH+K I HRD+K ENIL E VK+C
Sbjct: 105 ----RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENIL--CEHPNQVSP--VKIC 156
Query: 723 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM-HKPNLYGLEVDIWSYG 781
DFD ++ I+ + P G+ +MAPEV+ A + ++Y D+WS G
Sbjct: 157 DFDLGSGIKLNGDCSPISTPELLTP---CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG 213
Query: 782 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 841
+L LL+ P++G + E++ +E P+
Sbjct: 214 VILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK----------YEFPDK 263
Query: 842 ELETLSFLV-DVFRRCTEENPTERPTAGDL 870
+ +S D+ + + +R +A +
Sbjct: 264 DWAHISCAAKDLISKLLVRDAKQRLSAAQV 293
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 60/242 (24%), Positives = 99/242 (40%), Gaps = 51/242 (21%)
Query: 578 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGN 635
A K+ SA+E++ + L EV +L + H I+++ + + N
Sbjct: 46 AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD---------TYETN 96
Query: 636 PEHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVELHSK 692
L+ + +K G + +Y+ LSE K I + + + LH
Sbjct: 97 TFFFLV-----FDLMKKGELFDYLTEKVTLSE--------KETRKIMRALLEVICALHKL 143
Query: 693 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVC 750
+I+HRD+K ENIL+ D +KL DF + L L C
Sbjct: 144 NIVHRDLKPENILL-------DDDMNIKLTDFGFSCQLDPGEKLREVC------------ 184
Query: 751 VGTPRWMAPEVLRAMHKPNL--YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 808
GTP ++APE++ N YG EVD+WS G ++ LL P+ ++ + +I
Sbjct: 185 -GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243
Query: 809 GK 810
G
Sbjct: 244 GN 245
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 51/301 (16%), Positives = 107/301 (35%), Gaps = 83/301 (27%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
++ L+ +S + L E ++ ++ + + + G I +
Sbjct: 49 IKELRE-ATSPKANKEI----LDEAYVMASVDNPHVCRLLG--ICLT-------ST---- 90
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
+Q + + + G + +Y+ + + ++ + L +A + L + ++HRD+
Sbjct: 91 VQ--LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA 144
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP------ 754
+ N+L+ + VK+ DF A + + A +
Sbjct: 145 ARNVLVKTPQ-------HVKITDFGLA--------------KLLGAEEKEYHAEGGKVPI 183
Query: 755 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPR 813
+WMA E + +Y + D+WSYG + EL+T PY G+ EI +++ G+R
Sbjct: 184 KWMALESILH----RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-- 237
Query: 814 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 873
L C + + R+C + RP +L
Sbjct: 238 ----LPQPPIC--------------TID-------VYMIMRKCWMIDADSRPKFRELIIE 272
Query: 874 F 874
F
Sbjct: 273 F 273
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-24
Identities = 47/223 (21%), Positives = 77/223 (34%), Gaps = 56/223 (25%)
Query: 604 EVRMLGALRHSCIVEMY--GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 661
E + L + H IV+++ G+P + I MEYV G S+K +
Sbjct: 129 ERQFLAEVVHPSIVQIFNFVEH------TDRHGDPVGY-----IVMEYVGGQSLKRSKGQ 177
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
+ V A+ ++ AL LHS +++ D+K ENI++ E+ +KL
Sbjct: 178 -------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ--------LKL 222
Query: 722 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV---DIW 778
D I + GTP + APE++R DI+
Sbjct: 223 IDLG-------------AV-SRINSFGYLYGTPGFQAPEIVR--------TGPTVATDIY 260
Query: 779 SYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL 821
+ G L L G + + + D L
Sbjct: 261 TVGRTLAALTLDLPTRNGRYVDGLPEDDP---VLKTYDSYGRL 300
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 55/297 (18%), Positives = 105/297 (35%), Gaps = 77/297 (25%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
++T++ S ++ F + E ++ L H +V++YG + + P
Sbjct: 37 IKTIREGAMSEED---F----IEEAEVMMKLSHPKLVQLYG--VCLEQAPIC-------- 79
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
+ E+++ G + +Y+ + + L + DV + L ++HRD+
Sbjct: 80 ----LVTEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 131
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 758
+ N L+ + V+K+ DF R L + G P +W +
Sbjct: 132 ARNCLVGENQ-------VIKVSDFGMT---RFVLDDQYTSSTGTKFPV--------KWAS 173
Query: 759 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 817
PEV + Y + D+WS+G L+ E+ + ++PY S E+ + I G R
Sbjct: 174 PEVFSF----SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------ 223
Query: 818 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
L + + C E P +RP L
Sbjct: 224 LYKPRLA--------------STH-------VYQIMNHCWRERPEDRPAFSRLLRQL 259
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 66/297 (22%), Positives = 119/297 (40%), Gaps = 77/297 (25%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V++LK S D F L E ++ L+H +V +Y + ++ P +
Sbjct: 42 VKSLKQGSMSPDA---F----LAEANLMKQLQHQRLVRLYA--VVTQ-------EPIY-- 83
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
I EY++ GS+ ++ L +++ L +A +A + + ++ +HRD++
Sbjct: 84 ----IITEYMENGSLVDF---LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLR 136
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 758
+ NIL+ K+ DF A R A G P +W A
Sbjct: 137 AANILVSDTL-------SCKIADFGLA---RLIEDNEYTAREGAKFPI--------KWTA 178
Query: 759 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 817
PE + + ++ D+WS+G LL E++T ++PY G++ E+ ++ G R
Sbjct: 179 PEAINY----GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR------ 228
Query: 818 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
+ +C PE L + R C +E P +RPT L +
Sbjct: 229 MVRPDNC--------------PEE-------LYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 59/300 (19%), Positives = 105/300 (35%), Gaps = 82/300 (27%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+T K + D F + E ++ L H IV++ G I + P
Sbjct: 45 VKTCKK-DCTLDNKEKF----MSEAVIMKNLDHPHIVKLIG--IIEE-------EP---- 86
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
+ I ME G + +Y+E+ + + V + + + A+ L S + +HRDI
Sbjct: 87 --TWIIMELYPYGELGHYLER----NKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIA 140
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 758
NIL+ VKL DF + R +P +WM+
Sbjct: 141 VRNILVASPE-------CVKLGDFGLS---RYIEDEDYYKASVTRLPI--------KWMS 182
Query: 759 PEVLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRL 814
PE + + D+W + + E+L+ + P+ L ++ +++ G R
Sbjct: 183 PESI-------NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR--- 232
Query: 815 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
L C P L + RC + +P++RP +L
Sbjct: 233 ---LPKPDLC--------------PPV-------LYTLMTRCWDYDPSDRPRFTELVCSL 268
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-23
Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 21/167 (12%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
M+Y GG + + K E + ++A F ++ A+ +H H +HRDIK +NIL+
Sbjct: 153 MDYYVGGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM 208
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 766
D +G ++L DF + L G V VGTP +++PE+L+AM
Sbjct: 209 D-----MNGH--IRLADFGSCLKLME---------DGTVQSSVAVGTPDYISPEILQAME 252
Query: 767 KPNL-YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 812
YG E D WS G + E+L + P+ S +E + I K
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER 299
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 68/299 (22%), Positives = 113/299 (37%), Gaps = 77/299 (25%)
Query: 578 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 636
A K+ R V SS ++ EV +L L H I+++Y +
Sbjct: 66 AIKIIRKTSVSTSSNSKLLE-------EVAVLKLLDHPNIMKLYDFFEDKR--------- 109
Query: 637 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 696
++L+ ME KGG + + I + A I + V + + LH +I+H
Sbjct: 110 NYYLV-----MECYKGGELFDEIIH-----RMKFNEVDAAVIIKQVLSGVTYLHKHNIVH 159
Query: 697 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTP 754
RD+K EN+L LE K+ D +K+ DF + + GT
Sbjct: 160 RDLKPENLL--LESKEKDAL--IKIVDFGLSAVFENQKKMKERL-------------GTA 202
Query: 755 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 814
++APEVLR Y + D+WS G +L LL P+ G ++ EI ++ GK
Sbjct: 203 YYIAPEVLRKK-----YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK---- 253
Query: 815 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV-DVFRRCTEENPTERPTAGDLYE 872
+ E + +S D+ ++ + + R +A E
Sbjct: 254 ---------------------YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-23
Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 43/209 (20%)
Query: 602 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 661
L E R+L A+ +V++ + L +++ MEYV GG + +++ +
Sbjct: 89 LNEKRILQAVNFPFLVKLEFSFKDNSNL---------YMV-----MEYVAGGEMFSHLRR 134
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
S A F A + LHS +++RD+K EN+LID G +++
Sbjct: 135 -----IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-----QQGY--IQV 182
Query: 722 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781
DF A ++ T C GTP +APE++ + K Y VD W+ G
Sbjct: 183 TDFGFAKRVKGRTWTLC-------------GTPEALAPEII--LSKG--YNKAVDWWALG 225
Query: 782 CLLLELLTLQVPYMGLSELEIHDLIQMGK 810
L+ E+ P+ ++I++ I GK
Sbjct: 226 VLIYEMAAGYPPFFADQPIQIYEKIVSGK 254
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 57/236 (24%), Positives = 96/236 (40%), Gaps = 51/236 (21%)
Query: 578 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 636
A KV I EV +L L H I++++ + +
Sbjct: 51 AVKVINKASAKNKDTSTILR-------EVELLKKLDHPNIMKLFE---------ILEDSS 94
Query: 637 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 696
+++ E GG + + I K K S A I + V + + +H +I+H
Sbjct: 95 SFYIV-----GELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 697 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTP 754
RD+K ENIL++ + K D +K+ DF + + + + GT
Sbjct: 145 RDLKPENILLESKEKDCD----IKIIDFGLSTCFQQNTKMKDRI-------------GTA 187
Query: 755 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
++APEVLR Y + D+WS G +L LL+ P+ G +E +I ++ GK
Sbjct: 188 YYIAPEVLR---GT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK 238
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 66/303 (21%), Positives = 110/303 (36%), Gaps = 77/303 (25%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+TL S + +F L E ++ H IV G +S + LP
Sbjct: 65 VKTLPE-VCSEQDELDF----LMEALIISKFNHQNIVRCIG--VSLQSLP---------R 108
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA--LFIAQDVAAALVELHSKHIMHRD 698
I ME + GG +K+++ + + S+ + L +A+D+A L H +HRD
Sbjct: 109 F---ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRD 165
Query: 699 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP---- 754
I + N L+ G+ V K+ DF A R I
Sbjct: 166 IAARNCLLT---CPGPGR-VAKIGDFGMA--------------RDIYRASYYRKGGCAML 207
Query: 755 --RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 811
+WM PE ++ + D WS+G LL E+ +L +PY S E+ + + G R
Sbjct: 208 PVKWMPPEAF----MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263
Query: 812 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 871
++ +C P + + +C + P +RP +
Sbjct: 264 ------MDPPKNC--------------PGP-------VYRIMTQCWQHQPEDRPNFAIIL 296
Query: 872 EMF 874
E
Sbjct: 297 ERI 299
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 46/218 (21%), Positives = 80/218 (36%), Gaps = 56/218 (25%)
Query: 602 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF----MEYVKGGSVKN 657
E ++ L H V++Y Q + Y K G +
Sbjct: 78 TRERDVMSRLDHPFFVKLYFT------------------FQDDEKLYFGLSYAKNGELLK 119
Query: 658 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 717
YI K F ++ +AL LH K I+HRD+K ENIL++ D
Sbjct: 120 YIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-----EDMH- 168
Query: 718 VVKLCDFDRA-----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 772
+++ DF A ++ ++ GT ++++PE+L K
Sbjct: 169 -IQITDFGTAKVLSPESKQARANSFV-------------GTAQYVSPELLT--EKS--AC 210
Query: 773 LEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
D+W+ GC++ +L+ P+ +E I I +
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 248
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 68/297 (22%), Positives = 111/297 (37%), Gaps = 77/297 (25%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
++ +K S DE F + E +++ L H +V++YG + +K P
Sbjct: 53 IKMIKEGSMSEDE---F----IEEAKVMMNLSHEKLVQLYG--VCTK------QRPIF-- 95
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
I EY+ G + NY+ + + L + +DV A+ L SK +HRD+
Sbjct: 96 ----IITEYMANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 147
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 758
+ N L++ + VVK+ DF + R L + G P RW
Sbjct: 148 ARNCLVNDQG-------VVKVSDFGLS---RYVLDDEYTSSVGSKFPV--------RWSP 189
Query: 759 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 817
PEVL + + + DIW++G L+ E+ +L ++PY + E + I G R
Sbjct: 190 PEVLMY----SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR------ 239
Query: 818 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
L E + + C E ERPT L
Sbjct: 240 LYRPHLA--------------SEK-------VYTIMYSCWHEKADERPTFKILLSNI 275
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 54/233 (23%), Positives = 93/233 (39%), Gaps = 56/233 (24%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
I MEYV G ++++ + E ++ K A+ + D AL H I+HRD+K NI
Sbjct: 93 IVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANI 147
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 764
+I A VK+ DF A + ++ + +GT ++++PE R
Sbjct: 148 MIS-----ATNA--VKVMDFGIARAIADSGNS-------VTQTAAVIGTAQYLSPEQAR- 192
Query: 765 MHKPNLYGLEV----DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEA 820
G V D++S GC+L E+LT + P+ G S + + Q + ++
Sbjct: 193 -------GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQ-----HVREDPIP 238
Query: 821 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-TAGDLYE 872
S ++ L V + +NP R TA ++
Sbjct: 239 P-SARHEGLSAD----------------LDAVVLKALAKNPENRYQTAAEMRA 274
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 66/299 (22%), Positives = 115/299 (38%), Gaps = 77/299 (25%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
++TLK G + + +F LGE ++G H I+ + G + SK+ P
Sbjct: 78 IKTLKA-GYTEKQRVDF----LGEAGIMGQFSHHNIIRLEG--VISKYKPMM-------- 122
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
I EY++ G++ ++ + + SV + + + +AA + L + + +HRD+
Sbjct: 123 ----IITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLA 174
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWMAP 759
+ NIL++ V K+ DF + L G IP RW AP
Sbjct: 175 ARNILVNSNL-------VCKVSDFGLSRVLEDDPEATYTTSGGKIPI--------RWTAP 219
Query: 760 EVLRAMHKPNLYGL---EVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 815
E + Y D+WS+G ++ E++T + PY LS E+ I G R
Sbjct: 220 EAI-------SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR---- 268
Query: 816 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
L C P A + + +C ++ RP D+ +
Sbjct: 269 --LPTPMDC--------------PSA-------IYQLMMQCWQQERARRPKFADIVSIL 304
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-23
Identities = 60/236 (25%), Positives = 95/236 (40%), Gaps = 51/236 (21%)
Query: 578 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 636
A KV I EV +L L H I++++ S
Sbjct: 51 AVKVINKASAKNKDTSTILR-------EVELLKKLDHPNIMKLFEILEDSS--------- 94
Query: 637 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 696
+++ E GG + + I K K S A I + V + + +H +I+H
Sbjct: 95 SFYIV-----GELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 697 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTP 754
RD+K ENIL LE K+ D +K+ DF + + + + GT
Sbjct: 145 RDLKPENIL--LESKEKDCD--IKIIDFGLSTCFQQNTKMKDRI-------------GTA 187
Query: 755 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
++APEVLR Y + D+WS G +L LL+ P+ G +E +I ++ GK
Sbjct: 188 YYIAPEVLR---GT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK 238
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 5e-23
Identities = 58/267 (21%), Positives = 101/267 (37%), Gaps = 69/267 (25%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E+ ++ +L H I+ +Y + + +L+ ME GG + +
Sbjct: 56 EIEIMKSLDHPNIIRLYETFEDNT---------DIYLV-----MELCTGGELFERVVH-- 99
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
++ A I +DV +A+ H ++ HRD+K EN L + + +KL D
Sbjct: 100 ---KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSP----LKLID 152
Query: 724 FDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781
F A + + T GTP +++P+VL LYG E D WS G
Sbjct: 153 FGLAARFKPGKMMRTKV-------------GTPYYVSPQVLE-----GLYGPECDEWSAG 194
Query: 782 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 841
++ LL P+ ++ E+ I+ G F PE
Sbjct: 195 VMMYVLLCGYPPFSAPTDSEVMLKIREGT-------------------------FTFPEK 229
Query: 842 ELETLSFLV-DVFRRCTEENPTERPTA 867
+ +S + RR ++P +R T+
Sbjct: 230 DWLNVSPQAESLIRRLLTKSPKQRITS 256
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 6e-23
Identities = 68/297 (22%), Positives = 129/297 (43%), Gaps = 76/297 (25%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+TLK +E F L E ++ ++H +V++ G + ++ P +
Sbjct: 43 VKTLKEDTMEVEE---F----LKEAAVMKEIKHPNLVQLLG--VCTR------EPPFY-- 85
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
I E++ G++ +Y L E + VS + L++A +++A+ L K+ +HRD+
Sbjct: 86 ----IITEFMTYGNLLDY---LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA 138
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 758
+ N L+ +VK+ DF + R AH G P +W A
Sbjct: 139 ARNCLVGENH-------LVKVADFGLS---RLMTGDTYTAHAGAKFPI--------KWTA 180
Query: 759 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 817
PE L N + ++ D+W++G LL E+ T PY G+ ++++L++ R
Sbjct: 181 PESLAY----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------ 230
Query: 818 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
+E C PE + ++ R C + NP++RP+ ++++ F
Sbjct: 231 MERPEGC--------------PEK-------VYELMRACWQWNPSDRPSFAEIHQAF 266
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-23
Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 73/295 (24%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
++TLK S + L E +++ LRH +V++Y
Sbjct: 213 IKTLKPGTMSPEAF-------LQEAQVMKKLRHEKLVQLYAVVSEEPIY----------- 254
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
I EY+ GS+ ++ L K++ + + +A +A+ + + + +HRD++
Sbjct: 255 ----IVTEYMSKGSLLDF---LKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 307
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 760
+ NIL+ V K+ DF A R A +G P +W APE
Sbjct: 308 AANILVGENL-------VCKVADFGLA---RLIEDNEYTARQGAKFP------IKWTAPE 351
Query: 761 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 819
+ ++ D+WS+G LL EL T +VPY G+ E+ D ++ G R +
Sbjct: 352 AALY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------MP 401
Query: 820 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
C PE+ L D+ +C + P ERPT L
Sbjct: 402 CPPEC--------------PES-------LHDLMCQCWRKEPEERPTFEYLQAFL 435
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 48/170 (28%), Positives = 73/170 (42%), Gaps = 31/170 (18%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
E +KGG + + I + +K S + A + + + LH++ ++HRD+K NIL
Sbjct: 95 TELMKGGELLDKILR-----QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILY 149
Query: 707 DLERKKADGKPVVKLCDFDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 763
++ +++CDF A LR L T C T ++APEVL
Sbjct: 150 ---VDESGNPESIRICDFGFAKQLRAENGLLMTPC-------------YTANFVAPEVL- 192
Query: 764 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGK 810
+ Y DIWS G LL +LT P+ + EI I GK
Sbjct: 193 ---ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK 239
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-23
Identities = 68/313 (21%), Positives = 121/313 (38%), Gaps = 89/313 (28%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V++LK S + I + E+ +L L H IV+ G I ++ GN
Sbjct: 55 VKSLKP-ESGGNHIADL----KKEIEILRNLYHENIVKYKG--ICTE----DGGNG---- 99
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
++ + ME++ GS+K Y+ K + +++K L A + + L S+ +HRD+
Sbjct: 100 IK--LIMEFLPSGSLKEYLPK----NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLA 153
Query: 701 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 756
+ N+L++ E VK+ DF +A+ +T P W
Sbjct: 154 ARNVLVESEH-------QVKIGDFGLTKAIETDKEYYT---VKDDRDSPV--------FW 195
Query: 757 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL---------------QVPYMGLSELE 801
APE L + + + D+WS+G L ELLT + ++
Sbjct: 196 YAPECLMQ----SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251
Query: 802 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 861
+ + ++ GKR L +C P+ + + R+C E P
Sbjct: 252 LVNTLKEGKR------LPCPPNC--------------PDE-------VYQLMRKCWEFQP 284
Query: 862 TERPTAGDLYEMF 874
+ R + +L E F
Sbjct: 285 SNRTSFQNLIEGF 297
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-23
Identities = 52/237 (21%), Positives = 80/237 (33%), Gaps = 71/237 (29%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
+ M + G + + + + ++ A+ I + + +AL H+ HRD+K ENI
Sbjct: 111 VDMRLINGVDLAAMLRR-----QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENI 165
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR----GIPAPDVCVGTPRWMAPE 760
L+ AD L DF IA + VGT +MAPE
Sbjct: 166 LVS-----ADDF--AYLVDFG-------------IASATTDEKLTQLGNTVGTLYYMAPE 205
Query: 761 VLRAMHKPNLYGLEV----DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 816
DI++ C+L E LT PY G D + +
Sbjct: 206 RFS--------ESHATYRADIYALTCVLYECLTGSPPYQG-------DQLSV-------- 242
Query: 817 ELEALGSCHEHEVAQSGSGFEKPE--AELETLSFLVDVFRRCTEENPTER-PTAGDL 870
H ++ S +P + V R +NP +R T GDL
Sbjct: 243 ---MGA--HINQAIPRPSTV-RPGIPVAFD------AVIARGMAKNPEDRYVTCGDL 287
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 50/213 (23%), Positives = 87/213 (40%), Gaps = 50/213 (23%)
Query: 602 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA----IFMEYVKGGSVKN 657
E++++ L H +V ++ Q + ++ + GG ++
Sbjct: 63 FKELQIMQGLEHPFLVNLWYS------------------FQDEEDMFMVVDLLLGGDLRY 104
Query: 658 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 717
++++ E+ V LFI + + AL L ++ I+HRD+K +NIL+D G
Sbjct: 105 HLQQNVHFKEETV----KLFICE-LVMALDYLQNQRIIHRDMKPDNILLD-----EHGH- 153
Query: 718 VVKLCDFDRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 775
V + DF+ A +P + + T GT +MAPE+ K Y V
Sbjct: 154 -VHITDFNIAAMLPRETQITTMA-------------GTKPYMAPEMFS-SRKGAGYSFAV 198
Query: 776 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 808
D WS G ELL + PY S +++
Sbjct: 199 DWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT 231
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 49/209 (23%), Positives = 83/209 (39%), Gaps = 39/209 (18%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E+ +L +L H I++++ +++ ME +GG + I
Sbjct: 70 EIEVLKSLDHPNIIKIFEVFEDYH---------NMYIV-----METCEGGELLERIVSAQ 115
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
G K +S + + + AL HS+H++H+D+K ENIL + +K+ D
Sbjct: 116 ARG-KALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENIL--FQDTSPHSP--IKIID 170
Query: 724 FDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781
F A +S GT +MAPEV + + DIWS G
Sbjct: 171 FGLAELFKSDEHSTNAA-------------GTALYMAPEVFK-----RDVTFKCDIWSAG 212
Query: 782 CLLLELLTLQVPYMGLSELEIHDLIQMGK 810
++ LLT +P+ G S E+ +
Sbjct: 213 VVMYFLLTGCLPFTGTSLEEVQQKATYKE 241
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 60/239 (25%), Positives = 95/239 (39%), Gaps = 56/239 (23%)
Query: 578 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 636
AAK+ T K+ ++ E R+ L+H IV ++ S
Sbjct: 58 AAKIINTKKLSARDFQKLER-------EARICRKLQHPNIVRLHD---------SIQEES 101
Query: 637 EHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 693
H+L+ + V GG + I E SE A Q + ++ HS
Sbjct: 102 FHYLV-----FDLVTGGELFEDIVAREFYSE--------ADASHCIQQILESIAYCHSNG 148
Query: 694 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCV 751
I+HR++K EN+L+ + K A VKL DF A+ + H
Sbjct: 149 IVHRNLKPENLLLASKAKGAA----VKLADFGLAIEVNDSEAWHGFA------------- 191
Query: 752 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
GTP +++PEVL+ + Y VDIW+ G +L LL P+ + ++ I+ G
Sbjct: 192 GTPGYLSPEVLKK----DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 246
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-22
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 43/209 (20%)
Query: 602 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 661
E ML + H I+ M+G ++ + ++ M+Y++GG + + + K
Sbjct: 54 NDERLMLSIVTHPFIIRMWGTFQDAQQI---------FMI-----MDYIEGGELFSLLRK 99
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
+ +A F A +V AL LHSK I++RD+K ENIL+D +G +K+
Sbjct: 100 -----SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD-----KNGH--IKI 147
Query: 722 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781
DF A + +T C GTP ++APEV+ KP Y +D WS+G
Sbjct: 148 TDFGFAKYVPDVTYTLC-------------GTPDYIAPEVVS--TKP--YNKSIDWWSFG 190
Query: 782 CLLLELLTLQVPYMGLSELEIHDLIQMGK 810
L+ E+L P+ + ++ ++ I +
Sbjct: 191 ILIYEMLAGYTPFYDSNTMKTYEKILNAE 219
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 43/209 (20%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
EV++L L H I+++Y + +L+ E GG + + I
Sbjct: 76 EVQLLKQLDHPNIMKLYE---------FFEDKGYFYLV-----GEVYTGGELFDEIIS-- 119
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
K S A I + V + + +H I+HRD+K EN+L++ + K A+ +++ D
Sbjct: 120 ---RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDAN----IRIID 172
Query: 724 FDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781
F + + + GT ++APEVL Y + D+WS G
Sbjct: 173 FGLSTHFEASKKMKDKI-------------GTAYYIAPEVLH-----GTYDEKCDVWSTG 214
Query: 782 CLLLELLTLQVPYMGLSELEIHDLIQMGK 810
+L LL+ P+ G +E +I ++ GK
Sbjct: 215 VILYILLSGCPPFNGANEYDILKKVEKGK 243
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 59/297 (19%), Positives = 107/297 (36%), Gaps = 71/297 (23%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
+++L + ++ F L E ++ L H ++ + G I
Sbjct: 54 IKSLSR-ITEMQQVEAF----LREGLLMRGLNHPNVLALIG--IMLPPEGLP-------- 98
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
+ + Y+ G + +I +++ +VK + VA + L + +HRD+
Sbjct: 99 ---HVLLPYMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLA 151
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 758
+ N ++D VK+ DF A + + HR +P +W A
Sbjct: 152 ARNCMLDESF-------TVKVADFGLARDILDREYYSVQQHRHARLPV--------KWTA 196
Query: 759 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 817
E L + + + D+WS+G LL ELLT PY + ++ + G+R
Sbjct: 197 LESL----QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR------ 246
Query: 818 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
L C P++ L V ++C E +P RPT L
Sbjct: 247 LPQPEYC--------------PDS-------LYQVMQQCWEADPAVRPTFRVLVGEV 282
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-22
Identities = 66/295 (22%), Positives = 127/295 (43%), Gaps = 72/295 (24%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+TLK +E L E ++ ++H +V++ G + ++ E
Sbjct: 250 VKTLKEDTMEVEEF-------LKEAAVMKEIKHPNLVQLLG--VCTR---------EPPF 291
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
I E++ G++ +Y L E + VS + L++A +++A+ L K+ +HR++
Sbjct: 292 Y---IITEFMTYGNLLDY---LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLA 345
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 760
+ N L+ +VK+ DF + R AH G P +W APE
Sbjct: 346 ARNCLVGENH-------LVKVADFGLS---RLMTGDTYTAHAGAKFP------IKWTAPE 389
Query: 761 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 819
L N + ++ D+W++G LL E+ T PY G+ ++++L++ R +E
Sbjct: 390 SLAY----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------ME 439
Query: 820 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
C PE + ++ R C + NP++RP+ ++++ F
Sbjct: 440 RPEGC--------------PEK-------VYELMRACWQWNPSDRPSFAEIHQAF 473
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 56/215 (26%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYI-- 659
EVR++ L H IV+++ I ++ ++ MEY GG V +Y+
Sbjct: 64 EVRIMKILNHPNIVKLF-EVIETE---------------KTLYLIMEYASGGEVFDYLVA 107
Query: 660 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 718
++ E K A + + +A+ H K I+HRD+K+EN+L+D +
Sbjct: 108 HGRMKE--------KEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN------- 152
Query: 719 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 775
+K+ DF + L C G P + APE+ + Y G EV
Sbjct: 153 IKIADFGFSNEFTVGGKLDAFC-------------GAPPYAAPELFQG----KKYDGPEV 195
Query: 776 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
D+WS G +L L++ +P+ G + E+ + + GK
Sbjct: 196 DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 230
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 61/314 (19%), Positives = 111/314 (35%), Gaps = 91/314 (28%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+ L+ S+ + +R+F E+ +L +L+H IV+ G S+
Sbjct: 44 VKKLQH--STEEHLRDF----EREIEILKSLQHDNIVKYKGVCYSAGRRN---------- 87
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
L+ + MEY+ GS+++Y++K ++ + L + + L +K +HRD+
Sbjct: 88 LK--LIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA 141
Query: 701 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 756
+ NIL++ E VK+ DF + +P P W
Sbjct: 142 TRNILVENEN-------RVKIGDFGLTKVLPQDKEFFK---VKEPGESPI--------FW 183
Query: 757 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL----------------QVPYMGLSEL 800
APE L + + + D+WS+G +L EL T +
Sbjct: 184 YAPESLTE----SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239
Query: 801 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 860
+ +L++ R L C P+ + + C N
Sbjct: 240 HLIELLKNNGR------LPRPDGC--------------PDE-------IYMIMTECWNNN 272
Query: 861 PTERPTAGDLYEMF 874
+RP+ DL
Sbjct: 273 VNQRPSFRDLALRV 286
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 59/296 (19%), Positives = 110/296 (37%), Gaps = 71/296 (23%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
++ LK G + + R+F L E ++G H I+ + G + ++ G
Sbjct: 82 IKALKA-GYTERQRRDF----LSEASIMGQFDHPNIIRLEG--VVTR------GRLAM-- 126
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
I EY++ GS+ ++ + ++ + + + V A + L +HRD+
Sbjct: 127 ----IVTEYMENGSLDTFLRT----HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLA 178
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWMAP 759
+ N+L+D V K+ DF + L G IP RW AP
Sbjct: 179 ARNVLVDSNL-------VCKVSDFGLSRVLEDDPDAAYTTTGGKIPI--------RWTAP 223
Query: 760 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDEL 818
E + A + D+WS+G ++ E+L + PY ++ ++ ++ G R L
Sbjct: 224 EAI-AFRT---FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR------L 273
Query: 819 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
A C P A L + C ++ +RP + +
Sbjct: 274 PAPMGC--------------PHA-------LHQLMLDCWHKDRAQRPRFSQIVSVL 308
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 47/211 (22%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---E 660
E+ +L ++H IV + S+ ++L M+ V GG + + I
Sbjct: 56 EIAVLKKIKHENIVTLEDIYESTT---------HYYL-----VMQLVSGGELFDRILERG 101
Query: 661 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 720
+E K A + Q V +A+ LH I+HRD+K EN+L + + K +
Sbjct: 102 VYTE--------KDASLVIQQVLSAVKYLHENGIVHRDLKPENLL--YLTPEENSK--IM 149
Query: 721 LCDFDRAVPLR-SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 779
+ DF + + + T C GTP ++APEVL KP Y VD WS
Sbjct: 150 ITDFGLSKMEQNGIMSTAC-------------GTPGYVAPEVLA--QKP--YSKAVDCWS 192
Query: 780 YGCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
G + LL P+ +E ++ + I+ G
Sbjct: 193 IGVITYILLCGYPPFYEETESKLFEKIKEGY 223
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 55/241 (22%), Positives = 98/241 (40%), Gaps = 50/241 (20%)
Query: 578 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSADGNP 636
A K+ + S +++ + E +L + H I+ + S + +
Sbjct: 123 AVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID---------SYESSS 173
Query: 637 EHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 693
L+ + ++ G + +Y+ LSE K I + + A+ LH+ +
Sbjct: 174 FMFLV-----FDLMRKGELFDYLTEKVALSE--------KETRSIMRSLLEAVSFLHANN 220
Query: 694 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCV 751
I+HRD+K ENIL+ D ++L DF + L L C
Sbjct: 221 IVHRDLKPENILL-------DDNMQIRLSDFGFSCHLEPGEKLRELC------------- 260
Query: 752 GTPRWMAPEVLRAMHKPNL--YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG 809
GTP ++APE+L+ YG EVD+W+ G +L LL P+ ++ + +I G
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG 320
Query: 810 K 810
+
Sbjct: 321 Q 321
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 64/303 (21%), Positives = 108/303 (35%), Gaps = 77/303 (25%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+TL S + +F L E ++ H IV G +S + LP
Sbjct: 106 VKTLPE-VCSEQDELDF----LMEALIISKFNHQNIVRCIG--VSLQSLP---------R 149
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA--LFIAQDVAAALVELHSKHIMHRD 698
I +E + GG +K+++ + + S+ + L +A+D+A L H +HRD
Sbjct: 150 F---ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRD 206
Query: 699 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP---- 754
I + N L+ G+ V K+ DF A R I
Sbjct: 207 IAARNCLLT---CPGPGR-VAKIGDFGMA--------------RDIYRAGYYRKGGCAML 248
Query: 755 --RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 811
+WM PE ++ + D WS+G LL E+ +L +PY S E+ + + G R
Sbjct: 249 PVKWMPPEAF----MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304
Query: 812 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 871
+ P+ + + +C + P +RP +
Sbjct: 305 ------------------------MDPPK---NCPGPVYRIMTQCWQHQPEDRPNFAIIL 337
Query: 872 EMF 874
E
Sbjct: 338 ERI 340
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 62/297 (20%), Positives = 113/297 (38%), Gaps = 71/297 (23%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V++L + E+ F L E ++ H ++ + G I + ++G+P
Sbjct: 58 VKSLNR-ITDIGEVSQF----LTEGIIMKDFSHPNVLSLLG--ICLR----SEGSP---- 102
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
+ + Y+K G ++N+I + +VK + VA + L SK +HRD+
Sbjct: 103 ---LVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLA 155
Query: 701 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 758
+ N ++D + VK+ DF R + + + +P +WMA
Sbjct: 156 ARNCMLDEKF-------TVKVADFGLARDMYDKEYYSVHNKTGAKLPV--------KWMA 200
Query: 759 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 817
E L+ + + D+WS+G LL EL+T PY ++ +I + G+R
Sbjct: 201 LESLQT----QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR------ 250
Query: 818 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
L C P+ L +V +C RP+ +L
Sbjct: 251 LLQPEYC--------------PDP-------LYEVMLKCWHPKAEMRPSFSELVSRI 286
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 4e-22
Identities = 57/297 (19%), Positives = 102/297 (34%), Gaps = 76/297 (25%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
++T K +S F L E + H IV++ G +
Sbjct: 423 IKTCKN-CTSDSVREKF----LQEALTMRQFDHPHIVKLIGVITENPVW----------- 466
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
I ME G ++++++ + + + + A ++ AL L SK +HRDI
Sbjct: 467 ----IIMELCTLGELRSFLQV----RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIA 518
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 758
+ N+L+ VKL DF + R + +P +WMA
Sbjct: 519 ARNVLVSSND-------CVKLGDFGLS---RYMEDSTYYKASKGKLPI--------KWMA 560
Query: 759 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 817
PE + + D+W +G + E+L P+ G+ ++ I+ G+R
Sbjct: 561 PESINF----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------ 610
Query: 818 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
L +C P L + +C +P+ RP +L
Sbjct: 611 LPMPPNC--------------PPT-------LYSLMTKCWAYDPSRRPRFTELKAQL 646
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 5e-22
Identities = 64/296 (21%), Positives = 113/296 (38%), Gaps = 71/296 (23%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
++TLKV G + + R+F LGE ++G H I+ + G + +K P
Sbjct: 78 IKTLKV-GYTEKQRRDF----LGEASIMGQFDHPNIIRLEG--VVTKSKPVM-------- 122
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
I EY++ GS+ +++ K + +V + + + +A+ + L +HRD+
Sbjct: 123 ----IVTEYMENGSLDSFLRK----HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLA 174
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWMAP 759
+ NILI+ V K+ DF L G IP RW +P
Sbjct: 175 ARNILINSNL-------VCKVSDFGLGRVLEDDPEAAYTTRGGKIPI--------RWTSP 219
Query: 760 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDEL 818
E + + D+WSYG +L E+++ + PY +S ++ + G R L
Sbjct: 220 EAI----AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR------L 269
Query: 819 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
C P A L + C +++ RP + +
Sbjct: 270 PPPMDC--------------PAA-------LYQLMLDCWQKDRNNRPKFEQIVSIL 304
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 5e-22
Identities = 54/240 (22%), Positives = 95/240 (39%), Gaps = 53/240 (22%)
Query: 578 AAKV---RTLKVCGSSAD--EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 632
AAK R + EI EV +L + H ++ ++
Sbjct: 41 AAKFIKKRQSRASRRGVSREEIER-------EVSILRQVLHHNVITLHD---------VY 84
Query: 633 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 692
+ + L+ +E V GG + +++ ++ +S + A + + + LH+K
Sbjct: 85 ENRTDVVLI-----LELVSGGELFDFL-----AQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 693 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL--RSFLHTCCIAHRGIPAPDVC 750
I H D+K ENI++ K P +KL DF A +
Sbjct: 135 KIAHFDLKPENIML---LDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF------------ 179
Query: 751 VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
GTP ++APE++ ++P GLE D+WS G + LL+ P++G ++ E I
Sbjct: 180 -GTPEFVAPEIVN--YEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVS 234
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 5e-22
Identities = 61/314 (19%), Positives = 112/314 (35%), Gaps = 91/314 (28%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+ L+ S+ + +R+F E+ +L +L+H IV+ G S+
Sbjct: 75 VKKLQH--STEEHLRDF----EREIEILKSLQHDNIVKYKGVCYSAGRRN---------- 118
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
L+ + MEY+ GS+++Y++K ++ + L + + L +K +HRD+
Sbjct: 119 LK--LIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA 172
Query: 701 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 756
+ NIL++ E VK+ DF + +P + P W
Sbjct: 173 TRNILVENEN-------RVKIGDFGLTKVLPQDKEYYK---VKEPGESPI--------FW 214
Query: 757 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL----------------QVPYMGLSEL 800
APE L + + + D+WS+G +L EL T +
Sbjct: 215 YAPESLTE----SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270
Query: 801 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 860
+ +L++ R L C P+ + + C N
Sbjct: 271 HLIELLKNNGR------LPRPDGC--------------PDE-------IYMIMTECWNNN 303
Query: 861 PTERPTAGDLYEMF 874
+RP+ DL
Sbjct: 304 VNQRPSFRDLALRV 317
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 5e-22
Identities = 49/195 (25%), Positives = 75/195 (38%), Gaps = 55/195 (28%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE--- 660
E+ + L H +V+ YGH + +F+EY GG + + IE
Sbjct: 55 EICINKMLNHENVVKFYGH-RREG----------NIQ---YLFLEYCSGGELFDRIEPDI 100
Query: 661 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 720
+ E A + A +V LH I HRDIK EN+L+ D + +K
Sbjct: 101 GMPE--------PDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL-------DERDNLK 145
Query: 721 LCDF-----DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLE 774
+ DF R L+ C GT ++APE+L+ +
Sbjct: 146 ISDFGLATVFRYNNRERLLNKMC-------------GTLPYVAPELLKR----REFHAEP 188
Query: 775 VDIWSYGCLLLELLT 789
VD+WS G +L +L
Sbjct: 189 VDVWSCGIVLTAMLA 203
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 8e-22
Identities = 53/167 (31%), Positives = 78/167 (46%), Gaps = 32/167 (19%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
MEY+ GG + +I+ + A F A ++ L LHSK I++RD+K +NIL+
Sbjct: 97 MEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 151
Query: 707 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 763
D DG +K+ DF + + +T C GTP ++APE+L
Sbjct: 152 D-----KDGH--IKIADFGMCKENMLGDAKTNTFC-------------GTPDYIAPEILL 191
Query: 764 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
Y VD WS+G LL E+L Q P+ G E E+ I+M
Sbjct: 192 GQK----YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN 234
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 9e-22
Identities = 63/318 (19%), Positives = 113/318 (35%), Gaps = 83/318 (26%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
++T+ +S E F L E ++ +V + G + S+ P
Sbjct: 60 IKTVNE-AASMRERIEF----LNEASVMKEFNCHHVVRLLG--VVSQGQP---------T 103
Query: 641 LQSAIFMEYVKGGSVKNYI-----EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 695
L + ME + G +K+Y+ + S+ + +A ++A + L++ +
Sbjct: 104 L---VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 160
Query: 696 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT-- 753
HRD+ + N ++ + VK+ DF R I D
Sbjct: 161 HRDLAARNCMVAEDF-------TVKIGDFGMT--------------RDIYETDYYRKGGK 199
Query: 754 ---P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQM 808
P RWM+PE L K ++ D+WS+G +L E+ TL + PY GLS ++ +
Sbjct: 200 GLLPVRWMSPESL----KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255
Query: 809 GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868
G +KP+ L ++ R C + NP RP+
Sbjct: 256 GGL------------------------LDKPD---NCPDMLFELMRMCWQYNPKMRPSFL 288
Query: 869 DLYEMFVARTSSSISSRS 886
++ S
Sbjct: 289 EIISSIKEEMEPGFREVS 306
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 46/174 (26%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
+++++GG + + K E + + F ++A AL LHS I++RD+K ENIL+
Sbjct: 105 LDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL 159
Query: 707 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 756
D +G +KL DF +A ++ C GT +
Sbjct: 160 D-----EEGH--IKLTDFGLSKESIDHEKKA-------YSFC-------------GTVEY 192
Query: 757 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
MAPEV+ + D WS+G L+ E+LT +P+ G E +I K
Sbjct: 193 MAPEVVNRRG----HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK 242
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 61/243 (25%), Positives = 96/243 (39%), Gaps = 59/243 (24%)
Query: 578 AAKV---RTLKVCGSSAD--EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 632
AAK R L EI EV +L +RH I+ ++
Sbjct: 34 AAKFIKKRRLSSSRRGVSREEIER-------EVNILREIRHPNIITLHD---------IF 77
Query: 633 DGNPEHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVEL 689
+ + L+ +E V GG + +++ E L+E A + + + L
Sbjct: 78 ENKTDVVLI-----LELVSGGELFDFLAEKESLTE--------DEATQFLKQILDGVHYL 124
Query: 690 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAP 747
HSK I H D+K ENI+ L K P +KL DF A + +
Sbjct: 125 HSKRIAHFDLKPENIM--LLDKNVPN-PRIKLIDFGIAHKIEAGNEFKNIF--------- 172
Query: 748 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ 807
GTP ++APE++ ++P GLE D+WS G + LL+ P++G ++ E I
Sbjct: 173 ----GTPEFVAPEIVN--YEP--LGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS 224
Query: 808 MGK 810
Sbjct: 225 AVN 227
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 1e-21
Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 73/295 (24%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
++TLK S + L E +++ LRH +V++Y
Sbjct: 296 IKTLKPGTMSPEAF-------LQEAQVMKKLRHEKLVQLYAVVSEEPIY----------- 337
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
I EY+ GS+ ++ L K++ + + +A +A+ + + + +HRD++
Sbjct: 338 ----IVTEYMSKGSLLDF---LKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 390
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 760
+ NIL+ V K+ DF A R A +G P +W APE
Sbjct: 391 AANILVGENL-------VCKVADFGLA---RLIEDNEYTARQGAKFP------IKWTAPE 434
Query: 761 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 819
+ ++ D+WS+G LL EL T +VPY G+ E+ D ++ G R +
Sbjct: 435 AALY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------MP 484
Query: 820 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
C PE+ L D+ +C + P ERPT L
Sbjct: 485 CPPEC--------------PES-------LHDLMCQCWRKEPEERPTFEYLQAFL 518
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 55/299 (18%), Positives = 102/299 (34%), Gaps = 78/299 (26%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+ LK + L E ++ L + IV M G I E +
Sbjct: 49 VKILKNEANDPALKDEL----LAEANVMQQLDNPYIVRMIG--ICEA---------ESWM 93
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
+ ME + G + Y+++ +HV K + + V+ + L + +HRD+
Sbjct: 94 ----LVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLA 144
Query: 701 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 756
+ N+L+ + K+ DF +A+ + A P +W
Sbjct: 145 ARNVLLVTQH-------YAKISDFGLSKALRADENYYK---AQTHGKWPV--------KW 186
Query: 757 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 815
APE + + + D+WS+G L+ E + Q PY G+ E+ +++ G+R
Sbjct: 187 YAPECINY----YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---- 238
Query: 816 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
+ C P + D+ C + RP +
Sbjct: 239 --MGCPAGC--------------PRE-------MYDLMNLCWTYDVENRPGFAAVELRL 274
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 68/315 (21%), Positives = 118/315 (37%), Gaps = 96/315 (30%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+ LK + ++F E +L L+H IV+ YG + P L
Sbjct: 50 VKALK--DPTLAARKDF----QREAELLTNLQHEHIVKFYG--VCGDGDP---------L 92
Query: 641 LQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVEL 689
+ + EY+K G + + ++ + + + L IA +A+ +V L
Sbjct: 93 I---MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL 149
Query: 690 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 749
S+H +HRD+ + N L+ +VK+ DF + R + + D
Sbjct: 150 ASQHFVHRDLATRNCLVGANL-------LVKIGDFGMS--------------RDVYSTDY 188
Query: 750 CVGT-----P-RWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSE 799
P RWM PE + +Y E D+WS+G +L E+ T + P+ LS
Sbjct: 189 YRVGGHTMLPIRWMPPESI-------MYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 241
Query: 800 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 859
E+ + I G+ LE C P+ + DV C +
Sbjct: 242 TEVIECITQGRV------LERPRVC--------------PKE-------VYDVMLGCWQR 274
Query: 860 NPTERPTAGDLYEMF 874
P +R ++Y++
Sbjct: 275 EPQQRLNIKEIYKIL 289
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-21
Identities = 55/272 (20%), Positives = 100/272 (36%), Gaps = 69/272 (25%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E+ +L +L H I++++ K +L+ E+ +GG + I
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKK---------YFYLV-----TEFYEGGELFEQIIN-- 139
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
A I + + + + LH +I+HRDIK ENIL LE K + +K+ D
Sbjct: 140 ---RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENIL--LENKNSLLN--IKIVD 192
Query: 724 FDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781
F + L GT ++APEVL+ Y + D+WS G
Sbjct: 193 FGLSSFFSKDYKLRDRL-------------GTAYYIAPEVLK-----KKYNEKCDVWSCG 234
Query: 782 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 841
++ LL P+ G ++ +I ++ GK +
Sbjct: 235 VIMYILLCGYPPFGGQNDQDIIKKVEKGK-------------------------YYFDFN 269
Query: 842 ELETLSFLV-DVFRRCTEENPTERPTAGDLYE 872
+ + +S ++ + + +R TA +
Sbjct: 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 2e-21
Identities = 49/174 (28%), Positives = 73/174 (41%), Gaps = 46/174 (26%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
+EY+ GG + +E+ E A F +++ AL LH K I++RD+K ENI++
Sbjct: 100 LEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML 154
Query: 707 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 756
+ G VKL DF HT C GT +
Sbjct: 155 N-----HQGH--VKLTDFGLCKESIHDGTVT-------HTFC-------------GTIEY 187
Query: 757 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
MAPE+L + + VD WS G L+ ++LT P+ G + + D I K
Sbjct: 188 MAPEILMR----SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK 237
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 46/174 (26%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
MEY GG + ++ + E+ + + A F ++ +AL LHS+ +++RDIK EN+++
Sbjct: 84 MEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 138
Query: 707 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 756
D DG +K+ DF T C GTP +
Sbjct: 139 D-----KDGH--IKITDFGLCKEGISDGATM-------KTFC-------------GTPEY 171
Query: 757 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
+APEVL N YG VD W G ++ E++ ++P+ + +LI M +
Sbjct: 172 LAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 221
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 49/301 (16%), Positives = 105/301 (34%), Gaps = 83/301 (27%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
++ L+ +S + L E ++ ++ + + + G ++S
Sbjct: 49 IKELRE-ATSPKANKEI----LDEAYVMASVDNPHVCRLLGICLTSTVQ----------- 92
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
+ + + G + +Y+ + + ++ + L +A + L + ++HRD+
Sbjct: 93 ----LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA 144
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP------ 754
+ N+L+ + VK+ DF A + + A +
Sbjct: 145 ARNVLVKTPQ-------HVKITDFGLA--------------KLLGAEEKEYHAEGGKVPI 183
Query: 755 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPR 813
+WMA E + +Y + D+WSYG + EL+T PY G+ EI +++ G+R
Sbjct: 184 KWMALESILH----RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-- 237
Query: 814 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 873
L C + + +C + RP +L
Sbjct: 238 ----LPQPPIC--------------TID-------VYMIMVKCWMIDADSRPKFRELIIE 272
Query: 874 F 874
F
Sbjct: 273 F 273
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 49/195 (25%), Positives = 75/195 (38%), Gaps = 55/195 (28%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE--- 660
E+ + L H +V+ YGH + +F+EY GG + + IE
Sbjct: 55 EICINKMLNHENVVKFYGH-RREG----------NIQ---YLFLEYCSGGELFDRIEPDI 100
Query: 661 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 720
+ E A + A +V LH I HRDIK EN+L+ D + +K
Sbjct: 101 GMPE--------PDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL-------DERDNLK 145
Query: 721 LCDF-----DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLE 774
+ DF R L+ C GT ++APE+L+ +
Sbjct: 146 ISDFGLATVFRYNNRERLLNKMC-------------GTLPYVAPELLKR----REFHAEP 188
Query: 775 VDIWSYGCLLLELLT 789
VD+WS G +L +L
Sbjct: 189 VDVWSCGIVLTAMLA 203
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 62/313 (19%), Positives = 114/313 (36%), Gaps = 90/313 (28%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+ L+ G D+ R+F E+++L AL IV+ G
Sbjct: 57 VKQLQHSGP--DQQRDF----QREIQILKALHSDFIVKYRGVSYGPGRQS---------- 100
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
L+ + MEY+ G +++++++ + L + + + L S+ +HRD+
Sbjct: 101 LR--LVMEYLPSGCLRDFLQR----HRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLA 154
Query: 701 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 756
+ NIL++ E VK+ DF + +PL + P W
Sbjct: 155 ARNILVESEA-------HVKIADFGLAKLLPLDKDYYV---VREPGQSPI--------FW 196
Query: 757 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSEL--------------E 801
APE L N++ + D+WS+G +L EL T +E
Sbjct: 197 YAPESLSD----NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
Query: 802 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 861
+ +L++ G+R L A +C P + ++ + C +P
Sbjct: 253 LLELLEEGQR------LPAPPAC--------------PAE-------VHELMKLCWAPSP 285
Query: 862 TERPTAGDLYEMF 874
+RP+ L
Sbjct: 286 QDRPSFSALGPQL 298
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-21
Identities = 51/240 (21%), Positives = 97/240 (40%), Gaps = 53/240 (22%)
Query: 578 AAKV---RTLKVCGSSAD--EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 632
AAK R K +I EV +L ++H ++ ++
Sbjct: 40 AAKFIKKRRTKSSRRGVSREDIER-------EVSILKEIQHPNVITLHE---------VY 83
Query: 633 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 692
+ + L+ +E V GG + +++ + ++ ++ + A + + + LHS
Sbjct: 84 ENKTDVILI-----LELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSL 133
Query: 693 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVC 750
I H D+K ENI+ L + P +K+ DF A + +
Sbjct: 134 QIAHFDLKPENIM--LLDRNVPK-PRIKIIDFGLAHKIDFGNEFKNIF------------ 178
Query: 751 VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
GTP ++APE++ ++P GLE D+WS G + LL+ P++G ++ E +
Sbjct: 179 -GTPEFVAPEIVN--YEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 233
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-21
Identities = 62/297 (20%), Positives = 117/297 (39%), Gaps = 77/297 (25%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+T+K S + L E ++ L+H +V+++ + +K P +
Sbjct: 217 VKTMKPGSMSVEAF-------LAEANVMKTLQHDKLVKLHA--VVTK-------EPIY-- 258
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
I E++ GS+ ++ L + + + +A + + ++ +HRD++
Sbjct: 259 ----IITEFMAKGSLLDF---LKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR 311
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 758
+ NIL+ V K+ DF A R A G P +W A
Sbjct: 312 AANILVSASL-------VCKIADFGLA---RVIEDNEYTAREGAKFPI--------KWTA 353
Query: 759 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 817
PE + + ++ D+WS+G LL+E++T ++PY G+S E+ ++ G R
Sbjct: 354 PEAINF----GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR------ 403
Query: 818 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
+ +C PE L ++ RC + P ERPT + +
Sbjct: 404 MPRPENC--------------PEE-------LYNIMMRCWKNRPEERPTFEYIQSVL 439
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-21
Identities = 46/179 (25%), Positives = 72/179 (40%), Gaps = 49/179 (27%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
++Y+ GG + ++ + + + ++ AL LH I++RDIK ENIL+
Sbjct: 138 LDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL 192
Query: 707 DLERKKADGKPVVKLCDF-----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 755
D ++G V L DF +RA + C GT
Sbjct: 193 D-----SNGH--VVLTDFGLSKEFVADETERA-------YDFC-------------GTIE 225
Query: 756 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE----LEIHDLIQMGK 810
+MAP+++R + VD WS G L+ ELLT P+ E EI I +
Sbjct: 226 YMAPDIVRGGDSG--HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 55/299 (18%), Positives = 100/299 (33%), Gaps = 78/299 (26%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
++ LK G+ + + E +++ L + IV + G + +
Sbjct: 42 IKVLKQ-GTEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQAEALM----------- 85
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
+ ME GG + ++ + + V + V+ + L K+ +HRD+
Sbjct: 86 ----LVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLA 137
Query: 701 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 756
+ N+L+ K+ DF +A+ +T A P +W
Sbjct: 138 ARNVLLVNRH-------YAKISDFGLSKALGADDSYYT---ARSAGKWPL--------KW 179
Query: 757 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 815
APE + K + D+WSYG + E L+ Q PY + E+ I+ GKR
Sbjct: 180 YAPECI-NFRK---FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---- 231
Query: 816 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
+E C P L + C +RP + +
Sbjct: 232 --MECPPEC--------------PPE-------LYALMSDCWIYKWEDRPDFLTVEQRM 267
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 4e-21
Identities = 61/297 (20%), Positives = 110/297 (37%), Gaps = 80/297 (26%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+ +K ++A L E ++ LRHS +V++ G + +
Sbjct: 49 VKCIK-NDATAQAF-------LAEASVMTQLRHSNLVQLLG--VIVEEKGGL-------- 90
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
I EY+ GS+ +Y L G + L + DV A+ L + +HRD+
Sbjct: 91 ---YIVTEYMAKGSLVDY---LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 144
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 758
+ N+L+ + V K+ DF + + +P +W A
Sbjct: 145 ARNVLVSEDN-------VAKVSDFGLT---KE-ASS---TQDTGKLPV--------KWTA 182
Query: 759 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 817
PE LR + + D+WS+G LL E+ + +VPY + ++ ++ G +
Sbjct: 183 PEALRE----KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------ 232
Query: 818 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
++A C P A + +V + C + RP+ L E
Sbjct: 233 MDAPDGC--------------PPA-------VYEVMKNCWHLDAAMRPSFLQLREQL 268
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 66/313 (21%), Positives = 118/313 (37%), Gaps = 90/313 (28%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 639
V+ LK ++ ++ + + E+ M+ + +H I+ + G P +
Sbjct: 72 VKMLK-DDATEKDLSDL----VSEMEMMKMIGKHKNIINLLGA--------CTQDGPLY- 117
Query: 640 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 688
+ +EY G+++ Y ++ E+ ++ K + +A +
Sbjct: 118 -----VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 748
L S+ +HRD+ + N+L+ + V+K+ DF A R I D
Sbjct: 173 LASQKCIHRDLAARNVLV------TENN-VMKIADFGLA--------------RDINNID 211
Query: 749 VCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELE 801
T P +WMAPE L +Y + D+WS+G L+ E+ TL PY G+ E
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFD----RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267
Query: 802 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 861
+ L++ G R +KP + L + R C P
Sbjct: 268 LFKLLKEGHR------------------------MDKPA---NCTNELYMMMRDCWHAVP 300
Query: 862 TERPTAGDLYEMF 874
++RPT L E
Sbjct: 301 SQRPTFKQLVEDL 313
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 4e-21
Identities = 67/320 (20%), Positives = 125/320 (39%), Gaps = 97/320 (30%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+ LK +S E+R+ L E +L + H ++++YG + P L
Sbjct: 58 VKMLKE-NASPSELRDL----LSEFNVLKQVNHPHVIKLYGA--------CSQDGP---L 101
Query: 641 LQSAIFMEYVKGGSVKNY-------------------IEKLSETGEKHVSVKLALFIAQD 681
L + +EY K GS++ + L E+ +++ + A
Sbjct: 102 L---LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQ 158
Query: 682 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 741
++ + L ++HRD+ + NIL+ A+G+ +K+ DF +
Sbjct: 159 ISQGMQYLAEMKLVHRDLAARNILV------AEGR-KMKISDFGLS-------------- 197
Query: 742 RGIPAPDVCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPY 794
R + D V P +WMA E L ++Y + D+WS+G LL E++TL PY
Sbjct: 198 RDVYEEDSYVKRSQGRIPVKWMAIESLFD----HIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 795 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 854
G+ + +L++ G R E+P+ + +
Sbjct: 254 PGIPPERLFNLLKTGHR------------------------MERPD---NCSEEMYRLML 286
Query: 855 RCTEENPTERPTAGDLYEMF 874
+C ++ P +RP D+ +
Sbjct: 287 QCWKQEPDKRPVFADISKDL 306
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 71/311 (22%), Positives = 115/311 (36%), Gaps = 89/311 (28%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+ LK S ++F E +L L+H IV +G + ++ P L
Sbjct: 76 VKALKEA--SESARQDF----QREAELLTMLQHQHIVRFFG--VCTEGRP---------L 118
Query: 641 LQSAIFMEYVKGGSVKNY----------IEKLSETGEKHVSVKLALFIAQDVAAALVELH 690
L + EY++ G + + + + + + L +A VAA +V L
Sbjct: 119 L---MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA 175
Query: 691 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC 750
H +HRD+ + N L+ VVK+ DF + R I + D
Sbjct: 176 GLHFVHRDLATRNCLVGQGL-------VVKIGDFGMS--------------RDIYSTDYY 214
Query: 751 -VGT----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIH 803
VG P RWM PE + + E D+WS+G +L E+ T + P+ LS E
Sbjct: 215 RVGGRTMLPIRWMPPESI----LYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270
Query: 804 DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863
D I G+ LE +C P + + R C + P +
Sbjct: 271 DCITQGRE------LERPRAC--------------PPE-------VYAIMRGCWQREPQQ 303
Query: 864 RPTAGDLYEMF 874
R + D++
Sbjct: 304 RHSIKDVHARL 314
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 48/174 (27%), Positives = 73/174 (41%), Gaps = 36/174 (20%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
ME + GG + I+K +KH S A +I + + +A+ +H ++HRD+K EN+L
Sbjct: 85 MELLNGGELFERIKK-----KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLF 139
Query: 707 DLERKKADGKPVVKLCDFDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 763
+ +K+ DF A L T C T + APE+L
Sbjct: 140 ----TDENDNLEIKIIDFGFARLKPPDNQPLKTPC-------------FTLHYAAPELLN 182
Query: 764 AMHKPNLYGLEVDIWSYGCLLLELLTLQVP-------YMGLSELEIHDLIQMGK 810
N Y D+WS G +L +L+ QVP S +EI I+ G
Sbjct: 183 Q----NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 57/223 (25%), Positives = 88/223 (39%), Gaps = 47/223 (21%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
ME ++GG + ++ E G++ + + A I +D+ A+ LHS +I HRD+K EN+L
Sbjct: 105 MECMEGGEL---FSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL- 160
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRS-FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 765
K+ D V+KL DF A L T C TP ++APEVL
Sbjct: 161 -YTSKEKD--AVLKLTDFGFAKETTQNALQTPC-------------YTPYYVAPEVLGPE 204
Query: 766 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 825
Y D+WS G ++ LL P+ + I + +
Sbjct: 205 K----YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM-----------KRRIRLGQ 249
Query: 826 EHEVAQSGSGFEKPEAELETLSFLV-DVFRRCTEENPTERPTA 867
+ P E +S + R + +PTER T
Sbjct: 250 ----------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTI 282
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 6e-21
Identities = 64/297 (21%), Positives = 109/297 (36%), Gaps = 80/297 (26%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+ +K ++A L E ++ LRHS +V++ G + +
Sbjct: 221 VKCIK-NDATAQAF-------LAEASVMTQLRHSNLVQLLG--VIVEEKGGL-------- 262
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
I EY+ GS+ +Y L G + L + DV A+ L + +HRD+
Sbjct: 263 ---YIVTEYMAKGSLVDY---LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 316
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 758
+ N+L+ + V K+ DF S +P +W A
Sbjct: 317 ARNVLVSEDN-------VAKVSDFGLTKEASS-------TQDTGKLPV--------KWTA 354
Query: 759 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 817
PE LR + + D+WS+G LL E+ + +VPY + ++ ++ G +
Sbjct: 355 PEALRE----KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------ 404
Query: 818 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
++A C P A + DV + C + RPT L E
Sbjct: 405 MDAPDGC--------------PPA-------VYDVMKNCWHLDAATRPTFLQLREQL 440
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 8e-21
Identities = 58/243 (23%), Positives = 95/243 (39%), Gaps = 59/243 (24%)
Query: 578 AAKV---RTLKVCGSSAD--EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 632
AAK R + EI EV +L + H I+ ++
Sbjct: 41 AAKFIKKRQSRASRRGVCREEIER-------EVSILRQVLHPNIITLHD---------VY 84
Query: 633 DGNPEHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVEL 689
+ + L+ +E V GG + +++ E LSE + A + + + L
Sbjct: 85 ENRTDVVLI-----LELVSGGELFDFLAQKESLSE--------EEATSFIKQILDGVNYL 131
Query: 690 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL--RSFLHTCCIAHRGIPAP 747
H+K I H D+K ENI++ K P +KL DF A +
Sbjct: 132 HTKKIAHFDLKPENIML---LDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--------- 179
Query: 748 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ 807
GTP ++APE++ ++P GLE D+WS G + LL+ P++G ++ E I
Sbjct: 180 ----GTPEFVAPEIVN--YEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231
Query: 808 MGK 810
Sbjct: 232 AVS 234
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 8e-21
Identities = 51/174 (29%), Positives = 79/174 (45%), Gaps = 46/174 (26%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
MEYV GG + +I+++ E H A+F A ++A L L SK I++RD+K +N+++
Sbjct: 100 MEYVNGGDLMYHIQQVGRFKEPH-----AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 154
Query: 707 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 756
D ++G +K+ DF T C GTP +
Sbjct: 155 D-----SEGH--IKIADFGMCKENIWDGVTT-------KTFC-------------GTPDY 187
Query: 757 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
+APE++ YG VD W++G LL E+L Q P+ G E E+ I
Sbjct: 188 IAPEIIAYQP----YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 237
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 1e-20
Identities = 63/297 (21%), Positives = 112/297 (37%), Gaps = 71/297 (23%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V++L + E+ F L E ++ H ++ + G I + ++G+P
Sbjct: 122 VKSLNR-ITDIGEVSQF----LTEGIIMKDFSHPNVLSLLG--ICLR----SEGSP---- 166
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
+ + Y+K G ++N+I + +VK + VA + L SK +HRD+
Sbjct: 167 ---LVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLA 219
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 758
+ N ++D + VK+ DF A + G +P +WMA
Sbjct: 220 ARNCMLDEKF-------TVKVADFGLARDMYDKEFDSVHNKTGAKLPV--------KWMA 264
Query: 759 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 817
E L+ + + D+WS+G LL EL+T PY ++ +I + G+R
Sbjct: 265 LESLQT----QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR------ 314
Query: 818 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
L C P+ L +V +C RP+ +L
Sbjct: 315 LLQPEYC--------------PDP-------LYEVMLKCWHPKAEMRPSFSELVSRI 350
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 72/313 (23%), Positives = 120/313 (38%), Gaps = 90/313 (28%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 639
V+ LK ++ ++ + + E+ M+ + +H I+ + G ++ +
Sbjct: 106 VKMLK-SDATEKDLSDL----ISEMEMMKMIGKHKNIINLLG--ACTQ---------DGP 149
Query: 640 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 688
L + +EY G+++ Y S E+ +S K + A VA +
Sbjct: 150 LY---VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 206
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 748
L SK +HRD+ + N+L+ + V+K+ DF A R I D
Sbjct: 207 LASKKCIHRDLAARNVLVTEDN-------VMKIADFGLA--------------RDIHHID 245
Query: 749 VCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELE 801
T P +WMAPE L +Y + D+WS+G LL E+ TL PY G+ E
Sbjct: 246 YYKKTTNGRLPVKWMAPEAL----FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301
Query: 802 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 861
+ L++ G R +KP + L + R C P
Sbjct: 302 LFKLLKEGHR------------------------MDKPS---NCTNELYMMMRDCWHAVP 334
Query: 862 TERPTAGDLYEMF 874
++RPT L E
Sbjct: 335 SQRPTFKQLVEDL 347
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 45/198 (22%), Positives = 74/198 (37%), Gaps = 53/198 (26%)
Query: 604 EVRMLGALRHSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIE 660
EV +L + ++ + W D + + +E + + ++I
Sbjct: 96 EVVLLKKVSSGFSGVIRLLD------WFERPD-----SFV---LILERPEPVQDLFDFIT 141
Query: 661 ---KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 717
L E +LA V A+ H+ ++HRDIK ENILIDL R +
Sbjct: 142 ERGALQE--------ELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE----- 188
Query: 718 VVKLCDFD-RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 775
+KL DF A+ + GT + PE +R + Y G
Sbjct: 189 -LKLIDFGSGALLKDTVYTDFD-------------GTRVYSPPEWIRY----HRYHGRSA 230
Query: 776 DIWSYGCLLLELLTLQVP 793
+WS G LL +++ +P
Sbjct: 231 AVWSLGILLYDMVCGDIP 248
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 50/174 (28%), Positives = 78/174 (44%), Gaps = 46/174 (26%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
ME+V GG + +I+K + A F A ++ +AL+ LH K I++RD+K +N+L+
Sbjct: 103 MEFVNGGDLMFHIQK-----SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL 157
Query: 707 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 756
D +G KL DF T C GTP +
Sbjct: 158 D-----HEGH--CKLADFGMCKEGICNGVTT-------ATFC-------------GTPDY 190
Query: 757 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
+APE+L+ M YG VD W+ G LL E+L P+ +E ++ + I +
Sbjct: 191 IAPEILQEML----YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE 240
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 66/313 (21%), Positives = 118/313 (37%), Gaps = 90/313 (28%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 639
V+ LK ++ ++ + + E+ M+ + +H I+ + G P +
Sbjct: 118 VKMLKD-DATEKDLSDL----VSEMEMMKMIGKHKNIINLLGA--------CTQDGPLY- 163
Query: 640 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 688
+ +EY G+++ Y ++ E+ ++ K + +A +
Sbjct: 164 -----VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 218
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 748
L S+ +HRD+ + N+L+ + V+K+ DF A R I D
Sbjct: 219 LASQKCIHRDLAARNVLV------TENN-VMKIADFGLA--------------RDINNID 257
Query: 749 VCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELE 801
T P +WMAPE L +Y + D+WS+G L+ E+ TL PY G+ E
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFD----RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313
Query: 802 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 861
+ L++ G R +KP + L + R C P
Sbjct: 314 LFKLLKEGHR------------------------MDKPA---NCTNELYMMMRDCWHAVP 346
Query: 862 TERPTAGDLYEMF 874
++RPT L E
Sbjct: 347 SQRPTFKQLVEDL 359
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 67/313 (21%), Positives = 114/313 (36%), Gaps = 91/313 (29%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+ LK + + E+ +L L H I++ G A
Sbjct: 65 VKALKA-DAGPQHRSGW----KQEIDILRTLYHEHIIKYKG--CCED----AGAAS---- 109
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
LQ + MEYV GS+++Y+ + + + L AQ + + LH++H +HRD+
Sbjct: 110 LQ--LVMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLA 161
Query: 701 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 756
+ N+L+D +R +VK+ DF +AVP + P W
Sbjct: 162 ARNVLLDNDR-------LVKIGDFGLAKAVPEGHEYYR---VREDGDSPV--------FW 203
Query: 757 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL---------------QVPYMGLSELE 801
APE L+ + D+WS+G L ELLT + ++ L
Sbjct: 204 YAPECLKE----YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259
Query: 802 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 861
+ +L++ G+R L C P + + + C E
Sbjct: 260 LTELLERGER------LPRPDKC--------------PAE-------VYHLMKNCWETEA 292
Query: 862 TERPTAGDLYEMF 874
+ RPT +L +
Sbjct: 293 SFRPTFENLIPIL 305
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 53/205 (25%), Positives = 83/205 (40%), Gaps = 57/205 (27%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--ME-YVKGGSVKNYIE 660
E+ +L + H+ I+++ ++ ME + G + +I+
Sbjct: 79 EIAILSRVEHANIIKVL-DIFENQ---------------GFFQLVMEKHGSGLDLFAFID 122
Query: 661 ---KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 717
+L E LA +I + + +A+ L K I+HRDIK ENI+I
Sbjct: 123 RHPRLDE--------PLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI-------AEDF 167
Query: 718 VVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLE 774
+KL DF A L +T C GT + APEVL N Y G E
Sbjct: 168 TIKLIDFGSAAYLERGKLFYTFC-------------GTIEYCAPEVLMG----NPYRGPE 210
Query: 775 VDIWSYGCLLLELLTLQVPYMGLSE 799
+++WS G L L+ + P+ L E
Sbjct: 211 LEMWSLGVTLYTLVFEENPFCELEE 235
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 56/301 (18%), Positives = 103/301 (34%), Gaps = 83/301 (27%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
++ ++ S + + +G+L H+ IV + G S
Sbjct: 47 IKVIED-KSGRQSFQAV----TDHMLAIGSLDHAHIVRLLGLCPGSSLQ----------- 90
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
+ +Y+ GS+ +++ + + +L L +A + L ++HR++
Sbjct: 91 ----LVTQYLPLGSLLDHVRQ----HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLA 142
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP------ 754
+ N+L+ V++ DF A +P D +
Sbjct: 143 ARNVLLKSPS-------QVQVADFGVA--------------DLLPPDDKQLLYSEAKTPI 181
Query: 755 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPR 813
+WMA E + Y + D+WSYG + EL+T PY GL E+ DL++ G+R
Sbjct: 182 KWMALESIHF----GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER-- 235
Query: 814 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 873
L C + V +C + RPT +L
Sbjct: 236 ----LAQPQIC--------------TID-------VYMVMVKCWMIDENIRPTFKELANE 270
Query: 874 F 874
F
Sbjct: 271 F 271
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 52/210 (24%), Positives = 83/210 (39%), Gaps = 40/210 (19%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E + L+H IVE+ S +++ E++ G + I K
Sbjct: 76 EASICHMLKHPHIVELLETYSSDG---------MLYMV-----FEFMDGADLCFEIVK-R 120
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
S +A + + AL H +I+HRD+K +L+ K + P VKL
Sbjct: 121 ADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLA---SKENSAP-VKLGG 176
Query: 724 FDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 780
F A+ L GTP +MAPEV++ YG VD+W
Sbjct: 177 FGVAIQLGESGLVAGGRV-------------GTPHFMAPEVVKR----EPYGKPVDVWGC 219
Query: 781 GCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
G +L LL+ +P+ G ++ + + I GK
Sbjct: 220 GVILFILLSGCLPFYG-TKERLFEGIIKGK 248
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-20
Identities = 48/174 (27%), Positives = 75/174 (43%), Gaps = 46/174 (26%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
++Y+ GG + ++++ E+ A F A ++A+AL LHS +I++RD+K ENIL+
Sbjct: 118 LDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL 172
Query: 707 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 756
D + G + L DF T C GTP +
Sbjct: 173 D-----SQGH--IVLTDFGLCKENIEHNSTT-------STFC-------------GTPEY 205
Query: 757 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
+APEVL Y VD W G +L E+L P+ + E++D I
Sbjct: 206 LAPEVLHKQP----YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP 255
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-20
Identities = 55/237 (23%), Positives = 93/237 (39%), Gaps = 51/237 (21%)
Query: 578 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 636
AA + T K+ ++ E R+ L+H IV ++
Sbjct: 40 AAMIINTKKLSARDHQKLER-------EARICRLLKHPNIVRLHDSISEEG--------- 83
Query: 637 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 696
H+L+ + V GG + I ++ S A Q + A++ H ++H
Sbjct: 84 HHYLI-----FDLVTGGELFEDIVA-----REYYSEADASHCIQQILEAVLHCHQMGVVH 133
Query: 697 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS---FLHTCCIAHRGIPAPDVCVGT 753
R++K EN+L+ + K A VKL DF A+ + GT
Sbjct: 134 RNLKPENLLLASKLKGAA----VKLADFGLAIEVEGEQQAWFGFA-------------GT 176
Query: 754 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
P +++PEVLR + YG VD+W+ G +L LL P+ + ++ I+ G
Sbjct: 177 PGYLSPEVLRK----DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA 229
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 49/242 (20%), Positives = 87/242 (35%), Gaps = 59/242 (24%)
Query: 578 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS-CIVEMYGHKISSKWLPSADGN 635
AAK + + EI + E+ +L + ++ ++ +
Sbjct: 58 AAKFLKKRRRGQDCRAEILH-------EIAVLELAKSCPRVINLHE---------VYENT 101
Query: 636 PEHHLLQSAIFMEYVKGGS-----VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH 690
E L+ +EY GG + E +SE + + + + + LH
Sbjct: 102 SEIILI-----LEYAAGGEIFSLCLPELAEMVSE--------NDVIRLIKQILEGVYYLH 148
Query: 691 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPD 748
+I+H D+K +NIL L G +K+ DF + + L
Sbjct: 149 QNNIVHLDLKPQNIL--LSSIYPLGD--IKIVDFGMSRKIGHACELREIM---------- 194
Query: 749 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 808
GTP ++APE+L + P D+W+ G + LLT P++G E + I
Sbjct: 195 ---GTPEYLAPEILN--YDP--ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ 247
Query: 809 GK 810
Sbjct: 248 VN 249
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 4e-20
Identities = 56/194 (28%), Positives = 83/194 (42%), Gaps = 56/194 (28%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYI-- 659
E++ L RH I+++Y IS+ + F MEYV GG + +YI
Sbjct: 61 EIQNLKLFRHPHIIKLY-QVISTP---------------TDFFMVMEYVSGGELFDYICK 104
Query: 660 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 718
++ E A + Q + +A+ H ++HRD+K EN+L+D
Sbjct: 105 HGRVEE--------MEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN------- 149
Query: 719 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 775
K+ DF + + FL T C G+P + APEV+ LY G EV
Sbjct: 150 AKIADFGLSNMMSDGEFLRTSC-------------GSPNYAAPEVISG----RLYAGPEV 192
Query: 776 DIWSYGCLLLELLT 789
DIWS G +L LL
Sbjct: 193 DIWSCGVILYALLC 206
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-20
Identities = 50/190 (26%), Positives = 76/190 (40%), Gaps = 48/190 (25%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---E 660
E+ +L L H I+++ + E L+ +E V GG + + I
Sbjct: 98 EIGVLLRLSHPNIIKLKE------IFETPT---EISLV-----LELVTGGELFDRIVEKG 143
Query: 661 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 720
SE + A + + A+ LH I+HRD+K EN+L D +K
Sbjct: 144 YYSE--------RDAADAVKQILEAVAYLHENGIVHRDLKPENLL--YATPAPDAP--LK 191
Query: 721 LCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 778
+ DF + + + T C GTP + APE+LR YG EVD+W
Sbjct: 192 IADFGLSKIVEHQVLMKTVC-------------GTPGYCAPEILRGCA----YGPEVDMW 234
Query: 779 SYGCLLLELL 788
S G + LL
Sbjct: 235 SVGIITYILL 244
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 68/314 (21%), Positives = 119/314 (37%), Gaps = 90/314 (28%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 639
V+ LK G++ E R + E+++L + H +V + G +K P
Sbjct: 62 VKMLKE-GATHSEHRAL----MSELKILIHIGHHLNVVNLLG--ACTK--------PGGP 106
Query: 640 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 688
L+ + +E+ K G++ Y + + ++++ + + VA +
Sbjct: 107 LM---VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 163
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 748
L S+ +HRD+ + NIL+ ++ VVK+CDF A R I
Sbjct: 164 LASRKCIHRDLAARNILL------SEKN-VVKICDFGLA--------------RDIYKDP 202
Query: 749 VCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSE-L 800
V P +WMAPE + +Y ++ D+WS+G LL E+ +L PY G+
Sbjct: 203 DYVRKGDARLPLKWMAPETIFD----RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258
Query: 801 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 860
E ++ G R P+ T + C
Sbjct: 259 EFCRRLKEGTR------------------------MRAPD---YTTPEMYQTMLDCWHGE 291
Query: 861 PTERPTAGDLYEMF 874
P++RPT +L E
Sbjct: 292 PSQRPTFSELVEHL 305
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 5e-20
Identities = 56/192 (29%), Positives = 75/192 (39%), Gaps = 50/192 (26%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---E 660
E+ +LRH IV I + HL AI MEY GG + I
Sbjct: 66 EIINHRSLRHPNIVRFK-EVILTP----------THL---AIIMEYASGGELYERICNAG 111
Query: 661 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 720
+ SE A F Q + + + HS I HRD+K EN L+D P +K
Sbjct: 112 RFSE--------DEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLD-----GSPAPRLK 158
Query: 721 LCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEVDI 777
+CDF ++ L S + GTP ++APEVL Y G D+
Sbjct: 159 ICDFGYSKSSVLHSQPKSTV-------------GTPAYIAPEVLLR----QEYDGKIADV 201
Query: 778 WSYGCLLLELLT 789
WS G L +L
Sbjct: 202 WSCGVTLYVMLV 213
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 9e-20
Identities = 65/310 (20%), Positives = 115/310 (37%), Gaps = 75/310 (24%)
Query: 581 VRTLKV-CGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHH 639
V+ LK S + + +F + EV + +L H ++ +YG + P
Sbjct: 51 VKCLKPDVLSQPEAMDDF----IREVNAMHSLDHRNLIRLYG--VVL-------TPP--- 94
Query: 640 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 699
++ + E GS+ + + K + H + A VA + L SK +HRD+
Sbjct: 95 -MK--MVTELAPLGSLLDRLRK----HQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDL 147
Query: 700 KSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 757
+ N+L+ + +VK+ DF RA+P + P W
Sbjct: 148 AARNLLL-------ATRDLVKIGDFGLMRALPQND---DHYVMQEHRKVP------FAWC 191
Query: 758 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLI-QMGKRPRLT 815
APE L+ + D W +G L E+ T Q P++GL+ +I I + G+R
Sbjct: 192 APESLKT----RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER---- 243
Query: 816 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 875
L C P+ + +V +C P +RPT L + +
Sbjct: 244 --LPRPEDC--------------PQD-------IYNVMVQCWAHKPEDRPTFVALRDFLL 280
Query: 876 ARTSSSISSR 885
+ + +
Sbjct: 281 EAQPTDMRAE 290
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 9e-20
Identities = 49/170 (28%), Positives = 75/170 (44%), Gaps = 30/170 (17%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
ME + GG + ++ + G++ + + A I + + A+ LHS +I HRD+K EN+L
Sbjct: 138 MECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 194
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 764
+R A +KL DF A S L T C TP ++APEVL
Sbjct: 195 TSKRPNAI----LKLTDFGFAKETTSHNSLTTPC-------------YTPYYVAPEVL-- 235
Query: 765 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG----LSELEIHDLIQMGK 810
P Y D+WS G ++ LL P+ + I+MG+
Sbjct: 236 --GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 283
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 40/155 (25%), Positives = 59/155 (38%), Gaps = 37/155 (23%)
Query: 645 IFMEY-VKGGSVKNYIE---KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
+ +E + + +YI L E + V AA+ HS+ ++HRDIK
Sbjct: 115 LVLERPLPAQDLFDYITEKGPLGE--------GPSRCFFGQVVAAIQHCHSRGVVHRDIK 166
Query: 701 SENILIDLERKKADGKPVVKLCDFD-RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 759
ENILIDL R KL DF A+ GT + P
Sbjct: 167 DENILIDLRRGC------AKLIDFGSGALLHDEPYTDFD-------------GTRVYSPP 207
Query: 760 EVLRAMHKPNLY-GLEVDIWSYGCLLLELLTLQVP 793
E + + Y L +WS G LL +++ +P
Sbjct: 208 EWISR----HQYHALPATVWSLGILLYDMVCGDIP 238
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 1e-19
Identities = 52/227 (22%), Positives = 88/227 (38%), Gaps = 46/227 (20%)
Query: 595 RNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS 654
R E L E ++L + +V + A + L + + GG
Sbjct: 225 RKGEAMALNEKQILEKVNSRFVVSLA----------YAYETKDALCL----VLTLMNGGD 270
Query: 655 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 714
+K +I + G+ A+F A ++ L +LH + I++RD+K ENIL+D
Sbjct: 271 LKFHIYHM---GQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD-----DH 322
Query: 715 GKPVVKLCDFDRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 772
G +++ D A VP + GT +MAPEV++ Y
Sbjct: 323 GH--IRISDLGLAVHVPEGQTIKGRV-------------GTVGYMAPEVVKNER----YT 363
Query: 773 LEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 819
D W+ GCLL E++ Q P+ + + + +R E
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKEVPEE 407
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 68/320 (21%), Positives = 113/320 (35%), Gaps = 97/320 (30%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+ LK +SAD +F E ++ + IV++ G A G P +
Sbjct: 82 VKMLKE-EASADMQADF----QREAALMAEFDNPNIVKLLG--------VCAVGKP---M 125
Query: 641 LQSAIFMEYVKGGSVKNY-------------------IEKLSETGEKHVSVKLALFIAQD 681
+ EY+ G + + ++S G +S L IA+
Sbjct: 126 C---LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 182
Query: 682 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 741
VAA + L + +HRD+ + N L+ VVK+ DF +
Sbjct: 183 VAAGMAYLSERKFVHRDLATRNCLVGENM-------VVKIADFGLS-------------- 221
Query: 742 RGIPAPDVCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPY 794
R I + D P RWM PE + N Y E D+W+YG +L E+ + PY
Sbjct: 222 RNIYSADYYKADGNDAIPIRWMPPESI----FYNRYTTESDVWAYGVVLWEIFSYGLQPY 277
Query: 795 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 854
G++ E+ ++ G PE L ++ R
Sbjct: 278 YGMAHEEVIYYVRDGNI------------------------LACPE---NCPLELYNLMR 310
Query: 855 RCTEENPTERPTAGDLYEMF 874
C + P +RP+ ++ +
Sbjct: 311 LCWSKLPADRPSFCSIHRIL 330
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 33/168 (19%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENIL 705
MEY GG + ++ + E+ S A F ++ +AL LHS+ +++RD+K EN++
Sbjct: 227 MEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 281
Query: 706 IDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 762
+D DG +K+ DF + + + T C GTP ++APEVL
Sbjct: 282 LD-----KDGH--IKITDFGLCKEGIKDGATMKTFC-------------GTPEYLAPEVL 321
Query: 763 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
N YG VD W G ++ E++ ++P+ ++ +LI M +
Sbjct: 322 ED----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 365
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 50/233 (21%), Positives = 98/233 (42%), Gaps = 47/233 (20%)
Query: 578 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 637
AK +KV G+ ++ E+ +L RH I+ ++ S + E
Sbjct: 34 MAKF--VKVKGTDQVLVKK-------EISILNIARHRNILHLHE---------SFESMEE 75
Query: 638 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 697
++ E++ G + E+++ + + ++ ++ Q V AL LHS +I H
Sbjct: 76 LVMI-----FEFISGLDI---FERINTSAFELNEREIVSYVHQ-VCEALQFLHSHNIGHF 126
Query: 698 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 757
DI+ ENI+ + +++ +K+ +F +A L+ G + P +
Sbjct: 127 DIRPENII--YQTRRSS---TIKIIEFGQARQLKP----------GDNFRLLF-TAPEYY 170
Query: 758 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
APEV + H D+WS G L+ LL+ P++ + +I + I +
Sbjct: 171 APEVHQ--HDV--VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE 219
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 60/314 (19%), Positives = 107/314 (34%), Gaps = 95/314 (30%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
++TLK + F E + L+H +V + G + +K P
Sbjct: 44 IKTLKD-KAEGPLREEF----RHEAMLRARLQHPNVVCLLG--VVTK------DQP---- 86
Query: 641 LQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVEL 689
++ Y G + + T + + + + +AA + L
Sbjct: 87 --LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL 144
Query: 690 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 749
S H++H+D+ + N+L+ + VK+ D R + A D
Sbjct: 145 SSHHVVHKDLATRNVLVYDKL-------NVKISDLGLF--------------REVYAADY 183
Query: 750 CVGT-----P-RWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSE 799
P RWMAPE + +YG ++ DIWSYG +L E+ + PY G S
Sbjct: 184 YKLLGNSLLPIRWMAPEAI-------MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 236
Query: 800 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 859
++ ++I+ + L C P + + C E
Sbjct: 237 QDVVEMIRNRQV------LPCPDDC--------------PAW-------VYALMIECWNE 269
Query: 860 NPTERPTAGDLYEM 873
P+ RP D++
Sbjct: 270 FPSRRPRFKDIHSR 283
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 92.0 bits (228), Expect = 3e-19
Identities = 51/174 (29%), Positives = 79/174 (45%), Gaps = 46/174 (26%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
MEYV GG + +I+++ E H A+F A ++A L L SK I++RD+K +N+++
Sbjct: 421 MEYVNGGDLMYHIQQVGRFKEPH-----AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 475
Query: 707 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 756
D ++G +K+ DF T C GTP +
Sbjct: 476 D-----SEGH--IKIADFGMCKENIWDGVTT-------KTFC-------------GTPDY 508
Query: 757 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
+APE++ YG VD W++G LL E+L Q P+ G E E+ I
Sbjct: 509 IAPEIIAYQP----YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 558
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 4e-19
Identities = 38/163 (23%), Positives = 67/163 (41%), Gaps = 29/163 (17%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
++ + GG + ++ + S F A ++ L +H++ +++RD+K NIL+
Sbjct: 271 LDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 325
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFL-HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 765
D G V++ D A H GT +MAPEVL+
Sbjct: 326 D-----EHGH--VRISDLGLACDFSKKKPHASV-------------GTHGYMAPEVLQKG 365
Query: 766 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 808
Y D +S GC+L +LL P+ + H++ +M
Sbjct: 366 VA---YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 405
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 5e-19
Identities = 45/162 (27%), Positives = 81/162 (50%), Gaps = 34/162 (20%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
+EYV GG + ++++ + E+H A F + +++ AL LH + I++RD+K +N+L+
Sbjct: 89 IEYVNGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNYLHERGIIYRDLKLDNVLL 143
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV----CVGTPRWMAPEVL 762
D ++G +KL D+ + G+ D C GTP ++APE+L
Sbjct: 144 D-----SEGH--IKLTDY-------------GMCKEGLRPGDTTSTFC-GTPNYIAPEIL 182
Query: 763 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 804
R YG VD W+ G L+ E++ + P+ + + D
Sbjct: 183 RG----EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 72/316 (22%), Positives = 115/316 (36%), Gaps = 93/316 (29%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 639
V+ LK + E + E+++L L H IV + G G P
Sbjct: 58 VKMLKP-SAHLTEREAL----MSELKVLSYLGNHMNIVNLLGA--------CTIGGP--- 101
Query: 640 LLQSAIFMEYVKGGSVKNY-------------IEKLSETGEKHVSVKLALFIAQDVAAAL 686
L + EY G + N+ + E E + ++ L + VA +
Sbjct: 102 TL---VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM 158
Query: 687 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA 746
L SK+ +HRD+ + NIL+ R + K+CDF A R I
Sbjct: 159 AFLASKNCIHRDLAARNILLTHGR-------ITKICDFGLA--------------RDIKN 197
Query: 747 PDVCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSE 799
V P +WMAPE + +Y E D+WSYG L EL +L PY G+
Sbjct: 198 DSNYVVKGNARLPVKWMAPESI----FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 800 -LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 858
+ + +I+ G R PE + + D+ + C +
Sbjct: 254 DSKFYKMIKEGFR------------------------MLSPE---HAPAEMYDIMKTCWD 286
Query: 859 ENPTERPTAGDLYEMF 874
+P +RPT + ++
Sbjct: 287 ADPLKRPTFKQIVQLI 302
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-19
Identities = 68/312 (21%), Positives = 112/312 (35%), Gaps = 89/312 (28%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 639
V+ LK + ADE + E++++ L +H IV + G G P
Sbjct: 81 VKMLKS-TAHADEKEAL----MSELKIMSHLGQHENIVNLLGA--------CTHGGP--- 124
Query: 640 LLQSAIFMEYVKGGSVKNY---------IEKLSETGEKHVSVKLALFIAQDVAAALVELH 690
+L + EY G + N+ + S + L + VA + L
Sbjct: 125 VL---VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA 181
Query: 691 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC 750
SK+ +HRD+ + N+L+ +G V K+ DF A R I
Sbjct: 182 SKNCIHRDVAARNVLL------TNGH-VAKIGDFGLA--------------RDIMNDSNY 220
Query: 751 VGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMG-LSELEI 802
+ P +WMAPE + +Y ++ D+WSYG LL E+ +L PY G L +
Sbjct: 221 IVKGNARLPVKWMAPESI----FDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276
Query: 803 HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 862
+ L++ G + +P + + + C PT
Sbjct: 277 YKLVKDGYQ------------------------MAQPA---FAPKNIYSIMQACWALEPT 309
Query: 863 ERPTAGDLYEMF 874
RPT +
Sbjct: 310 HRPTFQQICSFL 321
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 1e-18
Identities = 53/299 (17%), Positives = 99/299 (33%), Gaps = 78/299 (26%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
++ LK G+ + + E +++ L + IV + G + +
Sbjct: 368 IKVLKQ-GTEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQAEALM----------- 411
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
+ ME GG + ++ + + V + V+ + L K+ +HR++
Sbjct: 412 ----LVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLA 463
Query: 701 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 756
+ N+L+ K+ DF +A+ +T A P +W
Sbjct: 464 ARNVLLVNRH-------YAKISDFGLSKALGADDSYYT---ARSAGKWPL--------KW 505
Query: 757 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 815
APE + + D+WSYG + E L+ Q PY + E+ I+ GKR
Sbjct: 506 YAPECINF----RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---- 557
Query: 816 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
+E C P L + C +RP + +
Sbjct: 558 --MECPPEC--------------PPE-------LYALMSDCWIYKWEDRPDFLTVEQRM 593
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 1e-18
Identities = 42/171 (24%), Positives = 71/171 (41%), Gaps = 32/171 (18%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
M + GG ++ +I + E A+F + + L LH ++I++RD+K EN+L+
Sbjct: 264 MTIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL 322
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSF---LHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 763
D DG V++ D AV L++ GTP +MAPE+L
Sbjct: 323 D-----DDGN--VRISDLGLAVELKAGQTKTKGYA-------------GTPGFMAPELLL 362
Query: 764 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL----EIHDLIQMGK 810
Y VD ++ G L E++ + P+ E E+ +
Sbjct: 363 GEE----YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA 409
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 68/307 (22%), Positives = 117/307 (38%), Gaps = 81/307 (26%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 639
++ +K +S D+ R+F GE+ +L L H I+ + G +
Sbjct: 57 IKRMKE-YASKDDHRDF----AGELEVLCKLGHHPNIINLLGA--------CEHRGYLY- 102
Query: 640 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 688
+ +EY G++ ++ ++ + +S + L A DVA +
Sbjct: 103 -----LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 157
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 748
L K +HRD+ + NIL+ V K+ DF + R +P
Sbjct: 158 LSQKQFIHRDLAARNILVGENY-------VAKIADFGLS---RGQEVYVKKTMGRLPV-- 205
Query: 749 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQ 807
RWMA E L ++Y D+WSYG LL E+++L PY G++ E+++ +
Sbjct: 206 ------RWMAIESLNY----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255
Query: 808 MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867
G R LE +C + + D+ R+C E P ERP+
Sbjct: 256 QGYR------LEKPLNC--------------DDE-------VYDLMRQCWREKPYERPSF 288
Query: 868 GDLYEMF 874
+
Sbjct: 289 AQILVSL 295
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-18
Identities = 45/168 (26%), Positives = 79/168 (47%), Gaps = 46/168 (27%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
+EYV GG + ++++ + E+H A F + +++ AL LH + I++RD+K +N+L+
Sbjct: 132 IEYVNGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNYLHERGIIYRDLKLDNVLL 186
Query: 707 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 756
D ++G +KL D+ D T C GTP +
Sbjct: 187 D-----SEGH--IKLTDYGMCKEGLRPGDTT-------STFC-------------GTPNY 219
Query: 757 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 804
+APE+LR YG VD W+ G L+ E++ + P+ + + D
Sbjct: 220 IAPEILRGED----YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 5e-18
Identities = 54/242 (22%), Positives = 86/242 (35%), Gaps = 58/242 (23%)
Query: 593 EIRNFEYSCLGEVRMLGALRHSCIVEMY----GHKISSKWLPSADGNPEHHLLQSAIFME 648
E S E+ +L L+H ++ + H WL +
Sbjct: 57 EGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL----------------LFD 100
Query: 649 YVKGGSVKNYIEKLSETGEKHVSVKLAL-----FIAQDVAAALVELHSKHIMHRDIKSEN 703
Y + + + I+ + V+L + Q + + LH+ ++HRD+K N
Sbjct: 101 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ-ILDGIHYLHANWVLHRDLKPAN 158
Query: 704 ILIDLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-A 758
IL+ E + VK+ D A PL+ D V T W A
Sbjct: 159 ILVMGE---GPERGRVKIADMGFARLFNSPLKPLAD-----------LDPVVVT-FWYRA 203
Query: 759 PEVL-RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE 817
PE+L A H Y +DIW+ GC+ ELLT + + E P D+
Sbjct: 204 PELLLGARH----YTKAIDIWAIGCIFAELLTSEPIFHCRQE------DIKTSNPYHHDQ 253
Query: 818 LE 819
L+
Sbjct: 254 LD 255
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 5e-18
Identities = 46/207 (22%), Positives = 82/207 (39%), Gaps = 38/207 (18%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E+ ++ L H ++ ++ + + E L +E++ GG + ++++
Sbjct: 98 EISIMNQLHHPKLINLHD---------AFEDKYEMVL-----ILEFLSGGEL---FDRIA 140
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
K ++ ++ Q L +H I+H DIK ENI+ E KKA VK+ D
Sbjct: 141 AEDYKMSEAEVINYMRQ-ACEGLKHMHEHSIVHLDIKPENIM--CETKKAS---SVKIID 194
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
F A L T + APE++ +P G D+W+ G L
Sbjct: 195 FGLATKLNP----------DEIVKVTT-ATAEFAAPEIVD--REP--VGFYTDMWAIGVL 239
Query: 784 LLELLTLQVPYMGLSELEIHDLIQMGK 810
LL+ P+ G +LE ++
Sbjct: 240 GYVLLSGLSPFAGEDDLETLQNVKRCD 266
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 7e-18
Identities = 58/194 (29%), Positives = 84/194 (43%), Gaps = 56/194 (28%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYI-- 659
E++ L RH I+++Y IS+ S IF MEYV GG + +YI
Sbjct: 66 EIQNLKLFRHPHIIKLY-QVISTP---------------SDIFMVMEYVSGGELFDYICK 109
Query: 660 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 718
+L E K + + Q + + + H ++HRD+K EN+L+D
Sbjct: 110 NGRLDE--------KESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN------- 154
Query: 719 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 775
K+ DF + + FL T C G+P + APEV+ LY G EV
Sbjct: 155 AKIADFGLSNMMSDGEFLRTSC-------------GSPNYAAPEVISG----RLYAGPEV 197
Query: 776 DIWSYGCLLLELLT 789
DIWS G +L LL
Sbjct: 198 DIWSSGVILYALLC 211
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 8e-18
Identities = 46/207 (22%), Positives = 79/207 (38%), Gaps = 38/207 (18%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E++ + LRH +V ++ + + + E ++ E++ GG + +
Sbjct: 204 EIQTMSVLRHPTLVNLHD---------AFEDDNEMVMI-----YEFMSGGELFEKV--AD 247
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
E +S A+ + V L +H + +H D+K ENI+ +R +KL D
Sbjct: 248 EHN--KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE-----LKLID 300
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
F L GT + APEV KP G D+WS G L
Sbjct: 301 FGLTAHLDP----------KQSVKVTT-GTAEFAAPEVAE--GKP--VGYYTDMWSVGVL 345
Query: 784 LLELLTLQVPYMGLSELEIHDLIQMGK 810
LL+ P+ G ++ E ++
Sbjct: 346 SYILLSGLSPFGGENDDETLRNVKSCD 372
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 53/194 (27%), Positives = 83/194 (42%), Gaps = 57/194 (29%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYI-- 659
E+ L LRH I+++Y I++ + I +EY GG + +YI
Sbjct: 59 EISYLKLLRHPHIIKLY-DVITTP---------------TDIVMVIEYA-GGELFDYIVE 101
Query: 660 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 718
++++E Q + A+ H I+HRD+K EN+L+D
Sbjct: 102 KKRMTE--------DEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN------- 146
Query: 719 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 775
VK+ DF + + +FL T C G+P + APEV+ LY G EV
Sbjct: 147 VKIADFGLSNIMTDGNFLKTSC-------------GSPNYAAPEVING----KLYAGPEV 189
Query: 776 DIWSYGCLLLELLT 789
D+WS G +L +L
Sbjct: 190 DVWSCGIVLYVMLV 203
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 39/199 (19%), Positives = 69/199 (34%), Gaps = 59/199 (29%)
Query: 604 EVRMLGALRHSCIVEMY---GHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVK-- 656
E+++L LRH ++++ ++ K ++ MEY G +
Sbjct: 56 EIQLLRRLRHKNVIQLVDVLYNEEKQK-----------------MYMVMEYCVCGMQEML 98
Query: 657 NYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 716
+ + + K V A + L LHS+ I+H+DIK N+L+
Sbjct: 99 DSVPE------KRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT----- 147
Query: 717 PVVKLCDF-----DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 771
+K+ T G+P + PE+ + +
Sbjct: 148 --LKISALGVAEALHPFAADDTCRTSQ-------------GSPAFQPPEIANGLD---TF 189
Query: 772 -GLEVDIWSYGCLLLELLT 789
G +VDIWS G L + T
Sbjct: 190 SGFKVDIWSAGVTLYNITT 208
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 47/213 (22%), Positives = 85/213 (39%), Gaps = 50/213 (23%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---- 659
E+ ++ L H+ ++++Y + + + L MEYV GG + + I
Sbjct: 136 EISVMNQLDHANLIQLYD---------AFESKNDIVL-----VMEYVDGGELFDRIIDES 181
Query: 660 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 719
L+E + + + + +H +I+H D+K ENIL + A +
Sbjct: 182 YNLTE--------LDTILFMKQICEGIRHMHQMYILHLDLKPENIL--CVNRDAK---QI 228
Query: 720 KLCDFDRAVPL--RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 777
K+ DF A R L GTP ++APEV+ + D+
Sbjct: 229 KIIDFGLARRYKPREKLKVNF-------------GTPEFLAPEVVN--YDF--VSFPTDM 271
Query: 778 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 810
WS G + LL+ P++G ++ E + I +
Sbjct: 272 WSVGVIAYMLLSGLSPFLGDNDAETLNNILACR 304
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 5e-17
Identities = 53/207 (25%), Positives = 82/207 (39%), Gaps = 57/207 (27%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYIEK 661
E+RML L+H +V + + + + EY +V + +++
Sbjct: 52 EIRMLKQLKHPNLVNLL--------------EVFRR--KRRLHLVFEYCDH-TVLHELDR 94
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
+H+ VK Q A+ H + +HRD+K ENILI V+KL
Sbjct: 95 YQRGVPEHL-VKS--ITWQ-TLQAVNFCHKHNCIHRDVKPENILIT-----KHS--VIKL 143
Query: 722 CDFD--RA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVL-RAMHKPNLYGLEV 775
CDF R P + V T RW +PE+L YG V
Sbjct: 144 CDFGFARLLTGPSDYYDDE--------------VAT-RWYRSPELLVGDTQ----YGPPV 184
Query: 776 DIWSYGCLLLELLTLQVPYM-GLSELE 801
D+W+ GC+ ELL+ P G S+++
Sbjct: 185 DVWAIGCVFAELLSGV-PLWPGKSDVD 210
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-17
Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 45/203 (22%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
EV +L L+H I+E+ + HH + + EY + +K Y++K
Sbjct: 83 EVSLLKELQHRNIIEL--KSV------------IHHNHRLHLIFEYAEN-DLKKYMDKNP 127
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
+ + + F+ Q + + HS+ +HRD+K +N+L+ + V+K+ D
Sbjct: 128 DVSMRVI----KSFLYQ-LINGVNFCHSRRCLHRDLKPQNLLLSVSDASETP--VLKIGD 180
Query: 724 F--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIW 778
F RA +P+R F H + T W PE+L Y VDIW
Sbjct: 181 FGLARAFGIPIRQFTHE--------------IIT-LWYRPPEILLGSRH---YSTSVDIW 222
Query: 779 SYGCLLLELLTLQVPYMGLSELE 801
S C+ E+L + G SE++
Sbjct: 223 SIACIWAEMLMKTPLFPGDSEID 245
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 9e-17
Identities = 69/324 (21%), Positives = 112/324 (34%), Gaps = 104/324 (32%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 639
V+ LK + + E + E++M+ L H IV + G P
Sbjct: 80 VKMLKE-KADSSEREAL----MSELKMMTQLGSHENIVNLLGA--------CTLSGP--- 123
Query: 640 LLQSAIFMEYVKGGSVKNY------------------IEKLSETGEKHVSVKLALFIAQD 681
+ + EY G + NY E ++ + L A
Sbjct: 124 IY---LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ 180
Query: 682 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 741
VA + L K +HRD+ + N+L+ + VVK+CDF A
Sbjct: 181 VAKGMEFLEFKSCVHRDLAARNVLVTHGK-------VVKICDFGLA-------------- 219
Query: 742 RGIPAPDVCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPY 794
R I + V P +WMAPE L +Y ++ D+WSYG LL E+ +L PY
Sbjct: 220 RDIMSDSNYVVRGNARLPVKWMAPESLFE----GIYTIKSDVWSYGILLWEIFSLGVNPY 275
Query: 795 MGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE---AELETLSFLV 850
G+ + + LIQ G + ++P E+
Sbjct: 276 PGIPVDANFYKLIQNGFK------------------------MDQPFYATEEIY------ 305
Query: 851 DVFRRCTEENPTERPTAGDLYEMF 874
+ + C + +RP+ +L
Sbjct: 306 IIMQSCWAFDSRKRPSFPNLTSFL 329
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 57/207 (27%)
Query: 604 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 661
E+++L LRH +V + K +L +F E+V ++ + +E
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYL---------------VF-EFVDH-TILDDLEL 116
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
+ V V+ ++ Q + + HS +I+HRDIK ENIL+ G VVKL
Sbjct: 117 FPNGLDYQV-VQK--YLFQ-IINGIGFCHSHNIIHRDIKPENILVS-----QSG--VVKL 165
Query: 722 CDF--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVL-RAMHKPNLYGLEV 775
CDF R P + V T RW APE+L + YG V
Sbjct: 166 CDFGFARTLAAPGEVYDD--------------EVAT-RWYRAPELLVGDVK----YGKAV 206
Query: 776 DIWSYGCLLLELLTLQVPYM-GLSELE 801
D+W+ GCL+ E+ + P G S+++
Sbjct: 207 DVWAIGCLVTEMFMGE-PLFPGDSDID 232
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 48/206 (23%), Positives = 82/206 (39%), Gaps = 54/206 (26%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 661
E+ +L L+H IV ++ + H + E+ +K Y +
Sbjct: 51 EICLLKELKHKNIVRLH--------------DVLHS--DKKLTLVFEFCDQ-DLKKYFDS 93
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
+ + + VK F+ Q + L HS++++HRD+K +N+LI+ +G +KL
Sbjct: 94 CNGDLDPEI-VKS--FLFQ-LLKGLGFCHSRNVLHRDLKPQNLLIN-----RNG--ELKL 142
Query: 722 CDF--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVD 776
+F RA +P+R + V T W P+VL Y +D
Sbjct: 143 ANFGLARAFGIPVRCYSA--------------EVVT-LWYRPPDVLFGAKL---YSTSID 184
Query: 777 IWSYGCLLLELLTLQVPYM-GLSELE 801
+WS GC+ EL P G +
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVDD 210
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-16
Identities = 46/193 (23%), Positives = 84/193 (43%), Gaps = 40/193 (20%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E++++ ++H +V++ + + D E L + +EYV +V +
Sbjct: 82 ELQIMRIVKHPNVVDLKAF-----FYSNGDKKDEVFLN---LVLEYV-PETVYRASRHYA 132
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
+ + + + L++ Q + +L +HS I HRDIK +N+L+D V+KL D
Sbjct: 133 KLKQTMPMLLIKLYMYQ-LLRSLAYIHSIGICHRDIKPQNLLLDPP------SGVLKLID 185
Query: 724 FDRA---VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEV-LRAMHKPNLYGLEVDIW 778
F A + + +C R+ APE+ A + Y +DIW
Sbjct: 186 FGSAKILIAGEPNVS------------YICS---RYYRAPELIFGATN----YTTNIDIW 226
Query: 779 SYGCLLLELLTLQ 791
S GC++ EL+ Q
Sbjct: 227 STGCVMAELMQGQ 239
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 66/286 (23%), Positives = 111/286 (38%), Gaps = 67/286 (23%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E++++ +H +VE+ G S+DG+ L ++ Y+ GS+ + +
Sbjct: 80 EIKVMAKCQHENLVELLGF--------SSDGD--DLCL---VY-VYMPNGSLLDRL--SC 123
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
G +S + IAQ A + LH H +HRDIKS NIL+D K+ D
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD-----EAFTA--KISD 176
Query: 724 FD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781
F RA + + R + VGT +MAPE LR + + DI+S+G
Sbjct: 177 FGLARASEKFAQTV---MTSR------I-VGTTAYMAPEALRG----EIT-PKSDIYSFG 221
Query: 782 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE--LEA-----LGSCHEHEVAQSGS 834
+LLE++T + L+ + K +E +E + V
Sbjct: 222 VVLLEIITGLPA-VDEHREP-QLLLDI-KEEIEDEEKTIEDYIDKKMNDADSTSVEA--- 275
Query: 835 GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 880
+ V +C E +RP + ++ T+S
Sbjct: 276 --------------MYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 37/151 (24%), Positives = 64/151 (42%), Gaps = 30/151 (19%)
Query: 644 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703
A+ E+V K + L++ + ++ + + AL HS IMHRD+K N
Sbjct: 109 ALVFEHVNNTDFKQLYQTLTD---YDI----RFYMYE-ILKALDYCHSMGIMHRDVKPHN 160
Query: 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVL 762
++ID E +K ++L D+ A + R V + R+ PE+L
Sbjct: 161 VMIDHEHRK------LRLIDWGLA---EFYHPGQEYNVR--------VAS-RYFKGPELL 202
Query: 763 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 793
Y +D+WS GC+L ++ + P
Sbjct: 203 VDYQM---YDYSLDMWSLGCMLASMIFRKEP 230
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-15
Identities = 52/206 (25%), Positives = 86/206 (41%), Gaps = 46/206 (22%)
Query: 594 IRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG 653
+ + E++++ L H IV + + S + E +L + ++YV
Sbjct: 87 VLQDKRFKNRELQIMRKLDHCNIVRLRYF-----FYSSGEKKDEVYL---NLVLDYV-PE 137
Query: 654 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 713
+V S + + + L++ Q + +L +HS I HRDIK +N+L+D +
Sbjct: 138 TVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSLAYIHSFGICHRDIKPQNLLLDPD---- 192
Query: 714 DGKPVVKLCDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEV-LRAM 765
V+KLCDF R P S+ +C R+ APE+ A
Sbjct: 193 --TAVLKLCDFGSAKQLVRGEPNVSY---------------ICS---RYYRAPELIFGAT 232
Query: 766 HKPNLYGLEVDIWSYGCLLLELLTLQ 791
Y +D+WS GC+L ELL Q
Sbjct: 233 D----YTSSIDVWSAGCVLAELLLGQ 254
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 4e-15
Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 49/203 (24%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E+ +L L+HS IV++Y + H + + E++ +K ++
Sbjct: 50 EISILKELKHSNIVKLY--------------DVIHTKKRLVLVFEHLDQ-DLKKLLDVCE 94
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
E K F+ Q + + H + ++HRD+K +N+LI+ +G +K+ D
Sbjct: 95 GGLESVT-AKS--FLLQ-LLNGIAYCHDRRVLHRDLKPQNLLIN-----REG--ELKIAD 143
Query: 724 F--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIW 778
F RA +P+R + H + T W AP+VL K Y +DIW
Sbjct: 144 FGLARAFGIPVRKYTH--------------EIVT-LWYRAPDVLMGSKK---YSTTIDIW 185
Query: 779 SYGCLLLELLTLQVPYMGLSELE 801
S GC+ E++ + G+SE +
Sbjct: 186 SVGCIFAEMVNGTPLFPGVSEAD 208
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 5e-15
Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 53/205 (25%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 661
E+ +L L H IV + + H + + E+++ +K +++
Sbjct: 69 EISLLKELHHPNIVSLI--------------DVIHS--ERCLTLVFEFMEK-DLKKVLDE 111
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
+ +K+ ++ Q + + H I+HRD+K +N+LI+ +DG +KL
Sbjct: 112 NKTGLQDSQ-IKI--YLYQ-LLRGVAHCHQHRILHRDLKPQNLLIN-----SDG--ALKL 160
Query: 722 CDF--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVD 776
DF RA +P+RS+ H V T W AP+VL K Y VD
Sbjct: 161 ADFGLARAFGIPVRSYTH--------------EVVT-LWYRAPDVLMGSKK---YSTSVD 202
Query: 777 IWSYGCLLLELLTLQVPYMGLSELE 801
IWS GC+ E++T + + G+++ +
Sbjct: 203 IWSIGCIFAEMITGKPLFPGVTDDD 227
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 8e-15
Identities = 45/126 (35%), Positives = 65/126 (51%), Gaps = 38/126 (30%)
Query: 685 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFD--RA--VPLRSFLHTCCIA 740
L LH I+HRD+K N+L+D +G V+KL DF ++ P R++ H
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLD-----ENG--VLKLADFGLAKSFGSPNRAYTH----- 171
Query: 741 HRGIPAPDVCVGTPRWM-APEVL---RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM- 795
V T RW APE+L R YG+ VD+W+ GC+L ELL +VP++
Sbjct: 172 ---------QVVT-RWYRAPELLFGARM------YGVGVDMWAVGCILAELLL-RVPFLP 214
Query: 796 GLSELE 801
G S+L+
Sbjct: 215 GDSDLD 220
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 48/164 (29%), Positives = 67/164 (40%), Gaps = 44/164 (26%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
E+V ++ Y++K G ++K + Q L LH+ I+HRD+K ENIL+
Sbjct: 98 FEHVDQ-DLRTYLDKAPPPGLPAETIKD--LMRQ-FLRGLDFLHANCIVHRDLKPENILV 153
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP----RWM-APEV 761
+ G VKL DF A R + TP W APEV
Sbjct: 154 T-----SGG--TVKLADFGLA---RIY---------SYQMA----LTPVVVTLWYRAPEV 190
Query: 762 LRAMHKPNL---YGLEVDIWSYGCLLLELLTLQVPYM-GLSELE 801
L L Y VD+WS GC+ E+ + P G SE +
Sbjct: 191 L-------LQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEAD 226
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 51/203 (25%), Positives = 85/203 (41%), Gaps = 49/203 (24%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
EV +L L+H+ IV + H I H + EY+ +K Y++
Sbjct: 50 EVSLLKDLKHANIVTL--HDI------------IHTEKSLTLVFEYLDK-DLKQYLDDCG 94
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
H VKL F+ Q + L H + ++HRD+K +N+LI+ G +KL D
Sbjct: 95 NIINMHN-VKL--FLFQ-LLRGLAYCHRQKVLHRDLKPQNLLIN-----ERG--ELKLAD 143
Query: 724 F--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIW 778
F RA +P +++ + V T W P++L Y ++D+W
Sbjct: 144 FGLARAKSIPTKTYDN--------------EVVT-LWYRPPDILLGSTD---YSTQIDMW 185
Query: 779 SYGCLLLELLTLQVPYMGLSELE 801
GC+ E+ T + + G + E
Sbjct: 186 GVGCIFYEMATGRPLFPGSTVEE 208
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 54/216 (25%), Positives = 86/216 (39%), Gaps = 56/216 (25%)
Query: 594 IRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG 653
IR E + L R L H +V + + + + E L + E+V
Sbjct: 59 IR--EVAVL---RHLETFEHPNVVRL--FDV----CTVSRTDRETKLT---LVFEHVDQ- 103
Query: 654 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 713
+ Y++K+ E G ++K + Q + L LHS ++HRD+K +NIL+ +
Sbjct: 104 DLTTYLDKVPEPGVPTETIKD--MMFQ-LLRGLDFLHSHRVVHRDLKPQNILVT-----S 155
Query: 714 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP----RWM-APEVLRAMHKP 768
G +KL DF A R + T W APEVL
Sbjct: 156 SG--QIKLADFGLA---RIY---------SFQMA----LTSVVVTLWYRAPEVL------ 191
Query: 769 NL---YGLEVDIWSYGCLLLELLTLQVPYMGLSELE 801
L Y VD+WS GC+ E+ + + G S+++
Sbjct: 192 -LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 226
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 51/212 (24%), Positives = 84/212 (39%), Gaps = 55/212 (25%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK---GGSVKNYIE 660
E+++L L+H +V + +K P +L+ ++ + G + N +
Sbjct: 66 EIKILQLLKHENVVNLIE-ICRTKASPYNRCKGSIYLV-----FDFCEHDLAGLLSNVLV 119
Query: 661 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 720
K + + K + + L +H I+HRD+K+ N+LI DG V+K
Sbjct: 120 KFTLSEIKR-------VMQM-LLNGLYYIHRNKILHRDMKAANVLIT-----RDG--VLK 164
Query: 721 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG-TPR----WM-APEVLRAMHKPNL---- 770
L DF A R+F + T R W PE+L L
Sbjct: 165 LADFGLA---RAF---------SLAKNSQPNRYTNRVVTLWYRPPELL-------LGERD 205
Query: 771 YGLEVDIWSYGCLLLELLTLQVPYM-GLSELE 801
YG +D+W GC++ E+ T P M G +E
Sbjct: 206 YGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQH 236
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 52/207 (25%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E+ ++ L+H IV + + + H + + E++ +K Y++ +
Sbjct: 53 EISLMKELKHENIVRL--YDV------------IHTENKLTLVFEFMDN-DLKKYMDSRT 97
Query: 664 ETGEKH----VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 719
VK F Q + L H I+HRD+K +N+LI+ G +
Sbjct: 98 VGNTPRGLELNLVKY--FQWQ-LLQGLAFCHENKILHRDLKPQNLLIN-----KRG--QL 147
Query: 720 KLCDF--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLE 774
KL DF RA +P+ +F V T W AP+VL Y
Sbjct: 148 KLGDFGLARAFGIPVNTFSS--------------EVVT-LWYRAPDVLMGSRT---YSTS 189
Query: 775 VDIWSYGCLLLELLTLQVPYMGLSELE 801
+DIWS GC+L E++T + + G ++ E
Sbjct: 190 IDIWSCGCILAEMITGKPLFPGTNDEE 216
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 6e-14
Identities = 51/229 (22%), Positives = 85/229 (37%), Gaps = 60/229 (26%)
Query: 654 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 713
S E + + ++++ + + VA + L S+ +HRD+ + NIL+ +
Sbjct: 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN--- 230
Query: 714 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT-----P-RWMAPEVLRAMHK 767
VVK+CDF A R I V P +WMAPE +
Sbjct: 231 ----VVKICDFGLA--------------RDIYKDPDYVRKGDARLPLKWMAPETIFD--- 269
Query: 768 PNLYGLEVDIWSYGCLLLELLTL-QVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCH 825
+Y ++ D+WS+G LL E+ +L PY G+ + E ++ G R + A
Sbjct: 270 -RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR------MRAPDYTT 322
Query: 826 EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
+ C P++RPT +L E
Sbjct: 323 PE---------------------MYQTMLDCWHGEPSQRPTFSELVEHL 350
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 6e-14
Identities = 53/241 (21%), Positives = 82/241 (34%), Gaps = 53/241 (21%)
Query: 660 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 719
E + + + S+ L A + L LH I+H D+K ENIL+ K G+ +
Sbjct: 187 ELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL-----KQQGRSGI 241
Query: 720 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 779
K+ DF + ++T I R AP+V +G YG+ +D+WS
Sbjct: 242 KVIDFGSSCYEHQRVYT-YIQSRFYRAPEVILGAR----------------YGMPIDMWS 284
Query: 780 YGCLLLELLTLQVPYMGLSELEI------------HDLIQMGKRPRLTDELEALGSCHEH 827
GC+L ELLT G E + L+ KR + +
Sbjct: 285 LGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTV 344
Query: 828 EVAQSGSGFEKP-------------------EAELETLSFLVDVFRRCTEENPTERPTAG 868
GS + +D ++C E +P R T G
Sbjct: 345 TTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404
Query: 869 D 869
Sbjct: 405 Q 405
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 27/195 (13%), Positives = 43/195 (22%), Gaps = 73/195 (37%)
Query: 604 EVRMLGALRHSCIVEMY--GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 661
L + + + H + E+++GGS
Sbjct: 81 RTLRLSRIDKPGVARVLDVVH---------TRAGG-------LVVAEWIRGGS------- 117
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
L E + S A+ Q +AAA H + + + DG V
Sbjct: 118 LQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS-----IDGDVV--- 169
Query: 722 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781
+ P M + DI G
Sbjct: 170 -----------------------------LAYPATMPDANPQD-----------DIRGIG 189
Query: 782 CLLLELLTLQVPYMG 796
L LL + P
Sbjct: 190 ASLYALLVNRWPLPE 204
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 47/251 (18%), Positives = 84/251 (33%), Gaps = 66/251 (26%)
Query: 660 EKLSETGEKHVSVKLALFIAQDVAAALVELHSK--HIMHRDIKSENILIDLERKKADGKP 717
+ L T + VS+ L AQ + AL+ L + I+H D+K ENIL+ +
Sbjct: 144 DLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILL-----CNPKRS 198
Query: 718 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 777
+K+ DF + L ++ I R +P+V +G P Y L +D+
Sbjct: 199 AIKIVDFGSSCQLGQRIYQY-IQSRFYRSPEVLLGMP----------------YDLAIDM 241
Query: 778 WSYGCLLLELLTLQVPYMGLSELEI------------HDLIQMGKR-------------- 811
WS GC+L+E+ T + + G +E++ ++ +
Sbjct: 242 WSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWN 301
Query: 812 -------------PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 858
P LG + + + D+ R +
Sbjct: 302 LKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAG---ESGHTVADYLKFKDLILRMLD 358
Query: 859 ENPTERPTAGD 869
+P R
Sbjct: 359 YDPKTRIQPYY 369
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 57/288 (19%), Positives = 99/288 (34%), Gaps = 67/288 (23%)
Query: 602 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 661
L ++ L L H IV++ + + +L + MEYV ++
Sbjct: 67 LQIMQDLAVLHHPNIVQLQ-SYFYT---LGERDRRDIYL---NVVMEYV-PDTLHRCCRN 118
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELH--SKHIMHRDIKSENILIDLERKKADGKPVV 719
+ + +F+ Q + ++ LH S ++ HRDIK N+L++ +ADG +
Sbjct: 119 YYRRQVAPPPILIKVFLFQ-LIRSIGCLHLPSVNVCHRDIKPHNVLVN----EADG--TL 171
Query: 720 KLCDFDRA---VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEV-LRAMHKPNLYGLE 774
KLCDF A P + C + R+ APE+ H Y
Sbjct: 172 KLCDFGSAKKLSPSEPNVAYIC--------------S-RYYRAPELIFGNQH----YTTA 212
Query: 775 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS 834
VDIWS GC+ E++ + + G + I + LG + +
Sbjct: 213 VDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI-----------VRVLGCPSREVLRKLNP 261
Query: 835 G-------------FEK--PEAELETLSFLVDVFRRCTEENPTERPTA 867
+ + L+ D+ + P ER
Sbjct: 262 SHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP 309
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 53/318 (16%), Positives = 110/318 (34%), Gaps = 85/318 (26%)
Query: 594 IRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA--------- 644
+ E+ ++ L H I+++ + ++ P +
Sbjct: 40 VLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNH 99
Query: 645 ---------------IFMEYVKGGSVKNYIEKLSETG----EKHVSVKLALFIAQDVAAA 685
+ MEYV ++ ++ +G +S ++I Q + A
Sbjct: 100 HKSVIVNPSQNKYLNVIMEYV-PDTLHKVLKSFIRSGRSIPMNLIS----IYIYQ-LFRA 153
Query: 686 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA---VPLRSFLHTCCIAHR 742
+ +HS I HRDIK +N+L++ + D +KLCDF A +P + C
Sbjct: 154 VGFIHSLGICHRDIKPQNLLVNSK----DN--TLKLCDFGSAKKLIPSEPSVAYIC---- 203
Query: 743 GIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 801
+ R+ APE+ M Y +D+WS GC+ EL+ + + G + ++
Sbjct: 204 ----------S-RFYRAPEL---MLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSID 249
Query: 802 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF------EKPEAELETL------SFL 849
I ++ +G+ + ++ + + + + S
Sbjct: 250 QLVRI-----------IQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA 298
Query: 850 VDVFRRCTEENPTERPTA 867
+D+ + P R
Sbjct: 299 IDLLEQILRYEPDLRINP 316
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 49/192 (25%), Positives = 77/192 (40%), Gaps = 32/192 (16%)
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 748
LH +++HRD+K N+LI+ ++ +K+CDF A R +
Sbjct: 128 LHGSNVIHRDLKPSNLLIN-----SNCD--LKVCDFGLA---RIIDESAADNSEPTGQQS 177
Query: 749 VC---VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 804
V T RW APEV+ K Y +D+WS GC+L EL + + G
Sbjct: 178 GMVEFVAT-RWYRAPEVMLTSAK---YSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL 233
Query: 805 LI--QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-------PEAELETLSFLVDVFRR 855
LI +G P ++L + S E +S + P + + L +R
Sbjct: 234 LIFGIIGT-PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLL----QR 288
Query: 856 CTEENPTERPTA 867
+P +R TA
Sbjct: 289 MLVFDPAKRITA 300
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 38/168 (22%), Positives = 63/168 (37%), Gaps = 47/168 (27%)
Query: 647 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706
ME + GG + ++ + G++ + + A I + + A+ LHS +I HRD+K EN+L
Sbjct: 94 MECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL- 149
Query: 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 766
K+ + +KL DF G A E
Sbjct: 150 -YTSKRPNAI--LKLTDF------------------GF-------------AKETTG--- 172
Query: 767 KPNLYGLEVDIWSYGCLLLELLTLQVPYMG----LSELEIHDLIQMGK 810
Y D+WS G ++ LL P+ + I+MG+
Sbjct: 173 --EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 218
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 41/209 (19%), Positives = 71/209 (33%), Gaps = 64/209 (30%)
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 748
LHS I+HRD+K NI++ +D +K+ DF A R
Sbjct: 143 LHSAGIIHRDLKPSNIVVK-----SDCT--LKILDFGLA--------------RTAGTSF 181
Query: 749 VC---VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 804
+ V T R+ APEV+ M Y VDIWS GC++ E++ V + G ++ +
Sbjct: 182 MMTPYVVT-RYYRAPEVILGMG----YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 236
Query: 805 LI------------------------QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 840
+ K + E L + + +
Sbjct: 237 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYS--FEKLFPDVLFPADSEHNKLKASQ 294
Query: 841 AELETLSFLVDVFRRCTEENPTERPTAGD 869
A D+ + + ++R + +
Sbjct: 295 A--------RDLLSKMLVIDASKRISVDE 315
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 36/237 (15%), Positives = 66/237 (27%), Gaps = 71/237 (29%)
Query: 678 IAQDVAAALVELHSKHIMHRDIKSENILI------------------DLERKKADGKPVV 719
++ AL L + H D+K ENIL+ + +
Sbjct: 142 YCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 720 KLCDFDRAVPLRSFLHTCCIAHRGIP---------APDVCVGTPRWMAPEVLRAMHKPNL 770
KL DF A AP+V +
Sbjct: 202 KLIDFGCA----------TFKSDYHGSIINTRQYRAPEVILNLG---------------- 235
Query: 771 YGLEVDIWSYGCLLLELLTLQVPYMGLSELEI------------HDLIQMGKRPR----L 814
+ + D+WS+GC+L EL T + + +E +++ + +
Sbjct: 236 WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYV 295
Query: 815 TDELEALGSCHEHEVAQSGSGFE--KPEAELETLSFLVDVFRRCTEENPTERPTAGD 869
+ L S + P ++ D + +PT RP+ +
Sbjct: 296 NKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAE 352
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 58/278 (20%), Positives = 101/278 (36%), Gaps = 69/278 (24%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E+ L RH +V + G + N +L I+ +Y++ G++K ++ S
Sbjct: 85 EIETLSFCRHPHLVSLIGF--------CDERN--EMIL---IY-KYMENGNLKRHLYG-S 129
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
+ +S + L I A L LH++ I+HRD+KS NIL+ D V K+ D
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL-------DENFVPKITD 182
Query: 724 FD--RAVPLRSFLH--TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV--DI 777
F + H T V GT ++ PE L D+
Sbjct: 183 FGISKKGTELDQTHLST------------VVKGTLGYIDPEYFIKGR------LTEKSDV 224
Query: 778 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL------GSCHEHEVAQ 831
+S+G +L E+L + + E+ +L + +LE + + +
Sbjct: 225 YSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRK 284
Query: 832 SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 869
D +C + +RP+ GD
Sbjct: 285 -----------------FGDTAVKCLALSSEDRPSMGD 305
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 33/112 (29%), Positives = 48/112 (42%), Gaps = 21/112 (18%)
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPA 746
LHS ++HRD+K NIL++ A+ VK+ DF R+ +
Sbjct: 125 LHSGGLLHRDMKPSNILLN-----AECH--VKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 747 PDVCVGTP--------RWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789
+ P RW APE+L K Y +D+WS GC+L E+L
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTK---YTKGIDMWSLGCILGEILC 226
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 46/200 (23%), Positives = 77/200 (38%), Gaps = 56/200 (28%)
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 748
+HS +++HRD+K N+ I+ E +K+ DF A R +
Sbjct: 136 IHSANVLHRDLKPANLFINTEDLV------LKIGDFGLA--------------RIMDPHY 175
Query: 749 VC-------VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL 800
+ T +W +P +L + + Y +D+W+ GC+ E+LT + + G EL
Sbjct: 176 SHKGHLSEGLVT-KWYRSPRLLLSPNN---YTKAIDMWAAGCIFAEMLTGKTLFAGAHEL 231
Query: 801 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF--------EKPEAELETL-----S 847
E LI LE++ HE + + S +P L L
Sbjct: 232 EQMQLI-----------LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISR 280
Query: 848 FLVDVFRRCTEENPTERPTA 867
VD + +P +R TA
Sbjct: 281 EAVDFLEQILTFSPMDRLTA 300
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 43/224 (19%), Positives = 73/224 (32%), Gaps = 53/224 (23%)
Query: 678 IAQDVAAALVELHSKHIMHRDIKSENILI------------DLERKKADGKPVVKLCDFD 725
+A + AL LH + H D+K ENIL +K+ +++ DF
Sbjct: 128 MAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 726 RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785
A HT +A R P+V + + D+WS GC+L
Sbjct: 188 SATFDHEH-HTTIVATRHYRPPEVILELG----------------WAQPCDVWSIGCILF 230
Query: 786 ELLTLQVPYMGLSELEI------------HDLIQMGKRPRLTDELEALGSCHEHEVAQSG 833
E + E +I ++ + + G E + G
Sbjct: 231 EYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYK----GGLVWDENSSDG 286
Query: 834 SGFEKPEAELETL--------SFLVDVFRRCTEENPTERPTAGD 869
++ L++ L D+ RR E +P +R T +
Sbjct: 287 RYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 6e-12
Identities = 40/224 (17%), Positives = 73/224 (32%), Gaps = 53/224 (23%)
Query: 678 IAQDVAAALVELHSKHIMHRDIKSENILI------------DLERKKADGKPVVKLCDFD 725
+A + ++ LHS + H D+K ENIL ++ P +K+ DF
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
Query: 726 RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785
A T ++ R AP+V + + D+WS GC+L+
Sbjct: 183 SATYDDEHHST-LVSTRHYRAPEVILALG----------------WSQPCDVWSIGCILI 225
Query: 786 ELLTLQVPYMGLSELEI------------HDLIQMGKRPRLTDELEALGSCHEHEVAQSG 833
E + E +IQ ++ + E + +G
Sbjct: 226 EYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHH----DRLDWDEHSSAG 281
Query: 834 SGFEKPEAELETL--------SFLVDVFRRCTEENPTERPTAGD 869
+ L+ L D+ ++ E +P +R T +
Sbjct: 282 RYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 6e-12
Identities = 46/197 (23%), Positives = 75/197 (38%), Gaps = 52/197 (26%)
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 748
+HS ++HRD+K N+ ++ D + +K+ DF A R +
Sbjct: 142 IHSAGVVHRDLKPGNLAVN-----EDCE--LKILDFGLA--------------RHA-DAE 179
Query: 749 VC--VGTPRW-MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 805
+ V T RW APEV+ + Y VDIWS GC++ E+LT + + G L+
Sbjct: 180 MTGYVVT-RWYRAPEVILSWMH---YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ 235
Query: 806 I--QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-----------PEAELETLSFLVDV 852
I G + ++ L QS + P+A D+
Sbjct: 236 ILKVTGVPGT--EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQA--------ADL 285
Query: 853 FRRCTEENPTERPTAGD 869
+ E + +R TA
Sbjct: 286 LEKMLELDVDKRLTAAQ 302
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 43/209 (20%), Positives = 72/209 (34%), Gaps = 64/209 (30%)
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 748
LHS I+HRD+K NI++ +D +K+ DF A R
Sbjct: 180 LHSAGIIHRDLKPSNIVVK-----SDCT--LKILDFGLA--------------RTAGTSF 218
Query: 749 VC---VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 804
+ V T R+ APEV+ M Y VDIWS GC++ E++ ++ + G ++ +
Sbjct: 219 MMTPYVVT-RYYRAPEVILGMG----YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 273
Query: 805 LI------------------------QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 840
+ K LT L + + +
Sbjct: 274 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLT--FPKLFPDSLFPADSEHNKLKASQ 331
Query: 841 AELETLSFLVDVFRRCTEENPTERPTAGD 869
A D+ + +P +R + D
Sbjct: 332 A--------RDLLSKMLVIDPAKRISVDD 352
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 48/195 (24%), Positives = 75/195 (38%), Gaps = 48/195 (24%)
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 748
+HS I+HRD+K N+ ++ D + +K+ DF A +
Sbjct: 148 IHSADIIHRDLKPSNLAVN-----EDCE--LKILDFGLARHTADEM-------------T 187
Query: 749 VCVGTPRW-MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI- 806
V T RW APE++ Y VDIWS GC++ ELLT + + G ++ LI
Sbjct: 188 GYVAT-RWYRAPEIMLNWMH---YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 243
Query: 807 -QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-----------PEAELETLSFLVDVFR 854
+G + L+ + S QS + K P A VD+
Sbjct: 244 RLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLA--------VDLLE 293
Query: 855 RCTEENPTERPTAGD 869
+ + +R TA
Sbjct: 294 KMLVLDSDKRITAAQ 308
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 47/195 (24%), Positives = 77/195 (39%), Gaps = 48/195 (24%)
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 748
+H+ I+HRD+K N+ ++ D + +K+ DF A S +
Sbjct: 144 IHAAGIIHRDLKPGNLAVN-----EDCE--LKILDFGLARQADSEMTG------------ 184
Query: 749 VCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI- 806
V T RW APEV+ + Y VDIWS GC++ E++T + + G L+ I
Sbjct: 185 -YVVT-RWYRAPEVILNWMR---YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 239
Query: 807 -QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-----------PEAELETLSFLVDVFR 854
G P + ++ L S + EK P A V++
Sbjct: 240 KVTGTPPA--EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLA--------VNLLE 289
Query: 855 RCTEENPTERPTAGD 869
+ + +R TAG+
Sbjct: 290 KMLVLDAEQRVTAGE 304
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 28/117 (23%), Positives = 43/117 (36%), Gaps = 22/117 (18%)
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPA 746
+H I+HRD+K N L++ D VK+CDF R + +
Sbjct: 145 IHESGIIHRDLKPANCLLN-----QDCS--VKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 747 PDVCVGTPRWM----------APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 793
+ + APE++ Y +DIWS GC+ ELL +
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQEN---YTKSIDIWSTGCIFAELLNMLQS 251
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 45/232 (19%), Positives = 72/232 (31%), Gaps = 65/232 (28%)
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPA 746
+HS I+HRD+K N L++ D VK+CDF R V ++
Sbjct: 172 VHSAGILHRDLKPANCLVN-----QDCS--VKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 747 PDVCVGTP--------------RWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 791
++ RW APE++ Y +D+WS GC+ ELL +
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN---YTEAIDVWSIGCIFAELLNMI 281
Query: 792 VP----------------YMGLSELEIHDLIQMGKRPRLTDEL----EALGSCHEHEVAQ 831
LS + D+L LG+ E ++
Sbjct: 282 KENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEA 341
Query: 832 SGSGFEKPEAELETLSF-----LVDVFRRCTEE-----------NPTERPTA 867
E + + L + F + + NP +R T
Sbjct: 342 LEK--EDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITI 391
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 27/105 (25%), Positives = 42/105 (40%), Gaps = 29/105 (27%)
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 748
LH ++HRD+ NIL+ + + +CDF+ A R A
Sbjct: 150 LHEAGVVHRDLHPGNILLA-----DNND--ITICDFNLA--------------REDTADA 188
Query: 749 VC---VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789
V RW APE++ + VD+WS GC++ E+
Sbjct: 189 NKTHYVTH-RWYRAPELVMQFKG---FTKLVDMWSAGCVMAEMFN 229
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 45/226 (19%), Positives = 74/226 (32%), Gaps = 49/226 (21%)
Query: 671 SVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 729
+ I++ + L +H + I+H DIK EN+L+++ + +K+ D A
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV-DSPENLIQIKIADLGNA-- 185
Query: 730 LRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789
C + T + +PEVL +G DIWS CL+ EL+T
Sbjct: 186 --------CWYDEHYTNS---IQTREYRSPEVLLGAP----WGCGADIWSTACLIFELIT 230
Query: 790 LQVPYMGLSELEI------------------HDLIQMGKRPRL--TDELEALGSCHE--- 826
+ L++ GK R
Sbjct: 231 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW 290
Query: 827 --HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 870
+V F K EA+ + D + +P +R AG L
Sbjct: 291 PLEDVLTEKYKFSKDEAKE-----ISDFLSPMLQLDPRKRADAGGL 331
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 45/196 (22%), Positives = 75/196 (38%), Gaps = 48/196 (24%)
Query: 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 748
+HS +++HRD+K N+L++ +K+CDF A R
Sbjct: 144 IHSANVLHRDLKPSNLLLN-----TTCD--LKICDFGLA--------------RVADPDH 182
Query: 749 VC-------VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL 800
V T RW APE++ Y +DIWS GC+L E+L+ + + G L
Sbjct: 183 DHTGFLTEYVAT-RWYRAPEIMLNSKG---YTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238
Query: 801 EIHDLI--QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-------PEAELETLSFLVD 851
+ + I +G + ++L + + S K P A+ + L L
Sbjct: 239 DQLNHILGILGSPSQ--EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLL-- 294
Query: 852 VFRRCTEENPTERPTA 867
+ NP +R
Sbjct: 295 --DKMLTFNPHKRIEV 308
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 50/254 (19%), Positives = 72/254 (28%), Gaps = 64/254 (25%)
Query: 674 LALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLE-----------------RKKADG 715
I Q V L LH+K I+H DIK ENIL+ +
Sbjct: 147 CVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 716 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV------------CVGTPRWMAPEVLR 763
V L + L + D+ + T ++ + EVL
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLI 266
Query: 764 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD----LIQM----GKRP--- 812
Y DIWS C+ EL T + S E + + GK P
Sbjct: 267 GSG----YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322
Query: 813 ----RLTDE----------LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 858
+ + E + L EV + + EA D E
Sbjct: 323 IVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAG-----FTDFLLPMLE 377
Query: 859 ENPTERPTAGDLYE 872
P +R TA +
Sbjct: 378 LIPEKRATAAECLR 391
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 4e-09
Identities = 74/314 (23%), Positives = 113/314 (35%), Gaps = 88/314 (28%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+ LK + E F EV M+ H ++ + G L
Sbjct: 59 VKRLKEERTQGGE-LQF----QTEVEMISMAVHRNLLRLRGF--------CMTPT--ERL 103
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---HIMHR 697
L ++ Y+ GSV + + + E + + IA A L LH I+HR
Sbjct: 104 L---VY-PYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHR 158
Query: 698 DIKSENILID--LERKKAD-GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 754
D+K+ NIL+D E D G + KL D+ + + T V GT
Sbjct: 159 DVKAANILLDEEFEAVVGDFG--LAKLMDYK-----DTHVTT-----------AV-RGTI 199
Query: 755 RWMAPEVLRAMH-----KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD----- 804
+APE K D++ YG +LLEL+T Q + D
Sbjct: 200 GHIAPEY--LSTGKSSEK-------TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 805 ----LIQMGKRPRLTD-ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 859
L++ K L D +L+ G+ + EV Q L+ V CT+
Sbjct: 251 WVKGLLKEKKLEALVDVDLQ--GNYKDEEVEQ-----------------LIQVALLCTQS 291
Query: 860 NPTERPTAGDLYEM 873
+P ERP ++ M
Sbjct: 292 SPMERPKMSEVVRM 305
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 39/168 (23%), Positives = 67/168 (39%), Gaps = 24/168 (14%)
Query: 660 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 719
E L + + SVK A+ + A + +H K +++RDIK +N LI K +
Sbjct: 93 EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANM--I 150
Query: 720 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC--VGTPRWMAPEVLRAMHKPNLYGLEV-- 775
+ DF + + H IP + GT R+M+ H G E
Sbjct: 151 YVVDFGMV---KFYRDPVTKQH--IPYREKKNLSGTARYMS----INTHL----GREQSR 197
Query: 776 --DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 818
D+ + G + + L +P+ GL + + ++ I K+ EL
Sbjct: 198 RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 245
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 39/169 (23%), Positives = 72/169 (42%), Gaps = 28/169 (16%)
Query: 660 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 719
E L + S+K L +A + + + +HSK+ +HRD+K +N L+ L +K +V
Sbjct: 92 EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKK----GNLV 147
Query: 720 KLCDFDRA---VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV- 775
+ DF A R+ H ++ + GT R+ + H G+E
Sbjct: 148 YIIDFGLAKKYRDARTHQHIPYRENKNL------TGTARYAS----INTHL----GIEQS 193
Query: 776 ---DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 818
D+ S G +L+ +P+ GL ++ + ++ I K + L
Sbjct: 194 RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 42/168 (25%), Positives = 72/168 (42%), Gaps = 24/168 (14%)
Query: 660 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 719
E L + ++ S+K L IA + + + +HSK++++RD+K EN LI K +
Sbjct: 92 EDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQV--I 149
Query: 720 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC--VGTPRWMAPEVLRAMHKPNLYGLEV-- 775
+ DF A + ++ H IP + GT R+M+ H G E
Sbjct: 150 HIIDFALA---KEYIDPETKKH--IPYREHKSLTGTARYMS----INTHL----GKEQSR 196
Query: 776 --DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 818
D+ + G + + L +P+ GL + E + I KR + L
Sbjct: 197 RDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVL 244
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 6e-08
Identities = 92/647 (14%), Positives = 172/647 (26%), Gaps = 209/647 (32%)
Query: 138 LDALASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAG 197
D S EE II D L LF
Sbjct: 39 QDMPKSILSKEEIDHIIMSKDAVSGTL--------RLFWT-------------------- 70
Query: 198 LESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKS 257
L S +E + + K + + +
Sbjct: 71 LLSKQEEMVQK----------FVEEVLRINYKFLMSPIKTEQR-----QPSMMTRMYIEQ 115
Query: 258 RKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTG--YEQTPHLDSREVIL 315
R + N +Q ++ Y+ R +P+++L E P + +L
Sbjct: 116 RDRL---YNDNQVFAK--------------YNVSRLQPYLKLRQALLELRPA----KNVL 154
Query: 316 VDR-----KSDEELDAIALSAQALV---------LHLKQLNGLTKDGVIEPVDNLQIALL 361
+D K+ + + + L+LK N + + V+E + L
Sbjct: 155 IDGVLGSGKT--WVALDVCLSYKVQCKMDFKIFWLNLKNCN--SPETVLEMLQKL----- 205
Query: 362 LALFVSDHFGGSDRSG--------IVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQ 413
L + SD S I R+ + Y +
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL----------------- 248
Query: 414 ILDAVEDI-VLS--DL-C-------EKSLRSIKSKRNSVVVPIGSVQFGVCRH--RAVLL 460
+L V++ + +L C K + S + + + + +++LL
Sbjct: 249 VLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL 308
Query: 461 KYLCDRVE--PPVPC-----------ELVRGYLD-FQPHAWNTILVKKGDSWIRMIVDAC 506
KYL R + P E +R L + W + K + I ++
Sbjct: 309 KYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDN--WKHVNCDKLTTIIESSLNVL 366
Query: 507 RPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDE--AGKSVS 564
P + R+ ++ ++ F S H P L F + S K
Sbjct: 367 EPAEYRK------------MFDRLSVFP-PSAHIPTILLSLIWFDVIKSDVMVVVNKLHK 413
Query: 565 SSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 624
SL + K T+ + + E + H IV+ Y I
Sbjct: 414 YSL-------VEKQPKESTISI----PSIYLELKVKLENEYAL-----HRSIVDHY--NI 455
Query: 625 SSKWLPSADGNPE----------HHLLQ----------SAIFMEYVKGGSVKNYIE-KLS 663
+ P HHL +F+++ ++E K+
Sbjct: 456 PKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDF-------RFLEQKIR 508
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 710
+ L Q ++ + +I D K E ++ +
Sbjct: 509 HDSTAWNASGSILNTLQQ-----LKFYKPYICDNDPKYERLVNAILD 550
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 3e-05
Identities = 69/519 (13%), Positives = 139/519 (26%), Gaps = 179/519 (34%)
Query: 321 DEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVE 380
D E + ++ + + + V ++ ++L + D V
Sbjct: 8 DFETGEHQYQYKDILSVFED--AFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDA---VS 62
Query: 381 RTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSD---LCEKSLRSIKSK 437
T + F S + VE+++ + L IK++
Sbjct: 63 GTLRL---------FWTLLSKQEE--------MVQKFVEEVLRINYKFLMSP----IKTE 101
Query: 438 RNSVVVPIGSVQFGVCRHRA-----VLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILV 492
+ + + + R R V KY R++P + +L + L+ +P +L+
Sbjct: 102 QRQPSMM--TRMYIEQRDRLYNDNQVFAKYNVSRLQPYL--KLRQALLELRPAKN--VLI 155
Query: 493 K----KGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAP---------FSTESDH 539
G +W + +D C + ++ + D + F ++ L +P + D
Sbjct: 156 DGVLGSGKTW--VALDVCLSYKVQCKMDFKIF--WLNLKNCNSPETVLEMLQKLLYQIDP 211
Query: 540 SPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTL----KVCGSSADEIR 595
+ S D S L + ++ L + K L V +A
Sbjct: 212 NWTSRSDHSSNIKLRI--HSIQAELRRLLKSK-------PYENCLLVLLNVQ--NAKAWN 260
Query: 596 NFEYSCLGEVRML--------------GALRHSCIVEM-------YGHKISSKW------ 628
F SC ++L H + + K+
Sbjct: 261 AFNLSC----KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQ 316
Query: 629 -LPS--ADGNPEHHLLQSAIFMEYVKGG-----------------SVKNYIEKLSETGEK 668
LP NP + +I E ++ G +++ + L +
Sbjct: 317 DLPREVLTTNP----RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR 372
Query: 669 HVSVKLALF-----I----------------AQDVAAALV-------------------- 687
+ +L++F I V L
Sbjct: 373 KMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY 432
Query: 688 -----------ELHSKHIMHRDIKSENILIDLERKKADG 715
LH + H +I DL D
Sbjct: 433 LELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQ 471
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 2e-04
Identities = 89/570 (15%), Positives = 164/570 (28%), Gaps = 178/570 (31%)
Query: 1 MHNLQN--LNLQYNKLLSYCQVPSWICCNLEGNGK-----DSSNDDFISSSAEMDVY--- 50
L+ L L+ K + + + G+GK D + + ++
Sbjct: 137 YLKLRQALLELRPAKNV--------LIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLN 188
Query: 51 ------EGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLTARKSS-KQWKRHHLQ 103
+LE + + T S +S ++ R S + R L+
Sbjct: 189 LKNCNSPETVLEMLQKLL---------YQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLK 239
Query: 104 QRARQERL------NNSRKWRG-EGHAQ---TSMKEGQRYKSGNLDALASETPSEEASDI 153
+ + L N++ W + T+ R+K D L++ T +
Sbjct: 240 SKPYENCLLVLLNVQNAKAWNAFNLSCKILLTT-----RFKQ-VTDFLSAATTTH----- 288
Query: 154 IGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDECSKHD 213
I LD L E ++LL D + + L E +
Sbjct: 289 ISLDHHSMTLT--PDEVKSLLLKYLDCRPQD---LPREVLTTNPR--------------- 328
Query: 214 SSSLSTANGATEQDEGSSSENSKAV-CKTKRHS-DRDLDNPKPCKSRKSMGENSNASQKY 271
LS + +D ++ +N K V C + L+ +P + R + +
Sbjct: 329 --RLSII-AESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR----------KMF 375
Query: 272 SSVSFCSIEDRLPDGFYDAGRDRPFMQLTGY-EQTPHLDSREVI-------LVDRKSDEE 323
S+ P A P + L+ D V+ LV+++ E
Sbjct: 376 DR---LSV---FPP---SA--HIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKES 424
Query: 324 --------LDAIALSAQALVLH---LKQLNGLTK----DGVIEPVDNLQIALLLALFVSD 368
L+ LH + N D + +D +
Sbjct: 425 TISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQY-----FYSHIGH 479
Query: 369 HFGGSDRSGIVERTRKTVSGSNYRKPFVCT--CSTGNSDSANTSQKQILDAVEDIVLSDL 426
H + + R ++R F+ + +A+ S IL+ ++
Sbjct: 480 HLKNIEHPERMTLFRMVFL--DFR--FLEQKIRHDSTAWNASGS---ILNTLQQ------ 526
Query: 427 CEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHA 486
L+ K Y+CD P LV LDF P
Sbjct: 527 ----LKFYK-------------------------PYICD--NDPKYERLVNAILDFLPKI 555
Query: 487 WNTILVKKGDSWIRMIVDACRPHD-IREEA 515
++ K +R+ + A + I EEA
Sbjct: 556 EENLICSKYTDLLRIALMA--EDEAIFEEA 583
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 41/169 (24%), Positives = 71/169 (42%), Gaps = 28/169 (16%)
Query: 660 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 719
E L + +S+K L +A + + +HSK +HRDIK +N L+ L R+ V
Sbjct: 90 EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR----ANQV 145
Query: 720 KLCDFDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV- 775
+ DF A R + H ++ + GT R+ + H G+E
Sbjct: 146 YIIDFGLAKKYRDTSTHQHIPYRENKNL------TGTARYAS----VNTHL----GIEQS 191
Query: 776 ---DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 818
D+ S G +L+ L +P+ GL ++ + ++ I K + L
Sbjct: 192 RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 31/169 (18%), Positives = 60/169 (35%), Gaps = 27/169 (15%)
Query: 659 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 718
++K+ E K S K L ++ + L +H +H DIK+ N+L++ +
Sbjct: 138 LQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD-----Q 192
Query: 719 VKLCDFDRAVPLRSFLHTCCIAHRGIP-APDVC-VGTPRWMAPEVLRAMHKPNLYGLEV- 775
V L D+ A + H+ P C GT + + H G+
Sbjct: 193 VYLVDYGLA---YRYCPEGV--HKAYAADPKRCHDGTIEFTS----IDAHN----GVAPS 239
Query: 776 ---DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 818
D+ G +++ LT +P+ + I+ + +
Sbjct: 240 RRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDK 288
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 5e-07
Identities = 30/168 (17%), Positives = 61/168 (36%), Gaps = 31/168 (18%)
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 721
L + + +S + L +A + AL LH +H ++ +ENI +D E + V L
Sbjct: 148 LDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQS-----QVTL 202
Query: 722 CDFDRAVPLRSFLHTCCIAHRGIPAPDVC----VGTPRWMAPEVLRAMHKPNLYGLEV-- 775
+ A + C + + + + G +++ +HK G
Sbjct: 203 AGYGFA---FRY----CPSGKHVAYVEGSRSPHEGDLEFIS----MDLHK----GCGPSR 247
Query: 776 --DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 818
D+ S G +L+ L +P+ +E + + +P
Sbjct: 248 RSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGP 295
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 25/134 (18%), Positives = 45/134 (33%), Gaps = 26/134 (19%)
Query: 671 SVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF---DRA 727
L + + L +H +H DIK+ N+L+ + V L D+ R
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD-----QVYLADYGLSYRY 203
Query: 728 VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV----DIWSYGCL 783
P + +G GT + + HK G+ + D+ G
Sbjct: 204 CPNGNHKQYQENPRKGH------NGTIEFTS----LDAHK----GVALSRRSDVEILGYC 249
Query: 784 LLELLTLQVPYMGL 797
+L L ++P+
Sbjct: 250 MLRWLCGKLPWEQN 263
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 886 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-42 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-38 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-37 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-37 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-36 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-36 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-36 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-36 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-35 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-34 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-34 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-34 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-34 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-34 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-33 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-33 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-33 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-33 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-33 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-32 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-32 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-32 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-32 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-32 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-31 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-31 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-31 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-30 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-30 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-30 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-30 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-29 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-29 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-29 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-28 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-28 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-28 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-28 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-28 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-28 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-28 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-27 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-27 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-26 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-26 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-25 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-25 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-25 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-25 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-25 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-24 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-24 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-24 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-23 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-23 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-21 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-21 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-10 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 4e-42
Identities = 65/315 (20%), Positives = 123/315 (39%), Gaps = 64/315 (20%)
Query: 560 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 619
G ++++ K+ D A K+ L V + +++ F EV +L RH I+
Sbjct: 17 GSGSFGTVYKGKWHG-DVAVKM--LNVTAPTPQQLQAF----KNEVGVLRKTRHVNILLF 69
Query: 620 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 679
G+ + + I ++ +G S+ +++ + E + + IA
Sbjct: 70 MGYSTAPQLA---------------IVTQWCEGSSLYHHLHII----ETKFEMIKLIDIA 110
Query: 680 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 739
+ A + LH+K I+HRD+KS NI + VK+ DF A + +
Sbjct: 111 RQTAQGMDYLHAKSIIHRDLKSNNIFL-------HEDLTVKIGDFGLATVKSRWSGSHQF 163
Query: 740 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE 799
G+ WMAPEV+R M N Y + D++++G +L EL+T Q+PY ++
Sbjct: 164 EQ--------LSGSILWMAPEVIR-MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214
Query: 800 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 859
+ + +G+ D + +C + + + C ++
Sbjct: 215 RDQIIFM-VGRGYLSPDLSKVRSNCPKA---------------------MKRLMAECLKK 252
Query: 860 NPTERPTAGDLYEMF 874
ERP +
Sbjct: 253 KRDERPLFPQILASI 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 2e-38
Identities = 69/314 (21%), Positives = 118/314 (37%), Gaps = 67/314 (21%)
Query: 560 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 619
G +++ + A + + S +E+ ++ + E+ +L + H IV++
Sbjct: 21 GDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDY----MVEIDILASCDHPNIVKL 74
Query: 620 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 679
L I +E+ GG+V + +L E+ ++ +
Sbjct: 75 LDAFYYENNL--------------WILIEFCAGGAVDAVMLEL----ERPLTESQIQVVC 116
Query: 680 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 739
+ AL LH I+HRD+K+ NIL DG +KL DF +
Sbjct: 117 KQTLDALNYLHDNKIIHRDLKAGNILFT-----LDG--DIKLADFGVS----------AK 159
Query: 740 AHRGIPAPDVCVGTPRWMAPEVLRA-MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS 798
R I D +GTP WMAPEV+ K Y + D+WS G L+E+ ++ P+ L+
Sbjct: 160 NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 219
Query: 799 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 858
+ + I + P L +P S D ++C E
Sbjct: 220 PMRVLLKIAKSEPPTL----------------------AQPS---RWSSNFKDFLKKCLE 254
Query: 859 ENPTERPTAGDLYE 872
+N R T L +
Sbjct: 255 KNVDARWTTSQLLQ 268
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 6e-37
Identities = 68/311 (21%), Positives = 115/311 (36%), Gaps = 66/311 (21%)
Query: 577 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 636
A K+ L++ + ++I E+++L IV YG S +
Sbjct: 34 MARKLIHLEIKPAIRNQIIR-------ELQVLHECNSPYIVGFYGAFYSDGEI------- 79
Query: 637 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IM 695
+I ME++ GGS+ ++K + ++ ++ V L L KH IM
Sbjct: 80 -------SICMEHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIM 127
Query: 696 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 755
HRD+K NIL++ + +KLCDF + L + VGT
Sbjct: 128 HRDVKPSNILVN-------SRGEIKLCDFGVSGQLIDSMAN------------SFVGTRS 168
Query: 756 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI--------- 806
+M+PE L+ H Y ++ DIWS G L+E+ + P E+ +
Sbjct: 169 YMSPERLQGTH----YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224
Query: 807 ------QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEE 859
+ RP + +++ E+ P+ S D +C +
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284
Query: 860 NPTERPTAGDL 870
NP ER L
Sbjct: 285 NPAERADLKQL 295
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 8e-37
Identities = 74/318 (23%), Positives = 115/318 (36%), Gaps = 70/318 (22%)
Query: 560 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 619
G + + S + L + E + + EV +L L+H IV
Sbjct: 13 GTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQML----VSEVNLLRELKHPNIVRY 68
Query: 620 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 679
Y I L I MEY +GG + + I K ++ +++ + L +
Sbjct: 69 YDRIIDRT---------NTTLY---IVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVM 115
Query: 680 QDVAAALVELHSKH-----IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFL 734
+ AL E H + ++HRD+K N+ +D GK VKL DF A
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-------GKQNVKLGDFGLA------- 161
Query: 735 HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 794
I + VGTP +M+PE + M Y + DIWS GCLL EL L P+
Sbjct: 162 ---RILNHDTSFAKAFVGTPYYMSPEQMNRMS----YNEKSDIWSLGCLLYELCALMPPF 214
Query: 795 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 854
S+ E+ I+ GK R+ + L ++
Sbjct: 215 TAFSQKELAGKIREGKFRRIPYRY--------------------SDE-------LNEIIT 247
Query: 855 RCTEENPTERPTAGDLYE 872
R RP+ ++ E
Sbjct: 248 RMLNLKDYHRPSVEEILE 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-36
Identities = 67/317 (21%), Positives = 115/317 (36%), Gaps = 73/317 (23%)
Query: 560 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 619
G+ ++++ L+ + E + F E ML L+H IV
Sbjct: 18 GRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRF----KEEAEMLKGLQHPNIVRF 73
Query: 620 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 679
Y W + G L+ E + G++K Y+++ K + +K+
Sbjct: 74 YDS-----WESTVKGKKCIVLV-----TELMTSGTLKTYLKR-----FKVMKIKVLRSWC 118
Query: 680 QDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR-SFLHT 736
+ + L LH++ I+HRD+K +NI I VK+ D A R SF
Sbjct: 119 RQILKGLQFLHTRTPPIIHRDLKCDNIFIT------GPTGSVKIGDLGLATLKRASFAKA 172
Query: 737 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 796
GTP +MAPE+ Y VD++++G +LE+ T + PY
Sbjct: 173 VI-------------GTPEFMAPEMYE-----EKYDESVDVYAFGMCMLEMATSEYPYSE 214
Query: 797 LSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 855
+I+ + G +P D++ PE + ++
Sbjct: 215 CQNAAQIYRRVTSGVKPASFDKVAI------------------PEVK--------EIIEG 248
Query: 856 CTEENPTERPTAGDLYE 872
C +N ER + DL
Sbjct: 249 CIRQNKDERYSIKDLLN 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-36
Identities = 52/294 (17%), Positives = 99/294 (33%), Gaps = 70/294 (23%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V+ LK + L E ++ L + IV M G + W+
Sbjct: 39 VKILKNEANDPALKDEL----LAEANVMQQLDNPYIVRMIGICEAESWM----------- 83
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
+ ME + G + Y+++ +HV K + + V+ + L + +HRD+
Sbjct: 84 ----LVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLA 134
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 760
+ N+L+ + K+ DF + LR+ + +W APE
Sbjct: 135 ARNVLL-------VTQHYAKISDFGLSKALRADENYYKAQTH-------GKWPVKWYAPE 180
Query: 761 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 819
+ + + D+WS+G L+ E + Q PY G+ E+ +++ G+R
Sbjct: 181 CINYYK----FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC- 235
Query: 820 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 873
P + D+ C + RP +
Sbjct: 236 -------------------PRE-------MYDLMNLCWTYDVENRPGFAAVELR 263
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-36
Identities = 59/272 (21%), Positives = 98/272 (36%), Gaps = 68/272 (25%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E ++ LRHS +V++ G + K L I EY+ GS+ +Y+
Sbjct: 50 EASVMTQLRHSNLVQLLGVIVEEK----------GGLY---IVTEYMAKGSLVDYLRS-- 94
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
G + L + DV A+ L + +HRD+ + N+L+ D V K+ D
Sbjct: 95 -RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-----EDN--VAKVSD 146
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
F S T +W APE LR + + D+WS+G L
Sbjct: 147 FGLTKEASSTQDTGK-------------LPVKWTAPEALREKK----FSTKSDVWSFGIL 189
Query: 784 LLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 842
L E+ + +VPY + ++ ++ G + D P A
Sbjct: 190 LWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC--------------------PPA- 228
Query: 843 LETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
+ +V + C + RP+ L E
Sbjct: 229 ------VYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 135 bits (341), Expect = 4e-36
Identities = 60/299 (20%), Positives = 109/299 (36%), Gaps = 64/299 (21%)
Query: 577 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSADGN 635
A + SA+E++ + L EV +L + H I+++ ++ +
Sbjct: 32 AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF------ 85
Query: 636 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 695
+ + +K G + +Y+ + + +S K I + + + LH +I+
Sbjct: 86 --------FLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLNIV 132
Query: 696 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 755
HRD+K ENIL+ D +KL DF + L GTP
Sbjct: 133 HRDLKPENILL-------DDDMNIKLTDFGFSCQLDPGEKL-----------REVCGTPS 174
Query: 756 WMAPEVLRAMHKPNL--YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPR 813
++APE++ N YG EVD+WS G ++ LL P+ ++ + +I G
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234
Query: 814 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 872
+ E + + D+ R P +R TA +
Sbjct: 235 GSPEWDDYSDT------------------------VKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 7e-36
Identities = 64/298 (21%), Positives = 107/298 (35%), Gaps = 71/298 (23%)
Query: 584 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 643
LKV + E E+ EV + LRH I+ +YG+ + +
Sbjct: 36 LKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY------------- 82
Query: 644 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703
+ +EY G+V ++K + ++A AL HSK ++HRDIK EN
Sbjct: 83 -LILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 136
Query: 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 763
+L+ +K+ DF +V S T GT ++ PE++
Sbjct: 137 LLL-------GSAGELKIADFGWSVHAPSSRRTT------------LCGTLDYLPPEMIE 177
Query: 764 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 823
+ +VD+WS G L E L + P+ + E + I D +
Sbjct: 178 GRM----HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFPDFV----- 227
Query: 824 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSS 880
E D+ R + NP++RP ++ E ++ SS
Sbjct: 228 ---------------TEG-------ARDLISRLLKHNPSQRPMLREVLEHPWITANSS 263
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (339), Expect = 2e-35
Identities = 66/289 (22%), Positives = 100/289 (34%), Gaps = 67/289 (23%)
Query: 584 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 643
+K S + + EVR L LRH ++ G + EH
Sbjct: 45 IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----------EHTAW-- 91
Query: 644 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703
+ MEY G + +K + + L LHS +++HRD+K+ N
Sbjct: 92 -LVMEYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGN 145
Query: 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 763
IL+ +VKL DF A PA GTP WMAPEV+
Sbjct: 146 ILL-------SEPGLVKLGDF-------------GSASIMAPANSFV-GTPYWMAPEVIL 184
Query: 764 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 823
AM + Y +VD+WS G +EL + P ++ + I + P L
Sbjct: 185 AMDE-GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG------ 237
Query: 824 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 872
E + C ++ P +RPT+ L +
Sbjct: 238 -------------HWSEY-------FRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 1e-34
Identities = 63/295 (21%), Positives = 110/295 (37%), Gaps = 69/295 (23%)
Query: 578 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 637
A K+ +K + I+ E+ + L H +V+ YGH+
Sbjct: 34 AVKIVDMKRAVDCPENIKK-------EICINKMLNHENVVKFYGHRREGNIQ-------- 78
Query: 638 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 697
+F+EY GG + + IE + + A + A +V LH I HR
Sbjct: 79 ------YLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 127
Query: 698 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 757
DIK EN+L+ D + +K+ DF L T + + GT ++
Sbjct: 128 DIKPENLLL-------DERDNLKISDFG--------LATVFRYNNRERLLNKMCGTLPYV 172
Query: 758 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE 817
APE+L+ + + VD+WS G +L +L ++P+ S+ K+ L
Sbjct: 173 APELLK---RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--- 226
Query: 818 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 872
P +++ S + + + ENP+ R T D+ +
Sbjct: 227 --------------------NPWKKID--SAPLALLHKILVENPSARITIPDIKK 259
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 133 bits (335), Expect = 2e-34
Identities = 48/270 (17%), Positives = 83/270 (30%), Gaps = 64/270 (23%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E++ + LRH +V ++ + + E++ GG + +
Sbjct: 73 EIQTMSVLRHPTLVNLHDAFEDDNEM--------------VMIYEFMSGGELFEKVAD-- 116
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
+S A+ + V L +H + +H D+K ENI+ +KL D
Sbjct: 117 --EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT-----TKRSNELKLID 169
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
F L GT + APEV G D+WS G L
Sbjct: 170 FGLTAHLDPKQSVKV-----------TTGTAEFAAPEVAEGKP----VGYYTDMWSVGVL 214
Query: 784 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 843
LL+ P+ G ++ E ++ + ++
Sbjct: 215 SYILLSGLSPFGGENDDETLRNVKSCD-------------------------WNMDDSAF 249
Query: 844 ETLSF-LVDVFRRCTEENPTERPTAGDLYE 872
+S D R+ +P R T E
Sbjct: 250 SGISEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 4e-34
Identities = 66/268 (24%), Positives = 102/268 (38%), Gaps = 68/268 (25%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E+ ++ ++ IV + L + MEY+ GGS+ + + +
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDEL--------------WVVMEYLAGGSLTDVVTE-- 110
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
+ + ++ AL LHS ++HRDIKS+NIL+ DG VKL D
Sbjct: 111 ----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG-----MDGS--VKLTD 159
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
F + VGTP WMAPEV+ YG +VDIWS G +
Sbjct: 160 FGFCAQITPEQSKR----------STMVGTPYWMAPEVVTRKA----YGPKVDIWSLGIM 205
Query: 784 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 843
+E++ + PY+ + L LI P L +
Sbjct: 206 AIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-------------------------- 239
Query: 844 ETLS-FLVDVFRRCTEENPTERPTAGDL 870
E LS D RC + + +R +A +L
Sbjct: 240 EKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 6e-34
Identities = 49/287 (17%), Positives = 91/287 (31%), Gaps = 69/287 (24%)
Query: 588 GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM 647
G+ + + E +++ L + IV + G + + + M
Sbjct: 47 GTEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQAEALM---------------LVM 87
Query: 648 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707
E GG + ++ + + V + V+ + L K+ +HRD+ + N+L+
Sbjct: 88 EMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL- 142
Query: 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 767
+ K+ DF + L + G +W APE +
Sbjct: 143 ------VNRHYAKISDFGLSKALGADDSYYTARSAG-------KWPLKWYAPECINFRK- 188
Query: 768 PNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE 826
+ D+WSYG + E L+ Q PY + E+ I+ GKR E
Sbjct: 189 ---FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC-------- 237
Query: 827 HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 873
P L + C +RP + +
Sbjct: 238 ------------PPE-------LYALMSDCWIYKWEDRPDFLTVEQR 265
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 131 bits (330), Expect = 8e-34
Identities = 51/284 (17%), Positives = 96/284 (33%), Gaps = 65/284 (22%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E+ ++ L H ++ ++ + + +E++ GG + + I
Sbjct: 76 EISIMNQLHHPKLINLHDAFEDKYEM--------------VLILEFLSGGELFDRIAA-- 119
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
+ +S + + L +H I+H DIK ENI+ + VK+ D
Sbjct: 120 --EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCE-----TKKASSVKIID 172
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
F A L T + APE++ G D+W+ G L
Sbjct: 173 FGLATKLNPDEIVKV-----------TTATAEFAAPEIVDREP----VGFYTDMWAIGVL 217
Query: 784 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 843
LL+ P+ G +LE ++ +E E
Sbjct: 218 GYVLLSGLSPFAGEDDLETLQNVKRCD-------------------------WEFDEDAF 252
Query: 844 ETLSF-LVDVFRRCTEENPTERPTAGDLYEM-FVARTSSSISSR 885
++S D + ++ P +R T D E ++ S+++SR
Sbjct: 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 296
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (325), Expect = 1e-33
Identities = 55/315 (17%), Positives = 119/315 (37%), Gaps = 69/315 (21%)
Query: 573 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 632
G + ++TLK G + + R+F L E ++G H ++ + G S +
Sbjct: 51 GKREIFVAIKTLKS-GYTEKQRRDF----LSEASIMGQFDHPNVIHLEGVVTKSTPV--- 102
Query: 633 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 692
I E+++ GS+ +++ + + +V + + + +AA + L
Sbjct: 103 -----------MIITEFMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLADM 147
Query: 693 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 752
+ +HRD+ + NIL++ ++ V K+ DF + L
Sbjct: 148 NYVHRDLAARNILVN-----SNL--VCKVSDFGLSRFLEDDTSDPTYTSAL-----GGKI 195
Query: 753 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 811
RW APE ++ + D+WSYG ++ E+++ + PY ++ ++ + I+ R
Sbjct: 196 PIRWTAPEAIQYRK----FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR 251
Query: 812 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 871
++ S L + C +++ RP G +
Sbjct: 252 L---------------------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 872 EMF--VARTSSSISS 884
+ R +S+ +
Sbjct: 285 NTLDKMIRNPNSLKA 299
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 2e-33
Identities = 60/295 (20%), Positives = 110/295 (37%), Gaps = 73/295 (24%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
V++LK S D E ++ L+H +V +Y
Sbjct: 42 VKSLKQGSMSPDAFLA-------EANLMKQLQHQRLVRLYAVVTQEPIY----------- 83
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
I EY++ GS+ ++++ +++ L +A +A + + ++ +HRD++
Sbjct: 84 ----IITEYMENGSLVDFLKT---PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLR 136
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 760
+ NIL+ K+ DF A I A + +W APE
Sbjct: 137 AANILV-------SDTLSCKIADFGLA---------RLIEDNEYTAREGAKFPIKWTAPE 180
Query: 761 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 819
+ + ++ D+WS+G LL E++T ++PY G++ E+ ++ G R D
Sbjct: 181 AINYGT----FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC- 235
Query: 820 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
PE L + R C +E P +RPT L +
Sbjct: 236 -------------------PEE-------LYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 3e-33
Identities = 62/294 (21%), Positives = 106/294 (36%), Gaps = 73/294 (24%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
++ +K S DE E +++ L H +V++YG + +
Sbjct: 33 IKMIKEGSMSEDEFIE-------EAKVMMNLSHEKLVQLYGVCTKQRPIF---------- 75
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
I EY+ G + NY+ + + L + +DV A+ L SK +HRD+
Sbjct: 76 ----IITEYMANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 127
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 760
+ N L+ + + VVK+ DF + + +T + RW PE
Sbjct: 128 ARNCLV-------NDQGVVKVSDFGLSRYVLDDEYTSSVG---------SKFPVRWSPPE 171
Query: 761 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 819
VL + + DIW++G L+ E+ +L ++PY + E + I G R
Sbjct: 172 VLMYSK----FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL------- 220
Query: 820 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 873
+P E + + C E ERPT L
Sbjct: 221 -----------------YRPHLASEK---VYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 8e-33
Identities = 58/295 (19%), Positives = 98/295 (33%), Gaps = 37/295 (12%)
Query: 584 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 643
+K+ S + E E+ LRH I+ AD Q
Sbjct: 31 VKIFSSREERSWFRE----AEIYQTVMLRHENILGFIA----------ADNKDNGTWTQL 76
Query: 644 AIFMEYVKGGSVKNYIEK--LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 701
+ +Y + GS+ +Y+ + ++ G +++ A +A + I HRD+KS
Sbjct: 77 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 136
Query: 702 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 761
+NIL+ + D AV S T IA VGT R+MAPEV
Sbjct: 137 KNILV-------KKNGTCCIADLGLAVRHDSATDTIDIAPNHR------VGTKRYMAPEV 183
Query: 762 LR--AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 819
L K DI++ G + E+ + ++ + P + + +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 820 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
+ E L + + R C N R TA + +
Sbjct: 244 VVCEQKLRP------NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 9e-33
Identities = 58/286 (20%), Positives = 97/286 (33%), Gaps = 39/286 (13%)
Query: 588 GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM 647
G ++ + L E+++L L H I+ + + ++
Sbjct: 34 GHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI--------------SLVF 79
Query: 648 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707
++++ + H L LH I+HRD+K N+L+D
Sbjct: 80 DFMETDLEVIIKDNSLVLTPSH-----IKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD 134
Query: 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 767
V+KL DF A S V T + APE+L
Sbjct: 135 -------ENGVLKLADFGLAKSFGSPNRAYTH----------QVVTRWYRAPELLFGARM 177
Query: 768 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH 827
YG+ VD+W+ GC+L ELL G S+L+ I ++ + S ++
Sbjct: 178 ---YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 828 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 873
+S G L+D+ + NP R TA +M
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 3e-32
Identities = 63/292 (21%), Positives = 109/292 (37%), Gaps = 70/292 (23%)
Query: 584 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 643
+K F L E +++ LRH +V++Y
Sbjct: 46 IKTLKPGTMSPEAF----LQEAQVMKKLRHEKLVQLYAVVSEEPIY-------------- 87
Query: 644 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703
I EY+ GS+ ++++ K++ + + +A +A+ + + + +HRD+++ N
Sbjct: 88 -IVTEYMSKGSLLDFLKG---ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 143
Query: 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 763
IL+ V K+ DF A + +T A +W APE
Sbjct: 144 ILV-------GENLVCKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAAL 187
Query: 764 AMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALG 822
+ ++ D+WS+G LL EL T +VPY G+ E+ D ++ G R E
Sbjct: 188 YGR----FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---- 239
Query: 823 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
PE+ L D+ +C + P ERPT L
Sbjct: 240 ----------------PES-------LHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 4e-32
Identities = 56/316 (17%), Positives = 99/316 (31%), Gaps = 64/316 (20%)
Query: 560 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 619
G + R ++ + +K + EV + +L H ++ +
Sbjct: 17 GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRL 76
Query: 620 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 679
YG ++ + E GS+ + + K + H + A
Sbjct: 77 YGVVLTPPMK---------------MVTELAPLGSLLDRLRK----HQGHFLLGTLSRYA 117
Query: 680 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 739
VA + L SK +HRD+ + N+L+ +VK+ DF L +
Sbjct: 118 VQVAEGMGYLESKRFIHRDLAARNLLLATRD-------LVKIGDFGLMRALPQNDDHYVM 170
Query: 740 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLS 798
W APE L+ + D W +G L E+ T Q P++GL+
Sbjct: 171 QEH-------RKVPFAWCAPESLKTRT----FSHASDTWMFGVTLWEMFTYGQEPWIGLN 219
Query: 799 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 858
+I I +PE + + +V +C
Sbjct: 220 GSQILHKIDKEGER-----------------------LPRPEDCPQD---IYNVMVQCWA 253
Query: 859 ENPTERPTAGDLYEMF 874
P +RPT L +
Sbjct: 254 HKPEDRPTFVALRDFL 269
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (313), Expect = 4e-32
Identities = 58/306 (18%), Positives = 106/306 (34%), Gaps = 84/306 (27%)
Query: 589 SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFME 648
+SAD +F E ++ + IV++ G K + + E
Sbjct: 55 ASADMQADF----QREAALMAEFDNPNIVKLLGVCAVGKPM--------------CLLFE 96
Query: 649 YVKGGSVKNYIEKL-------------------SETGEKHVSVKLALFIAQDVAAALVEL 689
Y+ G + ++ + S G +S L IA+ VAA + L
Sbjct: 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 156
Query: 690 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 749
+ +HRD+ + N L+ VVK+ DF + + S + +
Sbjct: 157 SERKFVHRDLATRNCLV-------GENMVVKIADFGLSRNIYSADYYKADGN-------- 201
Query: 750 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQM 808
RWM PE + Y E D+W+YG +L E+ + + PY G++ E+ ++
Sbjct: 202 DAIPIRWMPPESIFYNR----YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD 257
Query: 809 GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868
G + P L ++ R C + P +RP+
Sbjct: 258 GNILACPENC--------------------PLE-------LYNLMRLCWSKLPADRPSFC 290
Query: 869 DLYEMF 874
++ +
Sbjct: 291 SIHRIL 296
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 5e-32
Identities = 52/316 (16%), Positives = 105/316 (33%), Gaps = 74/316 (23%)
Query: 560 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 619
G + + + D A ++T++ S ++ E ++ L H +V++
Sbjct: 14 GSGQFGLVHLGYWLNKDKVA-IKTIREGAMSEEDFIE-------EAEVMMKLSHPKLVQL 65
Query: 620 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 679
YG + + + E+++ G + +Y+ + + L +
Sbjct: 66 YGVCLEQAPI--------------CLVFEFMEHGCLSDYLRT----QRGLFAAETLLGMC 107
Query: 680 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 739
DV + L ++HRD+ + N L+ V+K+ DF + +T
Sbjct: 108 LDVCEGMAYLEEACVIHRDLAARNCLVG-------ENQVIKVSDFGMTRFVLDDQYTSST 160
Query: 740 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLS 798
+W +PEV Y + D+WS+G L+ E+ + ++PY S
Sbjct: 161 G---------TKFPVKWASPEVFSFSR----YSSKSDVWSFGVLMWEVFSEGKIPYENRS 207
Query: 799 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 858
E+ + I G R + + + C +
Sbjct: 208 NSEVVEDISTGFRLYKPRLAS---------------------------THVYQIMNHCWK 240
Query: 859 ENPTERPTAGDLYEMF 874
E P +RP L
Sbjct: 241 ERPEDRPAFSRLLRQL 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 123 bits (310), Expect = 7e-32
Identities = 59/292 (20%), Positives = 120/292 (41%), Gaps = 69/292 (23%)
Query: 584 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 643
+K E+ F L E ++ ++H +V++ G
Sbjct: 47 VKTLKEDTMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTREPPF-------------- 88
Query: 644 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703
I E++ G++ +Y L E + VS + L++A +++A+ L K+ +HRD+ + N
Sbjct: 89 YIITEFMTYGNLLDY---LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 145
Query: 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 763
L+ + +VK+ DF + + +T +W APE L
Sbjct: 146 CLVG-----ENH--LVKVADFGLSRLMTGDTYTAHAG---------AKFPIKWTAPESLA 189
Query: 764 AMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALG 822
+ ++ D+W++G LL E+ T + PY G+ ++++L++ R
Sbjct: 190 YNK----FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---------- 235
Query: 823 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
E+PE E + ++ R C + NP++RP+ ++++ F
Sbjct: 236 --------------ERPEGCPEK---VYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 9e-32
Identities = 52/287 (18%), Positives = 95/287 (33%), Gaps = 66/287 (22%)
Query: 584 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 643
+K+ N E ++ L H V++Y + L
Sbjct: 38 IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL-------------- 83
Query: 644 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703
+ Y K G + YI K F ++ +AL LH K I+HRD+K EN
Sbjct: 84 YFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 138
Query: 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 763
IL+ + +++ DF A + VGT ++++PE+L
Sbjct: 139 ILL-------NEDMHIQITDFGTA--------KVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 764 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 823
D+W+ GC++ +L+ P+ +E I I + ++
Sbjct: 184 EKS----ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFF---- 234
Query: 824 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 870
P+A D+ + + T+R ++
Sbjct: 235 ---------------PKA--------RDLVEKLLVLDATKRLGCEEM 258
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 5e-31
Identities = 59/265 (22%), Positives = 94/265 (35%), Gaps = 54/265 (20%)
Query: 607 MLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG 666
A + IV + + LL I ME + GG + + I+ G
Sbjct: 58 HWRASQCPHIVRIVDVYENL-------YAGRKCLL---IVMECLDGGELFSRIQD---RG 104
Query: 667 EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDR 726
++ + + A I + + A+ LHS +I HRD+K EN+L ++KL DF
Sbjct: 105 DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT----SKRPNAILKLTDFGF 160
Query: 727 AVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786
A S + TP ++APEVL Y D+WS G ++
Sbjct: 161 AKETTSHNSLTTPCY-----------TPYYVAPEVLGPEK----YDKSCDMWSLGVIMYI 205
Query: 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 846
LL P+ L I ++ R +E P E +
Sbjct: 206 LLCGYPPFYSNHGLAISPGMKTRIRM---------------------GQYEFPNPEWSEV 244
Query: 847 SF-LVDVFRRCTEENPTERPTAGDL 870
S + + R + PT+R T +
Sbjct: 245 SEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 6e-31
Identities = 56/314 (17%), Positives = 106/314 (33%), Gaps = 71/314 (22%)
Query: 560 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 619
G+ + RC S+ + +KV G+ ++ E+ +L RH I+ +
Sbjct: 14 GRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK-------EISILNIARHRNILHL 66
Query: 620 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 679
+ S + L + E++ G + I ++ + +
Sbjct: 67 HESFESMEEL--------------VMIFEFISGLDIFERINT----SAFELNEREIVSYV 108
Query: 680 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 739
V AL LHS +I H DI+ ENI+ +K+ +F +A L+ +
Sbjct: 109 HQVCEALQFLHSHNIGHFDIRPENIIYQ-----TRRSSTIKIIEFGQARQLKPGDNF--- 160
Query: 740 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE 799
+ P + APEV + D+WS G L+ LL+ P++ +
Sbjct: 161 --------RLLFTAPEYYAPEVHQHDV----VSTATDMWSLGTLVYVLLSGINPFLAETN 208
Query: 800 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTE 858
+I + I + + E + +S +D R
Sbjct: 209 QQIIENIMNAE-------------------------YTFDEEAFKEISIEAMDFVDRLLV 243
Query: 859 ENPTERPTAGDLYE 872
+ R TA + +
Sbjct: 244 KERKSRMTASEALQ 257
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 6e-31
Identities = 48/270 (17%), Positives = 96/270 (35%), Gaps = 36/270 (13%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E+++L RH I+ + + P ++ + ++ G + ++
Sbjct: 56 EIKILLRFRHENIIGINDIIRA----------PTIEQMKDVYLVTHLMGADLYKLLKT-- 103
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
+H+S + + L +HS +++HRD+K N+L+ + +K+CD
Sbjct: 104 ----QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL-------NTTCDLKICD 152
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
F A V T + APE++ Y +DIWS GC+
Sbjct: 153 FGLARVADPDHDHTGFLTE-------YVATRWYRAPEIMLNSKG---YTKSIDIWSVGCI 202
Query: 784 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 843
L E+L+ + + G L+ + I ++L + + S K
Sbjct: 203 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 262
Query: 844 ETLSF---LVDVFRRCTEENPTERPTAGDL 870
+ +D+ + NP +R
Sbjct: 263 LFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 120 bits (302), Expect = 2e-30
Identities = 58/280 (20%), Positives = 96/280 (34%), Gaps = 64/280 (22%)
Query: 592 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK 651
+ E S E+ +L ++H IV + S L + M+ V
Sbjct: 45 KALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL--------------YLIMQLVS 90
Query: 652 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 711
GG + + I + + + + A + V A+ LH I+HRD+K EN+L
Sbjct: 91 GGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL-- 143
Query: 712 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 771
D + + DF + G C GTP ++APEVL Y
Sbjct: 144 --DEDSKIMISDF----------GLSKMEDPGSVLSTAC-GTPGYVAPEVLAQKP----Y 186
Query: 772 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ 831
VD WS G + LL P+ ++ ++ + I +
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE--------------------- 225
Query: 832 SGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDL 870
+E + +S D R E++P +R T
Sbjct: 226 ----YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-30
Identities = 71/348 (20%), Positives = 124/348 (35%), Gaps = 88/348 (25%)
Query: 547 PGSFPSLSSCD-----EAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEY 599
P +P L D G+ + + + A ++ +K +S D+ R+F
Sbjct: 1 PTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDF-- 57
Query: 600 SCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 658
GE+ +L L H I+ + G +L + +EY G++ ++
Sbjct: 58 --AGELEVLCKLGHHPNIINLLGACEHRGYL--------------YLAIEYAPHGNLLDF 101
Query: 659 IEK-----------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707
+ K ++ + +S + L A DVA + L K +HRD+ + NIL+
Sbjct: 102 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 161
Query: 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 767
V K+ DF + ++ RWMA E L
Sbjct: 162 -------ENYVAKIADFGLSRGQEVYVKKTM-----------GRLPVRWMAIESLNYSV- 202
Query: 768 PNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE 826
Y D+WSYG LL E+++L PY G++ E+++ + G R +
Sbjct: 203 ---YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD------- 252
Query: 827 HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
+ D+ R+C E P ERP+ +
Sbjct: 253 --------------------DEVYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 3e-30
Identities = 56/299 (18%), Positives = 102/299 (34%), Gaps = 72/299 (24%)
Query: 577 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 636
A ++T K C +S F L E + H IV++ G I+ +
Sbjct: 36 LAVAIKTCKNC-TSDSVREKF----LQEALTMRQFDHPHIVKLIGV-ITENPVW------ 83
Query: 637 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 696
I ME G ++++++ + + + + A ++ AL L SK +H
Sbjct: 84 --------IIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKRFVH 131
Query: 697 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 756
RDI + N+L+ VKL DF + + + +W
Sbjct: 132 RDIAARNVLVS-------SNDCVKLGDFGLSRYMEDSTYYKA---------SKGKLPIKW 175
Query: 757 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 815
MAPE + + D+W +G + E+L P+ G+ ++ I+ G+R +
Sbjct: 176 MAPESINFRR----FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 231
Query: 816 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
P L + +C +P+ RP +L
Sbjct: 232 PNC--------------------PPT-------LYSLMTKCWAYDPSRRPRFTELKAQL 263
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 3e-30
Identities = 51/286 (17%), Positives = 101/286 (35%), Gaps = 31/286 (10%)
Query: 589 SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFME 648
+E F + L E+++L L+H +V + + + + + +
Sbjct: 44 LMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY------LVFD 97
Query: 649 YVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708
+ + L ++ + Q + L +H I+HRD+K+ N+LI
Sbjct: 98 FCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT- 151
Query: 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 768
DG V+KL DF A ++ + V T + PE+L
Sbjct: 152 ----RDG--VLKLADFGLARAFSLAKNSQPNRYTNR------VVTLWYRPPELLLGERD- 198
Query: 769 NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE 828
YG +D+W GC++ E+ T G +E LI + + + +E
Sbjct: 199 --YGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYE 256
Query: 829 VAQSGSGFEKPEAELETLSFL----VDVFRRCTEENPTERPTAGDL 870
+ G ++ + +D+ + +P +R + D
Sbjct: 257 KLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 117 bits (295), Expect = 7e-30
Identities = 65/294 (22%), Positives = 104/294 (35%), Gaps = 60/294 (20%)
Query: 584 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 643
+KV + +F E + AL H IV +Y +
Sbjct: 37 VKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA----------ETPAGPLP 86
Query: 644 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703
I MEYV G ++++ + E ++ K A+ + D AL H I+HRD+K N
Sbjct: 87 YIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPAN 141
Query: 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 763
I+I VK+ DF A + ++ +GT ++++PE R
Sbjct: 142 IMIS-------ATNAVKVMDFGIARAIADSGNSVTQTAA-------VIGTAQYLSPEQAR 187
Query: 764 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 823
D++S GC+L E+LT + P+ G S + +
Sbjct: 188 GDS----VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP---------- 233
Query: 824 CHEHEVAQSGSGFEKPEAELETLS-FLVDVFRRCTEENPTERP-TAGDLYEMFV 875
P A E LS L V + +NP R TA ++ V
Sbjct: 234 ---------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 2e-29
Identities = 61/298 (20%), Positives = 105/298 (35%), Gaps = 66/298 (22%)
Query: 589 SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFME 648
+ E+ F L E ++ H ++ + G + E L + +
Sbjct: 67 TDIGEVSQF----LTEGIIMKDFSHPNVLSLLGICL----------RSEGSPL---VVLP 109
Query: 649 YVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708
Y+K G ++N+I + +VK + VA + L SK +HRD+ + N ++
Sbjct: 110 YMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML-- 163
Query: 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 768
D K VK+ DF A + G +WMA E L+
Sbjct: 164 -----DEKFTVKVADFGLARDMYDKEFDSVHNKTG------AKLPVKWMALESLQTQK-- 210
Query: 769 NLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH 827
+ + D+WS+G LL EL+T PY ++ +I + G+R +
Sbjct: 211 --FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC--------- 259
Query: 828 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSISSR 885
P+ L +V +C RP+ +L A S+ I
Sbjct: 260 -----------PDP-------LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 2e-29
Identities = 66/292 (22%), Positives = 105/292 (35%), Gaps = 76/292 (26%)
Query: 604 EVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE-- 660
E+ M+ + +H I+ + G L + +EY G+++ Y++
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPL--------------YVIVEYASKGNLREYLQAR 113
Query: 661 ---------KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 711
S E+ +S K + A VA + L SK +HRD+ + N+L+
Sbjct: 114 RPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---- 169
Query: 712 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 771
V+K+ DF A + + + +WMAPE L Y
Sbjct: 170 ---EDNVMKIADFGLARDIHHIDYYKKTTN--------GRLPVKWMAPEALFDRI----Y 214
Query: 772 GLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVA 830
+ D+WS+G LL E+ TL PY G+ E+ L++ G R
Sbjct: 215 THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNC------------ 262
Query: 831 QSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF---VARTS 879
L + R C P++RPT L E VA TS
Sbjct: 263 --------TNE-------LYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 299
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 5e-29
Identities = 54/295 (18%), Positives = 103/295 (34%), Gaps = 69/295 (23%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
++TLK + + LGE ++G H I+ + G K +
Sbjct: 41 IKTLKAGYTEKQRVD-----FLGEAGIMGQFSHHNIIRLEGVISKYKPMM---------- 85
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 700
I EY++ G++ ++ + + SV + + + +AA + L + + +HRD+
Sbjct: 86 ----IITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLA 137
Query: 701 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 760
+ NIL+ + V K+ DF + L G RW APE
Sbjct: 138 ARNILV-------NSNLVCKVSDFGLSRVLEDDPEATYTTSGG-------KIPIRWTAPE 183
Query: 761 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM-GLSELEIHDLIQMGKRPRLTDELE 819
+ + D+WS+G ++ E++T LS E+ I G R
Sbjct: 184 AISYRKFTS----ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-------- 231
Query: 820 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
++ S + + +C ++ RP D+ +
Sbjct: 232 -------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-28
Identities = 56/296 (18%), Positives = 108/296 (36%), Gaps = 65/296 (21%)
Query: 578 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 637
AAK +K + + EV +L ++H ++ ++ + +
Sbjct: 39 AAKF--IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV-------- 88
Query: 638 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 697
+ +E V GG + +++ + ++ ++ + A + + + LHS I H
Sbjct: 89 ------ILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQIAHF 137
Query: 698 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 757
D+K ENI++ + KP +K+ DF A + GTP ++
Sbjct: 138 DLKPENIMLL---DRNVPKPRIKIIDFGLAHKIDFGNEFKN-----------IFGTPEFV 183
Query: 758 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE 817
APE++ GLE D+WS G + LL+ P++G ++ E +
Sbjct: 184 APEIVNYEP----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN------- 232
Query: 818 LEALGSCHEHEVAQSGSGFEKPEAELETLS-FLVDVFRRCTEENPTERPTAGDLYE 872
+E + S D RR ++P +R T D +
Sbjct: 233 ------------------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (286), Expect = 1e-28
Identities = 40/271 (14%), Positives = 86/271 (31%), Gaps = 49/271 (18%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E ++ ++ + + ++++ + ME + +
Sbjct: 52 ESKIYKMMQGGVGIPTIRWCGA---------EGDYNV----MVMELLGPSLEDLFNFC-- 96
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
+ S+K L +A + + + +HSK+ +HRD+K +N L+ L +V + D
Sbjct: 97 ---SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG----KKGNLVYIID 149
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
F A R I + GT R+ + + D+ S G +
Sbjct: 150 FGLAKKYRDARTHQHIPY---RENKNLTGTARYASINTHLGIE----QSRRDDLESLGYV 202
Query: 784 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 843
L+ +P+ GL + +++ +E L + E
Sbjct: 203 LMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSE--------------- 247
Query: 844 ETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
C ++P L ++F
Sbjct: 248 -----FATYLNFCRSLRFDDKPDYSYLRQLF 273
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 2e-28
Identities = 47/288 (16%), Positives = 98/288 (34%), Gaps = 70/288 (24%)
Query: 588 GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM 647
+S + L E ++ ++ + + + G ++S +
Sbjct: 49 ATSPKANKEI----LDEAYVMASVDNPHVCRLLGICLTSTVQ---------------LIT 89
Query: 648 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707
+ + G + +Y+ + + ++ + L +A + L + ++HRD+ + N+L+
Sbjct: 90 QLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK 145
Query: 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 767
VK+ DF A L + + +WMA E +
Sbjct: 146 -------TPQHVKITDFGLAKLLGAEEKEYHA--------EGGKVPIKWMALESILHRI- 189
Query: 768 PNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE 826
Y + D+WSYG + EL+T PY G+ EI +++ G+R
Sbjct: 190 ---YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-------------- 232
Query: 827 HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
+P + + +C + RP +L F
Sbjct: 233 ----------PQPPICTIDV---YMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 2e-28
Identities = 61/291 (20%), Positives = 98/291 (33%), Gaps = 81/291 (27%)
Query: 604 EVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK- 661
E++M+ L H IV + G S + + EY G + NY+
Sbjct: 90 ELKMMTQLGSHENIVNLLGACTLSGPI--------------YLIFEYCCYGDLLNYLRSK 135
Query: 662 -----------------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
E ++ + L A VA + L K +HRD+ + N+
Sbjct: 136 REKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 195
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 764
L+ VVK+CDF A + S + + +WMAPE L
Sbjct: 196 LV-------THGKVVKICDFGLARDIMSDSNYVVRGN--------ARLPVKWMAPESLFE 240
Query: 765 MHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELE-IHDLIQMGKRPRLTDELEALG 822
Y ++ D+WSYG LL E+ +L PY G+ + LIQ G +
Sbjct: 241 GI----YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYA---- 292
Query: 823 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 873
E + + + C + +RP+ +L
Sbjct: 293 ----------------TEE-------IYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 3e-28
Identities = 61/264 (23%), Positives = 92/264 (34%), Gaps = 68/264 (25%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
+ + A H + M+ + + L MEY+ GG + +I+
Sbjct: 53 KRVLSLAWEHPFLTHMFCTFQTKENL--------------FFVMEYLNGGDLMYHIQS-- 96
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
+ A F A ++ L LHSK I++RD+K +NIL+D +K+ D
Sbjct: 97 ---CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD-------KDGHIKIAD 146
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
F GTP ++APE+L Y VD WS+G L
Sbjct: 147 FGMCKENMLGDAKTN----------TFCGTPDYIAPEILLGQK----YNHSVDWWSFGVL 192
Query: 784 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 843
L E+L Q P+ G E E+ I+M P LE EA
Sbjct: 193 LYEMLIGQSPFHGQDEEELFHSIRMD-NPFYPRWLE-------------------KEA-- 230
Query: 844 ETLSFLVDVFRRCTEENPTERPTA 867
D+ + P +R
Sbjct: 231 ------KDLLVKLFVREPEKRLGV 248
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 4e-28
Identities = 53/268 (19%), Positives = 96/268 (35%), Gaps = 38/268 (14%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
+R L H +V ++ S+ + + E+V L
Sbjct: 60 VLRHLETFEHPNVVRLFDVCTVSR---------TDRETKLTLVFEHVDQD----LTTYLD 106
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
+ E V + + + L LHS ++HRD+K +NIL+ + G+ +
Sbjct: 107 KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT-----SSGQIKLADFG 161
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
R + L + T + APEVL Y VD+WS GC+
Sbjct: 162 LARIYSFQMALTSVV-------------VTLWYRAPEVLLQSS----YATPVDLWSVGCI 204
Query: 784 LLELLTLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 842
E+ + + G S+++ I + P D + + ++S EK +
Sbjct: 205 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD 264
Query: 843 LETLSFLVDVFRRCTEENPTERPTAGDL 870
++ L D+ +C NP +R +A
Sbjct: 265 IDEL--GKDLLLKCLTFNPAKRISAYSA 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 112 bits (280), Expect = 7e-28
Identities = 38/230 (16%), Positives = 72/230 (31%), Gaps = 33/230 (14%)
Query: 645 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704
+ + + G S+++ ++ + SVK A+ + A + +H K +++RDIK +N
Sbjct: 77 VLVIDLLGPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF 132
Query: 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 764
LI K + + DF R + I + GT R+M+
Sbjct: 133 LIGRPNSKNANM--IYVVDFGMVKFYRDPVTKQHIPY---REKKNLSGTARYMSINT--- 184
Query: 765 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 824
H D+ + G + + L +P+ GL + + + L L +
Sbjct: 185 -HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 243
Query: 825 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
E P L +F
Sbjct: 244 FPEE--------------------FYKYMHYARNLAFDATPDYDYLQGLF 273
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 1e-27
Identities = 53/300 (17%), Positives = 103/300 (34%), Gaps = 71/300 (23%)
Query: 581 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 640
++T+ S + I L E ++ +V + G +
Sbjct: 55 IKTVNEAASMRERIE-----FLNEASVMKEFNCHHVVRLLGVVSQGQPTL---------- 99
Query: 641 LQSAIFMEYVKGGSVKNYIEKLSETGEKHV-----SVKLALFIAQDVAAALVELHSKHIM 695
+ ME + G +K+Y+ L + S+ + +A ++A + L++ +
Sbjct: 100 ----VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 155
Query: 696 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 755
HRD+ + N ++ VK+ DF + + R
Sbjct: 156 HRDLAARNCMVA-------EDFTVKIGDFG--------MTRDIYETDYYRKGGKGLLPVR 200
Query: 756 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRL 814
WM+PE L+ ++ D+WS+G +L E+ TL + PY GLS ++ + G
Sbjct: 201 WMSPESLK----DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 256
Query: 815 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
D + L ++ R C + NP RP+ ++
Sbjct: 257 PDNCPDM---------------------------LFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 109 bits (273), Expect = 6e-27
Identities = 52/277 (18%), Positives = 101/277 (36%), Gaps = 40/277 (14%)
Query: 595 RNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS 654
+ + E+ +L L+HS IV++Y + K L + E++
Sbjct: 41 EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLV--------------LVFEHLDQDL 86
Query: 655 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 714
K E + A + + H + ++HRD+K +N+LI+
Sbjct: 87 KKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN------- 134
Query: 715 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 774
+ +K+ DF A + + T + AP+VL K Y
Sbjct: 135 REGELKIADFGLARAFGIPVRKYT----------HEIVTLWYRAPDVLMGSKK---YSTT 181
Query: 775 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS 834
+DIWS GC+ E++ + G+SE + I + + +++ +
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 835 GFEKPEAELETLS-FLVDVFRRCTEENPTERPTAGDL 870
E+ L+ L +D+ + + +P +R TA
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 2e-26
Identities = 60/268 (22%), Positives = 97/268 (36%), Gaps = 31/268 (11%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E++++ L H IV + + S + E +L + ++YV +
Sbjct: 63 ELQIMRKLDHCNIVRLRYF-----FYSSGEKKDEVYL---NLVLDYVPETVYRVARHYSR 114
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
++ + V + +L +HS I HRDIK +N+L+D V+KLCD
Sbjct: 115 A--KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD------PDTAVLKLCD 166
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
F A L RG P + A Y +D+WS GC+
Sbjct: 167 FGSAKQLV----------RGEPNVSYICSRYYRAPELIFGATD----YTSSIDVWSAGCV 212
Query: 784 LLELLTLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 842
L ELL Q + G S ++ I ++ P E + E + Q +
Sbjct: 213 LAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 272
Query: 843 LETLSFLVDVFRRCTEENPTERPTAGDL 870
T + + R E PT R T +
Sbjct: 273 PRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 3e-26
Identities = 57/287 (19%), Positives = 102/287 (35%), Gaps = 76/287 (26%)
Query: 604 EVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK- 661
E+++L L H IV + G + EY G + N++ +
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPT--------------LVITEYCCYGDLLNFLRRK 121
Query: 662 ------------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709
+ E E + ++ L + VA + L SK+ +HRD+ + NIL+
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-- 179
Query: 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 769
+ K+CDF A +++ + + +WMAPE +
Sbjct: 180 -----HGRITKICDFGLARDIKNDSNYVVKGN--------ARLPVKWMAPESIFNCV--- 223
Query: 770 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELE--IHDLIQMGKRPRLTDELEALGSCHEH 827
Y E D+WSYG L EL +L ++ + +I+ G R
Sbjct: 224 -YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM--------------- 267
Query: 828 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 874
PE + D+ + C + +P +RPT + ++
Sbjct: 268 ---------LSPEHAPAEM---YDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 106 bits (265), Expect = 1e-25
Identities = 59/241 (24%), Positives = 101/241 (41%), Gaps = 46/241 (19%)
Query: 584 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 643
+KV E ML + H I+ M+G ++ +
Sbjct: 34 MKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI-------------- 79
Query: 644 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703
+ M+Y++GG + + + K A F A +V AL LHSK I++RD+K EN
Sbjct: 80 FMIMDYIEGGELFSLLRKSQRFPNPV-----AKFYAAEVCLALEYLHSKDIIYRDLKPEN 134
Query: 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 763
IL+D +G +K+ DF A + +T C GTP ++APEV+
Sbjct: 135 ILLD-----KNGH--IKITDFGFAKYVPDVTYTLC-------------GTPDYIAPEVVS 174
Query: 764 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR---PRLTDELEA 820
Y +D WS+G L+ E+L P+ + ++ ++ I + P ++++
Sbjct: 175 TKP----YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD 230
Query: 821 L 821
L
Sbjct: 231 L 231
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 2e-25
Identities = 51/279 (18%), Positives = 99/279 (35%), Gaps = 39/279 (13%)
Query: 593 EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKG 652
E + + E+ +L L H IV++ + L + E++
Sbjct: 40 ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY--------------LVFEFLH- 84
Query: 653 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 712
++ + + + + + L + L HS ++HRD+K +N+LI
Sbjct: 85 ---QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI------ 135
Query: 713 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 772
+ + +KL DF A + T V T + APE+L Y
Sbjct: 136 -NTEGAIKLADFGLARAFGVPVRTYT----------HEVVTLWYRAPEILLGCKY---YS 181
Query: 773 LEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS 832
VDIWS GC+ E++T + + G SE++ I + S +++ +
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 833 GSGFEKPEAELETLS-FLVDVFRRCTEENPTERPTAGDL 870
+ + L + + +P +R +A
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 105 bits (264), Expect = 4e-25
Identities = 46/265 (17%), Positives = 86/265 (32%), Gaps = 66/265 (24%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
+ ++ IV M + L + ++ + GG + ++ +
Sbjct: 57 MLSLVSTGDCPFIVCMSYAFHTPDKL--------------SFILDLMNGGDLHYHLSQHG 102
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
E F A ++ L +H++ +++RD+K NIL+ D V++ D
Sbjct: 103 VFSEAD-----MRFYAAEIILGLEHMHNRFVVYRDLKPANILL-------DEHGHVRISD 150
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
A + GT +MAPEVL+ Y D +S GC+
Sbjct: 151 LGLACDFSKKKPHASV------------GTHGYMAPEVLQKGVA---YDSSADWFSLGCM 195
Query: 784 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 843
L +LL P+ + H++ +M + E+ S S PE
Sbjct: 196 LFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-------------ELPDSFS----PELR- 237
Query: 844 ETLSFLVDVFRRCTEENPTERPTAG 868
+ + + R
Sbjct: 238 -------SLLEGLLQRDVNRRLGCL 255
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 4e-25
Identities = 50/270 (18%), Positives = 97/270 (35%), Gaps = 41/270 (15%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E+R+L +RH ++ + + M ++ G + ++
Sbjct: 67 ELRLLKHMRHENVIGLLDVFT--------PDETLDDFTDFYLVMPFM-GTDLGKLMKH-- 115
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
+ + F+ + L +H+ I+HRD+K N+ + + +K+ D
Sbjct: 116 ----EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV-------NEDCELKILD 164
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
F A S + T + APEV+ + Y VDIWS GC+
Sbjct: 165 FGLARQADSEMTGYV-------------VTRWYRAPEVILNWMR---YTQTVDIWSVGCI 208
Query: 784 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE- 842
+ E++T + + G L+ I + ++ L S + EK +
Sbjct: 209 MAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS 268
Query: 843 -LETLS-FLVDVFRRCTEENPTERPTAGDL 870
L S V++ + + +R TAG+
Sbjct: 269 ILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 5e-25
Identities = 52/272 (19%), Positives = 94/272 (34%), Gaps = 77/272 (28%)
Query: 604 EVRMLGALR--HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS-VKNYIE 660
EV +L + S ++ + + +E + + ++I
Sbjct: 57 EVVLLKKVSSGFSGVIRLLDWFERPDSF--------------VLILERPEPVQDLFDFIT 102
Query: 661 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 720
+ + +LA V A+ H+ ++HRDIK ENILIDL R + +K
Sbjct: 103 E-----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE------LK 151
Query: 721 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 780
L DF L+ ++T GT + PE +R +G +WS
Sbjct: 152 LIDFGSGALLKDTVYTD------------FDGTRVYSPPEWIRYHRY---HGRSAAVWSL 196
Query: 781 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 840
G LL +++ +P+ E+ + R R++ E +
Sbjct: 197 GILLYDMVCGDIPFEHDEEIIRGQVFF---RQRVSSECQ--------------------- 232
Query: 841 AELETLSFLVDVFRRCTEENPTERPTAGDLYE 872
+ R C P++RPT ++
Sbjct: 233 ----------HLIRWCLALRPSDRPTFEEIQN 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 6e-25
Identities = 59/285 (20%), Positives = 104/285 (36%), Gaps = 68/285 (23%)
Query: 584 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 643
+K+ ++ + E R+L RH + + + L
Sbjct: 35 MKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC------------- 81
Query: 644 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703
MEY GG + ++ + E+ + + A F ++ +AL LHS+ +++RDIK EN
Sbjct: 82 -FVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 135
Query: 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 763
+++ D +K+ DF S T GTP ++APEVL
Sbjct: 136 LML-------DKDGHIKITDFGLCKEGISDGATMKT----------FCGTPEYLAPEVLE 178
Query: 764 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 823
YG VD W G ++ E++ ++P+ + +LI M + R L
Sbjct: 179 DND----YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLS---- 229
Query: 824 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868
PEA + +++P +R G
Sbjct: 230 ---------------PEA--------KSLLAGLLKKDPKQRLGGG 251
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 2e-24
Identities = 50/270 (18%), Positives = 97/270 (35%), Gaps = 41/270 (15%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E+R+L ++H ++ + ++ L + ++ G + N ++
Sbjct: 67 ELRLLKHMKHENVIGLLDVFTPARSL---------EEFNDVYLVTHLMGADLNNIVKC-- 115
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
+ ++ F+ + L +HS I+HRD+K N+ ++ +K+ D
Sbjct: 116 ----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-------EDCELKILD 164
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
F A + T + APE++ Y VDIWS GC+
Sbjct: 165 FGLARHTDDEMTGYVA-------------TRWYRAPEIMLNWMH---YNQTVDIWSVGCI 208
Query: 784 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 843
+ ELLT + + G ++ LI + L+ + S QS + K
Sbjct: 209 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN 268
Query: 844 ETLSF---LVDVFRRCTEENPTERPTAGDL 870
+ VD+ + + +R TA
Sbjct: 269 VFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 3e-24
Identities = 50/313 (15%), Positives = 108/313 (34%), Gaps = 45/313 (14%)
Query: 560 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 619
G+ ++F+ K ++ +++ + L E+ +L L+H IV +
Sbjct: 11 GEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA----LREICLLKELKHKNIVRL 66
Query: 620 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 679
+ S K L + E+ ++K ++ + ++
Sbjct: 67 HDVLHSDKKLT--------------LVFEFCD-----QDLKKYFDSCNGDLDPEIVKSFL 107
Query: 680 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 739
+ L HS++++HRD+K +N+LI + +KL +F
Sbjct: 108 FQLLKGLGFCHSRNVLHRDLKPQNLLI-------NRNGELKLANFG----------LARA 150
Query: 740 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP-YMGLS 798
+ V T + P+VL Y +D+WS GC+ EL P + G
Sbjct: 151 FGIPVRCYSAEVVTLWYRPPDVLFGAKL---YSTSIDMWSAGCIFAELANAGRPLFPGND 207
Query: 799 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRRCT 857
+ I ++ ++ +++ + L+ D+ +
Sbjct: 208 VDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLL 267
Query: 858 EENPTERPTAGDL 870
+ NP +R +A +
Sbjct: 268 KCNPVQRISAEEA 280
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 101 bits (252), Expect = 8e-24
Identities = 51/278 (18%), Positives = 94/278 (33%), Gaps = 51/278 (18%)
Query: 604 EVRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 662
E+++L LR I+ + +P A+ E+V K + L
Sbjct: 79 EIKILENLRGGPNIITLADIVK----------DPVSRTP--ALVFEHVNNTDFKQLYQTL 126
Query: 663 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 722
++ F ++ AL HS IMHRD+K N++ID E +K ++L
Sbjct: 127 TD--------YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK------LRLI 172
Query: 723 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 782
D+ A V + + PE+ + +Y +D+WS GC
Sbjct: 173 DWGLAEFYHPGQEYNV-----------RVASRYFKGPEL---LVDYQMYDYSLDMWSLGC 218
Query: 783 LLLELLTLQVPYM-GLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 840
+L ++ + P+ G + I ++ L D ++ + +
Sbjct: 219 MLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKR 278
Query: 841 AELETLSF--------LVDVFRRCTEENPTERPTAGDL 870
E S +D + + R TA +
Sbjct: 279 WERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 8e-23
Identities = 58/292 (19%), Positives = 97/292 (33%), Gaps = 66/292 (22%)
Query: 578 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS-CIVEMYGHKISSKWLPSADGNP 636
A KV A + E ++L +R S +V ++ + L
Sbjct: 56 AMKVLKKATIVQKAKTTEHT----RTERQVLEHIRQSPFLVTLHYAFQTETKLH------ 105
Query: 637 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 696
+ ++Y+ GG + ++ + E V + + ++ AL LH I++
Sbjct: 106 --------LILDYINGGELFTHLSQRERFTEHEVQIYVG-----EIVLALEHLHKLGIIY 152
Query: 697 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 756
RDIK ENIL+D V L DF + + G +
Sbjct: 153 RDIKLENILLD-------SNGHVVLTDFGLSKEFVADETERAYDFCGTI---------EY 196
Query: 757 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 816
MAP+++R + VD WS G L+ ELLT P+ E I
Sbjct: 197 MAPDIVRGGDSG--HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK---- 250
Query: 817 ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868
+P E + D+ +R ++P +R G
Sbjct: 251 --------------------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCG 282
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 9e-23
Identities = 61/283 (21%), Positives = 103/283 (36%), Gaps = 71/283 (25%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK-- 661
E+++L + H V L A P L+ + +E+ K G++ Y+
Sbjct: 66 ELKILIHIGHHLNV---------VNLLGACTKPGGPLM---VIVEFCKFGNLSTYLRSKR 113
Query: 662 ---------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 712
+ + ++++ + + VA + L S+ +HRD+ + NIL+
Sbjct: 114 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----- 168
Query: 713 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 772
K VVK+CDF A + +WMAPE + Y
Sbjct: 169 --EKNVVKICDFGLARDIYKDPDYVRKGD--------ARLPLKWMAPETIFDRV----YT 214
Query: 773 LEVDIWSYGCLLLELLTLQV-PYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVA 830
++ D+WS+G LL E+ +L PY G+ E ++ G R R D
Sbjct: 215 IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTT----------- 263
Query: 831 QSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 873
PE + C P++RPT +L E
Sbjct: 264 --------PE--------MYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.4 bits (236), Expect = 1e-21
Identities = 47/281 (16%), Positives = 92/281 (32%), Gaps = 52/281 (18%)
Query: 604 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 663
E+ ++ + H I+ + K L + ME + + +L
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQ--------DVYLVMELMDANLCQVIQMELD 117
Query: 664 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 723
+ ++ + + LHS I+HRD+K NI++ +K+ D
Sbjct: 118 H--------ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV-------KSDCTLKILD 162
Query: 724 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783
F A + V T + APEV+ M Y VDIWS GC+
Sbjct: 163 FGLARTAGTSFMMTPY-----------VVTRYYRAPEVILGMG----YKENVDIWSVGCI 207
Query: 784 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 843
+ E++ ++ + G ++ + + + ++ L + V +L
Sbjct: 208 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267
Query: 844 ETLSF--------------LVDVFRRCTEENPTERPTAGDL 870
S D+ + +P +R + D
Sbjct: 268 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 93.7 bits (232), Expect = 4e-21
Identities = 47/229 (20%), Positives = 81/229 (35%), Gaps = 43/229 (18%)
Query: 584 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 643
+K+ L E R+L A+ +V++ + L + S
Sbjct: 71 MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 644 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703
+ S A F A + LHS +++RD+K EN
Sbjct: 131 HLRRI-------------------GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 763
+LI D + +++ DF A ++ T C GTP +APE++
Sbjct: 172 LLI-------DQQGYIQVTDFGFAKRVKGRTWTLC-------------GTPEALAPEIIL 211
Query: 764 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 812
+ Y VD W+ G L+ E+ P+ ++I++ I GK
Sbjct: 212 SKG----YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 82.0 bits (201), Expect = 4e-17
Identities = 48/290 (16%), Positives = 96/290 (33%), Gaps = 46/290 (15%)
Query: 604 EVRMLGALRHSCIVEMY--GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 661
E+++L + + + G K L +H + + + V +N +
Sbjct: 59 EIKLLQRVNDADNTKEDSMGANHILKLLDH-----FNHKGPNGVHVVMVFEVLGENLLAL 113
Query: 662 LSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENILIDLERKKADGKPVVK 720
+ + + + + I++ + L +H + I+H DIK EN+L+++ + +K
Sbjct: 114 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV-DSPENLIQIK 172
Query: 721 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 780
+ D A T + +PEVL +G DIWS
Sbjct: 173 IADLGNACWYDEHYTNSI-------------QTREYRSPEVLLGAP----WGCGADIWST 215
Query: 781 GCLLLELLTLQVPYMG-------------------LSELEIHDLIQMGKRPRLTDELEAL 821
CL+ EL+T + L EL + L + L
Sbjct: 216 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLL 275
Query: 822 GSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDL 870
+ + + + + + + D + +P +R AG L
Sbjct: 276 RNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 57.1 bits (137), Expect = 7e-10
Identities = 27/197 (13%), Positives = 59/197 (29%), Gaps = 65/197 (32%)
Query: 595 RNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS 654
S E R L L+ + ++Y + +A+ ME +
Sbjct: 55 VLAIRSARNEFRALQKLQGLAVPKVYAWE------------------GNAVLMELIDAKE 96
Query: 655 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 714
+ + + + + + + + + I+H D+ N+L+
Sbjct: 97 LYRVRVENPDE------------VLDMILEEVAKFYHRGIVHGDLSQYNVLVS------- 137
Query: 715 GKPVVKLCDFDRAVPL-----RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 769
+ + + DF ++V + R L DV ++ +
Sbjct: 138 -EEGIWIIDFPQSVEVGEEGWREIL-----------ERDVRN---------IITYFSRT- 175
Query: 770 LYGLEVDIWSYGCLLLE 786
Y E DI S +L+
Sbjct: 176 -YRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 886 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.43 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.97 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.61 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.78 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.58 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.58 | |
| d2f4ma1 | 287 | Peptide:N-glycanase 1, PNG1 {Mouse (Mus musculus) | 91.38 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=390.57 Aligned_cols=270 Identities=24% Similarity=0.360 Sum_probs=213.8
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEECCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 88899416423253494599999999912999999335689996888765674999999996179998122563685489
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 548 ~~~~~y~i~~~LG~GsfG~Vyka~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~~ 627 (886)
++.++|.+.+.||+|+||.||+|++++ .||+|+.. .........+.| .+|+.+|.+++|||||+++|++....
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~--~~~~~~~~~~~~----~~E~~~l~~l~HpnIv~~~~~~~~~~ 77 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLN--VTAPTPQQLQAF----KNEVGVLRKTRHVNILLFMGYSTAPQ 77 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECC--CSSCCTTHHHHH----HHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred CCCCCEEEEEEEEECCCCEEEEEEECC-EEEEEEEE--CCCCCHHHHHHH----HHHHHHHHHCCCCCEEEEEEEEECCE
T ss_conf 154518998898307885899999999-89999997--346998999999----99999998479987864567971558
Q ss_pred CCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEE
Q ss_conf 88889999976664089999025999999999987205997679999999999999999999858912147999978872
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILId 707 (886)
.+|||||+++|+|.+++.. ....+++..++.++.||+.||+|||+++||||||||+|||++
T Consensus 78 ---------------~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~ 138 (276)
T d1uwha_ 78 ---------------LAIVTQWCEGSSLYHHLHI----IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH 138 (276)
T ss_dssp ---------------CEEEEECCCEEEHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred ---------------EEEEEECCCCCCHHHHHHH----CCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCHHHEEEC
T ss_conf ---------------9999965899888999852----357899999999999999998887509995161478997981
Q ss_pred CCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 46657899980999315875224445543233467999997656898644525330145899999235699999999999
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~EL 787 (886)
.++ .+||+|||+|+........ .......||+.|||||++.+.. ...|+.++|||||||+||||
T Consensus 139 ~~~-------~~Kl~DFGla~~~~~~~~~--------~~~~~~~gt~~y~APE~l~~~~-~~~~~~~sDiwS~Gv~l~el 202 (276)
T d1uwha_ 139 EDL-------TVKIGDFGLATVKSRWSGS--------HQFEQLSGSILWMAPEVIRMQD-KNPYSFQSDVYAFGIVLYEL 202 (276)
T ss_dssp TTS-------SEEECCCCCSCC--------------------CCCCGGGCCHHHHTTCS-SCCCCHHHHHHHHHHHHHHH
T ss_pred CCC-------CEEECCCCCEEECCCCCCC--------CCCCCCCCCCCCCCHHHHHCCC-CCCCCCHHHHHHHHHHHHHH
T ss_conf 899-------7887500221333556776--------3125665574317999995056-89999531516359999999
Q ss_pred HHCCCCCCCCCHHH-HHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 91999999999889-99999808899950688641156520000259999996144662999999999801119999999
Q 002738 788 LTLQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 788 LTGk~Pf~g~s~~e-i~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRPS 866 (886)
+||+.||.+.+... +...+..+..++.... .....++.+.+|+.+||..||.+|||
T Consensus 203 ~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~-----------------------~~~~~~~~l~~li~~cl~~dp~~RPt 259 (276)
T d1uwha_ 203 MTGQLPYSNINNRDQIIFMVGRGYLSPDLSK-----------------------VRSNCPKAMKRLMAECLKKKRDERPL 259 (276)
T ss_dssp HHSSCTTTTCCCHHHHHHHHHHTSCCCCGGG-----------------------SCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHCCCCCCCCCHHHHHHHHHHCCCCCCCCHH-----------------------CCCCCHHHHHHHHHHHCCCCHHHCCC
T ss_conf 9788998998969999999965888986000-----------------------36555499999999975889768929
Q ss_pred HHHHHHHHHHHCCCCC
Q ss_conf 9999999980008899
Q 002738 867 AGDLYEMFVARTSSSI 882 (886)
Q Consensus 867 asEIL~hL~~l~~~s~ 882 (886)
|++|+++|+.+..+-|
T Consensus 260 ~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 260 FPQILASIELLARSLP 275 (276)
T ss_dssp HHHHHHHHHHHHHTCC
T ss_pred HHHHHHHHHHHHHCCC
T ss_conf 9999999999997098
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=386.89 Aligned_cols=270 Identities=20% Similarity=0.322 Sum_probs=216.7
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEECC---EEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE
Q ss_conf 888994164232534945999999999---12999999335689996888765674999999996179998122563685
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 624 (886)
Q Consensus 548 ~~~~~y~i~~~LG~GsfG~Vyka~~~~---~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~ 624 (886)
+....|.+.+.||+|+||.||+|.+.. ..++|+++.+... ......+.| .+|+.+|++++|||||+++|++.
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~----~~E~~~l~~l~HpnIv~l~g~~~ 97 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDF----LSEASIMGQFDHPNVIHLEGVVT 97 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHH----HHHHHHHTTCCCTTBCCEEEEEC
T ss_pred HCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCC-CCHHHHHHH----HHHHHHHHHCCCCCCCCEEEEEE
T ss_conf 0800427856980278829999999579978899999997844-598999999----99999998579988861899996
Q ss_pred CCCCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCE
Q ss_conf 48988889999976664089999025999999999987205997679999999999999999999858912147999978
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNI 704 (886)
.... .++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+||
T Consensus 98 ~~~~--------------~~iv~Ey~~~g~L~~~~~~----~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NI 159 (299)
T d1jpaa_ 98 KSTP--------------VMIITEFMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNI 159 (299)
T ss_dssp SSSS--------------CEEEEECCTTEEHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred ECCE--------------EEEEEEECCCCCCEEEECC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEE
T ss_conf 2887--------------7999972279853002104----567999999999999999988988527983576150448
Q ss_pred EEECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 87246657899980999315875224445543233467999997656898644525330145899999235699999999
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 705 LId~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL 784 (886)
|++.+ +++||+|||+|+.+........ ........||+.|||||++.+ ..++.++|||||||+|
T Consensus 160 Ll~~~-------~~~Kl~DFGla~~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~----~~~~~~sDvwS~Gvvl 223 (299)
T d1jpaa_ 160 LVNSN-------LVCKVSDFGLSRFLEDDTSDPT-----YTSALGGKIPIRWTAPEAIQY----RKFTSASDVWSYGIVM 223 (299)
T ss_dssp EECTT-------CCEEECCC----------------------------CGGGSCHHHHHS----CCCCHHHHHHHHHHHH
T ss_pred EECCC-------CCEEECCCCCCEECCCCCCCCE-----EEECCCCCCCCCCCCHHHHHC----CCCCCCCCCCCCHHHH
T ss_conf 98899-------9199888443157567777653-----650256668830038788836----9978612144535789
Q ss_pred HHHHH-CCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 99991-99999999988999999808899950688641156520000259999996144662999999999801119999
Q 002738 785 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 785 ~ELLT-Gk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~k 863 (886)
|||+| |+.||.+.+..++...+..+.+++.+.. .++.+.+|+.+||+.||.+
T Consensus 224 ~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~---------------------------~~~~l~~li~~cl~~~P~~ 276 (299)
T d1jpaa_ 224 WEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMD---------------------------CPSALHQLMLDCWQKDRNH 276 (299)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTT---------------------------CCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCC---------------------------CHHHHHHHHHHHCCCCHHH
T ss_conf 9998679999999999999999973788999742---------------------------2699999999975879768
Q ss_pred CCCHHHHHHHHHHHCCCCCC
Q ss_conf 99999999999800088999
Q 002738 864 RPTAGDLYEMFVARTSSSIS 883 (886)
Q Consensus 864 RPSasEIL~hL~~l~~~s~s 883 (886)
|||+.+|+++|+.+...+.+
T Consensus 277 RPs~~ei~~~L~~~l~~p~s 296 (299)
T d1jpaa_ 277 RPKFGQIVNTLDKMIRNPNS 296 (299)
T ss_dssp SCCHHHHHHHHHHHHHSGGG
T ss_pred CCCHHHHHHHHHHHHCCHHH
T ss_conf 92999999999998418621
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=379.79 Aligned_cols=257 Identities=22% Similarity=0.261 Sum_probs=212.8
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECC
Q ss_conf 889941642325349459999999--991299999933568999688876567499999999617999812256368548
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~ 626 (886)
.+++|.+.+.||+|+||.||+|++ .+..||+|++... .....+ .+.+|+.+|+.++|||||++++++...
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~----~~~~~~----~~~~E~~il~~l~HpnIv~~~~~~~~~ 95 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKE----TVRKEIQTMSVLRHPTLVNLHDAFEDD 95 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC----SHHHHH----HHHHHHHHHHHTCCTTBCCEEEEEEET
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC----CHHHHH----HHHHHHHHHHHCCCCCCCCEEEEEEEC
T ss_conf 865758988984076819999998899989999998452----431699----999999999867997999299999989
Q ss_pred CCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEE
Q ss_conf 98888999997666408999902599999999998720599767999999999999999999985891214799997887
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILI 706 (886)
.. .+||||||+||+|.+++.. ....+++..+..++.||+.||.|||++|||||||||+|||+
T Consensus 96 ~~--------------~~ivmE~~~gg~L~~~l~~----~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll 157 (350)
T d1koaa2 96 NE--------------MVMIYEFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMF 157 (350)
T ss_dssp TE--------------EEEEECCCCSCBHHHHHTC----TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CE--------------EEEEEECCCCCCHHHHHHH----HCCCCCHHHHHHHHHHHHHHHHHHHHCCCEEEEECHHHEEE
T ss_conf 99--------------9999985799889999976----23789999999999999999999975697600015467364
Q ss_pred ECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 24665789998099931587522444554323346799999765689864452533014589999923569999999999
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~E 786 (886)
+.+.+ +.+||+|||+|+.+...... ....||+.|||||++.+ ..++.++|||||||+|||
T Consensus 158 ~~~~~-----~~vkL~DFG~a~~~~~~~~~-----------~~~~gT~~Y~aPEv~~~----~~~~~~~DiwSlGvilye 217 (350)
T d1koaa2 158 TTKRS-----NELKLIDFGLTAHLDPKQSV-----------KVTTGTAEFAAPEVAEG----KPVGYYTDMWSVGVLSYI 217 (350)
T ss_dssp SSTTS-----CCEEECCCTTCEECCTTSCE-----------EEECSCTTTCCHHHHHT----CCBCHHHHHHHHHHHHHH
T ss_pred CCCCC-----CEEEEEECCHHEECCCCCCC-----------CEECCCCCCCCHHHHCC----CCCCHHHHHHHHHHHHHH
T ss_conf 16889-----86999545210442565432-----------00068624218899758----998726765546599999
Q ss_pred HHHCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 99199999999988999999808899950688641156520000259999996144662999999999801119999999
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 787 LLTGk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRPS 866 (886)
|++|+.||.+.+..++...+.......... .....++.+.+||.+||..||.+|||
T Consensus 218 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~~R~t 273 (350)
T d1koaa2 218 LLSGLSPFGGENDDETLRNVKSCDWNMDDS------------------------AFSGISEDGKDFIRKLLLADPNTRMT 273 (350)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCCSCCG------------------------GGGGCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHCCCCCCCCCHHHHHHHHHHCCCCCCCC------------------------CCCCCCHHHHHHHHHHCCCCHHHCCC
T ss_conf 985989989979999999998478898942------------------------23589999999999975689667908
Q ss_pred HHHHHHHHH
Q ss_conf 999999998
Q 002738 867 AGDLYEMFV 875 (886)
Q Consensus 867 asEIL~hL~ 875 (886)
++|+++|-+
T Consensus 274 ~~eil~hp~ 282 (350)
T d1koaa2 274 IHQALEHPW 282 (350)
T ss_dssp HHHHHHSTT
T ss_pred HHHHHCCCC
T ss_conf 999862913
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=380.73 Aligned_cols=254 Identities=25% Similarity=0.426 Sum_probs=211.0
Q ss_pred CCCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 89941642325349459999999--9912999999335689996888765674999999996179998122563685489
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~~ 627 (886)
-.+|.+.+.||+|+||.||+|.. .+..||+|++...... ..+ .+.+|+.+|+.++|||||++++++....
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~----~~~~E~~il~~l~HpnIv~~~~~~~~~~ 90 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKE----LIINEILVMRENKNPNIVNYLDSYLVGD 90 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS----CHH----HHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred CCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCH----HHH----HHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 10538878981285829999999899989999998430172----799----9999999998679998805857798899
Q ss_pred CCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEE
Q ss_conf 88889999976664089999025999999999987205997679999999999999999999858912147999978872
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILId 707 (886)
. .|||||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 91 ~--------------~~ivmEy~~gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~ 150 (293)
T d1yhwa1 91 E--------------LWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150 (293)
T ss_dssp E--------------EEEEEECCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred E--------------EEEEEEECCCCCHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEC
T ss_conf 9--------------8999970379808988641------5999999999999999999999987972267768886887
Q ss_pred CCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 46657899980999315875224445543233467999997656898644525330145899999235699999999999
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~EL 787 (886)
.++ .+||+|||+|+.+..... .....+||+.|||||++.+ ..|+.++|||||||+||+|
T Consensus 151 ~~~-------~vkl~DFG~a~~~~~~~~----------~~~~~~gt~~Y~aPE~~~~----~~~~~~~DiwSlGvilyem 209 (293)
T d1yhwa1 151 MDG-------SVKLTDFGFCAQITPEQS----------KRSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIEM 209 (293)
T ss_dssp TTC-------CEEECCCTTCEECCSTTC----------CBCCCCSCGGGCCHHHHSS----SCBCTHHHHHHHHHHHHHH
T ss_pred CCC-------CEEECCCHHHEEECCCCC----------CCCCCCCCCCCCCHHHHCC----CCCCCHHCEEHHHHHHHHH
T ss_conf 899-------686425156413213666----------4444444777368266447----9988012031372999998
Q ss_pred HHCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH
Q ss_conf 91999999999889999998088999506886411565200002599999961446629999999998011199999999
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 788 LTGk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRPSa 867 (886)
++|+.||.+.+..+....+.....+.++. ....++.+.+||.+||+.||.+|||+
T Consensus 210 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dP~~R~s~ 264 (293)
T d1yhwa1 210 IEGEPPYLNENPLRALYLIATNGTPELQN-------------------------PEKLSAIFRDFLNRCLDMDVEKRGSA 264 (293)
T ss_dssp HHSSCTTTTSCHHHHHHHHHHHCSCCCSS-------------------------GGGSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHCCCCCCCCCHHHHHHHHHHCCCCCCCC-------------------------CCCCCHHHHHHHHHHCCCCHHHCCCH
T ss_conf 04889989979999999998579998888-------------------------55379999999999866996689099
Q ss_pred HHHHHHHHHH
Q ss_conf 9999999800
Q 002738 868 GDLYEMFVAR 877 (886)
Q Consensus 868 sEIL~hL~~l 877 (886)
+|+++|-+-.
T Consensus 265 ~eil~Hp~~~ 274 (293)
T d1yhwa1 265 KELLQHQFLK 274 (293)
T ss_dssp HHHTTCGGGG
T ss_pred HHHHCCHHHC
T ss_conf 9996499657
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=384.79 Aligned_cols=259 Identities=27% Similarity=0.372 Sum_probs=214.4
Q ss_pred CCCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 89941642325349459999999--9912999999335689996888765674999999996179998122563685489
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~~ 627 (886)
.++|++.+.||+|+||.||+|+. .+..||+|++... .......+. +.+|+.+|++++|||||++++++....
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~----~~~E~~il~~l~HpnIv~~~~~~~~~~ 76 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYG--SMTEAEKQM----LVSEVNLLRELKHPNIVRYYDRIIDRT 76 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCT--TSCHHHHHH----HHHHHHHTTSCCCTTBCCEEEEEEC--
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH--HCCHHHHHH----HHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 33379967983088919999999999979999998746--579799999----999999999778999824899999178
Q ss_pred CCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCC
Q ss_conf 888899999766640899990259999999999872059976799999999999999999998589-----121479999
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-----IMHRDIKSE 702 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~g-----IVHRDLKps 702 (886)
. ..+|||||||++|+|.+++....+. ...+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 77 ~------------~~~~ivmEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~ 143 (269)
T d2java1 77 N------------TTLYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 143 (269)
T ss_dssp --------------CEEEEEECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGG
T ss_pred C------------CEEEEEEECCCCCCHHHHHHHCCCC-CCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHH
T ss_conf 9------------9899999568999389999851545-78999999999999999999999971677887885867654
Q ss_pred CEEEECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf 78872466578999809993158752244455432334679999976568986445253301458999992356999999
Q 002738 703 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 782 (886)
Q Consensus 703 NILId~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGV 782 (886)
|||++.++ .+||+|||+|+.+..... ......||+.|||||++.+ ..|+.++|||||||
T Consensus 144 NIll~~~~-------~vkl~DFG~a~~~~~~~~----------~~~~~~gt~~Y~APE~l~~----~~~~~~~DIwSlGv 202 (269)
T d2java1 144 NVFLDGKQ-------NVKLGDFGLARILNHDTS----------FAKAFVGTPYYMSPEQMNR----MSYNEKSDIWSLGC 202 (269)
T ss_dssp GEEECTTS-------CEEECCHHHHHHC---------------------CCCSCCCHHHHTT----CCCCHHHHHHHHHH
T ss_pred HCCCCCCC-------CEEEEECCCEEECCCCCC----------CCCCCCCCCCCCCHHHHCC----CCCCHHHHHHHHCH
T ss_conf 25747888-------579800100032245777----------5566778823279999839----99993898875278
Q ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 99999919999999998899999980889995068864115652000025999999614466299999999980111999
Q 002738 783 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 862 (886)
Q Consensus 783 IL~ELLTGk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~ 862 (886)
+||||+||+.||.+.+..++...+..+..+.++.. .++.+.+|+.+||+.||.
T Consensus 203 ilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~---------------------------~s~~l~~li~~~L~~dp~ 255 (269)
T d2java1 203 LLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR---------------------------YSDELNEIITRMLNLKDY 255 (269)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTT---------------------------SCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCC---------------------------CCHHHHHHHHHHCCCCHH
T ss_conf 99998018899899899999999971899889743---------------------------599999999997679955
Q ss_pred CCCCHHHHHHHHH
Q ss_conf 9999999999998
Q 002738 863 ERPTAGDLYEMFV 875 (886)
Q Consensus 863 kRPSasEIL~hL~ 875 (886)
+|||++||++|.+
T Consensus 256 ~Rps~~ell~hp~ 268 (269)
T d2java1 256 HRPSVEEILENPL 268 (269)
T ss_dssp GSCCHHHHHTSTT
T ss_pred HCCCHHHHHHCCC
T ss_conf 7918999972981
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=380.91 Aligned_cols=256 Identities=24% Similarity=0.297 Sum_probs=213.8
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECC
Q ss_conf 889941642325349459999999--991299999933568999688876567499999999617999812256368548
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~ 626 (886)
.+++|++.+.||+|+||.||+|++ .+..+|+|+..... .........+.+|+.+++.++|||||++++++..+
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 78 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-----LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA 78 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CHHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHH-----CCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC
T ss_conf 1537699889851778589999998999499999981688-----56768999999999999856888888599999989
Q ss_pred CCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEE
Q ss_conf 98888999997666408999902599999999998720599767999999999999999999985891214799997887
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILI 706 (886)
.. .+|||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus 79 ~~--------------~~ivmEy~~~g~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill 139 (263)
T d2j4za1 79 TR--------------VYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 139 (263)
T ss_dssp SE--------------EEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred CE--------------EEEEEEECCCCCHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCCEE
T ss_conf 99--------------8999850479858988750-----4899999999999999999999998894652202344146
Q ss_pred ECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 24665789998099931587522444554323346799999765689864452533014589999923569999999999
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~E 786 (886)
+.++ .+||+|||+|....... .....||+.|||||++.+ ..++.++|||||||+|||
T Consensus 140 ~~~~-------~~kl~DFG~a~~~~~~~------------~~~~~Gt~~Y~APE~~~~----~~~~~~~DiwSlGvilye 196 (263)
T d2j4za1 140 GSAG-------ELKIADFGWSVHAPSSR------------RTTLCGTLDYLPPEMIEG----RMHDEKVDLWSLGVLCYE 196 (263)
T ss_dssp CTTS-------CEEECCCCSCSCCCCCC------------CEETTEEGGGCCHHHHTT----CCCCTTHHHHHHHHHHHH
T ss_pred CCCC-------CEEECCCCEEEECCCCC------------CCCCCCCCCCCCHHHHCC----CCCCCHHHHHHHHHHHHH
T ss_conf 6899-------87115556335448885------------235578876349999758----998931440467599999
Q ss_pred HHHCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 99199999999988999999808899950688641156520000259999996144662999999999801119999999
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 787 LLTGk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRPS 866 (886)
|++|+.||.+.+..++...+.+... .+++ ..++.+.+|+.+||+.||.+|||
T Consensus 197 ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~~li~~~L~~dp~~R~t 248 (263)
T d2j4za1 197 FLVGKPPFEANTYQETYKRISRVEF-TFPD---------------------------FVTEGARDLISRLLKHNPSQRPM 248 (263)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHTTCC-CCCT---------------------------TSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHCCCCCCCCCCHHHHHHHHHCCCC-CCCC---------------------------CCCHHHHHHHHHHCCCCHHHCCC
T ss_conf 8329999888999999999971899-9986---------------------------68999999999976479768909
Q ss_pred HHHHHHHHHHHCC
Q ss_conf 9999999980008
Q 002738 867 AGDLYEMFVARTS 879 (886)
Q Consensus 867 asEIL~hL~~l~~ 879 (886)
++|+++|.+-...
T Consensus 249 ~~eil~hp~~~~~ 261 (263)
T d2j4za1 249 LREVLEHPWITAN 261 (263)
T ss_dssp HHHHHTCHHHHHH
T ss_pred HHHHHCCCCCCCC
T ss_conf 9999719070783
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=378.80 Aligned_cols=258 Identities=22% Similarity=0.305 Sum_probs=212.1
Q ss_pred CCCCEEEE-EECCCCCEEEEEEEEC----CEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE
Q ss_conf 89941642-3253494599999999----912999999335689996888765674999999996179998122563685
Q 002738 550 FPSLSSCD-EAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 624 (886)
Q Consensus 550 ~~~y~i~~-~LG~GsfG~Vyka~~~----~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~ 624 (886)
-++|.+.+ +||+|+||.||+|.+. +..||||+.. .. ......+.| .+|+.+|.+++|||||+++|++.
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~--~~-~~~~~~~~~----~~E~~il~~l~HpnIv~l~g~~~ 79 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK--QG-TEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQ 79 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEEC--SS-CCHHHHHHH----HHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEEC--HH-CCHHHHHHH----HHHHHHHHHCCCCCEEEEEEEEC
T ss_conf 447188784873060809999999608976899999988--20-397899999----99999998679988806865603
Q ss_pred CCCCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCE
Q ss_conf 48988889999976664089999025999999999987205997679999999999999999999858912147999978
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNI 704 (886)
.+. .+|||||+++|+|.+++.. ....+++..+..++.||+.||.|||+++|+||||||+||
T Consensus 80 ~~~---------------~~lvmE~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Ni 140 (285)
T d1u59a_ 80 AEA---------------LMLVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNV 140 (285)
T ss_dssp SSS---------------EEEEEECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred CCE---------------EEEEEEECCCCCHHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHE
T ss_conf 680---------------7999980789968997521----256999999999999999987899868810576764660
Q ss_pred EEECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 87246657899980999315875224445543233467999997656898644525330145899999235699999999
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 705 LId~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL 784 (886)
|++.+ +.+||+|||+|+.+........ ......||+.|||||++.. ..++.++|||||||+|
T Consensus 141 ll~~~-------~~~Kl~DFGla~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~----~~~~~ksDVwS~Gv~l 202 (285)
T d1u59a_ 141 LLVNR-------HYAKISDFGLSKALGADDSYYT-------ARSAGKWPLKWYAPECINF----RKFSSRSDVWSYGVTM 202 (285)
T ss_dssp EEEET-------TEEEECCCTTCEECTTCSCEEC-------CCCSSCCCGGGCCHHHHHH----CEECHHHHHHHHHHHH
T ss_pred EECCC-------CCEEECCCHHHHCCCCCCCCCC-------CCCCCCCCCCCCCHHHHHC----CCCCCCCHHHCCHHHH
T ss_conf 45468-------8542033134211554343211-------3562113743358688727----9999541232201789
Q ss_pred HHHHH-CCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 99991-99999999988999999808899950688641156520000259999996144662999999999801119999
Q 002738 785 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 785 ~ELLT-Gk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~k 863 (886)
|||+| |+.||.+.+..++...+..+.++.++.. .++.+.+||.+||..||.+
T Consensus 203 ~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~---------------------------~~~~l~~li~~cl~~~p~~ 255 (285)
T d1u59a_ 203 WEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE---------------------------CPPELYALMSDCWIYKWED 255 (285)
T ss_dssp HHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTT---------------------------CCHHHHHHHHHTTCSSGGG
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCC---------------------------CCHHHHHHHHHHCCCCHHH
T ss_conf 9999389999999799999999981899999976---------------------------7899999999975779768
Q ss_pred CCCHHHHHHHHHHHC
Q ss_conf 999999999998000
Q 002738 864 RPTAGDLYEMFVART 878 (886)
Q Consensus 864 RPSasEIL~hL~~l~ 878 (886)
||+|.+|++.|+...
T Consensus 256 RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 256 RPDFLTVEQRMRACY 270 (285)
T ss_dssp SCCHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHH
T ss_conf 909999999999999
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=379.63 Aligned_cols=254 Identities=26% Similarity=0.387 Sum_probs=209.5
Q ss_pred CCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCC
Q ss_conf 941642325349459999999--991299999933568999688876567499999999617999812256368548988
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~~~l 629 (886)
.|+..+.||+|+||.||+|++ ++..||+|+..... .......+ .+.+|+.+|+.++|||||++++++.....
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~----~~~~Ei~il~~l~HpnIv~~~~~~~~~~~- 89 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQ----DIIKEVRFLQKLRHPNTIQYRGCYLREHT- 89 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCS-SCHHHHHH----HHHHHHHHHTTCCCTTBCCEEEEEEETTE-
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-CCCHHHHH----HHHHHHHHHHHCCCCCEEEEEEEEEECCE-
T ss_conf 5676279701888099999998999399999984444-35889999----99999999997789998238999998998-
Q ss_pred CCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECC
Q ss_conf 88999997666408999902599999999998720599767999999999999999999985891214799997887246
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILId~d 709 (886)
.|||||||.+|+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 90 -------------~~iv~E~~~~g~l~~~~~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~ 151 (309)
T d1u5ra_ 90 -------------AWLVMEYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP 151 (309)
T ss_dssp -------------EEEEEECCSEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT
T ss_pred -------------EEEEEEECCCCCHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCEEEECCC
T ss_conf -------------8999980699945789973-----7999999999999999999999986897666788421798799
Q ss_pred CCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 65789998099931587522444554323346799999765689864452533014589999923569999999999991
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~ELLT 789 (886)
+.+||+|||+|...... ....||+.|||||++.+.. ...|+.++|||||||+||||++
T Consensus 152 -------~~~Kl~DFG~a~~~~~~--------------~~~~GT~~Y~APE~~~~~~-~~~y~~~~DiwSlGvilyel~~ 209 (309)
T d1u5ra_ 152 -------GLVKLGDFGSASIMAPA--------------NSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAE 209 (309)
T ss_dssp -------TEEEECCCTTCBSSSSB--------------CCCCSCGGGCCHHHHTTTT-SCCBCTHHHHHHHHHHHHHHHH
T ss_pred -------CCEEEEECCCCCCCCCC--------------CCCCCCCCCCCHHHHHCCC-CCCCCCHHHHHHHHHHHHHHHH
T ss_conf -------97898443653346778--------------7313476636889983467-8886721454558999999987
Q ss_pred CCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 99999999988999999808899950688641156520000259999996144662999999999801119999999999
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 869 (886)
Q Consensus 790 Gk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRPSasE 869 (886)
|..||.+.+..+....+..+..+.+.. ...++.+.+||.+||+.||.+|||+++
T Consensus 210 g~~Pf~~~~~~~~~~~i~~~~~~~~~~--------------------------~~~s~~~~~li~~~L~~dP~~Rpt~~e 263 (309)
T d1u5ra_ 210 RKPPLFNMNAMSALYHIAQNESPALQS--------------------------GHWSEYFRNFVDSCLQKIPQDRPTSEV 263 (309)
T ss_dssp SSCTTTTSCHHHHHHHHHHSCCCCCSC--------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCCCCC--------------------------CCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 889999979999999998289998887--------------------------888999999999977379657918999
Q ss_pred HHHHHHHH
Q ss_conf 99999800
Q 002738 870 LYEMFVAR 877 (886)
Q Consensus 870 IL~hL~~l 877 (886)
+++|.+-.
T Consensus 264 ll~Hp~~~ 271 (309)
T d1u5ra_ 264 LLKHRFVL 271 (309)
T ss_dssp HTTCHHHH
T ss_pred HHHCHHHC
T ss_conf 97199753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=375.79 Aligned_cols=261 Identities=22% Similarity=0.374 Sum_probs=214.8
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEC
Q ss_conf 8889941642325349459999999--99129999993356899968887656749999999961799981225636854
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~ 625 (886)
+..++|.+.+.||+|+||.||+|.+ .+..||+|+. +.... ..+. +.+|+.+|+.++|||||+++|++..
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i--~~~~~---~~~~----~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTM---EVEE----FLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEEC--CTTCS---CHHH----HHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEE--CCCCC---HHHH----HHHHHHHHHHCCCCCEECCCCCEEE
T ss_conf 4579939865982088808999999999969999997--77610---3999----9999999986799988267752745
Q ss_pred CCCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEE
Q ss_conf 89888899999766640899990259999999999872059976799999999999999999998589121479999788
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNIL 705 (886)
... .+|||||+++|+|..++.. .....+++..++.++.||+.||.|||+++|+||||||+|||
T Consensus 85 ~~~--------------~~iv~E~~~~g~l~~~l~~---~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NIL 147 (287)
T d1opja_ 85 EPP--------------FYIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 147 (287)
T ss_dssp SSS--------------CEEEEECCTTCBHHHHHHH---SCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred CCE--------------EEEEEECCCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEE
T ss_conf 785--------------4787631467606777530---35541579999999999999788898789305760457689
Q ss_pred EECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 72466578999809993158752244455432334679999976568986445253301458999992356999999999
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Id~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~ 785 (886)
++.++ .+||+|||+|+......... .....||+.|||||++.+ ..|+.++|||||||+||
T Consensus 148 l~~~~-------~~Kl~DFG~a~~~~~~~~~~---------~~~~~g~~~y~aPE~~~~----~~~~~k~DiwS~Gv~l~ 207 (287)
T d1opja_ 148 VGENH-------LVKVADFGLSRLMTGDTYTA---------HAGAKFPIKWTAPESLAY----NKFSIKSDVWAFGVLLW 207 (287)
T ss_dssp ECGGG-------CEEECCCCCTTTCCSSSSEE---------ETTEEECGGGCCHHHHHH----CCCSHHHHHHHHHHHHH
T ss_pred ECCCC-------CEEECCCCCEEECCCCCCEE---------ECCCCCCCCCCCHHHHCC----CCCCCHHHHHHHHHHHH
T ss_conf 98999-------28983244546537887221---------035566546669278727----99981043021789999
Q ss_pred HHHHCCCC-CCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 99919999-99999889999998088999506886411565200002599999961446629999999998011199999
Q 002738 786 ELLTLQVP-YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 864 (886)
Q Consensus 786 ELLTGk~P-f~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kR 864 (886)
||+++..| |.+.+..++...+..+.++.++.. .++.+.+|+.+||+.||.+|
T Consensus 208 ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~---------------------------~~~~l~~li~~cl~~dP~~R 260 (287)
T d1opja_ 208 EIATYGMSPYPGIDLSQVYELLEKDYRMERPEG---------------------------CPEKVYELMRACWQWNPSDR 260 (287)
T ss_dssp HHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTT---------------------------CCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCC---------------------------CHHHHHHHHHHHCCCCHHHC
T ss_conf 998679988774259999999855888888743---------------------------30999999999757797689
Q ss_pred CCHHHHHHHHHHHCCCC
Q ss_conf 99999999998000889
Q 002738 865 PTAGDLYEMFVARTSSS 881 (886)
Q Consensus 865 PSasEIL~hL~~l~~~s 881 (886)
||+++|++.|+.+...+
T Consensus 261 ps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 261 PSFAEIHQAFETMFQES 277 (287)
T ss_dssp CCHHHHHHHHHHTTSSS
T ss_pred CCHHHHHHHHHHHHHHC
T ss_conf 39999999999998757
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.40 Aligned_cols=255 Identities=21% Similarity=0.355 Sum_probs=213.3
Q ss_pred CCCEEEEEECCCCCEEEEEEEE-CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCC
Q ss_conf 9941642325349459999999-991299999933568999688876567499999999617999812256368548988
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 551 ~~y~i~~~LG~GsfG~Vyka~~-~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~~~l 629 (886)
.+|++.+.||+|+||.||+|.+ ++..||+|+. +..... .+. +.+|+.+++.++|||||+++|++.....
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i--~~~~~~---~~~----~~~E~~~l~~l~HpnIv~~~g~~~~~~~- 74 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI--REGAMS---EED----FIEEAEVMMKLSHPKLVQLYGVCLEQAP- 74 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEEC--CSSSSC---HHH----HHHHHHHHHHCCCTTBCCEEEEECSSSS-
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEE--CCCCCC---HHH----HHHHHHHHHHCCCCCCCCCCCEECCCCC-
T ss_conf 995888898208882999999889999999998--788676---899----9999999996689975653524315993-
Q ss_pred CCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECC
Q ss_conf 88999997666408999902599999999998720599767999999999999999999985891214799997887246
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILId~d 709 (886)
.++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+|||++.+
T Consensus 75 -------------~~lv~E~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~ 137 (263)
T d1sm2a_ 75 -------------ICLVFEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN 137 (263)
T ss_dssp -------------CEEEEECCTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGG
T ss_pred -------------EEEEEEECCCCCHHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCHHHEEECCC
T ss_conf -------------3799983699918997520----13478899999999999998776531643104431532666688
Q ss_pred CCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 65789998099931587522444554323346799999765689864452533014589999923569999999999991
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~ELLT 789 (886)
+ .+||+|||+|+........ ......||+.|||||++.+ ..|+.++|||||||+||||+|
T Consensus 138 ~-------~~Kl~DFGla~~~~~~~~~---------~~~~~~gt~~y~aPE~l~~----~~~~~k~DVwS~Gvil~el~t 197 (263)
T d1sm2a_ 138 Q-------VIKVSDFGMTRFVLDDQYT---------SSTGTKFPVKWASPEVFSF----SRYSSKSDVWSFGVLMWEVFS 197 (263)
T ss_dssp G-------CEEECSCC---------------------------CTTSCCHHHHTT----CCCCHHHHHHHHHHHHHHHHT
T ss_pred C-------CEEECCCCHHEECCCCCCE---------EECCEECCCCCCCHHHHCC----CCCCCHHHHCCHHHHHHHHHH
T ss_conf 7-------7686553210023688733---------5043001766678578607----999840332105999999987
Q ss_pred -CCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Q ss_conf -9999999998899999980889995068864115652000025999999614466299999999980111999999999
Q 002738 790 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868 (886)
Q Consensus 790 -Gk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRPSas 868 (886)
|.+||.+.+..++...+..+.++..+.. .++.+.+|+.+||+.||.+|||++
T Consensus 198 ~~~~~~~~~~~~~~~~~i~~~~~~~~p~~---------------------------~~~~l~~li~~cl~~~p~~Rps~~ 250 (263)
T d1sm2a_ 198 EGKIPYENRSNSEVVEDISTGFRLYKPRL---------------------------ASTHVYQIMNHCWKERPEDRPAFS 250 (263)
T ss_dssp TSCCTTCSCCHHHHHHHHHHTCCCCCCTT---------------------------SCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCCCCCHHHHHHHHHHCCCCCCCCC---------------------------CCHHHHHHHHHHCCCCHHHCCCHH
T ss_conf 89888778999999999980688899543---------------------------679999999997657976891999
Q ss_pred HHHHHHHHHCC
Q ss_conf 99999980008
Q 002738 869 DLYEMFVARTS 879 (886)
Q Consensus 869 EIL~hL~~l~~ 879 (886)
+|+++|+.+..
T Consensus 251 ~il~~L~~i~e 261 (263)
T d1sm2a_ 251 RLLRQLAEIAE 261 (263)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
T ss_conf 99999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=378.04 Aligned_cols=254 Identities=21% Similarity=0.325 Sum_probs=207.9
Q ss_pred CEEE-EEECCCCCEEEEEEEEC----CEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 4164-23253494599999999----912999999335689996888765674999999996179998122563685489
Q 002738 553 LSSC-DEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 553 y~i~-~~LG~GsfG~Vyka~~~----~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~~ 627 (886)
+.+. ++||+|+||.||+|.+. +..||+|+.... .......+ .+.+|+.+|++++|||||+++|++..+.
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~----~~~~E~~il~~l~HpnIv~~~g~~~~~~ 81 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE--ANDPALKD----ELLAEANVMQQLDNPYIVRMIGICEAES 81 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHH----HHHHHHHHHHTCCCTTBCCEEEEEESSS
T ss_pred CEECCCCCCCCCCEEEEEEEECCCCCCEEEEEEEECHH--HCCHHHHH----HHHHHHHHHHHCCCCCCCEEEEEECCCC
T ss_conf 70018783458782999999816973859999998801--08989999----9999999998679989852777750597
Q ss_pred CCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEE
Q ss_conf 88889999976664089999025999999999987205997679999999999999999999858912147999978872
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILId 707 (886)
.+|||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+|||++
T Consensus 82 ---------------~~lvmE~~~~g~L~~~l~~-----~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~ 141 (277)
T d1xbba_ 82 ---------------WMLVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV 141 (277)
T ss_dssp ---------------EEEEEECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred ---------------EEEEEECCCCCCHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCC
T ss_conf ---------------7999974788968999752-----25789999999999999997668747955677761131023
Q ss_pred CCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 46657899980999315875224445543233467999997656898644525330145899999235699999999999
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~EL 787 (886)
.++ .+||+|||+|+.+........ ......||+.|||||++.+ ..++.++|||||||++|||
T Consensus 142 ~~~-------~~kl~DFGla~~~~~~~~~~~-------~~~~~~gt~~y~APE~l~~----~~~~~~sDiwS~Gv~l~el 203 (277)
T d1xbba_ 142 TQH-------YAKISDFGLSKALRADENYYK-------AQTHGKWPVKWYAPECINY----YKFSSKSDVWSFGVLMWEA 203 (277)
T ss_dssp ETT-------EEEECCCTTCEECCTTCSEEE-------C----CCCGGGCCHHHHHH----CEEEHHHHHHHHHHHHHHH
T ss_pred CCC-------CCCCCCHHHHHHCCCCCCCCC-------CCCCCCCCCEECCCHHHCC----CCCCCHHHHCCCHHHHHHH
T ss_conf 567-------512341345331343234432-------2445677842039166537----9998434430340313289
Q ss_pred HH-CCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 91-99999999988999999808899950688641156520000259999996144662999999999801119999999
Q 002738 788 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 788 LT-Gk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRPS 866 (886)
+| |+.||.+.+..++...+..+.++.++.. .++.+.+|+.+||+.||.+|||
T Consensus 204 lt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~---------------------------~~~~~~~li~~cl~~dp~~RPs 256 (277)
T d1xbba_ 204 FSYGQKPYRGMKGSEVTAMLEKGERMGCPAG---------------------------CPREMYDLMNLCWTYDVENRPG 256 (277)
T ss_dssp HTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT---------------------------CCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHCCCCCCCCCCHHHHHHHHHCCCCCCCCCC---------------------------CCHHHHHHHHHHCCCCHHHCCC
T ss_conf 6589999999899999999982899999865---------------------------6799999999975889768909
Q ss_pred HHHHHHHHHHH
Q ss_conf 99999999800
Q 002738 867 AGDLYEMFVAR 877 (886)
Q Consensus 867 asEIL~hL~~l 877 (886)
+++|++.|+..
T Consensus 257 ~~~i~~~L~~~ 267 (277)
T d1xbba_ 257 FAAVELRLRNY 267 (277)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHCH
T ss_conf 89999985288
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=377.05 Aligned_cols=258 Identities=21% Similarity=0.271 Sum_probs=212.5
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEC
Q ss_conf 8889941642325349459999999--99129999993356899968887656749999999961799981225636854
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~ 625 (886)
..++.|++.+.||+|+||.||+|.. .+..||+|++... .....+ .+.+|+.+|++++|||||++++++..
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~----~~~~Ei~il~~l~HpnIv~~~~~~~~ 97 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKY----TVKNEISIMNQLHHPKLINLHDAFED 97 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHH----HHHHHHHHHTTCCSTTBCCEEEEEEC
T ss_pred CCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC----CHHHHH----HHHHHHHHHHHCCCCCCCCEEEEEEE
T ss_conf 8540359989993177829999999899979999998872----646799----99999999986799798919999998
Q ss_pred CCCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEE
Q ss_conf 89888899999766640899990259999999999872059976799999999999999999998589121479999788
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNIL 705 (886)
... .|||||||+||+|.+++.. ....+++..++.|+.||+.||.|||++||+||||||+|||
T Consensus 98 ~~~--------------~~ivmE~~~gg~L~~~~~~----~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NIL 159 (352)
T d1koba_ 98 KYE--------------MVLILEFLSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIM 159 (352)
T ss_dssp SSE--------------EEEEEECCCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CCE--------------EEEEEECCCCCHHHHHHHH----CCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCC
T ss_conf 999--------------9999982899808888986----3899899999999999999999999779265131445531
Q ss_pred EECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 72466578999809993158752244455432334679999976568986445253301458999992356999999999
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Id~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~ 785 (886)
++...+ +.+||+|||+|..+..... .....||+.|||||++.+ ..++.++|||||||+||
T Consensus 160 l~~~~~-----~~vkL~DFGla~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvily 219 (352)
T d1koba_ 160 CETKKA-----SSVKIIDFGLATKLNPDEI-----------VKVTTATAEFAAPEIVDR----EPVGFYTDMWAIGVLGY 219 (352)
T ss_dssp ESSTTC-----CCEEECCCTTCEECCTTSC-----------EEEECSSGGGCCHHHHTT----CCBCHHHHHHHHHHHHH
T ss_pred CCCCCC-----CEEEEEECCCCEECCCCCC-----------EEECCCCCCCCCHHHHCC----CCCCCCCCHHHHHHHHH
T ss_conf 134678-----8489952563034378872-----------010047645348999747----99897633389899999
Q ss_pred HHHHCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 99919999999998899999980889995068864115652000025999999614466299999999980111999999
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 786 ELLTGk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRP 865 (886)
||++|+.||.+.+..++...+..+..+.... .....++.+.+||.+||+.||.+||
T Consensus 220 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dp~~R~ 275 (352)
T d1koba_ 220 VLLSGLSPFAGEDDLETLQNVKRCDWEFDED------------------------AFSSVSPEAKDFIKNLLQKEPRKRL 275 (352)
T ss_dssp HHHHSCCSSCCSSHHHHHHHHHHCCCCCCSS------------------------TTTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred HHHHCCCCCCCCCHHHHHHHHHHCCCCCCCC------------------------CCCCCCHHHHHHHHHHCCCCHHHCC
T ss_conf 9996889989979999999998478898930------------------------0247999999999997569966891
Q ss_pred CHHHHHHHHH
Q ss_conf 9999999998
Q 002738 866 TAGDLYEMFV 875 (886)
Q Consensus 866 SasEIL~hL~ 875 (886)
|++|+++|-+
T Consensus 276 s~~eil~Hp~ 285 (352)
T d1koba_ 276 TVHDALEHPW 285 (352)
T ss_dssp CHHHHHTSTT
T ss_pred CHHHHHCCHH
T ss_conf 8999960973
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=379.18 Aligned_cols=258 Identities=28% Similarity=0.426 Sum_probs=212.6
Q ss_pred CCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCC
Q ss_conf 9941642325349459999999--99129999993356899968887656749999999961799981225636854898
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~~~ 628 (886)
+.|++.+.||+|+||.||+|++ .+..+|+|++... .....+.+ .+|+.+|+.++|||||++++++.....
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~----~~~~~~~~----~~E~~il~~l~HpnIv~l~~~~~~~~~ 83 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK----SEEELEDY----MVEIDILASCDHPNIVKLLDAFYYENN 83 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----SSGGGGGT----HHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCC----CHHHHHHH----HHHHHHHHHCCCCCCCEEEEEEEECCE
T ss_conf 3759847993077819999999999939999998728----99999999----999999986799998849889800995
Q ss_pred CCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEEC
Q ss_conf 88899999766640899990259999999999872059976799999999999999999998589121479999788724
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILId~ 708 (886)
.+|||||+++|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++.
T Consensus 84 --------------~~lvmEy~~~g~L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~ 145 (288)
T d2jfla1 84 --------------LWILIEFCAGGAVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTL 145 (288)
T ss_dssp --------------EEEEEECCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred --------------EEEEEECCCCCCHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEECCHHHEEECC
T ss_conf --------------89999627998188999862----899999999999999999999999889887140700314878
Q ss_pred CCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCC-CCCCCCCHHHHHHHHHHHHHH
Q ss_conf 6657899980999315875224445543233467999997656898644525330145-899999235699999999999
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~~s~KsDVWSLGVIL~EL 787 (886)
++ .+||+|||+|......... .....||+.|||||++.... ....|+.++|||||||+||||
T Consensus 146 ~~-------~~Kl~DFG~a~~~~~~~~~----------~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyem 208 (288)
T d2jfla1 146 DG-------DIKLADFGVSAKNTRTIQR----------RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 208 (288)
T ss_dssp TS-------CEEECCCTTCEECHHHHHH----------HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHH
T ss_pred CC-------CEEEEECHHHHCCCCCCCC----------CCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHH
T ss_conf 99-------9899716123035778641----------001025626479999832025788888066578789999998
Q ss_pred HHCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH
Q ss_conf 91999999999889999998088999506886411565200002599999961446629999999998011199999999
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 788 LTGk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRPSa 867 (886)
++|+.||.+.+..++...+..+..+.+.. ....++.+.+||.+||+.||.+|||+
T Consensus 209 ltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dp~~R~t~ 263 (288)
T d2jfla1 209 AEIEPPHHELNPMRVLLKIAKSEPPTLAQ-------------------------PSRWSSNFKDFLKKCLEKNVDARWTT 263 (288)
T ss_dssp HHSSCTTTTSCGGGHHHHHHHSCCCCCSS-------------------------GGGSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HHCCCCCCCCCHHHHHHHHHCCCCCCCCC-------------------------CCCCCHHHHHHHHHHCCCCHHHCCCH
T ss_conf 20889999989999999997079987776-------------------------56699999999999766996689199
Q ss_pred HHHHHHHHH
Q ss_conf 999999980
Q 002738 868 GDLYEMFVA 876 (886)
Q Consensus 868 sEIL~hL~~ 876 (886)
+|+++|.+-
T Consensus 264 ~ell~hp~~ 272 (288)
T d2jfla1 264 SQLLQHPFV 272 (288)
T ss_dssp HHHTTSGGG
T ss_pred HHHHCCCCC
T ss_conf 999629231
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.06 Aligned_cols=263 Identities=22% Similarity=0.280 Sum_probs=214.4
Q ss_pred CCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCC
Q ss_conf 9941642325349459999999--99129999993356899968887656749999999961799981225636854898
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~~~ 628 (886)
+.|.+.+.||+|+||.||+|++ .+..||+|++......... .....+.+.+|+.+|+.++|||||++++++.....
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR--RGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCS--SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHH--HHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf 6779827981178959999999999989999998756632134--06899999999999986799899938899997998
Q ss_pred CCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEEC
Q ss_conf 88899999766640899990259999999999872059976799999999999999999998589121479999788724
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILId~ 708 (886)
.+||||||+||+|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+|||++.
T Consensus 88 --------------~~iv~E~~~gg~L~~~i~~-----~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~ 148 (293)
T d1jksa_ 88 --------------VILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 148 (293)
T ss_dssp --------------EEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESC
T ss_pred --------------EEEEEECCCCCCCCCHHCC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEEC
T ss_conf --------------9999986778643100103-----564215578999999999987666254221133301279825
Q ss_pred CCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 66578999809993158752244455432334679999976568986445253301458999992356999999999999
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~ELL 788 (886)
++. ....+||+|||+|........ .....||+.|||||++.+ ..++.++|||||||+||||+
T Consensus 149 ~~~---~~~~vkl~DfG~a~~~~~~~~-----------~~~~~~t~~y~APE~~~~----~~~~~~~DiwSlGvilyell 210 (293)
T d1jksa_ 149 RNV---PKPRIKIIDFGLAHKIDFGNE-----------FKNIFGTPEFVAPEIVNY----EPLGLEADMWSIGVITYILL 210 (293)
T ss_dssp SSS---SSCCEEECCCTTCEECTTSCB-----------CSCCCCCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHHH
T ss_pred CCC---CCCCEEECCHHHHHHCCCCCC-----------CCCCCCCCCCCCHHHHCC----CCCCCCCCCHHHHHHHHHHH
T ss_conf 898---666469643344210577763-----------122477774309999818----99997665221409999997
Q ss_pred HCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Q ss_conf 19999999998899999980889995068864115652000025999999614466299999999980111999999999
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868 (886)
Q Consensus 789 TGk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRPSas 868 (886)
+|+.||.+.+..++...+............ ...++.+.+||.+||+.||.+|||++
T Consensus 211 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dP~~R~s~~ 266 (293)
T d1jksa_ 211 SGASPFLGDTKQETLANVSAVNYEFEDEYF------------------------SNTSALAKDFIRRLLVKDPKKRMTIQ 266 (293)
T ss_dssp HSSCSSCCSSHHHHHHHHHTTCCCCCHHHH------------------------TTSCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred CCCCCCCCCCHHHHHHHHHHCCCCCCCHHC------------------------CCCCHHHHHHHHHHCCCCHHHCCCHH
T ss_conf 088998899999999999816888870104------------------------78899999999998638966891999
Q ss_pred HHHHHHHH
Q ss_conf 99999980
Q 002738 869 DLYEMFVA 876 (886)
Q Consensus 869 EIL~hL~~ 876 (886)
++++|-+-
T Consensus 267 eil~hp~~ 274 (293)
T d1jksa_ 267 DSLQHPWI 274 (293)
T ss_dssp HHHHSTTT
T ss_pred HHHCCCCC
T ss_conf 99619041
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=378.80 Aligned_cols=263 Identities=25% Similarity=0.327 Sum_probs=207.8
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEECC-------EEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCEE
Q ss_conf 888994164232534945999999999-------1299999933568999688876567499999999617-99981225
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 619 (886)
Q Consensus 548 ~~~~~y~i~~~LG~GsfG~Vyka~~~~-------~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L-~HPNIV~l 619 (886)
++.++|.+.+.||+|+||.||+|++.+ ..||+|+..... .... ...+.+|+.+|.++ +|||||++
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~----~~~~~~E~~~l~~l~~HpnIv~l 106 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSE----REALMSELKMMTQLGSHENIVNL 106 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCC---CHHH----HHHHHHHHHHHHHHCCCCCEEEE
T ss_conf 7789939701983078819999998578855420499999966335---8789----99999999999971589968687
Q ss_pred EEEEECCCCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHC------------------CCCCCCCHHHHHHHHHH
Q ss_conf 636854898888999997666408999902599999999998720------------------59976799999999999
Q 002738 620 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE------------------TGEKHVSVKLALFIAQD 681 (886)
Q Consensus 620 lG~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k------------------~~~~~ls~~~~l~Ia~q 681 (886)
+|++..... .+||||||++|+|.+++..... .....+++..++.++.|
T Consensus 107 ~~~~~~~~~--------------~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 172 (325)
T d1rjba_ 107 LGACTLSGP--------------IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ 172 (325)
T ss_dssp EEEECSSSS--------------CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHH
T ss_pred EEEEEECCE--------------EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHH
T ss_conf 788862995--------------899997279995999998625777510221000012220012577899999999999
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHH
Q ss_conf 99999999858912147999978872466578999809993158752244455432334679999976568986445253
Q 002738 682 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 761 (886)
Q Consensus 682 Ia~gL~YLHs~gIVHRDLKpsNILId~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEv 761 (886)
|+.||.|||+++||||||||+|||++.+ +.+||+|||+|+......... ......||+.|||||+
T Consensus 173 i~~gl~yLH~~~IiHRDlKp~Nill~~~-------~~~Kl~DFGla~~~~~~~~~~--------~~~~~~gt~~y~aPE~ 237 (325)
T d1rjba_ 173 VAKGMEFLEFKSCVHRDLAARNVLVTHG-------KVVKICDFGLARDIMSDSNYV--------VRGNARLPVKWMAPES 237 (325)
T ss_dssp HHHHHHHHHHTTEEETTCSGGGEEEETT-------TEEEECCCGGGSCGGGCTTSE--------EETTEEECGGGCCHHH
T ss_pred HHHHHHHHHHCCEEECCCCHHCCCCCCC-------CEEEEEECCCCCCCCCCCCEE--------EECCCCCCCCCCCHHH
T ss_conf 9999999973990505270321443459-------828985142222045778615--------6234357876578388
Q ss_pred HHCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHH-HHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCC
Q ss_conf 3014589999923569999999999991-99999999988999-999808899950688641156520000259999996
Q 002738 762 LRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP 839 (886)
Q Consensus 762 L~~~~~~~~~s~KsDVWSLGVIL~ELLT-Gk~Pf~g~s~~ei~-~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~ 839 (886)
+.+ ..++.++|||||||+||||+| |+.||.+.+..+.+ ..+..+.++..+..
T Consensus 238 l~~----~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~---------------------- 291 (325)
T d1rjba_ 238 LFE----GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFY---------------------- 291 (325)
T ss_dssp HHH----CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTT----------------------
T ss_pred HCC----CCCCCCEECCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC----------------------
T ss_conf 727----999963303000399999983899999998989999999856998998876----------------------
Q ss_pred HHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 14466299999999980111999999999999999800
Q 002738 840 EAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 877 (886)
Q Consensus 840 e~~~~~s~~L~dLI~~CL~~DP~kRPSasEIL~hL~~l 877 (886)
.++.+.+||.+||+.||.+|||+++|++||...
T Consensus 292 -----~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~~ 324 (325)
T d1rjba_ 292 -----ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 324 (325)
T ss_dssp -----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf -----789999999997588966893999999997488
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=376.34 Aligned_cols=258 Identities=22% Similarity=0.213 Sum_probs=211.2
Q ss_pred CCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCC
Q ss_conf 9941642325349459999999--99129999993356899968887656749999999961799981225636854898
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~~~ 628 (886)
+.|.+.+.||+|+||.||+|.+ .+..||+|++...... .. ...+.+|+.+|+.++|||||++++++.....
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 81 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE---GK----EGSMENEIAVLHKIKHPNIVALDDIYESGGH 81 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------------CHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHH---HH----HHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf 6669988994065839999999999989999998157731---28----9999999999986799899919899998998
Q ss_pred CCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEEC
Q ss_conf 88899999766640899990259999999999872059976799999999999999999998589121479999788724
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILId~ 708 (886)
.|||||||+||+|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||+..
T Consensus 82 --------------~~lvmE~~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~ 142 (307)
T d1a06a_ 82 --------------LYLIMQLVSGGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYS 142 (307)
T ss_dssp --------------EEEEECCCCSCBHHHHHHT-----CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESS
T ss_pred --------------EEEEEECCCCCCHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHHCEEEEEEECCCCEEECC
T ss_conf --------------8898852689848886530-----367887899999999999987524130556870463001104
Q ss_pred CCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 66578999809993158752244455432334679999976568986445253301458999992356999999999999
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~ELL 788 (886)
.. ..+.+||+|||+|+....... ....+||+.|||||++.+ ..|+.++|||||||+||||+
T Consensus 143 ~~----~~~~vkl~DFG~a~~~~~~~~-----------~~~~~GT~~y~APE~~~~----~~~~~~~DiwSlGvilyell 203 (307)
T d1a06a_ 143 LD----EDSKIMISDFGLSKMEDPGSV-----------LSTACGTPGYVAPEVLAQ----KPYSKAVDCWSIGVIAYILL 203 (307)
T ss_dssp SS----TTCCEEECCC-----------------------------CTTSCHHHHTT----CCCCTHHHHHHHHHHHHHHH
T ss_pred CC----CCCEEEEECCCEEEECCCCCE-----------EEEEEECCCCCCCHHHCC----CCCCCHHHHHHHHHHHHHHH
T ss_conf 68----882499831543587258970-----------440032842259188737----99980787345159999998
Q ss_pred HCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Q ss_conf 19999999998899999980889995068864115652000025999999614466299999999980111999999999
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868 (886)
Q Consensus 789 TGk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRPSas 868 (886)
+|+.||.+.+..++...+..+....... .....++.+.+|+.+||+.||.+|||++
T Consensus 204 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~ 259 (307)
T d1a06a_ 204 CGYPPFYDENDAKLFEQILKAEYEFDSP------------------------YWDDISDSAKDFIRHLMEKDPEKRFTCE 259 (307)
T ss_dssp HSSCSCCCSSHHHHHHHHHTTCCCCCTT------------------------TTTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred HCCCCCCCCCHHHHHHHHHCCCCCCCCC------------------------CCCCCCHHHHHHHHHHCCCCHHHCCCHH
T ss_conf 5979999989999999986168777876------------------------6667899999999997608975791899
Q ss_pred HHHHHHHHH
Q ss_conf 999999800
Q 002738 869 DLYEMFVAR 877 (886)
Q Consensus 869 EIL~hL~~l 877 (886)
|+++|.+-.
T Consensus 260 eil~hp~~~ 268 (307)
T d1a06a_ 260 QALQHPWIA 268 (307)
T ss_dssp HHHHSTTTT
T ss_pred HHHCCHHHC
T ss_conf 986298447
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.37 Aligned_cols=259 Identities=23% Similarity=0.381 Sum_probs=212.5
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEEC-CEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECC
Q ss_conf 88899416423253494599999999-91299999933568999688876567499999999617999812256368548
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 548 ~~~~~y~i~~~LG~GsfG~Vyka~~~-~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~ 626 (886)
++.++|++.+.||+|+||.||+|.+. +..||||+... .... .+. +.+|+.+|.+++|||||+++|++...
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~--~~~~---~~~----~~~E~~~l~~l~HpnIv~~~g~~~~~ 80 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMS---PDA----FLAEANLMKQLQHQRLVRLYAVVTQE 80 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECT--TSSC---HHH----HHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECC--CCCC---HHH----HHHHHHHHHHCCCCCEEEEEEEECCC
T ss_conf 38899388679810798289999999999999999864--7688---899----99999999867999885787310459
Q ss_pred CCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEE
Q ss_conf 98888999997666408999902599999999998720599767999999999999999999985891214799997887
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILI 706 (886)
. .+|||||+++|+|.+++.... ...+++..++.|+.||+.||.|||+++|+||||||+|||+
T Consensus 81 ~---------------~~iv~Ey~~~g~L~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll 142 (272)
T d1qpca_ 81 P---------------IYIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV 142 (272)
T ss_dssp S---------------CEEEEECCTTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred C---------------EEEEEEECCCCCHHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEE
T ss_conf 7---------------699999578982888875147---8988788999999999999999974895467564225156
Q ss_pred ECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 24665789998099931587522444554323346799999765689864452533014589999923569999999999
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~E 786 (886)
+.+ +.+||+|||+|+........ ......||+.|||||++.. ..++.++|||||||+|||
T Consensus 143 ~~~-------~~~Kl~DFGla~~~~~~~~~---------~~~~~~gt~~y~APE~~~~----~~~~~~sDvwS~Gvvl~e 202 (272)
T d1qpca_ 143 SDT-------LSCKIADFGLARLIEDNEYT---------AREGAKFPIKWTAPEAINY----GTFTIKSDVWSFGILLTE 202 (272)
T ss_dssp CTT-------SCEEECCCTTCEECSSSCEE---------CCTTCCCCTTTSCHHHHHH----CEECHHHHHHHHHHHHHH
T ss_pred ECC-------CCEEECCCCCEEECCCCCCC---------CCCCCCCCCCCCCHHHHHC----CCCCCHHHHHHHHHHHHH
T ss_conf 202-------44042341014773588644---------2035677444458289837----999824564525799999
Q ss_pred HHHC-CCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 9919-999999998899999980889995068864115652000025999999614466299999999980111999999
Q 002738 787 LLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 787 LLTG-k~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRP 865 (886)
|+|+ .+||...+..++...+..+.++..+.. .++.+.+|+.+||+.||.+||
T Consensus 203 llt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~---------------------------~~~~l~~li~~cl~~~P~~Rp 255 (272)
T d1qpca_ 203 IVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN---------------------------CPEELYQLMRLCWKERPEDRP 255 (272)
T ss_dssp HHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT---------------------------CCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCC---------------------------CHHHHHHHHHHHCCCCHHHCC
T ss_conf 99689888888899999999970688889655---------------------------719999999997588976893
Q ss_pred CHHHHHHHHHHHCCC
Q ss_conf 999999999800088
Q 002738 866 TAGDLYEMFVARTSS 880 (886)
Q Consensus 866 SasEIL~hL~~l~~~ 880 (886)
|+++|++.|+..-++
T Consensus 256 t~~ei~~~L~~~fts 270 (272)
T d1qpca_ 256 TFDYLRSVLEDFFTA 270 (272)
T ss_dssp CHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHC
T ss_conf 999999986113213
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=377.50 Aligned_cols=279 Identities=24% Similarity=0.317 Sum_probs=204.7
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECC
Q ss_conf 889941642325349459999999--991299999933568999688876567499999999617999812256368548
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~ 626 (886)
.-++|++.+.||+|+||+||+|.+ .+..||+|+..... .... ...+.+|+.+|+.++|||||++++++..+
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 76 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAI----RNQIIRELQVLHECNSPYIVGFYGAFYSD 76 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC---CTTH----HHHHHHHGGGGGGCCCTTBCCEEEEEECS
T ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH---CHHH----HHHHHHHHHHHHHCCCCCCCCEEEEEEEC
T ss_conf 7568889789712778099999998999699999987540---9789----99999999999867999999499999989
Q ss_pred CCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCCCCCCEE
Q ss_conf 988889999976664089999025999999999987205997679999999999999999999858-9121479999788
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENIL 705 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~-gIVHRDLKpsNIL 705 (886)
. +.+|||||++||+|.+++.+ ...+++..+..++.||+.||.|||++ +|+||||||+|||
T Consensus 77 ~--------------~~~iVmEy~~gg~L~~~l~~-----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NIL 137 (322)
T d1s9ja_ 77 G--------------EISICMEHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL 137 (322)
T ss_dssp S--------------EEEEEEECCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEE
T ss_pred C--------------EEEEEEECCCCCCHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEE
T ss_conf 9--------------99999976799868998742-----4999999999999999999999998599971445779946
Q ss_pred EECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 72466578999809993158752244455432334679999976568986445253301458999992356999999999
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Id~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~ 785 (886)
++.++ .+||+|||+|+...... ....+||+.|||||++.+ ..|+.++||||+||+||
T Consensus 138 l~~~~-------~vkl~DFGla~~~~~~~------------~~~~~GT~~Y~APEvl~~----~~y~~~~DiWSlGvil~ 194 (322)
T d1s9ja_ 138 VNSRG-------EIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPERLQG----THYSVQSDIWSMGLSLV 194 (322)
T ss_dssp ECTTC-------CEEECCCCCCHHHHHHT------------C---CCSSCCCCHHHHHC----SCCCTTHHHHHHHHHHH
T ss_pred ECCCC-------CEEEEECCCCCCCCCCC------------CCCCCCCCCCCCCHHHCC----CCCCCHHHHHHHHHHHH
T ss_conf 87899-------89995487762567886------------211137714119468758----99894888998999999
Q ss_pred HHHHCCCCCCCCCHHHHHHHHH---CCCCCCCHHHHHHHCCCCCCCCCCCC-------------CCCCCCHHHHHHHHHH
Q ss_conf 9991999999999889999998---08899950688641156520000259-------------9999961446629999
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQ---MGKRPRLTDELEALGSCHEHEVAQSG-------------SGFEKPEAELETLSFL 849 (886)
Q Consensus 786 ELLTGk~Pf~g~s~~ei~~~I~---~~~rp~L~e~l~~~~~~~~~~~~~~~-------------~~~~~~e~~~~~s~~L 849 (886)
||++|+.||.+.+..+...... .+.....+.................. ............+..+
T Consensus 195 ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 274 (322)
T d1s9ja_ 195 EMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEF 274 (322)
T ss_dssp HHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHH
T ss_pred HHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHH
T ss_conf 99988899899887899999988751775457742123332211112223541347788766502687667644489999
Q ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf 999998011199999999999999980
Q 002738 850 VDVFRRCTEENPTERPTAGDLYEMFVA 876 (886)
Q Consensus 850 ~dLI~~CL~~DP~kRPSasEIL~hL~~ 876 (886)
.+|+.+||+.||.+|||++|+++|..-
T Consensus 275 ~dli~~~L~~dP~~R~ta~e~L~Hpf~ 301 (322)
T d1s9ja_ 275 QDFVNKCLIKNPAERADLKQLMVHAFI 301 (322)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HHHHHHHCCCCHHHCCCHHHHHHCHHH
T ss_conf 999999868994679089999609864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.48 Aligned_cols=264 Identities=21% Similarity=0.327 Sum_probs=213.7
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEECC------EEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
Q ss_conf 888994164232534945999999999------12999999335689996888765674999999996179998122563
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFGS------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 621 (886)
Q Consensus 548 ~~~~~y~i~~~LG~GsfG~Vyka~~~~------~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG 621 (886)
+.-..|++.+.||+|+||.||+|.+.. ..||+|++... ........ +.+|+.+++.++|||||+++|
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~----~~~E~~il~~l~H~nIv~~~g 76 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRVD----FLGEAGIMGQFSHHNIIRLEG 76 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT---CCHHHHHH----HHHHHHHHHTCCCTTBCCEEE
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCC---CCHHHHHH----HHHHHHHHHHCCCCCEEEEEE
T ss_conf 78899686159811779099999996899878799999998844---59689999----999999998568987832367
Q ss_pred EEECCCCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 68548988889999976664089999025999999999987205997679999999999999999999858912147999
Q 002738 622 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 701 (886)
Q Consensus 622 ~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKp 701 (886)
++..... .++||||+.+++|.+++.. ....+++..++.++.||+.||.|||+++|+||||||
T Consensus 77 ~~~~~~~--------------~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp 138 (283)
T d1mqba_ 77 VISKYKP--------------MMIITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAA 138 (283)
T ss_dssp EECSSSS--------------EEEEEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred EEECCCC--------------EEEEEEECCCCCCHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCC
T ss_conf 7833880--------------3899972135740222102----345420899999999999854121212342576564
Q ss_pred CCEEEECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHH
Q ss_conf 97887246657899980999315875224445543233467999997656898644525330145899999235699999
Q 002738 702 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781 (886)
Q Consensus 702 sNILId~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLG 781 (886)
+|||++.+ +.+||+|||+|+........ ........||+.|||||++.+ ..++.++||||||
T Consensus 139 ~NILl~~~-------~~~Kl~DFGla~~~~~~~~~-------~~~~~~~~gt~~Y~APE~l~~----~~~~~~sDI~S~G 200 (283)
T d1mqba_ 139 RNILVNSN-------LVCKVSDFGLSRVLEDDPEA-------TYTTSGGKIPIRWTAPEAISY----RKFTSASDVWSFG 200 (283)
T ss_dssp GGEEECTT-------CCEEECCCCC------------------------CCCGGGSCHHHHHS----CCCCHHHHHHHHH
T ss_pred CEEEECCC-------CEEEECCCCHHHCCCCCCCC-------CEEECCCCCCCCCCCHHHHCC----CCCCCCCCCCCCH
T ss_conf 42788899-------84998455103003578765-------267426777734348888704----9999735563448
Q ss_pred HHHHHHHHC-CCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC
Q ss_conf 999999919-9999999988999999808899950688641156520000259999996144662999999999801119
Q 002738 782 CLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 860 (886)
Q Consensus 782 VIL~ELLTG-k~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~D 860 (886)
|+||||+++ .+||.+.+..++...+..+.+++.+.. .+..+.+|+.+||+.|
T Consensus 201 vil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~---------------------------~~~~l~~li~~cl~~~ 253 (283)
T d1mqba_ 201 IVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD---------------------------CPSAIYQLMMQCWQQE 253 (283)
T ss_dssp HHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTT---------------------------CBHHHHHHHHHHTCSS
T ss_pred HHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCHH---------------------------HHHHHHHHHHHHCCCC
T ss_conf 9899999679886556899999999863578998504---------------------------5799999999977679
Q ss_pred CCCCCCHHHHHHHHHHHCCCC
Q ss_conf 999999999999998000889
Q 002738 861 PTERPTAGDLYEMFVARTSSS 881 (886)
Q Consensus 861 P~kRPSasEIL~hL~~l~~~s 881 (886)
|.+||++.+|++.|+.+..++
T Consensus 254 p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 254 RARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp TTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHCCCHHHHHHHHHHHHHCC
T ss_conf 768939999999999986695
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.75 Aligned_cols=255 Identities=23% Similarity=0.322 Sum_probs=212.9
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEC
Q ss_conf 8889941642325349459999999--99129999993356899968887656749999999961799981225636854
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~ 625 (886)
+.+++|.+.+.||+|+||.||+|+. .+..||+|++..... ........+.+|+.+|+.++|||||++++++..
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~-----~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 76 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI-----IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred CCHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC-----CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC
T ss_conf 844742898898317684999999989998999999815654-----497999999999999986799988778764035
Q ss_pred CCCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEE
Q ss_conf 89888899999766640899990259999999999872059976799999999999999999998589121479999788
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNIL 705 (886)
... +|+||||++||+|..++.. ...+++..++.++.||+.||.|||+++|+||||||+|||
T Consensus 77 ~~~--------------~~iv~ey~~gg~L~~~~~~-----~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIL 137 (337)
T d1o6la_ 77 HDR--------------LCFVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137 (337)
T ss_dssp SSE--------------EEEEEECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred CCC--------------CCCCEECCCCCCHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEE
T ss_conf 642--------------1110003579860555532-----567759999999999965211343159622464777847
Q ss_pred EECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 72466578999809993158752244455432334679999976568986445253301458999992356999999999
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Id~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~ 785 (886)
++.++ .+||+|||+|+....... .....+||+.|||||++.+ ..|+.++||||+||+||
T Consensus 138 l~~~g-------~vkl~DFG~a~~~~~~~~----------~~~~~~GT~~Y~aPE~~~~----~~y~~~~DiwSlGvily 196 (337)
T d1o6la_ 138 LDKDG-------HIKITDFGLCKEGISDGA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMY 196 (337)
T ss_dssp ECTTS-------CEEECCCTTCBCSCCTTC----------CBCCCEECGGGCCGGGGSS----SCBCTTHHHHHHHHHHH
T ss_pred ECCCC-------CEEEEECCCCCCCCCCCC----------CCCCCEECHHHHHHHHCCC----CCCCHHHCCCCHHHHHH
T ss_conf 65899-------888820565200356786----------2055100889966665048----98883331022306788
Q ss_pred HHHHCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 99919999999998899999980889995068864115652000025999999614466299999999980111999999
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 786 ELLTGk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRP 865 (886)
||++|+.||.+.+..++...+..+.. .++. ..++.+.+||.+||++||.+||
T Consensus 197 eml~G~~pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~dli~~~L~~dP~~R~ 248 (337)
T d1o6la_ 197 EMMCGRLPFYNQDHERLFELILMEEI-RFPR---------------------------TLSPEAKSLLAGLLKKDPKQRL 248 (337)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCC-CCCT---------------------------TSCHHHHHHHHHHTCSSTTTST
T ss_pred HHHHCCCCCCCCCHHHHHHHHHCCCC-CCCC---------------------------CCCHHHHHHHHHHCCCCCHHHC
T ss_conf 99878999999699999999852899-8986---------------------------6899999999866638934422
Q ss_pred C-----HHHHHHHHH
Q ss_conf 9-----999999998
Q 002738 866 T-----AGDLYEMFV 875 (886)
Q Consensus 866 S-----asEIL~hL~ 875 (886)
+ ++++++|..
T Consensus 249 ~~~~~~~~eil~Hp~ 263 (337)
T d1o6la_ 249 GGGPSDAKEVMEHRF 263 (337)
T ss_dssp TCSTTTHHHHHTSGG
T ss_pred CCCCCCHHHHHCCCC
T ss_conf 565234999972915
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.50 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=213.0
Q ss_pred CCCEEEEEECCCCCEEEEEEEEC-CEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCC
Q ss_conf 99416423253494599999999-91299999933568999688876567499999999617999812256368548988
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 551 ~~y~i~~~LG~GsfG~Vyka~~~-~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~~~l 629 (886)
++|++.+.||+|+||.||+|+++ +..||+|+.... .... +. +.+|+.++.+++|||||+++|++.....
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~--~~~~---~~----~~~Ev~~~~~l~HpnIv~~~g~~~~~~~- 73 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSE---DE----FIEEAKVMMNLSHEKLVQLYGVCTKQRP- 73 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS--SSCH---HH----HHHHHHHHHTCCCTTBCCEEEEECCSSS-
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCC--CCCH---HH----HHHHHHHHHHCCCCCEEEEEEEEEECCC-
T ss_conf 997996898207883999999889989999998747--5778---99----9999999996689860158899850781-
Q ss_pred CCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECC
Q ss_conf 88999997666408999902599999999998720599767999999999999999999985891214799997887246
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILId~d 709 (886)
.++||||+++|+|..++.. ....+++..+.+++.||++||.|||+++|+||||||+|||++.+
T Consensus 74 -------------~~iv~Ey~~~g~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~ 136 (258)
T d1k2pa_ 74 -------------IFIITEYMANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ 136 (258)
T ss_dssp -------------EEEEEECCTTEEHHHHHHS----GGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTT
T ss_pred -------------EEEEEECCCCCCHHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEECCC
T ss_conf -------------6999970489938886410----24677689999999999999998754684346654135887699
Q ss_pred CCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 65789998099931587522444554323346799999765689864452533014589999923569999999999991
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~ELLT 789 (886)
..+||+|||+++........ ......||+.|||||++.+ ..++.++||||||+++|||+|
T Consensus 137 -------~~~kl~DfG~a~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~----~~~~~ksDiwS~G~~l~el~t 196 (258)
T d1k2pa_ 137 -------GVVKVSDFGLSRYVLDDEYT---------SSVGSKFPVRWSPPEVLMY----SKFSSKSDIWAFGVLMWEIYS 196 (258)
T ss_dssp -------CCEEECCCSSCCBCSSSSCC---------CCCCSCCCGGGCCHHHHHH----CCCCHHHHHHHHHHHHHHHHT
T ss_pred -------CCEEECCCHHHEECCCCCCE---------EECCCCCCCCCCCCHHHCC----CCCCCCEEECCCCHHHHHHHH
T ss_conf -------84798861442023578722---------5246578877578078637----998852103364324673975
Q ss_pred -CCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Q ss_conf -9999999998899999980889995068864115652000025999999614466299999999980111999999999
Q 002738 790 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868 (886)
Q Consensus 790 -Gk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRPSas 868 (886)
|+.||.+.+..++...+..+.++..+.. .++.+.+|+.+||+.||.+||||+
T Consensus 197 ~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~---------------------------~~~~l~~li~~cl~~dP~~RPt~~ 249 (258)
T d1k2pa_ 197 LGKMPYERFTNSETAEHIAQGLRLYRPHL---------------------------ASEKVYTIMYSCWHEKADERPTFK 249 (258)
T ss_dssp TSCCTTTTSCHHHHHHHHHTTCCCCCCTT---------------------------CCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred CCCCCCCCCCHHHHHHHHHHCCCCCCCCC---------------------------CCHHHHHHHHHHCCCCHHHCCCHH
T ss_conf 59999889999999999980797899654---------------------------659999999997668976893999
Q ss_pred HHHHHHHHH
Q ss_conf 999999800
Q 002738 869 DLYEMFVAR 877 (886)
Q Consensus 869 EIL~hL~~l 877 (886)
+|++||..+
T Consensus 250 eil~~L~di 258 (258)
T d1k2pa_ 250 ILLSNILDV 258 (258)
T ss_dssp HHHHHHHCC
T ss_pred HHHHHHHCC
T ss_conf 999874188
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.66 Aligned_cols=256 Identities=19% Similarity=0.318 Sum_probs=211.2
Q ss_pred CCCEEEEEECCCCCEEEEEEEECC--E----EEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE
Q ss_conf 994164232534945999999999--1----2999999335689996888765674999999996179998122563685
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKFGS--A----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 624 (886)
Q Consensus 551 ~~y~i~~~LG~GsfG~Vyka~~~~--~----~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~ 624 (886)
.+|++.+.||+|+||.||+|.+.. . .||+|... .. ......+ .+.+|+.++++++|||||+++|++.
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~--~~-~~~~~~~----~~~~E~~~l~~l~HpnIv~l~g~~~ 81 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EA-TSPKANK----EILDEAYVMASVDNPHVCRLLGICL 81 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEEC--C-----CTHH----HHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEEC--CC-CCHHHHH----HHHHHHHHHHHCCCCCEEEEEEEEE
T ss_conf 999783198208992999999958998898999999965--13-4979999----9999999998679988815899996
Q ss_pred CCCCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCE
Q ss_conf 48988889999976664089999025999999999987205997679999999999999999999858912147999978
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNI 704 (886)
+.. .+++|||+.+|+|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+||
T Consensus 82 ~~~---------------~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NI 142 (317)
T d1xkka_ 82 TST---------------VQLITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNV 142 (317)
T ss_dssp SSS---------------EEEEEECCTTCBHHHHHHH----TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred CCC---------------EEEEEEECCCCCCCCCCCC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHCC
T ss_conf 198---------------3699984268740101113----345799999999999999999999876950476212031
Q ss_pred EEECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 87246657899980999315875224445543233467999997656898644525330145899999235699999999
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 705 LId~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL 784 (886)
|++.+ +.+||+|||+|+........ .......||+.|||||++.+ ..++.++|||||||+|
T Consensus 143 ll~~~-------~~~kl~DFGla~~~~~~~~~--------~~~~~~~gt~~y~APE~l~~----~~~~~~sDvwS~Gvil 203 (317)
T d1xkka_ 143 LVKTP-------QHVKITDFGLAKLLGAEEKE--------YHAEGGKVPIKWMALESILH----RIYTHQSDVWSYGVTV 203 (317)
T ss_dssp EEEET-------TEEEECCCSHHHHTTTTCC----------------CCTTTSCHHHHHH----CCCCHHHHHHHHHHHH
T ss_pred EECCC-------CCEEEECCCCCEECCCCCCC--------CCCCCCCCCCCCCCHHHHHC----CCCCHHHHHHHHHHHH
T ss_conf 16799-------87586025522233544453--------22365105864467088746----9998356544079999
Q ss_pred HHHHH-CCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 99991-99999999988999999808899950688641156520000259999996144662999999999801119999
Q 002738 785 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 785 ~ELLT-Gk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~k 863 (886)
|||+| |.+||.+.+..++...+..+.++..+.. .++.+.+|+.+||..||.+
T Consensus 204 ~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~---------------------------~~~~~~~li~~cl~~dP~~ 256 (317)
T d1xkka_ 204 WELMTFGSKPYDGIPASEISSILEKGERLPQPPI---------------------------CTIDVYMIMVKCWMIDADS 256 (317)
T ss_dssp HHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTT---------------------------BCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCC---------------------------CCHHHHHHHHHHCCCCHHH
T ss_conf 9999779999999998999999975998999855---------------------------6899999999847899346
Q ss_pred CCCHHHHHHHHHHHC
Q ss_conf 999999999998000
Q 002738 864 RPTAGDLYEMFVART 878 (886)
Q Consensus 864 RPSasEIL~hL~~l~ 878 (886)
|||+.+|+++|..+.
T Consensus 257 RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 257 RPKFRELIIEFSKMA 271 (317)
T ss_dssp SCCHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHH
T ss_conf 919999999999987
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.83 Aligned_cols=256 Identities=25% Similarity=0.287 Sum_probs=203.6
Q ss_pred CCCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 89941642325349459999999--9912999999335689996888765674999999996179998122563685489
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~~ 627 (886)
.++|++.+.||+|+||.||+|.+ .+..+|+|++..+.. .+.. +.+.+|+.+|+.++|||||++++++....
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~----~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~ 76 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCP----ENIKKEICINKMLNHENVVKFYGHRREGN 76 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC---CHHH----HHHHHHHHHHHHCCCCCEEEEEEEECCCC
T ss_conf 7460899897217480999999999997999999845664---1279----99999999998579988846965404674
Q ss_pred CCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEE
Q ss_conf 88889999976664089999025999999999987205997679999999999999999999858912147999978872
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILId 707 (886)
. .||||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 77 ~--------------~~ivmEy~~gg~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~ 137 (271)
T d1nvra_ 77 I--------------QYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 137 (271)
T ss_dssp E--------------EEEEEECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred E--------------EEEEEECCCCCCHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEC
T ss_conf 3--------------6798864589808999753-----79999999999999999999999975983575468997887
Q ss_pred CCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCC-CCCHHHHHHHHHHHHH
Q ss_conf 466578999809993158752244455432334679999976568986445253301458999-9923569999999999
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL-YGLEVDIWSYGCLLLE 786 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~-~s~KsDVWSLGVIL~E 786 (886)
.++ .+||+|||+|+........ ......+||+.|||||++.+ .. ++.++|||||||+|||
T Consensus 138 ~~~-------~~KL~DFG~a~~~~~~~~~--------~~~~~~~GT~~Y~APE~~~~----~~~~~~~~DiwSlGvilye 198 (271)
T d1nvra_ 138 ERD-------NLKISDFGLATVFRYNNRE--------RLLNKMCGTLPYVAPELLKR----REFHAEPVDVWSCGIVLTA 198 (271)
T ss_dssp TTC-------CEEECCCTTCEECEETTEE--------CCBCCCCSCGGGSCTHHHHC----SSBCHHHHHHHHHHHHHHH
T ss_pred CCC-------CEEECCCHHHEEECCCCCC--------CCCCCEEECCCCCCHHHHCC----CCCCCCCEEEEHHHHHHHH
T ss_conf 899-------8798323142240468865--------31113255747428728618----9999971016173799999
Q ss_pred HHHCCCCCCCCCHHH-HHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 991999999999889-9999980889995068864115652000025999999614466299999999980111999999
Q 002738 787 LLTLQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 787 LLTGk~Pf~g~s~~e-i~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRP 865 (886)
|++|+.||.+..... ....+..... ..+ .....++.+.+|+.+||+.||.+||
T Consensus 199 ml~G~~pf~~~~~~~~~~~~~~~~~~-~~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~ 252 (271)
T d1nvra_ 199 MLAGELPWDQPSDSCQEYSDWKEKKT-YLN-------------------------PWKKIDSAPLALLHKILVENPSARI 252 (271)
T ss_dssp HHHSSCSCSSSSTTSHHHHHHHTTCT-TST-------------------------TGGGSCHHHHHHHHHHSCSSTTTSC
T ss_pred HHHCCCCCCCCCHHHHHHHHHHCCCC-CCC-------------------------CCCCCCHHHHHHHHHHCCCCHHHCC
T ss_conf 98299788889859999999863888-788-------------------------6446999999999997679966890
Q ss_pred CHHHHHHHHHH
Q ss_conf 99999999980
Q 002738 866 TAGDLYEMFVA 876 (886)
Q Consensus 866 SasEIL~hL~~ 876 (886)
|++|+++|.+-
T Consensus 253 t~~eil~hpwf 263 (271)
T d1nvra_ 253 TIPDIKKDRWY 263 (271)
T ss_dssp CHHHHTTCTTT
T ss_pred CHHHHHCCHHH
T ss_conf 99999619845
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.72 Aligned_cols=253 Identities=24% Similarity=0.350 Sum_probs=200.0
Q ss_pred CEEEEEECCCCCEEEEEEEEC--CEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCC
Q ss_conf 416423253494599999999--912999999335689996888765674999999996179998122563685489888
Q 002738 553 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 630 (886)
Q Consensus 553 y~i~~~LG~GsfG~Vyka~~~--~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~~~l~ 630 (886)
|.+.++||+|+||+||+|.+. +..||+|+..... ......+. +.+|+++|++++|||||++++++.....
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~--~~~~~~~~----~~~E~~il~~l~HpnIv~~~~~~~~~~~-- 82 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--LTKSERQR----FKEEAEMLKGLQHPNIVRFYDSWESTVK-- 82 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHH----HHHHHHHHTTCCCTTBCCEEEEEEEESS--
T ss_pred EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHH--CCHHHHHH----HHHHHHHHHHCCCCCEEEEEEEEEECCC--
T ss_conf 885169700828499999999999599999985122--79899999----9999999985799985069999840334--
Q ss_pred CCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCEEEEC
Q ss_conf 899999766640899990259999999999872059976799999999999999999998589--121479999788724
Q 002738 631 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILIDL 708 (886)
Q Consensus 631 ~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~g--IVHRDLKpsNILId~ 708 (886)
.....+|||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 83 --------~~~~~~ivmE~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~ 149 (270)
T d1t4ha_ 83 --------GKKCIVLVTELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG 149 (270)
T ss_dssp --------SCEEEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS
T ss_pred --------CCCEEEEEEECCCCCCHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEEC
T ss_conf --------58889999957898948999751-----35546999999999999999999978997996876743511667
Q ss_pred CCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 66578999809993158752244455432334679999976568986445253301458999992356999999999999
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~ELL 788 (886)
+. +.+||+|||+|+...... ....+||+.|||||++.+ .++.++|||||||+||||+
T Consensus 150 ~~------~~~Kl~DFGla~~~~~~~------------~~~~~GT~~Y~aPE~~~~-----~~~~~~DIwSlGvilyel~ 206 (270)
T d1t4ha_ 150 PT------GSVKIGDLGLATLKRASF------------AKAVIGTPEFMAPEMYEE-----KYDESVDVYAFGMCMLEMA 206 (270)
T ss_dssp TT------SCEEECCTTGGGGCCTTS------------BEESCSSCCCCCGGGGGT-----CCCTHHHHHHHHHHHHHHH
T ss_pred CC------CCEEEEECCCCEECCCCC------------CCCCCCCCCCCCHHHHCC-----CCCCCCCHHHHHHHHHHHH
T ss_conf 99------988980057654236876------------677553813008988478-----9998671100799999998
Q ss_pred HCCCCCCCCC-HHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH
Q ss_conf 1999999999-889999998088999506886411565200002599999961446629999999998011199999999
Q 002738 789 TLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 789 TGk~Pf~g~s-~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRPSa 867 (886)
+|+.||.+.. ..++...+..+..+... ....++.+.+||.+||+.||.+|||+
T Consensus 207 ~g~~Pf~~~~~~~~~~~~i~~~~~~~~~--------------------------~~~~~~~~~~li~~~l~~dp~~R~s~ 260 (270)
T d1t4ha_ 207 TSEYPYSECQNAAQIYRRVTSGVKPASF--------------------------DKVAIPEVKEIIEGCIRQNKDERYSI 260 (270)
T ss_dssp HSSCTTTTCSSHHHHHHHHTTTCCCGGG--------------------------GGCCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred HCCCCCCCCCCHHHHHHHHHCCCCCCCC--------------------------CCCCCHHHHHHHHHHCCCCHHHCCCH
T ss_conf 7889998765599999999738998656--------------------------75578999999999763797589299
Q ss_pred HHHHHHHH
Q ss_conf 99999998
Q 002738 868 GDLYEMFV 875 (886)
Q Consensus 868 sEIL~hL~ 875 (886)
+|+++|.+
T Consensus 261 ~ell~Hp~ 268 (270)
T d1t4ha_ 261 KDLLNHAF 268 (270)
T ss_dssp HHHHTSGG
T ss_pred HHHHCCCC
T ss_conf 99967754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.20 Aligned_cols=256 Identities=21% Similarity=0.268 Sum_probs=213.1
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECC
Q ss_conf 889941642325349459999999--991299999933568999688876567499999999617999812256368548
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~ 626 (886)
.|++|.+.+.||+|+||+||+|.+ ++..||+|++..+. .... .+.+|+.+|+.++|||||++++++...
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~~~~----~~~~Ei~il~~l~HpnIv~~~~~~~~~ 73 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQV----LVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHH----HHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-----CCHH----HHHHHHHHHHHCCCCCCCEEEEEEEEC
T ss_conf 7010588789831778399999998999699999975786-----6599----999999999857997989098999889
Q ss_pred CCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEE
Q ss_conf 98888999997666408999902599999999998720599767999999999999999999985891214799997887
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILI 706 (886)
.. .|||||||+||+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 74 ~~--------------~~lvmE~~~gg~L~~~i~~----~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll 135 (321)
T d1tkia_ 74 EE--------------LVMIFEFISGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIY 135 (321)
T ss_dssp TE--------------EEEEECCCCCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CE--------------EEEEEECCCCCCHHHHHHH----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEE
T ss_conf 98--------------8999953899808899875----38999999999999999999999987699751355444344
Q ss_pred ECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 24665789998099931587522444554323346799999765689864452533014589999923569999999999
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~E 786 (886)
+.++. ..+||+|||+++........ ....||+.|+|||.+.+ ..|+.++||||+||+||+
T Consensus 136 ~~~~~-----~~ikl~DFG~~~~~~~~~~~-----------~~~~~t~~y~ape~~~~----~~~~~~~DiWSlGvily~ 195 (321)
T d1tkia_ 136 QTRRS-----STIKIIEFGQARQLKPGDNF-----------RLLFTAPEYYAPEVHQH----DVVSTATDMWSLGTLVYV 195 (321)
T ss_dssp SSSSC-----CCEEECCCTTCEECCTTCEE-----------EEEESCGGGSCHHHHTT----CEECHHHHHHHHHHHHHH
T ss_pred CCCCC-----EEEEECCCCHHHCCCCCCCC-----------CCCCCCCCCCCCHHCCC----CCCCCHHHCCCHHHHHHH
T ss_conf 37885-----18997644111003467753-----------21223322234021048----777840113027999999
Q ss_pred HHHCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 99199999999988999999808899950688641156520000259999996144662999999999801119999999
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 787 LLTGk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRPS 866 (886)
|++|..||.+.+..++...+...........+ ...++.+.+||.+||..||.+|||
T Consensus 196 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dp~~R~s 251 (321)
T d1tkia_ 196 LLSGINPFLAETNQQIIENIMNAEYTFDEEAF------------------------KEISIEAMDFVDRLLVKERKSRMT 251 (321)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH------------------------TTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred HHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHC------------------------CCCCHHHHHHHHHHCCCCHHHCCC
T ss_conf 98289999998999999999838999880223------------------------678999999999986699668909
Q ss_pred HHHHHHHHH
Q ss_conf 999999998
Q 002738 867 AGDLYEMFV 875 (886)
Q Consensus 867 asEIL~hL~ 875 (886)
++|+++|.+
T Consensus 252 ~~eil~hp~ 260 (321)
T d1tkia_ 252 ASEALQHPW 260 (321)
T ss_dssp HHHHHHSHH
T ss_pred HHHHHCCHH
T ss_conf 999963996
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.34 Aligned_cols=253 Identities=21% Similarity=0.279 Sum_probs=208.6
Q ss_pred CCCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 89941642325349459999999--9912999999335689996888765674999999996179998122563685489
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~~ 627 (886)
.++|++.+.||+|+||.||+|++ .+..||+|++..... ........+.+|+.+|++++|||||++++++....
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 81 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-----IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE 81 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS
T ss_pred CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHC-----CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 9877898898508790999999989997999999865775-----57778999999999998768888617999999899
Q ss_pred CCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEE
Q ss_conf 88889999976664089999025999999999987205997679999999999999999999858912147999978872
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILId 707 (886)
. .||||||++||+|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+|||++
T Consensus 82 ~--------------~~ivmEy~~gg~L~~~~~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~ 142 (288)
T d1uu3a_ 82 K--------------LYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN 142 (288)
T ss_dssp E--------------EEEEECCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred E--------------EEEEEECCCCCCHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCCCCCCCC
T ss_conf 8--------------8999970489877776531-----59999999999999999999762165088476774123668
Q ss_pred CCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 46657899980999315875224445543233467999997656898644525330145899999235699999999999
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~EL 787 (886)
.++ .+||+|||+|+.+...... ......+||+.|||||++.+ ..|+.++|||||||+||||
T Consensus 143 ~~~-------~vkl~DFG~a~~~~~~~~~--------~~~~~~~GT~~Y~APE~~~~----~~~~~~~DiwSlGvilyel 203 (288)
T d1uu3a_ 143 EDM-------HIQITDFGTAKVLSPESKQ--------ARANSFVGTAQYVSPELLTE----KSACKSSDLWALGCIIYQL 203 (288)
T ss_dssp TTS-------CEEECCCTTCEECC------------------CCCCGGGCCHHHHHT----CCCCHHHHHHHHHHHHHHH
T ss_pred CCC-------EEEECCCCCCEECCCCCCC--------CCCCCCCCCCCCCCCEEECC----CCCCCCCCEEHHHHHHHHH
T ss_conf 885-------3886032102422567764--------33355567755258440026----8989666230456999998
Q ss_pred HHCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH
Q ss_conf 91999999999889999998088999506886411565200002599999961446629999999998011199999999
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 788 LTGk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRPSa 867 (886)
++|+.||.+.+..++...+.++.. .++. ..++.+.+||.+||+.||.+|||+
T Consensus 204 l~g~~Pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~~li~~~L~~dP~~R~t~ 255 (288)
T d1uu3a_ 204 VAGLPPFRAGNEYLIFQKIIKLEY-DFPE---------------------------KFFPKARDLVEKLLVLDATKRLGC 255 (288)
T ss_dssp HHSSCSSCCSSHHHHHHHHHTTCC-CCCT---------------------------TCCHHHHHHHHTTSCSSGGGSTTS
T ss_pred HHCCCCCCCCCHHHHHHHHHCCCC-CCCC---------------------------CCCHHHHHHHHHHCCCCHHHCCCH
T ss_conf 038899899599999999971899-9985---------------------------479999999999855797689197
Q ss_pred HHHHHH
Q ss_conf 999999
Q 002738 868 GDLYEM 873 (886)
Q Consensus 868 sEIL~h 873 (886)
+|++++
T Consensus 256 ~e~~~~ 261 (288)
T d1uu3a_ 256 EEMEGY 261 (288)
T ss_dssp GGGTCH
T ss_pred HHHCCC
T ss_conf 897377
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.05 Aligned_cols=267 Identities=25% Similarity=0.419 Sum_probs=217.8
Q ss_pred CCCCCCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCEEEEEE
Q ss_conf 98889941642325349459999999--991299999933568999688876567499999999617-999812256368
Q 002738 547 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 623 (886)
Q Consensus 547 ~~~~~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L-~HPNIV~llG~~ 623 (886)
.+.|++|++.+.||+|+||.||+|.+ .+..++||++.++.... ....+. +.+|+.+|.++ +|||||+++|++
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~----~~~E~~~l~~l~~HpnIv~~~~~~ 80 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRD----FAGELEVLCKLGHHPNIINLLGAC 80 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CH----HHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred CCCHHHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCC-HHHHHH----HHHHHHHHHHCCCCCCEEEEEEEE
T ss_conf 668799688779820788289999998999699999999782338-579999----999999998622899883678888
Q ss_pred ECCCCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHH-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q ss_conf 5489888899999766640899990259999999999872-----------05997679999999999999999999858
Q 002738 624 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS-----------ETGEKHVSVKLALFIAQDVAAALVELHSK 692 (886)
Q Consensus 624 ~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~-----------k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~ 692 (886)
..... .+|||||+++|+|.+++.... ......+++..+..++.||+.||.|||++
T Consensus 81 ~~~~~--------------~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~ 146 (309)
T d1fvra_ 81 EHRGY--------------LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 146 (309)
T ss_dssp EETTE--------------EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ECCCE--------------EEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC
T ss_conf 41873--------------6999980289869999864035555512310123457899999999999999998766308
Q ss_pred CCCCCCCCCCCEEEECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf 91214799997887246657899980999315875224445543233467999997656898644525330145899999
Q 002738 693 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 772 (886)
Q Consensus 693 gIVHRDLKpsNILId~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s 772 (886)
+|+||||||+|||++.++ .+||+|||+|+........ ....||+.|+|||.+.. ..++
T Consensus 147 ~iiHrDlkp~NIL~~~~~-------~~kl~DfG~a~~~~~~~~~-----------~~~~gt~~y~aPE~l~~----~~~~ 204 (309)
T d1fvra_ 147 QFIHRDLAARNILVGENY-------VAKIADFGLSRGQEVYVKK-----------TMGRLPVRWMAIESLNY----SVYT 204 (309)
T ss_dssp TEECSCCSGGGEEECGGG-------CEEECCTTCEESSCEECCC---------------CCTTTCCHHHHHH----CEEC
T ss_pred CCCCCCCCCCEEEECCCC-------CEEECCCCCCCCCCCCCCC-----------CCEECCCCCCCHHHHCC----CCCC
T ss_conf 954555052048986887-------6387434432244422345-----------53013775555387526----9999
Q ss_pred CHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 2356999999999999199-999999988999999808899950688641156520000259999996144662999999
Q 002738 773 LEVDIWSYGCLLLELLTLQ-VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 851 (886)
Q Consensus 773 ~KsDVWSLGVIL~ELLTGk-~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~d 851 (886)
.++||||||+++|||++|. +||.+.+..++...+..+.++.++.. .++.+.+
T Consensus 205 ~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~~~~~---------------------------~~~~~~~ 257 (309)
T d1fvra_ 205 TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN---------------------------CDDEVYD 257 (309)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTT---------------------------BCHHHHH
T ss_pred CCCEEEHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCC---------------------------CCHHHHH
T ss_conf 6221531388999998368999999999999999982688888766---------------------------7899999
Q ss_pred HHHHHCCCCCCCCCCHHHHHHHHHHHCCCC
Q ss_conf 999801119999999999999998000889
Q 002738 852 VFRRCTEENPTERPTAGDLYEMFVARTSSS 881 (886)
Q Consensus 852 LI~~CL~~DP~kRPSasEIL~hL~~l~~~s 881 (886)
||.+||..||++|||+.+|+++|+.+....
T Consensus 258 li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 258 LMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf 999976789668949999999999998618
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.76 Aligned_cols=260 Identities=21% Similarity=0.320 Sum_probs=213.3
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEECC---EEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE
Q ss_conf 888994164232534945999999999---12999999335689996888765674999999996179998122563685
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 624 (886)
Q Consensus 548 ~~~~~y~i~~~LG~GsfG~Vyka~~~~---~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~ 624 (886)
++.++|++.+.||+|+||.||+|.+.. ..++++++.++... .....+. +.+|+.+|++++|||||+++|++.
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~----~~~E~~~l~~l~HpnIv~l~~~~~ 78 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREK----FLQEALTMRQFDHPHIVKLIGVIT 78 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHH----HHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCC-CHHHHHH----HHHHHHHHHHCCCCCEEEEEEEEE
T ss_conf 68899698779930788299999993699644999999936566-8799999----999999998689999856988995
Q ss_pred CCCCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCE
Q ss_conf 48988889999976664089999025999999999987205997679999999999999999999858912147999978
Q 002738 625 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 704 (886)
Q Consensus 625 ~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNI 704 (886)
. .. .++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+||
T Consensus 79 ~-~~--------------~~iv~E~~~~g~l~~~~~~----~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NI 139 (273)
T d1mp8a_ 79 E-NP--------------VWIIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNV 139 (273)
T ss_dssp S-SS--------------CEEEEECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred C-CE--------------EEEEEEECCCCCHHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCHHHE
T ss_conf 3-74--------------7999984069807765422----478999999999999998775230226744141026553
Q ss_pred EEECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 87246657899980999315875224445543233467999997656898644525330145899999235699999999
Q 002738 705 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 784 (886)
Q Consensus 705 LId~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL 784 (886)
|++.++ .+||+|||+|+........ ......||+.|||||++.+ ..++.++|||||||+|
T Consensus 140 ll~~~~-------~~Kl~DfG~a~~~~~~~~~---------~~~~~~gt~~y~apE~l~~----~~~~~~~DiwSlGvil 199 (273)
T d1mp8a_ 140 LVSSND-------CVKLGDFGLSRYMEDSTYY---------KASKGKLPIKWMAPESINF----RRFTSASDVWMFGVCM 199 (273)
T ss_dssp EEEETT-------EEEECC----------------------------CCGGGCCHHHHHH----CCCSHHHHHHHHHHHH
T ss_pred EECCCC-------CEEECCCHHHEECCCCCCE---------ECCCEECCCCCCHHHHHCC----CCCCCCCCCCCCHHHH
T ss_conf 206789-------6787650342133677623---------3054005831032667516----9988745244424789
Q ss_pred HHHHH-CCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 99991-99999999988999999808899950688641156520000259999996144662999999999801119999
Q 002738 785 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 785 ~ELLT-Gk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~k 863 (886)
|||++ |.+||.+.+..++...+..+.+++++.. .++.+.+||.+||..||.+
T Consensus 200 ~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~---------------------------~~~~~~~li~~cl~~dp~~ 252 (273)
T d1mp8a_ 200 WEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN---------------------------CPPTLYSLMTKCWAYDPSR 252 (273)
T ss_dssp HHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTT---------------------------CCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCC---------------------------CCHHHHHHHHHHCCCCHHH
T ss_conf 9998269999888999999999981899989877---------------------------7999999999976879768
Q ss_pred CCCHHHHHHHHHHHC
Q ss_conf 999999999998000
Q 002738 864 RPTAGDLYEMFVART 878 (886)
Q Consensus 864 RPSasEIL~hL~~l~ 878 (886)
|||+.+|+++|+.+.
T Consensus 253 Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 253 RPRFTELKAQLSTIL 267 (273)
T ss_dssp SCCHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHH
T ss_conf 929999999999997
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=365.74 Aligned_cols=251 Identities=24% Similarity=0.331 Sum_probs=210.4
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECC
Q ss_conf 889941642325349459999999--991299999933568999688876567499999999617999812256368548
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~ 626 (886)
++++|.+.+.||+|+||.||+|++ .+..||+|++..... ........+.+|+.+|+.++|||||++++++...
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 76 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-----VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA 76 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred CHHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHC-----CCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEEC
T ss_conf 65470888897207680899999989997999999845775-----4889999999999999863696753303568528
Q ss_pred CCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEE
Q ss_conf 98888999997666408999902599999999998720599767999999999999999999985891214799997887
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILI 706 (886)
.. .|+||||++||+|..++.. ...+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus 77 ~~--------------~~ivmE~~~gg~l~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl 137 (316)
T d1fota_ 77 QQ--------------IFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL 137 (316)
T ss_dssp SE--------------EEEEECCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred CE--------------EEEEEEECCCCCCCCCCCC-----CCCCCCCHHHHHHHHHHHHHHHHCCCCEECCCCCCHHEEE
T ss_conf 80--------------0567650378632234322-----2211100799999999876554124767705568105038
Q ss_pred ECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 24665789998099931587522444554323346799999765689864452533014589999923569999999999
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~E 786 (886)
+.++ .+||+|||+|+...... ....||+.|||||++.+ ..|+.++|||||||+|||
T Consensus 138 ~~~g-------~vkL~DFG~a~~~~~~~-------------~~~~Gt~~Y~APE~l~~----~~y~~~~DiwSlGvilye 193 (316)
T d1fota_ 138 DKNG-------HIKITDFGFAKYVPDVT-------------YTLCGTPDYIAPEVVST----KPYNKSIDWWSFGILIYE 193 (316)
T ss_dssp CTTS-------CEEECCCSSCEECSSCB-------------CCCCSCTTTCCHHHHTT----CCBCTTHHHHHHHHHHHH
T ss_pred CCCC-------CEEEECCCCCEEECCCC-------------CCCCCCCCCCCHHHHCC----CCCCCHHHCCCCCHHHHH
T ss_conf 6899-------88983175216712456-------------43457634359999838----999804304653336899
Q ss_pred HHHCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC-
Q ss_conf 9919999999998899999980889995068864115652000025999999614466299999999980111999999-
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP- 865 (886)
Q Consensus 787 LLTGk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRP- 865 (886)
|++|+.||.+.+..++...+..+... ++. ..++.+.+++.+||..||.+|+
T Consensus 194 mltG~~Pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~s~~~~~li~~~L~~dp~~R~~ 245 (316)
T d1fota_ 194 MLAGYTPFYDSNTMKTYEKILNAELR-FPP---------------------------FFNEDVKDLLSRLITRDLSQRLG 245 (316)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHHCCCC-CCT---------------------------TSCHHHHHHHHHHTCSCTTTCTT
T ss_pred HHHCCCCCCCCCHHHHHHHHHCCCCC-CCC---------------------------CCCHHHHHHHHHHHHHCHHHCCC
T ss_conf 97598999996999999999708988-997---------------------------78999999999995449976664
Q ss_pred ----CHHHHHHHHH
Q ss_conf ----9999999998
Q 002738 866 ----TAGDLYEMFV 875 (886)
Q Consensus 866 ----SasEIL~hL~ 875 (886)
++++|++|..
T Consensus 246 ~~r~t~~~il~Hp~ 259 (316)
T d1fota_ 246 NLQNGTEDVKNHPW 259 (316)
T ss_dssp SSTTTTHHHHTSGG
T ss_pred CCHHHHHHHHCCCC
T ss_conf 31021999981935
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=363.80 Aligned_cols=264 Identities=23% Similarity=0.362 Sum_probs=216.6
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEECC-------EEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEE
Q ss_conf 888994164232534945999999999-------1299999933568999688876567499999999617999812256
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 620 (886)
Q Consensus 548 ~~~~~y~i~~~LG~GsfG~Vyka~~~~-------~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~ll 620 (886)
.+.++|++.+.||+|+||.||+|++.+ ..||+|++. .. ......+ .+.+|+.+|+.++||||++++
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~--~~-~~~~~~~----~~~~E~~il~~l~h~niv~~~ 82 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK--EE-ASADMQA----DFQREAALMAEFDNPNIVKLL 82 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECC--TT-CCHHHHH----HHHHHHHHHHTCCCTTBCCEE
T ss_pred CCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEEC--HH-CCHHHHH----HHHHHHHHHHHCCCCCCCCCE
T ss_conf 8988938867982078839999998887657788299999988--21-0857999----999999999966899765524
Q ss_pred EEEECCCCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHC-------------------CCCCCCCHHHHHHHHHH
Q ss_conf 36854898888999997666408999902599999999998720-------------------59976799999999999
Q 002738 621 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------------------TGEKHVSVKLALFIAQD 681 (886)
Q Consensus 621 G~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k-------------------~~~~~ls~~~~l~Ia~q 681 (886)
+++..... .+++|||+++|+|.+++..... .....+++..++.++.|
T Consensus 83 ~~~~~~~~--------------~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 148 (301)
T d1lufa_ 83 GVCAVGKP--------------MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 148 (301)
T ss_dssp EEECSSSS--------------CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHH
T ss_pred EEECCCCC--------------EEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHH
T ss_conf 66605980--------------3899981589929999985275542100001110012103467889899999999999
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHH
Q ss_conf 99999999858912147999978872466578999809993158752244455432334679999976568986445253
Q 002738 682 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 761 (886)
Q Consensus 682 Ia~gL~YLHs~gIVHRDLKpsNILId~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEv 761 (886)
|+.||.|||+++||||||||+|||++.++ .+||+|||+|+......... ......||+.|||||+
T Consensus 149 i~~gl~ylH~~~ivHrDlKp~NILld~~~-------~~Kl~DFGls~~~~~~~~~~--------~~~~~~~~~~y~aPE~ 213 (301)
T d1lufa_ 149 VAAGMAYLSERKFVHRDLATRNCLVGENM-------VVKIADFGLSRNIYSADYYK--------ADGNDAIPIRWMPPES 213 (301)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGGG-------CEEECCCSCHHHHTGGGCBC------------CCBCGGGCCHHH
T ss_pred HHHHHHHCCCCCEEEEEECCCCEEECCCC-------CEEECCCHHHEECCCCCCCC--------CCCCCCCCCCCCCHHH
T ss_conf 99985541357868548840116898999-------28983314421136776411--------1577776767679899
Q ss_pred HHCCCCCCCCCCHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCH
Q ss_conf 301458999992356999999999999199-9999999889999998088999506886411565200002599999961
Q 002738 762 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQ-VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 840 (886)
Q Consensus 762 L~~~~~~~~~s~KsDVWSLGVIL~ELLTGk-~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e 840 (886)
+.+ ..|+.++|||||||+||||+++. +||.+.+..++...+..+.++.++..
T Consensus 214 ~~~----~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~----------------------- 266 (301)
T d1lufa_ 214 IFY----NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPEN----------------------- 266 (301)
T ss_dssp HHH----CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTT-----------------------
T ss_pred HCC----CCCCHHHHHCCCHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC-----------------------
T ss_conf 726----88980563025236299998068999999899999999973997888732-----------------------
Q ss_pred HHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf 44662999999999801119999999999999998000
Q 002738 841 AELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 878 (886)
Q Consensus 841 ~~~~~s~~L~dLI~~CL~~DP~kRPSasEIL~hL~~l~ 878 (886)
.++.+.+|+.+||+.+|.+||||.+|++.|+.+-
T Consensus 267 ----~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 267 ----CPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp ----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ----CHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf ----5299999999974889657939999999999842
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=365.38 Aligned_cols=252 Identities=23% Similarity=0.289 Sum_probs=211.0
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEC
Q ss_conf 8889941642325349459999999--99129999993356899968887656749999999961799981225636854
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 625 (886)
Q Consensus 548 ~~~~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~ 625 (886)
..+++|++.+.||+|+||.||+|++ .+..||+|++..... ........+.+|+.+|+.++|||||++++++..
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 112 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-----VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCCCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHC-----CCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCC
T ss_conf 872370898896117680899999989998999999826774-----588999999999999997487727403444432
Q ss_pred CCCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEE
Q ss_conf 89888899999766640899990259999999999872059976799999999999999999998589121479999788
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNIL 705 (886)
... .++||||+.+|+|..++.. ...+++..++.++.||+.||.|||+++||||||||+|||
T Consensus 113 ~~~--------------~~~v~e~~~~g~l~~~l~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NIL 173 (350)
T d1rdqe_ 113 NSN--------------LYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173 (350)
T ss_dssp SSE--------------EEEEEECCTTCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CCC--------------CCCCCCCCCCCCHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHCC
T ss_conf 222--------------2322223346622666751-----589899999999999999899998599861767999936
Q ss_pred EECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 72466578999809993158752244455432334679999976568986445253301458999992356999999999
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Id~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~ 785 (886)
++.++ .+||+|||+|+.+.... ....||+.|||||++.+ ..++.++|||||||+||
T Consensus 174 l~~~g-------~ikL~DFG~a~~~~~~~-------------~~~~Gt~~Y~APE~~~~----~~~~~~~DiwSlGvily 229 (350)
T d1rdqe_ 174 IDQQG-------YIQVTDFGFAKRVKGRT-------------WTLCGTPEALAPEIILS----KGYNKAVDWWALGVLIY 229 (350)
T ss_dssp ECTTS-------CEEECCCTTCEECSSCB-------------CCCEECGGGCCHHHHTT----CCBCTHHHHHHHHHHHH
T ss_pred CCCCC-------CEEEEECEEEEECCCCC-------------CCCCCCCCCCCHHHHCC----CCCCCCCCCCCHHHHHH
T ss_conf 07789-------78861010333225666-------------43367635678899717----99885331145007899
Q ss_pred HHHHCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 99919999999998899999980889995068864115652000025999999614466299999999980111999999
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 786 ELLTGk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRP 865 (886)
||+||+.||.+.+...+...+..+... ++. ..++.+.+||.+||+.||.+|+
T Consensus 230 emltG~~Pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~s~~~~~li~~~L~~dP~kR~ 281 (350)
T d1rdqe_ 230 EMAAGYPPFFADQPIQIYEKIVSGKVR-FPS---------------------------HFSSDLKDLLRNLLQVDLTKRF 281 (350)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCCC-CCT---------------------------TCCHHHHHHHHHHSCSCTTTCT
T ss_pred HHHHCCCCCCCCCHHHHHHHHHCCCCC-CCC---------------------------CCCHHHHHHHHHHHHHCHHHCC
T ss_conf 997588998995999999998617988-976---------------------------6899999999998340998606
Q ss_pred -----CHHHHHHHHH
Q ss_conf -----9999999998
Q 002738 866 -----TAGDLYEMFV 875 (886)
Q Consensus 866 -----SasEIL~hL~ 875 (886)
++++|++|-+
T Consensus 282 ~~~r~t~~ell~Hp~ 296 (350)
T d1rdqe_ 282 GNLKNGVNDIKNHKW 296 (350)
T ss_dssp TSSTTTTHHHHTSGG
T ss_pred CCCCCCHHHHHCCCC
T ss_conf 553454999971905
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.21 Aligned_cols=287 Identities=22% Similarity=0.216 Sum_probs=210.1
Q ss_pred EEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCCCC
Q ss_conf 642325349459999999--991299999933568999688876567499999999617999812256368548988889
Q 002738 555 SCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 632 (886)
Q Consensus 555 i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~~~l~~~ 632 (886)
..+.||+|+||+||+|++ .+..||+|++....... ....+...+.+|+.+|+.++|||||++++++.....
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~---- 74 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE---AKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN---- 74 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC----
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHH---HHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCC----
T ss_conf 5638512728299999999999699999984202124---567999999999999986799998689854225874----
Q ss_pred CCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCC
Q ss_conf 99997666408999902599999999998720599767999999999999999999985891214799997887246657
Q 002738 633 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 712 (886)
Q Consensus 633 ~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILId~d~~~ 712 (886)
.+|||||+.++++..+... ...+++..+..+++||+.||.|||+++|+||||||+|||++.++
T Consensus 75 ----------~~ivmE~~~~~~~~~~~~~-----~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~-- 137 (299)
T d1ua2a_ 75 ----------ISLVFDFMETDLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-- 137 (299)
T ss_dssp ----------CEEEEECCSEEHHHHHTTC-----CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--
T ss_pred ----------EEEHHHHHCCHHHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCC--
T ss_conf ----------0220455345077655412-----66778999999999999999886316355035776258853778--
Q ss_pred CCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCC
Q ss_conf 89998099931587522444554323346799999765689864452533014589999923569999999999991999
Q 002738 713 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 792 (886)
Q Consensus 713 ~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~ELLTGk~ 792 (886)
.+||+|||+|+....... .....+||+.|||||++.. ...|+.++|||||||+||||++|.+
T Consensus 138 -----~~KL~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlGvil~el~~g~~ 199 (299)
T d1ua2a_ 138 -----VLKLADFGLAKSFGSPNR----------AYTHQVVTRWYRAPELLFG---ARMYGVGVDMWAVGCILAELLLRVP 199 (299)
T ss_dssp -----CEEECCCGGGSTTTSCCC----------CCCCSCCCCTTCCHHHHTT---CSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred -----CCCCCCCCCCCCCCCCCC----------CCCCEECCHHHCCHHHHCC---CCCCCHHHHHHHCCHHHHHHHHCCC
T ss_conf -----411465761000578755----------4330204733363999726---7788805643630428999985969
Q ss_pred CCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 99999988999999808899950688641156520000259999996144662999999999801119999999999999
Q 002738 793 PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 872 (886)
Q Consensus 793 Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRPSasEIL~ 872 (886)
||.+.+..+.+..+......+....+...........................++.+.+|+.+||+.||.+|||++|+|+
T Consensus 200 pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 200 FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCCCHHHHHHHHHHHCCCCCHHHCCCHHCCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 99999999999999985189972545210002134430347898867856568999999999976389456908999967
Q ss_pred HHHHHCCCCCC
Q ss_conf 99800088999
Q 002738 873 MFVARTSSSIS 883 (886)
Q Consensus 873 hL~~l~~~s~s 883 (886)
|-.-...+.+.
T Consensus 280 Hp~f~~~p~p~ 290 (299)
T d1ua2a_ 280 MKYFSNRPGPT 290 (299)
T ss_dssp SGGGTSSSCCC
T ss_pred CHHHCCCCCCC
T ss_conf 99657899998
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=368.51 Aligned_cols=257 Identities=21% Similarity=0.268 Sum_probs=200.2
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECC
Q ss_conf 889941642325349459999999--991299999933568999688876567499999999617999812256368548
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~ 626 (886)
++++|.+.+.||+|+||.||+|++ .+..||+|++...... ............+|+.+++.++|||||++++++...
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~--~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~ 79 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK--MKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 79 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH--HHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCC--HHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEEC
T ss_conf 777685101884288909999999999979999998458754--266799999999999998508998588999999989
Q ss_pred CCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEE
Q ss_conf 98888999997666408999902599999999998720599767999999999999999999985891214799997887
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILI 706 (886)
.. .||||||++||+|.+++.. ...+++..+..++.||+.||.|||+++||||||||+|||+
T Consensus 80 ~~--------------~~ivmE~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl 140 (364)
T d1omwa3 80 DK--------------LSFILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 140 (364)
T ss_dssp SE--------------EEEEECCCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CE--------------EEEEEEECCCCCHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCEEEE
T ss_conf 98--------------8999991489838999873-----2553278999999999999999997796220444221678
Q ss_pred ECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 24665789998099931587522444554323346799999765689864452533014589999923569999999999
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~E 786 (886)
+.++ .+||+|||+|+.+.... .....||+.|||||++.. ...|+.++|||||||+|||
T Consensus 141 ~~~g-------~iKl~DFGla~~~~~~~------------~~~~~GT~~y~APE~~~~---~~~~~~~~DiwSlGvilye 198 (364)
T d1omwa3 141 DEHG-------HVRISDLGLACDFSKKK------------PHASVGTHGYMAPEVLQK---GVAYDSSADWFSLGCMLFK 198 (364)
T ss_dssp CSSS-------CEEECCCTTCEECSSSC------------CCSCCSCGGGCCHHHHST---TCCCCTHHHHHHHHHHHHH
T ss_pred CCCC-------CEEEEEECEEEECCCCC------------CCCCCCCCCCCHHHHHHC---CCCCCCCCCHHHHHHHHHH
T ss_conf 5889-------67982201023337886------------433113455421687603---8999844104677899999
Q ss_pred HHHCCCCCCCCCHHHHHHHHHCC--CCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 99199999999988999999808--8999506886411565200002599999961446629999999998011199999
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMG--KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 864 (886)
Q Consensus 787 LLTGk~Pf~g~s~~ei~~~I~~~--~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kR 864 (886)
|+||+.||.+.+........... ..+.++. ..++.+.+||.+||+.||.+|
T Consensus 199 mltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~s~~~~~li~~~L~~dP~~R 251 (364)
T d1omwa3 199 LLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD---------------------------SFSPELRSLLEGLLQRDVNRR 251 (364)
T ss_dssp HHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCS---------------------------SSCHHHHHHHHHHTCSSTTTS
T ss_pred HHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCC---------------------------CCCHHHHHHHHHHCCCCHHHH
T ss_conf 98599988889989999999860468887887---------------------------789999999999856698880
Q ss_pred CC-----HHHHHHHHH
Q ss_conf 99-----999999998
Q 002738 865 PT-----AGDLYEMFV 875 (886)
Q Consensus 865 PS-----asEIL~hL~ 875 (886)
|+ ++++++|-+
T Consensus 252 ~t~~~~~a~eil~Hp~ 267 (364)
T d1omwa3 252 LGCLGRGAQEVKESPF 267 (364)
T ss_dssp TTTSSSTHHHHHTSGG
T ss_pred CCCCCCCHHHHHCCCC
T ss_conf 8874357999974910
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=361.14 Aligned_cols=265 Identities=25% Similarity=0.367 Sum_probs=218.9
Q ss_pred CCCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCC-CCHHHHHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEC
Q ss_conf 89941642325349459999999--9912999999335689-996888765674999999996179-9981225636854
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCG-SSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 625 (886)
Q Consensus 550 ~~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~-~~~~~~k~f~~~~~rEV~IL~~L~-HPNIV~llG~~~~ 625 (886)
+++|++.+.||+|+||+||+|+. .+..+|+|++...... ......+.....+.+|+.++++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEE
Q ss_conf 89888899999766640899990259999999999872059976799999999999999999998589121479999788
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNIL 705 (886)
... .||||||+++|+|.++++. ...+++..++.++.||+.||.|||+++|+||||||+|||
T Consensus 82 ~~~--------------~~ivmE~~~~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nil 142 (277)
T d1phka_ 82 NTF--------------FFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL 142 (277)
T ss_dssp SSE--------------EEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CCC--------------EEEEEECCCCCHHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEE
T ss_conf 760--------------5999976898668999986-----599999999999999999999998759943234625489
Q ss_pred EECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCC--CCCCCCCHHHHHHHHHH
Q ss_conf 7246657899980999315875224445543233467999997656898644525330145--89999923569999999
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYGCL 783 (886)
Q Consensus 706 Id~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~--~~~~~s~KsDVWSLGVI 783 (886)
++.++ .+||+|||++..+..... ....+||+.|+|||++.+.. ....++.++||||+||+
T Consensus 143 l~~~~-------~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvi 204 (277)
T d1phka_ 143 LDDDM-------NIKLTDFGFSCQLDPGEK-----------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 204 (277)
T ss_dssp ECTTC-------CEEECCCTTCEECCTTCC-----------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHH
T ss_pred ECCCC-------CEEECCCHHEEECCCCCC-----------EEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHH
T ss_conf 86899-------838712403167268872-----------134524678889888605344567889923318565602
Q ss_pred HHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 99999199999999988999999808899950688641156520000259999996144662999999999801119999
Q 002738 784 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 784 L~ELLTGk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~k 863 (886)
|+||++|+.||.+.+...+...+..+....... .....++.+.+|+.+||+.||.+
T Consensus 205 lyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~~p~~ 260 (277)
T d1phka_ 205 MYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP------------------------EWDDYSDTVKDLVSRFLVVQPQK 260 (277)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT------------------------TGGGSCHHHHHHHHHHCCSSGGG
T ss_pred HHHHCCCCCCCCCCCHHHHHHHHHHCCCCCCCC------------------------CCCCCCHHHHHHHHHHCCCCHHH
T ss_conf 310322888988999999999998189888985------------------------43468999999999976589668
Q ss_pred CCCHHHHHHHHH
Q ss_conf 999999999998
Q 002738 864 RPTAGDLYEMFV 875 (886)
Q Consensus 864 RPSasEIL~hL~ 875 (886)
|||+++|++|-+
T Consensus 261 R~s~~eil~h~~ 272 (277)
T d1phka_ 261 RYTAEEALAHPF 272 (277)
T ss_dssp SCCHHHHTTSGG
T ss_pred CCCHHHHHCCHH
T ss_conf 919999973978
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.41 Aligned_cols=261 Identities=25% Similarity=0.350 Sum_probs=213.4
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEECC-EEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECC
Q ss_conf 888994164232534945999999999-1299999933568999688876567499999999617999812256368548
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 548 ~~~~~y~i~~~LG~GsfG~Vyka~~~~-~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~ 626 (886)
++.++|++.+.||+|+||.||+|.+.+ ..||+|++. ..... .+. +.+|+.+|.+++|||||+++|++...
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~--~~~~~---~~~----~~~E~~~l~~l~h~nIv~~~g~~~~~ 84 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMS---PEA----FLQEAQVMKKLRHEKLVQLYAVVSEE 84 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECC--TTSSC---HHH----HHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEC--CCCCC---HHH----HHHHHHHHHHCCCCCEEEEEEEEECC
T ss_conf 4779979846993079809999999999999999988--04488---899----99999999866667886899998239
Q ss_pred CCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEE
Q ss_conf 98888999997666408999902599999999998720599767999999999999999999985891214799997887
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILI 706 (886)
. .++||||+++|+|..++.... ...+++..++.++.||+.||+|||+++|+||||||+|||+
T Consensus 85 ~---------------~~lv~Ey~~~g~l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll 146 (285)
T d1fmka3 85 P---------------IYIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV 146 (285)
T ss_dssp S---------------CEEEECCCTTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred C---------------EEEEEEECCCCCHHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHHHHEECCCCCCEEEEE
T ss_conf 7---------------599999447994354200003---5530599999999999999998754114335312307999
Q ss_pred ECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 24665789998099931587522444554323346799999765689864452533014589999923569999999999
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~E 786 (886)
+.++ ++||+|||+|+........ ......||+.|+|||++.. ..++.++||||||++|||
T Consensus 147 ~~~~-------~~kl~DfGla~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~----~~~~~ksDI~S~Giil~e 206 (285)
T d1fmka3 147 GENL-------VCKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTE 206 (285)
T ss_dssp CGGG-------CEEECCCCTTC-----------------------CCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHH
T ss_pred CCCC-------CEEECCCCHHHHCCCCCCE---------EECCCCCCCCCCCHHHHHC----CCCCCHHHHHCCHHHHHH
T ss_conf 8999-------2998442555425688733---------5245455665458089837----998917741323589999
Q ss_pred HHHC-CCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 9919-999999998899999980889995068864115652000025999999614466299999999980111999999
Q 002738 787 LLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 787 LLTG-k~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRP 865 (886)
|++| .+|+.+....++...+..+.+++++.. .++.+.+|+.+||+.||.+||
T Consensus 207 l~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~---------------------------~~~~l~~li~~cl~~dP~~Rp 259 (285)
T d1fmka3 207 LTTKGRVPYPGMVNREVLDQVERGYRMPCPPE---------------------------CPESLHDLMCQCWRKEPEERP 259 (285)
T ss_dssp HHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT---------------------------SCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCC---------------------------CCHHHHHHHHHHCCCCHHHCC
T ss_conf 98689999988889999999982689999832---------------------------379999999997566975891
Q ss_pred CHHHHHHHHHHHCCCCC
Q ss_conf 99999999980008899
Q 002738 866 TAGDLYEMFVARTSSSI 882 (886)
Q Consensus 866 SasEIL~hL~~l~~~s~ 882 (886)
++++|++.|+...++..
T Consensus 260 s~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 260 TFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp CHHHHHHHHHTTTSCSC
T ss_pred CHHHHHHHHHHHHCCCC
T ss_conf 99999998766623899
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.52 Aligned_cols=255 Identities=24% Similarity=0.364 Sum_probs=216.5
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEECCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 88899416423253494599999999912999999335689996888765674999999996179998122563685489
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 548 ~~~~~y~i~~~LG~GsfG~Vyka~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~~ 627 (886)
+..++|.+.+.||+|+||.||+|.+.+..||+|+. +... ..+. +.+|+.++++++|||||+++|++....
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i--~~~~----~~~~----~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI--KNDA----TAQA----FLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEEC--CCCC------HH----HHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred CCHHHEEEEEEEECCCCEEEEEEEECCEEEEEEEE--CCHH----HHHH----HHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 57899488579820798089999999909999998--8577----7999----999999998678989854987887238
Q ss_pred CCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEE
Q ss_conf 88889999976664089999025999999999987205997679999999999999999999858912147999978872
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILId 707 (886)
. ..++||||+++|+|.+++.... ...+++..++.|+.||+.||.|||+.+|+||||||+|||++
T Consensus 74 ~-------------~~~lv~ey~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~ 137 (262)
T d1byga_ 74 G-------------GLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS 137 (262)
T ss_dssp --------------CCEEEECCCTTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred C-------------CEEEEEECCCCCCHHHHHHHCC---CCCCCHHHHHHHHHHHHHHCCCCCCCCEECCCCCHHHHEEC
T ss_conf 9-------------2899996369998999987457---88889999999999998523211337655366656760146
Q ss_pred CCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 46657899980999315875224445543233467999997656898644525330145899999235699999999999
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~EL 787 (886)
.++ .+||+|||+++...... ....+|+.|+|||++.+ ..++.++||||||+++|||
T Consensus 138 ~~~-------~~kl~dfg~s~~~~~~~-------------~~~~~~~~y~aPE~l~~----~~~t~~sDIwSfG~il~el 193 (262)
T d1byga_ 138 EDN-------VAKVSDFGLTKEASSTQ-------------DTGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEI 193 (262)
T ss_dssp TTS-------CEEECCCCC-------------------------CCTTTSCHHHHHH----CCCCHHHHHHHHHHHHHHH
T ss_pred CCC-------CEEECCCCCCEECCCCC-------------CCCCCCCCCCCHHHHHC----CCCCHHHHHHHHHHHHHHH
T ss_conf 899-------77632456003447877-------------65566646778178727----9888588777579999999
Q ss_pred HH-CCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 91-99999999988999999808899950688641156520000259999996144662999999999801119999999
Q 002738 788 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 788 LT-Gk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRPS 866 (886)
+| |.+||...+..++...+..+.+++++..+ ++.+.+|+.+||..||.+|||
T Consensus 194 ~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~---------------------------~~~~~~li~~cl~~dP~~Rps 246 (262)
T d1byga_ 194 YSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC---------------------------PPAVYEVMKNCWHLDAAMRPS 246 (262)
T ss_dssp HTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTC---------------------------CHHHHHHHHHHTCSSGGGSCC
T ss_pred HHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC---------------------------CHHHHHHHHHHCCCCHHHCCC
T ss_conf 97899999999999999999808999997657---------------------------999999999975669768939
Q ss_pred HHHHHHHHHHHCC
Q ss_conf 9999999980008
Q 002738 867 AGDLYEMFVARTS 879 (886)
Q Consensus 867 asEIL~hL~~l~~ 879 (886)
+.+|+++|+.+-+
T Consensus 247 ~~~l~~~L~~i~~ 259 (262)
T d1byga_ 247 FLQLREQLEHIKT 259 (262)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHH
T ss_conf 9999999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.54 Aligned_cols=267 Identities=24% Similarity=0.372 Sum_probs=218.3
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEECC---------EEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCC
Q ss_conf 888994164232534945999999999---------1299999933568999688876567499999999617-999812
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIV 617 (886)
Q Consensus 548 ~~~~~y~i~~~LG~GsfG~Vyka~~~~---------~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L-~HPNIV 617 (886)
++.++|.+.+.||+|+||.||+|+..+ ..||+|+. +. .........+ .+|+..+.++ +|||||
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~--~~-~~~~~~~~~~----~~e~~~l~~~~~HpnIv 82 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KS-DATEKDLSDL----ISEMEMMKMIGKHKNII 82 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECC--CT-TCCHHHHHHH----HHHHHHHHHHCCCTTBC
T ss_pred CCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEE--CC-CCCHHHHHHH----HHHHHHHHHHCCCCEEE
T ss_conf 25899697009851678289999985787555667549999998--81-1286889999----99999999813999697
Q ss_pred EEEEEEECCCCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHC-----------CCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 25636854898888999997666408999902599999999998720-----------5997679999999999999999
Q 002738 618 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAAL 686 (886)
Q Consensus 618 ~llG~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k-----------~~~~~ls~~~~l~Ia~qIa~gL 686 (886)
++++++..... .++||||+++|+|.+++..... .....+++..++.++.||+.||
T Consensus 83 ~~~~~~~~~~~--------------~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al 148 (299)
T d1fgka_ 83 NLLGACTQDGP--------------LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 148 (299)
T ss_dssp CEEEEECSSSS--------------CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHH
T ss_pred ECCCCCCCCCE--------------EEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH
T ss_conf 34652201886--------------8999973699909999986067764322233457434679999999999999999
Q ss_pred HHHHHCCCCCCCCCCCCEEEECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCC
Q ss_conf 99985891214799997887246657899980999315875224445543233467999997656898644525330145
Q 002738 687 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 766 (886)
Q Consensus 687 ~YLHs~gIVHRDLKpsNILId~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~ 766 (886)
.|||+++||||||||+|||++.++ .+||+|||+++........ .......||+.|||||++.+
T Consensus 149 ~ylH~~~ivHrDiKp~NiLl~~~~-------~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~l~~-- 211 (299)
T d1fgka_ 149 EYLASKKCIHRDLAARNVLVTEDN-------VMKIADFGLARDIHHIDYY--------KKTTNGRLPVKWMAPEALFD-- 211 (299)
T ss_dssp HHHHHTTCCCSCCSGGGEEECTTC-------CEEECSTTCCCCGGGCCTT--------CCCTTSCCGGGGSCHHHHHH--
T ss_pred HHHHHCCEEEEEECCCCEEECCCC-------CEEECCCHHHCCCCCCCCC--------CCCCCCCCCHHHHHHHHHCC--
T ss_conf 876637978630221022454789-------7676221110113555554--------31466788846632667517--
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHH
Q ss_conf 89999923569999999999991-99999999988999999808899950688641156520000259999996144662
Q 002738 767 KPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 845 (886)
Q Consensus 767 ~~~~~s~KsDVWSLGVIL~ELLT-Gk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~ 845 (886)
..|+.++||||||++||||++ |.+||.+.+..++...+..+.++..+.. .
T Consensus 212 --~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~p~~---------------------------~ 262 (299)
T d1fgka_ 212 --RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSN---------------------------C 262 (299)
T ss_dssp --CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSS---------------------------C
T ss_pred --CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC---------------------------C
T ss_conf --98882555477588888740179898999999999999972888898743---------------------------5
Q ss_pred HHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCC
Q ss_conf 999999999801119999999999999998000889
Q 002738 846 LSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSS 881 (886)
Q Consensus 846 s~~L~dLI~~CL~~DP~kRPSasEIL~hL~~l~~~s 881 (886)
++.+.+||.+||+.||.+|||+.+|++.|+.+.+-+
T Consensus 263 ~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~~ 298 (299)
T d1fgka_ 263 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 298 (299)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf 299999999976679767939999999998886047
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.82 Aligned_cols=266 Identities=21% Similarity=0.334 Sum_probs=218.5
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEEC-------CEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEE
Q ss_conf 88899416423253494599999999-------91299999933568999688876567499999999617999812256
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 620 (886)
Q Consensus 548 ~~~~~y~i~~~LG~GsfG~Vyka~~~-------~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~ll 620 (886)
++.++|.+.+.||+|+||.||+|.+. +..||||+. +.. ........ +.+|+.++++++|||||+++
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~--~~~-~~~~~~~~----~~~E~~il~~l~h~nIv~~~ 89 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEA-ASMRERIE----FLNEASVMKEFNCHHVVRLL 89 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEEC--CTT-SCHHHHHH----HHHHHHHGGGCCCTTBCCEE
T ss_pred ECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEE--CCC-CCHHHHHH----HHHHHHHHHHCCCCCEEEEE
T ss_conf 268991883598207881899999878644778968999998--701-28689999----99999999976999884125
Q ss_pred EEEECCCCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHC-----CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCC
Q ss_conf 36854898888999997666408999902599999999998720-----5997679999999999999999999858912
Q 002738 621 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----TGEKHVSVKLALFIAQDVAAALVELHSKHIM 695 (886)
Q Consensus 621 G~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k-----~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIV 695 (886)
|++..... .++||||+++|+|.+++..... .....+++..+..++.|++.||.|||+++|+
T Consensus 90 ~~~~~~~~--------------~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~iv 155 (308)
T d1p4oa_ 90 GVVSQGQP--------------TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 155 (308)
T ss_dssp EEECSSSS--------------CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred EEEECCCC--------------EEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEE
T ss_conf 47842881--------------0677760489988999875033211344468879999999999999999987647965
Q ss_pred CCCCCCCCEEEECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHH
Q ss_conf 14799997887246657899980999315875224445543233467999997656898644525330145899999235
Q 002738 696 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 775 (886)
Q Consensus 696 HRDLKpsNILId~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~Ks 775 (886)
||||||+|||++.+ .++||+|||+|+.......... .....||+.|||||.+.+ ..++.++
T Consensus 156 HrDlk~~NiLld~~-------~~~Kl~DFGla~~~~~~~~~~~--------~~~~~~t~~y~aPe~l~~----~~~~~~~ 216 (308)
T d1p4oa_ 156 HRDLAARNCMVAED-------FTVKIGDFGMTRDIYETDYYRK--------GGKGLLPVRWMSPESLKD----GVFTTYS 216 (308)
T ss_dssp CSCCSGGGEEECTT-------CCEEECCTTCCCGGGGGGCEEG--------GGSSEECGGGCCHHHHHH----CCCCHHH
T ss_pred ECEECCCCEEECCC-------CEEEEEECCCCEECCCCCCEEE--------CCCEECCCCCCCHHHHCC----CCCCCCC
T ss_conf 43286775403599-------6499942454202357763031--------340231632378888736----9988333
Q ss_pred HHHHHHHHHHHHHHC-CCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 699999999999919-9999999988999999808899950688641156520000259999996144662999999999
Q 002738 776 DIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 854 (886)
Q Consensus 776 DVWSLGVIL~ELLTG-k~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~ 854 (886)
||||||++||||+|+ ++||.+.+..++...+..+.++..+.. .++.+.+||.
T Consensus 217 Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~~---------------------------~~~~l~~li~ 269 (308)
T d1p4oa_ 217 DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN---------------------------CPDMLFELMR 269 (308)
T ss_dssp HHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTT---------------------------CCHHHHHHHH
T ss_pred CCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCC---------------------------CHHHHHHHHH
T ss_conf 4443789999999689999999899999999980888888633---------------------------5399999999
Q ss_pred HHCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf 80111999999999999999800088
Q 002738 855 RCTEENPTERPTAGDLYEMFVARTSS 880 (886)
Q Consensus 855 ~CL~~DP~kRPSasEIL~hL~~l~~~ 880 (886)
+||+.+|.+|||+++|+++|+....+
T Consensus 270 ~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 270 MCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp HHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHCCCCHHHCCCHHHHHHHHHHHCCC
T ss_conf 97577965893999999997876177
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.43 Aligned_cols=266 Identities=24% Similarity=0.370 Sum_probs=208.8
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEECC-------EEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCEE
Q ss_conf 888994164232534945999999999-------1299999933568999688876567499999999617-99981225
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 619 (886)
Q Consensus 548 ~~~~~y~i~~~LG~GsfG~Vyka~~~~-------~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L-~HPNIV~l 619 (886)
++.++|.+.+.||+|+||.||+|.+.+ ..||+|+. +.. ......+.+ .+|+.++.++ +|+|||.+
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l--~~~-~~~~~~~~~----~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEG-ATHSEHRAL----MSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHH----HHHHHHHHHHCCCTTBCCE
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEE--CCC-CCCHHHHHH----HHHHHHHHHHCCCCEEEEE
T ss_conf 167997984498416783999999867775557839999998--600-171789999----9999998861499849974
Q ss_pred EEEEECCCCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCC-----------CCCCCCHHHHHHHHHHHHHHHHH
Q ss_conf 6368548988889999976664089999025999999999987205-----------99767999999999999999999
Q 002738 620 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVE 688 (886)
Q Consensus 620 lG~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~-----------~~~~ls~~~~l~Ia~qIa~gL~Y 688 (886)
++++..... ..++|||||++|+|.+++...... ....+++..++.++.||+.||.|
T Consensus 83 ~~~~~~~~~-------------~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~y 149 (299)
T d1ywna1 83 LGACTKPGG-------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 149 (299)
T ss_dssp EEEECSTTS-------------CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHH
T ss_pred EEEECCCCC-------------EEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHH
T ss_conf 115404797-------------5799998458992999998536666653222023321468999999999999999998
Q ss_pred HHHCCCCCCCCCCCCEEEECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCC
Q ss_conf 98589121479999788724665789998099931587522444554323346799999765689864452533014589
Q 002738 689 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 768 (886)
Q Consensus 689 LHs~gIVHRDLKpsNILId~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~ 768 (886)
||+++||||||||+|||++.++ .+||+|||+|+........ .......||+.|||||++.+
T Consensus 150 lH~~~ivHrDlKp~NILl~~~~-------~~Kl~DFGla~~~~~~~~~--------~~~~~~~gt~~y~APE~l~~---- 210 (299)
T d1ywna1 150 LASRKCIHRDLAARNILLSEKN-------VVKICDFGLARDIYKDPDY--------VRKGDARLPLKWMAPETIFD---- 210 (299)
T ss_dssp HHHTTCCCSCCCGGGEEECGGG-------CEEECC------CCSCTTS--------CCTTSCCCGGGGCCHHHHHH----
T ss_pred HHHCCCCCCCCCCCCEEECCCC-------CEEECCCCCHHHCCCCCCC--------CCCCCEEECCCCCCHHHHHC----
T ss_conf 8737971786773106577998-------2898457520011356652--------22475166721020368646----
Q ss_pred CCCCCHHHHHHHHHHHHHHHHC-CCCCCCCCH-HHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 9999235699999999999919-999999998-89999998088999506886411565200002599999961446629
Q 002738 769 NLYGLEVDIWSYGCLLLELLTL-QVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 846 (886)
Q Consensus 769 ~~~s~KsDVWSLGVIL~ELLTG-k~Pf~g~s~-~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s 846 (886)
..++.++|||||||++|||+++ .+||.+... ..+...+..+.++.+++. .+
T Consensus 211 ~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~ 263 (299)
T d1ywna1 211 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY---------------------------TT 263 (299)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTT---------------------------CC
T ss_pred CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC---------------------------CC
T ss_conf 889966322136789999986889999899989999999963898888865---------------------------78
Q ss_pred HHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 999999998011199999999999999980008
Q 002738 847 SFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 879 (886)
Q Consensus 847 ~~L~dLI~~CL~~DP~kRPSasEIL~hL~~l~~ 879 (886)
+.+.+|+.+||+.||.+|||+++|++||+.+..
T Consensus 264 ~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 264 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 999999999767796679199999999979986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=355.96 Aligned_cols=268 Identities=24% Similarity=0.278 Sum_probs=214.2
Q ss_pred CCCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 89941642325349459999999--9912999999335689996888765674999999996179998122563685489
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~~ 627 (886)
-++|.+.+.||+|+||.||+|.+ .+..||+|++.... ....... ..+.+|+.+++.++|||||++++++....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~----~~~~~E~~~l~~~~hpniv~~~~~~~~~~ 80 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL-ARDPSFY----LRFRREAQNAAALNHPAIVAVYDTGEAET 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-TTCHHHH----HHHHHHHHHHHTCCCTTBCCEEEEEEEEC
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHH-CCCHHHH----HHHHHHHHHHHHCCCCCCCCCCCEEEECC
T ss_conf 620698689960899299999999999899999985566-4698999----99999999998569998873114354326
Q ss_pred CCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEE
Q ss_conf 88889999976664089999025999999999987205997679999999999999999999858912147999978872
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILId 707 (886)
. .....||||||++|++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 81 ~----------~~~~~~lvmE~~~g~~L~~~~~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~ 145 (277)
T d1o6ya_ 81 P----------AGPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 145 (277)
T ss_dssp S----------SSEEEEEEEECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred C----------CCCEEEEEEECCCCCEEHHHHCC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCC
T ss_conf 8----------87669999977889871011203-----58999999999999999999999857952763467556657
Q ss_pred CCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 46657899980999315875224445543233467999997656898644525330145899999235699999999999
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~EL 787 (886)
.++ .++++|||.+......... .......+||+.|||||++.+ ..++.++|||||||+||||
T Consensus 146 ~~~-------~~~l~d~~~~~~~~~~~~~-------~~~~~~~~Gt~~Y~aPE~~~~----~~~~~~~DiwSlGvilyel 207 (277)
T d1o6ya_ 146 ATN-------AVKVMDFGIARAIADSGNS-------VTQTAAVIGTAQYLSPEQARG----DSVDARSDVYSLGCVLYEV 207 (277)
T ss_dssp TTS-------CEEECCCTTCEECC-----------------------TTCCHHHHTT----CCCCHHHHHHHHHHHHHHH
T ss_pred CCC-------CCEEEHHHHHHHHCCCCCC-------CCCCCCCCCCCCCCCHHHHCC----CCCCCCEECCCCHHHHHHH
T ss_conf 543-------2010034443221235443-------333464257624369999839----9999663202652899999
Q ss_pred HHCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC-C
Q ss_conf 919999999998899999980889995068864115652000025999999614466299999999980111999999-9
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-T 866 (886)
Q Consensus 788 LTGk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRP-S 866 (886)
+||+.||.+.++.++...+.......... .....++.+.+||.+||+.||.+|| |
T Consensus 208 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~s~~l~~li~~~L~~dp~~R~~s 263 (277)
T d1o6ya_ 208 LTGEPPFTGDSPVSVAYQHVREDPIPPSA------------------------RHEGLSADLDAVVLKALAKNPENRYQT 263 (277)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHCCCCCGGG------------------------TSSSCCHHHHHHHHHHTCSSGGGSCSS
T ss_pred HHCCCCCCCCCHHHHHHHHHHCCCCCCCH------------------------HCCCCCHHHHHHHHHHCCCCHHHCHHH
T ss_conf 76979989969999999998469999710------------------------034789999999999866797677739
Q ss_pred HHHHHHHHHHHCC
Q ss_conf 9999999980008
Q 002738 867 AGDLYEMFVARTS 879 (886)
Q Consensus 867 asEIL~hL~~l~~ 879 (886)
++++++.|.++..
T Consensus 264 a~~l~~~l~r~~n 276 (277)
T d1o6ya_ 264 AAEMRADLVRVHN 276 (277)
T ss_dssp HHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHC
T ss_conf 9999999999758
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.95 Aligned_cols=261 Identities=23% Similarity=0.334 Sum_probs=209.9
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEEC---C--EEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
Q ss_conf 88899416423253494599999999---9--129999993356899968887656749999999961799981225636
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFG---S--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 622 (886)
Q Consensus 548 ~~~~~y~i~~~LG~GsfG~Vyka~~~---~--~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~ 622 (886)
+...+|++.+.||+|+||.||+|++. + ..||+|+..... .......+ .+.+|+.+|+.++|||||+++|+
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~-~~~~~~~~----~~~~Ei~~l~~l~H~nIv~~~g~ 79 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDV-LSQPEAMD----DFIREVNAMHSLDHRNLIRLYGV 79 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHH----HHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ECHHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHH-CCCHHHHH----HHHHHHHHHHHCCCCCEEEEEEE
T ss_conf 86489199789803888399999998899907999999998355-57989999----99999999986899998789877
Q ss_pred EECCCCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 85489888899999766640899990259999999999872059976799999999999999999998589121479999
Q 002738 623 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 702 (886)
Q Consensus 623 ~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKps 702 (886)
+.... .++||||+++|+|.+++... ...+++..++.++.||+.||.|||+++|+||||||+
T Consensus 80 ~~~~~---------------~~lv~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~ 140 (273)
T d1u46a_ 80 VLTPP---------------MKMVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAAR 140 (273)
T ss_dssp ECSSS---------------CEEEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred EEECC---------------HHEEEEEECCCCHHHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECHH
T ss_conf 74010---------------01146542386125444212----689999999999999999998752178752056688
Q ss_pred CEEEECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf 78872466578999809993158752244455432334679999976568986445253301458999992356999999
Q 002738 703 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 782 (886)
Q Consensus 703 NILId~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGV 782 (886)
|||++.+ ..+||+|||+++.......... ......|++.|+|||++.+ ..++.++||||||+
T Consensus 141 NIll~~~-------~~vkl~DfGl~~~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~----~~~~~~~Di~S~Gv 202 (273)
T d1u46a_ 141 NLLLATR-------DLVKIGDFGLMRALPQNDDHYV-------MQEHRKVPFAWCAPESLKT----RTFSHASDTWMFGV 202 (273)
T ss_dssp GEEEEET-------TEEEECCCTTCEECCC-CCEEE-------C-----CCGGGCCHHHHHH----CEEEHHHHHHHHHH
T ss_pred HHCCCCC-------CCEEECCCHHHHHCCCCCCCCE-------ECCCCCCCCCCCCHHHHHC----CCCCCCHHHHHHHH
T ss_conf 8156556-------5433256115553035887526-------5476325731079999837----99994215661489
Q ss_pred HHHHHHH-CCCCCCCCCHHHHHHHHHCC-CCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC
Q ss_conf 9999991-99999999988999999808-899950688641156520000259999996144662999999999801119
Q 002738 783 LLLELLT-LQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 860 (886)
Q Consensus 783 IL~ELLT-Gk~Pf~g~s~~ei~~~I~~~-~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~D 860 (886)
++|||+| |+.||.+.+..++...+.+. .+++.+. ..++.+.+|+.+||..|
T Consensus 203 il~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~d 255 (273)
T d1u46a_ 203 TLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE---------------------------DCPQDIYNVMVQCWAHK 255 (273)
T ss_dssp HHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCT---------------------------TCCHHHHHHHHHHTCSS
T ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCC---------------------------CCCHHHHHHHHHHCCCC
T ss_conf 999999689999999699999999984799999854---------------------------45399999999976889
Q ss_pred CCCCCCHHHHHHHHHHH
Q ss_conf 99999999999999800
Q 002738 861 PTERPTAGDLYEMFVAR 877 (886)
Q Consensus 861 P~kRPSasEIL~hL~~l 877 (886)
|.+||||++|++.|+..
T Consensus 256 p~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 256 PEDRPTFVALRDFLLEA 272 (273)
T ss_dssp GGGSCCHHHHHHHHHHH
T ss_pred HHHCCCHHHHHHHHHHC
T ss_conf 66792999999999964
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.88 Aligned_cols=252 Identities=27% Similarity=0.347 Sum_probs=206.4
Q ss_pred CCCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCCCCCEEEEEEECC
Q ss_conf 89941642325349459999999--9912999999335689996888765674999999996-17999812256368548
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLG-ALRHSCIVEMYGHKISS 626 (886)
Q Consensus 550 ~~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~-~L~HPNIV~llG~~~~~ 626 (886)
+++|.+.+.||+|+||+||+|+. .+..||+|++..... ..+.....+.+|+.++. .++|||||++++++...
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~-----~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~ 75 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV-----LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 75 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHC-----CCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCC
T ss_conf 9971886589408782899999999998999999805553-----38489999999999999847999687898897049
Q ss_pred CCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEE
Q ss_conf 98888999997666408999902599999999998720599767999999999999999999985891214799997887
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILI 706 (886)
.. .||||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus 76 ~~--------------~yivmEy~~~g~L~~~i~~-----~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~ 136 (320)
T d1xjda_ 76 EN--------------LFFVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 136 (320)
T ss_dssp SE--------------EEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE
T ss_pred CC--------------EEEEEEECCCCCHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEE
T ss_conf 83--------------1677750379808998640-----4789999999999999999999986893403476540444
Q ss_pred ECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 24665789998099931587522444554323346799999765689864452533014589999923569999999999
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~E 786 (886)
+.++ .+||+|||+|+........ .....||+.|||||++.+ ..|+.++|||||||+|||
T Consensus 137 ~~~~-------~~kl~DFG~a~~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvilye 195 (320)
T d1xjda_ 137 DKDG-------HIKIADFGMCKENMLGDAK----------TNTFCGTPDYIAPEILLG----QKYNHSVDWWSFGVLLYE 195 (320)
T ss_dssp CTTS-------CEEECCCTTCBCCCCTTCC----------BCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHH
T ss_pred CCCC-------CEECCCCCHHHHCCCCCCC----------CCCCCCCCCCCCHHHHCC----CCCCCHHHHHHHHHHHHH
T ss_conf 4899-------6301555302323566533----------454578777689999827----998832320112278989
Q ss_pred HHHCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 99199999999988999999808899950688641156520000259999996144662999999999801119999999
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 866 (886)
Q Consensus 787 LLTGk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRPS 866 (886)
|++|+.||.+.+..++...+..+. +.++. ..++.+.+||.+||..||.+||+
T Consensus 196 mltG~~PF~~~~~~~~~~~i~~~~-~~~p~---------------------------~~s~~~~dli~~~L~~dP~~R~s 247 (320)
T d1xjda_ 196 MLIGQSPFHGQDEEELFHSIRMDN-PFYPR---------------------------WLEKEAKDLLVKLFVREPEKRLG 247 (320)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHCC-CCCCT---------------------------TSCHHHHHHHHHHSCSSGGGSBT
T ss_pred HHHCCCCCCCCCHHHHHHHHHCCC-CCCCC---------------------------CCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 873889999989999999997189-98975---------------------------67999999999965448987838
Q ss_pred HH-HHHHHH
Q ss_conf 99-999999
Q 002738 867 AG-DLYEMF 874 (886)
Q Consensus 867 as-EIL~hL 874 (886)
+. ++++|.
T Consensus 248 ~~~~l~~hp 256 (320)
T d1xjda_ 248 VRGDIRQHP 256 (320)
T ss_dssp TBSCGGGSG
T ss_pred HHHHHHHCC
T ss_conf 899998090
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.01 Aligned_cols=261 Identities=23% Similarity=0.342 Sum_probs=207.2
Q ss_pred EEEEEECCCCCEEEEEEEECC-----EEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCC
Q ss_conf 164232534945999999999-----129999993356899968887656749999999961799981225636854898
Q 002738 554 SSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 554 ~i~~~LG~GsfG~Vyka~~~~-----~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~~~ 628 (886)
.+.++||+|+||+||+|.+.. ..||||.. +.. ......+.| .+|+.+|++++|||||+++|++.....
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~--~~~-~~~~~~~~~----~~E~~~l~~l~HpnIv~~~g~~~~~~~ 102 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRI-TDIGEVSQF----LTEGIIMKDFSHPNVLSLLGICLRSEG 102 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEE--CCC-CCHHHHHHH----HHHHHHHHTCCCTTBCCCCEEEEETTT
T ss_pred CCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEE--CCC-CCHHHHHHH----HHHHHHHHHCCCCCEEEEEEEEEECCC
T ss_conf 2666981368809999999779987999999998--843-697899999----999999986789998678678980699
Q ss_pred CCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEEC
Q ss_conf 88899999766640899990259999999999872059976799999999999999999998589121479999788724
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILId~ 708 (886)
..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+|+||||||+|||++.
T Consensus 103 -------------~~~lv~E~~~~g~l~~~~~~----~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~ 165 (311)
T d1r0pa_ 103 -------------SPLVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE 165 (311)
T ss_dssp -------------EEEEEEECCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred -------------CEEEEEEEEECCCHHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHEEECC
T ss_conf -------------43899987406741442101----3454048999999999887652003367625776687576779
Q ss_pred CCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 66578999809993158752244455432334679999976568986445253301458999992356999999999999
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~ELL 788 (886)
+ +.+||+|||+++......... ........||+.|+|||++.. ..++.++||||||++||||+
T Consensus 166 ~-------~~~kL~DFG~~~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDI~SfGivl~El~ 228 (311)
T d1r0pa_ 166 K-------FTVKVADFGLARDMYDKEFDS------VHNKTGAKLPVKWMALESLQT----QKFTTKSDVWSFGVLLWELM 228 (311)
T ss_dssp T-------CCEEECSSGGGCCTTTTTCCC------TTCTTCSSCCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEECCCCHHHCCCCCCCC------CEECCCCCCCCCCCCHHHHHC----CCCCCHHHHHHHHHHHHHHH
T ss_conf 9-------988991065232255665553------100256555645567688743----79997457466199999999
Q ss_pred HCCCCCC-CCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH
Q ss_conf 1999999-999889999998088999506886411565200002599999961446629999999998011199999999
Q 002738 789 TLQVPYM-GLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 789 TGk~Pf~-g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRPSa 867 (886)
++..||. +.+..++...+..+.++..+.. .++.+.+|+.+||+.||.+||++
T Consensus 229 t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~---------------------------~~~~l~~li~~cl~~dP~~RPs~ 281 (311)
T d1r0pa_ 229 TRGAPPYPDVNTFDITVYLLQGRRLLQPEY---------------------------CPDPLYEVMLKCWHPKAEMRPSF 281 (311)
T ss_dssp TTSCCSCC------CHHHHHTTCCCCCCTT---------------------------CCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HCCCCCCCCCCHHHHHHHHHCCCCCCCCCC---------------------------CCHHHHHHHHHHCCCCHHHCCCH
T ss_conf 789999888999999999980898899644---------------------------75999999999768897689399
Q ss_pred HHHHHHHHHHCCCCC
Q ss_conf 999999980008899
Q 002738 868 GDLYEMFVARTSSSI 882 (886)
Q Consensus 868 sEIL~hL~~l~~~s~ 882 (886)
.||+++|+.+.++-+
T Consensus 282 ~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 282 SELVSRISAIFSTFI 296 (311)
T ss_dssp HHHHHHHHHHHHTCC
T ss_pred HHHHHHHHHHHHHHH
T ss_conf 999999999997520
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.88 Aligned_cols=263 Identities=22% Similarity=0.238 Sum_probs=202.7
Q ss_pred CCCCCCEEEE-EECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCEEEEEE
Q ss_conf 8889941642-325349459999999--991299999933568999688876567499999999617-999812256368
Q 002738 548 GSFPSLSSCD-EAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 623 (886)
Q Consensus 548 ~~~~~y~i~~-~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L-~HPNIV~llG~~ 623 (886)
..+++|.+.. .||+|+||+||+|.+ .+..||+|+.... . .+.+|+.++.++ +|||||++++++
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~----~~~~E~~~~~~~~~hpnIv~l~~~~ 74 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------P----KARREVELHWRASQCPHIVRIVDVY 74 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------H----HHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred CCCCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC---------H----HHHHHHHHHHHHCCCCCCCEEEEEE
T ss_conf 70148798107965454869999998899989999998974---------7----7999999999866999978298999
Q ss_pred ECCCCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 54898888999997666408999902599999999998720599767999999999999999999985891214799997
Q 002738 624 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703 (886)
Q Consensus 624 ~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsN 703 (886)
..... .....|||||||+||+|.+++.. .+...+++..+..|+.||+.||+|||+++|+||||||+|
T Consensus 75 ~~~~~----------~~~~~~ivmEy~~gg~L~~~i~~---~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~N 141 (335)
T d2ozaa1 75 ENLYA----------GRKCLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 141 (335)
T ss_dssp EEEET----------TEEEEEEEEECCCSEEHHHHHHS---CSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred EECCC----------CCCEEEEEEECCCCCCHHHHHHH---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCC
T ss_conf 50346----------89789999977899849999986---278775799999999999999999997698644410022
Q ss_pred EEEECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf 88724665789998099931587522444554323346799999765689864452533014589999923569999999
Q 002738 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783 (886)
Q Consensus 704 ILId~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVI 783 (886)
||++... ....+||+|||+|+....... .....||+.|||||++.+ ..|+.++|||||||+
T Consensus 142 Ill~~~~----~~~~~Kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~y~~~~DiwSlGvi 202 (335)
T d2ozaa1 142 LLYTSKR----PNAILKLTDFGFAKETTSHNS-----------LTTPCYTPYYVAPEVLGP----EKYDKSCDMWSLGVI 202 (335)
T ss_dssp EEESCSS----TTCCEEECCCTTCEECCCCCC-----------CCCCSCCCSSCCCCCCCG----GGGSHHHHHHHHHHH
T ss_pred CCCCCCC----CCCCCCCCCCCEEEECCCCCC-----------CCCCCCCCCCCCCHHHCC----CCCCHHHHHHHHCHH
T ss_conf 0113555----566311354551233368886-----------432267756379277748----988888888764516
Q ss_pred HHHHHHCCCCCCCCCHHHHHHHHHCC-CCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 99999199999999988999999808-89995068864115652000025999999614466299999999980111999
Q 002738 784 LLELLTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 862 (886)
Q Consensus 784 L~ELLTGk~Pf~g~s~~ei~~~I~~~-~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~ 862 (886)
||+|+||+.||.+.+.......+... ...... + +.......++.+.+||.+||+.||.
T Consensus 203 ly~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~--------------------~-~~~~~~~~s~~~~~li~~~L~~dP~ 261 (335)
T d2ozaa1 203 MYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE--------------------F-PNPEWSEVSEEVKMLIRNLLKTEPT 261 (335)
T ss_dssp HHHHTTSSCSCEETTCC--------CCCSCSSS--------------------C-CTTHHHHSCHHHHHHHHHHSCSSTT
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCC--------------------C-CCCCCCCCCHHHHHHHHHHCCCCHH
T ss_conf 778865889988988778899999998538888--------------------8-9854346999999999997569965
Q ss_pred CCCCHHHHHHHHHH
Q ss_conf 99999999999980
Q 002738 863 ERPTAGDLYEMFVA 876 (886)
Q Consensus 863 kRPSasEIL~hL~~ 876 (886)
+|||+.++++|-+-
T Consensus 262 ~R~s~~eil~hp~~ 275 (335)
T d2ozaa1 262 QRMTITEFMNHPWI 275 (335)
T ss_dssp TSCCHHHHHHSHHH
T ss_pred HCCCHHHHHCCHHH
T ss_conf 79099999709876
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.35 Aligned_cols=286 Identities=20% Similarity=0.251 Sum_probs=209.7
Q ss_pred CCCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 89941642325349459999999--9912999999335689996888765674999999996179998122563685489
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~~ 627 (886)
+++|.+.+.||+|+||.||+|.+ .+..||+|++..... . +.....+.+|+.+|+.++|||||++++++....
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~----~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~ 74 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--T----EGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 74 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC--C----HHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCC
T ss_conf 9997765177237680999999999997999999802225--7----589999999999998679983887445332243
Q ss_pred CCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEE
Q ss_conf 88889999976664089999025999999999987205997679999999999999999999858912147999978872
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILId 707 (886)
+.++||||+.+ ++..++.. .....+++..+..++.||+.||.|||+++||||||||+|||++
T Consensus 75 --------------~~~iv~e~~~~-~~~~~~~~---~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~ 136 (298)
T d1gz8a_ 75 --------------KLYLVFEFLHQ-DLKKFMDA---SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN 136 (298)
T ss_dssp --------------EEEEEEECCSE-EHHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred --------------CEEEEEEECCC-CHHHHHHH---HCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCHHEEEC
T ss_conf --------------20378862377-44555442---0256888899999999999999986528899213571140113
Q ss_pred CCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 46657899980999315875224445543233467999997656898644525330145899999235699999999999
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~EL 787 (886)
.++ .+||+|||+|+........ .....||+.|+|||++.. ...++.++|||||||++|+|
T Consensus 137 ~~~-------~~kl~DFG~a~~~~~~~~~----------~~~~~gt~~y~apE~~~~---~~~~~~~~DiwSlGvily~m 196 (298)
T d1gz8a_ 137 TEG-------AIKLADFGLARAFGVPVRT----------YTHEVVTLWYRAPEILLG---CKYYSTAVDIWSLGCIFAEM 196 (298)
T ss_dssp TTS-------CEEECSTTHHHHHCCCSBC----------TTCCBCCCTTCCHHHHTT---CSSCCTHHHHHHHHHHHHHH
T ss_pred CCC-------CCEECCCCCCEECCCCCCC----------CEEECCCCEEEEHHHHCC---CCCCCCCCCCCCCCHHHHHH
T ss_conf 467-------6210357861343688641----------001036521541122136---65777422103333134279
Q ss_pred HHCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCC--CCCHHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 9199999999988999999808899950688641156520000259999--99614466299999999980111999999
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF--EKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 788 LTGk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~--~~~e~~~~~s~~L~dLI~~CL~~DP~kRP 865 (886)
++|+.||.+.+.......+...........+......... ........ .........++.+.+|+.+||+.||.+||
T Consensus 197 ~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ 275 (298)
T d1gz8a_ 197 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI 275 (298)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC-CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSC
T ss_pred HHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCCCCCC-CCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCC
T ss_conf 6687998988999999999983289833314442224212-434543222204441667899999999997639955791
Q ss_pred CHHHHHHH--HHHHCCC
Q ss_conf 99999999--9800088
Q 002738 866 TAGDLYEM--FVARTSS 880 (886)
Q Consensus 866 SasEIL~h--L~~l~~~ 880 (886)
|++|+++| ++.+..|
T Consensus 276 t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 276 SAKAALAHPFFQDVTKP 292 (298)
T ss_dssp CHHHHHTSGGGTTCCCC
T ss_pred CHHHHHCCHHHCCCCCC
T ss_conf 89999678701469999
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.21 Aligned_cols=267 Identities=24% Similarity=0.373 Sum_probs=211.9
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEEC-------CEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCEE
Q ss_conf 88899416423253494599999999-------91299999933568999688876567499999999617-99981225
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 619 (886)
Q Consensus 548 ~~~~~y~i~~~LG~GsfG~Vyka~~~-------~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L-~HPNIV~l 619 (886)
++.++|++.+.||+|+||.||+|++. +..||||+.. ... ....... +.+|+.++..+ +|||||++
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~--~~~-~~~~~~~----~~~E~~~~~~l~~HpnIv~~ 92 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK--PSA-HLTEREA----LMSELKVLSYLGNHMNIVNL 92 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEEC--TTC-CHHHHHH----HHHHHHHHHHHCCCTTBCCE
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEEC--CCC-CHHHHHH----HHHHHHHHHHCCCCCCEEEE
T ss_conf 7789969854982068829999998066447788699999987--424-8779999----99999998762699988789
Q ss_pred EEEEECCCCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHC-------------CCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 636854898888999997666408999902599999999998720-------------5997679999999999999999
Q 002738 620 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------------TGEKHVSVKLALFIAQDVAAAL 686 (886)
Q Consensus 620 lG~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k-------------~~~~~ls~~~~l~Ia~qIa~gL 686 (886)
+|++..... .+||||||++|+|.+++..... .....+++..+..++.||+.||
T Consensus 93 ~g~~~~~~~--------------~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl 158 (311)
T d1t46a_ 93 LGACTIGGP--------------TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM 158 (311)
T ss_dssp EEEECSSSS--------------CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHH
T ss_pred EEEEEECCE--------------EEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH
T ss_conf 989831997--------------899997379987999998535665444445332223345889999999999999999
Q ss_pred HHHHHCCCCCCCCCCCCEEEECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCC
Q ss_conf 99985891214799997887246657899980999315875224445543233467999997656898644525330145
Q 002738 687 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 766 (886)
Q Consensus 687 ~YLHs~gIVHRDLKpsNILId~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~ 766 (886)
+|||+++||||||||+|||++.++ .+|++|||+++......... ......||+.|+|||++..
T Consensus 159 ~~LH~~~ivHrDLKp~NIl~~~~~-------~~ki~DfG~~~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-- 221 (311)
T d1t46a_ 159 AFLASKNCIHRDLAARNILLTHGR-------ITKICDFGLARDIKNDSNYV--------VKGNARLPVKWMAPESIFN-- 221 (311)
T ss_dssp HHHHHTTCCCSCCSGGGEEEETTT-------EEEECCCGGGSCTTSCTTSE--------ECSSSEECGGGCCHHHHHH--
T ss_pred HHHHHCCEEECCCCCCCCCCCCCC-------CCCCCCCCHHEECCCCCCCE--------EEEECCCCHHHCCHHHHCC--
T ss_conf 988757926662410210000257-------52102340102336788615--------8620135968767788617--
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHH-HHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHH
Q ss_conf 89999923569999999999991-9999999998899-999980889995068864115652000025999999614466
Q 002738 767 KPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 844 (886)
Q Consensus 767 ~~~~~s~KsDVWSLGVIL~ELLT-Gk~Pf~g~s~~ei-~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~ 844 (886)
..++.++||||||++||||+| |.+||.+.+.... ...+..+.++..+..
T Consensus 222 --~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~--------------------------- 272 (311)
T d1t46a_ 222 --CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEH--------------------------- 272 (311)
T ss_dssp --CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTT---------------------------
T ss_pred --CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC---------------------------
T ss_conf --999974001025899999985899887789989999999866898898543---------------------------
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCC
Q ss_conf 2999999999801119999999999999998000889
Q 002738 845 TLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSS 881 (886)
Q Consensus 845 ~s~~L~dLI~~CL~~DP~kRPSasEIL~hL~~l~~~s 881 (886)
.++.+.+||.+||+.||.+||||++|++.|+++.+.+
T Consensus 273 ~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 273 APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCC
T ss_conf 6599999999975779657929999999998765349
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.13 Aligned_cols=284 Identities=21% Similarity=0.206 Sum_probs=206.4
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC---CEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCEEEEEE
Q ss_conf 899416423253494599999999---91299999933568999688876567499999999617---999812256368
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHK 623 (886)
Q Consensus 550 ~~~y~i~~~LG~GsfG~Vyka~~~---~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L---~HPNIV~llG~~ 623 (886)
-++|++.++||+|+||+||+|++. +..||+|++........ .. ..+.+|+.+|+.| +|||||++++++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~--~~----~~~~~E~~~l~~l~~~~HpnIv~~~~~~ 79 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MP----LSTIREVAVLRHLETFEHPNVVRLFDVC 79 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS--CB----CTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCH--HH----HHHHHHHHHHHHHHHCCCCCCCEEEEEE
T ss_conf 58979888992155869999999888998999999802324516--79----9999999999987425898802366322
Q ss_pred ECCCCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 54898888999997666408999902599999999998720599767999999999999999999985891214799997
Q 002738 624 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 703 (886)
Q Consensus 624 ~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsN 703 (886)
..... ......+++|||+.++.+...... ....+++..++.++.||+.||+|||+++|+||||||+|
T Consensus 80 ~~~~~---------~~~~~~~~~~e~~~~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~N 146 (305)
T d1blxa_ 80 TVSRT---------DRETKLTLVFEHVDQDLTTYLDKV----PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 146 (305)
T ss_dssp EEEEC---------SSEEEEEEEEECCSCBHHHHHHHS----CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred CCCCC---------CCCCEEEEEEEECCCCCHHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCE
T ss_conf 14666---------667469999974058714444430----37899989999999999999999975889835798627
Q ss_pred EEEECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf 88724665789998099931587522444554323346799999765689864452533014589999923569999999
Q 002738 704 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 783 (886)
Q Consensus 704 ILId~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVI 783 (886)
||++.++ .+||+|||++........ .....||+.|||||++.+ ..|+.++||||+||+
T Consensus 147 ILi~~~~-------~~kl~dfg~~~~~~~~~~-----------~~~~~gT~~Y~APE~~~~----~~y~~~~DiwSlG~i 204 (305)
T d1blxa_ 147 ILVTSSG-------QIKLADFGLARIYSFQMA-----------LTSVVVTLWYRAPEVLLQ----SSYATPVDLWSVGCI 204 (305)
T ss_dssp EEECTTC-------CEEECSCCSCCCCCGGGG-----------GCCCCCCCTTCCHHHHTT----CCCCTHHHHHHHHHH
T ss_pred EEECCCC-------CEEECCHHHHHHHCCCCC-----------CCCCCCCHHHCCCCHHCC----CCCCHHEHHHCHHHH
T ss_conf 8985899-------754210001011002345-----------777654851148310017----988811100032899
Q ss_pred HHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 99999199999999988999999808899950688641156520000259999996144662999999999801119999
Q 002738 784 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 784 L~ELLTGk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~k 863 (886)
||||++|+.||.+.++.+....+...........++.......... ...............++.+.+||.+||++||.+
T Consensus 205 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~ 283 (305)
T d1blxa_ 205 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF-HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK 283 (305)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGS-CCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTT
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHCCCCCCCCHHHHH-CCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHH
T ss_conf 9999878799899898999999998407996110532111103330-223456454404458999999999987489667
Q ss_pred CCCHHHHHHHHH
Q ss_conf 999999999998
Q 002738 864 RPTAGDLYEMFV 875 (886)
Q Consensus 864 RPSasEIL~hL~ 875 (886)
|||++|+++|.+
T Consensus 284 R~sa~e~L~Hpf 295 (305)
T d1blxa_ 284 RISAYSALSHPY 295 (305)
T ss_dssp SCCHHHHHTSGG
T ss_pred CCCHHHHHCCHH
T ss_conf 918999966963
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.88 Aligned_cols=269 Identities=25% Similarity=0.282 Sum_probs=201.7
Q ss_pred CCCEEEEEECCCCCEEEEEEEECCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCC
Q ss_conf 99416423253494599999999912999999335689996888765674999999996179998122563685489888
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 630 (886)
Q Consensus 551 ~~y~i~~~LG~GsfG~Vyka~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~~~l~ 630 (886)
.+|.+.+.||+|+||.||+|++++..||+|++... ..+.+ ....|+..+..++|||||+++|++.....
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~-------~~~~~--~~e~ei~~~~~~~HpnIv~~~~~~~~~~~-- 71 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-------EERSW--FREAEIYQTVMLRHENILGFIAADNKDNG-- 71 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGG-------GHHHH--HHHHHHHTSTTCCCTTBCCEEEEEEEECS--
T ss_pred CEEEEEEEEEECCCEEEEEEEECCEEEEEEEECCC-------CHHHH--HHHHHHHHHHHCCCCCCCCEEEEEEECCC--
T ss_conf 68999889820788199999999989999998720-------04679--99999999962799868326889983798--
Q ss_pred CCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCCCCCCCCC
Q ss_conf 8999997666408999902599999999998720599767999999999999999999985--------89121479999
Q 002738 631 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS--------KHIMHRDIKSE 702 (886)
Q Consensus 631 ~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs--------~gIVHRDLKps 702 (886)
.....++||||+++|+|.++++. ..+++..++.++.|++.||.|||. ++|+||||||+
T Consensus 72 --------~~~~~~lv~Ey~~~g~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~ 137 (303)
T d1vjya_ 72 --------TWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 137 (303)
T ss_dssp --------SSEEEEEEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGG
T ss_pred --------CCEEEEEEEECCCCCCHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCC
T ss_conf --------60489999964669898999865------8999899999999999999998876652046898661531731
Q ss_pred CEEEECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCC--CCCCCHHHHHHH
Q ss_conf 788724665789998099931587522444554323346799999765689864452533014589--999923569999
Q 002738 703 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP--NLYGLEVDIWSY 780 (886)
Q Consensus 703 NILId~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~--~~~s~KsDVWSL 780 (886)
|||++.+ +.+||+|||+++.......... ......+||+.|||||++.+.... ..++.++|||||
T Consensus 138 NILl~~~-------~~~Kl~DFGl~~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~ 204 (303)
T d1vjya_ 138 NILVKKN-------GTCCIADLGLAVRHDSATDTID------IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 204 (303)
T ss_dssp GEEECTT-------SCEEECCCTTCEEEETTTTEEC------C----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred CEEECCC-------CCEEEEECCCCCCCCCCCCCEE------CCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHH
T ss_conf 3578688-------7768876386623467776200------13552503547678221056545467776750122015
Q ss_pred HHHHHHHHHCCCCCCCCC---------------HHHHHHHHHC-CCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHH
Q ss_conf 999999991999999999---------------8899999980-889995068864115652000025999999614466
Q 002738 781 GCLLLELLTLQVPYMGLS---------------ELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 844 (886)
Q Consensus 781 GVIL~ELLTGk~Pf~g~s---------------~~ei~~~I~~-~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~ 844 (886)
||+||||+||..||.... ...+...+.. ..+|.++..+ ...+
T Consensus 205 Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~----------------------~~~~ 262 (303)
T d1vjya_ 205 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW----------------------QSCE 262 (303)
T ss_dssp HHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG----------------------GGCH
T ss_pred HHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCCCCCCCCC----------------------CCHH
T ss_conf 999999962899887663112410122556430999999875024688877655----------------------7768
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 29999999998011199999999999999980008
Q 002738 845 TLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 879 (886)
Q Consensus 845 ~s~~L~dLI~~CL~~DP~kRPSasEIL~hL~~l~~ 879 (886)
....+.+|+.+||+.||.+|||+.||+++|..+..
T Consensus 263 ~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 263 ALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 99999999999760698589599999999998888
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.66 Aligned_cols=282 Identities=19% Similarity=0.224 Sum_probs=211.1
Q ss_pred CCCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 89941642325349459999999--9912999999335689996888765674999999996179998122563685489
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~~ 627 (886)
-++|.+.+.||+|+||+||+|.+ .+..||+|++. .........+ .+.+|+.+|+.++|||||++++++....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~--~~~~~~~~~~----~~~~Ei~il~~l~hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY--RPFQSELFAK----RAYRELRLLKHMRHENVIGLLDVFTPDE 90 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECS--STTSSHHHHH----HHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEC--HHHCCHHHHH----HHHHHHHHHHHCCCCCEEEEEEEECCCC
T ss_conf 771899889801778199999999999899999985--2225969999----9999999998668987547999863576
Q ss_pred CCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEE
Q ss_conf 88889999976664089999025999999999987205997679999999999999999999858912147999978872
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILId 707 (886)
.+ ......++||||+ +.+|..+++. ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 91 ~~--------~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~ 155 (346)
T d1cm8a_ 91 TL--------DDFTDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN 155 (346)
T ss_dssp ST--------TTCCCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred CC--------CCCCEEEEEEECC-CCCHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHCC
T ss_conf 55--------5541599998405-5218999874------0226999999999999999998737876456685111121
Q ss_pred CCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 46657899980999315875224445543233467999997656898644525330145899999235699999999999
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~EL 787 (886)
.++ .+|++|||+|+...... ...+||+.|+|||++.+ ...++.++||||+||+||+|
T Consensus 156 ~~~-------~~kl~Dfg~a~~~~~~~-------------~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlGvil~el 212 (346)
T d1cm8a_ 156 EDC-------ELKILDFGLARQADSEM-------------TGYVVTRWYRAPEVILN---WMRYTQTVDIWSVGCIMAEM 212 (346)
T ss_dssp TTC-------CEEECCCTTCEECCSSC-------------CSSCSCGGGCCTHHHHT---TTCCCTTHHHHHHHHHHHHH
T ss_pred CCC-------CCCCCCCCCEECCCCCC-------------CCCCCCCCCCCHHHHCC---CCCCCCCCHHHCCHHHHHHH
T ss_conf 001-------22113431022068763-------------10245533358899817---87899650103003899999
Q ss_pred HHCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 91999999999889999998088999506886411565200002599---999961446629999999998011199999
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS---GFEKPEAELETLSFLVDVFRRCTEENPTER 864 (886)
Q Consensus 788 LTGk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~---~~~~~e~~~~~s~~L~dLI~~CL~~DP~kR 864 (886)
++|+.||.+.+.......+...........+................ ...........++.+.+||.+||..||.+|
T Consensus 213 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R 292 (346)
T d1cm8a_ 213 ITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR 292 (346)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTS
T ss_pred HHCCCCCCCCCHHHHHHHHHHCCCCCCHHHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHC
T ss_conf 97869988897689999998503788488886530003443311578666556677556899999999999772995579
Q ss_pred CCHHHHHHHHH
Q ss_conf 99999999998
Q 002738 865 PTAGDLYEMFV 875 (886)
Q Consensus 865 PSasEIL~hL~ 875 (886)
||++|+|+|-+
T Consensus 293 ~ta~eiL~Hp~ 303 (346)
T d1cm8a_ 293 VTAGEALAHPY 303 (346)
T ss_dssp CCHHHHHHSGG
T ss_pred CCHHHHHCCHH
T ss_conf 29999963962
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=348.98 Aligned_cols=281 Identities=19% Similarity=0.209 Sum_probs=209.5
Q ss_pred CCCCEEEEEECCCCCEEEEEEEE-CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCC
Q ss_conf 89941642325349459999999-99129999993356899968887656749999999961799981225636854898
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 550 ~~~y~i~~~LG~GsfG~Vyka~~-~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~~~ 628 (886)
+++|.+.++||+|+||+||+|++ .+..||+|++..... . +.....+.+|+.+|+.++|||||++++++.....
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~--~----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 74 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE--D----EGIPSTTIREISILKELKHSNIVKLYDVIHTKKR 74 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG--G----GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred CCCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHC--C----HHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCC
T ss_conf 999634318722778189999968999999999812326--8----5899999999999986799868766012046773
Q ss_pred CCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEEC
Q ss_conf 88899999766640899990259999999999872059976799999999999999999998589121479999788724
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILId~ 708 (886)
.+++|||+.++.+..+... ...+++..+..++.||+.||+|||+.+||||||||+|||++.
T Consensus 75 --------------~~i~~e~~~~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~ 135 (286)
T d1ob3a_ 75 --------------LVLVFEHLDQDLKKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR 135 (286)
T ss_dssp --------------EEEEEECCSEEHHHHHHTS-----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred --------------EEEEEEEEHHHHHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCEEEECC
T ss_conf --------------1589974004567899860-----477514456899999999999860574882678775056868
Q ss_pred CCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 66578999809993158752244455432334679999976568986445253301458999992356999999999999
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~ELL 788 (886)
++ .+||+|||.|......... ....+|++.|+|||.+.+ ...++.++|||||||+||||+
T Consensus 136 ~~-------~~kl~DfG~a~~~~~~~~~----------~~~~~~~~~y~~pE~~~~---~~~~~~~~DiwslGv~l~el~ 195 (286)
T d1ob3a_ 136 EG-------ELKIADFGLARAFGIPVRK----------YTHEIVTLWYRAPDVLMG---SKKYSTTIDIWSVGCIFAEMV 195 (286)
T ss_dssp TS-------CEEECCTTHHHHHCC-------------------CCCTTCCHHHHTT---CCSCCTHHHHHHHHHHHHHHH
T ss_pred CC-------CEEECCCCCCEECCCCCCC----------CCEECCCCHHHHHHHHHC---CCCCCCCEEEHHCCCHHHHHH
T ss_conf 99-------7873236643011467654----------101024311013788717---888884100211175899997
Q ss_pred HCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH
Q ss_conf 19999999998899999980889995068864115652000-02599999961446629999999998011199999999
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEV-AQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 867 (886)
Q Consensus 789 TGk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~-~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRPSa 867 (886)
+|+.||.+.+..+....+......+....+........... ................++.+.+|+.+||++||.+|||+
T Consensus 196 ~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~ 275 (286)
T d1ob3a_ 196 NGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275 (286)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCH
T ss_conf 79799898898999999998638997110421233322143333356764666512589999999999866896689099
Q ss_pred HHHHHHHH
Q ss_conf 99999998
Q 002738 868 GDLYEMFV 875 (886)
Q Consensus 868 sEIL~hL~ 875 (886)
+|+++|.+
T Consensus 276 ~ell~Hp~ 283 (286)
T d1ob3a_ 276 KQALEHAY 283 (286)
T ss_dssp HHHHTSGG
T ss_pred HHHHCCCC
T ss_conf 99856922
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.70 Aligned_cols=281 Identities=22% Similarity=0.226 Sum_probs=205.2
Q ss_pred CCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCC
Q ss_conf 941642325349459999999--991299999933568999688876567499999999617999812256368548988
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 629 (886)
Q Consensus 552 ~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~~~l 629 (886)
+|...++||+|+||+||+|++ .+..||+|++..... .+ .+|+.+|++++|||||++++++.....
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--------~~----~~Ei~il~~l~h~niv~~~~~~~~~~~- 87 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FK----NRELQIMRKLDHCNIVRLRYFFYSSGE- 87 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--------SC----CHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH--------HH----HHHHHHHHHCCCCCCCCEEEEEEECCC-
T ss_conf 76751698217683999999999997999999881606--------89----999999986689898738789974476-
Q ss_pred CCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECC
Q ss_conf 88999997666408999902599999999998720599767999999999999999999985891214799997887246
Q 002738 630 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 709 (886)
Q Consensus 630 ~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILId~d 709 (886)
.......+|||||+++ ++...+.... .....+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 88 -------~~~~~~~~lv~Ey~~~-~~~~~l~~~~-~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~ 158 (350)
T d1q5ka_ 88 -------KKDEVYLNLVLDYVPE-TVYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD 158 (350)
T ss_dssp -------CCSCCEEEEEEECCSE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT
T ss_pred -------CCCCEEEEEEEECCCC-CCHHHHHHHH-HCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECC
T ss_conf -------5773189999841688-6078888631-036899999999999999999999986687645788603787358
Q ss_pred CCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 65789998099931587522444554323346799999765689864452533014589999923569999999999991
Q 002738 710 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 789 (886)
Q Consensus 710 ~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~ELLT 789 (886)
+ ..+||+|||++..+..... ....+||+.|+|||.+.+ ...++.++||||+||++|||++
T Consensus 159 ~------~~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~---~~~~~~~~DIwSlG~il~el~~ 218 (350)
T d1q5ka_ 159 T------AVLKLCDFGSAKQLVRGEP-----------NVSYICSRYYRAPELIFG---ATDYTSSIDVWSAGCVLAELLL 218 (350)
T ss_dssp T------CCEEECCCTTCEECCTTSC-----------CCSCCSCTTSCCHHHHTT---CSSCCTHHHHHHHHHHHHHHHH
T ss_pred C------CCEEEECCCCHHHCCCCCC-----------CCCCCCCCCCCCHHHHHC---CCCCCCCEEECCCCEEEEEHHH
T ss_conf 9------7116733660544047765-----------320025555568277640---4688821000246527785502
Q ss_pred CCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCC-CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Q ss_conf 9999999998899999980889995068864115652-000025999999614466299999999980111999999999
Q 002738 790 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE-HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 868 (886)
Q Consensus 790 Gk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~-~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRPSas 868 (886)
|+.||.+.+.......+.........+.+........ ..+................++.+.+|+.+||+.||.+|||+.
T Consensus 219 g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~ 298 (350)
T d1q5ka_ 219 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298 (350)
T ss_dssp TSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCCCCCHHHHHHHHHHHHCCCHHHHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHH
T ss_conf 87998987999999999997489817765430621011035544567444431568999999999997658955792999
Q ss_pred HHHHHH
Q ss_conf 999999
Q 002738 869 DLYEMF 874 (886)
Q Consensus 869 EIL~hL 874 (886)
|+++|-
T Consensus 299 e~L~Hp 304 (350)
T d1q5ka_ 299 EACAHS 304 (350)
T ss_dssp HHHTSG
T ss_pred HHHCCH
T ss_conf 996698
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.15 Aligned_cols=302 Identities=17% Similarity=0.196 Sum_probs=215.5
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECC
Q ss_conf 889941642325349459999999--991299999933568999688876567499999999617999812256368548
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 626 (886)
Q Consensus 549 ~~~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~ 626 (886)
...+|.+.++||+|+||+||+|++ .+..||||++...... +.+..++.+|+.+|+.++||||+++++++...
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~ 81 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK------EGFPITALREIKILQLLKHENVVNLIEICRTK 81 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT------TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC------HHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC
T ss_conf 627988999972274829999999899979999998422246------37899999999999983599966067654024
Q ss_pred CCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEE
Q ss_conf 98888999997666408999902599999999998720599767999999999999999999985891214799997887
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 706 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILI 706 (886)
.... .......++||||+.++.+..+.. ....+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus 82 ~~~~------~~~~~~~~iv~e~~~~~~~~~~~~-----~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl 150 (318)
T d3blha1 82 ASPY------NRCKGSIYLVFDFCEHDLAGLLSN-----VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI 150 (318)
T ss_dssp ---------------CEEEEEECCCEEHHHHHTC-----TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CCCC------CCCCCEEEEEEECCCCCCCCHHHH-----CCCCCCCHHHHHHHHHHHHHHHHHCCCCEEECCCCCHHEEE
T ss_conf 6544------445763899985357874101222-----03443308999999999999988522998856767222036
Q ss_pred ECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 24665789998099931587522444554323346799999765689864452533014589999923569999999999
Q 002738 707 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 786 (886)
Q Consensus 707 d~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~E 786 (886)
+.++ .+||+|||++..+....... .......+||+.|+|||++.+ ...++.++|||||||++||
T Consensus 151 ~~~~-------~~kl~dfg~~~~~~~~~~~~------~~~~~~~~gT~~Y~aPE~~~~---~~~~~~k~DiwSlGvil~e 214 (318)
T d3blha1 151 TRDG-------VLKLADFGLARAFSLAKNSQ------PNRYTNRVVTLWYRPPELLLG---ERDYGPPIDLWGAGCIMAE 214 (318)
T ss_dssp CTTS-------CEEECCCTTCEECCC-----------CCCCCSCCSCGGGCCHHHHTT---CSSCCTHHHHHHHHHHHHH
T ss_pred CCCC-------CEEEEECCEEEECCCCCCCC------CCCCCCEECCHHHHHHHHHCC---CCCCCCHHHCCCCCCEEEE
T ss_conf 6899-------68763135002235544432------113566024978742899707---9998917870067864661
Q ss_pred HHHCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCH----HHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 991999999999889999998088999506886411565200002599999961----4466299999999980111999
Q 002738 787 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE----AELETLSFLVDVFRRCTEENPT 862 (886)
Q Consensus 787 LLTGk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e----~~~~~s~~L~dLI~~CL~~DP~ 862 (886)
|++|+.||.+.++......+........++........................ ......+.+.+||.+||+.||.
T Consensus 215 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~ 294 (318)
T d3blha1 215 MWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 294 (318)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTT
T ss_pred HHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHH
T ss_conf 74487998998999999999984189982553443203444332013344555033404445998999999998738965
Q ss_pred CCCCHHHHHHHHHHHCCCCCC
Q ss_conf 999999999999800088999
Q 002738 863 ERPTAGDLYEMFVARTSSSIS 883 (886)
Q Consensus 863 kRPSasEIL~hL~~l~~~s~s 883 (886)
+|||++|+++|-+-...+-|+
T Consensus 295 ~R~sa~elL~Hpff~~~p~p~ 315 (318)
T d3blha1 295 QRIDSDDALNHDFFWSDPMPS 315 (318)
T ss_dssp TSCCHHHHHHSGGGSSSSCCC
T ss_pred HCCCHHHHHCCHHHCCCCCCC
T ss_conf 890999997495015699997
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.69 Aligned_cols=285 Identities=18% Similarity=0.219 Sum_probs=205.5
Q ss_pred CCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCC
Q ss_conf 9941642325349459999999--99129999993356899968887656749999999961799981225636854898
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~~~ 628 (886)
++|.+.++||+|+||+||+|.. ++..||+|++... . .....+ .+.+|+.+|+.|+||||+++++++.....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~-~~~~~~----~~~~Ei~il~~l~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF--E-HQTYCQ----RTLREIKILLRFRHENIIGINDIIRAPTI 80 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT--T-CHHHHH----HHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHH--C-CHHHHH----HHHHHHHHHHHCCCCCCCCEEEEEEECCC
T ss_conf 9859978994064809999999999949999998031--0-958999----99999999997689898858889950564
Q ss_pred CCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEEC
Q ss_conf 88899999766640899990259999999999872059976799999999999999999998589121479999788724
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILId~ 708 (886)
. ....+++++|+.+|+|.+++.. ..+++..++.++.||+.||.|||++|||||||||+|||++.
T Consensus 81 ~----------~~~~~~l~~~~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~ 144 (345)
T d1pmea_ 81 E----------QMKDVYLVTHLMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 144 (345)
T ss_dssp T----------TCCCEEEEEECCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred C----------CCCEEEEEEEECCCCHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECC
T ss_conf 5----------5414999996259865664405------89999999999999999999999789867778764378879
Q ss_pred CCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 66578999809993158752244455432334679999976568986445253301458999992356999999999999
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~ELL 788 (886)
++ .+||+|||+|.......... ......+||+.|+|||++.. ...++.++||||+||++++|+
T Consensus 145 ~~-------~~kl~DfG~a~~~~~~~~~~-------~~~~~~~gt~~y~aPE~l~~---~~~~~~~~DiwSlG~il~eml 207 (345)
T d1pmea_ 145 TC-------DLKICDFGLARVADPDHDHT-------GFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEML 207 (345)
T ss_dssp TC-------CEEECCCTTCEECCGGGCBC-------CTTCCCCSCGGGCCGGGTTT---BCSCSTHHHHHHHHHHHHHHH
T ss_pred CC-------CEEECCCCCEEECCCCCCCC-------EEECCCCCCCEECHHHHHHC---CCCCCCHHHHHCCCCEEHHHH
T ss_conf 99-------77875457056504777641-------01011026520003878604---788874101004670133776
Q ss_pred HCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCC-CCCCCCC--CCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 199999999988999999808899950688641156520-0002599--9999614466299999999980111999999
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH-EVAQSGS--GFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 789 TGk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~-~~~~~~~--~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRP 865 (886)
+|+.||.+.+............................. ....... ...........++.+.+|+.+||+.||.+||
T Consensus 208 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 287 (345)
T d1pmea_ 208 SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 287 (345)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred HCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCC
T ss_conf 69799788888999998765206997566423433222202446775577877783789999999999997648956790
Q ss_pred CHHHHHHHHH
Q ss_conf 9999999998
Q 002738 866 TAGDLYEMFV 875 (886)
Q Consensus 866 SasEIL~hL~ 875 (886)
|++++++|-.
T Consensus 288 ta~e~L~hpf 297 (345)
T d1pmea_ 288 EVEQALAHPY 297 (345)
T ss_dssp CHHHHHTSGG
T ss_pred CHHHHHCCHH
T ss_conf 8999861986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.70 Aligned_cols=282 Identities=17% Similarity=0.223 Sum_probs=213.2
Q ss_pred CCCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 89941642325349459999999--9912999999335689996888765674999999996179998122563685489
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~~ 627 (886)
.++|.+.++||+|+||+||+|.+ .+..||+|++.... ........ +.+|+.+++.++|||||++++++....
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~--~~~~~~~~----~~~Ei~il~~l~hpnIv~~~~~f~~~~ 89 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKR----AYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT--SSHHHHHH----HHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH--CCHHHHHH----HHHHHHHHHHCCCCCEEEEEEEEECCC
T ss_conf 377599889621758599999999999899999988233--69799999----999999998648987648998970256
Q ss_pred CCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEE
Q ss_conf 88889999976664089999025999999999987205997679999999999999999999858912147999978872
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILId 707 (886)
.. ......|+||||+.+ ++.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 90 ~~--------~~~~~~~iv~Ey~~~-~l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~ 153 (355)
T d2b1pa1 90 TL--------EEFQDVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 153 (355)
T ss_dssp ST--------TTCCEEEEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred CC--------CCCCEEEEEEECCCH-HHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCC
T ss_conf 43--------457626999841446-7787650-------3899999999999999999886522112456776321136
Q ss_pred CCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 46657899980999315875224445543233467999997656898644525330145899999235699999999999
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~EL 787 (886)
.++ .+|++|||+++....... .....||+.|+|||++.+ ..++.++||||+||++++|
T Consensus 154 ~~~-------~~kl~df~~~~~~~~~~~-----------~~~~~~t~~y~aPE~l~~----~~~~~~~DiwSlG~~l~el 211 (355)
T d2b1pa1 154 SDC-------TLKILDFGLARTAGTSFM-----------MTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGEM 211 (355)
T ss_dssp TTC-------CEEECCCCC--------------------------CCTTCCHHHHTT----CCCCTTHHHHHHHHHHHHH
T ss_pred CCC-------CEEEECHHHHHCCCCCCC-----------CCCCCCCCCCCCHHHHCC----CCCCCCCCCCCCCCHHHHH
T ss_conf 544-------313201023211466655-----------332214655558133147----7778774333566257898
Q ss_pred HHCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCC---------------CCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 9199999999988999999808899950688641156520---------------0002599999961446629999999
Q 002738 788 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH---------------EVAQSGSGFEKPEAELETLSFLVDV 852 (886)
Q Consensus 788 LTGk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~---------------~~~~~~~~~~~~e~~~~~s~~L~dL 852 (886)
++|+.||.+.+.......+........++.+...+..... .+..... ..........++.+.+|
T Consensus 212 l~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dl 290 (355)
T d2b1pa1 212 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLF-PADSEHNKLKASQARDL 290 (355)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGS-CCSSHHHHHHHHHHHHH
T ss_pred HHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCHHHHHH
T ss_conf 65989988897788999999720589879998765667777641754356664212643335-43210133379999999
Q ss_pred HHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf 998011199999999999999980
Q 002738 853 FRRCTEENPTERPTAGDLYEMFVA 876 (886)
Q Consensus 853 I~~CL~~DP~kRPSasEIL~hL~~ 876 (886)
+.+||..||.+||||+|+|+|.+-
T Consensus 291 l~~mL~~dP~~R~ta~elL~Hpw~ 314 (355)
T d2b1pa1 291 LSKMLVIDPAKRISVDDALQHPYI 314 (355)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred HHHHCCCCHHHCCCHHHHHCCCCC
T ss_conf 999876994579089999669420
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.80 Aligned_cols=282 Identities=20% Similarity=0.241 Sum_probs=209.5
Q ss_pred CCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCC
Q ss_conf 9941642325349459999999--99129999993356899968887656749999999961799981225636854898
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~~~ 628 (886)
++|++.+.||+|+||+||+|++ .+..||+|++. .........+. +.+|+.+|+.++|||||++++++.....
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~--~~~~~~~~~~~----~~~Ei~il~~l~h~~iv~~~~~~~~~~~ 91 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKR----TYRELRLLKHMKHENVIGLLDVFTPARS 91 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECS--CTTSSHHHHHH----HHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEC--CHHCCHHHHHH----HHHHHHHHHHCCCCCEEEEEEEEEECCC
T ss_conf 87188889831788399999999999799999988--20028689999----9999999986689874259999963464
Q ss_pred CCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEEC
Q ss_conf 88899999766640899990259999999999872059976799999999999999999998589121479999788724
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILId~ 708 (886)
. .....+++|+|+.+|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 92 ~---------~~~~~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~ 156 (348)
T d2gfsa1 92 L---------EEFNDVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 156 (348)
T ss_dssp T---------TTCCCCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred C---------CCCCEEEEEEEECCCCHHHHCCC------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCC
T ss_conf 5---------66864999996258862320022------45309999999999999999997388765166776334554
Q ss_pred CCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 66578999809993158752244455432334679999976568986445253301458999992356999999999999
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~ELL 788 (886)
++ .+|++|||+|....... ....||+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 157 ~~-------~~kl~dfg~a~~~~~~~-------------~~~~g~~~y~apE~~~~---~~~~~~~~DiwSlGv~l~~ll 213 (348)
T d2gfsa1 157 DC-------ELKILDFGLARHTDDEM-------------TGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAELL 213 (348)
T ss_dssp TC-------CEEECCC----CCTGGG-------------SSSCHHHHTSCHHHHTT---CSCCCTTHHHHHHHHHHHHHH
T ss_pred CC-------CCCCCCCCHHCCCCCCC-------------CCCCCCCCCCCCHHHCC---CCCCCCCCCHHHHHHHHHHHH
T ss_conf 32-------20013210001257544-------------44345435558355337---756785512432058999997
Q ss_pred HCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCC---CCHHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 1999999999889999998088999506886411565200002599999---9614466299999999980111999999
Q 002738 789 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE---KPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 789 TGk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~---~~e~~~~~s~~L~dLI~~CL~~DP~kRP 865 (886)
+|+.||.+.+.......+.........+..................... ........++.+.+||.+||..||.+||
T Consensus 214 ~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ 293 (348)
T d2gfsa1 214 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293 (348)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred HCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCC
T ss_conf 68899788988999999997307997577320010244544430355787555662678999999999997758834593
Q ss_pred CHHHHHHHHHH
Q ss_conf 99999999980
Q 002738 866 TAGDLYEMFVA 876 (886)
Q Consensus 866 SasEIL~hL~~ 876 (886)
|++|+|+|-+-
T Consensus 294 ta~elL~Hp~f 304 (348)
T d2gfsa1 294 TAAQALAHAYF 304 (348)
T ss_dssp CHHHHHTSGGG
T ss_pred CHHHHHCCHHH
T ss_conf 89998559954
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.53 Aligned_cols=250 Identities=22% Similarity=0.251 Sum_probs=195.8
Q ss_pred CCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCEEEEEEECC
Q ss_conf 9941642325349459999999--9912999999335689996888765674999999996179--99812256368548
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKISS 626 (886)
Q Consensus 551 ~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~--HPNIV~llG~~~~~ 626 (886)
++|++.+.||+|+||.||+|++ .+..||+|++.......... . ....++.+|+.+|++++ |||||++++++...
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~-~-~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-L-PNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEE-C-TTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHH-H-HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEEC
T ss_conf 83799679840878399999999999799999985688443345-5-679999999999997435898812799998309
Q ss_pred CCCCCCCCCCCCCCCEEEEEEECCCC-CCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEE
Q ss_conf 98888999997666408999902599-99999999872059976799999999999999999998589121479999788
Q 002738 627 KWLPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 627 ~~l~~~~~~~~~~~~~~~IVmEy~~g-GSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNIL 705 (886)
.. .++||||+.+ +++.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||
T Consensus 82 ~~--------------~~lv~e~~~~~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIl 142 (273)
T d1xwsa_ 82 DS--------------FVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENIL 142 (273)
T ss_dssp SE--------------EEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CE--------------EEEEEEECCCCCHHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEE
T ss_conf 96--------------89999833686228999861-----589999999999999999999998779755667611147
Q ss_pred EECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 72466578999809993158752244455432334679999976568986445253301458999992356999999999
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Id~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~ 785 (886)
++.+. ..+||+|||+|........ ....||+.|||||++.+ ...++.++|||||||+||
T Consensus 143 l~~~~------~~vkl~DFG~a~~~~~~~~------------~~~~GT~~y~aPE~~~~---~~~~~~~~DiwSlGvily 201 (273)
T d1xwsa_ 143 IDLNR------GELKLIDFGSGALLKDTVY------------TDFDGTRVYSPPEWIRY---HRYHGRSAAVWSLGILLY 201 (273)
T ss_dssp EETTT------TEEEECCCTTCEECCSSCB------------CCCCSCGGGSCHHHHHH---SCBCHHHHHHHHHHHHHH
T ss_pred EECCC------CEEEECCCCCCEECCCCCC------------CCCCCCCCCCCHHHHCC---CCCCCCCCCCCCCEEEEH
T ss_conf 74478------8489775465353244455------------66565877479999848---997886533255403453
Q ss_pred HHHHCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 99919999999998899999980889995068864115652000025999999614466299999999980111999999
Q 002738 786 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 786 ELLTGk~Pf~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRP 865 (886)
||++|+.||.+.+ .+.++.. .++. ..++.+.+||.+||..||.+||
T Consensus 202 ell~g~~Pf~~~~------~i~~~~~-~~~~---------------------------~~s~~~~~li~~~L~~dp~~R~ 247 (273)
T d1xwsa_ 202 DMVCGDIPFEHDE------EIIRGQV-FFRQ---------------------------RVSSECQHLIRWCLALRPSDRP 247 (273)
T ss_dssp HHHHSSCSCCSHH------HHHHCCC-CCSS---------------------------CCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHCCCCCCCCH------HHHHCCC-CCCC---------------------------CCCHHHHHHHHHHCCCCHHHCC
T ss_conf 6756889988736------7761544-7787---------------------------7999999999997608975893
Q ss_pred CHHHHHHHHHH
Q ss_conf 99999999980
Q 002738 866 TAGDLYEMFVA 876 (886)
Q Consensus 866 SasEIL~hL~~ 876 (886)
|++|+++|.+-
T Consensus 248 s~~eil~hp~~ 258 (273)
T d1xwsa_ 248 TFEEIQNHPWM 258 (273)
T ss_dssp CHHHHHTSGGG
T ss_pred CHHHHHCCHHH
T ss_conf 99998539866
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=331.98 Aligned_cols=264 Identities=16% Similarity=0.161 Sum_probs=198.4
Q ss_pred CCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCC
Q ss_conf 9941642325349459999999--99129999993356899968887656749999999961799981225636854898
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 628 (886)
Q Consensus 551 ~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~~~ 628 (886)
++|++.+.||+|+||.||+|++ .+..||+|+...+.. .. .+.+|+++++.++|+|+|..++.+.....
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~----~~~~E~~i~~~l~~~~~i~~~~~~~~~~~ 76 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HP----QLHIESKIYKMMQGGVGIPTIRWCGAEGD 76 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT------SC----CHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC------CH----HHHHHHHHHHHCCCCCCCCEEEEEEECCC
T ss_conf 889996898507880999999988998999999721005------88----89999999997038996017999995198
Q ss_pred CCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEEC
Q ss_conf 88899999766640899990259999999999872059976799999999999999999998589121479999788724
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 708 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILId~ 708 (886)
..++||||+. ++|...+.. ....+++..+..++.|++.||.|||+++|+||||||+|||++.
T Consensus 77 -------------~~~ivme~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~ 138 (299)
T d1ckia_ 77 -------------YNVMVMELLG-PSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGL 138 (299)
T ss_dssp -------------EEEEEEECCC-CBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECC
T ss_pred -------------EEEEEEEECC-CCHHHHHHH----CCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHCCCCC
T ss_conf -------------7789998738-713332443----0688768999999999999999999799442667876606433
Q ss_pred CCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 66578999809993158752244455432334679999976568986445253301458999992356999999999999
Q 002738 709 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 788 (886)
Q Consensus 709 d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~ELL 788 (886)
.+. ...+||+|||+|+.+........ .........+||+.|||||++.+ ..++.++|||||||++|||+
T Consensus 139 ~~~----~~~vkl~DFG~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~~l~el~ 207 (299)
T d1ckia_ 139 GKK----GNLVYIIDFGLAKKYRDARTHQH---IPYRENKNLTGTARYASINTHLG----IEQSRRDDLESLGYVLMYFN 207 (299)
T ss_dssp GGG----TTCEEECCCSSCEECBCTTTCCB---CCCCBCCSCCCCSSSCCHHHHTT----BCCCHHHHHHHHHHHHHHHH
T ss_pred CCC----CCEEEEECCCCCEECCCCCCCCC---EECCCCCCCCCCCCCCCHHHHHC----CCCCCHHHEEECCHHHHHHH
T ss_conf 577----76156504675134255445541---00013577678735329999918----99898321886177899998
Q ss_pred HCCCCCCCCCHHHHHHHHHCCC----CCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 1999999999889999998088----999506886411565200002599999961446629999999998011199999
Q 002738 789 TLQVPYMGLSELEIHDLIQMGK----RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 864 (886)
Q Consensus 789 TGk~Pf~g~s~~ei~~~I~~~~----rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kR 864 (886)
+|+.||.+.........+.+.. .++.+. .....++.+.+|+..||..+|.+|
T Consensus 208 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~p~~~~~li~~cl~~~p~~R 263 (299)
T d1ckia_ 208 LGSLPWQGLKAATKRQKYERISEKKMSTPIEV------------------------LCKGYPSEFATYLNFCRSLRFDDK 263 (299)
T ss_dssp HSSCTTCCCC-------HHHHHHHHHHSCHHH------------------------HTTTSCHHHHHHHHHHHHSCTTCC
T ss_pred HCCCCCCCCCHHHHHHHHHHHHCCCCCCCHHH------------------------HCCCCCHHHHHHHHHHCCCCHHHC
T ss_conf 49876655305779999998523567898357------------------------534788999999999843995579
Q ss_pred CCHHHHHHHHHHH
Q ss_conf 9999999999800
Q 002738 865 PTAGDLYEMFVAR 877 (886)
Q Consensus 865 PSasEIL~hL~~l 877 (886)
|++++|.+.|+.+
T Consensus 264 P~~~~i~~~l~~~ 276 (299)
T d1ckia_ 264 PDYSYLRQLFRNL 276 (299)
T ss_dssp CCHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHH
T ss_conf 1999999999999
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.28 Aligned_cols=282 Identities=19% Similarity=0.209 Sum_probs=209.6
Q ss_pred CCCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 89941642325349459999999--9912999999335689996888765674999999996179998122563685489
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 627 (886)
Q Consensus 550 ~~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG~~~~~~ 627 (886)
+++|++.++||+|+||+||+|++ ++..||+|++..... ...... ++.+|+.+|+.++|||||++++++....
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~--~~~~~~----~~~~E~~il~~l~h~niv~~~~~~~~~~ 74 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPS----SALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHH----HHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC--CHHHHH----HHHHHHHHHHHCCCCCEEEECCCCCCCC
T ss_conf 9997862697128681999999999996999999803217--868999----9999999998567578882135444443
Q ss_pred CCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEE
Q ss_conf 88889999976664089999025999999999987205997679999999999999999999858912147999978872
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILId 707 (886)
. .++|||++.+++|..++.. ...+++..+..++.|++.||+|||+++|+||||||+|||++
T Consensus 75 ~--------------~~iv~~~~~~~~l~~~~~~-----~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~ 135 (292)
T d1unla_ 75 K--------------LTLVFEFCDQDLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN 135 (292)
T ss_dssp E--------------EEEEEECCSEEHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred C--------------EEEEEEECCCCCCCCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCC
T ss_conf 1--------------1588630233222112123-----56540367899999999998774339986001467612113
Q ss_pred CCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 46657899980999315875224445543233467999997656898644525330145899999235699999999999
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~EL 787 (886)
.++ .+||+|||.|......... .....+++.|+|||++.. ...++.++|||||||++|||
T Consensus 136 ~~~-------~~kl~DFG~a~~~~~~~~~----------~~~~~~~~~~~~pe~~~~---~~~~~~~~DiwSlG~il~el 195 (292)
T d1unla_ 136 RNG-------ELKLANFGLARAFGIPVRC----------YSAEVVTLWYRPPDVLFG---AKLYSTSIDMWSAGCIFAEL 195 (292)
T ss_dssp TTC-------CEEECCCTTCEECCSCCSC----------CCSCCSCGGGCCHHHHTT---CSCCCTHHHHHHHHHHHHHH
T ss_pred CCC-------CEEEEECCHHHCCCCCCCC----------CEEECCCCCHHHHHHHCC---CCCCCCHHHCCCCCHHHHHH
T ss_conf 378-------2665204601104688751----------001034431014667506---98888044402654188998
Q ss_pred HHCCCCC-CCCCHHHHHHHHHCCCCCCCHHHHHHHCCCCCC-CCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 9199999-999988999999808899950688641156520-00025999999614466299999999980111999999
Q 002738 788 LTLQVPY-MGLSELEIHDLIQMGKRPRLTDELEALGSCHEH-EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 865 (886)
Q Consensus 788 LTGk~Pf-~g~s~~ei~~~I~~~~rp~L~e~l~~~~~~~~~-~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~kRP 865 (886)
++|+.|| .+.+..+....+.....+.....+......... ..................++.+.+|+.+||+.||.+||
T Consensus 196 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ 275 (292)
T d1unla_ 196 ANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275 (292)
T ss_dssp TTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred HHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCC
T ss_conf 51899998899999999999861189973551344322211334445443104330656899999999998649966890
Q ss_pred CHHHHHHHHHH
Q ss_conf 99999999980
Q 002738 866 TAGDLYEMFVA 876 (886)
Q Consensus 866 SasEIL~hL~~ 876 (886)
|++|+|+|-+-
T Consensus 276 sa~e~L~Hp~f 286 (292)
T d1unla_ 276 SAEEALQHPYF 286 (292)
T ss_dssp CHHHHTTSGGG
T ss_pred CHHHHHCCHHH
T ss_conf 99999649534
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=331.21 Aligned_cols=278 Identities=19% Similarity=0.200 Sum_probs=201.0
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEC
Q ss_conf 889941642325349459999999--9912999999335689996888765674999999996179-9981225636854
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 625 (886)
Q Consensus 549 ~~~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~-HPNIV~llG~~~~ 625 (886)
..++|++.++||+|+||+||+|+. .+..||+|++... ..+ ++.+|+.+|..++ ||||+++++++..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-------~~~----~~~~Ei~il~~l~~hpnIv~~~~~~~~ 101 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKK----KIKREIKILENLRGGPNIITLADIVKD 101 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-------CHH----HHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH-------HHH----HHHHHHHHHHHCCCCCCCCEEEEEEEE
T ss_conf 986718978983174819999998899979999998889-------999----999999999851579987679999981
Q ss_pred CCCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEE
Q ss_conf 89888899999766640899990259999999999872059976799999999999999999998589121479999788
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 705 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNIL 705 (886)
... ...++||||+.+++|..+. +.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 102 ~~~------------~~~~~v~e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NIL 161 (328)
T d3bqca1 102 PVS------------RTPALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 161 (328)
T ss_dssp TTT------------CSEEEEEECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CCC------------CCEEEEEEECCCCCHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEE
T ss_conf 687------------7126888631798589974--------68999999999999999998876433443456441237
Q ss_pred EECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 72466578999809993158752244455432334679999976568986445253301458999992356999999999
Q 002738 706 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 785 (886)
Q Consensus 706 Id~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~ 785 (886)
++.++ ..+||+|||+|........ ....+||+.|+|||.+.+ ...++.++||||+||+++
T Consensus 162 i~~~~------~~vkl~DFG~a~~~~~~~~-----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~~l~ 221 (328)
T d3bqca1 162 IDHEH------RKLRLIDWGLAEFYHPGQE-----------YNVRVASRYFKGPELLVD---YQMYDYSLDMWSLGCMLA 221 (328)
T ss_dssp EETTT------TEEEECCGGGCEECCTTCC-----------CCSCCSCGGGCCHHHHTT---CCCCCTHHHHHHHHHHHH
T ss_pred ECCCC------CEEEECCCCCCEECCCCCC-----------CCCCCCCCCCCCCCCCCC---CCCCCCCCCHHHHHHHHH
T ss_conf 74899------8366415654266468874-----------443224864247610268---888884523233545558
Q ss_pred HHHHCCCCCCCCC-HHHHHHHHHCCCCCCCHHHHHHHCCC-CCCCCCCCCC--------CCCCCHHHHHHHHHHHHHHHH
Q ss_conf 9991999999999-88999999808899950688641156-5200002599--------999961446629999999998
Q 002738 786 ELLTLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSC-HEHEVAQSGS--------GFEKPEAELETLSFLVDVFRR 855 (886)
Q Consensus 786 ELLTGk~Pf~g~s-~~ei~~~I~~~~rp~L~e~l~~~~~~-~~~~~~~~~~--------~~~~~e~~~~~s~~L~dLI~~ 855 (886)
||++|+.||.... .......+......+........... ....+..... ...........++.+.+||.+
T Consensus 222 e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~ 301 (328)
T d3bqca1 222 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301 (328)
T ss_dssp HHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHH
T ss_pred HHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHH
T ss_conf 76048899988760189999999987884155555422544474300000333433112115521124489999999999
Q ss_pred HCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 0111999999999999999800
Q 002738 856 CTEENPTERPTAGDLYEMFVAR 877 (886)
Q Consensus 856 CL~~DP~kRPSasEIL~hL~~l 877 (886)
||+.||.+|||++|+|+|..-.
T Consensus 302 mL~~dP~~R~ta~e~L~Hp~F~ 323 (328)
T d3bqca1 302 LLRYDHQSRLTAREAMEHPYFY 323 (328)
T ss_dssp HSCSSGGGSCCHHHHHTSGGGT
T ss_pred HCCCCHHHCCCHHHHHCCCCCC
T ss_conf 8669956890899996493558
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.01 Aligned_cols=260 Identities=22% Similarity=0.271 Sum_probs=203.5
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEE-----CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCC-CCCCEEEE
Q ss_conf 8889941642325349459999999-----99129999993356899968887656749999999961799-98122563
Q 002738 548 GSFPSLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-SCIVEMYG 621 (886)
Q Consensus 548 ~~~~~y~i~~~LG~GsfG~Vyka~~-----~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~H-PNIV~llG 621 (886)
..+++|.+.+.||+|+||.||+|.. .+..||+|++............+ .+.+|+.+|++++| |||+++++
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~----~~~~E~~il~~l~h~pnIv~~~~ 96 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTE----HTRTERQVLEHIRQSPFLVTLHY 96 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGG----GCCCHHHHHHHHHTCTTBCCEEE
T ss_pred CCHHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHH----HHHHHHHHHHHCCCCCEEEEEEE
T ss_conf 45102599989832878399999987658879489999983677210168999----99999999986467983999620
Q ss_pred EEECCCCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 68548988889999976664089999025999999999987205997679999999999999999999858912147999
Q 002738 622 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 701 (886)
Q Consensus 622 ~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKp 701 (886)
++..... .+++|||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++|+||||||
T Consensus 97 ~~~~~~~--------------~~~v~e~~~~~~L~~~i~~-----~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp 157 (322)
T d1vzoa_ 97 AFQTETK--------------LHLILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKL 157 (322)
T ss_dssp EEEETTE--------------EEEEECCCCSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred EECCCCC--------------EEEEEECCCCCHHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCC
T ss_conf 0024873--------------0012312341179999873-----04543788888899999999885149989654773
Q ss_pred CCEEEECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHH
Q ss_conf 97887246657899980999315875224445543233467999997656898644525330145899999235699999
Q 002738 702 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 781 (886)
Q Consensus 702 sNILId~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLG 781 (886)
+|||++.++ .+||+|||+|+.+....... .....|++.|+|||.+.+. ...++.++||||||
T Consensus 158 ~Nill~~~~-------~vkL~DFG~a~~~~~~~~~~---------~~~~~g~~~~~~pe~~~~~--~~~~~~ksDIWSlG 219 (322)
T d1vzoa_ 158 ENILLDSNG-------HVVLTDFGLSKEFVADETER---------AYDFCGTIEYMAPDIVRGG--DSGHDKAVDWWSLG 219 (322)
T ss_dssp GGEEECTTS-------CEEESCSSEEEECCGGGGGG---------GCGGGSCCTTCCHHHHTTC--C---CTHHHHHHHH
T ss_pred CCEEECCCC-------CEEEEECCCHHHHCCCCCCC---------CCCCCCCCCCCHHHHHHCC--CCCCCCHHHHHHHH
T ss_conf 201246999-------88874132022203444432---------2122233333106876057--76887132517777
Q ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHHCC---CCCCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCC
Q ss_conf 9999999199999999988999999808---8999506886411565200002599999961446629999999998011
Q 002738 782 CLLLELLTLQVPYMGLSELEIHDLIQMG---KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 858 (886)
Q Consensus 782 VIL~ELLTGk~Pf~g~s~~ei~~~I~~~---~rp~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~ 858 (886)
|+||||++|+.||.+.+.......+.+. ..+.++. ..++.+.+|+.+||.
T Consensus 220 ~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~---------------------------~~s~~~~~li~~~l~ 272 (322)
T d1vzoa_ 220 VLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ---------------------------EMSALAKDLIQRLLM 272 (322)
T ss_dssp HHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT---------------------------TSCHHHHHHHHHHTC
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC---------------------------CCCHHHHHHHHHHCC
T ss_conf 99999976899988887777999999833568998865---------------------------479999999999744
Q ss_pred CCCCCCC-----CHHHHHHHHH
Q ss_conf 1999999-----9999999998
Q 002738 859 ENPTERP-----TAGDLYEMFV 875 (886)
Q Consensus 859 ~DP~kRP-----SasEIL~hL~ 875 (886)
+||.+|| +++|+++|.+
T Consensus 273 ~dP~~R~s~~~~t~~eil~Hpf 294 (322)
T d1vzoa_ 273 KDPKKRLGCGPRDADEIKEHLF 294 (322)
T ss_dssp SSGGGSTTSSTTTHHHHHTSGG
T ss_pred CCHHHCCCCCCCCHHHHHCCHH
T ss_conf 5898819997450999974972
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=315.00 Aligned_cols=266 Identities=17% Similarity=0.185 Sum_probs=202.4
Q ss_pred CCCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCC-CCCCEEEEEEECCC
Q ss_conf 9941642325349459999999--99129999993356899968887656749999999961799-98122563685489
Q 002738 551 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-SCIVEMYGHKISSK 627 (886)
Q Consensus 551 ~~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~H-PNIV~llG~~~~~~ 627 (886)
.+|.+.+.||+|+||.||+|++ .+..+|+|+...... .. .+.+|++++..|+| +||+.+++++....
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~----~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 74 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------AP----QLRDEYRTYKLLAGCTGIPNVYYFGQEGL 74 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SC----CHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC------CH----HHHHHHHHHHHHCCCCCCCEEEEEEECCC
T ss_conf 806997998417882999999988997999999750258------29----99999999999648999877999960188
Q ss_pred CCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEE
Q ss_conf 88889999976664089999025999999999987205997679999999999999999999858912147999978872
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 707 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKpsNILId 707 (886)
..++||||+ +++|.+++.. ....+++..+..++.|++.||.|||++||+||||||+|||++
T Consensus 75 --------------~~~~vme~~-~~~l~~~~~~----~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~ 135 (293)
T d1csna_ 75 --------------HNVLVIDLL-GPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIG 135 (293)
T ss_dssp --------------EEEEEEECC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC
T ss_pred --------------CCEEEEEEC-CCCHHHHHHH----HCCCHHHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEC
T ss_conf --------------117999964-8887999975----203110689999999999999999977966266771315234
Q ss_pred CCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 46657899980999315875224445543233467999997656898644525330145899999235699999999999
Q 002738 708 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 787 (886)
Q Consensus 708 ~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsDVWSLGVIL~EL 787 (886)
.... .....+||+|||+|+.+......... ........+||+.|||||++.+ ..++.++||||||+++|||
T Consensus 136 ~~~~--~~~~~vkl~DFG~a~~~~~~~~~~~~---~~~~~~~~~GT~~y~aPE~~~~----~~~~~~~DiwSlG~~l~el 206 (293)
T d1csna_ 136 RPNS--KNANMIYVVDFGMVKFYRDPVTKQHI---PYREKKNLSGTARYMSINTHLG----REQSRRDDLEALGHVFMYF 206 (293)
T ss_dssp CSSS--TTTTCEEECCCTTCEESBCTTTCCBC---CCCCCCCCCSCTTTCCHHHHTT----CCCCHHHHHHHHHHHHHHH
T ss_pred CCCC--CCCCCEEECCCCEEEECCCCCCCCCE---EECCCCCEEECHHHCCHHHHCC----CCCCHHHHHHHHHHHHHHH
T ss_conf 7543--44795687236605771467665411---1024676277510267989648----8888699989831999999
Q ss_pred HHCCCCCCCCCH---HHHHHHHHCCCC-CCCHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 919999999998---899999980889-9950688641156520000259999996144662999999999801119999
Q 002738 788 LTLQVPYMGLSE---LEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 863 (886)
Q Consensus 788 LTGk~Pf~g~s~---~ei~~~I~~~~r-p~L~e~l~~~~~~~~~~~~~~~~~~~~~e~~~~~s~~L~dLI~~CL~~DP~k 863 (886)
++|+.||.+... ......+..... +..++. ....++.+.+|+..||..+|.+
T Consensus 207 ltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l------------------------~~~~p~~l~~ii~~~~~~~~~~ 262 (293)
T d1csna_ 207 LRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL------------------------CAGFPEEFYKYMHYARNLAFDA 262 (293)
T ss_dssp HHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH------------------------TTTSCHHHHHHHHHHHHCCTTC
T ss_pred HHCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHH------------------------CCCCCHHHHHHHHHHHCCCCCC
T ss_conf 8698767885302199999999705679995896------------------------5799899999999984399300
Q ss_pred CCCHHHHHHHHHHHC
Q ss_conf 999999999998000
Q 002738 864 RPTAGDLYEMFVART 878 (886)
Q Consensus 864 RPSasEIL~hL~~l~ 878 (886)
||+++.+.+.|..+.
T Consensus 263 rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 263 TPDYDYLQGLFSKVL 277 (293)
T ss_dssp CCCHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHH
T ss_conf 859999999999999
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-43 Score=287.32 Aligned_cols=283 Identities=19% Similarity=0.210 Sum_probs=191.4
Q ss_pred CCEEEEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----------CCCCCE
Q ss_conf 941642325349459999999--9912999999335689996888765674999999996179-----------998122
Q 002738 552 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-----------HSCIVE 618 (886)
Q Consensus 552 ~y~i~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~-----------HPNIV~ 618 (886)
+|.+.++||+|+||+||+|+. .+..||+|++... .... ..+.+|+.+++.++ |+||++
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-----~~~~----~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~ 84 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYT----EAAEDEIKLLQRVNDADNTKEDSMGANHILK 84 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHH----HHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred CEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECC-----CCCH----HHHHHHHHHHHHHCCHHHHHHHHCCCCCEEE
T ss_conf 579989975077818999999999979999998343-----1336----8999999999984014555554227676478
Q ss_pred EEEEEECCCCCCCCCCCCCCCCCEEEEEEECCCCC-CHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCC
Q ss_conf 56368548988889999976664089999025999-99999998720599767999999999999999999985-89121
Q 002738 619 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG-SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMH 696 (886)
Q Consensus 619 llG~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gG-SL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs-~gIVH 696 (886)
+++++..... ...+++|+++..+ ........ .....+++..+..++.||+.||.|||+ .||+|
T Consensus 85 ~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvH 149 (362)
T d1q8ya_ 85 LLDHFNHKGP------------NGVHVVMVFEVLGENLLALIKK---YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIH 149 (362)
T ss_dssp CCEEEEEEET------------TEEEEEEEECCCCEEHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEEC
T ss_pred EEEEEEECCC------------CCEEEEEEECCCCCCCCCCCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 9987631256------------5202343200035420000012---234678689999999999999888764058646
Q ss_pred CCCCCCCEEEECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCHHH
Q ss_conf 47999978872466578999809993158752244455432334679999976568986445253301458999992356
Q 002738 697 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 776 (886)
Q Consensus 697 RDLKpsNILId~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~~s~KsD 776 (886)
|||||+|||++.++.. .....++++|||.|....... ...+||+.|+|||++.. ..++.++|
T Consensus 150 rDlKp~NIll~~~~~~-~~~~~~kl~dfg~s~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~D 211 (362)
T d1q8ya_ 150 TDIKPENVLMEIVDSP-ENLIQIKIADLGNACWYDEHY-------------TNSIQTREYRSPEVLLG----APWGCGAD 211 (362)
T ss_dssp SCCSGGGEEEEEEETT-TTEEEEEECCCTTCEETTBCC-------------CSCCSCGGGCCHHHHHT----CCCCTHHH
T ss_pred CCCCHHHEEEECCCCC-CCCCEEEEEECCCCCCCCCCC-------------CCCCCCCCCCCHHHCCC----CCCCCCCC
T ss_conf 5677057056305765-644305675314421234454-------------22366521057132146----67776432
Q ss_pred HHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHCCCCCCCHHHHHHHCCCCCCCC-----CCCCCCCC--------
Q ss_conf 999999999999199999999988------99999980889995068864115652000-----02599999--------
Q 002738 777 IWSYGCLLLELLTLQVPYMGLSEL------EIHDLIQMGKRPRLTDELEALGSCHEHEV-----AQSGSGFE-------- 837 (886)
Q Consensus 777 VWSLGVIL~ELLTGk~Pf~g~s~~------ei~~~I~~~~rp~L~e~l~~~~~~~~~~~-----~~~~~~~~-------- 837 (886)
|||+||++++|++|+.||...... ........... ..+.............+ ........
T Consensus 212 iwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (362)
T d1q8ya_ 212 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG-ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL 290 (362)
T ss_dssp HHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHC-SCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHH
T ss_pred CCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHC
T ss_conf 01237899999878899898755432102689999999837-99878862453220001320122024323577644421
Q ss_pred --CCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf --9614466299999999980111999999999999999800
Q 002738 838 --KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 877 (886)
Q Consensus 838 --~~e~~~~~s~~L~dLI~~CL~~DP~kRPSasEIL~hL~~l 877 (886)
........++.+.+|+.+||..||.+|||++|+|+|-.-.
T Consensus 291 ~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~ 332 (362)
T d1q8ya_ 291 TEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK 332 (362)
T ss_dssp HHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGT
T ss_pred CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCC
T ss_conf 000156743589999999998779945790899996693407
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=1.9e-24 Score=168.70 Aligned_cols=172 Identities=18% Similarity=0.170 Sum_probs=120.5
Q ss_pred CEEEEEECCCCCEEEEEEEE-CCEEEEEEEEECCCCCCC----------HHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
Q ss_conf 41642325349459999999-991299999933568999----------6888765674999999996179998122563
Q 002738 553 LSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSS----------ADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 621 (886)
Q Consensus 553 y~i~~~LG~GsfG~Vyka~~-~~~~VAVKI~~lk~~~~~----------~~~~k~f~~~~~rEV~IL~~L~HPNIV~llG 621 (886)
+.+.++||+|+||.||+|.. ++..||+|+.+....... ............+|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred CHHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf 02277802485659999997999999999986044346665565630008889999997789999999816999144998
Q ss_pred EEECCCCCCCCCCCCCCCCCEEEEEEECCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 68548988889999976664089999025999999999987205997679999999999999999999858912147999
Q 002738 622 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 701 (886)
Q Consensus 622 ~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~~~~k~~~~~ls~~~~l~Ia~qIa~gL~YLHs~gIVHRDLKp 701 (886)
... .+++|||+++..+. .++...+..++.|++.+|.|||++||+||||||
T Consensus 82 ~~~------------------~~lvme~~~~~~~~------------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP 131 (191)
T d1zara2 82 WEG------------------NAVLMELIDAKELY------------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQ 131 (191)
T ss_dssp EET------------------TEEEEECCCCEEGG------------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCST
T ss_pred ECC------------------CEEEEEEECCCCCC------------CHHHHHHHHHHHHHHHHHHHHHHCCEEECCCCH
T ss_conf 628------------------88999950456542------------001578999999999999998268889836890
Q ss_pred CCEEEECCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------HHHHHCCCCCCCCCCHH
Q ss_conf 978872466578999809993158752244455432334679999976568986445------25330145899999235
Q 002738 702 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA------PEVLRAMHKPNLYGLEV 775 (886)
Q Consensus 702 sNILId~d~~~~~~~~~VKLsDFGLA~~~~~~~~t~~~s~~~~~~~~~~vGT~~YmA------PEvL~~~~~~~~~s~Ks 775 (886)
+|||++.+ .++|+|||.|+....... ..|.. .+.+. ..|+.++
T Consensus 132 ~NILv~~~--------~~~liDFG~a~~~~~~~~------------------~~~l~rd~~~~~~~f~-----r~y~~~~ 180 (191)
T d1zara2 132 YNVLVSEE--------GIWIIDFPQSVEVGEEGW------------------REILERDVRNIITYFS-----RTYRTEK 180 (191)
T ss_dssp TSEEEETT--------EEEECCCTTCEETTSTTH------------------HHHHHHHHHHHHHHHH-----HHHCCCC
T ss_pred HHEEEECC--------CEEEEECCCCCCCCCCCC------------------HHHHHHHHHHHHHHHC-----CCCCCCC
T ss_conf 36114289--------899987788430899870------------------9999877999999975-----7899844
Q ss_pred HHHHHHHHHH
Q ss_conf 6999999999
Q 002738 776 DIWSYGCLLL 785 (886)
Q Consensus 776 DVWSLGVIL~ 785 (886)
|+||..--+.
T Consensus 181 d~~s~~~~~~ 190 (191)
T d1zara2 181 DINSAIDRIL 190 (191)
T ss_dssp CHHHHHHHHH
T ss_pred CHHHHHHHHH
T ss_conf 6899999874
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.43 E-value=2.8e-06 Score=54.32 Aligned_cols=150 Identities=14% Similarity=0.121 Sum_probs=82.6
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEECCCC
Q ss_conf 899416423253494599999999912999999335689996888765674999999996179-9981225636854898
Q 002738 550 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 628 (886)
Q Consensus 550 ~~~y~i~~~LG~GsfG~Vyka~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~-HPNIV~llG~~~~~~~ 628 (886)
+..|+..+..+.++...||+....+..+.+|+........ . ..+.+|+.++..|. +-.+.+++.+....+
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~-~-------~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~- 83 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT-T-------YDVEREKDMMLWLEGKLPVPKVLHFERHDG- 83 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS-T-------TCHHHHHHHHHHHTTTSCCCCEEEEEEETT-
T ss_pred HHCEEEEECCCCCCCCCEEEEEECCCEEEEEECCCCCCCC-H-------HHHHHHHHHHHHHHCCCCCCCEEEEEECCC-
T ss_conf 1352799767899877189999089869999848876532-5-------569999999998760699872899975089-
Q ss_pred CCCCCCCCCCCCCEEEEEEECCCCCCHHHHHH-----------------HHHCCCCC--C--CCHHHHHHHH--------
Q ss_conf 88899999766640899990259999999999-----------------87205997--6--7999999999--------
Q 002738 629 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE-----------------KLSETGEK--H--VSVKLALFIA-------- 679 (886)
Q Consensus 629 l~~~~~~~~~~~~~~~IVmEy~~gGSL~d~L~-----------------~~~k~~~~--~--ls~~~~l~Ia-------- 679 (886)
..++||++++|.++..... ..-..... + ..........
T Consensus 84 -------------~~~lv~~~l~G~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (263)
T d1j7la_ 84 -------------WSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL 150 (263)
T ss_dssp -------------EEEEEEECCSSEEHHHHTTTCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred -------------CEEEEEEECCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHH
T ss_conf -------------6499998604334354334402699999989999999855684214357644656555778998776
Q ss_pred --------------HHHHHHHHHHHHC------CCCCCCCCCCCEEEECCCCCCCCCCEEEEEECCCCC
Q ss_conf --------------9999999999858------912147999978872466578999809993158752
Q 002738 680 --------------QDVAAALVELHSK------HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 728 (886)
Q Consensus 680 --------------~qIa~gL~YLHs~------gIVHRDLKpsNILId~d~~~~~~~~~VKLsDFGLA~ 728 (886)
..+......+... .++|+|+.+.|||++.++ .+.|+||+.+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~-------~~~lIDwe~a~ 212 (263)
T d1j7la_ 151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-------VSGFIDLGRSG 212 (263)
T ss_dssp SCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTE-------EEEECCCTTCE
T ss_pred HHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCC-------EEEEEECHHCC
T ss_conf 555543033232005799999999844986781789860047642364996-------59996023144
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.97 E-value=1.7e-05 Score=49.50 Aligned_cols=82 Identities=12% Similarity=-0.028 Sum_probs=45.1
Q ss_pred EEEECCCCCEEEEEEEE--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCC-C--CCCCEEEEEEECCCCCC
Q ss_conf 42325349459999999--9912999999335689996888765674999999996179-9--98122563685489888
Q 002738 556 CDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-H--SCIVEMYGHKISSKWLP 630 (886)
Q Consensus 556 ~~~LG~GsfG~Vyka~~--~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~-H--PNIV~llG~~~~~~~l~ 630 (886)
.+.||.|....||++.. ++..+++|.-.......+.. ......+...|.+.|..+. + ..+.+++.+....
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~-~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~~---- 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGES-WPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEM---- 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CC-CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTT----
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCC-CCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEECCCC----
T ss_conf 998079852768999957998489996177130346777-888778999999999986505798855289985988----
Q ss_pred CCCCCCCCCCCEEEEEEECCCCCC
Q ss_conf 899999766640899990259999
Q 002738 631 SADGNPEHHLLQSAIFMEYVKGGS 654 (886)
Q Consensus 631 ~~~~~~~~~~~~~~IVmEy~~gGS 654 (886)
.++|||++.+..
T Consensus 106 ------------~~lvmE~L~~~~ 117 (392)
T d2pula1 106 ------------AVTVMEDLSHLK 117 (392)
T ss_dssp ------------TEEEECCCTTSE
T ss_pred ------------CEEEEECCCCCC
T ss_conf ------------779871357765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.61 E-value=0.00037 Score=40.99 Aligned_cols=144 Identities=15% Similarity=0.108 Sum_probs=75.8
Q ss_pred CCEEEEEECCCCC-EEEEEEEEC-CEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCEEEEEEECCC
Q ss_conf 9416423253494-599999999-912999999335689996888765674999999996179--998122563685489
Q 002738 552 SLSSCDEAGKSVS-SSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKISSK 627 (886)
Q Consensus 552 ~y~i~~~LG~Gsf-G~Vyka~~~-~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~--HPNIV~llG~~~~~~ 627 (886)
.+... .+..|.. ..||+.... +..+.+|+..... . . .+..|++++..|. .-.+.+++++.....
T Consensus 12 g~~~~-~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~-----~----~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~ 79 (255)
T d1nd4a_ 12 GYDWA-QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--L-----N----ELQDEAARLSWLATTGVPCAAVLDVVTEAG 79 (255)
T ss_dssp TCEEE-ECSCTTSSCEEEEEECTTSCCEEEEEECSCT--T-----S----CHHHHHHHHHHHHTTTCCBCCEEEEEECSS
T ss_pred CCCEE-ECCCCCCCCEEEEEEECCCCEEEEEECCCCC--H-----H----HHHHHHHHHHHHHHCCCCCCCEEEECCCCC
T ss_conf 98358-7678654775899993898789999589667--7-----6----899999999999865999886132224566
Q ss_pred CCCCCCCCCCCCCCEEEEEEECCCCCCHH--------------HHHHHHHC----CCCCCCCHHHHHH-----H------
Q ss_conf 88889999976664089999025999999--------------99998720----5997679999999-----9------
Q 002738 628 WLPSADGNPEHHLLQSAIFMEYVKGGSVK--------------NYIEKLSE----TGEKHVSVKLALF-----I------ 678 (886)
Q Consensus 628 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~--------------d~L~~~~k----~~~~~ls~~~~l~-----I------ 678 (886)
..++||++++|.++. ..+...-. ............. +
T Consensus 80 --------------~~~~v~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (255)
T d1nd4a_ 80 --------------RDWLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVD 145 (255)
T ss_dssp --------------CEEEEEECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCC
T ss_pred --------------CEEEEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHC
T ss_conf --------------159998744135543221268999999999999873688544887554124688999999875411
Q ss_pred ---------HHHHHHHHHHHHHC-------CCCCCCCCCCCEEEECCCCCCCCCCEEEEEECCCCC
Q ss_conf ---------99999999999858-------912147999978872466578999809993158752
Q 002738 679 ---------AQDVAAALVELHSK-------HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 728 (886)
Q Consensus 679 ---------a~qIa~gL~YLHs~-------gIVHRDLKpsNILId~d~~~~~~~~~VKLsDFGLA~ 728 (886)
.......+..+... .++|+|+.+.|||++.+. .+-|+||+.+.
T Consensus 146 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~-------~~~iID~~~~~ 204 (255)
T d1nd4a_ 146 QDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR-------FSGFIDCGRLG 204 (255)
T ss_dssp TTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE-------EEEECCCTTCE
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCCEEEECCC-------EEEEEECHHCC
T ss_conf 011340112137999999998718765795678678887635773796-------58999853326
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.78 E-value=0.0054 Score=33.72 Aligned_cols=138 Identities=13% Similarity=0.116 Sum_probs=66.9
Q ss_pred CEEEEEEEE-CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCC--CEEEEEEECCCCCCCCCCCCCCCC
Q ss_conf 459999999-99129999993356899968887656749999999961799981--225636854898888999997666
Q 002738 564 SSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI--VEMYGHKISSKWLPSADGNPEHHL 640 (886)
Q Consensus 564 fG~Vyka~~-~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNI--V~llG~~~~~~~l~~~~~~~~~~~ 640 (886)
--.||++.. .+..+++|+.+.. ..+. ++ +..|...+..|....| +..+. . .++..-...
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~--~~s~---~~----i~~E~~~l~~L~~~gipv~~p~~--~-------~g~~~~~~~ 96 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE--RWTA---DQ----ILEEHQFALQLVNDEVPVAAPVA--F-------NGQTLLNHQ 96 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT--TSCH---HH----HHHHHHHHHHHHHTTCSBCCCCC--B-------TTBSCEEET
T ss_pred CCEEEEEECCCCCEEEEEEECCC--CCCH---HH----HHHHHHHHHHHHHCCCCCCCCEE--C-------CCCEEEEEE
T ss_conf 20269998389997999984787--7889---99----99999999999855998787520--6-------898056653
Q ss_pred CEEEEEEECCCCCC-----HHH------HH---HHHHC----CCCCCCCHH-------------------HHHHHHHHHH
Q ss_conf 40899990259999-----999------99---98720----599767999-------------------9999999999
Q 002738 641 LQSAIFMEYVKGGS-----VKN------YI---EKLSE----TGEKHVSVK-------------------LALFIAQDVA 683 (886)
Q Consensus 641 ~~~~IVmEy~~gGS-----L~d------~L---~~~~k----~~~~~ls~~-------------------~~l~Ia~qIa 683 (886)
...+.++++++|.. ... .+ +.... .....+... ....+...+.
T Consensus 97 ~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (325)
T d1zyla1 97 GFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATD 176 (325)
T ss_dssp TEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHH
T ss_pred EEEEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHH
T ss_conf 47999986527768899999999998999999886303578655677897887665689998747699889899999999
Q ss_pred HHHHHHHH-------CCCCCCCCCCCCEEEECCCCCCCCCCEEEEEECCCCC
Q ss_conf 99999985-------8912147999978872466578999809993158752
Q 002738 684 AALVELHS-------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 728 (886)
Q Consensus 684 ~gL~YLHs-------~gIVHRDLKpsNILId~d~~~~~~~~~VKLsDFGLA~ 728 (886)
..++.+.. .++||+|+.+.|||++.+ ..++||+-+.
T Consensus 177 ~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~---------~~~IDFdd~~ 219 (325)
T d1zyla1 177 ELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG---------PMFVDLDDAR 219 (325)
T ss_dssp HHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS---------EEECCCTTCC
T ss_pred HHHHHHHHHCCCCCCCEEECCCCCCCCEEEECC---------CEEEECHHCC
T ss_conf 999999984545687120247888042878389---------3588652014
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.58 E-value=0.016 Score=30.76 Aligned_cols=71 Identities=15% Similarity=0.269 Sum_probs=43.3
Q ss_pred EEEECCCCCEEEEEEEECC---------EEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCC-CEEEEEEEC
Q ss_conf 4232534945999999999---------129999993356899968887656749999999961799981-225636854
Q 002738 556 CDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI-VEMYGHKIS 625 (886)
Q Consensus 556 ~~~LG~GsfG~Vyka~~~~---------~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNI-V~llG~~~~ 625 (886)
.+.|+.|-.-.+|++.... ..+.+.+.. . ...... ..+|..+++.+.-.++ .++++.+.
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~--~~~~id-------r~~E~~i~~~ls~~gl~Pkll~~~~- 115 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N--PETESH-------LVAESVIFTLLSERHLGPKLYGIFS- 115 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S--CCCHHH-------HHHHHHHHHHHHHTTSSSCEEEEET-
T ss_pred EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-C--CCHHHH-------HHHHHHHHHHHHHCCCCCEEEEECC-
T ss_conf 9991785334348999688775445789817999659-9--611658-------9999999999975799980899818-
Q ss_pred CCCCCCCCCCCCCCCCEEEEEEECCCCCC
Q ss_conf 89888899999766640899990259999
Q 002738 626 SKWLPSADGNPEHHLLQSAIFMEYVKGGS 654 (886)
Q Consensus 626 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGS 654 (886)
+ ++||||++|..
T Consensus 116 -~----------------g~I~efi~g~~ 127 (395)
T d1nw1a_ 116 -G----------------GRLEEYIPSRP 127 (395)
T ss_dssp -T----------------EEEECCCCEEE
T ss_pred -C----------------CEEEEEECCCC
T ss_conf -9----------------56999734554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.58 E-value=0.017 Score=30.59 Aligned_cols=154 Identities=16% Similarity=0.121 Sum_probs=76.0
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEECCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCC--EEEEEEECC
Q ss_conf 889941642325349459999999991299999933568999688876567499999999617999812--256368548
Q 002738 549 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV--EMYGHKISS 626 (886)
Q Consensus 549 ~~~~y~i~~~LG~GsfG~Vyka~~~~~~VAVKI~~lk~~~~~~~~~k~f~~~~~rEV~IL~~L~HPNIV--~llG~~~~~ 626 (886)
.+..+.-.+.|..|.--+.|+....+..+++|++.... ... . +..|+.+|..|...++. ..+
T Consensus 16 ~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~---~~~---~----l~~~~~~l~~L~~~g~pvp~pi------ 79 (316)
T d2ppqa1 16 DVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV---EKN---D----LPFFLGLMQHLAAKGLSCPLPL------ 79 (316)
T ss_dssp CCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC------CC---H----HHHHHHHHHHHHHTTCCCCCBC------
T ss_pred CCCCCEEEECCCCCCCCCEEEEEECCCCEEEEECCCCC---CHH---H----HHHHHHHHHHHHHCCCCCCCCC------
T ss_conf 99985685237888526738999789728999807899---988---9----9999999875430255545564------
Q ss_pred CCCCCCCCCC-CCCCCEEEEEEECCCCCCH-----------HHHH---HHHHCC----CCCCCCHH--------------
Q ss_conf 9888899999-7666408999902599999-----------9999---987205----99767999--------------
Q 002738 627 KWLPSADGNP-EHHLLQSAIFMEYVKGGSV-----------KNYI---EKLSET----GEKHVSVK-------------- 673 (886)
Q Consensus 627 ~~l~~~~~~~-~~~~~~~~IVmEy~~gGSL-----------~d~L---~~~~k~----~~~~ls~~-------------- 673 (886)
...+|.. ..-....+.++.+..+... ...+ +..... ........
T Consensus 80 ---~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (316)
T d2ppqa1 80 ---PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD 156 (316)
T ss_dssp ---CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred ---EECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHH
T ss_conf ---10489762134125502453114655333204678888899876454443202453101110120024567777653
Q ss_pred ----HHHHHHHHHHHHHHHHHH----CCCCCCCCCCCCEEEECCCCCCCCCCEEEEEECCCCC
Q ss_conf ----999999999999999985----8912147999978872466578999809993158752
Q 002738 674 ----LALFIAQDVAAALVELHS----KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 728 (886)
Q Consensus 674 ----~~l~Ia~qIa~gL~YLHs----~gIVHRDLKpsNILId~d~~~~~~~~~VKLsDFGLA~ 728 (886)
.....+..+...+...+. .|+||+|+.+.|||++.+. ..-++||+.+.
T Consensus 157 ~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~-------v~gvIDF~~~~ 212 (316)
T d2ppqa1 157 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDE-------LSGLIDFYFAC 212 (316)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTE-------EEEECCCTTCE
T ss_pred HCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCC-------CEEEECCCCCC
T ss_conf 114127999999987642048554545033378636564020454-------12674222123
|
| >d2f4ma1 d.3.1.4 (A:164-450) Peptide:N-glycanase 1, PNG1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Cysteine proteinases superfamily: Cysteine proteinases family: Transglutaminase core domain: Peptide:N-glycanase 1, PNG1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=91.38 E-value=0.052 Score=27.50 Aligned_cols=54 Identities=22% Similarity=0.562 Sum_probs=44.5
Q ss_pred CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCEEEEEECCCEEEEEECCCC
Q ss_conf 4002457778999998620169985542122222557888630378738932899741127
Q 002738 447 SVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACR 507 (886)
Q Consensus 447 ~l~~GlcrHRAlLfK~LaD~~~~~lpCrLvrG~~~c~~~a~nsilVr~G~~~~~~lvD~~~ 507 (886)
.-..|.|.+=|.+|-.+|-.+| +|+|+|.|. ..|+|.++-......| ..+|.|.
T Consensus 137 ~tr~G~C~e~a~~~~~~~Ra~g--~~aR~v~~~---~~H~W~Ev~~~~~~rW--v~vDp~~ 190 (287)
T d2f4ma1 137 ETRCGRCGEWANCFTLCCRALG--FEARYVWDY---TDHVWTEVYSPSQQRW--LHCDACE 190 (287)
T ss_dssp HHCEESHHHHHHHHHHHHHHTT--CCEEEEEET---TTEEEEEEEETTTTEE--EEEETTT
T ss_pred HHCCCCHHHHHHHHHHHHHHCC--CCEEEEECC---CCCEEEEEEECCCCCE--EEECCCC
T ss_conf 8568358999999999999849--973898057---7636678873687817--8864700
|